Citrus Sinensis ID: 046598
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 986 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.966 | 0.943 | 0.451 | 0.0 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.959 | 0.917 | 0.457 | 0.0 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.972 | 0.935 | 0.463 | 0.0 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.894 | 0.751 | 0.352 | 1e-132 | |
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.834 | 0.839 | 0.350 | 1e-126 | |
| Q9LP24 | 1120 | Probable leucine-rich rep | no | no | 0.892 | 0.785 | 0.327 | 1e-124 | |
| P93194 | 1109 | Receptor-like protein kin | N/A | no | 0.962 | 0.855 | 0.310 | 1e-122 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.926 | 0.829 | 0.317 | 1e-121 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.937 | 0.822 | 0.317 | 1e-121 | |
| Q9M0G7 | 1013 | Leucine-rich repeat recep | no | no | 0.921 | 0.897 | 0.324 | 1e-118 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 795 bits (2053), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 445/985 (45%), Positives = 616/985 (62%), Gaps = 32/985 (3%)
Query: 18 NETDRLALLELKSKITHDPLGVLASWNESSHFCQWRGVTCSRRHQRVTILDLESLKLAGS 77
+ETDR ALL+ KS+++ D VL+SWN S C W+GVTC R+++RVT L+L L+L G
Sbjct: 22 DETDRQALLQFKSQVSEDKRVVLSSWNHSFPLCNWKGVTCGRKNKRVTHLELGRLQLGGV 81
Query: 78 ISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLI 137
ISP +GNLSFL L LY N F IP E +L RL+ L + N + G IP + +CS L+
Sbjct: 82 ISPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCSRLL 141
Query: 138 QLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGS 197
LRL N+L G +PSEL SL+ + +++ NN+ G +P+SLGNL+ + L LS NNLEG
Sbjct: 142 NLRLDSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNLEGE 201
Query: 198 IPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNL 257
IP + L + +L + N SG P +++N+SS+ G N G + D G L NL
Sbjct: 202 IPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPNL 261
Query: 258 QFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSR 317
F++G N TG+IP T+SN S LE + N LTG+ P + L + + NSLGS
Sbjct: 262 LSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIPTFGNVPNLKLLFLHTNSLGSD 321
Query: 318 GDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAI 377
RDL FL SLTN T+L+ L I N GG LP I+NLS L L L I G+IP I
Sbjct: 322 SSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIPYDI 381
Query: 378 GKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLF-ILYLS 436
G +NLQ+L + N LSG +P ++G+L NL+ L L NR G IP IGN+ + L LS
Sbjct: 382 GNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDLS 441
Query: 437 YNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSE 496
N +G +P+SLG L + + +N L GTIP + + + L+ LD+S N L GS+P +
Sbjct: 442 NNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKI-QQLLRLDMSGNSLIGSLPQD 500
Query: 497 VGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDL 556
+G L+NL L++ NKL G++P TLG+C+ +E L ++ N G IP L L G+ +DL
Sbjct: 501 IGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIP-DLKGLVGVKEVDL 559
Query: 557 SQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQGVFKNASITSVFGNLKLCGGIPEF 616
S N+LSG IPE ++ LNLS N+LEG VP +G+F+NA+ S+ GN LCGGI F
Sbjct: 560 SNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMGF 619
Query: 617 QLPTCSSKKSKHKKSLALKLVLAIISGLIGLSLALSI----IVLCLVRKRKEKQNPNSPI 672
QL C S+ K + +L +I +G++L L + + L +RKRK+ + N+P
Sbjct: 620 QLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKETNNPT 679
Query: 673 NS-----FPNISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHG 727
S ISY +L NAT+ FSS N +G GSFG+V+K +L + +AVKV N+ G
Sbjct: 680 PSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRG 739
Query: 728 AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITRE 787
A KSF+AEC +LK+IRHRNLVK+LTACS +D+QGN+F+AL++EFM N SL+ WLHP E
Sbjct: 740 AMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVE 799
Query: 788 DETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDF 847
E R+L L++RLNI+IDVA L+YLH C PIAHCDLKPSN+LLD+D+ AH+ DF
Sbjct: 800 -EIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDF 858
Query: 848 GLARFLPLSSA-----QTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRK 902
GLAR L Q SS G +G+IGY APEYG+G + SI+GDVYS+GILLLE+ T K
Sbjct: 859 GLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTGK 918
Query: 903 KPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVK-SRIEC 961
+PT+ +F G+ L++ ++ALP+ ++DIVD ++L+ G RV +EC
Sbjct: 919 RPTNELFGGNFTLNSYTKSALPERILDIVDESILHIG-------------LRVGFPVVEC 965
Query: 962 LISMVRIGVACSMESPEDRMSMTNV 986
L + +G+ C ESP +R++ + V
Sbjct: 966 LTMVFEVGLRCCEESPMNRLATSIV 990
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 764 bits (1973), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 453/991 (45%), Positives = 600/991 (60%), Gaps = 45/991 (4%)
Query: 10 VTASTVAGNETDRLALLELKSKIT-HDPLGVLASWNESSHFCQWRGVTCSRRHQRVTILD 68
+ A NETD ALLE KS+++ ++ VLASWN SS FC W GVTC RR +RV L+
Sbjct: 20 IFAQARFSNETDMQALLEFKSQVSENNKREVLASWNHSSPFCNWIGVTCGRRRERVISLN 79
Query: 69 LESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPA 128
L KL G ISP +GNLSFL++L L +NSF IP + RL RLQ L + YN + G IP+
Sbjct: 80 LGGFKLTGVISPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSYNLLEGRIPS 139
Query: 129 NISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLF 188
++S+CS L + L N L +PSEL SLSK+ + ++ NNLTG+ P+SLGNL+S++ L
Sbjct: 140 SLSNCSRLSTVDLSSNHLGHGVPSELGSLSKLAILDLSKNNLTGNFPASLGNLTSLQKLD 199
Query: 189 LSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPL 248
+ N + G IPD + L +V +A N SG P +++NISS+ N G +
Sbjct: 200 FAYNQMRGEIPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRA 259
Query: 249 DYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPY-LEKLQRLLVF 307
D+G+ L NL+ +G NQ TGAIP T++N S+LE F S N L+G+ P KL+ L
Sbjct: 260 DFGYLLPNLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWL 319
Query: 308 GILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNN 367
GI NSLG+ L F+ ++ N T+L++L + N GG LPA I+NLSTTL L L N
Sbjct: 320 GIRNNSLGNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQN 379
Query: 368 QIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGN 427
I G IP IG V+LQ L + +N LSG +P + G+L NL+ + L N G IP GN
Sbjct: 380 LISGTIPHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGN 439
Query: 428 L-KLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSR 486
+ +L L+L+ N G IP SLGR L + + N L GTIP + + + SL +DLS
Sbjct: 440 MTRLQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQI-PSLAYIDLSN 498
Query: 487 NQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLS 546
N LTG P EVG L+ L L NKL G++P +G C+ +E L MQ N G IP +S
Sbjct: 499 NFLTGHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIP-DIS 557
Query: 547 SLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQGVFKNASITSVFGN 606
L L +D S NNLSG+IP L L ++NLNLS N EG VPT GVF+NA+ SVFGN
Sbjct: 558 RLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGN 617
Query: 607 LKLCGGIPEFQLPTCSSKKSKHKK---SLALKLVLAIISGLIGLSLALSIIVLCLVRKRK 663
+CGG+ E QL C + S K+ S+ K+V I G+ L L + + LC KRK
Sbjct: 618 TNICGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRK 677
Query: 664 EKQNPN--SPINS------FPNISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTT 715
+K N + +P +S +SY+ L++AT RFSS N IG G+FG+VFKG+L
Sbjct: 678 KKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKL 737
Query: 716 IAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNR 775
+AVKV NLL HGA KSF+AEC T K IRHRNLVK++T CS +D +GNDF+ALV+EFM
Sbjct: 738 VAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKG 797
Query: 776 SLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNIL 835
SL+ WL E D + RSL ++LNI+IDVA AL YLH C P+AHCD+KPSNIL
Sbjct: 798 SLDMWLQLEDLERVNDHS-RSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNIL 856
Query: 836 LDEDMIAHIGDFGLARFLPLSSA-----QTSSIGAKGSIGYIAPEYGLGSEVSISGDVYS 890
LD+D+ AH+ DFGLA+ L Q SS G +G+IGY APEYG+G + SI GDVYS
Sbjct: 857 LDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYS 916
Query: 891 YGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQ 950
+GILLLE+ + KKPTD F GD NLH+ ++ I+ + G + I G
Sbjct: 917 FGILLLEMFSGKKPTDESFAGDYNLHSYTKS--------ILSGCTSSGGSNAIDEG---- 964
Query: 951 RQARVKSRIECLISMVRIGVACSMESPEDRM 981
L ++++G+ CS E P DRM
Sbjct: 965 -----------LRLVLQVGIKCSEEYPRDRM 984
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 729 bits (1882), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 461/995 (46%), Positives = 606/995 (60%), Gaps = 36/995 (3%)
Query: 10 VTASTVA-GNETDRLALLELKSKITHDPLGVLASWNESSHFCQWRGVTCSRRHQRVTILD 68
V A T+ ETD+ ALLE KS+++ VL SWN+S C W GV C +H+RVT +D
Sbjct: 28 VCAQTIRLTEETDKQALLEFKSQVSETSRVVLGSWNDSLPLCSWTGVKCGLKHRRVTGVD 87
Query: 69 LESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPA 128
L LKL G +SP VGNLSFL+ L L +N F+ IPSE L RLQ L + N GG IP
Sbjct: 88 LGGLKLTGVVSPFVGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPV 147
Query: 129 NISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLF 188
+S+CS+L L L N L +P E SLSK+ +S+ NNLTG P+SLGNL+S++ L
Sbjct: 148 VLSNCSSLSTLDLSSNHLEQGVPLEFGSLSKLVLLSLGRNNLTGKFPASLGNLTSLQMLD 207
Query: 189 LSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPL 248
N +EG IP + LK ++ +A N+ +G P I+N+SS+ N G +
Sbjct: 208 FIYNQIEGEIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRP 267
Query: 249 DYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPY-LEKLQRLLVF 307
D+G L NLQ +G N TG IP T+SN S+L N LTG P +LQ LL+
Sbjct: 268 DFGSLLPNLQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLL 327
Query: 308 GILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNN 367
G+ NSLG+ DL+FL +LTN ++L++L + N GG LP I+NLST L L L N
Sbjct: 328 GLNNNSLGNYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGN 387
Query: 368 QIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGN 427
I G+IP IG V+LQ LD+ N L+G +PP++GEL L+ + L N G IP S+GN
Sbjct: 388 LISGSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGN 447
Query: 428 LK-LFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSR 486
+ L LYL N +GSIPSSLG L ++L N L G+IP + + L SL+VL++S
Sbjct: 448 ISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMEL-PSLVVLNVSF 506
Query: 487 NQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLS 546
N L G + ++G LK L L+V NKL G+IP TL +C+ LE L +Q N GPIP +
Sbjct: 507 NLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIP-DIR 565
Query: 547 SLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQGVFKNASITSVFGN 606
L GL LDLS+NNLSG IPE + ++NLNLS N+ +G VPT+GVF+N S SVFGN
Sbjct: 566 GLTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGN 625
Query: 607 LKLCGGIPEFQLPTCSSKKSKHKKSLALKLVLAIISGLIGLSLALSIIVLCL------VR 660
+ LCGGIP QL CS + + S+ K++ +S ++ L L + V+ L V+
Sbjct: 626 INLCGGIPSLQLQPCSVELPRRHSSVR-KIITICVSAVMAALLLLCLCVVYLCWYKLRVK 684
Query: 661 KRKEKQNPN----SPINSF-PNISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTT 715
+ N N SP+ SF ISY LY T FSS N IG G+FG+VFKG L
Sbjct: 685 SVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKA 744
Query: 716 IAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNR 775
+A+KV NL GA KSFIAEC L IRHRNLVK++T CS D++GNDF+ALV+EFM N
Sbjct: 745 VAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNG 804
Query: 776 SLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNIL 835
+L+ WLHP E ET R+L L RLNI+IDVA AL YLH C PIAHCD+KPSNIL
Sbjct: 805 NLDMWLHPDEIE-ETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNIL 863
Query: 836 LDEDMIAHIGDFGLARFL-----PLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYS 890
LD+D+ AH+ DFGLA+ L Q SS G +G+IGY APEYG+G SI GDVYS
Sbjct: 864 LDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYS 923
Query: 891 YGILLLELITRKKPTDIMFEGDMNLHNLARTALPD-HVMDIVDSTLLNDGEDLIVHGNQR 949
+GI+LLE+ T K+PT+ +F + LH+ ++AL +DI D T+L R
Sbjct: 924 FGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETIL------------R 971
Query: 950 QRQARVKSRIECLISMVRIGVACSMESPEDRMSMT 984
A+ + +ECL + R+GV+CS ESP +R+SM
Sbjct: 972 GAYAQHFNMVECLTLVFRVGVSCSEESPVNRISMA 1006
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 474 bits (1219), Expect = e-132, Method: Compositional matrix adjust.
Identities = 344/977 (35%), Positives = 512/977 (52%), Gaps = 95/977 (9%)
Query: 74 LAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSC 133
L GSI +G L+ L L L N +IP +F L LQ L L N + G IPA I +C
Sbjct: 204 LTGSIPVSIGTLANLTDLDLSGNQLTGKIPRDFGNLLNLQSLVLTENLLEGDIPAEIGNC 263
Query: 134 SNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNN 193
S+L+QL L+ NQL GKIP+EL +L +++ + + N LT SIPSSL L+ + L LS N+
Sbjct: 264 SSLVQLELYDNQLTGKIPAELGNLVQLQALRIYKNKLTSSIPSSLFRLTQLTHLGLSENH 323
Query: 194 LEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFS 253
L G I + +G+L++L LT+ N +G P SI N+ ++T G N I G +P D G
Sbjct: 324 LVGPISEEIGFLESLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNNISGELPADLGL- 382
Query: 254 LQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNS 313
L NL+ S +N LTG IP +ISN + L++ S N++TG P L I N
Sbjct: 383 LTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGFGRMNLTFISIGRNH 442
Query: 314 LGSRGDRDLNFLCS-------------------LTNATRLKWLLININNFGGSLPACISN 354
D+ F CS + +L+ L ++ N+ G +P I N
Sbjct: 443 FTGEIPDDI-FNCSNLETLSVADNNLTGTLKPLIGKLQKLRILQVSYNSLTGPIPREIGN 501
Query: 355 LSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQR 414
L L +L L +N G IP + LQ L M SN L G IP + +++ L L L
Sbjct: 502 LK-DLNILYLHSNGFTGRIPREMSNLTLLQGLRMYSNDLEGPIPEEMFDMKLLSVLDLSN 560
Query: 415 NRFQGNIPPSIGNLK-LFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFI 473
N+F G IP L+ L L L N GSIP+SL L T D+S+N LTGTIP + +
Sbjct: 561 NKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTIPGELL 620
Query: 474 G-LSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEM 532
L + + L+ S N LTG+IP E+G L+ ++ +++ N G IP +L +C + L+
Sbjct: 621 ASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVFTLDF 680
Query: 533 QENFL-------------------------QGPIPSSLSSLRGLSVLDLSQNNLSGKIPE 567
+N L G IP S ++ L LDLS NNL+G+IPE
Sbjct: 681 SQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPE 740
Query: 568 LLIRLQLVKNLNLSNNDLEGVVPTQGVFKNASITSVFGNLKLCGGIPEFQLPTCSSKKSK 627
L L +K+L L++N+L+G VP GVFKN + + + GN LCG + P +KS
Sbjct: 741 SLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKKPLK-PCTIKQKSS 799
Query: 628 H--KKSLALKLVLAIISGLIGLSLALSIIVLCLVRKRKEKQNPNSPINSFPNISY----- 680
H K++ + ++L + L+ + L + I+ C +++K + NS +S P++
Sbjct: 800 HFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIE---NSSESSLPDLDSALKLK 856
Query: 681 ----QNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAF--KSFIA 734
+ L ATD F+S N IG S +V+KG L+DG T IAVKV NL A K F
Sbjct: 857 RFEPKELEQATDSFNSANIIGSSSLSTVYKGQLEDG-TVIAVKVLNLKEFSAESDKWFYT 915
Query: 735 ECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAP 794
E TL ++HRNLVKIL G ++ KALV FM N +LE+ +H AP
Sbjct: 916 EAKTLSQLKHRNLVKIL----GFAWESGKTKALVLPFMENGNLEDTIH-------GSAAP 964
Query: 795 RSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLP 854
+L++++++ + +A ++YLH PI HCDLKP+NILLD D +AH+ DFG AR L
Sbjct: 965 IG-SLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILG 1023
Query: 855 L---SSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEG 911
S S+ +G+IGY+APE+ +V+ DV+S+GI+++EL+T+++PT + E
Sbjct: 1024 FREDGSTTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDED 1083
Query: 912 --DMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIG 969
DM L L ++ + +V + G+ ++ + +Q +A IE +++
Sbjct: 1084 SQDMTLRQLVEKSIGNGRKGMVRVLDMELGDSIV---SLKQEEA-----IE---DFLKLC 1132
Query: 970 VACSMESPEDRMSMTNV 986
+ C+ PEDR M +
Sbjct: 1133 LFCTSSRPEDRPDMNEI 1149
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 454 bits (1168), Expect = e-126, Method: Compositional matrix adjust.
Identities = 320/914 (35%), Positives = 481/914 (52%), Gaps = 91/914 (9%)
Query: 134 SNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNL-SSIRSLFLSGN 192
+ +I+L + L G+I +++L+ + + ++ N G IP +G+L +++ L LS N
Sbjct: 66 TQVIELDISGRDLGGEISPSIANLTGLTVLDLSRNFFVGKIPPEIGSLHETLKQLSLSEN 125
Query: 193 NLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIF---NISSITGFDAGVNKIQGAIPLD 249
L G+IP LG L LV L + NRL+G+IP +F + SS+ D N + G IPL+
Sbjct: 126 LLHGNIPQELGLLNRLVYLDLGSNRLNGSIPVQLFCNGSSSSLQYIDLSNNSLTGEIPLN 185
Query: 250 YGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAP--YLEKLQRLLVF 307
Y L+ L+F + N+LTG +P ++SN++NL+ N L+G P + K+ +L
Sbjct: 186 YHCHLKELRFLLLWSNKLTGTVPSSLSNSTNLKWMDLESNMLSGELPSQVISKMPQLQFL 245
Query: 308 GILGNSLGSRGDRD--LNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLD 365
+ N S + F SL N++ L+ L + N+ GG + + + +LS L + LD
Sbjct: 246 YLSYNHFVSHNNNTNLEPFFASLANSSDLQELELAGNSLGGEITSSVRHLSVNLVQIHLD 305
Query: 366 NNQIFGNIPAAIG------------------------KFVNLQRLDMCSNRLSGTIPPAI 401
N+I G+IP I K L+R+ + +N L+G IP +
Sbjct: 306 QNRIHGSIPPEISNLLNLTLLNLSSNLLSGPIPRELCKLSKLERVYLSNNHLTGEIPMEL 365
Query: 402 GELQNLKDLRLQRNRFQGNIPPSIGNL-KLFILYLSYNFLQGSIPSSLGRYETLTTIDLS 460
G++ L L + RN G+IP S GNL +L L L N L G++P SLG+ L +DLS
Sbjct: 366 GDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEILDLS 425
Query: 461 NNNLTGTIPPQFIG-LSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPS 519
+NNLTGTIP + + L + + L+LS N L+G IP E+ + + +++ N+L G+IP
Sbjct: 426 HNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIPP 485
Query: 520 TLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLN 579
LGSCI LE L + N +PSSL L L LD+S N L+G IP + +K+LN
Sbjct: 486 QLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLN 545
Query: 580 LSNNDLEGVVPTQGVFKNASITSVFGNLKLCGGIPEFQLPTCSSKKSKHKKSLALKLVLA 639
S N L G V +G F +I S G+ LCG I Q KK K+ L L+
Sbjct: 546 FSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIKGMQ---ACKKKHKYPSVLLPVLLSL 602
Query: 640 IISGLIGLSLALSIIVLCLVRKRK----------------EKQNPNSPINSFPNISYQNL 683
I + + L + LV++ + EKQN N P +P ISYQ L
Sbjct: 603 IATPV------LCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDP--KYPRISYQQL 654
Query: 684 YNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFK-SFIAECNTLKNI 742
AT F++ + IG G FG V+KG+L + T +AVKV + F SF EC LK
Sbjct: 655 IAATGGFNASSLIGSGRFGHVYKGVLRN-NTKVAVKVLDPKTALEFSGSFKRECQILKRT 713
Query: 743 RHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQR 802
RHRNL++I+T CS F ALV M N SLE L+P + + ++L+LIQ
Sbjct: 714 RHRNLIRIITTCSKP-----GFNALVLPLMPNGSLERHLYP------GEYSSKNLDLIQL 762
Query: 803 LNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFL-----PLSS 857
+NI DVA + YLHH + HCDLKPSNILLD++M A + DFG++R + +S+
Sbjct: 763 VNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVST 822
Query: 858 AQTSSIGAK-----GSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGD 912
+ S G+ GS+GYIAPEYG+G S GDVYS+G+LLLE+++ ++PTD++
Sbjct: 823 DDSVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEG 882
Query: 913 MNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVAC 972
+LH ++ PD + I++ L Q + + K E ++ M+ +G+ C
Sbjct: 883 SSLHEFMKSHYPDSLEGIIEQALSR-------WKPQGKPEKCEKLWREVILEMIELGLVC 935
Query: 973 SMESPEDRMSMTNV 986
+ +P R M +V
Sbjct: 936 TQYNPSTRPDMLDV 949
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 448 bits (1152), Expect = e-124, Method: Compositional matrix adjust.
Identities = 338/1033 (32%), Positives = 508/1033 (49%), Gaps = 153/1033 (14%)
Query: 63 RVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSI 122
++ DL + L G ISP +GNL L VL L+ N IPSE + + LAL N +
Sbjct: 127 KLIYFDLSTNHLTGEISPSLGNLKNLTVLYLHQNYLTSVIPSELGNMESMTDLALSQNKL 186
Query: 123 GGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLS 182
G+IP+++ + NL+ L L+ N L G IP EL ++ + ++++ N LTGSIPS+LGNL
Sbjct: 187 TGSIPSSLGNLKNLMVLYLYENYLTGVIPPELGNMESMTDLALSQNKLTGSIPSTLGNLK 246
Query: 183 SIRSLF------------------------LSGNNLEGSIPDTLGWLKNLVNLTMAQNRL 218
++ L+ LS N L GSIP +LG LKNL L++ QN L
Sbjct: 247 NLMVLYLYENYLTGVIPPEIGNMESMTNLALSQNKLTGSIPSSLGNLKNLTLLSLFQNYL 306
Query: 219 SGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNA 278
+G IP + NI S+ + NK+ G+IP G +L+NL + EN LTG IPP + N
Sbjct: 307 TGGIPPKLGNIESMIDLELSNNKLTGSIPSSLG-NLKNLTILYLYENYLTGVIPPELGNM 365
Query: 279 SNLEIFHGSVNKLTGAAP---------YLEKLQRLLVFGILGNSLGSRG-----DRDLNF 324
++ + NKLTG+ P L + G++ LG+ D N
Sbjct: 366 ESMIDLQLNNNKLTGSIPSSFGNLKNLTYLYLYLNYLTGVIPQELGNMESMINLDLSQNK 425
Query: 325 LC-----SLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGK 379
L S N T+L+ L + +N+ G++P ++N S+ L L+LD N G P + K
Sbjct: 426 LTGSVPDSFGNFTKLESLYLRVNHLSGAIPPGVAN-SSHLTTLILDTNNFTGFFPETVCK 484
Query: 380 FVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNL-KLFILYLSYN 438
LQ + + N L G IP ++ + ++L R N+F G+I + G L + S+N
Sbjct: 485 GRKLQNISLDYNHLEGPIPKSLRDCKSLIRARFLGNKFTGDIFEAFGIYPDLNFIDFSHN 544
Query: 439 FLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVG 498
G I S+ + L + +SNNN+TG IP + + + L+ LDLS N L G +P +G
Sbjct: 545 KFHGEISSNWEKSPKLGALIMSNNNITGAIPTEIWNM-TQLVELDLSTNNLFGELPEAIG 603
Query: 499 NLKNLEILNVFGNKLKG------------------------EIPSTLGSCIKLE------ 528
NL NL L + GN+L G EIP T S +KL
Sbjct: 604 NLTNLSRLRLNGNQLSGRVPAGLSFLTNLESLDLSSNNFSSEIPQTFDSFLKLHDMNLSR 663
Query: 529 -----------------QLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIR 571
QL++ N L G IPS LSSL+ L LDLS NNLSG IP
Sbjct: 664 NKFDGSIPRLSKLTQLTQLDLSHNQLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTFEG 723
Query: 572 LQLVKNLNLSNNDLEGVVPTQGVFKNASITSVFGNLKLCGGIPEFQLPTCSS-KKSKHKK 630
+ + N+++SNN LEG +P F+ A+ ++ N+ LC IP+ +L C KK K
Sbjct: 724 MIALTNVDISNNKLEGPLPDTPTFRKATADALEENIGLCSNIPKQRLKPCRELKKPKKNG 783
Query: 631 SLALKLVLAIISGLIGLSLALSIIVLCLVRKRKEKQNPNSPINSFPNIS---------YQ 681
+L + +++ I+ L+ LS+ + C +RKRK + N+ + N+S YQ
Sbjct: 784 NLVVWILVPILGVLVILSICANTFTYC-IRKRKLQNGRNTDPETGENMSIFSVDGKFKYQ 842
Query: 682 NLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFN------LLHHGAFKSFIAE 735
++ +T+ F + IG G + V++ L D T IAVK + + + F+ E
Sbjct: 843 DIIESTNEFDPTHLIGTGGYSKVYRANLQD--TIIAVKRLHDTIDEEISKPVVKQEFLNE 900
Query: 736 CNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPR 795
L IRHRN+VK+ CS ++ + F L++E+M SL + L DE +
Sbjct: 901 VKALTEIRHRNVVKLFGFCS---HRRHTF--LIYEYMEKGSLNKLL-------ANDEEAK 948
Query: 796 SLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPL 855
L +R+N+ VA AL+Y+HHD PI H D+ NILLD D A I DFG A+ L
Sbjct: 949 RLTWTKRINVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTAKLLKT 1008
Query: 856 SSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNL 915
S+ S++ G+ GY+APE+ +V+ DVYS+G+L+LELI K P
Sbjct: 1009 DSSNWSAVA--GTYGYVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHPG---------- 1056
Query: 916 HNLARTALPDHVMDIVDSTLLNDGEDLIVH--GNQRQRQARVKSRIECLISMVRIGVACS 973
D+V S + GE L + ++R + R ++R E L+ MV + + C
Sbjct: 1057 -------------DLVSSLSSSPGEALSLRSISDERVLEPRGQNR-EKLLKMVEMALLCL 1102
Query: 974 MESPEDRMSMTNV 986
+PE R +M ++
Sbjct: 1103 QANPESRPTMLSI 1115
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P93194|RPK1_IPONI Receptor-like protein kinase OS=Ipomoea nil GN=INRPK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 440 bits (1131), Expect = e-122, Method: Compositional matrix adjust.
Identities = 344/1109 (31%), Positives = 513/1109 (46%), Gaps = 160/1109 (14%)
Query: 7 FLGVTASTVAGNE--TDRLALLELKSKITHDPLGVLASWNES-SHFCQWRGVTCSRRHQR 63
FL T+S A +D ALL L T P + SWN S S C W GV C RR Q
Sbjct: 11 FLCSTSSIYAAFALNSDGAALLSLTRHWTSIPSDITQSWNASDSTPCSWLGVECDRR-QF 69
Query: 64 VTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIG 123
V L+L S ++G P + +L LK + L N F IPS+ L+ + L NS
Sbjct: 70 VDTLNLSSYGISGEFGPEISHLKHLKKVVLSGNGFFGSIPSQLGNCSLLEHIDLSSNSFT 129
Query: 124 GAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSS 183
G IP + + NL L LF N L+G P L S+ +E + N L GSIPS++GN+S
Sbjct: 130 GNIPDTLGALQNLRNLSLFFNSLIGPFPESLLSIPHLETVYFTGNGLNGSIPSNIGNMSE 189
Query: 184 IRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQ 243
+ +L+L N G +P +LG + L L + N L GT+P ++ N+ ++ D N +
Sbjct: 190 LTTLWLDDNQFSGPVPSSLGNITTLQELYLNDNNLVGTLPVTLNNLENLVYLDVRNNSLV 249
Query: 244 GAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPY-LEKLQ 302
GAIPLD+ S + + S+ NQ TG +PP + N ++L F L+G P +L
Sbjct: 250 GAIPLDF-VSCKQIDTISLSNNQFTGGLPPGLGNCTSLREFGAFSCALSGPIPSCFGQLT 308
Query: 303 RLLVFGILGNSLGSRGDRDLNFLCSLTNA------------------TRLKWLLININNF 344
+L + GN R +L S+ + ++L++L + NN
Sbjct: 309 KLDTLYLAGNHFSGRIPPELGKCKSMIDLQLQQNQLEGEIPGELGMLSQLQYLHLYTNNL 368
Query: 345 GGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGEL 404
G +P I + + L+ L L N + G +P + + L L + N +G IP +G
Sbjct: 369 SGEVPLSIWKIQS-LQSLQLYQNNLSGELPVDMTELKQLVSLALYENHFTGVIPQDLGAN 427
Query: 405 QNLKDLRLQRNRFQGNIPPSI-GNLKLFILYLSYNFLQGSIPSSLGRYETLTTI------ 457
+L+ L L RN F G+IPP++ KL L L YN+L+GS+PS LG TL +
Sbjct: 428 SSLEVLDLTRNMFTGHIPPNLCSQKKLKRLLLGYNYLEGSVPSDLGGCSTLERLILEENN 487
Query: 458 -----------------DLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNL 500
DLS NN TG IPP +G ++ + LS NQL+GSIP E+G+L
Sbjct: 488 LRGGLPDFVEKQNLLFFDLSGNNFTGPIPPS-LGNLKNVTAIYLSSNQLSGSIPPELGSL 546
Query: 501 KNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNN 560
LE LN+ N LKG +PS L +C KL +L+ N L G IPS+L SL L+ L L +N+
Sbjct: 547 VKLEHLNLSHNILKGILPSELSNCHKLSELDASHNLLNGSIPSTLGSLTELTKLSLGENS 606
Query: 561 LSGKIPELLIR-----------------------LQLVKNLNLSNNDLEG---------- 587
SG IP L + LQ +++LNLS+N L G
Sbjct: 607 FSGGIPTSLFQSNKLLNLQLGGNLLAGDIPPVGALQALRSLNLSSNKLNGQLPIDLGKLK 666
Query: 588 --------------------------------------VVPTQGVFKNASITSVFGNLKL 609
V P+ F N+S TS GN L
Sbjct: 667 MLEELDVSHNNLSGTLRVLSTIQSLTFINISHNLFSGPVPPSLTKFLNSSPTSFSGNSDL 726
Query: 610 CGGIPEFQLPT--------CSSKKSKHKKSLA-LKLVLAIISGLIGLSLALSIIVLCLVR 660
C P L C+ + + K L+ L + + ++ L+ + +
Sbjct: 727 CINCPADGLACPESSILRPCNMQSNTGKGGLSTLGIAMIVLGALLFIICLFLFSAFLFLH 786
Query: 661 KRKEKQNPNSPINSFPNISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVK- 719
+K Q + AT+ + IG+G+ G+++K L + K
Sbjct: 787 CKKSVQEIAISAQEGDGSLLNKVLEATENLNDKYVIGKGAHGTIYKATLSPDKVYAVKKL 846
Query: 720 VFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEE 779
VF + +G+ S + E T+ +RHRNL+K+ + ++ +++ +M N SL +
Sbjct: 847 VFTGIKNGSV-SMVREIETIGKVRHRNLIKLEEF-----WLRKEYGLILYTYMENGSLHD 900
Query: 780 WLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED 839
LH ET+ P+ L+ R NI++ A L YLH DC P I H D+KP NILLD D
Sbjct: 901 ILH------ETN-PPKPLDWSTRHNIAVGTAHGLAYLHFDCDPAIVHRDIKPMNILLDSD 953
Query: 840 MIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELI 899
+ HI DFG+A+ L S+ S +G+IGY+APE + S DVYSYG++LLELI
Sbjct: 954 LEPHISDFGIAKLLDQSATSIPSNTVQGTIGYMAPENAFTTVKSRESDVYSYGVVLLELI 1013
Query: 900 TRKKPTDIMFEGDMNLHNLARTALPD--HVMDIVDSTLLNDGEDLIVHGNQRQRQARVKS 957
TRKK D F G+ ++ R+ + IVD +LL++ D S
Sbjct: 1014 TRKKALDPSFNGETDIVGWVRSVWTQTGEIQKIVDPSLLDELID--------------SS 1059
Query: 958 RIECLISMVRIGVACSMESPEDRMSMTNV 986
+E + + + + C+ + + R +M +V
Sbjct: 1060 VMEQVTEALSLALRCAEKEVDKRPTMRDV 1088
|
Possible role in short-day photoperiod floral induction. Ipomoea nil (taxid: 35883) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 437 bits (1123), Expect = e-121, Method: Compositional matrix adjust.
Identities = 346/1089 (31%), Positives = 529/1089 (48%), Gaps = 175/1089 (16%)
Query: 25 LLELKSKITHDPLGVLASWNESSHF-CQWRGVTCSRRHQ--RVTILDLESLKLAGSISP- 80
LLE+KSK D L +WN + C W GV CS V L+L S+ L+G +SP
Sbjct: 34 LLEIKSKFV-DAKQNLRNWNSNDSVPCGWTGVMCSNYSSDPEVLSLNLSSMVLSGKLSPS 92
Query: 81 -----------------------HVGNLSFLKVLRLYNNSFNHEIPSEFDRL-------- 109
+GN S L++L+L NN F+ EIP E +L
Sbjct: 93 IGGLVHLKQLDLSYNGLSGKIPKEIGNCSSLEILKLNNNQFDGEIPVEIGKLVSLENLII 152
Query: 110 ----------------------------------------RRLQVLALHYNSIGGAIPAN 129
+RL N I G++P+
Sbjct: 153 YNNRISGSLPVEIGNLLSLSQLVTYSNNISGQLPRSIGNLKRLTSFRAGQNMISGSLPSE 212
Query: 130 ISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFL 189
I C +L+ L L NQL G++P E+ L K+ + + +N +G IP + N +S+ +L L
Sbjct: 213 IGGCESLVMLGLAQNQLSGELPKEIGMLKKLSQVILWENEFSGFIPREISNCTSLETLAL 272
Query: 190 SGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLD 249
N L G IP LG L++L L + +N L+GTIP I N+S D N + G IPL+
Sbjct: 273 YKNQLVGPIPKELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEIPLE 332
Query: 250 YGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPY-LEKLQRLLVFG 308
G +++ L+ + ENQLTG IP +S NL S+N LTG P + L+ L +
Sbjct: 333 LG-NIEGLELLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQ 391
Query: 309 ILGNSLGSRGDRDLNFLCSLTNATRLKWLL-ININNFGGSLPACISNLSTTLEVLLLDNN 367
+ NSL L + L W+L ++ N+ G +P+ + L + + +L L N
Sbjct: 392 LFQNSLSGTIPPKLGWYSDL-------WVLDMSDNHLSGRIPSYLC-LHSNMIILNLGTN 443
Query: 368 QIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGN 427
+ GNIP I L +L + N L G P + + N+ + L +NRF+G+IP +GN
Sbjct: 444 NLSGNIPTGITTCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGN 503
Query: 428 LK-LFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSR 486
L L L+ N G +P +G L T+++S+N LTG +P + L LD+
Sbjct: 504 CSALQRLQLADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFN-CKMLQRLDMCC 562
Query: 487 NQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLS 546
N +G++PSEVG+L LE+L + N L G IP LG+ +L +L+M N G IP L
Sbjct: 563 NNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELG 622
Query: 547 SLRGLSV-LDLSQNNLSGKIPELLIRLQLVK------------------------NLNLS 581
SL GL + L+LS N L+G+IP L L +++ N S
Sbjct: 623 SLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFS 682
Query: 582 NNDLEGVVPTQGVFKNASITSVFGNLKLCGGIPEFQL----PTCSSKKSKHKKSLALKLV 637
N L G +P + +N S++S GN LCG P Q P S+ + + +
Sbjct: 683 YNSLTGPIP---LLRNISMSSFIGNEGLCGP-PLNQCIQTQPFAPSQSTGKPGGMRSSKI 738
Query: 638 LAIISGLI-GLSLALSIIVLCLVRK--------RKEKQNPNSPIN-SFP---NISYQNLY 684
+AI + +I G+SL L +++ L+R+ ++ Q ++ FP ++Q+L
Sbjct: 739 IAITAAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQPSEMSLDIYFPPKEGFTFQDLV 798
Query: 685 NATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGA-----FKSFIAECNTL 739
ATD F +G G+ G+V+K +L G T+AVK H G SF AE TL
Sbjct: 799 AATDNFDESFVVGRGACGTVYKAVLPAGY-TLAVKKLASNHEGGNNNNVDNSFRAEILTL 857
Query: 740 KNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNL 799
NIRHRN+VK+ C ++QG++ L++E+M SL E LH + +L+
Sbjct: 858 GNIRHRNIVKLHGFC---NHQGSNL--LLYEYMPKGSLGEILH---------DPSCNLDW 903
Query: 800 IQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQ 859
+R I++ A L YLHHDC+P I H D+K +NILLD+ AH+GDFGLA+ + + ++
Sbjct: 904 SKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSK 963
Query: 860 TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLA 919
+ S A GS GYIAPEY +V+ D+YSYG++LLEL+T K P + +G ++ N
Sbjct: 964 SMSAIA-GSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGG-DVVNWV 1021
Query: 920 RTALPDHVMD--IVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESP 977
R+ + + ++D+ L + E ++ H ++++++I + C+ SP
Sbjct: 1022 RSYIRRDALSSGVLDARLTLEDERIVSH----------------MLTVLKIALLCTSVSP 1065
Query: 978 EDRMSMTNV 986
R SM V
Sbjct: 1066 VARPSMRQV 1074
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 435 bits (1119), Expect = e-121, Method: Compositional matrix adjust.
Identities = 351/1104 (31%), Positives = 527/1104 (47%), Gaps = 180/1104 (16%)
Query: 20 TDRLALLELKSKITHDPLGVLASWNESSHF-CQWRGVTCSRRHQR-------VTILDLES 71
+D LLELK++ D L L +WN C W GV CS + VT LDL S
Sbjct: 35 SDGQFLLELKNRGFQDSLNRLHNWNGIDETPCNWIGVNCSSQGSSSSSNSLVVTSLDLSS 94
Query: 72 LKLAGSISP------------------------HVGNLSFLKVLRLYNNSFNHEIPSEFD 107
+ L+G +SP +GN S L+V+ L NN F IP E +
Sbjct: 95 MNLSGIVSPSIGGLVNLVYLNLAYNALTGDIPREIGNCSKLEVMFLNNNQFGGSIPVEIN 154
Query: 108 RLRRLQVLALHYNSIGGA------------------------------------------ 125
+L +L+ + N + G
Sbjct: 155 KLSQLRSFNICNNKLSGPLPEEIGDLYNLEELVAYTNNLTGPLPRSLGNLNKLTTFRAGQ 214
Query: 126 ------IPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLG 179
IP I C NL L L N + G++P E+ L K++ + + N +G IP +G
Sbjct: 215 NDFSGNIPTEIGKCLNLKLLGLAQNFISGELPKEIGMLVKLQEVILWQNKFSGFIPKDIG 274
Query: 180 NLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGV 239
NL+S+ +L L GN+L G IP +G +K+L L + QN+L+GTIP + +S + D
Sbjct: 275 NLTSLETLALYGNSLVGPIPSEIGNMKSLKKLYLYQNQLNGTIPKELGKLSKVMEIDFSE 334
Query: 240 NKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGA-APYL 298
N + G IP++ + L+ + +N+LTG IP +S NL S+N LTG P
Sbjct: 335 NLLSGEIPVELS-KISELRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSLTGPIPPGF 393
Query: 299 EKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLL-ININNFGGSLPACISNLST 357
+ L + + NSL + L L W++ + N G +P I S
Sbjct: 394 QNLTSMRQLQLFHNSLSGVIPQGLGLYSPL-------WVVDFSENQLSGKIPPFICQQSN 446
Query: 358 TLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRF 417
L +L L +N+IFGNIP + + +L +L + NRL+G P + +L NL + L +NRF
Sbjct: 447 -LILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRF 505
Query: 418 QGNIPPSIGNL-KLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLS 476
G +PP IG KL L+L+ N ++P+ + + L T ++S+N+LTG IP + I
Sbjct: 506 SGPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPIPSE-IANC 564
Query: 477 SSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENF 536
L LDLSRN GS+P E+G+L LEIL + N+ G IP T+G+ L +L+M N
Sbjct: 565 KMLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNLTHLTELQMGGNL 624
Query: 537 LQGPIPSSLSSLRGLSV-LDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQ--- 592
G IP L L L + ++LS N+ SG+IP + L L+ L+L+NN L G +PT
Sbjct: 625 FSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFEN 684
Query: 593 ---------------------GVFKNASITSVFGNLKLCGGIPEFQLPTCSSKKSKHKKS 631
+F+N ++TS GN LCGG L +C S
Sbjct: 685 LSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGG----HLRSCDPSHSSWPHI 740
Query: 632 LALKLVLA--------IISGLIGLSLALSIIVLCLVRKRKEKQNP----------NSPIN 673
+LK A + S + G+SL L IV+ +R E P S I
Sbjct: 741 SSLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHFLRNPVEPTAPYVHDKEPFFQESDIY 800
Query: 674 SFPN--ISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKS 731
P + +++ AT F +G G+ G+V+K ++ G+T IAVK G +
Sbjct: 801 FVPKERFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKT-IAVKKLESNREGNNNN 859
Query: 732 -------FIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPI 784
F AE TL IRHRN+V++ + C +QG++ L++E+M SL E LH
Sbjct: 860 SNNTDNSFRAEILTLGKIRHRNIVRLYSFCY---HQGSNSNLLLYEYMSRGSLGELLH-- 914
Query: 785 TREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844
S++ R I++ A L YLHHDC+P I H D+K +NIL+DE+ AH+
Sbjct: 915 ------GGKSHSMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHV 968
Query: 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
GDFGLA+ + + +++ S A GS GYIAPEY +V+ D+YS+G++LLEL+T K P
Sbjct: 969 GDFGLAKVIDMPLSKSVSAVA-GSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAP 1027
Query: 905 TDIMFEGDMNLHNLARTALPDHVM--DIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECL 962
+ +G +L R + DH + +I+D L +D+I++ +
Sbjct: 1028 VQPLEQGG-DLATWTRNHIRDHSLTSEILDPYLTKVEDDVILNH---------------M 1071
Query: 963 ISMVRIGVACSMESPEDRMSMTNV 986
I++ +I V C+ SP DR +M V
Sbjct: 1072 ITVTKIAVLCTKSSPSDRPTMREV 1095
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 425 bits (1093), Expect = e-118, Method: Compositional matrix adjust.
Identities = 334/1030 (32%), Positives = 508/1030 (49%), Gaps = 121/1030 (11%)
Query: 7 FLGVTASTVAG--NETDRLALLELKSKITHDPLGVLASW--NESSHFCQWRGVTCSRRHQ 62
++G T+S +A N + LL +KS + DPL L W +++S C W GV C+ +
Sbjct: 14 YIGSTSSVLASIDNVNELSVLLSVKSTLV-DPLNFLKDWKLSDTSDHCNWTGVRCNS-NG 71
Query: 63 RVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSI 122
V LDL + L G IS + LS L + N F +P L+ + + NS
Sbjct: 72 NVEKLDLAGMNLTGKISDSISQLSSLVSFNISCNGFESLLPKSIPPLKSIDI---SQNSF 128
Query: 123 GGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLS 182
G++ + L+ L N L G + +L +L +E + + N GS+PSS NL
Sbjct: 129 SGSLFLFSNESLGLVHLNASGNNLSGNLTEDLGNLVSLEVLDLRGNFFQGSLPSSFKNLQ 188
Query: 183 SIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKI 242
+R L LSGNNL G +P LG L +L + N G IP NI+S+ D + K+
Sbjct: 189 KLRFLGLSGNNLTGELPSVLGQLPSLETAILGYNEFKGPIPPEFGNINSLKYLDLAIGKL 248
Query: 243 QGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQ 302
G IP + G L++L+ + EN TG IP I + + L++ S N LTG P
Sbjct: 249 SGEIPSELG-KLKSLETLLLYENNFTGTIPREIGSITTLKVLDFSDNALTGEIPM----- 302
Query: 303 RLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVL 362
+T L+ L + N GS+P IS+L+ L+VL
Sbjct: 303 ------------------------EITKLKNLQLLNLMRNKLSGSIPPAISSLAQ-LQVL 337
Query: 363 LLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIP 422
L NN + G +P+ +GK LQ LD+ SN SG IP + NL L L N F G IP
Sbjct: 338 ELWNNTLSGELPSDLGKNSPLQWLDVSSNSFSGEIPSTLCNKGNLTKLILFNNTFTGQIP 397
Query: 423 PSIGNLKLFI-LYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIV 481
++ + + + + N L GSIP G+ E L ++L+ N L+G IP I S SL
Sbjct: 398 ATLSTCQSLVRVRMQNNLLNGSIPIGFGKLEKLQRLELAGNRLSGGIPGD-ISDSVSLSF 456
Query: 482 LDLSRNQLTGSIPSEVGNLKNLEI------------------------LNVFGNKLKGEI 517
+D SRNQ+ S+PS + ++ NL+ L++ N L G I
Sbjct: 457 IDFSRNQIRSSLPSTILSIHNLQAFLVADNFISGEVPDQFQDCPSLSNLDLSSNTLTGTI 516
Query: 518 PSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKN 577
PS++ SC KL L ++ N L G IP ++++ L+VLDLS N+L+G +PE + ++
Sbjct: 517 PSSIASCEKLVSLNLRNNNLTGEIPRQITTMSALAVLDLSNNSLTGVLPESIGTSPALEL 576
Query: 578 LNLSNNDLEGVVPTQGVFKNASITSVFGNLKLCGGIPEFQLPTCSS--KKSKHKKSLALK 635
LN+S N L G VP G K + + GN LCGG+ LP CS + + SL K
Sbjct: 577 LNVSYNKLTGPVPINGFLKTINPDDLRGNSGLCGGV----LPPCSKFQRATSSHSSLHGK 632
Query: 636 LVLAIISGLIGLSLALSIIVLCLVRKRKEKQ--------NPNSPINSFPN--ISYQNL-Y 684
++A LIG++ L++ +L +V + K+ + + +P +++ L +
Sbjct: 633 RIVA--GWLIGIASVLALGILTIVTRTLYKKWYSNGFCGDETASKGEWPWRLMAFHRLGF 690
Query: 685 NATDRFSSV---NQIGEGSFGSVFKGILDDGRTTIAVKVFNL----LHHGAFKSFIAECN 737
A+D + + N IG G+ G V+K + T +AVK + G F+ E N
Sbjct: 691 TASDILACIKESNMIGMGATGIVYKAEMSRSSTVLAVKKLWRSAADIEDGTTGDFVGEVN 750
Query: 738 TLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSL 797
L +RHRN+V++L G Y + +V+EFM N +L + +H + A R L
Sbjct: 751 LLGKLRHRNIVRLL----GFLYNDKNM-MIVYEFMLNGNLGDAIH------GKNAAGRLL 799
Query: 798 -NLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLS 856
+ + R NI++ VA L YLHHDC PP+ H D+K +NILLD ++ A I DFGLAR +
Sbjct: 800 VDWVSRYNIALGVAHGLAYLHHDCHPPVIHRDIKSNNILLDANLDARIADFGLARMMARK 859
Query: 857 SAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLH 916
S + GS GYIAPEYG +V D+YSYG++LLEL+T ++P + F +++
Sbjct: 860 KETVSMVA--GSYGYIAPEYGYTLKVDEKIDIYSYGVVLLELLTGRRPLEPEFGESVDIV 917
Query: 917 NLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMES 976
R + D++ L + D V GN R Q E ++ +++I + C+ +
Sbjct: 918 EWVRRKIRDNIS-------LEEALDPNV-GNCRYVQ-------EEMLLVLQIALLCTTKL 962
Query: 977 PEDRMSMTNV 986
P+DR SM +V
Sbjct: 963 PKDRPSMRDV 972
|
Involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 986 | ||||||
| 255581223 | 1015 | receptor-kinase, putative [Ricinus commu | 0.982 | 0.954 | 0.559 | 0.0 | |
| 359486510 | 965 | PREDICTED: probable LRR receptor-like se | 0.942 | 0.962 | 0.567 | 0.0 | |
| 224119102 | 1007 | predicted protein [Populus trichocarpa] | 0.976 | 0.956 | 0.538 | 0.0 | |
| 224119022 | 1021 | predicted protein [Populus trichocarpa] | 0.982 | 0.949 | 0.533 | 0.0 | |
| 255585471 | 963 | serine-threonine protein kinase, plant-t | 0.918 | 0.940 | 0.554 | 0.0 | |
| 224097752 | 1025 | predicted protein [Populus trichocarpa] | 0.982 | 0.945 | 0.530 | 0.0 | |
| 224127492 | 1022 | predicted protein [Populus trichocarpa] | 0.986 | 0.952 | 0.516 | 0.0 | |
| 255570308 | 1033 | receptor-kinase, putative [Ricinus commu | 0.984 | 0.939 | 0.529 | 0.0 | |
| 224097750 | 1023 | predicted protein [Populus trichocarpa] | 0.986 | 0.951 | 0.516 | 0.0 | |
| 359482058 | 1040 | PREDICTED: probable LRR receptor-like se | 0.979 | 0.928 | 0.526 | 0.0 |
| >gi|255581223|ref|XP_002531424.1| receptor-kinase, putative [Ricinus communis] gi|223528974|gb|EEF30966.1| receptor-kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1013 bits (2619), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 551/984 (55%), Positives = 688/984 (69%), Gaps = 15/984 (1%)
Query: 10 VTASTVAGNETDRLALLELKSKITHDPLGVLASWNESSHFCQWRGVTCSRRHQRVTILDL 69
+ A + GN TDRLALL+ K+KIT DPLG + WN+S+HFCQW GVTCSRRHQRV IL+L
Sbjct: 23 LAACVINGNLTDRLALLDFKAKITDDPLGFMPLWNDSTHFCQWYGVTCSRRHQRVAILNL 82
Query: 70 ESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPAN 129
SL+LAGSISPH+GNLSFL+ L L NNSF+H IP E RLRRLQ L L NS+ G IP+N
Sbjct: 83 RSLQLAGSISPHIGNLSFLRDLYLQNNSFSHGIPPEVGRLRRLQRLRLSNNSLTGNIPSN 142
Query: 130 ISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFL 189
IS+CS L ++ +NQL G+IP ELS L+K++ IS+ N +GSIP S+GNLSS++ L
Sbjct: 143 ISACSKLSEIYFAYNQLEGEIPEELSLLAKLQVISIQKNYFSGSIPPSIGNLSSLQVLSA 202
Query: 190 SGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLD 249
N L G+IPD +G L NL+ ++++ N LSGTIP SI+N+SSI + N+IQG +P +
Sbjct: 203 PENYLSGNIPDAIGQLNNLIFISLSVNNLSGTIPPSIYNLSSINTLNIVYNQIQGRLPSN 262
Query: 250 YGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGI 309
G +L NLQ F++ N G+IP + SNASNL S NKLTG P LE+L L + G+
Sbjct: 263 LGITLPNLQVFAIARNDFIGSIPSSFSNASNLVWLIMSENKLTGRVPSLEQLHNLQILGL 322
Query: 310 LGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQI 369
N LG + DL+F+ SL N T L L I+ N F G LP ISN STT L++ N I
Sbjct: 323 GYNYLGLEAN-DLDFVSSLVNCTNLWRLEIHNNKFHGVLPESISNFSTTFSQLVIAENNI 381
Query: 370 FGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLK 429
G IP++I VNL+RL+M +N+LSG IP G L LK L L N+ G IP S+GNL
Sbjct: 382 AGRIPSSISNLVNLERLEMANNQLSGNIPSNFGNLNMLKVLHLFGNKLSGTIPSSLGNLT 441
Query: 430 LFILYLSY--NFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRN 487
+ +L LS+ N LQG IPSSL E L +DL+ NNL+G+IP Q GLSS I LDLS N
Sbjct: 442 M-LLTLSFYDNNLQGRIPSSLAECENLMVLDLAKNNLSGSIPLQVFGLSSLSIALDLSAN 500
Query: 488 QLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSS 547
TG IP EVGNLK+LE L + N L G IP +LGSCIKLE L +Q NF G +PSSLSS
Sbjct: 501 HFTGVIPMEVGNLKDLEQLGISDNMLSGRIPDSLGSCIKLEVLALQGNFFDGLVPSSLSS 560
Query: 548 LRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQGVFKNASITSVFGNL 607
LRGL VLD S NNLSG+IPE L L+++LNLS N+ EG VP +G+F+NAS T V GN
Sbjct: 561 LRGLRVLDFSSNNLSGEIPEFLQSFDLLESLNLSYNNFEGRVPVEGIFRNASTTLVMGND 620
Query: 608 KLCGGIPEFQLPTCSSKKSKHKKSLALKLVLAIISGLIGLSLALSIIVLCLVRKRKEKQN 667
KLCGGIPEF L C++K K K +L LK+V++ I L+GLS L + +RK+KE+
Sbjct: 621 KLCGGIPEFHLAKCNAKSPK-KLTLLLKIVISTICSLLGLSFILIFALTFWLRKKKEEPT 679
Query: 668 PNSPINSFPNISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHG 727
+ + N+S+Q+L ATD FSS N IG GSFG V+KG LD+G TIAVKV NLLHHG
Sbjct: 680 SDPYGHLLLNVSFQSLLRATDGFSSANLIGRGSFGHVYKGFLDEGNVTIAVKVLNLLHHG 739
Query: 728 AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITRE 787
A SFIAEC L+NIRHRNLVK+LTACSG+DYQGNDFKALV+E+M N SLEEWLHPI R
Sbjct: 740 ASTSFIAECEALRNIRHRNLVKVLTACSGIDYQGNDFKALVYEYMVNGSLEEWLHPIPRT 799
Query: 788 DETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDF 847
+E E PRSLNL+QRLNI+IDVA AL+YLH+ C PI HCDLKPSN+LLD +M H+ DF
Sbjct: 800 EEV-EPPRSLNLLQRLNIAIDVASALDYLHNQCTTPIVHCDLKPSNVLLDSEMNGHVSDF 858
Query: 848 GLARFLPLSS-----AQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRK 902
GLA+ L S+ +Q+SSIG +G++G+ PEYG+GS VS GDVYSYGILLLEL T K
Sbjct: 859 GLAKILSESTNSFPVSQSSSIGVRGTVGFAPPEYGVGSNVSTYGDVYSYGILLLELFTGK 918
Query: 903 KPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECL 962
+PTD MF+ D+NLHN A A D + ++ D LL + N R+ Q R++ ECL
Sbjct: 919 RPTDDMFKEDLNLHNFAEIAFRDQLAEVADPILLQETAVRETRLNSRKCQ-RLE---ECL 974
Query: 963 ISMVRIGVACSMESPEDRMSMTNV 986
SM+RIGVACS E P++RM + +V
Sbjct: 975 FSMLRIGVACSTEMPQERMKINDV 998
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359486510|ref|XP_002271317.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like, partial [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1006 bits (2602), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 535/942 (56%), Positives = 679/942 (72%), Gaps = 13/942 (1%)
Query: 54 GVTCSRRHQRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQ 113
GV C RRHQRVT+LDL+S KL GSISPH+GNLSFL+VL+L N FNHEIP E LRRLQ
Sbjct: 1 GVKCGRRHQRVTMLDLQSQKLVGSISPHIGNLSFLRVLQLEENGFNHEIPPEIGHLRRLQ 60
Query: 114 VLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGS 173
+L L NS+ G IPAN+SSCS L+ + + N+LVGKIP+EL SLSK++++ ++ N+L+G
Sbjct: 61 MLFLSNNSLSGEIPANLSSCSKLMYIYVGWNRLVGKIPAELGSLSKLQYLFIHANSLSGG 120
Query: 174 IPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSIT 233
IP S GNLSS+ L + NN+ G+IP +L L L ++ + N LSGTIP S+ N+SS+
Sbjct: 121 IPRSFGNLSSLERLSATQNNIVGTIPASLFQLITLTHVALNANGLSGTIPPSLSNLSSLI 180
Query: 234 GFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTG 293
F N + G +P + G +L NLQ S+ N+ TG+IP ++SNASNLE F + N LTG
Sbjct: 181 FFAVSFNHLHGNLPSNLGITLPNLQDLSLSGNRFTGSIPVSLSNASNLEYFSCNGNNLTG 240
Query: 294 AAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACIS 353
P LEKLQRL F + N+LG+ DL FL SLTN + L+ L +N+NNFGG LP I
Sbjct: 241 KVPSLEKLQRLHFFSVTSNNLGNGEIEDLGFLSSLTNVSNLEVLALNVNNFGGVLPESIG 300
Query: 354 NLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQ 413
N ST L LLLD N+I G+IPA IG V+L+RL+M N+LSG+IP IG+LQNL+ L L
Sbjct: 301 NWSTKLATLLLDGNKIGGSIPAGIGNLVSLERLEMWENQLSGSIPVDIGKLQNLRVLMLI 360
Query: 414 RNRFQGNIPPSIGNLK-LFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQF 472
+N+ G +P S+GNL+ L L L N+ QG IPSSLG+ + L +DLS NNL+GTIPPQ
Sbjct: 361 KNKLSGILPSSLGNLENLIQLVLGRNYFQGKIPSSLGKCQNLLFLDLSLNNLSGTIPPQV 420
Query: 473 IGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEM 532
+ LSS I LD+S N+LTG++P EVGNLKNL +L+V N L G IPS++GSC LE L M
Sbjct: 421 VSLSSLSISLDISDNRLTGALPIEVGNLKNLGVLDVSNNMLSGGIPSSVGSCTSLEYLSM 480
Query: 533 QENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELL--IRLQLVKNLNLSNNDLEGVVP 590
+ NF QG IPSS SSLRG+ +LDLS NNLSGKIPE L I QLV NLS ND EG++P
Sbjct: 481 KGNFFQGSIPSSFSSLRGIRILDLSHNNLSGKIPEFLQDIHFQLV---NLSYNDFEGILP 537
Query: 591 TQGVFKNASITSVFGNLKLCGGIPEFQLPTCSSKKSKHKK-SLALKLVLAIISGLIGLSL 649
T+GVFKN S TS+ GN KLCGGIPEFQLP C+ ++ K + SLALK+++A +SGL+ ++
Sbjct: 538 TEGVFKNVSATSIMGNSKLCGGIPEFQLPKCNLQEPKKRGLSLALKIIIATVSGLLAITC 597
Query: 650 ALSIIVLCLVRKRKEKQNPNSPINSFPNISYQNLYNATDRFSSVNQIGEGSFGSVFKGIL 709
LS ++ +RK+K + +S S +SYQ+L ATD FSS N IG GSFGSV+KGIL
Sbjct: 598 VLSFLIFLWLRKKKGEPASSSSEKSLLKVSYQSLLRATDGFSSSNLIGVGSFGSVYKGIL 657
Query: 710 DDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVF 769
D T IAVKV NLL GA KSFIAEC L+NIRHRNLVK+LTACSGVDYQGNDFKA+V+
Sbjct: 658 DHDGTAIAVKVLNLLRKGASKSFIAECEALRNIRHRNLVKVLTACSGVDYQGNDFKAVVY 717
Query: 770 EFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDL 829
EFM N SLE+WLHP E PR LN +QRLNI+IDVACAL+YLHH CQ PI HCDL
Sbjct: 718 EFMVNGSLEQWLHPTPTTAEASAPPRKLNFLQRLNIAIDVACALDYLHHQCQTPIVHCDL 777
Query: 830 KPSNILLDEDMIAHIGDFGLARFLPLSSA-----QTSSIGAKGSIGYIAPEYGLGSEVSI 884
KPSN+LLD +M H+GDFG+A+FLP ++ Q+SSIG +G+IGY APEYG+GSEVS
Sbjct: 778 KPSNVLLDTEMTGHVGDFGIAKFLPEAATRVPEIQSSSIGIRGTIGYAAPEYGMGSEVST 837
Query: 885 SGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIV 944
SGDVYS+GILLLE+ T K+PT+ MF+ +N+HN +TA+P+ V +I D LL +G ++
Sbjct: 838 SGDVYSFGILLLEMFTGKRPTEDMFKDSLNIHNFVKTAVPERVAEIADPVLLQEGVEMDN 897
Query: 945 HGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986
+QR R A ECLIS+ IG+ACS E P +R ++T+
Sbjct: 898 TTSQR-RMASSHDAQECLISIFGIGLACSAELPRERKNITDA 938
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224119102|ref|XP_002331325.1| predicted protein [Populus trichocarpa] gi|222873908|gb|EEF11039.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1002 bits (2591), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 529/982 (53%), Positives = 694/982 (70%), Gaps = 19/982 (1%)
Query: 11 TASTVAGNETDRLALLELKSKITHDPLGVLASWNESSHFCQWRGVTCSRRHQRVTILDLE 70
+A ++ NETDRLALL+ KSKITHDPLG++ WN S HFC W GVTCS++HQRV +LDL+
Sbjct: 25 SALSIGRNETDRLALLDFKSKITHDPLGIMRLWNSSIHFCHWFGVTCSQKHQRVAVLDLQ 84
Query: 71 SLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANI 130
SLKL+GS+SP++GNLSFL+ L L +NSF+HEIP++ L RLQ+LALH NS G IPA++
Sbjct: 85 SLKLSGSVSPYIGNLSFLRNLYLQHNSFSHEIPAQIGHLHRLQILALHNNSFTGEIPASM 144
Query: 131 SSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLS 190
SS NL+ L L +N+L G+IP E S K+ + ++DNNL G+IP SLGN+SS++ L+L
Sbjct: 145 SSSYNLVSLILDNNKLTGEIPKEFGSFLKLTDLYIDDNNLVGTIPPSLGNISSLQELWLD 204
Query: 191 GNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDY 250
NNL G++P TL L NL L++ NR SGTIP S+ N+SS+ F G+N QG +P D
Sbjct: 205 DNNLFGNLPATLSKLVNLRVLSLFNNRFSGTIPPSMLNLSSLRTFQVGLNHFQGNLPPDL 264
Query: 251 GFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGIL 310
G SL NL+FFS+ NQ TG++P +ISN SNLE+ ++NKL G P LEKLQRLL I
Sbjct: 265 GISLPNLEFFSIYSNQFTGSVPVSISNLSNLEMLELNLNKLRGKMPSLEKLQRLLSITIA 324
Query: 311 GNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIF 370
N+LGS DL+FL SLTNAT L+ L+I NNF G LP ISNLSTTLE++ LD+N +F
Sbjct: 325 SNNLGSGEANDLSFLSSLTNATNLEELIITQNNFQGQLPPQISNLSTTLEIMGLDSNLLF 384
Query: 371 GNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKL 430
G+IP I ++L ++ +N LSG IP IG+LQNL+ L L N F G+IP S+GNL
Sbjct: 385 GSIPDGIENLISLNDFEVQNNHLSGIIPSTIGKLQNLEILGLALNNFSGDIPSSLGNLTN 444
Query: 431 FI-LYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQL 489
I LYL+ +QGSIPSSL L +DLS N +TG+IPP GLSS I LDLSRN L
Sbjct: 445 LIGLYLNDINVQGSIPSSLANCNKLLELDLSGNYITGSIPPGIFGLSSLSINLDLSRNHL 504
Query: 490 TGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLR 549
+GS+P EVGNL+NLEI + GN + G+IPS+L CI L+ L + NF +G +PSSLS+LR
Sbjct: 505 SGSLPKEVGNLENLEIFAISGNMISGKIPSSLAQCISLQFLYLDANFFEGSVPSSLSTLR 564
Query: 550 GLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQGVFKNASITSVFGNLKL 609
G+ + S NNLSGKI E + ++ L+LS N+ EG+VP +G+FKNA+ TSV GN KL
Sbjct: 565 GIQEFNFSHNNLSGKIHEFFQDFRSLEILDLSYNNFEGMVPFRGIFKNATATSVIGNSKL 624
Query: 610 CGGIPEFQLPTCSSKKSKHKKSLALKLVLAIISGLIGLSLALSIIVLCLVRKRKEKQNPN 669
CGG P+F+LP C+ K K + SL +K+ + +IS L+ +++ ++ + L RK++ + P+
Sbjct: 625 CGGTPDFELPPCNFKHPK-RLSLKMKITIFVISLLLAVAVLITGLFLFWSRKKRREFTPS 683
Query: 670 SPINSFPNISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAF 729
S N +SYQ+L AT+ FSS+N IG GSFGSV+KGILD T +AVKV NL GA
Sbjct: 684 SDGNVLLKVSYQSLLKATNGFSSINLIGTGSFGSVYKGILDHNGTAVAVKVLNLRRQGAS 743
Query: 730 KSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDE 789
KSF+AEC L N+RHRNLVK++TACSGVDY GNDFKALV+EFM N SLE WLHP
Sbjct: 744 KSFMAECEALPNVRHRNLVKVVTACSGVDYHGNDFKALVYEFMVNGSLETWLHP---SRA 800
Query: 790 TDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGL 849
TDE L+L QRL+I+IDVA AL+Y HH C+ I HCDLKP N+LLD++M+ H+GDFGL
Sbjct: 801 TDEVRGILDLTQRLSIAIDVAHALDYFHHQCEKQIVHCDLKPGNVLLDDEMVGHVGDFGL 860
Query: 850 ARF-----LPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
A+F L S+ +SSIG +G+IGY PEYG G+EVS GDVYSYGILLLE+ T K+P
Sbjct: 861 AKFLLEDTLHHSTNPSSSIGIRGTIGYTPPEYGAGNEVSAYGDVYSYGILLLEMFTGKRP 920
Query: 905 TDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLIS 964
TD +F G +NLH+ +T LP+ V+ I D TL + GN + Q RV ++CL+S
Sbjct: 921 TDDLFNG-LNLHSYVKTFLPEKVLQIADPTL----PQINFEGNSIE-QNRV---LQCLVS 971
Query: 965 MVRIGVACSMESPEDRMSMTNV 986
+ G++CS+ESP++RM + +V
Sbjct: 972 VFTTGISCSVESPQERMGIADV 993
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224119022|ref|XP_002331306.1| predicted protein [Populus trichocarpa] gi|222873889|gb|EEF11020.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 994 bits (2569), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 529/991 (53%), Positives = 678/991 (68%), Gaps = 22/991 (2%)
Query: 7 FLGVTASTVAGNETDRLALLELKSKITHDPLGVLASWNESSHFCQWRGVTCSRRHQRVTI 66
+ VT S NETD LAL++ K+KI DPLG+++SWN + HFCQW GV+C RRHQRV +
Sbjct: 17 LISVTCSDYT-NETDLLALIQFKNKIVDDPLGIMSSWNSTIHFCQWHGVSCGRRHQRVRV 75
Query: 67 LDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAI 126
L L+SLKL+G+ISPH+GNLSFL+ L L NNSF HEIP + RLR LQ+ +LH NSI G I
Sbjct: 76 LALQSLKLSGTISPHIGNLSFLRELHLQNNSFFHEIPPQVGRLRSLQIFSLHNNSISGQI 135
Query: 127 PANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRS 186
P +IS CSNLI +++ N L G+IP EL SL K++++++ N LTG+IP SLGNLSS+
Sbjct: 136 PPSISDCSNLISIKIEFNNLTGEIPMELGSLLKLKNLTLEVNGLTGTIPPSLGNLSSLEI 195
Query: 187 LFLSGNN-LEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGA 245
L L N L G++P TLG LKNL L + NRLSG IP SIFN+SS+T D G N G
Sbjct: 196 LRLEKNKILFGNVPSTLGKLKNLRILNLMDNRLSGVIPPSIFNLSSLTALDIGFNLFHGN 255
Query: 246 IPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLL 305
+P D G SL NL+FFS+ NQ TG+IP +ISNASN+E+ S+N LTG P LEKL RL
Sbjct: 256 LPSDIGISLPNLEFFSIASNQFTGSIPVSISNASNIELLQVSLNNLTGEVPTLEKLHRLN 315
Query: 306 VFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLD 365
F + N LGS DL+FL SLTNAT L++L I NNFGG LP ISNLST L V+ L
Sbjct: 316 FFTLFSNHLGSGQANDLSFLSSLTNATTLEYLSIKRNNFGGELPKQISNLSTMLGVISLP 375
Query: 366 NNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSI 425
N I G+IPA I K VNL+ D+ +N++SG IP +IGELQNL+ L L N G IP S+
Sbjct: 376 ENNILGSIPAGIEKLVNLKVFDVGNNKISGIIPSSIGELQNLEGLVLDYNNLSGRIPSSV 435
Query: 426 GNL-KLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDL 484
GNL KL LYL N L+GSIPSSLG + L + L NNL+G IPP G+ SL+ +
Sbjct: 436 GNLTKLMALYLGDNSLEGSIPSSLGNCKKLLVLTLCGNNLSGDIPPGLFGI-FSLLYICF 494
Query: 485 SRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSS 544
S+N +GS+P E+G L NLE L+V GN L GEIPS+LG CI LE L M NF G IPS+
Sbjct: 495 SKNHFSGSLPIEIGKLINLEFLDVSGNMLSGEIPSSLGGCISLEDLYMNSNFFHGSIPSA 554
Query: 545 LSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQGVFKNASITSVF 604
LSSLRG+ + S NNLSGKIPE ++ L+LS N+ EG++P +G+FKN++ SV
Sbjct: 555 LSSLRGVLQFNFSHNNLSGKIPEFFQGFNSLEMLDLSYNNFEGMIPDEGIFKNSTAVSVI 614
Query: 605 GNLKLCGGIPEFQLPTCSSKKSKHKKSLALKLVLAIISGLIGLSLALSIIVLCLVRKRKE 664
GN +LCGG E LP C + K K L LK+ + I+ L+ L+L ++ + LC R+++
Sbjct: 615 GNSQLCGGNTELGLPRCKVHQPKRLK-LKLKIAIFAITVLLALALVVTCLFLCSSRRKRR 673
Query: 665 KQNPNSPINSFPNISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL 724
+ +S N +SYQ L AT+ FSS N +G GSFGSV+KG+LD IAVKV NL+
Sbjct: 674 EIKLSSMRNELLEVSYQILLKATNGFSSSNLVGIGSFGSVYKGMLDQNGMVIAVKVLNLM 733
Query: 725 HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPI 784
GA +SFIAEC L+NIRHRNLVK+LTACS +DY GNDFKA+V+EFM N SLE+WLHP
Sbjct: 734 RQGASRSFIAECEALRNIRHRNLVKVLTACSSIDYHGNDFKAIVYEFMANGSLEDWLHPT 793
Query: 785 TREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844
T +QRLNI+IDVACAL YLHH C+ PIAHCDLKPSN+LLD+++ H+
Sbjct: 794 GTGGGTTLTLNL---LQRLNIAIDVACALEYLHHHCEMPIAHCDLKPSNVLLDDELTGHV 850
Query: 845 GDFGLARFLPLSSA-----QTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELI 899
GDFGLA+FL +S +++SIG +G+IGY PEYG+G EVS GD YSYGILLLE+
Sbjct: 851 GDFGLAKFLSGASLDYPTNESTSIGVRGTIGYAPPEYGVGGEVSAYGDTYSYGILLLEMF 910
Query: 900 TRKKPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLND---GEDLIVHGNQRQRQARVK 956
T K+PTD MF NLHN + A+P+ V I D TLL + G+D ++ + +
Sbjct: 911 TGKRPTDEMFREGSNLHNFVKRAVPEQVKQITDPTLLQEEPTGDD-----DKHEISSMRN 965
Query: 957 SR-IECLISMVRIGVACSMESPEDRMSMTNV 986
SR +ECL S++RIG++CS+E P +RM +++
Sbjct: 966 SRPLECLNSILRIGISCSVEFPRERMKISDA 996
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255585471|ref|XP_002533428.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223526716|gb|EEF28948.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 980 bits (2533), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 523/944 (55%), Positives = 655/944 (69%), Gaps = 38/944 (4%)
Query: 7 FLGVTASTVAGNETDRLALLELKSKITHDPLGVLASWNESSHFCQWRGVTCSRRHQRVTI 66
F T+S ++GNETD ALLE KSKITHDP VL SWNE+ HFCQW+GVTC H+RVT+
Sbjct: 26 FSSTTSSAISGNETDLQALLEFKSKITHDPFQVLRSWNETIHFCQWQGVTCGLLHRRVTV 85
Query: 67 LDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAI 126
LDL SLK++GSISP++GNLSFL+ L + NNSF HEIP + LRRL+ L L+ NS+GG I
Sbjct: 86 LDLHSLKISGSISPYIGNLSFLRALNIQNNSFGHEIPQQIGYLRRLEELRLNNNSVGGKI 145
Query: 127 PANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRS 186
P NIS CSNL+ + L N+L G +P EL LS ++ +S+ N LTGSIP SLGNLS ++
Sbjct: 146 PTNISRCSNLVFISLGKNKLEGNVPEELGVLSNLQVLSIFGNKLTGSIPHSLGNLSQLQR 205
Query: 187 LFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAI 246
L L+ N + G +P++LGWL+NL L++ NRLSGTIPSS+FN+SSI D G N G +
Sbjct: 206 LSLAENRMVGEVPNSLGWLRNLTFLSLRSNRLSGTIPSSLFNLSSIRNLDIGENNFHGNL 265
Query: 247 PLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLV 306
P D GF L N+++F++ N+ TG IP ++SNA+NLE N LTG P L KL RL V
Sbjct: 266 PSDIGFLLPNIRWFAISSNEFTGKIPVSLSNATNLESLLLLQNNLTGEVPSLAKLDRLRV 325
Query: 307 FGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDN 366
F + N+LG+ DL+FL SLTN T L+ L +N NNFGG LP I+NLSTTL +LLLDN
Sbjct: 326 FSLTSNNLGTGKADDLSFLHSLTNTTALEELGVNGNNFGGMLPDSIANLSTTLRILLLDN 385
Query: 367 NQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIG 426
N+I G+IP+ I V+L+ ++ +N+LSG IP +IG+LQNL L L N G+IP S+G
Sbjct: 386 NRIIGSIPSGIENLVSLEDFEVWNNQLSGFIPDSIGKLQNLVVLALNSNMLSGHIPSSLG 445
Query: 427 NL-KLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLS 485
NL L L + N L G IPS LGR + + + LS NN +G+IPP+ I +SS I LDLS
Sbjct: 446 NLTNLIQLLVEDNNLSGRIPSDLGRCQNMLGLSLSQNNFSGSIPPEVISISSLSIYLDLS 505
Query: 486 RNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSL 545
+N LTG++P EVGNLK+L +V GNKL GEIP TLGSCI LE L M N QG IPSSL
Sbjct: 506 QNNLTGTLPMEVGNLKSLSEFDVSGNKLSGEIPRTLGSCISLEILNMAGNNFQGLIPSSL 565
Query: 546 SSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQGVFKNASITSVFG 605
SSLR L +LDLS NN L G+VP++G+FKNAS TSV G
Sbjct: 566 SSLRALQILDLS------------------------NNHLSGMVPSKGIFKNASATSVEG 601
Query: 606 NLKLCGGIPEFQLPTC-SSKKSKHKKSLALKLVLAIISGLIGLSLALSIIVLCLVRKRKE 664
N LCGGIPEFQLP C S++ K++ + LK V++ ISG +A I++L L R++
Sbjct: 602 NNMLCGGIPEFQLPVCNSARHKKNRLTPVLKTVISAISG-----MAFLILMLYLFWFRQK 656
Query: 665 KQNPNSPINSFPNI---SYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVF 721
K N + S I SYQNL+ ATD FSS N IG GSFGSV+KG LD T IAVKVF
Sbjct: 657 KVNETTADFSEKKIMELSYQNLHKATDGFSSANIIGMGSFGSVYKGRLDREGTLIAVKVF 716
Query: 722 NLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWL 781
NL+ G FKSF+AEC L+NIRHRNL+K+LTACS +DY GNDFKALV+EFM N SLEEWL
Sbjct: 717 NLMRRGGFKSFLAECEALRNIRHRNLLKVLTACSSLDYHGNDFKALVYEFMVNGSLEEWL 776
Query: 782 HPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI 841
HP +E + R LN +QRLNI+IDVA AL YLHH C+P I HCDLKPSNILLDE++
Sbjct: 777 HPPVATNEAELETRKLNFLQRLNIAIDVASALYYLHHHCEPQIVHCDLKPSNILLDEELT 836
Query: 842 AHIGDFGLARFLPLSS----AQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLE 897
H+GDFGLARFL ++ Q+SSIG +G++GY PEYG+ SEVS GDVYSYGILLLE
Sbjct: 837 GHVGDFGLARFLLDATQNHYTQSSSIGVRGTVGYAPPEYGMSSEVSTYGDVYSYGILLLE 896
Query: 898 LITRKKPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGED 941
+ T K+P D MF+ NLHN + ALP+ V++IVD LL + E+
Sbjct: 897 MFTGKRPMDDMFKDGFNLHNFVKAALPNQVVEIVDPNLLPEIEE 940
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224097752|ref|XP_002311067.1| predicted protein [Populus trichocarpa] gi|222850887|gb|EEE88434.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 976 bits (2522), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 520/980 (53%), Positives = 675/980 (68%), Gaps = 11/980 (1%)
Query: 15 VAGNETDRLALLELKSKITHDPLGVLASWNESSHFCQWRGVTCSRRHQRVTILDLESLKL 74
GNETDRL+LL LKS+IT+DP G+L+SWNES HFC W GV C +RH+RV +DL S +L
Sbjct: 29 TGGNETDRLSLLALKSQITNDPFGMLSSWNESLHFCDWSGVICGKRHRRVVEIDLHSAQL 88
Query: 75 AGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCS 134
GS+SPH+GNLSFL++L+L NN F+H IP E L RL++L+L N+ G IP NIS CS
Sbjct: 89 VGSLSPHIGNLSFLRILKLENNRFSHNIPQELGHLFRLRMLSLENNTFDGKIPVNISHCS 148
Query: 135 NLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNL 194
NL+ L L N L GK+P EL SLSK++ N L G IPSS GNLS+I +F +GN L
Sbjct: 149 NLLILSLSGNNLTGKLPIELGSLSKLQVFFFQFNYLVGGIPSSFGNLSAIIQIFGAGNYL 208
Query: 195 EGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSL 254
+G IP+++G LK+L + + +N ++G IP SI+N+SS+ F VN++ G +P D G +L
Sbjct: 209 QGGIPNSIGQLKSLKSFSFGRNNMTGMIPPSIYNLSSLMRFAVPVNQLHGNLPPDLGLTL 268
Query: 255 QNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSL 314
NL+ + N+ +G+IPPT SNAS + + S N LTG P L L +L + N L
Sbjct: 269 PNLEILLMSFNRFSGSIPPTFSNASTIAVIELSNNNLTGRVPDLSSLSKLRWLIVDVNYL 328
Query: 315 GSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIP 374
G+ D DL+FL L N T L+ L IN NNFGG LP ISN S L+ + NQI G+IP
Sbjct: 329 GNGNDDDLSFLPPLANKTSLEELSINDNNFGGLLPKIISNFSENLKRMTFGRNQIRGSIP 388
Query: 375 AAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNL-KLFIL 433
+ IG + L L + N+L+G IP +IG+LQNL L L N+ GNIP S+GN+ L +
Sbjct: 389 SGIGNLIGLDTLGLEMNQLTGVIPNSIGKLQNLGVLALGGNKISGNIPSSMGNITSLLEV 448
Query: 434 YLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSI 493
YLS N LQG IPSSLG + L + L NNL+G+IP + I + SS +L LS NQLTGS+
Sbjct: 449 YLSANNLQGRIPSSLGNCQNLLILHLDQNNLSGSIPKEVISIPSSSRILVLSENQLTGSL 508
Query: 494 PSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSV 553
P EVG L NL N+ N+L GEIP TLGSC+ LE L M+ N QGPIP SLSSLR L +
Sbjct: 509 PLEVGKLANLGYFNLSHNRLSGEIPRTLGSCVSLEFLYMEGNLFQGPIPESLSSLRALQI 568
Query: 554 LDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQGVFKNASITSVFGNLKLCGGI 613
L+LS NNLSG+IP+ L L+L+ +L+LS N+LEG VP QG+F AS S+ GN KLCGG+
Sbjct: 569 LNLSHNNLSGEIPKFLAELKLLTSLDLSFNNLEGEVPVQGIFARASGFSMLGNKKLCGGM 628
Query: 614 PEFQLPTC-SSKKSKHKKSLALKLVLAIISGLIGLSLALSIIVLCLVRKRKEKQNPNSPI 672
P+ L C S K K K S LKL++AI G +G+ L +S ++ ++++K + SP
Sbjct: 629 PQLNLSRCTSKKSRKLKSSTKLKLIIAIPCGFVGIILVVSYMLFFFLKEKKSRPASGSPW 688
Query: 673 NS-FPNISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKS 731
S F ++Y++L AT+ FS N IG GSFGSV+KGIL +AVKVFNLL GA KS
Sbjct: 689 ESTFQRVAYEDLLQATNGFSPANLIGAGSFGSVYKGILRSDGAAVAVKVFNLLREGASKS 748
Query: 732 FIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETD 791
F+AEC L NIRHRNLVK+LTACSG+D+QGNDFKALV+EFM N SLEEWLHP DE
Sbjct: 749 FMAECAALINIRHRNLVKVLTACSGIDFQGNDFKALVYEFMVNGSLEEWLHPAQISDEAH 808
Query: 792 EAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLAR 851
R L+L+QRLNI+IDVA AL+YLH+ CQ I HCDLKPSN+LLD D+ AH+GDFGLAR
Sbjct: 809 RR-RDLSLLQRLNIAIDVASALDYLHNHCQIAIVHCDLKPSNVLLDGDLTAHVGDFGLAR 867
Query: 852 FLPLSSA-----QTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTD 906
LP +S QTSSIG KG+IGY APEYGLGSEVS GDVYSYGILLLE+ T ++PTD
Sbjct: 868 LLPQASHQLCLDQTSSIGLKGTIGYAAPEYGLGSEVSPYGDVYSYGILLLEVFTGRRPTD 927
Query: 907 IMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMV 966
+F+ +NLHN A+TALP V +++D L+ + E+ G+ +R + + + +ECL ++V
Sbjct: 928 GLFKDGLNLHNFAKTALPISVAEVLDPVLVTEAEE--TSGDASRRMSHIGNHMECLAAIV 985
Query: 967 RIGVACSMESPEDRMSMTNV 986
++GVACS E P +RM +++V
Sbjct: 986 KVGVACSAEFPRERMEISSV 1005
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224127492|ref|XP_002329291.1| predicted protein [Populus trichocarpa] gi|222870745|gb|EEF07876.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 967 bits (2499), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 506/979 (51%), Positives = 661/979 (67%), Gaps = 6/979 (0%)
Query: 13 STVAGNETDRLALLELKSKITHDPLGVLASWNESSHFCQWRGVTCSRRHQRVTILDLESL 72
S GNETD+L+LL K++IT DPLG L+SWNESS FCQW GVTC RRHQRV LDL S
Sbjct: 27 SIYGGNETDKLSLLTFKAQITGDPLGKLSSWNESSQFCQWSGVTCGRRHQRVVELDLHSY 86
Query: 73 KLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISS 132
+L GS+SPH+GNLSFL++L L NNS + IP E RL RL+ L L N+ G IPANIS
Sbjct: 87 QLVGSLSPHIGNLSFLRILNLANNSLSLYIPQELGRLFRLEELVLRNNTFDGGIPANISR 146
Query: 133 CSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGN 192
C+NL L L GK+P+EL LSK++ +++ NN G IP S GNLS+I +++ S N
Sbjct: 147 CANLRILDFSRGNLTGKLPAELGLLSKLQVLTIELNNFVGEIPYSFGNLSAINAIYGSIN 206
Query: 193 NLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGF 252
NLEGSIP+ G LK L L++ N LSG IP SIFN+SS+T VN++ G++P G
Sbjct: 207 NLEGSIPNVFGQLKRLKILSLGANNLSGMIPPSIFNLSSLTLLSFPVNQLYGSLPHTLGL 266
Query: 253 SLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGN 312
+L NLQ F++ NQ G IP T SNASNL F N G P L L V G+ N
Sbjct: 267 TLPNLQVFNIHTNQFGGLIPATFSNASNLLSFQIGSNNFNGKVPPLSSSHDLQVLGVGDN 326
Query: 313 SLGSRGDRDLNFLCSLT-NATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFG 371
+LG + DLNF+ L N T L+ L + NNFGG LP +SN ST L + NQI G
Sbjct: 327 NLGKGENNDLNFVYPLANNMTSLEALDTSDNNFGGVLPEIVSNFSTKLMKMTFARNQIRG 386
Query: 372 NIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNL-KL 430
+IP IG +NL+ L + +N+L+G IP ++G+LQ L DL L N+ G IP S+GN+ L
Sbjct: 387 SIPTQIGNLINLEALGLETNQLTGMIPSSMGKLQKLSDLFLNGNKISGMIPSSMGNMTSL 446
Query: 431 FILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLT 490
+ + N L+GSIP SLG ++ L ++ LS NNL+G IP + + + S + L LS N+LT
Sbjct: 447 GRVNMRLNNLEGSIPPSLGNWQKLLSLALSQNNLSGPIPKELVSIPSLSMYLVLSENELT 506
Query: 491 GSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRG 550
GS+P E+ L NL L+V N+ GEIP +LGSC+ LE L ++ENFLQGPIP +LSSLR
Sbjct: 507 GSLPIEMEKLVNLGYLDVSKNRFSGEIPKSLGSCVSLESLHLEENFLQGPIPITLSSLRA 566
Query: 551 LSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQGVFKNASITSVFGNLKLC 610
+ L+LS NNL+G+IPE L +L+++LNLS ND EG VP QG F+N S S+FGN KLC
Sbjct: 567 IQELNLSYNNLTGQIPEFLEDFKLLESLNLSFNDFEGEVPVQGAFQNTSAISIFGNKKLC 626
Query: 611 GGIPEFQLPTC-SSKKSKHKKSLALKLVLAIISGLIGLSLALSIIVLCLVRKRKEKQNPN 669
GGIP+ L C SS+ + K L ++ + G +G+ L +S ++ RK+K+K +
Sbjct: 627 GGIPQLNLTRCPSSEPTNSKSPTKLIWIIGSVCGFLGVILIISFLLFYCFRKKKDKPAAS 686
Query: 670 SPI--NSFPNISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHG 727
P SFP ++Y++L ATD FSS N IGEGSFGSVFKGIL + +AVKV NLL G
Sbjct: 687 QPSLETSFPRVAYEDLLGATDGFSSANLIGEGSFGSVFKGILGPDKIVVAVKVLNLLRKG 746
Query: 728 AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITRE 787
A KSF+AEC LK+IRHRNLVK+LT CS +D+QGNDFKALV+EFM N +LEEWLHP+
Sbjct: 747 ASKSFMAECEALKSIRHRNLVKLLTTCSSIDFQGNDFKALVYEFMVNGNLEEWLHPVQTS 806
Query: 788 DETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDF 847
DE + P++L+L+ RLNI+I +A ALNYLHHDCQ PI HCDLKPSNILLD +M AH+GDF
Sbjct: 807 DEAN-GPKALDLMHRLNIAIHMASALNYLHHDCQMPIIHCDLKPSNILLDTNMTAHVGDF 865
Query: 848 GLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDI 907
GLARF +S QTSS+G KG+IGY APEYG+G +VS GDVYSYGILLLE+ T K+P D
Sbjct: 866 GLARFHSEASNQTSSVGLKGTIGYAAPEYGIGGKVSTYGDVYSYGILLLEMFTGKRPVDG 925
Query: 908 MFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVR 967
MF+ +NLH+ A+ ALPD ++++VD L+ + + CL+++++
Sbjct: 926 MFKDGLNLHSYAKMALPDRIVEVVDPLLVREIRSVNSSDEMGMYHIGPHEISACLMTIIK 985
Query: 968 IGVACSMESPEDRMSMTNV 986
+GVACS+E P +RM + +V
Sbjct: 986 MGVACSVELPRERMDIGDV 1004
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255570308|ref|XP_002526114.1| receptor-kinase, putative [Ricinus communis] gi|223534611|gb|EEF36308.1| receptor-kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 959 bits (2479), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 525/991 (52%), Positives = 680/991 (68%), Gaps = 20/991 (2%)
Query: 7 FLGV----TASTVAGNETDRLALLELKSKITHDPLGVLASWNESSHFCQWRGVTCSRRHQ 62
F G+ T+ GNETD+LALL K++IT DPL +L SWN +SHFC WRGVTC RHQ
Sbjct: 17 FFGILCLSTSGEAHGNETDKLALLSFKAQITDDPLELLQSWNATSHFCDWRGVTCGNRHQ 76
Query: 63 RVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSI 122
RV L+L SLKL+GS+ H+GNLSFL+VL L+NNS + EIPSE LRRLQVL L NSI
Sbjct: 77 RVVKLELYSLKLSGSLPHHIGNLSFLRVLDLHNNSLSGEIPSEIGYLRRLQVLNLRNNSI 136
Query: 123 GGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLS 182
G IPANISSCS+L+ + N+L+G IPS L LSK+ V+ N LTGSIPSS GNLS
Sbjct: 137 VGKIPANISSCSSLLHFNVGGNRLMGDIPSALGKLSKLVFFGVDRNTLTGSIPSSFGNLS 196
Query: 183 SIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKI 242
S++ L + N + G+IPD LG L N+++ + N SG IP IFN+SS+ D VN
Sbjct: 197 SLQVLAIHVNKMNGNIPDELGRLTNVLDFIVHTNNFSGAIPPPIFNLSSLVRMDLSVNNF 256
Query: 243 QGAIPLDYGFSLQNLQFFSVGEN-QLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKL 301
+G +P + G SL NLQFFSV N + TG IP +ISNASNL F+ + NK TG P LE L
Sbjct: 257 RGNLPSNMGISLPNLQFFSVLMNYEFTGPIPISISNASNLLYFNLAGNKFTGEVPTLENL 316
Query: 302 QRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEV 361
L + N LGS G DL+FLC+LTN T + L IN+NNFGG LP CI N ST L +
Sbjct: 317 HELEALSLTSNHLGSAGTNDLSFLCTLTNGTNFRRLAINLNNFGGDLPGCIGNFSTRLRL 376
Query: 362 LLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNI 421
L + +N I G++PA IG V+L DM +N+ SG++PP+I +LQ LK L LQ N+F G I
Sbjct: 377 LSMSDNMISGSMPAEIGNLVSLDVFDMGNNQFSGSLPPSITKLQQLKVLYLQANKFSGEI 436
Query: 422 PPSIGNLKLFI-LYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLI 480
P +GNL L L L+ N +G IP SLGR + L +DL+NNNL G+IPP+ LSS
Sbjct: 437 PHYLGNLTLLTELMLNDNSFRGMIPLSLGRCQNLLLLDLANNNLNGSIPPELFDLSSLSA 496
Query: 481 VLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGP 540
L LS N L G++ +V NL NL +L V N L GEIPS+LGSCI+LE+L M++N +G
Sbjct: 497 YLRLSHNHLVGALSEKVQNLNNLGVLYVDHNFLSGEIPSSLGSCIRLERLNMRDNSFKGS 556
Query: 541 IPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQGVFKNASI 600
IPSSLS+LRGL V+DLS NNLSG+IPE L +++LNLS ND EG+VPT+GVFKNAS
Sbjct: 557 IPSSLSALRGLQVVDLSHNNLSGQIPEFLGSFPFLQSLNLSFNDFEGLVPTEGVFKNASS 616
Query: 601 TSVFGNLKLCGGIPEFQLPTCSSKKSKHKKSLALKLVLAIISGLIGLSLALSIIVLCLVR 660
TSV GN KLCGG+ +F L C+ + S +++ L LK ++A ++ L+G L LS +++ R
Sbjct: 617 TSVMGNNKLCGGVSDFHLLACNIRSSTNRR-LKLKAIIASVAVLLGALLMLSFLLILRSR 675
Query: 661 KRKEKQNPNSPINSFPNISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKV 720
K+ + +S I +SYQNL++AT FSS N I G FGSV++G+L + +AVKV
Sbjct: 676 KKSQAPALSSEI-PLLRVSYQNLHDATKGFSSSNLINVGGFGSVYQGVLGESGQLVAVKV 734
Query: 721 FNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEW 780
N+ H A KSF+ EC LK+IRHRNLVK+LTACS +DYQGNDFKALV+EFM N SLEEW
Sbjct: 735 LNVQHQTAAKSFMVECEVLKSIRHRNLVKVLTACSSIDYQGNDFKALVYEFMVNGSLEEW 794
Query: 781 LHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDM 840
LHP+ D +DE P+ L+L+QRLNI+ID+A AL YL + C+ I HCDLKPSN+LLD ++
Sbjct: 795 LHPVV-VDGSDEPPKKLDLLQRLNIAIDIASALEYLQNHCETTIVHCDLKPSNVLLDAEL 853
Query: 841 IAHIGDFGLARFL-----PLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILL 895
H+ DFG+A+FL S+ +SS+ +G+IGY PEYG+G +VSI GD+YSYGILL
Sbjct: 854 TGHVSDFGIAKFLLKDNNNRSTNLSSSVQLRGTIGYAPPEYGMGGQVSIFGDIYSYGILL 913
Query: 896 LELITRKKPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARV 955
LE+ T K+PT+ MF+ +NLH A++ALPD V +I+D LL + G R R
Sbjct: 914 LEMFTGKRPTNDMFKEGLNLHKFAKSALPDGVAEILDPVLLQES------GEIDSRSIRT 967
Query: 956 KSRIECLISMVRIGVACSMESPEDRMSMTNV 986
K ++CLIS+V IGV+CS E P DR+ ++V
Sbjct: 968 KKIMDCLISIVDIGVSCSAELPGDRVCTSDV 998
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224097750|ref|XP_002311066.1| predicted protein [Populus trichocarpa] gi|222850886|gb|EEE88433.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 956 bits (2472), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 509/985 (51%), Positives = 670/985 (68%), Gaps = 12/985 (1%)
Query: 10 VTASTVAGNETDRLALLELKSKITHDPLGVLASWNESSHFCQWRGVTCSRRHQRVTILDL 69
+ + + GNETDRL+LL K++I+ DPLG L+SWNES HFC+W GV C R+H+RV LDL
Sbjct: 23 IASCLLVGNETDRLSLLAFKTQIS-DPLGKLSSWNESLHFCEWSGVICGRKHRRVVELDL 81
Query: 70 ESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPAN 129
S +LAGS+SPH+GNLSFL++L L NSF++ IP E RL R+Q L+L N+ G IP N
Sbjct: 82 HSSQLAGSLSPHIGNLSFLRILNLEKNSFSYLIPQELGRLFRIQELSLGNNTFSGEIPVN 141
Query: 130 ISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFL 189
IS C+NL+ + L N L GK+P+E SLSK++ ++ N+L G IP S GNLS ++ +
Sbjct: 142 ISRCTNLLSIGLASNNLTGKLPAEFGSLSKLQVLNFQRNHLFGEIPPSYGNLSELQIIRG 201
Query: 190 SGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLD 249
NNL+G IPD++G LK L + T N LSGTIPSSI+N+SS+ F A +N++ G +P +
Sbjct: 202 VRNNLQGGIPDSIGQLKRLADFTFGVNSLSGTIPSSIYNMSSLVRFSAPLNQLYGILPPE 261
Query: 250 YGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGI 309
G +L NL F++ NQ G IP T+SNAS + N TG P L L L +
Sbjct: 262 LGLTLPNLDTFNILSNQFRGLIPSTLSNASKISDLQLRNNSFTGKVPSLAGLHNLQRLVL 321
Query: 310 LGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQI 369
N+LG+ D DL FL L N T L+ L IN NNFGG LP + N ST L ++++ N +
Sbjct: 322 NFNNLGNNEDDDLGFLYPLANTTSLEILAINHNNFGGVLPEIVCNFSTKLRIMIIGENNL 381
Query: 370 FGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNL- 428
G+IP IGK + L L + N+L+G IP +IG+LQ L + N+ GNIP S+GN+
Sbjct: 382 RGSIPTEIGKLIGLDTLGLELNQLTGIIPSSIGKLQRLGVFNINGNKISGNIPSSLGNIT 441
Query: 429 KLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQ 488
L +Y N LQG IPSSLG + L + L NNL+G+IP + +G+SS + LDL+ NQ
Sbjct: 442 SLLEVYFFANNLQGRIPSSLGNCQNLLMLRLDQNNLSGSIPKEVLGISSLSMYLDLAENQ 501
Query: 489 LTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSL 548
L G +PSEVG L +L LNV+ N+L GEIP L SC+ LE L + NF QG IP SLSSL
Sbjct: 502 LIGPLPSEVGKLVHLGGLNVYKNRLSGEIPGILSSCVSLEHLNLGPNFFQGSIPESLSSL 561
Query: 549 RGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQGVFKNASITSVFGNLK 608
R L +L+LS NNLSGKIP+ L +L+ +L+LS N+LEG VP QGVF AS S+ GN K
Sbjct: 562 RALQILNLSHNNLSGKIPKFLAEFKLLTSLDLSFNNLEGEVPVQGVFARASGFSMLGNKK 621
Query: 609 LCGGIPEFQLPTC-SSKKSKHKKSLALKLVLAIISGLIGLSLALSIIVLCLVRKRKEKQN 667
LCGG P+ L C S K K K S +KL++AI G +G+ L +S ++ L++++K +
Sbjct: 622 LCGGRPQLNLSRCTSKKSRKLKSSTKMKLIIAIPCGFVGIILLVSYMLFFLLKEKKSRPA 681
Query: 668 PNSPINS-FPNISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH 726
SP S F ++Y++L AT FS N IG GSFGSV+KGIL +AVKVFNLL
Sbjct: 682 SGSPWESTFQRVAYEDLLQATKGFSPANLIGAGSFGSVYKGILRSDGAAVAVKVFNLLRE 741
Query: 727 GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITR 786
GA KSF+AEC L NIRHRNLVK+LTACSG+D+QGNDFKALV+EFM N SLEEWLHP+
Sbjct: 742 GASKSFMAECAALINIRHRNLVKVLTACSGIDFQGNDFKALVYEFMVNGSLEEWLHPVQI 801
Query: 787 EDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846
DE R L+L+QRLNI+IDVA AL+YLH+ CQ +AHCDLKPSN+LLD DM AH+GD
Sbjct: 802 SDEA-HVRRDLSLLQRLNIAIDVASALDYLHNHCQIAVAHCDLKPSNVLLDGDMTAHVGD 860
Query: 847 FGLARFLPLSSA-----QTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITR 901
FGLAR LP +S QTSSIG KG+IGY APEYGLGSEVS GDVYSYGILLLE+ T
Sbjct: 861 FGLARLLPQASHQLCLDQTSSIGLKGTIGYAAPEYGLGSEVSPYGDVYSYGILLLEVFTG 920
Query: 902 KKPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIEC 961
++PT+ +F+ +NLHN A+TALP V +++D L+ + E+ G+ +R + + + +EC
Sbjct: 921 RRPTNGLFKDGLNLHNFAKTALPISVAEVLDPVLVTEAEE--TSGDASRRMSHIGNHMEC 978
Query: 962 LISMVRIGVACSMESPEDRMSMTNV 986
L ++V++GVACS E P +RM +++V
Sbjct: 979 LAAIVKVGVACSAEFPRERMEISSV 1003
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359482058|ref|XP_002274540.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 956 bits (2470), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 516/980 (52%), Positives = 657/980 (67%), Gaps = 14/980 (1%)
Query: 18 NETDRLALLELKSKITHDPLGVLASWNESSHFCQWRGVTCSRRHQRVTILDLESLKLAGS 77
NETDRLALL +K++IT DPLG+ SWN+S HFC W GVTC RHQRV L+L SL L GS
Sbjct: 37 NETDRLALLAIKAQITQDPLGITTSWNDSVHFCNWTGVTCGHRHQRVNTLNLNSLHLVGS 96
Query: 78 ISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLI 137
+SP +GNL+FL L L N+F+ +IP E RL RL+ L L NS G IPAN+S CSNL+
Sbjct: 97 LSPSIGNLTFLTGLNLELNNFHGQIPQELGRLSRLRALNLTNNSFSGEIPANLSRCSNLV 156
Query: 138 QLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGS 197
RL N L+G+IPS L S K+ + ++ NNLTG +P SLGNL+SI+SL + N+LEGS
Sbjct: 157 YFRLGFNNLIGRIPSWLGSYPKVVRMQLHYNNLTGPVPDSLGNLTSIKSLSFAVNHLEGS 216
Query: 198 IPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNL 257
IP LG L+ L + + N SG IPSS++N+SS+ F NK+ G++P D F+L NL
Sbjct: 217 IPQALGQLQTLEFMGLGMNGFSGIIPSSVYNMSSLEVFSLPYNKLYGSLPWDLAFTLPNL 276
Query: 258 QFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPY-LEKLQRLLVFGILGNSLGS 316
Q ++G N TG++P ++SNASNL F +++ TG + L + N LG
Sbjct: 277 QVLNIGNNDFTGSLPSSLSNASNLLEFDITMSNFTGKVSIDFGGMPNLWGLFLASNPLGK 336
Query: 317 RGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAA 376
DL+FL SL LK L ++ + FGG LP I+NLST L L LDNNQ+ G IP
Sbjct: 337 GEADDLSFLNSLMKCRALKVLDLSGSQFGGVLPNSIANLSTQLMKLKLDNNQLSGTIPPG 396
Query: 377 IGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNL-KLFILYL 435
IG VNL L + +N +G+IP IG LQ L + L RN+ G+IP S+GN+ +L+ L+L
Sbjct: 397 IGNLVNLTDLILANNDFTGSIPVLIGNLQMLGRIDLSRNQLSGHIPSSLGNITRLYSLHL 456
Query: 436 SYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPS 495
N L G IPSS G L +DLS N+L GTIP + + L S I L+L+RNQLTG +PS
Sbjct: 457 QNNHLSGKIPSSFGNLLYLQELDLSYNSLNGTIPEKVMDLVSLTISLNLARNQLTGLLPS 516
Query: 496 EVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLD 555
EV LKNL L+V NKL GEIP LGSC+ LE L M+ NF +G IP S SLRGL LD
Sbjct: 517 EVRKLKNLGHLDVSENKLSGEIPDGLGSCLTLEHLHMEGNFFKGSIPPSFISLRGLLDLD 576
Query: 556 LSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQGVFKNASITSVFGNLKLCGGIPE 615
LS+NNLSG+IPE L +L L NLNLS N+ EG +PT+GVF NA+ TSV GN KLCGGIPE
Sbjct: 577 LSRNNLSGQIPEFLQQLSL-SNLNLSFNNFEGQLPTKGVFNNATSTSVAGNNKLCGGIPE 635
Query: 616 FQLPTCSSKKSKHKKS-LALKLVLAIISGLIGLSLALSIIVLCLVR--KRKEKQNPNSPI 672
LP C K K +S LKL++ +++G +GL L +S++V+ +R KR+ Q S
Sbjct: 636 LHLPACPVTKPKTGESKRGLKLMIGLLTGFLGLVLIMSLLVINRLRRVKREPSQTSASSK 695
Query: 673 NSFPNISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSF 732
+ N+SY L+ AT FSS N IG G FGSV+KGIL T +AVKV L GA KSF
Sbjct: 696 DLILNVSYDGLFKATGGFSSANLIGTGGFGSVYKGILGQDETVVAVKVIQLHQRGAVKSF 755
Query: 733 IAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDE 792
AEC L+NIRHRNLVK+LT CS VDYQGNDFKALV+EFM N SLE WLHP+ DE ++
Sbjct: 756 KAECEALRNIRHRNLVKVLTTCSSVDYQGNDFKALVYEFMPNGSLENWLHPVPTPDEIND 815
Query: 793 APRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARF 852
R L+L QRLNI+IDVA AL+YLHH C PI HCDLKPSNILLD DM AH+GDFGLARF
Sbjct: 816 VLRILSLPQRLNIAIDVASALDYLHHHCHKPIVHCDLKPSNILLDNDMTAHVGDFGLARF 875
Query: 853 LPLSS-----AQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDI 907
+P ++ +Q+SSIG KG+IGY APEYG+G++VS GD YSYGILLLE+ T K+PT+
Sbjct: 876 IPEAAGRSHPSQSSSIGLKGTIGYAAPEYGMGTKVSALGDTYSYGILLLEMFTGKRPTES 935
Query: 908 MFEGDMNLHNLARTALPDHVMDIVDSTLLND---GEDLIVHGNQRQRQARVKSRIECLIS 964
MF +NLHN + ALP+ + DI+D L+ E+ + + + ECLIS
Sbjct: 936 MFSDQLNLHNFVKMALPERIADIIDPFFLSSEAKEEETTAADSSNLAHMKREKMHECLIS 995
Query: 965 MVRIGVACSMESPEDRMSMT 984
++RIGV+CS+ESP +RM++T
Sbjct: 996 ILRIGVSCSLESPRERMAIT 1015
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 986 | ||||||
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.618 | 0.595 | 0.450 | 4.7e-207 | |
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.966 | 0.943 | 0.431 | 4.4e-203 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.962 | 0.940 | 0.429 | 1.2e-200 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.951 | 0.909 | 0.439 | 4.7e-199 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.966 | 0.942 | 0.418 | 9.7e-199 | |
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.609 | 0.586 | 0.427 | 4.2e-195 | |
| UNIPROTKB|O24435 | 813 | O24435 "Receptor kinase-like p | 0.718 | 0.870 | 0.399 | 5.3e-127 | |
| TAIR|locus:2170483 | 1173 | FLS2 "FLAGELLIN-SENSITIVE 2" [ | 0.899 | 0.756 | 0.342 | 4.8e-126 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.604 | 0.477 | 0.343 | 5.2e-121 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.541 | 0.475 | 0.336 | 3.6e-115 |
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1263 (449.7 bits), Expect = 4.7e-207, Sum P(2) = 4.7e-207
Identities = 277/615 (45%), Positives = 366/615 (59%)
Query: 10 VTASTVA-GNETDRLALLELKSKITHDPLGVLASWNESSHFCQWRGVTCSRRHQRVTILD 68
V A T+ ETD+ ALLE KS+++ VL SWN+S C W GV C +H+RVT +D
Sbjct: 28 VCAQTIRLTEETDKQALLEFKSQVSETSRVVLGSWNDSLPLCSWTGVKCGLKHRRVTGVD 87
Query: 69 LESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPA 128
L LKL G +SP VGNLSFL+ L L +N F+ IPSE L RLQ L + N GG IP
Sbjct: 88 LGGLKLTGVVSPFVGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPV 147
Query: 129 NISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLF 188
+S+CS+L L L N L +P E SLSK+ +S+ NNLTG P+SLGNL+S++ L
Sbjct: 148 VLSNCSSLSTLDLSSNHLEQGVPLEFGSLSKLVLLSLGRNNLTGKFPASLGNLTSLQMLD 207
Query: 189 LSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPL 248
N +EG IP + LK ++ +A N+ +G P I+N+SS+ N G +
Sbjct: 208 FIYNQIEGEIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRP 267
Query: 249 DYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPY-LEKLQRLLVF 307
D+G L NLQ +G N TG IP T+SN S+L N LTG P +LQ LL+
Sbjct: 268 DFGSLLPNLQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLL 327
Query: 308 GILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNN 367
G+ NSLG+ DL+FL +LTN ++L++L + N GG LP I+NLST L L L N
Sbjct: 328 GLNNNSLGNYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGN 387
Query: 368 QIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGN 427
I G+IP IG V+LQ LD+ N L+G +PP++GEL L+ + L N G IP S+GN
Sbjct: 388 LISGSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGN 447
Query: 428 LK-LFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSR 486
+ L LYL N +GSIPSSLG L ++L N L G+IP + + L S L+VL++S
Sbjct: 448 ISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPS-LVVLNVSF 506
Query: 487 NQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPXXXX 546
N L G + ++G LK L L+V NKL G+IP TL +C+ LE L +Q N GPIP
Sbjct: 507 NLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRG 566
Query: 547 XXXXXXXXXXXQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQGVFKNASITSVFGN 606
+NNLSG IPE + ++NLNLS N+ +G VPT+GVF+N S SVFGN
Sbjct: 567 LTGLRFLDLS-KNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGN 625
Query: 607 LKLCGGIPEFQLPTC 621
+ LCGGIP QL C
Sbjct: 626 INLCGGIPSLQLQPC 640
|
|
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1965 (696.8 bits), Expect = 4.4e-203, P = 4.4e-203
Identities = 425/985 (43%), Positives = 586/985 (59%)
Query: 18 NETDRLALLELKSKITHDPLGVLASWNESSHFCQWRGVTCSRRHQRVTILDLESLKLAGS 77
+ETDR ALL+ KS+++ D VL+SWN S C W+GVTC R+++RVT L+L L+L G
Sbjct: 22 DETDRQALLQFKSQVSEDKRVVLSSWNHSFPLCNWKGVTCGRKNKRVTHLELGRLQLGGV 81
Query: 78 ISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLI 137
ISP +GNLSFL L LY N F IP E +L RL+ L + N + G IP + +CS L+
Sbjct: 82 ISPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCSRLL 141
Query: 138 QLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGS 197
LRL N+L G +PSEL SL+ + +++ NN+ G +P+SLGNL+ + L LS NNLEG
Sbjct: 142 NLRLDSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNLEGE 201
Query: 198 IPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNL 257
IP + L + +L + N SG P +++N+SS+ G N G + D G L NL
Sbjct: 202 IPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPNL 261
Query: 258 QFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSR 317
F++G N TG+IP T+SN S LE + N LTG+ P + L + + NSLGS
Sbjct: 262 LSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIPTFGNVPNLKLLFLHTNSLGSD 321
Query: 318 GDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAI 377
RDL FL SLTN T+L+ L I N GG LP I+NLS L L L I G+IP I
Sbjct: 322 SSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIPYDI 381
Query: 378 GKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLF-ILYLS 436
G +NLQ+L + N LSG +P ++G+L NL+ L L NR G IP IGN+ + L LS
Sbjct: 382 GNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDLS 441
Query: 437 YNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSE 496
N +G +P+SLG L + + +N L GTIP + + + L+ LD+S N L GS+P +
Sbjct: 442 NNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQ-LLRLDMSGNSLIGSLPQD 500
Query: 497 VGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPXXXXXXXXXXXXXX 556
+G L+NL L++ NKL G++P TLG+C+ +E L ++ N G IP
Sbjct: 501 IGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKGLVGVKEVDLS 560
Query: 557 XQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQGVFKNASITSVFGNLKLCGGIPEF 616
N+LSG IPE ++ LNLS N+LEG VP +G+F+NA+ S+ GN LCGGI F
Sbjct: 561 -NNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMGF 619
Query: 617 QLPTCXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXCL----VRKRKEKQXX---- 668
QL C + +RKRK+ +
Sbjct: 620 QLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKETNNPT 679
Query: 669 -XXXXXXXXXXXYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHG 727
Y +L NAT+ FSS N +G GSFG+V+K +L + +AVKV N+ G
Sbjct: 680 PSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRG 739
Query: 728 AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITRE 787
A KSF+AEC +LK+IRHRNLVK+LTACS +D+QGN+F+AL++EFM N SL+ WLHP
Sbjct: 740 AMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHP-EEV 798
Query: 788 DETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDF 847
+E R+L L++RLNI+IDVA L+YLH C PIAHCDLKPSN+LLD+D+ AH+ DF
Sbjct: 799 EEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDF 858
Query: 848 GLARFLPLSSA-----QTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRK 902
GLAR L Q SS G +G+IGY APEYG+G + SI+GDVYS+GILLLE+ T K
Sbjct: 859 GLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTGK 918
Query: 903 KPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRI-EC 961
+PT+ +F G+ L++ ++ALP+ ++DIVD ++L+ G RV + EC
Sbjct: 919 RPTNELFGGNFTLNSYTKSALPERILDIVDESILHIG-------------LRVGFPVVEC 965
Query: 962 LISMVRIGVACSMESPEDRMSMTNV 986
L + +G+ C ESP +R++ + V
Sbjct: 966 LTMVFEVGLRCCEESPMNRLATSIV 990
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1942 (688.7 bits), Expect = 1.2e-200, P = 1.2e-200
Identities = 421/980 (42%), Positives = 580/980 (59%)
Query: 18 NETDRLALLELKSKITHDPLGVLASWNESSHFCQWRGVTCSRRHQRVTILDLESLKLAGS 77
+E+DR ALLE+KS+++ L++WN S C W+ V C R+H+RVT LDL L+L G
Sbjct: 22 DESDRQALLEIKSQVSESKRDALSAWNNSFPLCSWKWVRCGRKHKRVTRLDLGGLQLGGV 81
Query: 78 ISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLI 137
ISP +GNLSFL L L NNSF IP E L RL+ LA+ +N + G IPA++S+CS L+
Sbjct: 82 ISPSIGNLSFLIYLDLSNNSFGGTIPQEMGNLFRLKYLAVGFNYLEGEIPASLSNCSRLL 141
Query: 138 QLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGS 197
L LF N L +PSEL SL K+ ++ + N+L G P + NL+S+ L L N+LEG
Sbjct: 142 YLDLFSNNLGDGVPSELGSLRKLLYLYLGLNDLKGKFPVFIRNLTSLIVLNLGYNHLEGE 201
Query: 198 IPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNL 257
IPD + L +V+LT+ N SG P + +N+SS+ N G + D+G L N+
Sbjct: 202 IPDDIAMLSQMVSLTLTMNNFSGVFPPAFYNLSSLENLYLLGNGFSGNLKPDFGNLLPNI 261
Query: 258 QFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGA-APYLEKLQRLLVFGILGNSLGS 316
S+ N LTGAIP T++N S LE+F N++TG+ +P KL+ L + NSLGS
Sbjct: 262 HELSLHGNFLTGAIPTTLANISTLEMFGIGKNRMTGSISPNFGKLENLHYLELANNSLGS 321
Query: 317 RGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAA 376
DL FL +LTN + L L ++ N GG+LP I N+ST L VL L N I+G+IP
Sbjct: 322 YSFGDLAFLDALTNCSHLHGLSVSYNRLGGALPTSIVNMSTELTVLNLKGNLIYGSIPHD 381
Query: 377 IGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNL-KLFILYL 435
IG + LQ L + N L+G +P ++G L L +L L NRF G IP IGNL +L LYL
Sbjct: 382 IGNLIGLQSLLLADNLLTGPLPTSLGNLVGLGELILFSNRFSGEIPSFIGNLTQLVKLYL 441
Query: 436 SYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPS 495
S N +G +P SLG + + + N L GTIP + + + + L+ L++ N L+GS+P+
Sbjct: 442 SNNSFEGIVPPSLGDCSHMLDLQIGYNKLNGTIPKEIMQIPT-LVHLNMESNSLSGSLPN 500
Query: 496 EVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPXXXXXXXXXXXXX 555
++G L+NL L + N L G +P TLG C+ +E + +QEN G IP
Sbjct: 501 DIGRLQNLVELLLGNNNLSGHLPQTLGKCLSMEVIYLQENHFDGTIPDIKGLMGVKNVDL 560
Query: 556 XXQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQGVFKNASITSVFGNLKLCGGIPE 615
NNLSG I E ++ LNLS+N+ EG VPT+G+F+NA++ SVFGN LCG I E
Sbjct: 561 S-NNNLSGSISEYFENFSKLEYLNLSDNNFEGRVPTEGIFQNATLVSVFGNKNLCGSIKE 619
Query: 616 FQLPTCXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXCL--VRKRKEKQXXXXXXX 673
+L C L +KRK Q
Sbjct: 620 LKLKPCIAQAPPVETRHPSLLKKVAIGVSVGIALLLLLFIVSLSWFKKRKNNQKINNSAP 679
Query: 674 XXXXX-----XYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGA 728
Y +L NATD FSS N +G GSFG+VFK +L +AVKV N+ GA
Sbjct: 680 FTLEIFHEKLSYGDLRNATDGFSSSNIVGSGSFGTVFKALLQTENKIVAVKVLNMQRRGA 739
Query: 729 FKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITRED 788
KSF+AEC +LK+IRHRNLVK+LTAC+ +D+QGN+F+AL++EFM N SL++WLHP +
Sbjct: 740 MKSFMAECESLKDIRHRNLVKLLTACASIDFQGNEFRALIYEFMPNGSLDKWLHP-EEVE 798
Query: 789 ETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFG 848
E R+L L++RLNI+IDVA L+YLH C PIAHCDLKPSNILLD+D+ AH+ DFG
Sbjct: 799 EIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNILLDDDLTAHVSDFG 858
Query: 849 LARFLPLSSA-----QTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKK 903
LAR L Q SS G +G+IGY APEYG+G + SI GDVYS+G+L+LE+ T K+
Sbjct: 859 LARLLLKFDQESFFNQLSSAGVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLVLEMFTGKR 918
Query: 904 PTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRI-ECL 962
PT+ +F G+ L++ + ALP+ V+DI D ++L+ G RV + ECL
Sbjct: 919 PTNELFGGNFTLNSYTKAALPERVLDIADKSILHSG-------------LRVGFPVLECL 965
Query: 963 ISMVRIGVACSMESPEDRMS 982
++ +G+ C ESP +R++
Sbjct: 966 KGILDVGLRCCEESPLNRLA 985
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1927 (683.4 bits), Expect = 4.7e-199, P = 4.7e-199
Identities = 432/983 (43%), Positives = 567/983 (57%)
Query: 18 NETDRLALLELKSKIT-HDPLGVLASWNESSHFCQWRGVTCSRRHQRVTILDLESLKLAG 76
NETD ALLE KS+++ ++ VLASWN SS FC W GVTC RR +RV L+L KL G
Sbjct: 28 NETDMQALLEFKSQVSENNKREVLASWNHSSPFCNWIGVTCGRRRERVISLNLGGFKLTG 87
Query: 77 SISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNL 136
ISP +GNLSFL++L L +NSF IP + RL RLQ L + YN + G IP+++S+CS L
Sbjct: 88 VISPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSYNLLEGRIPSSLSNCSRL 147
Query: 137 IQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEG 196
+ L N L +PSEL SLSK+ + ++ NNLTG+ P+SLGNL+S++ L + N + G
Sbjct: 148 STVDLSSNHLGHGVPSELGSLSKLAILDLSKNNLTGNFPASLGNLTSLQKLDFAYNQMRG 207
Query: 197 SIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQN 256
IPD + L +V +A N SG P +++NISS+ N G + D+G+ L N
Sbjct: 208 EIPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADFGYLLPN 267
Query: 257 LQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPY-LEKLQRLLVFGILGNSLG 315
L+ +G NQ TGAIP T++N S+LE F S N L+G+ P KL+ L GI NSLG
Sbjct: 268 LRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLG 327
Query: 316 SRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPA 375
+ L F+ ++ N T+L++L + N GG LPA I+NLSTTL L L N I G IP
Sbjct: 328 NNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTIPH 387
Query: 376 AIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNL-KLFILY 434
IG V+LQ L + +N LSG +P + G+L NL+ + L N G IP GN+ +L L+
Sbjct: 388 DIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLH 447
Query: 435 LSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIP 494
L+ N G IP SLGR L + + N L GTIP + + + S L +DLS N LTG P
Sbjct: 448 LNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPS-LAYIDLSNNFLTGHFP 506
Query: 495 SEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPXXXXXXXXXXXX 554
EVG L+ L L NKL G++P +G C+ +E L MQ N G IP
Sbjct: 507 EEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPDISRLVSLKNVD 566
Query: 555 XXXQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQGVFKNASITSVFGNLKLCGGIP 614
NNLSG+IP L L ++NLNLS N EG VPT GVF+NA+ SVFGN +CGG+
Sbjct: 567 FS-NNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVR 625
Query: 615 EFQLPTCXXXXXXXXXXXXXXXXXXXXXX---XXXXXXXXXXXXXCLVRKRKEKQXXXXX 671
E QL C C KRK+K
Sbjct: 626 EMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDG 685
Query: 672 XXXXXXX--------XYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL 723
Y+ L++AT RFSS N IG G+FG+VFKG+L +AVKV NL
Sbjct: 686 NPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNL 745
Query: 724 LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHP 783
L HGA KSF+AEC T K IRHRNLVK++T CS +D +GNDF+ALV+EFM SL+ WL
Sbjct: 746 LKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQL 805
Query: 784 ITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843
E D + RSL ++LNI+IDVA AL YLH C P+AHCD+KPSNILLD+D+ AH
Sbjct: 806 EDLERVNDHS-RSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAH 864
Query: 844 IGDFGLARFLPLSSAQT-----SSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLEL 898
+ DFGLA+ L ++ SS G +G+IGY APEYG+G + SI GDVYS+GILLLE+
Sbjct: 865 VSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEM 924
Query: 899 ITRKKPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSR 958
+ KKPTD F GD NLH+ ++ I+ + G + I G
Sbjct: 925 FSGKKPTDESFAGDYNLHSYTKS--------ILSGCTSSGGSNAIDEG------------ 964
Query: 959 IECLISMVRIGVACSMESPEDRM 981
L ++++G+ CS E P DRM
Sbjct: 965 ---LRLVLQVGIKCSEEYPRDRM 984
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1924 (682.3 bits), Expect = 9.7e-199, P = 9.7e-199
Identities = 413/986 (41%), Positives = 581/986 (58%)
Query: 18 NETDRLALLELKSKITHDPLGVLASWNESSHFCQWRGVTCSRRHQRVTILDLESLKLAGS 77
+ETDR ALLE KS+++ VL+SWN S C W+ VTC R+H+RVT L+L L+L G
Sbjct: 22 DETDRQALLEFKSQVSEGKRDVLSSWNNSFPLCNWKWVTCGRKHKRVTHLNLGGLQLGGI 81
Query: 78 ISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLI 137
+SP +GN+SFL L L +N+F IP E L RL+ L + +NS+ G IPA +S+CS L+
Sbjct: 82 VSPSIGNVSFLISLDLSDNAFGGIIPREVGNLFRLEHLYMAFNSLEGGIPATLSNCSRLL 141
Query: 138 QLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGS 197
L L+ N L +PSEL SL+K+ + + NNL G +P SLGNL+S++SL + NN+EG
Sbjct: 142 NLDLYSNPLRQGVPSELGSLTKLVILDLGRNNLKGKLPRSLGNLTSLKSLGFTDNNIEGE 201
Query: 198 IPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNL 257
+PD L L +V L ++ N+ G P +I+N+S++ + G++ D+G L N+
Sbjct: 202 VPDELARLSQMVGLGLSMNKFFGVFPPAIYNLSALEDLFLFGSGFSGSLKPDFGNLLPNI 261
Query: 258 QFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAA-PYLEKLQRLLVFGILGNSLGS 316
+ ++GEN L GAIP T+SN S L+ F + N +TG P K+ L + N LGS
Sbjct: 262 RELNLGENDLVGAIPTTLSNISTLQKFGINKNMMTGGIYPNFGKVPSLQYLDLSENPLGS 321
Query: 317 RGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAA 376
DL F+ SLTN T L+ L + GG+LP I+N+ST L L L N FG+IP
Sbjct: 322 YTFGDLEFIDSLTNCTHLQLLSVGYTRLGGALPTSIANMSTELISLNLIGNHFFGSIPQD 381
Query: 377 IGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNL-KLFILYL 435
IG + LQRL + N L+G +P ++G+L L L L NR G IP IGNL +L ILYL
Sbjct: 382 IGNLIGLQRLQLGKNMLTGPLPTSLGKLLRLGLLSLYSNRMSGEIPSFIGNLTQLEILYL 441
Query: 436 SYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPS 495
S N +G +P SLG+ + + + N L GTIP + + + + L+ L + N L+GS+P+
Sbjct: 442 SNNSFEGIVPPSLGKCSHMLDLRIGYNKLNGTIPKEIMQIPT-LVNLSMEGNSLSGSLPN 500
Query: 496 EVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPXXXXXXXXXXXXX 555
++G+L+NL L++ NK G +P TLG+C+ +EQL +Q N G IP
Sbjct: 501 DIGSLQNLVKLSLENNKFSGHLPQTLGNCLAMEQLFLQGNSFDGAIPNIRGLMGVRRVDL 560
Query: 556 XXQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQGVFKNASITSVFGNLKLCGGIPE 615
N+LSG IPE ++ LNLS N+ G VP++G F+N++I VFGN LCGGI +
Sbjct: 561 S-NNDLSGSIPEYFANFSKLEYLNLSINNFTGKVPSKGNFQNSTIVFVFGNKNLCGGIKD 619
Query: 616 FQLPTCXXXX----XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXCLVRKRKEKQXX--- 668
+L C C RKR++ Q
Sbjct: 620 LKLKPCLAQEPPVETKHSSHLKKVAILVSIGIALLLLLVIASMVLCWFRKRRKNQQTNNL 679
Query: 669 --XXXXXXXXXXXYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH 726
Y +L NAT+ FSS N +G GSFG+VFK +L +AVKV N+
Sbjct: 680 VPSKLEIFHEKISYGDLRNATNGFSSSNMVGSGSFGTVFKALLPTESKIVAVKVLNMQRR 739
Query: 727 GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITR 786
GA KSF+AEC +LK+ RHRNLVK+LTAC+ D+QGN+F+AL++E++ N S++ WLHP
Sbjct: 740 GAMKSFMAECESLKDTRHRNLVKLLTACASTDFQGNEFRALIYEYLPNGSVDMWLHP-EE 798
Query: 787 EDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846
+E PR+L L++RLNI IDVA L+YLH C PIAHCDLKPSN+LL++D+ AH+ D
Sbjct: 799 VEEIRRPPRTLTLLERLNIVIDVASVLDYLHVHCHEPIAHCDLKPSNVLLEDDLTAHVSD 858
Query: 847 FGLARFLPLSSA-----QTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITR 901
FGLAR L Q SS G +G+IGY APEYG+G + SI GDVYS+G+LLLE+ T
Sbjct: 859 FGLARLLLKFDKESFLNQLSSAGVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLLLEMFTG 918
Query: 902 KKPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRI-E 960
K+PTD +F G++ LH+ + ALP+ V +I D +L+ G RV R E
Sbjct: 919 KRPTDELFGGNLTLHSYTKLALPEKVFEIADKAILHIG-------------LRVGFRTAE 965
Query: 961 CLISMVRIGVACSMESPEDRMSMTNV 986
CL ++ +G+ C E P +R++ + V
Sbjct: 966 CLTLVLEVGLRCCEEYPTNRLATSEV 991
|
|
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 1162 (414.1 bits), Expect = 4.2e-195, Sum P(2) = 4.2e-195
Identities = 261/610 (42%), Positives = 356/610 (58%)
Query: 21 DRLALLELKSKITHDPLGVLASWNESSH--FCQWRGVTCSRRHQR----VTILDLESLKL 74
D LALL KS + + LASWN S H C W GV C RR +R V L L S L
Sbjct: 32 DELALLSFKSSLLYQGGQSLASWNTSGHGQHCTWVGVVCGRRRRRHPHRVVKLLLRSSNL 91
Query: 75 AGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCS 134
+G ISP +GNLSFL+ L L +N + EIP E RL RLQ+L L NSI G+IPA I +C+
Sbjct: 92 SGIISPSLGNLSFLRELDLGDNYLSGEIPPELSRLSRLQLLELSDNSIQGSIPAAIGACT 151
Query: 135 NLIQLRLFHNQLVGKIPSEL-SSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNN 193
L L L HNQL G IP E+ +SL + ++ + N L+G IPS+LGNL+S++ LS N
Sbjct: 152 KLTSLDLSHNQLRGMIPREIGASLKHLSNLYLYKNGLSGEIPSALGNLTSLQEFDLSFNR 211
Query: 194 LEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFS 253
L G+IP +LG L +L+ + + QN LSG IP+SI+N+SS+ F NK+ G IP + +
Sbjct: 212 LSGAIPSSLGQLSSLLTMNLGQNNLSGMIPNSIWNLSSLRAFSVRENKLGGMIPTNAFKT 271
Query: 254 LQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPY-LEKLQRLLVFGILGN 312
L L+ +G N+ G IP +++NAS+L + N +G +L+ L + N
Sbjct: 272 LHLLEVIDMGTNRFHGKIPASVANASHLTVIQIYGNLFSGIITSGFGRLRNLTELYLWRN 331
Query: 313 SLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGN 372
+R D F+ LTN ++L+ L + NN GG LP SNLST+L L L+ N+I G+
Sbjct: 332 LFQTREQDDWGFISDLTNCSKLQTLNLGENNLGGVLPNSFSNLSTSLSFLALELNKITGS 391
Query: 373 IPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNL-KLF 431
IP IG + LQ L +C+N G++P ++G L+NL L N G+IP +IGNL +L
Sbjct: 392 IPKDIGNLIGLQHLYLCNNNFRGSLPSSLGRLKNLGILLAYENNLSGSIPLAIGNLTELN 451
Query: 432 ILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTG 491
IL L N G IP +L L ++ LS NNL+G IP + + + I++++S+N L G
Sbjct: 452 ILLLGTNKFSGWIPYTLSNLTNLLSLGLSTNNLSGPIPSELFNIQTLSIMINVSKNNLEG 511
Query: 492 SIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPXXXXXXXXX 551
SIP E+G+LKNL + N+L G+IP+TLG C L L +Q N L G IP
Sbjct: 512 SIPQEIGHLKNLVEFHAESNRLSGKIPNTLGDCQLLRYLYLQNNLLSGSIPSALGQLKGL 571
Query: 552 XXXXXXQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQGVFKNASITSVFGNLKLCG 611
NNLSG+IP L + ++ +LNLS N G VPT G F AS S+ GN KLCG
Sbjct: 572 ETLDLSSNNLSGQIPTSLADITMLHSLNLSFNSFVGEVPTIGAFAAASGISIQGNAKLCG 631
Query: 612 GIPEFQLPTC 621
GIP+ LP C
Sbjct: 632 GIPDLHLPRC 641
|
|
| UNIPROTKB|O24435 O24435 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 1247 (444.0 bits), Expect = 5.3e-127, P = 5.3e-127
Identities = 289/723 (39%), Positives = 404/723 (55%)
Query: 91 LRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKI 150
LRL +++ I L L+ L L N + G IP +S S L QL L N L G+I
Sbjct: 83 LRLRSSNLAGIISPSLGNLSFLRTLQLSDNHLSGKIPQELSRLSRLQQLVLNFNSLSGEI 142
Query: 151 PSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVN 210
P+ L +L+ + + + +N L+G+IPSSLG L+ + L L+ N L GSIP + G L+ L
Sbjct: 143 PAALGNLTSLSVLELTNNTLSGAIPSSLGKLTGLTDLALAENTLSGSIPSSFGQLRRLSF 202
Query: 211 LTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGA 270
L++A N LSG IP I+NISS+T F+ NK+ G +P + +L +LQ + NQ G
Sbjct: 203 LSLAFNNLSGAIPDPIWNISSLTIFEVISNKLSGTLPTNAFSNLPSLQEVYMYYNQFHGR 262
Query: 271 IPPTISNASNLEIFHGSVNKLTGAAP----YLEKLQRLLVFGILGNSLGSRGDRDLNFLC 326
IP +I NASN+ IF +N +G P + LQRL + L + D F+
Sbjct: 263 IPASIGNASNISIFTIGLNSFSGVVPPEIGRMRNLQRLELPETLSEA---EETNDWKFMT 319
Query: 327 SLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRL 386
+LTN + L+ + + FGG LP +SNLS++L L + +N+I G++P IG VNLQ L
Sbjct: 320 ALTNCSNLQEVELGGCKFGGVLPDSVSNLSSSLVSLSIRDNKISGSLPRDIGNLVNLQYL 379
Query: 387 DMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNL-KLFILYLSYNFLQGSIP 445
+ +N L+G++P + +L+NL+ L + N+ G++P +IGNL +L + + +N G+IP
Sbjct: 380 SLANNSLTGSLPSSFSKLKNLRRLTVDNNKLIGSLPLTIGNLTQLTNMEVQFNAFGGTIP 439
Query: 446 SSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEI 505
S+LG L I+L +NN G IP + + + +LD+S N L GSIP E+G LKN+
Sbjct: 440 STLGNLTKLFQINLGHNNFIGQIPIEIFSIPALSEILDVSHNNLEGSIPKEIGKLKNIVE 499
Query: 506 LNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPXXXXXXXXXXXXXXXQNNLSGKI 565
+ NKL GE PST+G C L+ L +Q NFL G IP NNLSG+I
Sbjct: 500 FHADSNKLSGENPSTIGECQLLQHLFLQNNFLNGSIPIALTQLKGLDTLDLSGNNLSGQI 559
Query: 566 PELLIRLQLVKNLNLSNNDLEGVVPTQGVFKNASITSVFGNLKLCGGIPEFQLPTCXXXX 625
P L + L+ +LNLS N G VPT GVF NAS + GN +CGGIPE LPTC
Sbjct: 560 PMSLGDMPLLHSLNLSFNSFHGEVPTNGVFANASEIYIQGNAHICGGIPELHLPTCSLKS 619
Query: 626 XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXCLVRKRKEKQXXXXXXXXXXXXXYQNLYN 685
++RK++ Y+ L
Sbjct: 620 RKKKKHQILLLVVVICLVSTLAVFSLLYMLLTCHKRRKKEVPATTSMQGHPMITYKQLVK 679
Query: 686 ATDRFSSVNQIGEGSFGSVFKGILD--DGRTT--IAVKVFNLLHHGAFKSFIAECNTLKN 741
ATD FSS + +G GSFGSV+KG D DG T +AV+V L A KSF AEC TL+N
Sbjct: 680 ATDGFSSSHLLGSGSFGSVYKGEFDSQDGEITSLVAVRVLKLETPKALKSFTAECETLRN 739
Query: 742 IRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQ 801
RHRNLVKI+T CS +D +GNDFKA+V++FM N SLE+WLHP T D+ ++ R L L Q
Sbjct: 740 TRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWLHPETN-DQAEQ--RHLTLHQ 796
Query: 802 RLN 804
R++
Sbjct: 797 RVS 799
|
|
| TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1238 (440.9 bits), Expect = 4.8e-126, P = 4.8e-126
Identities = 324/945 (34%), Positives = 480/945 (50%)
Query: 66 ILDLESLKLA-----GSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYN 120
+L+L+SL L G I +GN S L L LY+N +IP+E L +LQ L ++ N
Sbjct: 239 LLNLQSLVLTENLLEGDIPAEIGNCSSLVQLELYDNQLTGKIPAELGNLVQLQALRIYKN 298
Query: 121 SIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGN 180
+ +IP+++ + L L L N LVG I E+ L +E ++++ NN TG P S+ N
Sbjct: 299 KLTSSIPSSLFRLTQLTHLGLSENHLVGPISEEIGFLESLEVLTLHSNNFTGEFPQSITN 358
Query: 181 LSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVN 240
L ++ L + NN+ G +P LG L NL NL+ N L+G IPSSI N + + D N
Sbjct: 359 LRNLTVLTVGFNNISGELPADLGLLTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHN 418
Query: 241 KIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAA-PYLE 299
++ G IP GF NL F S+G N TG IP I N SNLE + N LTG P +
Sbjct: 419 QMTGEIPR--GFGRMNLTFISIGRNHFTGEIPDDIFNCSNLETLSVADNNLTGTLKPLIG 476
Query: 300 KLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTL 359
KLQ+L + + NSL R++ N L L ++ N F G +P +SNL T L
Sbjct: 477 KLQKLRILQVSYNSLTGPIPREIG------NLKDLNILYLHSNGFTGRIPREMSNL-TLL 529
Query: 360 EVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQG 419
+ L + +N + G IP + L LD+ +N+ SG IP +L++L L LQ N+F G
Sbjct: 530 QGLRMYSNDLEGPIPEEMFDMKLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNG 589
Query: 420 NIPPSIGNLKLFILY-LSYNFLQGSIPSSL-GRYETLTT-IDLSNNNLTGTIPPQFIGLS 476
+IP S+ +L L + +S N L G+IP L + + ++ SNN LTGTIP + +G
Sbjct: 590 SIPASLKSLSLLNTFDISDNLLTGTIPGELLASLKNMQLYLNFSNNLLTGTIPKE-LGKL 648
Query: 477 SSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLE-QLEMQEN 535
+ +DLS N +GSIP + KN+ L+ N L G IP + + + L + N
Sbjct: 649 EMVQEIDLSNNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRN 708
Query: 536 FLQGPIPXXXXXXXXXXXXXXXQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQGVF 595
G IP NNL+G+IPE L L +K+L L++N+L+G VP GVF
Sbjct: 709 SFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVF 768
Query: 596 KNASITSVFGNLKLCGGIPEFQLPTCXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX 655
KN + + + GN LCG + T
Sbjct: 769 KNINASDLMGNTDLCGSKKPLKPCTIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLIL 828
Query: 656 XCLVRKRKEKQXXXXXXXXXXXXXYQ-------NLYNATDRFSSVNQIGEGSFGSVFKGI 708
C +K K+ + + L ATD F+S N IG S +V+KG
Sbjct: 829 TCCKKKEKKIENSSESSLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQ 888
Query: 709 LDDGRTTIAVKVFNLLHHGAF--KSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766
L+DG T IAVKV NL A K F E TL ++HRNLVKIL G ++ KA
Sbjct: 889 LEDG-TVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKIL----GFAWESGKTKA 943
Query: 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAH 826
LV FM N +LE+ +H AP +L++++++ + +A ++YLH PI H
Sbjct: 944 LVLPFMENGNLEDTIHG-------SAAPIG-SLLEKIDLCVHIASGIDYLHSGYGFPIVH 995
Query: 827 CDLKPSNILLDEDMIAHIGDFGLARFLPL--SSAQTSSIGA-KGSIGYIAPEYGLGSEVS 883
CDLKP+NILLD D +AH+ DFG AR L + T+S A +G+IGY+APE+ +V+
Sbjct: 996 CDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPEFAYMRKVT 1055
Query: 884 ISGDVYSYGILLLELITRKKPTDIMFEG--DMNLHNLARTALPDHVMDIVDSTLLNDGED 941
DV+S+GI+++EL+T+++PT + E DM L L ++ + +V + G+
Sbjct: 1056 TKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMVRVLDMELGDS 1115
Query: 942 LIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986
++ + +Q +A IE +++ + C+ PEDR M +
Sbjct: 1116 IV---SLKQEEA-----IE---DFLKLCLFCTSSRPEDRPDMNEI 1149
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 800 (286.7 bits), Expect = 5.2e-121, Sum P(2) = 5.2e-121
Identities = 211/615 (34%), Positives = 309/615 (50%)
Query: 7 FLGVTASTVAGNETDRLALLELKSKITHDPL--GVLASWNESS-HFCQWRGVTCSRRHQ- 62
F G+ + N D LLE+K + +P L WN + ++C W GVTC
Sbjct: 14 FSGLGQPGIINN--DLQTLLEVKKSLVTNPQEDDPLRQWNSDNINYCSWTGVTCDNTGLF 71
Query: 63 RVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSI 122
RV L+L L L GSISP G L L L +N+ IP+ L L+ L L N +
Sbjct: 72 RVIALNLTGLGLTGSISPWFGRFDNLIHLDLSSNNLVGPIPTALSNLTSLESLFLFSNQL 131
Query: 123 GGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLS 182
G IP+ + S N+ LR+ N+LVG IP L +L ++ +++ LTG IPS LG L
Sbjct: 132 TGEIPSQLGSLVNIRSLRIGDNELVGDIPETLGNLVNLQMLALASCRLTGPIPSQLGRLV 191
Query: 183 SIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKI 242
++SL L N LEG IP LG +L T A+N L+GTIP+ + + ++ + N +
Sbjct: 192 RVQSLILQDNYLEGPIPAELGNCSDLTVFTAAENMLNGTIPAELGRLENLEILNLANNSL 251
Query: 243 QGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPY-LEKL 301
G IP G + LQ+ S+ NQL G IP ++++ NL+ S N LTG P +
Sbjct: 252 TGEIPSQLG-EMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWNM 310
Query: 302 QRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEV 361
+LL + N L + + CS N T L+ L+++ G +P +S + L+
Sbjct: 311 SQLLDLVLANNHLSGSLPKSI---CS--NNTNLEQLVLSGTQLSGEIPVELSKCQS-LKQ 364
Query: 362 LLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNI 421
L L NN + G+IP A+ + V L L + +N L GT+ P+I L NL+ L L N +G +
Sbjct: 365 LDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKL 424
Query: 422 PPSIGNL-KLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLI 480
P I L KL +L+L N G IP +G +L ID+ N+ G IPP IG L
Sbjct: 425 PKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPS-IGRLKELN 483
Query: 481 VLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGP 540
+L L +N+L G +P+ +GN L IL++ N+L G IPS+ G LEQL + N LQG
Sbjct: 484 LLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGN 543
Query: 541 IPXXXXXXXXXXXXXXXQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQ-GVFKNAS 599
+P N L+G I L + + +++NN E +P + G +N
Sbjct: 544 LPDSLISLRNLTRINLSHNRLNGTIHPLCGSSSYL-SFDVTNNGFEDEIPLELGNSQNLD 602
Query: 600 ITSVFGNLKLCGGIP 614
+ G +L G IP
Sbjct: 603 RLRL-GKNQLTGKIP 616
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 752 (269.8 bits), Expect = 3.6e-115, Sum P(2) = 3.6e-115
Identities = 186/552 (33%), Positives = 282/552 (51%)
Query: 73 KLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISS 132
KL+G + +G+L L+ L Y N+ +P L +L N G IP I
Sbjct: 168 KLSGPLPEEIGDLYNLEELVAYTNNLTGPLPRSLGNLNKLTTFRAGQNDFSGNIPTEIGK 227
Query: 133 CSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGN 192
C NL L L N + G++P E+ L K++ + + N +G IP +GNL+S+ +L L GN
Sbjct: 228 CLNLKLLGLAQNFISGELPKEIGMLVKLQEVILWQNKFSGFIPKDIGNLTSLETLALYGN 287
Query: 193 NLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGF 252
+L G IP +G +K+L L + QN+L+GTIP + +S + D N + G IP++
Sbjct: 288 SLVGPIPSEIGNMKSLKKLYLYQNQLNGTIPKELGKLSKVMEIDFSENLLSGEIPVELS- 346
Query: 253 SLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPY-LEKLQRLLVFGILG 311
+ L+ + +N+LTG IP +S NL S+N LTG P + L + +
Sbjct: 347 KISELRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFH 406
Query: 312 NSLGSRGDRDLNFLCSLTNATRLKWLL-ININNFGGSLPACISNLSTTLEVLLLDNNQIF 370
NSL + L L W++ + N G +P I S + +L L +N+IF
Sbjct: 407 NSLSGVIPQGLGLYSPL-------WVVDFSENQLSGKIPPFICQQSNLI-LLNLGSNRIF 458
Query: 371 GNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNL-K 429
GNIP + + +L +L + NRL+G P + +L NL + L +NRF G +PP IG K
Sbjct: 459 GNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGPLPPEIGTCQK 518
Query: 430 LFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQL 489
L L+L+ N ++P+ + + L T ++S+N+LTG IP + I L LDLSRN
Sbjct: 519 LQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPIPSE-IANCKMLQRLDLSRNSF 577
Query: 490 TGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIP-XXXXXX 548
GS+P E+G+L LEIL + N+ G IP T+G+ L +L+M N G IP
Sbjct: 578 IGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLS 637
Query: 549 XXXXXXXXXQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQGVFKNAS--ITSVFGN 606
N+ SG+IP + L L+ L+L+NN L G +PT F+N S + F
Sbjct: 638 SLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPT--TFENLSSLLGCNFSY 695
Query: 607 LKLCGGIPEFQL 618
L G +P Q+
Sbjct: 696 NNLTGQLPHTQI 707
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGP4 | Y3475_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4517 | 0.9665 | 0.9435 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.01680026 | hypothetical protein (1007 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 986 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-119 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-40 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-38 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-37 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-37 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-35 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-35 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-34 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-29 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-28 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-25 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-24 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-23 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-22 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-22 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-22 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-21 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-21 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-21 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-20 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-20 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-20 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-20 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-19 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-18 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-18 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-18 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-17 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-17 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 9e-17 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-16 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-16 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-16 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-16 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-15 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-15 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-15 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-15 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-15 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-15 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-15 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-15 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-14 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-14 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-14 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-14 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-14 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-13 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-13 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-13 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-13 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-13 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 9e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-12 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-12 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-12 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-12 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 9e-12 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 9e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-12 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 9e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-11 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-11 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-11 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-11 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-11 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-10 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-10 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-10 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-10 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-10 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-10 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-09 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-09 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-09 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-09 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-09 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 8e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 9e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 9e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 9e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 9e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-08 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-08 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-08 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-08 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-08 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 8e-08 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 9e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 9e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-08 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-07 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-07 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-07 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-07 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-07 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-07 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-07 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-07 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-07 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-07 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-07 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-07 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-07 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 7e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-07 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-06 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-06 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-06 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-06 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-06 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-06 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-06 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-06 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-06 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 8e-06 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-06 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-06 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-05 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-05 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-05 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-05 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-05 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-05 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-05 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-05 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-05 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-05 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 4e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-05 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-05 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 6e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-05 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-05 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 9e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 1e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-04 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-04 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-04 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-04 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-04 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-04 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-04 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-04 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-04 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 9e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 0.001 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 0.001 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 0.001 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.003 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 388 bits (999), Expect = e-119
Identities = 311/1015 (30%), Positives = 473/1015 (46%), Gaps = 123/1015 (12%)
Query: 7 FLGVTASTVAGNETDRLALLELKSKITHDPLGVLASWNESSHFCQWRGVTCSRRHQRVTI 66
FL + S + E + LL KS I +DPL L++WN S+ C W+G+TC+ RV
Sbjct: 18 FLFLNFSMLHAEELE--LLLSFKSSI-NDPLKYLSNWNSSADVCLWQGITCNN-SSRVVS 73
Query: 67 LDLESLKLAGSISPHVGNLSFLKV-------------------------LRLYNNSFNHE 101
+DL ++G IS + L +++ L L NN+F
Sbjct: 74 IDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGS 133
Query: 102 IPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIE 161
IP + L+ L L N + G IP +I S S+L L L N LVGKIP+ L++L+ +E
Sbjct: 134 IPRGS--IPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLE 191
Query: 162 HISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGT 221
+++ N L G IP LG + S++ ++L NNL G IP +G L +L +L + N L+G
Sbjct: 192 FLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGP 251
Query: 222 IPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNL 281
IPSS+ N+ ++ NK+ G IP FSLQ L + +N L+G IP + NL
Sbjct: 252 IPSSLGNLKNLQYLFLYQNKLSGPIPPSI-FSLQKLISLDLSDNSLSGEIPELVIQLQNL 310
Query: 282 EIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLINI 341
EI H N TG P +LT+ RL+ L +
Sbjct: 311 EILHLFSNNFTGKIPV-----------------------------ALTSLPRLQVLQLWS 341
Query: 342 NNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAI 401
N F G +P + L VL L N + G IP + NL +L + SN L G IP ++
Sbjct: 342 NKFSGEIPKNLGK-HNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSL 400
Query: 402 GELQNLKDLRLQRNRFQGNIPPSIGNLKL-FILYLSYNFLQGSIPSSLGRYETLTTIDLS 460
G ++L+ +RLQ N F G +P L L + L +S N LQG I S +L + L+
Sbjct: 401 GACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLA 460
Query: 461 NNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPST 520
N G +P F S L LDLSRNQ +G++P ++G+L L L + NKL GEIP
Sbjct: 461 RNKFFGGLPDSF--GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDE 518
Query: 521 LGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNL 580
L SC KL L++ N L G IP+S S + LS LDLSQN LSG+IP+ L ++ + +N+
Sbjct: 519 LSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNI 578
Query: 581 SNNDLEGVVPTQGVFKNASITSVFGNLKLCGGIPEFQLPTCSSKKSKHKKSLALKLVLAI 640
S+N L G +P+ G F + ++V GN+ LCGG LP C K K +
Sbjct: 579 SHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPC---KRVRKTPSWWFYITCT 635
Query: 641 ISGLIGLSLALSIIVLCLVR-----KRKEKQNPNSPINSFPNISYQNLYNATDRFSSV-- 693
+ + L+L V R KR E ++ + F + D SS+
Sbjct: 636 LGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFF-DSKVSKSITINDILSSLKE 694
Query: 694 -NQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILT 752
N I G G+ +KG VK N ++ S IA+ + ++H N+VK++
Sbjct: 695 ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP-SSEIAD---MGKLQHPNIVKLIG 750
Query: 753 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACA 812
C + L+ E++ ++L E L R+L+ +R I+I +A A
Sbjct: 751 LC-----RSEKGAYLIHEYIEGKNLSEVL-------------RNLSWERRRKIAIGIAKA 792
Query: 813 LNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYI 872
L +LH C P + +L P I++D H+ L L + S Y+
Sbjct: 793 LRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL-------RLSLPGLLCTDTKCFISSAYV 845
Query: 873 APEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVMDI-V 931
APE +++ D+Y +G++L+EL+T K P D F ++ AR D +D+ +
Sbjct: 846 APETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWI 905
Query: 932 DSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986
D ++ D V NQ + ++ ++ + + C+ P R +V
Sbjct: 906 DPSIRGD-----VSVNQNE-----------IVEVMNLALHCTATDPTARPCANDV 944
|
Length = 968 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 74/256 (28%), Positives = 111/256 (43%), Gaps = 27/256 (10%)
Query: 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLV 748
+ + ++GEGSFG V+ +A+KV + + E LK ++H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 749 KILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISID 808
++ ++ D LV E+ L + L L+ +
Sbjct: 61 RLYDV-----FEDEDKLYLVMEYCEGGDLFDLLK----------KRGRLSEDEARFYLRQ 105
Query: 809 VACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGS 868
+ AL YLH I H DLKP NILLDED + DFGLAR L T+ + G+
Sbjct: 106 ILSALEYLHSKG---IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV---GT 159
Query: 869 IGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTAL-PDHV 927
Y+APE LG + D++S G++L EL+T K P F GD L L + P
Sbjct: 160 PEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPP----FPGDDQLLELFKKIGKPKPP 215
Query: 928 MDIVDSTLLNDGEDLI 943
+ + + +DLI
Sbjct: 216 FPPPEWDISPEAKDLI 231
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 1e-38
Identities = 72/256 (28%), Positives = 114/256 (44%), Gaps = 31/256 (12%)
Query: 695 QIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILT 752
++G GSFG+V+K +AVK+ ++ E L+ + H N+V+++
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI- 64
Query: 753 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACA 812
+ LV E+ L ++L L+ + I++ +
Sbjct: 65 ---DAFEDKDHL-YLVMEYCEGGDLFDYL----------SRGGPLSEDEAKKIALQILRG 110
Query: 813 LNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYI 872
L YLH + I H DLKP NILLDE+ + I DFGLA+ L SS+ ++ G+ Y+
Sbjct: 111 LEYLHSN---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV--GTPWYM 165
Query: 873 APE-YGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTAL----PDHV 927
APE G+ DV+S G++L EL+T K P F G+ L L P
Sbjct: 166 APEVLLGGNGYGPKVDVWSLGVILYELLTGKPP----FSGENILDQLQLIRRILGPPLEF 221
Query: 928 MDIVDSTLLNDGEDLI 943
+ S+ + +DLI
Sbjct: 222 DEPKWSSGSEEAKDLI 237
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 24/213 (11%)
Query: 695 QIGEGSFGSVFKGIL----DDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVK 749
++GEG+FG V+KG L + T +AVK + F+ E + +K + H N+V+
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 750 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDV 809
+L C+ QG +V E+M L ++L + L L L +++ +
Sbjct: 66 LLGVCT----QGEPLY-IVTEYMPGGDLLDFLR---------KHGEKLTLKDLLQMALQI 111
Query: 810 ACALNYLH-HDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGS 868
A + YL + + H DL N L+ E+++ I DFGL+R + G K
Sbjct: 112 AKGMEYLESKNF---V-HRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLP 167
Query: 869 IGYIAPEYGLGSEVSISGDVYSYGILLLELITR 901
I ++APE + + DV+S+G+LL E+ T
Sbjct: 168 IKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 6e-37
Identities = 63/206 (30%), Positives = 95/206 (46%), Gaps = 22/206 (10%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFNL-LHHGAFKSFIAECNTLKNIRHRNLVKILTAC 754
+GEG FG+V+ +A+K+ + + E LK + H N+VK+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLY--- 57
Query: 755 SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALN 814
GV ++ + LV E+ SL++ L E L+ + L I + + L
Sbjct: 58 -GV-FEDENHLYLVMEYCEGGSLKDLLK---------ENEGKLSEDEILRILLQILEGLE 106
Query: 815 YLHHDCQPPIAHCDLKPSNILLDED-MIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIA 873
YLH I H DLKP NILLD D + DFGL++ L + +I G+ Y+A
Sbjct: 107 YLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV--GTPAYMA 161
Query: 874 PEYGLG-SEVSISGDVYSYGILLLEL 898
PE LG S D++S G++L EL
Sbjct: 162 PEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 66/217 (30%), Positives = 102/217 (47%), Gaps = 23/217 (10%)
Query: 694 NQIGEGSFGSVFKGIL---DDGRTTIAVKVFNLLHHGAFKS----FIAECNTLKNIRHRN 746
++GEG+FG V+KG L D T +AVK L A + F+ E +K + H N
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKT---LKEDASEEERKDFLKEARVMKKLGHPN 57
Query: 747 LVKILTACSGVD--YQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLN 804
+V++L C+ + Y LV E+M L ++L +R +L+L L+
Sbjct: 58 VVRLLGVCTEEEPLY-------LVLEYMEGGDLLDYLR-KSRPVFPSPEKSTLSLKDLLS 109
Query: 805 ISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIG 864
+I +A + YL H DL N L+ ED++ I DFGL+R + G
Sbjct: 110 FAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTG 166
Query: 865 AKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITR 901
K I ++APE + DV+S+G+LL E+ T
Sbjct: 167 GKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTL 203
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 4e-35
Identities = 64/218 (29%), Positives = 101/218 (46%), Gaps = 34/218 (15%)
Query: 695 QIGEGSFGSVFKGIL----DDGRTTIAVKVFNLLHHGAF----KSFIAECNTLKNIRHRN 746
++GEG+FG V+KG L D +AVK L A + F+ E ++ + H N
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKT---LKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 747 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNIS 806
+VK+L C+ + +V E+M L ++L P+ L+L L+ +
Sbjct: 63 IVKLLGVCTEEEPL-----MIVMEYMPGGDLLDYLR--------KNRPKELSLSDLLSFA 109
Query: 807 IDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAK 866
+ +A + YL H DL N L+ E+++ I DFGL+R L G K
Sbjct: 110 LQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLY-DDDYYKVKGGK 165
Query: 867 GSIGYIAPE---YGLGSEVSISGDVYSYGILLLELITR 901
I ++APE G + S DV+S+G+LL E+ T
Sbjct: 166 LPIRWMAPESLKEGKFTSKS---DVWSFGVLLWEIFTL 200
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 62/218 (28%), Positives = 99/218 (45%), Gaps = 35/218 (16%)
Query: 695 QIGEGSFGSVFKGIL----DDGRTTIAVKVFNLLHHGAF----KSFIAECNTLKNIRHRN 746
++GEG+FG V+KG L + +AVK L A + F+ E ++ + H N
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKT---LKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 747 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNIS 806
+VK+L C+ + +V E+M L +L + L+L L+ +
Sbjct: 63 VVKLLGVCTEEEPL-----YIVMEYMEGGDLLSYLR---------KNRPKLSLSDLLSFA 108
Query: 807 IDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAK 866
+ +A + YL H DL N L+ E+++ I DFGL+R L G K
Sbjct: 109 LQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY-DDDYYRKRGGK 164
Query: 867 GSIGYIAPE---YGLGSEVSISGDVYSYGILLLELITR 901
I ++APE G + S DV+S+G+LL E+ T
Sbjct: 165 LPIRWMAPESLKEGKFTSKS---DVWSFGVLLWEIFTL 199
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 9e-29
Identities = 68/209 (32%), Positives = 103/209 (49%), Gaps = 27/209 (12%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFK--SFIAECNTLKNIRHRNLVKILTA 753
+G G FG V+ G + G T +AVK L G +F+ E +K +RH LV++
Sbjct: 14 LGAGQFGEVWMGTWN-GTTKVAVKT---LKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 754 CSGVD--YQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVAC 811
CS + Y +V E+M SL ++L + E + L L Q ++++ +A
Sbjct: 70 CSEEEPIY-------IVTEYMSKGSLLDFLK-------SGEG-KKLRLPQLVDMAAQIAE 114
Query: 812 ALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGY 871
+ YL H DL NIL+ E+++ I DFGLAR + T+ GAK I +
Sbjct: 115 GMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIE-DDEYTAREGAKFPIKW 170
Query: 872 IAPEYGLGSEVSISGDVYSYGILLLELIT 900
APE +I DV+S+GILL E++T
Sbjct: 171 TAPEAANYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 56/220 (25%), Positives = 97/220 (44%), Gaps = 22/220 (10%)
Query: 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRN 746
++ +G GSFGSV+ + D +AVK L ++ E L +++H N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 747 LVKILTACSGVDYQGNDFKALVF-EFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNI 805
+V+ G + +F E++ SL L + E +I++
Sbjct: 61 IVRYY----GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPE--------PVIRKY-- 106
Query: 806 SIDVACALNYLH-HDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIG 864
+ + L YLH + I H D+K +NIL+D D + + DFG A+ L +
Sbjct: 107 TRQILEGLAYLHSNG----IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGS 162
Query: 865 AKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
+G+ ++APE G E + D++S G ++E+ T K P
Sbjct: 163 VRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 9e-28
Identities = 73/212 (34%), Positives = 109/212 (51%), Gaps = 27/212 (12%)
Query: 693 VNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAF--KSFIAECNTLKNIRHRNLVKI 750
+ ++G G FG V++G L + T +AVK L G K F+AE +K +RH L+++
Sbjct: 11 LRKLGAGQFGEVWEG-LWNNTTPVAVKT---LKPGTMDPKDFLAEAQIMKKLRHPKLIQL 66
Query: 751 LTACSGVD--YQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISID 808
C+ + Y +V E M SL E+L A R+L L Q ++++
Sbjct: 67 YAVCTLEEPIY-------IVTELMKYGSLLEYLQ--------GGAGRALKLPQLIDMAAQ 111
Query: 809 VACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGS 868
VA + YL + Q I H DL N+L+ E+ I + DFGLAR + + GAK
Sbjct: 112 VASGMAYL--EAQNYI-HRDLAARNVLVGENNICKVADFGLARVI-KEDIYEAREGAKFP 167
Query: 869 IGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
I + APE L + SI DV+S+GILL E++T
Sbjct: 168 IKWTAPEAALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 68/205 (33%), Positives = 103/205 (50%), Gaps = 26/205 (12%)
Query: 695 QIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTAC 754
IG+G FG V G G+ +AVK A ++F+AE + + +RH NLV++L
Sbjct: 13 TIGKGEFGDVMLGDYR-GQK-VAVKCLKD-DSTAAQAFLAEASVMTTLRHPNLVQLL--- 66
Query: 755 SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRS-LNLIQRLNISIDVACAL 813
GV QGN +V E+M SL ++L +R R+ + L Q+L ++DV +
Sbjct: 67 -GVVLQGNPL-YIVTEYMAKGSLVDYLR--SRG-------RAVITLAQQLGFALDVCEGM 115
Query: 814 NYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIA 873
YL + H DL N+L+ ED++A + DFGLA+ A K + + A
Sbjct: 116 EYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTA 167
Query: 874 PEYGLGSEVSISGDVYSYGILLLEL 898
PE + S DV+S+GILL E+
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 68/234 (29%), Positives = 109/234 (46%), Gaps = 37/234 (15%)
Query: 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVKVF---NLLHHGAFKSFIAECNTLKNIRHRN 746
F+ ++G G FG V++G L R +A+K+ +LL F+ E LK +RH++
Sbjct: 8 FTLERKLGSGYFGEVWEG-LWKNRVRVAIKILKSDDLLKQQDFQK---EVQALKRLRHKH 63
Query: 747 LVKILTACSGVD--YQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLN 804
L+ + CS + Y ++ E M SL +L R E + L + ++
Sbjct: 64 LISLFAVCSVGEPVY-------IITELMEKGSLLAFL----RSPEG----QVLPVASLID 108
Query: 805 ISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFL--PLSSAQTSS 862
++ VA + YL + H DL NIL+ ED++ + DFGLAR + + +
Sbjct: 109 MACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKK 165
Query: 863 IGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLH 916
I K + APE S DV+S+GILL E+ T + + + G MN H
Sbjct: 166 IPYK----WTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQ---VPYPG-MNNH 211
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 63/218 (28%), Positives = 93/218 (42%), Gaps = 26/218 (11%)
Query: 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVK 749
F + +IG+G FG V+K +A+KV L + I E LK +H N+VK
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 750 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITRE-DETDEAPRSLNLIQRLNISID 808
+ Y D +V EF SL++ L + E+ A L++
Sbjct: 62 YYGS-----YLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLK------- 109
Query: 809 VACALNYLH--HDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAK 866
L YLH I H D+K +NILL D + DFGL+ L + A+ + +G
Sbjct: 110 ---GLEYLHSNG-----IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTP 161
Query: 867 GSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
++APE G D++S GI +EL K P
Sbjct: 162 ---YWMAPEVINGKPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 5e-23
Identities = 83/290 (28%), Positives = 133/290 (45%), Gaps = 55/290 (18%)
Query: 693 VNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAF--KSFIAECNTLKNIRHRNLVKI 750
+ ++G G FG V+ G + G T +AVK L G +SF+ E +K +RH LV++
Sbjct: 11 IKKLGNGQFGEVWMGTWN-GNTKVAVKT---LKPGTMSPESFLEEAQIMKKLRHDKLVQL 66
Query: 751 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVA 810
S + +V E+M SL ++L D R+L L ++++ VA
Sbjct: 67 YAVVS------EEPIYIVTEYMSKGSLLDFL--------KDGEGRALKLPNLVDMAAQVA 112
Query: 811 CALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIG 870
+ Y+ + H DL+ +NIL+ + ++ I DFGLAR + + T+ GAK I
Sbjct: 113 AGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIE-DNEYTARQGAKFPIK 168
Query: 871 YIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVMDI 930
+ APE L +I DV+S+GILL EL+T+ R P
Sbjct: 169 WTAPEAALYGRFTIKSDVWSFGILLTELVTK-----------------GRVPYPG----- 206
Query: 931 VDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDR 980
+N+ E L Q +R R+ +C IS+ + + C + PE+R
Sbjct: 207 -----MNNREVL----EQVERGYRMPCPQDCPISLHELMLQCWKKDPEER 247
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (248), Expect = 1e-22
Identities = 74/239 (30%), Positives = 118/239 (49%), Gaps = 37/239 (15%)
Query: 690 FSSVNQIGEGSFGSVFKGILDDGRT--TIAVKVFNLLHH--GAFKSFIAECNTLKNIRHR 745
+ + ++GEG++G V+K D +T +A+K L + G + + E + LK ++H
Sbjct: 1 YEKLEKLGEGTYGVVYKAR--DKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHP 58
Query: 746 NLVKILTACSGVDYQGNDFK-ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLN 804
N+VK+L D + K LVFE+ + L+++L P S NLI+
Sbjct: 59 NIVKLL------DVIHTERKLYLVFEYC-DMDLKKYLDKRPG-------PLSPNLIKS-- 102
Query: 805 ISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARF--LPLSSAQTSS 862
I + L Y H I H DLKP NIL++ D + + DFGLAR +PL +
Sbjct: 103 IMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEV 159
Query: 863 IGAKGSIGYIAPEYGLGSEV-SISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLAR 920
+ ++ Y APE LGS+ S + D++S G + E+IT K +F GD + L +
Sbjct: 160 V----TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK----PLFPGDSEIDQLFK 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 1e-22
Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 18/207 (8%)
Query: 694 NQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTA 753
+++G G +G V++G+ T+AVK + F+ E +K I+H NLV++L
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 754 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACAL 813
C+ + F ++ EFM +L ++L R+ +N + L ++ ++ A+
Sbjct: 71 CT----REPPF-YIITEFMTYGNLLDYLRECNRQ--------EVNAVVLLYMATQISSAM 117
Query: 814 NYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIA 873
YL + H DL N L+ E+ + + DFGL+R + T+ GAK I + A
Sbjct: 118 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTA 173
Query: 874 PEYGLGSEVSISGDVYSYGILLLELIT 900
PE ++ SI DV+++G+LL E+ T
Sbjct: 174 PESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 3e-22
Identities = 79/288 (27%), Positives = 133/288 (46%), Gaps = 55/288 (19%)
Query: 695 QIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAF--KSFIAECNTLKNIRHRNLVKILT 752
++G+G FG V+ G + G T +A+K L G ++F+ E +K +RH LV++
Sbjct: 13 KLGQGCFGEVWMGTWN-GTTRVAIKT---LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 68
Query: 753 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACA 812
S + +V E+M SL ++L E + L L Q ++++ +A
Sbjct: 69 VVS------EEPIYIVTEYMSKGSLLDFL--------KGEMGKYLRLPQLVDMAAQIASG 114
Query: 813 LNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYI 872
+ Y+ + H DL+ +NIL+ E+++ + DFGLAR + + T+ GAK I +
Sbjct: 115 MAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWT 170
Query: 873 APEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVMDIVD 932
APE L +I DV+S+GILL EL T+ + + + G +N V+D
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELTTKGR---VPYPGMVN----------REVLD--- 214
Query: 933 STLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDR 980
Q +R R+ EC S+ + C + PE+R
Sbjct: 215 ---------------QVERGYRMPCPPECPESLHDLMCQCWRKEPEER 247
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 69/223 (30%), Positives = 105/223 (47%), Gaps = 35/223 (15%)
Query: 694 NQIGEGSFGSVFKGI-LDDGRTTIAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKI 750
N+IG G+FG V+ + LD G +AVK + K E L+ ++H NLVK
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGEL-MAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK- 63
Query: 751 LTACSGVDYQGNDFKALVF-EFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDV 809
GV+ K +F E+ +LEE L DE ++I+ + +
Sbjct: 64 ---YYGVEVHRE--KVYIFMEYCSGGTLEELLEHGRILDE--------HVIRVYTLQLLE 110
Query: 810 ACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAK--- 866
L YLH I H D+KP+NI LD + + +GDFG A L T+++G +
Sbjct: 111 G--LAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKL---KNNTTTMGEEVQS 162
Query: 867 --GSIGYIAPEYGLGSEVSISG---DVYSYGILLLELITRKKP 904
G+ Y+APE G + G D++S G ++LE+ T K+P
Sbjct: 163 LAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 7e-22
Identities = 68/239 (28%), Positives = 106/239 (44%), Gaps = 33/239 (13%)
Query: 691 SSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAF--KSFIAECNTLKNIRHRNLV 748
+ + ++G G FG V G G+ +A+K ++ GA FI E + + H NLV
Sbjct: 7 TFLKELGSGQFGVVHLGKWR-GKIDVAIK---MIREGAMSEDDFIEEAKVMMKLSHPNLV 62
Query: 749 KILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISID 808
++ C+ Q F +V E+M N L +L E L L++ D
Sbjct: 63 QLYGVCT---KQRPIF--IVTEYMANGCLLNYLR---------ERKGKLGTEWLLDMCSD 108
Query: 809 VACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGS 868
V A+ YL + H DL N L+ ED + + DFGLAR++ L TSS G K
Sbjct: 109 VCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYV-LDDQYTSSQGTKFP 164
Query: 869 IGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHV 927
+ + PE S S DV+S+G+L+ E+ + EG M + + + + V
Sbjct: 165 VKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFS---------EGKMPYERFSNSEVVESV 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 9e-22
Identities = 62/212 (29%), Positives = 105/212 (49%), Gaps = 24/212 (11%)
Query: 696 IGEGSFGSVFKGI-LDDGRTTIAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKILT 752
IG G+FG V+KG+ L+ G +A+K +L + A KS + E + LKN++H N+VK +
Sbjct: 8 IGRGAFGVVYKGLNLETGDF-VAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 753 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACA 812
+ + +D ++ E+ N SL + + E+ A + + Q L
Sbjct: 67 S-----IETSDSLYIILEYAENGSLRQIIKKFGPFPESLVA---VYVYQVLQ-------G 111
Query: 813 LNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYI 872
L YLH + + H D+K +NIL +D + + DFG+A L+ G+ ++
Sbjct: 112 LAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVA--TKLNDVSKDDASVVGTPYWM 166
Query: 873 APEYGLGSEVSISGDVYSYGILLLELITRKKP 904
APE S S + D++S G ++EL+T P
Sbjct: 167 APEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 65/219 (29%), Positives = 96/219 (43%), Gaps = 21/219 (9%)
Query: 693 VNQIGEGSFGSVFKG---ILDDG-RTTIAVKVFNLLHHGAFKS-FIAECNTLKNIRHRNL 747
+ Q+GEG FG V L D +AVK N +S F E L+ + H N+
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 748 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISI 807
VK C G L+ E++ + SL ++L R+ +NL + L S
Sbjct: 69 VKYKGVCEK---PGGRSLRLIMEYLPSGSLRDYL-QRHRD--------QINLKRLLLFSS 116
Query: 808 DVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKG 867
+ ++YL H DL NIL++ + + I DFGLA+ LP
Sbjct: 117 QICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGE 173
Query: 868 S-IGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPT 905
S I + APE S+ S + DV+S+G+ L EL T P+
Sbjct: 174 SPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 97.5 bits (241), Expect = 2e-21
Identities = 80/286 (27%), Positives = 122/286 (42%), Gaps = 36/286 (12%)
Query: 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL---LHHGAFKSFIAECNTLKNIRH-R 745
+ + ++GEGSFG V+ R +A+KV + F+ E L ++ H
Sbjct: 2 YRILRKLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 746 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNI 805
N+VK+ +Q LV E++ SLE+ L I R+ L+ + L I
Sbjct: 59 NIVKLYDF-----FQDEGSLYLVMEYVDGGSLEDLLKKIGRK-------GPLSESEALFI 106
Query: 806 SIDVACALNYLHHDCQPPIAHCDLKPSNILLDED-MIAHIGDFGLARFLPLSSAQTSSIG 864
+ AL YLH I H D+KP NILLD D + + DFGLA+ LP + +S
Sbjct: 107 LAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPA 163
Query: 865 AK----GSIGYIAPEYGLGSE---VSISGDVYSYGILLLELITRKKP------TDIMFEG 911
G+ GY+APE LG S S D++S GI L EL+T P + +
Sbjct: 164 LPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT 223
Query: 912 DMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKS 957
+ L +L + + DL+ + + R+ S
Sbjct: 224 LKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSS 269
|
Length = 384 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 38/222 (17%)
Query: 693 VNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIA-ECNTLKNIRHRNLVKIL 751
V +G+GS G V+K A+K ++ F+ + E TL++ +VK
Sbjct: 6 VKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK-- 63
Query: 752 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLN------- 804
C G Y+ + ++V E+M SL + L++++
Sbjct: 64 --CYGAFYKEGEI-SIVLEYMDGGSLAD-------------------LLKKVGKIPEPVL 101
Query: 805 --ISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSS 862
I+ + L+YLH I H D+KPSN+L++ I DFG+++ L + Q ++
Sbjct: 102 AYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT 159
Query: 863 IGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
G++ Y++PE G S + D++S G+ LLE K P
Sbjct: 160 --FVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 8e-21
Identities = 64/213 (30%), Positives = 94/213 (44%), Gaps = 25/213 (11%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKILT 752
+G+GSFG V D A+KV ++ + + E N L I H +VK
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK--L 58
Query: 753 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACA 812
+ +Q + LV E+ L L R E + + ++ A
Sbjct: 59 HYA---FQTEEKLYLVLEYAPGGELFSHLSKEGRFSEER--------ARF--YAAEIVLA 105
Query: 813 LNYLH-HDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGY 871
L YLH I + DLKP NILLD D + DFGLA+ L ++T++ G+ Y
Sbjct: 106 LEYLHSLG----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTF--CGTPEY 159
Query: 872 IAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
+APE LG + D +S G+LL E++T K P
Sbjct: 160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-20
Identities = 65/213 (30%), Positives = 113/213 (53%), Gaps = 30/213 (14%)
Query: 693 VNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAF--KSFIAECNTLKNIRHRNLVKI 750
V ++G G FG V+ G + G T +A+K L G+ ++F+AE N +K ++H LV++
Sbjct: 11 VKKLGAGQFGEVWMGYYN-GHTKVAIKS---LKQGSMSPEAFLAEANLMKQLQHPRLVRL 66
Query: 751 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVA 810
+ + ++ E+M N SL ++L +T E + L + + ++++ +A
Sbjct: 67 YAVVT------QEPIYIITEYMENGSLVDFL-------KTPEGIK-LTINKLIDMAAQIA 112
Query: 811 CALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIG 870
+ ++ + H DL+ +NIL+ E + I DFGLAR + + T+ GAK I
Sbjct: 113 EGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIE-DNEYTAREGAKFPIK 168
Query: 871 YIAPE---YGLGSEVSISGDVYSYGILLLELIT 900
+ APE YG +I DV+S+GILL E++T
Sbjct: 169 WTAPEAINYGT---FTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 67/211 (31%), Positives = 110/211 (52%), Gaps = 24/211 (11%)
Query: 695 QIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAF--KSFIAECNTLKNIRHRNLVKILT 752
++G+G FG V+ G + G T +A+K L G ++F+ E +K +RH LV +
Sbjct: 13 KLGQGCFGEVWMGTWN-GTTKVAIKT---LKPGTMMPEAFLQEAQIMKKLRHDKLVPLYA 68
Query: 753 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACA 812
S + +V EFM SL ++L E D + L L Q ++++ +A
Sbjct: 69 VVS------EEPIYIVTEFMGKGSLLDFL------KEGDG--KYLKLPQLVDMAAQIADG 114
Query: 813 LNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYI 872
+ Y+ + H DL+ +NIL+ ++++ I DFGLAR + + T+ GAK I +
Sbjct: 115 MAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIE-DNEYTARQGAKFPIKWT 170
Query: 873 APEYGLGSEVSISGDVYSYGILLLELITRKK 903
APE L +I DV+S+GILL EL+T+ +
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 6e-20
Identities = 65/227 (28%), Positives = 104/227 (45%), Gaps = 30/227 (13%)
Query: 693 VNQIGEGSFGSVFKG-----ILDDGRTTIAVKVF-NLLHHGAFKSFIAECNTLKNIRHRN 746
++GEG+FG VF G ++ + +AVK + A K F E L N +H N
Sbjct: 10 KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHEN 69
Query: 747 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHP----ITREDETDEAPRSLNLIQR 802
+VK C+ +G D +VFE+M + L ++L D L L Q
Sbjct: 70 IVKFYGVCT----EG-DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQL 124
Query: 803 LNISIDVACALNYL--HHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQT 860
L I++ +A + YL H H DL N L+ D++ IGDFG++R + +
Sbjct: 125 LQIAVQIASGMVYLASQH-----FVHRDLATRNCLVGYDLVVKIGDFGMSR--DVYTTDY 177
Query: 861 SSIGAKGS----IGYIAPEYGLGSEVSISGDVYSYGILLLELITRKK 903
+G G I ++ PE + + + DV+S+G++L E+ T K
Sbjct: 178 YRVG--GHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 8e-20
Identities = 64/206 (31%), Positives = 99/206 (48%), Gaps = 26/206 (12%)
Query: 695 QIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTAC 754
IGEG FG+V +G + +AVK N+ ++F+ E + + H+NLV++L
Sbjct: 13 IIGEGEFGAVLQGEYTGQK--VAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGV- 67
Query: 755 SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALN 814
+ + G +V E M +L +L R +++IQ L S+DVA +
Sbjct: 68 --ILHNG---LYIVMELMSKGNLVNFLRTRGRA--------LVSVIQLLQFSLDVAEGME 114
Query: 815 YLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAP 874
YL + H DL NIL+ ED +A + DFGLAR + S + K + AP
Sbjct: 115 YLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM-GVDNSKLPVK----WTAP 166
Query: 875 EYGLGSEVSISGDVYSYGILLLELIT 900
E + S DV+SYG+LL E+ +
Sbjct: 167 EALKHKKFSSKSDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 64/203 (31%), Positives = 96/203 (47%), Gaps = 24/203 (11%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACS 755
IG+G FG V G D +AVK + ++F+AE + + +RH NLV++L
Sbjct: 14 IGKGEFGDVMLG--DYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLL---- 65
Query: 756 GVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNY 815
GV + +V E+M SL ++L R + L S+DV A+ Y
Sbjct: 66 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDC--------LLKFSLDVCEAMEY 117
Query: 816 LHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPE 875
L + H DL N+L+ ED +A + DFGL + SS Q + K + + APE
Sbjct: 118 LEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDT---GKLPVKWTAPE 169
Query: 876 YGLGSEVSISGDVYSYGILLLEL 898
+ S DV+S+GILL E+
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 6e-19
Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 24/218 (11%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAF--KSFIAECNTLKNIRHR 745
+ V +IG G FG V+ G + + +A+K + GA + FI E + + H
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKT---IREGAMSEEDFIEEAQVMMKLSHP 59
Query: 746 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNI 805
LV++ C+ LVFEFM + L ++L R + +L L +
Sbjct: 60 KLVQLYGVCTE-----RSPICLVFEFMEHGCLSDYL----RAQRGKFSQETL-----LGM 105
Query: 806 SIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGA 865
+DV + YL + H DL N L+ E+ + + DFG+ RF+ L TSS G
Sbjct: 106 CLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFV-LDDQYTSSTGT 161
Query: 866 KGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKK 903
K + + +PE S+ S DV+S+G+L+ E+ + K
Sbjct: 162 KFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 24/221 (10%)
Query: 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFN---LLHHGAFKSFIAECNTLKNIRHRN 746
F + IG+G+FG V D + A+K N + G+ ++ + E L+ + H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 747 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNIS 806
LV + + +Q + LV + + L H ++++ + E + I
Sbjct: 62 LVNLWYS-----FQDEENMYLVVDLLLGGDLR--YH-LSQKVKFSEE------QVKFWIC 107
Query: 807 IDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAK 866
++ AL YLH I H D+KP NILLDE HI DF +A + T +
Sbjct: 108 -EIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVT---PDTLTTSTS 160
Query: 867 GSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDI 907
G+ GY+APE S++ D +S G+ E + K+P
Sbjct: 161 GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (214), Expect = 2e-18
Identities = 64/248 (25%), Positives = 102/248 (41%), Gaps = 59/248 (23%)
Query: 693 VNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAF--KSFIAECNTLKNIRHRNLVKI 750
+ QIG+GSFG V+ +K +L + + + E LK + H N++K
Sbjct: 5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKY 64
Query: 751 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLH-------PITREDETDEAPRSLNLIQRL 803
++ +V E+ L + + P E++ L
Sbjct: 65 YE-----SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFP-EEQI------------L 106
Query: 804 NISIDVACALNYLH--HDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTS 861
+ + + AL YLH I H D+KP NI L + + +GDFG+++ L ++
Sbjct: 107 DWFVQLCLALKYLHSRK-----ILHRDIKPQNIFLTSNGLVKLGDFGISKVL-----SST 156
Query: 862 SIGAKGSIG---YIAPE------YGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGD 912
AK +G Y++PE Y S D++S G +L EL T K P FEG+
Sbjct: 157 VDLAKTVVGTPYYLSPELCQNKPYNYKS------DIWSLGCVLYELCTLKHP----FEGE 206
Query: 913 MNLHNLAR 920
NL LA
Sbjct: 207 -NLLELAL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 695 QIGEGSFGSVFKGIL-----DDGRTTIAVK-VFNLLHHGAFKSFIAECNTLKNIRHRNLV 748
++G+GSFG V++G+ + T +A+K V F+ E + +K ++V
Sbjct: 13 ELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVV 72
Query: 749 KILTACSGVDYQGNDFKALV-FEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISI 807
++L GV G LV E M L+ +L E E + L + + ++
Sbjct: 73 RLL----GVVSTGQ--PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAA 126
Query: 808 DVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKG 867
++A + YL H DL N ++ ED+ IGDFG+ R + G KG
Sbjct: 127 EIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTR--DIYETDYYRKGGKG 181
Query: 868 --SIGYIAPEYGLGSEV-SISGDVYSYGILLLELIT 900
+ ++APE L V + DV+S+G++L E+ T
Sbjct: 182 LLPVRWMAPE-SLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-18
Identities = 64/215 (29%), Positives = 111/215 (51%), Gaps = 27/215 (12%)
Query: 693 VNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAF--KSFIAECNTLKNIRHRNLVKI 750
V ++G G FG V+ G ++ T +AVK L G ++F+ E N +K ++H LV++
Sbjct: 11 VKKLGAGQFGEVWMGYYNNS-TKVAVKT---LKPGTMSVQAFLEEANLMKTLQHDKLVRL 66
Query: 751 LTACSGVD--YQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISID 808
+ + Y ++ E+M SL ++L ++DE + + L + ++ S
Sbjct: 67 YAVVTKEEPIY-------IITEYMAKGSLLDFL-------KSDEGGK-VLLPKLIDFSAQ 111
Query: 809 VACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGS 868
+A + Y+ + H DL+ +N+L+ E ++ I DFGLAR + + T+ GAK
Sbjct: 112 IAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIE-DNEYTAREGAKFP 167
Query: 869 IGYIAPEYGLGSEVSISGDVYSYGILLLELITRKK 903
I + APE +I DV+S+GILL E++T K
Sbjct: 168 IKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGK 202
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 4e-18
Identities = 64/236 (27%), Positives = 103/236 (43%), Gaps = 31/236 (13%)
Query: 690 FSSVNQIGEGSFGSVFKGI-LDDGRTTIAVKVFNLLHH--GAFKSFIAECNTLKNIRHRN 746
+ + +IGEG++G V+K G +A+K L G K+ + E LK + H N
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEI-VAIKKIKLRFESEGIPKTALREIKLLKELNHPN 59
Query: 747 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNIS 806
++K+L V D LVFEFM L + + + R L +
Sbjct: 60 IIKLLD----VFRHKGDL-YLVFEFMDT-DLYKLI---------KDRQRGLPESLIKSYL 104
Query: 807 IDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLAR-FLPLSSAQTSSIGA 865
+ L + H I H DLKP N+L++ + + + DFGLAR F T +
Sbjct: 105 YQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVT 161
Query: 866 KGSIGYIAPEYGLGSEVSISG-DVYSYGILLLELITRKKPTDIMFEGDMNLHNLAR 920
+ Y APE LG + + D++S G + EL++R+ +F G + L +
Sbjct: 162 R---WYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR----PLFPGKSEIDQLFK 210
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 59/213 (27%), Positives = 100/213 (46%), Gaps = 29/213 (13%)
Query: 696 IGEGSFGSVFKGILD-DGRTTIAVKVFNLLHHGAFKS----FIAECNTLKNIRHRNLVKI 750
IG G FG V +G L G+ I V + L G+ F+ E + + H N++++
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAI-KTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRL 70
Query: 751 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVA 810
GV + ++ E+M N SL+++L E D + Q + + +A
Sbjct: 71 E----GVVTKSRPV-MIITEYMENGSLDKFLR------ENDG---KFTVGQLVGMLRGIA 116
Query: 811 CALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIG 870
+ YL H DL NIL++ +++ + DFGL+R L S A ++ G K I
Sbjct: 117 SGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIR 173
Query: 871 YIAPE---YGLGSEVSISGDVYSYGILLLELIT 900
+ APE Y + S DV+S+GI++ E+++
Sbjct: 174 WTAPEAIAYRKFTSAS---DVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 22/221 (9%)
Query: 695 QIGEGSFGSVFKG-----ILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVK 749
++GEG+FG VF + + + +AVK A + F E L ++H+++V+
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 750 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLH---PITR--EDETDEAPRSLNLIQRLN 804
C+ +VFE+M + L +L P + D AP L L Q L
Sbjct: 72 FYGVCTE-----GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLA 126
Query: 805 ISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIG 864
I+ +A + YL H DL N L+ + ++ IGDFG++R + S +G
Sbjct: 127 IASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR--DIYSTDYYRVG 181
Query: 865 AKG--SIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKK 903
+ I ++ PE L + + D++S+G++L E+ T K
Sbjct: 182 GRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 2e-17
Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 693 VNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKS--FIAECNTLKNIRHRNLVKI 750
+ ++G G FG V G G+ +A+K ++ G+ FI E + + H LV++
Sbjct: 9 LKELGTGQFGVVKYGKWR-GQYDVAIK---MIKEGSMSEDEFIEEAKVMMKLSHEKLVQL 64
Query: 751 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVA 810
C+ Q + +V E+M N L +L E + Q L + DV
Sbjct: 65 YGVCTK---QRPIY--IVTEYMSNGCLLNYLR---------EHGKRFQPSQLLEMCKDVC 110
Query: 811 CALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIG 870
+ YL H DL N L+D+ + DFGL+R++ L TSS+G+K +
Sbjct: 111 EGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYV-LDDEYTSSVGSKFPVR 166
Query: 871 YIAPEYGLGSEVSISGDVYSYGILLLELITRKK 903
+ PE L S+ S DV+++G+L+ E+ + K
Sbjct: 167 WSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 5e-17
Identities = 55/213 (25%), Positives = 83/213 (38%), Gaps = 26/213 (12%)
Query: 695 QIGEGSFGSVFKGILDDG---RTTIAVKVF---NLLHHGAFKSFIAECNTLKNIRHRNLV 748
++G+GSFG V +G +AVK L F+ E + ++ H NL+
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLI 59
Query: 749 KILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISID 808
++ GV +V E SL + L +A + + ++
Sbjct: 60 RLY----GVVLT--HPLMMVTELAPLGSLLDRLR--------KDALGHFLISTLCDYAVQ 105
Query: 809 VACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQ-TSSIGAKG 867
+A + YL H DL NILL D IGDFGL R LP + K
Sbjct: 106 IANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV 162
Query: 868 SIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
+ APE S + DV+ +G+ L E+ T
Sbjct: 163 PFAWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 7e-17
Identities = 69/237 (29%), Positives = 114/237 (48%), Gaps = 32/237 (13%)
Query: 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNL 747
F V +IGEG++G V+K +A+K L G + I E + LK + H N+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 748 VKILTACSGVDYQGNDFKA-LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNIS 806
VK+L D + K LVFEF+H + L++++ D + + L LI+
Sbjct: 62 VKLL------DVIHTENKLYLVFEFLH-QDLKKFM------DASPLSGIPLPLIKSYLFQ 108
Query: 807 IDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARF--LPLSSAQTSSIG 864
+ A + H + H DLKP N+L++ + + DFGLAR +P+ + +
Sbjct: 109 LLQGLAFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV- 162
Query: 865 AKGSIGYIAPEYGLGSEV-SISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLAR 920
++ Y APE LG + S + D++S G + E++TR+ +F GD + L R
Sbjct: 163 ---TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQLFR 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 9e-17
Identities = 58/223 (26%), Positives = 95/223 (42%), Gaps = 36/223 (16%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHG--AFKSFIAECNTLKNIRHR 745
+++ + +GEG++G V K +A+K F K+ + E L+ +RH
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 746 NLVKILTAC--SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSL--NLIQ 801
N+V + A G Y LVFE++ LE + +P L + ++
Sbjct: 61 NIVNLKEAFRRKGRLY-------LVFEYVERTLLEL----------LEASPGGLPPDAVR 103
Query: 802 RLNISIDVACALNYLH-HDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQ- 859
+ A+ Y H H+ I H D+KP NIL+ E + + DFG AR L A
Sbjct: 104 S--YIWQLLQAIAYCHSHN----IIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157
Query: 860 -TSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELIT 900
T + + Y APE +G DV++ G ++ EL+
Sbjct: 158 LTDYVATR---WYRAPELLVGDTNYGKPVDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 60/235 (25%), Positives = 90/235 (38%), Gaps = 59/235 (25%)
Query: 696 IGEGSFGSVFKGI-LDDGRTTIAVKVFNLLHHGAFKS-----FIAECNTLKNIRHRNLVK 749
IG+GSFG+V K DG+ + K + +G ++E N L+ ++H N+V+
Sbjct: 8 IGKGSFGTVRKVRRKSDGKI-LVWKE---IDYGNMTEKEKQQLVSEVNILRELKHPNIVR 63
Query: 750 ---------------ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAP 794
++ C G D K + +EE
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKC----KKERKYIEE--------------- 104
Query: 795 RSLNLIQRLNISIDVACALNYLHH--DCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARF 852
I I + AL H+ D + H DLKP+NI LD + +GDFGLA+
Sbjct: 105 ---EFI--WRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159
Query: 853 LPLSSAQTSSIGAKGSIG---YIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
L S AK +G Y++PE D++S G L+ EL P
Sbjct: 160 LG-----HDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-16
Identities = 39/83 (46%), Positives = 53/83 (63%), Gaps = 1/83 (1%)
Query: 440 LQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGN 499
L+G IP+ + + L +I+LS N++ G IPP G +SL VLDLS N GSIP +G
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSL-GSITSLEVLDLSYNSFNGSIPESLGQ 488
Query: 500 LKNLEILNVFGNKLKGEIPSTLG 522
L +L ILN+ GN L G +P+ LG
Sbjct: 489 LTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 62/236 (26%), Positives = 105/236 (44%), Gaps = 24/236 (10%)
Query: 687 TDRFSSVNQIGEGSFGSVFKGI-LDDGRTTI--AVKVFNLLHHGAFKSFIAECNTLKNIR 743
F +IG+G F V+K I L DGR V++F ++ A + + E + LK +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 744 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRL 803
H N++K L + + N+ +V E L + ++
Sbjct: 61 HPNVIKYLAS-----FIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYF--- 112
Query: 804 NISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSI 863
+ + AL ++H I H D+KP+N+ + + +GD GL RF SS T++
Sbjct: 113 ---VQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAH 164
Query: 864 GAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGD-MNLHNL 918
G+ Y++PE + + D++S G LL E+ + P F GD MNL++L
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLYSL 216
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 59/237 (24%), Positives = 93/237 (39%), Gaps = 40/237 (16%)
Query: 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFN---LLHHGAFKSFIAECNTL-KNIRHR 745
F IGEGSF +V + A+K+ + L+ K E L + H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 746 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNI 805
++K+ +Q + V E+ N L +++ SL+
Sbjct: 63 GIIKLYYT-----FQDEENLYFVLEYAPNGELLQYIRKY----------GSLDEKCTRFY 107
Query: 806 SIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLP---------LS 856
+ ++ AL YLH I H DLKP NILLD+DM I DFG A+ L
Sbjct: 108 AAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGD 164
Query: 857 SAQTSSIGAK---------GSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
+ S K G+ Y++PE S D+++ G ++ +++T K P
Sbjct: 165 ATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 62/237 (26%)
Query: 690 FSSVNQIGEGSFGSVFKGI-LDDGRTTIAVKVFNLLHH--GAFKSFIAECNTLKNIRHRN 746
+ + QIGEG++G V+K G +A+K + + G + I E L+ +RH N
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGEL-VALKKIRMENEKEGFPITAIREIKLLQKLRHPN 59
Query: 747 LVK---ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLN-LIQR 802
+V+ I+T+ +G+ + +VFE+M + D L L+
Sbjct: 60 IVRLKEIVTSKG----KGSIY--MVFEYM----------------DHD-----LTGLLDS 92
Query: 803 LNISIDVA---C-------ALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARF 852
+ + C L YLH + I H D+K SNIL++ D + + DFGLAR
Sbjct: 93 PEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARP 149
Query: 853 LPLSSAQ--TSSIGAKGSIGYIAPEYGLGS-----EVSISGDVYSYGILLLELITRK 902
++ T+ + ++ Y PE LG+ EV D++S G +L EL K
Sbjct: 150 YTKRNSADYTNRV---ITLWYRPPELLLGATRYGPEV----DMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 65/230 (28%), Positives = 98/230 (42%), Gaps = 30/230 (13%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKILTA 753
IGEG+ G VFK + T+A+K L L G + E L+ +H +VK+L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD- 66
Query: 754 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACAL 813
V G+ F LV E+M L E L R P ++ + A
Sbjct: 67 ---VFPHGSGF-VLVMEYM-PSDLSEVLRDEER-------PLPEAQVKSYMRMLLKGVA- 113
Query: 814 NYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFL--PLSSAQTSSIGAKGSIGY 871
Y+H I H DLKP+N+L+ D + I DFGLAR + + + Y
Sbjct: 114 -YMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATR---WY 166
Query: 872 IAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLAR 920
APE G+ + D+++ G + EL+ P +F G+ ++ LA
Sbjct: 167 RAPELLYGARKYDPGVDLWAVGCIFAELL-NGSP---LFPGENDIEQLAI 212
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 4e-16
Identities = 69/260 (26%), Positives = 111/260 (42%), Gaps = 54/260 (20%)
Query: 689 RFSSVNQIGEGSFGSVFKGILDDGRT--TIAVK----VFNLLHHGAFKSFIAECNTLKNI 742
R+ + IG G++G V + D RT +A+K VF+ L K + E L+++
Sbjct: 1 RYELLKPIGSGAYGVVCSAV--DKRTGRKVAIKKISNVFDDLIDA--KRILREIKLLRHL 56
Query: 743 RHRNLVKILTACSGVDYQGNDFKAL--VFEFMHNRSLEEWLHPITREDETDEAPRSLNLI 800
RH N++ +L DF + V E M L + + + + TD+ + L
Sbjct: 57 RHENIIGLLDIL--RPPSPEDFNDVYIVTELMET-DLHKVIK--SPQPLTDDHIQYF-LY 110
Query: 801 QRLNISIDVACALNYLH--HDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSA 858
Q L L YLH + + H DLKPSNIL++ + I DFGLAR
Sbjct: 111 QIL-------RGLKYLHSAN-----VIHRDLKPSNILVNSNCDLKICDFGLAR-----GV 153
Query: 859 QTSSIGAKGSIGYI------APEYGLGS-EVSISGDVYSYGILLLELITRKKPTDIMFEG 911
Y+ APE L S + + D++S G + EL+TRK +F G
Sbjct: 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK----PLFPG 209
Query: 912 DMNLHNLARTALPDHVMDIV 931
+ L + +++++
Sbjct: 210 RDYIDQL------NLIVEVL 223
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 4e-16
Identities = 60/222 (27%), Positives = 99/222 (44%), Gaps = 35/222 (15%)
Query: 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVK 749
F + ++GEGS+GSV+K I + +A+KV + + I E + LK +VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVK 62
Query: 750 ILTACSGVDYQGNDFKA----LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNI 805
Y G+ FK +V E+ S+ + + IT ++L + I
Sbjct: 63 ---------YYGSYFKNTDLWIVMEYCGAGSVSD-IMKITN--------KTLTEEEIAAI 104
Query: 806 SIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGA 865
L YLH H D+K NILL+E+ A + DFG++ L + A+ +++
Sbjct: 105 LYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTV-- 159
Query: 866 KGSIG---YIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
IG ++APE + D++S GI +E+ K P
Sbjct: 160 ---IGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 4e-16
Identities = 61/226 (26%), Positives = 105/226 (46%), Gaps = 30/226 (13%)
Query: 689 RFSSVNQIGEGSFGSVFKGIL-----DDGRTTIAVKVFNLLHHGAFKS-FIAECNTLKNI 742
RF ++GEG+FG V+KG L T++A+K + F E + ++
Sbjct: 8 RFLE--ELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL 65
Query: 743 RHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWL---HPI---TREDETDEAPRS 796
+H N+V +L C+ ++FE++ + L E+L P E + S
Sbjct: 66 QHPNIVCLLGVCTK-----EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120
Query: 797 LNLIQRLNISIDVACALNYL--HHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLP 854
L+ L+I+I +A + YL HH H DL N L+ E + I DFGL+R
Sbjct: 121 LDCSDFLHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSR--D 173
Query: 855 LSSAQTSSIGAKG--SIGYIAPEYGLGSEVSISGDVYSYGILLLEL 898
+ SA + +K + ++ PE L + + D++S+G++L E+
Sbjct: 174 IYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-16
Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 24/208 (11%)
Query: 695 QIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAF--KSFIAECNTLKNIRHRNLVKILT 752
++G G FG V+ + T +AVK + G+ ++F+AE N +K ++H LVK+
Sbjct: 13 KLGAGQFGEVWMATYNK-HTKVAVKT---MKPGSMSVEAFLAEANVMKTLQHDKLVKLHA 68
Query: 753 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACA 812
+ + ++ EFM SL ++L + DE + P L + ++ S +A
Sbjct: 69 VVT------KEPIYIITEFMAKGSLLDFL----KSDEGSKQP----LPKLIDFSAQIAEG 114
Query: 813 LNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYI 872
+ ++ Q H DL+ +NIL+ ++ I DFGLAR + + T+ GAK I +
Sbjct: 115 MAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWT 170
Query: 873 APEYGLGSEVSISGDVYSYGILLLELIT 900
APE +I DV+S+GILL+E++T
Sbjct: 171 APEAINFGSFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 8e-16
Identities = 69/235 (29%), Positives = 105/235 (44%), Gaps = 28/235 (11%)
Query: 693 VNQIGEGSFGSVFKGI-LDDGRTTIAVK--VFNLLHHGAFKSFIAECNTLKNIR---HRN 746
+ +IGEG++G+V+K L+ GR +A+K L G S + E LK + H N
Sbjct: 4 LAEIGEGAYGTVYKARDLNTGR-FVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPN 62
Query: 747 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRS-LNLIQRLNI 805
+V++L C G LVFE + + L +L + P+ L ++
Sbjct: 63 IVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYL---------SKCPKPGLPPETIKDL 112
Query: 806 SIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGA 865
+ +++LH I H DLKP NIL+ D I DFGLAR A TS +
Sbjct: 113 MRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVV-- 167
Query: 866 KGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLAR 920
++ Y APE L S + D++S G + EL R+ +F G L +
Sbjct: 168 -VTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRP----LFRGTSEADQLDK 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 23/227 (10%)
Query: 688 DRFSSVNQIGEGSFGSVFKGIL-----DDGRTTIAVKVFNL-LHHGAFKSFIAECNTLKN 741
DR + +GEG+FG V K + +T+AVK+ ++E +K
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 742 I-RHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLH----PITREDETDEAPRS 796
I +H+N++ +L C+ +G + +V E+ + +L ++L P D P
Sbjct: 72 IGKHKNIINLLGVCTQ---EGPLY--VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPE 126
Query: 797 LNLIQR--LNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLP 854
L Q+ ++ + VA + +L H DL N+L+ ED + I DFGLAR +
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIH 183
Query: 855 LSSAQTSSIGAKGSIGYIAPEYGLGSEV-SISGDVYSYGILLLELIT 900
+ + + ++APE L V + DV+S+G+LL E+ T
Sbjct: 184 HIDYYRKTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-15
Identities = 69/220 (31%), Positives = 101/220 (45%), Gaps = 25/220 (11%)
Query: 694 NQIGEGSFGSVFKG----ILDDGRTTIAVKVFNLLHHGA----FKSFIAECNTLKNIRHR 745
N +G G+FG V++G IL G I V V L GA K F+ E + + N H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAV-KTLRKGATDQEKKEFLKEAHLMSNFNHP 59
Query: 746 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNI 805
N+VK+L C + N+ + ++ E M L L + P L L + L+I
Sbjct: 60 NIVKLLGVC--LL---NEPQYIIMELMEGGDL---LSYLRDARVERFGPPLLTLKELLDI 111
Query: 806 SIDVACALNYLHHDCQPPIAHCDLKPSNILLDE-----DMIAHIGDFGLARFLPLSSAQT 860
+DVA YL Q H DL N L+ E D + IGDFGLAR + S
Sbjct: 112 CLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYR 168
Query: 861 SSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
+ ++APE L + + DV+S+G+L+ E++T
Sbjct: 169 KEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 64/223 (28%), Positives = 104/223 (46%), Gaps = 30/223 (13%)
Query: 695 QIGEGSFGSVFK-GILDDGRTTIAVKVFNLLHHGAF--------KSF---IAECNTLK-N 741
+G G+FG V+K ++G+ +A+K N+ H+ AF KS ++E +K
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINV-HNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 742 IRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQ 801
+RH N+V+ + ND +V + + L E + + + + R N
Sbjct: 66 LRHPNIVRYYKT-----FLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN--- 117
Query: 802 RLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTS 861
I + + AL YLH + + I H DL P+NI+L ED I DFGLA+ S TS
Sbjct: 118 ---IFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTS 172
Query: 862 SIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
+ G+I Y PE DV+++G +L ++ T + P
Sbjct: 173 VV---GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-15
Identities = 64/229 (27%), Positives = 103/229 (44%), Gaps = 32/229 (13%)
Query: 693 VNQIGEGSFGSVFK----GIL-DDGRTTIAVKVFNLLHHGAF----KSFIAECNTLKNIR 743
V IG+G+FG VF+ G+L + T +AVK +L A F E +
Sbjct: 10 VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVK---MLKEEASADMQADFQREAALMAEFD 66
Query: 744 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWL------------HPITREDETD 791
H N+VK+L C+ G L+FE+M L E+L H + +
Sbjct: 67 HPNIVKLLGVCA----VGKPM-CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121
Query: 792 EAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLAR 851
P L+ ++L I+ VA + YL + H DL N L+ E+M+ I DFGL+R
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 178
Query: 852 FLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
+ + +S I ++ PE + + DV++YG++L E+ +
Sbjct: 179 NIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 28/219 (12%)
Query: 696 IGEGSFGSVFKGI-LDDGRTT---IAVKVF-NLLHHGAFKSFIAECNTLKNIRHRNLVKI 750
+G G+FG+V+KG+ + +G +A+KV A K + E + ++ H ++V++
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 751 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVA 810
L C Q L+ + M L +++ R + + + L LN + +A
Sbjct: 75 LGICLSSQVQ------LITQLMPLGCLLDYV----RNHKDNIGSQYL-----LNWCVQIA 119
Query: 811 CALNYL--HHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGS 868
++YL + H DL N+L+ I DFGLA+ L + + + G K
Sbjct: 120 KGMSYLEEKR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVP 174
Query: 869 IGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTD 906
I ++A E L + DV+SYG+ + EL+T KP +
Sbjct: 175 IKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 67/211 (31%), Positives = 97/211 (45%), Gaps = 27/211 (12%)
Query: 695 QIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFK-SFIAECNTLKNIRHRNLVKILTA 753
+IG+G+FG V+KG+L T +AVK K F+ E LK H N+VK++
Sbjct: 2 KIGKGNFGDVYKGVLKGN-TEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 754 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACAL 813
C V Q +V E + SL +L +++ L + + L +S+D A +
Sbjct: 61 C--VQKQP---IYIVMELVPGGSLLTFLR--KKKNR-------LTVKKLLQMSLDAAAGM 106
Query: 814 NYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKG-SIGYI 872
YL H DL N L+ E+ + I DFG++R T S G K I +
Sbjct: 107 EYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSR-EEEGGIYTVSDGLKQIPIKWT 162
Query: 873 APE---YGLGSEVSISGDVYSYGILLLELIT 900
APE YG + DV+SYGILL E +
Sbjct: 163 APEALNYG---RYTSESDVWSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-15
Identities = 57/186 (30%), Positives = 85/186 (45%), Gaps = 35/186 (18%)
Query: 482 LDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPI 541
L L L G IP+++ L++L+ +N+ GN ++G IP +LGS LE L++ N G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 542 PSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQGVFKNASIT 601
P SL L L +L+L+ N+LSG++P L G N
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL-----------------GGRLLHRASFN---- 521
Query: 602 SVFGNLKLCGGIPEFQLPTCSSKKSKHKKSLALKLVLAIISGLIGLSLALSIIVLCLVRK 661
N LC GIP L C S+ K+ +A G+S+A +V+C +
Sbjct: 522 -FTDNAGLC-GIP--GLRACGP-----HLSVGAKIGIA-----FGVSVAFLFLVICAMCW 567
Query: 662 RKEKQN 667
K +QN
Sbjct: 568 WKRRQN 573
|
Length = 623 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 58/220 (26%), Positives = 85/220 (38%), Gaps = 29/220 (13%)
Query: 694 NQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGA-FKSFIAECNTLKNIRHRNLVKILT 752
IG G+ V+ I +A+K +L E + H N+VK
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK--Y 64
Query: 753 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACA 812
S V D LV ++ SL + + DEA + L + L
Sbjct: 65 YTSFVV---GDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLK-------G 114
Query: 813 LNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIG-- 870
L YLH + Q H D+K NILL ED I DFG++ L + K +G
Sbjct: 115 LEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASL-ADGGDRTRKVRKTFVGTP 170
Query: 871 -YIAPE-----YGLGSEVSISGDVYSYGILLLELITRKKP 904
++APE +G + D++S+GI +EL T P
Sbjct: 171 CWMAPEVMEQVHGYDFKA----DIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 35/222 (15%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVF------NLLHHGAFKSFIAECNTLKN 741
+++ +++IGEGS+G VFK + +A+K F ++ A + E LK
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR----EIRMLKQ 56
Query: 742 IRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQ 801
++H NLV ++ ++ LVFE+ + L +E ++ PR +
Sbjct: 57 LKHPNLVNLIEV-----FRRKRKLHLVFEYCDHTVL----------NELEKNPRGVPEHL 101
Query: 802 RLNISIDVACALNYLH-HDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFL-PLSSAQ 859
I A+N+ H H+C H D+KP NIL+ + + DFG AR L
Sbjct: 102 IKKIIWQTLQAVNFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY 157
Query: 860 TSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELIT 900
T + + Y APE +G ++ DV++ G + EL+T
Sbjct: 158 TDYVATR---WYRAPELLVGDTQYGPPVDVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 4e-15
Identities = 67/220 (30%), Positives = 98/220 (44%), Gaps = 27/220 (12%)
Query: 693 VNQIGEGSFGSV----FKGILDDGRTTIAVKVFNLLHHGAFKS-FIAECNTLKNIRHRNL 747
+ +GEG FG V + D +AVK S + E N LK + H N+
Sbjct: 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 748 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPR-SLNLIQRLNIS 806
VK CS QG L+ E++ SL ++L P+ LNL Q L +
Sbjct: 69 VKYKGCCSE---QGGKGLQLIMEYVPLGSLRDYL------------PKHKLNLAQLLLFA 113
Query: 807 IDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAK 866
+ + YLH Q I H DL N+LLD D + IGDFGLA+ +P + +
Sbjct: 114 QQICEGMAYLH--SQHYI-HRDLAARNVLLDNDRLVKIGDFGLAKAVP-EGHEYYRVRED 169
Query: 867 GS--IGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
G + + A E ++ S + DV+S+G+ L EL+T
Sbjct: 170 GDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDS 209
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 21/213 (9%)
Query: 693 VNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGA-FKSFIAECNTLKNIRHRNLVKIL 751
+ ++G G+ G V K + +AVK L + A K + E + L +V
Sbjct: 6 LGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFY 65
Query: 752 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVAC 811
A Y D ++ E+M SL++ L E + I++ V
Sbjct: 66 GAF----YNNGDI-SICMEYMDGGSLDKIL---------KEVQGRIPERILGKIAVAVLK 111
Query: 812 ALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGY 871
L YLH + I H D+KPSNIL++ + DFG++ L S A+T G+ Y
Sbjct: 112 GLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV----GTSSY 165
Query: 872 IAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
+APE G++ S+ D++S G+ L+EL T + P
Sbjct: 166 MAPERIQGNDYSVKSDIWSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 6e-15
Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 23/222 (10%)
Query: 695 QIGEGSFGSVFKGIL-----DDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVK 749
++GEG+FG VF + +AVK A K F E L N++H ++VK
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 750 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHP------ITREDETDEAPRSLNLIQRL 803
C D D +VFE+M + L ++L I + + +A L L Q L
Sbjct: 72 FYGVC--GD---GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML 126
Query: 804 NISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSI 863
+I+ +A + YL H DL N L+ +++ IGDFG++R + S +
Sbjct: 127 HIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR--DVYSTDYYRV 181
Query: 864 GAKG--SIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKK 903
G I ++ PE + + + DV+S+G++L E+ T K
Sbjct: 182 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 6e-15
Identities = 64/251 (25%), Positives = 104/251 (41%), Gaps = 54/251 (21%)
Query: 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-----HGAFKSFIAECNTLKNIR 743
R+ ++GEG++ V+K + +A+K L G + + E L+ ++
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 744 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETD-EAPRSLNLIQR 802
H N++ +L + LVFEFM ETD E +I+
Sbjct: 61 HPNIIGLLDV-----FGHKSNINLVFEFM----------------ETDLEK-----VIKD 94
Query: 803 LNISI---DVAC-------ALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARF 852
+I + D+ L YLH + I H DLKP+N+L+ D + + DFGLAR
Sbjct: 95 KSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARS 151
Query: 853 LPLSSAQ-TSSIGAKGSIGYIAPEYGLGSEVSISG-DVYSYGILLLELITRKKPTDIMFE 910
+ + T + Y APE G+ G D++S G + EL+ R P
Sbjct: 152 FGSPNRKMTHQVVT---RWYRAPELLFGARHYGVGVDMWSVGCIFAELLLR-VP---FLP 204
Query: 911 GDMNLHNLART 921
GD ++ L +
Sbjct: 205 GDSDIDQLGKI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 8e-15
Identities = 64/225 (28%), Positives = 100/225 (44%), Gaps = 27/225 (12%)
Query: 693 VNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAF--KSFIAECNTLKNIRHRNLVKI 750
+ ++G G FG V G R I V + ++ GA + FI E + + H LV++
Sbjct: 9 MKELGSGQFGVVHLG---KWRAQIKVAI-KAINEGAMSEEDFIEEAKVMMKLSHPKLVQL 64
Query: 751 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVA 810
C+ Q +V EFM N L +L R+ + + L L++ DV
Sbjct: 65 YGVCT----QQKPL-YIVTEFMENGCLLNYL----RQRQGKLSKDML-----LSMCQDVC 110
Query: 811 CALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIG 870
+ YL + H DL N L+ + + DFG+ R++ L TSS GAK +
Sbjct: 111 EGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYV-LDDEYTSSSGAKFPVK 166
Query: 871 YIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNL 915
+ PE S+ S DV+S+G+L+ E+ T K + FE N
Sbjct: 167 WSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGK---MPFEKKSNY 208
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-14
Identities = 35/84 (41%), Positives = 59/84 (70%), Gaps = 1/84 (1%)
Query: 144 NQ-LVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTL 202
NQ L G IP+++S L ++ I+++ N++ G+IP SLG+++S+ L LS N+ GSIP++L
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486
Query: 203 GWLKNLVNLTMAQNRLSGTIPSSI 226
G L +L L + N LSG +P+++
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-14
Identities = 61/219 (27%), Positives = 99/219 (45%), Gaps = 20/219 (9%)
Query: 695 QIGEGSFGSVFKG-----ILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVK 749
++GEG+FG VF + + +AVK A K F E L N++H ++VK
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 750 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLH---PITREDETDEAPRSLNLIQRLNIS 806
C +G+ +VFE+M + L ++L P P L Q L+I+
Sbjct: 72 FYGVC----VEGDPL-IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIA 126
Query: 807 IDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAK 866
+A + YL H DL N L+ E+++ IGDFG++R + S +G
Sbjct: 127 QQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR--DVYSTDYYRVGGH 181
Query: 867 G--SIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKK 903
I ++ PE + + + DV+S G++L E+ T K
Sbjct: 182 TMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 75/299 (25%), Positives = 121/299 (40%), Gaps = 52/299 (17%)
Query: 696 IGEGSFGSVFKGILDDGRTT---IAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKI 750
+GEG FGSV +G L + +AVK L + + F++E +K+ H N++K+
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 751 LTAC-SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDV 809
+ C Q ++ FM + L +L P L L L +D+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL----YSRLGGLPEKLPLQTLLKFMVDI 122
Query: 810 ACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSI 869
A + YL + H DL N +L EDM + DFGL++ + AK +
Sbjct: 123 ALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179
Query: 870 GYIAPEYGLGSEVSIS-GDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALP---D 925
+IA E L V S DV+++G+ + E+ TR +T P +
Sbjct: 180 KWIAIE-SLADRVYTSKSDVWAFGVTMWEIATR-----------------GQTPYPGVEN 221
Query: 926 HVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMT 984
H + D + HGN R+K +CL + + +C P+DR + T
Sbjct: 222 HEI-----------YDYLRHGN------RLKQPEDCLDELYDLMYSCWRADPKDRPTFT 263
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 1e-14
Identities = 74/256 (28%), Positives = 114/256 (44%), Gaps = 43/256 (16%)
Query: 668 PNSPINSFPNISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHG 727
+S S S + +R VN+IG G+ G+V+K I A+KV H
Sbjct: 57 SSSSSASGSAPSAAKSLSELER---VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHED 113
Query: 728 AFKSFIA-ECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITR 786
+ I E L+++ H N+VK C + + + L+ EFM SLE I
Sbjct: 114 TVRRQICREIEILRDVNHPNVVK----CHDMFDHNGEIQVLL-EFMDGGSLEG--THIAD 166
Query: 787 EDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846
E + R Q L+ + YLH + I H D+KPSN+L++ I D
Sbjct: 167 EQFLADVAR-----QILS-------GIAYLH---RRHIVHRDIKPSNLLINSAKNVKIAD 211
Query: 847 FGLARFLPLSSAQT-----SSIGAKGSIGYIAPE-----YGLGSEVSISGDVYSYGILLL 896
FG++R L AQT SS+ G+I Y++PE G+ +GD++S G+ +L
Sbjct: 212 FGVSRIL----AQTMDPCNSSV---GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSIL 264
Query: 897 ELITRKKPTDIMFEGD 912
E + P + +GD
Sbjct: 265 EFYLGRFPFGVGRQGD 280
|
Length = 353 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 58/223 (26%), Positives = 110/223 (49%), Gaps = 14/223 (6%)
Query: 683 LYNATDRFSSVNQIGEGSFGSVFKGILDD--GRTTIAVKVFNLLHHGA---FKSFIAECN 737
+ + DR + + + EG+FG +F GIL D V V + H + + E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 738 TLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSL 797
L + H+N++ IL C + + +++ +M+ +L+ +L R E + P++L
Sbjct: 61 LLYGLSHQNILPILHVCI----EDGEPPFVLYPYMNWGNLKLFLQ-QCRLGEAN-NPQAL 114
Query: 798 NLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSS 857
+ Q ++++I +AC ++YLH + + H D+ N ++DE++ I D L+R L
Sbjct: 115 STQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD 171
Query: 858 AQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
+ ++A E + E S + DV+S+G+LL EL+T
Sbjct: 172 YHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 57/228 (25%), Positives = 98/228 (42%), Gaps = 34/228 (14%)
Query: 696 IGEGSFGSVFKGILDD-----GRTTIAVKVFNLLHHGA----FKSFIAECNTLKNIRHRN 746
+GEG FG V K G TT+AVK +L A + ++E N LK + H +
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVK---MLKENASSSELRDLLSEFNLLKQVNHPH 64
Query: 747 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLH------------PITREDETDEAP 794
++K+ ACS + L+ E+ SL +L R + P
Sbjct: 65 VIKLYGACSQ-----DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119
Query: 795 --RSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARF 852
R+L + ++ + ++ + YL + + H DL N+L+ E I DFGL+R
Sbjct: 120 DERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD 176
Query: 853 LPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
+ + + + ++A E + DV+S+G+LL E++T
Sbjct: 177 VYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 55/219 (25%), Positives = 94/219 (42%), Gaps = 32/219 (14%)
Query: 687 TDRFSSVNQIGEGSFGSVFKGI-LDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHR 745
+ + ++ +IGEG+ G V+K G+ +A+K L + I E +K+ +H
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKE-VAIKKMRLRKQNK-ELIINEILIMKDCKHP 75
Query: 746 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNI 805
N+V + Y D +V E+M SL + + + +N Q +
Sbjct: 76 NIVDYYDS-----YLVGDELWVVMEYMDGGSLTDII---------TQNFVRMNEPQIAYV 121
Query: 806 SIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGA 865
+V L YLH + H D+K NILL +D + DFG A AQ + +
Sbjct: 122 CREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFA-------AQLTKEKS 171
Query: 866 K-----GSIGYIAPEYGLGSEVSISGDVYSYGILLLELI 899
K G+ ++APE + D++S GI+ +E+
Sbjct: 172 KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 60/212 (28%), Positives = 104/212 (49%), Gaps = 26/212 (12%)
Query: 696 IGEGSFGSVFKGILD-DGRTTIAVKVFNLLHHGAFKS---FIAECNTLKNIRHRNLVKIL 751
IG G FG VF+GIL GR +AV + L K F++E + + H N++++
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL- 71
Query: 752 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVAC 811
GV + ++ E+M N +L+++L R+ + + + L+ L +A
Sbjct: 72 ---EGVVTKFKPA-MIITEYMENGALDKYL----RDHDGEFSS--YQLVGMLR---GIAA 118
Query: 812 ALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFL---PLSSAQTSSIGAKGS 868
+ YL H DL NIL++ ++ + DFGL+R L P + TS G K
Sbjct: 119 GMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTS--GGKIP 173
Query: 869 IGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
I + APE + + + DV+S+GI++ E+++
Sbjct: 174 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 3e-14
Identities = 59/217 (27%), Positives = 106/217 (48%), Gaps = 34/217 (15%)
Query: 696 IGEGSFGSVFKGILD-DGRTTIAVKVFNLLHHGAF-----KSFIAECNTLKNIRHRNLVK 749
IG G FG V +G L G+ I V + L + + F++E + + H N++
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTL--KSGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 750 ---ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNIS 806
++T V ++ EFM N +L+ +L R+++ +IQ + +
Sbjct: 70 LEGVVTKSRPV--------MIITEFMENGALDSFL----RQNDG-----QFTVIQLVGML 112
Query: 807 IDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQ---TSSI 863
+A + YL + H DL NIL++ +++ + DFGL+RFL ++ TSS+
Sbjct: 113 RGIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSL 169
Query: 864 GAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
G K I + APE + + + DV+SYGI++ E+++
Sbjct: 170 GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 5e-14
Identities = 63/269 (23%), Positives = 102/269 (37%), Gaps = 49/269 (18%)
Query: 694 NQIGEGSFGSVFKGIL---DDGRTTIAVKVFNLLHHGAFKS----FIAECNTLKNIRHRN 746
++G G+FGSV KG+ +AVK L + F+ E + + + H
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKT---LKQEHIAAGKKEFLREASVMAQLDHPC 57
Query: 747 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWL--HPITREDETDEAPRSLNLIQRLN 804
+V+++ C +G LV E L ++L +L
Sbjct: 58 IVRLIGVC-----KGEPL-MLVMELAPLGPLLKYLKKRREIPV---------SDL---KE 99
Query: 805 ISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFL-PLSSAQTSSI 863
++ VA + YL H DL N+LL A I DFG++R L S ++
Sbjct: 100 LAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156
Query: 864 GAKGSIGYIAPE---YGLGSEVSISGDVYSYGILLLELITR-------KKPTDIMFEGDM 913
+ + + APE YG + S DV+SYG+ L E + K +++ +
Sbjct: 157 AGRWPLKWYAPECINYG---KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES 213
Query: 914 NLHNLARTAL-PDHVMDIVDSTLLNDGED 941
L R P + I+ S ED
Sbjct: 214 G-ERLPRPEECPQEIYSIMLSCWKYRPED 241
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 6e-14
Identities = 70/245 (28%), Positives = 110/245 (44%), Gaps = 42/245 (17%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVK----VFNLLHHGAFKSFIAECNTLKNIR 743
R+ + IG G++G V I +A+K F++ K + E L++ +
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLA--KRTLRELKILRHFK 62
Query: 744 HRNLVKILTACSGVDYQGNDFKA--LVFEFMHNRSLEEWLHPI--TREDETDEAPRSLNL 799
H N++ I + G DFK +V + M E LH I + + T+E R L
Sbjct: 63 HDNIIAIRDI---LRPPGADFKDVYVVMDLM-----ESDLHHIIHSDQPLTEEHIRYF-L 113
Query: 800 IQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQ 859
Q L L Y+H + H DLKPSN+L++ED IGDFG+AR L S +
Sbjct: 114 YQLL-------RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163
Query: 860 -----TSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDIMFEGDM 913
T + + Y APE L E + + D++S G + E++ R++ +F G
Sbjct: 164 HKYFMTEYVATR---WYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ----LFPGKN 216
Query: 914 NLHNL 918
+H L
Sbjct: 217 YVHQL 221
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 6e-14
Identities = 70/237 (29%), Positives = 117/237 (49%), Gaps = 30/237 (12%)
Query: 675 FPNISYQNLYNATDRFSSVNQIGEGSFGSVFKG-ILDDG-RTTIAVK-VFNLLHHGAFKS 731
+P + + ++ +F V IGEG+FG V K I DG R A+K + +
Sbjct: 1 YPVLEWNDI-----KFQDV--IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 53
Query: 732 FIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDET 790
F E L + H N++ +L AC +++G + L E+ + +L ++L +R ET
Sbjct: 54 FAGELEVLCKLGHHPNIINLLGAC---EHRG--YLYLAIEYAPHGNLLDFLRK-SRVLET 107
Query: 791 DEA-------PRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843
D A +L+ Q L+ + DVA ++YL Q H DL NIL+ E+ +A
Sbjct: 108 DPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAK 164
Query: 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
I DFGL+R + +T + + ++A E S + + DV+SYG+LL E+++
Sbjct: 165 IADFGLSRGQEVYVKKTM---GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 7e-14
Identities = 62/221 (28%), Positives = 99/221 (44%), Gaps = 36/221 (16%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNL 747
+ + + +IG G++G V+K +A+KV L F+ E + LK RH N+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 748 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISI 807
V + Y D +V E+ SL++ +TR L+ +Q +
Sbjct: 63 VAYFGS-----YLRRDKLWIVMEYCGGGSLQDIYQ-VTR--------GPLSELQIAYVCR 108
Query: 808 DVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQ-TSSIGAK 866
+ L YLH I H D+K +NILL ED + DFG+ SAQ T++I +
Sbjct: 109 ETLKGLAYLHE--TGKI-HRDIKGANILLTEDGDVKLADFGV-------SAQLTATIAKR 158
Query: 867 GS-IG---YIAPEYGLGSEVSISG-----DVYSYGILLLEL 898
S IG ++APE + + G D+++ GI +EL
Sbjct: 159 KSFIGTPYWMAPE--VAAVERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 8e-14
Identities = 68/236 (28%), Positives = 110/236 (46%), Gaps = 29/236 (12%)
Query: 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNL 747
++ + +IGEG++G V+KG +A+K L G + I E + LK ++H N+
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 748 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISI 807
V + V Q + L+FEF+ + L+++L + + D L Q L
Sbjct: 62 VCLQD----VLMQESRL-YLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQ--- 112
Query: 808 DVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARF--LPLSSAQTSSIGA 865
+ + H + H DLKP N+L+D + + DFGLAR +P+ +
Sbjct: 113 ----GILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-- 163
Query: 866 KGSIGYIAPEYGLGSE-VSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLAR 920
++ Y APE LGS S D++S G + E+ T KKP +F GD + L R
Sbjct: 164 --TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKP---LFHGDSEIDQLFR 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 8e-14
Identities = 67/228 (29%), Positives = 107/228 (46%), Gaps = 30/228 (13%)
Query: 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNL 747
+ V +IGEG++G V+K +A+K L G + I E + LK + H N+
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI 60
Query: 748 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISI 807
V++L V + N LVFEF+ + L++++ +S L Q L
Sbjct: 61 VRLLD----VVHSENKL-YLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSY-LYQLLQ--- 110
Query: 808 DVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLAR-F-LPLSSAQTSSIGA 865
+ Y H + H DLKP N+L+D + + DFGLAR F +P+ T +
Sbjct: 111 ----GIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-RTYTHEV-- 160
Query: 866 KGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDIMFEGD 912
++ Y APE LGS + S D++S G + E++ R+ +F GD
Sbjct: 161 -VTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRP----LFPGD 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 1e-13
Identities = 43/166 (25%), Positives = 74/166 (44%), Gaps = 29/166 (17%)
Query: 693 VNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIR-------HR 745
+ Q+G+G+FGSV+ + +A+K F S+ EC L+ ++ H
Sbjct: 4 IKQLGDGTFGSVYLARNKETGELVAIKKMK----KKFYSW-EECMNLREVKSLRKLNEHP 58
Query: 746 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNI 805
N+VK+ ++ ND VFE+M E L+ + ++ + + + +I
Sbjct: 59 NIVKLKEV-----FRENDELYFVFEYM-----EGNLYQLMKDRK----GKPFSESVIRSI 104
Query: 806 SIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLAR 851
+ L ++H H DLKP N+L+ + I DFGLAR
Sbjct: 105 IYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 79/277 (28%), Positives = 118/277 (42%), Gaps = 56/277 (20%)
Query: 696 IGEGSFGSVFKGI-LDDGRTTIAVKVFNLLHHG-----AFKSFIAECNTLKNIRHRNLVK 749
+G GSFGSV++G+ LDDG AVK +L G A K E L ++H N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDG-DFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 750 IL-TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISID 808
L T D + E + SL + L + E L Q L
Sbjct: 67 YLGTEREE------DNLYIFLELVPGGSLAKLLK---KYGSFPEPVIRLYTRQILL---- 113
Query: 809 VACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGS 868
L YLH H D+K +NIL+D + + + DFG+A+ + + + KGS
Sbjct: 114 ---GLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGS 164
Query: 869 IGYIAPE-------YGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLART 921
++APE YGL + D++S G +LE+ T K P EG + + R+
Sbjct: 165 PYWMAPEVIAQQGGYGL------AADIWSLGCTVLEMATGKPPWS-QLEGVAAVFKIGRS 217
Query: 922 ----ALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQAR 954
+PDH L ++ +D I+ QR R
Sbjct: 218 KELPPIPDH--------LSDEAKDFILKCLQRDPSLR 246
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 26/216 (12%)
Query: 693 VNQIGEGSFGSV----FKGILDDGRTTIAVKVFNLLHHGA--FKSFIAECNTLKNIRHRN 746
+ Q+G+G+FGSV + + D+ +AVK L H A + F E LK+++H N
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVK--KLQHSTAEHLRDFEREIEILKSLQHDN 66
Query: 747 LVKILTACSGVDYQ-GNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNI 805
+VK GV Y G LV E++ SL ++L + E + + L ++
Sbjct: 67 IVKY----KGVCYSAGRRNLRLVMEYLPYGSLRDYLQ---KHRERLDHRKLLLYASQICK 119
Query: 806 SIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSA-QTSSIG 864
++ + Y+H D L NIL++ + IGDFGL + LP
Sbjct: 120 GMEYLGSKRYVHRD---------LATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREP 170
Query: 865 AKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
+ I + APE S+ S++ DV+S+G++L EL T
Sbjct: 171 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 60/213 (28%), Positives = 93/213 (43%), Gaps = 19/213 (8%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAF-KSFIAECNTLKNIRHRN 746
++ ++++GEG+ GSV K L + A+K + K + E K+ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 747 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPI-TREDETDEAPRSLNLIQRLNI 805
+VK A +D + + E+ SL+ + R E I
Sbjct: 61 IVKYYGAF--LDESSSSIG-IAMEYCEGGSLDSIYKKVKKRGGRIGEKVL-------GKI 110
Query: 806 SIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGA 865
+ V L+YLH I H D+KPSNILL + DFG++ L S A T +
Sbjct: 111 AESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT--- 164
Query: 866 KGSIGYIAPEYGLGSEVSISGDVYSYGILLLEL 898
G+ Y+APE G SI+ DV+S G+ LLE+
Sbjct: 165 -GTSFYMAPERIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 59/227 (25%), Positives = 94/227 (41%), Gaps = 26/227 (11%)
Query: 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAF--KSFIAECNTLKNIRHRNL 747
F +N+IG+GSFG VFK + + A+K +L + I E L + +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 748 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISI 807
++ S +D +V E+ N L + L P + + R I I
Sbjct: 62 IRYYE--SFLDKG---KLNIVMEYAENGDLHKLLK------MQRGRPLPEDQVWRFFIQI 110
Query: 808 DVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKG 867
+ L +LH I H D+K N+ LD IGD G+A+ L ++ A
Sbjct: 111 LLG--LAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLL-----SDNTNFANT 160
Query: 868 SIG---YIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEG 911
+G Y++PE + DV++ G++L E T K P D +G
Sbjct: 161 IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG 207
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 2e-13
Identities = 69/261 (26%), Positives = 110/261 (42%), Gaps = 60/261 (22%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKV----FNLLHHGAFKSFIAECNTLKNIR 743
DR+ +++ +G G++G V +A+K F H K E LK++
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHA--KRTYRELRLLKHMD 72
Query: 744 HRN---LVKILTACSGVDYQGNDFKA--LVFEFMHNRSLEEWLHPITREDE-TDEAPRSL 797
H N L+ + T S + DF+ LV M L+ I + + +D+ + L
Sbjct: 73 HENVIGLLDVFTPASSL----EDFQDVYLVTHLMGAD-----LNNIVKCQKLSDDHIQFL 123
Query: 798 NLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSS 857
+ Q L L Y+H I H DLKPSNI ++ED I DFGLAR
Sbjct: 124 -VYQILR-------GLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLAR--HTDD 170
Query: 858 AQTSSIGAKGSIGYIAPEYGLGSEV-------SISGDVYSYGILLLELITRKKPTDIMFE 910
T GY+A + E+ + + D++S G ++ EL+T K +F
Sbjct: 171 EMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK----TLFP 217
Query: 911 GDMNLHNLARTALPDHVMDIV 931
G ++ L R +M++V
Sbjct: 218 GSDHIDQLKR------IMNLV 232
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-13
Identities = 38/89 (42%), Positives = 55/89 (61%), Gaps = 1/89 (1%)
Query: 362 LLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNI 421
L LDN + G IP I K +LQ +++ N + G IPP++G + +L+ L L N F G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 422 PPSIGNL-KLFILYLSYNFLQGSIPSSLG 449
P S+G L L IL L+ N L G +P++LG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-13
Identities = 35/78 (44%), Positives = 53/78 (67%), Gaps = 1/78 (1%)
Query: 393 LSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLK-LFILYLSYNFLQGSIPSSLGRY 451
L G IP I +L++L+ + L N +GNIPPS+G++ L +L LSYN GSIP SLG+
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 452 ETLTTIDLSNNNLTGTIP 469
+L ++L+ N+L+G +P
Sbjct: 490 TSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-13
Identities = 71/262 (27%), Positives = 121/262 (46%), Gaps = 49/262 (18%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHR 745
D++ V +IGEG++G V+K TIA+K L G + I E + LK ++H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 746 NLVKILTACSGVDYQGNDFKA-LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLN 804
N+V++ D ++ + LVFE++ + L++ + D + + ++ LI+
Sbjct: 62 NIVRLQ------DVVHSEKRLYLVFEYL-DLDLKKHM------DSSPDFAKNPRLIKTYL 108
Query: 805 ISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA-HIGDFGLARF--LPLSSAQTS 861
I A + H + H DLKP N+L+D A + DFGLAR +P+ +
Sbjct: 109 YQILRGIAYCHSHR-----VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE 163
Query: 862 SIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLAR 920
+ ++ Y APE LGS S D++S G + E++ +K +F GD + L +
Sbjct: 164 VV----TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKP----LFPGDSEIDELFK 215
Query: 921 ----------------TALPDH 926
T+LPD+
Sbjct: 216 IFRILGTPNEETWPGVTSLPDY 237
|
Length = 294 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 3e-13
Identities = 57/214 (26%), Positives = 88/214 (41%), Gaps = 27/214 (12%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKILT 752
I +G++G VF A+KV ++ + E + L + +VK+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 753 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACA 812
+ +QG LV E++ L L + DE D A ++ A
Sbjct: 61 S-----FQGKKNLYLVMEYLPGGDLASLLENVGSLDE-DVAR---------IYIAEIVLA 105
Query: 813 LNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARF------LPLSSAQTSSIGAK 866
L YLH I H DLKP NIL+D + + DFGL++ + L+ +
Sbjct: 106 LEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV 162
Query: 867 GSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
G+ YIAPE LG S + D +S G +L E +
Sbjct: 163 GTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-13
Identities = 64/220 (29%), Positives = 104/220 (47%), Gaps = 24/220 (10%)
Query: 693 VNQIGEGSFGSVFKGI-LDDGRTT---IAVKVFN-LLHHGAFKSFIAECNTLKNIRHRNL 747
V +G G+FG+V+KGI + +G T +A+K+ N A F+ E + ++ H +L
Sbjct: 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 71
Query: 748 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISI 807
V++L C Q LV + M + L +++H + D L LN +
Sbjct: 72 VRLLGVCLSPTIQ------LVTQLMPHGCLLDYVH-----EHKDNIGSQL----LLNWCV 116
Query: 808 DVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKG 867
+A + YL + + H DL N+L+ I DFGLAR L + ++ G K
Sbjct: 117 QIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM 173
Query: 868 SIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTD 906
I ++A E + + DV+SYG+ + EL+T KP D
Sbjct: 174 PIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 30/208 (14%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFK-SFIAECNTLKNIRHRNLVKILTAC 754
+G+G+FG VFKG L D +T +AVK K F++E LK H N+VK++ C
Sbjct: 3 LGKGNFGEVFKGTLKD-KTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 755 SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALN 814
+ + ++ M ++L + ++ + L Q + ++D A +
Sbjct: 62 TQ--------RQPIYIVMELVPGGDFLSFLRKKKD------ELKTKQLVKFALDAAAGMA 107
Query: 815 YLH-HDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKG-SIGYI 872
YL +C H DL N L+ E+ + I DFG++R SS G K I +
Sbjct: 108 YLESKNC----IHRDLAARNCLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQIPIKWT 161
Query: 873 APE---YGLGSEVSISGDVYSYGILLLE 897
APE YG S S DV+SYGILL E
Sbjct: 162 APEALNYGRYSSES---DVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 58/212 (27%), Positives = 90/212 (42%), Gaps = 19/212 (8%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKILT 752
+G+G FG V + A K N L ++ + E L + R +V +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 753 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACA 812
A +Q LV M+ L ++ + E+ PR+ + +
Sbjct: 61 A-----FQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFY------TAQIISG 109
Query: 813 LNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYI 872
L +LH Q I + DLKP N+LLD D I D GLA + L Q+ + G G+ G++
Sbjct: 110 LEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPGFM 164
Query: 873 APEYGLGSEVSISGDVYSYGILLLELITRKKP 904
APE G E S D ++ G+ L E+I + P
Sbjct: 165 APELLQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 4e-13
Identities = 59/218 (27%), Positives = 111/218 (50%), Gaps = 30/218 (13%)
Query: 690 FSSVNQIGEGSFGSVFKGILDDGRTT---IAVKVFNL-LHHGAFKSFIAECNTLKNIRHR 745
F + ++GEG++ +V+KG RTT +A+K +L G + I E + +K ++H
Sbjct: 2 FKQLEKLGEGTYATVYKGR---NRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHE 58
Query: 746 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNI 805
N+V++ V + N LVFE+M L++++ +T +L+ +
Sbjct: 59 NIVRL----HDVIHTENKL-MLVFEYMDK-DLKKYM-------DTHGVRGALDPNTVKSF 105
Query: 806 SIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARF--LPLSSAQTSSI 863
+ + + + H + + H DLKP N+L+++ + DFGLAR +P+++ +
Sbjct: 106 TYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV 162
Query: 864 GAKGSIGYIAPEYGLGSEV-SISGDVYSYGILLLELIT 900
++ Y AP+ LGS S S D++S G ++ E+IT
Sbjct: 163 ----TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 57/225 (25%), Positives = 107/225 (47%), Gaps = 22/225 (9%)
Query: 686 ATDRFSSVNQIGEGSFGSVFKGIL-----DDGRTTIAVKVFNLLHHGAFKS---FIAECN 737
A ++ + ++G+GSFG V++GI D+ T +A+K N + + F+ E +
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEAS 61
Query: 738 TLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSL 797
+K ++V++L GV QG ++ E M L+ +L + E E +
Sbjct: 62 VMKEFNCHHVVRLL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPP 116
Query: 798 NLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSS 857
+L + + ++ ++A + YL+ + H DL N ++ ED IGDFG+ R +
Sbjct: 117 SLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYE 171
Query: 858 AQTSSIGAKG--SIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
G KG + +++PE + DV+S+G++L E+ T
Sbjct: 172 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 4e-13
Identities = 80/272 (29%), Positives = 114/272 (41%), Gaps = 95/272 (34%)
Query: 689 RFSSVNQIGEGSFGSVFKGILDDGRT--TIAVK-VFNLLHHGAFK------------SFI 733
++ + ++G+G++G V+K I D RT +A+K +F AF+ F+
Sbjct: 8 KYEILQKLGKGAYGIVWKAI--DRRTKEVVALKKIF-----DAFRNATDAQRTFREIMFL 60
Query: 734 AECNTLKNIRHRNLVKILTACSGVDYQGNDFKA-------LVFEFMHNRSLEEWLHPITR 786
E L + H N+VK+L N KA LVFE+M
Sbjct: 61 QE---LGD--HPNIVKLL----------NVIKAENDKDIYLVFEYM-------------- 91
Query: 787 EDETDEAPRSLNLIQRLNISIDVAC---------ALNYLHHDCQPPIAHCDLKPSNILLD 837
ETD L+ + R NI DV AL Y+H + H DLKPSNILL+
Sbjct: 92 --ETD-----LHAVIRANILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLN 141
Query: 838 EDMIAHIGDFGLARFLPLSSAQTSSIGAKGSI--------GYIAPEYGLGSEVSISG-DV 888
D + DFGLAR S + + Y APE LGS G D+
Sbjct: 142 SDCRVKLADFGLAR-----SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDM 196
Query: 889 YSYGILLLELITRKKPTDIMFEGDMNLHNLAR 920
+S G +L E++ KP +F G L+ L +
Sbjct: 197 WSVGCILGEML-LGKP---LFPGTSTLNQLEK 224
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 4e-13
Identities = 66/225 (29%), Positives = 106/225 (47%), Gaps = 34/225 (15%)
Query: 689 RF-SSVNQIGEGSFGSV----FKGILDDGRTTIAVKVFNLLHHGAFKSFIA----ECNTL 739
RF + +GEG FG V + D+ +AVK L + + IA E L
Sbjct: 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKS---LKPESGGNHIADLKKEIEIL 60
Query: 740 KNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRS--- 796
+N+ H N+VK C+ + GN K L+ EF+ + SL+E+L PR+
Sbjct: 61 RNLYHENIVKYKGICT--EDGGNGIK-LIMEFLPSGSLKEYL------------PRNKNK 105
Query: 797 LNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLS 856
+NL Q+L ++ + ++YL H DL N+L++ + IGDFGL + +
Sbjct: 106 INLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162
Query: 857 SAQ-TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
T + + APE + S+ I+ DV+S+G+ L EL+T
Sbjct: 163 KEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 9e-13
Identities = 37/107 (34%), Positives = 59/107 (55%)
Query: 87 FLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQL 146
F+ L L N IP++ +LR LQ + L NSI G IP ++ S ++L L L +N
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478
Query: 147 VGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNN 193
G IP L L+ + +++N N+L+G +P++LG R+ F +N
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 9e-13
Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 23/210 (10%)
Query: 696 IGEGSFGSVFKGI-LDDGRTT---IAVKVF-NLLHHGAFKSFIAECNTLKNIRHRNLVKI 750
+G G FG+V KGI + +G + +A+K + F+ + ++ H +V++
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 751 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVA 810
L C G Q LV + SL + + R+ P+ L LN + +A
Sbjct: 75 LGICPGASLQ------LVTQLSPLGSLLDHV----RQHRDSLDPQRL-----LNWCVQIA 119
Query: 811 CALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIG 870
+ YL + H +L NILL D I I DFG+A L + K I
Sbjct: 120 KGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK 176
Query: 871 YIAPEYGLGSEVSISGDVYSYGILLLELIT 900
++A E L + DV+SYG+ + E+++
Sbjct: 177 WMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 63/237 (26%), Positives = 107/237 (45%), Gaps = 24/237 (10%)
Query: 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIR--- 743
++ V +IG G++G+V+K +A+K + G S + E LK +
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 744 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRL 803
H N+V+++ C+ LVFE + ++ L +L + E + +L+++
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIK--DLMRQF 117
Query: 804 NISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSI 863
L++LH +C I H DLKP NIL+ + DFGLAR A T +
Sbjct: 118 ------LRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVV 168
Query: 864 GAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLAR 920
++ Y APE L S + D++S G + E+ R+KP +F G+ L +
Sbjct: 169 ---VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKP---LFCGNSEADQLGK 218
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 35/99 (35%), Positives = 47/99 (47%), Gaps = 6/99 (6%)
Query: 806 SIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGA 865
+ + C L +LH Q I + DLKP N+LLD+ I D GLA L G
Sbjct: 101 AAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELK---GGKKIKGR 154
Query: 866 KGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
G+ GY+APE G S D ++ G L E+I + P
Sbjct: 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 70/296 (23%), Positives = 122/296 (41%), Gaps = 43/296 (14%)
Query: 696 IGEGSFGSVFKGIL--DDGRTTIAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKIL 751
+GEG FGSV +G L DD +AVK + + F++E +K H N+++++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 752 TAC-SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVA 810
C V+ +G ++ FM + L H + P+ L + D+A
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDL----HSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122
Query: 811 CALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIG 870
+ YL H DL N +L+E+M + DFGL++ + AK +
Sbjct: 123 SGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179
Query: 871 YIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVMDI 930
+IA E + DV+S+G+ + E+ TR +T P +
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATR-----------------GQTPYP----GV 218
Query: 931 VDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986
+S + D + GN R+K +CL + + +C + +P+DR S +
Sbjct: 219 ENSEIY----DYLRQGN------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETL 264
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 2e-12
Identities = 87/268 (32%), Positives = 128/268 (47%), Gaps = 17/268 (6%)
Query: 320 RDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGK 379
+++ L LTN T L NI +P I L + L+ L L +N+I ++P+ +
Sbjct: 107 SNISELLELTNLTSLDLDNNNIT----DIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRN 161
Query: 380 FVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNL-KLFILYLSYN 438
NL+ LD+ N LS +P + L NL +L L N+ ++PP I L L L LS N
Sbjct: 162 LPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNN 219
Query: 439 FLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVG 498
+ + SSL + L+ ++LSNN L P+ IG S+L LDLS NQ+ S S +G
Sbjct: 220 SII-ELLSSLSNLKNLSGLELSNNKLED--LPESIGNLSNLETLDLSNNQI--SSISSLG 274
Query: 499 NLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQ 558
+L NL L++ GN L +P + LE L N L L L ++
Sbjct: 275 SLTNLRELDLSGNSLSNALPLIALLLLLLELL---LNLLLTLKALELKLNSILLNNNILS 331
Query: 559 NNLSGKIPELLIRLQLVKNLNLSNNDLE 586
N PE L L+ + NL +N L+
Sbjct: 332 NGE-TSSPEALSILESLNNLWTLDNALD 358
|
Length = 394 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-12
Identities = 36/109 (33%), Positives = 59/109 (54%), Gaps = 6/109 (5%)
Query: 326 CSLTNATRLKWLL--ININNFG--GSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFV 381
C + KW + + ++N G G +P IS L L+ + L N I GNIP ++G
Sbjct: 409 CQFDSTKG-KWFIDGLGLDNQGLRGFIPNDISKLRH-LQSINLSGNSIRGNIPPSLGSIT 466
Query: 382 NLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKL 430
+L+ LD+ N +G+IP ++G+L +L+ L L N G +P ++G L
Sbjct: 467 SLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLL 515
|
Length = 623 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 59/238 (24%), Positives = 104/238 (43%), Gaps = 30/238 (12%)
Query: 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVK---VFNLLHHGAFKSFIAECNTLKNIRHRN 746
F +IG G F V++ +A+K +F+L+ A I E + LK + H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 747 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNI- 805
++K + + N+ +V E L + ++ LI +
Sbjct: 64 VIKYYASF----IEDNELN-IVLELADAGDLSRMIKHFKKQKR---------LIPEKTVW 109
Query: 806 --SIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSI 863
+ + AL ++H + H D+KP+N+ + + +GD GL RF SS T++
Sbjct: 110 KYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAH 164
Query: 864 GAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGD-MNLHNLAR 920
G+ Y++PE + + D++S G LL E+ + P F GD MNL++L +
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLYSLCK 218
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 67/238 (28%), Positives = 109/238 (45%), Gaps = 25/238 (10%)
Query: 689 RFSSVNQIGEGSFGSVFKGI-LDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIR-- 743
++ V +IGEG++G VFK L +G +A+K + G S I E L+++
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 744 -HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQR 802
H N+V++ C+ LVFE + ++ L +L + E + + + Q
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDM-MFQL 119
Query: 803 LNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSS 862
L L++LH + H DLKP NIL+ + DFGLAR A TS
Sbjct: 120 LR-------GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV 169
Query: 863 IGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLAR 920
+ ++ Y APE L S + D++S G + E+ R+KP +F G ++ L +
Sbjct: 170 V---VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKP---LFRGSSDVDQLGK 220
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 63/216 (29%), Positives = 89/216 (41%), Gaps = 42/216 (19%)
Query: 695 QIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKS-FIAECNTLKNIRHRNLVKILTA 753
+IG G+FG VF G L T +AVK K+ F+ E LK H N+V+++
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 754 CSGVD--------YQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNI 805
C+ QG DF F+ E PR L + + + +
Sbjct: 62 CTQKQPIYIVMELVQGGDFLT----FLRT-----------------EGPR-LKVKELIQM 99
Query: 806 SIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGA 865
+ A + YL H DL N L+ E + I DFG++R S+ G
Sbjct: 100 VENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSR-EEEDGVYASTGGM 155
Query: 866 KG-SIGYIAPE---YGLGSEVSISGDVYSYGILLLE 897
K + + APE YG S S DV+S+GILL E
Sbjct: 156 KQIPVKWTAPEALNYGRYSSES---DVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 55/221 (24%), Positives = 96/221 (43%), Gaps = 30/221 (13%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFNL----------LHHGAFKSFIAECNTLKNIRHR 745
IG+G++G V+ + +AVK L K+ +E TLK++ H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 746 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNI 805
N+V G + ++ ++ E++ S+ L R +E L++
Sbjct: 69 NIV----QYLGFE-TTEEYLSIFLEYVPGGSIGSCLRTYGRFEE--------QLVRFF-- 113
Query: 806 SIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGA 865
+ V L YLH I H DLK N+L+D D I I DFG+++ ++
Sbjct: 114 TEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSM 170
Query: 866 KGSIGYIAPEYGLGSEVSISG--DVYSYGILLLELITRKKP 904
+GS+ ++APE S D++S G ++LE+ ++P
Sbjct: 171 QGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 5e-12
Identities = 76/248 (30%), Positives = 113/248 (45%), Gaps = 44/248 (17%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH--GAFKSFIAECNTLKNIRHR 745
D+F + QIGEG++G V+K D +A+K L + G + I E L+ + HR
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHR 66
Query: 746 NLVK---ILTACSGVDYQGNDFKA------LVFEFM-HNRS--LEEWLHPITREDETDEA 793
N+V I+T DFK LVFE+M H+ LE L +++
Sbjct: 67 NIVNLKEIVTD----KQDALDFKKDKGAFYLVFEYMDHDLMGLLESGL-----VHFSEDH 117
Query: 794 PRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFL 853
+S + Q L LNY H + H D+K SNILL+ + DFGLAR
Sbjct: 118 IKSF-MKQLLE-------GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLY 166
Query: 854 PLSSAQ--TSSIGAKGSIGYIAPEYGLGSE-VSISGDVYSYGILLLELITRKKPTDIMFE 910
++ T+ + ++ Y PE LG E + DV+S G +L EL T+K +F+
Sbjct: 167 NSEESRPYTNKV---ITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKP----IFQ 219
Query: 911 GDMNLHNL 918
+ L L
Sbjct: 220 ANQELAQL 227
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 57/236 (24%), Positives = 105/236 (44%), Gaps = 30/236 (12%)
Query: 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVK---VFNLLHHGAFKSFIAECNTLKNIRHRN 746
F +IG G F V++ R +A+K +F ++ A + + E + LK + H N
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 747 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNI- 805
++K L + + ++ +V E L + + ++ LI +
Sbjct: 64 VIKYLDS-----FIEDNELNIVLELADAGDLSQMIKYFKKQKR---------LIPERTVW 109
Query: 806 --SIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSI 863
+ + A+ ++H + H D+KP+N+ + + +GD GL RF SS T++
Sbjct: 110 KYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAH 164
Query: 864 GAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGD-MNLHNL 918
G+ Y++PE + + D++S G LL E+ + P F GD MNL +L
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLFSL 216
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 7e-12
Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 26/207 (12%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKILT 752
+G GSFG V A+K+ + ++ + + E L++IRH LV +
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 753 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACA 812
+ +Q + LV E++ L L R E A R + V A
Sbjct: 69 S-----FQDDSNLYLVMEYVPGGELFSHLRKSGRFPE-PVA--------RFYAA-QVVLA 113
Query: 813 LNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYI 872
L YLH I + DLKP N+LLD D I DFG A+ + +T ++ G+ Y+
Sbjct: 114 LEYLHS-LD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVK---GRTYTLC--GTPEYL 165
Query: 873 APEYGLGSEVSISGDVYSYGILLLELI 899
APE L + D ++ GIL+ E++
Sbjct: 166 APEIILSKGYGKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 9e-12
Identities = 61/216 (28%), Positives = 94/216 (43%), Gaps = 21/216 (9%)
Query: 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVKV--FNLLHHGAFKSFIAECNTLKNIRHRNL 747
F +N+IGEG++G V++ +A+K + G S + E L N+RH N+
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 748 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISI 807
V++ G + D LV E+ + L L D P + Q + +
Sbjct: 69 VELKEVVVG---KHLDSIFLVMEYC-EQDLASLL---------DNMPTPFSESQVKCLML 115
Query: 808 DVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKG 867
+ L YLH + I H DLK SN+LL + I DFGLAR
Sbjct: 116 QLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPAKPMTPKVV 170
Query: 868 SIGYIAPEYGLGSEV-SISGDVYSYGILLLELITRK 902
++ Y APE LG + + D+++ G +L EL+ K
Sbjct: 171 TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 9e-12
Identities = 22/42 (52%), Positives = 24/42 (57%), Gaps = 1/42 (2%)
Query: 18 NETDRLALLELKSKITHDPLGVLASWNES-SHFCQWRGVTCS 58
DR ALL KS + DP G L+SWN S S C W GVTC
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 9e-12
Identities = 71/234 (30%), Positives = 110/234 (47%), Gaps = 43/234 (18%)
Query: 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFI------AECNTLKNI 742
R++S+ Q+G G++GSV I D RT V + L F+S I E LK++
Sbjct: 16 RYTSLKQVGSGAYGSVCSAI--DKRTGEKVAIKKL--SRPFQSEIFAKRAYRELTLLKHM 71
Query: 743 RHRNLVKIL----TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLN 798
+H N++ +L +A SG ++Q DF LV +M + HP++ +
Sbjct: 72 QHENVIGLLDVFTSAVSGDEFQ--DF-YLVMPYMQTDLQKIMGHPLSEDK---------- 118
Query: 799 LIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSA 858
+Q L + C L Y+H I H DLKP N+ ++ED I DFGLAR A
Sbjct: 119 -VQYL--VYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----HA 167
Query: 859 QTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDIMFEG 911
G + Y APE L + + D++S G ++ E++T K +F+G
Sbjct: 168 DAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKT----LFKG 217
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 9e-12
Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 32/215 (14%)
Query: 696 IGEGSFGSVFKGILD-DGRTTIAVKVFNL---LHHGAFKSFIAECNTLKNIRHRNLVK-- 749
IG G FG V G L G+ I V + L + F++E + + H N++
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 750 -ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISID 808
++T V +V E+M N SL+ +L + D +IQ + +
Sbjct: 72 GVVTKSKPV--------MIVTEYMENGSLDAFLR---KHDG------QFTVIQLVGMLRG 114
Query: 809 VACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFL---PLSSAQTSSIGA 865
+A + YL H DL NIL++ +++ + DFGL+R L P ++ T G
Sbjct: 115 IASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR--GG 169
Query: 866 KGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
K I + APE + + + DV+SYGI++ E+++
Sbjct: 170 KIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 66/242 (27%), Positives = 108/242 (44%), Gaps = 31/242 (12%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSF----IAECNTLKNIR 743
++ + +IG+G+FG VFK + +A+K +L + F + E L+ ++
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALK--KVLMENEKEGFPITALREIKILQLLK 69
Query: 744 HRNLVKILTACSGVDYQGNDFKA---LVFEFM-HNRSLEEWLHPITREDETDEAPRSLNL 799
H N+V ++ C N +K LVFEF H+ L L + E + +
Sbjct: 70 HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHD--LAGLLSNKNVKFTLSEIKKVMK- 126
Query: 800 IQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLAR--FLPLSS 857
LN L Y+H + I H D+K +NIL+ +D I + DFGLAR L +S
Sbjct: 127 -MLLN-------GLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNS 175
Query: 858 AQTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLH 916
++ Y PE LG + D++ G ++ E+ TR + IM +G+ H
Sbjct: 176 KPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTR---SPIM-QGNTEQH 231
Query: 917 NL 918
L
Sbjct: 232 QL 233
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 55/225 (24%), Positives = 105/225 (46%), Gaps = 22/225 (9%)
Query: 686 ATDRFSSVNQIGEGSFGSVFKGILDD-----GRTTIAVKVFNLLHHGAFKS---FIAECN 737
+ ++ + + ++G+GSFG V++G D T +AVK N + + F+ E +
Sbjct: 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEAS 61
Query: 738 TLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSL 797
+K ++V++L GV +G +V E M + L+ +L + E E +
Sbjct: 62 VMKGFTCHHVVRLL----GVVSKGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 116
Query: 798 NLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSS 857
L + + ++ ++A + YL+ H DL N ++ D IGDFG+ R +
Sbjct: 117 TLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYE 171
Query: 858 AQTSSIGAKG--SIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
G KG + ++APE + S D++S+G++L E+ +
Sbjct: 172 TDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 59/237 (24%), Positives = 106/237 (44%), Gaps = 29/237 (12%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIA--ECNTLKNIRHR 745
+++ ++ +GEGS+G V K + +A+K F IA E LK +RH
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 746 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNI 805
NLV ++ + LVFEF+ + L D+ ++ P L+ +
Sbjct: 61 NLVNLIEVFR----RKKRLY-LVFEFVDHTVL----------DDLEKYPNGLDESRVRKY 105
Query: 806 SIDVACALNYLH-HDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIG 864
+ + + H H+ I H D+KP NIL+ + + + DFG AR L++
Sbjct: 106 LFQILRGIEFCHSHN----IIHRDIKPENILVSQSGVVKLCDFGFART--LAAPGEVYTD 159
Query: 865 AKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLAR 920
+ Y APE +G ++ + D+++ G L+ E++T + +F GD ++ L
Sbjct: 160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLT----GEPLFPGDSDIDQLYH 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 76/291 (26%), Positives = 119/291 (40%), Gaps = 56/291 (19%)
Query: 696 IGEGSFGSVFKGI-LDDG---RTTIAVKVFNL-LHHGAFKSFIAECNTLKNIRHRNLVKI 750
+G G+FG+V+KGI + DG + +A+KV A K + E + + + ++
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 751 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVA 810
L C Q LV + M L +++ RE++ + L LN + +A
Sbjct: 75 LGICLTSTVQ------LVTQLMPYGCLLDYV----RENKDRIGSQDL-----LNWCVQIA 119
Query: 811 CALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIG 870
++YL + + H DL N+L+ I DFGLAR L + + + G K I
Sbjct: 120 KGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK 176
Query: 871 YIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALPDHVMD 929
++A E L + DV+SYG+ + EL+T KP D + +PD
Sbjct: 177 WMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD----------GIPAREIPD---- 222
Query: 930 IVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDR 980
LL GE R+ C I + I V C M E R
Sbjct: 223 -----LLEKGE-------------RLPQPPICTIDVYMIMVKCWMIDSECR 255
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 64/236 (27%), Positives = 101/236 (42%), Gaps = 49/236 (20%)
Query: 689 RFSSVNQIGEGSFGSVFKGILDDGRTT--IAVKVF---NLLHHGAFKSFIAECNTLKNIR 743
++ IG G++G V+K +G+ A+K F + G +S E L+ ++
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 744 HRNLVK----ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPIT--REDETDEAP--- 794
H N+V L Y L+F++ + + I R+ + P
Sbjct: 61 HENVVSLVEVFLEHADKSVY-------LLFDYAEH----DLWQIIKFHRQAKRVSIPPSM 109
Query: 795 -RSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILL----DEDMIAHIGDFGL 849
+SL L Q LN ++YLH + + H DLKP+NIL+ E + IGD GL
Sbjct: 110 VKSL-LWQILN-------GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGL 158
Query: 850 ARFL--PLSSAQTSSIGAKGSIGYIAPEYGLGSE---VSISGDVYSYGILLLELIT 900
AR PL +I Y APE LG+ +I D+++ G + EL+T
Sbjct: 159 ARLFNAPLKPLADLD-PVVVTIWYRAPELLLGARHYTKAI--DIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 23/216 (10%)
Query: 696 IGEGSFGSVFKGIL--DDGRTTIAVKVFN-LLHHGAFKSFIAECNTLKNI-RHRNLVKIL 751
IGEG+FG V + ++ D + A+K+ + F E L + H N++ +L
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 752 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEA-------PRSLNLIQRLN 804
AC Y + E+ +L ++L +R ETD A +L Q L
Sbjct: 70 GACENRGYL-----YIAIEYAPYGNLLDFLRK-SRVLETDPAFAKEHGTASTLTSQQLLQ 123
Query: 805 ISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIG 864
+ DVA + YL + H DL N+L+ E++ + I DFGL+R + +T
Sbjct: 124 FASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTM--- 177
Query: 865 AKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
+ + ++A E S + DV+S+G+LL E+++
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 52/170 (30%), Positives = 76/170 (44%), Gaps = 19/170 (11%)
Query: 735 ECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAP 794
E L+ + R +V + A Y+ D LV M+ L+ H + E
Sbjct: 50 EKQILEKVNSRFVVSLAYA-----YETKDALCLVLTLMNGGDLK--FHIYHMGEAGFEEG 102
Query: 795 RSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLP 854
R++ + ++ C L LH Q I + DLKP NILLD+ I D GLA +P
Sbjct: 103 RAVFY------AAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVP 153
Query: 855 LSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
QT G G++GY+APE + S D ++ G LL E+I + P
Sbjct: 154 --EGQTIK-GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 63/217 (29%), Positives = 97/217 (44%), Gaps = 27/217 (12%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFNLLHHG-AFKSFIAECNTLKNIRHRNLVKILTAC 754
IG G+FG+V K + T +AVK K + + + + R + I
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVM--RSSDCPYI---- 65
Query: 755 SGVDYQGNDFKA----LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVA 810
V + G F+ + E M + SL++ + E P ++ + I++
Sbjct: 66 --VKFYGALFREGDCWICMELM-DISLDK-FYKYVYEVLKSVIPE--EILGK--IAVATV 117
Query: 811 CALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIG 870
ALNYL + + I H D+KPSNILLD + + DFG++ L S A+T G +
Sbjct: 118 KALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCR---P 172
Query: 871 YIAPEYGLGSEVS---ISGDVYSYGILLLELITRKKP 904
Y+APE S + DV+S GI L E+ T K P
Sbjct: 173 YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-11
Identities = 66/234 (28%), Positives = 110/234 (47%), Gaps = 34/234 (14%)
Query: 684 YNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNI 742
+ + + ++++GEG++ +VFKG +A+K L H GA + I E + LKN+
Sbjct: 1 FGKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL 60
Query: 743 RHRNLVKILTACSGVDYQGNDFK-ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQ 801
+H N+V + D + LVFE++ + L+++L NL+
Sbjct: 61 KHANIVTLH------DIIHTERCLTLVFEYLDS-DLKQYLDNCG------------NLMS 101
Query: 802 RLNISI---DVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSA 858
N+ I + L+Y H I H DLKP N+L++E + DFGLAR + +
Sbjct: 102 MHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158
Query: 859 QTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDIMFEG 911
S+ ++ Y P+ LGS E S D++ G +L E+ T + MF G
Sbjct: 159 TYSN--EVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRP----MFPG 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 51/212 (24%), Positives = 93/212 (43%), Gaps = 13/212 (6%)
Query: 696 IGEGSFGSVFKGIL---DDGRTTIAVKVF--NLLHHGAFKSFIAECNTLKNIRHRNLVKI 750
+G+G FGSV + L D +AVK+ ++ + F+ E +K H N++K+
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 751 LTACSGVDYQGN-DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDV 809
+ +G ++ FM + L H E P +L L + ID+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDL----HTFLLMSRIGEEPFTLPLQTLVRFMIDI 122
Query: 810 ACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSI 869
A + YL H DL N +L+E+M + DFGL++ + +K +
Sbjct: 123 ASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPV 179
Query: 870 GYIAPEYGLGSEVSISGDVYSYGILLLELITR 901
++A E + + DV+++G+ + E++TR
Sbjct: 180 KWLALESLADNVYTTHSDVWAFGVTMWEIMTR 211
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 64/235 (27%), Positives = 103/235 (43%), Gaps = 54/235 (22%)
Query: 684 YNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNI 742
+ + + ++++GEGS+ +V+KG +A+K L H GA + I E + LK++
Sbjct: 1 FGKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDL 60
Query: 743 RHRNLV---------KILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEA 793
+H N+V K LT LVFE++ L++++ D+
Sbjct: 61 KHANIVTLHDIIHTKKTLT--------------LVFEYLD-TDLKQYM---------DDC 96
Query: 794 PRSLN-------LIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846
L+ L Q L L Y H + H DLKP N+L+ E + D
Sbjct: 97 GGGLSMHNVRLFLFQLLR-------GLAYCHQR---RVLHRDLKPQNLLISERGELKLAD 146
Query: 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELIT 900
FGLAR + S S+ ++ Y P+ LGS E S S D++ G + E+ T
Sbjct: 147 FGLARAKSVPSKTYSN--EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 60/222 (27%), Positives = 103/222 (46%), Gaps = 34/222 (15%)
Query: 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVK 749
F+ + +IG+GSFG VFKGI + + +A+K+ +L AE + +++I+ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--------AE-DEIEDIQQE--IT 54
Query: 750 ILTACSG---VDYQGNDFKA----LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQR 802
+L+ C Y G+ K ++ E++ S + L P P L+ Q
Sbjct: 55 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP---------GP--LDETQI 103
Query: 803 LNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSS 862
I ++ L+YLH + + H D+K +N+LL E + DFG+A L+ Q
Sbjct: 104 ATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKR 158
Query: 863 IGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
G+ ++APE S D++S GI +EL + P
Sbjct: 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 76/314 (24%), Positives = 118/314 (37%), Gaps = 59/314 (18%)
Query: 686 ATDRFSSVNQIGEGSFGSVFKGIL-----DDGRTTIAVKVFNLLHHGAFKS-FIAECNTL 739
D + + +G G+FG V++G+ D +AVK +S F+ E +
Sbjct: 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63
Query: 740 KNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDE-TDEAPRSLN 798
H+N+V+ GV ++ + ++ E M L+ +L RE+ E P SL
Sbjct: 64 SKFNHQNIVR----LIGVSFERLP-RFILLELMAGGDLKSFL----RENRPRPERPSSLT 114
Query: 799 LIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLD---EDMIAHIGDFGLARFLPL 855
+ L + DVA YL + H D+ N LL +A I DFG+AR +
Sbjct: 115 MKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYR 171
Query: 856 SSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDM-- 913
+S A I ++ PE L + DV+S+G+LL E I G M
Sbjct: 172 ASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWE---------IFSLGYMPY 222
Query: 914 -NLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVAC 972
N VM+ V R+ C + RI C
Sbjct: 223 PGRTN-------QEVMEFV------------------TGGGRLDPPKGCPGPVYRIMTDC 257
Query: 973 SMESPEDRMSMTNV 986
+PEDR + +
Sbjct: 258 WQHTPEDRPNFATI 271
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-11
Identities = 64/236 (27%), Positives = 100/236 (42%), Gaps = 46/236 (19%)
Query: 685 NATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRH 744
N + + + ++G+G+FG V+K + A KV + + ++ E + L + H
Sbjct: 2 NPEEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDH 61
Query: 745 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLN 804
N+VK+L A Y N+ L+ EF +++ + E R L Q
Sbjct: 62 PNIVKLLDAF----YYENNLWILI-EFCAGGAVDAVML---------ELERPLTEPQ--- 104
Query: 805 ISIDVAC-----ALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQ 859
I V C ALNYLH + I H DLK NIL D + DFG +S+
Sbjct: 105 --IRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFG------VSAKN 153
Query: 860 TSSIGAKGSIGYIAPEYGLGSEVSI-----------SGDVYSYGILLLELITRKKP 904
T +I + S +I Y + EV + DV+S GI L+E+ + P
Sbjct: 154 TRTIQRRDS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 6e-11
Identities = 63/255 (24%), Positives = 107/255 (41%), Gaps = 47/255 (18%)
Query: 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFK----SFIAECNTLKNIRH 744
++ + +G G+FG V + + +K + K + EC LK + H
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPV--EQMTKDERLAAQNECQVLKLLSH 58
Query: 745 RNLVKILTACSGVDYQGN--DFKAL--VFEFMHNRSLEEWLHPITREDETDEAPRSLNLI 800
N++ +Y N + KAL V E+ +L E++ ++
Sbjct: 59 PNII---------EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTI------ 103
Query: 801 QRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDE-DMIAHIGDFGLARFLPLSSAQ 859
L+ + + AL+++H I H DLK NILLD+ M+ IGDFG+++ L S
Sbjct: 104 --LHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA 158
Query: 860 TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLA 919
+ +G YI+PE G + D+++ G +L EL + K+ FE
Sbjct: 159 YTVVGTP---CYISPELCEGKPYNQKSDIWALGCVLYELASLKRA----FEA-------- 203
Query: 920 RTALPDHVMDIVDST 934
LP V+ I+ T
Sbjct: 204 -ANLPALVLKIMSGT 217
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-11
Identities = 58/223 (26%), Positives = 103/223 (46%), Gaps = 24/223 (10%)
Query: 690 FSSVNQIGEGSFGSVFKGI-LDDG---RTTIAVKVF-NLLHHGAFKSFIAECNTLKNIRH 744
F + +G G+FG+V+KG+ + +G + +A+K A K + E + ++ +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 745 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLN 804
++ ++L C Q L+ + M L +++ RE + + + L LN
Sbjct: 69 PHVCRLLGICLTSTVQ------LITQLMPFGCLLDYV----REHKDNIGSQYL-----LN 113
Query: 805 ISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIG 864
+ +A +NYL + + H DL N+L+ I DFGLA+ L + + G
Sbjct: 114 WCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEG 170
Query: 865 AKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTD 906
K I ++A E L + DV+SYG+ + EL+T KP D
Sbjct: 171 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 7e-11
Identities = 59/215 (27%), Positives = 94/215 (43%), Gaps = 29/215 (13%)
Query: 696 IGEGSFGSVFKG-----ILDDGRTTIAVKVFNLLHHGAFK-SFIAECNTLKNI-RHRNLV 748
+G G+FG V + D +AVK+ H + + + ++E + ++ H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 749 KILTAC--SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNIS 806
+L AC G ++ E+ L +L R+ E+ L L L+ S
Sbjct: 103 NLLGACTIGGPIL-------VITEYCCYGDLLNFLR---RKRES-----FLTLEDLLSFS 147
Query: 807 IDVACALNYL-HHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGA 865
VA + +L +C H DL N+LL I I DFGLAR + S A
Sbjct: 148 YQVAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNA 203
Query: 866 KGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
+ + ++APE + DV+SYGILL E+ +
Sbjct: 204 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 1e-10
Identities = 67/248 (27%), Positives = 111/248 (44%), Gaps = 40/248 (16%)
Query: 681 QNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFI------A 734
+ ++ DR+ + Q+G G++G+V + D RT V + L + F+S +
Sbjct: 8 KTIWEVPDRYRDLKQVGSGAYGTVCSAL--DRRTGAKVAIKKL--YRPFQSELFAKRAYR 63
Query: 735 ECNTLKNIRHRN---LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETD 791
E LK+++H N L+ + T +D + +DF LV FM L + + ++
Sbjct: 64 ELRLLKHMKHENVIGLLDVFTPDLSLD-RFHDF-YLVMPFMGTD-----LGKLMKHEKLS 116
Query: 792 EAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLAR 851
E + Q L L Y+H I H DLKP N+ ++ED I DFGLAR
Sbjct: 117 EDRIQFLVYQMLK-------GLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR 166
Query: 852 FLPLSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDIMFE 910
+ G + Y APE L + + D++S G ++ E++T K +F+
Sbjct: 167 -----QTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKP----LFK 217
Query: 911 GDMNLHNL 918
G +L L
Sbjct: 218 GHDHLDQL 225
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 60/226 (26%), Positives = 103/226 (45%), Gaps = 34/226 (15%)
Query: 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVK 749
F+ + +IG+GSFG VFKGI + + +A+K+ +L AE + +++I+ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--------AE-DEIEDIQQE--IT 54
Query: 750 ILTACSG---VDYQGNDFKA----LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQR 802
+L+ C Y G+ K ++ E++ S + L R DE Q
Sbjct: 55 VLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLL----RAGPFDE-------FQI 103
Query: 803 LNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSS 862
+ ++ L+YLH + + H D+K +N+LL E + DFG+A L+ Q
Sbjct: 104 ATMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKR 158
Query: 863 IGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIM 908
G+ ++APE S D++S GI +EL + P M
Sbjct: 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 32/217 (14%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIA-ECNTLKNIRHRNLVKILTAC 754
IG G++G+V++G +A+K+ NL S I E L +R I
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNI---- 64
Query: 755 SGVDYQGNDFKA----LVFEFMHNRSLEEWLH--PITREDETDEAPRSLNLIQRLNISID 808
Y G+ K ++ E+ S+ + PI A + +++I R +
Sbjct: 65 --TKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPI--------AEKYISVIIR-----E 109
Query: 809 VACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGS 868
V AL Y+H + H D+K +NIL+ + DFG+A L +S++ S+ G+
Sbjct: 110 VLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTF--VGT 164
Query: 869 IGYIAPEYGL-GSEVSISGDVYSYGILLLELITRKKP 904
++APE G D++S GI + E+ T P
Sbjct: 165 PYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 58/222 (26%), Positives = 103/222 (46%), Gaps = 34/222 (15%)
Query: 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVK 749
F+ + +IG+GSFG V+KGI + + +A+K+ +L AE + +++I+ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--------AE-DEIEDIQQE--IT 54
Query: 750 ILTACSG---VDYQGNDFKA----LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQR 802
+L+ C Y G+ K ++ E++ S + L P E+ + I R
Sbjct: 55 VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETY------IATILR 108
Query: 803 LNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSS 862
++ L+YLH + + H D+K +N+LL E + DFG+A L+ Q
Sbjct: 109 -----EILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKR 158
Query: 863 IGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
G+ ++APE S D++S GI +EL + P
Sbjct: 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 38/104 (36%), Positives = 54/104 (51%), Gaps = 9/104 (8%)
Query: 805 ISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIG 864
+++ + AL+YL + H D+KPSNILLD + DFG++ L S A+T S
Sbjct: 119 MTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS-- 174
Query: 865 AKGSIGYIAPEY----GLGSEVSISGDVYSYGILLLELITRKKP 904
G Y+APE + I DV+S GI L+EL T + P
Sbjct: 175 -AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 37/113 (32%), Positives = 59/113 (52%), Gaps = 12/113 (10%)
Query: 805 ISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIG 864
I++ + AL YLH + + H D+KPSN+L++ + + DFG++ +L S A+T G
Sbjct: 108 IAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAG 165
Query: 865 AKGSIGYIAPEY----GLGSEVSISGDVYSYGILLLELITRKKPTD---IMFE 910
K Y+APE + DV+S GI ++EL T + P D F+
Sbjct: 166 CK---PYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ 215
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 62/217 (28%), Positives = 98/217 (45%), Gaps = 26/217 (11%)
Query: 696 IGEGSFGSVFKGIL---DDGRTTIAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKIL 751
IG+G FG V+ G L D + AVK N + + F+ E +K+ H N++ +L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 752 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVAC 811
C + +G+ +V +M + L ++ T P +LI + VA
Sbjct: 63 GIC--LPSEGSPL--VVLPYMKHGDLRNFIRSETHN------PTVKDLI---GFGLQVAK 109
Query: 812 ALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSI----GAKG 867
+ YL H DL N +LDE + DFGLAR + + S+ GAK
Sbjct: 110 GMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLAR--DIYDKEYYSVHNHTGAKL 164
Query: 868 SIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
+ ++A E + + DV+S+G+LL EL+TR P
Sbjct: 165 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 2e-10
Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 22/218 (10%)
Query: 684 YNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH-GAFKSFIAECNTLKNI 742
+ D + + ++GEGS+ +V+KG +A+KV L G + I E + LK +
Sbjct: 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL 60
Query: 743 RHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQR 802
+H N+V + + LVFE++H L +++ D+ P L+
Sbjct: 61 KHANIVLLHDII-----HTKETLTLVFEYVHT-DLCQYM---------DKHPGGLHPENV 105
Query: 803 LNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSS 862
+ L+Y+H Q I H DLKP N+L+ + + DFGLAR + S S+
Sbjct: 106 KLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSN 162
Query: 863 IGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELI 899
++ Y P+ LGS E S D++ G + +E+I
Sbjct: 163 --EVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 60/215 (27%), Positives = 88/215 (40%), Gaps = 30/215 (13%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILT 752
+G G FG V + T A+K H G + +E L+ H +VK+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 753 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVAC- 811
++ + ++ E+ L L DE R +AC
Sbjct: 61 T-----FKDKKYIYMLMEYCLGGELWTILRDRGLFDE--YTARFY-----------IACV 102
Query: 812 --ALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSI 869
A YLH+ I + DLKP N+LLD + + DFG A+ L S +T + G+
Sbjct: 103 VLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLK-SGQKTWTF--CGTP 156
Query: 870 GYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
Y+APE L S D +S GILL EL+T + P
Sbjct: 157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 37/97 (38%), Positives = 54/97 (55%), Gaps = 5/97 (5%)
Query: 808 DVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKG 867
++ C L +LH I + DLK NILLD D I DFG+ + L A+T + G
Sbjct: 104 EIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC--G 158
Query: 868 SIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
+ YIAPE LG + + S D +S+G+LL E++ + P
Sbjct: 159 TPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-10
Identities = 79/279 (28%), Positives = 126/279 (45%), Gaps = 13/279 (4%)
Query: 65 TILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGG 124
LDL +L +IS + L+ L L L NN+ P L+ L L N I
Sbjct: 96 PSLDLNLNRLRSNISELL-ELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKI-E 153
Query: 125 AIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSI 184
++P+ + + NL L L N L +P LS+LS + ++ ++ N ++ +P + LS++
Sbjct: 154 SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSAL 211
Query: 185 RSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQG 244
L LS N++ + +L LKNL L ++ N+L +P SI N+S++ D N+I
Sbjct: 212 EELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISS 269
Query: 245 AIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRL 304
+ SL NL+ + N L+ A+P LE+ LT A L+ L
Sbjct: 270 ---ISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELL--LNLLLTLKALELKLNSIL 324
Query: 305 LVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININN 343
L IL N S + SL N L ++ +N
Sbjct: 325 LNNNILSNGETSSPEALSIL-ESLNNLWTL-DNALDESN 361
|
Length = 394 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 64/233 (27%), Positives = 100/233 (42%), Gaps = 29/233 (12%)
Query: 686 ATDRFSSVNQIGEGSFGSVFKGI---LDDGR----TTIAVKVFNLLHHGA----FKSFIA 734
DR +GEG FG V LD + T +AVK +L A I+
Sbjct: 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVK---MLKSDATEKDLSDLIS 72
Query: 735 ECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLH---PITRE--- 787
E +K I +H+N++ +L AC+ Q +V E+ +L E+L P E
Sbjct: 73 EMEMMKMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYCY 127
Query: 788 DETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDF 847
+ T L+ ++ + VA + YL H DL N+L+ ED + I DF
Sbjct: 128 NPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADF 184
Query: 848 GLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
GLAR + + + + ++APE + DV+S+G+LL E+ T
Sbjct: 185 GLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 3e-10
Identities = 68/286 (23%), Positives = 115/286 (40%), Gaps = 61/286 (21%)
Query: 684 YNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAF-KSFIAECNTLKNI 742
++ R+ +++ IGEG++G V +A+K + H F + + E L+
Sbjct: 1 FDVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF 60
Query: 743 RHRNLVKILTACSGVDYQGNDFKA--LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLI 800
+H N++ IL ++ F +V E M ETD LI
Sbjct: 61 KHENIIGILDIIRPPSFE--SFNDVYIVQELM----------------ETD----LYKLI 98
Query: 801 QRLNISIDVAC--------ALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARF 852
+ ++S D L Y+H + H DLKPSN+LL+ + I DFGLAR
Sbjct: 99 KTQHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLAR- 154
Query: 853 LPLSSAQTSSIGAKGSIGYI------APEYGLGS-EVSISGDVYSYGILLLELITRKKPT 905
A Y+ APE L S + + D++S G +L E+++ +
Sbjct: 155 ----IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRP-- 208
Query: 906 DIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQR 951
+F G LH L + ++ ++ + D +I + R R
Sbjct: 209 --LFPGKDYLHQL------NLILGVLGTPSQEDLNCII---SLRAR 243
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 65/239 (27%), Positives = 110/239 (46%), Gaps = 26/239 (10%)
Query: 688 DRFSSVNQIGEGSFGSVFKGI-LDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRH 744
D + + +IGEG++G V+K + G+ +A+K L G + + E + L+ +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKL-VALKKTRLEMDEEGIPPTALREISLLQMLSE 59
Query: 745 RN-LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRL 803
+V++L + G LVFE++ + L++++ R P I+
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGR---PLPAKTIKSF 115
Query: 804 NISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED-MIAHIGDFGLAR--FLPLSSAQT 860
+ A + H + + H DLKP N+L+D+ + I D GL R +P+ S T
Sbjct: 116 MYQLLKGVA--HCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS-YT 169
Query: 861 SSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNL 918
I ++ Y APE LGS S D++S G + E+ RK+P +F GD L L
Sbjct: 170 HEI---VTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS-RKQP---LFPGDSELQQL 221
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 64/231 (27%), Positives = 105/231 (45%), Gaps = 36/231 (15%)
Query: 689 RFSSVNQIGEGSFGSVFKGIL----DDGRTTIAVKVF----NLLHHGAFKSFIAECNTLK 740
RF + ++GE +FG ++KG L D +A+K N G F+ E + +
Sbjct: 8 RF--MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQ---EASLMA 62
Query: 741 NIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITRE---------DETD 791
+ H N+V +L GV Q ++FE+++ L E+L I R DE
Sbjct: 63 ELHHPNIVCLL----GVVTQEQPV-CMLFEYLNQGDLHEFL--IMRSPHSDVGCSSDEDG 115
Query: 792 EAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLAR 851
SL+ L+I+I +A + YL H DL NIL+ E + I D GL+R
Sbjct: 116 TVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSR 172
Query: 852 FLPLSSAQTSSIGAKG--SIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
+ SA + K I ++ PE + + S D++S+G++L E+ +
Sbjct: 173 --EIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 65/256 (25%), Positives = 105/256 (41%), Gaps = 41/256 (16%)
Query: 664 EKQNPNSPINSFPNISYQNLYNATDRFSSVNQIGEGSFGSVFK----GILDDG---RTTI 716
E + P P F D+ + +GEG FG V GI D T+
Sbjct: 1 EYELPEDPRWEFSR----------DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTV 50
Query: 717 AVKVFNLLHHGA----FKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVFEF 771
AVK +L A ++E +K I +H+N++ +L AC+ Q +V E+
Sbjct: 51 AVK---MLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT----QDGPLYVIV-EY 102
Query: 772 MHNRSLEEWLH---PITRE---DETDEAPRSLNLIQRLNISIDVACALNYL-HHDCQPPI 824
+L E+L P E D + ++ + VA + YL C
Sbjct: 103 ASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKC---- 158
Query: 825 AHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSI 884
H DL N+L+ E+ + I DFGLAR + + + + ++APE +
Sbjct: 159 IHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 218
Query: 885 SGDVYSYGILLLELIT 900
DV+S+G+L+ E+ T
Sbjct: 219 QSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 67/253 (26%), Positives = 98/253 (38%), Gaps = 65/253 (25%)
Query: 677 NISYQNLYNATD---RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGA----- 728
+ L++ D F+ + +IG GSFG+V+ D RT V + + + G
Sbjct: 1 DPEIAELFSKDDPEKLFTDLREIGHGSFGAVYFA--RDVRTNEVVAIKKMSYSGKQSNEK 58
Query: 729 FKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA----LVFEF----------MHN 774
++ I E L+ +RH N + +Y+G + LV E+ +H
Sbjct: 59 WQDIIKEVRFLQQLRHPNTI---------EYKGCYLREHTAWLVMEYCLGSASDILEVHK 109
Query: 775 RSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNI 834
+ L +E E I L YLH + H D+K NI
Sbjct: 110 KPL--------QEVEIAA------------ICHGALQGLAYLHSHER---IHRDIKAGNI 146
Query: 835 LLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISG--DVYSY 891
LL E + DFG A L S S +G ++APE L E G DV+S
Sbjct: 147 LLTEPGTVKLADFGSA---SLVSPANSFVGTP---YWMAPEVILAMDEGQYDGKVDVWSL 200
Query: 892 GILLLELITRKKP 904
GI +EL RK P
Sbjct: 201 GITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 62/223 (27%), Positives = 98/223 (43%), Gaps = 29/223 (13%)
Query: 696 IGEGSFGSVFK----GILDD---GRTTIAVKVFNLLHHGA----FKSFIAECNTLKNI-R 743
+GEG FG V GI D T+AVK +L A ++E +K I +
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVK---MLKDDATDKDLSDLVSEMEMMKMIGK 76
Query: 744 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHP-----ITREDETDEAP-RSL 797
H+N++ +L AC+ Q LV E+ +L E+L + +T + P L
Sbjct: 77 HKNIINLLGACT----QDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQL 131
Query: 798 NLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSS 857
++ + VA + YL H DL N+L+ ED + I DFGLAR +
Sbjct: 132 TFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNID 188
Query: 858 AQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
+ + + ++APE + DV+S+G+LL E+ T
Sbjct: 189 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 4e-10
Identities = 59/241 (24%), Positives = 104/241 (43%), Gaps = 34/241 (14%)
Query: 696 IGEGSFGSVFKGI---LDDGRTTIAVKVFNLLHHGAFKS-FIAECNTLKNIRHRNLVKIL 751
IGEG FG V++G+ ++ + +AVK + + F+ E ++ H ++VK++
Sbjct: 14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73
Query: 752 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVAC 811
+ + +V E L +L + SL+L + S ++
Sbjct: 74 GVIT------ENPVWIVMELAPLGELRSYLQ--VNKY-------SLDLASLILYSYQLST 118
Query: 812 ALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGY 871
AL YL H D+ N+L+ +GDFGL+R+L S +S G K I +
Sbjct: 119 ALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKG-KLPIKW 174
Query: 872 IAPEYGLGSEVSISGDVYSYGILLLELITR-KKPTDIMFEGDMN------LHNLARTALP 924
+APE + + DV+ +G+ + E++ KP F+G N + N R +P
Sbjct: 175 MAPESINFRRFTSASDVWMFGVCMWEILMLGVKP----FQGVKNNDVIGRIENGERLPMP 230
Query: 925 D 925
Sbjct: 231 P 231
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 67/247 (27%), Positives = 111/247 (44%), Gaps = 33/247 (13%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFNL---------LHHGAFKSFIAECNTLKNIRHRN 746
IG GSFGSV+ G+ +AVK L + E LK ++H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 747 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNIS 806
+V+ L + D+ N F E++ S+ L+ +ET L++ N
Sbjct: 68 IVQYLGSSLDADHL-NIF----LEYVPGGSVAALLNNYGAFEET--------LVR--NFV 112
Query: 807 IDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAK 866
+ LNYLH+ I H D+K +NIL+D I DFG+++ L +S T + GA+
Sbjct: 113 RQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGAR 169
Query: 867 ----GSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIM--FEGDMNLHNLAR 920
GS+ ++APE + + D++S G L++E++T K P + + A
Sbjct: 170 PSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENAS 229
Query: 921 TALPDHV 927
+P ++
Sbjct: 230 PEIPSNI 236
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 5e-10
Identities = 65/231 (28%), Positives = 103/231 (44%), Gaps = 29/231 (12%)
Query: 688 DRFSSVNQIGEGSFGSVFK----GI---LDDGRTTIAVKVFNLLHHGAFKSF---IAECN 737
DR +GEG FG V + GI D T+AVK+ L + K I+E
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKM--LKDNATDKDLADLISEME 69
Query: 738 TLKNI-RHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLH---PITREDETD-- 791
+K I +H+N++ +L C+ Q +V E+ +L E+L P + D
Sbjct: 70 LMKLIGKHKNIINLLGVCT----QEGPLYVIV-EYAAKGNLREFLRARRPPGPDYTFDIT 124
Query: 792 EAPRS-LNLIQRLNISIDVACALNYLH-HDCQPPIAHCDLKPSNILLDEDMIAHIGDFGL 849
+ P L+ ++ + VA + YL C H DL N+L+ ED + I DFGL
Sbjct: 125 KVPEEQLSFKDLVSCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGL 180
Query: 850 ARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
AR + + + + ++APE + DV+S+GIL+ E+ T
Sbjct: 181 ARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 57/219 (26%), Positives = 105/219 (47%), Gaps = 22/219 (10%)
Query: 684 YNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH-GAFKSFIAECNTLKNI 742
+ + + ++++GEG++ +V+KG +A+K L H GA + I E + LK++
Sbjct: 2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL 61
Query: 743 RHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQR 802
+H N+V + LVFE++ ++ L+++L D+ S+N+
Sbjct: 62 KHANIVTLHDII-----HTEKSLTLVFEYL-DKDLKQYL---------DDCGNSINMHNV 106
Query: 803 LNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSS 862
+ LNY H + + H DLKP N+L++E + DFGLAR + + S+
Sbjct: 107 KLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSN 163
Query: 863 IGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELIT 900
++ Y P+ LGS + S D++ G + E+ T
Sbjct: 164 --EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMST 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 5e-10
Identities = 62/236 (26%), Positives = 91/236 (38%), Gaps = 50/236 (21%)
Query: 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFN--LLHH-GAFKSFIAECNTLKNIRHRN 746
F + Q+G+G +G VF D +A+K LL + + E + L +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 747 LVKILTACSGVDY--------QGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLN 798
LVK+L A +Y G DF+ L+ + L E D A
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLL---NNLGVLSE-----------DHA----- 103
Query: 799 LIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI--GDFGLARFLPLS 856
R + ++ A++ LH + H DLKP N L+D HI DFGL+
Sbjct: 104 ---RFYM-AEMFEAVDALH---ELGYIHRDLKPENFLIDAS--GHIKLTDFGLS-----K 149
Query: 857 SAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGD 912
T + GS Y+APE G + D +S G +L E + P F G
Sbjct: 150 GIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP----FSGS 201
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 6e-10
Identities = 62/247 (25%), Positives = 102/247 (41%), Gaps = 33/247 (13%)
Query: 696 IGEGSFGSVFKGI-LDDGRTTIAVKVFNLLHHGA-----FKSFIAECNTLKNIRHRNLVK 749
+G+G+FG V+ +D GR +AVK + E LKN++H +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRE-LAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 750 ILTACSGVDYQGNDFKALVF-EFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISID 808
+D +F E+M S+++ L ET + +++
Sbjct: 69 YYGC------LRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILE------- 115
Query: 809 VACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLA-RFLPLSSAQTSSIGAKG 867
+ YLH + I H D+K +NIL D +GDFG + R + S+ T G
Sbjct: 116 ---GVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTG 169
Query: 868 SIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLART----AL 923
+ +++PE G DV+S G ++E++T K P FE + +A L
Sbjct: 170 TPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWA-EFEAMAAIFKIATQPTNPQL 228
Query: 924 PDHVMDI 930
P HV
Sbjct: 229 PSHVSPD 235
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 7e-10
Identities = 58/216 (26%), Positives = 93/216 (43%), Gaps = 27/216 (12%)
Query: 695 QIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKS---FIAECNTLKNIRHRNLVKIL 751
+IG G FG V G ++ G T V V L + + F+ E ++++H NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 752 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVAC 811
C+ V LV EF L+ +L + + P +L QR+ + ++A
Sbjct: 62 GQCTEVTPY-----LLVMEFCPLGDLKGYLRSCRKAELMTPDPTTL---QRM--ACEIAL 111
Query: 812 ALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGY 871
L +LH + H DL N LL D+ IGD+GL+ + + +
Sbjct: 112 GLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRW 168
Query: 872 IAPEYGLGSEV---------SISGDVYSYGILLLEL 898
IAPE L EV + +V+S G+ + EL
Sbjct: 169 IAPE--LVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 8e-10
Identities = 66/208 (31%), Positives = 90/208 (43%), Gaps = 24/208 (11%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFN---LLHHGAFKSFIAECNTL-KNIRHRNLVKIL 751
IG+GSFG V AVKV +L K +AE N L KN++H LV
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV--- 59
Query: 752 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVAC 811
G+ Y L F + E + H + RE E PR+ R + ++A
Sbjct: 60 ----GLHYSFQTADKLYFVLDYVNGGELFFH-LQRERSFPE-PRA-----RF-YAAEIAS 107
Query: 812 ALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGY 871
AL YLH I + DLKP NILLD + DFGL + S TS+ G+ Y
Sbjct: 108 ALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC--GTPEY 162
Query: 872 IAPEYGLGSEVSISGDVYSYGILLLELI 899
+APE + D + G +L E++
Sbjct: 163 LAPEVLRKQPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 35/98 (35%), Positives = 51/98 (52%), Gaps = 8/98 (8%)
Query: 808 DVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSI-GAK 866
++ C L LH + + DLKP NILLD+ I D GLA +P + SI G
Sbjct: 110 EILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIP----EGESIRGRV 162
Query: 867 GSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
G++GY+APE ++S D + G L+ E+I + P
Sbjct: 163 GTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 67/239 (28%), Positives = 104/239 (43%), Gaps = 38/239 (15%)
Query: 689 RFSSVNQIGEGSFGSVF--KGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRN 746
R+ + +IGEGSFG ++ K D I + ++ E L ++H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 747 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITRED----ETDEAPRSLNLIQR 802
+V + +Q N +V E+ L + I R+ D Q
Sbjct: 61 IVTFFAS-----FQENGRLFIVMEYCDGGDL---MKRINRQRGVLFSED---------QI 103
Query: 803 LNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED-MIAHIGDFGLARFLPLSS--AQ 859
L+ + ++ L ++H I H D+K NI L ++ M+A +GDFG+AR L S A
Sbjct: 104 LSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY 160
Query: 860 TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNL 918
T G+ Y++PE + D++S G +L EL T K P FEG+ NLH L
Sbjct: 161 TCV----GTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP----FEGN-NLHQL 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 1e-09
Identities = 65/227 (28%), Positives = 95/227 (41%), Gaps = 40/227 (17%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIA-ECNTLKNIRHRN 746
+ F+ + IG+GSFG V+K I +A+KV +L I E L R
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 747 LVKILTACSGVDYQG---NDFK-ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQR 802
+ K Y G K ++ E+ S + L P + DET A I R
Sbjct: 61 ITK---------YYGSFLKGSKLWIIMEYCGGGSCLDLLKPG-KLDETYIA-----FILR 105
Query: 803 LNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSS 862
+V L YLH + I H D+K +NILL E+ + DFG+ S Q +S
Sbjct: 106 -----EVLLGLEYLH--EEGKI-HRDIKAANILLSEEGDVKLADFGV-------SGQLTS 150
Query: 863 IGAK-----GSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
+K G+ ++APE S D++S GI +EL + P
Sbjct: 151 TMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-09
Identities = 37/133 (27%), Positives = 70/133 (52%), Gaps = 6/133 (4%)
Query: 160 IEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLS 219
I+ + +++ L G IP+ + L ++S+ LSGN++ G+IP +LG + +L L ++ N +
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 220 GTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIP------P 273
G+IP S+ ++S+ + N + G +P G L + F+ +N IP P
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACGP 539
Query: 274 TISNASNLEIFHG 286
+S + + I G
Sbjct: 540 HLSVGAKIGIAFG 552
|
Length = 623 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 2e-09
Identities = 66/224 (29%), Positives = 107/224 (47%), Gaps = 33/224 (14%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSF----IAECNTLKNIR 743
D + +N+I EG++G V++ D +T V + L + F + E N L ++
Sbjct: 5 DEYEKLNRIEEGTYGVVYRAR--DKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQ 62
Query: 744 HRNLVKILTACSGVDYQGNDFKALVFEFMHN--RSLEEWLHPITREDETDEAPRSLNLIQ 801
H N+V + G + D +V E++ + +SL E + + E + L ++Q
Sbjct: 63 HPNIVTVKEVVVGSNL---DKIYMVMEYVEHDLKSLMETMKQPFLQSEV----KCL-MLQ 114
Query: 802 RLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFL--PLSSAQ 859
L+ + +LH + I H DLK SN+LL+ I I DFGLAR PL
Sbjct: 115 LLS-------GVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL-KPY 163
Query: 860 TSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRK 902
T + ++ Y APE LG E S + D++S G + EL+T+K
Sbjct: 164 TQLV---VTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 69/246 (28%), Positives = 106/246 (43%), Gaps = 43/246 (17%)
Query: 689 RFSSVNQIGEGSFGSV----FKGILDDGRTTIAVK----VFN--LLHHGAFKSFIAECNT 738
R+ + ++G+G++G V ++ T+A+K VF+ +L K + E
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEE--ETVAIKKITNVFSKKIL----AKRALRELKL 54
Query: 739 LKNIR-HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDE--TDEAPR 795
L++ R H+N+ L V + L E M E LH I R + TD +
Sbjct: 55 LRHFRGHKNITC-LYDMDIVFPGNFNELYLYEELM-----EADLHQIIRSGQPLTDAHFQ 108
Query: 796 SLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLAR-FLP 854
S + Q L C L Y+H + H DLKP N+L++ D I DFGLAR F
Sbjct: 109 SF-IYQIL-------CGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSE 157
Query: 855 LSSAQTSSI-GAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDIMFEGD 912
+ + Y APE L + + DV+S G +L EL+ RK +F+G
Sbjct: 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKP----VFKGK 213
Query: 913 MNLHNL 918
+ L
Sbjct: 214 DYVDQL 219
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 65/272 (23%), Positives = 114/272 (41%), Gaps = 52/272 (19%)
Query: 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLV 748
R+ + +G GS G VF + D +AVK L + K + E ++ + H N+V
Sbjct: 6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIV 65
Query: 749 KILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISID 808
K+ + + E ++E++ ETD A N++++ +S +
Sbjct: 66 KVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-------ETDLA----NVLEQGPLSEE 114
Query: 809 VAC--------ALNYLHHDCQPPIAHCDLKPSNILLD-EDMIAHIGDFGLARFLP----- 854
A L Y+H + H DLKP+N+ ++ ED++ IGDFGLAR +
Sbjct: 115 HARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSH 171
Query: 855 ---LSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDIMFE 910
LS + Y +P L + + + D+++ G + E++T K +F
Sbjct: 172 KGYLSEGLVTK-------WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK----PLFA 220
Query: 911 GDMNLHNLARTALPDHVMDIVDSTLLNDGEDL 942
G H L + L I++S + ED
Sbjct: 221 GA---HELEQMQL------ILESVPVVREEDR 243
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 23/216 (10%)
Query: 696 IGEGSFGSVFKGIL--DDGRTTIAVKVFN-LLHHGAFKSFIAECNTLKNI-RHRNLVKIL 751
IGEG+FG V K + D R A+K + F E L + H N++ +L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 752 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEA-------PRSLNLIQRLN 804
AC + + L E+ + +L ++L +R ETD A +L+ Q L+
Sbjct: 63 GAC-----EHRGYLYLAIEYAPHGNLLDFLRK-SRVLETDPAFAIANSTASTLSSQQLLH 116
Query: 805 ISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIG 864
+ DVA ++YL Q H DL NIL+ E+ +A I DFGL+R + +T
Sbjct: 117 FAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM--- 170
Query: 865 AKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
+ + ++A E S + + DV+SYG+LL E+++
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 62/234 (26%), Positives = 98/234 (41%), Gaps = 42/234 (17%)
Query: 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL--LHHGAFKSFIAECNTLKNIRHRN 746
F + ++G+GS+GSV+K A+K +L + + + E L ++ H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 747 LVKILTA-------CSGVDYQ--GNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSL 797
++ A C ++Y G+ KA+ + + E
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPE------------------ 102
Query: 798 NLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSS 857
I R I I + L LH + I H DLK +NILL + + IGD G+++ L +
Sbjct: 103 QEIWR--IFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157
Query: 858 AQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEG 911
A+T G+ Y+APE G S D++S G LL E+ T P FE
Sbjct: 158 AKTQI----GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP----FEA 203
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 58/223 (26%), Positives = 103/223 (46%), Gaps = 32/223 (14%)
Query: 684 YNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL-LHHGAFKSFIAECNTLKNI 742
+ A + ++ ++GEGS+ +V+KGI +A+KV ++ G + I E + LK +
Sbjct: 1 FGAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL 60
Query: 743 RHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQR 802
+H N+V + + VFE+MH L +++ + P L+
Sbjct: 61 KHANIVLLHDII-----HTKETLTFVFEYMHT-DLAQYM---------IQHPGGLHPYNV 105
Query: 803 LNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG-----DFGLARFLPLSS 857
+ L Y+H I H DLKP N+L I+++G DFGLAR + S
Sbjct: 106 RLFMFQLLRGLAYIHGQ---HILHRDLKPQNLL-----ISYLGELKLADFGLARAKSIPS 157
Query: 858 AQTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELI 899
SS ++ Y P+ LG+ + S + D++ G + +E++
Sbjct: 158 QTYSS--EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 4e-09
Identities = 66/231 (28%), Positives = 99/231 (42%), Gaps = 48/231 (20%)
Query: 696 IGEGSFGSVFKGILDDGRTT---IAVKVFNLLHHGAFKSFI-----AECN-TLKNI---- 742
+G+GSFG V L + + T AVKV K I EC T K +
Sbjct: 3 LGKGSFGKVL---LAELKGTDELYAVKVLK-------KDVILQDDDVECTMTEKRVLALA 52
Query: 743 -RHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQ 801
+H L + L +C +Q D V E+++ L + R DE PR+
Sbjct: 53 GKHPFLTQ-LHSC----FQTKDRLFFVMEYVNGGDLMFHIQRSGRFDE----PRARFY-- 101
Query: 802 RLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTS 861
+ ++ L +LH + I + DLK N+LLD + I DFG+ + L TS
Sbjct: 102 ----AAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS 154
Query: 862 SIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGD 912
+ G+ YIAPE + D ++ G+LL E++ + P FEGD
Sbjct: 155 TFC--GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSP----FEGD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 4e-09
Identities = 56/217 (25%), Positives = 105/217 (48%), Gaps = 22/217 (10%)
Query: 684 YNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH-GAFKSFIAECNTLKNI 742
+ + + + ++GEG++ +VFKG +A+K L H GA + I E + LK++
Sbjct: 2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDL 61
Query: 743 RHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQR 802
+H N+V + + LVFE++ ++ L++++ D+ N++
Sbjct: 62 KHANIVTLHDIV-----HTDKSLTLVFEYL-DKDLKQYM------DDCG------NIMSM 103
Query: 803 LNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSS 862
N+ I + L L + + + H DLKP N+L++E + DFGLAR + + S+
Sbjct: 104 HNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSN 163
Query: 863 IGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLEL 898
++ Y P+ LG SE S D++ G + E+
Sbjct: 164 --EVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEM 198
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 49/216 (22%), Positives = 90/216 (41%), Gaps = 24/216 (11%)
Query: 695 QIGEGSFGSVF----KGILD-DGRTTIAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLV 748
+G G FG VF KGI + G T + VK F E + + + H+N+V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 749 KILTACSGVD--YQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNIS 806
++L C + Y ++ E+ L+++L T+ + P L+ Q++ +
Sbjct: 72 RLLGLCREAEPHY-------MILEYTDLGDLKQFLR-ATKSKDEKLKPPPLSTKQKVALC 123
Query: 807 IDVACALNYL--HHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIG 864
+A +++L H DL N L+ + L++ +S
Sbjct: 124 TQIALGMDHLSNAR-----FVHRDLAARNCLVSSQREVKVSLLSLSK-DVYNSEYYKLRN 177
Query: 865 AKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
A + ++APE + S DV+S+G+L+ E+ T
Sbjct: 178 ALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 54/224 (24%), Positives = 88/224 (39%), Gaps = 34/224 (15%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKS---FIAECNTLKNIRH 744
D + +G G+FG V A+KV + K E LK + H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 745 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLN 804
++++ F ++ E++ L +L + L
Sbjct: 61 PFIIRLFWT-----EHDQRFLYMLMEYVPGGELFSYL----------RNSGRFSNSTGLF 105
Query: 805 ISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIG 864
+ ++ CAL YLH I + DLKP NILLD++ + DFG A+ L +T ++
Sbjct: 106 YASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL---RDRTWTLC 159
Query: 865 AKGSIGYIAPEY----GLGSEVSISGDVYSYGILLLELITRKKP 904
G+ Y+APE G V D ++ GIL+ E++ P
Sbjct: 160 --GTPEYLAPEVIQSKGHNKAV----DWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 6e-09
Identities = 67/242 (27%), Positives = 104/242 (42%), Gaps = 40/242 (16%)
Query: 696 IGEGSFGSVF---KGILDDGRTTIAVKVFNLLHHGAFK-----SFIAECNTLKNIRHRNL 747
+G+GSFG VF K D A+KV L K E + L + H +
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKV---LKKATLKVRDRVRTKMERDILAEVNHPFI 60
Query: 748 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISI 807
VK+ A +Q L+ +F+ L L ++E E L +
Sbjct: 61 VKLHYA-----FQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAE------ 106
Query: 808 DVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKG 867
+A AL++LH I + DLKP NILLDE+ + DFGL++ + S G
Sbjct: 107 -LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC--G 160
Query: 868 SIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGD-----MNLHNLARTA 922
++ Y+APE + S D +S+G+L+ E++T P F+G M + A+
Sbjct: 161 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP----FQGKDRKETMTMILKAKLG 216
Query: 923 LP 924
+P
Sbjct: 217 MP 218
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 32/115 (27%), Positives = 58/115 (50%), Gaps = 16/115 (13%)
Query: 807 IDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAK 866
+ A++Y+H + I H D+K NI L + + +GDFG+++ L + A+
Sbjct: 108 FQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKIL-----GSEYSMAE 159
Query: 867 GSIG---YIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNL 918
+G Y++PE G + + D+++ G +L EL+T K+ F+ N NL
Sbjct: 160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKR----TFDAT-NPLNL 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 7e-09
Identities = 61/257 (23%), Positives = 94/257 (36%), Gaps = 75/257 (29%)
Query: 683 LYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNI 742
L + T F V IGEG++G V+K +A+K+ +++ + E N L+
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE-EEIKEEYNILRKY 59
Query: 743 -RHRNLVKILTACSGVDYQGNDFKA----------LVFEF--------------MHNRSL 777
H N+ + G K LV E + L
Sbjct: 60 SNHPNI---------ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRL 110
Query: 778 -EEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILL 836
EEW+ I RE L YLH + + H D+K NILL
Sbjct: 111 KEEWIAYILRE---------------------TLRGLAYLH---ENKVIHRDIKGQNILL 146
Query: 837 DEDMIAHIGDFGLARFLPLSSAQTSSIGAKGS-IG---YIAPE-----YGLGSEVSISGD 887
++ + DFG++ L S++G + + IG ++APE + D
Sbjct: 147 TKNAEVKLVDFGVSAQL------DSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSD 200
Query: 888 VYSYGILLLELITRKKP 904
V+S GI +EL K P
Sbjct: 201 VWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 8e-09
Identities = 37/115 (32%), Positives = 58/115 (50%), Gaps = 5/115 (4%)
Query: 787 EDETDEAPRSLNLIQRLNISIDVACALNYL-HHDCQPPIAHCDLKPSNILLDEDMIAHIG 845
++E E L+L L S VA +++L +C H D+ N+LL + +A I
Sbjct: 199 DEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKIC 254
Query: 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
DFGLAR + S A+ + ++APE ++ DV+SYGILL E+ +
Sbjct: 255 DFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 8e-09
Identities = 36/97 (37%), Positives = 50/97 (51%), Gaps = 6/97 (6%)
Query: 808 DVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKG 867
++ C L LH + I + DLKP NILLD+ I D GLA +P +T G G
Sbjct: 110 EITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIP--EGETIR-GRVG 163
Query: 868 SIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
++GY+APE + S D + G L+ E+I K P
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 9e-09
Identities = 65/238 (27%), Positives = 104/238 (43%), Gaps = 52/238 (21%)
Query: 681 QNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFI------A 734
+ ++ +R+ +++ +G G++GSV D +T + V V L F+S I
Sbjct: 10 KTIWEVPERYQNLSPVGSGAYGSVCAAF--DTKTGLRVAVKKLSR--PFQSIIHAKRTYR 65
Query: 735 ECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEW--LHPITREDETDE 792
E LK+++H N++ +L F RSLEE+ ++ +T D
Sbjct: 66 ELRLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLVTHLMGAD- 107
Query: 793 APRSLNLI---QRLN------ISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843
LN I Q+L + + L Y+H I H DLKPSN+ ++ED
Sbjct: 108 ----LNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELK 160
Query: 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELIT 900
I DFGLAR G + Y APE L + + D++S G ++ EL+T
Sbjct: 161 ILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 213
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 9e-09
Identities = 68/240 (28%), Positives = 97/240 (40%), Gaps = 51/240 (21%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNI------RHRNLVK 749
IG G++G V + +A+K AF + I TL+ I H N++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKI----ANAFDNRIDAKRTLREIKLLRHLDHENVIA 68
Query: 750 ILTACSGVDYQGNDFKA--LVFEFMHNRSLEEWLHPITREDE--TDEAPRSLNLIQRLNI 805
I F +V+E M LH I R + +D+ + L Q L
Sbjct: 69 IKDIMPPP--HREAFNDVYIVYELMDTD-----LHQIIRSSQTLSDDHCQYF-LYQLLR- 119
Query: 806 SIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGA 865
L Y+H + H DLKPSN+LL+ + I DFGLAR T+S
Sbjct: 120 ------GLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR--------TTSEKG 162
Query: 866 KGSIGYI------APEYGLG-SEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNL 918
Y+ APE L SE + + DV+S G + EL+ RK +F G +H L
Sbjct: 163 DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKP----LFPGKDYVHQL 218
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 9e-09
Identities = 38/108 (35%), Positives = 59/108 (54%), Gaps = 6/108 (5%)
Query: 808 DVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKG 867
++ ALN+LH + I + DLK N+LLD D + D+G+ + L T+S G
Sbjct: 104 EICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTFC-G 158
Query: 868 SIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEG-DMN 914
+ YIAPE G E S D ++ G+L+ E++ + P DI+ + DMN
Sbjct: 159 TPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN 206
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 9e-09
Identities = 35/105 (33%), Positives = 54/105 (51%), Gaps = 9/105 (8%)
Query: 808 DVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKG 867
++ C L +LH I + DLK N++LD D I DFG+ + + S+ G
Sbjct: 104 EIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC--G 158
Query: 868 SIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGD 912
+ YIAPE G + + S D +S+G+LL E++ + P F GD
Sbjct: 159 TPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP----FHGD 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 9e-09
Identities = 64/259 (24%), Positives = 97/259 (37%), Gaps = 56/259 (21%)
Query: 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKV-------FNLLHHGAFKSFIAECNTLKN 741
R+ + IG+G G V+ +A+K LL K F+ E +
Sbjct: 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLK----KRFLREAKIAAD 58
Query: 742 IRHRNLVKILTACSGVD--------YQGNDFKALVFEFMHNRSLEEWLHPITREDETDEA 793
+ H +V + + CS D +G K+L+ SL + L E + A
Sbjct: 59 LIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELA----EKTSVGA 114
Query: 794 PRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFL 853
L+I + + Y+H + H DLKP NILL I D+G A F
Sbjct: 115 --------FLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFK 163
Query: 854 PLSSAQTSSIGAK----------------GSIGYIAPEYGLGSEVSISGDVYSYGILLLE 897
L I G+ Y+APE LG S S D+Y+ G++L +
Sbjct: 164 KLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQ 223
Query: 898 LIT------RKKPTDIMFE 910
++T RKK I +
Sbjct: 224 MLTLSFPYRRKKGRKISYR 242
|
Length = 932 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 54/217 (24%), Positives = 96/217 (44%), Gaps = 23/217 (10%)
Query: 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLV 748
+++ +IG+G+ G+V+ I +A+K NL + I E ++ +H N+V
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIV 79
Query: 749 KILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISID 808
L + Y D +V E++ SL + + E DE Q + +
Sbjct: 80 NYLDS-----YLVGDELWVVMEYLAGGSLTD----VVTETCMDEG-------QIAAVCRE 123
Query: 809 VACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGL-ARFLPLSSAQTSSIGAKG 867
AL +LH + + H D+K NILL D + DFG A+ P S +++ +G
Sbjct: 124 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP- 179
Query: 868 SIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
++APE D++S GI+ +E++ + P
Sbjct: 180 --YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-08
Identities = 33/107 (30%), Positives = 51/107 (47%), Gaps = 4/107 (3%)
Query: 52 WRGVTC----SRRHQRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFD 107
W G C ++ + L L++ L G I + L L+ + L NS IP
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG 463
Query: 108 RLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSEL 154
+ L+VL L YNS G+IP ++ ++L L L N L G++P+ L
Sbjct: 464 SITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 35/105 (33%), Positives = 55/105 (52%), Gaps = 9/105 (8%)
Query: 808 DVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKG 867
++ C L +LH I + DLK N+LLD+D I DFG+ + + S+ G
Sbjct: 104 EIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC--G 158
Query: 868 SIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGD 912
+ YIAPE G + + S D +S+G+LL E++ + P F G+
Sbjct: 159 TPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP----FHGE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-08
Identities = 52/196 (26%), Positives = 80/196 (40%), Gaps = 28/196 (14%)
Query: 716 IAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFM 772
+A+K+ F E + H N+V +L SG VFE++
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLD--SGE--APPGLLFAVFEYV 61
Query: 773 HNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPS 832
R+L E L D A L + + + V AL H+ I H DLKP
Sbjct: 62 PGRTLREVL-------AADGA---LPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQ 108
Query: 833 NILL---DEDMIAHIGDFGLARFLP-----LSSAQTSSIGAKGSIGYIAPEYGLGSEVSI 884
NI++ A + DFG+ LP + T + G+ Y APE G V+
Sbjct: 109 NIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTP 168
Query: 885 SGDVYSYGILLLELIT 900
+ D+Y++G++ LE +T
Sbjct: 169 NSDLYAWGLIFLECLT 184
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 2e-08
Identities = 64/235 (27%), Positives = 98/235 (41%), Gaps = 42/235 (17%)
Query: 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKV------FNLLHHG--AFKSFIAECNTLK 740
R+ ++ IG G+ G V D T V + F + H A++ + +K
Sbjct: 17 RYQNLKPIGSGAQGIVCAA--YDTVTGQNVAIKKLSRPFQNVTHAKRAYRELV----LMK 70
Query: 741 NIRHRNLVKILTACSGVDYQGNDFKA--LVFEFM-HNRSLEEWLHPITREDETDEAPRSL 797
+ H+N++ +L + +F+ LV E M N L + + D D S
Sbjct: 71 LVNHKNIIGLLNVFTP-QKSLEEFQDVYLVMELMDAN------LCQVIQMD-LDHERMSY 122
Query: 798 NLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSS 857
L Q L C + +LH I H DLKPSNI++ D I DFGLAR S
Sbjct: 123 LLYQML-------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 172
Query: 858 AQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGD 912
T + + Y APE LG + D++S G ++ E+I ++F G
Sbjct: 173 MMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT----VLFPGT 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 73/270 (27%), Positives = 114/270 (42%), Gaps = 59/270 (21%)
Query: 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGA-----FKSFIAECNTLKNIRH 744
F+ + +IG GSFG+V+ D RT V + + + G ++ I E L+ I+H
Sbjct: 27 FTDLREIGHGSFGAVY--FARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH 84
Query: 745 RNLVKILTACSGVDYQGNDFKA----LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLI 800
N ++Y+G + LV E+ + D + + L +
Sbjct: 85 PN---------SIEYKGCYLREHTAWLVMEYCLGSA----------SDLLEVHKKPLQEV 125
Query: 801 QRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQT 860
+ I+ L YLH + H D+K NILL E + DFG A ++S
Sbjct: 126 EIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSAS---IASPAN 179
Query: 861 SSIGAKGSIGYIAPEYGLG-SEVSISG--DVYSYGILLLELITRKKPTDIMFEGDMN--- 914
S +G ++APE L E G DV+S GI +EL RK P +F +MN
Sbjct: 180 SFVGTP---YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LF--NMNAMS 231
Query: 915 -LHNLARTALP--------DHVMDIVDSTL 935
L+++A+ P D+ + VDS L
Sbjct: 232 ALYHIAQNESPTLQSNEWSDYFRNFVDSCL 261
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 63/264 (23%), Positives = 108/264 (40%), Gaps = 51/264 (19%)
Query: 685 NATDRFSSVNQ-IGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKS----FIAEC--- 736
+ ++R+ +GEG++G V K +A+K ++ + + C
Sbjct: 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIH 64
Query: 737 -------NTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDE 789
+ I+H N++ ++ Y DF LV + M + L++ + R
Sbjct: 65 FTTLRELKIMNEIKHENIMGLVDV-----YVEGDFINLVMDIMAS-DLKKVVDRKIR--- 115
Query: 790 TDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGL 849
E+ L+Q LN LN LH + H DL P+NI ++ I I DFGL
Sbjct: 116 LTESQVKCILLQILN-------GLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGL 165
Query: 850 AR---FLPLSSAQTSSIGAKG---------SIGYIAPEYGLGSE-VSISGDVYSYGILLL 896
AR + P S + + ++ Y APE +G+E + D++S G +
Sbjct: 166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFA 225
Query: 897 ELITRKKPTDIMFEGDMNLHNLAR 920
EL+T K +F G+ + L R
Sbjct: 226 ELLTGKP----LFPGENEIDQLGR 245
|
Length = 335 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 36/107 (33%), Positives = 58/107 (54%), Gaps = 5/107 (4%)
Query: 806 SIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGA 865
S +++ ALNYLH + I + DLK N+LLD + + D+G+ + L T+S
Sbjct: 102 SAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFC 157
Query: 866 KGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGD 912
G+ YIAPE G + S D ++ G+L+ E++ + P DI+ D
Sbjct: 158 -GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 203
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 4e-08
Identities = 61/238 (25%), Positives = 95/238 (39%), Gaps = 40/238 (16%)
Query: 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSF----IAECNTLKN 741
+ + ++GEG+FG V+K +A+K +L H F + E LK
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALK--KILMHNEKDGFPITALREIKILKK 63
Query: 742 IRHRNLVKIL-TACSGVDYQGNDFKA--LVFEFM-HNRS--LEEWLHPITREDETDEAPR 795
++H N+V ++ A D + +V +M H+ S LE P
Sbjct: 64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN--------------PS 109
Query: 796 -SLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLP 854
L Q + + +NYLH + I H D+K +NIL+D I I DFGLAR
Sbjct: 110 VKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYD 166
Query: 855 LSSAQTSSIGAKGSIGYI---------APEYGLG-SEVSISGDVYSYGILLLELITRK 902
G G+ Y PE LG + + D++ G + E+ TR+
Sbjct: 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 4e-08
Identities = 64/208 (30%), Positives = 90/208 (43%), Gaps = 24/208 (11%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFN---LLHHGAFKSFIAECNTL-KNIRHRNLVKIL 751
IG+GSFG V + AVKV +L +AE N L KN++H LV
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV--- 59
Query: 752 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVAC 811
G+ Y + L F + E + H + RE E PR+ R + +VA
Sbjct: 60 ----GLHYSFQTAEKLYFVLDYVNGGELFFH-LQRERCFLE-PRA-----RF-YAAEVAS 107
Query: 812 ALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGY 871
A+ YLH I + DLKP NILLD + DFGL + TS+ G+ Y
Sbjct: 108 AIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC--GTPEY 162
Query: 872 IAPEYGLGSEVSISGDVYSYGILLLELI 899
+APE + D + G +L E++
Sbjct: 163 LAPEVLRKEPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 5e-08
Identities = 62/243 (25%), Positives = 100/243 (41%), Gaps = 50/243 (20%)
Query: 684 YNATDRFSSVNQIGEGSFGSV---FKGILDDGRTTIAVKVFN--LLHHGAFKSFIAECNT 738
+ R+ ++ IG G+ G V + +LD +A+K + + K E
Sbjct: 13 FTVLKRYQNLKPIGSGAQGIVCAAYDAVLD---RNVAIKKLSRPFQNQTHAKRAYRELVL 69
Query: 739 LKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLN 798
+K + H+N++ +L F +SLEE+ + D N
Sbjct: 70 MKCVNHKNIISLLNV-----------------FTPQKSLEEFQDVYLVMELMDA-----N 107
Query: 799 LIQRLNISID----------VACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFG 848
L Q + + +D + C + +LH I H DLKPSNI++ D I DFG
Sbjct: 108 LCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG 164
Query: 849 LARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIM 908
LAR S T + + Y APE LG + D++S G ++ E++ K I+
Sbjct: 165 LARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK----IL 217
Query: 909 FEG 911
F G
Sbjct: 218 FPG 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 5e-08
Identities = 70/242 (28%), Positives = 108/242 (44%), Gaps = 37/242 (15%)
Query: 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVK-VFNLLHHGAFKSFI-AECNTLKNIRHRN 746
R+ IG+GS+G V I +A+K + ++ H + + I E L+ +RH +
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60
Query: 747 LVKILTACSGVDYQGNDFKAL--VFEFMHNRSLEEWLHPITR--EDETDEAPRSLNLIQR 802
+V+I + +FK + VFE M E LH + + +D T E + L Q
Sbjct: 61 IVEIKHIM--LPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLTPEHHQFF-LYQL 112
Query: 803 LNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFL----PLSSA 858
L AL Y+H + H DLKP NIL + D I DFGLAR P +
Sbjct: 113 LR-------ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 162
Query: 859 QTSSIGAKGSIGYIAPEY--GLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLH 916
T + + Y APE S+ + + D++S G + E++T K +F G +H
Sbjct: 163 WTDYVATR---WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP----LFPGKNVVH 215
Query: 917 NL 918
L
Sbjct: 216 QL 217
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 6e-08
Identities = 37/111 (33%), Positives = 54/111 (48%), Gaps = 5/111 (4%)
Query: 791 DEAPRSLNLIQRLNISIDVACALNYL-HHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGL 849
+E +L+ L+ S VA +++L +C H DL NILL I I DFGL
Sbjct: 205 EEDELALDTEDLLSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGL 260
Query: 850 ARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
AR + S A+ + ++APE + DV+SYGILL E+ +
Sbjct: 261 ARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 6e-08
Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 23/217 (10%)
Query: 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLV 748
+++ +IG+G+ G+VF I +A+K NL + I E +K +++ N+V
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIV 79
Query: 749 KILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISID 808
L + + D +V E++ SL + + E DEA Q + +
Sbjct: 80 NFLDS-----FLVGDELFVVMEYLAGGSLTD----VVTETCMDEA-------QIAAVCRE 123
Query: 809 VACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGL-ARFLPLSSAQTSSIGAKG 867
AL +LH + + H D+K N+LL D + DFG A+ P S +++ +G
Sbjct: 124 CLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP- 179
Query: 868 SIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
++APE D++S GI+ +E++ + P
Sbjct: 180 --YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 6e-08
Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 41/219 (18%)
Query: 694 NQIGEGSFGSVFKGILDDGRTTIAVKVFNL-LHHGAFKSFIAECNTLKNIRHRNLVKILT 752
+G G+ G+V+K R +AVKV L + K ++E ++IL
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSE------------LEILY 54
Query: 753 ACSG---VDYQGNDFK----ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNI 805
C + + G F ++ EFM SL D + P +++ R I
Sbjct: 55 KCDSPYIIGFYGAFFVENRISICTEFMDGGSL----------DVYRKIPE--HVLGR--I 100
Query: 806 SIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGA 865
++ V L YL I H D+KPSN+L++ + DFG++ L S A+T
Sbjct: 101 AVAVVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV--- 154
Query: 866 KGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
G+ Y+APE G + I DV+S GI +EL + P
Sbjct: 155 -GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 6e-08
Identities = 67/236 (28%), Positives = 103/236 (43%), Gaps = 27/236 (11%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKILT 752
+G+GSFG V L A+KV +L + E L + L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 753 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACA 812
C +Q D V E+++ L + I R + DE PRS R + +V A
Sbjct: 63 CC----FQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDE-PRS-----RF-YAAEVTLA 108
Query: 813 LNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYI 872
L +LH + + + DLK NILLD + + DFG+ + L+ T++ G+ YI
Sbjct: 109 LMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC--GTPDYI 163
Query: 873 APEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVM 928
APE E S D ++ G+L+ E++ + P FE D N +L + L D V+
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQPP----FEAD-NEDDLFESILHDDVL 214
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 7e-08
Identities = 71/271 (26%), Positives = 116/271 (42%), Gaps = 61/271 (22%)
Query: 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGA-----FKSFIAECNTLKNIRH 744
FS + +IG GSFG+V+ D R + V + + + G ++ I E L+ +RH
Sbjct: 17 FSDLREIGHGSFGAVY--FARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 745 RNLVKILTACSGVDYQGNDFKA----LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLI 800
N + Y+G + LV E+ + D + + L +
Sbjct: 75 PNTI---------QYRGCYLREHTAWLVMEYCLGSA----------SDLLEVHKKPLQEV 115
Query: 801 QRLNISIDVACALNYLH-HDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQ 859
+ ++ L YLH H+ + H D+K NILL E + +GDFG A + ++
Sbjct: 116 EIAAVTHGALQGLAYLHSHN----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF 171
Query: 860 TSSIGAKGSIGYIAPEYGLG-SEVSISG--DVYSYGILLLELITRKKPTDIMFEGDMN-- 914
G+ ++APE L E G DV+S GI +EL RK P +F +MN
Sbjct: 172 V------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LF--NMNAM 220
Query: 915 --LHNLARTALP--------DHVMDIVDSTL 935
L+++A+ P ++ + VDS L
Sbjct: 221 SALYHIAQNESPALQSGHWSEYFRNFVDSCL 251
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 34/97 (35%), Positives = 50/97 (51%), Gaps = 6/97 (6%)
Query: 808 DVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKG 867
++ C L L + I + DLKP NILLD+ I D GLA +P +T G G
Sbjct: 110 ELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIP--EGETVR-GRVG 163
Query: 868 SIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
++GY+APE + + S D + G L+ E+I + P
Sbjct: 164 TVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 8e-08
Identities = 56/222 (25%), Positives = 84/222 (37%), Gaps = 33/222 (14%)
Query: 694 NQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFK---SFIAECNTLKNIRHRNLVKI 750
++IG G FG V G G + V V L F+ E + + H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 751 LTAC-SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDV 809
L C + Y LV EF L+ +L L QR+ + +V
Sbjct: 61 LGQCIESIPY------LLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVL---QRM--ACEV 109
Query: 810 ACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGS- 868
A L +LH Q H DL N L D+ IGD+GLA L K
Sbjct: 110 ASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLA----LEQYPEDYYITKDCH 162
Query: 869 ---IGYIAPEYG-------LGSEVSISGDVYSYGILLLELIT 900
+ ++APE L + + +++S G+ + EL T
Sbjct: 163 AVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 9e-08
Identities = 46/159 (28%), Positives = 69/159 (43%), Gaps = 32/159 (20%)
Query: 805 ISIDVACALNYL---HHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTS 861
I++ V L YL H I H D+KPSNIL++ + DFG++ L S A T
Sbjct: 108 IAVAVVEGLTYLYNVHR-----IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTF 162
Query: 862 SIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMN------- 914
G+ Y++PE G + ++ DV+S GI ++EL K P D +
Sbjct: 163 V----GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFA-FSNIDDDGQDDPMG 217
Query: 915 ----LH--------NLARTALPDHVMDIVDSTLLNDGED 941
L L + P+ + D VD+ LL D +
Sbjct: 218 ILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTE 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 9e-08
Identities = 57/222 (25%), Positives = 104/222 (46%), Gaps = 29/222 (13%)
Query: 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL--LHHGAFKSFIAECNTLKNIRHRN 746
++ + +IGEG++G+VFK + +A+K L G S + E LK ++H+N
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 747 LVKILTACSGVDYQGNDFK-ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNI 805
+V++ D +D K LVFE+ ++ L+++ + D + Q L
Sbjct: 61 IVRL------YDVLHSDKKLTLVFEYC-DQDLKKYFDSC--NGDIDPEIVKSFMFQLLK- 110
Query: 806 SIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARF--LPLSSAQTSSI 863
L + H + H DLKP N+L++++ + DFGLAR +P+ +
Sbjct: 111 ------GLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV 161
Query: 864 GAKGSIGYIAPEYGLGSEV-SISGDVYSYGILLLELITRKKP 904
++ Y P+ G+++ S S D++S G + EL +P
Sbjct: 162 ----TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 9e-08
Identities = 68/248 (27%), Positives = 114/248 (45%), Gaps = 46/248 (18%)
Query: 664 EKQNPNSPINSFPNISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL 723
E++ ++ IN PN SY+ N IG GSFG V++ I D +A+K +
Sbjct: 52 EEKMIDNDINRSPNKSYK----------LGNIIGNGSFGVVYEAICIDTSEKVAIK--KV 99
Query: 724 LHHGAFKSFIAECNTLKNIRHRNLVKI----LTACSGVDYQGNDFKALVFEFMHNRSLEE 779
L +K+ E +KN+ H N++ + T C + + N F +V EF+ +++ +
Sbjct: 100 LQDPQYKN--RELLIMKNLNHINIIFLKDYYYTECFKKN-EKNIFLNVVMEFI-PQTVHK 155
Query: 780 WLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED 839
++ R + +L L S + AL Y+H I H DLKP N+L+D +
Sbjct: 156 YMKHYARNNH------ALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPN 206
Query: 840 M-IAHIGDFGLARFLPLSSAQTSSIGAKGSIGYI------APEYGLGS-EVSISGDVYSY 891
+ DFG A+ L + + S+ YI APE LG+ + D++S
Sbjct: 207 THTLKLCDFGSAKNL---------LAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSL 257
Query: 892 GILLLELI 899
G ++ E+I
Sbjct: 258 GCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 9e-08
Identities = 69/261 (26%), Positives = 114/261 (43%), Gaps = 46/261 (17%)
Query: 681 QNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFI------A 734
+ ++ +R+ ++ +G G++GSV R +AVK + F+S I
Sbjct: 8 KTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSR----PFQSLIHARRTYR 63
Query: 735 ECNTLKNIRHRNLVKILTACSGVDYQGNDFKA--LVFEFMHNRSLEEWLHPITR-EDETD 791
E LK+++H N++ +L + +F LV M L+ I + + +D
Sbjct: 64 ELRLLKHMKHENVIGLLDVFTPAT-SIENFNEVYLVTNLMGAD-----LNNIVKCQKLSD 117
Query: 792 EAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLAR 851
E + L + Q L L Y+H I H DLKPSN+ ++ED I DFGLAR
Sbjct: 118 EHVQFL-IYQLLR-------GLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR 166
Query: 852 FLPLSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDIMFE 910
A G + Y APE L + + D++S G ++ EL+ K +F
Sbjct: 167 -----QADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK----ALFP 217
Query: 911 GDMNLHNLARTALPDHVMDIV 931
G+ + L R +M++V
Sbjct: 218 GNDYIDQLKR------IMEVV 232
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 1e-07
Identities = 58/246 (23%), Positives = 92/246 (37%), Gaps = 56/246 (22%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFN---LLHHGAFKSFIAECNTLKNIRH 744
D F + IG G+FG V+ D A+KV ++ AE + L +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 745 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWL--HPITREDETDEAPRSLNLIQR 802
+VK+ + +Q + LV E+M L L + E+ R
Sbjct: 61 PWIVKLYYS-----FQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETA-----------R 104
Query: 803 LNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI--GDFGLA---------- 850
I+ ++ AL+ +H + H D+KP NIL+D D HI DFGL
Sbjct: 105 FYIA-ELVLALDSVH---KLGFIHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDRE 158
Query: 851 -----------------RFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGI 893
R + + G+ YIAPE G+ + D +S G+
Sbjct: 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGV 218
Query: 894 LLLELI 899
+L E++
Sbjct: 219 ILYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 53/217 (24%), Positives = 97/217 (44%), Gaps = 23/217 (10%)
Query: 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLV 748
+++ +IG+G+ G+V+ I +A+K NL + I E ++ ++ N+V
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIV 79
Query: 749 KILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISID 808
L + Y D +V E++ SL + + E DE Q + +
Sbjct: 80 NYLDS-----YLVGDELWVVMEYLAGGSLTD----VVTETCMDEG-------QIAAVCRE 123
Query: 809 VACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGL-ARFLPLSSAQTSSIGAKG 867
AL++LH + + H D+K NILL D + DFG A+ P S +++ +G
Sbjct: 124 CLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP- 179
Query: 868 SIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
++APE D++S GI+ +E++ + P
Sbjct: 180 --YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-07
Identities = 61/243 (25%), Positives = 99/243 (40%), Gaps = 50/243 (20%)
Query: 684 YNATDRFSSVNQIGEGSFGSV---FKGILDDGRTTIAVKVFN--LLHHGAFKSFIAECNT 738
+ R+ ++ IG G+ G V + IL+ +A+K + + K E
Sbjct: 20 FTVLKRYQNLKPIGSGAQGIVCAAYDAILE---RNVAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 739 LKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLN 798
+K + H+N++ +L F +SLEE+ + D N
Sbjct: 77 MKCVNHKNIIGLLNV-----------------FTPQKSLEEFQDVYIVMELMDA-----N 114
Query: 799 LIQRLNISID----------VACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFG 848
L Q + + +D + C + +LH I H DLKPSNI++ D I DFG
Sbjct: 115 LCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG 171
Query: 849 LARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIM 908
LAR S T + + Y APE LG + D++S G ++ E+I ++
Sbjct: 172 LARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG----VL 224
Query: 909 FEG 911
F G
Sbjct: 225 FPG 227
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 1e-07
Identities = 52/212 (24%), Positives = 89/212 (41%), Gaps = 31/212 (14%)
Query: 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVK 749
++ + + GS G VF + +K+ G + + E L+N+ H ++++
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKI------GQKGTTLIEAMLLQNVNHPSVIR 121
Query: 750 IL-TACSGVDYQGNDFKALVFEFMHNRS-LEEWLHPITREDETDEAPRSLNLIQRLNISI 807
+ T SG +V H S L +L T+ R L + Q L I
Sbjct: 122 MKDTLVSG------AITCMVLP--HYSSDLYTYL---TKRS------RPLPIDQALIIEK 164
Query: 808 DVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKG 867
+ L YLH I H D+K NI +++ IGD G A+F + +G G
Sbjct: 165 QILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQF---PVVAPAFLGLAG 218
Query: 868 SIGYIAPEYGLGSEVSISGDVYSYGILLLELI 899
++ APE + + D++S GI+L E++
Sbjct: 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-07
Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 816 LHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAK---GSIGYI 872
+HH + H D+K +NILL + + +GDFG F + +A S + G+ Y+
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG---FSKMYAATVSDDVGRTFCGTPYYV 212
Query: 873 APEYGLGSEVSISGDVYSYGILLLELITRKKPTD 906
APE S D++S G+LL EL+T K+P D
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFN---LLHHGAFKSFIAECNTL-KNIRHRNLVKIL 751
IG+GSFG V AVKV +L+ K +AE N L KN++H LV +
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 752 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVAC 811
+ +Q + V +F++ L + H + RE E PR+ R + ++A
Sbjct: 63 YS-----FQTTEKLYFVLDFVNGGEL--FFH-LQRERSFPE-PRA-----RFYAA-EIAS 107
Query: 812 ALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGY 871
AL YLH I + DLKP NILLD + DFGL + ++ + T++ G+ Y
Sbjct: 108 ALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFC-GTPEY 162
Query: 872 IAPEYGLGSEVSISGDVYSYGILLLELI 899
+APE + D + G +L E++
Sbjct: 163 LAPEVIRKQPYDNTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 56/229 (24%), Positives = 102/229 (44%), Gaps = 26/229 (11%)
Query: 686 ATDRFSSVNQIGEGSFGSVFKGIL-----DDGRTTIAVKVFNLLHHGAFKS-FIAECNTL 739
+T RF + ++GE FG V+KG L + +A+K G + F E
Sbjct: 5 STVRF--MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMR 62
Query: 740 KNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWL-----HPITREDETDEAP 794
++H N+V +L GV + +++F + + L E+L H + D+
Sbjct: 63 SRLQHPNIVCLL----GVVTKEQPL-SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTV 117
Query: 795 RS-LNLIQRLNISIDVACALNYL--HHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLAR 851
+S L ++I +A + +L HH H DL N+L+ + + I D GL R
Sbjct: 118 KSTLEPADFVHIVTQIAAGMEFLSSHHVV-----HKDLATRNVLVFDKLNVKISDLGLFR 172
Query: 852 FLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
+ + + I +++PE + + SI D++SYG++L E+ +
Sbjct: 173 EVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 3e-07
Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 8/213 (3%)
Query: 396 TIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQ-GSIPSSLGRYETL 454
P + E + L L + + PS + L + LS + + +L L
Sbjct: 36 NFPDSNLESVAVNRLALNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPL 95
Query: 455 TTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLK-NLEILNVFGNKL 513
++DL+ N L I ++L LDL N +T IP +G LK NL+ L++ NK+
Sbjct: 96 PSLDLNLNRLRSNISELLE--LTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKI 152
Query: 514 KGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQ 573
+ +PS L + L+ L++ N L +P LS+L L+ LDLS N +S +P + L
Sbjct: 153 E-SLPSPLRNLPNLKNLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLS 209
Query: 574 LVKNLNLSNNDLEGVVPTQGVFKNASITSVFGN 606
++ L+LSNN + ++ + KN S + N
Sbjct: 210 ALEELDLSNNSIIELLSSLSNLKNLSGLELSNN 242
|
Length = 394 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-07
Identities = 61/225 (27%), Positives = 92/225 (40%), Gaps = 38/225 (16%)
Query: 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL---LHHGAFKSFIAECNTLKNIRHRN 746
F +++IG GSFG+V+ +AVK + + ++ I E L+ ++H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 747 LVKILTACSGVDYQGNDFKA----LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQR 802
+ +Y+G K LV E+ + D + + L ++
Sbjct: 83 TI---------EYKGCYLKEHTAWLVMEYCLGSA----------SDLLEVHKKPLQEVEI 123
Query: 803 LNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSS 862
I+ L YLH + H D+K NILL E + DFG A SS S
Sbjct: 124 AAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSAS---KSSPANSF 177
Query: 863 IGAKGSIGYIAPEYGLG-SEVSISG--DVYSYGILLLELITRKKP 904
+G ++APE L E G DV+S GI +EL RK P
Sbjct: 178 VGTP---YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 219
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 58/268 (21%), Positives = 101/268 (37%), Gaps = 61/268 (22%)
Query: 696 IGEGSFGSVFKGILDDGRTT---IAVKVF---NLLHHGAFKSFIAECNTLKNIRHR-NLV 748
I +G+FGSV+ L R+T A+KV +++ + AE + +
Sbjct: 4 ISKGAFGSVY---LAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 749 KILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLN-ISI 807
K+ + +Q D+ LV E+++ +LI+ L +
Sbjct: 61 KLYYS-----FQSKDYLYLVMEYLNGGDCA-------------------SLIKTLGGLPE 96
Query: 808 DVAC--------ALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQ 859
D A + LH I H D+KP N+L+D+ + DFGL+R +
Sbjct: 97 DWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKF 153
Query: 860 TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP-----TDIMFE---- 910
G+ Y+APE LG D +S G ++ E + P D +F+
Sbjct: 154 V------GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS 207
Query: 911 GDMNLHNLARTALPDHVMDIVDSTLLND 938
+N + +D+++ L D
Sbjct: 208 RRINWPEEVKEFCSPEAVDLINRLLCMD 235
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 54/231 (23%), Positives = 91/231 (39%), Gaps = 36/231 (15%)
Query: 685 NATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRH 744
+ + + + ++G+G+FG V+K + A KV + ++ E L H
Sbjct: 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNH 68
Query: 745 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLN 804
+VK+L G Y ++ EF +++ + E R L Q
Sbjct: 69 PYIVKLL----GAFYWDGKLWIMI-EFCPGGAVDAIML---------ELDRGLTEPQIQV 114
Query: 805 ISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIG 864
I + AL YLH I H DLK N+LL D + DFG +S+ ++
Sbjct: 115 ICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFG------VSAKNVKTLQ 165
Query: 865 AKGSIGYIAPEYGLGSEVSI-----------SGDVYSYGILLLELITRKKP 904
+ S +I Y + EV + D++S GI L+E+ + P
Sbjct: 166 RRDS--FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-07
Identities = 59/218 (27%), Positives = 94/218 (43%), Gaps = 22/218 (10%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKS-FIAECNTLKNIRHRN 746
D F ++++G G+ G V K +A K+ +L A ++ I E L H
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVL----HEC 60
Query: 747 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNIS 806
+ G Y + ++ E M SL++ L R E +S
Sbjct: 61 NSPYIVGFYGAFYSDGEI-SICMEHMDGGSLDQVLKEAKRIPEEILG----------KVS 109
Query: 807 IDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAK 866
I V L YL Q I H D+KPSNIL++ + DFG++ L + S S +G +
Sbjct: 110 IAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFVGTR 166
Query: 867 GSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
Y++PE G+ S+ D++S G+ L+EL + P
Sbjct: 167 S---YMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 30/211 (14%)
Query: 695 QIGEGSFGSVFKGILD--DGRTTIAVKVF-NLLHHGAFK-SFIAECNTLKNIRHRNLVKI 750
++G G+FG+V KG+ T+AVK+ N + A K + E N ++ + + +V++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 751 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVA 810
+ C + LV E L P+ + + ++ N+ + ++ V+
Sbjct: 62 IGICEAESWM------LVMELAE-------LGPLNKFLQKNKHVTEKNITELVH---QVS 105
Query: 811 CALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGS-- 868
+ YL + H DL N+LL A I DFGL++ L A + AK
Sbjct: 106 MGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKAL---GADENYYKAKTHGK 159
Query: 869 --IGYIAPEYGLGSEVSISGDVYSYGILLLE 897
+ + APE + S DV+S+G+L+ E
Sbjct: 160 WPVKWYAPECMNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-07
Identities = 62/243 (25%), Positives = 96/243 (39%), Gaps = 50/243 (20%)
Query: 684 YNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVF-----NLLHHGAFKSFIAECNT 738
+ R+ + IG G+ G V +AVK N H K E
Sbjct: 17 FTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHA---KRAYRELVL 73
Query: 739 LKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLN 798
LK + H+N++ +L F +SLEE+ + D N
Sbjct: 74 LKCVNHKNIISLLNV-----------------FTPQKSLEEFQDVYLVMELMDA-----N 111
Query: 799 LIQRLNISID----------VACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFG 848
L Q +++ +D + C + +LH I H DLKPSNI++ D I DFG
Sbjct: 112 LCQVIHMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG 168
Query: 849 LARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIM 908
LAR + T + + Y APE LG + D++S G ++ EL+ ++
Sbjct: 169 LARTACTNFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGELVK----GSVI 221
Query: 909 FEG 911
F+G
Sbjct: 222 FQG 224
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 29/221 (13%)
Query: 694 NQIGEGSFGSVFKGILDDGRTTIAVKVFNL------LHHGAFKSFIAECNTLKNIRHRNL 747
+G+G++G+V+ G+ + G+ IAVK L ++ E + LK+++H N+
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQL-IAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 748 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISI 807
V+ L C N ++ EF+ S+ L+ E + ++
Sbjct: 65 VQYLGTC----LDDNTI-SIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD------ 113
Query: 808 DVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSI---- 863
+ YLH++C + H D+K +N++L + I + DFG AR L +
Sbjct: 114 ----GVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLK 166
Query: 864 GAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
G+ ++APE S D++S G + E+ T K P
Sbjct: 167 SMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 4e-07
Identities = 59/231 (25%), Positives = 96/231 (41%), Gaps = 36/231 (15%)
Query: 685 NATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRH 744
N D + + ++G+G+FG V+K + A K+ + + F+ E + L +H
Sbjct: 2 NPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKH 61
Query: 745 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLN 804
N+V + A Y + ++ EF +L+ + E R L Q
Sbjct: 62 PNIVGLYEA-----YFYENKLWILIEFCDGGALDSIM---------LELERGLTEPQIRY 107
Query: 805 ISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIG 864
+ + ALN+LH + H DLK NILL D + DFG+ SA+ S
Sbjct: 108 VCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGV-------SAKNKSTL 157
Query: 865 AK-----GSIGYIAPEYGLGSEVSIS------GDVYSYGILLLELITRKKP 904
K G+ ++APE + E D++S GI L+EL + P
Sbjct: 158 QKRDTFIGTPYWMAPEV-VACETFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 4e-07
Identities = 52/217 (23%), Positives = 96/217 (44%), Gaps = 23/217 (10%)
Query: 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLV 748
+++ +IG+G+ G+V+ + +A++ NL + I E ++ ++ N+V
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 749 KILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISID 808
L + Y D +V E++ SL + + E DE Q + +
Sbjct: 81 NYLDS-----YLVGDELWVVMEYLAGGSLTD----VVTETCMDEG-------QIAAVCRE 124
Query: 809 VACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGL-ARFLPLSSAQTSSIGAKG 867
AL +LH + + H D+K NILL D + DFG A+ P S +++ +G
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP- 180
Query: 868 SIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
++APE D++S GI+ +E+I + P
Sbjct: 181 --YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 4e-07
Identities = 60/229 (26%), Positives = 101/229 (44%), Gaps = 47/229 (20%)
Query: 689 RFSSVNQIGEGSFGSVFKGILDDGRT--TIAVKVFNLLHHGAFKSFIAECNTLKNIRHRN 746
+ +IGEGS G V I D T +AVK +L + E +++ +H N
Sbjct: 20 YLDNFVKIGEGSTGIVC--IATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPN 77
Query: 747 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNIS 806
+V++ ++ Y D +V EF+ +L + + TR +E Q +
Sbjct: 78 IVEMYSS-----YLVGDELWVVMEFLEGGALTDIVTH-TRMNEE----------QIATVC 121
Query: 807 IDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAK 866
+ V AL++LH + H D+K +ILL D + DFG AQ S +
Sbjct: 122 LAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFC-------AQVSKEVPR 171
Query: 867 -----GSIGYIAPE------YGLGSEVSISGDVYSYGILLLELITRKKP 904
G+ ++APE Y G+EV D++S GI+++E++ + P
Sbjct: 172 RKSLVGTPYWMAPEVISRLPY--GTEV----DIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 5e-07
Identities = 33/100 (33%), Positives = 54/100 (54%), Gaps = 6/100 (6%)
Query: 805 ISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIG 864
ISI V L YL + I H D+KPSNIL++ + DFG++ L + S S +G
Sbjct: 104 ISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFVG 160
Query: 865 AKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
+ Y++PE G+ ++ D++S G+ L+E+ + P
Sbjct: 161 TRS---YMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 55/212 (25%), Positives = 86/212 (40%), Gaps = 19/212 (8%)
Query: 693 VNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAE--CNTLKNIRHRNLVKI 750
V +G+GS+G V +K NL + + AE L ++H N+V
Sbjct: 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 751 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVA 810
+ G D +V F L L +E + P + Q + + +A
Sbjct: 65 RESWEGEDGL----LYIVMGFCEGGDLYHKL----KEQKGKLLPEN----QVVEWFVQIA 112
Query: 811 CALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIG 870
AL YLH + I H DLK N+ L I +GD G+AR L S++ G+
Sbjct: 113 MALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTL--IGTPY 167
Query: 871 YIAPEYGLGSEVSISGDVYSYGILLLELITRK 902
Y++PE + DV++ G + E+ T K
Sbjct: 168 YMSPELFSNKPYNYKSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 5e-07
Identities = 55/215 (25%), Positives = 96/215 (44%), Gaps = 22/215 (10%)
Query: 696 IGEGSFGSVFKGI-LDDGRTTIAVKV-FNLLHHGAFKSFIA-ECNT--LKNIRHRNLVKI 750
+G+G+FG V+ +D GR A +V F+ K A EC LKN++H +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 751 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVA 810
C + + + E+M S+++ L E+ + +++
Sbjct: 70 Y-GC--LRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILE--------- 117
Query: 811 CALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLA-RFLPLSSAQTSSIGAKGSI 869
++YLH + I H D+K +NIL D +GDFG + R + + T G+
Sbjct: 118 -GMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTP 173
Query: 870 GYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
+++PE G DV+S G ++E++T K P
Sbjct: 174 YWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 56/210 (26%), Positives = 89/210 (42%), Gaps = 28/210 (13%)
Query: 695 QIGEGSFGSVFKGI--LDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHR----NLV 748
++G G+FG V KG+ + + +A+KV L + KS E I H+ +V
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKV---LKNENEKSVRDEMMREAEIMHQLDNPYIV 58
Query: 749 KILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISID 808
+++ C LV E L ++L + DE S N+++ ++
Sbjct: 59 RMIGVCEAEALM------LVMEMASGGPLNKFL-----SGKKDEITVS-NVVELMH---Q 103
Query: 809 VACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPL-SSAQTSSIGAKG 867
V+ + YL H DL N+LL A I DFGL++ L S + K
Sbjct: 104 VSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKW 160
Query: 868 SIGYIAPEYGLGSEVSISGDVYSYGILLLE 897
+ + APE + S DV+SYGI + E
Sbjct: 161 PLKWYAPECINFRKFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 52/216 (24%), Positives = 90/216 (41%), Gaps = 28/216 (12%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACS 755
+G+G++G V+ + IA+K + E ++HRN+V+ L + S
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 756 GVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNY 815
N F + E + SL L + P N + + + L Y
Sbjct: 76 E-----NGFFKIFMEQVPGGSLSALL-------RSKWGPLKDNEQTIIFYTKQILEGLKY 123
Query: 816 LHHDCQPPIAHCDLKPSNILLDE-DMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAP 874
LH + I H D+K N+L++ + I DFG ++ L + T + G++ Y+AP
Sbjct: 124 LHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF--TGTLQYMAP 178
Query: 875 EY------GLGSEVSISGDVYSYGILLLELITRKKP 904
E G G+ D++S G ++E+ T K P
Sbjct: 179 EVIDKGPRGYGA----PADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 7e-07
Identities = 33/103 (32%), Positives = 57/103 (55%), Gaps = 5/103 (4%)
Query: 806 SIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGA 865
S +++ ALN+LH + I + DLK N+LLD + + D+G+ + + T+S
Sbjct: 102 SAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK-EGIRPGDTTSTFC 157
Query: 866 KGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIM 908
G+ YIAPE G + S D ++ G+L+ E++ + P DI+
Sbjct: 158 -GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 199
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 8e-07
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 24/219 (10%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKS-FIAECNTLKNIRHRN 746
D F ++++G G+ G VFK +A K+ +L A ++ I E L H
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVL----HEC 60
Query: 747 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRL-NI 805
+ G Y + ++ E M SL++ L R E Q L +
Sbjct: 61 NSPYIVGFYGAFYSDGEI-SICMEHMDGGSLDQVLKKAGRIPE-----------QILGKV 108
Query: 806 SIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGA 865
SI V L YL + I H D+KPSNIL++ + DFG++ L + S S +G
Sbjct: 109 SIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFVGT 165
Query: 866 KGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
+ Y++PE G+ S+ D++S G+ L+E+ + P
Sbjct: 166 R---SYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 8e-07
Identities = 52/219 (23%), Positives = 92/219 (42%), Gaps = 27/219 (12%)
Query: 695 QIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGA------FKSFIAECNTLKNIRHRNLV 748
Q+G G+F S ++ T +AVK + + + ++ E + + H +++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 749 KILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISID 808
+ G + + F V E+M S+ L +I +N +
Sbjct: 67 R----MLGATCEDSHFNLFV-EWMAGGSVSHLLS--------KYGAFKEAVI--INYTEQ 111
Query: 809 VACALNYLHHDCQPPIAHCDLKPSNILLDED-MIAHIGDFGLARFLPLSSAQTSSIGAK- 866
+ L+YLH + I H D+K +N+L+D I DFG A L +
Sbjct: 112 LLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQL 168
Query: 867 -GSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
G+I ++APE G + S DV+S G +++E+ T K P
Sbjct: 169 LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 58/212 (27%), Positives = 90/212 (42%), Gaps = 23/212 (10%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILT 752
IG+GSFG V + D + A+K H +AE L + +V +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-- 58
Query: 753 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACA 812
+Q + LV F++ L H + RE D + + L CA
Sbjct: 59 ---KFSFQSPEKLYLVLAFINGGEL---FHHLQREGRFDLSRARFYTAELL-------CA 105
Query: 813 LNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYI 872
L LH + + + DLKP NILLD + DFGL + +T++ G+ Y+
Sbjct: 106 LENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC--GTPEYL 160
Query: 873 APEYGLGSEVSISGDVYSYGILLLELITRKKP 904
APE LG + + D ++ G+LL E++T P
Sbjct: 161 APELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-06
Identities = 56/223 (25%), Positives = 89/223 (39%), Gaps = 29/223 (13%)
Query: 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVK 749
FS + G+ G F I + + +K G E + L+ I H ++++
Sbjct: 94 FSILETFTPGAEGFAFACIDNKTCEHVVIKA------GQRGGTATEAHILRAINHPSIIQ 147
Query: 750 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDV 809
+ + N F L+ + L +L A R++ + L I V
Sbjct: 148 LKGT-----FTYNKFTCLILP-RYKTDLYCYL----------AAKRNIAICDILAIERSV 191
Query: 810 ACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSI 869
A+ YLH + I H D+K NI ++ +GDFG A F P+ G G+I
Sbjct: 192 LRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACF-PVDINANKYYGWAGTI 247
Query: 870 GYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGD 912
APE + D++S GI+L E+ T D +FE D
Sbjct: 248 ATNAPELLARDPYGPAVDIWSAGIVLFEMATCH---DSLFEKD 287
|
Length = 391 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 65/251 (25%), Positives = 104/251 (41%), Gaps = 27/251 (10%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKILT 752
+G+GSFG V L + AVKV +L + + E L R+ + L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 753 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACA 812
C +Q D V EF++ L + R DE R+ + ++ A
Sbjct: 63 CC----FQTPDRLFFVMEFVNGGDLMFHIQKSRRFDE----ARARFY------AAEITSA 108
Query: 813 LNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYI 872
L +LH I + DLK N+LLD + + DFG+ + + TS+ G+ YI
Sbjct: 109 LMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC--GTPDYI 163
Query: 873 APEYGLGSEVSISGDVYSYGILLLELITRKKP-----TDIMFEGDMNLHNLARTALPDHV 927
APE S D ++ G+LL E++ P D +FE +N + T L
Sbjct: 164 APEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDA 223
Query: 928 MDIVDSTLLND 938
+DI+ + + +
Sbjct: 224 VDILKAFMTKN 234
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 60/235 (25%), Positives = 96/235 (40%), Gaps = 38/235 (16%)
Query: 685 NATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRH 744
N + F + +IG G++G V+K + A+KV L F E +K+ +H
Sbjct: 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKH 65
Query: 745 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLN 804
N+V + Y D + EF SL++ H E+ A S +Q
Sbjct: 66 SNIVAYFGS-----YLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQ--- 117
Query: 805 ISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIG 864
L YLH + H D+K +NILL ++ + DFG+ SAQ ++
Sbjct: 118 -------GLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGV-------SAQITATI 160
Query: 865 AKGSIGYIAPEYGLGSEVSISG---------DVYSYGILLLELITRKKPTDIMFE 910
AK +I Y + EV+ D+++ GI +EL + P MF+
Sbjct: 161 AKRK-SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPP---MFD 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 46/162 (28%), Positives = 72/162 (44%), Gaps = 25/162 (15%)
Query: 808 DVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLAR-FLPLSSAQTSSIGAK 866
++ AL++LH Q I + D+K NILLD + + DFGL++ FL + S
Sbjct: 113 EIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC-- 167
Query: 867 GSIGYIAPEY------GLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLH-NLA 919
G+I Y+APE G V D +S G+L EL+T P + +G+ N ++
Sbjct: 168 GTIEYMAPEVIRGGSGGHDKAV----DWWSLGVLTFELLTGASPFTV--DGEQNSQSEIS 221
Query: 920 RTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIEC 961
R L T+ + D I Q+ + K R+
Sbjct: 222 RRILKSKPP--FPKTMSAEARDFI----QKLLEKDPKKRLGA 257
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 25/215 (11%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVF--NLLHHGAFKSFIAECNTLKNIRHR 745
++F + +GEG++G V K + + +A+K F + + ++ + E L+ ++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 746 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNI 805
N+V++ A ++ LVFE++ LE + E P + +
Sbjct: 61 NIVELKEA-----FRRRGKLYLVFEYVEKNMLE-----LLEEMPNGVPPEKVR-----SY 105
Query: 806 SIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQ--TSSI 863
+ A+++ H + I H D+KP N+L+ + + + DFG AR L S T +
Sbjct: 106 IYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYV 162
Query: 864 GAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLEL 898
+ Y +PE LG+ + D++S G +L EL
Sbjct: 163 ATR---WYRSPELLLGAPYGKAVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 696 IGEGSFGSVFKGILD-DGRTTIAVKVFNLLHHGAF----KSFIAECNTLKNIRHRNLVKI 750
+G G FG + +G L + + V + + L G + F+AE TL H N+V++
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAI-HTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 751 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVA 810
GV +GN +V E+M N +L+ +L R+ E L Q + + +A
Sbjct: 72 ----EGVITRGNTM-MIVTEYMSNGALDSFL----RKHEG-----QLVAGQLMGMLPGLA 117
Query: 811 CALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQT--SSIGAKGS 868
+ YL + H L +L++ D++ I F R L ++ +++ K
Sbjct: 118 SGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGF---RRLQEDKSEAIYTTMSGKSP 171
Query: 869 IGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
+ + APE S + DV+S+GI++ E+++
Sbjct: 172 VLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 47/131 (35%), Positives = 64/131 (48%), Gaps = 25/131 (19%)
Query: 798 NLIQRLNISID--------VACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGL 849
+L QR N S D + AL +LH + I + D+K NILLD + + DFGL
Sbjct: 95 HLYQRDNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGL 151
Query: 850 AR-FLPLSSAQTSSIGAKGSIGYIAPEY-----GLGSEVSISGDVYSYGILLLELITRKK 903
++ FL +T S G+I Y+APE G G V D +S GIL+ EL+T
Sbjct: 152 SKEFLSEEKERTYSFC--GTIEYMAPEIIRGKGGHGKAV----DWWSLGILIFELLTGAS 205
Query: 904 PTDIMFEGDMN 914
P EG+ N
Sbjct: 206 P--FTLEGERN 214
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 66/271 (24%), Positives = 100/271 (36%), Gaps = 65/271 (23%)
Query: 688 DRFSSVNQIGEGSFGSVFK----GILDDGR-TTIAVKVFNLLHHGA----FKSFIAECNT 738
DR +G G+FG V + GI T+AVK +L GA +K+ + E
Sbjct: 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVK---MLKEGATASEYKALMTELKI 63
Query: 739 LKNI-RHRNLVKILTACSG--------VDY-----QGNDFKALVFEFMHNR----SLEEW 780
L +I H N+V +L AC+ V+Y N ++ F R E
Sbjct: 64 LIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREM 123
Query: 781 LHPI------TREDETDEAPRS------------------------LNLIQRLNISIDVA 810
+ + S L L ++ S VA
Sbjct: 124 KQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVA 183
Query: 811 CALNYL-HHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSI 869
+ +L C H DL NILL E+ + I DFGLAR + A+ +
Sbjct: 184 RGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239
Query: 870 GYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
++APE + DV+S+G+LL E+ +
Sbjct: 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 2e-06
Identities = 84/329 (25%), Positives = 130/329 (39%), Gaps = 15/329 (4%)
Query: 96 NSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELS 155
++ +PS RL L +L+ S N+ + L L L N+L SEL
Sbjct: 56 SNTLLLLPSSLSRLLSLDLLSPSGISSLDGSE-NLLNLLPLPSLDLNLNRLR-SNISELL 113
Query: 156 SLSKIEHISVNDNNLTGSIPSSLGNL-SSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMA 214
L+ + + +++NN+T IP +G L S+++ L LS N +E S+P L L NL NL ++
Sbjct: 114 ELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLS 171
Query: 215 QNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPT 274
N LS +P + N+S++ D NKI +P + L L+ + N + + +
Sbjct: 172 FNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIEL-LSALEELDLSNNSII-ELLSS 227
Query: 275 ISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGS-RGDRDLNFLCSLTNATR 333
+SN NL S NKL + L L + N + S L L L +
Sbjct: 228 LSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQISSISSLGSLTNLRELDLSGN 287
Query: 334 LKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRL 393
+ + L + NL TL+ L L N I N I + S
Sbjct: 288 SLSNALPLIALLLLLLELLLNLLLTLKALELKLNSILLNN--NILSNGETSSPEALSILE 345
Query: 394 SGTIPPAIGELQNLKDLRLQRNRFQGNIP 422
S + L N D N
Sbjct: 346 SLN---NLWTLDNALDESNLNRYIVKNPN 371
|
Length = 394 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 2e-06
Identities = 55/235 (23%), Positives = 102/235 (43%), Gaps = 31/235 (13%)
Query: 695 QIGEGSFGSV----------FKGI----LDDGRTTIAVKVFNL-LHHGAFKSFIAECNTL 739
++GEG FG V F G D +AVK+ + A F+ E +
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 740 KNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPR---- 795
+++ N++++L C +D ++ E+M N L ++L RE E+
Sbjct: 72 SRLKNPNIIRLLGVCVS-----DDPLCMITEYMENGDLNQFLS--QREIESTFTHANNIP 124
Query: 796 SLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPL 855
S+++ L +++ +A + YL H DL N L+ I DFG++R L
Sbjct: 125 SVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYS 181
Query: 856 SSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT--RKKPTDIM 908
A I ++A E L + + + DV+++G+ L E+ T +++P ++
Sbjct: 182 GDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL 236
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 68/262 (25%), Positives = 113/262 (43%), Gaps = 32/262 (12%)
Query: 695 QIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTAC 754
+IGEGS G V +AVK +L + E +++ H N+V + +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNS- 87
Query: 755 SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALN 814
Y D +V EF+ +L + + TR +E A L++++ AL+
Sbjct: 88 ----YLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLR----------ALS 132
Query: 815 YLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAP 874
YLH+ + H D+K +ILL D + DFG + + S+ G+ ++AP
Sbjct: 133 YLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL--VGTPYWMAP 187
Query: 875 E----YGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVMDI 930
E G+EV D++S GI+++E+I + P E + R LP V D
Sbjct: 188 EVISRLPYGTEV----DIWSLGIMVIEMIDGEPP--YFNEPPLQAMRRIRDNLPPRVKDS 241
Query: 931 VD-STLLNDGEDLIVHGNQRQR 951
S++L DL++ QR
Sbjct: 242 HKVSSVLRGFLDLMLVREPSQR 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-06
Identities = 59/229 (25%), Positives = 90/229 (39%), Gaps = 41/229 (17%)
Query: 684 YNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVK-VFNLLHHGAF-KSFIAECNTLKN 741
+ T+R+ + +G G+FG V +A+K + K E LK+
Sbjct: 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKH 65
Query: 742 IRHRNLVKILTACSGVDYQGNDFKALVFEFMH---NRSLEEWLHPITREDETDEAPRSLN 798
+RH N++ + S + + V E + +R L +R E L
Sbjct: 66 LRHENIISL----SDIFISPLEDIYFVTELLGTDLHRLLT------SRPLEKQFIQYFLY 115
Query: 799 LIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSA 858
I R L Y+H + H DLKPSNIL++E+ I DFGLAR
Sbjct: 116 QILR---------GLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLAR--IQDPQ 161
Query: 859 QTSSIGAKGSIGYIAPEYGL-----GSEVSISGDVYSYGILLLELITRK 902
T + + Y APE L EV D++S G + E++ K
Sbjct: 162 MTGYVSTR---YYRAPEIMLTWQKYDVEV----DIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 4e-06
Identities = 66/254 (25%), Positives = 107/254 (42%), Gaps = 69/254 (27%)
Query: 689 RFSSVNQIGEGSFGSVFKGIL----DDGRTTIAVKVFNL--LHHGAFKSFIAECNTLKNI 742
++ V +IGEGSFG K IL +DG+ + +K N+ + + E L N+
Sbjct: 1 KYVKVKKIGEGSFG---KAILVKSKEDGKQYV-IKEINISKMSPKEREESRKEVAVLSNM 56
Query: 743 RHRNLVK-------------ILTACSGVD-YQG-NDFKALVFEFMHNRSLEEWLHPITRE 787
+H N+V+ ++ C G D Y+ N + ++F E
Sbjct: 57 KHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFP----------------E 100
Query: 788 DETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDF 847
D Q L+ + + AL ++H I H D+K NI L +D +GDF
Sbjct: 101 D------------QILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDF 145
Query: 848 GLARFLPLSSAQTSSIGAKGSIG---YIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
G+AR L ++ A+ IG Y++PE + D+++ G +L E+ T K
Sbjct: 146 GIARVL-----NSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHA 200
Query: 905 TDIMFEGDMNLHNL 918
FE N+ NL
Sbjct: 201 ----FEAG-NMKNL 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 61/228 (26%), Positives = 100/228 (43%), Gaps = 18/228 (7%)
Query: 677 NISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAEC 736
I + + + +D + + IG+G++G VFK + + AVK+ + +H + AE
Sbjct: 7 TIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEY 65
Query: 737 NTLKNIR-HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPR 795
N LK + H N+VK D + D LV E + S+ + + + E E P
Sbjct: 66 NILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI 125
Query: 796 SLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPL 855
I+ + AL L H H D+K +NILL + + DFG++ L
Sbjct: 126 ---------IAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSA--QL 174
Query: 856 SSAQTSSIGAKGSIGYIAPEY-----GLGSEVSISGDVYSYGILLLEL 898
+S + + G+ ++APE L S DV+S GI +EL
Sbjct: 175 TSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 31/110 (28%), Positives = 50/110 (45%), Gaps = 6/110 (5%)
Query: 795 RSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLP 854
R L + + ++ S + C + +LH I + D+KP N+LLD+ + D GLA L
Sbjct: 90 RGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELK 146
Query: 855 LSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
T G GY+APE S D ++ G + E++ + P
Sbjct: 147 DGKTITQRAGTN---GYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 5e-06
Identities = 55/221 (24%), Positives = 98/221 (44%), Gaps = 28/221 (12%)
Query: 695 QIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTAC 754
++G G++G V+K DG+ + + G S E L+ ++H N++ A
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVI----AL 63
Query: 755 SGVDYQGNDFKA-LVFEFMHNRSLEEWLHPIT--REDETDEAPRSLNLIQRLNISIDVAC 811
V +D K L+F++ + + W H I R + ++ P L ++ +
Sbjct: 64 QKVFLSHSDRKVWLLFDYAEH---DLW-HIIKFHRASKANKKPMQLPRSMVKSLLYQILD 119
Query: 812 ALNYLHHDCQPPIAHCDLKPSNILL----DEDMIAHIGDFGLARFL-----PLSSAQTSS 862
++YLH + + H DLKP+NIL+ E I D G AR PL+
Sbjct: 120 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 863 IGAKGSIGYIAPEYGLGSE-VSISGDVYSYGILLLELITRK 902
+ + Y APE LG+ + + D+++ G + EL+T +
Sbjct: 177 V----TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 6e-06
Identities = 40/124 (32%), Positives = 48/124 (38%), Gaps = 42/124 (33%)
Query: 809 VACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI--GDFGLARFLPLSSAQTSSIGAK 866
V AL YLH I + DLKP NILL E HI DF L++ + S K
Sbjct: 112 VLLALEYLH--LLG-IVYRDLKPENILLHES--GHIMLSDFDLSKQSDVEPPPVSKALRK 166
Query: 867 GSIG---------------------------YIAPE----YGLGSEVSISGDVYSYGILL 895
GS YIAPE G GS V D ++ GILL
Sbjct: 167 GSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV----DWWTLGILL 222
Query: 896 LELI 899
E++
Sbjct: 223 YEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 6e-06
Identities = 35/112 (31%), Positives = 54/112 (48%), Gaps = 5/112 (4%)
Query: 790 TDEAPRSLNLIQRLNISIDVACALNYL-HHDCQPPIAHCDLKPSNILLDEDMIAHIGDFG 848
+D+ L + L+ + VA + +L +C H DL N+LL + I I DFG
Sbjct: 227 SDDGSEGLTTLDLLSFTYQVARGMEFLASKNC----VHRDLAARNVLLAQGKIVKICDFG 282
Query: 849 LARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
LAR + S S + ++APE + + DV+SYGILL E+ +
Sbjct: 283 LARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 8e-06
Identities = 34/101 (33%), Positives = 52/101 (51%), Gaps = 13/101 (12%)
Query: 813 LNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQ--TSSIGAKGSIG 870
L YLH I H D+KP N+L++ + + I DFGLAR ++ T + +
Sbjct: 116 LKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ---Y 169
Query: 871 YIAPEYGLGSEVSISG-DVYSYGILLLELITRKKPTDIMFE 910
Y APE +GS S D++S G + EL+ R+ I+F+
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR----ILFQ 206
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-06
Identities = 54/214 (25%), Positives = 95/214 (44%), Gaps = 29/214 (13%)
Query: 695 QIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTAC 754
+IGEGS G V + +AVK +L + E +++ +H N+V++ +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS- 85
Query: 755 SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALN 814
Y D +V EF+ +L + + TR +E A L +++ AL+
Sbjct: 86 ----YLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLK----------ALS 130
Query: 815 YLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAP 874
LH + H D+K +ILL D + DFG + + S+ G+ ++AP
Sbjct: 131 VLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL--VGTPYWMAP 185
Query: 875 E----YGLGSEVSISGDVYSYGILLLELITRKKP 904
E G EV D++S GI+++E++ + P
Sbjct: 186 ELISRLPYGPEV----DIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 8e-06
Identities = 65/247 (26%), Positives = 104/247 (42%), Gaps = 33/247 (13%)
Query: 696 IGEGSFGSVFKGI-LDDGRTTIAVKV-FNLLHHGAFKSFIA-ECNT--LKNIRHRNLVKI 750
+G G+FG V+ D GR +V F+ K A EC LKN+RH +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 751 LTACSGVDYQGNDFKALVF-EFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDV 809
G + K +F E+M S+++ L E + ++Q
Sbjct: 70 Y----GCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQ-------- 117
Query: 810 ACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSI 869
++YLH + I H D+K +NIL D +GDFG ++ + + S G K
Sbjct: 118 --GVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK--RIQTICMSGTGIKSVT 170
Query: 870 G---YIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLA----RTA 922
G +++PE G DV+S ++E++T K P +E + +A +
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWA-EYEAMAAIFKIATQPTKPM 229
Query: 923 LPDHVMD 929
LPD V D
Sbjct: 230 LPDGVSD 236
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 8e-06
Identities = 62/208 (29%), Positives = 92/208 (44%), Gaps = 24/208 (11%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFN---LLHHGAFKSFIAECNTL-KNIRHRNLVKIL 751
IG+GSFG V AVKV +L K ++E N L KN++H LV +
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL- 61
Query: 752 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVAC 811
+Q D V ++++ L + + RE E PR+ R + ++A
Sbjct: 62 ----HFSFQTADKLYFVLDYINGGEL---FYHLQRERCFLE-PRA-----RF-YAAEIAS 107
Query: 812 ALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGY 871
AL YLH I + DLKP NILLD + DFGL + + TS+ G+ Y
Sbjct: 108 ALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC--GTPEY 162
Query: 872 IAPEYGLGSEVSISGDVYSYGILLLELI 899
+APE + D + G +L E++
Sbjct: 163 LAPEVLHKQPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 59/222 (26%), Positives = 107/222 (48%), Gaps = 33/222 (14%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL-LHHGAFKSFIAECNTLKNIRHRN 746
D ++++G+G++GSV+K + T+A+K L L F I E + L H+
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDIL----HKA 56
Query: 747 LVKILTACSGVDYQGNDF-KALVF---EFMHNRSLEEWLHPITREDETDEAPRSLNLIQR 802
+ + VD+ G F + V+ E+M SL++ + E ++++R
Sbjct: 57 VSPYI-----VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPE-----DVLRR 106
Query: 803 LNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSS 862
I+ V L +L + I H D+KP+N+L++ + + DFG++ L S A+T +
Sbjct: 107 --ITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKT-N 161
Query: 863 IGAKGSIGYIAPEY--GLGSE----VSISGDVYSYGILLLEL 898
IG + Y+APE G ++ DV+S G+ +LE+
Sbjct: 162 IGCQ---SYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEM 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 34/112 (30%), Positives = 57/112 (50%), Gaps = 10/112 (8%)
Query: 808 DVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLAR-FLPLSSAQTSSIGAK 866
++ AL +LH + I + D+K NILLD + + DFGL++ F + S
Sbjct: 113 EIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFC-- 167
Query: 867 GSIGYIAPEYGLGSEV--SISGDVYSYGILLLELITRKKPTDIMFEGDMNLH 916
G+I Y+AP+ G + + D +S G+L+ EL+T P + +G+ N
Sbjct: 168 GTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV--DGEKNSQ 217
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 56/243 (23%), Positives = 100/243 (41%), Gaps = 42/243 (17%)
Query: 689 RFSSVNQIGEGSFGSV-------FKGILD---------DGRTTIAVKVFNLLHHGAFKS- 731
+ V ++GEG FG V + + D +AVKV L A +
Sbjct: 6 PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKV---LRPDASDNA 62
Query: 732 ---FIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITRED 788
F+ E L + N+ ++L C+ + ++ E+M N L ++L
Sbjct: 63 REDFLKEVKILSRLSDPNIARLLGVCT-----VDPPLCMIMEYMENGDLNQFLQ--KHVA 115
Query: 789 ETDEAPRSLNLIQR---LNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845
ET + + L ++ +A + YL H DL N L+ ++ I
Sbjct: 116 ETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIA 172
Query: 846 DFGLARFLPLSSAQTSSIG--AKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT--R 901
DFG++R L S+ + A I ++A E L + + DV+++G+ L E++T R
Sbjct: 173 DFGMSR--NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCR 230
Query: 902 KKP 904
++P
Sbjct: 231 EQP 233
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 52/216 (24%), Positives = 88/216 (40%), Gaps = 24/216 (11%)
Query: 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFK-----SFIAECNTLKNIR 743
R+ ++G+GSFG+V+ +KV + G E L +
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 744 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLN-LIQR 802
H +VK + + D ++ E+ R L+ L + +T + IQ
Sbjct: 61 HPAIVKFHAS-----FLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQL 115
Query: 803 LNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSS 862
L ++Y+H Q I H DLK NI L +++ IGDFG++R L S ++
Sbjct: 116 L-------LGVHYMH---QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATT 164
Query: 863 IGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLEL 898
G+ Y++PE D++S G +L E+
Sbjct: 165 F--TGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-05
Identities = 49/171 (28%), Positives = 71/171 (41%), Gaps = 46/171 (26%)
Query: 808 DVAC--------ALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQ 859
D AC AL +LH I + DLKP NILLD + DFGL +
Sbjct: 100 DTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV 156
Query: 860 TSSIGAKGSIGYIAPEY----GLGSEVSISGDVYSYGILLLELIT---------RKKPTD 906
T + G+I Y+APE G G V D +S G L+ +++T RKK D
Sbjct: 157 THTFC--GTIEYMAPEILMRSGHGKAV----DWWSLGALMYDMLTGAPPFTAENRKKTID 210
Query: 907 IMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKS 957
+ +G +N LP + L + DL+ +R +R+ +
Sbjct: 211 KILKGKLN--------LPPY--------LTPEARDLLKKLLKRNPSSRLGA 245
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 57/218 (26%), Positives = 88/218 (40%), Gaps = 34/218 (15%)
Query: 694 NQIGEGSFGSVFKGILDDGRTTIAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKI 750
+G GSFG V A+K +L + E + L + H +V +
Sbjct: 24 ETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNM 83
Query: 751 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVA 810
+ CS +Q + + EF+ L L +A R N + + ++
Sbjct: 84 M--CS---FQDENRVYFLLEFVVGGELFTHLR---------KAGRFPNDVAKF-YHAELV 128
Query: 811 CALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIG 870
A YLH I + DLKP N+LLD + DFG A+ +P +T ++ G+
Sbjct: 129 LAFEYLH-SKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP---DRTFTLC--GTPE 180
Query: 871 YIAPEY----GLGSEVSISGDVYSYGILLLELITRKKP 904
Y+APE G G V D ++ G+LL E I P
Sbjct: 181 YLAPEVIQSKGHGKAV----DWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-05
Identities = 30/96 (31%), Positives = 48/96 (50%), Gaps = 3/96 (3%)
Query: 809 VACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGS 868
+ AL+ +H + H DLK +NI L I +GDFG ++ S + + G+
Sbjct: 178 IVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGT 234
Query: 869 IGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
Y+APE S D++S G++L EL+T +P
Sbjct: 235 PYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 39/133 (29%), Positives = 61/133 (45%), Gaps = 11/133 (8%)
Query: 771 FMHNRSLEEWLHPITREDETDE--APRSLNLIQRLNISIDVACALNYL-HHDCQPPIAHC 827
F+ +SL + + E+ E + L L + S VA + +L C H
Sbjct: 152 FVEEKSLSD----VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKC----IHR 203
Query: 828 DLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGD 887
DL NILL E+ + I DFGLAR + A+ + ++APE +I D
Sbjct: 204 DLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSD 263
Query: 888 VYSYGILLLELIT 900
V+S+G+LL E+ +
Sbjct: 264 VWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 2e-05
Identities = 42/164 (25%), Positives = 69/164 (42%), Gaps = 36/164 (21%)
Query: 804 NISIDVACALNYLH-HDCQPPIAHCDLKPSNILLDEDMI-AHIGDFGLARFLPLSSAQTS 861
I + ALN LH H+ I H D+K N+L D ++ D+GL +
Sbjct: 113 KIIRQLVEALNDLHKHN----IIHNDIKLENVLYDRAKDRIYLCDYGLCK---------- 158
Query: 862 SIGAK----GSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHN 917
IG G++ Y +PE G +S D ++ G+L EL+T K P + +++L +
Sbjct: 159 IIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLES 218
Query: 918 LAR---------TALPDHVMDIVDSTL-------LNDGEDLIVH 945
L + + + D V S L L + ++I H
Sbjct: 219 LLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262
|
Length = 267 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 31/100 (31%), Positives = 50/100 (50%), Gaps = 8/100 (8%)
Query: 806 SIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGA 865
+ ++ L ++H+ + + DLKP+NILLDE I D GLA ++ +
Sbjct: 103 ATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHAS 155
Query: 866 KGSIGYIAPE-YGLGSEVSISGDVYSYGILLLELITRKKP 904
G+ GY+APE G+ S D +S G +L +L+ P
Sbjct: 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 36/122 (29%), Positives = 53/122 (43%), Gaps = 18/122 (14%)
Query: 780 WLHPITREDETDEAPRSLNLIQRLNISIDVACALNYL-HHDCQPPIAHCDLKPSNILLDE 838
W P+T ED + S VA + +L C H DL NILL E
Sbjct: 167 WKSPLTMED-------------LICYSFQVARGMEFLASRKC----IHRDLAARNILLSE 209
Query: 839 DMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLEL 898
+ + I DFGLAR + A+ + ++APE + DV+S+G+LL E+
Sbjct: 210 NNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 269
Query: 899 IT 900
+
Sbjct: 270 FS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 38/115 (33%), Positives = 59/115 (51%), Gaps = 14/115 (12%)
Query: 791 DEAPRSLNLIQRLNISIDVACALNYL-HHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGL 849
+E+P +L+ + + S VA + +L +C H DL N+L+ E + I DFGL
Sbjct: 231 NESP-ALSYMDLVGFSYQVANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGL 285
Query: 850 ARFLPLSSAQTSSIGAKGS----IGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
AR + S S KGS + ++APE + + DV+S+GILL E+ T
Sbjct: 286 ARDIMRDSNYIS----KGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 49/233 (21%), Positives = 100/233 (42%), Gaps = 30/233 (12%)
Query: 688 DRFSSVNQIGEGSFGSVF----KGILD------------DGRTTIAVKVFNL-LHHGAFK 730
R + ++GEG FG V +G+ + +AVK+ + A
Sbjct: 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARN 64
Query: 731 SFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPIT-REDE 789
F+ E + ++ N++++L C + +D ++ E+M N L ++L +E
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVC--IT---SDPLCMITEYMENGDLNQFLSRHEPQEAA 119
Query: 790 TDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGL 849
+++ + ++ +A + YL H DL N L+ ++ I DFG+
Sbjct: 120 EKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGM 176
Query: 850 ARFLPLSSAQTSSIGAKG--SIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
+R L S I + I +++ E L + + + DV+++G+ L E++T
Sbjct: 177 SR--NLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 3e-05
Identities = 33/106 (31%), Positives = 55/106 (51%), Gaps = 7/106 (6%)
Query: 794 PRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLD--EDMIAHIGDFGLAR 851
R L L Q ++ + A++Y+H + I H D+K N+L++ ED+ +GDFG A
Sbjct: 254 LRPLGLAQVTAVARQLLSAIDYIH--GEG-IIHRDIKTENVLVNGPEDIC--LGDFGAAC 308
Query: 852 FLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLE 897
F S + G G++ APE G + S D++S G+++ E
Sbjct: 309 FARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 60/232 (25%), Positives = 104/232 (44%), Gaps = 28/232 (12%)
Query: 678 ISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECN 737
+ ++L + TD + + IG+G++G V+K + AVK+ + + + AE N
Sbjct: 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYN 70
Query: 738 TLKNI-RHRNLVKILTACSGVDYQGNDFKA----LVFEFMHNRSLEEWLHPITREDET-D 791
L+++ H N+VK G+ Y+ + LV E + S+ E + + + D
Sbjct: 71 ILQSLPNHPNVVKFY----GMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLD 126
Query: 792 EAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLAR 851
EA S L L L +LH++ I H D+K +NILL + + DFG++
Sbjct: 127 EAMISYILYGAL-------LGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSA 176
Query: 852 FLPLSSAQTSSIGAKGSIGYIAPEY-----GLGSEVSISGDVYSYGILLLEL 898
L+S + + G+ ++APE DV+S GI +EL
Sbjct: 177 --QLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 3e-05
Identities = 51/212 (24%), Positives = 92/212 (43%), Gaps = 23/212 (10%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKILT 752
+G+G+FG V A+K+ ++ + E LKN RH L +
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 753 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACA 812
+ +Q D V E+++ L + H ++RE R + + ++ A
Sbjct: 63 S-----FQTKDRLCFVMEYVNGGEL--FFH-LSRE-------RVFSEDRTRFYGAEIVSA 107
Query: 813 LNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYI 872
L+YLH I + DLK N++LD+D I DFGL + +A + G+ Y+
Sbjct: 108 LDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC--GTPEYL 162
Query: 873 APEYGLGSEVSISGDVYSYGILLLELITRKKP 904
APE ++ + D + G+++ E++ + P
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 65/271 (23%), Positives = 109/271 (40%), Gaps = 42/271 (15%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFN---LLHHGAFKSFIAECNTLKNIRH 744
D F + IG G+FG V + A+K+ N +L F E N L N
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 745 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLN--LIQR 802
+ + + A +Q ++ LV ++ L L D P + I
Sbjct: 61 QWITTLHYA-----FQDENYLYLVMDYYVGGDLLTLLSKFE-----DRLPEDMARFYIAE 110
Query: 803 LNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSS 862
+ ++I L+Y+H D +KP N+LLD + + DFG + SS
Sbjct: 111 MVLAIHSIHQLHYVHRD---------IKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSS 161
Query: 863 IGAKGSIGYIAPEY------GLGSEVSISGDVYSYGILLLELITRKKP--TDIMFE--GD 912
+ A G+ YI+PE G+G + D +S G+ + E++ + P + + E G
Sbjct: 162 V-AVGTPDYISPEILQAMEDGMG-KYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 219
Query: 913 MNLHNLARTALPDHVMDIVDSTLLNDGEDLI 943
+ H R P H+ D+ + + +DLI
Sbjct: 220 IMNHE-ERFQFPSHITDVSE-----EAKDLI 244
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 30/99 (30%), Positives = 48/99 (48%), Gaps = 5/99 (5%)
Query: 808 DVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKG 867
++A L +LH I + DLK N++LD + I DFG+ + T + G
Sbjct: 109 EIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC--G 163
Query: 868 SIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTD 906
+ YIAPE S D +++G+LL E++ + P D
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 34/117 (29%), Positives = 58/117 (49%), Gaps = 11/117 (9%)
Query: 808 DVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKG 867
+++ L +LH + I + DLK N++LD + I DFG+ + + T + G
Sbjct: 109 EISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFC--G 163
Query: 868 SIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP-----TDIMFEGDMNLHNLA 919
+ YIAPE S D ++YG+LL E++ + P D +F+ M HN++
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME-HNVS 219
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 4e-05
Identities = 50/182 (27%), Positives = 76/182 (41%), Gaps = 24/182 (13%)
Query: 429 KLFILYLSYNFLQGSIP---SSLGRYETLTTIDLSNNNLTGTIPPQFIG----LSSSLIV 481
L L LS N L SL R +L + L+NN L L +L
Sbjct: 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEK 141
Query: 482 LDLSRNQLTG----SIPSEVGNLKNLEILNVFGNKLKGE-IPST---LGSCIKLEQLEMQ 533
L L RN+L G ++ + ++L+ LN+ N + I + L + LE L++
Sbjct: 142 LVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLN 201
Query: 534 ENFLQ----GPIPSSLSSLRGLSVLDLSQNNLSGKI-----PELLIRLQLVKNLNLSNND 584
N L + +L+SL+ L VL+L NNL+ LL + L+LS ND
Sbjct: 202 NNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCND 261
Query: 585 LE 586
+
Sbjct: 262 IT 263
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-05
Identities = 61/261 (23%), Positives = 111/261 (42%), Gaps = 29/261 (11%)
Query: 695 QIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTAC 754
++G G++G V+K DG+ + + G S E L+ ++H N++ +
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISL---- 63
Query: 755 SGVDYQGNDFKA-LVFEFMHNRSLEEWLHPIT--REDETDEAPRSLNLIQRLNISIDVAC 811
V D K L+F++ + + W H I R + ++ P L ++ +
Sbjct: 64 QKVFLSHADRKVWLLFDYAEH---DLW-HIIKFHRASKANKKPVQLPRGMVKSLLYQILD 119
Query: 812 ALNYLHHDCQPPIAHCDLKPSNILL----DEDMIAHIGDFGLARFL-----PLSSAQTSS 862
++YLH + + H DLKP+NIL+ E I D G AR PL+
Sbjct: 120 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 863 IGAKGSIGYIAPEYGLGSE-VSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLART 921
+ + Y APE LG+ + + D+++ G + EL+T +P + D+ N
Sbjct: 177 V----TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDIKTSNPYHH 231
Query: 922 ALPDHVMDIVDSTLLNDGEDL 942
D + +++ D ED+
Sbjct: 232 DQLDRIFNVMGFPADKDWEDI 252
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 36/123 (29%), Positives = 58/123 (47%), Gaps = 9/123 (7%)
Query: 812 ALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFL-PLSSAQTSSIGAKGSIG 870
++YLH + I H D+K +NIL D +GDFG ++ L + + T G+
Sbjct: 118 GVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPY 174
Query: 871 YIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLA----RTALPDH 926
+++PE G D++S G ++E++T K P FE + +A LP H
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPW-AEFEAMAAIFKIATQPTNPVLPPH 233
Query: 927 VMD 929
V D
Sbjct: 234 VSD 236
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 5e-05
Identities = 29/78 (37%), Positives = 39/78 (50%), Gaps = 5/78 (6%)
Query: 828 DLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPE-YGLGSEVSISG 886
DLKP+NILLDE I D GLA ++ + G+ GY+APE G S
Sbjct: 122 DLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSA 177
Query: 887 DVYSYGILLLELITRKKP 904
D +S G +L +L+ P
Sbjct: 178 DWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 5e-05
Identities = 59/221 (26%), Positives = 92/221 (41%), Gaps = 49/221 (22%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACS 755
IG+G+FG V++ D R A+KV + K +A+ I RN++ +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSK------KEIVAKKEVAHTIGERNIL----VRT 50
Query: 756 GVD-----------YQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLN 804
+D +Q + LV ++M L L R E R
Sbjct: 51 LLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSE-----------DRAK 99
Query: 805 ISI-DVACALNYLH-HDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSS 862
I ++ AL +LH +D I + DLKP NILLD + DFGL++ + T++
Sbjct: 100 FYIAELVLALEHLHKYD----IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT 155
Query: 863 IGAKGSIGYIAPEY-----GLGSEVSISGDVYSYGILLLEL 898
G+ Y+APE G V D +S G+L+ E+
Sbjct: 156 FC--GTTEYLAPEVLLDEKGYTKHV----DFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 6e-05
Identities = 51/221 (23%), Positives = 89/221 (40%), Gaps = 31/221 (14%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFK---SFIAECNTLKNIRHRNLVKILT 752
I E S++KGI ++ + ++ F H G E L+ I N++KI
Sbjct: 28 IKENDQNSIYKGIFNN--KEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY- 84
Query: 753 ACSGVDYQGND---FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDV 809
G D +L+ E+ L E L + + L+ +L+++ID
Sbjct: 85 ---GFIIDIVDDLPRLSLILEYCTRGYLREVL----------DKEKDLSFKTKLDMAIDC 131
Query: 810 ACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSI 869
L L+ P + L + L+ E+ I GL + L SS ++ +
Sbjct: 132 CKGLYNLYKYTNKPYKN--LTSVSFLVTENYKLKIICHGLEKIL--SSPPFKNVNF---M 184
Query: 870 GYIAPEYGLG--SEVSISGDVYSYGILLLELITRKKPTDIM 908
Y + + SE +I D+YS G++L E+ T K P + +
Sbjct: 185 VYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL 225
|
Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 7e-05
Identities = 29/113 (25%), Positives = 50/113 (44%), Gaps = 25/113 (22%)
Query: 184 IRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQ 243
I L L L G IP+ + L++L ++ ++ N + G IP S+ +I+S+ D
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLD------- 472
Query: 244 GAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAP 296
L Y N G+IP ++ ++L I + + N L+G P
Sbjct: 473 ----LSY--------------NSFNGSIPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 31/104 (29%), Positives = 49/104 (47%), Gaps = 9/104 (8%)
Query: 803 LNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFL--PLSSAQT 860
L + + + ++H + + H D+K NI L ++ +GDFG AR L P + A T
Sbjct: 103 LQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT 159
Query: 861 SSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
G+ Y+ PE + D++S G +L EL T K P
Sbjct: 160 YV----GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 8e-05
Identities = 48/210 (22%), Positives = 90/210 (42%), Gaps = 21/210 (10%)
Query: 695 QIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTAC 754
+IGEGS G V +AVK+ +L + E +++ +H+N+V++ +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKS- 86
Query: 755 SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALN 814
Y + ++ EF+ +L + + +E Q + V AL
Sbjct: 87 ----YLVGEELWVLMEFLQGGALTDIVSQTRLNEE-----------QIATVCESVLQALC 131
Query: 815 YLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAP 874
YLH + H D+K +ILL D + DFG + + S+ G+ ++AP
Sbjct: 132 YLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL--VGTPYWMAP 186
Query: 875 EYGLGSEVSISGDVYSYGILLLELITRKKP 904
E + D++S GI+++E++ + P
Sbjct: 187 EVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 9e-05
Identities = 26/60 (43%), Positives = 32/60 (53%), Gaps = 1/60 (1%)
Query: 454 LTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKL 513
L ++DLSNN LT IP +L VLDLS N LT P L +L L++ GN L
Sbjct: 2 LKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-04
Identities = 28/87 (32%), Positives = 45/87 (51%), Gaps = 2/87 (2%)
Query: 232 ITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKL 291
I G ++G IP D L++LQ ++ N + G IPP++ + ++LE+ S N
Sbjct: 420 IDGLGLDNQGLRGFIPNDIS-KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478
Query: 292 TGAAP-YLEKLQRLLVFGILGNSLGSR 317
G+ P L +L L + + GNSL R
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGR 505
|
Length = 623 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 29/106 (27%), Positives = 52/106 (49%), Gaps = 8/106 (7%)
Query: 804 NISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSS-----A 858
NI D+ L Y+H + I+H D+KP NI++D + +I D+G+A + +
Sbjct: 130 NIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYS 186
Query: 859 QTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
+ +G++ Y + G+ V+ GD+ S G +L+ K P
Sbjct: 187 KEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLP 232
|
Length = 294 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-04
Identities = 57/223 (25%), Positives = 90/223 (40%), Gaps = 26/223 (11%)
Query: 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFN---LLHHGAFKSFIAECNTLKNIRHRN 746
F + IG G+FG V L + A+K+ N +L F E + L N ++
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 747 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNIS 806
+ + A +Q + LV ++ L L ED E L + + I+
Sbjct: 63 ITTLHYA-----FQDENNLYLVMDYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMV-IA 114
Query: 807 IDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAK 866
ID L+Y+H D +KP NIL+D + + DFG L SS+ A
Sbjct: 115 IDSVHQLHYVHRD---------IKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV-AV 164
Query: 867 GSIGYIAPEYGLGSE-----VSISGDVYSYGILLLELITRKKP 904
G+ YI+PE E D +S G+ + E++ + P
Sbjct: 165 GTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 27/81 (33%), Positives = 41/81 (50%), Gaps = 5/81 (6%)
Query: 824 IAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVS 883
I + DLKP N+LLD+D + DFG A+ + T + G+ YIAPE L
Sbjct: 152 IVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPEYIAPEILLNVGHG 206
Query: 884 ISGDVYSYGILLLELITRKKP 904
+ D ++ GI + E++ P
Sbjct: 207 KAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 55/238 (23%), Positives = 104/238 (43%), Gaps = 36/238 (15%)
Query: 695 QIGEGSFGSV---------------FKGILDDGRTT-IAVKVFNL-LHHGAFKSFIAECN 737
++GEG FG V F + GR +AVK+ + A F+ E
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 738 TLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPR-- 795
L ++ N++++L C VD D ++ E+M N L ++L +D+ +
Sbjct: 72 ILSRLKDPNIIRLLGVC--VD---EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126
Query: 796 -------SLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFG 848
+++ L++++ +A + YL H DL N L+ E++ I DFG
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFG 183
Query: 849 LARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT--RKKP 904
++R L A I ++A E L + + + DV+++G+ L E++ +++P
Sbjct: 184 MSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 2e-04
Identities = 22/60 (36%), Positives = 32/60 (53%)
Query: 526 KLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDL 585
L+ L++ N L + L L VLDLS NNL+ PE L +++L+LS N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 37/167 (22%), Positives = 66/167 (39%), Gaps = 30/167 (17%)
Query: 691 SSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLV-- 748
SS+ + G V+ L +K+ GA E L+ + + L
Sbjct: 1 SSIKLLKGGLTNRVYL--LGTKDEDYVLKINPSREKGAD--REREVAILQLLARKGLPVP 56
Query: 749 KILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRL-NISI 807
K+L + + L+ E++ +L+E ++ E++ D A + L+ +L + +
Sbjct: 57 KVLASGESDGWS-----YLLMEWIEGETLDE----VSEEEKEDIAEQLAELLAKLHQLPL 107
Query: 808 DVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLP 854
V C H DL P NIL+D+ I I D+ A + P
Sbjct: 108 LVLC--------------HGDLHPGNILVDDGKILGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 35/117 (29%), Positives = 56/117 (47%), Gaps = 11/117 (9%)
Query: 808 DVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKG 867
++A L +LH I + DLK N++LD + I DFG+ + T + G
Sbjct: 109 EIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC--G 163
Query: 868 SIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP-----TDIMFEGDMNLHNLA 919
+ YIAPE S D +++G+LL E++ + P D +F+ M HN+A
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME-HNVA 219
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 54/232 (23%), Positives = 96/232 (41%), Gaps = 32/232 (13%)
Query: 685 NATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRH 744
N + + ++G G++G V+K AVK+ L F E +K +H
Sbjct: 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKH 65
Query: 745 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLN 804
N+V + Y + + E+ SL++ H L+ +Q
Sbjct: 66 CNIVAYFGS-----YLSREKLWICMEYCGGGSLQDIYH----------VTGPLSELQIAY 110
Query: 805 ISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIG 864
+ + L YLH + H D+K +NILL ++ + DFG+A + + A+ S
Sbjct: 111 VCRETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSF- 166
Query: 865 AKGSIGYIAPEYGLGSEVSISG------DVYSYGILLLELITRKKPTDIMFE 910
G+ ++APE + V +G D+++ GI +EL + P MF+
Sbjct: 167 -IGTPYWMAPEV---AAVEKNGGYNQLCDIWAVGITAIELAELQPP---MFD 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 35/148 (23%), Positives = 67/148 (45%), Gaps = 24/148 (16%)
Query: 696 IGEGSFGSVFKGI----LDDG---RTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLV 748
+G+G+F +FKGI D G +T + +KV + H +SF + + + H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 749 KILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISID 808
C D +V E++ SL+ +L + +N+ +L ++
Sbjct: 63 LNYGVCVCGDES-----IMVQEYVKFGSLDTYLK---------KNKNLINISWKLEVAKQ 108
Query: 809 VACALNYLHHDCQPPIAHCDLKPSNILL 836
+A AL++L + H ++ N+LL
Sbjct: 109 LAWALHFLE---DKGLTHGNVCAKNVLL 133
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 4e-04
Identities = 56/245 (22%), Positives = 98/245 (40%), Gaps = 43/245 (17%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFK-----SFIAECNTLKNI 742
+ + + +IG G FG VF L + T + + + K + E N ++ +
Sbjct: 13 NEYEVIKKIGNGRFGEVF---LVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMREL 69
Query: 743 RHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQR 802
+H+N+V+ + + N ++ EF L + + E +++ ++
Sbjct: 70 KHKNIVRYIDRFLN---KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQ 126
Query: 803 LNISIDVACALNYLHHDCQPP----IAHCDLKPSNILLDEDM-----------------I 841
L AL Y H+ P + H DLKP NI L + I
Sbjct: 127 L------LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180
Query: 842 AHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSI--SGDVYSYGILLLELI 899
A IGDFGL++ + + S S +G Y +PE L S D+++ G ++ EL
Sbjct: 181 AKIGDFGLSKNIGIESMAHSCVGTP---YYWSPELLLHETKSYDDKSDMWALGCIIYELC 237
Query: 900 TRKKP 904
+ K P
Sbjct: 238 SGKTP 242
|
Length = 1021 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 6e-04
Identities = 44/165 (26%), Positives = 72/165 (43%), Gaps = 21/165 (12%)
Query: 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVKVF---NLLHHGAFKSFIAECNTLKNIRHRN 746
F V I G+FG V+ G + AVKV ++++ AE + L +
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPF 65
Query: 747 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNIS 806
+V + + Q + LV E++ ++ LH DE ++ I
Sbjct: 66 IVHLYYS-----LQSANNVYLVMEYLIGGDVKSLLHIYGYFDE----EMAVKYIS----- 111
Query: 807 IDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLAR 851
+VA AL+YLH + I H DLKP N+L+ + + DFGL++
Sbjct: 112 -EVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 6e-04
Identities = 58/235 (24%), Positives = 92/235 (39%), Gaps = 47/235 (20%)
Query: 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLV 748
F V +G G++G V+KG A+KV ++ + E N LK HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIA 66
Query: 749 KILTACSGVDYQGNDFKA-LVFEFMHNRSL-------------EEWLHPITREDETDEAP 794
A + G D + LV EF S+ EEW+ I RE
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICRE------- 119
Query: 795 RSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLP 854
+ L++LH Q + H D+K N+LL E+ + DFG++ L
Sbjct: 120 --------------ILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 162
Query: 855 LSSAQTSSIGAKGSIGYIAPEYGLGSE-----VSISGDVYSYGILLLELITRKKP 904
+ + ++ G+ ++APE E D++S GI +E+ P
Sbjct: 163 RTVGRRNTF--IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 6e-04
Identities = 32/104 (30%), Positives = 51/104 (49%), Gaps = 9/104 (8%)
Query: 809 VACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGS 868
V L YLH + I + DLK N+LLD + I DFGL + +TS+ G+
Sbjct: 110 VVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC--GT 164
Query: 869 IGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGD 912
++APE + + + D + G+L+ E++ + P F GD
Sbjct: 165 PEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP----FPGD 204
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 7e-04
Identities = 47/175 (26%), Positives = 80/175 (45%), Gaps = 47/175 (26%)
Query: 693 VNQIGEGSFGSVFKGI-LDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIR-------H 744
+ +IGEG+F V K G A+K FKS + + N L+ I+ H
Sbjct: 4 LGKIGEGTFSEVLKAQSRKTG-KYYAIKCMK----KHFKS-LEQVNNLREIQALRRLSPH 57
Query: 745 RNLVKILTACSGVDYQGNDFK----ALVFEFMHNRSLEEWL----HPITREDETDEAPRS 796
N+++++ V + D K ALVFE M + +L E + P+ + R
Sbjct: 58 PNILRLIE----VLF---DRKTGRLALVFELM-DMNLYELIKGRKRPLPEK-------RV 102
Query: 797 LNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLAR 851
+ + +L +L+++H + I H D+KP NIL+ +D++ + DFG R
Sbjct: 103 KSYMYQL------LKSLDHMHRN---GIFHRDIKPENILIKDDIL-KLADFGSCR 147
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 7e-04
Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 31/216 (14%)
Query: 696 IGEGSFGSVFKGILDDGRTT---IAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVK 749
+G+G+FG V IL + T A+K+ ++ + E L+N RH L
Sbjct: 3 LGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59
Query: 750 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDE-TDEAPRSLNLIQRLNISID 808
+ A +Q +D V E+ + L + H ++RE T+E R +
Sbjct: 60 LKYA-----FQTHDRLCFVMEYANGGEL--FFH-LSRERVFTEERARFY--------GAE 103
Query: 809 VACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGS 868
+ AL YLH + + D+K N++LD+D I DFGL + A + G+
Sbjct: 104 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC--GT 158
Query: 869 IGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
Y+APE ++ + D + G+++ E++ + P
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 8e-04
Identities = 48/172 (27%), Positives = 69/172 (40%), Gaps = 23/172 (13%)
Query: 735 ECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAP 794
E + LK I HR ++ ++ A +K+ V M P + D
Sbjct: 136 EIDILKTISHRAIINLIHAYR--------WKSTVCMVM----------PKYKCDLFTYVD 177
Query: 795 RS--LNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARF 852
RS L L Q + I + AL YLH I H D+K NI LDE A +GDFG A
Sbjct: 178 RSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACK 234
Query: 853 LPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
L G G++ +PE D++S G++L E+ +
Sbjct: 235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 9e-04
Identities = 34/91 (37%), Positives = 43/91 (47%), Gaps = 8/91 (8%)
Query: 812 ALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGY 871
AL+ LH + I DL P+NILLD G L F S + S G Y
Sbjct: 97 ALDALH---REGIVCRDLNPNNILLD-----DRGHIQLTYFSRWSEVEDSCDGEAVENMY 148
Query: 872 IAPEYGLGSEVSISGDVYSYGILLLELITRK 902
APE G SE + + D +S G +L EL+T K
Sbjct: 149 CAPEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 0.001
Identities = 17/60 (28%), Positives = 32/60 (53%)
Query: 159 KIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRL 218
++ + +++N LT + L +++ L LSGNNL P+ L +L +L ++ N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 0.001
Identities = 23/60 (38%), Positives = 32/60 (53%)
Query: 135 NLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNL 194
NL L L +N+L L ++ + ++ NNLT P + L S+RSL LSGNNL
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 61/258 (23%), Positives = 95/258 (36%), Gaps = 61/258 (23%)
Query: 674 SFPNISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFI 733
S +I L + F V +G G++G V+KG A+KV ++ +
Sbjct: 2 SLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIK 60
Query: 734 AECNTLKNI-RHRNLVKILTACSGVDYQGNDFKA-LVFEFMHNRSL-------------E 778
E N LK HRN+ A G+D + LV EF S+ E
Sbjct: 61 LEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE 120
Query: 779 EWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDE 838
+W+ I RE + L +LH + H D+K N+LL E
Sbjct: 121 DWIAYICRE---------------------ILRGLAHLHAH---KVIHRDIKGQNVLLTE 156
Query: 839 DMIAHIGDFGLARFLPLSSAQTS-SIGAKGSIGYIAPEYGLGSEV-----------SISG 886
+ + DFG+ SAQ ++G + + +I Y + EV
Sbjct: 157 NAEVKLVDFGV-------SAQLDRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDYRS 207
Query: 887 DVYSYGILLLELITRKKP 904
D++S GI +E+ P
Sbjct: 208 DIWSLGITAIEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.001
Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 29/215 (13%)
Query: 696 IGEGSFGSVFKGILDDGRTT---IAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVK 749
+G+G+FG V IL + T A+K+ ++ + E L+N RH L
Sbjct: 3 LGKGTFGKV---ILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTA 59
Query: 750 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDV 809
+ + +Q +D V E+ + L + H ++RE E R+ R ++
Sbjct: 60 LKYS-----FQTHDRLCFVMEYANGGEL--FFH-LSRERVFSE-DRA-----RF-YGAEI 104
Query: 810 ACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSI 869
AL YLH C + + DLK N++LD+D I DFGL + +S T G+
Sbjct: 105 VSALGYLH-SCD--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFC-GTP 159
Query: 870 GYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
Y+APE ++ + D + G+++ E++ + P
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 54/215 (25%), Positives = 94/215 (43%), Gaps = 28/215 (13%)
Query: 696 IGEGSFGSVFKGILDDGRTT---IAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVK 749
+G+G+FG V IL + T A+K+ ++ + E L+N RH
Sbjct: 3 LGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH----P 55
Query: 750 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDV 809
LTA +Q +D V E+ + L + H ++RE E ++
Sbjct: 56 FLTALK-YSFQTHDRLCFVMEYANGGEL--FFH-LSRERVFSEDRARF-------YGAEI 104
Query: 810 ACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSI 869
AL+YLH + + + DLK N++LD+D I DFGL + A + G+
Sbjct: 105 VSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC--GTP 160
Query: 870 GYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
Y+APE ++ + D + G+++ E++ + P
Sbjct: 161 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.003
Identities = 51/196 (26%), Positives = 82/196 (41%), Gaps = 31/196 (15%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFN---LLHHGAFKSFIAECNTLKNIRH 744
D F + IG G+FG V + + A+K+ N +L F E + L N
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 745 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLN--LIQR 802
R + + A +Q + LV ++ L L +++ + D P + +
Sbjct: 61 RWITNLHYA-----FQDENNLYLVMDYYVGGDL---LTLLSKFE--DRLPEDMARFYLAE 110
Query: 803 LNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI--GDFG-LARFLPLSSAQ 859
+ ++ID L Y+H D +KP N+LL D HI DFG R L + Q
Sbjct: 111 MVLAIDSVHQLGYVHRD---------IKPDNVLL--DKNGHIRLADFGSCLRLLADGTVQ 159
Query: 860 TSSIGAKGSIGYIAPE 875
++ A G+ YI+PE
Sbjct: 160 SNV--AVGTPDYISPE 173
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 986 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.79 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.79 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.78 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.74 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.73 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.72 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.72 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.71 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.69 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.66 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.65 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.64 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.64 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.59 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.58 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.57 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.55 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.54 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.54 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.5 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.48 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.43 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.37 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.34 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.33 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.31 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.3 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.27 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.27 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.24 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.17 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.16 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.14 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.13 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.08 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.06 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.05 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 99.04 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.03 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.03 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.02 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.98 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.96 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.95 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.94 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.94 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.94 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.9 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.89 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.87 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.85 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.84 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.81 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.75 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.69 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.68 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.64 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.52 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.52 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.51 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.47 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.44 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-114 Score=1101.10 Aligned_cols=905 Identities=31% Similarity=0.520 Sum_probs=765.5
Q ss_pred CHhHHHHHHHHHHhccCCCcCCCCCCCCCCCCCcceeeEecCCCCeEEEEeccCCCCccccCcCccCCCCCCEEEccCCC
Q 046598 18 NETDRLALLELKSKITHDPLGVLASWNESSHFCQWRGVTCSRRHQRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNS 97 (986)
Q Consensus 18 ~~~~~~~ll~~k~~~~~~~~~~l~~w~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~ 97 (986)
.++|+.||++||+++ .+|.+.+.+|+...+||.|.||+|++ .++|+.|||++++++|.+++.+..+++|+.|+|++|+
T Consensus 27 ~~~~~~~l~~~~~~~-~~~~~~~~~w~~~~~~c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~ 104 (968)
T PLN00113 27 HAEELELLLSFKSSI-NDPLKYLSNWNSSADVCLWQGITCNN-SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQ 104 (968)
T ss_pred CHHHHHHHHHHHHhC-CCCcccCCCCCCCCCCCcCcceecCC-CCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCc
Confidence 468999999999999 48888899998888999999999986 4589999999999999999999999999999999999
Q ss_pred ccccCCcchh-ccccCceeeceecccCCCCccchhcCccccceecccccccCccCccccCCCCCCeEEccCCcCCCCccc
Q 046598 98 FNHEIPSEFD-RLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPS 176 (986)
Q Consensus 98 l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 176 (986)
+.+.+|..+. .+++|++|+|++|.+++.+|. +.+++|++|+|++|.+++.+|..|+++++|++|+|++|.+.+.+|.
T Consensus 105 ~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~ 182 (968)
T PLN00113 105 LSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPN 182 (968)
T ss_pred cCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCCh
Confidence 9998887655 999999999999999998886 5689999999999999999999999999999999999999999999
Q ss_pred ccCCCcCcceeeccCCcccCcCcchhhccCCCceeecccccccccCCccccCCCCccEEeccccccccccCCcccccccc
Q 046598 177 SLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQN 256 (986)
Q Consensus 177 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~ 256 (986)
.|+++++|++|+|++|++++.+|..|+.+++|++|+|++|++++.+|..+.++++|++|+++.|.+.+.+|..+. ++++
T Consensus 183 ~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~ 261 (968)
T PLN00113 183 SLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLG-NLKN 261 (968)
T ss_pred hhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHh-CCCC
Confidence 999999999999999999999999999999999999999999999999999999999999999999999987765 7999
Q ss_pred cceEEecCceecccCCccccCCCCCcEEecccccccCCC-chhhhhhhHhhhhhccCCCCCCCCCCcccccccccccccc
Q 046598 257 LQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAA-PYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLK 335 (986)
Q Consensus 257 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~-~~l~~l~~L~~l~l~~n~l~~~~~~~l~~l~~l~~~~~L~ 335 (986)
|++|++++|++++.+|..+.++++|+.|++++|++++.. ..+..+++|+.+++.+|.+..... ..+..+++|+
T Consensus 262 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~------~~~~~l~~L~ 335 (968)
T PLN00113 262 LQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIP------VALTSLPRLQ 335 (968)
T ss_pred CCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCC------hhHhcCCCCC
Confidence 999999999999999999999999999999999998755 457889999999999998865332 3466788999
Q ss_pred eeeccccccccCCCcccccccccceEEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCc
Q 046598 336 WLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRN 415 (986)
Q Consensus 336 ~l~l~~n~~~~~~p~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 415 (986)
.|+++.|.+.+.+|..+..+ .+|+.|++++|++++.+|..+..+++|+.|++++|.+.+.+|..+..+++|+.|+|++|
T Consensus 336 ~L~L~~n~l~~~~p~~l~~~-~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n 414 (968)
T PLN00113 336 VLQLWSNKFSGEIPKNLGKH-NNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDN 414 (968)
T ss_pred EEECcCCCCcCcCChHHhCC-CCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCC
Confidence 99999999999999988877 68999999999999999999999999999999999999999999999999999999999
Q ss_pred cceeecCcccccc-cccEEEecccccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCC
Q 046598 416 RFQGNIPPSIGNL-KLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIP 494 (986)
Q Consensus 416 ~l~~~~~~~~~~~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p 494 (986)
++++.+|..+..+ .|+.|++++|.+++.+|..+..+++|+.|+|++|++.+.+|.. + ..++|+.|++++|++++.+|
T Consensus 415 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~-~-~~~~L~~L~ls~n~l~~~~~ 492 (968)
T PLN00113 415 SFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDS-F-GSKRLENLDLSRNQFSGAVP 492 (968)
T ss_pred EeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcc-c-ccccceEEECcCCccCCccC
Confidence 9999999888766 5999999999999999999999999999999999999888876 3 34789999999999999999
Q ss_pred cccccccccchhhccCccccccCcccccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccc
Q 046598 495 SEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQL 574 (986)
Q Consensus 495 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 574 (986)
..+.++++|+.|+|++|++.+.+|..+..+++|++|+|++|.+++.+|..|..+++|+.|||++|++++.+|..+..+++
T Consensus 493 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 572 (968)
T PLN00113 493 RKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVES 572 (968)
T ss_pred hhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cceeeccCCccccccCCccccccccceeeeCCcccccCCCCCCCCCCCCcCccccchhhHHHHHHHHHHHHHHHHHHHHh
Q 046598 575 VKNLNLSNNDLEGVVPTQGVFKNASITSVFGNLKLCGGIPEFQLPTCSSKKSKHKKSLALKLVLAIISGLIGLSLALSII 654 (986)
Q Consensus 575 L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lcg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~ 654 (986)
|++|++++|+++|.+|..+++..+...++.||+.+||..+....+.|....+. .....++++++++++ ++++++++
T Consensus 573 L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~---~~~~~~~~~~~~~~~-~~~~~~~~ 648 (968)
T PLN00113 573 LVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKT---PSWWFYITCTLGAFL-VLALVAFG 648 (968)
T ss_pred cCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCcccccc---ceeeeehhHHHHHHH-HHHHHHHH
Confidence 99999999999999999999998888999999999998766556677532211 111122222222222 22222222
Q ss_pred hheeeecccccCCC--C--CCCCCCCCc-----ChHHHHHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC
Q 046598 655 VLCLVRKRKEKQNP--N--SPINSFPNI-----SYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH 725 (986)
Q Consensus 655 ~~~~~~~~~~~~~~--~--~~~~~~~~~-----~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~ 725 (986)
++ +++++++++.+ . ........+ ...........|...+.||+|+||.||+|++..++..||||+++...
T Consensus 649 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~ 727 (968)
T PLN00113 649 FV-FIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVN 727 (968)
T ss_pred HH-HHHhhhcccccccccccccccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCc
Confidence 22 22222211111 0 000000000 01122233456788899999999999999998889999999986433
Q ss_pred chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHH
Q 046598 726 HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNI 805 (986)
Q Consensus 726 ~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i 805 (986)
. ...+|++++++++|||||+++++|. +++..++||||+++|+|.++++ .++|.++.+|
T Consensus 728 ~----~~~~~~~~l~~l~HpnIv~~~~~~~-----~~~~~~lv~Ey~~~g~L~~~l~-------------~l~~~~~~~i 785 (968)
T PLN00113 728 S----IPSSEIADMGKLQHPNIVKLIGLCR-----SEKGAYLIHEYIEGKNLSEVLR-------------NLSWERRRKI 785 (968)
T ss_pred c----ccHHHHHHHhhCCCCCcceEEEEEE-----cCCCCEEEEeCCCCCcHHHHHh-------------cCCHHHHHHH
Confidence 2 2235688999999999999999963 3467899999999999999994 3789999999
Q ss_pred HHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcc
Q 046598 806 SIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSIS 885 (986)
Q Consensus 806 ~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 885 (986)
+.||++|++|||..+.++|+||||||+||+++.++.+++. ||.+..... .....+++.|+|||++.+..++.+
T Consensus 786 ~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~ 858 (968)
T PLN00113 786 AIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPETRETKDITEK 858 (968)
T ss_pred HHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------CCCccccccccCcccccCCCCCcc
Confidence 9999999999997666699999999999999999988875 665543211 112357899999999999999999
Q ss_pred cchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCc-hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHH
Q 046598 886 GDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDH-VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLIS 964 (986)
Q Consensus 886 sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 964 (986)
+|||||||++|||+||+.||+...........|.+...... ...++|+.+.... ....++..+
T Consensus 859 sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~ 922 (968)
T PLN00113 859 SDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV----------------SVNQNEIVE 922 (968)
T ss_pred cchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC----------------CccHHHHHH
Confidence 99999999999999999999755544455555555443322 3334444332211 111244567
Q ss_pred HHHHHhcccCCCCCCCCCCCCC
Q 046598 965 MVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 965 l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+.+++.+||+.||++||||+||
T Consensus 923 ~~~l~~~Cl~~~P~~RPt~~ev 944 (968)
T PLN00113 923 VMNLALHCTATDPTARPCANDV 944 (968)
T ss_pred HHHHHHhhCcCCchhCcCHHHH
Confidence 8899999999999999999875
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-60 Score=607.17 Aligned_cols=513 Identities=35% Similarity=0.535 Sum_probs=477.7
Q ss_pred CCCCEEEccCCCccccCCcchhccccCceeeceecccCCCCccchh-cCccccceecccccccCccCccccCCCCCCeEE
Q 046598 86 SFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANIS-SCSNLIQLRLFHNQLVGKIPSELSSLSKIEHIS 164 (986)
Q Consensus 86 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 164 (986)
++++.|+|++|++++.+|.+|..+++|++|+|++|++++.+|..+. .+++|++|+|++|.+++.+|. +.+++|++|+
T Consensus 69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~ 146 (968)
T PLN00113 69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLD 146 (968)
T ss_pred CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEE
Confidence 4688999999999999999999999999999999999999998765 999999999999999998885 5689999999
Q ss_pred ccCCcCCCCcccccCCCcCcceeeccCCcccCcCcchhhccCCCceeecccccccccCCccccCCCCccEEecccccccc
Q 046598 165 VNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQG 244 (986)
Q Consensus 165 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~ 244 (986)
|++|.+++.+|..++++++|++|+|++|.+.+.+|..|+.+++|++|+|++|++++.+|..+.++.+|+.|+++.|.+.+
T Consensus 147 Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~ 226 (968)
T PLN00113 147 LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSG 226 (968)
T ss_pred CcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCcccccccccceEEecCceecccCCccccCCCCCcEEecccccccCC-CchhhhhhhHhhhhhccCCCCCCCCCCcc
Q 046598 245 AIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGA-APYLEKLQRLLVFGILGNSLGSRGDRDLN 323 (986)
Q Consensus 245 ~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~-~~~l~~l~~L~~l~l~~n~l~~~~~~~l~ 323 (986)
.+|..+. ++++|++|++++|.+++.+|..++++++|+.|++++|++++. +..+..+++|+.+++++|.+.....
T Consensus 227 ~~p~~l~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p---- 301 (968)
T PLN00113 227 EIPYEIG-GLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIP---- 301 (968)
T ss_pred cCChhHh-cCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCC----
Confidence 9998765 799999999999999999999999999999999999999865 4578899999999999998764322
Q ss_pred cccccccccccceeeccccccccCCCcccccccccceEEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccC
Q 046598 324 FLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGE 403 (986)
Q Consensus 324 ~l~~l~~~~~L~~l~l~~n~~~~~~p~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 403 (986)
..+.++++|+.|+++.|.+.+.+|..+..+ ++|+.|++++|.+.+.+|..++.+++|+.|++++|++++.+|..+..
T Consensus 302 --~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l-~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~ 378 (968)
T PLN00113 302 --ELVIQLQNLEILHLFSNNFTGKIPVALTSL-PRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCS 378 (968)
T ss_pred --hhHcCCCCCcEEECCCCccCCcCChhHhcC-CCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhC
Confidence 345678899999999999999999988877 68999999999999999999999999999999999999999999999
Q ss_pred CCCCCEEEccCccceeecCcccccc-cccEEEecccccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEE
Q 046598 404 LQNLKDLRLQRNRFQGNIPPSIGNL-KLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVL 482 (986)
Q Consensus 404 l~~L~~L~Ls~N~l~~~~~~~~~~~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L 482 (986)
+++|+.|++++|++.+.+|..+... +|+.|++++|++++.+|..|..+++|+.|++++|++++.+|.. +..+++|+.|
T Consensus 379 ~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~-~~~l~~L~~L 457 (968)
T PLN00113 379 SGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSR-KWDMPSLQML 457 (968)
T ss_pred cCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChh-hccCCCCcEE
Confidence 9999999999999999999888765 5999999999999999999999999999999999999888876 5678999999
Q ss_pred EccCCcccccCCcccccccccchhhccCccccccCcccccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCc
Q 046598 483 DLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLS 562 (986)
Q Consensus 483 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 562 (986)
++++|++.+.+|..+ ..++|+.|+|++|++++.+|..|.++++|++|+|++|++++.+|..+..+++|++|+|++|+++
T Consensus 458 ~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 536 (968)
T PLN00113 458 SLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLS 536 (968)
T ss_pred ECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCccc
Confidence 999999999888766 4689999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCchhhhcccccceeeccCCccccccCCc-cccccccceeeeCCcccc
Q 046598 563 GKIPELLIRLQLVKNLNLSNNDLEGVVPTQ-GVFKNASITSVFGNLKLC 610 (986)
Q Consensus 563 ~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~~lc 610 (986)
+.+|..+..+++|++|+|++|+++|.+|.. ..+..+..+++.+|+..+
T Consensus 537 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~ 585 (968)
T PLN00113 537 GQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHG 585 (968)
T ss_pred ccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCccee
Confidence 999999999999999999999999999876 556778889999887544
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-47 Score=416.39 Aligned_cols=282 Identities=39% Similarity=0.660 Sum_probs=235.0
Q ss_pred CCCCcChHHHHHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeee
Q 046598 674 SFPNISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTA 753 (986)
Q Consensus 674 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 753 (986)
....|++.++..+|++|...+.||+|+||.||+|...++ +.||||++........++|.+|+.++.+++|||+|+++||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 466799999999999999999999999999999999884 8999998875443214569999999999999999999999
Q ss_pred ccccccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCC
Q 046598 754 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSN 833 (986)
Q Consensus 754 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~N 833 (986)
|.+. +++.++|||||++|+|.++++.... . +++|.++++||.++|+||+|||+.+.+.||||||||+|
T Consensus 140 C~e~----~~~~~LVYEym~nGsL~d~L~~~~~-------~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssN 207 (361)
T KOG1187|consen 140 CLEG----GEHRLLVYEYMPNGSLEDHLHGKKG-------E-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSN 207 (361)
T ss_pred EecC----CceEEEEEEccCCCCHHHHhCCCCC-------C-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHH
Confidence 8533 2269999999999999999973221 1 78999999999999999999999988899999999999
Q ss_pred eEecCCCcEEEcccccceecCCCCCccccccc-cccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccc-cc
Q 046598 834 ILLDEDMIAHIGDFGLARFLPLSSAQTSSIGA-KGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMF-EG 911 (986)
Q Consensus 834 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~-~~ 911 (986)
||+|+++++||+|||+|+..+.. ....... .||.+|+|||+...+..+.|+|||||||++.|++||+.|.+... .+
T Consensus 208 ILLD~~~~aKlsDFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~ 285 (361)
T KOG1187|consen 208 ILLDEDFNAKLSDFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRG 285 (361)
T ss_pred eeECCCCCEEccCccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcc
Confidence 99999999999999999765431 1111112 79999999999999999999999999999999999999987544 33
Q ss_pred cccHHHHHHhhCCC-chhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 912 DMNLHNLARTALPD-HVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 912 ~~~~~~~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
...+..|....+.+ .+.+++|+.+...... ..+...++..++.+|++.+|++||+|.||
T Consensus 286 ~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~----------------~~~~~~~~~~~a~~C~~~~~~~RP~m~~V 345 (361)
T KOG1187|consen 286 ELSLVEWAKPLLEEGKLREIVDPRLKEGEYP----------------DEKEVKKLAELALRCLRPDPKERPTMSQV 345 (361)
T ss_pred cccHHHHHHHHHHCcchhheeCCCccCCCCC----------------hHHHHHHHHHHHHHHcCcCCCcCcCHHHH
Confidence 44577777666655 5888999887632211 01456668999999999999999999875
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=379.48 Aligned_cols=249 Identities=24% Similarity=0.314 Sum_probs=206.1
Q ss_pred CCCCcccccccceeEEEEEECCCCeEEEEEEeecc-CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc-eEEE
Q 046598 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND-FKAL 767 (986)
Q Consensus 690 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~-~~~l 767 (986)
.+.++.||+|..|+||+++++.+++.+|+|++... +....+++.+|++++++.+||+||.+||+| ..+. ..+|
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF-----~~~~~~isI 155 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAF-----YSNGEEISI 155 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEE-----EeCCceEEe
Confidence 35568899999999999999999999999999543 344567899999999999999999999995 3445 5999
Q ss_pred EEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 768 VFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHH-DCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 768 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||.+|+|++++.. .+.+++...-+|+.++++||.|||+ + +||||||||+|||++..|++||||
T Consensus 156 ~mEYMDgGSLd~~~k~----------~g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicD 222 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKR----------VGRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICD 222 (364)
T ss_pred ehhhcCCCCHHHHHhh----------cCCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEecc
Confidence 9999999999999952 2569999999999999999999996 6 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCc
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDH 926 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 926 (986)
||.++.+..+ .....+||..|||||.+.+..|+.++||||||++++|+.+|+.||....+... .
T Consensus 223 FGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~------------~ 286 (364)
T KOG0581|consen 223 FGVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYL------------D 286 (364)
T ss_pred ccccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCC------------C
Confidence 9999876433 34557899999999999999999999999999999999999999874311111 2
Q ss_pred hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 927 VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 927 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+.++++......|... +.. .+..++..++..|++.||.+|||++|+
T Consensus 287 ~~~Ll~~Iv~~ppP~l-------------P~~-~fS~ef~~FV~~CL~Kdp~~R~s~~qL 332 (364)
T KOG0581|consen 287 IFELLCAIVDEPPPRL-------------PEG-EFSPEFRSFVSCCLRKDPSERPSAKQL 332 (364)
T ss_pred HHHHHHHHhcCCCCCC-------------Ccc-cCCHHHHHHHHHHhcCCcccCCCHHHH
Confidence 3344443333332221 111 467788899999999999999998764
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-45 Score=375.42 Aligned_cols=201 Identities=31% Similarity=0.508 Sum_probs=180.8
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc--CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
..++|...++||+|+||+||+|+++.++..||||.+... .....+.+..|+++|+.++|||||+++++ ...++
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~-----~~~~~ 82 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDC-----IEDDD 82 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEE-----EecCC
Confidence 356899999999999999999999999999999999754 55566778999999999999999999999 45568
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCC----
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED---- 839 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---- 839 (986)
..|+|||||.||+|.+|++.. +.+++..++.++.|||.||++||++ +||||||||+|||++..
T Consensus 83 ~i~lVMEyC~gGDLs~yi~~~----------~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~ 149 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIRRR----------GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARND 149 (429)
T ss_pred eEEEEEEeCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCC
Confidence 999999999999999999633 3689999999999999999999999 99999999999999865
Q ss_pred --CcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 840 --MIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 840 --~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
-.+||+|||+|+.... .......+|++.|||||+++.++|+.|+|+||+|+++|++++|+.||+.
T Consensus 150 ~~~~LKIADFGfAR~L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 150 TSPVLKIADFGFARFLQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred CCceEEecccchhhhCCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 4699999999998753 3334457899999999999999999999999999999999999999974
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=372.69 Aligned_cols=252 Identities=22% Similarity=0.267 Sum_probs=201.6
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC-------chhHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-------HGAFKSFIAECNTLKNIRHRNLVKILTACSGVD 758 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 758 (986)
..+.|.+.+.||+|+||.|-+|..+.+++.||||+++... ........+|+++|++++||+||+++++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~----- 244 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDF----- 244 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeee-----
Confidence 3456888999999999999999999999999999996321 1123346799999999999999999999
Q ss_pred cCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecC
Q 046598 759 YQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDE 838 (986)
Q Consensus 759 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 838 (986)
++..+..|+|||||+||+|.+++- ..+.+.+..-+.+++|++.|+.|||++ ||+||||||+|||+..
T Consensus 245 f~~~ds~YmVlE~v~GGeLfd~vv----------~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~ 311 (475)
T KOG0615|consen 245 FEVPDSSYMVLEYVEGGELFDKVV----------ANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSN 311 (475)
T ss_pred eecCCceEEEEEEecCccHHHHHH----------hccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEecc
Confidence 667788899999999999999994 344567777789999999999999999 9999999999999976
Q ss_pred C---CcEEEcccccceecCCCCCccccccccccccccccccccCCC---cCcccchhhHHHHHHHHHhCCCCCCcccccc
Q 046598 839 D---MIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSE---VSISGDVYSYGILLLELITRKKPTDIMFEGD 912 (986)
Q Consensus 839 ~---~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvvl~elltg~~pf~~~~~~~ 912 (986)
+ ..+||+|||+|+... ....+...+||+.|.|||++.+.. +..++|+||+||++|-+++|.+||.......
T Consensus 312 ~~e~~llKItDFGlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~ 388 (475)
T KOG0615|consen 312 DAEDCLLKITDFGLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP 388 (475)
T ss_pred CCcceEEEecccchhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc
Confidence 5 689999999999764 445566789999999999998764 3347899999999999999999997433321
Q ss_pred ccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 913 MNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.-.....+..+.. ......++.++..+++.+|+..||++|||++|+
T Consensus 389 sl~eQI~~G~y~f----------------------------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~ea 434 (475)
T KOG0615|consen 389 SLKEQILKGRYAF----------------------------GPLQWDRISEEALDLINWMLVVDPENRPSADEA 434 (475)
T ss_pred cHHHHHhcCcccc----------------------------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHH
Confidence 1111111111111 111223556677899999999999999999873
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=388.64 Aligned_cols=248 Identities=32% Similarity=0.464 Sum_probs=198.1
Q ss_pred CCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchh--HHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEE
Q 046598 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGA--FKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 767 (986)
Q Consensus 690 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 767 (986)
..+.+.+|+|+||+||+|.+++ ...||||++....... .++|.+|+.+|.+++|||||+++|+|... ....++
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g-~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~----~~~~~i 117 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRG-TDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP----PGSLCI 117 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCC-ceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC----CCceEE
Confidence 3445669999999999999986 2339999997543222 56899999999999999999999997543 226899
Q ss_pred EEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCC-eEeecCCCCCeEecCCC-cEEEc
Q 046598 768 VFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPP-IAHCDLKPSNILLDEDM-IAHIG 845 (986)
Q Consensus 768 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~-ivH~Dlkp~NIll~~~~-~~kL~ 845 (986)
|||||++|+|.++++.. ....+++..+..||.|||+||.|||++ + ||||||||+|||++.++ ++||+
T Consensus 118 VtEy~~~GsL~~~l~~~--------~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~ 186 (362)
T KOG0192|consen 118 VTEYMPGGSLSVLLHKK--------RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIA 186 (362)
T ss_pred EEEeCCCCcHHHHHhhc--------ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEEC
Confidence 99999999999999742 246799999999999999999999999 7 99999999999999998 99999
Q ss_pred ccccceecCCCCCcccccccccccccccccccc--CCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhC
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGL--GSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTAL 923 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 923 (986)
|||+++...... ...+...||+.|||||++. ...|+.|+||||||+++|||+||+.||.................
T Consensus 187 DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~- 263 (362)
T KOG0192|consen 187 DFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGL- 263 (362)
T ss_pred CCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCC-
Confidence 999998754322 3334467999999999999 56999999999999999999999999975433111111110100
Q ss_pred CCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 924 PDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 924 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
|...+.+++..+..++.+||+.||+.||++.|+
T Consensus 264 ------------------------------Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei 296 (362)
T KOG0192|consen 264 ------------------------------RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEI 296 (362)
T ss_pred ------------------------------CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHH
Confidence 111112366778899999999999999998764
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=387.60 Aligned_cols=246 Identities=25% Similarity=0.338 Sum_probs=207.3
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeec---cCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL---LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
.+|...+.||+|||+.||++++.+++..||+|++.. ......+.+.+|++|.++++|||||+++++ |++.++
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~-----FEDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHF-----FEDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeE-----eecCCc
Confidence 679999999999999999999988899999999974 334556789999999999999999999999 778899
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.|||.|+|+.++|.++++ ..+++++.+++.+.+||+.||.|||++ +|+|||||..|+|++++.++||
T Consensus 93 VYivLELC~~~sL~el~K----------rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKI 159 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLK----------RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKI 159 (592)
T ss_pred eEEEEEecCCccHHHHHH----------hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEe
Confidence 999999999999999994 346799999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCC
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALP 924 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 924 (986)
+|||+|..+..+ .......+||+.|.|||++....++..+||||+|||+|.|++|++||+.. .+.
T Consensus 160 gDFGLAt~le~~--~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk-----~vk-------- 224 (592)
T KOG0575|consen 160 GDFGLATQLEYD--GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK-----TVK-------- 224 (592)
T ss_pred cccceeeeecCc--ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc-----hHH--------
Confidence 999999987533 23445688999999999999999999999999999999999999999732 111
Q ss_pred CchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 925 DHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 925 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+..++.-..++ ..+.....+..++|.++++.+|.+|||+++|
T Consensus 225 ----ety~~Ik~~~Y----------------~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~v 266 (592)
T KOG0575|consen 225 ----ETYNKIKLNEY----------------SMPSHLSAEAKDLIRKLLRPNPSERPSLDEV 266 (592)
T ss_pred ----HHHHHHHhcCc----------------ccccccCHHHHHHHHHHhcCCcccCCCHHHH
Confidence 11111111110 0011233445689999999999999999875
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=358.32 Aligned_cols=254 Identities=24% Similarity=0.344 Sum_probs=205.9
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeec--cCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
..+|++.++||+|.||+||++....++..||.|.++- .+....++...|+.+|++++|||||+++++-. .++...
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f---~~~~ev 94 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSF---IEDNEV 94 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhh---hccchh
Confidence 3458889999999999999999999999999998863 34455678899999999999999999998521 233444
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeecCCCCCeEecCCCcE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPP--IAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~ 842 (986)
.+||||||.+|+|.+.++..+. ..+.+++..+++++.|++.||.++|+. .+. |+||||||.|||++++|.+
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~------qkr~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvv 167 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKK------QKRLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVV 167 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHh------ccccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCce
Confidence 8999999999999999986653 356799999999999999999999994 235 9999999999999999999
Q ss_pred EEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 046598 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 922 (986)
||+|||+++.+.. ........+|||.||+||.+.+.+|++||||||+||++|||+.-++||.+. ++.......
T Consensus 168 KLGDfGL~r~l~s--~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~KI 240 (375)
T KOG0591|consen 168 KLGDFGLGRFLSS--KTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCKKI 240 (375)
T ss_pred eeccchhHhHhcc--hhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHHHH
Confidence 9999999998753 334455678999999999999999999999999999999999999999632 333332221
Q ss_pred CCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 046598 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSM 983 (986)
Q Consensus 923 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 983 (986)
-...... - ...-....+..++..|+..||+.||+.
T Consensus 241 ~qgd~~~--------~------------------p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 241 EQGDYPP--------L------------------PDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HcCCCCC--------C------------------cHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 1111000 0 012345667889999999999999974
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=386.66 Aligned_cols=245 Identities=32% Similarity=0.486 Sum_probs=206.2
Q ss_pred CCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEEE
Q 046598 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVF 769 (986)
Q Consensus 690 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 769 (986)
+..++.||+|.||+||.|.+.. ...||+|.++... ...++|.+|+++|++++|++||+++++|.. ++..||||
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~-----~~piyIVt 280 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTK-----QEPIYIVT 280 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcC-CCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEec-----CCceEEEE
Confidence 4567889999999999999987 5689999998653 344789999999999999999999999743 34799999
Q ss_pred EeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccccc
Q 046598 770 EFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGL 849 (986)
Q Consensus 770 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~ 849 (986)
|||+.|+|.+|++. ..+..+...+.+.++.|||+|++||+++ ++|||||.++||||+++..+||+|||+
T Consensus 281 E~m~~GsLl~yLr~--------~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGL 349 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRT--------REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGL 349 (468)
T ss_pred EecccCcHHHHhhh--------cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccccc
Confidence 99999999999974 2345789999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCchh
Q 046598 850 ARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALPDHVM 928 (986)
Q Consensus 850 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 928 (986)
|+... ++......+..-+..|.|||.+..+.++.|||||||||+||||+| |+.||... ...+...
T Consensus 350 Ar~~~-d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m-----sn~ev~~-------- 415 (468)
T KOG0197|consen 350 ARLIG-DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM-----SNEEVLE-------- 415 (468)
T ss_pred ccccC-CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC-----CHHHHHH--------
Confidence 99443 334444555667889999999999999999999999999999999 99887632 2222211
Q ss_pred HHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCC
Q 046598 929 DIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTN 985 (986)
Q Consensus 929 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 985 (986)
....+.|.+.+..|+.+++++|..||+.+|++|||++.
T Consensus 416 -------------------~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~ 453 (468)
T KOG0197|consen 416 -------------------LLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFET 453 (468)
T ss_pred -------------------HHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHH
Confidence 11233466667789999999999999999999999863
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=382.29 Aligned_cols=493 Identities=27% Similarity=0.354 Sum_probs=377.1
Q ss_pred eEEEEeccCCCCccccCcCccCCCCCCEEEccCCCccccCCcchhccccCceeeceecccCCCCccchhcCccccceecc
Q 046598 63 RVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLF 142 (986)
Q Consensus 63 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 142 (986)
....+++++|.+. .+.+.+.+|..|++|++++|++. ..|.+++.+..++.|+.++|+++ .+|+.++++.+|+.|+.+
T Consensus 46 ~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s 122 (565)
T KOG0472|consen 46 DLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCS 122 (565)
T ss_pred chhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcc
Confidence 3678889999988 67788899999999999999997 78889999999999999999998 899999999999999999
Q ss_pred cccccCccCccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeeccCCcccCcCcchhhccCCCceeecccccccccC
Q 046598 143 HNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTI 222 (986)
Q Consensus 143 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 222 (986)
+|.+. .+|+.++.+..|+.|+..+|+++ ..|..+.++.+|..|++.+|+++...|+ .-.++.|++||...|-++ .+
T Consensus 123 ~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~-~i~m~~L~~ld~~~N~L~-tl 198 (565)
T KOG0472|consen 123 SNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPEN-HIAMKRLKHLDCNSNLLE-TL 198 (565)
T ss_pred cccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHH-HHHHHHHHhcccchhhhh-cC
Confidence 99998 88889999999999999999998 7788889999999999999999954444 445999999999999987 88
Q ss_pred CccccCCCCccEEeccccccccccCCcccccccccceEEecCceecccCCcccc-CCCCCcEEecccccccCCCchhhhh
Q 046598 223 PSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTIS-NASNLEIFHGSVNKLTGAAPYLEKL 301 (986)
Q Consensus 223 p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~-~l~~L~~L~ls~N~l~~~~~~l~~l 301 (986)
|..++.+.+|..|++..|++. .+| . |.++..|.+|+++.|+|+ .+|.+.+ ++.++.+||++.|+++.+|..+..+
T Consensus 199 P~~lg~l~~L~~LyL~~Nki~-~lP-e-f~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklke~Pde~clL 274 (565)
T KOG0472|consen 199 PPELGGLESLELLYLRRNKIR-FLP-E-FPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLKEVPDEICLL 274 (565)
T ss_pred ChhhcchhhhHHHHhhhcccc-cCC-C-CCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccccCchHHHHh
Confidence 999999999999999999997 667 3 336788999999999998 6666655 8999999999999999999988888
Q ss_pred hhHhhhhhccCCCCCCCCCCcccccccccccccceeeccccccccCCCcccccccccceEEEccCCcccccCCccccC--
Q 046598 302 QRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGK-- 379 (986)
Q Consensus 302 ~~L~~l~l~~n~l~~~~~~~l~~l~~l~~~~~L~~l~l~~n~~~~~~p~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~-- 379 (986)
++|..++++.|.|+..+. ++.++ .|+.|-+.+ |.+..+-.+.+.+
T Consensus 275 rsL~rLDlSNN~is~Lp~-------sLgnl-hL~~L~leG-------------------------NPlrTiRr~ii~~gT 321 (565)
T KOG0472|consen 275 RSLERLDLSNNDISSLPY-------SLGNL-HLKFLALEG-------------------------NPLRTIRREIISKGT 321 (565)
T ss_pred hhhhhhcccCCccccCCc-------ccccc-eeeehhhcC-------------------------CchHHHHHHHHcccH
Confidence 888888888877765332 33444 444444444 4433111111100
Q ss_pred ---CCCCCE----EEccCcc---c-cCc-CC---CcccCCCCCCEEEccCccceeecCccccccc---ccEEEecccccC
Q 046598 380 ---FVNLQR----LDMCSNR---L-SGT-IP---PAIGELQNLKDLRLQRNRFQGNIPPSIGNLK---LFILYLSYNFLQ 441 (986)
Q Consensus 380 ---l~~L~~----L~L~~N~---l-~~~-~~---~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~---L~~L~L~~N~l~ 441 (986)
++.|+. =-++..+ - .+. .+ .....+.+.+.|+++.-+++....+.|...+ ....+++.|++.
T Consensus 322 ~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~ 401 (565)
T KOG0472|consen 322 QEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC 401 (565)
T ss_pred HHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHh
Confidence 000000 0000000 0 001 01 1223455677788888787755445555443 778888888888
Q ss_pred CCCCcccCCCCCC-CeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccCccc
Q 046598 442 GSIPSSLGRYETL-TTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPST 520 (986)
Q Consensus 442 ~~~p~~~~~l~~L-~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 520 (986)
.+|..+..+..+ +.+.+++|.++ .+|.. ++.+++|..|+|++|-+. .+|.+++.+..|+.||+|.|+|. .+|..
T Consensus 402 -elPk~L~~lkelvT~l~lsnn~is-fv~~~-l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~ 476 (565)
T KOG0472|consen 402 -ELPKRLVELKELVTDLVLSNNKIS-FVPLE-LSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPEC 476 (565)
T ss_pred -hhhhhhHHHHHHHHHHHhhcCccc-cchHH-HHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHH
Confidence 778877777665 44566777775 66655 778889999999999888 68888998888999999999998 88988
Q ss_pred ccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCccccccCCccccc-ccc
Q 046598 521 LGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQGVFK-NAS 599 (986)
Q Consensus 521 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~~~~-~~~ 599 (986)
+..+..|+.+-.++|++..+.|..+.+|.+|.+|||.+|.|. .+|..++++.+|++|+|++|+++ .|+.....+ +..
T Consensus 477 ~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr-~Pr~~iLmkgT~a 554 (565)
T KOG0472|consen 477 LYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR-QPRHQILMKGTAA 554 (565)
T ss_pred HhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC-CCHHHHhccChHH
Confidence 888888888888889998777777999999999999999998 78889999999999999999999 555544333 234
Q ss_pred ceeeeCC
Q 046598 600 ITSVFGN 606 (986)
Q Consensus 600 ~~~~~~n 606 (986)
.+++.++
T Consensus 555 iL~ylrd 561 (565)
T KOG0472|consen 555 ILSYLRD 561 (565)
T ss_pred HHHHhcc
Confidence 4455554
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=356.84 Aligned_cols=201 Identities=32% Similarity=0.416 Sum_probs=181.4
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
..++|++.+.||+|+||+||.++.+++++.+|+|++++. ...+.+...+|..++.+++||.||+++.. |++.
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ys-----FQt~ 97 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYS-----FQTE 97 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEe-----cccC
Confidence 356799999999999999999999999999999999742 33456778999999999999999999987 7888
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
+..|+|+||+.||.|..+++ ..+.+++..++-++.+|+.||.|||+. |||||||||+|||+|++|++
T Consensus 98 ~kLylVld~~~GGeLf~hL~----------~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi 164 (357)
T KOG0598|consen 98 EKLYLVLDYLNGGELFYHLQ----------REGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHI 164 (357)
T ss_pred CeEEEEEeccCCccHHHHHH----------hcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcE
Confidence 99999999999999999995 345689999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCC
Q 046598 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTD 906 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~ 906 (986)
+|+|||+++..-.. .......+||+.|||||++.+..|+.++|.||+|+++|||++|.+||.
T Consensus 165 ~LtDFgL~k~~~~~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~ 226 (357)
T KOG0598|consen 165 KLTDFGLCKEDLKD--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFY 226 (357)
T ss_pred EEeccccchhcccC--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCc
Confidence 99999999854322 233445799999999999999999999999999999999999999997
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=342.74 Aligned_cols=274 Identities=23% Similarity=0.339 Sum_probs=202.7
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc--hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
++|+...++|+|+||.||+++++++|+.||||.+....+ .-.+-.++|+++|++++|+|+|.++++ +......
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEV-----Frrkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEV-----FRRKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHH-----HHhccee
Confidence 568889999999999999999999999999999964333 334567899999999999999999999 5566889
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
++|+|||+..-|.+ +. .....++...+.+++.|+++|+.|+|++ +++||||||+||||+.+|.+|||
T Consensus 77 hLVFE~~dhTvL~e-Le---------~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLC 143 (396)
T KOG0593|consen 77 HLVFEYCDHTVLHE-LE---------RYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLC 143 (396)
T ss_pred EEEeeecchHHHHH-HH---------hccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEec
Confidence 99999997744444 43 2234578889999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHh---
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLART--- 921 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~--- 921 (986)
|||+|+.+.. .....+..+.|..|+|||.+.| .+|+..+||||+||++.||++|.+-|.+..+-+. -..++.
T Consensus 144 DFGFAR~L~~--pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQ--Ly~I~ktLG 219 (396)
T KOG0593|consen 144 DFGFARTLSA--PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQ--LYLIRKTLG 219 (396)
T ss_pred cchhhHhhcC--CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHH--HHHHHHHHc
Confidence 9999998753 2333455778999999999887 6899999999999999999999998764332221 111111
Q ss_pred hCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 922 ALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 922 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+......++..--....-. +. ....++...........-+.+++..|++.||++|++-+|+
T Consensus 220 ~L~prhq~iF~~N~~F~Gv~-lP--~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~ql 281 (396)
T KOG0593|consen 220 NLIPRHQSIFSSNPFFHGVR-LP--EPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQL 281 (396)
T ss_pred ccCHHHHHHhccCCceeeee-cC--CCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHH
Confidence 11222222222110000000 00 0000111111122334467899999999999999997653
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=380.98 Aligned_cols=454 Identities=27% Similarity=0.407 Sum_probs=336.6
Q ss_pred ccCCCCCCEEEccCCCccccCCcchhccccCceeeceecccCCCCccchhcCccccceecccccccCccCccccCCCCCC
Q 046598 82 VGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIE 161 (986)
Q Consensus 82 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 161 (986)
.++-..|+.|.+++|.+. .+-+.+.++..|.+|++++|+++ ..|.+++.+.+++.|+.|+|+++ .+|..++.+.+|.
T Consensus 41 wW~qv~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~ 117 (565)
T KOG0472|consen 41 WWEQVDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLV 117 (565)
T ss_pred hhhhcchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhh
Confidence 445567889999999997 56667889999999999999998 88889999999999999999998 8898999999999
Q ss_pred eEEccCCcCCCCcccccCCCcCcceeeccCCcccCcCcchhhccCCCceeecccccccccCCccccCCCCccEEeccccc
Q 046598 162 HISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNK 241 (986)
Q Consensus 162 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~ 241 (986)
.|+.+.|.+. .+|++++.+..|..|+..+|+++ ..|+.++.+.+|..|++.+|++. ..|+..-++.+|++||+..|.
T Consensus 118 ~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~-~l~~~~i~m~~L~~ld~~~N~ 194 (565)
T KOG0472|consen 118 KLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLK-ALPENHIAMKRLKHLDCNSNL 194 (565)
T ss_pred hhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchh-hCCHHHHHHHHHHhcccchhh
Confidence 9999999988 77778888888899999999888 67888888888888888888888 444443335555555555444
Q ss_pred cccccCCcccccccccceEEecCceecccCCccccCCCCCcEEecccccccCCCchhhhhhhHhhhhhccCCCCCCCCCC
Q 046598 242 IQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRD 321 (986)
Q Consensus 242 l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~l~~l~~L~~l~l~~n~l~~~~~~~ 321 (986)
++ .+|+.++.+.+|+.|++..|++..+| .|+.+..|.++.+..|+|.
T Consensus 195 -------------------------L~-tlP~~lg~l~~L~~LyL~~Nki~~lP-ef~gcs~L~Elh~g~N~i~------ 241 (565)
T KOG0472|consen 195 -------------------------LE-TLPPELGGLESLELLYLRRNKIRFLP-EFPGCSLLKELHVGENQIE------ 241 (565)
T ss_pred -------------------------hh-cCChhhcchhhhHHHHhhhcccccCC-CCCccHHHHHHHhcccHHH------
Confidence 44 55666666666666666666666444 4444444444444333332
Q ss_pred cccccccccccccceeeccccccccCCCcccccccccceEEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcc
Q 046598 322 LNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAI 401 (986)
Q Consensus 322 l~~l~~l~~~~~L~~l~l~~n~~~~~~p~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 401 (986)
.+|.......+++.+|+|.+|++. ..|+.++.+++|++||+|+|.|+ ..|..+
T Consensus 242 -------------------------~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sL 294 (565)
T KOG0472|consen 242 -------------------------MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSL 294 (565)
T ss_pred -------------------------hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCccc
Confidence 456555544467788888888888 77888888888888888888888 677788
Q ss_pred cCCCCCCEEEccCccceeecCc--------------------------------------ccc----cccccEEEecccc
Q 046598 402 GELQNLKDLRLQRNRFQGNIPP--------------------------------------SIG----NLKLFILYLSYNF 439 (986)
Q Consensus 402 ~~l~~L~~L~Ls~N~l~~~~~~--------------------------------------~~~----~~~L~~L~L~~N~ 439 (986)
+++ .|+.|-+.+|.+..+-.+ .+. ....+.|+++.-+
T Consensus 295 gnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~q 373 (565)
T KOG0472|consen 295 GNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQ 373 (565)
T ss_pred ccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccc
Confidence 888 888888888876521111 111 1246667777777
Q ss_pred cCCCCCcccCCCCC---CCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCcccccc
Q 046598 440 LQGSIPSSLGRYET---LTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGE 516 (986)
Q Consensus 440 l~~~~p~~~~~l~~---L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 516 (986)
++ .+|+......+ .+..+++.|++. ++|......-.-.+.+.+++|.+. .+|..++.+++|+.|+|++|-+. .
T Consensus 374 lt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~ 449 (565)
T KOG0472|consen 374 LT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-D 449 (565)
T ss_pred cc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-h
Confidence 77 34443322222 667777777776 777663222222344566666665 67777777788888888888777 6
Q ss_pred CcccccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCccccccCCccccc
Q 046598 517 IPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQGVFK 596 (986)
Q Consensus 517 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~~~~ 596 (986)
+|..++.+..|+.||+|.|++. .+|..+..+..|+.+-.++|++....|..+.+|.+|.+|||.+|.+..+||..+...
T Consensus 450 LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~Lgnmt 528 (565)
T KOG0472|consen 450 LPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMT 528 (565)
T ss_pred cchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhcccc
Confidence 7777788777888888888777 677777777777777777788876666669999999999999999999999999999
Q ss_pred cccceeeeCCc
Q 046598 597 NASITSVFGNL 607 (986)
Q Consensus 597 ~~~~~~~~~n~ 607 (986)
++..+.+.|||
T Consensus 529 nL~hLeL~gNp 539 (565)
T KOG0472|consen 529 NLRHLELDGNP 539 (565)
T ss_pred ceeEEEecCCc
Confidence 99999999996
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=395.06 Aligned_cols=258 Identities=26% Similarity=0.446 Sum_probs=213.1
Q ss_pred cCCCCCcccccccceeEEEEEECC-----CCeEEEEEEeeccCch-hHHHHHHHHHHHhcCCCCcceeeeeeccccccCC
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDD-----GRTTIAVKVFNLLHHG-AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 761 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 761 (986)
.+....+.||+|+||+||+|+..+ ....||||.++..... ...+|++|++++..++|||||+++|.|. .
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~-----~ 560 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR-----E 560 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc-----c
Confidence 345567899999999999999743 3577999999865555 7789999999999999999999999974 4
Q ss_pred CceEEEEEEeccCCCHhHhhccCCCCCccccC----CCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEec
Q 046598 762 NDFKALVFEFMHNRSLEEWLHPITREDETDEA----PRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLD 837 (986)
Q Consensus 762 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 837 (986)
++..|+|+|||..|||.+|+............ ..+++..+.+.||.|||.|++||-++ .+|||||..+|+||.
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVG 637 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceec
Confidence 58899999999999999999865544332222 45599999999999999999999999 999999999999999
Q ss_pred CCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHH
Q 046598 838 EDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLH 916 (986)
Q Consensus 838 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~ 916 (986)
++..|||+|||+++.+...+.........-+.+|||||.+..++||.+||||||||++||+++ |+.||.+....+
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E---- 713 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE---- 713 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH----
Confidence 999999999999998766665554444556889999999999999999999999999999999 999986433221
Q ss_pred HHHHhhCCCchhHHhh-hhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 917 NLARTALPDHVMDIVD-STLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 917 ~~~~~~~~~~~~~~~d-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+.+.+. ..+ .+.++.||.+++.||..||+.+|++||+++||
T Consensus 714 ----------VIe~i~~g~l-------------------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 714 ----------VIECIRAGQL-------------------LSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred ----------HHHHHHcCCc-------------------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 111111 111 23345789999999999999999999999875
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=358.58 Aligned_cols=277 Identities=24% Similarity=0.290 Sum_probs=206.1
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
+.|+.+++||+|.||.||+|++..+++.||+|.++... .+...-..+||.||++++||||+++.+.... ......
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~---~~~~si 193 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTS---KLSGSI 193 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEe---cCCceE
Confidence 45777899999999999999999999999999997644 3445667899999999999999999998432 235789
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
|+|+|||++ +|..++. ...-.+++.+++.++.|++.||+|+|++ ||+|||||.+|||||.+|.+||+
T Consensus 194 YlVFeYMdh-DL~GLl~---------~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKia 260 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLS---------SPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIA 260 (560)
T ss_pred EEEEecccc-hhhhhhc---------CCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEec
Confidence 999999966 8888885 3345799999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCC
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALP 924 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 924 (986)
|||+|+++....... .+..+.|..|+|||.+.|. .|+.++|+||.|||+.||++|++.|.+..+- ..++.. .....
T Consensus 261 DFGLAr~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEv-eQl~kI-fklcG 337 (560)
T KOG0600|consen 261 DFGLARFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEV-EQLHKI-FKLCG 337 (560)
T ss_pred cccceeeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHH-HHHHHH-HHHhC
Confidence 999999886554333 5567889999999998885 7999999999999999999999988643221 111111 11111
Q ss_pred CchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCC
Q 046598 925 DHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTN 985 (986)
Q Consensus 925 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 985 (986)
.+-.+.+. ..+-|.-..............+.....+...++|+..++..||.+|.||.+
T Consensus 338 SP~e~~W~--~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~ 396 (560)
T KOG0600|consen 338 SPTEDYWP--VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASS 396 (560)
T ss_pred CCChhccc--cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHH
Confidence 11111100 000010000000000000111112344566789999999999999999875
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=361.81 Aligned_cols=205 Identities=28% Similarity=0.412 Sum_probs=180.7
Q ss_pred HhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeec---cCchhHHHHHHHHHHHhcC-CCCcceeeeeeccccccC
Q 046598 685 NATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL---LHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQ 760 (986)
Q Consensus 685 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 760 (986)
....+|...+.||+|+|++|++|+.+.+++.||||++.+ ..+...+.+..|-.+|.++ .||.|++++.. |+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~T-----FQ 144 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFT-----FQ 144 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEE-----ee
Confidence 345679999999999999999999999999999999863 2223345677888899999 89999999987 78
Q ss_pred CCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCC
Q 046598 761 GNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDM 840 (986)
Q Consensus 761 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 840 (986)
++...|+|+||+++|+|.++|++. +.+++..++.++.||+.|++|||++ |||||||||+|||+|+|+
T Consensus 145 D~~sLYFvLe~A~nGdll~~i~K~----------Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dm 211 (604)
T KOG0592|consen 145 DEESLYFVLEYAPNGDLLDLIKKY----------GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDG 211 (604)
T ss_pred cccceEEEEEecCCCcHHHHHHHh----------CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCC
Confidence 889999999999999999999643 4689999999999999999999999 999999999999999999
Q ss_pred cEEEcccccceecCCCCCc---------ccc--ccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 841 IAHIGDFGLARFLPLSSAQ---------TSS--IGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 841 ~~kL~DFG~a~~~~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
++||+|||.|+.+...... ... ..++||..|.+||++.+...++.+|+|+||||+|+|+.|++||..
T Consensus 212 hikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra 289 (604)
T KOG0592|consen 212 HIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA 289 (604)
T ss_pred cEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc
Confidence 9999999999987543221 111 458899999999999999999999999999999999999999974
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=356.81 Aligned_cols=255 Identities=26% Similarity=0.363 Sum_probs=198.7
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
..+|...+.||+|+||+||++.+.+++...|||.+...+....+.+.+|+++|++++|||||+++|..... ....++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~---~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSR---ENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccc---cCeeeE
Confidence 44678889999999999999999988999999998765444467789999999999999999999973211 113799
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecC-CCcEEEc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDE-DMIAHIG 845 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~ 845 (986)
+.|||+++|+|.+++...+ ..+++..++.+++||++||+|||++ |||||||||+|||++. ++.+||+
T Consensus 93 i~mEy~~~GsL~~~~~~~g---------~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~Kla 160 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYG---------GKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLA 160 (313)
T ss_pred eeeeccCCCcHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEec
Confidence 9999999999999996322 2699999999999999999999999 9999999999999999 7999999
Q ss_pred ccccceecCC-CCCccccccccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhC
Q 046598 846 DFGLARFLPL-SSAQTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTAL 923 (986)
Q Consensus 846 DFG~a~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 923 (986)
|||+++.... ...........||+.|||||++.++ ...+++||||+||++.||+||++||..... ..........
T Consensus 161 DFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~---~~~~~~~ig~ 237 (313)
T KOG0198|consen 161 DFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE---EAEALLLIGR 237 (313)
T ss_pred cCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc---hHHHHHHHhc
Confidence 9999987653 1122233457799999999999853 344699999999999999999999874311 1111111111
Q ss_pred CCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 924 PDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 924 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
...... -+...+.+..+++.+|++.||++||||+++
T Consensus 238 ~~~~P~---------------------------ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eL 273 (313)
T KOG0198|consen 238 EDSLPE---------------------------IPDSLSDEAKDFLRKCFKRDPEKRPTAEEL 273 (313)
T ss_pred cCCCCC---------------------------CCcccCHHHHHHHHHHhhcCcccCcCHHHH
Confidence 110000 011234456789999999999999999864
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=359.81 Aligned_cols=271 Identities=21% Similarity=0.250 Sum_probs=203.8
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchh-HHHHHHHHHHHhcCC-CCcceeeeeeccccccCCCc
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGA-FKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~ 763 (986)
..++|.++++||.|.||.||+|+...++..||||.++..-... .-.-.+|+..|++++ |||||++.+++. +.+.
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~----d~~~ 83 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIR----DNDR 83 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhh----ccCc
Confidence 4578999999999999999999999999999999997533332 223468999999998 999999999853 3333
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..++||||| ..+|++.++ .+++.+++.+++.|+.||++||+|+|++ |+.|||+||+|||+.....+|
T Consensus 84 ~L~fVfE~M-d~NLYqLmK---------~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iK 150 (538)
T KOG0661|consen 84 ILYFVFEFM-DCNLYQLMK---------DRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIK 150 (538)
T ss_pred eEeeeHHhh-hhhHHHHHh---------hcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeE
Confidence 999999999 569999997 3356899999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCcccccccccccccccccccc-CCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGL-GSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 922 (986)
|+|||+|+.+..... .+..+.|..|+|||++. .+-|+.+.||||+|||++|+.+-++-|.+..+-+.-+. . -..
T Consensus 151 iaDFGLARev~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~K-I-c~V 225 (538)
T KOG0661|consen 151 IADFGLAREVRSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYK-I-CEV 225 (538)
T ss_pred ecccccccccccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHH-H-HHH
Confidence 999999998754333 34567899999999854 57899999999999999999999998875444322211 1 111
Q ss_pred CCCc----hhH--HhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCC
Q 046598 923 LPDH----VMD--IVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTN 985 (986)
Q Consensus 923 ~~~~----~~~--~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 985 (986)
+..+ +.+ -+-..+....... .+.....-...+..+..+++.+|+++||++||||+|
T Consensus 226 LGtP~~~~~~eg~~La~~mnf~~P~~-------~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~ 287 (538)
T KOG0661|consen 226 LGTPDKDSWPEGYNLASAMNFRFPQV-------KPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQ 287 (538)
T ss_pred hCCCccccchhHHHHHHHhccCCCcC-------CCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHH
Confidence 1111 100 0111111110000 000000111235667789999999999999999976
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=366.33 Aligned_cols=252 Identities=30% Similarity=0.462 Sum_probs=200.2
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc--hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
..+...+.++||+|.||+||+|+|.+ .||||+++.... +..+.|++|+..+++-+|.||+-+.|||.. +.
T Consensus 390 p~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~-----p~ 461 (678)
T KOG0193|consen 390 PPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN-----PP 461 (678)
T ss_pred CHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC-----Cc
Confidence 34556778999999999999999986 699999986433 456889999999999999999999999743 23
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..||+.+|+|-+|+.+++ .....+...+.+.||+|||+|+.|||.+ +|||||||..|||+.+++.||
T Consensus 462 -~AIiTqwCeGsSLY~hlH---------v~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVk 528 (678)
T KOG0193|consen 462 -LAIITQWCEGSSLYTHLH---------VQETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVK 528 (678)
T ss_pred -eeeeehhccCchhhhhcc---------chhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEE
Confidence 499999999999999998 3345689999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccCC---CcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHH
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS---EVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLAR 920 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~ 920 (986)
|+|||++.....-..........|...|||||+++.+ +|++++||||||+|+|||+||..||. ....+..+....+
T Consensus 529 IgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmVGr 607 (678)
T KOG0193|consen 529 IGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMVGR 607 (678)
T ss_pred EecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEecc
Confidence 9999999754333223333345588899999998753 79999999999999999999999997 2111111111111
Q ss_pred hhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 921 TALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 921 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..... ........+++++.+|+..||.++|++||.+.+|
T Consensus 608 G~l~p---------------------------d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~i 646 (678)
T KOG0193|consen 608 GYLMP---------------------------DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQL 646 (678)
T ss_pred cccCc---------------------------cchhhhccCHHHHHHHHHHHHhcCcccCccHHHH
Confidence 10000 0112234678899999999999999999998754
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=344.24 Aligned_cols=261 Identities=23% Similarity=0.295 Sum_probs=206.9
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCch-hHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHG-AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
.+.|++.+.||.|..++||+|+....+..||||++...... +.+.+.+|+..|+.++||||++++.. |..+...
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~s-----Fvv~~~L 99 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCS-----FVVDSEL 99 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEE-----EEeccee
Confidence 46799999999999999999999988999999999864433 35889999999999999999999987 5667899
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
|+||.||.+|++.+.++.... ..+.+..+..|.+++++||.|||.+ |.||||||+.||||+.+|.|||+
T Consensus 100 WvVmpfMa~GS~ldIik~~~~--------~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLa 168 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTYYP--------DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLA 168 (516)
T ss_pred EEeehhhcCCcHHHHHHHHcc--------ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEc
Confidence 999999999999999974432 3489999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCcc--ccccccccccccccccccC--CCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHh
Q 046598 846 DFGLARFLPLSSAQT--SSIGAKGSIGYIAPEYGLG--SEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLART 921 (986)
Q Consensus 846 DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~ 921 (986)
|||.+..+....... .....+||+.|||||++.. ..|+.|+||||||++..|+.+|..||....+..+
T Consensus 169 dFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv-------- 240 (516)
T KOG0582|consen 169 DFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV-------- 240 (516)
T ss_pred CceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH--------
Confidence 999987665433211 1145689999999999554 4699999999999999999999999974433211
Q ss_pred hCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 922 ALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 922 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+-..+..+|........ ..++.......+.+++..|+..||++||||+++
T Consensus 241 ---------Ll~tLqn~pp~~~t~~~------~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskL 290 (516)
T KOG0582|consen 241 ---------LLLTLQNDPPTLLTSGL------DKDEDKKFSKSFREMIALCLVKDPSKRPTASKL 290 (516)
T ss_pred ---------HHHHhcCCCCCcccccC------ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHH
Confidence 11112222211110000 111222334478889999999999999999864
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=373.50 Aligned_cols=261 Identities=23% Similarity=0.412 Sum_probs=215.9
Q ss_pred CcChHHHHHhhc---------CCCCCcccccccceeEEEEEECCCC---eEEEEEEeeccC-chhHHHHHHHHHHHhcCC
Q 046598 677 NISYQNLYNATD---------RFSSVNQIGEGSFGSVFKGILDDGR---TTIAVKVFNLLH-HGAFKSFIAECNTLKNIR 743 (986)
Q Consensus 677 ~~~~~~~~~~~~---------~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~ 743 (986)
.++|+|.-.+.. ...+.+.||.|.||+||+|+.+..+ ..||||.++... +....+|..|+.||.+++
T Consensus 609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd 688 (996)
T KOG0196|consen 609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD 688 (996)
T ss_pred CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC
Confidence 355665544433 3456789999999999999997544 569999998643 445678999999999999
Q ss_pred CCcceeeeeeccccccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 046598 744 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPP 823 (986)
Q Consensus 744 h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ 823 (986)
||||+++.|+ .......+||+|||++|+|+.|++ ..++++++.+...+.++||.|++||-++ +
T Consensus 689 HPNIIrLEGV-----VTks~PvMIiTEyMENGsLDsFLR---------~~DGqftviQLVgMLrGIAsGMkYLsdm---~ 751 (996)
T KOG0196|consen 689 HPNIIRLEGV-----VTKSKPVMIITEYMENGSLDSFLR---------QNDGQFTVIQLVGMLRGIASGMKYLSDM---N 751 (996)
T ss_pred CCcEEEEEEE-----EecCceeEEEhhhhhCCcHHHHHh---------hcCCceEeehHHHHHHHHHHHhHHHhhc---C
Confidence 9999999999 566688999999999999999997 4446799999999999999999999999 9
Q ss_pred eEeecCCCCCeEecCCCcEEEcccccceecCCCC-CccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-C
Q 046598 824 IAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSS-AQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-R 901 (986)
Q Consensus 824 ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g 901 (986)
+|||||.++||||+.+..+|++|||+++.++.+. ......+..-+.+|.|||.+..+++|.+|||||||+++||.++ |
T Consensus 752 YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyG 831 (996)
T KOG0196|consen 752 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYG 831 (996)
T ss_pred chhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccC
Confidence 9999999999999999999999999999876544 2333344556789999999999999999999999999999988 9
Q ss_pred CCCCCccccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCC
Q 046598 902 KKPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRM 981 (986)
Q Consensus 902 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 981 (986)
..||...... +.+. ..+.+.|.+.+++|+..+.+||..||++|-.+||
T Consensus 832 ERPYWdmSNQ-----dVIk---------------------------aIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP 879 (996)
T KOG0196|consen 832 ERPYWDMSNQ-----DVIK---------------------------AIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRP 879 (996)
T ss_pred CCcccccchH-----HHHH---------------------------HHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCC
Confidence 9998633221 1111 1123346677789999999999999999999999
Q ss_pred CCCCC
Q 046598 982 SMTNV 986 (986)
Q Consensus 982 t~~eV 986 (986)
+++||
T Consensus 880 ~F~qi 884 (996)
T KOG0196|consen 880 KFAQI 884 (996)
T ss_pred CHHHH
Confidence 99864
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=357.57 Aligned_cols=249 Identities=22% Similarity=0.311 Sum_probs=208.8
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
...|...++||+|+.|.||.|....+++.||||++........+-+.+|+.+|+..+|+|||.+++.| -.++..|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sy-----lv~deLW 346 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSY-----LVGDELW 346 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHh-----cccceeE
Confidence 34677888999999999999999999999999999887777778899999999999999999999984 4458899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+|||||+||+|.+.+.. ..+++.++..|++++++||+|||.+ ||+|||||.+|||++.+|.+||+|
T Consensus 347 VVMEym~ggsLTDvVt~-----------~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltD 412 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVTK-----------TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTD 412 (550)
T ss_pred EEEeecCCCchhhhhhc-----------ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEee
Confidence 99999999999999852 3489999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCc
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDH 926 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 926 (986)
||++..+..... .....+||+.|||||+.....|++|+||||||++++||+-|.+||-. +..+..+..-.-.
T Consensus 413 FGFcaqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln----E~PlrAlyLIa~n-- 484 (550)
T KOG0578|consen 413 FGFCAQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN----ENPLRALYLIATN-- 484 (550)
T ss_pred eeeeeccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC----CChHHHHHHHhhc--
Confidence 999988754433 34557899999999999999999999999999999999999999841 2222222211100
Q ss_pred hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 927 VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 927 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+. ............+.+++.+|+..||++||+|.|+
T Consensus 485 ----------g~--------------P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eL 520 (550)
T KOG0578|consen 485 ----------GT--------------PKLKNPEKLSPELKDFLDRCLVVDVEQRASAKEL 520 (550)
T ss_pred ----------CC--------------CCcCCccccCHHHHHHHHHHhhcchhcCCCHHHH
Confidence 00 1122233456678899999999999999999875
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=319.42 Aligned_cols=262 Identities=24% Similarity=0.363 Sum_probs=204.2
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCch--hHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHG--AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
++|...+++|+|.||.||+|++..+++.||||.++..... -.....+|++.|+.++|+||+.++++ |...+..
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~-----F~~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDV-----FPHKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhh-----ccCCCce
Confidence 5788999999999999999999999999999999864332 24567899999999999999999999 6777889
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
.+|+|||+ .+|...++ .....++..+++.++.++++|++|+|++ .|+||||||.|+|++++|.+||+
T Consensus 77 ~lVfEfm~-tdLe~vIk---------d~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiA 143 (318)
T KOG0659|consen 77 SLVFEFMP-TDLEVVIK---------DKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIA 143 (318)
T ss_pred EEEEEecc-ccHHHHhc---------ccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEee
Confidence 99999994 59999996 4456799999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHH--h-
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLAR--T- 921 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~--~- 921 (986)
|||+|+.+...... ....+-|..|+|||.+.| +.|+..+||||.||++.||+-|.+-|. |+.++.+... .
T Consensus 144 DFGLAr~f~~p~~~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fp----G~sDidQL~~If~~ 217 (318)
T KOG0659|consen 144 DFGLARFFGSPNRI--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFP----GDSDIDQLSKIFRA 217 (318)
T ss_pred cccchhccCCCCcc--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCC----CCchHHHHHHHHHH
Confidence 99999987544332 223378999999999887 479999999999999999999988664 3333333321 1
Q ss_pred -------hCCCc--hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 922 -------ALPDH--VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 922 -------~~~~~--~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+|+- +.+.++-.....+. ...--..+..+..+++.+++.+||.+|+|++|.
T Consensus 218 LGTP~~~~WP~~~~lpdY~~~~~~P~~~-------------~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qa 278 (318)
T KOG0659|consen 218 LGTPTPDQWPEMTSLPDYVKIQQFPKPP-------------LNNLFPAASSDALDLLSKMLTYNPKKRITASQA 278 (318)
T ss_pred cCCCCcccCccccccccHHHHhcCCCCc-------------cccccccccHHHHHHHHhhhccCchhcccHHHH
Confidence 11111 11111111000000 000111334456899999999999999999863
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=350.81 Aligned_cols=198 Identities=30% Similarity=0.454 Sum_probs=180.7
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
++|.+.+.||+|.||.||+|+.+.+.+.||+|.+.+.. ..+.+.+.+|++|++.++|||||.++++ |+...+.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~es-----fEt~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLES-----FETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHh-----hcccceE
Confidence 57999999999999999999999999999999996533 3456779999999999999999999999 6777999
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
++|+||+.| +|..++. .++.+++++++.|+.|+..||.|||+. +|.|||+||+||+++.++.+|++
T Consensus 77 ~vVte~a~g-~L~~il~----------~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~Klc 142 (808)
T KOG0597|consen 77 WVVTEYAVG-DLFTILE----------QDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLC 142 (808)
T ss_pred EEEehhhhh-hHHHHHH----------hccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeec
Confidence 999999966 9999994 456799999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCC
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTD 906 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~ 906 (986)
|||+|+.+.. .....+...||+.|||||...+++|+..+|.||+||++||+++|++||-
T Consensus 143 dFg~Ar~m~~--~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~ 201 (808)
T KOG0597|consen 143 DFGLARAMST--NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY 201 (808)
T ss_pred hhhhhhhccc--CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch
Confidence 9999997643 3445566789999999999999999999999999999999999999985
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=359.61 Aligned_cols=397 Identities=24% Similarity=0.271 Sum_probs=240.4
Q ss_pred CCCCCCcceeeEecCCCCeEEEEeccCCCCccccCcCccCCCCCCEEEccCCCccccCCcchhccccCceeeceecccCC
Q 046598 45 ESSHFCQWRGVTCSRRHQRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGG 124 (986)
Q Consensus 45 ~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 124 (986)
+.++.|.-.-..|+..+ +..+|- .++.|.+|. .-+.||+++|.++.+-+..|.++++|+.++|.+|.++
T Consensus 47 pa~c~c~~~lldcs~~~--lea~~~--~~l~g~lp~------~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt- 115 (873)
T KOG4194|consen 47 PATCPCNTRLLDCSDRE--LEAIDK--SRLKGFLPS------QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT- 115 (873)
T ss_pred CCcCCCCceeeecCccc--cccccc--cccCCcCcc------ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-
Confidence 44455555555565432 333332 234455443 2346777777777777777777777777777777777
Q ss_pred CCccchhcCccccceecccccccCccCccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeeccCCcccCcCcchhhc
Q 046598 125 AIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGW 204 (986)
Q Consensus 125 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 204 (986)
.+|...+...+|+.|+|.+|.|+..-..+++-++.|+.|||+.|.|+.+.-.+|..-.++++|+|++|+|+...-+.|..
T Consensus 116 ~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~ 195 (873)
T KOG4194|consen 116 RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDS 195 (873)
T ss_pred hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccc
Confidence 66655555556666677666666555556666666666666666666444445555556666666666666555556666
Q ss_pred cCCCceeecccccccccCCccccCCCCccEEeccccccccccCCcccccccccceEEecCceecccCCccccCCCCCcEE
Q 046598 205 LKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIF 284 (986)
Q Consensus 205 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 284 (986)
+.+|..|.|+.|+++ .+|...|.+|++|+.|+|..|+|.-.---+|.+|+
T Consensus 196 lnsL~tlkLsrNrit-------------------------tLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~----- 245 (873)
T KOG4194|consen 196 LNSLLTLKLSRNRIT-------------------------TLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLP----- 245 (873)
T ss_pred cchheeeecccCccc-------------------------ccCHHHhhhcchhhhhhccccceeeehhhhhcCch-----
Confidence 666666666666655 33434443455566666666665522222333333
Q ss_pred ecccccccCCCchhhhhhhHhhhhhccCCCCCCCCCCcccccccccccccceeeccccccccCCCcccccccccceEEEc
Q 046598 285 HGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLL 364 (986)
Q Consensus 285 ~ls~N~l~~~~~~l~~l~~L~~l~l~~n~l~~~~~~~l~~l~~l~~~~~L~~l~l~~n~~~~~~p~~~~~~~~~L~~L~L 364 (986)
+|+.|.|
T Consensus 246 -------------------------------------------------------------------------Sl~nlkl 252 (873)
T KOG4194|consen 246 -------------------------------------------------------------------------SLQNLKL 252 (873)
T ss_pred -------------------------------------------------------------------------hhhhhhh
Confidence 3344445
Q ss_pred cCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCcccccc-cccEEEecccccCCC
Q 046598 365 DNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNL-KLFILYLSYNFLQGS 443 (986)
Q Consensus 365 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~-~L~~L~L~~N~l~~~ 443 (986)
..|.|.....++|..+.++++|+|+.|+++..-..++.++++|+.|+||+|.|..+.++.+... +|++|+|++|+|+..
T Consensus 253 qrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l 332 (873)
T KOG4194|consen 253 QRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRL 332 (873)
T ss_pred hhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccC
Confidence 5555555556667777777777777777776666777777777777777777766555555433 466666666666666
Q ss_pred CCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCc---ccccccccchhhccCccccccCccc
Q 046598 444 IPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPS---EVGNLKNLEILNVFGNKLKGEIPST 520 (986)
Q Consensus 444 ~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~Ls~N~l~~~~p~~ 520 (986)
.+..|..+..|++|+|++|+|+ .+.+..|..+++|+.|||++|.|+..+.+ .|..|+.|+.|+|.+|+|..+.-.+
T Consensus 333 ~~~sf~~L~~Le~LnLs~Nsi~-~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krA 411 (873)
T KOG4194|consen 333 DEGSFRVLSQLEELNLSHNSID-HLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRA 411 (873)
T ss_pred ChhHHHHHHHhhhhcccccchH-HHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhh
Confidence 6666666666666666666666 55555566666666666666666654432 3555666666666666666433456
Q ss_pred ccCCccccEEecccccccccCCccccCCCCCCEEeCC
Q 046598 521 LGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLS 557 (986)
Q Consensus 521 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 557 (986)
|.++..|++|||.+|.|..+.|.+|..| .|+.|.++
T Consensus 412 fsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~n 447 (873)
T KOG4194|consen 412 FSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMN 447 (873)
T ss_pred hccCcccceecCCCCcceeecccccccc-hhhhhhhc
Confidence 6666666666666666666666666666 66665544
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=337.58 Aligned_cols=288 Identities=22% Similarity=0.245 Sum_probs=215.9
Q ss_pred HHHHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEee--ccCchhHHHHHHHHHHHhcCCCCcceeeeeecccccc
Q 046598 682 NLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFN--LLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY 759 (986)
Q Consensus 682 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 759 (986)
+......+|...+.||+|+||.|+.|.+..+++.||||.+. .......++..+|+++++.++|+||+.+++.+.....
T Consensus 16 ~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 16 ELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR 95 (359)
T ss_pred eEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence 44556677888899999999999999999999999999986 4555667889999999999999999999999766445
Q ss_pred CCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCC
Q 046598 760 QGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED 839 (986)
Q Consensus 760 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 839 (986)
..-...|+|+|+| +.+|.+.++ .+..++...+..+..||++||.|+|+. +|+|||+||.|++++.+
T Consensus 96 ~~f~DvYiV~elM-etDL~~iik----------~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~ 161 (359)
T KOG0660|consen 96 DKFNDVYLVFELM-ETDLHQIIK----------SQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNAD 161 (359)
T ss_pred cccceeEEehhHH-hhHHHHHHH----------cCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccC
Confidence 5667899999999 779999995 234589999999999999999999999 99999999999999999
Q ss_pred CcEEEcccccceecCCCCCccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHH
Q 046598 840 MIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNL 918 (986)
Q Consensus 840 ~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~ 918 (986)
..+||+|||+|+...........+..+.|..|+|||++.. ..|+.+.||||.|||+.||++|++-|.+... ...-..
T Consensus 162 c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~--v~Ql~l 239 (359)
T KOG0660|consen 162 CDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY--VHQLQL 239 (359)
T ss_pred CCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch--HHHHHH
Confidence 9999999999998765444555677889999999998654 6899999999999999999999998753211 111112
Q ss_pred HHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCC
Q 046598 919 ARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTN 985 (986)
Q Consensus 919 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 985 (986)
+....+.+-.+.+...-.......+.......+......-........+++.+|+..||.+|+|++|
T Consensus 240 I~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~e 306 (359)
T KOG0660|consen 240 ILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEE 306 (359)
T ss_pred HHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHH
Confidence 2222222211111111111111111111111111111111234455679999999999999999876
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=357.00 Aligned_cols=393 Identities=23% Similarity=0.220 Sum_probs=318.6
Q ss_pred ceeeceecccCCCCccchhcC--ccccceecccccccCccCccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeecc
Q 046598 113 QVLALHYNSIGGAIPANISSC--SNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLS 190 (986)
Q Consensus 113 ~~L~L~~N~l~~~~p~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 190 (986)
+.||.+.+.+...--..+.+. +.-++||+|+|+++.+-+..|.++++|+++++.+|.++ .+|.......+|+.|+|.
T Consensus 55 ~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~ 133 (873)
T KOG4194|consen 55 RLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLR 133 (873)
T ss_pred eeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeee
Confidence 457888888764322222221 23356888888888887888888888888888888888 777655555568888888
Q ss_pred CCcccCcCcchhhccCCCceeecccccccccCCccccCCCCccEEeccccccccccCCcccccccccceEEecCceeccc
Q 046598 191 GNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGA 270 (986)
Q Consensus 191 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~ 270 (986)
+|.|+.+-.+.+..++.|+.||||.|.|+ .+|. .-+..-.++++|+|++|.|+..
T Consensus 134 ~N~I~sv~se~L~~l~alrslDLSrN~is-~i~~------------------------~sfp~~~ni~~L~La~N~It~l 188 (873)
T KOG4194|consen 134 HNLISSVTSEELSALPALRSLDLSRNLIS-EIPK------------------------PSFPAKVNIKKLNLASNRITTL 188 (873)
T ss_pred ccccccccHHHHHhHhhhhhhhhhhchhh-cccC------------------------CCCCCCCCceEEeecccccccc
Confidence 88888777788888888888888888887 3332 2222335677888888888877
Q ss_pred CCccccCCCCCcEEecccccccCCCchhhhhhhHhhhhhccCCCCCCCCCCcccccccccccccceeeccccccccCCCc
Q 046598 271 IPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPA 350 (986)
Q Consensus 271 ~p~~l~~l~~L~~L~ls~N~l~~~~~~l~~l~~L~~l~l~~n~l~~~~~~~l~~l~~l~~~~~L~~l~l~~n~~~~~~p~ 350 (986)
--..|..+.+|..|.|++|+++.+| .
T Consensus 189 ~~~~F~~lnsL~tlkLsrNrittLp------------------------------------------------------~ 214 (873)
T KOG4194|consen 189 ETGHFDSLNSLLTLKLSRNRITTLP------------------------------------------------------Q 214 (873)
T ss_pred ccccccccchheeeecccCcccccC------------------------------------------------------H
Confidence 7778888888888888888887544 3
Q ss_pred ccccccccceEEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCcccccc-c
Q 046598 351 CISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNL-K 429 (986)
Q Consensus 351 ~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~-~ 429 (986)
..++..++|+.|+|..|+|....--.|..+++|+.|.|..|.|+....+.|..+.++++|+|+.|++...-..++-++ +
T Consensus 215 r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~ 294 (873)
T KOG4194|consen 215 RSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTS 294 (873)
T ss_pred HHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccch
Confidence 333333567777788888875556789999999999999999998889999999999999999999998777766544 6
Q ss_pred ccEEEecccccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhcc
Q 046598 430 LFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVF 509 (986)
Q Consensus 430 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 509 (986)
|+.|+||+|.|..+.++.+...++|++|+|++|+|+ .+++..|..+..|++|+|++|.|+..-...|..+.+|+.|||+
T Consensus 295 L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~-~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr 373 (873)
T KOG4194|consen 295 LEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRIT-RLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLR 373 (873)
T ss_pred hhhhccchhhhheeecchhhhcccceeEeccccccc-cCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCc
Confidence 999999999999999999999999999999999999 7888878889999999999999997667789999999999999
Q ss_pred CccccccCc---ccccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCccc
Q 046598 510 GNKLKGEIP---STLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLE 586 (986)
Q Consensus 510 ~N~l~~~~p---~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~ 586 (986)
+|.|+..+. ..|.+|+.|+.|+|.+|+|+.+.-.+|.++..|+.|||.+|.|..+-|+.|..+ .|+.|-++.-.+-
T Consensus 374 ~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssfl 452 (873)
T KOG4194|consen 374 SNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSFL 452 (873)
T ss_pred CCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccceE
Confidence 999997664 458889999999999999996666899999999999999999999999999998 8888877655554
Q ss_pred c
Q 046598 587 G 587 (986)
Q Consensus 587 ~ 587 (986)
+
T Consensus 453 C 453 (873)
T KOG4194|consen 453 C 453 (873)
T ss_pred E
Confidence 4
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=357.50 Aligned_cols=249 Identities=24% Similarity=0.309 Sum_probs=202.7
Q ss_pred HhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc----Cc-hhHHHHHHHHHHHhcCC-CCcceeeeeeccccc
Q 046598 685 NATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL----HH-GAFKSFIAECNTLKNIR-HRNLVKILTACSGVD 758 (986)
Q Consensus 685 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 758 (986)
...++|.+.+.||+|+||+|+.|.+..++..||+|++... .. ...+.+.+|+.++++++ ||||++++++
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev----- 88 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEV----- 88 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEE-----
Confidence 4567899999999999999999999999999999987542 11 23456778999999998 9999999999
Q ss_pred cCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecC
Q 046598 759 YQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDE 838 (986)
Q Consensus 759 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 838 (986)
+......++||||+.||+|.+++.. .+++.+.+++.+++|++.|++|+|++ ||+||||||+||+++.
T Consensus 89 ~~t~~~~~ivmEy~~gGdL~~~i~~----------~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~ 155 (370)
T KOG0583|consen 89 FATPTKIYIVMEYCSGGDLFDYIVN----------KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDG 155 (370)
T ss_pred EecCCeEEEEEEecCCccHHHHHHH----------cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecC
Confidence 4555779999999999999999962 45788999999999999999999999 9999999999999999
Q ss_pred C-CcEEEcccccceecCCCCCccccccccccccccccccccCCC-cC-cccchhhHHHHHHHHHhCCCCCCccccccccH
Q 046598 839 D-MIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSE-VS-ISGDVYSYGILLLELITRKKPTDIMFEGDMNL 915 (986)
Q Consensus 839 ~-~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~ 915 (986)
+ +++||+|||++.... .........+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||+. ...
T Consensus 156 ~~~~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-----~~~ 228 (370)
T KOG0583|consen 156 NEGNLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-----SNV 228 (370)
T ss_pred CCCCEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-----ccH
Confidence 9 999999999998763 2233445678999999999999977 86 889999999999999999999974 222
Q ss_pred HHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHH-HHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 916 HNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIEC-LISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 916 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
....+......+ .-| ... ..++..++.+|+..||.+|+|+.||
T Consensus 229 ~~l~~ki~~~~~---------~~p-------------------~~~~S~~~~~Li~~mL~~~P~~R~t~~~i 272 (370)
T KOG0583|consen 229 PNLYRKIRKGEF---------KIP-------------------SYLLSPEARSLIEKMLVPDPSTRITLLEI 272 (370)
T ss_pred HHHHHHHhcCCc---------cCC-------------------CCcCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 222221111100 000 011 3456789999999999999998764
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=346.43 Aligned_cols=204 Identities=24% Similarity=0.340 Sum_probs=178.5
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
..++|++++.||+|+||+||+|+-+++|..+|+|++++. .....+.+..|-.+|...++|.||++|.. |++.
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs-----FQD~ 213 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYS-----FQDK 213 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEE-----ecCC
Confidence 356899999999999999999999999999999999753 33456778899999999999999999988 7888
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
+..|+||||++||++..++. ....+++..++.++.+++-|++.+|+. |+|||||||+|+|||..|++
T Consensus 214 ~~LYLiMEylPGGD~mTLL~----------~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHi 280 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLM----------RKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHI 280 (550)
T ss_pred CeeEEEEEecCCccHHHHHH----------hcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCE
Confidence 99999999999999999995 345799999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCC----------------------CCCcc-----------------------ccccccccccccccccc
Q 046598 843 HIGDFGLARFLPL----------------------SSAQT-----------------------SSIGAKGSIGYIAPEYG 877 (986)
Q Consensus 843 kL~DFG~a~~~~~----------------------~~~~~-----------------------~~~~~~gt~~y~aPE~~ 877 (986)
||+|||++.-+.. .+... .....+|||.|||||++
T Consensus 281 KLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVl 360 (550)
T KOG0605|consen 281 KLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVL 360 (550)
T ss_pred eeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHH
Confidence 9999999953211 00000 00234599999999999
Q ss_pred cCCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 878 LGSEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 878 ~~~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
.+..|+..+|.||+|||+|||+.|.+||..
T Consensus 361 l~kgY~~~cDwWSLG~ImyEmLvGyPPF~s 390 (550)
T KOG0605|consen 361 LGKGYGKECDWWSLGCIMYEMLVGYPPFCS 390 (550)
T ss_pred hcCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999999999973
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=318.94 Aligned_cols=198 Identities=26% Similarity=0.350 Sum_probs=178.9
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
.++|++.+.||.|+||.|.+++.+.++..+|+|+++... ....+...+|.++|+.+.||.++++++. +.+..
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t-----~~d~~ 117 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGT-----FKDNS 117 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEe-----eccCC
Confidence 356889999999999999999999999999999997533 2334567889999999999999999998 56678
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..|+||||++||.|..++++. +++++..++-+|.||+.|++|||+. +|++||+||+|||+|.+|.+|
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~----------~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iK 184 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKS----------GRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIK 184 (355)
T ss_pred eEEEEEeccCCccHHHHHHhc----------CCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEE
Confidence 999999999999999999643 4688999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
|+|||.|+.+. ......+||+.|+|||++...+|+.++|.|||||++|||+.|.+||..
T Consensus 185 itDFGFAK~v~-----~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~ 243 (355)
T KOG0616|consen 185 ITDFGFAKRVS-----GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYD 243 (355)
T ss_pred EEeccceEEec-----CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcC
Confidence 99999999863 224567899999999999999999999999999999999999999964
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=335.58 Aligned_cols=255 Identities=23% Similarity=0.336 Sum_probs=199.0
Q ss_pred HHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--------------chhHHHHHHHHHHHhcCCCCccee
Q 046598 684 YNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--------------HGAFKSFIAECNTLKNIRHRNLVK 749 (986)
Q Consensus 684 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~~E~~~l~~l~h~niv~ 749 (986)
.+..+.|++.+.||+|.||.|-+|++..+++.||||++.+.. ....+...+|+.||++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 345688999999999999999999999999999999985211 112458899999999999999999
Q ss_pred eeeeccccccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCc-cCHHHHHHHHHHHHHHHHHHHhcCCCCeEeec
Q 046598 750 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRS-LNLIQRLNISIDVACALNYLHHDCQPPIAHCD 828 (986)
Q Consensus 750 l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~-l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~D 828 (986)
++++..+ ...+..|+|+|||..|.+...- ..++ +++.+++++++++..||+|||.+ ||||||
T Consensus 173 LiEvLDD---P~s~~~YlVley~s~G~v~w~p-----------~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRD 235 (576)
T KOG0585|consen 173 LIEVLDD---PESDKLYLVLEYCSKGEVKWCP-----------PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRD 235 (576)
T ss_pred EEEeecC---cccCceEEEEEeccCCccccCC-----------CCcccccHHHHHHHHHHHHHHHHHHHhc---Ceeccc
Confidence 9998433 3457899999999988765432 1233 99999999999999999999999 999999
Q ss_pred CCCCCeEecCCCcEEEcccccceecCCC---CCccccccccccccccccccccCCC----cCcccchhhHHHHHHHHHhC
Q 046598 829 LKPSNILLDEDMIAHIGDFGLARFLPLS---SAQTSSIGAKGSIGYIAPEYGLGSE----VSISGDVYSYGILLLELITR 901 (986)
Q Consensus 829 lkp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvvl~elltg 901 (986)
|||+|+|++++|++||+|||.+...... +........+||+.|+|||...++. .+.+.||||+||+||.|+.|
T Consensus 236 IKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG 315 (576)
T KOG0585|consen 236 IKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFG 315 (576)
T ss_pred cchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhc
Confidence 9999999999999999999999866322 1122233467999999999987732 35788999999999999999
Q ss_pred CCCCCccccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCC
Q 046598 902 KKPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRM 981 (986)
Q Consensus 902 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 981 (986)
+.||...+. .+..++.... +- .++...++..++.+++.+++..||+.|.
T Consensus 316 ~~PF~~~~~-----------------~~l~~KIvn~-pL-------------~fP~~pe~~e~~kDli~~lL~KdP~~Ri 364 (576)
T KOG0585|consen 316 QLPFFDDFE-----------------LELFDKIVND-PL-------------EFPENPEINEDLKDLIKRLLEKDPEQRI 364 (576)
T ss_pred cCCcccchH-----------------HHHHHHHhcC-cc-------------cCCCcccccHHHHHHHHHHhhcChhhee
Confidence 999963221 1111111110 00 1111224456678999999999999999
Q ss_pred CCCCC
Q 046598 982 SMTNV 986 (986)
Q Consensus 982 t~~eV 986 (986)
+..+|
T Consensus 365 ~l~~i 369 (576)
T KOG0585|consen 365 TLPDI 369 (576)
T ss_pred ehhhh
Confidence 98775
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=345.03 Aligned_cols=248 Identities=24% Similarity=0.341 Sum_probs=203.3
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc-CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
...|...+.||+|.||.||+|.+..+++.||+|++... ...+.++.++|+.++.+.+++||.++|+. +-.+...
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygs-----yl~g~~L 86 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGS-----YLKGTKL 86 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhh-----eeecccH
Confidence 34577789999999999999999999999999999853 34556889999999999999999999998 5566889
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
+++||||.||++.+.++ .+..+.+..+.-|++++..|+.|||.+ +.+|||||+.||++..+|.+|++
T Consensus 87 wiiMey~~gGsv~~lL~----------~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~ 153 (467)
T KOG0201|consen 87 WIIMEYCGGGSVLDLLK----------SGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLA 153 (467)
T ss_pred HHHHHHhcCcchhhhhc----------cCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEE
Confidence 99999999999999995 333457777888999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCC
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPD 925 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 925 (986)
|||.+..+...... ....+||+.|||||++.+..|+.|+||||||++.+||.+|.+|+....+.. +...+....|+
T Consensus 154 DfgVa~ql~~~~~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr--vlflIpk~~PP 229 (467)
T KOG0201|consen 154 DFGVAGQLTNTVKR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR--VLFLIPKSAPP 229 (467)
T ss_pred ecceeeeeechhhc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce--EEEeccCCCCC
Confidence 99999877543332 256889999999999999899999999999999999999999986432210 00000001111
Q ss_pred chhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 926 HVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 926 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+.+. .+.+.+.+++..|++.||+.||+|.++
T Consensus 230 ----------------------------~L~~--~~S~~~kEFV~~CL~k~P~~RpsA~~L 260 (467)
T KOG0201|consen 230 ----------------------------RLDG--DFSPPFKEFVEACLDKNPEFRPSAKEL 260 (467)
T ss_pred ----------------------------cccc--ccCHHHHHHHHHHhhcCcccCcCHHHH
Confidence 0111 344567889999999999999999864
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=352.31 Aligned_cols=246 Identities=23% Similarity=0.277 Sum_probs=206.6
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
.+-|...+.||.|+-|.|-+|++..+|+.+|||++... .......+.+|+-||+-+.||||+++|++ +++..
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydV-----we~~~ 85 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDV-----WENKQ 85 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeee-----eccCc
Confidence 45688999999999999999999999999999999643 22234568899999999999999999999 78889
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
++|+|.||++||.|.+++- ..+++++.++.++++||+.|+.|+|.. +|+|||+||+|+++|..+++|
T Consensus 86 ~lylvlEyv~gGELFdylv----------~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIK 152 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYLV----------RKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIK 152 (786)
T ss_pred eEEEEEEecCCchhHHHHH----------hhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEe
Confidence 9999999999999999994 456799999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccCCCcC-cccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVS-ISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 922 (986)
|+|||+|..-.. ..-....+|++.|.|||+++|.+|. .++||||.|||+|.|+||+.||+ +.++.......
T Consensus 153 IADFGMAsLe~~---gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd-----DdNir~LLlKV 224 (786)
T KOG0588|consen 153 IADFGMASLEVP---GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD-----DDNIRVLLLKV 224 (786)
T ss_pred eeccceeecccC---CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC-----CccHHHHHHHH
Confidence 999999975322 2223456899999999999999985 88999999999999999999997 33444333322
Q ss_pred CCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 923 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.... +..+..++.+..+|+.+|+..||++|.|++||
T Consensus 225 ~~G~----------------------------f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI 260 (786)
T KOG0588|consen 225 QRGV----------------------------FEMPSNISSEAQDLLRRMLDVDPSTRITTEEI 260 (786)
T ss_pred HcCc----------------------------ccCCCcCCHHHHHHHHHHhccCccccccHHHH
Confidence 1111 11123456677899999999999999998875
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=380.54 Aligned_cols=255 Identities=25% Similarity=0.404 Sum_probs=206.6
Q ss_pred cCCCCCcccccccceeEEEEEECCCC-----eEEEEEEeec-cCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCC
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGR-----TTIAVKVFNL-LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 761 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 761 (986)
.+-+..+.||+|+||.||+|...+.. ..||||.++. .+.++..+|.+|..+|+.++|||||+++|+|..
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~----- 766 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD----- 766 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-----
Confidence 34456678999999999999986432 3489998865 445667899999999999999999999999853
Q ss_pred CceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCc
Q 046598 762 NDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI 841 (986)
Q Consensus 762 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 841 (986)
....+|++|||+||+|..|++..+... .....++..+.+.++.|||+|+.||+++ ++|||||.++|+|+++...
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~---~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~ 840 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAP---FQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRV 840 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhccccc---CCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCc
Confidence 577899999999999999998654332 2256799999999999999999999999 9999999999999999999
Q ss_pred EEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHH
Q 046598 842 AHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLAR 920 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~ 920 (986)
|||+|||+|+.+...+.........-+.+|||||.+.++.++.|+|||||||++||++| |..||...... +.
T Consensus 841 VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~-----~v-- 913 (1025)
T KOG1095|consen 841 VKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF-----EV-- 913 (1025)
T ss_pred EEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH-----HH--
Confidence 99999999996554444433333345679999999999999999999999999999999 99998632211 11
Q ss_pred hhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCC
Q 046598 921 TALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTN 985 (986)
Q Consensus 921 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 985 (986)
+...+ .+.|.+.+..|+..++++|..||+.+|++||++.+
T Consensus 914 ----------~~~~~---------------~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~ 953 (1025)
T KOG1095|consen 914 ----------LLDVL---------------EGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRT 953 (1025)
T ss_pred ----------HHHHH---------------hCCccCCCCCCChHHHHHHHHHccCChhhCccHHH
Confidence 11000 01134445578899999999999999999999865
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=315.78 Aligned_cols=265 Identities=18% Similarity=0.251 Sum_probs=211.8
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
..+||.+.+.+|+|||+.||.++.-.++..+|+|++.....++.+..++|++..++++||||+++++++.....+.....
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 35789999999999999999999988899999999987777788899999999999999999999999765545566789
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
|++++|+..|+|.+.+..... .+..+++.+++.|+.+|++||++||+. .++++||||||.||++.+++.+++.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~------kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~ 171 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKI------KGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLM 171 (302)
T ss_pred EEEeehhccccHHHHHHHHhh------cCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEE
Confidence 999999999999999975543 345799999999999999999999998 4459999999999999999999999
Q ss_pred ccccceecCCCCCc-------ccccccccccccccccccc---CCCcCcccchhhHHHHHHHHHhCCCCCCccccccccH
Q 046598 846 DFGLARFLPLSSAQ-------TSSIGAKGSIGYIAPEYGL---GSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNL 915 (986)
Q Consensus 846 DFG~a~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~ 915 (986)
|||.++..+..-.. ........|..|+|||.+. +...++++|||||||++|+|+.|..||+.....+.++
T Consensus 172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl 251 (302)
T KOG2345|consen 172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL 251 (302)
T ss_pred eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE
Confidence 99999765422110 1112345799999999865 4567899999999999999999999998554433222
Q ss_pred HHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 916 HNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 916 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.-.+.. ..+ .++.....+..+.+++..|++.||.+||++.|+
T Consensus 252 aLAv~n-----------~q~------------------s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~l 293 (302)
T KOG2345|consen 252 ALAVQN-----------AQI------------------SIPNSSRYSEALHQLIKSMLQVDPNQRPTIPEL 293 (302)
T ss_pred EEeeec-----------ccc------------------ccCCCCCccHHHHHHHHHHhcCCcccCCCHHHH
Confidence 211110 000 001111245668899999999999999998764
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=357.62 Aligned_cols=262 Identities=26% Similarity=0.365 Sum_probs=198.0
Q ss_pred hcCCCCCcccccccceeEEEEEEC-----CCCeEEEEEEeeccC-chhHHHHHHHHHHHhcC-CCCcceeeeeecccccc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILD-----DGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDY 759 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 759 (986)
.++|++.++||+|+||.||+|.+. .+++.||||+++... ....+.+.+|+++++++ +||||++++++|.
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~---- 81 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT---- 81 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec----
Confidence 468999999999999999999852 335679999986432 23456789999999999 8999999999863
Q ss_pred CCCceEEEEEEeccCCCHhHhhccCCCCCc--------------------------------------------------
Q 046598 760 QGNDFKALVFEFMHNRSLEEWLHPITREDE-------------------------------------------------- 789 (986)
Q Consensus 760 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-------------------------------------------------- 789 (986)
..+...++||||+++|+|.+++........
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 334568999999999999999964321100
Q ss_pred --cccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcccccceecCCCCCccccccccc
Q 046598 790 --TDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKG 867 (986)
Q Consensus 790 --~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~g 867 (986)
......++++.++..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++...............+
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence 000124588999999999999999999999 999999999999999999999999999986543322222233446
Q ss_pred cccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhcc
Q 046598 868 SIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHG 946 (986)
Q Consensus 868 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 946 (986)
+..|+|||++.+..++.++|||||||++|||++ |..||....... .+.... .+.....
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-~~~~~~-----------~~~~~~~--------- 297 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-EFCQRL-----------KDGTRMR--------- 297 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-HHHHHH-----------hcCCCCC---------
Confidence 788999999999999999999999999999997 999986422110 000000 0000000
Q ss_pred chhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 947 NQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 947 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+..++.++.+++.+||+.||++|||+.||
T Consensus 298 ----------~~~~~~~~l~~li~~cl~~dp~~RPs~~el 327 (338)
T cd05102 298 ----------APENATPEIYRIMLACWQGDPKERPTFSAL 327 (338)
T ss_pred ----------CCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 001234467899999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=320.51 Aligned_cols=204 Identities=27% Similarity=0.358 Sum_probs=176.2
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCch--hHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHG--AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
.+.|+.+++|++|.||.||+|+++.+++.||+|+++..... -.-.-.+|+.++.+.+|||||.+-.+..+ .+-+.
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG---~~~d~ 151 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVG---SNMDK 151 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEec---cccce
Confidence 35688899999999999999999999999999999864322 22356899999999999999999888543 34456
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.|+|||||+. +|...+. ....++...+++.++.|+++|++|||.+ .|+||||||+|+|+...|.+||
T Consensus 152 iy~VMe~~Eh-DLksl~d---------~m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKi 218 (419)
T KOG0663|consen 152 IYIVMEYVEH-DLKSLME---------TMKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKI 218 (419)
T ss_pred eeeeHHHHHh-hHHHHHH---------hccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEe
Confidence 9999999966 8999986 3346799999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCccccccccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCcc
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDIM 908 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~ 908 (986)
+|||+|+.+... ....+..+.|..|+|||.+.+. .|+.+.|+||+|||+.||+++++-|.+.
T Consensus 219 aDFGLAR~ygsp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~ 281 (419)
T KOG0663|consen 219 ADFGLAREYGSP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGK 281 (419)
T ss_pred cccchhhhhcCC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCC
Confidence 999999987533 3445567789999999998875 6999999999999999999999988644
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=347.03 Aligned_cols=244 Identities=24% Similarity=0.315 Sum_probs=203.4
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeec---cCchhHHHHHHHHHHHhcC-CCCcceeeeeeccccccCC
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL---LHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQG 761 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 761 (986)
..++|...++||+|.||+|++|..+.+++.+|||++++ ...++.+..+.|.+|+... +||.+++++.+ |+.
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~-----fQT 440 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSC-----FQT 440 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccc-----ccc
Confidence 35679999999999999999999999999999999985 3345677889999998887 59999999998 788
Q ss_pred CceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCc
Q 046598 762 NDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI 841 (986)
Q Consensus 762 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 841 (986)
.++.|.||||+.||++..+.+ ...+++..++-+|..|+.||.|||++ ||||||||.+|||+|.+|+
T Consensus 441 ~~~l~fvmey~~Ggdm~~~~~-----------~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh 506 (694)
T KOG0694|consen 441 KEHLFFVMEYVAGGDLMHHIH-----------TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGH 506 (694)
T ss_pred CCeEEEEEEecCCCcEEEEEe-----------cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCc
Confidence 899999999999999555443 34689999999999999999999999 9999999999999999999
Q ss_pred EEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHh
Q 046598 842 AHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLART 921 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~ 921 (986)
+||+|||+++..-. ....+.+.+||+.|||||++.+..|+.++|.|||||++|||+.|+.||.+..+
T Consensus 507 ~kiADFGlcKe~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE----------- 573 (694)
T KOG0694|consen 507 VKIADFGLCKEGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE----------- 573 (694)
T ss_pred EEecccccccccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH-----------
Confidence 99999999986421 23345668999999999999999999999999999999999999999973322
Q ss_pred hCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 046598 922 ALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSM 983 (986)
Q Consensus 922 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 983 (986)
.+++|..+..++.. +...+.+...++++.+..+|++|-.+
T Consensus 574 ------ee~FdsI~~d~~~y----------------P~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 574 ------EEVFDSIVNDEVRY----------------PRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ------HHHHHHHhcCCCCC----------------CCcccHHHHHHHHHHhccCcccccCC
Confidence 23344444333322 11344566788888888999998765
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=328.11 Aligned_cols=269 Identities=27% Similarity=0.360 Sum_probs=197.8
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhc--CCCCcceeeeeeccccccCCCce
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKN--IRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
.......+.+|+|+||.||+|...+ +.||||++... +.+.|+.|-+|.+. ++|+||++++++-..... .+..
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~~--~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~-~~~e 282 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLDN--RLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA-DRME 282 (534)
T ss_pred CCchhhHHHhhcCccceeehhhccC--ceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCc-cccc
Confidence 3455667889999999999999986 89999999753 44678888888776 489999999988333211 2458
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhc------CCCCeEeecCCCCCeEecC
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHD------CQPPIAHCDLKPSNILLDE 838 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~------~~~~ivH~Dlkp~NIll~~ 838 (986)
+++|+||.+.|+|.+|+.. ..++|....+|+..+++||+|||+. ++|+|+|||||++||||.+
T Consensus 283 ywLVt~fh~kGsL~dyL~~-----------ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~ 351 (534)
T KOG3653|consen 283 YWLVTEFHPKGSLCDYLKA-----------NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKN 351 (534)
T ss_pred eeEEeeeccCCcHHHHHHh-----------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEcc
Confidence 9999999999999999963 3589999999999999999999986 3778999999999999999
Q ss_pred CCcEEEcccccceecCCCCCccccccccccccccccccccCCC------cCcccchhhHHHHHHHHHhCCCCCC--cccc
Q 046598 839 DMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSE------VSISGDVYSYGILLLELITRKKPTD--IMFE 910 (986)
Q Consensus 839 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlGvvl~elltg~~pf~--~~~~ 910 (986)
|+++.|+|||+|..+.........-..+||.+|||||++.+.. .-.+.||||+|.|+|||+++..-++ ...+
T Consensus 352 DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~ 431 (534)
T KOG3653|consen 352 DLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPE 431 (534)
T ss_pred CCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCc
Confidence 9999999999999887766666666689999999999987752 2256899999999999999766542 1111
Q ss_pred ccccHHHHHHhhC-CCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 046598 911 GDMNLHNLARTAL-PDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMT 984 (986)
Q Consensus 911 ~~~~~~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 984 (986)
....+...+...- -+.+++.+- . +..++.....+... ..+.-+.+.+..||+.||+.|-||.
T Consensus 432 Yqlpfe~evG~hPt~e~mq~~VV---~--------kK~RP~~p~~W~~h-~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 432 YQLPFEAEVGNHPTLEEMQELVV---R--------KKQRPKIPDAWRKH-AGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred ccCchhHHhcCCCCHHHHHHHHH---h--------hccCCCChhhhhcC-ccHHHHHHHHHHHcCCchhhhhhhH
Confidence 1222222211110 011111110 0 00111111111111 4455677889999999999999874
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=343.32 Aligned_cols=233 Identities=26% Similarity=0.413 Sum_probs=191.8
Q ss_pred CcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEEEEec
Q 046598 693 VNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFM 772 (986)
Q Consensus 693 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 772 (986)
++.||.|+.|.||+|+.++ +.||||.++.. -..+++-|++++||||+.+.|+|... ..+|||||||
T Consensus 129 LeWlGSGaQGAVF~Grl~n--etVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqs-----PcyCIiMEfC 194 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLHN--ETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQS-----PCYCIIMEFC 194 (904)
T ss_pred hhhhccCcccceeeeeccC--ceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCC-----ceeEEeeecc
Confidence 4679999999999999986 88999987532 23478889999999999999998643 6799999999
Q ss_pred cCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccccccee
Q 046598 773 HNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARF 852 (986)
Q Consensus 773 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~ 852 (986)
..|-|++.++ .+..++......|..+||.|+.|||.+ .|||||||.-||||..+..+||+|||.++.
T Consensus 195 a~GqL~~VLk----------a~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e 261 (904)
T KOG4721|consen 195 AQGQLYEVLK----------AGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKE 261 (904)
T ss_pred ccccHHHHHh----------ccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHh
Confidence 9999999994 345788889999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCchhHHhh
Q 046598 853 LPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVMDIVD 932 (986)
Q Consensus 853 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d 932 (986)
... ...+..++||..|||||+++..+.++|+||||||||||||+||..||...... ..++..-...
T Consensus 262 ~~~---~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss-----AIIwGVGsNs------ 327 (904)
T KOG4721|consen 262 LSD---KSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS-----AIIWGVGSNS------ 327 (904)
T ss_pred hhh---hhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh-----eeEEeccCCc------
Confidence 532 23344578999999999999999999999999999999999999998632211 1111100000
Q ss_pred hhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 933 STLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 933 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
...+.+.+|+.-+.-|+++||+..|..||++.++
T Consensus 328 --------------------L~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqi 361 (904)
T KOG4721|consen 328 --------------------LHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQI 361 (904)
T ss_pred --------------------ccccCcccCchHHHHHHHHHHhcCCCCCccHHHH
Confidence 0122334677788899999999999999998764
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=353.37 Aligned_cols=205 Identities=27% Similarity=0.322 Sum_probs=171.8
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeecc--CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
+|++.+.||+|+||.||+|++..+++.||||+++.. ......++.+|++++++++||||+++++++...........|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 588999999999999999999988999999998642 223345788999999999999999999986543333445689
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+ +++|.+++.. ...+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 81 lv~e~~-~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~D 146 (338)
T cd07859 81 VVFELM-ESDLHQVIKA----------NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICD 146 (338)
T ss_pred EEEecC-CCCHHHHHHh----------cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEcc
Confidence 999999 5689998842 23589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCC-ccccccccccccccccccccC--CCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 847 FGLARFLPLSSA-QTSSIGAKGSIGYIAPEYGLG--SEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 847 FG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
||+++....... ........|++.|+|||++.+ ..++.++|||||||++|||++|++||..
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~ 210 (338)
T cd07859 147 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 210 (338)
T ss_pred CccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 999975432211 112234568999999999876 6789999999999999999999999963
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=326.69 Aligned_cols=245 Identities=22% Similarity=0.329 Sum_probs=204.0
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
..+|++.+.||+|.||.|-+|.....++.||||.++.. +.++.-.+.+|++||+.++||||+++|.+ |++.+
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEV-----FENkd 126 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEV-----FENKD 126 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhh-----hcCCc
Confidence 45799999999999999999999888999999998643 33445567899999999999999999998 77889
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
...|||||..+|.|++|+. ..+.+++.+++.+++||..|+.|+|.+ +++|||||.+|||+|.++++|
T Consensus 127 KIvivMEYaS~GeLYDYiS----------er~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiK 193 (668)
T KOG0611|consen 127 KIVIVMEYASGGELYDYIS----------ERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIK 193 (668)
T ss_pred eEEEEEEecCCccHHHHHH----------HhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCee
Confidence 9999999999999999995 345799999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccCCCcC-cccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVS-ISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 922 (986)
|+|||++-.+. .......++|++-|.+||++.|.+|. +.+|-||+||++|.++.|..||++ .+...+++..
T Consensus 194 IADFGLSNly~---~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG-----~Dhk~lvrQI 265 (668)
T KOG0611|consen 194 IADFGLSNLYA---DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG-----RDHKRLVRQI 265 (668)
T ss_pred eeccchhhhhc---cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC-----chHHHHHHHh
Confidence 99999997764 33445668999999999999999885 889999999999999999999973 2333333322
Q ss_pred CCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 923 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
-..... +| +-+-...-+|++|+..+|++|.|+.+|
T Consensus 266 s~GaYr---------EP--------------------~~PSdA~gLIRwmLmVNP~RRATieDi 300 (668)
T KOG0611|consen 266 SRGAYR---------EP--------------------ETPSDASGLIRWMLMVNPERRATIEDI 300 (668)
T ss_pred hccccc---------CC--------------------CCCchHHHHHHHHHhcCcccchhHHHH
Confidence 111111 11 111223468889999999999998765
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=338.32 Aligned_cols=258 Identities=23% Similarity=0.380 Sum_probs=206.1
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchh-HHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGA-FKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
.+...+.++||+|-||+|.++.... +.+||||.++...... ..+|.+|+++|.+++||||++++|+|. .++.+
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~-----~DePi 610 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCV-----QDDPL 610 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeee-----cCCch
Confidence 3456678999999999999999986 7999999998655444 489999999999999999999999984 34789
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
++|+|||++|+|.+|+..+... .+..+...+|+.||+.|++||.+. ++||||+.++|+|++.++++||+
T Consensus 611 cmI~EYmEnGDLnqFl~aheap--------t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKia 679 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELP--------TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIA 679 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCc--------ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEec
Confidence 9999999999999999744322 134456677999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh--CCCCCCccccccccHHHHHHhhC
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT--RKKPTDIMFEGDMNLHNLARTAL 923 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt--g~~pf~~~~~~~~~~~~~~~~~~ 923 (986)
|||+++.+...+........+-+.+|||||.+.-++++.+||||+|||++||+++ ...||....+.+ ..+
T Consensus 680 dfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~--vve------ 751 (807)
T KOG1094|consen 680 DFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ--VVE------ 751 (807)
T ss_pred CcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH--HHH------
Confidence 9999997766666666667778899999999999999999999999999999977 677775332211 111
Q ss_pred CCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 924 PDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 924 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
...++++ ..+.. .-...+.-|+..++++|.+||+.|-++||++++|
T Consensus 752 --n~~~~~~----~~~~~-----------~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~l 797 (807)
T KOG1094|consen 752 --NAGEFFR----DQGRQ-----------VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQL 797 (807)
T ss_pred --hhhhhcC----CCCcc-----------eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHH
Confidence 1111111 11100 0112233577889999999999999999999864
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=337.10 Aligned_cols=247 Identities=24% Similarity=0.344 Sum_probs=194.7
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
.|+..+.||+|+||.||+|.+..+++.||+|++.... ......+.+|++++++++|++|++++++ +..++..
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~-----~~~~~~~ 75 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYA-----YETKDAL 75 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEE-----EccCCeE
Confidence 3778899999999999999999889999999986432 2233467889999999999999999988 4456789
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
++||||+++|+|.+++... ....+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+
T Consensus 76 ~lv~e~~~~g~L~~~~~~~--------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~ 144 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYNM--------GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRIS 144 (285)
T ss_pred EEEEEecCCCcHHHHHHhh--------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEe
Confidence 9999999999999887521 123588999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCC
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPD 925 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 925 (986)
|||+++...... ......|+..|+|||++.+..++.++|||||||++|||++|+.||....... ..
T Consensus 145 Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~--------- 210 (285)
T cd05631 145 DLGLAVQIPEGE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV--KR--------- 210 (285)
T ss_pred eCCCcEEcCCCC---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch--hH---------
Confidence 999998753222 1223568999999999999999999999999999999999999997432211 00
Q ss_pred chhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 046598 926 HVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSM 983 (986)
Q Consensus 926 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 983 (986)
+.++..+...... .......++.+++.+||+.||++||++
T Consensus 211 ---~~~~~~~~~~~~~---------------~~~~~s~~~~~li~~~l~~~P~~R~~~ 250 (285)
T cd05631 211 ---EEVDRRVKEDQEE---------------YSEKFSEDAKSICRMLLTKNPKERLGC 250 (285)
T ss_pred ---HHHHHHhhccccc---------------CCccCCHHHHHHHHHHhhcCHHHhcCC
Confidence 0111111000000 001234467789999999999999984
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=304.49 Aligned_cols=248 Identities=21% Similarity=0.291 Sum_probs=204.9
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
..++|++.+.||+|.||.||.|+.+.++-.||+|++.+.. .+...++.+|++|-+.++||||+++|++ +.+.
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~-----fhd~ 94 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGY-----FHDS 94 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhh-----eecc
Confidence 4578999999999999999999999999999999986432 2335678999999999999999999999 6677
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
...|+++||.++|++...++. ...+++++.....+..|+|.|+.|+|.. +|+||||||+|+|++.++..
T Consensus 95 ~riyLilEya~~gel~k~L~~--------~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~l 163 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQE--------GRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGEL 163 (281)
T ss_pred ceeEEEEEecCCchHHHHHHh--------cccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCe
Confidence 899999999999999999962 2345678888899999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 046598 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 922 (986)
||+|||-+...+ .......+||..|.|||+..+..++..+|+|++|++.||++.|.+||.... .+..+.......
T Consensus 164 kiAdfGwsV~~p----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~~ 238 (281)
T KOG0580|consen 164 KIADFGWSVHAP----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKVD 238 (281)
T ss_pred eccCCCceeecC----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHcc
Confidence 999999997643 222344789999999999999999999999999999999999999998544 222222222211
Q ss_pred CCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 923 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+. .| ........+++.+|+..+|.+|.+..||
T Consensus 239 ~~-------------~p-------------------~~is~~a~dlI~~ll~~~p~~r~~l~~v 270 (281)
T KOG0580|consen 239 LK-------------FP-------------------STISGGAADLISRLLVKNPIERLALTEV 270 (281)
T ss_pred cc-------------CC-------------------cccChhHHHHHHHHhccCccccccHHHH
Confidence 10 01 1234456789999999999999987664
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=348.55 Aligned_cols=246 Identities=27% Similarity=0.411 Sum_probs=195.0
Q ss_pred CCCcccccccceeEEEEEECCCC----eEEEEEEeec---cCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 691 SSVNQIGEGSFGSVFKGILDDGR----TTIAVKVFNL---LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 691 ~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
...++||+|+||.||+|.....+ ..||||..+. ......+++++|+++|++++|||||++||++ ..+.
T Consensus 160 ~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa-----~~~~ 234 (474)
T KOG0194|consen 160 ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA-----VLEE 234 (474)
T ss_pred cccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----cCCC
Confidence 44589999999999999986532 2389999874 3456678999999999999999999999995 4557
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..++|||+|+||+|.+|++.. .+.++..++..++.++|.||+|||++ +++||||.++|+|++.++.+|
T Consensus 235 Pl~ivmEl~~gGsL~~~L~k~---------~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vK 302 (474)
T KOG0194|consen 235 PLMLVMELCNGGSLDDYLKKN---------KKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVK 302 (474)
T ss_pred ccEEEEEecCCCcHHHHHHhC---------CCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEE
Confidence 899999999999999999732 33699999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhh
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~ 922 (986)
|+|||+++.-. ..........-+.+|+|||.+....|++++|||||||++||+++ |..||...... ......
T Consensus 303 ISDFGLs~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~-----~v~~kI 375 (474)
T KOG0194|consen 303 ISDFGLSRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY-----EVKAKI 375 (474)
T ss_pred eCccccccCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-----HHHHHH
Confidence 99999997542 11111212346789999999999999999999999999999999 88898633221 111100
Q ss_pred CCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 923 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
... ..+.+.+...+.++..++.+||..+|++||||.+|
T Consensus 376 ~~~--------------------------~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i 413 (474)
T KOG0194|consen 376 VKN--------------------------GYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTI 413 (474)
T ss_pred Hhc--------------------------CccCCCCCCCHHHHHHHHHHhccCChhhccCHHHH
Confidence 000 00111112445667788999999999999999764
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=338.85 Aligned_cols=277 Identities=21% Similarity=0.276 Sum_probs=200.5
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
++|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|++++++++||||++++++ +..++..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-----~~~~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA-----FRRRGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhh-----EecCCEE
Confidence 47999999999999999999999989999999987532 2334678899999999999999999988 4556789
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
++||||++++.+..+.. ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 76 ~lv~e~~~~~~l~~~~~----------~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~ 142 (287)
T cd07848 76 YLVFEYVEKNMLELLEE----------MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLC 142 (287)
T ss_pred EEEEecCCCCHHHHHHh----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEe
Confidence 99999999877765542 123588999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCC
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPD 925 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 925 (986)
|||+++....... .......|++.|+|||++.+..++.++||||+||++|||++|+.||......+. .... ......
T Consensus 143 Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~-~~~~-~~~~~~ 219 (287)
T cd07848 143 DFGFARNLSEGSN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ-LFTI-QKVLGP 219 (287)
T ss_pred eccCccccccccc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHH-HHhhCC
Confidence 9999987543221 122235689999999999998999999999999999999999999974322111 1111 110000
Q ss_pred chhHHhhhhcccCCc--chhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 926 HVMDIVDSTLLNDGE--DLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 926 ~~~~~~d~~l~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
...+... ....++. .....................+.++.+++.+|++.||++|||++|+
T Consensus 220 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~ 281 (287)
T cd07848 220 LPAEQMK-LFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQC 281 (287)
T ss_pred CCHHHHH-hhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHH
Confidence 0000000 0000000 0000000000000011112345678999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=341.82 Aligned_cols=202 Identities=28% Similarity=0.454 Sum_probs=171.0
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc-hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
.++|++.+.||+|+||.||+|++..+++.||||+++.... .....+.+|+.+++.++||||++++++ +..+...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~-----~~~~~~~ 78 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDI-----IHTKETL 78 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEE-----EecCCeE
Confidence 5789999999999999999999998899999999874332 223467889999999999999999998 4556789
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
++||||++ ++|.+++.. ....++..++..++.||+.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 79 ~lv~e~~~-~~l~~~~~~---------~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~ 145 (303)
T cd07869 79 TLVFEYVH-TDLCQYMDK---------HPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLA 145 (303)
T ss_pred EEEEECCC-cCHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEC
Confidence 99999995 688888752 224588899999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCcc
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDIM 908 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~ 908 (986)
|||+++...... .......+++.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 146 Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 146 DFGLARAKSVPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred CCCcceeccCCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999997543221 12233568899999998865 45889999999999999999999999743
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=340.62 Aligned_cols=267 Identities=21% Similarity=0.343 Sum_probs=198.1
Q ss_pred hcCCCCCcccccccceeEEEEEECC----------------CCeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCccee
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDD----------------GRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVK 749 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 749 (986)
.++|.+.++||+|+||.||+|.+.. ++..||+|++.... .....++.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3679999999999999999998643 34579999987543 234567899999999999999999
Q ss_pred eeeeccccccCCCceEEEEEEeccCCCHhHhhccCCCCCcc---------ccCCCccCHHHHHHHHHHHHHHHHHHHhcC
Q 046598 750 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDET---------DEAPRSLNLIQRLNISIDVACALNYLHHDC 820 (986)
Q Consensus 750 l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~---------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ 820 (986)
+++++ ...+..++||||+++|+|.+++......... ......+++.++..++.||+.||+|||+.
T Consensus 84 ~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~- 157 (304)
T cd05096 84 LLGVC-----VDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL- 157 (304)
T ss_pred EEEEE-----ecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC-
Confidence 99995 3456789999999999999998643221111 12234578999999999999999999999
Q ss_pred CCCeEeecCCCCCeEecCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh
Q 046598 821 QPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900 (986)
Q Consensus 821 ~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt 900 (986)
+|+||||||+||+++.++.+||+|||+++...............++..|+|||++.++.++.++|||||||++|||++
T Consensus 158 --~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~ 235 (304)
T cd05096 158 --NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235 (304)
T ss_pred --CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHH
Confidence 999999999999999999999999999986543332222333446789999999988899999999999999999997
Q ss_pred --CCCCCCccccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCC
Q 046598 901 --RKKPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPE 978 (986)
Q Consensus 901 --g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~ 978 (986)
+..||...... ........ ......... .......++..+.+++.+||+.||+
T Consensus 236 ~~~~~p~~~~~~~--~~~~~~~~--------~~~~~~~~~---------------~~~~~~~~~~~~~~li~~cl~~~p~ 290 (304)
T cd05096 236 LCKEQPYGELTDE--QVIENAGE--------FFRDQGRQV---------------YLFRPPPCPQGLYELMLQCWSRDCR 290 (304)
T ss_pred ccCCCCCCcCCHH--HHHHHHHH--------Hhhhccccc---------------cccCCCCCCHHHHHHHHHHccCCch
Confidence 55676532211 11111000 000000000 0000112345688999999999999
Q ss_pred CCCCCCCC
Q 046598 979 DRMSMTNV 986 (986)
Q Consensus 979 ~RPt~~eV 986 (986)
+|||++||
T Consensus 291 ~RPs~~~i 298 (304)
T cd05096 291 ERPSFSDI 298 (304)
T ss_pred hCcCHHHH
Confidence 99999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=327.46 Aligned_cols=276 Identities=24% Similarity=0.278 Sum_probs=198.6
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEE
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALV 768 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 768 (986)
.|...+.+|.|+||.||+|+...++..||||..-... +--.+|+++|+.++|||||++..+|......+.-...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4677899999999999999999989999999875322 223469999999999999999988754422223456799
Q ss_pred EEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCC-CcEEEccc
Q 046598 769 FEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED-MIAHIGDF 847 (986)
Q Consensus 769 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kL~DF 847 (986)
|||||. +|.++++.+. ..+..++...++-+.+||.+||+|||+. +|+||||||.|+|+|.+ |.+|||||
T Consensus 101 leymP~-tL~~~~r~~~------~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDF 170 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYT------RANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDF 170 (364)
T ss_pred HHhchH-HHHHHHHHHh------hcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccC
Confidence 999965 9999997543 2345688888999999999999999998 99999999999999977 89999999
Q ss_pred ccceecCCCCCccccccccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCc
Q 046598 848 GLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDH 926 (986)
Q Consensus 848 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 926 (986)
|.|+........ .....|..|+|||.+.|. .|+.+.||||.|||+.||+-|++-|.+.... ..+... -..+..+
T Consensus 171 GSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~-dQL~eI-ik~lG~P 245 (364)
T KOG0658|consen 171 GSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV-DQLVEI-IKVLGTP 245 (364)
T ss_pred CcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH-HHHHHH-HHHhCCC
Confidence 999987544332 345689999999998885 7999999999999999999999988642221 112222 1222222
Q ss_pred hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCC
Q 046598 927 VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTN 985 (986)
Q Consensus 927 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 985 (986)
-.+-+..+-.. ..+.. ...........-.....+.+..+++.++++++|.+|.++.|
T Consensus 246 t~e~I~~mn~~-y~~~~-~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~ 302 (364)
T KOG0658|consen 246 TREDIKSMNPN-YTEFK-FPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALE 302 (364)
T ss_pred CHHHHhhcCcc-ccccc-CcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHH
Confidence 22222222111 00000 00000000000112234566789999999999999998765
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=340.44 Aligned_cols=197 Identities=25% Similarity=0.369 Sum_probs=173.4
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||++++++ +.++..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~-----~~~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWT-----EHDQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhh-----hccCCe
Confidence 47899999999999999999999889999999986432 2334668899999999999999999988 456688
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.++||||+++|+|.+++.. .+.+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl 142 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRN----------SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKL 142 (291)
T ss_pred EEEEEeCCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEE
Confidence 9999999999999999952 23588999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
+|||+++..... .....|++.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 143 ~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~ 200 (291)
T cd05612 143 TDFGFAKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD 200 (291)
T ss_pred EecCcchhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999765321 1234689999999999999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=372.56 Aligned_cols=485 Identities=29% Similarity=0.348 Sum_probs=394.4
Q ss_pred EEeccCCCCccccCcCccCCCCCCEEEccCCCccccCCcchhccccCceeeceecccCCCCccchhcCccccceeccccc
Q 046598 66 ILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQ 145 (986)
Q Consensus 66 ~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 145 (986)
.+|.+...+. .||..+..-..++.|+++.|.+-...-+.+....+|+.|||++|+++ ..|..+..+..|+.|+++.|.
T Consensus 2 ~vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~ 79 (1081)
T KOG0618|consen 2 HVDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNY 79 (1081)
T ss_pred CcccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhh
Confidence 3567777776 77877777777999999999886433455666777999999999998 899999999999999999999
Q ss_pred ccCccCccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeeccCCcccCcCcchhhccCCCceeecccccccccCCcc
Q 046598 146 LVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSS 225 (986)
Q Consensus 146 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 225 (986)
+. ..|.+..++.+|++|.|.+|.+. ..|.++..+.+|++|+++.|++. .+|..+..++.++.+..++|.....++.
T Consensus 80 i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~- 155 (1081)
T KOG0618|consen 80 IR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQ- 155 (1081)
T ss_pred Hh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhcc-
Confidence 99 88999999999999999999998 89999999999999999999998 8999999999999999999933222222
Q ss_pred ccCCCCccEEeccccccccccCCcccccccccceEEecCceecccCCccccCCCCCcEEecccccccCCCchhhhhhhHh
Q 046598 226 IFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLL 305 (986)
Q Consensus 226 l~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~l~~l~~L~ 305 (986)
+.++.+++..|.+.+.++.+.. .++. .|+|++|.+. -..+..+.+|+.++++.|++..+.- .-.+++
T Consensus 156 ----~~ik~~~l~~n~l~~~~~~~i~-~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~~---~g~~l~ 222 (1081)
T KOG0618|consen 156 ----TSIKKLDLRLNVLGGSFLIDIY-NLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELEI---SGPSLT 222 (1081)
T ss_pred ----ccchhhhhhhhhcccchhcchh-hhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEEe---cCcchh
Confidence 2388999999999988887765 2333 5999999987 3467888999999999999875432 234566
Q ss_pred hhhhccCCCCCCCCCCcccccccccccccceeeccccccccCCCcccccccccceEEEccCCcccccCCccccCCCCCCE
Q 046598 306 VFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQR 385 (986)
Q Consensus 306 ~l~l~~n~l~~~~~~~l~~l~~l~~~~~L~~l~l~~n~~~~~~p~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 385 (986)
.+..+.|.+.. .-......+|++++++.|+++ .+|+++..+ .+|+.+...+|+++ .+|..+...++|+.
T Consensus 223 ~L~a~~n~l~~--------~~~~p~p~nl~~~dis~n~l~-~lp~wi~~~-~nle~l~~n~N~l~-~lp~ri~~~~~L~~ 291 (1081)
T KOG0618|consen 223 ALYADHNPLTT--------LDVHPVPLNLQYLDISHNNLS-NLPEWIGAC-ANLEALNANHNRLV-ALPLRISRITSLVS 291 (1081)
T ss_pred eeeeccCccee--------eccccccccceeeecchhhhh-cchHHHHhc-ccceEecccchhHH-hhHHHHhhhhhHHH
Confidence 67777776652 112334567899999999998 577888777 68999999999995 78889999999999
Q ss_pred EEccCccccCcCCCcccCCCCCCEEEccCccceeecCcccccc--cccEEEecccccCCCCCcccCCCCCCCeeecCCCc
Q 046598 386 LDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNL--KLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNN 463 (986)
Q Consensus 386 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~--~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 463 (986)
|++..|.++ .+|+...+++.|++|+|..|+|....+..+.-. .|..|+.+.|++....--.=..++.|+.|++.+|.
T Consensus 292 l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~ 370 (1081)
T KOG0618|consen 292 LSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNH 370 (1081)
T ss_pred HHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCc
Confidence 999999998 788888889999999999999985544444332 48888889999884332222335679999999999
Q ss_pred cCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccCcccccCCccccEEecccccccccCCc
Q 046598 464 LTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPS 543 (986)
Q Consensus 464 l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 543 (986)
++...-+. +.+...|+.|+|++|+|.......+.++..|++|+||+|+++ .+|.++..++.|+.|...+|+|. ..|
T Consensus 371 Ltd~c~p~-l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP- 446 (1081)
T KOG0618|consen 371 LTDSCFPV-LVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP- 446 (1081)
T ss_pred ccccchhh-hccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-
Confidence 98655444 567789999999999998544456888999999999999999 89999999999999999999998 677
Q ss_pred cccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCcc
Q 046598 544 SLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDL 585 (986)
Q Consensus 544 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l 585 (986)
++..+++|+.+|+|.|+|+...-.....-++|++|||++|.-
T Consensus 447 e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 447 ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 899999999999999999743322222338999999999985
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=337.62 Aligned_cols=247 Identities=25% Similarity=0.409 Sum_probs=207.0
Q ss_pred CCCCCcccccccceeEEEEEECCC----CeEEEEEEeec-cCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDG----RTTIAVKVFNL-LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~----~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
.....++||+|-||.||+|...+. .-.||||..+. ...+..+.|.+|..+|+.++|||||+++|+|.. .
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e------~ 463 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE------Q 463 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec------c
Confidence 344567899999999999998542 34599999876 344557889999999999999999999999843 5
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..+||||.++.|.|.+|++.. ...++......++.||+.||+|||+. .+|||||..+||+|.....+|
T Consensus 464 P~WivmEL~~~GELr~yLq~n---------k~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVK 531 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQN---------KDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVK 531 (974)
T ss_pred ceeEEEecccchhHHHHHHhc---------cccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceee
Confidence 689999999999999999743 34689999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhh
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~ 922 (986)
|+|||+++.+..+...... ...-+..|||||.+.-++++.+||||.|||++||++. |..||......+.-
T Consensus 532 LaDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-------- 602 (974)
T KOG4257|consen 532 LADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-------- 602 (974)
T ss_pred ecccchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE--------
Confidence 9999999998766554443 4556889999999999999999999999999999998 99999743322110
Q ss_pred CCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 923 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
...+.+.|.+.++.|+..++.++.+||++||.+||++.|+
T Consensus 603 ------------------------~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei 642 (974)
T KOG4257|consen 603 ------------------------GHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEI 642 (974)
T ss_pred ------------------------EEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHH
Confidence 0112234556667899999999999999999999998764
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=336.56 Aligned_cols=201 Identities=28% Similarity=0.446 Sum_probs=170.9
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
.++|++.++||+|+||.||+|++..+++.||+|+++... ......+.+|++++++++||||++++++ +..+...
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~-----~~~~~~~ 78 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI-----IHTERCL 78 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEE-----EcCCCeE
Confidence 357999999999999999999999989999999986432 2234567899999999999999999998 4456789
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
++||||++ ++|.+++.. ....+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 79 ~lv~e~~~-~~l~~~l~~---------~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~ 145 (288)
T cd07871 79 TLVFEYLD-SDLKQYLDN---------CGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLA 145 (288)
T ss_pred EEEEeCCC-cCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEC
Confidence 99999996 499998852 223578899999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
|||+++...... .......+++.|+|||++.+ ..++.++||||+||++|||+||+.||..
T Consensus 146 DfG~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~ 206 (288)
T cd07871 146 DFGLARAKSVPT--KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPG 206 (288)
T ss_pred cCcceeeccCCC--ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999997643221 12233467899999998865 5689999999999999999999999964
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=341.86 Aligned_cols=200 Identities=27% Similarity=0.343 Sum_probs=174.5
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
.++|++.+.||+|+||.||+|++..++..||+|++.... ....+++.+|++++++++||||+++++++ ..++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 78 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGEI 78 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EECCEE
Confidence 468999999999999999999999999999999987542 23346799999999999999999999984 455789
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+
T Consensus 79 ~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~ 146 (331)
T cd06649 79 SICMEHMDGGSLDQVLKE----------AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLC 146 (331)
T ss_pred EEEeecCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEc
Confidence 999999999999999952 235789999999999999999999851 69999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
|||+++..... ......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 147 Dfg~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 147 DFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred cCccccccccc----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 99999765322 12234689999999999999999999999999999999999999963
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=354.38 Aligned_cols=256 Identities=22% Similarity=0.259 Sum_probs=203.0
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCC-CCcceeeeeeccccc-cCC-Cc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVD-YQG-ND 763 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~-~~ 763 (986)
..++++.+.|.+|||+.||+|.+...+..||+|++-..++...+...+|+++|+.++ |+|||.+++...... ... ..
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 346778899999999999999999877999999998778888899999999999995 999999999432221 222 35
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
+++|.||||+||.|-++|.... ...+++.++++|+.|+++|+++||.. +++|||||||-+|||+..+++.|
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rl--------q~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~K 186 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRL--------QTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYK 186 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHH--------hccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEE
Confidence 7899999999999999996322 22499999999999999999999996 78899999999999999999999
Q ss_pred EcccccceecCCCCCcc-------ccccccccccccccccc---cCCCcCcccchhhHHHHHHHHHhCCCCCCccccccc
Q 046598 844 IGDFGLARFLPLSSAQT-------SSIGAKGSIGYIAPEYG---LGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDM 913 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~ 913 (986)
|||||.|+..-...... .......|+.|+|||++ .+.+.++|+|||||||+||-|+....||+....-
T Consensus 187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-- 264 (738)
T KOG1989|consen 187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-- 264 (738)
T ss_pred eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce--
Confidence 99999997543222111 11223468999999974 5678999999999999999999999999732111
Q ss_pred cHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 914 NLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.++... +.++........+.+||+.||+.||++||++.||
T Consensus 265 ---------------aIlng~------------------Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv 304 (738)
T KOG1989|consen 265 ---------------AILNGN------------------YSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQV 304 (738)
T ss_pred ---------------eEEecc------------------ccCCCCccHHHHHHHHHHHHhccCcccCCCHHHH
Confidence 000000 0111222456678899999999999999998664
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=336.53 Aligned_cols=250 Identities=24% Similarity=0.313 Sum_probs=205.9
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
.++|..++.+|+|+||.++.++++..++.+|+|.+.... ....+...+|+.++++++|||||.+.+. |..++.
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds-----~~~~~~ 77 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDS-----FEEDGQ 77 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccc-----hhcCCc
Confidence 367999999999999999999999999999999997533 3334577899999999999999999998 445555
Q ss_pred -EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 765 -KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 765 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
.+|||+|++||++.+.+... .+..++++.+..|+.|++.|+.|||+. .|+|||||+.|||++.++.||
T Consensus 78 ~l~Ivm~Y~eGg~l~~~i~~~--------k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~Vk 146 (426)
T KOG0589|consen 78 LLCIVMEYCEGGDLAQLIKEQ--------KGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVK 146 (426)
T ss_pred eEEEEEeecCCCCHHHHHHHH--------hhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCcee
Confidence 99999999999999999632 245789999999999999999999998 999999999999999999999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhC
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTAL 923 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 923 (986)
|+|||+|+.+.... ......+||+.||+||.+.+.+|+.|+||||+||++|||++-+++|... +....+..
T Consensus 147 LgDfGlaK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~-----~m~~Li~k-- 217 (426)
T KOG0589|consen 147 LGDFGLAKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS-----NMSELILK-- 217 (426)
T ss_pred ecchhhhhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc-----chHHHHHH--
Confidence 99999999875443 2344578999999999999999999999999999999999999998732 22222111
Q ss_pred CCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 924 PDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 924 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
++....... +.....++..++..|++.+|+.||++.++
T Consensus 218 ------i~~~~~~Pl-------------------p~~ys~el~~lv~~~l~~~P~~RPsa~~L 255 (426)
T KOG0589|consen 218 ------INRGLYSPL-------------------PSMYSSELRSLVKSMLRKNPEHRPSALEL 255 (426)
T ss_pred ------HhhccCCCC-------------------CccccHHHHHHHHHHhhcCCccCCCHHHH
Confidence 111111111 11345567899999999999999999764
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=307.75 Aligned_cols=250 Identities=22% Similarity=0.306 Sum_probs=200.0
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeec--cCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
..+.|++.+.||+|.|+.||++.+..+++.+|+|++.. ......+++.+|++|-+.++||||+++.+. +....
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~t-----i~~~~ 83 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS-----IQEES 83 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhh-----hcccc
Confidence 35678888999999999999999999999999999852 233466889999999999999999999988 66778
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCC---C
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED---M 840 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~ 840 (986)
..|+|+|+|.|++|..-+- .....++..+-.+++||++||.|+|.+ +|||||+||+|+++... -
T Consensus 84 ~~ylvFe~m~G~dl~~eIV----------~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A 150 (355)
T KOG0033|consen 84 FHYLVFDLVTGGELFEDIV----------AREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGA 150 (355)
T ss_pred eeEEEEecccchHHHHHHH----------HHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCC
Confidence 9999999999999977662 224578899999999999999999999 99999999999999533 3
Q ss_pred cEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHH
Q 046598 841 IAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLAR 920 (986)
Q Consensus 841 ~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~ 920 (986)
-+||+|||+|..+. ......+.+||+.|||||+++..+|+..+|||+.||++|-++.|.+||... +......
T Consensus 151 ~vKL~~FGvAi~l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~-----~~~rlye 222 (355)
T KOG0033|consen 151 AVKLADFGLAIEVN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE-----DQHRLYE 222 (355)
T ss_pred ceeecccceEEEeC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc-----cHHHHHH
Confidence 69999999998876 334455688999999999999999999999999999999999999999631 1111111
Q ss_pred hhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCC
Q 046598 921 TALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTN 985 (986)
Q Consensus 921 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 985 (986)
.. ...++.- +. +......++..+++++|+..||++|.|+.|
T Consensus 223 ~I------------~~g~yd~---------~~---~~w~~is~~Ak~LvrrML~~dP~kRIta~E 263 (355)
T KOG0033|consen 223 QI------------KAGAYDY---------PS---PEWDTVTPEAKSLIRRMLTVNPKKRITADE 263 (355)
T ss_pred HH------------hccccCC---------CC---cccCcCCHHHHHHHHHHhccChhhhccHHH
Confidence 11 1110000 00 001123345568899999999999999876
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=333.51 Aligned_cols=257 Identities=21% Similarity=0.318 Sum_probs=195.2
Q ss_pred CCCCcChHHHHHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchh---HHHHHHHHHHHhcCCCCcceee
Q 046598 674 SFPNISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGA---FKSFIAECNTLKNIRHRNLVKI 750 (986)
Q Consensus 674 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l 750 (986)
....++.+++ +......||+|++|.||+|.+. ++.||||+++...... .+.+.+|++++++++||||+++
T Consensus 11 ~~~~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~ 83 (283)
T PHA02988 11 DIKCIESDDI-----DKYTSVLIKENDQNSIYKGIFN--NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKI 83 (283)
T ss_pred cceecCHHHc-----CCCCCeEEeeCCceEEEEEEEC--CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEE
Confidence 3444555555 2222357999999999999984 6899999987543322 4678899999999999999999
Q ss_pred eeeccccccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCC
Q 046598 751 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLK 830 (986)
Q Consensus 751 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlk 830 (986)
++++... .......++||||+++|+|.+++.. .+.+++..+..++.|++.|+.|||+.. +++|||||
T Consensus 84 ~g~~~~~-~~~~~~~~lv~Ey~~~g~L~~~l~~----------~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlk 150 (283)
T PHA02988 84 YGFIIDI-VDDLPRLSLILEYCTRGYLREVLDK----------EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLT 150 (283)
T ss_pred eeeEEec-ccCCCceEEEEEeCCCCcHHHHHhh----------CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCC
Confidence 9986432 1234578999999999999999952 235889999999999999999999731 78899999
Q ss_pred CCCeEecCCCcEEEcccccceecCCCCCccccccccccccccccccccC--CCcCcccchhhHHHHHHHHHhCCCCCCcc
Q 046598 831 PSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG--SEVSISGDVYSYGILLLELITRKKPTDIM 908 (986)
Q Consensus 831 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~pf~~~ 908 (986)
|+||++++++.+||+|||+++...... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 151 p~nill~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~ 225 (283)
T PHA02988 151 SVSFLVTENYKLKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL 225 (283)
T ss_pred hhhEEECCCCcEEEcccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC
Confidence 999999999999999999997653221 23457899999999876 68999999999999999999999999732
Q ss_pred ccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 909 FEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.. ...... ....... ...+..++.++.+++.+||+.||++|||++||
T Consensus 226 ~~-----~~~~~~------------i~~~~~~--------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~el 272 (283)
T PHA02988 226 TT-----KEIYDL------------IINKNNS--------------LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEI 272 (283)
T ss_pred CH-----HHHHHH------------HHhcCCC--------------CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHH
Confidence 11 111110 0000000 00001245568899999999999999999874
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=348.71 Aligned_cols=261 Identities=24% Similarity=0.357 Sum_probs=197.5
Q ss_pred hcCCCCCcccccccceeEEEEEECC-----CCeEEEEEEeeccC-chhHHHHHHHHHHHhcC-CCCcceeeeeecccccc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDD-----GRTTIAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDY 759 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 759 (986)
.++|++.+.||+|+||.||+|++.. +...||+|+++... ....+.+.+|+++++.+ +|+||++++++|
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~----- 111 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC----- 111 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe-----
Confidence 3579999999999999999998643 33579999997533 33456788999999999 899999999985
Q ss_pred CCCceEEEEEEeccCCCHhHhhccCCCC----------------------------------------------------
Q 046598 760 QGNDFKALVFEFMHNRSLEEWLHPITRE---------------------------------------------------- 787 (986)
Q Consensus 760 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------------- 787 (986)
......++||||+++|+|.++++.....
T Consensus 112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 4457899999999999999998642210
Q ss_pred --------CccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcccccceecCCCCCc
Q 046598 788 --------DETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQ 859 (986)
Q Consensus 788 --------~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 859 (986)
........++++.++++|+.||+.||+|||++ +|+||||||+||++++++.+||+|||+++........
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 00011234588999999999999999999999 9999999999999999999999999999865433222
Q ss_pred cccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCchhHHhhhhcccC
Q 046598 860 TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLND 938 (986)
Q Consensus 860 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 938 (986)
.......++..|||||++.+..++.++|||||||++|||++ |+.||....... ...... .......
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~------------~~~~~~~ 335 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMV------------KRGYQMS 335 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHH------------HcccCcc
Confidence 22223345678999999998999999999999999999997 999986432211 111111 1000000
Q ss_pred CcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 939 GEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
. +...+.++.+++.+||+.||++|||+.||
T Consensus 336 ~------------------~~~~~~~l~~li~~cl~~dp~~RPs~~~l 365 (374)
T cd05106 336 R------------------PDFAPPEIYSIMKMCWNLEPTERPTFSQI 365 (374)
T ss_pred C------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 0 00123467899999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=343.02 Aligned_cols=193 Identities=24% Similarity=0.312 Sum_probs=168.2
Q ss_pred cccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEEEE
Q 046598 694 NQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFE 770 (986)
Q Consensus 694 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 770 (986)
+.||+|+||.||+|++..+++.||+|+++.. .......+.+|++++++++||||++++++ +..++..|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~-----~~~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYS-----FQTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEE-----EEcCCEEEEEEe
Confidence 4699999999999999988999999999743 22344567889999999999999999988 456688999999
Q ss_pred eccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcccccc
Q 046598 771 FMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLA 850 (986)
Q Consensus 771 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a 850 (986)
|+++|+|.+++.. .+.+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 76 ~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a 142 (323)
T cd05571 76 YANGGELFFHLSR----------ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLC 142 (323)
T ss_pred CCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCC
Confidence 9999999999852 34689999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCC
Q 046598 851 RFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTD 906 (986)
Q Consensus 851 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~ 906 (986)
+..... ........||+.|+|||++.+..++.++||||+||++|||++|+.||.
T Consensus 143 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 196 (323)
T cd05571 143 KEGISD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 196 (323)
T ss_pred cccccC--CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCC
Confidence 753221 122234568999999999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=346.03 Aligned_cols=251 Identities=22% Similarity=0.286 Sum_probs=198.6
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
++|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|++++..++||||++++++ +..+..
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~-----~~~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYA-----FQDDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEE-----EEcCCE
Confidence 46999999999999999999999889999999997532 2344678899999999999999999988 456678
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.|+||||+++|+|.+++.. ...+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~e~~~g~~L~~~l~~----------~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL 142 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNN----------LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKL 142 (333)
T ss_pred EEEEEeCCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEE
Confidence 9999999999999999952 23588999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCC
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALP 924 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 924 (986)
+|||+++.... ......|++.|+|||++.+..++.++|||||||++|||++|+.||......+ .+..... ..
T Consensus 143 ~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~i~~--~~ 214 (333)
T cd05600 143 TDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE-TWENLKY--WK 214 (333)
T ss_pred EeCcCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH-HHHHHHh--cc
Confidence 99999976432 2234568999999999999999999999999999999999999996322110 0000000 00
Q ss_pred CchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 925 DHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 925 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
. .+ ..+.. .........++.+++.+|+..+|++||+++||
T Consensus 215 ~--------~~-~~~~~-------------~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~l 254 (333)
T cd05600 215 E--------TL-QRPVY-------------DDPRFNLSDEAWDLITKLINDPSRRFGSLEDI 254 (333)
T ss_pred c--------cc-cCCCC-------------CccccccCHHHHHHHHHHhhChhhhcCCHHHH
Confidence 0 00 00000 00001234567789999999999999998764
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=335.16 Aligned_cols=278 Identities=24% Similarity=0.321 Sum_probs=196.8
Q ss_pred cCCCCCcccccccceeEEEEEEC-CCCeEEEEEEeeccC--chhHHHHHHHHHHHhcC---CCCcceeeeeeccccccCC
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILD-DGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNI---RHRNLVKILTACSGVDYQG 761 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~ 761 (986)
++|++.+.||+|+||.||+|++. .+++.||+|+++... ......+.+|+.+++.+ +||||++++++|.......
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 47999999999999999999985 446889999986432 22234566777776665 6999999999875443445
Q ss_pred CceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCc
Q 046598 762 NDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI 841 (986)
Q Consensus 762 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 841 (986)
....++||||++ ++|.+++... ....+++.++..++.||+.||+|||+. +|+||||||+||+++.++.
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~--------~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~ 148 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV--------PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQ 148 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC--------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCC
Confidence 667999999995 6999998532 123588999999999999999999999 9999999999999999999
Q ss_pred EEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHh
Q 046598 842 AHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLART 921 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~ 921 (986)
+||+|||+++..... .......|++.|+|||++.+..++.++|||||||++|||++|++||......+ .+......
T Consensus 149 ~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-~~~~i~~~ 224 (290)
T cd07862 149 IKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDV 224 (290)
T ss_pred EEEccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHH
Confidence 999999999865432 22234568999999999998899999999999999999999999997432211 11111111
Q ss_pred hCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 922 ALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 922 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.......++ ..... .+.. ........+ ...........+.+++.+|++.||++|||+.|+
T Consensus 225 ~~~~~~~~~-~~~~~-~~~~-~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~ 284 (290)
T cd07862 225 IGLPGEEDW-PRDVA-LPRQ-AFHSKSAQP--IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 284 (290)
T ss_pred hCCCChhhc-hhhhc-ccch-hccCCCCCC--HHHHccCCCHHHHHHHHHHhccCchhcCCHHHH
Confidence 000000000 00000 0000 000000000 000111234567799999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=347.41 Aligned_cols=261 Identities=26% Similarity=0.336 Sum_probs=198.0
Q ss_pred hcCCCCCcccccccceeEEEEEE-----CCCCeEEEEEEeeccC-chhHHHHHHHHHHHhcC-CCCcceeeeeecccccc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGIL-----DDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDY 759 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 759 (986)
.++|++.+.||+|+||.||+|.+ .+++..||||+++... ....+.+.+|+++++.+ +||||++++++|
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~----- 108 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC----- 108 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee-----
Confidence 45799999999999999999975 3446789999986432 33456788999999999 899999999995
Q ss_pred CCCceEEEEEEeccCCCHhHhhccCCCCCc--------------------------------------------------
Q 046598 760 QGNDFKALVFEFMHNRSLEEWLHPITREDE-------------------------------------------------- 789 (986)
Q Consensus 760 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-------------------------------------------------- 789 (986)
..+...++||||+++|+|.++++.......
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 455778999999999999999964321000
Q ss_pred ---------------cccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcccccceecC
Q 046598 790 ---------------TDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLP 854 (986)
Q Consensus 790 ---------------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 854 (986)
.......+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceecc
Confidence 001123588999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCchhHHhhh
Q 046598 855 LSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALPDHVMDIVDS 933 (986)
Q Consensus 855 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 933 (986)
............++..|+|||++.+..++.++|||||||++|||++ |..||....... ..... +..
T Consensus 266 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~~~~------------~~~ 332 (375)
T cd05104 266 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KFYKM------------IKE 332 (375)
T ss_pred CcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HHHHH------------HHh
Confidence 3332222222345678999999999999999999999999999998 888986432111 11111 110
Q ss_pred hcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 934 TLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 934 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..... .+...+.++.+++.+||+.||++|||++||
T Consensus 333 ~~~~~------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~ei 367 (375)
T cd05104 333 GYRML------------------SPECAPSEMYDIMKSCWDADPLKRPTFKQI 367 (375)
T ss_pred CccCC------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 00000 000123467899999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=315.58 Aligned_cols=260 Identities=23% Similarity=0.364 Sum_probs=199.1
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcC--CCCcceeeeeeccccccCCCc
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNI--RHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~~~~~~ 763 (986)
..++....+.||+|.||+||+|.|++ +.||||++...+ ++.+.+|.+|.+.. +|+||+.+++.-... -..-.
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wrG--e~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~-~gs~T 282 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWRG--EDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKD-NGSWT 282 (513)
T ss_pred hhheeEEEEEecCccccceeeccccC--CceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccC-CCceE
Confidence 34567788999999999999999985 889999997543 36677888888765 999999999872111 11123
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEeecCCCCCeEecC
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHD-----CQPPIAHCDLKPSNILLDE 838 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-----~~~~ivH~Dlkp~NIll~~ 838 (986)
..++|++|.+.|||.+|+.+ ..++....++++..+|.||+|||.. .+|.|.|||||+.||||..
T Consensus 283 QLwLvTdYHe~GSL~DyL~r-----------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKk 351 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNR-----------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 351 (513)
T ss_pred EEEEeeecccCCcHHHHHhh-----------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEcc
Confidence 68999999999999999963 3588999999999999999999975 4889999999999999999
Q ss_pred CCcEEEcccccceecCCCCC--ccccccccccccccccccccCCC------cCcccchhhHHHHHHHHHhC---------
Q 046598 839 DMIAHIGDFGLARFLPLSSA--QTSSIGAKGSIGYIAPEYGLGSE------VSISGDVYSYGILLLELITR--------- 901 (986)
Q Consensus 839 ~~~~kL~DFG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlGvvl~elltg--------- 901 (986)
++.+.|+|+|+|........ .......+||.+|||||++...- .-..+||||||.|+||+...
T Consensus 352 n~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~ee 431 (513)
T KOG2052|consen 352 NGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEE 431 (513)
T ss_pred CCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehh
Confidence 99999999999977654422 23345678999999999986541 22568999999999999763
Q ss_pred -CCCCCccccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCC
Q 046598 902 -KKPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDR 980 (986)
Q Consensus 902 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R 980 (986)
+.||....+.+.+++++......+.+...+. .++ ...++...+.++|+.||..+|+.|
T Consensus 432 y~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ip--------------------nrW-~s~~~l~~m~klMkeCW~~Np~aR 490 (513)
T KOG2052|consen 432 YQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIP--------------------NRW-KSDPALRVMAKLMKECWYANPAAR 490 (513)
T ss_pred hcCCcccCCCCCCCHHHHhcceeecccCCCCC--------------------ccc-ccCHHHHHHHHHHHHhhcCCchhh
Confidence 3566666565555555543322222222121 122 223567789999999999999999
Q ss_pred CCC
Q 046598 981 MSM 983 (986)
Q Consensus 981 Pt~ 983 (986)
-||
T Consensus 491 ltA 493 (513)
T KOG2052|consen 491 LTA 493 (513)
T ss_pred hHH
Confidence 876
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=341.72 Aligned_cols=197 Identities=24% Similarity=0.329 Sum_probs=174.1
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
.++|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|+.++++++||||++++++ +.+++
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~-----~~~~~ 91 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCS-----FQDEN 91 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEE-----EEcCC
Confidence 357899999999999999999999989999999987432 2334678899999999999999999998 45668
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+|
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~k 158 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRK----------AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVK 158 (329)
T ss_pred EEEEEEcCCCCChHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEE
Confidence 89999999999999999852 23578889999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCC
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTD 906 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~ 906 (986)
|+|||+++...... ....|++.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 159 l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 216 (329)
T PTZ00263 159 VTDFGFAKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFF 216 (329)
T ss_pred EeeccCceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCC
Confidence 99999998653221 23468999999999999999999999999999999999999985
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=337.41 Aligned_cols=236 Identities=25% Similarity=0.324 Sum_probs=189.2
Q ss_pred cccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEEEEec
Q 046598 696 IGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFM 772 (986)
Q Consensus 696 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 772 (986)
||+|+||.||+|++..+++.||+|+++.. .......+.+|+.++++++||||++++++ +..++..++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-----~~~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFS-----FQSPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeE-----EecCCeEEEEEcCC
Confidence 69999999999999988999999998742 23345678899999999999999999988 45567899999999
Q ss_pred cCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccccccee
Q 046598 773 HNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARF 852 (986)
Q Consensus 773 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~ 852 (986)
++|+|.+++.. .+.+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 76 ~~g~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~ 142 (312)
T cd05585 76 NGGELFHHLQR----------EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKL 142 (312)
T ss_pred CCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECccccc
Confidence 99999999952 23588999999999999999999999 999999999999999999999999999975
Q ss_pred cCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCchhHHhh
Q 046598 853 LPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVMDIVD 932 (986)
Q Consensus 853 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d 932 (986)
..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||... .............
T Consensus 143 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~-----~~~~~~~~~~~~~------ 209 (312)
T cd05585 143 NMKDD--DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE-----NVNEMYRKILQEP------ 209 (312)
T ss_pred CccCC--CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC-----CHHHHHHHHHcCC------
Confidence 42221 2223456899999999999999999999999999999999999999632 1111111111100
Q ss_pred hhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 046598 933 STLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMT 984 (986)
Q Consensus 933 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 984 (986)
. . .+.....++.+++.+||+.||++||++.
T Consensus 210 --~-----~---------------~~~~~~~~~~~li~~~L~~dp~~R~~~~ 239 (312)
T cd05585 210 --L-----R---------------FPDGFDRDAKDLLIGLLSRDPTRRLGYN 239 (312)
T ss_pred --C-----C---------------CCCcCCHHHHHHHHHHcCCCHHHcCCCC
Confidence 0 0 0012334567899999999999998753
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=316.46 Aligned_cols=212 Identities=28% Similarity=0.426 Sum_probs=177.1
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc--hhHHHHHHHHHHHhcCCCCc-ceeeeeeccccc-cCCC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH--GAFKSFIAECNTLKNIRHRN-LVKILTACSGVD-YQGN 762 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~-~~~~ 762 (986)
...|..+++||+|+||+||+|+...+++.||+|.++.... +......+|+.+++.++|+| |+++++++.... +...
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 4557778899999999999999999999999999976433 34566789999999999999 999999965431 1223
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
...++||||+ .-+|.+++....... ..++...++.+++||++||+|||++ +|+||||||+||+|+++|.+
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~------~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~l 159 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKP------QGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVL 159 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccc------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcE
Confidence 4789999999 569999997544221 3466688999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCccccccccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCcccc
Q 046598 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDIMFE 910 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~ 910 (986)
||+|||+|+..... ....+..++|..|+|||++.+. .|+...||||+||+++||+++++-|.+..+
T Consensus 160 KlaDFGlAra~~ip--~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se 226 (323)
T KOG0594|consen 160 KLADFGLARAFSIP--MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE 226 (323)
T ss_pred eeeccchHHHhcCC--cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH
Confidence 99999999865422 2224456789999999999886 799999999999999999999998865443
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=344.81 Aligned_cols=247 Identities=26% Similarity=0.402 Sum_probs=205.8
Q ss_pred CCCCcccccccceeEEEEEECCC----CeEEEEEEeec-cCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 690 FSSVNQIGEGSFGSVFKGILDDG----RTTIAVKVFNL-LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 690 y~~~~~lg~G~~g~Vy~~~~~~~----~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
....++||+|+||+||+|.+--. +.+||+|++.. ......+++..|+.+|.+++|||+++++++|... .
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s------~ 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS------T 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc------h
Confidence 34567899999999999999432 45689999864 4445568899999999999999999999998543 3
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
..||++||+.|+|.+|++.. ...+.....+.|..|||+||.|||.+ ++|||||.++||||.+...+||
T Consensus 772 ~qlvtq~mP~G~LlDyvr~h---------r~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvki 839 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREH---------RDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKI 839 (1177)
T ss_pred HHHHHHhcccchHHHHHHHh---------hccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEE
Confidence 78999999999999999743 34688889999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhC
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTAL 923 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 923 (986)
.|||+|+....++.........-.+.|||=|.+....|+.++|||||||++||++| |..|++.....
T Consensus 840 tdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~------------ 907 (1177)
T KOG1025|consen 840 TDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE------------ 907 (1177)
T ss_pred EecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH------------
Confidence 99999998877766666666667889999999999999999999999999999999 99998743221
Q ss_pred CCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 924 PDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 924 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
++.+++. .+.|.+.++-+..+++.++.+||..|++.||+|+++
T Consensus 908 --eI~dlle------------------~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel 950 (1177)
T KOG1025|consen 908 --EIPDLLE------------------KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKEL 950 (1177)
T ss_pred --HhhHHHh------------------ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHH
Confidence 1122221 112345556788899999999999999999999763
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=334.04 Aligned_cols=248 Identities=28% Similarity=0.476 Sum_probs=209.2
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEE
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALV 768 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 768 (986)
+...-++||-|.||.||.|.|+.-.-.||||.++. +..+.++|.+|+.+|+.++|||+|+++|+|.. +...|||
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~-----EpPFYIi 341 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH-----EPPFYII 341 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhcc-----CCCeEEE
Confidence 45566899999999999999998889999999975 34567899999999999999999999999853 4678999
Q ss_pred EEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcccc
Q 046598 769 FEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFG 848 (986)
Q Consensus 769 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG 848 (986)
+|||..|+|.+|++++.+. .++....+.+|.||+.|++||..+ .+|||||.++|.||.++..+|++|||
T Consensus 342 TEfM~yGNLLdYLRecnr~--------ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFG 410 (1157)
T KOG4278|consen 342 TEFMCYGNLLDYLRECNRS--------EVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFG 410 (1157)
T ss_pred EecccCccHHHHHHHhchh--------hcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccc
Confidence 9999999999999876654 456667889999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCch
Q 046598 849 LARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALPDHV 927 (986)
Q Consensus 849 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 927 (986)
+++.+..+ ..+...+..-++.|.|||-+.-..++.|+|||+|||++||+.| |..||.+. ++.. +
T Consensus 411 LsRlMtgD-TYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi-----dlSq---------V 475 (1157)
T KOG4278|consen 411 LSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQ---------V 475 (1157)
T ss_pred hhhhhcCC-ceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc-----cHHH---------H
Confidence 99988643 4444555667889999999999999999999999999999999 88887632 1111 2
Q ss_pred hHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 928 MDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 928 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+++.. ++|.+.++.|+..++++|+.||+++|.+||+++|+
T Consensus 476 Y~LLEk------------------gyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 476 YGLLEK------------------GYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred HHHHhc------------------cccccCCCCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence 222221 23455566899999999999999999999999874
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=356.26 Aligned_cols=252 Identities=19% Similarity=0.221 Sum_probs=200.6
Q ss_pred CCCCCcccccccceeEEEEEECCC-CeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEE
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDG-RTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 767 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 767 (986)
.|.+.+.||+|++|.||+|....+ ++.||+|.+..........+.+|+.+++.++||||++++++| ..++..|+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~-----~~~~~~~l 142 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDF-----KSDDKLLL 142 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEE-----EECCEEEE
Confidence 489999999999999999998776 788999987655555556788899999999999999999994 45678999
Q ss_pred EEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccc
Q 046598 768 VFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDF 847 (986)
Q Consensus 768 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DF 847 (986)
||||+++|+|.++++... ....++++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 143 v~E~~~gg~L~~~l~~~~------~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DF 213 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRL------KEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDF 213 (478)
T ss_pred EEECCCCCCHHHHHHHHH------hccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeC
Confidence 999999999999885321 1234688999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCch
Q 046598 848 GLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHV 927 (986)
Q Consensus 848 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 927 (986)
|+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...
T Consensus 214 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-----~~~--------- 279 (478)
T PTZ00267 214 GFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-----REI--------- 279 (478)
T ss_pred cCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----HHH---------
Confidence 999876433322233445699999999999999999999999999999999999999863211 111
Q ss_pred hHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 928 MDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 928 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+...+...... .+...+.++.+++.+||+.||++||+++++
T Consensus 280 ---~~~~~~~~~~~---------------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~ 320 (478)
T PTZ00267 280 ---MQQVLYGKYDP---------------FPCPVSSGMKALLDPLLSKNPALRPTTQQL 320 (478)
T ss_pred ---HHHHHhCCCCC---------------CCccCCHHHHHHHHHHhccChhhCcCHHHH
Confidence 11111110000 001223457899999999999999998763
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=316.06 Aligned_cols=206 Identities=26% Similarity=0.354 Sum_probs=178.4
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
.+.|+.++.||.|.-|+||+++..+++..+|+|++.+. ......+.+.|-+||+.++||.++.+|+. ++.++
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~-----fet~~ 150 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYAS-----FETDK 150 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhe-----eeccc
Confidence 34577889999999999999999999999999999643 23445677889999999999999999998 77889
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..|+|||||+||+|....++ +..+.+++..++-++.+++-||+|||-. |||+|||||+||||.++|++.
T Consensus 151 ~~cl~meyCpGGdL~~Lrqk--------Qp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIM 219 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQK--------QPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIM 219 (459)
T ss_pred eeEEEEecCCCccHHHHHhh--------CCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEE
Confidence 99999999999999999873 4456899999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCC--------------------------------C-C---------------------ccccccccccc
Q 046598 844 IGDFGLARFLPLS--------------------------------S-A---------------------QTSSIGAKGSI 869 (986)
Q Consensus 844 L~DFG~a~~~~~~--------------------------------~-~---------------------~~~~~~~~gt~ 869 (986)
|+||.++...... . . .......+||-
T Consensus 220 LsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGTh 299 (459)
T KOG0610|consen 220 LSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTH 299 (459)
T ss_pred eeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccc
Confidence 9999998533110 0 0 01123456999
Q ss_pred cccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCcc
Q 046598 870 GYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIM 908 (986)
Q Consensus 870 ~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~ 908 (986)
.|.|||++.|...+.++|.|+|||++|||+.|..||.+.
T Consensus 300 EYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~ 338 (459)
T KOG0610|consen 300 EYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGS 338 (459)
T ss_pred ccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCC
Confidence 999999999999999999999999999999999999743
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=336.23 Aligned_cols=243 Identities=22% Similarity=0.307 Sum_probs=199.9
Q ss_pred ccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEEEEeccC
Q 046598 695 QIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHN 774 (986)
Q Consensus 695 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~ 774 (986)
.||+|.||+||-|++.++...+|||.+...+....+-+..|+...++++|.|||+++|.| ..+++.-|.||.++|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQVPG 656 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecCCC
Confidence 699999999999999999999999999877777778889999999999999999999994 456789999999999
Q ss_pred CCHhHhhccCCCCCccccCCCcc--CHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEec-CCCcEEEcccccce
Q 046598 775 RSLEEWLHPITREDETDEAPRSL--NLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLD-EDMIAHIGDFGLAR 851 (986)
Q Consensus 775 gsL~~~l~~~~~~~~~~~~~~~l--~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kL~DFG~a~ 851 (986)
|+|.+.++ ...+++ .+...-.+.+||++||.|||++ .|||||||-+||+|+ ..|.+||+|||.++
T Consensus 657 GSLSsLLr---------skWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsK 724 (1226)
T KOG4279|consen 657 GSLSSLLR---------SKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSK 724 (1226)
T ss_pred CcHHHHHH---------hccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccch
Confidence 99999996 445566 6778888999999999999999 999999999999995 67899999999998
Q ss_pred ecCCCCCccccccccccccccccccccCC--CcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCchhH
Q 046598 852 FLPLSSAQTSSIGAKGSIGYIAPEYGLGS--EVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVMD 929 (986)
Q Consensus 852 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 929 (986)
.... -.+.+..+.||..|||||++..+ .|+.++|||||||++.||.||++||-.... ....+.+...
T Consensus 725 RLAg--inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs---pqAAMFkVGm------ 793 (1226)
T KOG4279|consen 725 RLAG--INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGS---PQAAMFKVGM------ 793 (1226)
T ss_pred hhcc--CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCC---hhHhhhhhcc------
Confidence 7642 23444557799999999999875 588999999999999999999999964322 1222211110
Q ss_pred HhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 930 IVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 930 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
... .++.+.+...+...++.+|+.+||.+||+|+++
T Consensus 794 -----yKv----------------HP~iPeelsaeak~FilrcFepd~~~R~sA~~L 829 (1226)
T KOG4279|consen 794 -----YKV----------------HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDL 829 (1226)
T ss_pred -----eec----------------CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHh
Confidence 000 011233556677899999999999999999874
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=343.33 Aligned_cols=193 Identities=25% Similarity=0.340 Sum_probs=167.4
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 767 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 767 (986)
++|++.+.||+|+||.||+|.+..+++.||+|+.. ...+.+|++++++++||||+++++++ ..+...++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~l 160 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTF-----TYNKFTCL 160 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEE-----EECCeeEE
Confidence 57999999999999999999999999999999743 24567899999999999999999984 45678999
Q ss_pred EEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccc
Q 046598 768 VFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDF 847 (986)
Q Consensus 768 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DF 847 (986)
|||++ +++|..++.. ...+++.+++.|+.||+.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 161 v~e~~-~~~L~~~l~~----------~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DF 226 (391)
T PHA03212 161 ILPRY-KTDLYCYLAA----------KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDF 226 (391)
T ss_pred EEecC-CCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeC
Confidence 99999 5789888842 23578999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCC
Q 046598 848 GLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTD 906 (986)
Q Consensus 848 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~ 906 (986)
|+|+...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||-
T Consensus 227 G~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 227 GAACFPVDIN-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred Cccccccccc-ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 9997532211 122234579999999999999999999999999999999999998864
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=338.58 Aligned_cols=193 Identities=24% Similarity=0.318 Sum_probs=167.5
Q ss_pred cccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEEEE
Q 046598 694 NQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFE 770 (986)
Q Consensus 694 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 770 (986)
+.||+|+||.||+|++..+++.||+|+++.. .......+.+|+++++.++||||++++++ +..++..|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~-----~~~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYA-----FQTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeE-----EecCCEEEEEEe
Confidence 4699999999999999988999999999743 22344567889999999999999999988 455678999999
Q ss_pred eccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcccccc
Q 046598 771 FMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLA 850 (986)
Q Consensus 771 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a 850 (986)
|+++|+|..++.. ...+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 76 ~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~ 142 (323)
T cd05595 76 YANGGELFFHLSR----------ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLC 142 (323)
T ss_pred CCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHh
Confidence 9999999988842 23688999999999999999999999 9999999999999999999999999998
Q ss_pred eecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCC
Q 046598 851 RFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTD 906 (986)
Q Consensus 851 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~ 906 (986)
+..... ........|++.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 143 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~ 196 (323)
T cd05595 143 KEGISD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 196 (323)
T ss_pred ccccCC--CCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCC
Confidence 753221 112233568999999999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=355.32 Aligned_cols=263 Identities=23% Similarity=0.279 Sum_probs=204.3
Q ss_pred HHHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc--CchhHHHHHHHHHHHhcCCCCcceeeeeecccccc-
Q 046598 683 LYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY- 759 (986)
Q Consensus 683 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~- 759 (986)
.....++|++.+.||+|+||+||+|++..+++.||||++... .......+.+|+.++..++|+||+++++.+.....
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 334567999999999999999999999988999999998653 23445678899999999999999998876432211
Q ss_pred --CCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEec
Q 046598 760 --QGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLD 837 (986)
Q Consensus 760 --~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 837 (986)
......++||||+++|+|.++++... .....+++..+..++.|++.||.|||+. +|+||||||+||+++
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~------~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~ 177 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRA------KTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLC 177 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhh------ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEe
Confidence 11124789999999999999996322 2234689999999999999999999999 999999999999999
Q ss_pred CCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHH
Q 046598 838 EDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHN 917 (986)
Q Consensus 838 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~ 917 (986)
.++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||... ....
T Consensus 178 ~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~-----~~~~ 252 (496)
T PTZ00283 178 SNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE-----NMEE 252 (496)
T ss_pred CCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC-----CHHH
Confidence 99999999999998764332223333467999999999999999999999999999999999999999632 1111
Q ss_pred HHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 918 LARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 918 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
... ..+...... .+...+.++.+++.+||+.||++||++.+|
T Consensus 253 ~~~------------~~~~~~~~~---------------~~~~~~~~l~~li~~~L~~dP~~RPs~~el 294 (496)
T PTZ00283 253 VMH------------KTLAGRYDP---------------LPPSISPEMQEIVTALLSSDPKRRPSSSKL 294 (496)
T ss_pred HHH------------HHhcCCCCC---------------CCCCCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 111 111110000 001234567899999999999999998764
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=315.94 Aligned_cols=246 Identities=24% Similarity=0.323 Sum_probs=205.5
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEE
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALV 768 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 768 (986)
-|.++.+||+|+||.||+|.++.+|+.||+|.+... .+.+++.+|+.|+++.+.|+||++||. +-.....++|
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGS-----YFK~sDLWIV 106 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGS-----YFKHSDLWIV 106 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhh-----hccCCceEee
Confidence 377889999999999999999999999999998764 456889999999999999999999998 4455779999
Q ss_pred EEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcccc
Q 046598 769 FEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFG 848 (986)
Q Consensus 769 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG 848 (986)
||||..|++.+.++ ...+++++.++..+++..++||+|||.. .-+|||||+.||+++.+|.+||+|||
T Consensus 107 MEYCGAGSiSDI~R---------~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFG 174 (502)
T KOG0574|consen 107 MEYCGAGSISDIMR---------ARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFG 174 (502)
T ss_pred hhhcCCCcHHHHHH---------HhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhcc
Confidence 99999999999996 5567899999999999999999999999 88999999999999999999999999
Q ss_pred cceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCchh
Q 046598 849 LARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVM 928 (986)
Q Consensus 849 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 928 (986)
.|..+. +.........||+.|||||++..-.|+.++||||+|++..||..|++||....+...-+
T Consensus 175 VAGQLT--DTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF------------- 239 (502)
T KOG0574|consen 175 VAGQLT--DTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF------------- 239 (502)
T ss_pred ccchhh--hhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE-------------
Confidence 997653 23333445789999999999999999999999999999999999999987432211000
Q ss_pred HHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCC
Q 046598 929 DIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTN 985 (986)
Q Consensus 929 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 985 (986)
.....+...+..+++-..++.++++.|+-..|++|-||.+
T Consensus 240 -----------------MIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~ 279 (502)
T KOG0574|consen 240 -----------------MIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALR 279 (502)
T ss_pred -----------------eccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHH
Confidence 0011122233444556667889999999999999988754
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=337.83 Aligned_cols=193 Identities=25% Similarity=0.335 Sum_probs=168.2
Q ss_pred cccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEEEE
Q 046598 694 NQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFE 770 (986)
Q Consensus 694 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 770 (986)
+.||+|+||.||+|.+..+++.||+|++... .......+.+|+++++.++||||++++++ +..++..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~-----~~~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYS-----FQTKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEE-----EEcCCEEEEEEe
Confidence 4689999999999999998999999999743 23345678899999999999999999988 456688999999
Q ss_pred eccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcccccc
Q 046598 771 FMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLA 850 (986)
Q Consensus 771 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a 850 (986)
|+++|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 76 y~~~g~L~~~l~~----------~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~ 142 (328)
T cd05593 76 YVNGGELFFHLSR----------ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLC 142 (328)
T ss_pred CCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCC
Confidence 9999999998842 24689999999999999999999999 9999999999999999999999999998
Q ss_pred eecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCC
Q 046598 851 RFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTD 906 (986)
Q Consensus 851 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~ 906 (986)
+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 143 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~ 196 (328)
T cd05593 143 KEGITD--AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 196 (328)
T ss_pred ccCCCc--ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCC
Confidence 753221 112233568999999999999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=336.51 Aligned_cols=200 Identities=27% Similarity=0.353 Sum_probs=173.5
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
.++|++.++||+|+||.||+|.+..++..+|+|+++... ....+.+.+|++++++++||||++++++| ..++..
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 78 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGEI 78 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEE-----EECCEE
Confidence 468999999999999999999999889999999987542 23446789999999999999999999995 445789
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
++||||+++++|.+++.. .+.+++..+..++.|++.|+.|||+. .+|+||||||+||+++.++.+||+
T Consensus 79 ~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~ 146 (333)
T cd06650 79 SICMEHMDGGSLDQVLKK----------AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLC 146 (333)
T ss_pred EEEEecCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEe
Confidence 999999999999999952 23578889999999999999999974 179999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
|||++...... ......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 147 Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 147 DFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred eCCcchhhhhh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 99999754321 11234688999999999998999999999999999999999999863
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=341.57 Aligned_cols=246 Identities=25% Similarity=0.376 Sum_probs=190.3
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc-hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
++|+..++||+|+||.||+|++..+++.||||++..... ...+.+.+|+++++.++|+||++++++ +..++..+
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-----~~~~~~~~ 148 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDM-----FDHNGEIQ 148 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeE-----eccCCeEE
Confidence 456778999999999999999998899999999865332 334678999999999999999999998 45667899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+++++|.+.. ..++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|
T Consensus 149 lv~e~~~~~~L~~~~--------------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~D 211 (353)
T PLN00034 149 VLLEFMDGGSLEGTH--------------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIAD 211 (353)
T ss_pred EEEecCCCCcccccc--------------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcc
Confidence 999999999986543 245677889999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccC-----CCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHh
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-----SEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLART 921 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~ 921 (986)
||+++.+..... ......|+..|+|||++.. ...+.++|||||||++|||++|+.||.....+ .+......
T Consensus 212 fG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~~~~~~~ 287 (353)
T PLN00034 212 FGVSRILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--DWASLMCA 287 (353)
T ss_pred cccceecccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--cHHHHHHH
Confidence 999986542211 1233568999999998743 23457899999999999999999999722111 11111110
Q ss_pred hCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 922 ALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 922 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
. ...... .....+..++.+++.+||+.||++|||+.||
T Consensus 288 ~------------~~~~~~---------------~~~~~~~~~l~~li~~~l~~~P~~Rpt~~el 325 (353)
T PLN00034 288 I------------CMSQPP---------------EAPATASREFRHFISCCLQREPAKRWSAMQL 325 (353)
T ss_pred H------------hccCCC---------------CCCCccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 0 000000 0001234567899999999999999999874
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=336.17 Aligned_cols=242 Identities=22% Similarity=0.284 Sum_probs=190.4
Q ss_pred CCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHH---hcCCCCcceeeeeeccccccCCCc
Q 046598 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTL---KNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 690 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
|++.+.||+|+||.||+|.+..+++.||||+++... ....+.+.+|++++ +.++||||++++++ +...+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~-----~~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFAC-----FQTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeE-----EEcCC
Confidence 678899999999999999999889999999997432 23345566676655 56689999999998 45668
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..|+||||+++++|..+++ ...+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+|
T Consensus 76 ~~~lv~E~~~~~~L~~~~~-----------~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~k 141 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIH-----------TDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVK 141 (324)
T ss_pred EEEEEEcCCCCCcHHHHhh-----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEE
Confidence 8999999999999998874 13589999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhC
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTAL 923 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 923 (986)
|+|||+++..... ........|++.|+|||++.+..++.++|||||||++|||++|+.||..... .....
T Consensus 142 L~Dfg~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~-----~~~~~--- 211 (324)
T cd05589 142 IADFGLCKEGMGF--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE-----EEVFD--- 211 (324)
T ss_pred eCcccCCccCCCC--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH-----HHHHH---
Confidence 9999998753221 1222345689999999999999999999999999999999999999863211 11111
Q ss_pred CCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCC
Q 046598 924 PDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTN 985 (986)
Q Consensus 924 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 985 (986)
......+. .+...+..+.+++.+|++.||++||++.+
T Consensus 212 ---------~i~~~~~~----------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~ 248 (324)
T cd05589 212 ---------SIVNDEVR----------------YPRFLSREAISIMRRLLRRNPERRLGSGE 248 (324)
T ss_pred ---------HHHhCCCC----------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 00000000 00122445678999999999999997643
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=329.07 Aligned_cols=261 Identities=23% Similarity=0.392 Sum_probs=198.4
Q ss_pred hhcCCCCCcccccccceeEEEEEECC-----CCeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeecccccc
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDD-----GRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY 759 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 759 (986)
.+++|++.+.||+|+||.||+|.+.. .+..||+|+++... .....++.+|+.+++.++||||+++++++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~----- 78 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV----- 78 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence 46789999999999999999998752 35679999886432 23445788999999999999999999984
Q ss_pred CCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCC
Q 046598 760 QGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED 839 (986)
Q Consensus 760 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 839 (986)
..+...++||||+++++|.++++..............+++..+..++.|++.|++|||+. +++||||||+||+++++
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~ 155 (277)
T cd05062 79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 155 (277)
T ss_pred cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCC
Confidence 455789999999999999999964332211111234578889999999999999999999 99999999999999999
Q ss_pred CcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHH
Q 046598 840 MIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNL 918 (986)
Q Consensus 840 ~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~ 918 (986)
+.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||..... ...
T Consensus 156 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-----~~~ 230 (277)
T cd05062 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-----EQV 230 (277)
T ss_pred CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHH
Confidence 9999999999976543322222222345778999999999899999999999999999999 7888863211 111
Q ss_pred HHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 919 ARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 919 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.... ........+ ..++..+.+++.+||+.+|++|||+.|+
T Consensus 231 ~~~~--------~~~~~~~~~-------------------~~~~~~~~~li~~~l~~~p~~Rps~~e~ 271 (277)
T cd05062 231 LRFV--------MEGGLLDKP-------------------DNCPDMLFELMRMCWQYNPKMRPSFLEI 271 (277)
T ss_pred HHHH--------HcCCcCCCC-------------------CCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 1100 000000000 1234467899999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=329.03 Aligned_cols=259 Identities=23% Similarity=0.421 Sum_probs=201.4
Q ss_pred cCCCCCcccccccceeEEEEEECCCC-----eEEEEEEeeccCc-hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCC
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGR-----TTIAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 761 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 761 (986)
++|++.+.||+|+||.||+|.....+ ..||+|.++.... ....++.+|++++++++||||+++++++ ..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~ 79 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVC-----TK 79 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEE-----cC
Confidence 46889999999999999999986544 6799999864332 3346789999999999999999999984 44
Q ss_pred CceEEEEEEeccCCCHhHhhccCCCCCcc------ccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeE
Q 046598 762 NDFKALVFEFMHNRSLEEWLHPITREDET------DEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNIL 835 (986)
Q Consensus 762 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIl 835 (986)
....+++|||+++++|.+++......... ......+++.+++.++.|++.||+|||+. +++||||||+||+
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil 156 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCL 156 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEE
Confidence 57789999999999999999754322111 11125689999999999999999999999 9999999999999
Q ss_pred ecCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCcccccccc
Q 046598 836 LDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMN 914 (986)
Q Consensus 836 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~ 914 (986)
+++++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 157 ~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--- 233 (283)
T cd05048 157 VGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--- 233 (283)
T ss_pred EcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---
Confidence 99999999999999986543332233334456789999999998899999999999999999998 99998632211
Q ss_pred HHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 915 LHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 915 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
... +.+.... . ...+..++.++.+++.+||+.||++||+++||
T Consensus 234 --~~~---------~~i~~~~---~---------------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i 276 (283)
T cd05048 234 --EVI---------EMIRSRQ---L---------------LPCPEDCPARVYALMIECWNEIPARRPRFKDI 276 (283)
T ss_pred --HHH---------HHHHcCC---c---------------CCCcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 111 1111000 0 00112456778899999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=327.26 Aligned_cols=250 Identities=20% Similarity=0.323 Sum_probs=194.6
Q ss_pred hcCCCCCcccccccceeEEEEEEC---CCCeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILD---DGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
.++|++.+.||+|+||.||+|.+. ..+..||+|+++... ....+.+.+|+.++++++||||+++++++ ..+
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~ 78 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVI-----TRG 78 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEE-----ecC
Confidence 356899999999999999999875 346789999987543 23346789999999999999999999984 456
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
...++||||+++|+|.+++.. ....+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~---------~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~ 146 (266)
T cd05064 79 NTMMIVTEYMSNGALDSFLRK---------HEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVC 146 (266)
T ss_pred CCcEEEEEeCCCCcHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcE
Confidence 789999999999999999952 224689999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHh
Q 046598 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLART 921 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~ 921 (986)
|++|||.+....... ........++..|+|||++.+..++.++|||||||++||+++ |+.||...... .....
T Consensus 147 ~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~-----~~~~~ 220 (266)
T cd05064 147 KISGFRRLQEDKSEA-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-----DVIKA 220 (266)
T ss_pred EECCCcccccccccc-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-----HHHHH
Confidence 999999876532111 111112335678999999999999999999999999999875 99998633211 11110
Q ss_pred hCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 922 ALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 922 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+.+... .+.+..++..+.+++.+||+.+|++||+++||
T Consensus 221 --------~~~~~~-------------------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i 258 (266)
T cd05064 221 --------VEDGFR-------------------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQI 258 (266)
T ss_pred --------HHCCCC-------------------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHH
Confidence 000000 00011345568899999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=339.54 Aligned_cols=198 Identities=24% Similarity=0.391 Sum_probs=172.5
Q ss_pred hcCCCCCcccccccceeEEEEEECCCC-eEEEEEEeecc---CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGR-TTIAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
.++|++.+.||+|+||.||+|.+..++ ..||+|++... .....+.+.+|+++++.++||||++++++ +.++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~-----~~~~ 103 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGS-----FKDE 103 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEE-----EEeC
Confidence 457999999999999999999976544 68999998642 22345678899999999999999999999 4556
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
...++||||+++|+|.+++.. .+.+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~i 170 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRR----------NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFI 170 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCE
Confidence 789999999999999999952 24588999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 171 kL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~ 230 (340)
T PTZ00426 171 KMTDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA 230 (340)
T ss_pred EEecCCCCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCC
Confidence 99999999865321 2235689999999999998899999999999999999999999963
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=336.11 Aligned_cols=249 Identities=24% Similarity=0.397 Sum_probs=193.8
Q ss_pred cCCCCCcccccccceeEEEEEECCCCe----EEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRT----TIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
.+|++.+.||+|+||.||+|++..++. .||+|+++... ....+++.+|+.+++.++||||++++++|..
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~------ 80 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------ 80 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC------
Confidence 469999999999999999999865444 48999986433 3445678899999999999999999998642
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
...++|+||+++|+|.+++.. ....+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+
T Consensus 81 ~~~~~v~e~~~~g~l~~~l~~---------~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~ 148 (316)
T cd05108 81 STVQLITQLMPFGCLLDYVRE---------HKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHV 148 (316)
T ss_pred CCceeeeecCCCCCHHHHHHh---------ccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcE
Confidence 346799999999999999962 223578899999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHh
Q 046598 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLART 921 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~ 921 (986)
||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||+..... .....
T Consensus 149 kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~~~~~--- 223 (316)
T cd05108 149 KITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSI--- 223 (316)
T ss_pred EEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH---
Confidence 9999999987653332222223335678999999999999999999999999999998 99998632111 11111
Q ss_pred hCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 922 ALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 922 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+..... .+....+..++.+++.+||+.+|++||++.+|
T Consensus 224 ---------~~~~~~------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l 261 (316)
T cd05108 224 ---------LEKGER------------------LPQPPICTIDVYMIMVKCWMIDADSRPKFREL 261 (316)
T ss_pred ---------HhCCCC------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 100000 00001223457789999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=334.78 Aligned_cols=198 Identities=29% Similarity=0.379 Sum_probs=172.1
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCC-C-----CcceeeeeeccccccC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIR-H-----RNLVKILTACSGVDYQ 760 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~ 760 (986)
..+|++.+.||+|.||.|.+|.+..+++.||||+++.. ..-..+-+.|+.+|..++ | -|+|+++++ +.
T Consensus 185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~-----F~ 258 (586)
T KOG0667|consen 185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDY-----FY 258 (586)
T ss_pred EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeec-----cc
Confidence 44899999999999999999999999999999999753 234466788999999996 4 389999999 67
Q ss_pred CCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCC
Q 046598 761 GNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDM 840 (986)
Q Consensus 761 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 840 (986)
.+++.|||+|.+ ..+|+++++... -..++...++.|+.||+.||.+||+. +|||+||||+|||+.+.+
T Consensus 259 fr~HlciVfELL-~~NLYellK~n~--------f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~ 326 (586)
T KOG0667|consen 259 FRNHLCIVFELL-STNLYELLKNNK--------FRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPK 326 (586)
T ss_pred cccceeeeehhh-hhhHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCC
Confidence 789999999999 679999997543 23599999999999999999999999 999999999999997544
Q ss_pred --cEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 841 --IAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 841 --~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
.+||+|||.|++.... ......+..|+|||++.|.+|+.+.||||||||++||++|.+-|.+
T Consensus 327 r~~vKVIDFGSSc~~~q~-----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 327 RSRIKVIDFGSSCFESQR-----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred cCceeEEecccccccCCc-----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 7999999999875321 1246678999999999999999999999999999999999887754
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=332.11 Aligned_cols=238 Identities=22% Similarity=0.287 Sum_probs=186.6
Q ss_pred cccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcC-CCCcceeeeeeccccccCCCceEEEEE
Q 046598 694 NQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVF 769 (986)
Q Consensus 694 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 769 (986)
+.||+|+||.||+|++..+++.||+|+++.. .....+....|..++... +||||++++++ +..++..++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~-----~~~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCT-----FQTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeE-----EEcCCEEEEEE
Confidence 4699999999999999998999999999743 223344566677777654 89999999988 45567899999
Q ss_pred EeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccccc
Q 046598 770 EFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGL 849 (986)
Q Consensus 770 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~ 849 (986)
||+++|+|.+++.. ...+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 e~~~gg~L~~~~~~----------~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~ 142 (316)
T cd05592 76 EYLNGGDLMFHIQS----------SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGM 142 (316)
T ss_pred cCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcC
Confidence 99999999999852 23588999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCchhH
Q 046598 850 ARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVMD 929 (986)
Q Consensus 850 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 929 (986)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......
T Consensus 143 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-----~~~~~~i------- 208 (316)
T cd05592 143 CKENMNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-----DELFDSI------- 208 (316)
T ss_pred CeECCCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-----HHHHHHH-------
Confidence 97643222 222345689999999999999999999999999999999999999963211 1111100
Q ss_pred HhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 046598 930 IVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMT 984 (986)
Q Consensus 930 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 984 (986)
. ...+. .+.....++.+++.+||+.||++||++.
T Consensus 209 --~---~~~~~----------------~~~~~~~~~~~ll~~~l~~~P~~R~~~~ 242 (316)
T cd05592 209 --L---NDRPH----------------FPRWISKEAKDCLSKLFERDPTKRLGVD 242 (316)
T ss_pred --H---cCCCC----------------CCCCCCHHHHHHHHHHccCCHHHcCCCh
Confidence 0 00000 0001234467889999999999999874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=343.86 Aligned_cols=201 Identities=23% Similarity=0.318 Sum_probs=172.4
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
.|++++.||+|+||+||+|++..+++.||+|+++.. .....+.+.+|++++++++||||++++++ +.+++..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~-----~~~~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYS-----FQDKDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEE-----EecCCEE
Confidence 588999999999999999999999999999999753 22345678899999999999999999998 4556789
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
++||||+++|+|.+++.. ...+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 77 ~lv~E~~~gg~L~~~l~~----------~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~ 143 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIR----------MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLT 143 (381)
T ss_pred EEEEecCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEe
Confidence 999999999999999852 23578899999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCC---------------------------------------------ccccccccccccccccccccCC
Q 046598 846 DFGLARFLPLSSA---------------------------------------------QTSSIGAKGSIGYIAPEYGLGS 880 (986)
Q Consensus 846 DFG~a~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~ 880 (986)
|||+++....... ........||+.|+|||++.+.
T Consensus 144 DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~ 223 (381)
T cd05626 144 DFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK 223 (381)
T ss_pred eCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC
Confidence 9999754311000 0001234699999999999998
Q ss_pred CcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 881 EVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 881 ~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
.++.++|||||||++|||++|+.||..
T Consensus 224 ~~~~~~DiwSlG~il~elltG~~Pf~~ 250 (381)
T cd05626 224 GYTQLCDWWSVGVILFEMLVGQPPFLA 250 (381)
T ss_pred CCCCccceeehhhHHHHHHhCCCCCcC
Confidence 999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=332.45 Aligned_cols=238 Identities=24% Similarity=0.299 Sum_probs=189.0
Q ss_pred cccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcC-CCCcceeeeeeccccccCCCceEEEEE
Q 046598 694 NQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVF 769 (986)
Q Consensus 694 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 769 (986)
+.||+|+||+||+|++..+++.||+|+++.. .....+.+..|.+++... +||||++++++ +...+..|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~-----~~~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCC-----FQTPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeE-----EEcCCEEEEEE
Confidence 4699999999999999988999999998742 223456677888888876 79999999998 45668899999
Q ss_pred EeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccccc
Q 046598 770 EFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGL 849 (986)
Q Consensus 770 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~ 849 (986)
||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 76 Ey~~~g~L~~~i~~----------~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~ 142 (320)
T cd05590 76 EFVNGGDLMFHIQK----------SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGM 142 (320)
T ss_pred cCCCCchHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCC
Confidence 99999999998852 23588999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCchhH
Q 046598 850 ARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVMD 929 (986)
Q Consensus 850 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 929 (986)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .........
T Consensus 143 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----~~~~~~i~~----- 210 (320)
T cd05590 143 CKEGIFNG--KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-----DDLFEAILN----- 210 (320)
T ss_pred CeecCcCC--CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----HHHHHHHhc-----
Confidence 87542221 122345689999999999999999999999999999999999999963211 111111100
Q ss_pred HhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 046598 930 IVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMT 984 (986)
Q Consensus 930 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 984 (986)
..+.. +.....++.+++.+|++.||++||++.
T Consensus 211 -------~~~~~----------------~~~~~~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 211 -------DEVVY----------------PTWLSQDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred -------CCCCC----------------CCCCCHHHHHHHHHHcccCHHHCCCCC
Confidence 00000 001234567899999999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=335.57 Aligned_cols=262 Identities=24% Similarity=0.356 Sum_probs=198.0
Q ss_pred hcCCCCCcccccccceeEEEEEECC-----CCeEEEEEEeeccC-chhHHHHHHHHHHHhcC-CCCcceeeeeecccccc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDD-----GRTTIAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDY 759 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 759 (986)
.++|++.+.||+|+||.||+|.+.+ +++.||+|+++... ....+.+.+|+.+++++ +|+||++++++|.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~---- 81 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT---- 81 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe----
Confidence 3579999999999999999997543 34789999986432 23346788899999999 8999999999863
Q ss_pred CCCceEEEEEEeccCCCHhHhhccCCCCCc--------------------------------------------------
Q 046598 760 QGNDFKALVFEFMHNRSLEEWLHPITREDE-------------------------------------------------- 789 (986)
Q Consensus 760 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-------------------------------------------------- 789 (986)
..+...++||||+++++|.+++........
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 345678999999999999999864321100
Q ss_pred -cccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcccccceecCCCCCcccccccccc
Q 046598 790 -TDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGS 868 (986)
Q Consensus 790 -~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt 868 (986)
.......+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.+.............++
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence 000123689999999999999999999999 9999999999999999999999999999876433222223334567
Q ss_pred ccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccc
Q 046598 869 IGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGN 947 (986)
Q Consensus 869 ~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 947 (986)
..|+|||++.+..++.++|||||||++|||++ |..||......+ .+... +......
T Consensus 239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~------------~~~~~~~---------- 295 (337)
T cd05054 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRR------------LKEGTRM---------- 295 (337)
T ss_pred ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHH------------HhccCCC----------
Confidence 78999999999999999999999999999998 999986321111 11110 0000000
Q ss_pred hhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 948 QRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 948 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..+.....++.+++.+||+.+|++||++.||
T Consensus 296 --------~~~~~~~~~~~~l~~~cl~~~p~~RPs~~el 326 (337)
T cd05054 296 --------RAPEYATPEIYSIMLDCWHNNPEDRPTFSEL 326 (337)
T ss_pred --------CCCccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 0001223467899999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=342.98 Aligned_cols=202 Identities=24% Similarity=0.332 Sum_probs=174.3
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
++|++.+.||+|+||+||+|++..+++.||||+++... ......+.+|+++++.++||||++++++ +.++..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~-----~~~~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYS-----FQDENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEE-----EEcCCe
Confidence 47999999999999999999999989999999997532 2334567889999999999999999998 556788
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.++||||+++|+|.+++.. .+.+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~E~~~~g~L~~~l~~----------~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl 142 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMK----------KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKL 142 (364)
T ss_pred EEEEECCCCCcHHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEE
Confidence 9999999999999999852 23589999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCcc------------------------------------ccccccccccccccccccCCCcCcccch
Q 046598 845 GDFGLARFLPLSSAQT------------------------------------SSIGAKGSIGYIAPEYGLGSEVSISGDV 888 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv 888 (986)
+|||+++.+....... .....+||+.|+|||++.+..++.++||
T Consensus 143 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 222 (364)
T cd05599 143 SDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDW 222 (364)
T ss_pred eecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeee
Confidence 9999997543211000 0112458999999999999999999999
Q ss_pred hhHHHHHHHHHhCCCCCCc
Q 046598 889 YSYGILLLELITRKKPTDI 907 (986)
Q Consensus 889 wSlGvvl~elltg~~pf~~ 907 (986)
|||||++|||++|+.||..
T Consensus 223 wSlG~il~el~~G~~Pf~~ 241 (364)
T cd05599 223 WSLGVIMYEMLVGYPPFCS 241 (364)
T ss_pred ecchhHHHHhhcCCCCCCC
Confidence 9999999999999999963
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=332.29 Aligned_cols=242 Identities=22% Similarity=0.284 Sum_probs=191.2
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcCCCC-cceeeeeeccccccCCCce
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNIRHR-NLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~~~~ 764 (986)
+|++.+.||+|+||.||+|++..+++.||||+++.. .....+.+..|.+++..+.|+ +|++++++ +...+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~-----~~~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSC-----FQTMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEE-----EEcCCE
Confidence 488999999999999999999998999999999742 233456788899999999765 57788877 455678
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.|+||||+++|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~E~~~~g~L~~~~~~----------~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL 142 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQ----------VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKI 142 (324)
T ss_pred EEEEEcCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEE
Confidence 9999999999999999852 23578899999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCC
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALP 924 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 924 (986)
+|||+++...... .......||+.|+|||++.+..++.++||||+||++|||+||+.||..... ......
T Consensus 143 ~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-----~~~~~~--- 212 (324)
T cd05587 143 ADFGMCKENIFGG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-----DELFQS--- 212 (324)
T ss_pred eecCcceecCCCC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHH---
Confidence 9999987532111 122345689999999999999999999999999999999999999963211 111110
Q ss_pred CchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 046598 925 DHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSM 983 (986)
Q Consensus 925 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 983 (986)
+..... .-+ .....++.+++.+|+..||++||++
T Consensus 213 -----i~~~~~-~~~-------------------~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 213 -----IMEHNV-SYP-------------------KSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -----HHcCCC-CCC-------------------CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 000000 000 0123456789999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=340.30 Aligned_cols=202 Identities=24% Similarity=0.319 Sum_probs=174.4
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
++|++.+.||+|+||+||+|.+..+++.||+|+++... ......+.+|+.++.+++||+|++++++ +.++..
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~-----~~~~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYS-----FQDKLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEE-----EecCCe
Confidence 47899999999999999999999989999999997532 2334567889999999999999999998 456688
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.|+||||+++|+|.+++.. .+.+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~E~~~gg~L~~~l~~----------~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL 142 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMK----------KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKL 142 (363)
T ss_pred EEEEEcCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEE
Confidence 9999999999999999952 24689999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCc---------------------------------cccccccccccccccccccCCCcCcccchhhH
Q 046598 845 GDFGLARFLPLSSAQ---------------------------------TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSY 891 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 891 (986)
+|||+++........ ......+||+.|+|||++.+..++.++|||||
T Consensus 143 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSl 222 (363)
T cd05628 143 SDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSL 222 (363)
T ss_pred eeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhh
Confidence 999999754321100 00123579999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCc
Q 046598 892 GILLLELITRKKPTDI 907 (986)
Q Consensus 892 Gvvl~elltg~~pf~~ 907 (986)
||++|||++|+.||..
T Consensus 223 Gvil~ell~G~~Pf~~ 238 (363)
T cd05628 223 GVIMYEMLIGYPPFCS 238 (363)
T ss_pred HHHHHHHHhCCCCCCC
Confidence 9999999999999963
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=340.56 Aligned_cols=262 Identities=25% Similarity=0.360 Sum_probs=198.8
Q ss_pred hhcCCCCCcccccccceeEEEEEECCC-----CeEEEEEEeeccC-chhHHHHHHHHHHHhcCC-CCcceeeeeeccccc
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDG-----RTTIAVKVFNLLH-HGAFKSFIAECNTLKNIR-HRNLVKILTACSGVD 758 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 758 (986)
..++|.+.+.||+|+||.||+|.+... ...||||+++... ....+.+.+|+++++++. ||||++++++|
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~---- 110 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC---- 110 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE----
Confidence 356899999999999999999987432 3469999996433 233567899999999995 99999999995
Q ss_pred cCCCceEEEEEEeccCCCHhHhhccCCCCCc-------------------------------------------------
Q 046598 759 YQGNDFKALVFEFMHNRSLEEWLHPITREDE------------------------------------------------- 789 (986)
Q Consensus 759 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------------------------------------------------- 789 (986)
......|+||||+++|+|.++++.......
T Consensus 111 -~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 111 -TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred -ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 455789999999999999999865321000
Q ss_pred -------------------------------------cccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCC
Q 046598 790 -------------------------------------TDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPS 832 (986)
Q Consensus 790 -------------------------------------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~ 832 (986)
.......+++.++..++.||++||+|||+. +|+||||||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~ 266 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAAR 266 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChH
Confidence 000123588999999999999999999999 9999999999
Q ss_pred CeEecCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccc
Q 046598 833 NILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEG 911 (986)
Q Consensus 833 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~ 911 (986)
||+++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 267 Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 267 NVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred hEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 99999999999999999986543322222233456788999999999999999999999999999997 99998632211
Q ss_pred cccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 912 DMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.. .. ..+.... +......++.++.+++.+||+.||++|||+.+|
T Consensus 347 ~~-~~------------~~~~~~~------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l 390 (400)
T cd05105 347 ST-FY------------NKIKSGY------------------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHL 390 (400)
T ss_pred HH-HH------------HHHhcCC------------------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHH
Confidence 10 00 0000000 000111345568899999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=327.21 Aligned_cols=247 Identities=32% Similarity=0.496 Sum_probs=188.3
Q ss_pred CCcccccccceeEEEEEEC----CCCeEEEEEEeeccCc-hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 692 SVNQIGEGSFGSVFKGILD----DGRTTIAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 692 ~~~~lg~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
+.+.||.|.||.||+|.+. ..+..|+||+++.... ...+.+.+|++.+++++||||++++|+|. ..+..+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~-----~~~~~~ 77 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCI-----ENEPLF 77 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEE-----SSSSEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccc-----cccccc
Confidence 4578999999999999998 3467899999965333 34688999999999999999999999964 345699
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+++|+|.+++... ....+++.++..|+.||++||+|||+. +++||||+++||+++.++.+||+|
T Consensus 78 lv~e~~~~g~L~~~L~~~--------~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~ 146 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSK--------NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSD 146 (259)
T ss_dssp EEEE--TTEBHHHHHHHT--------CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEES
T ss_pred cccccccccccccccccc--------ccccccccccccccccccccccccccc---cccccccccccccccccccccccc
Confidence 999999999999999743 134689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCC
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALPD 925 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 925 (986)
||++....................|+|||.+.+..++.++||||||+++|||++ |+.||..... .......
T Consensus 147 f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~-----~~~~~~~--- 218 (259)
T PF07714_consen 147 FGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN-----EEIIEKL--- 218 (259)
T ss_dssp TTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH-----HHHHHHH---
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----ccccccc---
Confidence 999987633333333344557789999999999899999999999999999999 7888763311 1111110
Q ss_pred chhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 926 HVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 926 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..... ......++..+.+++.+||+.+|++|||++||
T Consensus 219 ------~~~~~------------------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i 255 (259)
T PF07714_consen 219 ------KQGQR------------------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEI 255 (259)
T ss_dssp ------HTTEE------------------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHH
T ss_pred ------ccccc------------------ceeccchhHHHHHHHHHHcCCChhhCcCHHHH
Confidence 00000 00011234567899999999999999998764
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=324.05 Aligned_cols=245 Identities=24% Similarity=0.315 Sum_probs=190.9
Q ss_pred cccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEEEEec
Q 046598 696 IGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFM 772 (986)
Q Consensus 696 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 772 (986)
||+|+||+||++.+..+++.||+|++.... ....+.+..|+++++.++||||+++.++ +..+...++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~-----~~~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYA-----FQTKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEE-----EcCCCeEEEEEeCC
Confidence 699999999999999889999999986432 2233567889999999999999999988 45567899999999
Q ss_pred cCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccccccee
Q 046598 773 HNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARF 852 (986)
Q Consensus 773 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~ 852 (986)
++|+|.+++.... .....+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||.+..
T Consensus 76 ~~g~L~~~~~~~~------~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 146 (280)
T cd05608 76 NGGDLRYHIYNVD------EENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVE 146 (280)
T ss_pred CCCCHHHHHHhcc------ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcccee
Confidence 9999998875322 2234689999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCchhHHhh
Q 046598 853 LPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVMDIVD 932 (986)
Q Consensus 853 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d 932 (986)
...... ......|++.|+|||++.+..++.++|||||||++|||++|+.||....... .......
T Consensus 147 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~------------ 211 (280)
T cd05608 147 LKDGQS--KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQ------------ 211 (280)
T ss_pred cCCCCc--cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-hHHHHHH------------
Confidence 543222 2233568999999999999999999999999999999999999996322110 0011111
Q ss_pred hhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCC
Q 046598 933 STLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTN 985 (986)
Q Consensus 933 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 985 (986)
..... +. ..+...+.++.+++.+|++.||++||++++
T Consensus 212 ~~~~~-~~---------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ 248 (280)
T cd05608 212 RILND-SV---------------TYPDKFSPASKSFCEALLAKDPEKRLGFRD 248 (280)
T ss_pred hhccc-CC---------------CCcccCCHHHHHHHHHHhcCCHHHhcCCCC
Confidence 00000 00 001123456779999999999999996643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=342.06 Aligned_cols=202 Identities=26% Similarity=0.366 Sum_probs=176.2
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
++|++.+.||+|+||+||+|++..+++.||+|+++.. .......+.+|++++..++||||++++++ +.+++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~-----~~~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYS-----FQDEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhh-----eecCCe
Confidence 4799999999999999999999988999999999743 22345678899999999999999999988 556688
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.++||||+++++|.+++.. ...+++..++.++.||+.||+|||+. ||+||||||+||+++.++.+||
T Consensus 76 ~~lv~e~~~~~~L~~~l~~----------~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL 142 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIR----------KDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKL 142 (350)
T ss_pred EEEEEcCCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEe
Confidence 9999999999999999952 24688999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCC---------------------------CccccccccccccccccccccCCCcCcccchhhHHHHHHH
Q 046598 845 GDFGLARFLPLSS---------------------------AQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLE 897 (986)
Q Consensus 845 ~DFG~a~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~e 897 (986)
+|||+++...... .........||+.|+|||++.+..++.++|||||||++||
T Consensus 143 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 222 (350)
T cd05573 143 ADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222 (350)
T ss_pred ecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhh
Confidence 9999997654332 0012234568999999999999999999999999999999
Q ss_pred HHhCCCCCCc
Q 046598 898 LITRKKPTDI 907 (986)
Q Consensus 898 lltg~~pf~~ 907 (986)
|++|+.||..
T Consensus 223 ll~g~~Pf~~ 232 (350)
T cd05573 223 MLYGFPPFYS 232 (350)
T ss_pred hccCCCCCCC
Confidence 9999999963
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=338.90 Aligned_cols=202 Identities=23% Similarity=0.275 Sum_probs=174.1
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
++|++.+.||+|+||+||+|++..+++.||+|+++... ....+.+.+|+.+++.++||||++++++ +.++..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~-----~~~~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYA-----FQDKDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeE-----EecCCe
Confidence 46899999999999999999999999999999997532 2345678899999999999999999988 455678
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.++||||+++|+|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~---------~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL 143 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRY---------EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKL 143 (330)
T ss_pred EEEEECCCCCCCHHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEe
Confidence 99999999999999999632 24689999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCcccccccccccccccccccc------CCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGL------GSEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
+|||++......... ......||+.|+|||++. +..++.++|||||||++|||++|+.||..
T Consensus 144 ~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 211 (330)
T cd05601 144 ADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE 211 (330)
T ss_pred ccCCCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCC
Confidence 999999876433221 223346899999999986 45678999999999999999999999963
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=326.22 Aligned_cols=260 Identities=27% Similarity=0.437 Sum_probs=201.0
Q ss_pred hcCCCCCcccccccceeEEEEEECC-----CCeEEEEEEeeccCch-hHHHHHHHHHHHhcCCCCcceeeeeeccccccC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDD-----GRTTIAVKVFNLLHHG-AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ 760 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 760 (986)
.++|.+.+.||+|+||.||+|.+.. .++.||||+++..... ..+.+.+|+++++.++||||+++++++ .
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~ 78 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVC-----T 78 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEE-----e
Confidence 4568899999999999999998753 3578999998754443 457899999999999999999999994 4
Q ss_pred CCceEEEEEEeccCCCHhHhhccCCCCCc----cccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEe
Q 046598 761 GNDFKALVFEFMHNRSLEEWLHPITREDE----TDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILL 836 (986)
Q Consensus 761 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~----~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 836 (986)
.....++||||+++++|.+++........ .......+++.++..++.|++.|++|||+. +++||||||+||++
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili 155 (280)
T cd05049 79 EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLV 155 (280)
T ss_pred cCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEE
Confidence 45789999999999999999975432100 012345689999999999999999999999 99999999999999
Q ss_pred cCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccH
Q 046598 837 DEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNL 915 (986)
Q Consensus 837 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~ 915 (986)
+.++.+||+|||.++...............+++.|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 156 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~---- 231 (280)
T cd05049 156 GYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE---- 231 (280)
T ss_pred cCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH----
Confidence 9999999999999976533322222233446788999999999999999999999999999999 99998532111
Q ss_pred HHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 916 HNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 916 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.... .+.......+ ....+..+.+++.+||+.||++||++.||
T Consensus 232 -~~~~---------~~~~~~~~~~------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~ei 274 (280)
T cd05049 232 -EVIE---------CITQGRLLQR------------------PRTCPSEVYDIMLGCWKRDPQQRINIKDI 274 (280)
T ss_pred -HHHH---------HHHcCCcCCC------------------CCCCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 1110 0000000000 01234567899999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=326.54 Aligned_cols=259 Identities=24% Similarity=0.395 Sum_probs=199.6
Q ss_pred cCCCCCcccccccceeEEEEEEC-----CCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILD-----DGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
++|.+.+.||+|+||.||++... .++..+|+|.+........+.+.+|++++++++||||++++++| ...
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 79 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVC-----VEG 79 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence 56889999999999999999862 34567999998765555567899999999999999999999984 445
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCc---cccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCC
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDE---TDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED 839 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~---~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 839 (986)
...++||||+++++|.+++........ .......+++.+++.++.|++.||+|||+. |++||||||+||+++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~ 156 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN 156 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC
Confidence 789999999999999999964332100 112234589999999999999999999999 99999999999999999
Q ss_pred CcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHH
Q 046598 840 MIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNL 918 (986)
Q Consensus 840 ~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~ 918 (986)
+.+||+|||.++...............++..|+|||++.+..++.++|||||||++|+|++ |..||...... ..
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~-----~~ 231 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-----EV 231 (288)
T ss_pred CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----HH
Confidence 9999999999986543322222223345778999999998899999999999999999999 99998633211 11
Q ss_pred HHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 919 ARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 919 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
... ........ .....+.++.+++.+||+.+|.+|||++||
T Consensus 232 ~~~------------i~~~~~~~---------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v 272 (288)
T cd05093 232 IEC------------ITQGRVLQ---------------RPRTCPKEVYDLMLGCWQREPHMRLNIKEI 272 (288)
T ss_pred HHH------------HHcCCcCC---------------CCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 100 00000000 000123457899999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=320.99 Aligned_cols=243 Identities=23% Similarity=0.320 Sum_probs=189.1
Q ss_pred cccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEEEEec
Q 046598 696 IGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFM 772 (986)
Q Consensus 696 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 772 (986)
||+|+||.||+++...+++.||+|++.... ....+....|++++++++||||++++++ +..+...++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~-----~~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYA-----FESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEE-----EecCCeEEEEEecC
Confidence 699999999999999889999999986321 1223456679999999999999999988 45667899999999
Q ss_pred cCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccccccee
Q 046598 773 HNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARF 852 (986)
Q Consensus 773 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~ 852 (986)
++++|.+++.... ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 76 ~g~~L~~~~~~~~--------~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~ 144 (277)
T cd05607 76 NGGDLKYHIYNVG--------ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVE 144 (277)
T ss_pred CCCCHHHHHHhcc--------ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeee
Confidence 9999998885221 23578999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCchhHHhh
Q 046598 853 LPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVMDIVD 932 (986)
Q Consensus 853 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d 932 (986)
..... ......|+..|+|||++.+..++.++||||+||++|||++|+.||...... ........
T Consensus 145 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~-~~~~~~~~------------ 208 (277)
T cd05607 145 LKDGK---TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK-VAKEELKR------------ 208 (277)
T ss_pred cCCCc---eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch-hhHHHHHH------------
Confidence 54321 122346889999999999989999999999999999999999998632211 11111111
Q ss_pred hhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCC
Q 046598 933 STLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTN 985 (986)
Q Consensus 933 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 985 (986)
..+...... .....+.++.+++.+||+.||++||+++|
T Consensus 209 ~~~~~~~~~---------------~~~~~~~~~~~li~~~L~~~P~~R~~~~~ 246 (277)
T cd05607 209 RTLEDEVKF---------------EHQNFTEESKDICRLFLAKKPEDRLGSRE 246 (277)
T ss_pred Hhhcccccc---------------ccccCCHHHHHHHHHHhccCHhhCCCCcc
Confidence 111000000 00022345679999999999999999965
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=332.07 Aligned_cols=238 Identities=26% Similarity=0.281 Sum_probs=186.3
Q ss_pred cccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHH-HHhcCCCCcceeeeeeccccccCCCceEEEEE
Q 046598 694 NQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECN-TLKNIRHRNLVKILTACSGVDYQGNDFKALVF 769 (986)
Q Consensus 694 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 769 (986)
+.||+|+||+||+|++..+++.||+|++.... ....+.+..|.. +++.++||||++++++ +..++..++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~-----~~~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYS-----FQTADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEE-----EEeCCEEEEEE
Confidence 46999999999999999889999999987432 222344555554 5678899999999988 45567899999
Q ss_pred EeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccccc
Q 046598 770 EFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGL 849 (986)
Q Consensus 770 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~ 849 (986)
||+++|+|.++++. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 e~~~~g~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~ 142 (323)
T cd05575 76 DYVNGGELFFHLQR----------ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGL 142 (323)
T ss_pred cCCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCC
Confidence 99999999999852 24688999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCchhH
Q 046598 850 ARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVMD 929 (986)
Q Consensus 850 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 929 (986)
++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......
T Consensus 143 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-----~~~~~~~-------- 207 (323)
T cd05575 143 CKEGIEH--SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----TAEMYDN-------- 207 (323)
T ss_pred CcccccC--CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC-----HHHHHHH--------
Confidence 8753221 122234568999999999999999999999999999999999999986321 1111111
Q ss_pred HhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 046598 930 IVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMT 984 (986)
Q Consensus 930 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 984 (986)
+........ ...+.++.+++.+|++.||++||++.
T Consensus 208 i~~~~~~~~--------------------~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 208 ILNKPLRLK--------------------PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHcCCCCCC--------------------CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 110000000 01234567899999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=329.68 Aligned_cols=238 Identities=26% Similarity=0.360 Sum_probs=187.1
Q ss_pred cccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcC-CCCcceeeeeeccccccCCCceEEEEE
Q 046598 694 NQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVF 769 (986)
Q Consensus 694 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 769 (986)
+.||+|+||+||+|++..+++.||||+++... ....+.+..|..++... +||||++++++ +.+++..++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~-----~~~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCT-----FQTKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEE-----EEeCCEEEEEE
Confidence 46999999999999999989999999997531 23345667788888764 99999999998 45567899999
Q ss_pred EeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccccc
Q 046598 770 EFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGL 849 (986)
Q Consensus 770 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~ 849 (986)
||+++|+|.+++.. ...+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 76 ey~~~g~L~~~l~~----------~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~ 142 (316)
T cd05619 76 EYLNGGDLMFHIQS----------CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGM 142 (316)
T ss_pred eCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCc
Confidence 99999999999852 23578899999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCchhH
Q 046598 850 ARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVMD 929 (986)
Q Consensus 850 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 929 (986)
++...... .......||..|+|||++.+..++.++||||+||++|||++|+.||..... ......
T Consensus 143 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-----~~~~~~-------- 207 (316)
T cd05619 143 CKENMLGD--AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-----EELFQS-------- 207 (316)
T ss_pred ceECCCCC--CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH-----HHHHHH--------
Confidence 97532211 122345689999999999999999999999999999999999999963211 111110
Q ss_pred HhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 046598 930 IVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMT 984 (986)
Q Consensus 930 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 984 (986)
+. ...+. .+.....++.+++.+|++.||++||++.
T Consensus 208 -i~---~~~~~----------------~~~~~~~~~~~li~~~l~~~P~~R~~~~ 242 (316)
T cd05619 208 -IR---MDNPC----------------YPRWLTREAKDILVKLFVREPERRLGVK 242 (316)
T ss_pred -HH---hCCCC----------------CCccCCHHHHHHHHHHhccCHhhcCCCh
Confidence 00 00000 0001223467889999999999999986
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=336.46 Aligned_cols=193 Identities=24% Similarity=0.318 Sum_probs=167.1
Q ss_pred cccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEEEE
Q 046598 694 NQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFE 770 (986)
Q Consensus 694 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 770 (986)
+.||+|+||.||+|.+..+++.||+|+++.. .......+.+|+++++.++||||++++++ +..++..|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~-----~~~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYS-----FQTHDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEE-----EEcCCEEEEEEe
Confidence 4699999999999999988999999999743 22344667889999999999999999988 456688999999
Q ss_pred eccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCCeEecCCCcEEEccccc
Q 046598 771 FMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHH-DCQPPIAHCDLKPSNILLDEDMIAHIGDFGL 849 (986)
Q Consensus 771 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~ 849 (986)
|+++|+|..++.. ...+++.++..++.||+.||+|||+ . +|+||||||+||+++.++.+||+|||+
T Consensus 76 ~~~~~~L~~~l~~----------~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~ 142 (325)
T cd05594 76 YANGGELFFHLSR----------ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGL 142 (325)
T ss_pred CCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCC
Confidence 9999999998842 2468999999999999999999997 6 999999999999999999999999999
Q ss_pred ceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCC
Q 046598 850 ARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTD 906 (986)
Q Consensus 850 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~ 906 (986)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 143 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~ 197 (325)
T cd05594 143 CKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 197 (325)
T ss_pred CeecCCCC--cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCC
Confidence 97542221 12223568999999999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=331.23 Aligned_cols=242 Identities=21% Similarity=0.274 Sum_probs=191.1
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcC-CCCcceeeeeeccccccCCCce
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~ 764 (986)
+|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+..|..++... +|++|++++++ +...+.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~-----~~~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSC-----FQTMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEE-----EecCCE
Confidence 4888999999999999999999989999999987432 22334567788888777 58899999888 455678
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.++||||+++|+|.+++.. ...+++.++..++.||+.||+|||+. +|+||||||+||++++++.+||
T Consensus 76 ~~lv~E~~~~g~L~~~~~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL 142 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQ----------VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKI 142 (323)
T ss_pred EEEEEcCCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEE
Confidence 9999999999999999852 23588999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCC
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALP 924 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 924 (986)
+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||+||+.||..... ......
T Consensus 143 ~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-----~~~~~~--- 212 (323)
T cd05616 143 ADFGMCKENMWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DELFQS--- 212 (323)
T ss_pred ccCCCceecCCCC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH-----HHHHHH---
Confidence 9999997543221 122345689999999999999999999999999999999999999963211 111110
Q ss_pred CchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 046598 925 DHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSM 983 (986)
Q Consensus 925 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 983 (986)
+..... .-+ .....++.+++.+|++.+|++|+++
T Consensus 213 -----i~~~~~-~~p-------------------~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 213 -----IMEHNV-AYP-------------------KSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -----HHhCCC-CCC-------------------CcCCHHHHHHHHHHcccCHHhcCCC
Confidence 000000 000 0123456789999999999999986
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=333.02 Aligned_cols=194 Identities=26% Similarity=0.358 Sum_probs=166.8
Q ss_pred cccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcC-CCCcceeeeeeccccccCCCceEEEEE
Q 046598 694 NQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVF 769 (986)
Q Consensus 694 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 769 (986)
+.||+|+||.||+|++..+++.||+|+++.. .....+.+..|.+++..+ +||||++++++ +..++..|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~-----~~~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCC-----FQTKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeE-----EEcCCeEEEEE
Confidence 4699999999999999998999999998743 233445677888888866 89999999998 45667899999
Q ss_pred EeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccccc
Q 046598 770 EFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGL 849 (986)
Q Consensus 770 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~ 849 (986)
||+++|+|..++.. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 E~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~ 142 (321)
T cd05591 76 EYVNGGDLMFQIQR----------SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGM 142 (321)
T ss_pred eCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeeccc
Confidence 99999999998852 23588999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 850 ARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 850 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
++...... .......|++.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 143 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~ 198 (321)
T cd05591 143 CKEGILNG--VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA 198 (321)
T ss_pred ceecccCC--ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCC
Confidence 97543221 122345689999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=332.09 Aligned_cols=194 Identities=26% Similarity=0.362 Sum_probs=166.9
Q ss_pred cccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcC-CCCcceeeeeeccccccCCCceEEEEE
Q 046598 694 NQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVF 769 (986)
Q Consensus 694 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 769 (986)
+.||+|+||.||+|++..+++.||+|+++.. .....+.+.+|+.++.++ +||||++++++ +..+...++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~-----~~~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC-----FQTESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeE-----EEeCCEEEEEE
Confidence 4699999999999999999999999999753 233445677888888776 89999999998 45567899999
Q ss_pred EeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccccc
Q 046598 770 EFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGL 849 (986)
Q Consensus 770 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~ 849 (986)
||+++|+|..++.. ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 E~~~~~~L~~~~~~----------~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~ 142 (329)
T cd05618 76 EYVNGGDLMFHMQR----------QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGM 142 (329)
T ss_pred eCCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCc
Confidence 99999999988842 24689999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 850 ARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 850 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 143 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 143 CKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred cccccCCC--CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 97532211 122335689999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=338.42 Aligned_cols=365 Identities=32% Similarity=0.534 Sum_probs=223.0
Q ss_pred CCCCCCEEEccCCCcc-ccCCcchhccccCceeeceecccCCCCccchhcCccccceecccccccCccCccccCCCCCCe
Q 046598 84 NLSFLKVLRLYNNSFN-HEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEH 162 (986)
Q Consensus 84 ~l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 162 (986)
-|+..+-.|+++|.++ +..|.....+++++.|.|...++. .+|+.++.+.+|++|.+++|++. .+-..++.|+.|+.
T Consensus 5 VLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRs 82 (1255)
T KOG0444|consen 5 VLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRS 82 (1255)
T ss_pred ccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHH
Confidence 3455666777777777 467888888888888888888887 78888888888888888888887 56666777777777
Q ss_pred EEccCCcCCC-CcccccCCCcCcceeeccCCcccCcCcchhhccCCCceeecccccccccCCccccCCCCccEEeccccc
Q 046598 163 ISVNDNNLTG-SIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNK 241 (986)
Q Consensus 163 L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~ 241 (986)
+.+.+|++.. -+|..+..|..|+.||||+|++. ..|..+..-+++-.|+||+|+|. .||
T Consensus 83 v~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIP------------------ 142 (1255)
T KOG0444|consen 83 VIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIP------------------ 142 (1255)
T ss_pred HhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCC------------------
Confidence 7777777752 25666677777777777777777 66777777777777777777776 333
Q ss_pred cccccCCcccccccccceEEecCceecccCCccccCCCCCcEEecccccccCCCchhhhhhhHhhhhhccCCCCCCCCCC
Q 046598 242 IQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRD 321 (986)
Q Consensus 242 l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~l~~l~~L~~l~l~~n~l~~~~~~~ 321 (986)
..++.+|..|-+|||++|++. .+|..+..+.+|++|.+++|.+. ..
T Consensus 143 ------n~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~-----------------------hf---- 188 (1255)
T KOG0444|consen 143 ------NSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLN-----------------------HF---- 188 (1255)
T ss_pred ------chHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhh-----------------------HH----
Confidence 333334455555555555555 44555555555555555555543 10
Q ss_pred cccccccccccccceeeccccccccCCCcccccccccceEEEccCCccc-ccCCccccCCCCCCEEEccCccccCcCCCc
Q 046598 322 LNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIF-GNIPAAIGKFVNLQRLDMCSNRLSGTIPPA 400 (986)
Q Consensus 322 l~~l~~l~~~~~L~~l~l~~n~~~~~~p~~~~~~~~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 400 (986)
.+..++.++ +|++|.+++.+=+ ..+|.++..+.+|..+|||.|.+. .+|++
T Consensus 189 --QLrQLPsmt-------------------------sL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPec 240 (1255)
T KOG0444|consen 189 --QLRQLPSMT-------------------------SLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPEC 240 (1255)
T ss_pred --HHhcCccch-------------------------hhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHH
Confidence 011122222 2333444433322 246777777777777777777777 77777
Q ss_pred ccCCCCCCEEEccCccceeecCcccccccccEEEecccccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcce
Q 046598 401 IGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLI 480 (986)
Q Consensus 401 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~ 480 (986)
+.++++|+.|+||+|+|+. +....+...+|++|+||+|+++ .+|+. ...++.|+
T Consensus 241 ly~l~~LrrLNLS~N~ite------------------------L~~~~~~W~~lEtLNlSrNQLt-~LP~a-vcKL~kL~ 294 (1255)
T KOG0444|consen 241 LYKLRNLRRLNLSGNKITE------------------------LNMTEGEWENLETLNLSRNQLT-VLPDA-VCKLTKLT 294 (1255)
T ss_pred HhhhhhhheeccCcCceee------------------------eeccHHHHhhhhhhccccchhc-cchHH-HhhhHHHH
Confidence 7777777777777777662 1122223334444444444444 44443 33444444
Q ss_pred EEEccCCcccc-cCCcccccccccchhhccCccccccCcccccCCccccEEecccccccccCCccccCCCCCCEEeCCCc
Q 046598 481 VLDLSRNQLTG-SIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQN 559 (986)
Q Consensus 481 ~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 559 (986)
.|++.+|+++- -+|..++.|.+|+.+.+++|++. .+|+.++.+.+|+.|.|++|++- .+|..+.-|+.|+.|||.+|
T Consensus 295 kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreN 372 (1255)
T KOG0444|consen 295 KLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLREN 372 (1255)
T ss_pred HHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCC
Confidence 44444444431 14555666666666666666665 55666666666666666666655 45555555555555555555
Q ss_pred c
Q 046598 560 N 560 (986)
Q Consensus 560 ~ 560 (986)
+
T Consensus 373 p 373 (1255)
T KOG0444|consen 373 P 373 (1255)
T ss_pred c
Confidence 4
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=325.28 Aligned_cols=246 Identities=25% Similarity=0.340 Sum_probs=193.3
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
+|++.+.||+|+||+||+|.+..+++.||+|++.... ......+.+|++++++++||||++++++ +..++..
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-----~~~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYA-----YETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeee-----ecCCCeE
Confidence 4888999999999999999998889999999986432 1223457789999999999999999988 4455789
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
++||||+++|+|.+++... ....+++.++..++.|++.|+.|||+. +++||||||+||++++++.++|+
T Consensus 76 ~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~ 144 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNM--------GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRIS 144 (285)
T ss_pred EEEEeccCCCcHHHHHHhc--------CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEe
Confidence 9999999999999888521 123589999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCC
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPD 925 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 925 (986)
|||+++....... .....|+..|+|||++.+..++.++||||+||++|||++|+.||...... ...... .
T Consensus 145 Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-~~~~~~-~----- 214 (285)
T cd05605 145 DLGLAVEIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-VKREEV-E----- 214 (285)
T ss_pred eCCCceecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-hHHHHH-H-----
Confidence 9999987532221 12346899999999999999999999999999999999999999632110 000000 0
Q ss_pred chhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCC
Q 046598 926 HVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMS 982 (986)
Q Consensus 926 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt 982 (986)
..+. .... ......+..+.+++.+||+.||++||+
T Consensus 215 ---~~~~----~~~~---------------~~~~~~~~~~~~li~~~l~~~P~~R~~ 249 (285)
T cd05605 215 ---RRVK----EDQE---------------EYSEKFSEAARSICRQLLTKDPGFRLG 249 (285)
T ss_pred ---HHhh----hccc---------------ccCcccCHHHHHHHHHHccCCHHHhcC
Confidence 0000 0000 001123456789999999999999994
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=329.64 Aligned_cols=238 Identities=23% Similarity=0.312 Sum_probs=187.5
Q ss_pred cccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcC-CCCcceeeeeeccccccCCCceEEEEE
Q 046598 694 NQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVF 769 (986)
Q Consensus 694 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 769 (986)
+.||+|+||.||+|++..+++.||+|+++... ....+....|.+++... +||+|++++++ +..++..|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~-----~~~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCT-----FQTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEE-----EEeCCEEEEEE
Confidence 46999999999999999999999999997532 23345667788888754 89999999998 45668899999
Q ss_pred EeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccccc
Q 046598 770 EFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGL 849 (986)
Q Consensus 770 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~ 849 (986)
||+++|+|.+++.. ...+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 76 E~~~~g~L~~~i~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~ 142 (316)
T cd05620 76 EFLNGGDLMFHIQD----------KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGM 142 (316)
T ss_pred CCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCC
Confidence 99999999999852 23578999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCchhH
Q 046598 850 ARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVMD 929 (986)
Q Consensus 850 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 929 (986)
++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......
T Consensus 143 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~-----~~~~~~-------- 207 (316)
T cd05620 143 CKENVFGD--NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-----DELFES-------- 207 (316)
T ss_pred CeecccCC--CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHH--------
Confidence 87532111 222345689999999999999999999999999999999999999963211 111110
Q ss_pred HhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 046598 930 IVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMT 984 (986)
Q Consensus 930 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 984 (986)
+.. ..+.- +.....++.+++.+|++.||++||++.
T Consensus 208 -~~~---~~~~~----------------~~~~~~~~~~li~~~l~~dP~~R~~~~ 242 (316)
T cd05620 208 -IRV---DTPHY----------------PRWITKESKDILEKLFERDPTRRLGVV 242 (316)
T ss_pred -HHh---CCCCC----------------CCCCCHHHHHHHHHHccCCHHHcCCCh
Confidence 000 00000 001234567899999999999999974
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=331.49 Aligned_cols=194 Identities=27% Similarity=0.363 Sum_probs=167.6
Q ss_pred cccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcC-CCCcceeeeeeccccccCCCceEEEEE
Q 046598 694 NQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVF 769 (986)
Q Consensus 694 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 769 (986)
+.||+|+||.||+|.+..+++.||+|+++.. .....+.+.+|..+++++ +||||++++++ +..+...|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~-----~~~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSC-----FQTESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEE-----EEcCCEEEEEE
Confidence 4689999999999999998999999999753 223345678899999888 79999999998 45567899999
Q ss_pred EeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccccc
Q 046598 770 EFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGL 849 (986)
Q Consensus 770 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~ 849 (986)
||+++|+|.+++.. .+.+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 76 e~~~~g~L~~~~~~----------~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~ 142 (329)
T cd05588 76 EFVSGGDLMFHMQR----------QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGM 142 (329)
T ss_pred eCCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCcc
Confidence 99999999998842 24689999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 850 ARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 850 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||+.
T Consensus 143 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 143 CKEGIRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccccccC--CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 9743211 1122345689999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=340.13 Aligned_cols=201 Identities=22% Similarity=0.330 Sum_probs=172.3
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
.++|++.+.||+|+||.||+|++..+++.||+|+++.. .....+.+.+|+.+++.++||||++++++ +.++.
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~-----~~~~~ 116 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYA-----FQDDK 116 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEE-----EecCC
Confidence 56799999999999999999999999999999999642 22334557889999999999999999988 45668
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+|
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~-----------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~k 182 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSN-----------YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLK 182 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEE
Confidence 89999999999999999852 2477888999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccCC----CcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS----EVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
|+|||.++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 183 L~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 249 (370)
T cd05596 183 LADFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (370)
T ss_pred EEeccceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC
Confidence 999999986543221 122345699999999998653 478999999999999999999999963
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=329.20 Aligned_cols=276 Identities=22% Similarity=0.311 Sum_probs=197.2
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
++|.+.+.||+|+||.||+|++..+++.||+|+++... ......+.+|++++++++||||+++++++ ..++..+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 80 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV-----HTDKSLT 80 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEE-----eeCCeEE
Confidence 67999999999999999999999889999999987433 22335678899999999999999999984 4557899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+++ +|.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 81 lv~e~~~~-~l~~~~~~---------~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~D 147 (309)
T cd07872 81 LVFEYLDK-DLKQYMDD---------CGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLAD 147 (309)
T ss_pred EEEeCCCC-CHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECc
Confidence 99999964 88888752 233578999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCC
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPD 925 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 925 (986)
||+++...... .......++..|+|||++.+ ..++.++||||+||++|||+||+.||......+ ..... ......
T Consensus 148 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-~~~~~-~~~~~~ 223 (309)
T cd07872 148 FGLARAKSVPT--KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED-ELHLI-FRLLGT 223 (309)
T ss_pred cccceecCCCc--cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHH-HHHhCC
Confidence 99997643221 11223457899999998765 468999999999999999999999996432211 11111 111111
Q ss_pred chhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 926 HVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 926 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
...+................. ................++.+++.+|++.||++|||++|+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 283 (309)
T cd07872 224 PTEETWPGISSNDEFKNYNFP-KYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEA 283 (309)
T ss_pred CCHHHHhhhcchhhhhhhhcC-ccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHH
Confidence 111111100000000000000 000000001112244567899999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=345.13 Aligned_cols=202 Identities=24% Similarity=0.320 Sum_probs=172.6
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
.+|++++.||+|+||.||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++. +.+++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~-----~~~~~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYS-----FQDKDN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEE-----EEcCCE
Confidence 36999999999999999999999999999999986422 2234668899999999999999999998 456789
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.|+||||+++|+|.+++.. .+.+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~E~~~~g~L~~~i~~----------~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL 142 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIR----------LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKL 142 (376)
T ss_pred EEEEEeCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEE
Confidence 9999999999999999952 23578889999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCC-----------------------------------------ccccccccccccccccccccCCCcC
Q 046598 845 GDFGLARFLPLSSA-----------------------------------------QTSSIGAKGSIGYIAPEYGLGSEVS 883 (986)
Q Consensus 845 ~DFG~a~~~~~~~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~ 883 (986)
+|||+|..+..... ........||+.|+|||++.+..++
T Consensus 143 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 222 (376)
T cd05598 143 TDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT 222 (376)
T ss_pred EeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC
Confidence 99999853311000 0001134689999999999999999
Q ss_pred cccchhhHHHHHHHHHhCCCCCCc
Q 046598 884 ISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 884 ~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
.++|||||||++|||++|+.||..
T Consensus 223 ~~~DiwSlGvilyell~G~~Pf~~ 246 (376)
T cd05598 223 QLCDWWSVGVILYEMLVGQPPFLA 246 (376)
T ss_pred cceeeeeccceeeehhhCCCCCCC
Confidence 999999999999999999999964
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=344.09 Aligned_cols=279 Identities=23% Similarity=0.264 Sum_probs=194.4
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeecccccc---CCCc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY---QGND 763 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~~~~ 763 (986)
.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++....+ ....
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 457999999999999999999999889999999885422 234579999999999999999887543222 2223
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCC-cE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDM-IA 842 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~ 842 (986)
..++||||++ +++.+++.... .....+++..++.++.||+.||+|||+. +|+||||||+||+++.++ .+
T Consensus 141 ~l~lvmE~~~-~~l~~~~~~~~------~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~v 210 (440)
T PTZ00036 141 FLNVVMEFIP-QTVHKYMKHYA------RNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTL 210 (440)
T ss_pred EEEEEEecCC-ccHHHHHHHHh------hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCce
Confidence 5779999996 47877774322 2235689999999999999999999999 999999999999999665 79
Q ss_pred EEcccccceecCCCCCccccccccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHh
Q 046598 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLART 921 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~ 921 (986)
||+|||+|+.+.... ......||+.|+|||++.+. .++.++||||+||++|||++|++||......+ .+.....
T Consensus 211 kL~DFGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~i~~- 285 (440)
T PTZ00036 211 KLCDFGSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD-QLVRIIQ- 285 (440)
T ss_pred eeeccccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHH-
Confidence 999999998654222 12235689999999998764 68999999999999999999999996432111 1111111
Q ss_pred hCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 922 ALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 922 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.......+.+... .....+... ........+...+...+.++.+++.+||++||++|||+.|+
T Consensus 286 ~~~~p~~~~~~~~-~~~~~~~~~-~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~ 348 (440)
T PTZ00036 286 VLGTPTEDQLKEM-NPNYADIKF-PDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEA 348 (440)
T ss_pred HhCCCCHHHHHHh-chhhhcccC-CccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 1111111100000 000000000 00000000111111234578899999999999999999763
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=354.71 Aligned_cols=212 Identities=25% Similarity=0.360 Sum_probs=176.5
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
++|++.++||+|+||.||+|++..+++.||+|+++... ....+++.+|++++++++||||+++++++ .+++.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~-----~d~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSIC-----SDGDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEE-----eeCCE
Confidence 58999999999999999999999889999999986422 22346789999999999999999999984 45578
Q ss_pred EEEEEEeccCCCHhHhhccCCCCC-ccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITRED-ETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~-~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
.++||||++||+|.+++....... .........++.++..++.||++||+|||+. ||+||||||+||+++.++.+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vK 153 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVV 153 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEE
Confidence 999999999999999986432111 1112234577888999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCC----------------ccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 844 IGDFGLARFLPLSSA----------------QTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 844 L~DFG~a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
|+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 999999986521110 0111234689999999999999999999999999999999999999964
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=319.70 Aligned_cols=247 Identities=26% Similarity=0.382 Sum_probs=193.3
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 767 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 767 (986)
++|++.+.||+|+||.||+|.++. +..+|+|.++... ...+.+.+|++++++++||||++++++| ..+...++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~i 76 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVC-----TQQKPLYI 76 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEE-----ccCCCEEE
Confidence 468889999999999999999876 5679999876432 3346788999999999999999999984 45577999
Q ss_pred EEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccc
Q 046598 768 VFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDF 847 (986)
Q Consensus 768 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DF 847 (986)
||||+++|+|.++++. ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 77 v~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~ 144 (256)
T cd05114 77 VTEFMENGCLLNYLRQ---------RQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDF 144 (256)
T ss_pred EEEcCCCCcHHHHHHh---------CccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCC
Confidence 9999999999999862 123588999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCc
Q 046598 848 GLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALPDH 926 (986)
Q Consensus 848 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 926 (986)
|.++....... .......++..|+|||++.+..++.++||||||+++|||++ |+.||..... .......
T Consensus 145 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-----~~~~~~i---- 214 (256)
T cd05114 145 GMTRYVLDDEY-TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-----YEVVEMI---- 214 (256)
T ss_pred CCccccCCCce-eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHH----
Confidence 99976532221 12223345678999999988899999999999999999999 8999863211 1111100
Q ss_pred hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 927 VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 927 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
........+ ...+.++.+++.+||+.+|++||+++||
T Consensus 215 ----~~~~~~~~~-------------------~~~~~~~~~li~~c~~~~p~~Rps~~~l 251 (256)
T cd05114 215 ----SRGFRLYRP-------------------KLASMTVYEVMYSCWHEKPEGRPTFAEL 251 (256)
T ss_pred ----HCCCCCCCC-------------------CCCCHHHHHHHHHHccCCcccCcCHHHH
Confidence 000000000 0123457899999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=325.72 Aligned_cols=277 Identities=24% Similarity=0.291 Sum_probs=196.2
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcC---CCCcceeeeeeccccccCCCc
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNI---RHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~~~ 763 (986)
+|++.+.||+|+||+||+|.+..+++.||+|+++... ......+.+|+.+++.+ +||||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5889999999999999999999999999999986432 12224556677776655 799999999987554344556
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..++||||++ ++|.+++.... ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~--------~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~k 148 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVP--------PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVK 148 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEE
Confidence 7899999996 58988885321 23589999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhC
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTAL 923 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 923 (986)
|+|||+++...... ......++..|+|||++.+..++.++||||+||++|||++|++||......+ ..........
T Consensus 149 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~ 224 (288)
T cd07863 149 LADFGLARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIG 224 (288)
T ss_pred ECccCccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH-HHHHHHHHhC
Confidence 99999998653221 1223457899999999999999999999999999999999999986332211 1111111000
Q ss_pred CCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 924 PDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 924 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
...... ...... .+.........+. ......+...++.+++.+|++.||++|||+.|+
T Consensus 225 ~~~~~~-~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~ 282 (288)
T cd07863 225 LPPEDD-WPRDVT-LPRGAFSPRGPRP---VQSVVPEIEESGAQLLLEMLTFNPHKRISAFRA 282 (288)
T ss_pred CCChhh-Cccccc-ccccccCCCCCCc---hHHhCcCcCHHHHHHHHHHhccCcccCCCHHHH
Confidence 000000 000000 0000000000000 001111344567899999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=321.03 Aligned_cols=258 Identities=25% Similarity=0.388 Sum_probs=196.5
Q ss_pred CCCCcccccccceeEEEEEECCC---CeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeecccccc-CCCc
Q 046598 690 FSSVNQIGEGSFGSVFKGILDDG---RTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY-QGND 763 (986)
Q Consensus 690 y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~ 763 (986)
|++.+.||+|+||.||+|....+ +..||+|+++... ......+.+|++.++.++||||+++++++..... ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 67889999999999999998643 3789999987432 2345678999999999999999999998643321 2334
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..++||||+++|+|..++...... .....+++..+..++.|++.||+|||+. +++||||||+||++++++.+|
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~----~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~k 153 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLG----GLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVC 153 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhcc----CCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEE
Confidence 589999999999999998543211 2234689999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhh
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~ 922 (986)
|+|||.++...............++..|+|||++.+..++.++|||||||++|||++ |..||...... ..
T Consensus 154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~-----~~---- 224 (273)
T cd05035 154 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH-----EI---- 224 (273)
T ss_pred ECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH-----HH----
Confidence 999999987644333222222335678999999988899999999999999999999 88888632110 11
Q ss_pred CCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 923 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+........ ..+..++.++.+++.+||+.||++|||+.||
T Consensus 225 --------~~~~~~~~~~---------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~ 265 (273)
T cd05035 225 --------YDYLRHGNRL---------------KQPEDCLDELYDLMYSCWRADPKDRPTFTKL 265 (273)
T ss_pred --------HHHHHcCCCC---------------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 1100000000 0011234567899999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=341.66 Aligned_cols=202 Identities=23% Similarity=0.294 Sum_probs=172.7
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
++|++++.||+|+||+||+|.+..+++.||||++... .....+.+.+|++++++++||||++++++ +.++..
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~-----~~~~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYS-----FQDAQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEE-----EEcCCe
Confidence 4789999999999999999999999999999998642 22334678889999999999999999998 456688
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.|+||||+++|+|.+++.. .+.+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~E~~~gg~L~~~l~~----------~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl 142 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIK----------YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKL 142 (377)
T ss_pred eEEEEeCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEE
Confidence 9999999999999999852 23578899999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCc------------c---------------------------------ccccccccccccccccccC
Q 046598 845 GDFGLARFLPLSSAQ------------T---------------------------------SSIGAKGSIGYIAPEYGLG 879 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~------------~---------------------------------~~~~~~gt~~y~aPE~~~~ 879 (986)
+|||+++.+...... . ......||+.|+|||++.+
T Consensus 143 ~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 222 (377)
T cd05629 143 SDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ 222 (377)
T ss_pred eecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc
Confidence 999999643211000 0 0012468999999999999
Q ss_pred CCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 880 SEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 880 ~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
..++.++|||||||++|||++|+.||..
T Consensus 223 ~~~~~~~DiwSlGvil~elltG~~Pf~~ 250 (377)
T cd05629 223 QGYGQECDWWSLGAIMFECLIGWPPFCS 250 (377)
T ss_pred CCCCCceeeEecchhhhhhhcCCCCCCC
Confidence 9999999999999999999999999963
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=322.32 Aligned_cols=249 Identities=24% Similarity=0.352 Sum_probs=192.3
Q ss_pred cCCCCCcccccccceeEEEEEECCCCe----EEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRT----TIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
++|++.+.||+|+||+||+|.+..+++ .|++|.+.... .....++..|+.++++++||||+++++++. +
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~------~ 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP------G 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC------C
Confidence 468889999999999999999866554 47777775322 233467788888999999999999999852 2
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
...++|+||+++|+|.+++.. ....+++..+..|+.||+.||+|||+. +++||||||+||++++++.+
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~---------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~ 148 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQ---------HRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIV 148 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcE
Confidence 446899999999999999962 234589999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHh
Q 046598 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLART 921 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~ 921 (986)
||+|||.++...............++..|+|||++.++.++.++|||||||++||+++ |+.||...... .
T Consensus 149 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~------- 219 (279)
T cd05111 149 QIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--E------- 219 (279)
T ss_pred EEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--H-------
Confidence 9999999987643332222334457788999999998899999999999999999998 99998632111 0
Q ss_pred hCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 922 ALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 922 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..+++........ ...++.++.+++.+||..+|++|||+.||
T Consensus 220 -----~~~~~~~~~~~~~------------------~~~~~~~~~~li~~c~~~~p~~Rps~~el 261 (279)
T cd05111 220 -----VPDLLEKGERLAQ------------------PQICTIDVYMVMVKCWMIDENVRPTFKEL 261 (279)
T ss_pred -----HHHHHHCCCcCCC------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 1111110000000 00123356788999999999999999874
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=320.91 Aligned_cols=251 Identities=22% Similarity=0.390 Sum_probs=197.1
Q ss_pred hcCCCCCcccccccceeEEEEEECCC---CeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDG---RTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
.++|++.+.||+|+||.||+|.+... ...||||+++... .....++.+|+.++++++||||+++++++ ..+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 77 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVV-----TKS 77 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEE-----ecC
Confidence 46799999999999999999998643 4679999986533 33456788999999999999999999984 455
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
+..++||||+++++|.+++.. ..+.+++.++..++.|++.|++|||++ +|+||||||+||++++++.+
T Consensus 78 ~~~~iv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~ 145 (266)
T cd05033 78 RPVMIITEYMENGSLDKFLRE---------NDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVC 145 (266)
T ss_pred CceEEEEEcCCCCCHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCE
Confidence 778999999999999999962 223689999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHh
Q 046598 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLART 921 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~ 921 (986)
||+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ....
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~-----~~~~- 219 (266)
T cd05033 146 KVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ-----DVIK- 219 (266)
T ss_pred EECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH-----HHHH-
Confidence 9999999987642222222223345678999999999999999999999999999998 99998532111 1100
Q ss_pred hCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 922 ALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 922 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+...... + ....++..+.+++.+||+.+|++||+++||
T Consensus 220 --------~~~~~~~~-~-----------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei 258 (266)
T cd05033 220 --------AVEDGYRL-P-----------------PPMDCPSALYQLMLDCWQKDRNERPTFSQI 258 (266)
T ss_pred --------HHHcCCCC-C-----------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 00000000 0 001234567899999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=331.25 Aligned_cols=195 Identities=27% Similarity=0.342 Sum_probs=165.7
Q ss_pred CcccccccceeEEEEEEC---CCCeEEEEEEeecc----CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 693 VNQIGEGSFGSVFKGILD---DGRTTIAVKVFNLL----HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 693 ~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
++.||+|+||.||+|+.. ..++.||+|+++.. .......+.+|+++++.++||||++++++ +..++..
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~-----~~~~~~~ 75 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYA-----FQTGGKL 75 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeE-----EecCCeE
Confidence 367999999999999874 45789999998742 22334567889999999999999999988 4556789
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
|+||||+++++|.+++.. .+.+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 76 ~lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~ 142 (323)
T cd05584 76 YLILEYLSGGELFMHLER----------EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLT 142 (323)
T ss_pred EEEEeCCCCchHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEe
Confidence 999999999999999852 24578889999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
|||+++....... ......|++.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 143 Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~ 202 (323)
T cd05584 143 DFGLCKESIHEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA 202 (323)
T ss_pred eCcCCeecccCCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCC
Confidence 9999975422221 12235689999999999998999999999999999999999999963
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=326.52 Aligned_cols=249 Identities=21% Similarity=0.278 Sum_probs=199.1
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
..+|++.+.||+|+||.||+|++..+++.||+|.+........+.+.+|+.+++.++||||+++++++ ..+...+
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~-----~~~~~~~ 93 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDELW 93 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEE-----EeCCEEE
Confidence 35799999999999999999999888999999999765555567889999999999999999999984 3457899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+++++|.+++.. ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 94 lv~e~~~~~~L~~~~~~-----------~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~d 159 (296)
T cd06654 94 VVMEYLAGGSLTDVVTE-----------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTD 159 (296)
T ss_pred EeecccCCCCHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECc
Confidence 99999999999999851 2478889999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCc
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDH 926 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 926 (986)
||.+....... .......+++.|+|||.+.+..++.++|||||||++|+|++|+.||...... ....... ..
T Consensus 160 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~----~~~~~~~-~~- 231 (296)
T cd06654 160 FGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL----RALYLIA-TN- 231 (296)
T ss_pred cccchhccccc--cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH----HhHHHHh-cC-
Confidence 99987643221 1122346888999999999888999999999999999999999999632211 1110000 00
Q ss_pred hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 927 VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 927 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..+. .......+..+.+++.+||..+|++|||+.||
T Consensus 232 ----------~~~~--------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ei 267 (296)
T cd06654 232 ----------GTPE--------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267 (296)
T ss_pred ----------CCCC--------------CCCccccCHHHHHHHHHHCcCCcccCcCHHHH
Confidence 0000 00011233457789999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=322.03 Aligned_cols=258 Identities=23% Similarity=0.402 Sum_probs=194.8
Q ss_pred CCCCcccccccceeEEEEEECCCCe--EEEEEEeecc--CchhHHHHHHHHHHHhcCCCCcceeeeeecccccc-CCCce
Q 046598 690 FSSVNQIGEGSFGSVFKGILDDGRT--TIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY-QGNDF 764 (986)
Q Consensus 690 y~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~~ 764 (986)
|.+.+.||+|+||.||+|++..++. .||+|.++.. .....+.+.+|+++++.++||||++++++|..... .....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4577899999999999999876654 6999988643 33445778999999999999999999998643211 22346
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.++||||+++|+|.+++...... .....+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~----~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl 153 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLG----DCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCV 153 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhccc----CCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEE
Confidence 79999999999999988432211 2234589999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhC
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTAL 923 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 923 (986)
+|||+++.+.............+++.|+|||+..+..++.++|||||||++|||++ |+.||..... ......
T Consensus 154 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~~~~~~-- 226 (272)
T cd05075 154 ADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-----SEIYDY-- 226 (272)
T ss_pred CCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHH--
Confidence 99999987643322222222346778999999999999999999999999999999 8889863211 111110
Q ss_pred CCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 924 PDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 924 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+.. .... .....++..+.+++.+||+.+|++|||+.||
T Consensus 227 -------~~~---~~~~---------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l 264 (272)
T cd05075 227 -------LRQ---GNRL---------------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETL 264 (272)
T ss_pred -------HHc---CCCC---------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 000 0000 0001233457899999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=343.22 Aligned_cols=201 Identities=23% Similarity=0.326 Sum_probs=172.0
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
+|+++++||+|+||+||+|++..+++.||+|++.... ....+.+.+|++++++++||||++++++ +.+++..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~-----~~~~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYS-----FQDKDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEE-----EEeCCEE
Confidence 5889999999999999999999999999999987432 2334678899999999999999999998 4556789
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
|+||||+++|+|.+++.. .+.+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+
T Consensus 77 ~lv~E~~~gg~L~~~l~~----------~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~ 143 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIR----------MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLT 143 (382)
T ss_pred EEEEeCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEe
Confidence 999999999999999852 23578889999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCC---------------------------------------------ccccccccccccccccccccCC
Q 046598 846 DFGLARFLPLSSA---------------------------------------------QTSSIGAKGSIGYIAPEYGLGS 880 (986)
Q Consensus 846 DFG~a~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~ 880 (986)
|||+++....... ........||+.|+|||++.+.
T Consensus 144 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~ 223 (382)
T cd05625 144 DFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT 223 (382)
T ss_pred ECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC
Confidence 9999753211000 0001224689999999999999
Q ss_pred CcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 881 EVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 881 ~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
.++.++||||+||++|||++|+.||..
T Consensus 224 ~~~~~~DiwSlGvil~elltG~~Pf~~ 250 (382)
T cd05625 224 GYTQLCDWWSVGVILYEMLVGQPPFLA 250 (382)
T ss_pred CCCCeeeEEechHHHHHHHhCCCCCCC
Confidence 999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=320.48 Aligned_cols=254 Identities=21% Similarity=0.351 Sum_probs=199.2
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
++|++.+.||+|+||.||+|++..+++.||||.++.. .......+.+|+++++.++||||+++++++ ...+.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSF-----IEDNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeE-----EECCe
Confidence 5799999999999999999999988999999987642 233345788999999999999999999984 44578
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.++||||+++++|.+++.... .....+++.++..++.|+++||+|||++ +++||||||+||+++.++.++|
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l 147 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFK------KQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKL 147 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhh------hccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEE
Confidence 899999999999999885322 1234578999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCC
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALP 924 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 924 (986)
+|||.+....... .......++..|+|||.+.+..++.++||||+|+++|||++|+.||..... ........
T Consensus 148 ~d~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~---~~~~~~~~--- 219 (267)
T cd08228 148 GDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLFSLCQK--- 219 (267)
T ss_pred Cccccceeccchh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc---cHHHHHHH---
Confidence 9999998654322 112234588899999999888899999999999999999999999853211 11111110
Q ss_pred CchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 925 DHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 925 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+... ..+. ......+..+.+++.+||+.+|++||++.||
T Consensus 220 ------~~~~--~~~~---------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~v 258 (267)
T cd08228 220 ------IEQC--DYPP---------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYV 258 (267)
T ss_pred ------HhcC--CCCC---------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHH
Confidence 0000 0000 0011334567899999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=330.32 Aligned_cols=237 Identities=23% Similarity=0.288 Sum_probs=188.8
Q ss_pred cccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcC-CCCcceeeeeeccccccCCCceEEEEE
Q 046598 694 NQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVF 769 (986)
Q Consensus 694 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 769 (986)
+.||+|+||.||+|++..+++.||+|+++.. .......+.+|.++++.+ +||||++++++ +...+..|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~-----~~~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSC-----FQTKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeE-----EEcCCEEEEEE
Confidence 4699999999999999988999999999753 233456677888998887 79999999998 45567899999
Q ss_pred EeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccccc
Q 046598 770 EFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGL 849 (986)
Q Consensus 770 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~ 849 (986)
||+++|+|..++.. ...+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 76 e~~~~~~L~~~~~~----------~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~ 142 (318)
T cd05570 76 EYVNGGDLMFHIQR----------SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGM 142 (318)
T ss_pred cCCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCC
Confidence 99999999998852 23589999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCchhH
Q 046598 850 ARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVMD 929 (986)
Q Consensus 850 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 929 (986)
++...... .......|++.|+|||++.+..++.++|||||||++|+|++|+.||..... .......
T Consensus 143 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~-----~~~~~~i------- 208 (318)
T cd05570 143 CKEGILGG--VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-----DELFQSI------- 208 (318)
T ss_pred CeecCcCC--CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH-----HHHHHHH-------
Confidence 97532221 112234689999999999999999999999999999999999999963211 1111100
Q ss_pred HhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 046598 930 IVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSM 983 (986)
Q Consensus 930 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 983 (986)
.. ..+. .+...+.++.+++.+||+.||++|||+
T Consensus 209 -~~----~~~~----------------~~~~~~~~~~~li~~~l~~dP~~R~s~ 241 (318)
T cd05570 209 -LE----DEVR----------------YPRWLSKEAKSILKSFLTKNPEKRLGC 241 (318)
T ss_pred -Hc----CCCC----------------CCCcCCHHHHHHHHHHccCCHHHcCCC
Confidence 00 0000 000123457799999999999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=317.48 Aligned_cols=244 Identities=24% Similarity=0.353 Sum_probs=189.4
Q ss_pred cccccccceeEEEEEECCCCeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEEEEec
Q 046598 694 NQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFM 772 (986)
Q Consensus 694 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 772 (986)
+.||+|+||.||+|.+..+++.||+|.+.... ......+.+|++++++++||||++++++| ......++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC-----TQKQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----cCCCCeEEEEeec
Confidence 46999999999999998889999999876432 33456789999999999999999999985 3457789999999
Q ss_pred cCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccccccee
Q 046598 773 HNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARF 852 (986)
Q Consensus 773 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~ 852 (986)
++++|.+++.. ....+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||.+..
T Consensus 76 ~~~~L~~~~~~---------~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 143 (252)
T cd05084 76 QGGDFLTFLRT---------EGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSRE 143 (252)
T ss_pred cCCcHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcc
Confidence 99999999852 223588999999999999999999999 999999999999999999999999999975
Q ss_pred cCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCchhHHh
Q 046598 853 LPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALPDHVMDIV 931 (986)
Q Consensus 853 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (986)
...............+..|+|||.+.++.++.++|||||||++|||++ |..||...... . ....+
T Consensus 144 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--~------------~~~~~ 209 (252)
T cd05084 144 EEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--Q------------TREAI 209 (252)
T ss_pred cccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--H------------HHHHH
Confidence 432111111111223567999999999899999999999999999998 88888532111 0 11111
Q ss_pred hhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 932 DSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 932 d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
....... ....++.++.+++.+|++.+|++|||+.||
T Consensus 210 ~~~~~~~------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 246 (252)
T cd05084 210 EQGVRLP------------------CPELCPDAVYRLMERCWEYDPGQRPSFSTV 246 (252)
T ss_pred HcCCCCC------------------CcccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 1100000 001234567899999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=332.62 Aligned_cols=205 Identities=26% Similarity=0.339 Sum_probs=172.9
Q ss_pred HHHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeeccccc-c
Q 046598 683 LYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-Y 759 (986)
Q Consensus 683 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~ 759 (986)
.....++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|++++++++||||+++++++.... .
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 4456789999999999999999999999889999999986432 223456788999999999999999998864321 1
Q ss_pred CCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCC
Q 046598 760 QGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED 839 (986)
Q Consensus 760 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 839 (986)
......|+++|++ +++|.+++. ...+++.++..++.||+.||+|||++ +|+||||||+||+++++
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~ 154 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVK-----------CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNED 154 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCC
Confidence 2235679999988 889988874 13589999999999999999999999 99999999999999999
Q ss_pred CcEEEcccccceecCCCCCccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 840 MIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 840 ~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
+.+||+|||+++..... .....|+..|+|||++.+ ..++.++||||+||++|+|++|+.||..
T Consensus 155 ~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 218 (343)
T cd07878 155 CELRILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218 (343)
T ss_pred CCEEEcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999999999865321 223568999999999877 5789999999999999999999999863
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=295.23 Aligned_cols=252 Identities=23% Similarity=0.307 Sum_probs=201.4
Q ss_pred HHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc--------hhHHHHHHHHHHHhcC-CCCcceeeeeec
Q 046598 684 YNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH--------GAFKSFIAECNTLKNI-RHRNLVKILTAC 754 (986)
Q Consensus 684 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 754 (986)
....++|...+.+|.|..++|-++.++.++..+|+|++..... .-.++-.+|+.|++++ .||+|+++.++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~- 91 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV- 91 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee-
Confidence 3445678888999999999999999999999999999863211 1135567899999998 79999999999
Q ss_pred cccccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCe
Q 046598 755 SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNI 834 (986)
Q Consensus 755 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NI 834 (986)
++.+...++|+|.|+.|.|.+++. ....+++.+.++|++|+..|++|||.. .|||||+||+||
T Consensus 92 ----yes~sF~FlVFdl~prGELFDyLt----------s~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENI 154 (411)
T KOG0599|consen 92 ----YESDAFVFLVFDLMPRGELFDYLT----------SKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENI 154 (411)
T ss_pred ----ccCcchhhhhhhhcccchHHHHhh----------hheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhhe
Confidence 677889999999999999999994 345789999999999999999999999 999999999999
Q ss_pred EecCCCcEEEcccccceecCCCCCccccccccccccccccccccC------CCcCcccchhhHHHHHHHHHhCCCCCCcc
Q 046598 835 LLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG------SEVSISGDVYSYGILLLELITRKKPTDIM 908 (986)
Q Consensus 835 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlGvvl~elltg~~pf~~~ 908 (986)
+++++.++||+|||.|+.++... .....+||++|.|||.+.- ..|+..+|+||.||++|.++.|.+||..-
T Consensus 155 Llddn~~i~isDFGFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR 231 (411)
T KOG0599|consen 155 LLDDNMNIKISDFGFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR 231 (411)
T ss_pred eeccccceEEeccceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH
Confidence 99999999999999999876543 3345789999999998753 25888999999999999999999998511
Q ss_pred ccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCC
Q 046598 909 FEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTN 985 (986)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 985 (986)
. ..++-..+.+ +. .+.+.++-.+...+..+++.+|++.||.+|.|++|
T Consensus 232 k------QmlMLR~Ime-----------Gk------------yqF~speWadis~~~KdLIsrlLqVdp~~Ritake 279 (411)
T KOG0599|consen 232 K------QMLMLRMIME-----------GK------------YQFRSPEWADISATVKDLISRLLQVDPTKRITAKE 279 (411)
T ss_pred H------HHHHHHHHHh-----------cc------------cccCCcchhhccccHHHHHHHHHeeCchhcccHHH
Confidence 0 0000000000 00 01122233345566788999999999999999876
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=337.14 Aligned_cols=202 Identities=22% Similarity=0.324 Sum_probs=173.5
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
..++|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.+++.++||||++++++ +.++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~-----~~~~ 115 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCA-----FQDD 115 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEE-----EEcC
Confidence 457899999999999999999999999999999998642 22234567889999999999999999998 4566
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
...|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~-----------~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~ 181 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSN-----------YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHL 181 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCE
Confidence 889999999999999999852 2478889999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCccccccccccccccccccccCC----CcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS----EVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
||+|||+|+....... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus 182 kL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~ 249 (370)
T cd05621 182 KLADFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA 249 (370)
T ss_pred EEEecccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC
Confidence 9999999987642221 122345699999999998754 378999999999999999999999963
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=322.18 Aligned_cols=252 Identities=20% Similarity=0.291 Sum_probs=196.9
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
.++|++.+.||+|+||.||+|++..+++.||+|++..........+.+|+.++++++||||+++++++ ..++..+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~-----~~~~~~~ 82 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY-----LSREKLW 82 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEE-----EeCCEEE
Confidence 45799999999999999999999888999999999765545556788999999999999999999984 4457899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+++++|.++++. ...+++.++..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|
T Consensus 83 iv~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~d 149 (267)
T cd06646 83 ICMEYCGGGSLQDIYHV----------TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLAD 149 (267)
T ss_pred EEEeCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECc
Confidence 99999999999999852 23578999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccc---CCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhC
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGL---GSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTAL 923 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 923 (986)
||+++...... .......++..|+|||.+. ...++.++|||||||++|||++|+.||........ ........
T Consensus 150 fg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-~~~~~~~~- 225 (267)
T cd06646 150 FGVAAKITATI--AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMSKSN- 225 (267)
T ss_pred Cccceeecccc--cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-heeeecCC-
Confidence 99998653221 1122345888999999874 34578899999999999999999999853211100 00000000
Q ss_pred CCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 924 PDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 924 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.. +. ........+..+.+++.+||+.+|++|||+++|
T Consensus 226 -----------~~--~~-------------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~i 262 (267)
T cd06646 226 -----------FQ--PP-------------KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERL 262 (267)
T ss_pred -----------CC--CC-------------CCccccccCHHHHHHHHHHhhCChhhCcCHHHH
Confidence 00 00 000011233467899999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=337.51 Aligned_cols=204 Identities=25% Similarity=0.318 Sum_probs=170.2
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeecc--CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
+|++.+.||+|+||.||+|.+..+++.||+|++... .....+++.+|+++++.++||||+++++++...........|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999999888999999998642 223456788999999999999999999986433222223789
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+. ++|.+++. ....+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 81 lv~e~~~-~~l~~~~~----------~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~D 146 (372)
T cd07853 81 VVTELMQ-SDLHKIIV----------SPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICD 146 (372)
T ss_pred EEeeccc-cCHHHHHh----------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEecc
Confidence 9999995 68888774 234689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
||+++....... .......++..|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus 147 fg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 207 (372)
T cd07853 147 FGLARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQA 207 (372)
T ss_pred ccceeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCC
Confidence 999986543221 222334578999999998774 579999999999999999999999974
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=328.46 Aligned_cols=243 Identities=22% Similarity=0.288 Sum_probs=191.0
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcCC-CCcceeeeeeccccccCCCce
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~ 764 (986)
+|+..+.||+|+||+||+|++..+++.||+|+++.. .....+.+..|.++++.+. |++|++++++ +...+.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~-----~~~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSC-----FQTVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeE-----EecCCE
Confidence 477889999999999999999998999999998743 2233456788899988885 5778888887 455678
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.|+||||+++|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~----------~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL 142 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQ----------VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKI 142 (323)
T ss_pred EEEEEcCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEE
Confidence 9999999999999999842 24589999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCC
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALP 924 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 924 (986)
+|||+++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... .....
T Consensus 143 ~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-----~~~~~---- 211 (323)
T cd05615 143 ADFGMCKEHMVDG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-----DELFQ---- 211 (323)
T ss_pred eccccccccCCCC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHH----
Confidence 9999997542221 122335689999999999999999999999999999999999999963211 11111
Q ss_pred CchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 046598 925 DHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMT 984 (986)
Q Consensus 925 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 984 (986)
.+..... ..+ .....++.+++.+|++.+|++|+++.
T Consensus 212 ----~i~~~~~-~~p-------------------~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 212 ----SIMEHNV-SYP-------------------KSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred ----HHHhCCC-CCC-------------------ccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 0110000 000 01234567899999999999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=323.10 Aligned_cols=260 Identities=22% Similarity=0.367 Sum_probs=200.0
Q ss_pred hcCCCCCcccccccceeEEEEEECCC-----CeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDG-----RTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ 760 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 760 (986)
.++|++.+.||+|+||.||+|.+... +..||+|.+.... ......+.+|+.+++.++||||+++++++ .
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~ 79 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----S 79 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEE-----c
Confidence 45789999999999999999998643 3789999986433 23346788999999999999999999994 4
Q ss_pred CCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCC
Q 046598 761 GNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDM 840 (986)
Q Consensus 761 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 840 (986)
.....++||||+++++|.+++...............+++..+..++.|++.||.|||+. +++||||||+||+++.++
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~ 156 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDL 156 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCC
Confidence 55789999999999999999975432211112334688999999999999999999999 999999999999999999
Q ss_pred cEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHH
Q 046598 841 IAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLA 919 (986)
Q Consensus 841 ~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~ 919 (986)
.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++||+++ |..||..... ....
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-----~~~~ 231 (277)
T cd05032 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-----EEVL 231 (277)
T ss_pred CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH-----HHHH
Confidence 999999999976543332222233446789999999988899999999999999999998 9999853211 1111
Q ss_pred HhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 920 RTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 920 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
. .+. ...... .+..++.++.+++.+||+.+|++|||+.||
T Consensus 232 ~---------~~~---~~~~~~---------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l 271 (277)
T cd05032 232 K---------FVI---DGGHLD---------------LPENCPDKLLELMRMCWQYNPKMRPTFLEI 271 (277)
T ss_pred H---------HHh---cCCCCC---------------CCCCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 1 000 000000 001224567899999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=324.38 Aligned_cols=259 Identities=25% Similarity=0.412 Sum_probs=199.9
Q ss_pred cCCCCCcccccccceeEEEEEECC-----CCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDD-----GRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
++|.+.+.||+|+||.||+|++.. +...+++|.++.......+.+.+|++++++++||||+++++++ ..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 79 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVC-----GDG 79 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEE-----ccC
Confidence 458888999999999999998642 3566899998765555567899999999999999999999994 445
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCC------CccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEe
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITRE------DETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILL 836 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 836 (986)
...++||||+++++|.+++...... .........+++.+++.++.||+.|++|||++ +|+||||||+||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~ 156 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLV 156 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEE
Confidence 7789999999999999999643321 01112234689999999999999999999999 99999999999999
Q ss_pred cCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccH
Q 046598 837 DEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNL 915 (986)
Q Consensus 837 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~ 915 (986)
+.++.+||+|||.++...............++..|+|||++.+..++.++|||||||++|||+| |+.||......
T Consensus 157 ~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---- 232 (291)
T cd05094 157 GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT---- 232 (291)
T ss_pred ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----
Confidence 9999999999999976543322222333456788999999999999999999999999999999 99998532211
Q ss_pred HHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 916 HNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 916 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..... +. ...... ....++..+.+++.+||+.+|++|||+++|
T Consensus 233 -~~~~~---------~~---~~~~~~---------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v 275 (291)
T cd05094 233 -EVIEC---------IT---QGRVLE---------------RPRVCPKEVYDIMLGCWQREPQQRLNIKEI 275 (291)
T ss_pred -HHHHH---------Hh---CCCCCC---------------CCccCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 11110 00 000000 001234567899999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=322.16 Aligned_cols=258 Identities=26% Similarity=0.370 Sum_probs=197.9
Q ss_pred hhcCCCCCcccccccceeEEEEEECC-----CCeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeecccccc
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDD-----GRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY 759 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 759 (986)
..++|.+.+.||+|+||.||+|.+.. .+..||+|.++... ......+.+|+.++++++|+||+++++++
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~----- 78 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVS----- 78 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----
Confidence 35679999999999999999999976 67889999886433 33346789999999999999999999984
Q ss_pred CCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCC
Q 046598 760 QGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED 839 (986)
Q Consensus 760 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 839 (986)
.+....++||||+++++|.+++....... .....+++.++..++.||+.|++|||+. +++||||||+||+++.+
T Consensus 79 ~~~~~~~lv~e~~~g~~L~~~i~~~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~ 152 (277)
T cd05036 79 FERLPRFILLELMAGGDLKSFLRENRPRP---ERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCK 152 (277)
T ss_pred ccCCCcEEEEecCCCCCHHHHHHHhCCCC---CCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEecc
Confidence 34467899999999999999996543221 1234689999999999999999999999 99999999999999865
Q ss_pred C---cEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccH
Q 046598 840 M---IAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNL 915 (986)
Q Consensus 840 ~---~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~ 915 (986)
+ .+||+|||+++................+..|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---- 228 (277)
T cd05036 153 GPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---- 228 (277)
T ss_pred CCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----
Confidence 4 699999999986632222221222234568999999999999999999999999999997 99998632111
Q ss_pred HHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 916 HNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 916 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.. .+.+....... .+..++.++.+++.+|++.+|++|||+.||
T Consensus 229 -~~---------~~~~~~~~~~~------------------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~v 271 (277)
T cd05036 229 -EV---------MEFVTGGGRLD------------------PPKGCPGPVYRIMTDCWQHTPEDRPNFATI 271 (277)
T ss_pred -HH---------HHHHHcCCcCC------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 11 11111000000 001234567899999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=333.69 Aligned_cols=204 Identities=26% Similarity=0.298 Sum_probs=171.3
Q ss_pred HhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc--CchhHHHHHHHHHHHhcCCCCcceeeeeeccccc-cCC
Q 046598 685 NATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-YQG 761 (986)
Q Consensus 685 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~ 761 (986)
...++|++.+.||+|+||.||+|.+..+++.||+|++... .......+.+|+.+++.++||||+++++++.... ...
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 3468899999999999999999999988999999998642 2334567889999999999999999999864321 122
Q ss_pred CceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCc
Q 046598 762 NDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI 841 (986)
Q Consensus 762 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 841 (986)
....|+||||+++ ++.+.++ ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~------------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~ 161 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIH------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCT 161 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHh------------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCC
Confidence 3467999999965 6666663 2377888999999999999999999 9999999999999999999
Q ss_pred EEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 842 AHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
+||+|||+++..... .......+|+.|+|||++.+..++.++||||+||++|+|++|+.||..
T Consensus 162 ~kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 224 (359)
T cd07876 162 LKILDFGLARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG 224 (359)
T ss_pred EEEecCCCccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 999999999754321 122335689999999999999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=329.20 Aligned_cols=244 Identities=23% Similarity=0.298 Sum_probs=190.2
Q ss_pred cccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcC-CCCcceeeeeeccccccCCCceEEEEE
Q 046598 694 NQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVF 769 (986)
Q Consensus 694 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 769 (986)
+.||+|+||.||+|++..+++.||+|+++.. .....+.+.+|+.++.++ +||+|++++++ +......|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~-----~~~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSC-----FQTTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEE-----EEeCCEEEEEE
Confidence 4699999999999999998999999999753 223445678899999888 69999999998 45567899999
Q ss_pred EeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccccc
Q 046598 770 EFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGL 849 (986)
Q Consensus 770 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~ 849 (986)
||+++|+|..++.. .+.+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 76 e~~~~~~L~~~~~~----------~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~ 142 (327)
T cd05617 76 EYVNGGDLMFHMQR----------QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGM 142 (327)
T ss_pred eCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEecccc
Confidence 99999999998842 24589999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCcccccc-ccHHHHHHhhCCCchh
Q 046598 850 ARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGD-MNLHNLARTALPDHVM 928 (986)
Q Consensus 850 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~ 928 (986)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .........
T Consensus 143 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~------- 213 (327)
T cd05617 143 CKEGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQ------- 213 (327)
T ss_pred ceeccCCC--CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHH-------
Confidence 97532111 12234568999999999999999999999999999999999999996432211 111111100
Q ss_pred HHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 046598 929 DIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMT 984 (986)
Q Consensus 929 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 984 (986)
.....+.. .+...+..+.+++.+|++.||++||++.
T Consensus 214 -----~~~~~~~~---------------~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 214 -----VILEKPIR---------------IPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred -----HHHhCCCC---------------CCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 00000000 0001234467899999999999999874
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=331.82 Aligned_cols=248 Identities=23% Similarity=0.260 Sum_probs=191.3
Q ss_pred CCCCCcccccccceeEEEEEEC---CCCeEEEEEEeecc----CchhHHHHHHHHHHHhcC-CCCcceeeeeeccccccC
Q 046598 689 RFSSVNQIGEGSFGSVFKGILD---DGRTTIAVKVFNLL----HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQ 760 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 760 (986)
+|++.+.||+|+||.||+|+.. .+++.||+|+++.. .....+.+.+|+.+++.+ +||+|++++++ +.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~-----~~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYA-----FQ 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEE-----Ee
Confidence 4889999999999999999874 45789999998642 222345678899999999 59999999988 45
Q ss_pred CCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCC
Q 046598 761 GNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDM 840 (986)
Q Consensus 761 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 840 (986)
.++..++||||+++|+|.+++.. ...+++.++..++.||+.||+|||+. +|+||||||+|||++.++
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~ 142 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLYQ----------RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEG 142 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCC
Confidence 66789999999999999999842 23588999999999999999999999 999999999999999999
Q ss_pred cEEEcccccceecCCCCCccccccccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHH
Q 046598 841 IAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLA 919 (986)
Q Consensus 841 ~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~ 919 (986)
.+||+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||+||+.||....... ......
T Consensus 143 ~~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~~~ 220 (332)
T cd05614 143 HVVLTDFGLSKEFLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN-TQSEVS 220 (332)
T ss_pred CEEEeeCcCCccccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC-CHHHHH
Confidence 999999999976532221 222345689999999998875 47899999999999999999999996322211 111111
Q ss_pred HhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 046598 920 RTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMT 984 (986)
Q Consensus 920 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 984 (986)
. .....++. ........+.+++.+|++.||++||++.
T Consensus 221 ~------------~~~~~~~~----------------~~~~~~~~~~~li~~~l~~dp~~R~~~~ 257 (332)
T cd05614 221 R------------RILKCDPP----------------FPSFIGPEAQDLLHKLLRKDPKKRLGAG 257 (332)
T ss_pred H------------HHhcCCCC----------------CCCCCCHHHHHHHHHHcCCCHHHcCCCC
Confidence 1 00100000 0001234567899999999999999654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=331.58 Aligned_cols=240 Identities=25% Similarity=0.271 Sum_probs=189.7
Q ss_pred CcccccccceeEEEEEE---CCCCeEEEEEEeeccCc--hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEE
Q 046598 693 VNQIGEGSFGSVFKGIL---DDGRTTIAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 767 (986)
Q Consensus 693 ~~~lg~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 767 (986)
++.||+|+||.||++++ ..+++.||+|+++.... .....+.+|++++++++||||++++++ +..+...|+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~-----~~~~~~~~l 75 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYA-----FQTEGKLYL 75 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEE-----EEcCCEEEE
Confidence 36799999999999987 34678999999975322 234567789999999999999999998 455678999
Q ss_pred EEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccc
Q 046598 768 VFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDF 847 (986)
Q Consensus 768 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DF 847 (986)
||||+++|+|.+++.. ...+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 76 v~e~~~~~~L~~~l~~----------~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Df 142 (318)
T cd05582 76 ILDFLRGGDLFTRLSK----------EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDF 142 (318)
T ss_pred EEcCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeec
Confidence 9999999999999842 24589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCch
Q 046598 848 GLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHV 927 (986)
Q Consensus 848 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 927 (986)
|+++...... .......|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......
T Consensus 143 g~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-----~~~~~~------ 209 (318)
T cd05582 143 GLSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR-----KETMTM------ 209 (318)
T ss_pred cCCcccCCCC--CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH-----HHHHHH------
Confidence 9997643221 222345689999999999988899999999999999999999999863211 111110
Q ss_pred hHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCC
Q 046598 928 MDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTN 985 (986)
Q Consensus 928 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 985 (986)
+..... .-+ ...+.++.+++.+||+.||++||++.+
T Consensus 210 --i~~~~~-~~p-------------------~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 210 --ILKAKL-GMP-------------------QFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred --HHcCCC-CCC-------------------CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 000000 000 012345678999999999999999865
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=319.12 Aligned_cols=249 Identities=27% Similarity=0.434 Sum_probs=195.8
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
.++|++.++||+|+||.||+|.... +..||+|.+.... ...+.+.+|+.++++++|+||++++++ +...+..+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~-----~~~~~~~~ 77 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAV-----VTKEEPIY 77 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEE-----EcCCCCcE
Confidence 3578999999999999999999765 5779999876533 345788999999999999999999988 44567789
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+++++|.++++.. ....+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|
T Consensus 78 lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~d 146 (261)
T cd05072 78 IITEYMAKGSLLDFLKSD--------EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIAD 146 (261)
T ss_pred EEEecCCCCcHHHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECC
Confidence 999999999999999632 234578899999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCC
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALPD 925 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 925 (986)
||.++....... .......++..|+|||++.+..++.++|||||||++|+|+| |+.||......+ ..........
T Consensus 147 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~~~~~~- 222 (261)
T cd05072 147 FGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD--VMSALQRGYR- 222 (261)
T ss_pred CccceecCCCce-eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH--HHHHHHcCCC-
Confidence 999987543221 11223345678999999988899999999999999999998 999986321110 1111000000
Q ss_pred chhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 926 HVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 926 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
. +.....+.++.+++.+|++.+|++||+++++
T Consensus 223 -----------~------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 254 (261)
T cd05072 223 -----------M------------------PRMENCPDELYDIMKTCWKEKAEERPTFDYL 254 (261)
T ss_pred -----------C------------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHH
Confidence 0 0001234457899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=323.03 Aligned_cols=266 Identities=26% Similarity=0.398 Sum_probs=197.6
Q ss_pred cCCCCCcccccccceeEEEEEE----CCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 688 DRFSSVNQIGEGSFGSVFKGIL----DDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
.+|++.+.||+|+||.||+|.. ..++..||+|+++.......+.+.+|++++++++||||+++++++.. .+..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEcc---CCCC
Confidence 4788999999999999999984 34578899999876665666789999999999999999999998642 3345
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..++||||+++++|.+++.. ....+++..+..++.|++.||+|||+. ||+||||||+||++++++.+|
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~---------~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~ 148 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQK---------HRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVK 148 (284)
T ss_pred ceEEEEEecCCCCHHHHHHh---------cCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEE
Confidence 68999999999999999952 223589999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCccc-cccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 046598 844 IGDFGLARFLPLSSAQTS-SIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 922 (986)
|+|||+++.......... .....++..|+|||++.+..++.++|||||||++|||++|..|+..... .+.......
T Consensus 149 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~~~~~~~ 225 (284)
T cd05081 149 IGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA---EFMRMMGND 225 (284)
T ss_pred ECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch---hhhhhcccc
Confidence 999999987643322111 1112244569999999988999999999999999999998877532111 111100100
Q ss_pred CC--CchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 923 LP--DHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 923 ~~--~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.. .....+.+ .+... .+.+....++.++.+++.+||+.+|++||||.||
T Consensus 226 ~~~~~~~~~~~~-~~~~~--------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei 276 (284)
T cd05081 226 KQGQMIVYHLIE-LLKNN--------------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSEL 276 (284)
T ss_pred cccccchHHHHH-HHhcC--------------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 00 00011110 00000 0001111334568899999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=322.36 Aligned_cols=259 Identities=24% Similarity=0.395 Sum_probs=196.7
Q ss_pred cCCCCCcccccccceeEEEEEE----CCCCeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 688 DRFSSVNQIGEGSFGSVFKGIL----DDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
++|++.+.||+|+||.||+|.+ ...+..||+|.++... ......+.+|++++++++||||++++++ +..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~-----~~~~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGV-----VTQE 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEE-----EecC
Confidence 4688889999999999999985 2346789999987433 2334678899999999999999999998 4455
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCC-------ccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITRED-------ETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNIL 835 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~-------~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIl 835 (986)
...|+||||+++++|.+++....... ........+++.++..++.|++.||+|||++ +++||||||+||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nil 156 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNIL 156 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEE
Confidence 77899999999999999985322110 0111134588999999999999999999999 9999999999999
Q ss_pred ecCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCcccccccc
Q 046598 836 LDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMN 914 (986)
Q Consensus 836 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~ 914 (986)
+++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||..... ..
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--~~ 234 (283)
T cd05090 157 IGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--QE 234 (283)
T ss_pred EcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HH
Confidence 99999999999999986543332222333446778999999988889999999999999999999 9999853211 01
Q ss_pred HHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 915 LHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 915 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
........ . .... ...++.++.+++.+||+.||++||++.+|
T Consensus 235 ~~~~~~~~---~--------~~~~-------------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i 276 (283)
T cd05090 235 VIEMVRKR---Q--------LLPC-------------------SEDCPPRMYSLMTECWQEGPSRRPRFKDI 276 (283)
T ss_pred HHHHHHcC---C--------cCCC-------------------CCCCCHHHHHHHHHHcccCcccCcCHHHH
Confidence 11111100 0 0000 01234467789999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=328.64 Aligned_cols=239 Identities=25% Similarity=0.275 Sum_probs=185.6
Q ss_pred cccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHH-HHhcCCCCcceeeeeeccccccCCCceEEEEE
Q 046598 694 NQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECN-TLKNIRHRNLVKILTACSGVDYQGNDFKALVF 769 (986)
Q Consensus 694 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 769 (986)
+.||+|+||+||+|++..+++.||+|++.... ......+..|.. +++.++||||++++++ +..++..++||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~-----~~~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFS-----FQTADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEE-----EEcCCeEEEEE
Confidence 46999999999999999989999999987422 122234444444 5678899999999988 45567899999
Q ss_pred EeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccccc
Q 046598 770 EFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGL 849 (986)
Q Consensus 770 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~ 849 (986)
||+++|+|.+++.. ...+++.++..++.||++||+|||+. ||+||||||+||+++.++.+||+|||+
T Consensus 76 e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~ 142 (325)
T cd05602 76 DYINGGELFYHLQR----------ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGL 142 (325)
T ss_pred eCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCC
Confidence 99999999999852 23577888999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCchhH
Q 046598 850 ARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVMD 929 (986)
Q Consensus 850 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 929 (986)
++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......
T Consensus 143 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~-------- 207 (325)
T cd05602 143 CKENIEHN--GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-----AEMYDN-------- 207 (325)
T ss_pred CcccccCC--CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH-----HHHHHH--------
Confidence 97542211 122345689999999999999999999999999999999999999963211 111111
Q ss_pred HhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCC
Q 046598 930 IVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTN 985 (986)
Q Consensus 930 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 985 (986)
+........ ...+..+.+++.+|++.+|.+||++.+
T Consensus 208 i~~~~~~~~--------------------~~~~~~~~~li~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 208 ILNKPLQLK--------------------PNITNSARHLLEGLLQKDRTKRLGAKD 243 (325)
T ss_pred HHhCCcCCC--------------------CCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 111000000 022345678999999999999999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=318.66 Aligned_cols=249 Identities=27% Similarity=0.441 Sum_probs=196.4
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 767 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 767 (986)
.+|++.+.||+|+||.||+|.+...++.||+|+++.. ....+.+.+|++++++++||||++++++| ..+...++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 79 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPFYI 79 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEE-----cCCCCcEE
Confidence 4578889999999999999999988999999998753 33456789999999999999999999984 34567899
Q ss_pred EEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccc
Q 046598 768 VFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDF 847 (986)
Q Consensus 768 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DF 847 (986)
||||+++++|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 80 v~e~~~~~~L~~~~~~~~--------~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df 148 (263)
T cd05052 80 ITEFMTYGNLLDYLRECN--------RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADF 148 (263)
T ss_pred EEEeCCCCcHHHHHHhCC--------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCC
Confidence 999999999999985321 23588999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCc
Q 046598 848 GLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALPDH 926 (986)
Q Consensus 848 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 926 (986)
|.+....... ........++..|+|||.+.+..++.++|||||||++|||++ |..||.... .......
T Consensus 149 ~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~-----~~~~~~~----- 217 (263)
T cd05052 149 GLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYEL----- 217 (263)
T ss_pred ccccccccce-eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHH-----
Confidence 9997654221 111122234568999999999999999999999999999998 999986321 1111111
Q ss_pred hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 927 VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 927 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+....... .+..++.++.+++.+||+.+|++|||+.||
T Consensus 218 ----~~~~~~~~------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l 255 (263)
T cd05052 218 ----LEKGYRME------------------RPEGCPPKVYELMRACWQWNPSDRPSFAEI 255 (263)
T ss_pred ----HHCCCCCC------------------CCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 11000000 001234567899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=334.93 Aligned_cols=204 Identities=25% Similarity=0.295 Sum_probs=172.3
Q ss_pred HhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc--CchhHHHHHHHHHHHhcCCCCcceeeeeeccccc-cCC
Q 046598 685 NATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-YQG 761 (986)
Q Consensus 685 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~ 761 (986)
...++|++.+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.+++.++||||+++++++.... ...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 4567999999999999999999999988999999998643 2334567889999999999999999999864321 223
Q ss_pred CceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCc
Q 046598 762 NDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI 841 (986)
Q Consensus 762 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 841 (986)
....++||||+++ ++.+++. ..+++..+..++.|++.||+|||++ ||+||||||+||+++.++.
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~------------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~ 157 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCT 157 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh------------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCC
Confidence 3568999999964 6777663 2478889999999999999999999 9999999999999999999
Q ss_pred EEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 842 AHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
+||+|||+++..... .......+|..|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 158 ~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 220 (355)
T cd07874 158 LKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_pred EEEeeCcccccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999764322 122335689999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=317.67 Aligned_cols=250 Identities=21% Similarity=0.285 Sum_probs=197.0
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc-----hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH-----GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
++|.+.+.||+|++|.||+|.+..+++.||+|++..... ...+.+.+|++++++++||||+++++++ ..+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCL-----RDD 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ccC
Confidence 579999999999999999999988899999999864321 2235688899999999999999999994 455
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
+..++||||+++++|.+++.. ...+++..+..++.|++.|+.|||+. +++||||+|+||++++++.+
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~----------~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~ 143 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKA----------YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNV 143 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHH----------hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCE
Confidence 789999999999999999852 23578899999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCccc-cccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHh
Q 046598 843 HIGDFGLARFLPLSSAQTS-SIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLART 921 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~ 921 (986)
+|+|||.++.......... .....++..|+|||++.+..++.++||||+|+++|||++|+.||..... .......
T Consensus 144 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~ 219 (263)
T cd06625 144 KLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA----MAAIFKI 219 (263)
T ss_pred EEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch----HHHHHHH
Confidence 9999999976532211111 1234578899999999999999999999999999999999999863211 1111100
Q ss_pred hCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 922 ALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 922 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..... . ...+......+.+++.+||..+|++|||+.||
T Consensus 220 ~~~~~------------~---------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l 257 (263)
T cd06625 220 ATQPT------------N---------------PQLPSHVSPDARNFLRRTFVENAKKRPSAEEL 257 (263)
T ss_pred hccCC------------C---------------CCCCccCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 00000 0 00011234457789999999999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=322.23 Aligned_cols=261 Identities=25% Similarity=0.380 Sum_probs=195.9
Q ss_pred cCC-CCCcccccccceeEEEEEE----CCCCeEEEEEEeeccCc-hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCC
Q 046598 688 DRF-SSVNQIGEGSFGSVFKGIL----DDGRTTIAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 761 (986)
Q Consensus 688 ~~y-~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 761 (986)
++| ++.+.||+|+||+||++.. ..+++.||+|+++.... ...+.+.+|++++++++||||++++++|.. ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~ 79 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE---QG 79 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CC
Confidence 345 8899999999999988653 34578899999875432 345678899999999999999999998642 23
Q ss_pred CceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCc
Q 046598 762 NDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI 841 (986)
Q Consensus 762 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 841 (986)
....++||||+++++|.+++.. ..+++.+++.++.|+++|++|||+. +|+||||||+||++++++.
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~-----------~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~ 145 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPK-----------HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRL 145 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHH-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCc
Confidence 4568999999999999999851 2489999999999999999999999 9999999999999999999
Q ss_pred EEEcccccceecCCCCCcc-ccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHH
Q 046598 842 AHIGDFGLARFLPLSSAQT-SSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLAR 920 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~ 920 (986)
+||+|||+++......... ......++..|+|||.+.+..++.++||||||+++|||+||+.||...... +.....
T Consensus 146 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~---~~~~~~ 222 (283)
T cd05080 146 VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK---FEEMIG 222 (283)
T ss_pred EEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch---hhhhhc
Confidence 9999999998664322211 112233567799999998889999999999999999999999998632211 111111
Q ss_pred hhCC----CchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 921 TALP----DHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 921 ~~~~----~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.... ..+.+.++.... .+.+..++.++.+++.+||+.+|++|||+++|
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i 274 (283)
T cd05080 223 PKQGQMTVVRLIELLERGMR------------------LPCPKNCPQEVYILMKNCWETEAKFRPTFRSL 274 (283)
T ss_pred ccccccchhhhhhhhhcCCC------------------CCCCCCCCHHHHHHHHHHhccChhhCCCHHHH
Confidence 1100 011111111110 00111345678899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=315.49 Aligned_cols=248 Identities=23% Similarity=0.300 Sum_probs=199.5
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeecc--CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
+|++.+.||+|++|.||+|.+..+++.|++|.+... .....+++.+|++++++++||||+++++++ ..++..+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESF-----LDKGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeee-----ccCCEEE
Confidence 478889999999999999999988999999998643 344567889999999999999999999984 4557899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+++++|.++++.. ....+++.++..++.|++.|+.|||+. +++||||||+||++++++.+||+|
T Consensus 76 lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~d 144 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQ--------RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGD 144 (256)
T ss_pred EEEEeCCCCcHHHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcc
Confidence 999999999999999632 134688999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCc
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDH 926 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 926 (986)
||.++....... ......++..|+|||+..+..++.++|||||||++|+|++|+.||..... .......
T Consensus 145 f~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~---- 213 (256)
T cd08529 145 LGVAKLLSDNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-----GALILKI---- 213 (256)
T ss_pred cccceeccCccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHH----
Confidence 999986643221 12234578899999999999999999999999999999999999863321 1111100
Q ss_pred hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 927 VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 927 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
....... .....+.++.+++.+||+.+|++||++.||
T Consensus 214 --------~~~~~~~---------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l 250 (256)
T cd08529 214 --------IRGVFPP---------------VSQMYSQQLAQLIDQCLTKDYRQRPDTFQL 250 (256)
T ss_pred --------HcCCCCC---------------CccccCHHHHHHHHHHccCCcccCcCHHHH
Confidence 0000000 001234567899999999999999999764
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=320.75 Aligned_cols=250 Identities=27% Similarity=0.456 Sum_probs=200.2
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
...+|++.++||+|+||.||+|.+.. +..+|+|++..........+.+|+.+++.++||||+++++++ ......
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~ 77 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC-----SVGEPV 77 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeE-----ecCCCe
Confidence 35679999999999999999999988 889999999876555567889999999999999999999984 455778
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
++||||+++++|.++++.. ....+++.++..++.|++.|+.|||+. +++||||||+||++++++.+||+
T Consensus 78 ~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~ 146 (261)
T cd05148 78 YIITELMEKGSLLAFLRSP--------EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVA 146 (261)
T ss_pred EEEEeecccCCHHHHHhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEc
Confidence 9999999999999999632 234689999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCC
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALP 924 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 924 (986)
|||.+........ ......++..|+|||++.+..++.++||||||+++|+|++ |+.||...... ....
T Consensus 147 d~g~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~-----~~~~---- 215 (261)
T cd05148 147 DFGLARLIKEDVY--LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH-----EVYD---- 215 (261)
T ss_pred cccchhhcCCccc--cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH-----HHHH----
Confidence 9999976532211 1123346778999999988899999999999999999998 89998632211 1100
Q ss_pred CchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 925 DHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 925 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+..... .+....++.++.+++.+||+.||++|||++++
T Consensus 216 -----~~~~~~~------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l 254 (261)
T cd05148 216 -----QITAGYR------------------MPCPAKCPQEIYKIMLECWAAEPEDRPSFKAL 254 (261)
T ss_pred -----HHHhCCc------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 0000000 00011334567899999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=329.71 Aligned_cols=238 Identities=26% Similarity=0.286 Sum_probs=186.3
Q ss_pred cccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHH-HHhcCCCCcceeeeeeccccccCCCceEEEEE
Q 046598 694 NQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECN-TLKNIRHRNLVKILTACSGVDYQGNDFKALVF 769 (986)
Q Consensus 694 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 769 (986)
+.||+|+||+||+|++..+++.||+|++... .....+.+..|.. +++.++||||++++++ +..++..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~-----~~~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYS-----FQTTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEE-----EecCCEEEEEE
Confidence 4699999999999999988999999998643 2223345555655 4677899999999988 45567899999
Q ss_pred EeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccccc
Q 046598 770 EFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGL 849 (986)
Q Consensus 770 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~ 849 (986)
||+++|+|..++. ....+++.++..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+
T Consensus 76 e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~ 142 (325)
T cd05604 76 DFVNGGELFFHLQ----------RERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGL 142 (325)
T ss_pred cCCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCC
Confidence 9999999998884 234689999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCchhH
Q 046598 850 ARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVMD 929 (986)
Q Consensus 850 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 929 (986)
++..... ........|++.|+|||++.+..++.++|||||||++|||++|+.||.... ........
T Consensus 143 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-----~~~~~~~~------- 208 (325)
T cd05604 143 CKEGIAQ--SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD-----VAEMYDNI------- 208 (325)
T ss_pred cccCCCC--CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC-----HHHHHHHH-------
Confidence 8753211 122234568999999999999999999999999999999999999986321 11111111
Q ss_pred HhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 046598 930 IVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMT 984 (986)
Q Consensus 930 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 984 (986)
....+...+ .....+.+++.+|++.+|++||++.
T Consensus 209 -~~~~~~~~~--------------------~~~~~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 209 -LHKPLVLRP--------------------GASLTAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred -HcCCccCCC--------------------CCCHHHHHHHHHHhccCHHhcCCCC
Confidence 110000000 1233466899999999999999986
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=320.21 Aligned_cols=249 Identities=24% Similarity=0.297 Sum_probs=194.4
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc-CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
++|++.+.||+|+||.||+|.+..+++.||+|++... .....+++.+|++++++++||||+++++++ ..++..+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 75 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF-----FVENRIS 75 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----EECCEEE
Confidence 3688899999999999999999888999999998653 233446788999999999999999999985 4457789
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+++++|..+. .+++..+..++.|++.|++|||+. +|+|+||||+||+++.++.+||+|
T Consensus 76 lv~e~~~~~~l~~~~--------------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~d 138 (279)
T cd06619 76 ICTEFMDGGSLDVYR--------------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCD 138 (279)
T ss_pred EEEecCCCCChHHhh--------------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEee
Confidence 999999999997653 367888999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCc
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDH 926 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 926 (986)
||++...... ......++..|+|||++.+..++.++|||||||++|+|++|+.||............
T Consensus 139 fg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~--------- 205 (279)
T cd06619 139 FGVSTQLVNS----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMP--------- 205 (279)
T ss_pred CCcceecccc----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccch---------
Confidence 9999765322 122356899999999999999999999999999999999999999643221111000
Q ss_pred hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 927 VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 927 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
...........+... .......++.+++.+|++.+|++||+++||
T Consensus 206 -~~~~~~~~~~~~~~~--------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~ei 250 (279)
T cd06619 206 -LQLLQCIVDEDPPVL--------------PVGQFSEKFVHFITQCMRKQPKERPAPENL 250 (279)
T ss_pred -HHHHHHHhccCCCCC--------------CCCcCCHHHHHHHHHHhhCChhhCCCHHHH
Confidence 000000000000000 000123457799999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=327.52 Aligned_cols=238 Identities=24% Similarity=0.269 Sum_probs=185.2
Q ss_pred cccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHH-HHhcCCCCcceeeeeeccccccCCCceEEEEE
Q 046598 694 NQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECN-TLKNIRHRNLVKILTACSGVDYQGNDFKALVF 769 (986)
Q Consensus 694 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 769 (986)
+.||+|+||.||+|++..+++.||+|++.... ......+.+|.. +++.++||||++++++ +.+.+..++||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~-----~~~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYS-----FQTAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeE-----EEcCCEEEEEE
Confidence 46999999999999999889999999986422 222344555554 5788999999999988 45567899999
Q ss_pred EeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccccc
Q 046598 770 EFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGL 849 (986)
Q Consensus 770 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~ 849 (986)
||+++++|..++.. ...+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 142 (321)
T cd05603 76 DYVNGGELFFHLQR----------ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGL 142 (321)
T ss_pred cCCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCC
Confidence 99999999988842 24578889999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCchhH
Q 046598 850 ARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVMD 929 (986)
Q Consensus 850 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 929 (986)
++..... ........|++.|+|||++.+..++.++|||||||++|||++|+.||.... ........
T Consensus 143 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~i------- 208 (321)
T cd05603 143 CKEGVEP--EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----VSQMYDNI------- 208 (321)
T ss_pred CccCCCC--CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC-----HHHHHHHH-------
Confidence 8753211 122234568999999999999999999999999999999999999986321 11111111
Q ss_pred HhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 046598 930 IVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMT 984 (986)
Q Consensus 930 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 984 (986)
....... + .....++.+++.+|++.||++||++.
T Consensus 209 -~~~~~~~-~-------------------~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 209 -LHKPLQL-P-------------------GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred -hcCCCCC-C-------------------CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 0000000 0 01233567899999999999999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=320.43 Aligned_cols=250 Identities=26% Similarity=0.392 Sum_probs=194.2
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCe----EEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRT----TIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 761 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 761 (986)
.++|++.++||+|+||+||+|.+..+++ +||+|+++... ....+++.+|+.+++.++||||++++++|..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----- 80 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT----- 80 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-----
Confidence 3578899999999999999999865554 58999986432 3345678899999999999999999998632
Q ss_pred CceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCc
Q 046598 762 NDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI 841 (986)
Q Consensus 762 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 841 (986)
...+++|||+++|+|.++++. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 81 -~~~~l~~~~~~~g~l~~~l~~---------~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~ 147 (279)
T cd05109 81 -STVQLVTQLMPYGCLLDYVRE---------NKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNH 147 (279)
T ss_pred -CCcEEEEEcCCCCCHHHHHhh---------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCc
Confidence 346799999999999999962 224589999999999999999999999 9999999999999999999
Q ss_pred EEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHH
Q 046598 842 AHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLAR 920 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~ 920 (986)
+||+|||+++...............++..|+|||...+..++.++|||||||++|||++ |..||+..... ...
T Consensus 148 ~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~---- 221 (279)
T cd05109 148 VKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--EIP---- 221 (279)
T ss_pred EEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHH----
Confidence 99999999987643332222222345678999999998899999999999999999998 89998632111 111
Q ss_pred hhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 921 TALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 921 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..+...... +....++.++.+++.+||+.||++||++.|+
T Consensus 222 --------~~~~~~~~~------------------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l 261 (279)
T cd05109 222 --------DLLEKGERL------------------PQPPICTIDVYMIMVKCWMIDSECRPRFREL 261 (279)
T ss_pred --------HHHHCCCcC------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 111110000 0001234467899999999999999999764
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=322.81 Aligned_cols=261 Identities=21% Similarity=0.391 Sum_probs=197.4
Q ss_pred hhcCCCCCcccccccceeEEEEEECC-----CCeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeecccccc
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDD-----GRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY 759 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 759 (986)
..++|++.+.||+|+||.||+|..++ .+..||+|.++... .....++.+|+.+++.++||||+++++++
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~----- 78 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVV----- 78 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence 46789999999999999999997642 24579999876432 22345678899999999999999999984
Q ss_pred CCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCC
Q 046598 760 QGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED 839 (986)
Q Consensus 760 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 839 (986)
......++||||+++|+|.+++................++..+..++.|++.||+|||++ +|+||||||+||+++++
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~ 155 (288)
T cd05061 79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHD 155 (288)
T ss_pred cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCC
Confidence 445678999999999999999975432211112234567888999999999999999999 99999999999999999
Q ss_pred CcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHH
Q 046598 840 MIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNL 918 (986)
Q Consensus 840 ~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~ 918 (986)
+.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||..... ...
T Consensus 156 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~-----~~~ 230 (288)
T cd05061 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-----EQV 230 (288)
T ss_pred CcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-----HHH
Confidence 9999999999986543322222222345678999999998899999999999999999999 7888853211 111
Q ss_pred HHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 919 ARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 919 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
... +.+...... ...++..+.+++.+|++.+|++|||+.|+
T Consensus 231 ~~~--------~~~~~~~~~-------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~l 271 (288)
T cd05061 231 LKF--------VMDGGYLDQ-------------------PDNCPERVTDLMRMCWQFNPKMRPTFLEI 271 (288)
T ss_pred HHH--------HHcCCCCCC-------------------CCCCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 110 000000000 01224568899999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=322.41 Aligned_cols=258 Identities=22% Similarity=0.392 Sum_probs=196.9
Q ss_pred CCCCCcccccccceeEEEEEECC-----CCeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDD-----GRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
+|++.+.||+|+||.||+|+... ....+|+|.+.... ....+++.+|+.+++.++||||+++++.| ..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGAC-----SQD 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecC
Confidence 47889999999999999998743 23568999886433 23456789999999999999999999984 445
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCC--------------ccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeec
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITRED--------------ETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCD 828 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~--------------~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~D 828 (986)
+..++||||+++++|.+++....... ........+++.+++.++.|++.||+|||+. +++|||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~d 152 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRD 152 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhh
Confidence 77899999999999999986432211 0112234689999999999999999999999 999999
Q ss_pred CCCCCeEecCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCc
Q 046598 829 LKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDI 907 (986)
Q Consensus 829 lkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~ 907 (986)
|||+||++++++.+||+|||.++...............++..|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus 153 ikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 153 LAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred hhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999976543322222233446778999999988899999999999999999999 9999863
Q ss_pred cccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 908 MFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.... .+.+.+........ ....+.++.+++.+||+.+|++||+++||
T Consensus 233 ~~~~--------------~~~~~~~~~~~~~~------------------~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i 279 (290)
T cd05045 233 IAPE--------------RLFNLLKTGYRMER------------------PENCSEEMYNLMLTCWKQEPDKRPTFADI 279 (290)
T ss_pred CCHH--------------HHHHHHhCCCCCCC------------------CCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 2111 11111111110000 01234567899999999999999999874
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=344.80 Aligned_cols=202 Identities=25% Similarity=0.331 Sum_probs=165.6
Q ss_pred HHHHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCC------Ccceeeeeecc
Q 046598 682 NLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRH------RNLVKILTACS 755 (986)
Q Consensus 682 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~ 755 (986)
++....++|++.++||+|+||+||+|.+..+++.||||+++... ...+....|+.+++.++| .+++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34445789999999999999999999999889999999986432 223445667777766654 45888888752
Q ss_pred ccccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCCe
Q 046598 756 GVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHH-DCQPPIAHCDLKPSNI 834 (986)
Q Consensus 756 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NI 834 (986)
....+.|+|||++ +++|.+++.. ...+++.++..|+.||+.||+|||+ . |||||||||+||
T Consensus 202 ----~~~~~~~iv~~~~-g~~l~~~l~~----------~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NI 263 (467)
T PTZ00284 202 ----NETGHMCIVMPKY-GPCLLDWIMK----------HGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENI 263 (467)
T ss_pred ----cCCceEEEEEecc-CCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHE
Confidence 3346789999998 7889988842 2368999999999999999999997 6 999999999999
Q ss_pred EecCCC----------------cEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHH
Q 046598 835 LLDEDM----------------IAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLEL 898 (986)
Q Consensus 835 ll~~~~----------------~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~el 898 (986)
|++.++ .+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||
T Consensus 264 Ll~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~el 338 (467)
T PTZ00284 264 LMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYEL 338 (467)
T ss_pred EEecCCcccccccccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHH
Confidence 998765 49999999886422 122345789999999999999999999999999999999
Q ss_pred HhCCCCCCc
Q 046598 899 ITRKKPTDI 907 (986)
Q Consensus 899 ltg~~pf~~ 907 (986)
++|+.||+.
T Consensus 339 ltG~~pf~~ 347 (467)
T PTZ00284 339 YTGKLLYDT 347 (467)
T ss_pred HhCCCCCCC
Confidence 999999974
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=320.22 Aligned_cols=252 Identities=22% Similarity=0.318 Sum_probs=197.4
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
.++|++.+.||+|+||.||+|++..+++.||+|+++.........+.+|+.+++.++||||++++++ +..++..+
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~-----~~~~~~~~ 82 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGS-----YLRRDKLW 82 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEE-----EEeCCEEE
Confidence 3578889999999999999999998899999999986655555678899999999999999999998 44567899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+++++|.+++.. .+.+++.+++.++.|++.|+.|||+. +++|+||||+||+++.++.+||+|
T Consensus 83 lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~d 149 (267)
T cd06645 83 ICMEFCGGGSLQDIYHV----------TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLAD 149 (267)
T ss_pred EEEeccCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECc
Confidence 99999999999999842 23588999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccc---CCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhC
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGL---GSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTAL 923 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 923 (986)
||.+...... ........|+..|+|||++. ...++.++||||+||++|+|++|+.||........ .........
T Consensus 150 fg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-~~~~~~~~~ 226 (267)
T cd06645 150 FGVSAQITAT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMTKSNF 226 (267)
T ss_pred ceeeeEccCc--ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-HHhhhccCC
Confidence 9999765322 11223356889999999874 45688999999999999999999999853221110 000000000
Q ss_pred CCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 924 PDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 924 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
. +.. .......+..+.+++.+|++.+|++|||+++|
T Consensus 227 ~--------------~~~-------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~l 262 (267)
T cd06645 227 Q--------------PPK-------------LKDKMKWSNSFHHFVKMALTKNPKKRPTAEKL 262 (267)
T ss_pred C--------------CCc-------------ccccCCCCHHHHHHHHHHccCCchhCcCHHHH
Confidence 0 000 00000123346789999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=322.23 Aligned_cols=259 Identities=20% Similarity=0.330 Sum_probs=196.4
Q ss_pred cCCCCCcccccccceeEEEEEECCC-----CeEEEEEEeeccCch-hHHHHHHHHHHHhcCCCCcceeeeeeccccccCC
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDG-----RTTIAVKVFNLLHHG-AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 761 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 761 (986)
.+|++.+.||+|+||.||+|.+..+ ++.||+|+++..... ..+.+.+|+.+++.++||||+++++++ ..
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~-----~~ 79 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVV-----TK 79 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEE-----cC
Confidence 3577889999999999999997542 578999998754332 346688999999999999999999984 44
Q ss_pred CceEEEEEEeccCCCHhHhhccCCCC------CccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeE
Q 046598 762 NDFKALVFEFMHNRSLEEWLHPITRE------DETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNIL 835 (986)
Q Consensus 762 ~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIl 835 (986)
....++++||+++++|.+++...... .........+++..+..++.|++.||+|+|++ +|+||||||+||+
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil 156 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVL 156 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheE
Confidence 56789999999999999998532110 01112234688999999999999999999999 9999999999999
Q ss_pred ecCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCcccccccc
Q 046598 836 LDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMN 914 (986)
Q Consensus 836 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~ 914 (986)
+++++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 157 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---- 232 (283)
T cd05091 157 VFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---- 232 (283)
T ss_pred ecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH----
Confidence 99999999999999886543322222233446789999999988889999999999999999998 8888753211
Q ss_pred HHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 915 LHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 915 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
........ + .... .....++..+.+++.+||+.+|++||+++||
T Consensus 233 -~~~~~~i~--------~----~~~~---------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i 276 (283)
T cd05091 233 -QDVIEMIR--------N----RQVL---------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDI 276 (283)
T ss_pred -HHHHHHHH--------c----CCcC---------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHH
Confidence 11111000 0 0000 0011345567899999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=334.13 Aligned_cols=207 Identities=23% Similarity=0.314 Sum_probs=176.2
Q ss_pred HHHHHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcCCCCcceeeeeecccc
Q 046598 681 QNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGV 757 (986)
Q Consensus 681 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 757 (986)
.+.....++|++.+.||+|+||.||+|++..+++.||+|++... .....+.+.+|+.+++.++||||++++++
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~---- 111 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA---- 111 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEE----
Confidence 34445568999999999999999999999999999999998642 22334567889999999999999999988
Q ss_pred ccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEec
Q 046598 758 DYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLD 837 (986)
Q Consensus 758 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 837 (986)
+..+...++||||+++|+|.+++.. ..++...+..++.||+.||+|||++ +|+||||||+||+++
T Consensus 112 -~~~~~~~~lv~Ey~~gg~L~~~~~~-----------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~ 176 (371)
T cd05622 112 -FQDDRYLYMVMEYMPGGDLVNLMSN-----------YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLD 176 (371)
T ss_pred -EEcCCEEEEEEcCCCCCcHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEEC
Confidence 4566889999999999999999852 2478888999999999999999999 999999999999999
Q ss_pred CCCcEEEcccccceecCCCCCccccccccccccccccccccCC----CcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 838 EDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS----EVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 838 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
.++.+||+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 177 ~~~~ikL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 249 (371)
T cd05622 177 KSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (371)
T ss_pred CCCCEEEEeCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC
Confidence 999999999999987643221 122345699999999998754 378999999999999999999999963
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=315.77 Aligned_cols=253 Identities=23% Similarity=0.333 Sum_probs=201.7
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
.++|++.+.||+|+||.||+|.+..+++.+|+|++........+.+.+|++++++++||||++++++ +..+...+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~-----~~~~~~~~ 76 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS-----YLRRDKLW 76 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEE-----EEeCCEEE
Confidence 3679999999999999999999988889999999987655567889999999999999999999998 45567899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
++|||+++++|.+++.. ....+++.++..++.|++.|++|||+. +++||||+|+||+++.++.+||+|
T Consensus 77 l~~e~~~~~~l~~~~~~---------~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d 144 (262)
T cd06613 77 IVMEYCGGGSLQDIYQV---------TRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLAD 144 (262)
T ss_pred EEEeCCCCCcHHHHHHh---------hccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECc
Confidence 99999999999999852 224688999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCC---CcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhC
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS---EVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTAL 923 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 923 (986)
||.+....... .......++..|+|||.+.+. .++.++|||||||++|||++|+.||......... ........
T Consensus 145 ~g~~~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~-~~~~~~~~ 221 (262)
T cd06613 145 FGVSAQLTATI--AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL-FLISKSNF 221 (262)
T ss_pred cccchhhhhhh--hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhccC
Confidence 99997653221 122234578899999998777 8899999999999999999999998632211100 00000000
Q ss_pred CCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 924 PDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 924 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
. +. ........+.++.+++.+||+.+|++|||++||
T Consensus 222 ~--------------~~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i 257 (262)
T cd06613 222 P--------------PP-------------KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKL 257 (262)
T ss_pred C--------------Cc-------------cccchhhhhHHHHHHHHHHcCCChhhCCCHHHH
Confidence 0 00 000112334568899999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=320.11 Aligned_cols=259 Identities=24% Similarity=0.399 Sum_probs=199.0
Q ss_pred cCCCCCcccccccceeEEEEEEC-----CCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILD-----DGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
.+|+..++||+|+||.||+|... .++..+|+|.++.......+.+.+|+++++.++|+||+++++++ ...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 79 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVC-----TEG 79 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEE-----ecC
Confidence 46788999999999999999753 34668999998766666667899999999999999999999984 445
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCC-----ccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEec
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITRED-----ETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLD 837 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~-----~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 837 (986)
...++||||+++++|.+++....... ........+++.+++.++.|++.|++|||+. +++||||||+||+++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~ 156 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVG 156 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEc
Confidence 77899999999999999996433210 0112224689999999999999999999999 999999999999999
Q ss_pred CCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHH
Q 046598 838 EDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLH 916 (986)
Q Consensus 838 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~ 916 (986)
+++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |++||......+
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---- 232 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE---- 232 (280)
T ss_pred CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH----
Confidence 999999999999976543322222223345678999999999999999999999999999998 999985321110
Q ss_pred HHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 917 NLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 917 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.. +.+. ...+. .....++..+.+++.+||+.||++||+++||
T Consensus 233 -~~---------~~~~---~~~~~---------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l 274 (280)
T cd05092 233 -AI---------ECIT---QGREL---------------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDI 274 (280)
T ss_pred -HH---------HHHH---cCccC---------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 00 0000 00000 0001234567899999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=320.23 Aligned_cols=249 Identities=23% Similarity=0.313 Sum_probs=196.0
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEE
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALV 768 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 768 (986)
-|++.+.||+|+||.||+|.+..++..+|+|.+........+.+.+|+++++.++||||+++++++ ..+...++|
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~-----~~~~~~~~v 80 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF-----YYENNLWIL 80 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEE-----eeCCEEEEE
Confidence 367889999999999999999988999999998765556667889999999999999999999984 445789999
Q ss_pred EEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcccc
Q 046598 769 FEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFG 848 (986)
Q Consensus 769 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG 848 (986)
|||+++++|..++.. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||
T Consensus 81 ~e~~~~~~l~~~~~~---------~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg 148 (282)
T cd06643 81 IEFCAGGAVDAVMLE---------LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFG 148 (282)
T ss_pred EEecCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccc
Confidence 999999999998752 224689999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCcccccccccccccccccccc-----CCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhC
Q 046598 849 LARFLPLSSAQTSSIGAKGSIGYIAPEYGL-----GSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTAL 923 (986)
Q Consensus 849 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 923 (986)
++...... ........++..|+|||++. +..++.++|||||||++|||++|+.||...... .......
T Consensus 149 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----~~~~~~~- 221 (282)
T cd06643 149 VSAKNTRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM----RVLLKIA- 221 (282)
T ss_pred cccccccc--ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH----HHHHHHh-
Confidence 99754321 11223346889999999874 456788999999999999999999998632211 1100000
Q ss_pred CCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 924 PDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 924 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
. ..+.. ...+...+.++.+++.+||+.+|++||++++|
T Consensus 222 ~------------~~~~~-------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 259 (282)
T cd06643 222 K------------SEPPT-------------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQL 259 (282)
T ss_pred h------------cCCCC-------------CCCccccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 0 00000 00001223457899999999999999998764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=332.77 Aligned_cols=204 Identities=25% Similarity=0.283 Sum_probs=172.5
Q ss_pred HhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc--CchhHHHHHHHHHHHhcCCCCcceeeeeeccccc-cCC
Q 046598 685 NATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-YQG 761 (986)
Q Consensus 685 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~ 761 (986)
...++|++.+.||+|+||.||+|.+...++.||||++... .....+.+.+|+.+++.++||||+++++++.... ...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 3467899999999999999999999988999999998642 2334567889999999999999999998754321 233
Q ss_pred CceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCc
Q 046598 762 NDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI 841 (986)
Q Consensus 762 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 841 (986)
....|+||||++ ++|.+++. ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 101 ~~~~~lv~e~~~-~~l~~~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~ 164 (364)
T cd07875 101 FQDVYIVMELMD-ANLCQVIQ------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCT 164 (364)
T ss_pred cCeEEEEEeCCC-CCHHHHHH------------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCc
Confidence 456899999995 47777773 2377888999999999999999999 9999999999999999999
Q ss_pred EEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 842 AHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
+||+|||+++..... .......++..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 165 ~kL~DfG~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 227 (364)
T cd07875 165 LKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 227 (364)
T ss_pred EEEEeCCCccccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Confidence 999999999765322 122335689999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=328.01 Aligned_cols=248 Identities=24% Similarity=0.346 Sum_probs=203.0
Q ss_pred CCCCcccccccceeEEEEEECCC---CeEEEEEEeeccCch-hHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 690 FSSVNQIGEGSFGSVFKGILDDG---RTTIAVKVFNLLHHG-AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 690 y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
....++||+|.||.|++|.|... ...||||.++..... ...+|.+|+.+|-+++|||++++||+..+ ...
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~------qp~ 185 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD------QPA 185 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc------chh
Confidence 34567899999999999999642 356999999864443 67899999999999999999999999432 567
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
.+|||.++.|+|.+.++. .....+-......++.|||.|+.||.++ ++||||+.++|+++-....+||+
T Consensus 186 mMV~ELaplGSLldrLrk--------a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~ 254 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRK--------AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKIC 254 (1039)
T ss_pred hHHhhhcccchHHHHHhh--------ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeee
Confidence 899999999999999974 2345688889999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCccccc-cccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhC
Q 046598 846 DFGLARFLPLSSAQTSSI-GAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTAL 923 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 923 (986)
|||+.+.+...++...+. ...-++.|+|||.+....++.+||||+|||++|||+| |..||-+....
T Consensus 255 DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~------------ 322 (1039)
T KOG0199|consen 255 DFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI------------ 322 (1039)
T ss_pred cccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH------------
Confidence 999999887665544433 3446788999999999999999999999999999999 88888632211
Q ss_pred CCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 924 PDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 924 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+.+.+| ..++.+.+..|+++++++|..||..+|++|||+..+
T Consensus 323 --qIL~~iD------------------~~erLpRPk~csedIY~imk~cWah~paDRptFsai 365 (1039)
T KOG0199|consen 323 --QILKNID------------------AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAI 365 (1039)
T ss_pred --HHHHhcc------------------ccccCCCCCCChHHHHHHHHHhccCCccccccHHHH
Confidence 0111122 112344455789999999999999999999998753
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=315.65 Aligned_cols=247 Identities=24% Similarity=0.363 Sum_probs=193.0
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 767 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 767 (986)
++|++.+.||+|+||.||.|.+.+ +..||+|.++... ...+.+.+|+.++++++||||++++++| ......++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 76 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVC-----TKQRPIYI 76 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEE-----ccCCCcEE
Confidence 468889999999999999998875 4569999886433 2346789999999999999999999995 34466899
Q ss_pred EEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccc
Q 046598 768 VFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDF 847 (986)
Q Consensus 768 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DF 847 (986)
||||+++++|.+++... ...+++.+++.++.||+.||+|||+. +++|+||||+||+++.++.+||+||
T Consensus 77 v~e~~~~~~l~~~i~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~ 144 (256)
T cd05113 77 VTEYMSNGCLLNYLREH---------GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDF 144 (256)
T ss_pred EEEcCCCCcHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCC
Confidence 99999999999998521 23588999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCc
Q 046598 848 GLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALPDH 926 (986)
Q Consensus 848 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 926 (986)
|.++....... .......++..|+|||+..+..++.++|||||||++|+|++ |+.||...... ....
T Consensus 145 g~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-----~~~~------ 212 (256)
T cd05113 145 GLSRYVLDDEY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS-----ETVE------ 212 (256)
T ss_pred ccceecCCCce-eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-----HHHH------
Confidence 99986533221 12222345678999999988889999999999999999999 99998632211 0100
Q ss_pred hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 927 VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 927 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
......... .....+..+.+++.+||+.+|++||++.+|
T Consensus 213 ------~~~~~~~~~---------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l 251 (256)
T cd05113 213 ------KVSQGLRLY---------------RPHLASEKVYAIMYSCWHEKAEERPTFQQL 251 (256)
T ss_pred ------HHhcCCCCC---------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 000000000 000123567899999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=321.72 Aligned_cols=267 Identities=19% Similarity=0.338 Sum_probs=197.8
Q ss_pred hcCCCCCcccccccceeEEEEEECC----------------CCeEEEEEEeecc-CchhHHHHHHHHHHHhcCCCCccee
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDD----------------GRTTIAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVK 749 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~ 749 (986)
.++|++.++||+|+||.||+|.+.. ++..||+|+++.. ......++.+|+.+++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 3579999999999999999986532 3457999998753 2334567899999999999999999
Q ss_pred eeeeccccccCCCceEEEEEEeccCCCHhHhhccCCCCCcc-ccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeec
Q 046598 750 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDET-DEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCD 828 (986)
Q Consensus 750 l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~D 828 (986)
+++++ ..++..++||||+++++|.+++......... ......+++.++..++.|++.|++|||+. +++|||
T Consensus 84 ~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~d 155 (296)
T cd05095 84 LLAVC-----ITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRD 155 (296)
T ss_pred EEEEE-----ecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Ceeccc
Confidence 99984 4456789999999999999999754322111 23344688999999999999999999999 999999
Q ss_pred CCCCCeEecCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh--CCCCCC
Q 046598 829 LKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT--RKKPTD 906 (986)
Q Consensus 829 lkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt--g~~pf~ 906 (986)
|||+||+++.++.+||+|||.++.+.............++..|+|||+..++.++.++|||||||++|||++ |..||.
T Consensus 156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~ 235 (296)
T cd05095 156 LATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYS 235 (296)
T ss_pred CChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcc
Confidence 999999999999999999999976543322222222345678999999888899999999999999999998 778875
Q ss_pred ccccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 907 IMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..... ..... ............. .+....++..+.+++.+||+.||++||+++||
T Consensus 236 ~~~~~-----~~~~~-----~~~~~~~~~~~~~---------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i 290 (296)
T cd05095 236 QLSDE-----QVIEN-----TGEFFRDQGRQVY---------------LPKPALCPDSLYKLMLSCWRRNAKERPSFQEI 290 (296)
T ss_pred ccChH-----HHHHH-----HHHHHhhcccccc---------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 32211 11100 0000000000000 00011234567899999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=315.57 Aligned_cols=248 Identities=21% Similarity=0.276 Sum_probs=197.6
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeecc-CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEE
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 767 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 767 (986)
+|++.+.||+|+||.||++.+..+++.||+|.++.. .....+.+.+|+.+++.++||||++++++ +..++..++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-----~~~~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES-----FEADGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEE-----EEECCEEEE
Confidence 588899999999999999999988999999998643 23445678899999999999999999998 456688999
Q ss_pred EEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccc
Q 046598 768 VFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDF 847 (986)
Q Consensus 768 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DF 847 (986)
||||+++++|.+++... ....+++..++.++.|++.|+.|||++ +++|+||||+||++++++.++++||
T Consensus 76 v~e~~~~~~l~~~~~~~--------~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~df 144 (255)
T cd08219 76 VMEYCDGGDLMQKIKLQ--------RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDF 144 (255)
T ss_pred EEeeCCCCcHHHHHHhc--------cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEccc
Confidence 99999999999988522 234578999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCch
Q 046598 848 GLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHV 927 (986)
Q Consensus 848 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 927 (986)
|.+....... .......++..|+|||++.+..++.++||||||+++|+|++|+.||.... ............
T Consensus 145 g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~-----~~~~~~~~~~~~- 216 (255)
T cd08219 145 GSARLLTSPG--AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS-----WKNLILKVCQGS- 216 (255)
T ss_pred Ccceeecccc--cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC-----HHHHHHHHhcCC-
Confidence 9997653222 12223568889999999998899999999999999999999999996321 111111100000
Q ss_pred hHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 928 MDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 928 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.... +...+..+.+++.+||+.||++|||+.||
T Consensus 217 -------~~~~-------------------~~~~~~~~~~li~~~l~~~P~~Rp~~~~i 249 (255)
T cd08219 217 -------YKPL-------------------PSHYSYELRSLIKQMFKRNPRSRPSATTI 249 (255)
T ss_pred -------CCCC-------------------CcccCHHHHHHHHHHHhCCcccCCCHHHH
Confidence 0000 01123456789999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=315.78 Aligned_cols=249 Identities=31% Similarity=0.489 Sum_probs=195.3
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
.++|++.+.||+|++|.||+|.+.. ++.||+|.++... ...+.+.+|++++++++||||+++++++ ...+..+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 77 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVC-----TLEEPIY 77 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEE-----ecCCCee
Confidence 4678999999999999999999865 5789999987543 2356789999999999999999999984 4557789
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+++++|.+++... ....+++.++..++.|++.|+.|||+. +|+||||||+||++++++.+||+|
T Consensus 78 lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d 146 (261)
T cd05068 78 IVTELMKYGSLLEYLQGG--------AGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVAD 146 (261)
T ss_pred eeeecccCCcHHHHHhcc--------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECC
Confidence 999999999999999532 134689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCC
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALPD 925 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 925 (986)
||+++....... ........+..|+|||+..+..++.++||||||+++|||++ |+.||...... ...
T Consensus 147 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~~------ 214 (261)
T cd05068 147 FGLARVIKEDIY-EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA-----EVL------ 214 (261)
T ss_pred cceEEEccCCcc-cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH-----HHH------
Confidence 999987642211 11122233468999999999999999999999999999999 99998632111 000
Q ss_pred chhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 926 HVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 926 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..++..... ......+..+.+++.+|++.+|++||++++|
T Consensus 215 ---~~~~~~~~~------------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l 254 (261)
T cd05068 215 ---QQVDQGYRM------------------PCPPGCPKELYDIMLDCWKEDPDDRPTFETL 254 (261)
T ss_pred ---HHHHcCCCC------------------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 001100000 0001234567899999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=333.41 Aligned_cols=202 Identities=24% Similarity=0.323 Sum_probs=174.1
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
++|++.+.||+|+||.||+|.+..+++.||+|+++.. .......+.+|+.++.+++||+|++++++ +.+++.
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~-----~~~~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYS-----FQDKRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEE-----EEcCCE
Confidence 4688999999999999999999999999999999742 22344678889999999999999999998 556688
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.|+||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||
T Consensus 76 ~~lv~E~~~gg~L~~~l~~----------~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL 142 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMK----------KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKL 142 (360)
T ss_pred EEEEEeCCCCccHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEE
Confidence 9999999999999999852 24588999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCc---------------------------------cccccccccccccccccccCCCcCcccchhhH
Q 046598 845 GDFGLARFLPLSSAQ---------------------------------TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSY 891 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 891 (986)
+|||+++........ .......||+.|+|||++.+..++.++|||||
T Consensus 143 ~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSl 222 (360)
T cd05627 143 SDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSL 222 (360)
T ss_pred eeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccc
Confidence 999998754221100 00123468999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCc
Q 046598 892 GILLLELITRKKPTDI 907 (986)
Q Consensus 892 Gvvl~elltg~~pf~~ 907 (986)
||++|||++|+.||..
T Consensus 223 Gvilyel~tG~~Pf~~ 238 (360)
T cd05627 223 GVIMYEMLIGYPPFCS 238 (360)
T ss_pred cceeeecccCCCCCCC
Confidence 9999999999999963
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=322.80 Aligned_cols=261 Identities=23% Similarity=0.388 Sum_probs=199.4
Q ss_pred hhcCCCCCcccccccceeEEEEEECCC-----CeEEEEEEeecc-CchhHHHHHHHHHHHhcC-CCCcceeeeeeccccc
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDG-----RTTIAVKVFNLL-HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVD 758 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 758 (986)
..++|++.+.||+|+||.||+|.+... ...||+|++... ......++.+|+++++++ +||||++++++|
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~---- 85 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC---- 85 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE----
Confidence 456789999999999999999998643 378999998743 223446788999999999 899999999984
Q ss_pred cCCCceEEEEEEeccCCCHhHhhccCCCCCc------cccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCC
Q 046598 759 YQGNDFKALVFEFMHNRSLEEWLHPITREDE------TDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPS 832 (986)
Q Consensus 759 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~ 832 (986)
..++..++||||+++|+|.++++....... .......+++..++.++.|++.|++|||+. +|+||||||+
T Consensus 86 -~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~ 161 (293)
T cd05053 86 -TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAAR 161 (293)
T ss_pred -cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Ccccccccee
Confidence 445779999999999999999964321100 112345789999999999999999999999 9999999999
Q ss_pred CeEecCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccc
Q 046598 833 NILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEG 911 (986)
Q Consensus 833 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~ 911 (986)
||+++.++.+||+|||.++.+.............++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 162 Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~- 240 (293)
T cd05053 162 NVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV- 240 (293)
T ss_pred eEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH-
Confidence 99999999999999999987643322222223345678999999988899999999999999999998 9998853211
Q ss_pred cccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 912 DMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..... .+...... .....++.++.+++.+||+.+|++||||.||
T Consensus 241 ----~~~~~---------~~~~~~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ei 284 (293)
T cd05053 241 ----EELFK---------LLKEGYRM------------------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQL 284 (293)
T ss_pred ----HHHHH---------HHHcCCcC------------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHH
Confidence 11111 11000000 0011234567899999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=351.49 Aligned_cols=461 Identities=27% Similarity=0.324 Sum_probs=321.3
Q ss_pred EEEEeccCCCCccccCcCccCCCCCCEEEccCCCccccCCcchhccccCceeeceecccCCCCccchhcCccccceeccc
Q 046598 64 VTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFH 143 (986)
Q Consensus 64 v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 143 (986)
+..||+++|.+. ..|..+..+.+|+.|+++.|.+. ..|.+..++++|++|+|..|++. ..|.++..+.+|++||+|.
T Consensus 47 L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~ 123 (1081)
T KOG0618|consen 47 LKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSF 123 (1081)
T ss_pred eEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccch
Confidence 566666666654 55666666666666666666665 45566666666666666666666 6666666666666666666
Q ss_pred ccccCccCccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeeccCCcccCcCcchhhccCCCceeecccccccccCC
Q 046598 144 NQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIP 223 (986)
Q Consensus 144 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 223 (986)
|.+. .+|..+..++.++.+..++|..... ++... ++.++|..|.+.+.++..+..++. .|+|++|.+. -
T Consensus 124 N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~----lg~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~ 192 (1081)
T KOG0618|consen 124 NHFG-PIPLVIEVLTAEEELAASNNEKIQR----LGQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---V 192 (1081)
T ss_pred hccC-CCchhHHhhhHHHHHhhhcchhhhh----hcccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh---h
Confidence 6666 5666666666666666666622212 22222 566666666666666666655555 5666666665 2
Q ss_pred ccccCCCCccEEeccccccccccCCcccccccccceEEecCceecccCCccccCCCCCcEEecccccccCCCchhhhhhh
Q 046598 224 SSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQR 303 (986)
Q Consensus 224 ~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~l~~l~~ 303 (986)
..+.++..|+.+....|++... -...++|+.|+.++|.++...+. .--.+|+++++++|+++++|.++..+
T Consensus 193 ~dls~~~~l~~l~c~rn~ls~l-----~~~g~~l~~L~a~~n~l~~~~~~--p~p~nl~~~dis~n~l~~lp~wi~~~-- 263 (1081)
T KOG0618|consen 193 LDLSNLANLEVLHCERNQLSEL-----EISGPSLTALYADHNPLTTLDVH--PVPLNLQYLDISHNNLSNLPEWIGAC-- 263 (1081)
T ss_pred hhhhhccchhhhhhhhcccceE-----EecCcchheeeeccCcceeeccc--cccccceeeecchhhhhcchHHHHhc--
Confidence 2344455555555555555421 11235566666666666622211 12235666666666666666544443
Q ss_pred HhhhhhccCCCCCCCCCCcccccccccccccceeeccccccccCCCcccccccccceEEEccCCcccccCCccccCCCCC
Q 046598 304 LLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNL 383 (986)
Q Consensus 304 L~~l~l~~n~l~~~~~~~l~~l~~l~~~~~L~~l~l~~n~~~~~~p~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L 383 (986)
.+|..+..+.|+++ .+|..++.. .+|+.|.+.+|.+. -+|.....++.|
T Consensus 264 ----------------------------~nle~l~~n~N~l~-~lp~ri~~~-~~L~~l~~~~nel~-yip~~le~~~sL 312 (1081)
T KOG0618|consen 264 ----------------------------ANLEALNANHNRLV-ALPLRISRI-TSLVSLSAAYNELE-YIPPFLEGLKSL 312 (1081)
T ss_pred ----------------------------ccceEecccchhHH-hhHHHHhhh-hhHHHHHhhhhhhh-hCCCccccccee
Confidence 34444555555552 566666655 57888888888888 567778889999
Q ss_pred CEEEccCccccCcCCCc-ccCCCC-CCEEEccCccceeecCc-ccccccccEEEecccccCCCCCcccCCCCCCCeeecC
Q 046598 384 QRLDMCSNRLSGTIPPA-IGELQN-LKDLRLQRNRFQGNIPP-SIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLS 460 (986)
Q Consensus 384 ~~L~L~~N~l~~~~~~~-~~~l~~-L~~L~Ls~N~l~~~~~~-~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 460 (986)
++|||..|+|. ..|+. |.-+.. |..|+.+.|++...... ......|+.|++.+|.++...-..+.++.+|+.|+|+
T Consensus 313 ~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLs 391 (1081)
T KOG0618|consen 313 RTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLS 391 (1081)
T ss_pred eeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeec
Confidence 99999999998 55554 344433 77888888888743311 1122359999999999998888889999999999999
Q ss_pred CCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccCcccccCCccccEEeccccccccc
Q 046598 461 NNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGP 540 (986)
Q Consensus 461 ~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 540 (986)
+|+|. ++|+..+..+..|+.|+||+|+++ .+|..+.+++.|++|...+|+|. ..| .+..++.|+.+|+|.|+|+..
T Consensus 392 yNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~ 467 (1081)
T KOG0618|consen 392 YNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEV 467 (1081)
T ss_pred ccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhh
Confidence 99998 999999999999999999999999 78999999999999999999998 788 899999999999999999864
Q ss_pred CCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCC
Q 046598 541 IPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNN 583 (986)
Q Consensus 541 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N 583 (986)
.-..-..-++|++|||++|.=....-+.|..++.+...+++-|
T Consensus 468 ~l~~~~p~p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 468 TLPEALPSPNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLN 510 (1081)
T ss_pred hhhhhCCCcccceeeccCCcccccchhhhHHhhhhhheecccC
Confidence 4333333389999999999844455667777888887887777
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=316.47 Aligned_cols=254 Identities=21% Similarity=0.269 Sum_probs=196.5
Q ss_pred HHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 684 YNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 684 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
+.+++.+.....||+|+||.||+|++..+++.||+|.+........+.+.+|+.++++++|+||+++++++ ..++
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~ 78 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD-----SENG 78 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeee-----ccCC
Confidence 44566666778999999999999999888999999998766555667899999999999999999999984 4457
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCcc--CHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecC-CC
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSL--NLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDE-DM 840 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l--~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~ 840 (986)
..++||||+++++|.++++.. ...+ ++..+..++.||+.|++|||+. +|+||||||+||+++. ++
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~ 146 (268)
T cd06624 79 FFKIFMEQVPGGSLSALLRSK---------WGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSG 146 (268)
T ss_pred EEEEEEecCCCCCHHHHHHHh---------cccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCC
Confidence 899999999999999999622 1223 7788899999999999999999 9999999999999976 67
Q ss_pred cEEEcccccceecCCCCCccccccccccccccccccccCC--CcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHH
Q 046598 841 IAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS--EVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNL 918 (986)
Q Consensus 841 ~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~ 918 (986)
.+||+|||.+........ ......++..|+|||++.+. .++.++||||||+++|+|++|+.||......... .+
T Consensus 147 ~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~--~~ 222 (268)
T cd06624 147 VVKISDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA--MF 222 (268)
T ss_pred eEEEecchhheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh--Hh
Confidence 999999999976532221 12234578899999998664 3789999999999999999999998632111000 00
Q ss_pred HHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 919 ARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 919 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
... .....+ ..+.....++.+++.+||+.+|++|||+.||
T Consensus 223 -~~~-----------~~~~~~----------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l 262 (268)
T cd06624 223 -KVG-----------MFKIHP----------------EIPESLSAEAKNFILRCFEPDPDKRASAHDL 262 (268)
T ss_pred -hhh-----------hhccCC----------------CCCcccCHHHHHHHHHHcCCCchhCCCHHHH
Confidence 000 000000 0011234557789999999999999999874
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=320.74 Aligned_cols=250 Identities=22% Similarity=0.290 Sum_probs=197.4
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 767 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 767 (986)
+.|++.++||+|+||.||+|++..+++.||+|++........+.+.+|+.+++.++||||+++++++ ..+...++
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 86 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF-----YWDGKLWI 86 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEE-----EeCCeEEE
Confidence 5699999999999999999999998999999999876666678899999999999999999999984 34578999
Q ss_pred EEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccc
Q 046598 768 VFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDF 847 (986)
Q Consensus 768 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DF 847 (986)
||||+++++|..++.. ....+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+||
T Consensus 87 v~e~~~~~~l~~~~~~---------~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~df 154 (292)
T cd06644 87 MIEFCPGGAVDAIMLE---------LDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADF 154 (292)
T ss_pred EEecCCCCcHHHHHHh---------hcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccC
Confidence 9999999999988752 224589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccccccccccccc-----CCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 046598 848 GLARFLPLSSAQTSSIGAKGSIGYIAPEYGL-----GSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 848 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 922 (986)
|.+...... ........++..|+|||++. ...++.++|||||||++|||++|+.||..... .......
T Consensus 155 g~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~~~~~~~ 227 (292)
T cd06644 155 GVSAKNVKT--LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-----MRVLLKI 227 (292)
T ss_pred ccceecccc--ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-----HHHHHHH
Confidence 998754221 11223345788999999874 34578899999999999999999999863211 0110000
Q ss_pred CCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 923 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
... .+.. .......+.++.+++.+||+.+|++||+++||
T Consensus 228 ~~~------------~~~~-------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 266 (292)
T cd06644 228 AKS------------EPPT-------------LSQPSKWSMEFRDFLKTALDKHPETRPSAAQL 266 (292)
T ss_pred hcC------------CCcc-------------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHH
Confidence 000 0000 00011233457789999999999999998764
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=317.88 Aligned_cols=251 Identities=28% Similarity=0.409 Sum_probs=196.9
Q ss_pred CCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHH--HHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEE
Q 046598 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFK--SFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 767 (986)
Q Consensus 690 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 767 (986)
|++.+.||+|+||+||+|++..+++.||+|++......... ...+|+.++++++||||+++++++ ......++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVF-----QDDNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEE-----EESSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccc-----cccccccc
Confidence 67789999999999999999999999999999865443322 345699999999999999999994 44688999
Q ss_pred EEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccc
Q 046598 768 VFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDF 847 (986)
Q Consensus 768 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DF 847 (986)
||||+++++|.+++. ....+++.++..++.|+++||++||+. +|+||||||+||++++++.++|+||
T Consensus 76 v~~~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Df 142 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQ----------KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDF 142 (260)
T ss_dssp EEEEETTEBHHHHHH----------HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSG
T ss_pred ccccccccccccccc----------ccccccccccccccccccccccccccc---ccccccccccccccccccccccccc
Confidence 999999999999995 234689999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccccccccccccc-CCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCc
Q 046598 848 GLARFLPLSSAQTSSIGAKGSIGYIAPEYGL-GSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDH 926 (986)
Q Consensus 848 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 926 (986)
|.+.... ..........++..|+|||++. +..++.++||||+|+++|+|++|..||..... .+............
T Consensus 143 g~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~--~~~~~~~~~~~~~~ 218 (260)
T PF00069_consen 143 GSSVKLS--ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS--DDQLEIIEKILKRP 218 (260)
T ss_dssp TTTEEST--STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH--HHHHHHHHHHHHTH
T ss_pred ccccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccccc--hhhhhhhhhccccc
Confidence 9997641 2223334566899999999998 88899999999999999999999999874310 01111111000000
Q ss_pred hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 927 VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 927 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
. . ............+.+++.+|++.||++|||+.|+
T Consensus 219 ~----~--------------------~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l 254 (260)
T PF00069_consen 219 L----P--------------------SSSQQSREKSEELRDLIKKMLSKDPEQRPSAEEL 254 (260)
T ss_dssp H----H--------------------HHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHH
T ss_pred c----c--------------------ccccccchhHHHHHHHHHHHccCChhHCcCHHHH
Confidence 0 0 0000000112578899999999999999998763
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=316.88 Aligned_cols=249 Identities=23% Similarity=0.315 Sum_probs=194.1
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
.|+..+.||+|+||+||+|.+..+++.||+|++.... ....+.+.+|++++++++|++|+++.++ +..++..
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~-----~~~~~~~ 75 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYA-----YETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEE-----EecCCEE
Confidence 3677889999999999999999889999999986432 2223457889999999999999999888 4556789
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
++||||+++++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+
T Consensus 76 ~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~ 144 (285)
T cd05632 76 CLVLTIMNGGDLKFHIYNM--------GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRIS 144 (285)
T ss_pred EEEEEeccCccHHHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEe
Confidence 9999999999999888521 123589999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCC
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPD 925 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 925 (986)
|||++....... ......|+..|+|||++.+..++.++||||+||++|||++|+.||....... ..... ......
T Consensus 145 Dfg~~~~~~~~~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~-~~~~~-~~~~~~ 219 (285)
T cd05632 145 DLGLAVKIPEGE---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV-KREEV-DRRVLE 219 (285)
T ss_pred cCCcceecCCCC---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHH-HHhhhc
Confidence 999997653221 1223468999999999999999999999999999999999999996321110 00000 000000
Q ss_pred chhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCC
Q 046598 926 HVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTN 985 (986)
Q Consensus 926 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 985 (986)
. ... .....+.++.+++.+|++.||++||++.|
T Consensus 220 ~------------~~~---------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~ 252 (285)
T cd05632 220 T------------EEV---------------YSAKFSEEAKSICKMLLTKDPKQRLGCQE 252 (285)
T ss_pred c------------ccc---------------cCccCCHHHHHHHHHHccCCHhHcCCCcc
Confidence 0 000 00122345678999999999999999653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=321.61 Aligned_cols=197 Identities=26% Similarity=0.352 Sum_probs=171.8
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
++|++.+.||+|+||.||+|.+..++..||+|.++... .....++.+|++++++++||||++++++| ..++..+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 75 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAF-----YSDGEIS 75 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----eeCCEEE
Confidence 46899999999999999999999889999999986532 23345688999999999999999999984 4567899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHH-DCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
+||||+++++|.++++. ...+++..+..++.|+++||+|||+ . +++||||||+||+++.++.+||+
T Consensus 76 lv~ey~~~~~L~~~l~~----------~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dl~p~nil~~~~~~~~l~ 142 (308)
T cd06615 76 ICMEHMDGGSLDQVLKK----------AGRIPENILGKISIAVLRGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLC 142 (308)
T ss_pred EEeeccCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhhC---CEEECCCChHHEEEecCCcEEEc
Confidence 99999999999999952 2457889999999999999999997 5 89999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCC
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTD 906 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~ 906 (986)
|||.+...... ......++..|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 143 dfg~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~ 199 (308)
T cd06615 143 DFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIP 199 (308)
T ss_pred cCCCccccccc----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 99998754322 1223468899999999988889999999999999999999999986
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=352.05 Aligned_cols=260 Identities=21% Similarity=0.286 Sum_probs=198.6
Q ss_pred HHHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc--CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccC
Q 046598 683 LYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ 760 (986)
Q Consensus 683 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 760 (986)
.....++|.+++.||+|+||+||+|.+..++..||+|++... .......+..|+.++++++|||||++++++.. .
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d---e 84 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN---K 84 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe---c
Confidence 344567899999999999999999999999999999998643 23345678999999999999999999998532 3
Q ss_pred CCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcC----CCCeEeecCCCCCeEe
Q 046598 761 GNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDC----QPPIAHCDLKPSNILL 836 (986)
Q Consensus 761 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~----~~~ivH~Dlkp~NIll 836 (986)
.....|+||||+++|+|.+++.... .....+++..++.|+.||+.||+|||+.. ..+||||||||+|||+
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~------~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL 158 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCY------KMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFL 158 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHh------hccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEe
Confidence 3467899999999999999996322 12346899999999999999999999851 1259999999999999
Q ss_pred cCC-----------------CcEEEcccccceecCCCCCccccccccccccccccccccC--CCcCcccchhhHHHHHHH
Q 046598 837 DED-----------------MIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG--SEVSISGDVYSYGILLLE 897 (986)
Q Consensus 837 ~~~-----------------~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~e 897 (986)
+.+ +.+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++||
T Consensus 159 ~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYE 235 (1021)
T PTZ00266 159 STGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYE 235 (1021)
T ss_pred ecCccccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHH
Confidence 642 359999999998653221 2233568999999999864 458899999999999999
Q ss_pred HHhCCCCCCccccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCC
Q 046598 898 LITRKKPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESP 977 (986)
Q Consensus 898 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP 977 (986)
|+||+.||.... ......... . ..+.. .....+.++.+++..||+.+|
T Consensus 236 LLTGk~PF~~~~----~~~qli~~l---------k----~~p~l---------------pi~~~S~eL~dLI~~~L~~dP 283 (1021)
T PTZ00266 236 LCSGKTPFHKAN----NFSQLISEL---------K----RGPDL---------------PIKGKSKELNILIKNLLNLSA 283 (1021)
T ss_pred HHHCCCCCCcCC----cHHHHHHHH---------h----cCCCC---------------CcCCCCHHHHHHHHHHhcCCh
Confidence 999999996321 111111110 0 00000 000123457799999999999
Q ss_pred CCCCCCCCC
Q 046598 978 EDRMSMTNV 986 (986)
Q Consensus 978 ~~RPt~~eV 986 (986)
++||++.|+
T Consensus 284 eeRPSa~Ql 292 (1021)
T PTZ00266 284 KERPSALQC 292 (1021)
T ss_pred hHCcCHHHH
Confidence 999998764
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=335.83 Aligned_cols=195 Identities=25% Similarity=0.340 Sum_probs=168.0
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
..+|.+.+.||+|+||.||+|.+..+++.||||... ...+.+|++++++++|+||+++++++ ..++..+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~-----~~~~~~~ 236 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVR-----VVGGLTC 236 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEE-----EECCEEE
Confidence 347999999999999999999999999999999643 23467899999999999999999984 3457889
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+|||++ .++|.+++.. ....+++.+++.|+.||+.||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 237 lv~e~~-~~~L~~~l~~---------~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~D 303 (461)
T PHA03211 237 LVLPKY-RSDLYTYLGA---------RLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGD 303 (461)
T ss_pred EEEEcc-CCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcc
Confidence 999999 5789888852 223689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCC
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPT 905 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf 905 (986)
||+++...............||..|+|||++.+..++.++|||||||++|||++|..|+
T Consensus 304 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 304 FGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 99998764332222233456999999999999999999999999999999999988764
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=322.44 Aligned_cols=277 Identities=22% Similarity=0.285 Sum_probs=197.7
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
.++|++.+.||+|+||.||+|.+..+++.||+|.++... ......+.+|+.+++.++||||++++++ +..+...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~-----~~~~~~~ 79 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI-----IHTEKSL 79 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEE-----EecCCeE
Confidence 367999999999999999999999889999999987432 2334567889999999999999999999 4456789
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
++||||++ ++|.+++.. ....+++..+..++.||++||+|||+. +|+||||||+||++++++.+||+
T Consensus 80 ~lv~e~~~-~~l~~~l~~---------~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~ 146 (301)
T cd07873 80 TLVFEYLD-KDLKQYLDD---------CGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLA 146 (301)
T ss_pred EEEEeccc-cCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEEC
Confidence 99999996 589988852 223578999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCC
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALP 924 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 924 (986)
|||++....... .......+++.|+|||++.+. .++.++|||||||++|||++|+.||...... ...........
T Consensus 147 dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~--~~~~~~~~~~~ 222 (301)
T cd07873 147 DFGLARAKSIPT--KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE--EQLHFIFRILG 222 (301)
T ss_pred cCcchhccCCCC--CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcC
Confidence 999997543221 112234568899999987654 5789999999999999999999999643211 11111111111
Q ss_pred CchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 925 DHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 925 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
....+.....+..+......... ................+.+++.+|++.||++|||++||
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~ei 283 (301)
T cd07873 223 TPTEETWPGILSNEEFKSYNYPK-YRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEA 283 (301)
T ss_pred CCChhhchhhhccccccccccCc-cccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHH
Confidence 11111111111100000000000 00000001111234567799999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=317.86 Aligned_cols=257 Identities=21% Similarity=0.260 Sum_probs=198.8
Q ss_pred HhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcC-CCCcceeeeeeccccccC-CC
Q 046598 685 NATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQ-GN 762 (986)
Q Consensus 685 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~-~~ 762 (986)
.+++.|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++++ +||||+++++++...... .+
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35678999999999999999999999889999999987543 3346788999999998 799999999987543211 13
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
...++||||+++++|.+++... ....+++..+..++.|++.|++|||++ +|+||||||+||++++++.+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~--------~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~ 150 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT--------KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEV 150 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc--------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCE
Confidence 5689999999999999998632 124588999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCcccccccccccccccccccc-----CCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHH
Q 046598 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGL-----GSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHN 917 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~ 917 (986)
||+|||++....... .......|+..|+|||++. +..++.++||||+||++|||++|+.||...... ..
T Consensus 151 ~l~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~----~~ 224 (272)
T cd06637 151 KLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM----RA 224 (272)
T ss_pred EEccCCCceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH----HH
Confidence 999999997653221 2223456889999999976 346888999999999999999999998632111 00
Q ss_pred HHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 918 LARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 918 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.... .. .+... .....++.++.+++.+||..+|.+|||++||
T Consensus 225 ~~~~---------~~-----~~~~~-------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i 266 (272)
T cd06637 225 LFLI---------PR-----NPAPR-------------LKSKKWSKKFQSFIESCLVKNHSQRPTTEQL 266 (272)
T ss_pred HHHH---------hc-----CCCCC-------------CCCCCcCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 0000 00 00000 0000123457799999999999999998764
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=319.60 Aligned_cols=267 Identities=24% Similarity=0.366 Sum_probs=199.6
Q ss_pred hcCCCCCcccccccceeEEEEEECCCC----------------eEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCccee
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGR----------------TTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVK 749 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~----------------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 749 (986)
.++|++.+.||+|+||.||+|.+...+ ..||+|++.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 467999999999999999999876533 568999987533 234567899999999999999999
Q ss_pred eeeeccccccCCCceEEEEEEeccCCCHhHhhccCCCCCcc-ccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeec
Q 046598 750 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDET-DEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCD 828 (986)
Q Consensus 750 l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~D 828 (986)
++++| ..+...++||||+++++|.+++......... ......+++..++.++.|++.||+|||+. +|+|||
T Consensus 84 ~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~d 155 (296)
T cd05051 84 LLGVC-----TVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRD 155 (296)
T ss_pred EEEEE-----ecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccc
Confidence 99984 4457899999999999999999644321111 12234689999999999999999999999 999999
Q ss_pred CCCCCeEecCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh--CCCCCC
Q 046598 829 LKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT--RKKPTD 906 (986)
Q Consensus 829 lkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt--g~~pf~ 906 (986)
|||+||+++.++.++|+|||.++...............++..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 156 LATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred cchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999986543332222334456788999999988889999999999999999998 677775
Q ss_pred ccccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 907 IMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
...... ............ .... .......++.++.+++.+|++.||++|||+.||
T Consensus 236 ~~~~~~--~~~~~~~~~~~~-----------~~~~------------~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el 290 (296)
T cd05051 236 HLTDQQ--VIENAGHFFRDD-----------GRQI------------YLPRPPNCPKDIYELMLECWRRDEEDRPTFREI 290 (296)
T ss_pred CcChHH--HHHHHHhccccc-----------cccc------------cCCCccCCCHHHHHHHHHHhccChhcCCCHHHH
Confidence 321110 000000000000 0000 000011234568899999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=321.53 Aligned_cols=249 Identities=20% Similarity=0.273 Sum_probs=199.5
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
..+|++.+.||+|+||.||+|++..+++.||+|.+........+.+.+|+.+++.++||||+++++++ ..++..+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 92 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDELW 92 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCEEE
Confidence 46799999999999999999999888999999999765555567788999999999999999999984 4567899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+++++|.+++.. ..+++.++..++.|++.||.|||+. +++||||||+||+++.++.+||+|
T Consensus 93 lv~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~D 158 (297)
T cd06656 93 VVMEYLAGGSLTDVVTE-----------TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTD 158 (297)
T ss_pred EeecccCCCCHHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECc
Confidence 99999999999999851 2478889999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCc
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDH 926 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 926 (986)
||.+........ ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||........... ....
T Consensus 159 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-~~~~----- 230 (297)
T cd06656 159 FGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-IATN----- 230 (297)
T ss_pred CccceEccCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-eccC-----
Confidence 999976543221 12234578899999999998899999999999999999999999963211110000 0000
Q ss_pred hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 927 VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 927 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..+. ...+...+..+.+++.+||+.+|++||+++||
T Consensus 231 ----------~~~~--------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i 266 (297)
T cd06656 231 ----------GTPE--------------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKEL 266 (297)
T ss_pred ----------CCCC--------------CCCccccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 0000 00011234456789999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=314.13 Aligned_cols=247 Identities=27% Similarity=0.392 Sum_probs=192.6
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 767 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 767 (986)
.+|++.+.||+|+||.||+|.++. +..+|+|++.... .....+.+|++++++++||||+++++++ ......++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~l 76 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVC-----TKQRPIFI 76 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecC-CccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEE-----cCCCceEE
Confidence 458899999999999999999875 6689999986432 2345788899999999999999999984 45577899
Q ss_pred EEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccc
Q 046598 768 VFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDF 847 (986)
Q Consensus 768 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DF 847 (986)
||||+++++|.+++.. ....+++..++.++.|++.|++|||+. +++||||||+||++++++.+||+||
T Consensus 77 v~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~df 144 (256)
T cd05059 77 VTEYMANGCLLNYLRE---------RKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDF 144 (256)
T ss_pred EEecCCCCCHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCc
Confidence 9999999999999852 123589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCc
Q 046598 848 GLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALPDH 926 (986)
Q Consensus 848 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 926 (986)
|.++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ .....
T Consensus 145 g~~~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~------- 214 (256)
T cd05059 145 GLARYVLDDQY-TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--VVESV------- 214 (256)
T ss_pred ccceecccccc-cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH--HHHHH-------
Confidence 99976532211 11112234567999999999999999999999999999999 899986322110 00000
Q ss_pred hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 927 VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 927 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..... + .....++.++.+++.+||+.+|++|||+.||
T Consensus 215 -----~~~~~--~----------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~ 251 (256)
T cd05059 215 -----SAGYR--L----------------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKL 251 (256)
T ss_pred -----HcCCc--C----------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 00000 0 0001234568899999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=316.62 Aligned_cols=254 Identities=21% Similarity=0.333 Sum_probs=199.0
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
++|++.+.||+|+||.||+|.+..+++.||||.+... ......++.+|+++++.++||||+++++++ ..++.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF-----IEDNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhhee-----EeCCe
Confidence 4688999999999999999999888999999987642 223446788999999999999999999984 45578
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.++||||+++++|.+++.... .....+++.+++.++.||++|++|||++ +++|+||||+||+++.++.++|
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l 147 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFK------KQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKL 147 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhh------ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEE
Confidence 999999999999999985322 1234689999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCC
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALP 924 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 924 (986)
+|||.+........ ......++..|+|||++.+..++.++||||||+++|+|++|..||...... .......
T Consensus 148 ~dfg~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~--- 219 (267)
T cd08229 148 GDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKK--- 219 (267)
T ss_pred CcchhhhccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch---HHHHhhh---
Confidence 99999876532221 122345888999999999889999999999999999999999998532111 1111110
Q ss_pred CchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 925 DHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 925 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+. ...+.. ......+.++.+++.+||+.+|++|||+++|
T Consensus 220 ------~~---~~~~~~--------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i 258 (267)
T cd08229 220 ------IE---QCDYPP--------------LPSDHYSEELRQLVNMCINPDPEKRPDITYV 258 (267)
T ss_pred ------hh---cCCCCC--------------CCcccccHHHHHHHHHhcCCCcccCCCHHHH
Confidence 00 000000 0001244568899999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=322.01 Aligned_cols=267 Identities=23% Similarity=0.300 Sum_probs=204.5
Q ss_pred cChHHHHHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcC-CCCcceeeeeeccc
Q 046598 678 ISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSG 756 (986)
Q Consensus 678 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 756 (986)
+.++.+..+.++|++.+.||+|+||.||+|.+..+++.+|+|+.+... .....+.+|+.+++++ +||||++++++|..
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 344566667899999999999999999999999889999999986432 2235678899999999 69999999998754
Q ss_pred cccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEe
Q 046598 757 VDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILL 836 (986)
Q Consensus 757 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 836 (986)
.....+...++||||+++++|.+++.... .....+++..+..++.|++.|+.|||+. +++||||||+||++
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili 157 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFL------KRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILL 157 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhh------ccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEE
Confidence 44456678999999999999999875321 1234688999999999999999999999 99999999999999
Q ss_pred cCCCcEEEcccccceecCCCCCccccccccccccccccccccC-----CCcCcccchhhHHHHHHHHHhCCCCCCccccc
Q 046598 837 DEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-----SEVSISGDVYSYGILLLELITRKKPTDIMFEG 911 (986)
Q Consensus 837 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~ 911 (986)
+.++.+||+|||+++...... .......|+..|+|||++.. ..++.++||||+||++|||++|+.||.....
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~- 234 (286)
T cd06638 158 TTEGGVKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP- 234 (286)
T ss_pred CCCCCEEEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch-
Confidence 999999999999998654321 12223468899999998753 4578999999999999999999999863211
Q ss_pred cccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 912 DMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
....... .. ..+.. ...+.....++.+++.+||+.||++|||+.||
T Consensus 235 ---~~~~~~~--~~-----------~~~~~-------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~el 280 (286)
T cd06638 235 ---MRALFKI--PR-----------NPPPT-------------LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDL 280 (286)
T ss_pred ---hHHHhhc--cc-----------cCCCc-------------ccCCCCcCHHHHHHHHHHccCCcccCCCHHHH
Confidence 1111000 00 00000 00000123357789999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=329.63 Aligned_cols=193 Identities=24% Similarity=0.378 Sum_probs=164.7
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
...+|++.+.||+|+||.||+|++..+++.||+|+.... ....|+.++++++||||+++++++ ......
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 132 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTL-----VSGAIT 132 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheE-----EeCCee
Confidence 446799999999999999999999988899999985432 235689999999999999999984 455778
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
++||||+ .++|.+++.. ....+++.+++.|+.||+.||.|||++ +|+||||||+||+++.++.+||+
T Consensus 133 ~lv~e~~-~~~l~~~l~~---------~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~ 199 (357)
T PHA03209 133 CMVLPHY-SSDLYTYLTK---------RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIG 199 (357)
T ss_pred EEEEEcc-CCcHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEe
Confidence 9999999 5688888852 234689999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCC
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPT 905 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf 905 (986)
|||.++..... .......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 200 DfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 200 DLGAAQFPVVA---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cCccccccccC---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 99999753211 1223456899999999999999999999999999999999965543
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=321.03 Aligned_cols=248 Identities=21% Similarity=0.281 Sum_probs=199.1
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 767 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 767 (986)
.+|++.+.||.|+||.||+|.+..+++.||+|.+........+.+.+|+.+++.++||||+++++++ ...+..++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~l 93 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF-----LVGDELFV 93 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeE-----ecCceEEE
Confidence 4699999999999999999999888999999999765555567889999999999999999999984 45578999
Q ss_pred EEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccc
Q 046598 768 VFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDF 847 (986)
Q Consensus 768 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DF 847 (986)
||||+++++|.+++.. ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+||
T Consensus 94 v~e~~~~~~L~~~~~~-----------~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~df 159 (296)
T cd06655 94 VMEYLAGGSLTDVVTE-----------TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDF 159 (296)
T ss_pred EEEecCCCcHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccC
Confidence 9999999999998841 2478999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCch
Q 046598 848 GLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHV 927 (986)
Q Consensus 848 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 927 (986)
|++........ ......++..|+|||.+.+..++.++|||||||++|+|++|+.||........ .... .......
T Consensus 160 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-~~~~-~~~~~~~- 234 (296)
T cd06655 160 GFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYLI-ATNGTPE- 234 (296)
T ss_pred ccchhcccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH-HhcCCcc-
Confidence 99876533221 12234588899999999988899999999999999999999999864221110 0000 0000000
Q ss_pred hHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 928 MDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 928 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.......+..+.+++.+||..||++|||+.+|
T Consensus 235 ---------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~i 266 (296)
T cd06655 235 ---------------------------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKEL 266 (296)
T ss_pred ---------------------------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHH
Confidence 00011234457789999999999999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=336.52 Aligned_cols=197 Identities=27% Similarity=0.335 Sum_probs=169.4
Q ss_pred hcCCCCCcccccccceeEEEEEECC--CCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDD--GRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
..+|.+.+.||+|+||.||+|...+ .+..||+|.+... +...+|++++++++||||++++++ +..+..
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~-----~~~~~~ 160 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHA-----YRWKST 160 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeee-----EeeCCE
Confidence 4579999999999999999998643 4578999987542 345689999999999999999988 455678
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.|+|||++. ++|.+++. ....+++.+++.|+.||+.||+|||+. +|+||||||+||+++.++.+||
T Consensus 161 ~~lv~e~~~-~~l~~~l~----------~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l 226 (392)
T PHA03207 161 VCMVMPKYK-CDLFTYVD----------RSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVL 226 (392)
T ss_pred EEEEehhcC-CCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEE
Confidence 999999994 68888883 224689999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 227 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 289 (392)
T PHA03207 227 GDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFG 289 (392)
T ss_pred ccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 999999866544333333456799999999999999999999999999999999999999864
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=320.48 Aligned_cols=253 Identities=24% Similarity=0.348 Sum_probs=195.4
Q ss_pred hcCCCCCcccccccceeEEEEEE-----CCCCeEEEEEEeeccC-chhHHHHHHHHHHHhcC-CCCcceeeeeecccccc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGIL-----DDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDY 759 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 759 (986)
.++|.+.+.||+|+||.||+|.+ ...+..||||+++... ....+.+.+|+++++++ +||||++++++|
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~----- 108 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC----- 108 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEE-----
Confidence 35799999999999999999986 2345679999987543 23446789999999999 799999999984
Q ss_pred CCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCC
Q 046598 760 QGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED 839 (986)
Q Consensus 760 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 839 (986)
...+..++||||+++|+|.++++... ...+++.++..++.|++.|++|||+. +|+||||||+||+++.+
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~ 177 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKR--------ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHG 177 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCC--------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCC
Confidence 44567899999999999999996321 22389999999999999999999999 99999999999999999
Q ss_pred CcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHH
Q 046598 840 MIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNL 918 (986)
Q Consensus 840 ~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~ 918 (986)
+.+|++|||.++...............++..|+|||++.+..++.++||||+||++|||++ |..||......+ .+
T Consensus 178 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-~~--- 253 (302)
T cd05055 178 KIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-KF--- 253 (302)
T ss_pred CeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-HH---
Confidence 9999999999986543322222222346778999999999999999999999999999998 999986332110 01
Q ss_pred HHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 919 ARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 919 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
...++....... ....+.++.+++.+|++.+|++|||+.||
T Consensus 254 ---------~~~~~~~~~~~~------------------~~~~~~~~~~li~~cl~~~p~~Rpt~~el 294 (302)
T cd05055 254 ---------YKLIKEGYRMAQ------------------PEHAPAEIYDIMKTCWDADPLKRPTFKQI 294 (302)
T ss_pred ---------HHHHHcCCcCCC------------------CCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 111111000000 00123457899999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=313.07 Aligned_cols=254 Identities=23% Similarity=0.347 Sum_probs=199.9
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeec---cCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL---LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
++|++.+.||+|+||.||+|....+++.||+|.++. ......+.+.+|++++++++|++++++++++ ..++.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~-----~~~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASF-----IENNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeee-----ecCCe
Confidence 679999999999999999999998899999998863 2233356789999999999999999999984 44578
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.++||||+++++|.+++.... .....+++.++..++.|+++|++|||+. |++||||+|+||+++.++.++|
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l 147 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFK------KQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKL 147 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhc------ccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEE
Confidence 899999999999999986332 2234588999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCC
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALP 924 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 924 (986)
+|||.+........ ......++..|+|||.+.+..++.++|||||||++|+|++|+.||.... ........
T Consensus 148 ~d~~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~---- 218 (267)
T cd08224 148 GDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLCK---- 218 (267)
T ss_pred eccceeeeccCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC---ccHHHHHh----
Confidence 99999976533221 1223457889999999998899999999999999999999999985221 11111111
Q ss_pred CchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 925 DHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 925 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
......... ......+..+.+++.+||+.+|++|||+.+|
T Consensus 219 --------~~~~~~~~~--------------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~i 258 (267)
T cd08224 219 --------KIEKCDYPP--------------LPADHYSEELRDLVSRCINPDPEKRPDISYV 258 (267)
T ss_pred --------hhhcCCCCC--------------CChhhcCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 000000000 0011334567899999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=319.47 Aligned_cols=251 Identities=23% Similarity=0.333 Sum_probs=198.9
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
.++|++.+.||+|+||.||+|.+..++..||+|+++.......+.+.+|++++++++||||+++++++ ..+...+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 78 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY-----FYENKLW 78 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEE-----ecCCeEE
Confidence 46799999999999999999999888899999999876666667899999999999999999999984 4567899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+++++|.+++.. ....+++.+++.++.|++.|+.|||+. +|+||||||+||+++.++.++|+|
T Consensus 79 lv~e~~~~~~L~~~~~~---------~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d 146 (280)
T cd06611 79 ILIEFCDGGALDSIMLE---------LERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLAD 146 (280)
T ss_pred EEeeccCCCcHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEcc
Confidence 99999999999999852 234689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccc-----CCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHh
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGL-----GSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLART 921 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~ 921 (986)
||.+....... .......++..|+|||++. +..++.++|||||||++|||++|+.||...... .....
T Consensus 147 ~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-----~~~~~ 219 (280)
T cd06611 147 FGVSAKNKSTL--QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-----RVLLK 219 (280)
T ss_pred Cccchhhcccc--cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-----HHHHH
Confidence 99986543221 1223345889999999874 345788999999999999999999998632111 10000
Q ss_pred hCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 922 ALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 922 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
. ....+. ....+...+.++.+++.+||+.+|++||++.+|
T Consensus 220 ~------------~~~~~~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i 259 (280)
T cd06611 220 I------------LKSEPP-------------TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAEL 259 (280)
T ss_pred H------------hcCCCC-------------CcCCcccCCHHHHHHHHHHhccChhhCcCHHHH
Confidence 0 000000 000011233457789999999999999998764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=321.20 Aligned_cols=250 Identities=22% Similarity=0.265 Sum_probs=203.4
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc---hhHHHHHHHHHHHhcCC-CCcceeeeeeccccccCC
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH---GAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQG 761 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 761 (986)
....|++.+.||+|.||.||+++.+.+++.+|+|++..... ...+.+.+|+++|+++. |||||.++++ ++.
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~-----~e~ 107 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDA-----FED 107 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEE-----EEc
Confidence 45679999999999999999999999999999999975333 24468999999999998 9999999999 566
Q ss_pred CceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCC--
Q 046598 762 NDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED-- 839 (986)
Q Consensus 762 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-- 839 (986)
....++|||++.||.|.+.+... .+++.++..++.|++.|++|||+. ||+|||+||+|+|+...
T Consensus 108 ~~~~~lvmEL~~GGeLfd~i~~~-----------~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~ 173 (382)
T KOG0032|consen 108 PDSVYLVMELCEGGELFDRIVKK-----------HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDE 173 (382)
T ss_pred CCeEEEEEEecCCchHHHHHHHc-----------cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccC
Confidence 78999999999999999999521 289999999999999999999999 99999999999999643
Q ss_pred --CcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHH
Q 046598 840 --MIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHN 917 (986)
Q Consensus 840 --~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~ 917 (986)
+.+|++|||+|..... .......+||+.|+|||++....|+.++||||+||++|.|++|.+||......... ..
T Consensus 174 ~~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~-~~ 249 (382)
T KOG0032|consen 174 GSGRIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF-LA 249 (382)
T ss_pred CCCcEEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH-HH
Confidence 4799999999998754 33455688999999999999999999999999999999999999999743322111 11
Q ss_pred HHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 918 LARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 918 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.....+ .....+ -........+++..|+..||.+|+|+.++
T Consensus 250 i~~~~~----------~f~~~~------------------w~~is~~akd~i~~ll~~dp~~R~ta~~~ 290 (382)
T KOG0032|consen 250 ILRGDF----------DFTSEP------------------WDDISESAKDFIRKLLEFDPRKRLTAAQA 290 (382)
T ss_pred HHcCCC----------CCCCCC------------------ccccCHHHHHHHHHhcccCcccCCCHHHH
Confidence 111110 000111 11334556789999999999999998763
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=313.29 Aligned_cols=249 Identities=24% Similarity=0.324 Sum_probs=200.0
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
.++|++.+.||+|+||.||+|.+..+++.||+|.++.... .+++.+|++++++++||||+++++++ ..+...|
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~ 74 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSY-----FKNTDLW 74 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCcEE
Confidence 3679999999999999999999998889999999875432 67899999999999999999999984 4558899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+++||+++++|.+++.. ....+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.+||+|
T Consensus 75 l~~e~~~~~~L~~~l~~---------~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~d 142 (256)
T cd06612 75 IVMEYCGAGSVSDIMKI---------TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLAD 142 (256)
T ss_pred EEEecCCCCcHHHHHHh---------CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcc
Confidence 99999999999999852 234689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCc
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDH 926 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 926 (986)
||.+........ ......++..|+|||++.+..++.++|||||||++|+|++|+.||....... ....
T Consensus 143 fg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~----~~~~------ 210 (256)
T cd06612 143 FGVSGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR----AIFM------ 210 (256)
T ss_pred cccchhcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh----hhhh------
Confidence 999986543221 2223447889999999999899999999999999999999999986322111 0000
Q ss_pred hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 927 VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 927 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+...... ..........++.+++.+||+.+|++|||++||
T Consensus 211 ----~~~~~~~----------------~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~i 250 (256)
T cd06612 211 ----IPNKPPP----------------TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQL 250 (256)
T ss_pred ----hccCCCC----------------CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHH
Confidence 0000000 000111234567889999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=316.75 Aligned_cols=200 Identities=27% Similarity=0.400 Sum_probs=171.4
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
.|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.++++++|++|+++++.+ ..++..
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~ 75 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEE-----ecCCEE
Confidence 3778899999999999999999999999999986432 22234577899999999999999999884 455789
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
++||||+++++|.+++.... ...+++.++..++.|++.||.|||+. +|+||||||+||+++.++.++|+
T Consensus 76 ~lv~e~~~g~~L~~~l~~~~--------~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~ 144 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYHMG--------EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRIS 144 (285)
T ss_pred EEEEEecCCCcHHHHHHHhc--------ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEe
Confidence 99999999999999885221 23588999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
|||++........ .....|+..|+|||++.+..++.++||||+||++|+|++|+.||..
T Consensus 145 Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~ 203 (285)
T cd05630 145 DLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 203 (285)
T ss_pred eccceeecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence 9999976532221 1234689999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=320.75 Aligned_cols=267 Identities=24% Similarity=0.276 Sum_probs=203.9
Q ss_pred cChHHHHHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcC-CCCcceeeeeeccc
Q 046598 678 ISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSG 756 (986)
Q Consensus 678 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 756 (986)
+.+.++..+.++|++.+.||+|+||.||+|....+++.+|+|++.... .....+.+|+.+++++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 344566667899999999999999999999999889999999986532 2345678899999998 89999999999754
Q ss_pred cccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEe
Q 046598 757 VDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILL 836 (986)
Q Consensus 757 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 836 (986)
.........++||||+++++|.++++... .....+++..++.++.|++.||+|||+. +++||||||+||++
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~------~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili 161 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLL------ICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILL 161 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhh------hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEE
Confidence 43334467899999999999999885321 1234688999999999999999999999 99999999999999
Q ss_pred cCCCcEEEcccccceecCCCCCccccccccccccccccccccCC-----CcCcccchhhHHHHHHHHHhCCCCCCccccc
Q 046598 837 DEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS-----EVSISGDVYSYGILLLELITRKKPTDIMFEG 911 (986)
Q Consensus 837 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlGvvl~elltg~~pf~~~~~~ 911 (986)
+.++.+||+|||.+........ ......++..|+|||++... .++.++|||||||++|||++|+.||......
T Consensus 162 ~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~ 239 (291)
T cd06639 162 TTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV 239 (291)
T ss_pred cCCCCEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH
Confidence 9999999999999976532221 12234578899999987643 3689999999999999999999998632111
Q ss_pred cccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 912 DMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..... +.. ..+.. .....+....+.+++.+||+.+|++||++.|+
T Consensus 240 ----~~~~~---------~~~----~~~~~-------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i 284 (291)
T cd06639 240 ----KTLFK---------IPR----NPPPT-------------LLHPEKWCRSFNHFISQCLIKDFEARPSVTHL 284 (291)
T ss_pred ----HHHHH---------Hhc----CCCCC-------------CCcccccCHHHHHHHHHHhhcChhhCcCHHHH
Confidence 11100 000 00000 00011233457899999999999999998764
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=326.80 Aligned_cols=262 Identities=25% Similarity=0.353 Sum_probs=195.5
Q ss_pred hcCCCCCcccccccceeEEEEEEC-----CCCeEEEEEEeeccC-chhHHHHHHHHHHHhcC-CCCcceeeeeecccccc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILD-----DGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDY 759 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 759 (986)
.++|++.+.||+|+||.||+|.+. .+++.||||+++... ......+.+|+.++.++ +||||++++++|.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~---- 81 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT---- 81 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee----
Confidence 468999999999999999999853 346789999997532 23456788999999999 6899999999863
Q ss_pred CCCceEEEEEEeccCCCHhHhhccCCCCCc--------------------------------------------------
Q 046598 760 QGNDFKALVFEFMHNRSLEEWLHPITREDE-------------------------------------------------- 789 (986)
Q Consensus 760 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-------------------------------------------------- 789 (986)
..+...++||||+++|+|.++++.......
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 334578999999999999999864321000
Q ss_pred -------cccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcccccceecCCCCCcccc
Q 046598 790 -------TDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSS 862 (986)
Q Consensus 790 -------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~ 862 (986)
.......+++.++..++.||++||+|||++ +|+||||||+||++++++.+||+|||+++...........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 238 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 238 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhc
Confidence 000123578999999999999999999999 9999999999999999999999999999765333222222
Q ss_pred ccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCchhHHhhhhcccCCcc
Q 046598 863 IGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGED 941 (986)
Q Consensus 863 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 941 (986)
....++..|+|||++.+..++.++||||||+++|+|++ |..||....... ......... .....+
T Consensus 239 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~~~~-----------~~~~~~-- 304 (343)
T cd05103 239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLKEG-----------TRMRAP-- 304 (343)
T ss_pred CCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-HHHHHHhcc-----------CCCCCC--
Confidence 23345678999999988899999999999999999997 999986321110 000000000 000000
Q ss_pred hhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 942 LIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.....++.+++.+||+.+|++|||+.||
T Consensus 305 -----------------~~~~~~~~~~~~~cl~~~p~~Rps~~ei 332 (343)
T cd05103 305 -----------------DYTTPEMYQTMLDCWHGEPSQRPTFSEL 332 (343)
T ss_pred -----------------CCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 0122357899999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=317.20 Aligned_cols=260 Identities=24% Similarity=0.414 Sum_probs=200.7
Q ss_pred hhcCCCCCcccccccceeEEEEEECC----CCeEEEEEEeecc-CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccC
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDD----GRTTIAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ 760 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 760 (986)
..++|++.+.||+|+||.||+|.+.. .+..||+|++... .....+.+.+|+.++++++||||+++++++ ..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~----~~ 79 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVC----IE 79 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE----ec
Confidence 35689999999999999999999875 3578999988643 234456788999999999999999999986 33
Q ss_pred CCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCC
Q 046598 761 GNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDM 840 (986)
Q Consensus 761 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 840 (986)
.+...++++||+++++|.+++....... ......+++.++..++.|++.||+|||+. +++||||||+||++++++
T Consensus 80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~ 154 (280)
T cd05043 80 DGEPPFVLYPYMNWGNLKLFLQQCRLGE--ANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEEL 154 (280)
T ss_pred CCCCCEEEEEcCCCCcHHHHHHhccccc--cccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCC
Confidence 3567899999999999999996443211 11235689999999999999999999999 999999999999999999
Q ss_pred cEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHH
Q 046598 841 IAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLA 919 (986)
Q Consensus 841 ~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~ 919 (986)
.+||+|||+++.+.............++..|+|||++.+..++.++|||||||++||+++ |+.||..... .......
T Consensus 155 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~ 232 (280)
T cd05043 155 QVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAAYL 232 (280)
T ss_pred cEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHHHH
Confidence 999999999986643332222223346778999999998899999999999999999999 9999863211 1111111
Q ss_pred HhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 920 RTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 920 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.. ... ......++.++.+++.+||+.+|++|||+.||
T Consensus 233 ~~------------~~~------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 269 (280)
T cd05043 233 KD------------GYR------------------LAQPINCPDELFAVMACCWALDPEERPSFSQL 269 (280)
T ss_pred Hc------------CCC------------------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 10 000 00001234567899999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=319.31 Aligned_cols=256 Identities=22% Similarity=0.372 Sum_probs=194.2
Q ss_pred cCCCCCcccccccceeEEEEEECCCCe--EEEEEEeec-cCchhHHHHHHHHHHHhcC-CCCcceeeeeeccccccCCCc
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRT--TIAVKVFNL-LHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 763 (986)
++|++.+.||+|+||.||+|.+..++. .+++|.++. ......+.+.+|+++++++ +||||+++++++ ....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----~~~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGAC-----ENRG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEE-----ccCC
Confidence 578999999999999999999876554 478888764 2333456789999999999 799999999984 4456
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCc------cccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEec
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDE------TDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLD 837 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 837 (986)
..++||||+++++|.++++....... .......+++.+++.++.|++.|++|||+. +|+||||||+||+++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~ 153 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVG 153 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEEC
Confidence 78999999999999999965332111 111234689999999999999999999999 999999999999999
Q ss_pred CCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHH
Q 046598 838 EDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLH 916 (986)
Q Consensus 838 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~ 916 (986)
+++.+||+|||++...... ........+..|+|||++.+..++.++|||||||++|||++ |..||..... .
T Consensus 154 ~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~-----~ 225 (297)
T cd05089 154 ENLASKIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC-----A 225 (297)
T ss_pred CCCeEEECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----H
Confidence 9999999999998643211 11111233567999999988899999999999999999998 9999863211 1
Q ss_pred HHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 917 NLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 917 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..... +....... .+..++.++.+++.+||+.+|.+|||+++|
T Consensus 226 ~~~~~---------~~~~~~~~------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 268 (297)
T cd05089 226 ELYEK---------LPQGYRME------------------KPRNCDDEVYELMRQCWRDRPYERPPFAQI 268 (297)
T ss_pred HHHHH---------HhcCCCCC------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 11111 00000000 001234567899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=313.81 Aligned_cols=248 Identities=28% Similarity=0.472 Sum_probs=194.1
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
.++|++.++||+|+||.||+|.+..+ ..||+|+++.... ..+++.+|++++++++||||+++++++ . ....+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~-----~-~~~~~ 76 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVV-----S-EEPIY 76 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEE-----C-CCCcE
Confidence 46799999999999999999998764 5699999875332 346789999999999999999999873 2 24579
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+++|+|.++++.. ....+++..+..++.|+++||+|+|+. +++||||||+||++++++.+||+|
T Consensus 77 lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~d 145 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGE--------MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVAD 145 (262)
T ss_pred EEEEcCCCCcHHHHHhhc--------cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEecc
Confidence 999999999999999631 123578999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCC
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALPD 925 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 925 (986)
||.++.+..... .......++..|+|||+..+..++.++|||||||++|||+| |+.||...... .....
T Consensus 146 fg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-----~~~~~---- 215 (262)
T cd05071 146 FGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVLDQ---- 215 (262)
T ss_pred CCceeecccccc-ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-----HHHHH----
Confidence 999986643322 11223346778999999988899999999999999999999 88888632111 11000
Q ss_pred chhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 926 HVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 926 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+.. ... .+...+.+..+.+++.+|++.+|++||+++++
T Consensus 216 -----~~~---~~~---------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~ 253 (262)
T cd05071 216 -----VER---GYR---------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYL 253 (262)
T ss_pred -----Hhc---CCC---------------CCCccccCHHHHHHHHHHccCCcccCCCHHHH
Confidence 000 000 00011345567899999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=316.28 Aligned_cols=201 Identities=28% Similarity=0.379 Sum_probs=171.1
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||+++++++ ......
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVF-----RRKRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEE-----eeCCEE
Confidence 47899999999999999999999889999999986432 22335678999999999999999999984 456789
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
++||||++++.+..++. ....+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+
T Consensus 76 ~~v~e~~~~~~l~~~~~----------~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~ 142 (286)
T cd07847 76 HLVFEYCDHTVLNELEK----------NPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLC 142 (286)
T ss_pred EEEEeccCccHHHHHHh----------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEEC
Confidence 99999999998888763 123589999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCcc
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDIM 908 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~ 908 (986)
|||.+........ ......++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 143 dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~ 204 (286)
T cd07847 143 DFGFARILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGK 204 (286)
T ss_pred ccccceecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 9999987643321 1223457789999999876 56889999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=315.71 Aligned_cols=250 Identities=23% Similarity=0.406 Sum_probs=194.4
Q ss_pred cCCCCCcccccccceeEEEEEECCCCe---EEEEEEeecc-CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRT---TIAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
.+|++.+.||+|+||.||+|.+..++. .||||+++.. .....+++..|+.++++++||||++++++ +..+.
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~-----~~~~~ 78 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGV-----VTKSR 78 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEE-----ECCCC
Confidence 457889999999999999999876543 6999998653 33445789999999999999999999998 45567
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..++||||+++++|.+++.. ..+.+++.+++.++.|++.|++|||+. |++||||||+||+++.++.+|
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~k 146 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQ---------NDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCK 146 (269)
T ss_pred ceEEEEecCCCCcHHHHHhh---------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEE
Confidence 88999999999999999862 234589999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCcccccc---ccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHH
Q 046598 844 IGDFGLARFLPLSSAQTSSIG---AKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLA 919 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~ 919 (986)
|+|||.+.............. ...+..|+|||++.+..++.++|||||||++||+++ |..||...... ......
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~i 224 (269)
T cd05065 147 VSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINAI 224 (269)
T ss_pred ECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHHH
Confidence 999999976543222111111 112457999999999999999999999999999987 99998632211 111111
Q ss_pred HhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 920 RTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 920 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
... . +.+...+++..+.+++.+||+.+|++||++++|
T Consensus 225 ~~~------------~------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 261 (269)
T cd05065 225 EQD------------Y------------------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQI 261 (269)
T ss_pred HcC------------C------------------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 000 0 000011334567899999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=318.33 Aligned_cols=260 Identities=26% Similarity=0.414 Sum_probs=198.1
Q ss_pred hcCCCCCcccccccceeEEEEEECC-----CCeEEEEEEeeccCc-hhHHHHHHHHHHHhcCCCCcceeeeeeccccccC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDD-----GRTTIAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ 760 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 760 (986)
.++|++.+.||+|+||.||+|.+.. ++..||+|++..... ...+++.+|+.++++++||||++++++| .
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~-----~ 78 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVC-----A 78 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEE-----c
Confidence 5679999999999999999999753 568899999865332 3346788999999999999999999984 4
Q ss_pred CCceEEEEEEeccCCCHhHhhccCCCCCc------------cccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeec
Q 046598 761 GNDFKALVFEFMHNRSLEEWLHPITREDE------------TDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCD 828 (986)
Q Consensus 761 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~D 828 (986)
.+...++||||+++++|.+++........ .......+++.+++.++.|++.||+|||+. +++|||
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~d 155 (288)
T cd05050 79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRD 155 (288)
T ss_pred CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceeccc
Confidence 45678999999999999999964322111 112234588999999999999999999999 999999
Q ss_pred CCCCCeEecCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCc
Q 046598 829 LKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDI 907 (986)
Q Consensus 829 lkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~ 907 (986)
|||+||++++++.+||+|||.++.+..............+..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 156 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 156 LATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred ccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999976533322222222345678999999998899999999999999999998 8888753
Q ss_pred cccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 908 MFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
... ....... .+...... ...++.++.+++.+|++.+|++|||+.||
T Consensus 236 ~~~-----~~~~~~~--------~~~~~~~~-------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~el 282 (288)
T cd05050 236 MAH-----EEVIYYV--------RDGNVLSC-------------------PDNCPLELYNLMRLCWSKLPSDRPSFASI 282 (288)
T ss_pred CCH-----HHHHHHH--------hcCCCCCC-------------------CCCCCHHHHHHHHHHcccCcccCCCHHHH
Confidence 211 1111100 00000000 01234568899999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=330.31 Aligned_cols=261 Identities=22% Similarity=0.316 Sum_probs=196.9
Q ss_pred hcCCCCCcccccccceeEEEEEECC-----CCeEEEEEEeeccCc-hhHHHHHHHHHHHhcCC-CCcceeeeeecccccc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDD-----GRTTIAVKVFNLLHH-GAFKSFIAECNTLKNIR-HRNLVKILTACSGVDY 759 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 759 (986)
.++|.+.++||+|+||.||+|.+.. .+..||+|+++.... ...+.+.+|++++.++. ||||++++++|
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~----- 110 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC----- 110 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE-----
Confidence 4568889999999999999999643 356899999975322 33457889999999997 99999999995
Q ss_pred CCCceEEEEEEeccCCCHhHhhccCCCCC---------------------------------------------------
Q 046598 760 QGNDFKALVFEFMHNRSLEEWLHPITRED--------------------------------------------------- 788 (986)
Q Consensus 760 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------------------------------------------- 788 (986)
..+...++||||+++|+|.++++......
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 34567999999999999999997543210
Q ss_pred -------------------------------------ccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCC
Q 046598 789 -------------------------------------ETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKP 831 (986)
Q Consensus 789 -------------------------------------~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 831 (986)
........+++.++..++.||+.||+|||+. +++||||||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp 267 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAA 267 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCc
Confidence 0001123578889999999999999999998 999999999
Q ss_pred CCeEecCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCcccc
Q 046598 832 SNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFE 910 (986)
Q Consensus 832 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~ 910 (986)
+||++++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 999999999999999999986533222222223346788999999998899999999999999999998 8899863221
Q ss_pred ccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 911 GDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+. . ...+...... ..+..++.++.+++.+||..+|++||+++||
T Consensus 348 ~~~----~---------~~~~~~~~~~------------------~~p~~~~~~l~~li~~cl~~~P~~RPs~~el 392 (401)
T cd05107 348 NEQ----F---------YNAIKRGYRM------------------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQL 392 (401)
T ss_pred hHH----H---------HHHHHcCCCC------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 110 0 0111100000 0001234567899999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=325.79 Aligned_cols=284 Identities=20% Similarity=0.245 Sum_probs=202.0
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc-CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
..++|++.+.||+|+||.||+|++..+++.||+|+++.. ......++.+|+.++++++||||+++++++....+.....
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 357899999999999999999999988999999998642 2334567889999999999999999999876554555567
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.++||||++ +++.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 83 ~~lv~e~~~-~~l~~~~~-----------~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl 147 (336)
T cd07849 83 VYIVQELME-TDLYKLIK-----------TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKI 147 (336)
T ss_pred EEEEehhcc-cCHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEE
Confidence 899999995 58887774 23589999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCc-cccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 046598 845 GDFGLARFLPLSSAQ-TSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 922 (986)
+|||++......... .......++..|+|||.+.+ ..++.++||||+||++|+|++|+.||..... ..........
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~--~~~~~~~~~~ 225 (336)
T cd07849 148 CDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY--LHQLNLILGV 225 (336)
T ss_pred CcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHH
Confidence 999999765332211 11223467899999998655 5689999999999999999999999963211 0111111111
Q ss_pred CCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 923 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
......+..+........+......................++.+++.+||+.+|++|||+.|+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~ 289 (336)
T cd07849 226 LGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEA 289 (336)
T ss_pred cCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHH
Confidence 1111111111111111100000000000000000111235668899999999999999999864
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=319.46 Aligned_cols=206 Identities=22% Similarity=0.304 Sum_probs=164.0
Q ss_pred CcccccccceeEEEEEECC--CCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEEEE
Q 046598 693 VNQIGEGSFGSVFKGILDD--GRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFE 770 (986)
Q Consensus 693 ~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 770 (986)
.++||+|+||+||+|++.. +++.||+|+++... ......+|++++++++||||+++++++.. ..+...++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLS---HADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEec---CCCcEEEEEEe
Confidence 4689999999999999753 56889999986432 23557889999999999999999988532 33467899999
Q ss_pred eccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEe----cCCCcEEEcc
Q 046598 771 FMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILL----DEDMIAHIGD 846 (986)
Q Consensus 771 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kL~D 846 (986)
|+. ++|.+++....... .......+++..++.++.||+.||+|||+. +|+||||||+||++ +.++.+||+|
T Consensus 81 ~~~-~~l~~~~~~~~~~~-~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07868 81 YAE-HDLWHIIKFHRASK-ANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred ccC-CCHHHHHHhccccc-ccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEee
Confidence 984 58888875332211 112234689999999999999999999999 99999999999999 4567899999
Q ss_pred cccceecCCCCC-ccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCcc
Q 046598 847 FGLARFLPLSSA-QTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDIM 908 (986)
Q Consensus 847 FG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~ 908 (986)
||+++....... ........+|+.|+|||++.+ ..++.++||||+||++|||++|++||...
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 999987643221 122234568999999999877 45899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=318.32 Aligned_cols=267 Identities=20% Similarity=0.339 Sum_probs=195.4
Q ss_pred hcCCCCCcccccccceeEEEEEECCC--------------CeEEEEEEeecc-CchhHHHHHHHHHHHhcCCCCcceeee
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDG--------------RTTIAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKIL 751 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~--------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~ 751 (986)
.++|++.+.||+|+||.||+|.+... ...||+|+++.. .......+.+|++++++++|||+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 35799999999999999999987542 235899998643 233446789999999999999999999
Q ss_pred eeccccccCCCceEEEEEEeccCCCHhHhhccCCCCC--ccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecC
Q 046598 752 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITRED--ETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDL 829 (986)
Q Consensus 752 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dl 829 (986)
+++ ..+...++||||+++++|.+++....... ........+++.+++.++.|++.|++|||+. +++||||
T Consensus 84 ~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dl 155 (295)
T cd05097 84 GVC-----VSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDL 155 (295)
T ss_pred EEE-----cCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---Ceecccc
Confidence 995 44577899999999999999986432110 0011123478899999999999999999999 9999999
Q ss_pred CCCCeEecCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh--CCCCCCc
Q 046598 830 KPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT--RKKPTDI 907 (986)
Q Consensus 830 kp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt--g~~pf~~ 907 (986)
||+||++++++.+||+|||++................++..|+|||+..++.++.++|||||||++|+|++ |..||..
T Consensus 156 kp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 156 ATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred ChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 99999999999999999999976543322222223345778999999988899999999999999999998 5667753
Q ss_pred cccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 908 MFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.... ...... ....+....... ......++..+.+++.+||+.+|++|||+++|
T Consensus 236 ~~~~-----~~~~~~-----~~~~~~~~~~~~---------------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i 289 (295)
T cd05097 236 LSDE-----QVIENT-----GEFFRNQGRQIY---------------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKI 289 (295)
T ss_pred cChH-----HHHHHH-----HHhhhhcccccc---------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 2211 110000 000000000000 00000134568899999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=314.63 Aligned_cols=251 Identities=22% Similarity=0.419 Sum_probs=194.8
Q ss_pred hcCCCCCcccccccceeEEEEEECCCC---eEEEEEEeecc-CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGR---TTIAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
.++|+..+.||+|+||.||+|....++ ..+|+|.++.. .....+.+.+|++++++++||||+++.+++ ...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 78 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVV-----TKF 78 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----ccC
Confidence 357888999999999999999987544 37999988654 233456789999999999999999999984 455
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
+..++||||+++++|.+++.. ....+++.++..++.|++.|++|||+. +++||||||+||+++.++.+
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~ 146 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRD---------HDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLEC 146 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcE
Confidence 778999999999999999852 224589999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCccc-cccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHH
Q 046598 843 HIGDFGLARFLPLSSAQTS-SIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLAR 920 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~ 920 (986)
||+|||++........... ......+..|+|||++.+..++.++|||||||++|||++ |+.||..... .....
T Consensus 147 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-----~~~~~ 221 (268)
T cd05063 147 KVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-----HEVMK 221 (268)
T ss_pred EECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-----HHHHH
Confidence 9999999976643222111 111223567999999988889999999999999999998 9999863221 11111
Q ss_pred hhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 921 TALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 921 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
. +.... ..+ ....++.++.+++.+||+.+|++||++.+|
T Consensus 222 ~---------i~~~~-~~~-----------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i 260 (268)
T cd05063 222 A---------INDGF-RLP-----------------APMDCPSAVYQLMLQCWQQDRARRPRFVDI 260 (268)
T ss_pred H---------HhcCC-CCC-----------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 0 00000 000 011234567899999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.92 Aligned_cols=251 Identities=20% Similarity=0.284 Sum_probs=194.5
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEee--ccCchhHHHHHHHHHHHhcC-CCCcceeeeeeccccccCCCc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFN--LLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 763 (986)
...|++.++||+||.+.||++...+ .+.||+|.+. ..+.....-|.+|+..|.++ .|.+||++++| .-.++
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DY-----Ev~d~ 433 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDY-----EVTDG 433 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeee-----eccCc
Confidence 3469999999999999999999876 4566666553 34556678899999999999 69999999999 45578
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..|+||||= ..+|.++++.... .++...++.+..|++.|+.++|.+ ||||.||||.|+++- .|.+|
T Consensus 434 ~lYmvmE~G-d~DL~kiL~k~~~---------~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LK 499 (677)
T KOG0596|consen 434 YLYMVMECG-DIDLNKILKKKKS---------IDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLK 499 (677)
T ss_pred eEEEEeecc-cccHHHHHHhccC---------CCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEE
Confidence 999999976 6799999974432 233237889999999999999999 999999999999986 47899
Q ss_pred EcccccceecCCCCCccccccccccccccccccccCC-----------CcCcccchhhHHHHHHHHHhCCCCCCcccccc
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS-----------EVSISGDVYSYGILLLELITRKKPTDIMFEGD 912 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~ 912 (986)
|+|||.|..+..+.........+||+.||+||.+... ..+++|||||+|||+|+|+.|+.||.......
T Consensus 500 LIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~ 579 (677)
T KOG0596|consen 500 LIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQI 579 (677)
T ss_pred eeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHH
Confidence 9999999999877777777788999999999987643 25689999999999999999999997332111
Q ss_pred ccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 913 MNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.. +..+.++--.-.+.+ .+ ...+++++|+.|+..||.+|||..||
T Consensus 580 aK------------l~aI~~P~~~Iefp~-------------~~----~~~~li~~mK~CL~rdPkkR~si~eL 624 (677)
T KOG0596|consen 580 AK------------LHAITDPNHEIEFPD-------------IP----ENDELIDVMKCCLARDPKKRWSIPEL 624 (677)
T ss_pred HH------------HHhhcCCCccccccC-------------CC----CchHHHHHHHHHHhcCcccCCCcHHH
Confidence 11 111111111000000 00 01127899999999999999998764
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=319.94 Aligned_cols=261 Identities=21% Similarity=0.371 Sum_probs=198.4
Q ss_pred hhcCCCCCcccccccceeEEEEEEC-------CCCeEEEEEEeecc-CchhHHHHHHHHHHHhcC-CCCcceeeeeeccc
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILD-------DGRTTIAVKVFNLL-HHGAFKSFIAECNTLKNI-RHRNLVKILTACSG 756 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 756 (986)
..++|.+.+.||+|+||.||+|++. ..+..||+|.++.. .....+++.+|+.+++.+ +||||+++++++
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~-- 90 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC-- 90 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE--
Confidence 3567899999999999999999752 22457999998643 234456789999999999 899999999984
Q ss_pred cccCCCceEEEEEEeccCCCHhHhhccCCCCCc------cccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCC
Q 046598 757 VDYQGNDFKALVFEFMHNRSLEEWLHPITREDE------TDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLK 830 (986)
Q Consensus 757 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlk 830 (986)
......++||||+++|+|.+++........ .......+++.++..++.||++||+|||++ |++|||||
T Consensus 91 ---~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlk 164 (304)
T cd05101 91 ---TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLA 164 (304)
T ss_pred ---ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccc
Confidence 455788999999999999999975322110 011234689999999999999999999999 99999999
Q ss_pred CCCeEecCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccc
Q 046598 831 PSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMF 909 (986)
Q Consensus 831 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~ 909 (986)
|+||++++++.+||+|||.++...............+++.|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 165 p~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~- 243 (304)
T cd05101 165 ARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI- 243 (304)
T ss_pred cceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-
Confidence 9999999999999999999987643332222333446678999999998899999999999999999998 78887522
Q ss_pred cccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 910 EGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+....... +.. .... .....++..+.+++.+||+.+|++|||+.||
T Consensus 244 ----~~~~~~~~---------~~~---~~~~---------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~ 289 (304)
T cd05101 244 ----PVEELFKL---------LKE---GHRM---------------DKPANCTNELYMMMRDCWHAIPSHRPTFKQL 289 (304)
T ss_pred ----CHHHHHHH---------HHc---CCcC---------------CCCCCCCHHHHHHHHHHcccChhhCCCHHHH
Confidence 11111111 000 0000 0001334567899999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=317.07 Aligned_cols=258 Identities=23% Similarity=0.305 Sum_probs=200.4
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
.++|++.+.||+|+||+||+|.+..+++.||+|++.... ....+.+.+|+++++.++||||+++++++ ......
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~ 78 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF-----LNENNI 78 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeE-----ecCCEE
Confidence 357889999999999999999999889999999986533 33457789999999999999999999994 445789
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHH-DCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
++||||+++++|.+++.. .+.+++..+..++.|++.|+.|||+ . +++||||||+||+++.++.++|
T Consensus 79 ~lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l 145 (284)
T cd06620 79 CMCMEFMDCGSLDRIYKK----------GGPIPVEILGKIAVAVVEGLTYLYNVH---RIMHRDIKPSNILVNSRGQIKL 145 (284)
T ss_pred EEEEecCCCCCHHHHHHh----------ccCCCHHHHHHHHHHHHHHHHHHHHhc---CeeccCCCHHHEEECCCCcEEE
Confidence 999999999999999852 2358899999999999999999997 5 8999999999999999999999
Q ss_pred cccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCC
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALP 924 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 924 (986)
+|||++....... .....++..|+|||++.+..++.++|||||||++|++++|+.||........ ....+
T Consensus 146 ~d~gl~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~------~~~~~ 215 (284)
T cd06620 146 CDFGVSGELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDD------GQDDP 215 (284)
T ss_pred ccCCcccchhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhh------hhhhh
Confidence 9999986542211 1234689999999999888999999999999999999999999974332111 00001
Q ss_pred CchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 925 DHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 925 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..+.+.+.......+.. . ...+++.++.+++.+|++.||++|||+.||
T Consensus 216 ~~~~~~~~~~~~~~~~~-------------~-~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~ 263 (284)
T cd06620 216 MGILDLLQQIVQEPPPR-------------L-PSSDFPEDLRDFVDACLLKDPTERPTPQQL 263 (284)
T ss_pred hHHHHHHHHHhhccCCC-------------C-CchhcCHHHHHHHHHHhcCCcccCcCHHHH
Confidence 11112222211111100 0 001245568899999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=331.24 Aligned_cols=373 Identities=29% Similarity=0.419 Sum_probs=287.0
Q ss_pred ccccCceeeceecccC-CCCccchhcCccccceecccccccCccCccccCCCCCCeEEccCCcCCCCcccccCCCcCcce
Q 046598 108 RLRRLQVLALHYNSIG-GAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRS 186 (986)
Q Consensus 108 ~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 186 (986)
-|+-.+-.|+++|.++ +..|.....+++++.|-|...++. .+|+.++.|.+|++|.+++|++. .+-..+..|+.|+.
T Consensus 5 VLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRs 82 (1255)
T KOG0444|consen 5 VLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRS 82 (1255)
T ss_pred ccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHH
Confidence 3455677888888888 568888888888888888888887 78888888888888888888887 55566777788888
Q ss_pred eeccCCcccC-cCcchhhccCCCceeecccccccccCCccccCCCCccEEeccccccccccCCcccccccccceEEecCc
Q 046598 187 LFLSGNNLEG-SIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGEN 265 (986)
Q Consensus 187 L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N 265 (986)
+.+.+|++.. -+|..+..|..|..||||+|++. ..|..+.. -+++-+|+|++|
T Consensus 83 v~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~-------------------------AKn~iVLNLS~N 136 (1255)
T KOG0444|consen 83 VIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEY-------------------------AKNSIVLNLSYN 136 (1255)
T ss_pred HhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhh-------------------------hcCcEEEEcccC
Confidence 8888888752 35666667777777777777776 44444332 355667777777
Q ss_pred eecccCCccccCCCCCcEEecccccccCCCchhhhhhhHhhhhhccCCCCCCCCCCcccccccccccccceeeccccccc
Q 046598 266 QLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFG 345 (986)
Q Consensus 266 ~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~l~~l~~L~~l~l~~n~l~~~~~~~l~~l~~l~~~~~L~~l~l~~n~~~ 345 (986)
+|..+...-|.+++.|-.||+|+|++..+||.+.++..|+++
T Consensus 137 ~IetIPn~lfinLtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL-------------------------------------- 178 (1255)
T KOG0444|consen 137 NIETIPNSLFINLTDLLFLDLSNNRLEMLPPQIRRLSMLQTL-------------------------------------- 178 (1255)
T ss_pred ccccCCchHHHhhHhHhhhccccchhhhcCHHHHHHhhhhhh--------------------------------------
Confidence 777444445667777777777777777666665555444333
Q ss_pred cCCCcccccccccceEEEccCCcccccCCccccCCCCCCEEEccCcccc-CcCCCcccCCCCCCEEEccCccceeecCcc
Q 046598 346 GSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLS-GTIPPAIGELQNLKDLRLQRNRFQGNIPPS 424 (986)
Q Consensus 346 ~~~p~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 424 (986)
.|++|.+.-.--..+..+++|+.|.+++.+=+ .-+|.++..+.+|..++||.|.+.
T Consensus 179 -----------------~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp------ 235 (1255)
T KOG0444|consen 179 -----------------KLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP------ 235 (1255)
T ss_pred -----------------hcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC------
Confidence 33333333222223445667777777765533 356666667776666666666665
Q ss_pred cccccccEEEecccccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccc
Q 046598 425 IGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLE 504 (986)
Q Consensus 425 ~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 504 (986)
.+|+.+.++.+|+.|+||+|+|+ .+... .+...+|+.|+||+|+++ .+|..++.|++|+
T Consensus 236 ------------------~vPecly~l~~LrrLNLS~N~it-eL~~~-~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~ 294 (1255)
T KOG0444|consen 236 ------------------IVPECLYKLRNLRRLNLSGNKIT-ELNMT-EGEWENLETLNLSRNQLT-VLPDAVCKLTKLT 294 (1255)
T ss_pred ------------------cchHHHhhhhhhheeccCcCcee-eeecc-HHHHhhhhhhccccchhc-cchHHHhhhHHHH
Confidence 89999999999999999999998 66554 566788999999999999 7999999999999
Q ss_pred hhhccCcccc-ccCcccccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCC
Q 046598 505 ILNVFGNKLK-GEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNN 583 (986)
Q Consensus 505 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N 583 (986)
.|++.+|+++ .-+|..++++.+|+.+..++|++. ..|..++.+.+|+.|.|+.|++- .+|+.+.-|+-|++|||.+|
T Consensus 295 kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreN 372 (1255)
T KOG0444|consen 295 KLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLREN 372 (1255)
T ss_pred HHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCC
Confidence 9999999998 348999999999999999999998 89999999999999999999998 69999999999999999999
Q ss_pred ccccccCCc
Q 046598 584 DLEGVVPTQ 592 (986)
Q Consensus 584 ~l~~~~p~~ 592 (986)
+=---+|..
T Consensus 373 pnLVMPPKP 381 (1255)
T KOG0444|consen 373 PNLVMPPKP 381 (1255)
T ss_pred cCccCCCCc
Confidence 876666665
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=320.93 Aligned_cols=242 Identities=27% Similarity=0.355 Sum_probs=193.1
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc---hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH---GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
.|.-.+.||.|+||.||-|++..+.+.||||.+.-... ....++.+|++.|.+++|||+|.+-|+ |-.+...
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgC-----yLre~Ta 101 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGC-----YLREHTA 101 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccce-----eeccchH
Confidence 46667889999999999999999999999999864333 345788999999999999999999998 4556778
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
|+||||| -|+-.+.+. ...+++.+.++..|+.+.+.||+|||+. +.||||||+.|||+++.|.|||+
T Consensus 102 WLVMEYC-lGSAsDlle---------VhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLa 168 (948)
T KOG0577|consen 102 WLVMEYC-LGSASDLLE---------VHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLA 168 (948)
T ss_pred HHHHHHH-hccHHHHHH---------HHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeec
Confidence 9999999 568888875 3346789999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccc---CCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGL---GSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 922 (986)
|||.|....+ ...++|||.|||||++. .++|+-|+||||+|++..|+.-.++|.-..... ..+...+...
T Consensus 169 DFGSAsi~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM-SALYHIAQNe 241 (948)
T KOG0577|consen 169 DFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNE 241 (948)
T ss_pred cccchhhcCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH-HHHHHHHhcC
Confidence 9999976532 23478999999999864 478999999999999999999999995321110 0111111111
Q ss_pred CCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCC
Q 046598 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTN 985 (986)
Q Consensus 923 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 985 (986)
.| .+. ..+-...+.+++..|++.-|.+|||.++
T Consensus 242 sP---------tLq---------------------s~eWS~~F~~Fvd~CLqKipqeRptse~ 274 (948)
T KOG0577|consen 242 SP---------TLQ---------------------SNEWSDYFRNFVDSCLQKIPQERPTSEE 274 (948)
T ss_pred CC---------CCC---------------------CchhHHHHHHHHHHHHhhCcccCCcHHH
Confidence 00 010 0123445678888999999999999765
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=309.63 Aligned_cols=249 Identities=23% Similarity=0.298 Sum_probs=197.3
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
+|++.+.||+|++|.||+|.+..+++.||+|.+.... ....+.+.+|++++++++|+|++++++.+. ..+...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence 5889999999999999999999888999999986432 234567889999999999999999988732 2345689
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+++++|.+++... ....+++.++..++.|++.|++|||+. +++||||||+||+++.++.++|+|
T Consensus 77 lv~e~~~~~~l~~~l~~~--------~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~d 145 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQ--------KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGD 145 (257)
T ss_pred EEecccCCCcHHHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEec
Confidence 999999999999999631 234589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCc
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDH 926 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 926 (986)
||++....... .......+++.|+|||+..+..++.++||||+|+++|+|++|+.||.... ...........
T Consensus 146 f~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~-----~~~~~~~~~~~- 217 (257)
T cd08223 146 LGIARVLENQC--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD-----MNSLVYRIIEG- 217 (257)
T ss_pred ccceEEecccC--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-----HHHHHHHHHhc-
Confidence 99998664322 12233557889999999999999999999999999999999999986321 11111110000
Q ss_pred hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 927 VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 927 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+ .. .....+.++.+++.+|++.+|++|||+.|+
T Consensus 218 -------~~-~~------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~ 251 (257)
T cd08223 218 -------KL-PP------------------MPKDYSPELGELIATMLSKRPEKRPSVKSI 251 (257)
T ss_pred -------CC-CC------------------CccccCHHHHHHHHHHhccCcccCCCHHHH
Confidence 00 00 001234567899999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=314.01 Aligned_cols=247 Identities=23% Similarity=0.305 Sum_probs=198.5
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
++|++.+.||.|+||.||+|++..+++.||+|++.... ......+.+|+++++.++|+||+++++++ .++...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSF-----LKGSKLW 75 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEE-----EECCeEE
Confidence 47889999999999999999999889999999987543 34456788999999999999999999984 4557899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+|+||+++++|.+++.. ..+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++|+|
T Consensus 76 ~v~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d 141 (274)
T cd06609 76 IIMEYCGGGSCLDLLKP-----------GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLAD 141 (274)
T ss_pred EEEEeeCCCcHHHHHhh-----------cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcc
Confidence 99999999999999852 1688999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCc
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDH 926 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 926 (986)
||.++...... .......++..|+|||++.+..++.++|||||||++|+|+||+.||...... ....
T Consensus 142 ~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-----~~~~------ 208 (274)
T cd06609 142 FGVSGQLTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-----RVLF------ 208 (274)
T ss_pred cccceeecccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-----HHHH------
Confidence 99998765332 1223345788999999999988999999999999999999999998632211 0000
Q ss_pred hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 927 VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 927 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+.........+ ...+.++.+++.+||..+|++|||+++|
T Consensus 209 ---~~~~~~~~~~~~-----------------~~~~~~~~~~l~~~l~~~p~~Rpt~~~i 248 (274)
T cd06609 209 ---LIPKNNPPSLEG-----------------NKFSKPFKDFVSLCLNKDPKERPSAKEL 248 (274)
T ss_pred ---HhhhcCCCCCcc-----------------cccCHHHHHHHHHHhhCChhhCcCHHHH
Confidence 000000000000 0034457789999999999999998764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=322.44 Aligned_cols=201 Identities=24% Similarity=0.311 Sum_probs=172.2
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
++|++.+.||+|+||+||+|++..+++.||+|++... .....+.+.+|+.+++.++|+||++++++ +..++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~-----~~~~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYA-----FQDENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEE-----EecCCe
Confidence 4799999999999999999999998999999998642 22334568899999999999999999998 456688
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.|+||||+++|+|.+++.. ....+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~e~~~g~~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl 143 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSK---------FEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRL 143 (331)
T ss_pred EEEEEecCCCCcHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEE
Confidence 9999999999999999952 224588999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCccccccccccccccccccccC-----CCcCcccchhhHHHHHHHHHhCCCCCC
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-----SEVSISGDVYSYGILLLELITRKKPTD 906 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~pf~ 906 (986)
+|||++........ .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.
T Consensus 144 ~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 209 (331)
T cd05597 144 ADFGSCLRLLADGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred EECCceeecCCCCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCC
Confidence 99999976543222 11223468999999999863 457889999999999999999999986
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=317.50 Aligned_cols=275 Identities=21% Similarity=0.277 Sum_probs=195.0
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
+|++.+.||+|+||.||+|++..+++.||+|+++... ......+.+|++++++++||||++++++ +.+....+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~-----~~~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV-----LHSDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHH-----hccCCceE
Confidence 5888999999999999999999889999999986432 2223567889999999999999999998 45667899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+|+||++ ++|.+++.. ....+++..++.++.||++||.|||+. +++||||||+||+++.++.+||+|
T Consensus 76 lv~e~~~-~~l~~~~~~---------~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d 142 (284)
T cd07839 76 LVFEYCD-QDLKKYFDS---------CNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLAD 142 (284)
T ss_pred EEEecCC-CCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECc
Confidence 9999996 588888752 224589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCC
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPD 925 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 925 (986)
||.++...... .......++..|+|||++.+. .++.++|||||||++|||+||..||.........+..........
T Consensus 143 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~ 220 (284)
T cd07839 143 FGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP 220 (284)
T ss_pred cchhhccCCCC--CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCC
Confidence 99997653221 112234578899999988764 478999999999999999999998642222111111111111000
Q ss_pred chhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 926 HVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 926 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.... .. .+...+... ............+.......++.+++.+|++.||++|||++|+
T Consensus 221 ~~~~-~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~i 278 (284)
T cd07839 221 TEES-WP-GVSKLPDYK-PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEA 278 (284)
T ss_pred ChHH-hH-Hhhhccccc-ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHH
Confidence 0000 00 000000000 0000000000011112245567799999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=309.62 Aligned_cols=242 Identities=24% Similarity=0.402 Sum_probs=186.7
Q ss_pred ccccccceeEEEEEEC--CCCeEEEEEEeeccCc-hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEEEEe
Q 046598 695 QIGEGSFGSVFKGILD--DGRTTIAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEF 771 (986)
Q Consensus 695 ~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~ 771 (986)
.||+|+||.||+|.+. ..+..||+|++..... ...+.+.+|+.++++++||||++++++|. ....++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~------~~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE------AEALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc------CCCeEEEEEe
Confidence 4899999999999875 4456799999875432 23467899999999999999999999852 2467999999
Q ss_pred ccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcccccce
Q 046598 772 MHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLAR 851 (986)
Q Consensus 772 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~ 851 (986)
+++++|.+++.. ....+++.++++++.|++.|++|||++ +++||||||+||+++.++.+||+|||.++
T Consensus 76 ~~~~~L~~~l~~---------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~ 143 (257)
T cd05115 76 ASGGPLNKFLSG---------KKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSK 143 (257)
T ss_pred CCCCCHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccc
Confidence 999999999852 234689999999999999999999999 99999999999999999999999999997
Q ss_pred ecCCCCCc-cccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCchhH
Q 046598 852 FLPLSSAQ-TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALPDHVMD 929 (986)
Q Consensus 852 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 929 (986)
........ .......++..|+|||++.+..++.++|||||||++||+++ |+.||...... .. ..
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----~~---------~~ 209 (257)
T cd05115 144 ALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-----EV---------MS 209 (257)
T ss_pred cccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-----HH---------HH
Confidence 55332221 11122234578999999988889999999999999999996 99998633211 11 01
Q ss_pred HhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 930 IVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 930 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+....... .+..++.++.+++.+||..+|++||++.+|
T Consensus 210 ~~~~~~~~~------------------~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i 248 (257)
T cd05115 210 FIEQGKRLD------------------CPAECPPEMYALMKDCWIYKWEDRPNFAKV 248 (257)
T ss_pred HHHCCCCCC------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 111100000 001234567899999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=311.03 Aligned_cols=248 Identities=29% Similarity=0.498 Sum_probs=193.4
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
.++|++.++||+|+||.||+|.+.. +..||+|.++.... ..+.+.+|+.++++++|++++++++++ . ....+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~-----~-~~~~~ 76 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVV-----S-EEPIY 76 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecC-CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEE-----C-CCCcE
Confidence 4579999999999999999998875 56799999875433 346789999999999999999999874 2 24578
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+++++|.++++.. ....+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|
T Consensus 77 lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~d 145 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDG--------EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIAD 145 (260)
T ss_pred EEEEecCCCcHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCC
Confidence 999999999999999631 224589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCC
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALPD 925 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 925 (986)
||.+........ .......++..|+|||+..+..++.++||||||+++|||++ |..||..... .....
T Consensus 146 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-----~~~~~----- 214 (260)
T cd05070 146 FGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-----REVLE----- 214 (260)
T ss_pred ceeeeeccCccc-ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH-----HHHHH-----
Confidence 999986543221 11122335678999999988899999999999999999999 8999863211 11111
Q ss_pred chhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 926 HVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 926 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+.... .. +.+...+.++.+++.+|++.+|++|||++++
T Consensus 215 ----~~~~~~---~~---------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l 253 (260)
T cd05070 215 ----QVERGY---RM---------------PCPQDCPISLHELMLQCWKKDPEERPTFEYL 253 (260)
T ss_pred ----HHHcCC---CC---------------CCCCcCCHHHHHHHHHHcccCcccCcCHHHH
Confidence 011000 00 0011234568899999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=316.10 Aligned_cols=201 Identities=27% Similarity=0.423 Sum_probs=169.5
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
+|++.+.||+|++|.||+|++..+++.||+|+++... ....+.+.+|+.++++++||||+++++++ ..+...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVL-----MQESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEE-----eeCCeEE
Confidence 4888999999999999999999889999999986432 22346788999999999999999999994 4567899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||++ ++|.+++.... ....+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|
T Consensus 76 ~v~e~~~-~~l~~~~~~~~-------~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d 144 (285)
T cd07861 76 LIFEFLS-MDLKKYLDSLP-------KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLAD 144 (285)
T ss_pred EEEecCC-CCHHHHHhcCC-------CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECc
Confidence 9999996 68988885322 124689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
||++....... .......+++.|+|||++.+. .++.++|||||||++|+|+||+.||..
T Consensus 145 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~ 204 (285)
T cd07861 145 FGLARAFGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHG 204 (285)
T ss_pred ccceeecCCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 99997653221 112234568899999987664 578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=320.26 Aligned_cols=260 Identities=24% Similarity=0.377 Sum_probs=195.7
Q ss_pred hcCCCCCcccccccceeEEEEEEC-------CCCeEEEEEEeeccC-chhHHHHHHHHHHHhcC-CCCcceeeeeecccc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILD-------DGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKILTACSGV 757 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 757 (986)
.++|.+.+.||+|+||.||+|.+. .....||+|+++... ......+.+|+++++++ +||||++++++|
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~--- 87 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC--- 87 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE---
Confidence 367899999999999999999863 234579999987432 23456788999999999 699999999985
Q ss_pred ccCCCceEEEEEEeccCCCHhHhhccCCCCC------ccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCC
Q 046598 758 DYQGNDFKALVFEFMHNRSLEEWLHPITRED------ETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKP 831 (986)
Q Consensus 758 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 831 (986)
..+...++||||+++|+|.+++....... ........+++.++..++.|++.||+|||++ |++||||||
T Consensus 88 --~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp 162 (314)
T cd05099 88 --TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAA 162 (314)
T ss_pred --ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeeccccc
Confidence 34567899999999999999996532110 0112234689999999999999999999999 999999999
Q ss_pred CCeEecCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCcccc
Q 046598 832 SNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFE 910 (986)
Q Consensus 832 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~ 910 (986)
+||+++.++.+||+|||.++...............++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~- 241 (314)
T cd05099 163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP- 241 (314)
T ss_pred eeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC-
Confidence 999999999999999999986543222221222234568999999999899999999999999999999 888885321
Q ss_pred ccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 911 GDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
....... +.. .... .....++.++.+++.+||+.+|++|||+.||
T Consensus 242 ----~~~~~~~---------~~~---~~~~---------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l 286 (314)
T cd05099 242 ----VEELFKL---------LRE---GHRM---------------DKPSNCTHELYMLMRECWHAVPTQRPTFKQL 286 (314)
T ss_pred ----HHHHHHH---------HHc---CCCC---------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 1111110 000 0000 0001234467789999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=317.49 Aligned_cols=203 Identities=27% Similarity=0.439 Sum_probs=169.1
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
++++|.+.+.||+|+||.||+|.+..+++.||+|+++... ......+.+|+.+++.++|+||+++++++ ..++.
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~~ 77 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII-----HTKET 77 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEE-----ecCCe
Confidence 4578999999999999999999998889999999986432 22334678899999999999999999984 45678
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.++||||+. +++.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 78 ~~lv~e~~~-~~l~~~~~~---------~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l 144 (291)
T cd07870 78 LTFVFEYMH-TDLAQYMIQ---------HPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKL 144 (291)
T ss_pred EEEEEeccc-CCHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEE
Confidence 999999995 678777642 123477888999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCccccccccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCcc
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDIM 908 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~ 908 (986)
+|||+++....... ......++..|+|||++.+. .++.++|||||||++|||++|+.||+..
T Consensus 145 ~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~ 207 (291)
T cd07870 145 ADFGLARAKSIPSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV 207 (291)
T ss_pred eccccccccCCCCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 99999975432211 12234578899999998764 5788999999999999999999999743
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=320.54 Aligned_cols=260 Identities=24% Similarity=0.385 Sum_probs=196.2
Q ss_pred hcCCCCCcccccccceeEEEEEECC-------CCeEEEEEEeeccC-chhHHHHHHHHHHHhcC-CCCcceeeeeecccc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDD-------GRTTIAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKILTACSGV 757 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 757 (986)
.++|.+.+.||+|+||.||+|.+.. ....||+|+++... .....++.+|+++++.+ +||||++++++|
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~--- 93 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC--- 93 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE---
Confidence 3679999999999999999998743 23569999987532 33456788899999999 799999999985
Q ss_pred ccCCCceEEEEEEeccCCCHhHhhccCCCCCc------cccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCC
Q 046598 758 DYQGNDFKALVFEFMHNRSLEEWLHPITREDE------TDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKP 831 (986)
Q Consensus 758 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 831 (986)
..++..++||||+++|+|.+++........ .......+++.+++.++.|++.||+|||+. +++||||||
T Consensus 94 --~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp 168 (307)
T cd05098 94 --TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAA 168 (307)
T ss_pred --ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccH
Confidence 445678999999999999999975332100 011234689999999999999999999999 999999999
Q ss_pred CCeEecCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCcccc
Q 046598 832 SNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFE 910 (986)
Q Consensus 832 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~ 910 (986)
+||+++.++.+||+|||.++...............++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~-- 246 (307)
T cd05098 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-- 246 (307)
T ss_pred HheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC--
Confidence 999999999999999999976532221111222234568999999999899999999999999999998 88887522
Q ss_pred ccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 911 GDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
....... .+..... ...+..++.++.+++.+||+.+|++|||+.||
T Consensus 247 ---~~~~~~~---------~~~~~~~------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ev 292 (307)
T cd05098 247 ---PVEELFK---------LLKEGHR------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 292 (307)
T ss_pred ---CHHHHHH---------HHHcCCC------------------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 1111111 1110000 00011234567889999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=310.19 Aligned_cols=241 Identities=23% Similarity=0.378 Sum_probs=187.1
Q ss_pred ccccccceeEEEEEE--CCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEEEE
Q 046598 695 QIGEGSFGSVFKGIL--DDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFE 770 (986)
Q Consensus 695 ~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 770 (986)
.||+|+||.||+|.+ ..++..||+|+++... ....+++.+|+.+++.++||||+++++++. .+..++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE------AESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc------CCCcEEEEe
Confidence 689999999999975 3457889999986433 233567899999999999999999999852 345789999
Q ss_pred eccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcccccc
Q 046598 771 FMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLA 850 (986)
Q Consensus 771 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a 850 (986)
|+++++|.+++.. ...+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||.+
T Consensus 76 ~~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~ 142 (257)
T cd05116 76 LAELGPLNKFLQK----------NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLS 142 (257)
T ss_pred cCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccc
Confidence 9999999999842 23588999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCcc-ccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCchh
Q 046598 851 RFLPLSSAQT-SSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALPDHVM 928 (986)
Q Consensus 851 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 928 (986)
+......... ......++..|+|||.+....++.++|||||||++|||++ |+.||...... .....
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~---------- 210 (257)
T cd05116 143 KALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVTQM---------- 210 (257)
T ss_pred cccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH----------
Confidence 8664332211 1122334678999999988889999999999999999998 99998632211 11111
Q ss_pred HHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 929 DIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 929 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
++...... .+..++.++.+++.+||+.||++||++++|
T Consensus 211 --i~~~~~~~------------------~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i 248 (257)
T cd05116 211 --IESGERME------------------CPQRCPPEMYDLMKLCWTYGVDERPGFAVV 248 (257)
T ss_pred --HHCCCCCC------------------CCCCCCHHHHHHHHHHhccCchhCcCHHHH
Confidence 11100000 001234567899999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=310.45 Aligned_cols=252 Identities=28% Similarity=0.449 Sum_probs=197.5
Q ss_pred cccccccceeEEEEEECCC---CeEEEEEEeeccCchh-HHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEEE
Q 046598 694 NQIGEGSFGSVFKGILDDG---RTTIAVKVFNLLHHGA-FKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVF 769 (986)
Q Consensus 694 ~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 769 (986)
+.||+|+||.||+|.+... +..||+|+++...... .+.+.+|+++++.++|+||+++++++ ..+...++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVC-----TEEEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeee-----cCCCceEEEE
Confidence 4699999999999999865 8899999997644333 67889999999999999999999984 3467899999
Q ss_pred EeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccccc
Q 046598 770 EFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGL 849 (986)
Q Consensus 770 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~ 849 (986)
||+++++|.++++...... .......+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.
T Consensus 76 e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~ 151 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVF-PSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGL 151 (262)
T ss_pred EeccCCcHHHHHhhccccc-cccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccc
Confidence 9999999999996431100 001135789999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCchh
Q 046598 850 ARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALPDHVM 928 (986)
Q Consensus 850 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 928 (986)
+................++..|+|||.+.+..++.++||||+||++|||++ |..||..... ......
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~------- 219 (262)
T cd00192 152 SRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-----EEVLEY------- 219 (262)
T ss_pred ccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH-------
Confidence 987654332233334557889999999988899999999999999999999 6999864311 111110
Q ss_pred HHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 929 DIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 929 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..+ .. +......++.++.+++.+||+.+|++|||++|+
T Consensus 220 -~~~----~~---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l 257 (262)
T cd00192 220 -LRK----GY---------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSEL 257 (262)
T ss_pred -HHc----CC---------------CCCCCccCChHHHHHHHHHccCCcccCcCHHHH
Confidence 000 00 000111235568899999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=312.72 Aligned_cols=201 Identities=24% Similarity=0.360 Sum_probs=161.8
Q ss_pred cccccccceeEEEEEECC--CCeEEEEEEeeccCc-hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEEEE
Q 046598 694 NQIGEGSFGSVFKGILDD--GRTTIAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFE 770 (986)
Q Consensus 694 ~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 770 (986)
+.||+|+||.||+|.+.. ++..+|+|.++.... .....+.+|+.++++++||||+++++++ .+....++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQC-----TEVTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----cCCCCcEEEEE
Confidence 468999999999998753 346799998865432 3345788999999999999999999985 34467899999
Q ss_pred eccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcccccc
Q 046598 771 FMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLA 850 (986)
Q Consensus 771 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a 850 (986)
|+++|+|.+++..... ......++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||.+
T Consensus 76 ~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~ 147 (269)
T cd05087 76 FCPLGDLKGYLRSCRK-----AELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLS 147 (269)
T ss_pred CCCCCcHHHHHHHhhh-----cccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCcccc
Confidence 9999999999964321 1123467788889999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCccccccccccccccccccccCC-------CcCcccchhhHHHHHHHHHh-CCCCCCc
Q 046598 851 RFLPLSSAQTSSIGAKGSIGYIAPEYGLGS-------EVSISGDVYSYGILLLELIT-RKKPTDI 907 (986)
Q Consensus 851 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDvwSlGvvl~ellt-g~~pf~~ 907 (986)
+...............++..|+|||++.+. .++.++|||||||++|||++ |+.||..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~ 212 (269)
T cd05087 148 HNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH 212 (269)
T ss_pred ccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence 754332222222334577889999987642 35789999999999999996 9999964
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=315.93 Aligned_cols=266 Identities=24% Similarity=0.383 Sum_probs=195.9
Q ss_pred cCCCCCcccccccceeEEEEEE----CCCCeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 688 DRFSSVNQIGEGSFGSVFKGIL----DDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
.-|++++.||+|+||.||+|.. ..++..||+|.++... ....+.+.+|++++++++||||+++++++.. .++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~ 80 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DGG 80 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEec---CCC
Confidence 3478899999999999999985 3457889999986443 3345678999999999999999999998632 224
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
...++||||+++++|.+++.. ....+++.++..++.|++.||+|||++ |++||||||+||+++.++.+
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~---------~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~ 148 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPR---------NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQV 148 (284)
T ss_pred CceEEEEEccCCCCHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCE
Confidence 668999999999999999852 123589999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCc-cccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHh
Q 046598 843 HIGDFGLARFLPLSSAQ-TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLART 921 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~ 921 (986)
||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||+|++.|+...... .......
T Consensus 149 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~---~~~~~~~ 225 (284)
T cd05079 149 KIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTL---FLKMIGP 225 (284)
T ss_pred EECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccch---hhhhccc
Confidence 99999999866432221 1122345677899999998889999999999999999999988765321110 0000000
Q ss_pred hCCCc-hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 922 ALPDH-VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 922 ~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
...+. ....+....... +.+....++.++.+++.+||+.+|++|||++||
T Consensus 226 ~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i 276 (284)
T cd05079 226 THGQMTVTRLVRVLEEGK---------------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNL 276 (284)
T ss_pred ccccccHHHHHHHHHcCc---------------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHH
Confidence 00000 011110000000 001111245678899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=307.92 Aligned_cols=248 Identities=20% Similarity=0.275 Sum_probs=202.6
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc--hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
..+=|...+.||+|.|+.|-+|++--+|.+||||++.+..- .....+.+|++-|+-++|||||++|++ .+.+.
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEV-----iDTQT 90 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEV-----IDTQT 90 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeeh-----hcccc
Confidence 34568899999999999999999999999999999975433 334578999999999999999999998 67778
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEec-CCCcE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLD-EDMIA 842 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~ 842 (986)
..|+|+|.-.+|+|.+|+-.. ...+.+..+.+++.||+.|+.|+|+. .+|||||||+||.+- .-|-+
T Consensus 91 KlyLiLELGD~GDl~DyImKH---------e~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlV 158 (864)
T KOG4717|consen 91 KLYLILELGDGGDLFDYIMKH---------EEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLV 158 (864)
T ss_pred eEEEEEEecCCchHHHHHHhh---------hccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCce
Confidence 999999999999999999633 34589999999999999999999999 999999999998775 55799
Q ss_pred EEcccccceecCCCCCccccccccccccccccccccCCCcC-cccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHh
Q 046598 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVS-ISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLART 921 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~ 921 (986)
||.|||++-.+.+.. .....+|+..|-|||++.|..|+ +++||||+|||+|.+++|++||+...+.+.
T Consensus 159 KLTDFGFSNkf~PG~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET-------- 227 (864)
T KOG4717|consen 159 KLTDFGFSNKFQPGK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET-------- 227 (864)
T ss_pred EeeeccccccCCCcc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh--------
Confidence 999999997664433 33457899999999999999887 678999999999999999999985544321
Q ss_pred hCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 922 ALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 922 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+.-++|-. +..+.....++.++|..|+..||.+|.+.+||
T Consensus 228 -----LTmImDCK--------------------YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI 267 (864)
T KOG4717|consen 228 -----LTMIMDCK--------------------YTVPSHVSKECRDLIQSMLVRDPKKRASLEEI 267 (864)
T ss_pred -----hhhhhccc--------------------ccCchhhhHHHHHHHHHHHhcCchhhccHHHH
Confidence 11111110 11122345567789999999999999987764
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=318.88 Aligned_cols=257 Identities=25% Similarity=0.392 Sum_probs=193.0
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCe--EEEEEEeecc-CchhHHHHHHHHHHHhcC-CCCcceeeeeeccccccCCC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRT--TIAVKVFNLL-HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~ 762 (986)
.++|++.+.||+|+||.||+|.+..++. .+|+|.++.. .....+.+.+|++++.++ +||||+++++++ ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~-----~~~ 80 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHR 80 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE-----CCC
Confidence 3568899999999999999999876654 4577766532 233456788999999999 899999999984 455
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCcc------ccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEe
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDET------DEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILL 836 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 836 (986)
+..++||||+++++|.++++........ ......+++.+++.++.|++.|++|||+. |++||||||+||++
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili 157 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILV 157 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEe
Confidence 7899999999999999999644321110 12234689999999999999999999999 99999999999999
Q ss_pred cCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccH
Q 046598 837 DEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNL 915 (986)
Q Consensus 837 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~ 915 (986)
++++.+||+|||+++.... ........++..|+|||++.+..++.++|||||||++|||+| |..||.....
T Consensus 158 ~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----- 229 (303)
T cd05088 158 GENYVAKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC----- 229 (303)
T ss_pred cCCCcEEeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh-----
Confidence 9999999999999864211 111112234678999999988889999999999999999998 9999853211
Q ss_pred HHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 916 HNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 916 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
....... +. .... ......+.++.+++.+||+.+|++||+++++
T Consensus 230 ~~~~~~~-~~--------~~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 273 (303)
T cd05088 230 AELYEKL-PQ--------GYRL------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQI 273 (303)
T ss_pred HHHHHHH-hc--------CCcC------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 1111100 00 0000 0001123457799999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=317.74 Aligned_cols=275 Identities=23% Similarity=0.327 Sum_probs=198.3
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc--hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+++++.++||||++++++ +..+...
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-----~~~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV-----FRRKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHh-----cccCCeE
Confidence 468899999999999999999998899999998754322 234678899999999999999999998 4556789
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
++||||+++++|.++... ...+++.++..++.||+.|++|||+. +++||||+|+||++++++.+||+
T Consensus 76 ~lv~e~~~~~~l~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~ 142 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKY----------PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLC 142 (286)
T ss_pred EEEEecCCccHHHHHHhc----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEE
Confidence 999999999999887641 23488999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHH--hh
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLAR--TA 922 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~--~~ 922 (986)
|||++....... .......++..|+|||++.+ ..++.++|||||||++|||++|++||...... ........ ..
T Consensus 143 dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~-~~~~~~~~~~~~ 219 (286)
T cd07846 143 DFGFARTLAAPG--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI-DQLYHIIKCLGN 219 (286)
T ss_pred eeeeeeeccCCc--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH-HHHHHHHHHhCC
Confidence 999998654322 22223457889999998875 45788999999999999999999998632211 01111110 00
Q ss_pred CCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 923 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.........+..-...... .................+..+.+++.+||+.+|++||+++||
T Consensus 220 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~i 280 (286)
T cd07846 220 LIPRHQEIFQKNPLFAGMR---LPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQL 280 (286)
T ss_pred CchhhHHHhccchHhhccc---cccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHH
Confidence 1111111111000000000 000000000111112345678899999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=322.09 Aligned_cols=201 Identities=24% Similarity=0.319 Sum_probs=172.7
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
++|++.+.||+|+||+||++++..+++.||+|++... .......+.+|..++..++|++|++++++ +.+++.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~-----~~~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYA-----FQDENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEE-----EEcCCE
Confidence 4799999999999999999999998999999998642 22334567889999999999999999998 456688
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.|+||||+++|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~---------~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl 143 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKF---------EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRL 143 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEE
Confidence 99999999999999999621 23588999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCccccccccccccccccccccC-----CCcCcccchhhHHHHHHHHHhCCCCCC
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-----SEVSISGDVYSYGILLLELITRKKPTD 906 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~pf~ 906 (986)
+|||+++........ ......|++.|+|||++.+ +.++.++|||||||++|||++|+.||.
T Consensus 144 ~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~ 209 (331)
T cd05624 144 ADFGSCLKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred EeccceeeccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCcc
Confidence 999999866432221 1223568999999999875 467899999999999999999999996
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=312.65 Aligned_cols=251 Identities=22% Similarity=0.397 Sum_probs=194.3
Q ss_pred hcCCCCCcccccccceeEEEEEECCC---CeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDG---RTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
.++|++.+.||+|+||.||+|.+..+ ...||+|.++... ....+.+.+|+.++++++||||+++++++ ..+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 77 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKS 77 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence 35788999999999999999998533 3479999886432 23456789999999999999999999984 455
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
+..++||||+++++|.+++.. ....+++.++..++.|++.|++|||+. +++||||||+||+++.++.+
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 145 (267)
T cd05066 78 KPVMIVTEYMENGSLDAFLRK---------HDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVC 145 (267)
T ss_pred CccEEEEEcCCCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeE
Confidence 788999999999999999962 224589999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCcc-ccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHH
Q 046598 843 HIGDFGLARFLPLSSAQT-SSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLAR 920 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~ 920 (986)
||+|||.+..+....... ......++..|+|||++.+..++.++|||||||++||+++ |+.||...... .......
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~ 223 (267)
T cd05066 146 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DVIKAIE 223 (267)
T ss_pred EeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HHHHHHh
Confidence 999999998764322211 1112223568999999998899999999999999999887 99998632211 0001000
Q ss_pred hhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 921 TALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 921 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.. .. .+....++..+.+++.+|++.+|++||++.+|
T Consensus 224 ~~------------~~------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 259 (267)
T cd05066 224 EG------------YR------------------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQI 259 (267)
T ss_pred CC------------Cc------------------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHH
Confidence 00 00 00001234567899999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=314.92 Aligned_cols=264 Identities=22% Similarity=0.257 Sum_probs=203.6
Q ss_pred cChHHHHHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcC-CCCcceeeeeeccc
Q 046598 678 ISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSG 756 (986)
Q Consensus 678 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 756 (986)
.+..++....+.|++.+.||+|+||.||+|++..+++.||+|++.... ....++..|+.+++++ +||||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 456666677899999999999999999999999889999999986543 3346688899999998 79999999998643
Q ss_pred cc-cCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeE
Q 046598 757 VD-YQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNIL 835 (986)
Q Consensus 757 ~~-~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIl 835 (986)
.. ...+...++||||+++|+|.+++.... ...+++..+..++.|++.|++|||+. +|+||||+|+||+
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nil 153 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTK--------GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVL 153 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHcc--------CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEE
Confidence 21 123568899999999999999986322 23578888999999999999999999 9999999999999
Q ss_pred ecCCCcEEEcccccceecCCCCCcccccccccccccccccccc-----CCCcCcccchhhHHHHHHHHHhCCCCCCcccc
Q 046598 836 LDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGL-----GSEVSISGDVYSYGILLLELITRKKPTDIMFE 910 (986)
Q Consensus 836 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~ 910 (986)
+++++.++|+|||.+....... .......++..|+|||.+. +..++.++|||||||++|||++|+.||.....
T Consensus 154 i~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~ 231 (282)
T cd06636 154 LTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP 231 (282)
T ss_pred ECCCCCEEEeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH
Confidence 9999999999999987543221 1122356889999999875 34688899999999999999999999863211
Q ss_pred ccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 911 GDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
. .... .. .... +.. .....++.++.+++.+||+.||.+|||+.||
T Consensus 232 ~----~~~~---------~~-~~~~---~~~--------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~el 276 (282)
T cd06636 232 M----RALF---------LI-PRNP---PPK--------------LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQL 276 (282)
T ss_pred H----hhhh---------hH-hhCC---CCC--------------CcccccCHHHHHHHHHHhCCChhhCcCHHHH
Confidence 1 0000 00 0000 000 0001234568899999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=307.53 Aligned_cols=248 Identities=20% Similarity=0.299 Sum_probs=199.4
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeecc--CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
+|++.+.||+|+||.||.++...+++.|++|.+... .....+++.+|++++++++|+||+++++++ .+.+..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHF-----MDDNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEE-----ecCCeEE
Confidence 588999999999999999999988999999998643 234456788999999999999999999994 4567899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+++++|.+++... ....+++.++..++.|++.|++|||+. +++||||+|+||++++++.+||+|
T Consensus 76 ~~~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d 144 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQ--------KGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGD 144 (256)
T ss_pred EEEEecCCCcHHHHHHhc--------cccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECc
Confidence 999999999999999622 134689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCc
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDH 926 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 926 (986)
||.+........ ......+++.|+|||+..+..++.++||||||+++|||++|+.||..... .....
T Consensus 145 ~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----~~~~~------ 211 (256)
T cd08221 145 FGISKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-----LNLVV------ 211 (256)
T ss_pred CcceEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-----HHHHH------
Confidence 999986643321 22335688999999999888899999999999999999999999863211 11111
Q ss_pred hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 927 VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 927 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+. ...... .....+.++.+++.+||+.+|++||+++|+
T Consensus 212 --~~~----~~~~~~---------------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~l 250 (256)
T cd08221 212 --KIV----QGNYTP---------------VVSVYSSELISLVHSLLQQDPEKRPTADEV 250 (256)
T ss_pred --HHH----cCCCCC---------------CccccCHHHHHHHHHHcccCcccCCCHHHH
Confidence 000 000000 001234567899999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=311.18 Aligned_cols=246 Identities=23% Similarity=0.328 Sum_probs=197.9
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
..|+..+.||+|+||.||+|.+..++..||+|+++... ....+.+.+|+.++++++||||+++++++ .++...+
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 78 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKGTKLW 78 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECCEEE
Confidence 45788899999999999999998889999999987533 34457789999999999999999999984 4567899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+++++|.+++.. ..+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.++++|
T Consensus 79 lv~e~~~~~~L~~~i~~-----------~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~d 144 (277)
T cd06640 79 IIMEYLGGGSALDLLRA-----------GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLAD 144 (277)
T ss_pred EEEecCCCCcHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcc
Confidence 99999999999999851 2478889999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCc
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDH 926 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 926 (986)
||.+....... .......++..|+|||++.+..++.++|||||||++|||++|+.||....... ..
T Consensus 145 fg~~~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-----~~------- 210 (277)
T cd06640 145 FGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR-----VL------- 210 (277)
T ss_pred cccceeccCCc--cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh-----Hh-------
Confidence 99997654322 11223457889999999988889999999999999999999999986322110 00
Q ss_pred hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 927 VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 927 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..+.. ..+. ......+..+.+++.+||+.+|++||+++||
T Consensus 211 --~~~~~---~~~~---------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 250 (277)
T cd06640 211 --FLIPK---NNPP---------------TLTGEFSKPFKEFIDACLNKDPSFRPTAKEL 250 (277)
T ss_pred --hhhhc---CCCC---------------CCchhhhHHHHHHHHHHcccCcccCcCHHHH
Confidence 00000 0000 0111345667899999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=310.89 Aligned_cols=248 Identities=24% Similarity=0.334 Sum_probs=194.9
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCch---------hHHHHHHHHHHHhcCCCCcceeeeeecccccc
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHG---------AFKSFIAECNTLKNIRHRNLVKILTACSGVDY 759 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 759 (986)
+|.+.+.||+|++|.||+|.+..+++.||+|++...... ..+.+.+|+.++++++||||+++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~----- 75 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSS----- 75 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----
Confidence 578889999999999999999888899999988643221 235688999999999999999999984
Q ss_pred CCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCC
Q 046598 760 QGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED 839 (986)
Q Consensus 760 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 839 (986)
...+..++||||+++++|.+++.. .+.+++..+..++.|++.|++|||+. +++||||+|+||+++.+
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~l~~----------~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~ 142 (267)
T cd06628 76 LDADHLNIFLEYVPGGSVAALLNN----------YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNK 142 (267)
T ss_pred EeCCccEEEEEecCCCCHHHHHHh----------ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCC
Confidence 445788999999999999999952 23578889999999999999999999 99999999999999999
Q ss_pred CcEEEcccccceecCCCCC----ccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccH
Q 046598 840 MIAHIGDFGLARFLPLSSA----QTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNL 915 (986)
Q Consensus 840 ~~~kL~DFG~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~ 915 (986)
+.+||+|||.++....... ........++..|+|||.+.+..++.++||||+||++|+|++|+.||..... .
T Consensus 143 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~ 218 (267)
T cd06628 143 GGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ----L 218 (267)
T ss_pred CCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH----H
Confidence 9999999999986642211 1111224578899999999998999999999999999999999999963211 1
Q ss_pred HHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 916 HNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 916 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.... ....... + ..+...+..+.+++.+||+.||++||++.||
T Consensus 219 ~~~~---------~~~~~~~---~----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 261 (267)
T cd06628 219 QAIF---------KIGENAS---P----------------EIPSNISSEAIDFLEKTFEIDHNKRPTAAEL 261 (267)
T ss_pred HHHH---------HHhccCC---C----------------cCCcccCHHHHHHHHHHccCCchhCcCHHHH
Confidence 1100 0000000 0 0001234567789999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=314.88 Aligned_cols=267 Identities=26% Similarity=0.377 Sum_probs=199.4
Q ss_pred cCCCCCcccccccceeEEEEEECC----CCeEEEEEEeeccCch-hHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDD----GRTTIAVKVFNLLHHG-AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
+.|++.+.||+|+||.||+|.+.. ++..||||+++..... ..+.+.+|+++++.++||||+++++++.. ..+
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CCC
Confidence 467888999999999999999753 3788999999765443 46789999999999999999999998532 235
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
...++||||+++++|.+++... ...+++.++..++.|++.||+|||+. +++||||||+||+++.++.+
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~---------~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~ 148 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRH---------RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLV 148 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhC---------ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCE
Confidence 6789999999999999999622 23589999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCc-cccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHh
Q 046598 843 HIGDFGLARFLPLSSAQ-TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLART 921 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~ 921 (986)
||+|||.+......... .......++..|+|||...+..++.++||||||+++|||++|+.||......... +...
T Consensus 149 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~~ 225 (284)
T cd05038 149 KISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR---MIGI 225 (284)
T ss_pred EEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc---cccc
Confidence 99999999876422221 1111233566799999998889999999999999999999999997532221110 0000
Q ss_pred hCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 922 ALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 922 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.........+...+.... +......++.++.+++.+||+.+|++||||.||
T Consensus 226 ~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei 276 (284)
T cd05038 226 AQGQMIVTRLLELLKEGE--------------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADL 276 (284)
T ss_pred ccccccHHHHHHHHHcCC--------------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHH
Confidence 000000111111110000 011112345678899999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=315.19 Aligned_cols=201 Identities=27% Similarity=0.430 Sum_probs=168.9
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc-hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
.++|++.+.||+|++|.||+|.++.+++.||+|.+..... .....+.+|++++++++||||++++++ +..+...
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~-----~~~~~~~ 78 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI-----IHTKKTL 78 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEE-----EecCCeE
Confidence 4679999999999999999999998889999999864322 223456789999999999999999998 4556789
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
++||||++ ++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+
T Consensus 79 ~lv~e~~~-~~L~~~~~~~---------~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~ 145 (291)
T cd07844 79 TLVFEYLD-TDLKQYMDDC---------GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLA 145 (291)
T ss_pred EEEEecCC-CCHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEEC
Confidence 99999997 4999988522 23578999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
|||.++....... ......++..|+|||++.+ ..++.++||||+||++|+|++|+.||..
T Consensus 146 dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~ 206 (291)
T cd07844 146 DFGLARAKSVPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPG 206 (291)
T ss_pred ccccccccCCCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999875432111 1122346788999998876 4588999999999999999999999964
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=309.51 Aligned_cols=248 Identities=27% Similarity=0.440 Sum_probs=194.5
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
.++|++.++||+|+||.||+|...+ ++.||+|.+.... ...+++.+|+.++++++||||+++++++ ..+..+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~------~~~~~~ 76 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVV------TQEPIY 76 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCC-CceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEE------ccCCcE
Confidence 4578999999999999999999765 6789999987543 3346789999999999999999999873 235689
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+++++|.+++... ....+++.++..++.|++.||+|||+. +++||||||+||+++.++.++|+|
T Consensus 77 ~v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~d 145 (260)
T cd05067 77 IITEYMENGSLVDFLKTP--------EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIAD 145 (260)
T ss_pred EEEEcCCCCCHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEcc
Confidence 999999999999998522 234688999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCC
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALPD 925 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 925 (986)
||.+........ .......++..|+|||++.+..++.++||||||+++||+++ |+.||...... ....
T Consensus 146 fg~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----~~~~----- 214 (260)
T cd05067 146 FGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP-----EVIQ----- 214 (260)
T ss_pred CcceeecCCCCc-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH-----HHHH-----
Confidence 999976542221 11223345778999999998899999999999999999999 99998632211 1100
Q ss_pred chhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 926 HVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 926 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+...... +.....+.++.+++.+|++.+|++|||++++
T Consensus 215 ----~~~~~~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l 253 (260)
T cd05067 215 ----NLERGYRM------------------PRPDNCPEELYELMRLCWKEKPEERPTFEYL 253 (260)
T ss_pred ----HHHcCCCC------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 00000000 0001223468899999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=309.53 Aligned_cols=204 Identities=24% Similarity=0.338 Sum_probs=171.7
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC-----chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-----HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
.+|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++.. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD---RAE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc---CCC
Confidence 46899999999999999999999889999999886422 1234568899999999999999999998532 234
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
...+++|||+++++|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~----------~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~ 145 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKA----------YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNV 145 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCE
Confidence 678999999999999999852 23478889999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCC-ccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 843 HIGDFGLARFLPLSSA-QTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
||+|||+++....... ........++..|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~ 211 (266)
T cd06651 146 KLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE 211 (266)
T ss_pred EEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccc
Confidence 9999999976532111 1111234578899999999998999999999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=321.04 Aligned_cols=200 Identities=20% Similarity=0.181 Sum_probs=164.9
Q ss_pred CCcccccc--cceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEE
Q 046598 692 SVNQIGEG--SFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 767 (986)
Q Consensus 692 ~~~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 767 (986)
++++||+| +|++||++.+..+++.||+|+++... ....+.+.+|+++++.++||||++++++| ..++..++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~-----~~~~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATF-----IADNELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----EECCEEEE
Confidence 46789999 67899999999999999999987532 23345677899999999999999999984 45578999
Q ss_pred EEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccc
Q 046598 768 VFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDF 847 (986)
Q Consensus 768 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DF 847 (986)
||||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++++||
T Consensus 77 v~e~~~~~~l~~~~~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~ 145 (327)
T cd08227 77 VTSFMAYGSAKDLICTHF--------MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGL 145 (327)
T ss_pred EEeccCCCcHHHHHHhhc--------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEccc
Confidence 999999999999985321 23488999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCc-----cccccccccccccccccccC--CCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 848 GLARFLPLSSAQ-----TSSIGAKGSIGYIAPEYGLG--SEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 848 G~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
|.+......... .......++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 146 RSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred chhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 876433211110 01122346778999999876 4689999999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=308.23 Aligned_cols=242 Identities=26% Similarity=0.409 Sum_probs=188.3
Q ss_pred cccccccceeEEEEEECCCC---eEEEEEEeeccCc-hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEEE
Q 046598 694 NQIGEGSFGSVFKGILDDGR---TTIAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVF 769 (986)
Q Consensus 694 ~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 769 (986)
++||+|+||.||+|.+...+ ..||+|.++.... ...+++.+|+++++++.||||+++++++. ....++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK------GEPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc------CCceEEEE
Confidence 47999999999999876544 7899999875433 34567899999999999999999999842 34579999
Q ss_pred EeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccccc
Q 046598 770 EFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGL 849 (986)
Q Consensus 770 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~ 849 (986)
||+++++|.+++.. ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.
T Consensus 75 e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~ 141 (257)
T cd05060 75 ELAPLGPLLKYLKK----------RREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGM 141 (257)
T ss_pred EeCCCCcHHHHHHh----------CCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccc
Confidence 99999999999952 22588999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCcc-ccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCch
Q 046598 850 ARFLPLSSAQT-SSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALPDHV 927 (986)
Q Consensus 850 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 927 (986)
++......... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||..... ...........+
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~~~~~--- 216 (257)
T cd05060 142 SRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLESGER--- 216 (257)
T ss_pred cceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcCCc---
Confidence 98664332211 1112224568999999998999999999999999999998 9999863211 111111110000
Q ss_pred hHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 928 MDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 928 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
. .....++..+.+++.+||..+|++||++.+|
T Consensus 217 ------------~---------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l 248 (257)
T cd05060 217 ------------L---------------PRPEECPQEIYSIMLSCWKYRPEDRPTFSEL 248 (257)
T ss_pred ------------C---------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 0 0001234567899999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=308.51 Aligned_cols=243 Identities=27% Similarity=0.398 Sum_probs=191.5
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 767 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 767 (986)
++|++.+.||+|+||.||+|... +..||+|..+.. ...+.+.+|+.++++++|++++++++++ +..+...++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~----~~~~~~~~l 77 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVI----VEEKGGLYI 77 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEE----EcCCCceEE
Confidence 47889999999999999999876 578999998643 2346789999999999999999999874 344567899
Q ss_pred EEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccc
Q 046598 768 VFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDF 847 (986)
Q Consensus 768 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DF 847 (986)
||||+++++|.++++... ...+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+||
T Consensus 78 v~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df 146 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRG--------RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDF 146 (256)
T ss_pred EEECCCCCcHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCC
Confidence 999999999999986321 23478999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCc
Q 046598 848 GLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALPDH 926 (986)
Q Consensus 848 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 926 (986)
|+++...... ....++..|+|||++.+..++.++|||||||++|||++ |+.||... ........
T Consensus 147 g~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~-----~~~~~~~~----- 211 (256)
T cd05082 147 GLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PLKDVVPR----- 211 (256)
T ss_pred ccceeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHH-----
Confidence 9997543221 12335678999999998899999999999999999998 99998522 11111110
Q ss_pred hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 927 VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 927 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+....... ....++..+.+++.+||+.+|++|||++++
T Consensus 212 ----~~~~~~~~------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l 249 (256)
T cd05082 212 ----VEKGYKMD------------------APDGCPPVVYDVMKQCWHLDAATRPSFLQL 249 (256)
T ss_pred ----HhcCCCCC------------------CCCCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 00000000 001234567899999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=314.10 Aligned_cols=246 Identities=22% Similarity=0.326 Sum_probs=195.8
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
+.|+..+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|++++++++||||+++++++ ..+...+
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 78 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY-----LKGTKLW 78 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccc-----ccCCceE
Confidence 34677788999999999999998888999999987432 34456789999999999999999999984 4567899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+++++|.+++.. ..+++..+..++.|+++|+.|||+. +++|+||+|+||++++++.+|++|
T Consensus 79 lv~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~d 144 (277)
T cd06642 79 IIMEYLGGGSALDLLKP-----------GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLAD 144 (277)
T ss_pred EEEEccCCCcHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEcc
Confidence 99999999999998841 3578899999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCc
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDH 926 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 926 (986)
||++....... .......++..|+|||++.+..++.++|||||||++|||++|+.||........ ...
T Consensus 145 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~-------- 212 (277)
T cd06642 145 FGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV--LFL-------- 212 (277)
T ss_pred ccccccccCcc--hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH--Hhh--------
Confidence 99997654221 112234578899999999998999999999999999999999999863221110 000
Q ss_pred hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 927 VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 927 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+.... +. ......+.++.+++.+||+.+|++||++.||
T Consensus 213 ----~~~~~---~~---------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 250 (277)
T cd06642 213 ----IPKNS---PP---------------TLEGQYSKPFKEFVEACLNKDPRFRPTAKEL 250 (277)
T ss_pred ----hhcCC---CC---------------CCCcccCHHHHHHHHHHccCCcccCcCHHHH
Confidence 00000 00 0001234557899999999999999999764
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=320.39 Aligned_cols=201 Identities=24% Similarity=0.309 Sum_probs=171.5
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
++|++.++||+|+||+||++++..+++.||+|++... .......+.+|+.++..++|++|++++++ +.++..
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~-----~~~~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYA-----FQDENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEE-----EecCCE
Confidence 4789999999999999999999998999999998642 22233457889999999999999999988 456688
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.++||||+++|+|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~---------~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL 143 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKF---------EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRL 143 (332)
T ss_pred EEEEEeccCCCcHHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEE
Confidence 99999999999999999621 23588999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCcccccccccccccccccccc-----CCCcCcccchhhHHHHHHHHHhCCCCCC
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGL-----GSEVSISGDVYSYGILLLELITRKKPTD 906 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~pf~ 906 (986)
+|||++........ .......||+.|+|||++. ...++.++|||||||++|||++|+.||.
T Consensus 144 ~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~ 209 (332)
T cd05623 144 ADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY 209 (332)
T ss_pred eecchheecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCC
Confidence 99999976532221 1222356899999999986 3468899999999999999999999996
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=321.78 Aligned_cols=245 Identities=22% Similarity=0.345 Sum_probs=191.6
Q ss_pred CCcccccccceeEEEEEECCCCeEEEEEEee---c-cCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEE
Q 046598 692 SVNQIGEGSFGSVFKGILDDGRTTIAVKVFN---L-LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 767 (986)
Q Consensus 692 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~---~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 767 (986)
....||+|+|-+||+|.+..+|..||=-.++ . ......++|..|+++|+.++|||||++|+++.+. ......+
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~---~n~~in~ 120 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDT---DNKTINF 120 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecC---CCceeee
Confidence 3467999999999999999888777633322 2 2344568999999999999999999999985432 3356889
Q ss_pred EEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecC-CCcEEEcc
Q 046598 768 VFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDE-DMIAHIGD 846 (986)
Q Consensus 768 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~D 846 (986)
|+|.|..|+|..|.++++ ..+...++.|++||++||.|||++ .|+|+|||||.+||||+. .|.|||+|
T Consensus 121 iTEL~TSGtLr~Y~kk~~----------~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGD 189 (632)
T KOG0584|consen 121 ITELFTSGTLREYRKKHR----------RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGD 189 (632)
T ss_pred eeecccCCcHHHHHHHhc----------cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecc
Confidence 999999999999996544 477889999999999999999997 889999999999999974 57999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCc
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDH 926 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 926 (986)
+|+|+....+.. ....|||.|||||++. ..|+..+||||||+++.||+|+..||........-|.+......|..
T Consensus 190 LGLAtl~r~s~a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~s 264 (632)
T KOG0584|consen 190 LGLATLLRKSHA----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAA 264 (632)
T ss_pred hhHHHHhhcccc----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHH
Confidence 999987654332 2368999999999976 78999999999999999999999998643322222222222222221
Q ss_pred hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 927 VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 927 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+..+- .+++.++|.+|+.. .++|||+.|+
T Consensus 265 l~kV~------------------------------dPevr~fIekCl~~-~~~R~sa~eL 293 (632)
T KOG0584|consen 265 LSKVK------------------------------DPEVREFIEKCLAT-KSERLSAKEL 293 (632)
T ss_pred hhccC------------------------------CHHHHHHHHHHhcC-chhccCHHHH
Confidence 21111 13467899999999 9999999774
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=323.88 Aligned_cols=191 Identities=27% Similarity=0.320 Sum_probs=160.3
Q ss_pred cccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcC---CCCcceeeeeeccccccCCCceEEEEE
Q 046598 696 IGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNI---RHRNLVKILTACSGVDYQGNDFKALVF 769 (986)
Q Consensus 696 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~~~~~~lv~ 769 (986)
||+|+||+||+|++..+++.||||++.... .........|..++... +||+|++++++ +..+...|+||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~-----~~~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFS-----FQTDSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEE-----EecCCeEEEEE
Confidence 699999999999999989999999986422 12234455677776655 69999999988 45668899999
Q ss_pred EeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccccc
Q 046598 770 EFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGL 849 (986)
Q Consensus 770 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~ 849 (986)
||+++|+|.+++.. .+.+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 76 e~~~~g~L~~~l~~----------~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~ 142 (330)
T cd05586 76 DYMSGGELFWHLQK----------EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGL 142 (330)
T ss_pred cCCCCChHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCc
Confidence 99999999998852 34588999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCccccccccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCC
Q 046598 850 ARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTD 906 (986)
Q Consensus 850 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~ 906 (986)
++...... .......||..|+|||++.+. .++.++||||+||++|||++|+.||.
T Consensus 143 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~ 198 (330)
T cd05586 143 SKANLTDN--KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFY 198 (330)
T ss_pred CcCCCCCC--CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCC
Confidence 97532221 122345689999999998764 48999999999999999999999986
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=307.34 Aligned_cols=248 Identities=22% Similarity=0.317 Sum_probs=198.6
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeecc--CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
+|++.+.||+|+||.||++....+++.||+|++... .....+++.+|++++++++||||++++++ +...+..+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~-----~~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES-----FEENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEee-----ecCCCeEE
Confidence 588999999999999999999988999999998643 23345678999999999999999999998 45667899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+++++|.+++... ....+++.++..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|
T Consensus 76 lv~e~~~~~~l~~~~~~~--------~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d 144 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQ--------RGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGD 144 (256)
T ss_pred EEEecCCCCcHHHHHHhc--------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEee
Confidence 999999999999998521 123578899999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCc
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDH 926 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 926 (986)
||.+........ ......++..|+|||+..+..++.++|||||||++|+|++|+.||... ...
T Consensus 145 ~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-----~~~---------- 207 (256)
T cd08218 145 FGIARVLNSTVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG-----NMK---------- 207 (256)
T ss_pred ccceeecCcchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC-----CHH----------
Confidence 999976533221 122345788999999999989999999999999999999999998521 111
Q ss_pred hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 927 VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 927 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+.++..+...... .....+.++.+++.+||+.+|++||++.||
T Consensus 208 --~~~~~~~~~~~~~---------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~v 250 (256)
T cd08218 208 --NLVLKIIRGSYPP---------------VSSHYSYDLRNLVSQLFKRNPRDRPSVNSI 250 (256)
T ss_pred --HHHHHHhcCCCCC---------------CcccCCHHHHHHHHHHhhCChhhCcCHHHH
Confidence 1111111111000 011234567899999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=312.78 Aligned_cols=249 Identities=25% Similarity=0.416 Sum_probs=193.9
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCe----EEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRT----TIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 761 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 761 (986)
.++|++.+.||+|+||.||+|.+..++. .||+|+.+... .....++.+|+.++++++||||++++++|..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 80 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS----- 80 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----
Confidence 3578899999999999999999865443 68999886543 2345678899999999999999999998632
Q ss_pred CceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCc
Q 046598 762 NDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI 841 (986)
Q Consensus 762 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 841 (986)
...++||||+++|+|.+++.. ....+++..+..++.||+.|++|||+. +++||||||+||++++++.
T Consensus 81 -~~~~~v~e~~~~g~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~ 147 (279)
T cd05057 81 -SQVQLITQLMPLGCLLDYVRN---------HKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQH 147 (279)
T ss_pred -CceEEEEecCCCCcHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCe
Confidence 578999999999999999962 223589999999999999999999998 9999999999999999999
Q ss_pred EEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHH
Q 046598 842 AHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLAR 920 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~ 920 (986)
+||+|||.++...............++..|+|||.+....++.++|||||||++||+++ |+.||+.... ....
T Consensus 148 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~- 221 (279)
T cd05057 148 VKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-----VEIP- 221 (279)
T ss_pred EEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-----HHHH-
Confidence 99999999987653322222222334678999999988899999999999999999999 9999864221 1111
Q ss_pred hhCCCchhHHhhhhc-ccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 921 TALPDHVMDIVDSTL-LNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 921 ~~~~~~~~~~~d~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+.+.... ...+ ..+...+.+++.+||..+|++|||+.++
T Consensus 222 --------~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~l~~~p~~Rp~~~~l 261 (279)
T cd05057 222 --------DLLEKGERLPQP-------------------PICTIDVYMVLVKCWMIDAESRPTFKEL 261 (279)
T ss_pred --------HHHhCCCCCCCC-------------------CCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 1111000 0000 0122356789999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=309.99 Aligned_cols=201 Identities=23% Similarity=0.326 Sum_probs=159.4
Q ss_pred cccccccceeEEEEEECC--CCeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEEEE
Q 046598 694 NQIGEGSFGSVFKGILDD--GRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFE 770 (986)
Q Consensus 694 ~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 770 (986)
+.||+|+||+||+|.... ....+|+|.+.... ......+.+|+++++.++||||++++++| ......++|||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~-----~~~~~~~lv~e 75 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQC-----IESIPYLLVLE 75 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEE-----CCCCceEEEEE
Confidence 368999999999997643 34578888875432 23345788999999999999999999985 44577999999
Q ss_pred eccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcccccc
Q 046598 771 FMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLA 850 (986)
Q Consensus 771 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a 850 (986)
|+++|+|.+++..... ......++..+..++.||+.|++|||+. +|+||||||+||++++++.+||+|||++
T Consensus 76 ~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~ 147 (269)
T cd05042 76 FCPLGDLKNYLRSNRG-----MVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLA 147 (269)
T ss_pred eCCCCcHHHHHHhccc-----cccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccc
Confidence 9999999999964321 1122356788899999999999999999 9999999999999999999999999998
Q ss_pred eecCCCCCccccccccccccccccccccC-------CCcCcccchhhHHHHHHHHHh-CCCCCCc
Q 046598 851 RFLPLSSAQTSSIGAKGSIGYIAPEYGLG-------SEVSISGDVYSYGILLLELIT-RKKPTDI 907 (986)
Q Consensus 851 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvvl~ellt-g~~pf~~ 907 (986)
................++..|+|||++.. ..++.++|||||||++|||++ |..||..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 212 (269)
T cd05042 148 LEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD 212 (269)
T ss_pred cccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCc
Confidence 75432222222233446778999998643 457889999999999999999 7888863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=320.20 Aligned_cols=259 Identities=24% Similarity=0.372 Sum_probs=195.9
Q ss_pred cCCCCCcccccccceeEEEEEECC-------CCeEEEEEEeeccC-chhHHHHHHHHHHHhcC-CCCcceeeeeeccccc
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDD-------GRTTIAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVD 758 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 758 (986)
.+|++.+.||+|+||.||+|.+.. ....||+|+++... ....+++.+|+++++++ +||||++++++|
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~---- 87 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC---- 87 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE----
Confidence 468999999999999999998643 13468999886432 33456889999999999 899999999985
Q ss_pred cCCCceEEEEEEeccCCCHhHhhccCCCCCc------cccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCC
Q 046598 759 YQGNDFKALVFEFMHNRSLEEWLHPITREDE------TDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPS 832 (986)
Q Consensus 759 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~ 832 (986)
..+...++||||+++|+|.+++........ .......+++.++..++.|++.||+|||+. +++||||||+
T Consensus 88 -~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~ 163 (334)
T cd05100 88 -TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAAR 163 (334)
T ss_pred -ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccc
Confidence 345678999999999999999964321100 012234689999999999999999999999 9999999999
Q ss_pred CeEecCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccc
Q 046598 833 NILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEG 911 (986)
Q Consensus 833 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~ 911 (986)
||+++.++.+||+|||.++...............++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--- 240 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI--- 240 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC---
Confidence 99999999999999999986543222222222334578999999999999999999999999999998 88888532
Q ss_pred cccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 912 DMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
........... ....+ ....++.++.+++.+||+.+|++|||+.||
T Consensus 241 --~~~~~~~~~~~------------~~~~~---------------~~~~~~~~l~~li~~cl~~~p~~Rps~~el 286 (334)
T cd05100 241 --PVEELFKLLKE------------GHRMD---------------KPANCTHELYMIMRECWHAVPSQRPTFKQL 286 (334)
T ss_pred --CHHHHHHHHHc------------CCCCC---------------CCCCCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 11111111000 00000 001234467899999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=315.06 Aligned_cols=204 Identities=23% Similarity=0.320 Sum_probs=163.1
Q ss_pred cccccccceeEEEEEECC--CCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEEEEe
Q 046598 694 NQIGEGSFGSVFKGILDD--GRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEF 771 (986)
Q Consensus 694 ~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~ 771 (986)
++||+|+||+||+|+..+ ++..||+|.++... ....+.+|++++++++||||+++++++.. ..+...++||||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLS---HSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEec---cCCCeEEEEEee
Confidence 579999999999999764 45789999886432 23567889999999999999999998632 345678999999
Q ss_pred ccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEe----cCCCcEEEccc
Q 046598 772 MHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILL----DEDMIAHIGDF 847 (986)
Q Consensus 772 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kL~DF 847 (986)
++ ++|.+++....... .......+++..++.++.||+.||+|||+. +|+||||||+||++ +.++.+||+||
T Consensus 82 ~~-~~l~~~~~~~~~~~-~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 82 AE-HDLWHIIKFHRASK-ANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred eC-CcHHHHHHhhhccc-cCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 85 58888875332211 112234689999999999999999999999 99999999999999 56679999999
Q ss_pred ccceecCCCCC-ccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 848 GLARFLPLSSA-QTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 848 G~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
|+++....... ........+|+.|+|||++.+ ..++.++|||||||++|||+||++||..
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 99987643221 112234568999999999876 4589999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=311.28 Aligned_cols=252 Identities=24% Similarity=0.326 Sum_probs=199.2
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
++|+..+.||+|+||.||+|.+..+++.||+|++.... ....+++.+|++++++++||||+++++++ ..+...+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF-----YNNGDIS 75 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheee-----ecCCEEE
Confidence 46888999999999999999999889999999987543 34456789999999999999999999984 4458899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHH-DCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
+|+||+++++|.+++... ...+++..+..++.|++.|++|||+ . +++||||||+||++++++.+||+
T Consensus 76 lv~e~~~~~~L~~~~~~~---------~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~ 143 (265)
T cd06605 76 ICMEYMDGGSLDKILKEV---------QGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLC 143 (265)
T ss_pred EEEEecCCCcHHHHHHHc---------cCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEe
Confidence 999999999999999632 1468899999999999999999999 8 99999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCC
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPD 925 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 925 (986)
|||.+........ ....++..|+|||++.+..++.++||||||+++|+|++|+.||..........
T Consensus 144 d~g~~~~~~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~---------- 209 (265)
T cd06605 144 DFGVSGQLVNSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI---------- 209 (265)
T ss_pred ecccchhhHHHHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccH----------
Confidence 9999875432111 11567889999999999999999999999999999999999986432211111
Q ss_pred chhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 926 HVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 926 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+.++......... .. ......++.+++.+||..+|++|||+.|+
T Consensus 210 --~~~~~~~~~~~~~~-------------~~-~~~~~~~~~~li~~~l~~~p~~Rpt~~~l 254 (265)
T cd06605 210 --FELLQYIVNEPPPR-------------LP-SGKFSPDFQDFVNLCLIKDPRERPSYKEL 254 (265)
T ss_pred --HHHHHHHhcCCCCC-------------CC-hhhcCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 11111111111100 00 00144567899999999999999998764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=312.32 Aligned_cols=260 Identities=24% Similarity=0.303 Sum_probs=201.6
Q ss_pred HhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcC-CCCcceeeeeecccccc-CCC
Q 046598 685 NATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDY-QGN 762 (986)
Q Consensus 685 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~-~~~ 762 (986)
..+++|++.+.||+|++|.||+|.+..+++.|++|++..... ..+.+.+|+++++++ .|+||+++++++..... ...
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 356899999999999999999999988889999999876443 346789999999999 79999999999754322 345
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
...++||||+++++|.++++... .....+++..+..++.|++.||.|||+. +++||||+|+||++++++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~ 152 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLR------KKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEV 152 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHh------hcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeE
Confidence 67899999999999999986322 1235689999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCccccccccccccccccccccC-----CCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHH
Q 046598 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-----SEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHN 917 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~ 917 (986)
||+|||.+....... .......++..|+|||++.. ..++.++|||||||++|+|++|+.||...... ..
T Consensus 153 ~l~d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~ 226 (275)
T cd06608 153 KLVDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM----RA 226 (275)
T ss_pred EECCCccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH----HH
Confidence 999999997653221 22233558889999998754 34778999999999999999999998632111 00
Q ss_pred HHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 918 LARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 918 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.. .+.. ..+. ..........++.+++.+||..||++|||++||
T Consensus 227 ~~---------~~~~----~~~~-------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~l 269 (275)
T cd06608 227 LF---------KIPR----NPPP-------------TLKSPENWSKKFNDFISECLIKNYEQRPFMEEL 269 (275)
T ss_pred HH---------Hhhc----cCCC-------------CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHH
Confidence 00 0000 0000 001111244567899999999999999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=312.53 Aligned_cols=251 Identities=22% Similarity=0.309 Sum_probs=195.0
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc-CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
++|++.+.||+|+||.||+|.+..+++.||+|.++.. .......+.+|++++++++||||++++++ +..++..+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~-----~~~~~~~~ 75 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA-----FFIEGAVY 75 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhh-----eecCCeEE
Confidence 4688999999999999999999988999999988653 33345678899999999999999999998 44568899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHH-DCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
+||||+++++|.++++... ....+++..+..++.|++.|+.|||+ . +|+||||||+||+++.++.+||+
T Consensus 76 lv~e~~~~~~l~~~~~~~~-------~~~~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~ 145 (286)
T cd06622 76 MCMEYMDAGSLDKLYAGGV-------ATEGIPEDVLRRITYAVVKGLKFLKEEH---NIIHRDVKPTNVLVNGNGQVKLC 145 (286)
T ss_pred EEEeecCCCCHHHHHHhcc-------ccCCCCHHHHHHHHHHHHHHHHHHHhcC---CEeeCCCCHHHEEECCCCCEEEe
Confidence 9999999999999985321 12468999999999999999999996 5 89999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccCC------CcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHH
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS------EVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLA 919 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~ 919 (986)
|||.+....... .....++..|+|||.+.+. .++.++|||||||++|+|++|+.||...... .....
T Consensus 146 dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~- 218 (286)
T cd06622 146 DFGVSGNLVASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA--NIFAQ- 218 (286)
T ss_pred ecCCcccccCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh--hHHHH-
Confidence 999997653221 1224578899999998554 3588999999999999999999998632110 00000
Q ss_pred HhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 920 RTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 920 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+.......+.. ...+...++.+++.+||+.+|++||+++|+
T Consensus 219 -----------~~~~~~~~~~~---------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l 259 (286)
T cd06622 219 -----------LSAIVDGDPPT---------------LPSGYSDDAQDFVAKCLNKIPNRRPTYAQL 259 (286)
T ss_pred -----------HHHHhhcCCCC---------------CCcccCHHHHHHHHHHcccCcccCCCHHHH
Confidence 00000000000 011244567799999999999999998764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=308.82 Aligned_cols=249 Identities=28% Similarity=0.463 Sum_probs=195.6
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
.++|++.+.||+|+||.||+|.+.+ ++.||||.+.... ...+++.+|+.++++++||||+++++++ ..+...+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 77 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVC-----SEEEPIY 77 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeee-----ecCCceE
Confidence 4689999999999999999999875 5789999987533 3346789999999999999999999984 4557789
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+++++|.+++... ....+++.++..++.|++.|++|||+. +++||||||+||++++++.+||+|
T Consensus 78 ~v~e~~~~~~L~~~i~~~--------~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d 146 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSG--------EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIAD 146 (261)
T ss_pred EEEeccCCCCHHHHHhcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECc
Confidence 999999999999999632 224689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCC
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALPD 925 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 925 (986)
||.++...... .........+..|+|||.+.+..++.++||||+||++|++++ |+.||...... .....
T Consensus 147 ~g~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-----~~~~~---- 216 (261)
T cd05034 147 FGLARLIEDDE-YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-----EVLEQ---- 216 (261)
T ss_pred cccceeccchh-hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHH----
Confidence 99998654321 111222335678999999998899999999999999999999 99998532111 11110
Q ss_pred chhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 926 HVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 926 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+...... + .....+.++.+++.+|++.+|++||+++++
T Consensus 217 -----~~~~~~~-~-----------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l 254 (261)
T cd05034 217 -----VERGYRM-P-----------------RPPNCPEELYDLMLQCWDKDPEERPTFEYL 254 (261)
T ss_pred -----HHcCCCC-C-----------------CCCCCCHHHHHHHHHHcccCcccCCCHHHH
Confidence 0000000 0 001124467899999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=308.85 Aligned_cols=249 Identities=22% Similarity=0.316 Sum_probs=193.0
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC------chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH------HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
+|++.+.||+|+||+||+|... +++.+|+|.++... ....+.+.+|++++++++|+||++++++| .+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTC-----LDD 74 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEe-----ecC
Confidence 5888999999999999999875 47889999886422 12235688999999999999999999995 445
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
...++||||+++++|.+++.. ...+++..+..++.|++.|++|||+. +|+|+||+|+||++++++.+
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~ 141 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNR----------FGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGII 141 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeE
Confidence 789999999999999999952 23578899999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCC----ccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHH
Q 046598 843 HIGDFGLARFLPLSSA----QTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNL 918 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~ 918 (986)
||+|||.+........ ........++..|+|||++.+..++.++|||||||++|+|++|+.||...... ...
T Consensus 142 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----~~~ 217 (265)
T cd06631 142 KLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL----AAM 217 (265)
T ss_pred EeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH----HHH
Confidence 9999999976432111 11122345888999999999988999999999999999999999999632111 000
Q ss_pred HHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 919 ARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 919 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
......... . .. .......++.+++.+||+.+|++||++.||
T Consensus 218 ~~~~~~~~~-------~-~~------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~ 259 (265)
T cd06631 218 FYIGAHRGL-------M-PR------------------LPDSFSAAAIDFVTSCLTRDQHERPSALQL 259 (265)
T ss_pred HHhhhccCC-------C-CC------------------CCCCCCHHHHHHHHHHhcCCcccCCCHHHH
Confidence 000000000 0 00 001234457899999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=316.97 Aligned_cols=250 Identities=26% Similarity=0.407 Sum_probs=192.2
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCe----EEEEEEeeccCc-hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRT----TIAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 761 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 761 (986)
.++|+..+.||+|+||.||+|.+..++. .||+|++..... ....++.+|+.+++.++||||++++++|..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~----- 80 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS----- 80 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-----
Confidence 3568889999999999999999865554 578888764332 233468899999999999999999998632
Q ss_pred CceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCc
Q 046598 762 NDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI 841 (986)
Q Consensus 762 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 841 (986)
...++|+||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 81 -~~~~~v~e~~~~g~l~~~~~~---------~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~ 147 (303)
T cd05110 81 -PTIQLVTQLMPHGCLLDYVHE---------HKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNH 147 (303)
T ss_pred -CCceeeehhcCCCCHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCc
Confidence 246799999999999999862 223578999999999999999999999 9999999999999999999
Q ss_pred EEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHH
Q 046598 842 AHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLAR 920 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~ 920 (986)
+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||...... ....+
T Consensus 148 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~--~~~~~-- 223 (303)
T cd05110 148 VKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR--EIPDL-- 223 (303)
T ss_pred eEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH--
Confidence 99999999987643332222233445778999999999999999999999999999998 89998632111 11111
Q ss_pred hhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 921 TALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 921 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+...... + ....++..+.+++.+||..+|++||+++||
T Consensus 224 ----------~~~~~~~-~-----------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l 261 (303)
T cd05110 224 ----------LEKGERL-P-----------------QPPICTIDVYMVMVKCWMIDADSRPKFKEL 261 (303)
T ss_pred ----------HHCCCCC-C-----------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 1100000 0 000123457789999999999999999874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=310.42 Aligned_cols=248 Identities=23% Similarity=0.375 Sum_probs=192.9
Q ss_pred cCCCCCcccccccceeEEEEEECCC---CeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDG---RTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
++|.+.+.||+|+||.||+|.+... ...||+|...... ....+.+.+|+.++++++||||++++++|. ..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~------~~ 79 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVIT------EN 79 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEc------CC
Confidence 4688899999999999999997543 4568999886544 344568999999999999999999999853 24
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..++||||+++++|.+++... ...+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+|
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~ 147 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVN---------KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVK 147 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeE
Confidence 568999999999999999532 23589999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhh
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~ 922 (986)
|+|||+++........ ......++..|+|||.+....++.++|||||||++||+++ |..||......+ .......
T Consensus 148 l~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~~~~~~- 223 (270)
T cd05056 148 LGDFGLSRYLEDESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--VIGRIEN- 223 (270)
T ss_pred EccCceeeecccccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHc-
Confidence 9999999866433211 1122334568999999988889999999999999999996 999986332111 0000000
Q ss_pred CCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 923 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.. +......++.++.+++.+|+..+|++|||+.|+
T Consensus 224 -~~----------------------------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~ 258 (270)
T cd05056 224 -GE----------------------------RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTEL 258 (270)
T ss_pred -CC----------------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 00 000011234567899999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=305.34 Aligned_cols=243 Identities=28% Similarity=0.415 Sum_probs=189.8
Q ss_pred cccccccceeEEEEEECCCCeEEEEEEeeccCch-hHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEEEEec
Q 046598 694 NQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHG-AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFM 772 (986)
Q Consensus 694 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 772 (986)
++||+|+||.||+|.+.. ++.||+|+++..... ..+.+.+|++++++++||||+++++++ ......++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC-----VQKQPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEE-----ecCCCeEEEEEcC
Confidence 479999999999999988 899999998754333 456889999999999999999999984 4557889999999
Q ss_pred cCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccccccee
Q 046598 773 HNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARF 852 (986)
Q Consensus 773 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~ 852 (986)
++++|.+++.. ....+++..+..++.|++.|++|||++ +++||||||+||+++.++.+||+|||.+..
T Consensus 75 ~~~~l~~~l~~---------~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~ 142 (251)
T cd05041 75 PGGSLLTFLRK---------KKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRE 142 (251)
T ss_pred CCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeecccccc
Confidence 99999999852 223578899999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCchhHHh
Q 046598 853 LPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALPDHVMDIV 931 (986)
Q Consensus 853 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (986)
...............+..|+|||.+.+..++.++|||||||++|||+| |..||...... ... +.+
T Consensus 143 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~~------------~~~ 208 (251)
T cd05041 143 EEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QTR------------ERI 208 (251)
T ss_pred ccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HHH------------HHH
Confidence 532111111112234567999999988899999999999999999999 88888532211 000 111
Q ss_pred hhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 932 DSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 932 d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
...... ......+.++.+++.+|+..+|++|||+.||
T Consensus 209 ~~~~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~el 245 (251)
T cd05041 209 ESGYRM------------------PAPQLCPEEIYRLMLQCWAYDPENRPSFSEI 245 (251)
T ss_pred hcCCCC------------------CCCccCCHHHHHHHHHHhccChhhCcCHHHH
Confidence 100000 0011234568899999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=311.40 Aligned_cols=262 Identities=24% Similarity=0.269 Sum_probs=198.9
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc-hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
++|+..+.||.|++|.||+|.+..+++.||+|++..... ....++.+|++++++++||||++++++|.. ......+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLD---ESSSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEc---cCCCeEE
Confidence 468889999999999999999998899999999875332 345678999999999999999999998632 2345789
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+++++|.+++.... .....+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|
T Consensus 78 lv~e~~~~~~L~~~l~~~~------~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d 148 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVK------KRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCD 148 (287)
T ss_pred EEEEecCCCCHHHHHHHHH------hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEee
Confidence 9999999999999875322 1234578899999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCc
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDH 926 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 926 (986)
||++....... .....++..|+|||.+.+..++.++||||+||++|+|++|+.||+....................
T Consensus 149 fg~~~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 224 (287)
T cd06621 149 FGVSGELVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP 224 (287)
T ss_pred ccccccccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC
Confidence 99987543221 11245788999999999999999999999999999999999999743211001111110000000
Q ss_pred hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 927 VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 927 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
. ..+...+ ......+.++.+++.+||+.+|++|||+.||
T Consensus 225 ~-----~~~~~~~----------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ei 263 (287)
T cd06621 225 N-----PELKDEP----------------GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDM 263 (287)
T ss_pred c-----hhhccCC----------------CCCCchHHHHHHHHHHHcCCCcccCCCHHHH
Confidence 0 0000000 0001124467899999999999999999764
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=307.99 Aligned_cols=245 Identities=25% Similarity=0.407 Sum_probs=184.3
Q ss_pred cccccccceeEEEEEECC---CCeEEEEEEeecc-CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEEE
Q 046598 694 NQIGEGSFGSVFKGILDD---GRTTIAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVF 769 (986)
Q Consensus 694 ~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 769 (986)
+.||+|+||.||+|.+.+ ....||+|.+... .....+.+.+|+.+++.++||||++++++|. ..+...++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICL----PSEGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEee----cCCCCcEEEE
Confidence 468999999999998743 3467999988542 2344578889999999999999999999753 3345688999
Q ss_pred EeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccccc
Q 046598 770 EFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGL 849 (986)
Q Consensus 770 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~ 849 (986)
||+++++|.+++... ....++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||+
T Consensus 77 e~~~~~~L~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~ 144 (262)
T cd05058 77 PYMKHGDLRNFIRSE---------THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGL 144 (262)
T ss_pred ecCCCCCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccc
Confidence 999999999999622 23467788899999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCc--cccccccccccccccccccCCCcCcccchhhHHHHHHHHHhC-CCCCCccccccccHHHHHHhhCCCc
Q 046598 850 ARFLPLSSAQ--TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITR-KKPTDIMFEGDMNLHNLARTALPDH 926 (986)
Q Consensus 850 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~ 926 (986)
++........ .......++..|+|||++.+..++.++|||||||++|||++| .+||.... ......
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-----~~~~~~------ 213 (262)
T cd05058 145 ARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD-----SFDITV------ 213 (262)
T ss_pred cccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH------
Confidence 9755322111 111233457789999999888999999999999999999995 55554211 111111
Q ss_pred hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 927 VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 927 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
........ ......+..+.+++.+||+.+|++||++.||
T Consensus 214 ------~~~~~~~~---------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i 252 (262)
T cd05058 214 ------YLLQGRRL---------------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSEL 252 (262)
T ss_pred ------HHhcCCCC---------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 00000000 0001223467899999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=306.85 Aligned_cols=245 Identities=24% Similarity=0.392 Sum_probs=191.3
Q ss_pred cccccccceeEEEEEECC-CC--eEEEEEEeeccCc-hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEEE
Q 046598 694 NQIGEGSFGSVFKGILDD-GR--TTIAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVF 769 (986)
Q Consensus 694 ~~lg~G~~g~Vy~~~~~~-~~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 769 (986)
+.||+|++|.||+|.+.. .+ ..||+|.++.... ...+++.+|++++++++||||+++++++ .. ...++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~-~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVV-----LT-HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEE-----cC-CeEEEEE
Confidence 468999999999999854 23 3699999976554 5567899999999999999999999984 23 7789999
Q ss_pred EeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccccc
Q 046598 770 EFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGL 849 (986)
Q Consensus 770 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~ 849 (986)
||+++++|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||.
T Consensus 75 e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~ 143 (257)
T cd05040 75 ELAPLGSLLDRLRKDA--------LGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGL 143 (257)
T ss_pred EecCCCcHHHHHHhcc--------cccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccc
Confidence 9999999999996321 14689999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCc-cccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCch
Q 046598 850 ARFLPLSSAQ-TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALPDHV 927 (986)
Q Consensus 850 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 927 (986)
++........ .......++..|+|||++.+..++.++|||||||++|||++ |+.||...... .....
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~~~~------ 212 (257)
T cd05040 144 MRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS-----QILKK------ 212 (257)
T ss_pred cccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHH------
Confidence 9876432221 11223456789999999998899999999999999999999 99998632111 11110
Q ss_pred hHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 928 MDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 928 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
++... . ........+..+.+++.+|++.+|++|||+.||
T Consensus 213 ---~~~~~--~---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 251 (257)
T cd05040 213 ---IDKEG--E---------------RLERPEACPQDIYNVMLQCWAHNPADRPTFAAL 251 (257)
T ss_pred ---HHhcC--C---------------cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHH
Confidence 00000 0 000001234568899999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=306.60 Aligned_cols=247 Identities=28% Similarity=0.452 Sum_probs=192.5
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 767 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 767 (986)
++|.+.+.||+|++|.||+|.+..+ ..||+|++.... ...+.+.+|++++++++|||++++++++. ....++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~ 77 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS------EEPIYI 77 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc------CCCcEE
Confidence 5689999999999999999998764 469999876433 23467889999999999999999998742 245789
Q ss_pred EEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccc
Q 046598 768 VFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDF 847 (986)
Q Consensus 768 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DF 847 (986)
||||+++++|.++++.. ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 78 v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~df 146 (260)
T cd05069 78 VTEFMGKGSLLDFLKEG--------DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADF 146 (260)
T ss_pred EEEcCCCCCHHHHHhhC--------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCC
Confidence 99999999999999632 123578999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCc
Q 046598 848 GLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALPDH 926 (986)
Q Consensus 848 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 926 (986)
|.++....... .......++..|+|||+..+..++.++|||||||++|||+| |+.||......+ ...........
T Consensus 147 g~~~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~~- 222 (260)
T cd05069 147 GLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--VLEQVERGYRM- 222 (260)
T ss_pred ccceEccCCcc-cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCCC-
Confidence 99986543221 12222346678999999988899999999999999999999 899986322110 00000000000
Q ss_pred hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 927 VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 927 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
. .....+..+.+++.+||+.+|++||++++|
T Consensus 223 ----------~-------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 253 (260)
T cd05069 223 ----------P-------------------CPQGCPESLHELMKLCWKKDPDERPTFEYI 253 (260)
T ss_pred ----------C-------------------CCcccCHHHHHHHHHHccCCcccCcCHHHH
Confidence 0 001234567899999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=315.21 Aligned_cols=247 Identities=23% Similarity=0.295 Sum_probs=194.8
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEE
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALV 768 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 768 (986)
.|.....||+|+||.||++.+..++..||||.+........+.+.+|+.++++++||||+++++.+ ..++..++|
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~-----~~~~~~~lv 97 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY-----LVGDELWVV 97 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhe-----ecCCeEEEE
Confidence 344457799999999999999888999999998765555667789999999999999999999984 456789999
Q ss_pred EEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcccc
Q 046598 769 FEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFG 848 (986)
Q Consensus 769 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG 848 (986)
|||+++++|.+++.. ..+++.++..++.||+.|++|||+. +|+||||||+||++++++.+||+|||
T Consensus 98 ~e~~~~~~L~~~~~~-----------~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg 163 (292)
T cd06658 98 MEFLEGGALTDIVTH-----------TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFG 163 (292)
T ss_pred EeCCCCCcHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCc
Confidence 999999999998841 2478899999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCchh
Q 046598 849 LARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVM 928 (986)
Q Consensus 849 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 928 (986)
++....... .......++..|+|||+..+..++.++|||||||++|||++|+.||..... .... .
T Consensus 164 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~----~~~~-~-------- 228 (292)
T cd06658 164 FCAQVSKEV--PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP----LQAM-R-------- 228 (292)
T ss_pred chhhccccc--ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHH-H--------
Confidence 997543221 122235688999999999888899999999999999999999999863211 1100 0
Q ss_pred HHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 929 DIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 929 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+........ .........+.+++.+||..||++|||++||
T Consensus 229 -~~~~~~~~~~----------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~i 269 (292)
T cd06658 229 -RIRDNLPPRV----------------KDSHKVSSVLRGFLDLMLVREPSQRATAQEL 269 (292)
T ss_pred -HHHhcCCCcc----------------ccccccCHHHHHHHHHHccCChhHCcCHHHH
Confidence 0000000000 0001223456788999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=310.67 Aligned_cols=275 Identities=24% Similarity=0.262 Sum_probs=198.8
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
+|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++ ..+...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVF-----PHGSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeeE
Confidence 5889999999999999999998889999999987543 33456789999999999999999999984 4567899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+ +++|.+++... ...+++.+++.++.||++||+|||+. +++|+||||+||+++.++.++|+|
T Consensus 76 ~v~e~~-~~~L~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~d 142 (286)
T cd07832 76 LVMEYM-PSDLSEVLRDE---------ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIAD 142 (286)
T ss_pred EEeccc-CCCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEee
Confidence 999999 99999998522 24689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCC
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPD 925 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 925 (986)
||.+........ .......++..|+|||++.+. .++.++||||+||++|||++|++||...... ..+.... .....
T Consensus 143 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~-~~~~~ 219 (286)
T cd07832 143 FGLARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-EQLAIVF-RTLGT 219 (286)
T ss_pred eeecccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-HHHHHHH-HHcCC
Confidence 999986643321 112234688899999998654 4689999999999999999998887532211 1111111 11111
Q ss_pred c-hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 926 H-VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 926 ~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
. .....+-.-..+............. ......+...++.+++.+|++.+|++|||++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 279 (286)
T cd07832 220 PNEETWPGLTSLPDYNKITFPESKPIP--LEEIFPDASPEALDLLKGLLVYDPSKRLSAAEA 279 (286)
T ss_pred CChHHHhhccCcchhhcccCCCCCcch--HHHhCCCccHHHHHHHHHHhccChhhCCCHHHH
Confidence 0 0000000000000000000000000 000111334678899999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=307.96 Aligned_cols=252 Identities=22% Similarity=0.288 Sum_probs=199.5
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeecc--CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
+|++.+.||.|+||.||+|.+..+++.||+|+++.. .....+++.+|++++++++||||+++++++. ...+...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~---~~~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRII---DRSNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeee---cCCCCEEE
Confidence 588899999999999999999988999999998643 2334567889999999999999999998753 23456789
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHH-----hcCCCCeEeecCCCCCeEecCCCc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLH-----HDCQPPIAHCDLKPSNILLDEDMI 841 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH-----~~~~~~ivH~Dlkp~NIll~~~~~ 841 (986)
++|||+++++|.+++.... .....+++.+++.++.||+.||+||| +. +++||||+|+||+++.++.
T Consensus 78 ~~~e~~~~~~L~~~l~~~~------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~ 148 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCK------KERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNN 148 (265)
T ss_pred EEehhccCCCHHHHHHHHh------hcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCC
Confidence 9999999999999996432 22356899999999999999999999 66 9999999999999999999
Q ss_pred EEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHh
Q 046598 842 AHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLART 921 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~ 921 (986)
+||+|||.+........ ......++..|+|||++.+..++.++||||||+++|+|++|+.||.... .......
T Consensus 149 ~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~ 221 (265)
T cd08217 149 VKLGDFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-----QLQLASK 221 (265)
T ss_pred EEEecccccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-----HHHHHHH
Confidence 99999999987643321 1223468899999999999889999999999999999999999986322 1111111
Q ss_pred hCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 922 ALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 922 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+.... ... .....+.++.+++.+|++.+|++|||+.||
T Consensus 222 ---------~~~~~---~~~---------------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~i 259 (265)
T cd08217 222 ---------IKEGK---FRR---------------IPYRYSSELNEVIKSMLNVDPDKRPSTEEL 259 (265)
T ss_pred ---------HhcCC---CCC---------------CccccCHHHHHHHHHHccCCcccCCCHHHH
Confidence 00000 000 001234567899999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=316.33 Aligned_cols=251 Identities=24% Similarity=0.336 Sum_probs=202.3
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
.+-|.++..||.|+||.||+|..+.++...|.|++......+.++|+-|++||+...||+||++++. |..++..+
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~a-----yy~enkLw 105 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSA-----YYFENKLW 105 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHH-----HhccCceE
Confidence 3456778889999999999999999888899999988888888999999999999999999999998 44557899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
|..|||.||-....+- .-+..+++.++..+++|++.||.|||++ .|||||||+.|||++-+|.++|+|
T Consensus 106 iliEFC~GGAVDaiml---------EL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLAD 173 (1187)
T KOG0579|consen 106 ILIEFCGGGAVDAIML---------ELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLAD 173 (1187)
T ss_pred EEEeecCCchHhHHHH---------HhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeec
Confidence 9999999999999886 3345799999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccc-----cCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHh
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYG-----LGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLART 921 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~ 921 (986)
||.+.... ........+.||+.|||||+. .+.+|++++||||||+++.||..+.+|-..... ....
T Consensus 174 FGVSAKn~--~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp-----MRVl-- 244 (1187)
T KOG0579|consen 174 FGVSAKNK--STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP-----MRVL-- 244 (1187)
T ss_pred ccccccch--hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch-----HHHH--
Confidence 99985421 122233457899999999975 456899999999999999999999999542211 1111
Q ss_pred hCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 922 ALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 922 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
-+.-..+|.. ...+..-...+.+++.+|+..+|+.||+++++
T Consensus 245 ----------lKiaKSePPT-------------LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaql 286 (1187)
T KOG0579|consen 245 ----------LKIAKSEPPT-------------LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQL 286 (1187)
T ss_pred ----------HHHhhcCCCc-------------ccCcchhhhHHHHHHHHHHhcCCccCCCHHHH
Confidence 1111111111 11112334567789999999999999998764
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=310.28 Aligned_cols=253 Identities=22% Similarity=0.321 Sum_probs=193.9
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc----------hhHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH----------GAFKSFIAECNTLKNIRHRNLVKILTACSGVD 758 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 758 (986)
+|.+.+.||+|+||.||+|....+++.||+|.++.... ...+.+.+|+.++++++|||++++++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~---- 77 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFE---- 77 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEe----
Confidence 57888999999999999999988899999998853211 1134678899999999999999999984
Q ss_pred cCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecC
Q 046598 759 YQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDE 838 (986)
Q Consensus 759 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 838 (986)
......++||||+++++|.++++.. ..+++..+..++.||+.|+.|||+. +++||||+|+||+++.
T Consensus 78 -~~~~~~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~ 143 (272)
T cd06629 78 -TTEEYLSIFLEYVPGGSIGSCLRTY----------GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDA 143 (272)
T ss_pred -ccCCceEEEEecCCCCcHHHHHhhc----------cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcC
Confidence 4457899999999999999999522 4588899999999999999999999 9999999999999999
Q ss_pred CCcEEEcccccceecCCCCCccccccccccccccccccccCCC--cCcccchhhHHHHHHHHHhCCCCCCccccccccHH
Q 046598 839 DMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSE--VSISGDVYSYGILLLELITRKKPTDIMFEGDMNLH 916 (986)
Q Consensus 839 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~ 916 (986)
++.+|++|||.++...............++..|+|||.+.... ++.++||||||+++|++++|..||.... ...
T Consensus 144 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~----~~~ 219 (272)
T cd06629 144 DGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE----AIA 219 (272)
T ss_pred CCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc----hHH
Confidence 9999999999997643222222223345788999999987654 8899999999999999999999985211 111
Q ss_pred HHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 917 NLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 917 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.... ...........+ ....+.+.++.+++.+||..+|++|||++||
T Consensus 220 ~~~~---------~~~~~~~~~~~~--------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i 266 (272)
T cd06629 220 AMFK---------LGNKRSAPPIPP--------------DVSMNLSPVALDFLNACFTINPDNRPTAREL 266 (272)
T ss_pred HHHH---------hhccccCCcCCc--------------cccccCCHHHHHHHHHHhcCChhhCCCHHHH
Confidence 1110 000000000000 0011235567889999999999999998874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=305.54 Aligned_cols=244 Identities=27% Similarity=0.424 Sum_probs=194.6
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
.++|++.+.||.|+||.||+|... ++.||+|.++.... ..+++.+|+.++++++|+||+++++++ ......+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 76 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVV-----LQGNPLY 76 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEE-----cCCCCeE
Confidence 357899999999999999999986 58899999976543 467899999999999999999999984 3467899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+++++|.+++.... ...+++.++..++.|++.|+.|||+. +++||||||+||+++.++.+||+|
T Consensus 77 ~v~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d 145 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRG--------RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSD 145 (256)
T ss_pred EEEEecCCCcHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcc
Confidence 9999999999999996321 23589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCC
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALPD 925 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 925 (986)
||.++....... ....+..|+|||++.+..++.++||||||+++||+++ |+.||..... .....
T Consensus 146 ~g~~~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~----- 210 (256)
T cd05039 146 FGLAKEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVVP----- 210 (256)
T ss_pred cccccccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHH-----
Confidence 999986532211 2335678999999988899999999999999999998 9999863211 11100
Q ss_pred chhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 926 HVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 926 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+...... ..+...+.++.+++.+|+..+|++|||+.||
T Consensus 211 ----~~~~~~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l 249 (256)
T cd05039 211 ----HVEKGYRM------------------EAPEGCPPEVYKVMKDCWELDPAKRPTFKQL 249 (256)
T ss_pred ----HHhcCCCC------------------CCccCCCHHHHHHHHHHhccChhhCcCHHHH
Confidence 00000000 0011234567899999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=320.62 Aligned_cols=283 Identities=21% Similarity=0.223 Sum_probs=200.1
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc--CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
..++|.+.+.||+|+||+||+|++..+++.||||.++.. .......+.+|+.+++.++||||+++++++.........
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 356899999999999999999999988999999998642 233345678899999999999999999986543333335
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..++||||+. ++|.+++. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+|
T Consensus 83 ~~~lv~e~~~-~~L~~~~~----------~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~k 148 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIR----------SSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLK 148 (337)
T ss_pred cEEEEEeCCC-CCHHHHHh----------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEE
Confidence 6899999995 78998884 234689999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 922 (986)
|+|||+++...... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... . .........
T Consensus 149 L~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~-~~~~~~~~~ 224 (337)
T cd07858 149 ICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY-V-HQLKLITEL 224 (337)
T ss_pred ECcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh-H-HHHHHHHHH
Confidence 99999998654322 12233457889999998765 4689999999999999999999999963211 0 000011110
Q ss_pred CCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 923 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
......+..+............................++.++.+++.+|++.+|++|||++||
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~el 288 (337)
T cd07858 225 LGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEA 288 (337)
T ss_pred hCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHH
Confidence 0000000000000000000000000000000011112456678899999999999999998764
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=306.82 Aligned_cols=236 Identities=20% Similarity=0.334 Sum_probs=181.1
Q ss_pred cccccccceeEEEEEECC------------CCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCC
Q 046598 694 NQIGEGSFGSVFKGILDD------------GRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 761 (986)
Q Consensus 694 ~~lg~G~~g~Vy~~~~~~------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 761 (986)
+.||+|+||.||+|.... ....||+|++..........+.+|+.+++.++||||+++++++ ..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~-----~~ 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVC-----VR 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEE-----ec
Confidence 468999999999998642 1346899988765555566788999999999999999999995 34
Q ss_pred CceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCc
Q 046598 762 NDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI 841 (986)
Q Consensus 762 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 841 (986)
+...++||||+++++|..++.. ....+++..++.++.||++|++|||+. +|+||||||+||+++.++.
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~---------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~ 143 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHR---------KSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGI 143 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCc
Confidence 4677999999999999998852 224589999999999999999999999 9999999999999987664
Q ss_pred -------EEEcccccceecCCCCCcccccccccccccccccccc-CCCcCcccchhhHHHHHHHHH-hCCCCCCcccccc
Q 046598 842 -------AHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGL-GSEVSISGDVYSYGILLLELI-TRKKPTDIMFEGD 912 (986)
Q Consensus 842 -------~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~ell-tg~~pf~~~~~~~ 912 (986)
+|++|||.+..... .....++..|+|||.+. +..++.++|||||||++|||+ +|+.||......
T Consensus 144 ~~~~~~~~~l~d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~- 216 (262)
T cd05077 144 DGECGPFIKLSDPGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA- 216 (262)
T ss_pred cCCCCceeEeCCCCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh-
Confidence 89999999865421 12245788999999886 467899999999999999998 588887532110
Q ss_pred ccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 913 MNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
... .......... .....++.+++.+||+.||++||++.||
T Consensus 217 ----~~~---------~~~~~~~~~~--------------------~~~~~~~~~li~~cl~~dp~~Rp~~~~i 257 (262)
T cd05077 217 ----EKE---------RFYEGQCMLV--------------------TPSCKELADLMTHCMNYDPNQRPFFRAI 257 (262)
T ss_pred ----HHH---------HHHhcCccCC--------------------CCChHHHHHHHHHHcCCChhhCcCHHHH
Confidence 000 0000000000 0112357789999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=307.62 Aligned_cols=250 Identities=26% Similarity=0.406 Sum_probs=187.6
Q ss_pred cccccccceeEEEEEECCCCe--EEEEEEeecc-CchhHHHHHHHHHHHhcC-CCCcceeeeeeccccccCCCceEEEEE
Q 046598 694 NQIGEGSFGSVFKGILDDGRT--TIAVKVFNLL-HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVF 769 (986)
Q Consensus 694 ~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 769 (986)
+.||+|+||.||+|++..++. .+|+|.++.. .....+.+.+|+++++++ +||||++++++| ......++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-----~~~~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRGYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEE-----ecCCCceEEE
Confidence 468999999999999977654 4688887642 234456788999999999 899999999985 3456789999
Q ss_pred EeccCCCHhHhhccCCCCCc------cccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 770 EFMHNRSLEEWLHPITREDE------TDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 770 e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
||+++|+|.+++........ .......+++.+++.++.|++.|++|||+. +++||||||+||++++++.+|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~k 152 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK 152 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEE
Confidence 99999999999964331100 012234588999999999999999999998 999999999999999999999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhh
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~ 922 (986)
|+|||++..... .........+..|+|||++.+..++.++|||||||++|||++ |..||.... .......
T Consensus 153 l~dfgl~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~-----~~~~~~~- 223 (270)
T cd05047 153 IADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-----CAELYEK- 223 (270)
T ss_pred ECCCCCccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC-----HHHHHHH-
Confidence 999999863221 111112234567999999988899999999999999999997 999985321 1111111
Q ss_pred CCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 923 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+.... .. .....++.++.+++.+||+.+|.+|||+.|+
T Consensus 224 --------~~~~~---~~---------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i 261 (270)
T cd05047 224 --------LPQGY---RL---------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQI 261 (270)
T ss_pred --------HhCCC---CC---------------CCCCcCCHHHHHHHHHHcccChhhCCCHHHH
Confidence 00000 00 0001233457899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=309.78 Aligned_cols=235 Identities=20% Similarity=0.308 Sum_probs=179.7
Q ss_pred ccccccceeEEEEEECC------------------------CCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceee
Q 046598 695 QIGEGSFGSVFKGILDD------------------------GRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKI 750 (986)
Q Consensus 695 ~lg~G~~g~Vy~~~~~~------------------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 750 (986)
.||+|+||.||+|.... ....||+|++.........++.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999998531 124589999876544455678899999999999999999
Q ss_pred eeeccccccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCC
Q 046598 751 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLK 830 (986)
Q Consensus 751 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlk 830 (986)
+++|. .+...++||||+++|+|..++.. ..+.+++..+..++.||++||+|||+. +|+|||||
T Consensus 82 ~~~~~-----~~~~~~lv~ey~~~g~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlk 144 (274)
T cd05076 82 HGVCV-----RGSENIMVEEFVEHGPLDVCLRK---------EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVC 144 (274)
T ss_pred EEEEE-----eCCceEEEEecCCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCC
Confidence 99953 44678999999999999999852 234688999999999999999999999 99999999
Q ss_pred CCCeEecCCC-------cEEEcccccceecCCCCCccccccccccccccccccccC-CCcCcccchhhHHHHHHHHH-hC
Q 046598 831 PSNILLDEDM-------IAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELI-TR 901 (986)
Q Consensus 831 p~NIll~~~~-------~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~ell-tg 901 (986)
|+||+++..+ .+|++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++||++ +|
T Consensus 145 p~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g 218 (274)
T cd05076 145 AKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDG 218 (274)
T ss_pred cccEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 9999997644 4899999998643211 12346788999998865 56899999999999999995 69
Q ss_pred CCCCCccccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCC
Q 046598 902 KKPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRM 981 (986)
Q Consensus 902 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 981 (986)
+.||....... ... ..+.... .+. ....++.+++.+||+.+|++||
T Consensus 219 ~~p~~~~~~~~--~~~------------~~~~~~~-~~~-------------------~~~~~~~~li~~cl~~~p~~Rp 264 (274)
T cd05076 219 EVPLKERTPSE--KER------------FYEKKHR-LPE-------------------PSCKELATLISQCLTYEPTQRP 264 (274)
T ss_pred CCCccccChHH--HHH------------HHHhccC-CCC-------------------CCChHHHHHHHHHcccChhhCc
Confidence 99986322111 000 1110000 000 0123477899999999999999
Q ss_pred CCCCC
Q 046598 982 SMTNV 986 (986)
Q Consensus 982 t~~eV 986 (986)
|+.+|
T Consensus 265 s~~~i 269 (274)
T cd05076 265 SFRTI 269 (274)
T ss_pred CHHHH
Confidence 99874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=313.29 Aligned_cols=249 Identities=21% Similarity=0.272 Sum_probs=193.8
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
++|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+++++.++||||++++++ +..+..
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~-----~~~~~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCS-----FETKRH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEE-----EecCCE
Confidence 36889999999999999999999999999999987543 2334578899999999999999999988 445678
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.++||||+++++|.+++.. .+.+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||
T Consensus 76 ~~lv~e~~~g~~L~~~l~~----------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l 142 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKN----------IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKL 142 (305)
T ss_pred EEEEEecCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEE
Confidence 9999999999999999952 23588999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCC-------------ccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccc
Q 046598 845 GDFGLARFLPLSSA-------------QTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEG 911 (986)
Q Consensus 845 ~DFG~a~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~ 911 (986)
+|||.++....... ........++..|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 143 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~-- 220 (305)
T cd05609 143 TDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT-- 220 (305)
T ss_pred eeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--
Confidence 99999864211100 001112357889999999988889999999999999999999999985221
Q ss_pred cccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 046598 912 DMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMT 984 (986)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 984 (986)
............ . ..+. .....+.++.+++.+||+.+|++||++.
T Consensus 221 ---~~~~~~~~~~~~--------~-~~~~----------------~~~~~~~~~~~li~~~l~~~P~~R~~~~ 265 (305)
T cd05609 221 ---PEELFGQVISDD--------I-EWPE----------------GDEALPADAQDLISRLLRQNPLERLGTG 265 (305)
T ss_pred ---HHHHHHHHHhcc--------c-CCCC----------------ccccCCHHHHHHHHHHhccChhhccCcc
Confidence 111111100000 0 0000 0002345578999999999999999964
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=305.33 Aligned_cols=247 Identities=23% Similarity=0.366 Sum_probs=196.3
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeecc--CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
+|+..+.||+|+||.||+|....+++.+|+|++... .....+.+.+|++++++++||||+++++. +..++..+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~-----~~~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN-----FLEDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeee-----EecCCEEE
Confidence 588999999999999999999988999999998653 23345778999999999999999999988 44567899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCC-CcEEEc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED-MIAHIG 845 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kL~ 845 (986)
+||||+++++|.+++.... ...+++..+..++.|+++|++|||++ +++||||+|+||+++++ +.+||+
T Consensus 76 lv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~ 144 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRC--------NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIG 144 (256)
T ss_pred EEEecCCCCCHHHHHHHhc--------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEc
Confidence 9999999999999996321 33588999999999999999999999 99999999999999855 468999
Q ss_pred ccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCC
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPD 925 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 925 (986)
|||.+....... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||+.... ......
T Consensus 145 d~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-----~~~~~~---- 212 (256)
T cd08220 145 DFGISKILSSKS---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-----PALVLK---- 212 (256)
T ss_pred cCCCceecCCCc---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch-----HHHHHH----
Confidence 999998764322 12234578899999999988899999999999999999999999863211 111110
Q ss_pred chhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 926 HVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 926 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
........ .....+..+.+++.+||+.+|++|||+.|+
T Consensus 213 ----~~~~~~~~-------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l 250 (256)
T cd08220 213 ----IMSGTFAP-------------------ISDRYSPDLRQLILSMLNLDPSKRPQLSQI 250 (256)
T ss_pred ----HHhcCCCC-------------------CCCCcCHHHHHHHHHHccCChhhCCCHHHH
Confidence 00000000 001234457799999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=305.56 Aligned_cols=246 Identities=25% Similarity=0.320 Sum_probs=195.2
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC-----chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-----HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
+|+..+.||+|+||.||+|....+++.||+|++.... ....+.+.+|+++++.++|+||+++++++ ..+.
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE-----REED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE-----ecCC
Confidence 5788899999999999999998778999999986533 23456789999999999999999999984 4557
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..++||||+++++|.+++.. ...+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+|
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~k 142 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKK----------YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVK 142 (258)
T ss_pred eEEEEEEecCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEE
Confidence 89999999999999999952 23578999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccCCC-cCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSE-VSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 922 (986)
|+|||.+....... ......++..|+|||.+.... ++.++|+|||||++|+|++|+.||..... ........
T Consensus 143 l~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~ 215 (258)
T cd06632 143 LADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG----VAAVFKIG 215 (258)
T ss_pred EccCccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH----HHHHHHHH
Confidence 99999997653322 223355888999999987766 89999999999999999999999864321 11100000
Q ss_pred CCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 923 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.... .. ........++.+++.+||+.+|++||++.|+
T Consensus 216 ~~~~--------~~-------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~ 252 (258)
T cd06632 216 RSKE--------LP-------------------PIPDHLSDEAKDFILKCLQRDPSLRPTAAEL 252 (258)
T ss_pred hccc--------CC-------------------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHH
Confidence 0000 00 0001223456789999999999999998764
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=311.93 Aligned_cols=201 Identities=27% Similarity=0.383 Sum_probs=171.8
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc--CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
++|++.+.||+|+||.||+|.+..+++.||+|+++.. .....+.+.+|++++++++|+||+++++++ ..++..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAF-----RRKGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheE-----EECCEE
Confidence 4789999999999999999999988999999998643 233356789999999999999999999984 446789
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
++||||++++.+..+.. ....+++.++..++.||+.|++|||+. +++||||+|+||++++++.+||+
T Consensus 76 ~iv~e~~~~~~l~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~ 142 (288)
T cd07833 76 YLVFEYVERTLLELLEA----------SPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLC 142 (288)
T ss_pred EEEEecCCCCHHHHHHh----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEE
Confidence 99999998877766553 223478999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
|||.+........ .......++..|+|||++.+. .++.++||||||+++|+|++|+.||..
T Consensus 143 d~g~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~ 204 (288)
T cd07833 143 DFGFARALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPG 204 (288)
T ss_pred eeecccccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999987643322 122335578899999999888 889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=311.94 Aligned_cols=249 Identities=21% Similarity=0.270 Sum_probs=198.6
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
.++|.+.+.||+|+||.||+|....++..||+|.+........+.+.+|+.++++++||||++++++| ...+..+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~ 92 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY-----LVGDELW 92 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhhee-----eeCCcEE
Confidence 36899999999999999999999888899999998765555567789999999999999999999984 4457899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+|+||+++++|.+++.. ..+++.++..++.|++.|+.|||++ +++||||||+||+++.++.+||+|
T Consensus 93 lv~e~~~~~~L~~~~~~-----------~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~d 158 (293)
T cd06647 93 VVMEYLAGGSLTDVVTE-----------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTD 158 (293)
T ss_pred EEEecCCCCcHHHHHhh-----------cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEcc
Confidence 99999999999999852 2478889999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCc
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDH 926 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 926 (986)
||.+........ ......+++.|+|||.+.+..++.++|||||||++|++++|+.||......... ..... .
T Consensus 159 fg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~-~~~~~---~-- 230 (293)
T cd06647 159 FGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-YLIAT---N-- 230 (293)
T ss_pred Ccceeccccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe-eehhc---C--
Confidence 999876543222 222345888999999998888999999999999999999999999632211100 00000 0
Q ss_pred hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 927 VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 927 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..+ ........+..+.+++.+||..+|++||++.|+
T Consensus 231 ----------~~~--------------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~i 266 (293)
T cd06647 231 ----------GTP--------------ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKEL 266 (293)
T ss_pred ----------CCC--------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 000 000111234457789999999999999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=305.67 Aligned_cols=203 Identities=24% Similarity=0.325 Sum_probs=170.7
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC-----chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-----HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
.+|++.+.||+|+||.||.|.+..+++.||+|++.... ....+.+.+|++++++++||||+++++++.. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD---PME 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEecc---CCC
Confidence 57899999999999999999999889999999885321 1234678889999999999999999998432 123
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
...++||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~ 145 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKS----------YGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNV 145 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCE
Confidence 568899999999999999852 23478888999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCC-ccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCC
Q 046598 843 HIGDFGLARFLPLSSA-QTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTD 906 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~ 906 (986)
||+|||.++....... ........++..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 146 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 210 (265)
T cd06652 146 KLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWA 210 (265)
T ss_pred EECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCC
Confidence 9999999975432111 111223458889999999988889999999999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=304.13 Aligned_cols=242 Identities=28% Similarity=0.380 Sum_probs=187.1
Q ss_pred cccccccceeEEEEEECCCCeEEEEEEeeccCc-hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEEEEec
Q 046598 694 NQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFM 772 (986)
Q Consensus 694 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 772 (986)
+.||+|+||.||+|...+ ++.||+|+++.... .....+.+|++++++++||||++++++| ......++||||+
T Consensus 1 ~~ig~g~~g~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKD-KTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC-----TQRQPIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEecC-CcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEE-----ecCCccEEEEECC
Confidence 468999999999999764 78899999865432 2345688999999999999999999985 3446789999999
Q ss_pred cCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccccccee
Q 046598 773 HNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARF 852 (986)
Q Consensus 773 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~ 852 (986)
++++|.+++.. ....+++..+..++.|++.||.|+|+. +++||||||+||+++.++.+||+|||++..
T Consensus 75 ~~~~L~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 142 (250)
T cd05085 75 PGGDFLSFLRK---------KKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQ 142 (250)
T ss_pred CCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCcccee
Confidence 99999999852 223578999999999999999999999 999999999999999999999999999975
Q ss_pred cCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCchhHHh
Q 046598 853 LPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALPDHVMDIV 931 (986)
Q Consensus 853 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (986)
...... .......++..|+|||++.+..++.++|||||||++|++++ |..||...... ..... +
T Consensus 143 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-----~~~~~---------~ 207 (250)
T cd05085 143 EDDGIY-SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-----QAREQ---------V 207 (250)
T ss_pred cccccc-ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-----HHHHH---------H
Confidence 432211 11112234678999999998899999999999999999999 99998632111 11000 0
Q ss_pred hhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 932 DSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 932 d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
....... ....++.++.+++.+|++.+|++||++.||
T Consensus 208 ~~~~~~~------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l 244 (250)
T cd05085 208 EKGYRMS------------------CPQKCPDDVYKVMQRCWDYKPENRPKFSEL 244 (250)
T ss_pred HcCCCCC------------------CCCCCCHHHHHHHHHHcccCcccCCCHHHH
Confidence 0000000 001234567899999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=308.94 Aligned_cols=250 Identities=28% Similarity=0.440 Sum_probs=191.0
Q ss_pred cccccccceeEEEEEECCCC------eEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 694 NQIGEGSFGSVFKGILDDGR------TTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 694 ~~lg~G~~g~Vy~~~~~~~~------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
+.||+|+||.||+|++.+.. +.||+|.+.... ......+.+|+.+++.++||||++++++| ...+..+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVC-----LLNEPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeee-----cCCCCeE
Confidence 46899999999999986433 689999875432 23456789999999999999999999985 3456789
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCC-----c
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDM-----I 841 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~ 841 (986)
+||||+++++|.++++..... ......+++.++..++.|++.|++|||+. +++|+||||+||+++.++ .
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~ 149 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVE---RFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRV 149 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhc---ccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcc
Confidence 999999999999999643221 01234578999999999999999999998 999999999999999877 8
Q ss_pred EEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHH
Q 046598 842 AHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLAR 920 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~ 920 (986)
+|++|||+++...............++..|+|||++.++.++.++|||||||++|||++ |+.||...... ....
T Consensus 150 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~-----~~~~ 224 (269)
T cd05044 150 VKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ-----EVLQ 224 (269)
T ss_pred eEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH-----HHHH
Confidence 99999999976543322222223345788999999999999999999999999999998 99998632110 1100
Q ss_pred hhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 921 TALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 921 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.++... +.......+..+.+++.+||+.+|++||++++|
T Consensus 225 ---------~~~~~~------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 263 (269)
T cd05044 225 ---------HVTAGG------------------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRI 263 (269)
T ss_pred ---------HHhcCC------------------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHH
Confidence 000000 000111234567899999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=319.21 Aligned_cols=283 Identities=22% Similarity=0.263 Sum_probs=200.6
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++... ......
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPP-GADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhcccc-CCCCce
Confidence 478999999999999999999999989999999986432 23346778899999999999999999886433 234467
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.++||||+. ++|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||
T Consensus 83 ~~lv~e~~~-~~l~~~~~----------~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl 148 (334)
T cd07855 83 VYVVMDLME-SDLHHIIH----------SDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRI 148 (334)
T ss_pred EEEEEehhh-hhHHHHhc----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEe
Confidence 899999995 68999884 223589999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCc--cccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHh
Q 046598 845 GDFGLARFLPLSSAQ--TSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLART 921 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~ 921 (986)
+|||.+......... .......++..|+|||++.+ ..++.++|||||||++|||++|+.||...... ........
T Consensus 149 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~--~~~~~~~~ 226 (334)
T cd07855 149 GDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV--HQLKLILS 226 (334)
T ss_pred cccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH--HHHHHHHH
Confidence 999999765332211 11223468889999998765 46899999999999999999999999642111 11111111
Q ss_pred hCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 922 ALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 922 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.......+..+.............................+.++.+++.+|++.+|++|||++|+
T Consensus 227 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~ 291 (334)
T cd07855 227 VLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQA 291 (334)
T ss_pred HhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 11111111111100000000000000000000000112346678899999999999999998764
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=304.91 Aligned_cols=251 Identities=25% Similarity=0.378 Sum_probs=197.9
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc--hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
+|.+.+.||+|+||.||+|.+..+++.||+|+++.... ...+.+.+|++++++++|+||++++++ ....+..+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~-----~~~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV-----EVHREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeee-----EecCCEEE
Confidence 58899999999999999999988889999999875444 356789999999999999999999998 34567899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+|+||+++++|.+++.. ...+++..+..++.|+++|++|||+. +++||||+|+||++++++.+||+|
T Consensus 76 lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d 142 (264)
T cd06626 76 IFMEYCSGGTLEELLEH----------GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGD 142 (264)
T ss_pred EEEecCCCCcHHHHHhh----------cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcc
Confidence 99999999999999852 23478889999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccc--cccccccccccccccccCCC---cCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHh
Q 046598 847 FGLARFLPLSSAQTS--SIGAKGSIGYIAPEYGLGSE---VSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLART 921 (986)
Q Consensus 847 FG~a~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~ 921 (986)
||.+........... .....++..|+|||++.+.. ++.++||||||+++|++++|+.||..... ........
T Consensus 143 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~---~~~~~~~~ 219 (264)
T cd06626 143 FGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN---EFQIMFHV 219 (264)
T ss_pred cccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc---hHHHHHHH
Confidence 999987643322111 12345788999999988766 88999999999999999999999963211 11110000
Q ss_pred hCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 922 ALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 922 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.. . ..+ ..+........+.+++.+||+.+|++|||+.|+
T Consensus 220 ~~-~-----------~~~--------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i 258 (264)
T cd06626 220 GA-G-----------HKP--------------PIPDSLQLSPEGKDFLDRCLESDPKKRPTASEL 258 (264)
T ss_pred hc-C-----------CCC--------------CCCcccccCHHHHHHHHHHccCCcccCCCHHHH
Confidence 00 0 000 000011224456789999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=305.15 Aligned_cols=248 Identities=27% Similarity=0.423 Sum_probs=193.1
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
..+|++.+.||+|+||.||+|.+.. +..+|+|+++... .....+.+|++++++++||+++++++++ ......+
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVC-----TERSPIC 75 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEE-----ccCCceE
Confidence 3468889999999999999999875 5689999886432 2346789999999999999999999984 4557789
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+++++|.+++.. ....+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|
T Consensus 76 ~v~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d 143 (256)
T cd05112 76 LVFEFMEHGCLSDYLRA---------QRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSD 143 (256)
T ss_pred EEEEcCCCCcHHHHHHh---------CccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECC
Confidence 99999999999999852 223578999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCC
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALPD 925 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 925 (986)
||.++....... .......++..|+|||++.+..++.++||||||+++|||++ |+.||..... .......
T Consensus 144 ~g~~~~~~~~~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~--- 214 (256)
T cd05112 144 FGMTRFVLDDQY-TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-----SEVVETI--- 214 (256)
T ss_pred CcceeecccCcc-cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-----HHHHHHH---
Confidence 999976532211 11222335678999999998899999999999999999998 9999863211 1111100
Q ss_pred chhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 926 HVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 926 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
........ +...+.++.+++.+||+.+|++|||+.||
T Consensus 215 ------~~~~~~~~------------------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~ 251 (256)
T cd05112 215 ------NAGFRLYK------------------PRLASQSVYELMQHCWKERPEDRPSFSLL 251 (256)
T ss_pred ------hCCCCCCC------------------CCCCCHHHHHHHHHHcccChhhCCCHHHH
Confidence 00000000 00123467899999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=304.09 Aligned_cols=199 Identities=21% Similarity=0.347 Sum_probs=157.0
Q ss_pred cccccccceeEEEEEECCC--CeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEEEE
Q 046598 694 NQIGEGSFGSVFKGILDDG--RTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFE 770 (986)
Q Consensus 694 ~~lg~G~~g~Vy~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 770 (986)
+.||+|+||.||+|....+ ...+++|.++... ....+.+.+|+.+++.++||||++++++| ......++|||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~-----~~~~~~~lv~e 75 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQC-----VEAIPYLLVFE 75 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEe-----cCCCccEEEEe
Confidence 3699999999999976432 2346677665432 33457899999999999999999999985 34567899999
Q ss_pred eccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcccccc
Q 046598 771 FMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLA 850 (986)
Q Consensus 771 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a 850 (986)
|+++|+|.++++.... .....++..+..++.||++||+|||+. +++||||||+||+++.++.+||+|||++
T Consensus 76 ~~~~~~L~~~l~~~~~------~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~ 146 (268)
T cd05086 76 YCELGDLKSYLSQEQW------HRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIG 146 (268)
T ss_pred cCCCCcHHHHHHhhhc------ccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccc
Confidence 9999999999964221 123467778889999999999999999 9999999999999999999999999998
Q ss_pred eecCCCCCccccccccccccccccccccC-------CCcCcccchhhHHHHHHHHHh-CCCCCC
Q 046598 851 RFLPLSSAQTSSIGAKGSIGYIAPEYGLG-------SEVSISGDVYSYGILLLELIT-RKKPTD 906 (986)
Q Consensus 851 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvvl~ellt-g~~pf~ 906 (986)
................++..|+|||++.. ..++.++|||||||++|||++ |..||.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~ 210 (268)
T cd05086 147 PSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYS 210 (268)
T ss_pred cccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Confidence 64322211122234567889999998743 245789999999999999997 567775
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=305.28 Aligned_cols=252 Identities=23% Similarity=0.323 Sum_probs=196.4
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC------chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH------HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
+|+..+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|++++++++|+||++++++ +.+.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~-----~~~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGA-----TCED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhce-----eccC
Confidence 4888899999999999999998889999999986432 1234678999999999999999999999 4556
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCC-c
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDM-I 841 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~ 841 (986)
+..++||||+++++|.+++.. ..++++..+..++.|++.||.|||+. +++||||+|+||+++.++ .
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~ 142 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSK----------YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQR 142 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHH----------hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCE
Confidence 789999999999999999852 23578999999999999999999999 999999999999998776 6
Q ss_pred EEEcccccceecCCCCC--ccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHH
Q 046598 842 AHIGDFGLARFLPLSSA--QTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLA 919 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~ 919 (986)
+||+|||.+........ ........++..|+|||.+.+..++.++||||+|+++|+|++|..||....... ......
T Consensus 143 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~ 221 (268)
T cd06630 143 LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN-HLALIF 221 (268)
T ss_pred EEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc-hHHHHH
Confidence 99999999976643211 111223457889999999988889999999999999999999999986321110 011000
Q ss_pred HhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 920 RTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 920 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.. .... .. ...+.....++.+++.+|+..+|++|||+.|+
T Consensus 222 ~~---------~~~~--~~----------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~l 261 (268)
T cd06630 222 KI---------ASAT--TA----------------PSIPEHLSPGLRDVTLRCLELQPEDRPPSREL 261 (268)
T ss_pred HH---------hccC--CC----------------CCCchhhCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 00 0000 00 00111344567889999999999999999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=309.35 Aligned_cols=236 Identities=21% Similarity=0.334 Sum_probs=181.2
Q ss_pred cccccccceeEEEEEECCCCe-------EEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 694 NQIGEGSFGSVFKGILDDGRT-------TIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 694 ~~lg~G~~g~Vy~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
+.||+|+||.||+|.+...+. .||+|+.........+++.+|+.+++.++||||+++++++ ..+...+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVC-----VCGDESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEE-----EeCCCcE
Confidence 469999999999999865443 4888888655555567889999999999999999999995 3446789
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCc-----
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI----- 841 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~----- 841 (986)
+||||+++|+|.++++.. ...+++..++.++.||+.|++|||+. +|+||||||+||+++.++.
T Consensus 76 lv~e~~~~g~L~~~l~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~ 143 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKN---------KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGN 143 (258)
T ss_pred EEEecCCCCcHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCC
Confidence 999999999999999632 23578999999999999999999999 9999999999999987765
Q ss_pred ---EEEcccccceecCCCCCccccccccccccccccccccCC-CcCcccchhhHHHHHHHHHhCC-CCCCccccccccHH
Q 046598 842 ---AHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRK-KPTDIMFEGDMNLH 916 (986)
Q Consensus 842 ---~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~-~pf~~~~~~~~~~~ 916 (986)
++++|||.+..... .....++..|+|||++.+. .++.++|||||||++|||++|. .||......
T Consensus 144 ~~~~~l~d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~----- 212 (258)
T cd05078 144 PPFIKLSDPGISITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ----- 212 (258)
T ss_pred CceEEecccccccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH-----
Confidence 69999999865422 1224578899999998874 5799999999999999999985 554321110
Q ss_pred HHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 917 NLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 917 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.. ......... -+ .....++.+++.+||+.+|++|||++|+
T Consensus 213 ~~---------~~~~~~~~~-~~-------------------~~~~~~~~~li~~~l~~~p~~Rps~~~i 253 (258)
T cd05078 213 KK---------LQFYEDRHQ-LP-------------------APKWTELANLINQCMDYEPDFRPSFRAI 253 (258)
T ss_pred HH---------HHHHHcccc-CC-------------------CCCcHHHHHHHHHHhccChhhCCCHHHH
Confidence 00 000000000 00 0112357799999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=287.24 Aligned_cols=257 Identities=20% Similarity=0.229 Sum_probs=200.6
Q ss_pred HhhcCCCCC-cccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcC-CCCcceeeeeeccccccCCC
Q 046598 685 NATDRFSSV-NQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 685 ~~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~ 762 (986)
..+++|.+. ++||-|-.|.|-.+.++.+++++|+|++... ....+|++..-.. .|||||+++++|... +...
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs-~~~r 131 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENS-YQGR 131 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhh-ccCc
Confidence 356677765 5799999999999999999999999998532 3446777765544 799999999997655 7788
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCC---
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED--- 839 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--- 839 (986)
....+|||.|+||.|.+.++..+ ...+++.++..|++||+.|+.|||+. +|.||||||+|+|....
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g--------~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~n 200 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRG--------DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPN 200 (400)
T ss_pred eeeEeeeecccchHHHHHHHHcc--------cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCC
Confidence 89999999999999999997433 34699999999999999999999999 99999999999999644
Q ss_pred CcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHH
Q 046598 840 MIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLA 919 (986)
Q Consensus 840 ~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~ 919 (986)
-.+||+|||+|+.-.. .......+-|+.|.|||++...+|+...|+||+||++|-|++|.+||.......
T Consensus 201 a~lKLtDfGFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a------- 270 (400)
T KOG0604|consen 201 APLKLTDFGFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA------- 270 (400)
T ss_pred cceEecccccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc-------
Confidence 4799999999986432 233445678999999999999999999999999999999999999997432211
Q ss_pred HhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 920 RTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 920 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
++..+..-+.. +...-+. ++-.+..++..++++..++.+|.+|.|++|+
T Consensus 271 ---ispgMk~rI~~------------gqy~FP~---pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~ 319 (400)
T KOG0604|consen 271 ---ISPGMKRRIRT------------GQYEFPE---PEWSCVSEAAKDLIRKLLKTEPTERLTIEEV 319 (400)
T ss_pred ---CChhHHhHhhc------------cCccCCC---hhHhHHHHHHHHHHHHHhcCCchhheeHHHh
Confidence 11111111110 0000011 1223556667789999999999999998875
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=303.37 Aligned_cols=248 Identities=27% Similarity=0.487 Sum_probs=194.9
Q ss_pred CCCCcccccccceeEEEEEECCCC----eEEEEEEeeccCch-hHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 690 FSSVNQIGEGSFGSVFKGILDDGR----TTIAVKVFNLLHHG-AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 690 y~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
+++.+.||.|+||.||+|++...+ ..||+|+++..... ..+.+.+|+++++.++|+||+++++++ ...+.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVC-----TEEEP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEE-----cCCCe
Confidence 457789999999999999998765 88999999754433 567899999999999999999999984 44478
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.++||||+++++|.+++.... ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.++|
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~--------~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l 144 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNR--------PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKI 144 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhh--------hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEE
Confidence 999999999999999996321 11289999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhC
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTAL 923 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 923 (986)
+|||.++........... ...++..|+|||.+.+..++.++||||+|+++|+|++ |+.||... ........
T Consensus 145 ~dfg~~~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~-----~~~~~~~~-- 216 (258)
T smart00219 145 SDFGLSRDLYDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM-----SNEEVLEY-- 216 (258)
T ss_pred cccCCceecccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHH--
Confidence 999999876533222111 2336789999999988889999999999999999998 88887631 11111110
Q ss_pred CCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 924 PDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 924 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+...... ......+.++.+++.+|++.+|++|||+.|+
T Consensus 217 -------~~~~~~~------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l 254 (258)
T smart00219 217 -------LKKGYRL------------------PKPENCPPEIYKLMLQCWAEDPEDRPTFSEL 254 (258)
T ss_pred -------HhcCCCC------------------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHH
Confidence 0000000 0001234568899999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=313.70 Aligned_cols=246 Identities=21% Similarity=0.284 Sum_probs=193.9
Q ss_pred CCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEEE
Q 046598 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVF 769 (986)
Q Consensus 690 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 769 (986)
|.....||+|+||.||+|.+..+++.||+|++........+.+.+|+.+++.++||||+++++++ ..++..++||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~iv~ 97 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY-----LVGEELWVLM 97 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhe-----eeCCeEEEEE
Confidence 34455799999999999999888899999998765555567788999999999999999999984 4567899999
Q ss_pred EeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccccc
Q 046598 770 EFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGL 849 (986)
Q Consensus 770 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~ 849 (986)
||+++++|..++.. ..+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+
T Consensus 98 e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~ 163 (297)
T cd06659 98 EFLQGGALTDIVSQ-----------TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGF 163 (297)
T ss_pred ecCCCCCHHHHHhh-----------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechh
Confidence 99999999998741 3478999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCchhH
Q 046598 850 ARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVMD 929 (986)
Q Consensus 850 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 929 (986)
+....... .......++..|+|||++.+..++.++|||||||++|||++|+.||..... ......
T Consensus 164 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~~~~~~--------- 228 (297)
T cd06659 164 CAQISKDV--PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP----VQAMKR--------- 228 (297)
T ss_pred Hhhccccc--ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHH---------
Confidence 97543221 122335688999999999988999999999999999999999999863211 111100
Q ss_pred HhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 930 IVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 930 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+........ .........+.+++.+||+.+|++||+++||
T Consensus 229 -~~~~~~~~~----------------~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~l 268 (297)
T cd06659 229 -LRDSPPPKL----------------KNAHKISPVLRDFLERMLTREPQERATAQEL 268 (297)
T ss_pred -HhccCCCCc----------------cccCCCCHHHHHHHHHHhcCCcccCcCHHHH
Confidence 000000000 0001123456789999999999999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=305.74 Aligned_cols=257 Identities=23% Similarity=0.287 Sum_probs=200.2
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
++|++.+.||.|+||+||+|....++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+ ..+...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF-----VVGDELW 75 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEE-----eeCCEEE
Confidence 47999999999999999999998888999999986432 23557889999999999999999999883 4567899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+++++|.++++.... ...+++..+..++.|++.|++|||+. +++||||+|+||++++++.+||+|
T Consensus 76 iv~e~~~~~~l~~~~~~~~~-------~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~d 145 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSSYP-------RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIAD 145 (267)
T ss_pred EEEeccCCCcHHHHHHHhcc-------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcc
Confidence 99999999999999963211 23588999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcc--ccccccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhC
Q 046598 847 FGLARFLPLSSAQT--SSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTAL 923 (986)
Q Consensus 847 FG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 923 (986)
||.+..+....... ......++..|+|||++... .++.++|||||||++|+|++|+.||....... .+......
T Consensus 146 f~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~-- 222 (267)
T cd06610 146 FGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLMLTLQN-- 222 (267)
T ss_pred cchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHHHhcC--
Confidence 99997664332221 22334588999999998776 78999999999999999999999986332211 01111000
Q ss_pred CCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 924 PDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 924 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+... . ........+..+.+++.+||+.||++|||++||
T Consensus 223 --------------~~~~~-~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l 261 (267)
T cd06610 223 --------------DPPSL-E---------TGADYKKYSKSFRKMISLCLQKDPSKRPTAEEL 261 (267)
T ss_pred --------------CCCCc-C---------CccccccccHHHHHHHHHHcCCChhhCcCHHHH
Confidence 00000 0 000011334567899999999999999998764
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=304.04 Aligned_cols=248 Identities=27% Similarity=0.424 Sum_probs=193.1
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
.++|++.++||+|+||.||+|.+.. +..+|+|.++.. ....+.+.+|++++++++|+||+++++++ .. ...+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~-~~~~ 76 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVV-----TK-EPIY 76 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecC-CccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEE-----cC-CCeE
Confidence 4689999999999999999998765 567999988643 23456788999999999999999999884 23 5689
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+++++|.+++... ....+++.++..++.|++.||.|||+. +++||||||+||+++.++.+||+|
T Consensus 77 ~v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d 145 (260)
T cd05073 77 IITEFMAKGSLLDFLKSD--------EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIAD 145 (260)
T ss_pred EEEEeCCCCcHHHHHHhC--------CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECC
Confidence 999999999999999632 234578899999999999999999998 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCC
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALPD 925 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 925 (986)
||.+........ .......++..|+|||++.+..++.++|||||||++|+++| |+.||...... ...........
T Consensus 146 ~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~- 221 (260)
T cd05073 146 FGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALERGYR- 221 (260)
T ss_pred CcceeeccCCCc-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHhCCCC-
Confidence 999976543221 12222345678999999998889999999999999999999 99998632111 01111000000
Q ss_pred chhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 926 HVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 926 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
. +.....+.++.+++.+|++.+|++||++.+|
T Consensus 222 -----------~------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l 253 (260)
T cd05073 222 -----------M------------------PRPENCPEELYNIMMRCWKNRPEERPTFEYI 253 (260)
T ss_pred -----------C------------------CCcccCCHHHHHHHHHHcccCcccCcCHHHH
Confidence 0 0001234567899999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=309.94 Aligned_cols=272 Identities=22% Similarity=0.256 Sum_probs=196.0
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCch-----hHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHG-----AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
+|++.+.||+|+||.||+|.+..+++.||+|.++..... ....+..|++++++++|+||+++++++ .+..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF-----GHKS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee-----ecCC
Confidence 588889999999999999999888999999999754322 335677899999999999999999994 4467
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..++||||+ +++|.+++... ...+++.++..++.||++||+|||++ +++||||||+||+++.++.+|
T Consensus 76 ~~~lv~e~~-~~~L~~~i~~~---------~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~ 142 (298)
T cd07841 76 NINLVFEFM-ETDLEKVIKDK---------SIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLK 142 (298)
T ss_pred EEEEEEccc-CCCHHHHHhcc---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEE
Confidence 899999999 99999999521 12589999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 922 (986)
|+|||.++....... ......++..|+|||.+.+ ..++.++|||||||++|||++|.+||...... ..+..... .
T Consensus 143 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~~~-~ 218 (298)
T cd07841 143 LADFGLARSFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKIFE-A 218 (298)
T ss_pred EccceeeeeccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHHHH-H
Confidence 999999987643221 1222346788999998755 46789999999999999999998877532211 11111111 1
Q ss_pred CCCchh-HHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 923 LPDHVM-DIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 923 ~~~~~~-~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
...... ...+..-..... ... ................++.+++.+||+.+|++|||++||
T Consensus 219 ~~~~~~~~~~~~~~~~~~~---~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~ 279 (298)
T cd07841 219 LGTPTEENWPGVTSLPDYV---EFK-PFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQA 279 (298)
T ss_pred cCCCchhhhhhcccccccc---ccc-ccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHH
Confidence 111000 000000000000 000 000000001112335678899999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=303.83 Aligned_cols=250 Identities=25% Similarity=0.312 Sum_probs=201.2
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc-hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
++|++.+.||+|++|.||+|++..+++.||+|++..... ...+.+.+|++++++++|+|++++++++ ......+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF-----YKEGEIS 75 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----ccCCeEE
Confidence 368899999999999999999998899999999876543 4467899999999999999999999984 4558899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHH-DCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
+||||+++++|.+++.. ...+++..+..++.|+++|++|||+ . +++||||+|+||+++.++.++|+
T Consensus 76 lv~e~~~~~~L~~~l~~----------~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~ 142 (264)
T cd06623 76 IVLEYMDGGSLADLLKK----------VGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIA 142 (264)
T ss_pred EEEEecCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEc
Confidence 99999999999999952 2468999999999999999999999 8 99999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCC
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPD 925 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 925 (986)
|||.+......... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ..........
T Consensus 143 df~~~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~--- 215 (264)
T cd06623 143 DFGISKVLENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ--PSFFELMQAI--- 215 (264)
T ss_pred cCccceecccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc--cCHHHHHHHH---
Confidence 99999876433222 1234578899999999999999999999999999999999999864332 0111111110
Q ss_pred chhHHhhhhcccCCcchhhccchhhhhHhhHHHHH-HHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 926 HVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIE-CLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 926 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
........ ... .+..+.+++.+|++.+|++|||+.|+
T Consensus 216 -----~~~~~~~~-------------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l 253 (264)
T cd06623 216 -----CDGPPPSL-------------------PAEEFSPEFRDFISACLQKDPKKRPSAAEL 253 (264)
T ss_pred -----hcCCCCCC-------------------CcccCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 00000000 001 34567899999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=284.54 Aligned_cols=212 Identities=25% Similarity=0.368 Sum_probs=180.8
Q ss_pred cChHHHHHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcC-CCCcceeeeeeccc
Q 046598 678 ISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSG 756 (986)
Q Consensus 678 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 756 (986)
-++.|+++.++ +.||+|+|+.|--++...++..+|||++.+.......++.+|++++.+. .|+||++++++
T Consensus 73 g~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLief--- 144 (463)
T KOG0607|consen 73 GKFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEF--- 144 (463)
T ss_pred chHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHH---
Confidence 35788888876 6799999999999999999999999999877666778999999999998 69999999999
Q ss_pred cccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEe
Q 046598 757 VDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILL 836 (986)
Q Consensus 757 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 836 (986)
|+++...|+|||.|.||+|..++++ .+.+++.++.++.++|+.||.|||.+ ||.|||+||+|||-
T Consensus 145 --FEdd~~FYLVfEKm~GGplLshI~~----------~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC 209 (463)
T KOG0607|consen 145 --FEDDTRFYLVFEKMRGGPLLSHIQK----------RKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILC 209 (463)
T ss_pred --hcccceEEEEEecccCchHHHHHHH----------hhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceee
Confidence 7788999999999999999999963 34689999999999999999999999 99999999999999
Q ss_pred cCCC---cEEEcccccceecCCC-----CCcccccccccccccccccccc---C--CCcCcccchhhHHHHHHHHHhCCC
Q 046598 837 DEDM---IAHIGDFGLARFLPLS-----SAQTSSIGAKGSIGYIAPEYGL---G--SEVSISGDVYSYGILLLELITRKK 903 (986)
Q Consensus 837 ~~~~---~~kL~DFG~a~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~---~--~~~~~~sDvwSlGvvl~elltg~~ 903 (986)
.... -+||+||.++.-+... ...+.....+|+..|||||+.. + ..|+.+.|.||+|||+|-|++|.+
T Consensus 210 ~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYp 289 (463)
T KOG0607|consen 210 ESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYP 289 (463)
T ss_pred cCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCC
Confidence 7655 4899999988544221 1233345678999999999743 2 368899999999999999999999
Q ss_pred CCCcccccc
Q 046598 904 PTDIMFEGD 912 (986)
Q Consensus 904 pf~~~~~~~ 912 (986)
||.+....+
T Consensus 290 PFvG~Cg~d 298 (463)
T KOG0607|consen 290 PFVGHCGAD 298 (463)
T ss_pred CccCccCCc
Confidence 998655543
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=305.14 Aligned_cols=246 Identities=24% Similarity=0.325 Sum_probs=198.1
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
+|++.+.||.|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||++++++ +.++...
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-----~~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS-----FQDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHh-----hcCCCeE
Confidence 5889999999999999999999889999999997432 2345788999999999999999999988 4566889
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
++||||+++++|.+++.. ...+++.++..++.|+++||.|||+. +++|+||+|+||++++++.++|+
T Consensus 76 ~lv~e~~~~~~L~~~l~~----------~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~ 142 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQ----------KVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHIT 142 (258)
T ss_pred EEEEeCCCCCCHHHHHHh----------cCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEe
Confidence 999999999999999952 24688999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCC
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPD 925 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 925 (986)
|||.+....... ......++..|+|||.+.+..++.++||||+|+++|+|++|+.||...... .......
T Consensus 143 d~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~----- 212 (258)
T cd05578 143 DFNIATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRA----- 212 (258)
T ss_pred ecccccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHH-----
Confidence 999997654322 223345788999999998888999999999999999999999998743221 0111110
Q ss_pred chhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCC--CC
Q 046598 926 HVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSM--TN 985 (986)
Q Consensus 926 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~--~e 985 (986)
.... . ....+...+..+.+++.+||+.||.+||++ +|
T Consensus 213 ----~~~~---~----------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~ 251 (258)
T cd05578 213 ----KQET---A----------------DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKD 251 (258)
T ss_pred ----Hhcc---c----------------cccCcccCcHHHHHHHHHHccCChhHcCCccHHH
Confidence 0000 0 000111234567899999999999999998 65
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=308.72 Aligned_cols=252 Identities=21% Similarity=0.293 Sum_probs=190.0
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC-chhHHHHHHHHHH-HhcCCCCcceeeeeeccccccCCCceE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-HGAFKSFIAECNT-LKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
++|++.+.||+|+||.||+|.+..+++.||+|+++... .....++..|+.+ ++..+||||+++++++ ..+...
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~-----~~~~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGAL-----FREGDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEE-----ecCCcE
Confidence 46899999999999999999999889999999987532 2233455566665 5667999999999985 345679
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
++||||++ |+|.+++.... .....+++..++.++.||+.|++|||++ .+++||||||+||+++.++.+||+
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~------~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~ 146 (283)
T cd06617 76 WICMEVMD-TSLDKFYKKVY------DKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLC 146 (283)
T ss_pred EEEhhhhc-ccHHHHHHHhc------cCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEe
Confidence 99999995 68888875322 1234689999999999999999999984 289999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccC----CCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHh
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG----SEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLART 921 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~ 921 (986)
|||.++..... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ......
T Consensus 147 dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~-- 218 (283)
T cd06617 147 DFGISGYLVDS---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT---PFQQLK-- 218 (283)
T ss_pred ecccccccccc---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc---CHHHHH--
Confidence 99999765322 11223457889999998765 4568999999999999999999999863211 111110
Q ss_pred hCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 922 ALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 922 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..........+ ....+.++.+++.+||..+|++||++.||
T Consensus 219 -------~~~~~~~~~~~------------------~~~~~~~l~~li~~~l~~~p~~Rp~~~~i 258 (283)
T cd06617 219 -------QVVEEPSPQLP------------------AEKFSPEFQDFVNKCLKKNYKERPNYPEL 258 (283)
T ss_pred -------HHHhcCCCCCC------------------ccccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 11100000000 00234567899999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=306.19 Aligned_cols=250 Identities=26% Similarity=0.406 Sum_probs=194.3
Q ss_pred CCCCCcccccccceeEEEEEECC-CCeEEEEEEeecc----------CchhHHHHHHHHHHHhc-CCCCcceeeeeeccc
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDD-GRTTIAVKVFNLL----------HHGAFKSFIAECNTLKN-IRHRNLVKILTACSG 756 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 756 (986)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+... ......++.+|+.++.+ ++||||+++++++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~-- 78 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF-- 78 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE--
Confidence 48889999999999999999987 6789999987532 22334567788888865 7999999999984
Q ss_pred cccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCCeE
Q 046598 757 VDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHH-DCQPPIAHCDLKPSNIL 835 (986)
Q Consensus 757 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIl 835 (986)
..++..++||||+++++|.+++.... .....+++..++.++.|++.|+.|||+ . +++||||+|+||+
T Consensus 79 ---~~~~~~~lv~e~~~~~~l~~~l~~~~------~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil 146 (269)
T cd08528 79 ---LENDRLYIVMDLIEGAPLGEHFNSLK------EKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIM 146 (269)
T ss_pred ---ccCCeEEEEEecCCCCcHHHHHHHHH------hccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEE
Confidence 45678999999999999999885321 223468999999999999999999996 5 8999999999999
Q ss_pred ecCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccH
Q 046598 836 LDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNL 915 (986)
Q Consensus 836 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~ 915 (986)
++.++.+||+|||.+....... ......++..|+|||++.+..++.++||||||+++|||++|+.||.... .
T Consensus 147 ~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~-----~ 218 (269)
T cd08528 147 LGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN-----M 218 (269)
T ss_pred ECCCCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC-----H
Confidence 9999999999999998654322 2334568899999999999889999999999999999999999986221 1
Q ss_pred HHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 916 HNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 916 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
...... +.+......+ ....+..+.+++.+||+.||++||++.||
T Consensus 219 ~~~~~~--------~~~~~~~~~~------------------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~ 263 (269)
T cd08528 219 LSLATK--------IVEAVYEPLP------------------EGMYSEDVTDVITSCLTPDAEARPDIIQV 263 (269)
T ss_pred HHHHHH--------HhhccCCcCC------------------cccCCHHHHHHHHHHCCCCCccCCCHHHH
Confidence 111110 0000000000 00123457889999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=306.33 Aligned_cols=258 Identities=22% Similarity=0.373 Sum_probs=192.9
Q ss_pred CCCCcccccccceeEEEEEECC---CCeEEEEEEeecc--CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccC-CCc
Q 046598 690 FSSVNQIGEGSFGSVFKGILDD---GRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ-GND 763 (986)
Q Consensus 690 y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~~~ 763 (986)
|.+.+.||+|+||.||+|.+.. +++.||||+++.. .....+++.+|++++++++||||+++++++...... ...
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 6778899999999999998743 4688999998643 233456788999999999999999999986432111 112
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..++++||+++|+|.+++...... .....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+|
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~----~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~k 153 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIG----EEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVC 153 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhccc----CCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEE
Confidence 457899999999999887532211 1223578999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhh
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~ 922 (986)
|+|||.++...............++..|++||.+.+..++.++|||||||++|||++ |++||..... .......
T Consensus 154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~-----~~~~~~~ 228 (273)
T cd05074 154 VADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-----SEIYNYL 228 (273)
T ss_pred ECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH-----HHHHHHH
Confidence 999999986543322222223345678999999998899999999999999999999 8888863211 1111000
Q ss_pred CCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 923 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.... .+ .. ....+.++.+++.+||+.+|++|||+.||
T Consensus 229 ~~~~-------~~-~~-------------------~~~~~~~~~~l~~~~l~~~p~~Rps~~~~ 265 (273)
T cd05074 229 IKGN-------RL-KQ-------------------PPDCLEDVYELMCQCWSPEPKCRPSFQHL 265 (273)
T ss_pred HcCC-------cC-CC-------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 0000 00 00 01234568899999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=312.78 Aligned_cols=248 Identities=24% Similarity=0.304 Sum_probs=195.9
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc---hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH---GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+++++.++||||+++++. +..+..
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~-----~~~~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYAS-----FQTETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheee-----eecCCE
Confidence 468899999999999999999998899999999875332 244678899999999999999999998 455678
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.++||||+.+++|.+++... ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~--------~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l 144 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQ--------PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIML 144 (316)
T ss_pred EEEEEEecCCCCHHHHHHhC--------CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEE
Confidence 99999999999999998522 234689999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCc---------------------------cccccccccccccccccccCCCcCcccchhhHHHHHHH
Q 046598 845 GDFGLARFLPLSSAQ---------------------------TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLE 897 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~e 897 (986)
+|||++......... .......|+..|+|||++.+..++.++||||||+++|+
T Consensus 145 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~ 224 (316)
T cd05574 145 SDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYE 224 (316)
T ss_pred eecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHH
Confidence 999998754322110 01112357889999999999899999999999999999
Q ss_pred HHhCCCCCCccccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCC
Q 046598 898 LITRKKPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESP 977 (986)
Q Consensus 898 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP 977 (986)
|++|+.||...... ..+ ..+.+.... .......+.++.+++.+|+..+|
T Consensus 225 l~~g~~pf~~~~~~-~~~------------~~~~~~~~~------------------~~~~~~~~~~~~~li~~~l~~~p 273 (316)
T cd05574 225 MLYGTTPFKGSNRD-ETF------------SNILKKEVT------------------FPGSPPVSSSARDLIRKLLVKDP 273 (316)
T ss_pred HhhCCCCCCCCchH-HHH------------HHHhcCCcc------------------CCCccccCHHHHHHHHHHccCCH
Confidence 99999998632211 001 111110000 00001135568899999999999
Q ss_pred CCCCC
Q 046598 978 EDRMS 982 (986)
Q Consensus 978 ~~RPt 982 (986)
++|||
T Consensus 274 ~~R~s 278 (316)
T cd05574 274 SKRLG 278 (316)
T ss_pred hHCCC
Confidence 99999
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=309.47 Aligned_cols=197 Identities=28% Similarity=0.371 Sum_probs=173.7
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
++|++.+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|++++++++||||++++++ +.++..
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-----~~~~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGS-----FQDDSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeE-----EEcCCe
Confidence 46899999999999999999999889999999986432 2345678899999999999999999998 455678
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.++||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||
T Consensus 76 ~~~v~e~~~~~~L~~~~~~----------~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl 142 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRK----------SGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKI 142 (290)
T ss_pred EEEEEecCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEE
Confidence 9999999999999999852 24688999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
+|||+++..... .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||..
T Consensus 143 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 200 (290)
T cd05580 143 TDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFD 200 (290)
T ss_pred eeCCCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 999999865432 2234588999999999888899999999999999999999999863
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=307.70 Aligned_cols=200 Identities=29% Similarity=0.453 Sum_probs=168.3
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
+|+.++.||+|++|.||+|++..+++.||||+++... ....+.+.+|++++++++||||++++++ +.+++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~-----~~~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV-----IHTENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhh-----cccCCcEE
Confidence 4888999999999999999999889999999886432 2233578899999999999999999998 44567899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+. ++|.+++... ....+++.++..++.|++.|++|||+. +++||||+|+||+++.++.+||+|
T Consensus 76 ~v~e~~~-~~l~~~~~~~--------~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~d 143 (284)
T cd07860 76 LVFEFLH-QDLKKFMDAS--------PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLAD 143 (284)
T ss_pred EEeeccc-cCHHHHHHhC--------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEee
Confidence 9999995 6899888532 234689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCCC-cCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSE-VSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
||.+....... .......++..|+|||++.+.. ++.++|||||||++|||+||+.||..
T Consensus 144 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~ 203 (284)
T cd07860 144 FGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG 203 (284)
T ss_pred ccchhhcccCc--cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 99987653221 1122234678999999887644 68899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=306.21 Aligned_cols=258 Identities=20% Similarity=0.350 Sum_probs=196.6
Q ss_pred cCCCCCcccccccceeEEEEEECC-----CCeEEEEEEeeccCch-hHHHHHHHHHHHhcCCCCcceeeeeeccccccCC
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDD-----GRTTIAVKVFNLLHHG-AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 761 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 761 (986)
++|++.+.||+|+||.||+|+.+. ..+.||+|.+...... ..+.+.+|++++++++||||+++++++ .+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 79 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC-----RE 79 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEE-----CC
Confidence 578999999999999999999753 3467999988654433 456789999999999999999999984 44
Q ss_pred CceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCc
Q 046598 762 NDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI 841 (986)
Q Consensus 762 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 841 (986)
....++||||+++|+|.++++..... ........+++.++..++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~-~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~ 155 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSK-DEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQRE 155 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhcccc-cccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCc
Confidence 56789999999999999999643311 1112233689999999999999999999999 9999999999999999999
Q ss_pred EEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHH
Q 046598 842 AHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLAR 920 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~ 920 (986)
++++|||.+....... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ....
T Consensus 156 ~~l~~~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~-----~~~~ 229 (275)
T cd05046 156 VKVSLLSLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-----EVLN 229 (275)
T ss_pred EEEcccccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH-----HHHH
Confidence 9999999987543221 122223456778999999988889999999999999999999 88888532211 1111
Q ss_pred hhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 921 TALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 921 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.. ....... .....++..+.+++.+||+.+|++|||+.|+
T Consensus 230 ~~--------~~~~~~~------------------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~ 269 (275)
T cd05046 230 RL--------QAGKLEL------------------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSEL 269 (275)
T ss_pred HH--------HcCCcCC------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 00 0000000 0001234568899999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=316.45 Aligned_cols=204 Identities=25% Similarity=0.284 Sum_probs=172.2
Q ss_pred HhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc--CchhHHHHHHHHHHHhcCCCCcceeeeeeccccc-cCC
Q 046598 685 NATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-YQG 761 (986)
Q Consensus 685 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~ 761 (986)
...++|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.++++++||||+++++++.... +.+
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 4568899999999999999999999988999999998632 2334466788999999999999999999864321 223
Q ss_pred CceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCc
Q 046598 762 NDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI 841 (986)
Q Consensus 762 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 841 (986)
....|+||||+. ++|.+++. ..++..++..++.|++.||+|||+. ||+||||||+||+++.++.
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~------------~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~ 156 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQ------------MDLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCT 156 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHh------------hcCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCC
Confidence 356899999995 58888874 1278889999999999999999999 9999999999999999999
Q ss_pred EEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 842 AHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
+||+|||.++...... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||..
T Consensus 157 ~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 219 (353)
T cd07850 157 LKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPG 219 (353)
T ss_pred EEEccCccceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCC
Confidence 9999999998653221 12234578899999999999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=310.99 Aligned_cols=208 Identities=24% Similarity=0.342 Sum_probs=170.6
Q ss_pred CCCCCcccccccceeEEEEEECC--CCeEEEEEEeeccC---chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDD--GRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
+|++.++||+|+||.||+|.+.. .++.||+|++.... ....+.+.+|+.++++++||||+++++++.. ..+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLE---HADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeC---CCCc
Confidence 58889999999999999999987 78999999997632 3344677889999999999999999999642 2237
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecC----C
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDE----D 839 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~----~ 839 (986)
..++||||+++ ++.+++..... .....+++..++.++.||+.|++|||+. +|+||||||+||+++. +
T Consensus 78 ~~~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~ 148 (316)
T cd07842 78 SVYLLFDYAEH-DLWQIIKFHRQ-----AKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPER 148 (316)
T ss_pred eEEEEEeCCCc-CHHHHHHhhcc-----CCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCcc
Confidence 89999999964 77777643221 1224689999999999999999999999 9999999999999999 8
Q ss_pred CcEEEcccccceecCCCCC-ccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCcc
Q 046598 840 MIAHIGDFGLARFLPLSSA-QTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDIM 908 (986)
Q Consensus 840 ~~~kL~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~ 908 (986)
+.+||+|||+++....... ........++..|+|||++.+ ..++.++|||||||++|+|++|++||...
T Consensus 149 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 219 (316)
T cd07842 149 GVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGR 219 (316)
T ss_pred ceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence 9999999999986543222 112233457889999998776 45889999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=315.90 Aligned_cols=281 Identities=22% Similarity=0.288 Sum_probs=197.9
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeec--cCchhHHHHHHHHHHHhcC-CCCcceeeeeeccccccCCC
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL--LHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~ 762 (986)
..++|++.+.||+|+||.||+|.+..+++.||+|++.. ........+.+|+.+++++ +||||++++++|.. .++
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~ 81 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---END 81 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCC
Confidence 46789999999999999999999988889999998853 2233345677899999999 99999999998532 234
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
...++||||++ ++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~-----------~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~ 146 (337)
T cd07852 82 KDIYLVFEYME-TDLHAVIRA-----------NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRV 146 (337)
T ss_pred ceEEEEecccc-cCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcE
Confidence 56899999996 599998851 1578889999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCc---cccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHH
Q 046598 843 HIGDFGLARFLPLSSAQ---TSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNL 918 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~ 918 (986)
||+|||.++........ .......++..|+|||++.+ ..++.++||||||+++|+|++|+.||......+ .....
T Consensus 147 kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~-~~~~~ 225 (337)
T cd07852 147 KLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN-QLEKI 225 (337)
T ss_pred EEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHH
Confidence 99999999865433221 22234568899999998765 467899999999999999999999986432211 11111
Q ss_pred HHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 919 ARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 919 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.. .......+.+.........+....................+.++.+++.+||+.+|++|||+.++
T Consensus 226 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~i 292 (337)
T cd07852 226 IE-VIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEA 292 (337)
T ss_pred HH-HhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHH
Confidence 11 11110000000000000000000000000000011111245678899999999999999998764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=314.31 Aligned_cols=206 Identities=30% Similarity=0.387 Sum_probs=175.3
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeec-cCchhHHHHHHHHHHHhcCCCCcceeeeeeccccc-cCCCceEE
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL-LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-YQGNDFKA 766 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~~~~ 766 (986)
.|...+.||+|+||.||+|+++.+|+.||||.++. ......++..+|++++++++|||||+++++-.+.. +.......
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 35566889999999999999999999999999975 33445678899999999999999999998832110 11245678
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEec--CCC--cE
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLD--EDM--IA 842 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~--~~ 842 (986)
+|||||.||||+..+.+. +....+++.+.+.+..+++.||.|||++ |||||||||.||++- ++| ..
T Consensus 94 lvmEyC~gGsL~~~L~~P-------EN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~Iy 163 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSP-------ENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIY 163 (732)
T ss_pred EEEeecCCCcHHHHhcCc-------ccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEE
Confidence 999999999999999633 4456799999999999999999999999 999999999999983 334 58
Q ss_pred EEcccccceecCCCCCcccccccccccccccccccc-CCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGL-GSEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
||+|||.|+..+... .....+||..|.+||++. .+.|+..+|.|||||++|+.+||..||..
T Consensus 164 KLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 164 KLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred eeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 999999999875443 456688999999999988 48899999999999999999999999974
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=304.37 Aligned_cols=247 Identities=21% Similarity=0.272 Sum_probs=195.8
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEE
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALV 768 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 768 (986)
.|...+.||+|++|.||+|.+..+++.||+|+++.......+.+.+|+.+++.++||||+++++++ ...+..++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~-----~~~~~~~~v 94 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY-----LVGDELWVV 94 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEE-----EcCCeEEEE
Confidence 355567999999999999999888999999998765555566788999999999999999999984 455789999
Q ss_pred EEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcccc
Q 046598 769 FEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFG 848 (986)
Q Consensus 769 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG 848 (986)
+||+++++|.+++.. ..+++.++..++.|++.|++|||++ +++||||+|+||+++.++.++|+|||
T Consensus 95 ~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g 160 (285)
T cd06648 95 MEFLEGGALTDIVTH-----------TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFG 160 (285)
T ss_pred EeccCCCCHHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccc
Confidence 999999999999852 3578899999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCchh
Q 046598 849 LARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVM 928 (986)
Q Consensus 849 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 928 (986)
.+....... .......|+..|+|||...+..++.++|||||||++|||++|+.||.... .. .........
T Consensus 161 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~----~~-~~~~~~~~~--- 230 (285)
T cd06648 161 FCAQVSKEV--PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP----PL-QAMKRIRDN--- 230 (285)
T ss_pred cchhhccCC--cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC----HH-HHHHHHHhc---
Confidence 887543221 11223458899999999998889999999999999999999999985311 11 111100000
Q ss_pred HHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 929 DIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 929 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+.. .......+..+.+++.+||+.+|++|||+.|+
T Consensus 231 ---------~~~~-------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i 266 (285)
T cd06648 231 ---------LPPK-------------LKNLHKVSPRLRSFLDRMLVRDPAQRATAAEL 266 (285)
T ss_pred ---------CCCC-------------CcccccCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 0000 00001234568899999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=308.33 Aligned_cols=202 Identities=27% Similarity=0.383 Sum_probs=169.2
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc--hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
++|++.+.||+|+||.||+|.+..+++.||+|.++.... .....+.+|+.++++++||||+++++++.. .+....
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~---~~~~~~ 81 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG---SNLDKI 81 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEe---cCCCcE
Confidence 579999999999999999999998899999999975332 223456789999999999999999998532 223789
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
|+||||++ ++|.+++... ...+++.+++.++.||+.||+|||+. +++||||||+||+++.++.+||+
T Consensus 82 ~lv~e~~~-~~L~~~~~~~---------~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~ 148 (293)
T cd07843 82 YMVMEYVE-HDLKSLMETM---------KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKIC 148 (293)
T ss_pred EEEehhcC-cCHHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEe
Confidence 99999996 5999988522 23589999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
|||.+....... .......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||..
T Consensus 149 d~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~ 209 (293)
T cd07843 149 DFGLAREYGSPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPG 209 (293)
T ss_pred ecCceeeccCCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999998664322 112234578899999988764 468999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=302.42 Aligned_cols=234 Identities=23% Similarity=0.388 Sum_probs=182.6
Q ss_pred cccccccceeEEEEEECCCC----------eEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 694 NQIGEGSFGSVFKGILDDGR----------TTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 694 ~~lg~G~~g~Vy~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
+.||+|+||.||+|.+..++ ..|++|++...... ...+.+|+.++++++||||++++++|. . .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~-~ 73 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCV-----R-D 73 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEe-----c-C
Confidence 46899999999999998765 45888887654333 578899999999999999999999853 2 4
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCC---
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDM--- 840 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--- 840 (986)
..++||||+++|+|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~ 141 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHRE---------KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNE 141 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHhh---------ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCcccc
Confidence 579999999999999999622 22688999999999999999999999 999999999999999888
Q ss_pred ----cEEEcccccceecCCCCCccccccccccccccccccccCC--CcCcccchhhHHHHHHHHHh-CCCCCCccccccc
Q 046598 841 ----IAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS--EVSISGDVYSYGILLLELIT-RKKPTDIMFEGDM 913 (986)
Q Consensus 841 ----~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~ 913 (986)
.+||+|||.+..... .....++..|+|||++.+. .++.++|||||||++|||++ |..||......
T Consensus 142 ~~~~~~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~-- 213 (259)
T cd05037 142 GYVPFIKLSDPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS-- 213 (259)
T ss_pred CCceeEEeCCCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--
Confidence 799999999976532 1223467789999998876 78999999999999999999 57777533211
Q ss_pred cHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 914 NLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
....... .......+ ....+.+++.+||..+|++|||+.||
T Consensus 214 ~~~~~~~-----------~~~~~~~~---------------------~~~~~~~li~~~l~~~p~~Rpt~~~i 254 (259)
T cd05037 214 EKERFYQ-----------DQHRLPMP---------------------DCAELANLINQCWTYDPTKRPSFRAI 254 (259)
T ss_pred hHHHHHh-----------cCCCCCCC---------------------CchHHHHHHHHHhccChhhCCCHHHH
Confidence 0000000 00000000 01457799999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=305.59 Aligned_cols=277 Identities=23% Similarity=0.252 Sum_probs=196.5
Q ss_pred CCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEE
Q 046598 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 767 (986)
Q Consensus 690 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 767 (986)
|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|++++++++|||++++++++... ..+..++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSK---GKGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecC---CCCcEEE
Confidence 678899999999999999999889999999997653 33446788999999999999999999985321 1378999
Q ss_pred EEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccc
Q 046598 768 VFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDF 847 (986)
Q Consensus 768 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DF 847 (986)
||||++ ++|.+++.. ....+++.+++.++.||++|++|||+. +++|+||+|+||++++++.+||+||
T Consensus 78 v~e~~~-~~l~~~~~~---------~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~ 144 (287)
T cd07840 78 VFEYMD-HDLTGLLDS---------PEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADF 144 (287)
T ss_pred Eecccc-ccHHHHHhc---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccc
Confidence 999996 489888852 124689999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCc
Q 046598 848 GLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDH 926 (986)
Q Consensus 848 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 926 (986)
|.+........ .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ........ .....
T Consensus 145 g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-~~~~~~~~-~~~~~ 221 (287)
T cd07840 145 GLARPYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-EQLEKIFE-LCGSP 221 (287)
T ss_pred cceeeccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHH-HhCCC
Confidence 99987644322 11223456788999998765 46789999999999999999999998643211 11111111 11000
Q ss_pred hhHHhhhhcccCCcchhhccchhhhhHhhHHHHH-HHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 927 VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIE-CLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 927 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..+... ....-...................... ++.++.+++.+||+.+|++||++++|
T Consensus 222 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~ 281 (287)
T cd07840 222 TDENWP-GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQA 281 (287)
T ss_pred chhhcc-ccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 000000 000000000000000000000011111 26678999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=303.97 Aligned_cols=246 Identities=22% Similarity=0.301 Sum_probs=193.8
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeecc-CchhHHHHHHHHHHHhcCC---CCcceeeeeeccccccCCCce
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL-HHGAFKSFIAECNTLKNIR---HRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~~~~ 764 (986)
.|++.+.||+|+||.||+|.+..+++.||+|+++.. .....+++.+|+.++++++ |||++++++++ ..+..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~-----~~~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSY-----LKGPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeee-----eeCCE
Confidence 478889999999999999999888999999998653 2334567888999999986 99999999984 45578
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.++||||+++++|.++++. ..+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++|
T Consensus 77 ~~lv~e~~~~~~L~~~~~~-----------~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l 142 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKA-----------GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKL 142 (277)
T ss_pred EEEEEecCCCCcHHHHHHc-----------cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEE
Confidence 9999999999999999851 2588999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhC
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTAL 923 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 923 (986)
+|||.+....... .......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...... .....
T Consensus 143 ~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-----~~~~~-- 213 (277)
T cd06917 143 CDFGVAALLNQNS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-----RAMML-- 213 (277)
T ss_pred ccCCceeecCCCc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-----hhhhc--
Confidence 9999998764332 12233468889999998765 45789999999999999999999998632111 00000
Q ss_pred CCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 924 PDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 924 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+... .+... . ....+.++.+++.+||+.||++||++.|+
T Consensus 214 -------~~~~---~~~~~-------------~-~~~~~~~~~~~i~~~l~~~p~~R~~~~~i 252 (277)
T cd06917 214 -------IPKS---KPPRL-------------E-DNGYSKLLREFVAACLDEEPKERLSAEEL 252 (277)
T ss_pred -------cccC---CCCCC-------------C-cccCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 0000 00000 0 00134467899999999999999998764
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=308.16 Aligned_cols=245 Identities=27% Similarity=0.341 Sum_probs=191.3
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
.++|++.+.||+|+||+||+|.+..+++.||+|++.... ....+++.+|+++++.++||||++++++| ..++
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~-----~~~~ 88 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCY-----LREH 88 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----EeCC
Confidence 456999999999999999999998889999999986432 23345788999999999999999999995 3457
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..++||||++ |++.+++.. ....+++.++..++.|++.||.|||+. +|+||||+|+||+++.++.+|
T Consensus 89 ~~~lv~e~~~-g~l~~~~~~---------~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~k 155 (307)
T cd06607 89 TAWLVMEYCL-GSASDILEV---------HKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVK 155 (307)
T ss_pred eEEEEHHhhC-CCHHHHHHH---------cccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEE
Confidence 7899999996 577777642 123589999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCcccccccccccccccccccc---CCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHH
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGL---GSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLAR 920 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~ 920 (986)
|+|||++...... ....++..|+|||++. ...++.++||||||+++|||+||+.||...... .....
T Consensus 156 L~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~----~~~~~ 225 (307)
T cd06607 156 LADFGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SALYH 225 (307)
T ss_pred EeecCcceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH----HHHHH
Confidence 9999999764322 1245788999999874 456889999999999999999999998532110 00000
Q ss_pred hhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 921 TALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 921 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
... ..+... .....+.++.+++.+||+.+|++||++.+|
T Consensus 226 ---------~~~----~~~~~~--------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 264 (307)
T cd06607 226 ---------IAQ----NDSPTL--------------SSNDWSDYFRNFVDSCLQKIPQDRPSSEEL 264 (307)
T ss_pred ---------Hhc----CCCCCC--------------CchhhCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 000 000000 001234567899999999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=300.84 Aligned_cols=241 Identities=28% Similarity=0.437 Sum_probs=189.2
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 767 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 767 (986)
++|++.+.||+|+||.||++... ++.||+|+++... ..+.+.+|+.++++++|||++++++++. . +..++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~--~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~-~~~~~ 75 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEYT--GQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVIL-----H-NGLYI 75 (254)
T ss_pred HHceeeeeeccCCCCceEecccC--CCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEc-----C-CCcEE
Confidence 56899999999999999999753 5789999986432 3467899999999999999999999852 2 34699
Q ss_pred EEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccc
Q 046598 768 VFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDF 847 (986)
Q Consensus 768 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DF 847 (986)
||||+++++|.+++.... ...+++..+..++.|++.|+.|||+. |++||||||+||+++.++.+||+||
T Consensus 76 v~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Df 144 (254)
T cd05083 76 VMELMSKGNLVNFLRTRG--------RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDF 144 (254)
T ss_pred EEECCCCCCHHHHHHhcC--------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCC
Confidence 999999999999996321 23578999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCc
Q 046598 848 GLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALPDH 926 (986)
Q Consensus 848 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 926 (986)
|.+...... ......+..|+|||++.+..++.++|||||||++|||++ |+.||..... ...
T Consensus 145 g~~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~-------- 206 (254)
T cd05083 145 GLARVGSMG-----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-----KEV-------- 206 (254)
T ss_pred ccceecccc-----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH-----HHH--------
Confidence 999754321 112234678999999988899999999999999999998 9999863211 111
Q ss_pred hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 927 VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 927 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+.+.......+ ...++.++.+++.+||+.+|++||++++|
T Consensus 207 -~~~~~~~~~~~~------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l 247 (254)
T cd05083 207 -KECVEKGYRMEP------------------PEGCPADVYVLMTSCWETEPKKRPSFHKL 247 (254)
T ss_pred -HHHHhCCCCCCC------------------CCcCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 111111100000 01234567899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=308.34 Aligned_cols=203 Identities=30% Similarity=0.428 Sum_probs=168.8
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc--hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.... .....+.+|+.++++++|+||+++++++.. ...+.
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~ 82 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVG---KHLDS 82 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEec---CCCCe
Confidence 4679999999999999999999998899999999874322 223456789999999999999999998532 22356
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.++||||+. ++|.+++... ...+++.++..++.||++|++|||+. +++||||||+||++++++.+||
T Consensus 83 ~~lv~e~~~-~~l~~~l~~~---------~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL 149 (309)
T cd07845 83 IFLVMEYCE-QDLASLLDNM---------PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKI 149 (309)
T ss_pred EEEEEecCC-CCHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEE
Confidence 899999996 5888888532 24689999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
+|||.+........ ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||..
T Consensus 150 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~ 211 (309)
T cd07845 150 ADFGLARTYGLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPG 211 (309)
T ss_pred CccceeeecCCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999987643221 1222345788999999866 4678999999999999999999999963
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=302.87 Aligned_cols=245 Identities=23% Similarity=0.333 Sum_probs=194.9
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEE
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 767 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 767 (986)
-|++.+.||+|+||.||+|.+..+++.||+|+..... ....+.+.+|+.++++++||||+++++++ ..+...++
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~l 79 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKDTKLWI 79 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEE-----EeCCeEEE
Confidence 4778899999999999999998888999999986432 23446788999999999999999999984 45678999
Q ss_pred EEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccc
Q 046598 768 VFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDF 847 (986)
Q Consensus 768 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DF 847 (986)
||||+++++|.+++.. ..+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+||
T Consensus 80 v~e~~~~~~l~~~i~~-----------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~df 145 (277)
T cd06641 80 IMEYLGGGSALDLLEP-----------GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADF 145 (277)
T ss_pred EEEeCCCCcHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeec
Confidence 9999999999999851 3578999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCch
Q 046598 848 GLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHV 927 (986)
Q Consensus 848 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 927 (986)
|++....... .......++..|+|||.+.+..++.++|||||||++|+|++|..||...... .....
T Consensus 146 g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~------ 212 (277)
T cd06641 146 GVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-----KVLFL------ 212 (277)
T ss_pred ccceecccch--hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-----HHHHH------
Confidence 9997654221 1122345788999999998888999999999999999999999998632111 00000
Q ss_pred hHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 928 MDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 928 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+... .+.. .....+.++.+++.+||+.+|++||++.|+
T Consensus 213 ---~~~~---~~~~---------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~ 250 (277)
T cd06641 213 ---IPKN---NPPT---------------LEGNYSKPLKEFVEACLNKEPSFRPTAKEL 250 (277)
T ss_pred ---HhcC---CCCC---------------CCcccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 0000 0000 001234557789999999999999998764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=307.28 Aligned_cols=209 Identities=26% Similarity=0.405 Sum_probs=170.4
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeecccccc---C
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY---Q 760 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~ 760 (986)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+|++++++++||||++++++|..... .
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 3467999999999999999999999889999999986432 2223456789999999999999999998754321 1
Q ss_pred CCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCC
Q 046598 761 GNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDM 840 (986)
Q Consensus 761 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 840 (986)
.....++||||+. +++.+++.. ....+++.+++.++.||+.||+|||++ +++||||||+||+++.++
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~---------~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~ 156 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSN---------KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDG 156 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCC
Confidence 2356799999995 588888752 223589999999999999999999999 999999999999999999
Q ss_pred cEEEcccccceecCCCCCc--cccccccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 841 IAHIGDFGLARFLPLSSAQ--TSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 841 ~~kL~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
.+||+|||.+......... .......++..|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~ 226 (310)
T cd07865 157 ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQG 226 (310)
T ss_pred cEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 9999999999765432211 112234578899999987664 478999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=303.27 Aligned_cols=273 Identities=22% Similarity=0.296 Sum_probs=197.2
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc-hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEE
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 767 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 767 (986)
+|++.++||+|++|.||+|++..+++.||||+++.... ...+.+.+|++++++++||||+++++++ ...+..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI-----HTENKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeE-----eeCCcEEE
Confidence 58899999999999999999998899999999875432 2346678899999999999999999994 44578899
Q ss_pred EEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccc
Q 046598 768 VFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDF 847 (986)
Q Consensus 768 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DF 847 (986)
||||+++ +|.+++..... ...+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 76 v~e~~~~-~l~~~~~~~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~ 144 (284)
T cd07836 76 VFEYMDK-DLKKYMDTHGV-------RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADF 144 (284)
T ss_pred EEecCCc-cHHHHHHhcCC-------CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeec
Confidence 9999974 89888853221 24589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCccccccccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhC-C-
Q 046598 848 GLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTAL-P- 924 (986)
Q Consensus 848 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~-~- 924 (986)
|.+....... .......++..|+|||++.+. .++.++|||||||++|+|++|+.||...... ........... +
T Consensus 145 g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~ 221 (284)
T cd07836 145 GLARAFGIPV--NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE-DQLLKIFRIMGTPT 221 (284)
T ss_pred chhhhhcCCc--cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCC
Confidence 9997543221 111234568899999987664 5789999999999999999999998643221 11111111100 0
Q ss_pred -CchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 925 -DHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 925 -~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.....+.+. ..... .................+..+.+++.+|++.||++||+++||
T Consensus 222 ~~~~~~~~~~---~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~ 278 (284)
T cd07836 222 ESTWPGISQL---PEYKP---TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDA 278 (284)
T ss_pred hhhHHHHhcC---chhcc---cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHH
Confidence 001111100 00000 000000011111112345678899999999999999998764
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=298.86 Aligned_cols=249 Identities=20% Similarity=0.239 Sum_probs=191.3
Q ss_pred ChHHHHHhhcCCCCCccc--ccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcC-CCCcceeeeeecc
Q 046598 679 SYQNLYNATDRFSSVNQI--GEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACS 755 (986)
Q Consensus 679 ~~~~~~~~~~~y~~~~~l--g~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 755 (986)
+..+.....++|++.+.+ |+|+||.||+++.+.++..+|+|++........ |+.....+ +||||+++++++
T Consensus 5 ~~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~- 78 (267)
T PHA03390 5 SLSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSV- 78 (267)
T ss_pred HHHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEE-
Confidence 345555667788888887 999999999999998899999999865322211 22222222 799999999984
Q ss_pred ccccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeE
Q 046598 756 GVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNIL 835 (986)
Q Consensus 756 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIl 835 (986)
..++..++||||+++++|.+++.. ...+++.++..++.|+++|+.|||+. +++||||||+||+
T Consensus 79 ----~~~~~~~iv~e~~~~~~L~~~l~~----------~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil 141 (267)
T PHA03390 79 ----TTLKGHVLIMDYIKDGDLFDLLKK----------EGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVL 141 (267)
T ss_pred ----ecCCeeEEEEEcCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEE
Confidence 445789999999999999999952 23689999999999999999999999 9999999999999
Q ss_pred ecCCC-cEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCcccccccc
Q 046598 836 LDEDM-IAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMN 914 (986)
Q Consensus 836 l~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~ 914 (986)
++.++ .++|+|||.++..... ....++..|+|||++.+..++.++||||+||++|||++|+.||.........
T Consensus 142 ~~~~~~~~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~ 215 (267)
T PHA03390 142 YDRAKDRIYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELD 215 (267)
T ss_pred EeCCCCeEEEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhh
Confidence 99998 9999999999765322 1235788999999999999999999999999999999999999743322212
Q ss_pred HHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCC-CC
Q 046598 915 LHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSM-TN 985 (986)
Q Consensus 915 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~-~e 985 (986)
...+.... .. .. .........+.+++.+|++.+|++||+. +|
T Consensus 216 ~~~~~~~~-~~------------~~----------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 258 (267)
T PHA03390 216 LESLLKRQ-QK------------KL----------------PFIKNVSKNANDFVQSMLKYNINYRLTNYNE 258 (267)
T ss_pred HHHHHHhh-cc------------cC----------------CcccccCHHHHHHHHHHhccChhhCCchHHH
Confidence 22211111 00 00 0001234567899999999999999964 65
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=312.30 Aligned_cols=282 Identities=22% Similarity=0.242 Sum_probs=201.4
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
+|++.+.||+|++|.||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++...........|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5889999999999999999998889999999987533 34457889999999999999999999986443222234789
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||++ ++|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++.++|+|
T Consensus 81 lv~e~~~-~~l~~~l~~----------~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~d 146 (330)
T cd07834 81 IVTELME-TDLHKVIKS----------PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICD 146 (330)
T ss_pred EEecchh-hhHHHHHhC----------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcc
Confidence 9999997 589888842 23689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCC-ccccccccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCC
Q 046598 847 FGLARFLPLSSA-QTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALP 924 (986)
Q Consensus 847 FG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 924 (986)
||.+........ ........++..|+|||++.+. .++.++||||+|+++|+|++|+.||......+ .+.. ......
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~-~~~~-i~~~~~ 224 (330)
T cd07834 147 FGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID-QLNL-IVEVLG 224 (330)
T ss_pred cCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH-HHHH-HHHhcC
Confidence 999987644321 0122334578899999999887 89999999999999999999999996432211 0111 111111
Q ss_pred CchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 925 DHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 925 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
....+...........+.+..................+..+.+++.+||+.+|++|||++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~l 286 (330)
T cd07834 225 TPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEA 286 (330)
T ss_pred CCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 00000000000000000000000000000111112245678899999999999999998764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=302.97 Aligned_cols=236 Identities=22% Similarity=0.272 Sum_probs=178.2
Q ss_pred ccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHH---hcCCCCcceeeeeeccccccCCCceEEEE
Q 046598 695 QIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTL---KNIRHRNLVKILTACSGVDYQGNDFKALV 768 (986)
Q Consensus 695 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~~~~~~lv 768 (986)
.||+|+||.||+|.+..+++.||+|.+.... ......+.+|..++ ...+||+|+.++++ +..++..++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~-----~~~~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYA-----FHTPDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEE-----EecCCeEEEE
Confidence 4899999999999999889999999886422 11223334444333 33479999999988 4455789999
Q ss_pred EEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcccc
Q 046598 769 FEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFG 848 (986)
Q Consensus 769 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG 848 (986)
|||+++++|.+++.. .+.+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 76 ~e~~~~~~L~~~i~~----------~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg 142 (279)
T cd05633 76 LDLMNGGDLHYHLSQ----------HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLG 142 (279)
T ss_pred EecCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCC
Confidence 999999999998842 24689999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCch
Q 046598 849 LARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHV 927 (986)
Q Consensus 849 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 927 (986)
++....... .....|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||....... ..........
T Consensus 143 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~--- 213 (279)
T cd05633 143 LACDFSKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMTLT--- 213 (279)
T ss_pred cceeccccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC--HHHHHHHhhc---
Confidence 997543221 123458999999998864 568999999999999999999999996432211 1111000000
Q ss_pred hHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCC
Q 046598 928 MDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMS 982 (986)
Q Consensus 928 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt 982 (986)
. . ...+...+.++.+++.+|++.||++||+
T Consensus 214 -------~--~----------------~~~~~~~~~~~~~li~~~l~~~p~~R~~ 243 (279)
T cd05633 214 -------V--N----------------VELPDSFSPELKSLLEGLLQRDVSKRLG 243 (279)
T ss_pred -------C--C----------------cCCccccCHHHHHHHHHHhcCCHHHhcC
Confidence 0 0 0001123456778999999999999995
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=311.22 Aligned_cols=279 Identities=22% Similarity=0.256 Sum_probs=199.2
Q ss_pred HHHHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc--CchhHHHHHHHHHHHhcCCCCcceeeeeecccccc
Q 046598 682 NLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY 759 (986)
Q Consensus 682 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 759 (986)
++...+++|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|++++++++||||+++++++.
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~---- 79 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFI---- 79 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEe----
Confidence 4456788999999999999999999999988999999987532 2233467889999999999999999999852
Q ss_pred CCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCC
Q 046598 760 QGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED 839 (986)
Q Consensus 760 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 839 (986)
......++||||+ +++|.++++ ...+++..+..++.|++.||+|||+. +|+||||+|+||+++++
T Consensus 80 ~~~~~~~lv~e~~-~~~L~~~~~-----------~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~ 144 (328)
T cd07856 80 SPLEDIYFVTELL-GTDLHRLLT-----------SRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINEN 144 (328)
T ss_pred cCCCcEEEEeehh-ccCHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCC
Confidence 2345789999998 678988874 12477888889999999999999999 99999999999999999
Q ss_pred CcEEEcccccceecCCCCCccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHH
Q 046598 840 MIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNL 918 (986)
Q Consensus 840 ~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~ 918 (986)
+.+||+|||.+...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...... .....
T Consensus 145 ~~~~l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~--~~~~~ 217 (328)
T cd07856 145 CDLKICDFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV--NQFSI 217 (328)
T ss_pred CCEEeCccccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH
Confidence 99999999999754221 122456888999998766 57899999999999999999999998633210 11111
Q ss_pred HHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 919 ARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 919 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..........++.+........+......................++.+++.+|++.+|++|||++||
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~el 285 (328)
T cd07856 218 ITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEA 285 (328)
T ss_pred HHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 11111111111111111111000000000000000000111234678899999999999999998764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=296.25 Aligned_cols=248 Identities=25% Similarity=0.326 Sum_probs=199.0
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
+.|..-++||+||||.||-++.+.+|+.+|.|.+.+. ..........|-.|+++++.+.||.+-.. |+..+.
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYA-----feTkd~ 259 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYA-----FETKDA 259 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeee-----ecCCCc
Confidence 4577778999999999999999999999999987431 22333556789999999999999998766 677899
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.|+|+..|.||+|.-++...+ ...+++..++.+|.+|+.||++||+. +||+||+||+|||+|+.|+++|
T Consensus 260 LClVLtlMNGGDLkfHiyn~g--------~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRI 328 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHG--------NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRI 328 (591)
T ss_pred eEEEEEeecCCceeEEeeccC--------CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEe
Confidence 999999999999998885332 24689999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCC
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALP 924 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 924 (986)
+|.|+|..++.... ..+.+||.+|||||++.+..|+...|.||+||++|||+.|+.||....+-
T Consensus 329 SDLGLAvei~~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK------------- 392 (591)
T KOG0986|consen 329 SDLGLAVEIPEGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK------------- 392 (591)
T ss_pred eccceEEecCCCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh-------------
Confidence 99999998754332 33458999999999999999999999999999999999999999632111
Q ss_pred CchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 046598 925 DHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSM 983 (986)
Q Consensus 925 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 983 (986)
.-.+-+|++...++.+ -++...++..++.+..++.||++|-..
T Consensus 393 -vk~eEvdrr~~~~~~e---------------y~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 393 -VKREEVDRRTLEDPEE---------------YSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred -hhHHHHHHHHhcchhh---------------cccccCHHHHHHHHHHHccCHHHhccC
Confidence 1122344444433322 112344556677778888899888643
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=306.89 Aligned_cols=260 Identities=20% Similarity=0.212 Sum_probs=183.6
Q ss_pred hcCCCCCcccccccceeEEEEEECCC---CeEEEEEEeeccCchhH-----------HHHHHHHHHHhcCCCCcceeeee
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDG---RTTIAVKVFNLLHHGAF-----------KSFIAECNTLKNIRHRNLVKILT 752 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l~~ 752 (986)
.++|.+.+.||+|+||.||+|.+..+ ...+|+|+......... .....+...+..+.|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 36899999999999999999999876 56778886543221110 11223344556678999999998
Q ss_pred eccccccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCC
Q 046598 753 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPS 832 (986)
Q Consensus 753 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~ 832 (986)
++... .......++++|++ ..++.+.+.. ....++..+..|+.|++.||+|||+. +|+||||||+
T Consensus 91 ~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~----------~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~ 155 (294)
T PHA02882 91 CGSFK-RCRMYYRFILLEKL-VENTKEIFKR----------IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPE 155 (294)
T ss_pred eeeEe-cCCceEEEEEEehh-ccCHHHHHHh----------hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHH
Confidence 74322 11223457888887 3466666632 12356778899999999999999999 9999999999
Q ss_pred CeEecCCCcEEEcccccceecCCCCCc-----cccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 833 NILLDEDMIAHIGDFGLARFLPLSSAQ-----TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 833 NIll~~~~~~kL~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
||+++.++.+||+|||+|+.+...... .......||+.|+|||+..+..++.++|||||||++|||++|+.||..
T Consensus 156 Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~ 235 (294)
T PHA02882 156 NIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKG 235 (294)
T ss_pred HEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCc
Confidence 999999999999999999876432211 112234699999999999999999999999999999999999999974
Q ss_pred cccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 908 MFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
...... ...... .+.+.+...... ....++..+.+++..|++.+|++||+++++
T Consensus 236 ~~~~~~-~~~~~~-------~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l 289 (294)
T PHA02882 236 FGHNGN-LIHAAK-------CDFIKRLHEGKI-----------------KIKNANKFIYDFIECVTKLSYEEKPDYDAL 289 (294)
T ss_pred cccchH-HHHHhH-------HHHHHHhhhhhh-----------------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHH
Confidence 422111 111100 011111100000 011235668899999999999999998764
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=341.21 Aligned_cols=249 Identities=26% Similarity=0.334 Sum_probs=198.4
Q ss_pred HhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeec--cCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 685 NATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 685 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
..+-+|+...+||.|.||.||-|...++|...|+|.++. ......+...+|+.++..++|||+|++||+ ..++
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGV-----EvHR 1306 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGV-----EVHR 1306 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCce-----eecH
Confidence 445678888999999999999999999999999998863 334455678899999999999999999998 6677
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
+..+|.||||++|+|.+.++. +.-.++.....+..|++.|++|||++ |||||||||.||+++.+|.+
T Consensus 1307 ekv~IFMEyC~~GsLa~ll~~----------gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~i 1373 (1509)
T KOG4645|consen 1307 EKVYIFMEYCEGGSLASLLEH----------GRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLI 1373 (1509)
T ss_pred HHHHHHHHHhccCcHHHHHHh----------cchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcE
Confidence 889999999999999999952 33456666777899999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCC--CccccccccccccccccccccCC---CcCcccchhhHHHHHHHHHhCCCCCCccccccccHHH
Q 046598 843 HIGDFGLARFLPLSS--AQTSSIGAKGSIGYIAPEYGLGS---EVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHN 917 (986)
Q Consensus 843 kL~DFG~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~ 917 (986)
|++|||.|..+.... .........||+.|||||++.+. ....++||||+|||+.||+||+.||..... .++-
T Consensus 1374 K~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn---e~aI 1450 (1509)
T KOG4645|consen 1374 KYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN---EWAI 1450 (1509)
T ss_pred EeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc---hhHH
Confidence 999999998875442 12334467799999999998874 356789999999999999999999974322 2222
Q ss_pred HHH---hhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCC
Q 046598 918 LAR---TALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTN 985 (986)
Q Consensus 918 ~~~---~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 985 (986)
+.. ...|+- +.....+=.+++..|+..||+.|.++.|
T Consensus 1451 My~V~~gh~Pq~-------------------------------P~~ls~~g~dFle~Cl~~dP~~Rw~~~q 1490 (1509)
T KOG4645|consen 1451 MYHVAAGHKPQI-------------------------------PERLSSEGRDFLEHCLEQDPKMRWTASQ 1490 (1509)
T ss_pred HhHHhccCCCCC-------------------------------chhhhHhHHHHHHHHHhcCchhhhHHHH
Confidence 211 111110 1112333457888999999999988754
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=301.04 Aligned_cols=248 Identities=25% Similarity=0.338 Sum_probs=196.0
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
+|++.+.||+|+||.||+|.+..++..||+|.+.... ....+.+.+|++++++++|+||++++++ +..+...+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~-----~~~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS-----FQENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhe-----eccCCeEE
Confidence 5888999999999999999999989999999986532 2344678899999999999999999998 45567899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCC-cEEEc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDM-IAHIG 845 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~ 845 (986)
+|+||+++++|.+++... ....+++..+..++.|+++|+.|||+. +++|+||||+||++++++ .+||+
T Consensus 76 lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~ 144 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQ--------RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLG 144 (257)
T ss_pred EEEecCCCCcHHHHHHhc--------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEec
Confidence 999999999999999532 123578999999999999999999999 999999999999999886 57999
Q ss_pred ccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCC
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPD 925 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 925 (986)
|||.+........ ......|++.|+|||+..+..++.++|||||||++|||++|+.||.... ...........
T Consensus 145 d~~~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~ 217 (257)
T cd08225 145 DFGIARQLNDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-----LHQLVLKICQG 217 (257)
T ss_pred ccccchhccCCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHhcc
Confidence 9999976543221 1223458889999999988889999999999999999999999986321 11111111111
Q ss_pred chhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 926 HVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 926 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
. ....+ ...+.++.+++.+||..+|++|||+.||
T Consensus 218 ~--------~~~~~-------------------~~~~~~~~~~i~~~l~~~p~~Rpt~~~l 251 (257)
T cd08225 218 Y--------FAPIS-------------------PNFSRDLRSLISQLFKVSPRDRPSITSI 251 (257)
T ss_pred c--------CCCCC-------------------CCCCHHHHHHHHHHhccChhhCcCHHHH
Confidence 0 00000 0123457789999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=304.28 Aligned_cols=252 Identities=24% Similarity=0.313 Sum_probs=200.0
Q ss_pred HhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 685 NATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 685 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
..++.|++.+.||+|++|.||+|.+..++..||+|+++.... ..+.+.+|+++++.++|+||+++++++ ..+..
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~ 89 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSY-----LVGDE 89 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEE-----EECCE
Confidence 356778999999999999999999997789999999976544 457788999999999999999999984 34578
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.++|+||+++++|.+++... ...+++.++..++.|++.||+|||+. |++|+||+|+||+++.++.+||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~---------~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l 157 (286)
T cd06614 90 LWVVMEYMDGGSLTDIITQN---------FVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKL 157 (286)
T ss_pred EEEEEeccCCCcHHHHHHHh---------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEE
Confidence 99999999999999999632 13689999999999999999999998 9999999999999999999999
Q ss_pred cccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCC
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALP 924 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 924 (986)
+|||.+........ ......++..|+|||++.+..++.++|||||||++|+|++|+.||...... .....
T Consensus 158 ~d~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~----~~~~~---- 227 (286)
T cd06614 158 ADFGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL----RALFL---- 227 (286)
T ss_pred Cccchhhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH----HHHHH----
Confidence 99999865432211 122334778999999999888999999999999999999999998632111 11100
Q ss_pred CchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 925 DHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 925 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+..... .. .......+..+.+++.+|++.+|.+|||+.+|
T Consensus 228 -----~~~~~~----~~-------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i 267 (286)
T cd06614 228 -----ITTKGI----PP-------------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEEL 267 (286)
T ss_pred -----HHhcCC----CC-------------CcchhhCCHHHHHHHHHHhccChhhCcCHHHH
Confidence 000000 00 00111234567899999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=330.22 Aligned_cols=259 Identities=25% Similarity=0.344 Sum_probs=192.5
Q ss_pred HhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc-CchhHHHHHHHHHHHhcCCCCcceeeeeeccccc-----
Q 046598 685 NATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD----- 758 (986)
Q Consensus 685 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 758 (986)
....+|+..+.||+||||.||+++.+-+|+.||||++... .........+|+..+++++|||||+++..+....
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 4556788899999999999999999999999999999743 3444567889999999999999999975431100
Q ss_pred ------------------------------------------------c--C----------------------------
Q 046598 759 ------------------------------------------------Y--Q---------------------------- 760 (986)
Q Consensus 759 ------------------------------------------------~--~---------------------------- 760 (986)
. .
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0 0
Q ss_pred -----------------------CC--------ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHH
Q 046598 761 -----------------------GN--------DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDV 809 (986)
Q Consensus 761 -----------------------~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi 809 (986)
.+ ...||=||||+...++++++..... -.....++++++|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~---------~~~d~~wrLFreI 706 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN---------SQRDEAWRLFREI 706 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc---------hhhHHHHHHHHHH
Confidence 00 2468889999988888888633221 0356789999999
Q ss_pred HHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcccccceecC----------------CCCCccccccccccccccc
Q 046598 810 ACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLP----------------LSSAQTSSIGAKGSIGYIA 873 (986)
Q Consensus 810 ~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~----------------~~~~~~~~~~~~gt~~y~a 873 (986)
+.||+|+|++ |||||||||.|||++++..|||+|||+|+... ........+..+||.-|+|
T Consensus 707 lEGLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvA 783 (1351)
T KOG1035|consen 707 LEGLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVA 783 (1351)
T ss_pred HHHHHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeec
Confidence 9999999999 99999999999999999999999999998621 1111224567889999999
Q ss_pred cccccCC---CcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhh
Q 046598 874 PEYGLGS---EVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQ 950 (986)
Q Consensus 874 PE~~~~~---~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~ 950 (986)
||++.+. .|+.|+|+||+|||++||+. ||...++....+...-...+|.. .++.++
T Consensus 784 PEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~-~~f~~~----------------- 842 (1351)
T KOG1035|consen 784 PELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP-ADFFDP----------------- 842 (1351)
T ss_pred HHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC-cccccc-----------------
Confidence 9998775 49999999999999999986 56644443222222222222222 111111
Q ss_pred hhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 951 RQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 951 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+++ .=.++++++++.||.+||||.|+
T Consensus 843 ---------~~~-~e~slI~~Ll~hdP~kRPtA~eL 868 (1351)
T KOG1035|consen 843 ---------EHP-EEASLIRWLLSHDPSKRPTATEL 868 (1351)
T ss_pred ---------cch-HHHHHHHHHhcCCCccCCCHHHH
Confidence 111 12378889999999999999874
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=297.16 Aligned_cols=248 Identities=27% Similarity=0.373 Sum_probs=199.3
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEE
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALV 768 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 768 (986)
+|+..+.||+|++|.||+|.+..+++.|++|++........+.+.+|++++++++|++++++++++ ..+...+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY-----LKKDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEE-----ecCCeEEEE
Confidence 478889999999999999999888899999999765545667899999999999999999999984 445789999
Q ss_pred EEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcccc
Q 046598 769 FEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFG 848 (986)
Q Consensus 769 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG 848 (986)
+||+++++|.+++... ...+++.++..++.|++.|++|||+. +++||||+|+||++++++.++|+|||
T Consensus 76 ~e~~~~~~L~~~~~~~---------~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~ 143 (253)
T cd05122 76 MEFCSGGSLKDLLKST---------NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFG 143 (253)
T ss_pred EecCCCCcHHHHHhhc---------CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecc
Confidence 9999999999998522 24689999999999999999999998 99999999999999999999999999
Q ss_pred cceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCchh
Q 046598 849 LARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVM 928 (986)
Q Consensus 849 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 928 (986)
.+........ .....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... .......
T Consensus 144 ~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~------- 209 (253)
T cd05122 144 LSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP----MKALFKI------- 209 (253)
T ss_pred cccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch----HHHHHHH-------
Confidence 9977643321 2345688899999999888899999999999999999999999863211 0000000
Q ss_pred HHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 929 DIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 929 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.. ..... .......+..+.+++.+||+.||++|||+.||
T Consensus 210 ---~~---~~~~~-------------~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~ 248 (253)
T cd05122 210 ---AT---NGPPG-------------LRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQL 248 (253)
T ss_pred ---Hh---cCCCC-------------cCcccccCHHHHHHHHHHccCChhhCCCHHHH
Confidence 00 00000 00001124567899999999999999999874
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=298.52 Aligned_cols=252 Identities=23% Similarity=0.295 Sum_probs=199.8
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc--hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
+|+..+.||+|++|.||+|.+..+++.|++|++..... ...+.+.+|++++++++||||+++++.+... .....+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDE---EKNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC---CCCeEE
Confidence 47888999999999999999998899999999875442 4567889999999999999999999984321 127899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+++++|.+++.. ...+++.++..++.|+++|++|||+. +++||||+|+||+++.++.+||+|
T Consensus 78 lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d 144 (260)
T cd06606 78 IFLEYVSGGSLSSLLKK----------FGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLAD 144 (260)
T ss_pred EEEEecCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcc
Confidence 99999999999999852 22689999999999999999999998 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCc
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDH 926 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 926 (986)
||.+................++..|+|||...+...+.++||||||+++|+|++|+.||.... ..........
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~--- 217 (260)
T cd06606 145 FGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG----NPMAALYKIG--- 217 (260)
T ss_pred cccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----chHHHHHhcc---
Confidence 999987654432112234568889999999988889999999999999999999999987432 1111110000
Q ss_pred hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 927 VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 927 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
. ..... ..+...+..+.+++.+|++.+|++||++.|+
T Consensus 218 -----~---~~~~~---------------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~l 254 (260)
T cd06606 218 -----S---SGEPP---------------EIPEHLSEEAKDFLRKCLRRDPKKRPTADEL 254 (260)
T ss_pred -----c---cCCCc---------------CCCcccCHHHHHHHHHhCcCChhhCCCHHHH
Confidence 0 00000 0011224568899999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=301.53 Aligned_cols=272 Identities=19% Similarity=0.213 Sum_probs=192.1
Q ss_pred CCCCcccccccceeEEEEEECCCCeEEEEEEeeccC-chhHHHHHHHHHHHhcCC-CCcceeeeeeccccccCCCceEEE
Q 046598 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDFKAL 767 (986)
Q Consensus 690 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~l 767 (986)
|++.+.||+|+||.||+|.+..+++.||+|+++... ........+|+.+++++. |+|++++++++.+ ...+..++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~---~~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFD---RKTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEec---CCCCcEEE
Confidence 678899999999999999999889999999986432 222234567888888885 9999999998532 12267899
Q ss_pred EEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccc
Q 046598 768 VFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDF 847 (986)
Q Consensus 768 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DF 847 (986)
||||++ +++.+++.. ....+++.+++.++.|++.||+|||+. +++||||+|+||+++. +.+||+||
T Consensus 78 v~e~~~-~~l~~~l~~---------~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~df 143 (282)
T cd07831 78 VFELMD-MNLYELIKG---------RKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADF 143 (282)
T ss_pred EEecCC-ccHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEec
Confidence 999996 588888752 224689999999999999999999999 9999999999999999 99999999
Q ss_pred ccceecCCCCCccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCc
Q 046598 848 GLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDH 926 (986)
Q Consensus 848 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 926 (986)
|.++........ ....++..|+|||++.+ ..++.++||||+||++|||++|+.||...... .............
T Consensus 144 g~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~--~~~~~~~~~~~~~ 218 (282)
T cd07831 144 GSCRGIYSKPPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL--DQIAKIHDVLGTP 218 (282)
T ss_pred ccccccccCCCc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH--HHHHHHHHHcCCC
Confidence 999865332221 22457889999997644 56789999999999999999999999642211 1111111111111
Q ss_pred hhHHhhhhcccCC-cchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 927 VMDIVDSTLLNDG-EDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 927 ~~~~~d~~l~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..++ ........ ...... ..............+.++.+++.+||+.+|++|||++|+
T Consensus 219 ~~~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~ 276 (282)
T cd07831 219 DAEV-LKKFRKSRHMNYNFP--SKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQA 276 (282)
T ss_pred CHHH-HHhhcccccccccCc--ccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHH
Confidence 1111 11110000 000000 000000011112446788999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=305.04 Aligned_cols=283 Identities=21% Similarity=0.260 Sum_probs=195.9
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCC-CCcceeeeeeccccccCCCce
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~ 764 (986)
++|++.+.||+|+||.||+|.+..+++.||+|+.+... ......+.+|+.++++++ ||||+++++++..........
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46899999999999999999999889999999986432 223457888999999995 699999999864332223334
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecC-CCcEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDE-DMIAH 843 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~k 843 (986)
.|+||||+++ +|.+++..... .....+++.+++.++.||+.||.|||+. +|+||||||+||+++. ++.+|
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~k 151 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGR-----GPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLK 151 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcc-----cCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEE
Confidence 8999999975 89888853321 1134689999999999999999999999 9999999999999998 88999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 922 (986)
|+|||.++.+..... ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||....... ....... .
T Consensus 152 l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~-~ 227 (295)
T cd07837 152 IADLGLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ-QLLHIFK-L 227 (295)
T ss_pred EeecccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHH-H
Confidence 999999976532211 1122346788999998765 457999999999999999999999986321111 0001110 0
Q ss_pred CCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 923 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
......... +...... +....... .+............++.+++.+|++.+|++||+++|+
T Consensus 228 ~~~~~~~~~-~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~ei 288 (295)
T cd07837 228 LGTPTEQVW-PGVSKLR-DWHEFPQW-KPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAA 288 (295)
T ss_pred hCCCChhhC-cchhhcc-chhhcCcc-cchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHH
Confidence 000000000 0000000 00000000 0000011112345678899999999999999998764
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=303.02 Aligned_cols=199 Identities=28% Similarity=0.437 Sum_probs=167.7
Q ss_pred CCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEE
Q 046598 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 767 (986)
Q Consensus 690 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 767 (986)
|++.+.||.|++|.||+|.+..+++.||+|++.... ....+.+.+|+++++.++|||++++++++ .++...++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~-----~~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVV-----HSENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhhee-----ccCCeEEE
Confidence 678899999999999999998889999999987433 22345688999999999999999999984 45588999
Q ss_pred EEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccc
Q 046598 768 VFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDF 847 (986)
Q Consensus 768 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DF 847 (986)
||||++ ++|.+++.... ...+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++|+||
T Consensus 76 v~e~~~-~~l~~~~~~~~--------~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df 143 (283)
T cd07835 76 VFEFLD-LDLKKYMDSSP--------LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADF 143 (283)
T ss_pred EEeccC-cCHHHHHhhCC--------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeec
Confidence 999994 69999985322 13589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCccccccccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 848 GLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 848 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
|.++....... ......++..|+|||++.+. .++.++|||||||++|+|++|+.||..
T Consensus 144 ~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 202 (283)
T cd07835 144 GLARAFGVPVR--TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPG 202 (283)
T ss_pred ccccccCCCcc--ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99976532211 11223468899999987664 578999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=300.03 Aligned_cols=242 Identities=24% Similarity=0.323 Sum_probs=188.6
Q ss_pred cccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEEEEec
Q 046598 696 IGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFM 772 (986)
Q Consensus 696 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 772 (986)
||+|+||+||+|.+..+++.||+|++.... ......+..|++++++++||||++++++ +..++..|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~-----~~~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYA-----FETKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeE-----EecCCeEEEEEecC
Confidence 689999999999999889999999986422 2234566789999999999999999988 45567899999999
Q ss_pred cCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccccccee
Q 046598 773 HNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARF 852 (986)
Q Consensus 773 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~ 852 (986)
++++|.+++.... ...+++.++..++.|++.|+.|||+. +++||||+|+||++++++.+||+|||.+..
T Consensus 76 ~~~~L~~~l~~~~--------~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~ 144 (277)
T cd05577 76 NGGDLKYHIYNVG--------EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVE 144 (277)
T ss_pred CCCcHHHHHHHcC--------cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhh
Confidence 9999999985322 13589999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCchhHHhh
Q 046598 853 LPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVMDIVD 932 (986)
Q Consensus 853 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d 932 (986)
.... .......++..|+|||++.+..++.++||||+||++|+|++|+.||...... ..........
T Consensus 145 ~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~---------- 210 (277)
T cd05577 145 LKGG---KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK-VEKEELKRRT---------- 210 (277)
T ss_pred hccC---CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc-ccHHHHHhcc----------
Confidence 5321 1122345788999999998888999999999999999999999998632211 0111111000
Q ss_pred hhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCC
Q 046598 933 STLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTN 985 (986)
Q Consensus 933 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 985 (986)
. ..+. .........+.+++.+||+.+|++||+++|
T Consensus 211 --~-~~~~---------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 211 --L-EMAV---------------EYPDKFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred --c-cccc---------------cCCccCCHHHHHHHHHHccCChhHccCCCc
Confidence 0 0000 000122445779999999999999997665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=306.73 Aligned_cols=202 Identities=27% Similarity=0.370 Sum_probs=178.4
Q ss_pred HhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc--hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 685 NATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 685 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
.....|.+.+.||+|.|+.|.+|++..++..||+|++....- .....+.+|+++|+.++|||||+++.+ ....
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v-----~~t~ 127 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSV-----IETE 127 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeee-----eeec
Confidence 346779999999999999999999999999999999975432 333558899999999999999999998 5667
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
...|+||||+.+|.+.+|+.... ...+..+..++.|+.+|++|+|++ .|||||||++||+++.+.++
T Consensus 128 ~~lylV~eya~~ge~~~yl~~~g----------r~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mni 194 (596)
T KOG0586|consen 128 ATLYLVMEYASGGELFDYLVKHG----------RMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNI 194 (596)
T ss_pred ceeEEEEEeccCchhHHHHHhcc----------cchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccce
Confidence 89999999999999999996443 455678899999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCccccccccccccccccccccCCCc-CcccchhhHHHHHHHHHhCCCCCCc
Q 046598 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEV-SISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
||+|||++..+.. .......+|++.|.|||++.+..| ++++|+||+|+++|.|+.|..||++
T Consensus 195 kIaDfgfS~~~~~---~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG 257 (596)
T KOG0586|consen 195 KIADFGFSTFFDY---GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG 257 (596)
T ss_pred eeeccccceeecc---cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC
Confidence 9999999988753 333455789999999999999876 4899999999999999999999984
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=310.08 Aligned_cols=200 Identities=28% Similarity=0.378 Sum_probs=166.7
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc--CchhHHHHHHHHHHHhcCCCCcceeeeeeccccc-cCCCc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-YQGND 763 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~ 763 (986)
.++|.+.+.||+|+||.||+|.+..+++.||+|++... .......+.+|++++++++||||+++++++.... .....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 47899999999999999999999888999999998642 2223456889999999999999999999864321 12234
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..++|+||+. .++..+.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+|
T Consensus 94 ~~~lv~e~~~-~~l~~~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~k 157 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG------------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELK 157 (342)
T ss_pred eEEEEecccc-cCHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEE
Confidence 5799999995 47776652 2478899999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
|+|||+++..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 158 L~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~ 217 (342)
T cd07879 158 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 217 (342)
T ss_pred EeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999754321 123457889999999876 4689999999999999999999999963
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=290.74 Aligned_cols=275 Identities=21% Similarity=0.250 Sum_probs=204.0
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCC-C-C----cceeeeeecccccc
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIR-H-R----NLVKILTACSGVDY 759 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~l~~~~~~~~~ 759 (986)
.+++|.++..+|+|.||.|-++.+...+..||||+++... ...++.+-|+++++++. + | -+|++.+| +
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w-----F 160 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDW-----F 160 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh-----h
Confidence 4789999999999999999999999989999999997543 34466788999999993 2 2 47788777 6
Q ss_pred CCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecC-
Q 046598 760 QGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDE- 838 (986)
Q Consensus 760 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~- 838 (986)
+..++.|||+|.+ |-|+.+++... ...+++...++.|++|++++++|||+. +++|-||||+||++..
T Consensus 161 dyrghiCivfell-G~S~~dFlk~N--------~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss 228 (415)
T KOG0671|consen 161 DYRGHICIVFELL-GLSTFDFLKEN--------NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSS 228 (415)
T ss_pred hccCceEEEEecc-ChhHHHHhccC--------CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEecc
Confidence 7789999999998 77999999743 234789999999999999999999999 9999999999999831
Q ss_pred -------------------CCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHH
Q 046598 839 -------------------DMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELI 899 (986)
Q Consensus 839 -------------------~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ell 899 (986)
...+|++|||.|+..... ....+.|..|+|||++.+-.|+.++||||+||||+|++
T Consensus 229 ~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Ely 303 (415)
T KOG0671|consen 229 EYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELY 303 (415)
T ss_pred ceEEEeccCCccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEee
Confidence 336999999999874322 24567899999999999999999999999999999999
Q ss_pred hCCCCCCccccccccHHHHHHhhCCCchhHHhhhhc--------ccCCcch-------hhccchhhhhHhhHHHHHHHHH
Q 046598 900 TRKKPTDIMFEGDMNLHNLARTALPDHVMDIVDSTL--------LNDGEDL-------IVHGNQRQRQARVKSRIECLIS 964 (986)
Q Consensus 900 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l--------~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~ 964 (986)
||..-|......+ .+ .++.....+....++.+.- .-+..+. .+....+...........+..+
T Consensus 304 tG~~LFqtHen~E-HL-aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~ 381 (415)
T KOG0671|consen 304 TGETLFQTHENLE-HL-AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQ 381 (415)
T ss_pred ccceecccCCcHH-HH-HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhH
Confidence 9999887433111 11 2222222222222222220 0000000 0000111122222333456667
Q ss_pred HHHHHhcccCCCCCCCCCCCC
Q 046598 965 MVRIGVACSMESPEDRMSMTN 985 (986)
Q Consensus 965 l~~l~~~Cl~~dP~~RPt~~e 985 (986)
+.+++++|+.+||.+|+|+.|
T Consensus 382 LfDLl~~mL~fDP~~RiTl~E 402 (415)
T KOG0671|consen 382 LFDLLRRMLEFDPARRITLRE 402 (415)
T ss_pred HHHHHHHHHccCccccccHHH
Confidence 999999999999999999987
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=296.50 Aligned_cols=250 Identities=24% Similarity=0.375 Sum_probs=200.6
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc--hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
+|++.+.||+|+||.||+|.+..++..||+|++..... ...+.+.+|+++++.++|||++++.+. +..+...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~-----~~~~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES-----FEEKGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEE-----EecCCEEE
Confidence 58889999999999999999998899999999975433 456778999999999999999999998 34458899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+|+||+++++|.+++.... .....+++.++..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|
T Consensus 76 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d 146 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQK------KEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGD 146 (258)
T ss_pred EEEEecCCCcHHHHHHHhh------ccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECC
Confidence 9999999999999996322 1235789999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCc
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDH 926 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 926 (986)
||.+....... .......+++.|+|||...+..++.++||||+|+++|+|++|+.||+... ........
T Consensus 147 ~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~---- 215 (258)
T cd08215 147 FGISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-----LLELALKI---- 215 (258)
T ss_pred ccceeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-----HHHHHHHH----
Confidence 99998654332 12233468889999999988899999999999999999999999986321 11111110
Q ss_pred hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 927 VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 927 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.......-+ ...+.++.+++.+||..+|++|||+.||
T Consensus 216 ----~~~~~~~~~-------------------~~~~~~~~~~i~~~l~~~p~~Rp~~~~l 252 (258)
T cd08215 216 ----LKGQYPPIP-------------------SQYSSELRNLVSSLLQKDPEERPSIAQI 252 (258)
T ss_pred ----hcCCCCCCC-------------------CCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 000000000 0223457789999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=301.11 Aligned_cols=274 Identities=23% Similarity=0.280 Sum_probs=198.1
Q ss_pred CCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc--hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEE
Q 046598 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 767 (986)
Q Consensus 690 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 767 (986)
|++.+.||+|++|.||+|.+..+++.+|+|+++.... .....+.+|++++++++|+||+++++++ ..+...++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVF-----RHKGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhh-----ccCCCEEE
Confidence 6788999999999999999988899999999864332 2456788999999999999999999984 45588999
Q ss_pred EEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccc
Q 046598 768 VFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDF 847 (986)
Q Consensus 768 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DF 847 (986)
||||+++ ++.+++.. ....+++.++..++.|++.||.|||+. +|+||||||+||+++.++.+||+||
T Consensus 76 v~e~~~~-~l~~~l~~---------~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df 142 (283)
T cd05118 76 VFEFMDT-DLYKLIKD---------RQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADF 142 (283)
T ss_pred EEeccCC-CHHHHHHh---------hcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeee
Confidence 9999965 88888852 224689999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCccccccccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCc
Q 046598 848 GLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDH 926 (986)
Q Consensus 848 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 926 (986)
|.+....... .......++..|+|||.+.+. .++.++||||+|+++|+|+||+.||......+ ..... .......
T Consensus 143 ~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~-~~~~~~~ 218 (283)
T cd05118 143 GLARSFGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID-QLFKI-FRTLGTP 218 (283)
T ss_pred eeeEecCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHH-HHHcCCC
Confidence 9998764332 112234577889999998776 78999999999999999999999986332111 11111 1111111
Q ss_pred hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 927 VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 927 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..+................. ............+.+.++.+++.+||+.||.+||+++|+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~l 277 (283)
T cd05118 219 DPEVWPKFTSLARNYKFSFP-KKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQA 277 (283)
T ss_pred chHhcccchhhhhhhhhhhc-cccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHH
Confidence 00000000000000000000 000000111223456788899999999999999999764
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=288.22 Aligned_cols=265 Identities=21% Similarity=0.301 Sum_probs=216.1
Q ss_pred HHHHHhhcCCCCCcccccccceeEEEEEECCCC-----eEEEEEEeec-cCchhHHHHHHHHHHHhcCCCCcceeeeeec
Q 046598 681 QNLYNATDRFSSVNQIGEGSFGSVFKGILDDGR-----TTIAVKVFNL-LHHGAFKSFIAECNTLKNIRHRNLVKILTAC 754 (986)
Q Consensus 681 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 754 (986)
+++.....|++....+-+|.||.||+|.+++.+ +.|-||.++. .++-....+..|.-.+..+.|||+.++.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 445556677888888999999999999886532 3466676643 3334456788888889999999999999987
Q ss_pred cccccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCe
Q 046598 755 SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNI 834 (986)
Q Consensus 755 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NI 834 (986)
. ++....++++.++.-|+|..|++.++.. .......++..+...++.|++.|++|||++ +|||.||.++|.
T Consensus 357 i----e~~~~P~V~y~~~~~gNLK~FL~~Cr~~--~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNC 427 (563)
T KOG1024|consen 357 I----EDYATPFVLYPATGVGNLKSFLQICRGD--DPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNC 427 (563)
T ss_pred e----eccCcceEEEeccCcchHHHHHHHhccC--CCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcc
Confidence 4 4567889999999999999999876632 224455688899999999999999999999 999999999999
Q ss_pred EecCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccc
Q 046598 835 LLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDM 913 (986)
Q Consensus 835 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~ 913 (986)
+||+..++||+|=.+++...+.+...-......+..||+||.+....|+.++|||||||++|||+| |+.|+....+.+
T Consensus 428 vIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE- 506 (563)
T KOG1024|consen 428 VIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE- 506 (563)
T ss_pred eehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH-
Confidence 999999999999999998877777666666778899999999999999999999999999999999 999986432211
Q ss_pred cHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 914 NLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+.. .+ ..+.|.+++..|+.++..+|.-||+.+|++||+++|+
T Consensus 507 ----m~~-------------yl--------------kdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Ql 548 (563)
T KOG1024|consen 507 ----MEH-------------YL--------------KDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQL 548 (563)
T ss_pred ----HHH-------------HH--------------hccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHH
Confidence 110 11 1123566677899999999999999999999999874
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=309.30 Aligned_cols=204 Identities=25% Similarity=0.336 Sum_probs=167.5
Q ss_pred CCCCCcccccccceeEEEEEECCC--CeEEEEEEeecc--CchhHHHHHHHHHHHhcC-CCCcceeeeeeccccccCCCc
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDG--RTTIAVKVFNLL--HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 763 (986)
+|++.+.||+|+||.||+|++... +..||+|++... .....+.+.+|+++++++ +||||+++++++... .....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVF-PGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeec-cccCC
Confidence 588899999999999999999887 889999998642 222346788899999999 599999999874322 23345
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..++++||+. ++|.+++. ....+++..++.++.||+.||+|||+. |++||||||+||+++.++.+|
T Consensus 80 ~~~~~~e~~~-~~L~~~l~----------~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~k 145 (332)
T cd07857 80 ELYLYEELME-ADLHQIIR----------SGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELK 145 (332)
T ss_pred cEEEEEeccc-CCHHHHHh----------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEE
Confidence 6789999985 68999884 234688999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCc--cccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 844 IGDFGLARFLPLSSAQ--TSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
|+|||.++........ .......|+..|+|||++.+ ..++.++||||+||++|+|++|++||..
T Consensus 146 l~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~ 212 (332)
T cd07857 146 ICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKG 212 (332)
T ss_pred eCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCC
Confidence 9999999865432211 11223468899999998765 5689999999999999999999999863
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=306.31 Aligned_cols=256 Identities=25% Similarity=0.293 Sum_probs=190.1
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC-chhHHHHHHHHHHHhcCC-CCcceeeeeeccccccCCCceE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~ 765 (986)
++|...+.||+|+||.||++.+..+++.||+|.+.... ......+.+|+.++.++. ||||+++++++ ..+...
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~-----~~~~~~ 78 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGAL-----FREGDC 78 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEE-----ecCCcE
Confidence 35666789999999999999999989999999986432 234567889999999996 99999999984 345778
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
+++|||+. +++.++..... ......+++..+..++.|++.||+|||+. .+++||||||+||+++.++.+||+
T Consensus 79 ~~~~e~~~-~~l~~l~~~~~-----~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~ 150 (288)
T cd06616 79 WICMELMD-ISLDKFYKYVY-----EVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLC 150 (288)
T ss_pred EEEEeccc-CCHHHHHHHHH-----HhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEe
Confidence 99999985 46555432110 01224689999999999999999999963 289999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccCC---CcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS---EVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 922 (986)
|||+++....... .....++..|+|||++.+. .++.++||||+||++|||++|+.||.... .........
T Consensus 151 dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~~ 223 (288)
T cd06616 151 DFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN----SVFDQLTQV 223 (288)
T ss_pred ecchhHHhccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----hHHHHHhhh
Confidence 9999976532211 1223578899999998776 68999999999999999999999986321 111111110
Q ss_pred CCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 923 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..... +.+.. .....++.++.+++.+||+.+|++|||++||
T Consensus 224 ~~~~~-----~~~~~------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i 264 (288)
T cd06616 224 VKGDP-----PILSN------------------SEEREFSPSFVNFINLCLIKDESKRPKYKEL 264 (288)
T ss_pred cCCCC-----CcCCC------------------cCCCccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 00000 00000 0001245568899999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=282.42 Aligned_cols=210 Identities=25% Similarity=0.344 Sum_probs=174.9
Q ss_pred HhhcCCCCCcccccccceeEEEEEECCCC----eEEEEEEeeccCc--hhHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 046598 685 NATDRFSSVNQIGEGSFGSVFKGILDDGR----TTIAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTACSGVD 758 (986)
Q Consensus 685 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 758 (986)
+....|+.+..||+|.||.||+|...++. ..+|+|.++.... +-.....+|+..++.++||||+.+..++
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vf---- 96 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVF---- 96 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHH----
Confidence 34567999999999999999999775543 2689999875422 2345678999999999999999999885
Q ss_pred cCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecC
Q 046598 759 YQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDE 838 (986)
Q Consensus 759 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 838 (986)
...+...++++||.+. +|.+.++..... ..+.++...++.|++||+.|+.|||++ =|+||||||.||||..
T Consensus 97 l~~d~~v~l~fdYAEh-DL~~II~fHr~~-----~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmg 167 (438)
T KOG0666|consen 97 LSHDKKVWLLFDYAEH-DLWHIIKFHRAS-----KAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMG 167 (438)
T ss_pred hccCceEEEEehhhhh-hHHHHHHHhccc-----hhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEec
Confidence 3337889999999976 999999755542 335899999999999999999999999 8999999999999987
Q ss_pred C----CcEEEcccccceecCCCCC-ccccccccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 839 D----MIAHIGDFGLARFLPLSSA-QTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 839 ~----~~~kL~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
+ |.|||+|||+|+.+...-. .......+.|..|+|||.+.|. .||++.||||.||++.||+|-++.|..
T Consensus 168 dgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 168 DGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred cCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 7 8999999999998754322 2244557789999999998885 699999999999999999999988863
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=296.45 Aligned_cols=203 Identities=24% Similarity=0.331 Sum_probs=171.6
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc-----CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL-----HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
.+|++.+.||+|+||.||+|.+..++..||+|++... .....+.+.+|++++++++||||+++++++.. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~---~~~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRD---PEE 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEc---CCC
Confidence 4789999999999999999999988999999987532 22344678899999999999999999998532 224
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
...++||||+++++|.+++.. ...+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~----------~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~ 145 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKA----------YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNV 145 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCE
Confidence 568899999999999999852 23478889999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCC-ccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCC
Q 046598 843 HIGDFGLARFLPLSSA-QTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTD 906 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~ 906 (986)
+|+|||.++....... ........++..|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 210 (264)
T cd06653 146 KLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWA 210 (264)
T ss_pred EECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 9999999976532111 111223458889999999998889999999999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=297.13 Aligned_cols=248 Identities=23% Similarity=0.288 Sum_probs=198.5
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
+|++.++||+|+||.||++.+..+++.+|+|.+.... .....++.+|++++++++|+||+++.+++ ......+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF-----LDGNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhh-----ccCCEEE
Confidence 5888999999999999999999889999999987532 33456778999999999999999999884 4558899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+++++|.+++.... .....+++..+..++.|++.|++|||+. +++||||+|+||++++++.+||+|
T Consensus 76 ~v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d 146 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRK------KKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGD 146 (256)
T ss_pred EEehhcCCCCHHHHHHHHH------hhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEee
Confidence 9999999999999986321 1234689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCc
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDH 926 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 926 (986)
||.++..... ......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||..... ......
T Consensus 147 ~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~----- 212 (256)
T cd08530 147 LGISKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM-----QDLRYK----- 212 (256)
T ss_pred ccchhhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHH-----
Confidence 9999776433 22234578899999999999999999999999999999999999863211 111000
Q ss_pred hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 927 VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 927 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+.. .... +.......++.+++.+|++.+|++|||+.||
T Consensus 213 ----~~~---~~~~---------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~ 250 (256)
T cd08530 213 ----VQR---GKYP---------------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKI 250 (256)
T ss_pred ----Hhc---CCCC---------------CCchhhCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 000 0000 0011334567899999999999999998764
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=281.76 Aligned_cols=200 Identities=25% Similarity=0.338 Sum_probs=176.8
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeec---cCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL---LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
.++|+..+.||+|.||.|.+++-+.+++.+|+|++++ ....+...-..|-++++..+||.+..+... ++..+
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYs-----FQt~d 241 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYS-----FQTQD 241 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhh-----hccCc
Confidence 4678899999999999999999999999999999974 233445566788999999999999888765 77889
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..|+||||+.||.|.-++.+ ...+++...+.+..+|..||.|||++ +||+||+|.+|.|+|.+|++|
T Consensus 242 rlCFVMeyanGGeLf~HLsr----------er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIK 308 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSR----------ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIK 308 (516)
T ss_pred eEEEEEEEccCceEeeehhh----------hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceE
Confidence 99999999999999988853 34688888899999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCC
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTD 906 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~ 906 (986)
|+|||+++.-- .....+...+||+.|.|||++....|+.++|.|.+||++|||++|+.||.
T Consensus 309 itDFGLCKE~I--~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFy 369 (516)
T KOG0690|consen 309 ITDFGLCKEEI--KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFY 369 (516)
T ss_pred eeecccchhcc--cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccc
Confidence 99999997532 23344556899999999999999999999999999999999999999996
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=295.39 Aligned_cols=239 Identities=22% Similarity=0.265 Sum_probs=183.7
Q ss_pred cccccccceeEEEEEECCCCeEEEEEEeeccCc---hhHHHHHHHHHHH-hcCCCCcceeeeeeccccccCCCceEEEEE
Q 046598 694 NQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH---GAFKSFIAECNTL-KNIRHRNLVKILTACSGVDYQGNDFKALVF 769 (986)
Q Consensus 694 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 769 (986)
+.||+|+||.||+|.+..+++.||+|+++.... .....+..|..++ ...+|+|++++++++ ..++..++||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF-----QSKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeE-----EcCCeEEEEE
Confidence 579999999999999988899999999864322 2223344555444 445899999999984 4567899999
Q ss_pred EeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccccc
Q 046598 770 EFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGL 849 (986)
Q Consensus 770 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~ 849 (986)
||+++++|.++++. ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||.
T Consensus 77 e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 143 (260)
T cd05611 77 EYLNGGDCASLIKT----------LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGL 143 (260)
T ss_pred eccCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeeccc
Confidence 99999999999852 23588999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCchhH
Q 046598 850 ARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVMD 929 (986)
Q Consensus 850 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 929 (986)
++.... .....++..|+|||.+.+..++.++||||||+++|+|++|..||..... ......
T Consensus 144 ~~~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~-------- 204 (260)
T cd05611 144 SRNGLE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP-----DAVFDN-------- 204 (260)
T ss_pred ceeccc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHH--------
Confidence 875432 1234578899999999888899999999999999999999999863211 111100
Q ss_pred HhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCC
Q 046598 930 IVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTN 985 (986)
Q Consensus 930 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 985 (986)
....... .+. .....++..+.+++.+||+.+|++||++.+
T Consensus 205 ~~~~~~~-~~~---------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ 244 (260)
T cd05611 205 ILSRRIN-WPE---------------EVKEFCSPEAVDLINRLLCMDPAKRLGANG 244 (260)
T ss_pred HHhcccC-CCC---------------cccccCCHHHHHHHHHHccCCHHHccCCCc
Confidence 0000000 000 001123456789999999999999998853
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=306.88 Aligned_cols=199 Identities=23% Similarity=0.294 Sum_probs=161.8
Q ss_pred cccccc--cceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEEE
Q 046598 694 NQIGEG--SFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVF 769 (986)
Q Consensus 694 ~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 769 (986)
..||+| +||+||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||++++++| ..++..++||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~-----~~~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVF-----TTGSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeE-----ecCCceEEEE
Confidence 456766 89999999999889999999986432 23457788999999999999999999994 4567899999
Q ss_pred EeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccccc
Q 046598 770 EFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGL 849 (986)
Q Consensus 770 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~ 849 (986)
||++++++.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+|++|||.
T Consensus 79 e~~~~~~l~~~l~~~~--------~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~ 147 (328)
T cd08226 79 PFMAYGSANSLLKTYF--------PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSH 147 (328)
T ss_pred ecccCCCHHHHHHhhc--------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHH
Confidence 9999999999986432 23488999999999999999999999 999999999999999999999999986
Q ss_pred ceecCCCCCcc-----ccccccccccccccccccCC--CcCcccchhhHHHHHHHHHhCCCCCCcc
Q 046598 850 ARFLPLSSAQT-----SSIGAKGSIGYIAPEYGLGS--EVSISGDVYSYGILLLELITRKKPTDIM 908 (986)
Q Consensus 850 a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~elltg~~pf~~~ 908 (986)
+.......... ......++..|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 213 (328)
T cd08226 148 LYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213 (328)
T ss_pred HhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 54322111100 01112346679999998764 4789999999999999999999999743
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=302.08 Aligned_cols=244 Identities=22% Similarity=0.302 Sum_probs=192.8
Q ss_pred CCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEEEEe
Q 046598 692 SVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEF 771 (986)
Q Consensus 692 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~ 771 (986)
...+||+|+||.||+|....+++.||+|++........+.+.+|+.+++.++|+||+++++++ ..++..++||||
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~ 98 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDELWVVMEF 98 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEE-----EeCCEEEEEEec
Confidence 346799999999999999988999999998655545567789999999999999999999984 456789999999
Q ss_pred ccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcccccce
Q 046598 772 MHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLAR 851 (986)
Q Consensus 772 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~ 851 (986)
+++++|.+++.. ..+++..+..++.|++.|++|||+. |++||||+|+||++++++.++|+|||.+.
T Consensus 99 ~~~~~L~~~~~~-----------~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~ 164 (292)
T cd06657 99 LEGGALTDIVTH-----------TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCA 164 (292)
T ss_pred CCCCcHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccce
Confidence 999999998741 2478899999999999999999999 99999999999999999999999999987
Q ss_pred ecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCchhHHh
Q 046598 852 FLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVMDIV 931 (986)
Q Consensus 852 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (986)
...... .......++..|+|||.+.+..++.++||||+||++|+|++|+.||..... ...........+...
T Consensus 165 ~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~---- 236 (292)
T cd06657 165 QVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLPPKL---- 236 (292)
T ss_pred eccccc--ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhhCCccc----
Confidence 653221 112334578899999999888899999999999999999999999863111 000011111111000
Q ss_pred hhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 932 DSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 932 d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
......+..+.+++.+||+.+|.+||++.||
T Consensus 237 ------------------------~~~~~~~~~l~~li~~~l~~~P~~R~~~~~l 267 (292)
T cd06657 237 ------------------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAEL 267 (292)
T ss_pred ------------------------CCcccCCHHHHHHHHHHHhCCcccCcCHHHH
Confidence 0001223456788999999999999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=303.12 Aligned_cols=209 Identities=29% Similarity=0.393 Sum_probs=170.9
Q ss_pred HhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeeccccc----
Q 046598 685 NATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVD---- 758 (986)
Q Consensus 685 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 758 (986)
...++|++.+.||+|+||.||+|.+..+++.||+|+++... ......+.+|++++++++||||+++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 35678999999999999999999999889999999987532 223356788999999999999999999864321
Q ss_pred -cCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEec
Q 046598 759 -YQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLD 837 (986)
Q Consensus 759 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 837 (986)
..+....++||||+++ ++.+++.. ....+++.+++.++.||+.||+|||+. +|+||||||+||+++
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~---------~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~ 150 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES---------GLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLN 150 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc---------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 1223479999999975 77777642 223589999999999999999999999 999999999999999
Q ss_pred CCCcEEEcccccceecCCCCCccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 838 EDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 838 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
+++.+||+|||.+........ .......++..|+|||.+.+ ..++.++|||||||++|||++|++||..
T Consensus 151 ~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~ 220 (302)
T cd07864 151 NKGQIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQA 220 (302)
T ss_pred CCCcEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999986543321 11122346788999998765 4578999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=303.71 Aligned_cols=243 Identities=26% Similarity=0.318 Sum_probs=189.1
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
.|+..+.||+|+||.||+|++..++..||+|++.... ....+.+.+|++++++++|||+++++++| ..+...
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~ 100 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCY-----LREHTA 100 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----eeCCeE
Confidence 3777889999999999999998889999999986432 23345788999999999999999999984 445778
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
++||||++ |++.+.+.. ....+++.++..++.|++.|+.|||+. +|+||||+|+||+++.++.+||+
T Consensus 101 ~lv~e~~~-g~l~~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~ 167 (317)
T cd06635 101 WLVMEYCL-GSASDLLEV---------HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLA 167 (317)
T ss_pred EEEEeCCC-CCHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEe
Confidence 99999996 578777742 234589999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccc---CCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGL---GSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 922 (986)
|||++...... ....++..|+|||++. ++.++.++|||||||++|||++|+.||....... .......
T Consensus 168 dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~-- 238 (317)
T cd06635 168 DFGSASIASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQ-- 238 (317)
T ss_pred cCCCccccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-HHHHHHh--
Confidence 99998754321 2245788999999873 4578999999999999999999999985321100 0000000
Q ss_pred CCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 923 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
...... .....+..+.+++.+||+.+|++||++.||
T Consensus 239 ----------~~~~~~------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i 274 (317)
T cd06635 239 ----------NESPTL------------------QSNEWSDYFRNFVDSCLQKIPQDRPTSEEL 274 (317)
T ss_pred ----------ccCCCC------------------CCccccHHHHHHHHHHccCCcccCcCHHHH
Confidence 000000 001233457889999999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=309.83 Aligned_cols=206 Identities=25% Similarity=0.361 Sum_probs=169.4
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccc--------
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-------- 758 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------- 758 (986)
..+|.+.+.||.|+||.||+|.+..+++.||+|++........+.+.+|++++++++||||+++++++....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 478999999999999999999999989999999987666566678899999999999999999998754321
Q ss_pred -cCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEec
Q 046598 759 -YQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLD 837 (986)
Q Consensus 759 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 837 (986)
.......++||||++ ++|.+++. ...+++..++.++.||+.||.|||+. ||+||||||+||+++
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~-----------~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~ 148 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE-----------QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFIN 148 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH-----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEc
Confidence 112246899999996 58988874 12588999999999999999999999 999999999999997
Q ss_pred -CCCcEEEcccccceecCCCCC-ccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 838 -EDMIAHIGDFGLARFLPLSSA-QTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 838 -~~~~~kL~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
+++.+|++|||.++....... ........++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..
T Consensus 149 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~ 221 (342)
T cd07854 149 TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAG 221 (342)
T ss_pred CCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 456799999999976532211 111122357889999997654 5688999999999999999999999963
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=312.10 Aligned_cols=280 Identities=21% Similarity=0.237 Sum_probs=198.2
Q ss_pred HhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc--CchhHHHHHHHHHHHhcCCCCcceeeeeecccccc-CC
Q 046598 685 NATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY-QG 761 (986)
Q Consensus 685 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~ 761 (986)
...++|++.+.||+|++|.||+|++..+++.||+|++... .....+.+.+|+.++++++||||+++.+++..... ..
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 4577899999999999999999999988999999998642 22334667789999999999999999987532211 22
Q ss_pred CceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCc
Q 046598 762 NDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI 841 (986)
Q Consensus 762 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 841 (986)
....++|+||+ +++|.+++.. ..+++.++..++.|+++|++|||+. ||+||||||+||++++++.
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~-----------~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~ 156 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC-----------QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCE 156 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCC
Confidence 23589999999 7799998851 3589999999999999999999999 9999999999999999999
Q ss_pred EEEcccccceecCCCCCccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHH
Q 046598 842 AHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLAR 920 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~ 920 (986)
+||+|||.+...... .....++..|+|||.+.+ ..++.++||||+||++||+++|+.||...... ..+... .
T Consensus 157 ~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-~~~~~i-~ 229 (343)
T cd07851 157 LKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI-DQLKRI-M 229 (343)
T ss_pred EEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHH-H
Confidence 999999999765322 223457889999998765 46789999999999999999999998632111 011111 1
Q ss_pred hhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 921 TALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 921 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.........+..........+......................++.+++.+|++.+|++|||+.||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~el 295 (343)
T cd07851 230 NLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEA 295 (343)
T ss_pred HhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHH
Confidence 111111111111111000000000000000000001111235678899999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=294.42 Aligned_cols=246 Identities=26% Similarity=0.356 Sum_probs=198.0
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc--hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
+|++.+.||+|++|.||+|++..+++.||+|.+..... ...+.+.+|++++++++|||++++++++ ..+...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSI-----ETSDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEE-----EeCCEEE
Confidence 58889999999999999999998889999999976543 4567899999999999999999999984 4457899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+++++|.+++.. ...+++..+..++.|++.|+.|||+. |++||||+|+||+++.++.+||+|
T Consensus 76 ~v~e~~~~~~L~~~~~~----------~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d 142 (254)
T cd06627 76 IILEYAENGSLRQIIKK----------FGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLAD 142 (254)
T ss_pred EEEecCCCCcHHHHHHh----------ccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEec
Confidence 99999999999999852 24689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCc
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDH 926 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 926 (986)
||.+......... .....++..|+|||...+..++.++||||+|+++|+|++|+.||..... ......... .
T Consensus 143 ~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~----~~~~~~~~~-~- 214 (254)
T cd06627 143 FGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP----MAALFRIVQ-D- 214 (254)
T ss_pred cccceecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH----HHHHHHHhc-c-
Confidence 9999876433221 2234578899999998888889999999999999999999999863221 111111000 0
Q ss_pred hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 927 VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 927 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..+ ..+...+..+.+++.+|+..+|++|||+.|+
T Consensus 215 ----------~~~----------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~ 248 (254)
T cd06627 215 ----------DHP----------------PLPEGISPELKDFLMQCFQKDPNLRPTAKQL 248 (254)
T ss_pred ----------CCC----------------CCCCCCCHHHHHHHHHHHhCChhhCcCHHHH
Confidence 000 0001223457789999999999999999764
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=304.54 Aligned_cols=208 Identities=25% Similarity=0.353 Sum_probs=168.8
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc--hhHHHHHHHHHHHhcCCCCcceeeeeeccccc---cCC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTACSGVD---YQG 761 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---~~~ 761 (986)
.++|++.++||+|+||.||+|.+..+++.||+|++..... .....+.+|++++++++||||+++++++.... ...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 5789999999999999999999998899999999864322 22346788999999999999999998754321 123
Q ss_pred CceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCc
Q 046598 762 NDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI 841 (986)
Q Consensus 762 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 841 (986)
....++||||+. +++...+.. ....+++.++..++.|+++||+|||+. +|+||||||+||++++++.
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~---------~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~ 153 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLEN---------PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGI 153 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhc---------cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCC
Confidence 456899999995 477777642 234689999999999999999999999 9999999999999999999
Q ss_pred EEEcccccceecCCCCCc---------cccccccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 842 AHIGDFGLARFLPLSSAQ---------TSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
+||+|||+++........ .......+++.|+|||.+.+. .++.++|||||||++|||++|++||..
T Consensus 154 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~ 229 (311)
T cd07866 154 LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQG 229 (311)
T ss_pred EEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCC
Confidence 999999999765322211 111233567889999987654 588999999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=296.81 Aligned_cols=241 Identities=25% Similarity=0.341 Sum_probs=189.9
Q ss_pred cccccceeEEEEEECCCCeEEEEEEeeccCc---hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEEEEec
Q 046598 696 IGEGSFGSVFKGILDDGRTTIAVKVFNLLHH---GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFM 772 (986)
Q Consensus 696 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 772 (986)
||+|+||.||+|++..+++.||+|++..... ...+.+.+|++++++++||||+++++. +..+...|+||||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~-----~~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYS-----FQGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHh-----eecCcEEEEEEecC
Confidence 6899999999999998899999999865332 345678899999999999999999987 45668899999999
Q ss_pred cCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccccccee
Q 046598 773 HNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARF 852 (986)
Q Consensus 773 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~ 852 (986)
++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||++..
T Consensus 76 ~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~ 142 (265)
T cd05579 76 PGGDLASLLEN----------VGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKV 142 (265)
T ss_pred CCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchh
Confidence 99999999952 22689999999999999999999999 999999999999999999999999999875
Q ss_pred cCCCCC------ccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCc
Q 046598 853 LPLSSA------QTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDH 926 (986)
Q Consensus 853 ~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 926 (986)
...... ........++..|+|||...+..++.++||||||+++|++++|+.||..... .....
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~------ 211 (265)
T cd05579 143 GLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP-----EEIFQ------ 211 (265)
T ss_pred cccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHH------
Confidence 432211 1122334578899999999888899999999999999999999999863221 11110
Q ss_pred hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCC
Q 046598 927 VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTN 985 (986)
Q Consensus 927 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 985 (986)
........ .+.....+..+.+++.+||+.+|++|||+.+
T Consensus 212 ------~~~~~~~~--------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ 250 (265)
T cd05579 212 ------NILNGKIE--------------WPEDVEVSDEAIDLISKLLVPDPEKRLGAKS 250 (265)
T ss_pred ------HHhcCCcC--------------CCccccCCHHHHHHHHHHhcCCHhhcCCCcc
Confidence 00000000 0000012456789999999999999999943
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=307.95 Aligned_cols=282 Identities=21% Similarity=0.240 Sum_probs=198.5
Q ss_pred HHHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc--CchhHHHHHHHHHHHhcCCCCcceeeeeeccccc-c
Q 046598 683 LYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-Y 759 (986)
Q Consensus 683 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~ 759 (986)
+....++|++.+.||+|+||.||+|.+..++..||||++... .....+.+.+|++++++++||||+++++++.... .
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 445678999999999999999999999988999999998542 2223456889999999999999999999864321 1
Q ss_pred CCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCC
Q 046598 760 QGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED 839 (986)
Q Consensus 760 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 839 (986)
......++||||+ +++|.+++. ...+++..++.++.|++.|++|||+. ||+||||||+||+++.+
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~ 154 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMK-----------HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNED 154 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC
Confidence 1123569999999 789998874 13588999999999999999999999 99999999999999999
Q ss_pred CcEEEcccccceecCCCCCccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHH
Q 046598 840 MIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNL 918 (986)
Q Consensus 840 ~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~ 918 (986)
+.+||+|||.+...... .....+++.|+|||.+.+ ..++.++||||+||++|++++|+.||...... ..+...
T Consensus 155 ~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~ 228 (343)
T cd07880 155 CELKILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL-DQLMEI 228 (343)
T ss_pred CCEEEeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH
Confidence 99999999999765321 123457889999998876 45889999999999999999999998632211 011111
Q ss_pred HHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 919 ARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 919 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.... .....++.+...............................++.+++.+|++.||++|||+.++
T Consensus 229 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~ 295 (343)
T cd07880 229 MKVT-GTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEA 295 (343)
T ss_pred HHhc-CCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHH
Confidence 1100 000111111100000000000000000000001112344567899999999999999998764
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=324.29 Aligned_cols=204 Identities=22% Similarity=0.298 Sum_probs=158.9
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCC-eEEEEE------------------EeeccCchhHHHHHHHHHHHhcCCCCc
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGR-TTIAVK------------------VFNLLHHGAFKSFIAECNTLKNIRHRN 746 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~h~n 746 (986)
..++|++++.||+|+||+||++..+... ..+++| .+. ........+.+|+.++++++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 4578999999999999999998764321 111211 111 11223456889999999999999
Q ss_pred ceeeeeeccccccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 046598 747 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAH 826 (986)
Q Consensus 747 iv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH 826 (986)
|+++++++ ...+..|+|+|++ ++++.+++..... .........+++.|+.||+.||+|||++ +|+|
T Consensus 225 Iv~l~~~~-----~~~~~~~lv~e~~-~~~l~~~l~~~~~-----~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiH 290 (501)
T PHA03210 225 ILKIEEIL-----RSEANTYMITQKY-DFDLYSFMYDEAF-----DWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIH 290 (501)
T ss_pred cCcEeEEE-----EECCeeEEEEecc-ccCHHHHHhhccc-----cccccccHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence 99999994 4557789999998 5678877743221 1112344667889999999999999999 9999
Q ss_pred ecCCCCCeEecCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCC
Q 046598 827 CDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPT 905 (986)
Q Consensus 827 ~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf 905 (986)
|||||+|||++.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|..++
T Consensus 291 rDLKP~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 291 RDIKLENIFLNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCCCHHHEEECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 99999999999999999999999987643221 2223456899999999999999999999999999999999987543
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=295.42 Aligned_cols=238 Identities=25% Similarity=0.300 Sum_probs=188.9
Q ss_pred cccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEEEEec
Q 046598 696 IGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFM 772 (986)
Q Consensus 696 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 772 (986)
||.|+||.||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||++++++ +.++...++||||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-----~~~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRT-----FKDKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeee-----EEcCCccEEEEecC
Confidence 689999999999999888999999986432 2345678999999999999999999998 44567899999999
Q ss_pred cCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccccccee
Q 046598 773 HNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARF 852 (986)
Q Consensus 773 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~ 852 (986)
++++|.+++.. ...+++.++..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||.++.
T Consensus 76 ~~~~L~~~l~~----------~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~ 142 (262)
T cd05572 76 LGGELWTILRD----------RGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKK 142 (262)
T ss_pred CCCcHHHHHhh----------cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccc
Confidence 99999999952 23488999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCchhHHhh
Q 046598 853 LPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVMDIVD 932 (986)
Q Consensus 853 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d 932 (986)
..... ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...... ...... ...+
T Consensus 143 ~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~--------~~~~ 208 (262)
T cd05572 143 LKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED---PMEIYN--------DILK 208 (262)
T ss_pred cCccc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC---HHHHHH--------HHhc
Confidence 64322 122345788999999998888999999999999999999999998643211 011111 0000
Q ss_pred hhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 046598 933 STLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSM 983 (986)
Q Consensus 933 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 983 (986)
..... ..+...+.++.+++.+||+.+|++||++
T Consensus 209 ~~~~~------------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~ 241 (262)
T cd05572 209 GNGKL------------------EFPNYIDKAAKDLIKQLLRRNPEERLGN 241 (262)
T ss_pred cCCCC------------------CCCcccCHHHHHHHHHHccCChhhCcCC
Confidence 00000 0001124567899999999999999993
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=297.82 Aligned_cols=276 Identities=24% Similarity=0.277 Sum_probs=195.2
Q ss_pred CCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc--hhHHHHHHHHHHHhcC---CCCcceeeeeeccccccCCCce
Q 046598 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH--GAFKSFIAECNTLKNI---RHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 690 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~~~~ 764 (986)
|++.+.||+|+||.||+|+++.+++.||+|+++.... .....+.+|+.+++++ +||||+++++++..........
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 6788999999999999999988889999999974322 2234566787777665 6999999999976543333345
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.+++|||++ ++|.+++.... ...+++.+++.++.|+++||+|||+. +++|+||+|+||+++.++.+||
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~--------~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l 148 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP--------KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKI 148 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc--------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEE
Confidence 899999996 58998885321 22589999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCC
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALP 924 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 924 (986)
+|||.+........ .....++..|+|||++.+..++.++|||||||++|||++|++||...... ............
T Consensus 149 ~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~ 224 (287)
T cd07838 149 ADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-DQLDKIFDVIGL 224 (287)
T ss_pred eccCcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-HHHHHHHHHcCC
Confidence 99999987643221 12234788999999999999999999999999999999999998643221 111111111100
Q ss_pred CchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 925 DHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 925 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.......... ......... ...........+....+.+++.+||+.||++||+++|+
T Consensus 225 ~~~~~~~~~~--~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~i 281 (287)
T cd07838 225 PSEEEWPRNV--SLPRSSFPS---YTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEA 281 (287)
T ss_pred CChHhcCCCc--ccchhhccc---ccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHH
Confidence 0000000000 000000000 00000011122445677899999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=301.55 Aligned_cols=192 Identities=23% Similarity=0.235 Sum_probs=157.7
Q ss_pred cceeEEEEEECCCCeEEEEEEeecc--CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEEEEeccCCCH
Q 046598 700 SFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSL 777 (986)
Q Consensus 700 ~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL 777 (986)
++|.||.++...+++.||||+++.. .....+.+.+|+++++.++||||++++++ +..++..+++|||+++++|
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~-----~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTS-----FIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhhe-----eecCCeEEEEEeccCCCCH
Confidence 4455666666667899999998753 34456789999999999999999999998 4556789999999999999
Q ss_pred hHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcccccceecCCCC
Q 046598 778 EEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSS 857 (986)
Q Consensus 778 ~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 857 (986)
.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+.......
T Consensus 87 ~~~l~~~~--------~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~ 155 (314)
T cd08216 87 EDLLKTHF--------PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHG 155 (314)
T ss_pred HHHHHHhc--------ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccc
Confidence 99996322 23578889999999999999999999 99999999999999999999999999987553221
Q ss_pred C-----ccccccccccccccccccccC--CCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 858 A-----QTSSIGAKGSIGYIAPEYGLG--SEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 858 ~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
. ........++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~ 212 (314)
T cd08216 156 KRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD 212 (314)
T ss_pred ccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 1 111223446778999999876 3588999999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=307.60 Aligned_cols=208 Identities=25% Similarity=0.339 Sum_probs=173.6
Q ss_pred hHHHHHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeecccc
Q 046598 680 YQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGV 757 (986)
Q Consensus 680 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 757 (986)
..++...+++|++.+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|+.++++++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 3466778899999999999999999999998889999999986432 22346678899999999999999999986432
Q ss_pred c-cCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEe
Q 046598 758 D-YQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILL 836 (986)
Q Consensus 758 ~-~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 836 (986)
. .......+++++++ +++|.+++.. ..+++..+..++.|+++|++|||+. +|+||||||+||++
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll 153 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC-----------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAV 153 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEE
Confidence 1 22334578888887 8899888741 2488999999999999999999999 99999999999999
Q ss_pred cCCCcEEEcccccceecCCCCCccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 837 DEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 837 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
++++.+||+|||+++.... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus 154 ~~~~~~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 220 (345)
T cd07877 154 NEDCELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220 (345)
T ss_pred cCCCCEEEecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999975422 1223457889999998766 5688999999999999999999999863
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=274.77 Aligned_cols=248 Identities=23% Similarity=0.287 Sum_probs=189.3
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeec-cCchhHHHHHHHHHHHhcC-CCCcceeeeeeccccccCCCceEE
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL-LHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
+.+.+..||.|..|.||+++.+.++...|||.+.. .+.++.+++...++++.+- ..|+||+.+||| -.+...+
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyF-----i~n~dV~ 167 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYF-----ITNTDVF 167 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEE-----eeCchHH
Confidence 34556779999999999999999999999999975 3445567788888876655 589999999994 4456678
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+.||.| .......+++. .+++++.-+-++...+.+||.||.+++ +|+|||+||+|||+|+.|++|+||
T Consensus 168 IcMelM-s~C~ekLlkri---------k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCD 235 (391)
T KOG0983|consen 168 ICMELM-STCAEKLLKRI---------KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCD 235 (391)
T ss_pred HHHHHH-HHHHHHHHHHh---------cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeec
Confidence 899988 44566666422 346888888899999999999998764 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCC---CcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhC
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS---EVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTAL 923 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 923 (986)
||.+..+-.+.. .+...|-+.|||||.+... .|+.++||||||++++|+.||+.||..... ++..+.
T Consensus 236 FGIsGrlvdSkA---htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t---dFe~lt---- 305 (391)
T KOG0983|consen 236 FGISGRLVDSKA---HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT---DFEVLT---- 305 (391)
T ss_pred ccccceeecccc---cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc---cHHHHH----
Confidence 999987654433 3345688999999988653 689999999999999999999999974322 222111
Q ss_pred CCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCC
Q 046598 924 PDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTN 985 (986)
Q Consensus 924 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 985 (986)
..+..+|. ..+........+.+++..|+..|+.+||.-.+
T Consensus 306 ---------kvln~ePP-------------~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~ 345 (391)
T KOG0983|consen 306 ---------KVLNEEPP-------------LLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNK 345 (391)
T ss_pred ---------HHHhcCCC-------------CCCcccCcCHHHHHHHHHHhhcCcccCcchHH
Confidence 11111111 01111124556788999999999999997544
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=296.21 Aligned_cols=191 Identities=24% Similarity=0.310 Sum_probs=157.4
Q ss_pred ccccccceeEEEEEECCCCeEEEEEEeeccCc---hhHHHHHHHH---HHHhcCCCCcceeeeeeccccccCCCceEEEE
Q 046598 695 QIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH---GAFKSFIAEC---NTLKNIRHRNLVKILTACSGVDYQGNDFKALV 768 (986)
Q Consensus 695 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 768 (986)
.||+|+||.||+|.+..+++.||+|++..... .....+..|. +.++...||+|++++++ +..++..++|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~-----~~~~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA-----FHTPDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeee-----eecCCEEEEE
Confidence 48999999999999988899999999864321 1122233443 34445589999999988 4556789999
Q ss_pred EEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcccc
Q 046598 769 FEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFG 848 (986)
Q Consensus 769 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG 848 (986)
|||++|++|.+++. ..+.+++.+++.|+.|+++|++|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ~e~~~g~~L~~~l~----------~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg 142 (278)
T cd05606 76 LDLMNGGDLHYHLS----------QHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLG 142 (278)
T ss_pred EecCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCc
Confidence 99999999999884 224689999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCccccccccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 849 LARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 849 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
.+....... .....|+..|+|||++.++ .++.++||||+||++|||++|+.||..
T Consensus 143 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~ 198 (278)
T cd05606 143 LACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 198 (278)
T ss_pred CccccCccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence 997543221 1234689999999998754 689999999999999999999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=326.24 Aligned_cols=259 Identities=26% Similarity=0.417 Sum_probs=202.0
Q ss_pred cCCCCCcccccccceeEEEEEECC-------CCeEEEEEEeec-cCchhHHHHHHHHHHHhcC-CCCcceeeeeeccccc
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDD-------GRTTIAVKVFNL-LHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVD 758 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 758 (986)
++..+.+.+|+|.||.||+|.... ....||||..+. ....+.+.+..|+++|+.+ .|+||+.++|+|..
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~-- 373 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ-- 373 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc--
Confidence 344566799999999999998631 256799999874 3335668899999999999 69999999999753
Q ss_pred cCCCceEEEEEEeccCCCHhHhhccCCCCCccccC----C--CccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCC
Q 046598 759 YQGNDFKALVFEFMHNRSLEEWLHPITREDETDEA----P--RSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPS 832 (986)
Q Consensus 759 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~----~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~ 832 (986)
++..++|+||++.|+|.+|++..+........ . ..++..+.+.++.|||.|++||++. ++||||+.++
T Consensus 374 ---~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaR 447 (609)
T KOG0200|consen 374 ---DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAAR 447 (609)
T ss_pred ---CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhh
Confidence 67899999999999999999876611111111 1 3499999999999999999999999 9999999999
Q ss_pred CeEecCCCcEEEcccccceecCCCCCccccccc-cccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCcccc
Q 046598 833 NILLDEDMIAHIGDFGLARFLPLSSAQTSSIGA-KGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFE 910 (986)
Q Consensus 833 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~ 910 (986)
||++.++..+||+|||+|+.....+........ .-+..|||||.+....|+.|||||||||++|||+| |..||.....
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 999999999999999999976544443322111 14567999999999999999999999999999999 8999863110
Q ss_pred ccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCC
Q 046598 911 GDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTN 985 (986)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 985 (986)
. .+++. .+ ..+.|.+.+..|..+++++|+.||+.+|++||++.|
T Consensus 528 ~----------------~~l~~-~l--------------~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~ 571 (609)
T KOG0200|consen 528 T----------------EELLE-FL--------------KEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSE 571 (609)
T ss_pred H----------------HHHHH-HH--------------hcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHH
Confidence 0 01111 00 112233445567888999999999999999999876
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=296.32 Aligned_cols=199 Identities=25% Similarity=0.342 Sum_probs=166.8
Q ss_pred CCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc-hhHHHHHHHHHHHhcCC-CCcceeeeeeccccccCCCceEEE
Q 046598 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH-GAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDFKAL 767 (986)
Q Consensus 690 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~l 767 (986)
|++.+.||+|++|+||+|+...+++.||+|++..... .......+|+..+++++ ||||+++++++ ..++..++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~-----~~~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVF-----RENDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHh-----hcCCcEEE
Confidence 6788999999999999999988889999999864322 22334567899999998 99999999984 44688999
Q ss_pred EEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccc
Q 046598 768 VFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDF 847 (986)
Q Consensus 768 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DF 847 (986)
||||+ +|+|.+++.... ...+++.++..++.|++.||.|||+. +++|+||+|+||++++++.++|+||
T Consensus 76 v~e~~-~~~l~~~~~~~~--------~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~ 143 (283)
T cd07830 76 VFEYM-EGNLYQLMKDRK--------GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADF 143 (283)
T ss_pred EEecC-CCCHHHHHHhcc--------cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeec
Confidence 99999 889999885321 24689999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCcc
Q 046598 848 GLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDIM 908 (986)
Q Consensus 848 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~ 908 (986)
|.++....... .....++..|+|||++.+ ..++.++||||||+++|||++|++||...
T Consensus 144 ~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~ 202 (283)
T cd07830 144 GLAREIRSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGS 202 (283)
T ss_pred ccceeccCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCC
Confidence 99986543221 123457889999998754 56889999999999999999999998643
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=299.66 Aligned_cols=201 Identities=28% Similarity=0.414 Sum_probs=166.1
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc--hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
++|++.+.||+|++|+||+|.+..+++.||+|++..... ...+.+.+|++++++++||||+++++++ ..+...
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVV-----HSEKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEE-----ecCCeE
Confidence 579999999999999999999998899999999864322 2345688999999999999999999994 456789
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecC-CCcEEE
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDE-DMIAHI 844 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kL 844 (986)
++||||++ ++|.+++... ....+++..+..++.||+.||+|||++ +++||||+|+||+++. ++.+||
T Consensus 77 ~lv~e~~~-~~l~~~~~~~--------~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl 144 (294)
T PLN00009 77 YLVFEYLD-LDLKKHMDSS--------PDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKL 144 (294)
T ss_pred EEEEeccc-ccHHHHHHhC--------CCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEE
Confidence 99999995 5888877421 122357888899999999999999999 9999999999999985 557999
Q ss_pred cccccceecCCCCCccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
+|||++....... .......+++.|+|||++.+ ..++.++||||+||++|+|+||+.||..
T Consensus 145 ~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~ 206 (294)
T PLN00009 145 ADFGLARAFGIPV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPG 206 (294)
T ss_pred cccccccccCCCc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999997653221 11123456889999998866 4578999999999999999999999864
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=298.19 Aligned_cols=245 Identities=26% Similarity=0.347 Sum_probs=196.3
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcCC-CCcceeeeeeccccccCCCc
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~ 763 (986)
++|.+.+.||+|+||.||+|....+++.||+|++... .....+.+.+|++++++++ ||||++++++ +..++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~-----~~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYT-----FQDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHH-----hcCCc
Confidence 4789999999999999999999988999999998642 2233467889999999998 9999999998 45667
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..++||||+++++|.+++.. ...+++.++..|+.|++.||+|||+. +++|+||+|+||+++.++.++
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~----------~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~ 142 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRK----------YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIK 142 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEE
Confidence 89999999999999999952 23689999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCc------------------cccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCC
Q 046598 844 IGDFGLARFLPLSSAQ------------------TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPT 905 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf 905 (986)
++|||++......... .......++..|+|||+..+..++.++||||||+++|++++|+.||
T Consensus 143 l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 222 (280)
T cd05581 143 ITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF 222 (280)
T ss_pred ecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCC
Confidence 9999999765432211 1222345788999999998888999999999999999999999998
Q ss_pred CccccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 046598 906 DIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSM 983 (986)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 983 (986)
..... .. ... ...+... .. +...+..+.+++.+||+.+|++|||+
T Consensus 223 ~~~~~----~~-~~~--------~~~~~~~-~~-------------------~~~~~~~~~~li~~~l~~~p~~R~~~ 267 (280)
T cd05581 223 RGSNE----YL-TFQ--------KILKLEY-SF-------------------PPNFPPDAKDLIEKLLVLDPQDRLGV 267 (280)
T ss_pred CCccH----HH-HHH--------HHHhcCC-CC-------------------CCccCHHHHHHHHHHhcCCHhhCCCc
Confidence 73321 00 000 0000000 00 01224557899999999999999999
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=299.84 Aligned_cols=250 Identities=22% Similarity=0.274 Sum_probs=188.7
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC-chhHHHHHHHHHHHhcC-CCCcceeeeeeccccccCCCce
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~ 764 (986)
.++|++.+.||+|+||.||+|.+..+++.||||+++... ......+.+|+.++.+. .||||++++++| ..+..
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~ 88 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYF-----ITDSD 88 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheee-----ecCCe
Confidence 467899999999999999999999888999999997533 23345566777766666 599999999995 44578
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCCeEecCCCcEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHH-DCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
.++||||++ +++.+++.. ....+++..+..++.|++.|++|||+ . +|+||||+|+||++++++.+|
T Consensus 89 ~~~v~e~~~-~~l~~l~~~---------~~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~k 155 (296)
T cd06618 89 VFICMELMS-TCLDKLLKR---------IQGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVK 155 (296)
T ss_pred EEEEeeccC-cCHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEE
Confidence 999999984 577777642 12368999999999999999999997 5 899999999999999999999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccCCC----cCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHH
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSE----VSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLA 919 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~ 919 (986)
|+|||.+..+..... .....++..|+|||++.+.. ++.++||||||+++|+|++|+.||...... ....
T Consensus 156 L~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~- 228 (296)
T cd06618 156 LCDFGISGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE---FEVL- 228 (296)
T ss_pred ECccccchhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH---HHHH-
Confidence 999999976532221 12234778999999987653 789999999999999999999998632111 1110
Q ss_pred HhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 920 RTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 920 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
. ...+.....-+ ....++.++.+++.+||+.||++||+++++
T Consensus 229 ~--------~~~~~~~~~~~-----------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~i 270 (296)
T cd06618 229 T--------KILQEEPPSLP-----------------PNEGFSPDFCSFVDLCLTKDHRKRPKYREL 270 (296)
T ss_pred H--------HHhcCCCCCCC-----------------CCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 0 00100000000 000234467899999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=300.93 Aligned_cols=245 Identities=26% Similarity=0.344 Sum_probs=189.9
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
...|+..+.||+|+||.||+|++..++..||+|.+... .....+++.+|+++++.++|+|++++++++ ....
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 88 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY-----LREH 88 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEE-----EcCC
Confidence 34577889999999999999999988899999998632 223345788999999999999999999984 3457
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..++||||+. |++.+++.. ....+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.+|
T Consensus 89 ~~~lv~e~~~-~~l~~~~~~---------~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~k 155 (308)
T cd06634 89 TAWLVMEYCL-GSASDLLEV---------HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVK 155 (308)
T ss_pred eeEEEEEccC-CCHHHHHHH---------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEE
Confidence 8899999996 688777742 223578999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCcccccccccccccccccccc---CCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHH
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGL---GSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLAR 920 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~ 920 (986)
|+|||.+...... ....++..|+|||.+. ...++.++|||||||++|+|++|+.||....... .......
T Consensus 156 l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~ 228 (308)
T cd06634 156 LGDFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQ 228 (308)
T ss_pred ECCcccceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-HHHHHhh
Confidence 9999999765321 2345788999999874 3568899999999999999999999985321100 0000000
Q ss_pred hhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 921 TALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 921 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
...+. .........+.+++.+||+.+|++||++++|
T Consensus 229 ~~~~~------------------------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l 264 (308)
T cd06634 229 NESPA------------------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 264 (308)
T ss_pred cCCCC------------------------------cCcccccHHHHHHHHHHhhCCcccCCCHHHH
Confidence 00000 0011234557799999999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=303.00 Aligned_cols=202 Identities=26% Similarity=0.379 Sum_probs=166.2
Q ss_pred hcCCCC-CcccccccceeEEEEEECCCCeEEEEEEeeccCchh--------------HHHHHHHHHHHhcCCCCcceeee
Q 046598 687 TDRFSS-VNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGA--------------FKSFIAECNTLKNIRHRNLVKIL 751 (986)
Q Consensus 687 ~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~ 751 (986)
.++|.. .+.||+|+||+||+|.+..+++.||||+++...... ...+.+|++++++++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 467765 467999999999999999889999999986432211 12477899999999999999999
Q ss_pred eeccccccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCC
Q 046598 752 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKP 831 (986)
Q Consensus 752 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 831 (986)
+++ ..++..++||||++ ++|.+++.. ...+++..+..++.|++.||+|||+. +++||||+|
T Consensus 87 ~~~-----~~~~~~~lv~e~~~-~~l~~~l~~----------~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~ 147 (335)
T PTZ00024 87 DVY-----VEGDFINLVMDIMA-SDLKKVVDR----------KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSP 147 (335)
T ss_pred EEE-----ecCCcEEEEEeccc-cCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccH
Confidence 984 45678999999996 699998842 23588999999999999999999999 999999999
Q ss_pred CCeEecCCCcEEEcccccceecCCCC------------CccccccccccccccccccccCC-CcCcccchhhHHHHHHHH
Q 046598 832 SNILLDEDMIAHIGDFGLARFLPLSS------------AQTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLEL 898 (986)
Q Consensus 832 ~NIll~~~~~~kL~DFG~a~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~el 898 (986)
+||+++.++.+||+|||.++...... .........++..|+|||++.+. .++.++||||+||++|||
T Consensus 148 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el 227 (335)
T PTZ00024 148 ANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAEL 227 (335)
T ss_pred HHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHH
Confidence 99999999999999999997654111 01111223467889999998764 478999999999999999
Q ss_pred HhCCCCCCc
Q 046598 899 ITRKKPTDI 907 (986)
Q Consensus 899 ltg~~pf~~ 907 (986)
++|+.||..
T Consensus 228 ~tg~~p~~~ 236 (335)
T PTZ00024 228 LTGKPLFPG 236 (335)
T ss_pred HhCCCCCCC
Confidence 999999864
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.1e-32 Score=297.88 Aligned_cols=242 Identities=26% Similarity=0.326 Sum_probs=187.7
Q ss_pred CCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 690 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
|...++||+|+||+||+|++..+++.||+|++.... ....+.+.+|+++++.++|||++++++++ .++...+
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 97 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCY-----LKEHTAW 97 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEE-----EeCCEEE
Confidence 667788999999999999998889999999986432 23345688899999999999999999984 4557889
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+. +++.+++.. ....+++.++..++.||+.|+.|||+. |++||||+|+||+++.++.+||+|
T Consensus 98 lv~e~~~-~~l~~~l~~---------~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~d 164 (313)
T cd06633 98 LVMEYCL-GSASDLLEV---------HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLAD 164 (313)
T ss_pred EEEecCC-CCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEee
Confidence 9999995 578877742 234588999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccc---CCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhC
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGL---GSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTAL 923 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 923 (986)
||.+..... .....++..|+|||++. ...++.++|||||||++|+|++|..||..... .........
T Consensus 165 fg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~----~~~~~~~~~ 234 (313)
T cd06633 165 FGSASKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MSALYHIAQ 234 (313)
T ss_pred cCCCcccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHh
Confidence 999864321 12345888999999974 45688999999999999999999999853211 111100000
Q ss_pred CCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 924 PDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 924 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.. .+.. .....+..+.+++.+||+.+|++||++.++
T Consensus 235 ~~------------~~~~---------------~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~ 270 (313)
T cd06633 235 ND------------SPTL---------------QSNEWTDSFRGFVDYCLQKIPQERPASAEL 270 (313)
T ss_pred cC------------CCCC---------------CccccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 00 0000 000122346789999999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-34 Score=276.23 Aligned_cols=209 Identities=25% Similarity=0.408 Sum_probs=174.1
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeec--cCchhHHHHHHHHHHHhcCCCCcceeeeeeccccc---cCC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD---YQG 761 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---~~~ 761 (986)
...|+...+||+|.||+||+|+.+++++.||+|++-. ...+-.....+|++++..++|+|++.+++.|.... ...
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 3457777899999999999999999999999997633 22233456789999999999999999999987542 223
Q ss_pred CceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCc
Q 046598 762 NDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI 841 (986)
Q Consensus 762 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 841 (986)
....|+||.+|+. +|...+. .....++..++.+++.++..||.|+|+. .|+|||+||+|++|+.+|.
T Consensus 96 r~t~ylVf~~ceh-DLaGlLs---------n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgi 162 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLS---------NRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGI 162 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhc---------CccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCce
Confidence 4468999999965 8888885 3345789999999999999999999999 9999999999999999999
Q ss_pred EEEcccccceecCCCCC--ccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCcc
Q 046598 842 AHIGDFGLARFLPLSSA--QTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDIM 908 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~ 908 (986)
+||+|||+++.+..... ....+..+.|..|++||.+.| ..|+++.|||+.||++.||+||.+.+.+.
T Consensus 163 lklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgn 232 (376)
T KOG0669|consen 163 LKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGN 232 (376)
T ss_pred EEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCC
Confidence 99999999976643322 333455667999999998877 57999999999999999999999987643
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=292.17 Aligned_cols=249 Identities=21% Similarity=0.276 Sum_probs=191.8
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeecc-----CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL-----HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
+|.+.+.||+|+||.||+|++...+..+++|+.+.. ......++..|+.++++++||||+++++++ .+..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF-----LERD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH-----hcCC
Confidence 588999999999999999999877677777776531 122334567899999999999999999984 4556
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..++||||+++++|.+++.... .....+++.+++.++.|++.|+.|||+. +++|+||+|+||+++. +.+|
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~ 145 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELK------HTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLK 145 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHh------hcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEe
Confidence 7899999999999999886322 2235689999999999999999999999 9999999999999975 5699
Q ss_pred EcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhC
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTAL 923 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 923 (986)
|+|||.++....... ......++..|+|||...+..++.++||||||+++|+|++|..||.... .........
T Consensus 146 l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-----~~~~~~~~~ 218 (260)
T cd08222 146 IGDFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-----FLSVVLRIV 218 (260)
T ss_pred ecccCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHH
Confidence 999999976533221 2223457889999999988889999999999999999999999985211 111111000
Q ss_pred CCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 924 PDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 924 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
. .... ..+...+.++.+++.+||+.+|++||++.|+
T Consensus 219 ~------------~~~~---------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 254 (260)
T cd08222 219 E------------GPTP---------------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEI 254 (260)
T ss_pred c------------CCCC---------------CCcchhcHHHHHHHHHHhcCChhhCcCHHHH
Confidence 0 0000 0011334567899999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.1e-32 Score=293.87 Aligned_cols=198 Identities=31% Similarity=0.454 Sum_probs=169.0
Q ss_pred CCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEE
Q 046598 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 767 (986)
Q Consensus 690 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 767 (986)
|+..+.||+|++|.||+|+...+++.||+|++.... ....+.+..|+.++++++|+|++++++++ ......++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVI-----HTERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhh-----hcCCceEE
Confidence 667789999999999999999889999999997642 33346788899999999999999999984 44578999
Q ss_pred EEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccc
Q 046598 768 VFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDF 847 (986)
Q Consensus 768 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DF 847 (986)
||||++ ++|.+++... ...+++.++..++.|++.||+|||+. +|+||||+|+||++++++.+||+||
T Consensus 76 v~e~~~-~~l~~~i~~~---------~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~ 142 (282)
T cd07829 76 VFEYCD-MDLKKYLDKR---------PGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADF 142 (282)
T ss_pred EecCcC-cCHHHHHHhh---------ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecC
Confidence 999997 5999999632 13689999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCccccccccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 848 GLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 848 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
|.++....... ......++..|+|||.+.+. .++.++|||||||++|||++|+.||..
T Consensus 143 g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~ 201 (282)
T cd07829 143 GLARAFGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPG 201 (282)
T ss_pred CcccccCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 99976543221 12223457789999998776 889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=295.71 Aligned_cols=250 Identities=22% Similarity=0.261 Sum_probs=190.9
Q ss_pred CCCCCcccccccceeEEEEEEC---CCCeEEEEEEeeccC----chhHHHHHHHHHHHhcC-CCCcceeeeeeccccccC
Q 046598 689 RFSSVNQIGEGSFGSVFKGILD---DGRTTIAVKVFNLLH----HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQ 760 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 760 (986)
+|++.+.||+|+||.||+|+.. .+++.||||+++... ....+.+.+|+++++++ +||+|++++++ +.
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~-----~~ 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYA-----FQ 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhhee-----ee
Confidence 4788899999999999999864 346789999986422 22345688999999999 69999999988 45
Q ss_pred CCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCC
Q 046598 761 GNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDM 840 (986)
Q Consensus 761 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 840 (986)
.+...++||||+++++|.+++.. ...+++.++..++.|+++||+|||+. +++||||+|+||+++.++
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~ 142 (288)
T cd05583 76 TDTKLHLILDYVNGGELFTHLYQ----------REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEG 142 (288)
T ss_pred cCCEEEEEEecCCCCcHHHHHhh----------cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCC
Confidence 66789999999999999999842 23578899999999999999999998 999999999999999999
Q ss_pred cEEEcccccceecCCCCCccccccccccccccccccccCCC--cCcccchhhHHHHHHHHHhCCCCCCccccccccHHHH
Q 046598 841 IAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSE--VSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNL 918 (986)
Q Consensus 841 ~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~ 918 (986)
.++|+|||+++....... .......++..|+|||...+.. .+.++||||||+++|||++|..||...... ......
T Consensus 143 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~~~ 220 (288)
T cd05583 143 HVVLTDFGLSKEFLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQSEI 220 (288)
T ss_pred CEEEEECccccccccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chHHHH
Confidence 999999999976543221 1122345788999999987655 788999999999999999999998532111 011111
Q ss_pred HHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 919 ARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 919 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
... .....+. .+......+.+++.+||+.+|++|||+.+|
T Consensus 221 ~~~------------~~~~~~~----------------~~~~~~~~l~~li~~~l~~~p~~R~t~~~~ 260 (288)
T cd05583 221 SRR------------ILKSKPP----------------FPKTMSAEARDFIQKLLEKDPKKRLGANGA 260 (288)
T ss_pred HHH------------HHccCCC----------------CCcccCHHHHHHHHHHhcCCHhhccCcchH
Confidence 110 0000000 001233457789999999999999998654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=291.20 Aligned_cols=247 Identities=24% Similarity=0.285 Sum_probs=188.8
Q ss_pred CCCCCcccccccceeEEEEEEC---CCCeEEEEEEeeccC----chhHHHHHHHHHHHhcC-CCCcceeeeeeccccccC
Q 046598 689 RFSSVNQIGEGSFGSVFKGILD---DGRTTIAVKVFNLLH----HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQ 760 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 760 (986)
+|++.+.||+|+||.||+|... .++..||+|+++... ....+.+.+|+++++++ +|++|++++++ +.
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~-----~~ 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA-----FQ 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeE-----ee
Confidence 4788999999999999999984 357899999987422 22346678899999999 69999999988 45
Q ss_pred CCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCC
Q 046598 761 GNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDM 840 (986)
Q Consensus 761 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 840 (986)
.+...++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~----------~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~ 142 (290)
T cd05613 76 TDTKLHLILDYINGGELFTHLSQ----------RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNG 142 (290)
T ss_pred cCCeEEEEEecCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCC
Confidence 56788999999999999999852 23578889999999999999999999 999999999999999999
Q ss_pred cEEEcccccceecCCCCCccccccccccccccccccccCC--CcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHH
Q 046598 841 IAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS--EVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNL 918 (986)
Q Consensus 841 ~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~ 918 (986)
.+||+|||++........ .......|+..|+|||.+.+. .++.++||||||+++|+|++|+.||...... ......
T Consensus 143 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~~~ 220 (290)
T cd05613 143 HVVLTDFGLSKEFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-NSQAEI 220 (290)
T ss_pred CEEEeeCccceecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-ccHHHH
Confidence 999999999976533221 112234588899999998753 4678999999999999999999998632111 111111
Q ss_pred HHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 046598 919 ARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSM 983 (986)
Q Consensus 919 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 983 (986)
.. ......+. ........+.+++.+||+.+|++||+.
T Consensus 221 ~~------------~~~~~~~~----------------~~~~~~~~~~~ll~~~l~~~p~~R~~~ 257 (290)
T cd05613 221 SR------------RILKSEPP----------------YPQEMSALAKDIIQRLLMKDPKKRLGC 257 (290)
T ss_pred HH------------HhhccCCC----------------CCccCCHHHHHHHHHHhcCCHHHhcCC
Confidence 11 11100000 001233457789999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=316.11 Aligned_cols=207 Identities=25% Similarity=0.328 Sum_probs=182.1
Q ss_pred HHHHHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeec---cCchhHHHHHHHHHHHhcCCCCcceeeeeecccc
Q 046598 681 QNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL---LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGV 757 (986)
Q Consensus 681 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 757 (986)
.++.-..++|.+++.||+|+||.|..++++.+++.||+|++.+ ....+..-|..|-.+|..-+.+=|+++...
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyA---- 143 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYA---- 143 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHH----
Confidence 3445567889999999999999999999999999999999975 334455678999999999899999998876
Q ss_pred ccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEec
Q 046598 758 DYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLD 837 (986)
Q Consensus 758 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 837 (986)
|+++.+.|+|||||+||+|-..+..+ .++++..++.++..|.-||.-+|+. |+|||||||+|||+|
T Consensus 144 -FQD~~~LYlVMdY~pGGDlltLlSk~----------~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld 209 (1317)
T KOG0612|consen 144 -FQDERYLYLVMDYMPGGDLLTLLSKF----------DRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLD 209 (1317)
T ss_pred -hcCccceEEEEecccCchHHHHHhhc----------CCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEec
Confidence 78899999999999999999999632 2689999999999999999999999 999999999999999
Q ss_pred CCCcEEEcccccceecCCCCCccccccccccccccccccccC-----CCcCcccchhhHHHHHHHHHhCCCCCC
Q 046598 838 EDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-----SEVSISGDVYSYGILLLELITRKKPTD 906 (986)
Q Consensus 838 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~pf~ 906 (986)
..|++||+|||.+-.+..++ .......+|||.|.+||++.. +.|++.+|.||+||++|||+.|..||.
T Consensus 210 ~~GHikLADFGsClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY 282 (1317)
T KOG0612|consen 210 KSGHIKLADFGSCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY 282 (1317)
T ss_pred ccCcEeeccchhHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence 99999999999998775443 334456789999999998752 579999999999999999999999996
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-33 Score=288.12 Aligned_cols=207 Identities=28% Similarity=0.410 Sum_probs=174.3
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--c-----hhHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--H-----GAFKSFIAECNTLKNIRHRNLVKILTACSGVD 758 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 758 (986)
..++|-.++.||+|||++||+|.+....+.||||+-.... . ...+...+|.+|.+.+.||.||++|+++.
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs--- 537 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS--- 537 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee---
Confidence 3567889999999999999999998888999999975321 1 12345678999999999999999999963
Q ss_pred cCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEec-
Q 046598 759 YQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLD- 837 (986)
Q Consensus 759 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~- 837 (986)
-+.+..|-|+|||+|.+|.-|++ ..+.+++.+++.|+.||+.||.||.+. +++|||-||||.|||+.
T Consensus 538 -lDtdsFCTVLEYceGNDLDFYLK----------QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~ 605 (775)
T KOG1151|consen 538 -LDTDSFCTVLEYCEGNDLDFYLK----------QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVN 605 (775)
T ss_pred -eccccceeeeeecCCCchhHHHH----------hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEec
Confidence 34567899999999999999995 345689999999999999999999996 88999999999999995
Q ss_pred --CCCcEEEcccccceecCCCCCc-----cccccccccccccccccccCC----CcCcccchhhHHHHHHHHHhCCCCCC
Q 046598 838 --EDMIAHIGDFGLARFLPLSSAQ-----TSSIGAKGSIGYIAPEYGLGS----EVSISGDVYSYGILLLELITRKKPTD 906 (986)
Q Consensus 838 --~~~~~kL~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvvl~elltg~~pf~ 906 (986)
.-|.+||+|||+++.++.+... .-.....||..|.+||.+.-+ ..+.|+||||+||++|+.+.|+.||.
T Consensus 606 GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFG 685 (775)
T KOG1151|consen 606 GTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFG 685 (775)
T ss_pred CcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCC
Confidence 4478999999999988655433 223456799999999976533 57889999999999999999999996
Q ss_pred c
Q 046598 907 I 907 (986)
Q Consensus 907 ~ 907 (986)
.
T Consensus 686 h 686 (775)
T KOG1151|consen 686 H 686 (775)
T ss_pred C
Confidence 3
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-32 Score=297.35 Aligned_cols=239 Identities=22% Similarity=0.218 Sum_probs=191.7
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcC-CCCcceeeeeeccccccCCCce
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~ 764 (986)
.++.|.....+|.|+|+.|-.+.+..+++..+||++.... .+..+|+.++... +||||+++.+. +.++.+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v-----~~~~~~ 390 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDV-----YEDGKE 390 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecce-----ecCCce
Confidence 3567888888999999999999999999999999997542 3345677666555 79999999998 567789
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEe-cCCCcEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILL-DEDMIAH 843 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~k 843 (986)
.|+|||++.|+-+.+.+... +....++..|+.+|+.|+.|||++ ||||||+||+|||+ +..++++
T Consensus 391 ~~~v~e~l~g~ell~ri~~~-----------~~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lr 456 (612)
T KOG0603|consen 391 IYLVMELLDGGELLRRIRSK-----------PEFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLR 456 (612)
T ss_pred eeeeehhccccHHHHHHHhc-----------chhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEE
Confidence 99999999999988888522 222367888999999999999999 99999999999999 6899999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhC
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTAL 923 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 923 (986)
|+|||.++..+.+ ....+-|..|.|||++....|++++|+||||+++|+|++|+.||.....+ ........
T Consensus 457 ltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----~ei~~~i~ 527 (612)
T KOG0603|consen 457 LTYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----IEIHTRIQ 527 (612)
T ss_pred EEEechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch----HHHHHhhc
Confidence 9999999876543 33456788999999999999999999999999999999999999744333 11111000
Q ss_pred CCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 924 PDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 924 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.... .........+++.+|++.||.+||+|.|+
T Consensus 528 ~~~~------------------------------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i 560 (612)
T KOG0603|consen 528 MPKF------------------------------SECVSDEAKDLLQQLLQVDPALRLGADEI 560 (612)
T ss_pred CCcc------------------------------ccccCHHHHHHHHHhccCChhhCcChhhh
Confidence 0000 12344556789999999999999999875
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=290.11 Aligned_cols=195 Identities=27% Similarity=0.400 Sum_probs=168.2
Q ss_pred CcccccccceeEEEEEECCCCeEEEEEEeecc--CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEEEE
Q 046598 693 VNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFE 770 (986)
Q Consensus 693 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 770 (986)
.+.||+|.||+||-|+++.+|+.||||++.+. .......+.+|+.||+++.||.||.+.-. ++..+..++|||
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M-----~ET~ervFVVME 643 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECM-----FETPERVFVVME 643 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEe-----ecCCceEEEEeh
Confidence 47899999999999999999999999999642 22334778999999999999999999877 566689999999
Q ss_pred eccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCC---CcEEEccc
Q 046598 771 FMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED---MIAHIGDF 847 (986)
Q Consensus 771 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kL~DF 847 (986)
.+. |+..+.+-. ...+++++.....+..||+.||.|||.+ +|+|+|+||+|||+... -++||+||
T Consensus 644 Kl~-GDMLEMILS--------sEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDF 711 (888)
T KOG4236|consen 644 KLH-GDMLEMILS--------SEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDF 711 (888)
T ss_pred hhc-chHHHHHHH--------hhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccc
Confidence 995 455555532 3456789988899999999999999999 99999999999999643 38999999
Q ss_pred ccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 848 GLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 848 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
|.|+.+.+.. .....+||+.|.|||+++...|...-|+||.||++|.-++|..||+.
T Consensus 712 GfARiIgEks---FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE 768 (888)
T KOG4236|consen 712 GFARIIGEKS---FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE 768 (888)
T ss_pred cceeecchhh---hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC
Confidence 9999886433 33457899999999999999999999999999999999999999974
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=245.73 Aligned_cols=199 Identities=26% Similarity=0.434 Sum_probs=170.6
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
.+|...++||+|.||+||+|+..++.+.||+|.++..+ ++......+|+-+++.++|.|||++++. ...+...
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dv-----lhsdkkl 76 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV-----LHSDKKL 76 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhh-----hccCcee
Confidence 35677889999999999999999999999999997533 3345678999999999999999999998 5667889
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
.+|+||| ..+|..|.. .-.+.++.+.++.++.|+++||.|+|++ .+.|||+||.|.+|+.+|+.|++
T Consensus 77 tlvfe~c-dqdlkkyfd---------slng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkla 143 (292)
T KOG0662|consen 77 TLVFEFC-DQDLKKYFD---------SLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLA 143 (292)
T ss_pred EEeHHHh-hHHHHHHHH---------hcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEec
Confidence 9999999 568999885 3445689999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccCC-CcCcccchhhHHHHHHHHHh-CCCCCC
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELIT-RKKPTD 906 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~ellt-g~~pf~ 906 (986)
|||+|+.+... -......+.|..|++|.++.+. -|+...|+||.||++.|+.. |++-|.
T Consensus 144 dfglarafgip--vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfp 204 (292)
T KOG0662|consen 144 DFGLARAFGIP--VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_pred ccchhhhcCCc--eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCC
Confidence 99999866422 1223345678999999998886 58899999999999999988 555554
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=280.86 Aligned_cols=278 Identities=22% Similarity=0.249 Sum_probs=202.9
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCC-----C---Ccceeeeeeccccc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIR-----H---RNLVKILTACSGVD 758 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~~~ 758 (986)
.++|.+.++||.|.|++||+|.+..+.+.||+|+.+... ...+..+.|+++|++++ | .+||++++.|...
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs- 154 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS- 154 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec-
Confidence 368999999999999999999999999999999998643 34467789999999983 2 4799999997644
Q ss_pred cCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecC
Q 046598 759 YQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDE 838 (986)
Q Consensus 759 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 838 (986)
..++.++|+|+|++ |.+|..+|..+. .+.++...+++|++||+.||.|||+.| ||||-||||+|||+..
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s~--------YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~ 223 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYSN--------YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCS 223 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHhC--------CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeec
Confidence 67788999999999 889999997443 346899999999999999999999998 9999999999999810
Q ss_pred C-------------------------------------------------------------------------------
Q 046598 839 D------------------------------------------------------------------------------- 839 (986)
Q Consensus 839 ~------------------------------------------------------------------------------- 839 (986)
+
T Consensus 224 ~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~ 303 (590)
T KOG1290|consen 224 TEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESY 303 (590)
T ss_pred cccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccccccc
Confidence 0
Q ss_pred --------------------------------------------------------------------------------
Q 046598 840 -------------------------------------------------------------------------------- 839 (986)
Q Consensus 840 -------------------------------------------------------------------------------- 839 (986)
T Consensus 304 n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~ 383 (590)
T KOG1290|consen 304 NNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPD 383 (590)
T ss_pred ccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCC
Confidence
Q ss_pred -------CcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCcccccc
Q 046598 840 -------MIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGD 912 (986)
Q Consensus 840 -------~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~ 912 (986)
..+||+|||-|+.+. ...+....|..|+|||++.+..|++.+||||++|++|||+||..-|+......
T Consensus 384 ~~~~~~di~vKIaDlGNACW~~-----khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~ 458 (590)
T KOG1290|consen 384 IPLPECDIRVKIADLGNACWVH-----KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGEN 458 (590)
T ss_pred CCCCccceeEEEeeccchhhhh-----hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCC
Confidence 014566666665431 12223446889999999999999999999999999999999999997433221
Q ss_pred -----ccHHHHHHh--hCC-------CchhHHhhhhcccCCcchhhcc----chhhhhHhhHHHHHHHHHHHHHHhcccC
Q 046598 913 -----MNLHNLART--ALP-------DHVMDIVDSTLLNDGEDLIVHG----NQRQRQARVKSRIECLISMVRIGVACSM 974 (986)
Q Consensus 913 -----~~~~~~~~~--~~~-------~~~~~~~d~~l~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~l~~~Cl~ 974 (986)
.-++.++.- .+| .+-.+++++.-.-. .|... ..........-..+...++.+++.-|++
T Consensus 459 Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~Lr---hI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLe 535 (590)
T KOG1290|consen 459 YSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELR---HIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLE 535 (590)
T ss_pred CCccHHHHHHHHHHHhhccHHHHhcCcchHhhhcccccee---cccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHh
Confidence 112222110 111 11233333221100 00000 0111122233345778889999999999
Q ss_pred CCCCCCCCCCC
Q 046598 975 ESPEDRMSMTN 985 (986)
Q Consensus 975 ~dP~~RPt~~e 985 (986)
.+|++||||.+
T Consensus 536 f~PeKR~tA~~ 546 (590)
T KOG1290|consen 536 FDPEKRPTAAQ 546 (590)
T ss_pred cCccccccHHH
Confidence 99999999975
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=283.28 Aligned_cols=236 Identities=28% Similarity=0.311 Sum_probs=189.2
Q ss_pred cccccceeEEEEEECCCCeEEEEEEeeccCc---hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEEEEec
Q 046598 696 IGEGSFGSVFKGILDDGRTTIAVKVFNLLHH---GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFM 772 (986)
Q Consensus 696 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 772 (986)
||+|+||.||++.+...++.||+|+++.... ...+.+..|++++++++||||+++++. +..+...++||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-----~~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYA-----FQTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHH-----eecCCeeEEEEecC
Confidence 6899999999999988889999999875322 245678899999999999999999988 55678899999999
Q ss_pred cCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccccccee
Q 046598 773 HNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARF 852 (986)
Q Consensus 773 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~ 852 (986)
++++|.+++.. ...+++.++..++.|++.|+.|+|+. +++|+||+|+||+++.++.++|+|||.+..
T Consensus 76 ~~~~L~~~l~~----------~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 142 (250)
T cd05123 76 PGGELFSHLSK----------EGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKE 142 (250)
T ss_pred CCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCccee
Confidence 99999999952 23589999999999999999999998 999999999999999999999999999976
Q ss_pred cCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCchhHHhh
Q 046598 853 LPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVMDIVD 932 (986)
Q Consensus 853 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d 932 (986)
..... .......++..|+|||...+..++.++|+||||+++|++++|+.||..... ....... ..
T Consensus 143 ~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~--------~~ 207 (250)
T cd05123 143 LSSEG--SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEIYEKI--------LK 207 (250)
T ss_pred cccCC--CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHH--------hc
Confidence 54321 122335578899999999888899999999999999999999999863211 1111110 00
Q ss_pred hhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 046598 933 STLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMT 984 (986)
Q Consensus 933 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 984 (986)
.... .+...+..+.+++.+||..||++||++.
T Consensus 208 ~~~~--------------------~~~~~~~~l~~~i~~~l~~~p~~R~~~~ 239 (250)
T cd05123 208 DPLR--------------------FPEFLSPEARDLISGLLQKDPTKRLGSG 239 (250)
T ss_pred CCCC--------------------CCCCCCHHHHHHHHHHhcCCHhhCCCcc
Confidence 0000 0001145577899999999999999993
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=321.79 Aligned_cols=147 Identities=28% Similarity=0.417 Sum_probs=130.4
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
.++|.+.++||+|+||.||+|.+..+++.||||+++... ......+.+|+.+++.++||||++++++ +....
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~-----~~~~~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYS-----LQSAN 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEE-----EEECC
Confidence 367999999999999999999999889999999987432 2334678899999999999999999988 44557
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..|+||||+++++|.+++.. .+.+++..++.|+.||+.||+|||+. +|+||||||+|||++.++.+|
T Consensus 78 ~~~lVmEy~~g~~L~~li~~----------~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vk 144 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHI----------YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIK 144 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEE
Confidence 89999999999999999852 23578889999999999999999999 999999999999999999999
Q ss_pred Ecccccce
Q 046598 844 IGDFGLAR 851 (986)
Q Consensus 844 L~DFG~a~ 851 (986)
|+|||+++
T Consensus 145 L~DFGls~ 152 (669)
T cd05610 145 LTDFGLSK 152 (669)
T ss_pred EEeCCCCc
Confidence 99999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-32 Score=276.25 Aligned_cols=202 Identities=23% Similarity=0.331 Sum_probs=173.0
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeec---cCchhHHHHHHHHHHHhcC-CCCcceeeeeeccccccCCC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL---LHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~ 762 (986)
..+|..+..||+|+||.|-+|..+.+.+.+|||+++. ...++.+--+.|-++|+-. +-|.++++..+ ++.-
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc-----FQTm 422 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC-----FQTM 422 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH-----hhhh
Confidence 4568999999999999999999999999999999974 2233345556777788766 57888998887 5566
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
+..|.||||+.||+|--.+++.+ .+.+..+.-+|.+||-||-+||++ ||++||||.+|||+|.+|++
T Consensus 423 DRLyFVMEyvnGGDLMyhiQQ~G----------kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHi 489 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHIQQVG----------KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHI 489 (683)
T ss_pred hheeeEEEEecCchhhhHHHHhc----------ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCce
Confidence 89999999999999999997544 456677888999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCcc
Q 046598 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIM 908 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~ 908 (986)
||+|||+++.--.. ...+...+||+.|+|||++...+|+..+|.|||||++|||+.|++||++.
T Consensus 490 Ki~DFGmcKEni~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe 553 (683)
T KOG0696|consen 490 KIADFGMCKENIFD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 553 (683)
T ss_pred EeeecccccccccC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999753222 23344578999999999999999999999999999999999999999843
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-33 Score=272.75 Aligned_cols=251 Identities=28% Similarity=0.330 Sum_probs=188.9
Q ss_pred cccccccceeEEEEEECCCCeEEEEEEeeccCc-hhHHHHHHHHHH-HhcCCCCcceeeeeeccccccCCCceEEEEEEe
Q 046598 694 NQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH-GAFKSFIAECNT-LKNIRHRNLVKILTACSGVDYQGNDFKALVFEF 771 (986)
Q Consensus 694 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~ 771 (986)
..||.|+||+|++-.++..++..|||+++.... .+.+++..|.+. ++.-+.||||++||.+. .++..|+.||.
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F-----~EGdcWiCMEL 144 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALF-----SEGDCWICMEL 144 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh-----cCCceeeeHHH
Confidence 569999999999999999999999999986443 566788888875 45558999999999953 34678999999
Q ss_pred ccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcccccce
Q 046598 772 MHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLAR 851 (986)
Q Consensus 772 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~ 851 (986)
| ..++..+-+... ......+++.-.-.|+....+||.||-+.. .|+|||+||+|||++..|.+||||||.+.
T Consensus 145 M-d~SlDklYk~vy-----~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcG 216 (361)
T KOG1006|consen 145 M-DISLDKLYKRVY-----SVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICG 216 (361)
T ss_pred H-hhhHHHHHHHHH-----HHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchH
Confidence 9 567766543211 123346888888889999999999998763 89999999999999999999999999997
Q ss_pred ecCCCCCccccccccccccccccccccCC--CcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCchhH
Q 046598 852 FLPLSSAQTSSIGAKGSIGYIAPEYGLGS--EVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVMD 929 (986)
Q Consensus 852 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 929 (986)
.+..+ ...+...|-..|||||.+... .|+.+|||||+|+++||+.||+.||..... +.+
T Consensus 217 qLv~S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s----------------vfe 277 (361)
T KOG1006|consen 217 QLVDS---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS----------------VFE 277 (361)
T ss_pred hHHHH---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH----------------HHH
Confidence 65432 233445688999999988653 589999999999999999999999863211 111
Q ss_pred HhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 930 IVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 930 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
-+.....++|..... .....+....+.+++..|+..|-.+||...++
T Consensus 278 ql~~Vv~gdpp~l~~----------~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~L 324 (361)
T KOG1006|consen 278 QLCQVVIGDPPILLF----------DKECVHYSFSMVRFINTCLIKDRSDRPKYDDL 324 (361)
T ss_pred HHHHHHcCCCCeecC----------cccccccCHHHHHHHHHHhhcccccCcchhhh
Confidence 111112222221110 01112456678899999999999999987653
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=279.69 Aligned_cols=222 Identities=22% Similarity=0.152 Sum_probs=174.8
Q ss_pred ccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEEEEeccCCCHh
Q 046598 699 GSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLE 778 (986)
Q Consensus 699 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~ 778 (986)
|.+|.||+|++..+++.||+|+++... .+.+|...+....||||++++++ +...+..++||||+++|+|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~-----~~~~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKY-----IVSEDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhh-----eecCCeEEEEEecCCCCCHH
Confidence 899999999999999999999986542 23345555556679999999998 45567899999999999999
Q ss_pred HhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcccccceecCCCCC
Q 046598 779 EWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSA 858 (986)
Q Consensus 779 ~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 858 (986)
+++.. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.++++|||.+......
T Consensus 74 ~~l~~----------~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-- 138 (237)
T cd05576 74 SHISK----------FLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-- 138 (237)
T ss_pred HHHHH----------hcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc--
Confidence 99852 23489999999999999999999999 9999999999999999999999999988654321
Q ss_pred ccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCchhHHhhhhcccC
Q 046598 859 QTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLND 938 (986)
Q Consensus 859 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 938 (986)
.....++..|+|||...+..++.++||||+||++|||++|+.||....... ... .. +
T Consensus 139 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------~~~----~~--~--- 195 (237)
T cd05576 139 ---CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------NTH----TT--L--- 195 (237)
T ss_pred ---cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------ccc----cc--c---
Confidence 122345678999999988889999999999999999999998865211100 000 00 0
Q ss_pred CcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCC
Q 046598 939 GEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTN 985 (986)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 985 (986)
..+......+.+++.+|++.||++||++.+
T Consensus 196 -----------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 196 -----------------NIPEWVSEEARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred -----------------CCcccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence 000112345678999999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=296.96 Aligned_cols=262 Identities=23% Similarity=0.274 Sum_probs=211.2
Q ss_pred HHHHHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcC-CCCcceeeeeecccccc
Q 046598 681 QNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDY 759 (986)
Q Consensus 681 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 759 (986)
+.+...++.|++.+.||.|.+|.||+++...+++.+|+|+...... ..++...|.++++.. .|||++.+||++.-..-
T Consensus 12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 3344457789999999999999999999999999999999876443 346778889999888 79999999999876656
Q ss_pred CCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCC
Q 046598 760 QGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED 839 (986)
Q Consensus 760 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 839 (986)
..++..|+|||||.+|+..+.++... +..+.|+.+..|++.++.|+.+||.. .++|||||-.||+++.+
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~--------g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e 159 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTK--------GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTEN 159 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhc--------ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEecc
Confidence 67889999999999999999997433 56799999999999999999999999 99999999999999999
Q ss_pred CcEEEcccccceecCCCCCccccccccccccccccccccCC-----CcCcccchhhHHHHHHHHHhCCCCCCcccccccc
Q 046598 840 MIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS-----EVSISGDVYSYGILLLELITRKKPTDIMFEGDMN 914 (986)
Q Consensus 840 ~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~ 914 (986)
+.+|++|||.+.... ..-.......||+.|||||++... .|+.++|+||+|++..||.-|.+|+....+.
T Consensus 160 ~~VKLvDFGvSaQld--sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm--- 234 (953)
T KOG0587|consen 160 AEVKLVDFGVSAQLD--STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM--- 234 (953)
T ss_pred CcEEEeeeeeeeeee--cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh---
Confidence 999999999998763 233344557899999999998643 5788999999999999999999997532221
Q ss_pred HHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 915 LHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 915 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..+.. ..|.+......+..-.+++.++|..|+..|-+.||++.++
T Consensus 235 -raLF~--------------------------IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~l 279 (953)
T KOG0587|consen 235 -RALFL--------------------------IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEEL 279 (953)
T ss_pred -hhhcc--------------------------CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhh
Confidence 11111 1112222233334455678899999999999999998763
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=253.49 Aligned_cols=265 Identities=22% Similarity=0.306 Sum_probs=199.6
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCC-CCcceeeeeeccccccCCCce
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~ 764 (986)
..++|++++++|+|.|++||.|....+.++++||++++.. .+...+|+.|++.+. ||||+++++...++ ....
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp---~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDP---ESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCc---cccC
Confidence 4678999999999999999999998888999999998643 467889999999996 99999999996543 3456
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCC-cEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDM-IAH 843 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~k 843 (986)
+.+|+||+.+.+...... .++..+++.++.++++||.|+|++ ||+|||+||.|+|||... ..+
T Consensus 110 paLiFE~v~n~Dfk~ly~-------------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLr 173 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLYP-------------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLR 173 (338)
T ss_pred chhHhhhhccccHHHHhh-------------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceee
Confidence 789999999988887763 578889999999999999999999 999999999999998654 799
Q ss_pred EcccccceecCCCCCccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 922 (986)
|+|+|+|.++.+..... ..+.+..|..||.+.+ ..|+..-|+|||||++..|+..+.||-...+....+...+.-.
T Consensus 174 lIDWGLAEFYHp~~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVL 250 (338)
T KOG0668|consen 174 LIDWGLAEFYHPGKEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVL 250 (338)
T ss_pred eeecchHhhcCCCceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHh
Confidence 99999999876544333 2456788999998876 4688999999999999999999999843222222222222211
Q ss_pred C---------------CCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCC
Q 046598 923 L---------------PDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTN 985 (986)
Q Consensus 923 ~---------------~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 985 (986)
- +....+++++.-.+....++....+. -...+..+++.+.+.+|-.+||||+|
T Consensus 251 Gt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~h----------l~~peaiDlldklLrYDHqeRlTakE 318 (338)
T KOG0668|consen 251 GTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQH----------LVSPEAIDLLDKLLRYDHQERLTAKE 318 (338)
T ss_pred ChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccc----------cCChHHHHHHHHHHhhccccccchHH
Confidence 1 12222222222222222211111110 11245678888999999999999986
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=247.93 Aligned_cols=211 Identities=25% Similarity=0.323 Sum_probs=172.9
Q ss_pred HHHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc-CchhHHHHHHHHHHHhc-CCCCcceeeeeeccccccC
Q 046598 683 LYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL-HHGAFKSFIAECNTLKN-IRHRNLVKILTACSGVDYQ 760 (986)
Q Consensus 683 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~ 760 (986)
+....+....+..||+|+||.|-+-++..+|+..|+|.++.. ..+..++...|+.+..+ ..+|.+|.+||. +.
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa-----~~ 115 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGA-----LF 115 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehh-----hh
Confidence 344455666778899999999999999999999999999742 33455677888886554 489999999997 45
Q ss_pred CCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCC
Q 046598 761 GNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDM 840 (986)
Q Consensus 761 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 840 (986)
.....++.||.| ..+|..+-.+. ...++.+++.-+-+||..+.+||.|||++. .++|||+||+|||++.+|
T Consensus 116 regdvwIcME~M-~tSldkfy~~v------~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~G 186 (282)
T KOG0984|consen 116 REGDVWICMELM-DTSLDKFYRKV------LKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDG 186 (282)
T ss_pred ccccEEEeHHHh-hhhHHHHHHHH------HhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCC
Confidence 567899999999 66888876532 245677899999999999999999999984 899999999999999999
Q ss_pred cEEEcccccceecCCCCCccccccccccccccccccccC----CCcCcccchhhHHHHHHHHHhCCCCCCcccc
Q 046598 841 IAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG----SEVSISGDVYSYGILLLELITRKKPTDIMFE 910 (986)
Q Consensus 841 ~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwSlGvvl~elltg~~pf~~~~~ 910 (986)
++|+||||.+..+..+-. .+...|-..|||||.+.. ..|+.||||||+|++++||.+++.||+....
T Consensus 187 qVKiCDFGIsG~L~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 187 QVKICDFGISGYLVDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred cEEEcccccceeehhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 999999999987653322 222457789999998754 3799999999999999999999999975433
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=262.21 Aligned_cols=202 Identities=25% Similarity=0.342 Sum_probs=176.9
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeec---cCchhHHHHHHHHHHHhcC-CCCcceeeeeeccccccCCC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL---LHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~ 762 (986)
.++|...+.||+|+|+.|-.++++.+.+.+|+|++++ .+.++..-.+.|-.+..+. +||.+|.+..+ ++.+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhsc-----fqte 323 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSC-----FQTE 323 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhh-----hccc
Confidence 4578999999999999999999999999999999974 3344455567777777776 79999999988 6777
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
...++|.||++||+|--+++ ....++++.++.+..+|.-||.|||++ ||++||+|.+||++|.+|++
T Consensus 324 srlffvieyv~ggdlmfhmq----------rqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghi 390 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQ----------RQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHI 390 (593)
T ss_pred ceEEEEEEEecCcceeeehh----------hhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCce
Confidence 89999999999999988775 234689999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCcc
Q 046598 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIM 908 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~ 908 (986)
|++|+|+++.--. ....+...+||+.|.|||++++..|...+|.|++||+++||+.|+.||+-.
T Consensus 391 kltdygmcke~l~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdiv 454 (593)
T KOG0695|consen 391 KLTDYGMCKEGLG--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIV 454 (593)
T ss_pred eecccchhhcCCC--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCccee
Confidence 9999999975322 223345688999999999999999999999999999999999999999843
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=300.78 Aligned_cols=213 Identities=22% Similarity=0.228 Sum_probs=147.2
Q ss_pred hhcCCCCCcccccccceeEEEEEECCC----CeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccc-cccC
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDG----RTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSG-VDYQ 760 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 760 (986)
..++|++.+.||+|+||.||+|.+..+ +..||||++..... .+....| .+....+.++..+...+.. ....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 467899999999999999999999988 89999998764322 1222222 1122223333332222111 1124
Q ss_pred CCceEEEEEEeccCCCHhHhhccCCCCCc----------cccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCC
Q 046598 761 GNDFKALVFEFMHNRSLEEWLHPITREDE----------TDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLK 830 (986)
Q Consensus 761 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~----------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlk 830 (986)
.+...++||||+++++|.++++....... ............+..|+.||+.||+|||++ +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 56789999999999999999864321000 000111223445678999999999999999 99999999
Q ss_pred CCCeEecC-CCcEEEcccccceecCCCCCccccccccccccccccccccCC----------------------CcCcccc
Q 046598 831 PSNILLDE-DMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS----------------------EVSISGD 887 (986)
Q Consensus 831 p~NIll~~-~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sD 887 (986)
|+|||++. ++.+||+|||+|+....... .......+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 57999999999986543222 222345689999999965322 2345679
Q ss_pred hhhHHHHHHHHHhCCCCCC
Q 046598 888 VYSYGILLLELITRKKPTD 906 (986)
Q Consensus 888 vwSlGvvl~elltg~~pf~ 906 (986)
||||||++|||+++..|++
T Consensus 362 VwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred cHHHHHHHHHHHhCcCCCc
Confidence 9999999999999876654
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-31 Score=260.39 Aligned_cols=203 Identities=25% Similarity=0.332 Sum_probs=169.1
Q ss_pred CCCCcccccccceeEEEEEECCCCeEEEEEEeec--cCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEE
Q 046598 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 767 (986)
Q Consensus 690 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 767 (986)
.+..+.||.|+||.||.+.+..+++.||+|.+.. .+-...+++.+|++++..++|.||+..+++-.....+--.+.|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 3456789999999999999999999999998853 23344578999999999999999999988743222222245688
Q ss_pred EEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccc
Q 046598 768 VFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDF 847 (986)
Q Consensus 768 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DF 847 (986)
|+|.| ..+|.+.+ .....++...++-+.+||++||+|||+. +|.||||||.|.+++.+-..||+||
T Consensus 135 ~TELm-QSDLHKII----------VSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDF 200 (449)
T KOG0664|consen 135 LTELM-QSDLHKII----------VSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDF 200 (449)
T ss_pred HHHHH-Hhhhhhee----------ccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEeccc
Confidence 89988 55888877 3456788889999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCccccccccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 848 GLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 848 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
|+|+..+.+ ....++..+.|..|+|||++.|. .|+.+.||||.||++.|++..+.-|..
T Consensus 201 GLARvee~d-~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA 260 (449)
T KOG0664|consen 201 GLARTWDQR-DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA 260 (449)
T ss_pred ccccccchh-hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc
Confidence 999865433 33445567789999999999885 699999999999999999999888763
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-31 Score=278.28 Aligned_cols=200 Identities=24% Similarity=0.327 Sum_probs=174.7
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
..++.++..||-||||.|=++........+|+|++++. +....+.+..|-+||...+.|.||++|.. |.+..
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrT-----frd~k 493 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRT-----FRDSK 493 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHH-----hccch
Confidence 34566778899999999999999876666899988643 33445667889999999999999999988 67778
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
+.|+.||-|-||.++..++. .+.++...++.++.-+.+|++|||++ +||+|||||+|.+++.+|-+|
T Consensus 494 yvYmLmEaClGGElWTiLrd----------Rg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~K 560 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILRD----------RGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLK 560 (732)
T ss_pred hhhhhHHhhcCchhhhhhhh----------cCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceE
Confidence 99999999999999999952 34577778888999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
|.|||+|+.+... ..+-.++||+.|.|||++.+...+.++|.||+|+++||+++|.+||..
T Consensus 561 LVDFGFAKki~~g---~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~ 621 (732)
T KOG0614|consen 561 LVDFGFAKKIGSG---RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSG 621 (732)
T ss_pred EeehhhHHHhccC---CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCC
Confidence 9999999987543 334457899999999999999999999999999999999999999974
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=267.59 Aligned_cols=237 Identities=28% Similarity=0.339 Sum_probs=187.3
Q ss_pred cceeEEEEEECCCCeEEEEEEeeccCchh-HHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEEEEeccCCCHh
Q 046598 700 SFGSVFKGILDDGRTTIAVKVFNLLHHGA-FKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLE 778 (986)
Q Consensus 700 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~ 778 (986)
+||.||+|++..+++.||+|++....... .+.+.+|++.+++++|+||+++++++ ......++||||+++++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVF-----EDEDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhhe-----eeCCEEEEEEeCCCCCCHH
Confidence 58999999999888999999997654433 68899999999999999999999984 3447899999999999999
Q ss_pred HhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcccccceecCCCCC
Q 046598 779 EWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSA 858 (986)
Q Consensus 779 ~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 858 (986)
+++... ..+++..+..++.++++++.|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 76 ~~~~~~----------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~- 141 (244)
T smart00220 76 DLLKKR----------GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG- 141 (244)
T ss_pred HHHHhc----------cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-
Confidence 998521 2278999999999999999999999 99999999999999999999999999998764332
Q ss_pred ccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCchhHHhhhhcccC
Q 046598 859 QTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLND 938 (986)
Q Consensus 859 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 938 (986)
......++..|+|||...+..++.++||||+|+++|++++|..||...... ..... .... ..
T Consensus 142 --~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~----~~~~~---------~~~~---~~ 203 (244)
T smart00220 142 --LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL----LELFK---------KIGK---PK 203 (244)
T ss_pred --ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH----HHHHH---------HHhc---cC
Confidence 223455788999999998888999999999999999999999998632111 11111 0000 00
Q ss_pred CcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 939 GEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
... .......+.++.+++.+|+..+|++||++.++
T Consensus 204 ~~~-------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~ 238 (244)
T smart00220 204 PPF-------------PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEA 238 (244)
T ss_pred CCC-------------ccccccCCHHHHHHHHHHccCCchhccCHHHH
Confidence 000 00000034567899999999999999998764
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-30 Score=274.98 Aligned_cols=207 Identities=23% Similarity=0.318 Sum_probs=174.6
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
-|..++.||-|+||+|.++.-.++...+|.|.+++.+ ......++.|-.||...+.+=||++|.. |++++.+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS-----FQDkdnL 704 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS-----FQDKDNL 704 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE-----eccCCce
Confidence 3667889999999999999999998999999986432 2334567889999999999999999987 7888999
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
|+||+|++||++-.++-+ -+.+.+..++.++.++..|+++.|+. |+|||||||+|||||.+|++||+
T Consensus 705 YFVMdYIPGGDmMSLLIr----------mgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLT 771 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLIR----------MGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLT 771 (1034)
T ss_pred EEEEeccCCccHHHHHHH----------hccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeee
Confidence 999999999999998842 34678888899999999999999999 99999999999999999999999
Q ss_pred ccccceecCC--------CCCcc--------------------------------ccccccccccccccccccCCCcCcc
Q 046598 846 DFGLARFLPL--------SSAQT--------------------------------SSIGAKGSIGYIAPEYGLGSEVSIS 885 (986)
Q Consensus 846 DFG~a~~~~~--------~~~~~--------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~ 885 (986)
|||+++-+.. ..+.. ..-..+||+.|+|||++....|+.-
T Consensus 772 DFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~ 851 (1034)
T KOG0608|consen 772 DFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQL 851 (1034)
T ss_pred eccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcccc
Confidence 9999963311 00000 0012359999999999999999999
Q ss_pred cchhhHHHHHHHHHhCCCCCCccccccc
Q 046598 886 GDVYSYGILLLELITRKKPTDIMFEGDM 913 (986)
Q Consensus 886 sDvwSlGvvl~elltg~~pf~~~~~~~~ 913 (986)
+|.||.|||||||+.|++||-....++.
T Consensus 852 cdwws~gvil~em~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 852 CDWWSVGVILYEMLVGQPPFLADTPGET 879 (1034)
T ss_pred chhhHhhHHHHHHhhCCCCccCCCCCcc
Confidence 9999999999999999999976655544
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=282.69 Aligned_cols=217 Identities=21% Similarity=0.266 Sum_probs=157.0
Q ss_pred hhcCCCCCcccccccceeEEEEEEC----------------CCCeEEEEEEeeccCchhHHHH--------------HHH
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILD----------------DGRTTIAVKVFNLLHHGAFKSF--------------IAE 735 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~----------------~~~~~vavK~~~~~~~~~~~~~--------------~~E 735 (986)
..++|++.++||+|+||.||+|.+. ..++.||||.+........++| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4678999999999999999999752 2346799999875433333333 346
Q ss_pred HHHHhcCCCCc-----ceeeeeeccccc---cCCCceEEEEEEeccCCCHhHhhccCCCCC--------------ccccC
Q 046598 736 CNTLKNIRHRN-----LVKILTACSGVD---YQGNDFKALVFEFMHNRSLEEWLHPITRED--------------ETDEA 793 (986)
Q Consensus 736 ~~~l~~l~h~n-----iv~l~~~~~~~~---~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------~~~~~ 793 (986)
+.++.+++|.+ +++++++|.... ...++..++||||+++++|.++++...... .....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 66777776554 466777764321 112456899999999999999997432110 00111
Q ss_pred CCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcccccceecCCCCCccccccccccccccc
Q 046598 794 PRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIA 873 (986)
Q Consensus 794 ~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~a 873 (986)
...+++..++.++.|++.||.|+|+. +|+||||||+||+++.++.+||+|||+++....... .......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 23467888999999999999999999 999999999999999999999999999976532211 11112335789999
Q ss_pred cccccCCC--------------------c--CcccchhhHHHHHHHHHhCCC-CCC
Q 046598 874 PEYGLGSE--------------------V--SISGDVYSYGILLLELITRKK-PTD 906 (986)
Q Consensus 874 PE~~~~~~--------------------~--~~~sDvwSlGvvl~elltg~~-pf~ 906 (986)
||.+.... + ..+.||||+||++|+|++|.. ||.
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 99875432 1 134799999999999999875 664
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-30 Score=285.96 Aligned_cols=242 Identities=26% Similarity=0.370 Sum_probs=183.7
Q ss_pred Cccccccccee-EEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcC-CCCcceeeeeeccccccCCCceEEEEEE
Q 046598 693 VNQIGEGSFGS-VFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVFE 770 (986)
Q Consensus 693 ~~~lg~G~~g~-Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e 770 (986)
.+.+|.|+.|+ ||+|...+ +.||||++-. +......+|+..++.- +|||||++|+. ..++.+.||..|
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye~--R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~-----E~d~qF~YIalE 583 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYEG--REVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCS-----EQDRQFLYIALE 583 (903)
T ss_pred HHHcccCCCCcEEEEEeeCC--ceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEee-----ccCCceEEEEeh
Confidence 45789999986 79999985 8999998743 3345678899999887 79999999988 778899999999
Q ss_pred eccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecC---C--CcEEEc
Q 046598 771 FMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDE---D--MIAHIG 845 (986)
Q Consensus 771 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~--~~~kL~ 845 (986)
.| ..+|.+++...... . .. ......+.+..|+++||++||+. +||||||||.||||+. + ..++|+
T Consensus 584 LC-~~sL~dlie~~~~d--~-~~---~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iS 653 (903)
T KOG1027|consen 584 LC-ACSLQDLIESSGLD--V-EM---QSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKIS 653 (903)
T ss_pred Hh-hhhHHHHHhccccc--h-hh---cccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEec
Confidence 99 56999999754111 0 11 11145677899999999999998 9999999999999975 3 479999
Q ss_pred ccccceecCCCCC-ccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhC-CCCCCccccccccHHHHHHhhC
Q 046598 846 DFGLARFLPLSSA-QTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITR-KKPTDIMFEGDMNLHNLARTAL 923 (986)
Q Consensus 846 DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg-~~pf~~~~~~~~~~~~~~~~~~ 923 (986)
|||+++....+.. .....+..||-+|+|||++....-+.++||||+||++|+.++| .+||......+.++..-
T Consensus 654 DfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~----- 728 (903)
T KOG1027|consen 654 DFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTG----- 728 (903)
T ss_pred ccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcC-----
Confidence 9999998865433 2334567799999999999998888999999999999999995 99997443332221110
Q ss_pred CCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 924 PDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 924 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.. .+. .+ ....++ +..++|.+|++++|..||+|.+|
T Consensus 729 -~~--~L~--~L--------------------~~~~d~--eA~dLI~~ml~~dP~~RPsa~~V 764 (903)
T KOG1027|consen 729 -NY--TLV--HL--------------------EPLPDC--EAKDLISRMLNPDPQLRPSATDV 764 (903)
T ss_pred -cc--cee--ee--------------------ccCchH--HHHHHHHHhcCCCcccCCCHHHH
Confidence 00 000 00 000111 45689999999999999999876
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-29 Score=267.89 Aligned_cols=201 Identities=22% Similarity=0.377 Sum_probs=171.3
Q ss_pred HHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--------chhHHHHHHHHHHHhcCC---CCcceeeee
Q 046598 684 YNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--------HGAFKSFIAECNTLKNIR---HRNLVKILT 752 (986)
Q Consensus 684 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---h~niv~l~~ 752 (986)
.+...+|...+.+|+|+||.|+.|.++.....|+||.+.+.. ....-....|++||..++ |+||+++++
T Consensus 557 ~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd 636 (772)
T KOG1152|consen 557 YKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD 636 (772)
T ss_pred ecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence 344557999999999999999999999988899999885321 111123567999999996 999999999
Q ss_pred eccccccCCCceEEEEEEec-cCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCC
Q 046598 753 ACSGVDYQGNDFKALVFEFM-HNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKP 831 (986)
Q Consensus 753 ~~~~~~~~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 831 (986)
+ |++++++|++||-- ++.+|.+++. ....+++.++..|++||+.|+++||++ ||||||||-
T Consensus 637 f-----FEddd~yyl~te~hg~gIDLFd~IE----------~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikd 698 (772)
T KOG1152|consen 637 F-----FEDDDYYYLETEVHGEGIDLFDFIE----------FKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKD 698 (772)
T ss_pred e-----eecCCeeEEEecCCCCCcchhhhhh----------ccCccchHHHHHHHHHHHhcccccccc---Cceeccccc
Confidence 9 78889999999964 5678999994 445789999999999999999999999 999999999
Q ss_pred CCeEecCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcC-cccchhhHHHHHHHHHhCCCCCC
Q 046598 832 SNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVS-ISGDVYSYGILLLELITRKKPTD 906 (986)
Q Consensus 832 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvvl~elltg~~pf~ 906 (986)
+||.++.+|-+||+|||.|..... ......+||..|.|||++.|.+|- ..-|||++|+++|.++....||.
T Consensus 699 envivd~~g~~klidfgsaa~~ks----gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 699 ENVIVDSNGFVKLIDFGSAAYTKS----GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccEEEecCCeEEEeeccchhhhcC----CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999999999999999999976532 233457899999999999998874 56899999999999999988874
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=256.78 Aligned_cols=202 Identities=26% Similarity=0.301 Sum_probs=172.4
Q ss_pred HhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCC------CCcceeeeeeccccc
Q 046598 685 NATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIR------HRNLVKILTACSGVD 758 (986)
Q Consensus 685 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~~~ 758 (986)
..-.+|.+.-..|+|-|++|.+|.+...+..||||++.... ...+.=.+|++||++++ --|+++++..
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~----- 502 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRH----- 502 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHH-----
Confidence 34568999999999999999999999889999999997533 33456678999999994 3488888877
Q ss_pred cCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecC
Q 046598 759 YQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDE 838 (986)
Q Consensus 759 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 838 (986)
|....++|+|||-+ .-+|.+.++.+++ ...+....++.++.|+.-||..|-.. ||+|.||||+||||.+
T Consensus 503 F~hknHLClVFE~L-slNLRevLKKyG~-------nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE 571 (752)
T KOG0670|consen 503 FKHKNHLCLVFEPL-SLNLREVLKKYGR-------NVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNE 571 (752)
T ss_pred hhhcceeEEEehhh-hchHHHHHHHhCc-------ccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEecc
Confidence 66779999999988 6699999986654 34588899999999999999999998 9999999999999987
Q ss_pred CC-cEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 839 DM-IAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 839 ~~-~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
.. .+||||||.|.......- +....+..|.|||++.|-+|+...|+||+||+|||+.||+.-|.+
T Consensus 572 ~k~iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG 637 (752)
T KOG0670|consen 572 SKNILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG 637 (752)
T ss_pred CcceeeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC
Confidence 65 799999999987643332 223457789999999999999999999999999999999998864
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-27 Score=233.83 Aligned_cols=209 Identities=22% Similarity=0.303 Sum_probs=169.8
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcC-CCCcceeeeeeccccccCCCceE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
.+.|.+.+.+|+|.||.+-+++++.+++.+|+|.++.. ....++|.+|...--.+ .|.||+.-|+.. ++.-+.+
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~va----Fqt~d~Y 97 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVA----FQTSDAY 97 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHH----hhcCceE
Confidence 45699999999999999999999999999999998753 34568899998766566 689999988763 6677899
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEec--CCCcEE
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLD--EDMIAH 843 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~k 843 (986)
++++||++.|+|..-+.. ..+.+....+++.|++.|+.|+|+. .+||||||.+||||- +...+|
T Consensus 98 vF~qE~aP~gdL~snv~~-----------~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvK 163 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEA-----------AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVK 163 (378)
T ss_pred EEeeccCccchhhhhcCc-----------ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEE
Confidence 999999999999988742 3467778899999999999999999 999999999999993 334899
Q ss_pred EcccccceecCCCCCccccccccccccccccccccCC-----CcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHH
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS-----EVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNL 918 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~ 918 (986)
++|||..+.... .......+..|.|||..... ...+.+|||.||+++|.++||+.||......+..+..|
T Consensus 164 lcDFG~t~k~g~-----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~ 238 (378)
T KOG1345|consen 164 LCDFGLTRKVGT-----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEW 238 (378)
T ss_pred eeecccccccCc-----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHH
Confidence 999999975421 11223356679999975432 45688999999999999999999998655555555554
Q ss_pred H
Q 046598 919 A 919 (986)
Q Consensus 919 ~ 919 (986)
.
T Consensus 239 ~ 239 (378)
T KOG1345|consen 239 E 239 (378)
T ss_pred H
Confidence 3
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-28 Score=266.42 Aligned_cols=200 Identities=25% Similarity=0.384 Sum_probs=176.8
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
..++|+..+++|.|.||.||+|++..++...|+|+++........-.++|+-+++..+|||||.+++. +..++..
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gs-----ylr~dkl 87 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGS-----YLRRDKL 87 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhh-----hhhhcCc
Confidence 35679999999999999999999999999999999998777778888999999999999999999998 5667889
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
++.||||.+|+|++.-+ ..+++++.++..++++..+|++|||+. |=+|||||-.||++++.|.+|++
T Consensus 88 wicMEycgggslQdiy~----------~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvkla 154 (829)
T KOG0576|consen 88 WICMEYCGGGSLQDIYH----------VTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLA 154 (829)
T ss_pred EEEEEecCCCcccceee----------ecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeec
Confidence 99999999999998764 346799999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccc---cCCCcCcccchhhHHHHHHHHHhCCCCC
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYG---LGSEVSISGDVYSYGILLLELITRKKPT 905 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlGvvl~elltg~~pf 905 (986)
|||.+..+.. .-.....+.||+.|||||+. +.+.|..++|||+.|++..|+---++|-
T Consensus 155 Dfgvsaqita--ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqppl 215 (829)
T KOG0576|consen 155 DFGVSAQITA--TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPL 215 (829)
T ss_pred ccCchhhhhh--hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcc
Confidence 9999976532 22333457799999999974 3467899999999999999998877773
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.6e-28 Score=241.09 Aligned_cols=201 Identities=26% Similarity=0.297 Sum_probs=169.7
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeec--cCchhHHHHHHHHHHHhcCCCCcceeeeeeccccc-cCCC
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-YQGN 762 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~ 762 (986)
...+|.-.+.+|.|.- .|..|.+.-.++.||+|.... ......++..+|...+..+.|+||++++.++.... ...-
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 3567888899999998 888888888899999998742 33445678889999999999999999999864221 1223
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
...|+|||+| ..+|.+.++ -.++-..+..|..|++.|++|||+. ||+||||||+||++..+..+
T Consensus 94 ~e~y~v~e~m-~~nl~~vi~------------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~l 157 (369)
T KOG0665|consen 94 QEVYLVMELM-DANLCQVIL------------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTL 157 (369)
T ss_pred HhHHHHHHhh-hhHHHHHHH------------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhhe
Confidence 4679999999 679999885 2366678899999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCC
Q 046598 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTD 906 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~ 906 (986)
||.|||+|+.... .-..+..+.|..|+|||++.+..+.+.+||||+||++.||++|+.-|.
T Consensus 158 Ki~dfg~ar~e~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~ 218 (369)
T KOG0665|consen 158 KILDFGLARTEDT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP 218 (369)
T ss_pred eeccchhhcccCc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec
Confidence 9999999986432 235566788999999999999889999999999999999999999775
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-26 Score=235.54 Aligned_cols=184 Identities=32% Similarity=0.513 Sum_probs=158.1
Q ss_pred cccccceeEEEEEECCCCeEEEEEEeeccCch-hHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEEEEeccC
Q 046598 696 IGEGSFGSVFKGILDDGRTTIAVKVFNLLHHG-AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHN 774 (986)
Q Consensus 696 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~ 774 (986)
||+|++|.||++....+++.+++|++...... ..+.+.+|++.++.++|++|+++++++ ......+++|||+++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF-----EDENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeee-----ecCCeEEEEEecCCC
Confidence 68999999999999887899999999764432 346789999999999999999999984 444789999999999
Q ss_pred CCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecC-CCcEEEcccccceec
Q 046598 775 RSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDE-DMIAHIGDFGLARFL 853 (986)
Q Consensus 775 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~DFG~a~~~ 853 (986)
++|.+++... ...+++..+..++.++++++.+||+. +++|+||+|.||+++. ++.++|+|||.+...
T Consensus 76 ~~l~~~~~~~---------~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~ 143 (215)
T cd00180 76 GSLKDLLKEN---------EGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLL 143 (215)
T ss_pred CcHHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEc
Confidence 9999998522 13588999999999999999999999 9999999999999999 899999999999866
Q ss_pred CCCCCccccccccccccccccccccCC-CcCcccchhhHHHHHHHH
Q 046598 854 PLSSAQTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLEL 898 (986)
Q Consensus 854 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~el 898 (986)
..... ......+...|++||..... .++.++|+|++|++++++
T Consensus 144 ~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 144 TSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred cCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 43321 12334578899999998877 888999999999999998
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-28 Score=253.52 Aligned_cols=197 Identities=22% Similarity=0.250 Sum_probs=102.0
Q ss_pred cceEEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCcccccccccEE--Ee
Q 046598 358 TLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFIL--YL 435 (986)
Q Consensus 358 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L--~L 435 (986)
.++.|+|..|+|..+....|.++..|++|+|.+|+|+...|.+|..+..|.+|+|-.|.+.-.- .|.+| .|
T Consensus 299 ~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC-------~l~wl~~Wl 371 (498)
T KOG4237|consen 299 ELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNC-------RLAWLGEWL 371 (498)
T ss_pred hhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCcc-------chHHHHHHH
Confidence 3445555555555555566667777777777777777677777777777777777766654211 11111 01
Q ss_pred cccccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhh-ccCcccc
Q 046598 436 SYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILN-VFGNKLK 514 (986)
Q Consensus 436 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~-Ls~N~l~ 514 (986)
..+.-.| .|. -..-..++.+.++.+.+. ..--. .. +++. ..+ .+..-..++-+.... -|++.++
T Consensus 372 r~~~~~~-~~~-Cq~p~~~~~~~~~dv~~~-~~~c~---~~---ee~~-----~~~-s~~cP~~c~c~~tVvRcSnk~lk 436 (498)
T KOG4237|consen 372 RKKSVVG-NPR-CQSPGFVRQIPISDVAFG-DFRCG---GP---EELG-----CLT-SSPCPPPCTCLDTVVRCSNKLLK 436 (498)
T ss_pred hhCCCCC-CCC-CCCCchhccccchhcccc-ccccC---Cc---cccC-----CCC-CCCCCCCcchhhhhHhhcccchh
Confidence 1122111 111 111123445555554443 10000 00 0000 000 000111233343333 3333333
Q ss_pred ccCcccccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCC
Q 046598 515 GEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNN 583 (986)
Q Consensus 515 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N 583 (986)
.+|..+- ..-.+|++.+|.++ .+|.+ .+.+| .+||++|+++..-...|.++++|.+|-||+|
T Consensus 437 -~lp~~iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 437 -LLPRGIP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred -hcCCCCC--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 5555443 24567777777777 56665 56667 7788888887666677888888888888776
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=236.29 Aligned_cols=200 Identities=31% Similarity=0.424 Sum_probs=171.5
Q ss_pred CCCCcccccccceeEEEEEECCCCeEEEEEEeeccCch-hHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEE
Q 046598 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHG-AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALV 768 (986)
Q Consensus 690 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 768 (986)
|.+.+.||+|++|.||+|....+++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++ ......+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVF-----EDPEPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeee-----ecCCceEEE
Confidence 56788999999999999999988899999999765544 567899999999999999999999984 445778999
Q ss_pred EEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcccc
Q 046598 769 FEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFG 848 (986)
Q Consensus 769 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG 848 (986)
+||+++++|.+++.... ..+++..+..++.+++.++.+||+. +++|+|++|+||+++.++.++|+|||
T Consensus 76 ~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g 143 (225)
T smart00221 76 MEYCEGGDLFDYLRKKG---------GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFG 143 (225)
T ss_pred EeccCCCCHHHHHHhcc---------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCc
Confidence 99999999999996321 1178899999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCccccccccccccccccccc-cCCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 849 LARFLPLSSAQTSSIGAKGSIGYIAPEYG-LGSEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 849 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
.+........ .......++..|++||.. ....++.++|||+||+++++|++|+.||+.
T Consensus 144 ~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 144 LARFIHRDLA-ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eeeEecCccc-ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 9987643321 122334577889999998 667788899999999999999999999963
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.2e-27 Score=243.49 Aligned_cols=203 Identities=27% Similarity=0.396 Sum_probs=168.8
Q ss_pred HHHhhcCCCCCcccccccceeEEEEEECC---CCeEEEEEEeeccCchhHHHHHHHHHHHhcC-CCCcceeeeeeccccc
Q 046598 683 LYNATDRFSSVNQIGEGSFGSVFKGILDD---GRTTIAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVD 758 (986)
Q Consensus 683 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 758 (986)
.....+.|..+++||+|.|++||+|.+.. ..+.||+|.+..... ..+...|+++|..+ .+.||+++.++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~----- 103 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGC----- 103 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhh-----
Confidence 33456679999999999999999999977 688999999876543 36788999999999 69999999998
Q ss_pred cCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecC
Q 046598 759 YQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDE 838 (986)
Q Consensus 759 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 838 (986)
+..++..++|+||++...-.++.. .++..++..+++.+..||+++|+. |||||||||+|++.+.
T Consensus 104 ~rnnd~v~ivlp~~~H~~f~~l~~-------------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~ 167 (418)
T KOG1167|consen 104 FRNNDQVAIVLPYFEHDRFRDLYR-------------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNR 167 (418)
T ss_pred hccCCeeEEEecccCccCHHHHHh-------------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCcccccccc
Confidence 677899999999999999998884 477889999999999999999999 9999999999999974
Q ss_pred -CCcEEEcccccceecCCCC------C------------------------------------ccccccccccccccccc
Q 046598 839 -DMIAHIGDFGLARFLPLSS------A------------------------------------QTSSIGAKGSIGYIAPE 875 (986)
Q Consensus 839 -~~~~kL~DFG~a~~~~~~~------~------------------------------------~~~~~~~~gt~~y~aPE 875 (986)
.+.-.|+|||+|...+... . ........||++|+|||
T Consensus 168 ~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPE 247 (418)
T KOG1167|consen 168 RTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPE 247 (418)
T ss_pred ccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchH
Confidence 4578999999997221000 0 00011234999999999
Q ss_pred cccCC-CcCcccchhhHHHHHHHHHhCCCCCCcc
Q 046598 876 YGLGS-EVSISGDVYSYGILLLELITRKKPTDIM 908 (986)
Q Consensus 876 ~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~ 908 (986)
++... .-++++||||.||++.-+++++.||-..
T Consensus 248 vL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 248 VLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKA 281 (418)
T ss_pred HHhhccCcCCccceeeccceeehhhccccccccC
Confidence 98764 5688999999999999999999998543
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.6e-24 Score=271.49 Aligned_cols=345 Identities=21% Similarity=0.320 Sum_probs=210.2
Q ss_pred CcCccCCCCCCEEEccCCC------ccccCCcchhccc-cCceeeceecccCCCCccchhcCccccceecccccccCccC
Q 046598 79 SPHVGNLSFLKVLRLYNNS------FNHEIPSEFDRLR-RLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIP 151 (986)
Q Consensus 79 ~~~~~~l~~L~~L~L~~n~------l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 151 (986)
+..|.++++|+.|.+..+. +...+|..|..++ +|+.|++.+|.++ .+|..| ...+|+.|+|++|++. .+|
T Consensus 551 ~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~ 627 (1153)
T PLN03210 551 ENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLW 627 (1153)
T ss_pred HHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccc
Confidence 3457788888888886653 2334677777764 5888888888876 667666 4678888888888877 677
Q ss_pred ccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeeccCCcccCcCcchhhccCCCceeecccccccccCCccccCCCC
Q 046598 152 SELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISS 231 (986)
Q Consensus 152 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 231 (986)
..+..+++|++|+|++|.....+|. ++.+++|++|+|++|.....+|..++.+++|+.|++++|.....+|..+ ++++
T Consensus 628 ~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~s 705 (1153)
T PLN03210 628 DGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKS 705 (1153)
T ss_pred cccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCC
Confidence 7777888888888887664446664 7777888888888876555778888888888888888765444667655 6777
Q ss_pred ccEEeccccccccccCCcccccccccceEEecCceecccCCccccCCCCCcEEecccccccCCCchhhhhhhHhhhhhcc
Q 046598 232 ITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILG 311 (986)
Q Consensus 232 L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~l~~l~~L~~l~l~~ 311 (986)
|+.|++++|.....+|.. ..+|++|++++|.++ .+|..+ .+++|+.|++.+++......
T Consensus 706 L~~L~Lsgc~~L~~~p~~----~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~--------------- 764 (1153)
T PLN03210 706 LYRLNLSGCSRLKSFPDI----STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWE--------------- 764 (1153)
T ss_pred CCEEeCCCCCCccccccc----cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccc---------------
Confidence 777777776655455432 345666666666655 344433 34555555444322111000
Q ss_pred CCCCCCCCCCcccccccccccccceeeccccccccCCCcccccccccceEEEccCCcccccCCccccCCCCCCEEEccCc
Q 046598 312 NSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSN 391 (986)
Q Consensus 312 n~l~~~~~~~l~~l~~l~~~~~L~~l~l~~n~~~~~~p~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 391 (986)
.+ ..++......+++|+.|+|++|...+.+|..++++++|+.|++++|
T Consensus 765 -------------------------------~~-~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C 812 (1153)
T PLN03210 765 -------------------------------RV-QPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENC 812 (1153)
T ss_pred -------------------------------cc-cccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCC
Confidence 00 0111112222356777777777766677777777777777777776
Q ss_pred cccCcCCCcccCCCCCCEEEccCccceeecCcccccccccEEEecccccCCCCCcccCCCCCCCeeecCC-CccCCCCCc
Q 046598 392 RLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSN-NNLTGTIPP 470 (986)
Q Consensus 392 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~ip~ 470 (986)
..-+.+|..+ .+++|+.|+|++|.....+|... .+|+.|+|++|.|+ .+|.++..+++|+.|+|++ |++. .+|.
T Consensus 813 ~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~~--~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~ 887 (1153)
T PLN03210 813 INLETLPTGI-NLESLESLDLSGCSRLRTFPDIS--TNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSL 887 (1153)
T ss_pred CCcCeeCCCC-CccccCEEECCCCCccccccccc--cccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCc
Confidence 4433566554 56777777777765443333322 13455555555554 3455555555555555554 3333 3443
Q ss_pred ccccCCCcceEEEccCC
Q 046598 471 QFIGLSSSLIVLDLSRN 487 (986)
Q Consensus 471 ~~~~~~~~L~~L~Ls~N 487 (986)
. ...++.|+.+++++|
T Consensus 888 ~-~~~L~~L~~L~l~~C 903 (1153)
T PLN03210 888 N-ISKLKHLETVDFSDC 903 (1153)
T ss_pred c-cccccCCCeeecCCC
Confidence 3 333444555544444
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=266.49 Aligned_cols=348 Identities=20% Similarity=0.269 Sum_probs=243.1
Q ss_pred cCCcchhccccCceeeceecc------cCCCCccchhcC-ccccceecccccccCccCccccCCCCCCeEEccCCcCCCC
Q 046598 101 EIPSEFDRLRRLQVLALHYNS------IGGAIPANISSC-SNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGS 173 (986)
Q Consensus 101 ~~p~~~~~l~~L~~L~L~~N~------l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 173 (986)
..+.+|.++++|+.|.+..+. +...+|..|..+ .+|+.|++.+|.+. .+|..| ...+|++|+|.+|++. .
T Consensus 549 i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~ 625 (1153)
T PLN03210 549 IHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-K 625 (1153)
T ss_pred ecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-c
Confidence 345679999999999997664 334577778776 46999999999987 778777 5789999999999998 6
Q ss_pred cccccCCCcCcceeeccCCcccCcCcchhhccCCCceeecccccccccCCccccCCCCccEEeccccccccccCCccccc
Q 046598 174 IPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFS 253 (986)
Q Consensus 174 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~ 253 (986)
++..+..+++|+.|+|++|.....+|+ ++.+++|++|+|++|.....+|..+.++.+|+.|++++|.....+|... +
T Consensus 626 L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i--~ 702 (1153)
T PLN03210 626 LWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI--N 702 (1153)
T ss_pred cccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC--C
Confidence 778889999999999998765446774 8889999999999987767899999999999999999887666777655 5
Q ss_pred ccccceEEecCceecccCCccccCCCCCcEEecccccccCCCchhhhhhhHhhhhhccCCCCCCCCCCcccccccccccc
Q 046598 254 LQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATR 333 (986)
Q Consensus 254 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~l~~l~~L~~l~l~~n~l~~~~~~~l~~l~~l~~~~~ 333 (986)
+++|+.|++++|...+.+|.. .++|+.|++++|.++.+|..+ . +++
T Consensus 703 l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~lP~~~-~------------------------------l~~ 748 (1153)
T PLN03210 703 LKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIEEFPSNL-R------------------------------LEN 748 (1153)
T ss_pred CCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccccccccc-c------------------------------ccc
Confidence 788889998888766566643 356777888877776544321 1 112
Q ss_pred cceeeccccccccCCCcccccccccceEEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEcc
Q 046598 334 LKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQ 413 (986)
Q Consensus 334 L~~l~l~~n~~~~~~p~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 413 (986)
|..|.+..+... .++ +.+....+..+...++|+.|+|++|...+.+|..++++++|+.|+|+
T Consensus 749 L~~L~l~~~~~~-~l~-----------------~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls 810 (1153)
T PLN03210 749 LDELILCEMKSE-KLW-----------------ERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIE 810 (1153)
T ss_pred cccccccccchh-hcc-----------------ccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECC
Confidence 222222211100 000 01111222233345678888888887766778888888888888887
Q ss_pred CccceeecCcccccccccEEEecccccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccC
Q 046598 414 RNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSI 493 (986)
Q Consensus 414 ~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~ 493 (986)
+|...+. +|..+ ++++|+.|++++|..-..+|.. .++|+.|+|++|.|+ .+
T Consensus 811 ~C~~L~~-----------------------LP~~~-~L~sL~~L~Ls~c~~L~~~p~~----~~nL~~L~Ls~n~i~-~i 861 (1153)
T PLN03210 811 NCINLET-----------------------LPTGI-NLESLESLDLSGCSRLRTFPDI----STNISDLNLSRTGIE-EV 861 (1153)
T ss_pred CCCCcCe-----------------------eCCCC-CccccCEEECCCCCcccccccc----ccccCEeECCCCCCc-cC
Confidence 7653323 33333 4566667777665443344432 356777777777777 56
Q ss_pred CcccccccccchhhccC-ccccccCcccccCCccccEEeccccc
Q 046598 494 PSEVGNLKNLEILNVFG-NKLKGEIPSTLGSCIKLEQLEMQENF 536 (986)
Q Consensus 494 p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~ 536 (986)
|..+..+++|+.|+|++ |++. .+|..+..+++|+.|+++++.
T Consensus 862 P~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 862 PWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred hHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence 77777777777777777 4555 566677777788887777663
|
syringae 6; Provisional |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-24 Score=266.83 Aligned_cols=153 Identities=22% Similarity=0.321 Sum_probs=115.2
Q ss_pred cCCC-Ccceeeeeeccccc--cCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHH
Q 046598 741 NIRH-RNLVKILTACSGVD--YQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLH 817 (986)
Q Consensus 741 ~l~h-~niv~l~~~~~~~~--~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH 817 (986)
.++| +||++++++|.... .......+.+|||+ +++|.+++.. ....+++.+++.++.||++||+|||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~al~~lH 97 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---------PDRSVDAFECFHVFRQIVEIVNAAH 97 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---------ccccccHHHHHHHHHHHHHHHHHHH
Confidence 3456 68888888753221 12234577888987 6799999952 2345899999999999999999999
Q ss_pred hcCCCCeEeecCCCCCeEecC-------------------CCcEEEcccccceecCCCCC--------------cccccc
Q 046598 818 HDCQPPIAHCDLKPSNILLDE-------------------DMIAHIGDFGLARFLPLSSA--------------QTSSIG 864 (986)
Q Consensus 818 ~~~~~~ivH~Dlkp~NIll~~-------------------~~~~kL~DFG~a~~~~~~~~--------------~~~~~~ 864 (986)
++ ||+||||||+|||++. ++.+|++|||+++....... ......
T Consensus 98 ~~---gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (793)
T PLN00181 98 SQ---GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQIL 174 (793)
T ss_pred hC---CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccc
Confidence 99 9999999999999954 44566667776654211000 000112
Q ss_pred ccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCC
Q 046598 865 AKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTD 906 (986)
Q Consensus 865 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~ 906 (986)
..||+.|||||++.+..++.++|||||||++|||++|.+|+.
T Consensus 175 ~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~ 216 (793)
T PLN00181 175 AMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSRE 216 (793)
T ss_pred cCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchh
Confidence 357888999999999999999999999999999999988864
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-25 Score=231.61 Aligned_cols=412 Identities=22% Similarity=0.251 Sum_probs=247.2
Q ss_pred CCCEEEccCCCccccCCcchhccccCceeeceecccCCCCccchhcCccccceeccc-ccccCccCccccCCCCCCeEEc
Q 046598 87 FLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFH-NQLVGKIPSELSSLSKIEHISV 165 (986)
Q Consensus 87 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L 165 (986)
.-+.++|..|+|+.+.|.+|+.+++|++||||+|+|+.+-|++|.++.+|..|-+.+ |+|+....+.|++|..|+.|.+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence 346788999999988888999999999999999999988899999999888777766 8898666678999999999999
Q ss_pred cCCcCCCCcccccCCCcCcceeeccCCcccCcCcchhhccCCCceeecccccccccCCccccCCCCccEEeccccccccc
Q 046598 166 NDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGA 245 (986)
Q Consensus 166 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~ 245 (986)
.-|++.-.....|..|++|..|.|.+|.+..+--.+|..+..++.+.++.|.+- ...+++.+.. ++..|.+.
T Consensus 148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~i-----cdCnL~wla~-~~a~~~ie-- 219 (498)
T KOG4237|consen 148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFI-----CDCNLPWLAD-DLAMNPIE-- 219 (498)
T ss_pred ChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccc-----cccccchhhh-HHhhchhh--
Confidence 999999888889999999999999999998444458899999999999998843 1222222211 11112111
Q ss_pred cCCcccccccccceEEecCceecccCCccccCCCCCcEEecccccccCCCchhhhhhhHhhhhhccCCCCCCCCCCcccc
Q 046598 246 IPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFL 325 (986)
Q Consensus 246 ~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~l~~l~~L~~l~l~~n~l~~~~~~~l~~l 325 (986)
+.+..-..-..+.++++..+-+..|.. .++++.+-
T Consensus 220 -----tsgarc~~p~rl~~~Ri~q~~a~kf~c----------------------~~esl~s~------------------ 254 (498)
T KOG4237|consen 220 -----TSGARCVSPYRLYYKRINQEDARKFLC----------------------SLESLPSR------------------ 254 (498)
T ss_pred -----cccceecchHHHHHHHhcccchhhhhh----------------------hHHhHHHh------------------
Confidence 112222223333334433222221110 00111000
Q ss_pred cccccccccceeeccccccccCCCcccccccccceEEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCC
Q 046598 326 CSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQ 405 (986)
Q Consensus 326 ~~l~~~~~L~~l~l~~n~~~~~~p~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 405 (986)
..+..+..+.-|..-+...++|++|+|++|+|+++-+.+|..+..++.|.|..|+|.......|.++.
T Consensus 255 ------------~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls 322 (498)
T KOG4237|consen 255 ------------LSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLS 322 (498)
T ss_pred ------------hccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccc
Confidence 00111122233444444445667777777777766677777777777777777777655566667777
Q ss_pred CCCEEEccCccceeecCcccccc-cccEEEecccccCCCCCcccCCCCCCCee--ecCCCccCCCCCcccccCCCcceEE
Q 046598 406 NLKDLRLQRNRFQGNIPPSIGNL-KLFILYLSYNFLQGSIPSSLGRYETLTTI--DLSNNNLTGTIPPQFIGLSSSLIVL 482 (986)
Q Consensus 406 ~L~~L~Ls~N~l~~~~~~~~~~~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L--~L~~N~l~~~ip~~~~~~~~~L~~L 482 (986)
.|+.|+|.+|+|+...|..|... .|.+|+|-.|.+.- ++ .|.+| .|..+.-. ..|+. .....++.+
T Consensus 323 ~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~C-------nC-~l~wl~~Wlr~~~~~-~~~~C--q~p~~~~~~ 391 (498)
T KOG4237|consen 323 GLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNC-------NC-RLAWLGEWLRKKSVV-GNPRC--QSPGFVRQI 391 (498)
T ss_pred cceeeeecCCeeEEEecccccccceeeeeehccCcccC-------cc-chHHHHHHHhhCCCC-CCCCC--CCCchhccc
Confidence 77777777777776666666544 36666665555431 10 12222 23333322 23332 233455666
Q ss_pred EccCCccccc---CCcccccccccchhhccCccccccCcccccCCccccE-EecccccccccCCccccCCCCCCEEeCCC
Q 046598 483 DLSRNQLTGS---IPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQ-LEMQENFLQGPIPSSLSSLRGLSVLDLSQ 558 (986)
Q Consensus 483 ~Ls~N~l~~~---~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~-L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 558 (986)
+++.+.+... .|++.+.. -++.-| ..++-+.. ..-|++.++ .+|..+- ..-.+|+|.+
T Consensus 392 ~~~dv~~~~~~c~~~ee~~~~------------~s~~cP---~~c~c~~tVvRcSnk~lk-~lp~~iP--~d~telyl~g 453 (498)
T KOG4237|consen 392 PISDVAFGDFRCGGPEELGCL------------TSSPCP---PPCTCLDTVVRCSNKLLK-LLPRGIP--VDVTELYLDG 453 (498)
T ss_pred cchhccccccccCCccccCCC------------CCCCCC---CCcchhhhhHhhcccchh-hcCCCCC--chhHHHhccc
Confidence 6666554421 11111110 011112 12233322 233444444 5555442 3467899999
Q ss_pred ccCcccCchhhhcccccceeeccCCccccccCCccccccc
Q 046598 559 NNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQGVFKNA 598 (986)
Q Consensus 559 N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~~~~~~ 598 (986)
|.++ .+|.. .+.+| .+|+|+|+++..- ...|+++
T Consensus 454 n~~~-~vp~~--~~~~l-~~dls~n~i~~Ls--n~tf~n~ 487 (498)
T KOG4237|consen 454 NAIT-SVPDE--LLRSL-LLDLSNNRISSLS--NYTFSNM 487 (498)
T ss_pred chhc-ccCHH--HHhhh-hcccccCceehhh--cccccch
Confidence 9999 67777 67788 8999999998543 2335444
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.4e-24 Score=212.09 Aligned_cols=160 Identities=24% Similarity=0.261 Sum_probs=118.6
Q ss_pred CCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcccccceecC
Q 046598 775 RSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLP 854 (986)
Q Consensus 775 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 854 (986)
|+|.++++. ....+++.+++.|+.||++||+|||++ + ||+||+++.++.+|+ ||.++...
T Consensus 1 GsL~~~l~~---------~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~ 60 (176)
T smart00750 1 VSLADILEV---------RGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKT 60 (176)
T ss_pred CcHHHHHHH---------hCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeec
Confidence 688888852 234699999999999999999999998 6 999999999999999 99998653
Q ss_pred CCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCchhHHhhhh
Q 046598 855 LSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVMDIVDST 934 (986)
Q Consensus 855 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 934 (986)
... ..|++.|||||++.+..++.++|||||||++|||+||+.||............ +....
T Consensus 61 ~~~-------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~------------~~~~~ 121 (176)
T smart00750 61 PEQ-------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEI------------LLNGM 121 (176)
T ss_pred ccc-------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHH------------HHHHh
Confidence 221 25789999999999999999999999999999999999998633221111111 11111
Q ss_pred cccCCcchhhccchhhhhHhhHHHHHHH--HHHHHHHhcccCCCCCCCCCCCCC
Q 046598 935 LLNDGEDLIVHGNQRQRQARVKSRIECL--ISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 935 l~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
....+.+. ....... .++.+++.+||+.+|++||++.||
T Consensus 122 ~~~~~~~~-------------~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~l 162 (176)
T smart00750 122 PADDPRDR-------------SNLESVSAARSFADFMRVCASRLPQRREAANHY 162 (176)
T ss_pred ccCCcccc-------------ccHHHHHhhhhHHHHHHHHHhcccccccCHHHH
Confidence 11111100 0011112 358899999999999999998764
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-23 Score=225.72 Aligned_cols=168 Identities=23% Similarity=0.152 Sum_probs=132.2
Q ss_pred HHhhcCCCCCcccccccceeEEEEEECC-CCeEEEEEEeecc-----CchhHHHHHHHHHHHhcCCCCccee-eeeeccc
Q 046598 684 YNATDRFSSVNQIGEGSFGSVFKGILDD-GRTTIAVKVFNLL-----HHGAFKSFIAECNTLKNIRHRNLVK-ILTACSG 756 (986)
Q Consensus 684 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~ 756 (986)
....++|.+.+.||+|+||+||+|++.. +++.||||+.... .....+.+.+|++++++++|+|+++ ++++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 3456789999999999999999999875 5778899986532 1223567899999999999999985 4432
Q ss_pred cccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecC-CCCCeE
Q 046598 757 VDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDL-KPSNIL 835 (986)
Q Consensus 757 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dl-kp~NIl 835 (986)
+..|+||||++|++|... . .. . ...++.|+++||+|||++ ||+|||| ||+||+
T Consensus 91 ------~~~~LVmE~~~G~~L~~~-~---------~~----~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NIL 144 (365)
T PRK09188 91 ------GKDGLVRGWTEGVPLHLA-R---------PH----G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWL 144 (365)
T ss_pred ------CCcEEEEEccCCCCHHHh-C---------cc----c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEE
Confidence 347999999999999732 1 00 0 146788999999999999 9999999 999999
Q ss_pred ecCCCcEEEcccccceecCCCCCccc------cccccccccccccccccCC
Q 046598 836 LDEDMIAHIGDFGLARFLPLSSAQTS------SIGAKGSIGYIAPEYGLGS 880 (986)
Q Consensus 836 l~~~~~~kL~DFG~a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~ 880 (986)
++.++.+||+|||+|+.+........ .....+++.|+|||++...
T Consensus 145 v~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 145 MGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred EcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99999999999999987754332211 1345678889999998754
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.5e-23 Score=243.39 Aligned_cols=121 Identities=32% Similarity=0.439 Sum_probs=56.2
Q ss_pred CCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccCcccccCCccccEEec
Q 046598 453 TLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEM 532 (986)
Q Consensus 453 ~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 532 (986)
+|+.|+|++|+|+ .+|.. .++|+.|++++|+|+ .+|... .+|+.|+|++|+|+ .+|.. .++|+.|++
T Consensus 343 ~Lq~LdLS~N~Ls-~LP~l----p~~L~~L~Ls~N~L~-~LP~l~---~~L~~LdLs~N~Lt-~LP~l---~s~L~~LdL 409 (788)
T PRK15387 343 GLQELSVSDNQLA-SLPTL----PSELYKLWAYNNRLT-SLPALP---SGLKELIVSGNRLT-SLPVL---PSELKELMV 409 (788)
T ss_pred ccceEecCCCccC-CCCCC----Ccccceehhhccccc-cCcccc---cccceEEecCCccc-CCCCc---ccCCCEEEc
Confidence 3444444444444 33321 123444444444444 233221 23444555555554 23322 134555555
Q ss_pred ccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCccccccCC
Q 046598 533 QENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPT 591 (986)
Q Consensus 533 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~ 591 (986)
++|+|++ +|..+ .+|+.|+|++|+|+ .+|..+.++++|+.|+|++|+|+|.+|.
T Consensus 410 S~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 410 SGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred cCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence 5555552 34322 24455555555555 4555555555555566666665555443
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.1e-23 Score=243.78 Aligned_cols=85 Identities=32% Similarity=0.372 Sum_probs=45.9
Q ss_pred ceEEEccCCcccccCCcccccccccchhhccCccccccCcccccCCccccEEecccccccccCCccccCCCCCCEEeCCC
Q 046598 479 LIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQ 558 (986)
Q Consensus 479 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 558 (986)
|+.|++++|+|++ +|... ++|+.|++++|+|+ .+|... .+|+.|+|++|+|+ .+|..+..+++|+.|+|++
T Consensus 384 L~~LdLs~N~Lt~-LP~l~---s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~ 454 (788)
T PRK15387 384 LKELIVSGNRLTS-LPVLP---SELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEG 454 (788)
T ss_pred cceEEecCCcccC-CCCcc---cCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCC
Confidence 4444444444442 33221 23444555555554 234321 24555666666665 4566666677777777777
Q ss_pred ccCcccCchhhhcc
Q 046598 559 NNLSGKIPELLIRL 572 (986)
Q Consensus 559 N~l~~~~p~~~~~l 572 (986)
|+|++..|..+..+
T Consensus 455 N~Ls~~~~~~L~~l 468 (788)
T PRK15387 455 NPLSERTLQALREI 468 (788)
T ss_pred CCCCchHHHHHHHH
Confidence 77777666665443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.9e-23 Score=200.14 Aligned_cols=242 Identities=22% Similarity=0.341 Sum_probs=179.5
Q ss_pred CCCcccccccceeEEEEEECCCCeEEEEEEeeccCch--hHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEE
Q 046598 691 SSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHG--AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALV 768 (986)
Q Consensus 691 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 768 (986)
....+|.+...|+.|+|++.+ ..+++|+++..... ..++|..|.-.++.+.||||..+++.|.. ..+..++
T Consensus 193 nl~tkl~e~hsgelwrgrwqg--ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacns-----ppnlv~i 265 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQG--NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNS-----PPNLVII 265 (448)
T ss_pred hhhhhhccCCCcccccccccC--cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccC-----CCCceEe
Confidence 345678999999999999986 56788888653322 23678999999999999999999999754 3778999
Q ss_pred EEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcccc
Q 046598 769 FEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFG 848 (986)
Q Consensus 769 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG 848 (986)
..||+.|+|+..++.. .....+..++.+++.+||+|++|||+. .+-|..--+.+..|++|++.+++|.= +
T Consensus 266 sq~mp~gslynvlhe~--------t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-a 335 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQ--------TSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-A 335 (448)
T ss_pred eeeccchHHHHHHhcC--------ccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-c
Confidence 9999999999999843 334577789999999999999999996 44555567999999999999888841 1
Q ss_pred cceecCCCCCccccccccccccccccccccCCCcC---cccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCC
Q 046598 849 LARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVS---ISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPD 925 (986)
Q Consensus 849 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 925 (986)
-+++ .-...+..-.+.||+||.++..+-+ .++|+|||++++||+.|...||......+....-.....
T Consensus 336 d~kf------sfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialegl--- 406 (448)
T KOG0195|consen 336 DTKF------SFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGL--- 406 (448)
T ss_pred ccee------eeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccc---
Confidence 1221 1111233457899999998876543 678999999999999999999985544332221111100
Q ss_pred chhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 926 HVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 926 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
|...+......+.++|.-|+..||.+||.+..|
T Consensus 407 ----------------------------rv~ippgis~hm~klm~icmnedpgkrpkfdmi 439 (448)
T KOG0195|consen 407 ----------------------------RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMI 439 (448)
T ss_pred ----------------------------cccCCCCccHHHHHHHHHHhcCCCCcCCCccee
Confidence 011111234456788999999999999998754
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-21 Score=196.26 Aligned_cols=201 Identities=22% Similarity=0.325 Sum_probs=172.5
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcC-CCCcceeeeeeccccccCCCceEE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
-.|.+.++||+|.||.++.|..--++++||||.-.... +..++..|.+..+.+ ..+.|..+|.+ .+.+.+-.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYF-----GqeG~~Ni 100 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYF-----GQEGKYNI 100 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeee-----ccccchhh
Confidence 46999999999999999999998889999999865433 335677888888888 57899988877 56777889
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCC-----c
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDM-----I 841 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~ 841 (986)
+|+|.+ |.+|.+.+.-++ ..++...+..||.|++.-++|+|++ .+|.|||||+|+||...+ .
T Consensus 101 LVidLL-GPSLEDLFD~Cg---------R~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~ 167 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLCG---------RRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANV 167 (449)
T ss_pred hhhhhh-CcCHHHHHHHhc---------CcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCce
Confidence 999998 889999986444 4599999999999999999999999 999999999999997554 5
Q ss_pred EEEcccccceecCCCCCc-----cccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCcc
Q 046598 842 AHIGDFGLARFLPLSSAQ-----TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIM 908 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~ 908 (986)
+.++|||+|+.+...... .......||.+||+-....|.+-+.+.|+=|+|-|+++.+-|..||.+.
T Consensus 168 IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 168 IHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 239 (449)
T ss_pred EEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence 999999999988654432 2334566999999999999999999999999999999999999999854
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-21 Score=230.54 Aligned_cols=332 Identities=23% Similarity=0.358 Sum_probs=232.1
Q ss_pred cCCCHhHHHHHHHHHHhccCCCcCCCCC----CCCCCCCCccee----------------eEecCCCCeEEEEeccCCCC
Q 046598 15 VAGNETDRLALLELKSKITHDPLGVLAS----WNESSHFCQWRG----------------VTCSRRHQRVTILDLESLKL 74 (986)
Q Consensus 15 ~~~~~~~~~~ll~~k~~~~~~~~~~l~~----w~~~~~~c~w~g----------------v~c~~~~~~v~~l~l~~~~l 74 (986)
.+-.++|.+.++++.+.+. -| +++.+ |+++++.|-=.. |.|... .||.+.--+...
T Consensus 58 ~~~~~~~~~~~~~~~~~l~-~p-~~~~~~~~~~~~~~~fc~~~~~~~~~l~~~~~~~~~tv~~~~~--~vt~l~~~g~~~ 133 (754)
T PRK15370 58 ETASPEEIKSKFECLRMLA-FP-AYADNIQYSRGGADQYCILSENSQEILSIVFNTEGYTVEGGGK--SVTYTRVTESEQ 133 (754)
T ss_pred CCCCHHHHHHHHHHHHHhc-CC-chhhccccccCCCCcccccCCcchhhheeeecCCceEEecCCC--cccccccccccc
Confidence 3345789999999999994 33 46666 998889994322 777543 233333222110
Q ss_pred cc--------------------ccCc--------Cc-----cCCCCCCEEEccCCCccccCCcchhccccCceeeceecc
Q 046598 75 AG--------------------SISP--------HV-----GNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNS 121 (986)
Q Consensus 75 ~~--------------------~~~~--------~~-----~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~ 121 (986)
.. ..++ .+ .-..+...|+|++++++ .+|..+. ++|+.|+|++|+
T Consensus 134 ~~~~~~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~ 210 (754)
T PRK15370 134 ASSASGSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLT-TIPACIP--EQITTLILDNNE 210 (754)
T ss_pred cccCCCCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCC
Confidence 00 0000 00 01145788999999998 4676553 579999999999
Q ss_pred cCCCCccchhcCccccceecccccccCccCccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeeccCCcccCcCcch
Q 046598 122 IGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDT 201 (986)
Q Consensus 122 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 201 (986)
|+ .+|..+. ++|++|+|++|+|+ .+|..+. .+|+.|+|++|++. .+|..+. ++|+.|+|++|+|+ .+|+.
T Consensus 211 Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~ 280 (754)
T PRK15370 211 LK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPEN 280 (754)
T ss_pred CC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccc
Confidence 99 5676654 58999999999998 5676664 47999999999998 6677664 58999999999998 57776
Q ss_pred hhccCCCceeecccccccccCCccccCCCCccEEeccccccccccCCcccccccccceEEecCceecccCCccccCCCCC
Q 046598 202 LGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNL 281 (986)
Q Consensus 202 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L 281 (986)
+. ++|+.|+|++|+++ .+|..+. ++|+.|++++|.+. .+|.... ++|+.|++++|.+++ +|..+. ++|
T Consensus 281 l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt-~LP~~l~---~sL~~L~Ls~N~Lt~-LP~~l~--~sL 348 (754)
T PRK15370 281 LP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLT-ALPETLP---PGLKTLEAGENALTS-LPASLP--PEL 348 (754)
T ss_pred cC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCccc-cCCcccc---ccceeccccCCcccc-CChhhc--Ccc
Confidence 64 58999999999998 5676553 47899999999998 4665443 689999999999985 676664 789
Q ss_pred cEEecccccccCCCchhhhhhhHhhhhhccCCCCCCCCCCcccccccccccccceeeccccccccCCCcccccccccceE
Q 046598 282 EIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEV 361 (986)
Q Consensus 282 ~~L~ls~N~l~~~~~~l~~l~~L~~l~l~~n~l~~~~~~~l~~l~~l~~~~~L~~l~l~~n~~~~~~p~~~~~~~~~L~~ 361 (986)
+.|++++|+++.++..+. + .|+.|++++|+++ .+|..+. ..|+.
T Consensus 349 ~~L~Ls~N~L~~LP~~lp--~------------------------------~L~~LdLs~N~Lt-~LP~~l~---~sL~~ 392 (754)
T PRK15370 349 QVLDVSKNQITVLPETLP--P------------------------------TITTLDVSRNALT-NLPENLP---AALQI 392 (754)
T ss_pred cEEECCCCCCCcCChhhc--C------------------------------CcCEEECCCCcCC-CCCHhHH---HHHHH
Confidence 999999999987665432 2 3455666666665 4565543 35788
Q ss_pred EEccCCcccccCCcc----ccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCcccee
Q 046598 362 LLLDNNQIFGNIPAA----IGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQG 419 (986)
Q Consensus 362 L~L~~n~l~~~~~~~----~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 419 (986)
|++++|+|+ .+|.. +..++++..|++.+|.++. ..+.+|+.| ++.+.+.|
T Consensus 393 LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~------~tl~~L~~L-l~s~~~~g 446 (754)
T PRK15370 393 MQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFSE------RTIQNMQRL-MSSVGYQG 446 (754)
T ss_pred HhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCccH------HHHHHHHHh-hhcccccC
Confidence 888888887 44443 3445788899999998872 344445555 34444443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-21 Score=188.55 Aligned_cols=205 Identities=22% Similarity=0.318 Sum_probs=167.7
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCC-CcceeeeeeccccccCCCce
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRH-RNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~~~~ 764 (986)
..++|.++++||.|+||.+|.|.....+..||||+-.... ....+..|.++...+++ ..|..+..+ ..++.+
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y-----~~e~~y 85 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHY-----GTEKDY 85 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhh-----cccccc
Confidence 4578999999999999999999999999999999865422 22456778888888864 445454444 456678
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCC---Cc
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED---MI 841 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~ 841 (986)
-.+||+.. |.+|.+.+.-+.+ .++..+++-+|.|++.-++|+|.+ +++||||||+|++..-+ ..
T Consensus 86 nvlVMdLL-GPsLEdLfnfC~R---------~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~k 152 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFNFCSR---------RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNK 152 (341)
T ss_pred ceeeeecc-CccHHHHHHHHhh---------hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccce
Confidence 89999998 8999999875543 588999999999999999999999 99999999999999633 47
Q ss_pred EEEcccccceecCCCCC-----ccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCcccc
Q 046598 842 AHIGDFGLARFLPLSSA-----QTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFE 910 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~ 910 (986)
+.++|||+|+.+..... ........||.+|.+-....+..-+.+.|+=|+|.++...--|..||.+...
T Consensus 153 l~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 153 LYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred EEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 99999999987643322 2233456699999999888888888999999999999999999999986543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.1e-21 Score=210.82 Aligned_cols=204 Identities=26% Similarity=0.327 Sum_probs=166.6
Q ss_pred CCCCCcccccccceeEEEEEECCCC-eEEEEEEeeccCchhHHHHHHHHHHHhcCCC----CcceeeeeeccccccCCCc
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGR-TTIAVKVFNLLHHGAFKSFIAECNTLKNIRH----RNLVKILTACSGVDYQGND 763 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~~~~~~~~~~ 763 (986)
+|.+.++||+|+||.||.|.+...+ ..+|+|+...........+..|..++..+.. +++..+++... ..+.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence 8999999999999999999997764 6789998765433332367888888888863 58888888721 4567
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCC----
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED---- 839 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---- 839 (986)
..++||+.+ |.+|.++..... .+.++..++..|+.|++.+|+++|+. |++||||||+|+++...
T Consensus 95 ~~~iVM~l~-G~sL~dl~~~~~--------~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~ 162 (322)
T KOG1164|consen 95 FNFIVMSLL-GPSLEDLRKRNP--------PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSE 162 (322)
T ss_pred eeEEEEecc-CccHHHHHHhCC--------CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcc
Confidence 889999988 899999874222 35799999999999999999999999 99999999999999865
Q ss_pred -CcEEEcccccce--ecCCCCC----cc-c-cccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCcc
Q 046598 840 -MIAHIGDFGLAR--FLPLSSA----QT-S-SIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIM 908 (986)
Q Consensus 840 -~~~kL~DFG~a~--~~~~~~~----~~-~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~ 908 (986)
..+.+.|||+|+ .+..... .. . .....||..|+++++..+...+.+.|+||++.++.|+..|..||...
T Consensus 163 ~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~ 240 (322)
T KOG1164|consen 163 VRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEAL 240 (322)
T ss_pred cceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccc
Confidence 369999999998 3321211 11 1 23456999999999999999999999999999999999999999643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.8e-22 Score=233.62 Aligned_cols=253 Identities=21% Similarity=0.225 Sum_probs=185.3
Q ss_pred CCCcccccccceeEEEEEECCCCeEEEEEEeec----c-Cc-hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 691 SSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL----L-HH-GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 691 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~----~-~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
...+.+|.|++|.|+.+.........+.|.++. . .. .....+..|+-+-..+.|||++..+..+.. ...
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~-----~~~ 395 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQE-----IDG 395 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhh-----ccc
Confidence 345789999999888888766555555554431 1 11 111226667777888899999888776432 233
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
..-+|||+++ +|..++.. ...++..++..++.|+..|++|+|+. ||.|||+|++|++++.+|.+||
T Consensus 396 ~~~~mE~~~~-Dlf~~~~~----------~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki 461 (601)
T KOG0590|consen 396 ILQSMEYCPY-DLFSLVMS----------NGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKI 461 (601)
T ss_pred chhhhhcccH-HHHHHHhc----------ccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEE
Confidence 3344999999 99999852 24688889999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCc--cccccccccccccccccccCCCcCcc-cchhhHHHHHHHHHhCCCCCCccccccccHHHHHHh
Q 046598 845 GDFGLARFLPLSSAQ--TSSIGAKGSIGYIAPEYGLGSEVSIS-GDVYSYGILLLELITRKKPTDIMFEGDMNLHNLART 921 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~ 921 (986)
+|||.+......... ....+.+|+-.|+|||++.+..|.+. .||||.|++++.|.+|+.||......+..+...
T Consensus 462 ~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~--- 538 (601)
T KOG0590|consen 462 IDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN--- 538 (601)
T ss_pred eecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh---
Confidence 999999766544433 56677889999999999999999865 799999999999999999997554443332000
Q ss_pred hCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 922 ALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 922 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
....+. .....-.......+.+...++.++++.||.+|-|+++|
T Consensus 539 ~~~~~~---------------------~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i 582 (601)
T KOG0590|consen 539 NYSDQR---------------------NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQI 582 (601)
T ss_pred cccccc---------------------ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHH
Confidence 000000 00000111123455667789999999999999998764
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=9e-21 Score=225.01 Aligned_cols=81 Identities=31% Similarity=0.566 Sum_probs=45.4
Q ss_pred cccceecccccccCccCccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeeccCCcccCcCcchhhccCCCceeecc
Q 046598 135 NLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMA 214 (986)
Q Consensus 135 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 214 (986)
+...|++++++++ .+|..+. ++|+.|+|++|+++ .+|..+. ++|++|+|++|+|+ .+|..+. .+|+.|+|+
T Consensus 179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls 249 (754)
T PRK15370 179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELS 249 (754)
T ss_pred CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence 4556666666666 4555443 35666666666666 3444332 35666666666666 3454432 356666666
Q ss_pred cccccccCCcc
Q 046598 215 QNRLSGTIPSS 225 (986)
Q Consensus 215 ~N~l~~~~p~~ 225 (986)
+|+++ .+|..
T Consensus 250 ~N~L~-~LP~~ 259 (754)
T PRK15370 250 INRIT-ELPER 259 (754)
T ss_pred CCccC-cCChh
Confidence 66665 44443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.9e-21 Score=193.63 Aligned_cols=182 Identities=13% Similarity=0.153 Sum_probs=137.0
Q ss_pred hHHHHH--hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHH---------HHHHHHHHhcCCCCcce
Q 046598 680 YQNLYN--ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKS---------FIAECNTLKNIRHRNLV 748 (986)
Q Consensus 680 ~~~~~~--~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h~niv 748 (986)
|.++.. ..++|.+.+.+|.|+||.||++... +..+|||+++.......+. +.+|++.+.++.||+|.
T Consensus 21 ~~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~~--~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~ 98 (232)
T PRK10359 21 YKEIFDDFLSYNIKTIKVFRNIDDTKVSLIDTD--YGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLA 98 (232)
T ss_pred HHHHHHHHhhCceEEEEEecCCCceEEEEEecC--CCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCC
Confidence 444433 4689999999999999999997663 5689999997433322222 68999999999999999
Q ss_pred eeeeecccccc---CCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 046598 749 KILTACSGVDY---QGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIA 825 (986)
Q Consensus 749 ~l~~~~~~~~~---~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iv 825 (986)
.+.+++..... ......++||||++|.+|.++.. ++. ....+++.++..+|+. |++
T Consensus 99 ~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------------~~~----~~~~~i~~~l~~lH~~---gi~ 157 (232)
T PRK10359 99 SLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE--------------ISE----DVKAKIKASIESLHQH---GMV 157 (232)
T ss_pred cceEeeeecccccccccCCeEEEEEEECCccHHHhhh--------------ccH----HHHHHHHHHHHHHHHc---CCc
Confidence 99887442211 12356899999999999988742 222 2456999999999999 999
Q ss_pred eecCCCCCeEecCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHH
Q 046598 826 HCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELI 899 (986)
Q Consensus 826 H~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ell 899 (986)
|||++|+||++++++ ++++|||..+........ ..+.....+..++|+||||+++....
T Consensus 158 H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 158 SGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred cCCCChHHEEEeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999999999988 999999998754221111 11344456778999999999977654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1e-19 Score=203.71 Aligned_cols=200 Identities=36% Similarity=0.547 Sum_probs=167.5
Q ss_pred CCCCcccccccceeEEEEEECCCCeEEEEEEeeccCch---hHHHHHHHHHHHhcCCCC-cceeeeeeccccccCCCceE
Q 046598 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHG---AFKSFIAECNTLKNIRHR-NLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 690 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~~~~~ 765 (986)
|.+.+.||.|+||.||++.+. ..+++|.+...... ....+.+|+.+++.+.|+ +++++++.+ ......
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF-----QDEGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEE-----ecCCEE
Confidence 678889999999999999998 67899998653332 367899999999999988 799999984 444558
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCC-cEEE
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDM-IAHI 844 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL 844 (986)
++++|++.++++.+++...... ..++......++.|++.++.|+|+. +++|||+||+||+++..+ .+++
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l 143 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRK-------GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKL 143 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccc-------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEE
Confidence 9999999999999777422110 3688899999999999999999999 999999999999999988 7999
Q ss_pred cccccceecCCCCCcc----ccccccccccccccccccC---CCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 845 GDFGLARFLPLSSAQT----SSIGAKGSIGYIAPEYGLG---SEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
+|||.++......... ......|+..|+|||.+.+ ..++...|+||+|++++++++|..||..
T Consensus 144 ~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~ 213 (384)
T COG0515 144 IDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEG 213 (384)
T ss_pred eccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 9999998654333221 3456779999999999887 5788999999999999999999999763
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.4e-20 Score=184.50 Aligned_cols=139 Identities=17% Similarity=0.101 Sum_probs=107.0
Q ss_pred CcccccccceeEEEEEECCCCeEEEEEEeeccCch--h-------H-----------------HHHHHHHHHHhcCCCCc
Q 046598 693 VNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHG--A-------F-----------------KSFIAECNTLKNIRHRN 746 (986)
Q Consensus 693 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~l~h~n 746 (986)
...||+|+||.||+|.+. +++.||||+++..... . . ....+|++.+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999997 6899999999753211 0 0 12235999999998777
Q ss_pred ceeeeeeccccccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHH-HhcCCCCeE
Q 046598 747 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYL-HHDCQPPIA 825 (986)
Q Consensus 747 iv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~~~~iv 825 (986)
+.....+ .. ...++||||++++++..... ....++..++..++.|++.+|.|+ |+. ||+
T Consensus 81 v~~p~~~-----~~--~~~~iVmE~i~g~~l~~~~~----------~~~~~~~~~~~~i~~qi~~~L~~l~H~~---gii 140 (190)
T cd05147 81 IPCPEPI-----LL--KSHVLVMEFIGDDGWAAPRL----------KDAPLSESKARELYLQVIQIMRILYQDC---RLV 140 (190)
T ss_pred CCCCcEE-----Ee--cCCEEEEEEeCCCCCcchhh----------hcCCCCHHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 6433322 11 22389999998877654431 123578899999999999999999 688 999
Q ss_pred eecCCCCCeEecCCCcEEEcccccceec
Q 046598 826 HCDLKPSNILLDEDMIAHIGDFGLARFL 853 (986)
Q Consensus 826 H~Dlkp~NIll~~~~~~kL~DFG~a~~~ 853 (986)
||||||+||+++ ++.++|+|||+|...
T Consensus 141 HrDlkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 141 HADLSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred cCCCCHHHEEEE-CCcEEEEEccccccC
Confidence 999999999998 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.6e-20 Score=191.63 Aligned_cols=242 Identities=19% Similarity=0.217 Sum_probs=151.8
Q ss_pred CCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcCCC----------Ccceeeeeeccc
Q 046598 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRH----------RNLVKILTACSG 756 (986)
Q Consensus 690 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~~~ 756 (986)
+...+.||.|+++.||.+.+..+++.+|||++.... ....+++.+|.-....+.+ -.++-.++....
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 445678999999999999999999999999986433 2335666666654444322 122222222110
Q ss_pred c---c----cCCCc-----eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 046598 757 V---D----YQGND-----FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPI 824 (986)
Q Consensus 757 ~---~----~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i 824 (986)
. . ..+.. ..+++|+-+ .++|.+++....... .....+....+..+..|+.+.+++||+. |+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~---~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---Gl 166 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRA---QTHSPLAFAARLSLTVQMIRLVANLHSY---GL 166 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHT---TTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcc---cccchhHHHHHHHHHHHHHHHHHHHhhc---ce
Confidence 0 0 01111 247788888 678888864221110 1123455667778889999999999999 99
Q ss_pred EeecCCCCCeEecCCCcEEEcccccceecCCCCCccccccccccccccccccccC--------CCcCcccchhhHHHHHH
Q 046598 825 AHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG--------SEVSISGDVYSYGILLL 896 (986)
Q Consensus 825 vH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwSlGvvl~ 896 (986)
||+||+|+|++++.+|.++|+||+....... .... ...+..|.+||.... ..++.+.|.|++|+++|
T Consensus 167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~----~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly 241 (288)
T PF14531_consen 167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAGT----RYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLY 241 (288)
T ss_dssp EEST-SGGGEEE-TTS-EEE--GGGEEETTE----EEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHH
T ss_pred EecccceeeEEEcCCCCEEEcChHHHeecCc----eeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHH
Confidence 9999999999999999999999998875421 1111 335578999997533 25789999999999999
Q ss_pred HHHhCCCCCCccccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCC
Q 046598 897 ELITRKKPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMES 976 (986)
Q Consensus 897 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~d 976 (986)
.|++|+.||+....+..... . +....+.++.+..++..+++++
T Consensus 242 ~lWC~~lPf~~~~~~~~~~~-------------~------------------------f~~C~~~Pe~v~~LI~~lL~~~ 284 (288)
T PF14531_consen 242 SLWCGRLPFGLSSPEADPEW-------------D------------------------FSRCRDMPEPVQFLIRGLLQRN 284 (288)
T ss_dssp HHHHSS-STCCCGGGSTSGG-------------G------------------------GTTSS---HHHHHHHHHHT-SS
T ss_pred HHHHccCCCCCCCccccccc-------------c------------------------chhcCCcCHHHHHHHHHHccCC
Confidence 99999999974432211100 0 0001145667889999999999
Q ss_pred CCCC
Q 046598 977 PEDR 980 (986)
Q Consensus 977 P~~R 980 (986)
|++|
T Consensus 285 ~~~R 288 (288)
T PF14531_consen 285 PEDR 288 (288)
T ss_dssp GGGS
T ss_pred cccC
Confidence 9988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.5e-19 Score=175.64 Aligned_cols=190 Identities=18% Similarity=0.099 Sum_probs=140.8
Q ss_pred CCCcccccccceeEEEEEECCCCeEEEEEEeeccCc----hhHHHHHHHHHHHhcCC-CCcceeeeeeccccccCCCceE
Q 046598 691 SSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH----GAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 691 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~ 765 (986)
.+...|++|+||+||.+.. .+.+++.+.+..... .....+.+|+++|+++. |++|++++++ ...
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---------~~~ 73 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---------DGR 73 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---------cCE
Confidence 4567899999999997766 357888777654322 11225789999999995 5889999886 346
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecC-CCCCeEecCCCcEEE
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDL-KPSNILLDEDMIAHI 844 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kL 844 (986)
+++|||++|.+|.+... . ....++.|++.+++++|+. ||+|||| ||+||+++.++.++|
T Consensus 74 ~lvmeyI~G~~L~~~~~---------~--------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~L 133 (218)
T PRK12274 74 HLDRSYLAGAAMYQRPP---------R--------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAV 133 (218)
T ss_pred EEEEeeecCccHHhhhh---------h--------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEE
Confidence 99999999999875431 0 1134778999999999999 9999999 799999999999999
Q ss_pred cccccceecCCCCCc----cc-------cccccccccccccccccCC-CcC-cccchhhHHHHHHHHHhCCCCCCccccc
Q 046598 845 GDFGLARFLPLSSAQ----TS-------SIGAKGSIGYIAPEYGLGS-EVS-ISGDVYSYGILLLELITRKKPTDIMFEG 911 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~----~~-------~~~~~gt~~y~aPE~~~~~-~~~-~~sDvwSlGvvl~elltg~~pf~~~~~~ 911 (986)
+|||+|......... .. ......++.|++|+...-- ..+ .+.+.++-|.-+|.++||..|+....++
T Consensus 134 IDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~~ 213 (218)
T PRK12274 134 IDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNEG 213 (218)
T ss_pred EECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCCC
Confidence 999999865433211 00 1112357777888753221 223 6679999999999999999987544433
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.2e-19 Score=177.92 Aligned_cols=139 Identities=21% Similarity=0.158 Sum_probs=109.2
Q ss_pred CcccccccceeEEEEEECCCCeEEEEEEeeccCchh--------------------------HHHHHHHHHHHhcCCCCc
Q 046598 693 VNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGA--------------------------FKSFIAECNTLKNIRHRN 746 (986)
Q Consensus 693 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~h~n 746 (986)
...||+|++|.||+|.+. +++.||||+++...... ...+..|.+.+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 568999999999999988 68999999987532110 112357889999999988
Q ss_pred ceeeeeeccccccCCCceEEEEEEeccCCCHhHh-hccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHh-cCCCCe
Q 046598 747 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEW-LHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHH-DCQPPI 824 (986)
Q Consensus 747 iv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~i 824 (986)
+.....+. . ...++||||++|+++... +. ...++..++..++.|++.++.++|+ . ||
T Consensus 81 i~~p~~~~----~---~~~~lVmE~~~g~~~~~~~l~-----------~~~~~~~~~~~i~~~l~~~l~~lH~~~---gi 139 (190)
T cd05145 81 VPVPEPIL----L---KKNVLVMEFIGDDGSPAPRLK-----------DVPLEEEEAEELYEQVVEQMRRLYQEA---GL 139 (190)
T ss_pred CCCceEEE----e---cCCEEEEEEecCCCchhhhhh-----------hccCCHHHHHHHHHHHHHHHHHHHHhC---CE
Confidence 75443331 1 124899999988855433 31 1346788999999999999999999 8 99
Q ss_pred EeecCCCCCeEecCCCcEEEcccccceecC
Q 046598 825 AHCDLKPSNILLDEDMIAHIGDFGLARFLP 854 (986)
Q Consensus 825 vH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 854 (986)
+||||||+||+++ ++.++|+|||+++...
T Consensus 140 vHrDlkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 140 VHGDLSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred ecCCCChhhEEEE-CCCEEEEEcccceecC
Confidence 9999999999999 8899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.9e-21 Score=174.93 Aligned_cols=174 Identities=24% Similarity=0.401 Sum_probs=129.9
Q ss_pred ccEEEecccccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhcc
Q 046598 430 LFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVF 509 (986)
Q Consensus 430 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 509 (986)
.+.|-||+|+++ .+|..++.+.+|+.|++++|+|. .+|.. ++.+++|+.|+++-|++. ..|..|+.++.|+.|||+
T Consensus 35 ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~-issl~klr~lnvgmnrl~-~lprgfgs~p~levldlt 110 (264)
T KOG0617|consen 35 ITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTS-ISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLT 110 (264)
T ss_pred hhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChh-hhhchhhhheecchhhhh-cCccccCCCchhhhhhcc
Confidence 334444444444 56667777788888888888887 77777 667778888888888887 678888888888888888
Q ss_pred Cccccc-cCcccccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCccccc
Q 046598 510 GNKLKG-EIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGV 588 (986)
Q Consensus 510 ~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~ 588 (986)
+|++.. .+|..|..+..|+-|+|++|.+. .+|..++++++|+.|.+.+|.+- .+|..++.+..|++|.+.+|+++-.
T Consensus 111 ynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~vl 188 (264)
T KOG0617|consen 111 YNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLTVL 188 (264)
T ss_pred ccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceeeec
Confidence 888773 46777888888888888888887 67888888888888888888877 5788888888888888888888887
Q ss_pred cCCccccccc---cceeeeCCccc
Q 046598 589 VPTQGVFKNA---SITSVFGNLKL 609 (986)
Q Consensus 589 ~p~~~~~~~~---~~~~~~~n~~l 609 (986)
+|..+.+.-. +...++.|||.
T Consensus 189 ppel~~l~l~~~k~v~r~E~NPwv 212 (264)
T KOG0617|consen 189 PPELANLDLVGNKQVMRMEENPWV 212 (264)
T ss_pred ChhhhhhhhhhhHHHHhhhhCCCC
Confidence 7776544332 23345566654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-19 Score=208.89 Aligned_cols=196 Identities=21% Similarity=0.229 Sum_probs=152.4
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC-chh---HHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-HGA---FKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
.|...+.||++.|=+|.+|++++ |. |+||++-..+ .-. .++...|++ ...++|||++++.-+ ...+..
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~-----~~t~kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKV-----LVTDKA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHH-----HHhhHH
Confidence 67888999999999999999987 43 8999985433 222 333444444 455699999998766 445567
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.|+|-+|+. -+|++++. ....+...+.+.|+.|++.|+..+|+. ||+|||||.+||||+.-..+.|
T Consensus 96 AylvRqyvk-hnLyDRlS----------TRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~L 161 (1431)
T KOG1240|consen 96 AYLVRQYVK-HNLYDRLS----------TRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYL 161 (1431)
T ss_pred HHHHHHHHh-hhhhhhhc----------cchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhh
Confidence 788989984 49999983 445788899999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCC-----ccccccccccccccccccccCC----------C-cCcccchhhHHHHHHHHHh-CCCCCC
Q 046598 845 GDFGLARFLPLSSA-----QTSSIGAKGSIGYIAPEYGLGS----------E-VSISGDVYSYGILLLELIT-RKKPTD 906 (986)
Q Consensus 845 ~DFG~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~sDvwSlGvvl~ellt-g~~pf~ 906 (986)
+||..-+......+ .........-..|.|||.+-.. . .+++.||||+||+++|+++ |++||+
T Consensus 162 tDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 162 TDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred hcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 99988764422221 1122233345579999976431 2 6788999999999999999 899986
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.2e-19 Score=182.36 Aligned_cols=196 Identities=22% Similarity=0.216 Sum_probs=137.2
Q ss_pred CCCcceeeeeeccccc----------------------cCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHH
Q 046598 743 RHRNLVKILTACSGVD----------------------YQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLI 800 (986)
Q Consensus 743 ~h~niv~l~~~~~~~~----------------------~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~ 800 (986)
+|||||++.++|.+.. ..++...|+||..++ .+|.+|+... ..+..
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~-----------~~s~r 341 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR-----------HRSYR 341 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC-----------CCchH
Confidence 5999999988764321 224567899999984 5999999632 35566
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEec--CCC--cEEEcccccceecCCC----CCcccccccccccccc
Q 046598 801 QRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLD--EDM--IAHIGDFGLARFLPLS----SAQTSSIGAKGSIGYI 872 (986)
Q Consensus 801 ~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~--~~kL~DFG~a~~~~~~----~~~~~~~~~~gt~~y~ 872 (986)
...-|..|+++|+.|||++ ||.|||+|++||++. +|+ ...++|||++-.-... ..........|...-|
T Consensus 342 ~~~~~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lm 418 (598)
T KOG4158|consen 342 TGRVILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLM 418 (598)
T ss_pred HHHHHHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceec
Confidence 7778999999999999999 999999999999993 333 6899999998532110 1111222345778899
Q ss_pred ccccccCCC------cCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhcc
Q 046598 873 APEYGLGSE------VSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHG 946 (986)
Q Consensus 873 aPE~~~~~~------~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 946 (986)
|||+....+ --.|+|.|+.|.+.||+++...||....+...+...+-...+
T Consensus 419 APEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qL----------------------- 475 (598)
T KOG4158|consen 419 APEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQL----------------------- 475 (598)
T ss_pred chhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhC-----------------------
Confidence 999876542 136899999999999999999999642111111111111111
Q ss_pred chhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 046598 947 NQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMT 984 (986)
Q Consensus 947 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 984 (986)
..-+..++..+.+++...++.||.+||++.
T Consensus 476 --------Palp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 476 --------PALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred --------CCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 111224555677888899999999999864
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=9.7e-21 Score=172.98 Aligned_cols=185 Identities=29% Similarity=0.493 Sum_probs=144.6
Q ss_pred cCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCcccccccccEEEecccccCCCCCcccCCCCCCCee
Q 046598 378 GKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTI 457 (986)
Q Consensus 378 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 457 (986)
-++.+++.|.||+|+++ .+|+.+..+.+|+.|++++|+|+ .+|..++.+++|+.|
T Consensus 30 f~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie------------------------~lp~~issl~klr~l 84 (264)
T KOG0617|consen 30 FNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE------------------------ELPTSISSLPKLRIL 84 (264)
T ss_pred cchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh------------------------hcChhhhhchhhhhe
Confidence 34566667777777776 66666677776666666666665 567777778888888
Q ss_pred ecCCCccCCCCCcccccCCCcceEEEccCCcccc-cCCcccccccccchhhccCccccccCcccccCCccccEEeccccc
Q 046598 458 DLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTG-SIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENF 536 (986)
Q Consensus 458 ~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 536 (986)
+++-|++. .+|.. |+.++.|+.|||++|++.. .+|..|..++.|+-|+|++|.+. .+|..++++++|+.|.+.+|.
T Consensus 85 nvgmnrl~-~lprg-fgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdnd 161 (264)
T KOG0617|consen 85 NVGMNRLN-ILPRG-FGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDND 161 (264)
T ss_pred ecchhhhh-cCccc-cCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCc
Confidence 88888887 77777 7777888888888887764 47888888999999999999998 889999999999999999999
Q ss_pred ccccCCccccCCCCCCEEeCCCccCcccCchhhhccccc---ceeeccCCccccccCCc
Q 046598 537 LQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLV---KNLNLSNNDLEGVVPTQ 592 (986)
Q Consensus 537 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L---~~l~ls~N~l~~~~p~~ 592 (986)
+- ..|.+++.+++|++|++.+|+++ .+|..++++.-+ +++.+.+|++-..+..+
T Consensus 162 ll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~l~l~~~k~v~r~E~NPwv~pIaeQ 218 (264)
T KOG0617|consen 162 LL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELANLDLVGNKQVMRMEENPWVNPIAEQ 218 (264)
T ss_pred hh-hCcHHHHHHHHHHHHhcccceee-ecChhhhhhhhhhhHHHHhhhhCCCCChHHHH
Confidence 88 68999999999999999999998 677777766433 56778888887655543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=4e-19 Score=210.09 Aligned_cols=201 Identities=19% Similarity=0.203 Sum_probs=159.9
Q ss_pred HHHHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCC---CCcceeeeeeccccc
Q 046598 682 NLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIR---HRNLVKILTACSGVD 758 (986)
Q Consensus 682 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~ 758 (986)
+.+...+.|.|.+.+|+|+||+||+|...+ ++.||+|+-+....-+. .--.+++.+++ -+.|..+..+
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEf---YI~~q~~~RLk~~~~~~~~~~~~a----- 762 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEF---YICLQVMERLKPQMLPSIMHISSA----- 762 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceee---eehHHHHHhhchhhhcchHHHHHH-----
Confidence 445566789999999999999999999988 99999999765443221 11122333343 2334444333
Q ss_pred cCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecC
Q 046598 759 YQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDE 838 (986)
Q Consensus 759 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 838 (986)
+...+..++|+||.+.|+|.+++. ..+.+++.-+..++.|+++.+++||.. +||||||||+|.++..
T Consensus 763 ~~~~~~S~lv~ey~~~Gtlld~~N----------~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~ 829 (974)
T KOG1166|consen 763 HVFQNASVLVSEYSPYGTLLDLIN----------TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRR 829 (974)
T ss_pred HccCCcceeeeeccccccHHHhhc----------cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeec
Confidence 233456789999999999999995 345689999999999999999999999 9999999999999942
Q ss_pred -------CCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCC
Q 046598 839 -------DMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904 (986)
Q Consensus 839 -------~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p 904 (986)
..-++|+|||.+-.+..-.+.......++|-.+-.+|+..|++|++++|.|.++.+++.|+.|+.-
T Consensus 830 ~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 830 EICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 336999999999766544455566677889999999999999999999999999999999999874
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.4e-18 Score=192.56 Aligned_cols=209 Identities=26% Similarity=0.407 Sum_probs=152.6
Q ss_pred HhcCCCCcceeeeeeccccccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHh
Q 046598 739 LKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHH 818 (986)
Q Consensus 739 l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~ 818 (986)
|+.+.|.|+.+++|.|.. +...++|.+|+..|+|.+.+. .....+++.-...+.++|++||+|+|+
T Consensus 1 l~~l~h~n~~~f~g~~~~-----~~~~~~i~~~c~rGsl~D~i~---------~~~~~~d~~F~~s~~rdi~~Gl~ylh~ 66 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVD-----GPEMIVIWEYCSRGSLLDILS---------NEDIKLDYFFILSFIRDISKGLAYLHN 66 (484)
T ss_pred CcccchhhhhhheeeEec-----CCceEEEEeeecCccHHhHHh---------ccccCccHHHHHHHHHHHHHHHHHHhc
Confidence 456899999999999643 378999999999999999996 234568899999999999999999998
Q ss_pred cCCCCe-EeecCCCCCeEecCCCcEEEcccccceecCCCCCccccccccccccccccccccCC-------CcCcccchhh
Q 046598 819 DCQPPI-AHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS-------EVSISGDVYS 890 (986)
Q Consensus 819 ~~~~~i-vH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDvwS 890 (986)
. +| .|+.+++.|.++|..+.+||+|||+.................-..-|.|||.+++. ..+.+.||||
T Consensus 67 s---~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs 143 (484)
T KOG1023|consen 67 S---PIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYS 143 (484)
T ss_pred C---cceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeeh
Confidence 7 54 99999999999999999999999999776431111222222345679999998774 1467799999
Q ss_pred HHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHh
Q 046598 891 YGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGV 970 (986)
Q Consensus 891 lGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 970 (986)
||++++|+++.+.||+........ .+.+.. +.. ... ...........+...++..++.
T Consensus 144 ~~ii~~ei~~r~~~~~~~~~~~~~-~eii~~---------~~~----~~~--------~~~rP~i~~~~e~~~~l~~l~~ 201 (484)
T KOG1023|consen 144 FGIIMYEILFRSGPFDLRNLVEDP-DEIILR---------VKK----GGS--------NPFRPSIELLNELPPELLLLVA 201 (484)
T ss_pred HHHHHHHHHhccCccccccccCCh-HHHHHH---------HHh----cCC--------CCcCcchhhhhhcchHHHHHHH
Confidence 999999999999999854332221 111111 000 000 0000011111144457889999
Q ss_pred cccCCCCCCCCCCCCC
Q 046598 971 ACSMESPEDRMSMTNV 986 (986)
Q Consensus 971 ~Cl~~dP~~RPt~~eV 986 (986)
+||..+|++||++++|
T Consensus 202 ~cw~e~P~~rPs~~~i 217 (484)
T KOG1023|consen 202 RCWEEIPEKRPSIEQI 217 (484)
T ss_pred HhcccChhhCccHHHH
Confidence 9999999999998764
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.5e-17 Score=168.36 Aligned_cols=139 Identities=17% Similarity=0.221 Sum_probs=105.5
Q ss_pred CCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcC-----CCCcceeeeeeccccccCCCce-
Q 046598 691 SSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNI-----RHRNLVKILTACSGVDYQGNDF- 764 (986)
Q Consensus 691 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~~~~~~~- 764 (986)
.-.+.||+|+||.||. +..++.. +||++........+.+.+|+++++.+ .||||++++|++.+. ...+.
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~--~g~g~v 79 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETD--CGTGYV 79 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeC--CCCeEE
Confidence 4457899999999995 5555555 69988765445567899999999999 579999999995332 11123
Q ss_pred EEEEEEe--ccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHH-HHHHhcCCCCeEeecCCCCCeEecC---
Q 046598 765 KALVFEF--MHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACAL-NYLHHDCQPPIAHCDLKPSNILLDE--- 838 (986)
Q Consensus 765 ~~lv~e~--~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L-~~LH~~~~~~ivH~Dlkp~NIll~~--- 838 (986)
..+|||| +++++|.++++. ..+++. ..++.|++.++ +|||++ +|+||||||+||+++.
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~-----------~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~ 143 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQ-----------CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISE 143 (210)
T ss_pred EEEEecCCCCcchhHHHHHHc-----------ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCC
Confidence 3478999 557999999952 124444 35678888777 999999 9999999999999974
Q ss_pred -CCcEEEcccccc
Q 046598 839 -DMIAHIGDFGLA 850 (986)
Q Consensus 839 -~~~~kL~DFG~a 850 (986)
++.++|+||+.+
T Consensus 144 ~~~~~~LiDg~G~ 156 (210)
T PRK10345 144 SEVIPVVCDNIGE 156 (210)
T ss_pred CCCcEEEEECCCC
Confidence 348999995444
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.2e-19 Score=195.67 Aligned_cols=187 Identities=27% Similarity=0.279 Sum_probs=152.7
Q ss_pred ccccccceeEEEEEE---CCCCeEEEEEEeeccCch--hHHHHHHHHHHHhcCC-CCcceeeeeeccccccCCCceEEEE
Q 046598 695 QIGEGSFGSVFKGIL---DDGRTTIAVKVFNLLHHG--AFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDFKALV 768 (986)
Q Consensus 695 ~lg~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~lv 768 (986)
.+|+|.||.|+++.- .+.+..+|.|+.+..... .......|..++...+ ||.++++... ++.+...+++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhya-----fqt~~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYA-----FQTDGKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeee-----eccccchhHh
Confidence 378999999987654 334677888887642211 1124566788888886 9999999877 6777889999
Q ss_pred EEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcccc
Q 046598 769 FEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFG 848 (986)
Q Consensus 769 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG 848 (986)
++|..+|.+...+.. ....++.....+...++-|++++|+. +++|||+|++||+++.+|++|+.|||
T Consensus 76 ld~~rgg~lft~l~~----------~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfg 142 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLSK----------EVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFG 142 (612)
T ss_pred hhhcccchhhhcccc----------CCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCch
Confidence 999999999988842 23467777888889999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 849 LARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 849 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
+++..-.... .+||..|||||++. ....++|.||||++++||+||..||..
T Consensus 143 lske~v~~~~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 143 LSKEAVKEKI------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred hhhHhHhhhh------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 9986432211 27999999999988 567899999999999999999999974
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.9e-17 Score=172.39 Aligned_cols=142 Identities=19% Similarity=0.139 Sum_probs=111.2
Q ss_pred CCCCCcccccccceeEEEEE-ECCCCeEEEEEEeeccCch------------------------hHHHHHHHHHHHhcCC
Q 046598 689 RFSSVNQIGEGSFGSVFKGI-LDDGRTTIAVKVFNLLHHG------------------------AFKSFIAECNTLKNIR 743 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~-~~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 743 (986)
-|.+.+.||+|++|.||+|. +..+++.||+|+++..... ....+..|++.++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48889999999999999999 5567899999998743210 0123568999999997
Q ss_pred CC--cceeeeeeccccccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCC
Q 046598 744 HR--NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQ 821 (986)
Q Consensus 744 h~--niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ 821 (986)
+. .+.+++++ ...++||||++|+++..+... .......++..++.||+.++++||+.
T Consensus 109 ~~~i~~p~~~~~---------~~~~lV~E~~~g~~L~~~~~~----------~~~~~~~~~~~i~~qi~~~l~~LH~~-- 167 (237)
T smart00090 109 EAGVPVPKPIAW---------RRNVLVMEFIGGDGLPAPRLK----------DVEPEEEEEFELYDDILEEMRKLYKE-- 167 (237)
T ss_pred hcCCCCCeeeEe---------cCceEEEEEecCCcccccccc----------cCCcchHHHHHHHHHHHHHHHHHHhc--
Confidence 53 34444443 234899999999888765421 12345566789999999999999999
Q ss_pred CC-eEeecCCCCCeEecCCCcEEEcccccceec
Q 046598 822 PP-IAHCDLKPSNILLDEDMIAHIGDFGLARFL 853 (986)
Q Consensus 822 ~~-ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 853 (986)
| |+||||||+||+++ ++.++|+|||.|...
T Consensus 168 -g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 168 -GELVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred -CCEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 9 99999999999999 889999999999754
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.9e-19 Score=199.76 Aligned_cols=153 Identities=27% Similarity=0.377 Sum_probs=73.2
Q ss_pred EeccCCCCc-cccCcCccCCCCCCEEEccCCCcccc----CCcchhccccCceeeceecccCC------CCccchhcCcc
Q 046598 67 LDLESLKLA-GSISPHVGNLSFLKVLRLYNNSFNHE----IPSEFDRLRRLQVLALHYNSIGG------AIPANISSCSN 135 (986)
Q Consensus 67 l~l~~~~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~L~~N~l~~------~~p~~~~~l~~ 135 (986)
|+|.++.++ ......+..+..|+.|+++++.++.. ++..+...++|++|+++++.+.+ .++..+..+++
T Consensus 3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~ 82 (319)
T cd00116 3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG 82 (319)
T ss_pred cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCc
Confidence 455555555 23334445555566666666665322 34445555556666666665542 12234444555
Q ss_pred ccceecccccccCccCccccCCCC---CCeEEccCCcCCC----CcccccCCC-cCcceeeccCCcccCc----Ccchhh
Q 046598 136 LIQLRLFHNQLVGKIPSELSSLSK---IEHISVNDNNLTG----SIPSSLGNL-SSIRSLFLSGNNLEGS----IPDTLG 203 (986)
Q Consensus 136 L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~----~~p~~~~~l-~~L~~L~L~~N~l~~~----~p~~~~ 203 (986)
|++|++++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|+.|+|++|.+++. ++..+.
T Consensus 83 L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~ 162 (319)
T cd00116 83 LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALR 162 (319)
T ss_pred eeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHH
Confidence 555555555555444444443333 5555555555542 122233344 4555555555555421 122333
Q ss_pred ccCCCceeeccccccc
Q 046598 204 WLKNLVNLTMAQNRLS 219 (986)
Q Consensus 204 ~l~~L~~L~L~~N~l~ 219 (986)
.+++|++|+|++|.++
T Consensus 163 ~~~~L~~L~l~~n~l~ 178 (319)
T cd00116 163 ANRDLKELNLANNGIG 178 (319)
T ss_pred hCCCcCEEECcCCCCc
Confidence 3444455555444444
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.72 E-value=9.8e-19 Score=189.13 Aligned_cols=125 Identities=31% Similarity=0.492 Sum_probs=108.8
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
.+.||.|+++...+|.+|+.+.. .....++.....++.|++.|++| + +.+|||+||.||+...+.++
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~-------~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~ 395 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRR-------TGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQL 395 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCC-------cccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhh
Confidence 46889999999999999996332 23346788889999999999999 5 99999999999999999999
Q ss_pred EEcccccceecCCCC----CccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh
Q 046598 843 HIGDFGLARFLPLSS----AQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900 (986)
Q Consensus 843 kL~DFG~a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt 900 (986)
||+|||+........ .....+...||..||+||.+.+..|+.|+||||+|++++|+++
T Consensus 396 kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 396 KIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 999999998765443 2345566789999999999999999999999999999999998
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.5e-17 Score=195.70 Aligned_cols=159 Identities=28% Similarity=0.437 Sum_probs=120.0
Q ss_pred HhhhccCcCCCHhHHHHHHHHHHhccCCCcCCCCCCCCCCCCC----cceeeEecCC--C--CeEEEEeccCCCCccccC
Q 046598 8 LGVTASTVAGNETDRLALLELKSKITHDPLGVLASWNESSHFC----QWRGVTCSRR--H--QRVTILDLESLKLAGSIS 79 (986)
Q Consensus 8 ~~~~~~~~~~~~~~~~~ll~~k~~~~~~~~~~l~~w~~~~~~c----~w~gv~c~~~--~--~~v~~l~l~~~~l~~~~~ 79 (986)
+.+......+.++|.+||+++|+++. +|.. .+|.+ .+|| .|.||.|+.. . ..|+.|+|+++++.|.+|
T Consensus 360 ~~~~~~~~~t~~~~~~aL~~~k~~~~-~~~~--~~W~g-~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip 435 (623)
T PLN03150 360 FEIITAESKTLLEEVSALQTLKSSLG-LPLR--FGWNG-DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIP 435 (623)
T ss_pred eeccccccccCchHHHHHHHHHHhcC-Cccc--CCCCC-CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCC
Confidence 33444455667889999999999984 5432 48974 3443 7999999632 1 258888888888888888
Q ss_pred cCccCCCCCCEEEccCCCccccCCcchhccccCceeeceecccCCCCccchhcCccccceecccccccCccCccccCC-C
Q 046598 80 PHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSL-S 158 (986)
Q Consensus 80 ~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~ 158 (986)
+.++.+++|+.|+|++|++.|.+|..++.+++|+.|+|++|+++|.+|+.++.+++|++|+|++|+++|.+|..++.+ .
T Consensus 436 ~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~ 515 (623)
T PLN03150 436 NDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLL 515 (623)
T ss_pred HHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccc
Confidence 888888888888888888888888888888888888888888888888888888888888888888888877777653 3
Q ss_pred CCCeEEccCCcC
Q 046598 159 KIEHISVNDNNL 170 (986)
Q Consensus 159 ~L~~L~L~~N~l 170 (986)
++..+++.+|..
T Consensus 516 ~~~~l~~~~N~~ 527 (623)
T PLN03150 516 HRASFNFTDNAG 527 (623)
T ss_pred cCceEEecCCcc
Confidence 455666666643
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.69 E-value=8.1e-19 Score=194.68 Aligned_cols=279 Identities=22% Similarity=0.278 Sum_probs=181.7
Q ss_pred EEEccCCCcc-ccCCcchhccccCceeeceecccCCC----CccchhcCccccceecccccccC------ccCccccCCC
Q 046598 90 VLRLYNNSFN-HEIPSEFDRLRRLQVLALHYNSIGGA----IPANISSCSNLIQLRLFHNQLVG------KIPSELSSLS 158 (986)
Q Consensus 90 ~L~L~~n~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~------~~p~~~~~l~ 158 (986)
.|+|+++.++ ...+..|..+.+|+.|++++|.++.. ++..+...++|++|+++++.+.+ .++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 4677777777 44566677778888888888887532 45556677778888888887762 2345667778
Q ss_pred CCCeEEccCCcCCCCcccccCCCcC---cceeeccCCcccC----cCcchhhcc-CCCceeeccccccccc----CCccc
Q 046598 159 KIEHISVNDNNLTGSIPSSLGNLSS---IRSLFLSGNNLEG----SIPDTLGWL-KNLVNLTMAQNRLSGT----IPSSI 226 (986)
Q Consensus 159 ~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~----~~p~~~~~l-~~L~~L~L~~N~l~~~----~p~~l 226 (986)
+|++|++++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|++|+|++|.+++. ++..+
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~ 161 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL 161 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence 8888888888887666666655555 8888888888763 233445566 7888888888888742 34455
Q ss_pred cCCCCccEEeccccccccccCCccc---ccccccceEEecCceeccc----CCccccCCCCCcEEecccccccCCCchhh
Q 046598 227 FNISSITGFDAGVNKIQGAIPLDYG---FSLQNLQFFSVGENQLTGA----IPPTISNASNLEIFHGSVNKLTGAAPYLE 299 (986)
Q Consensus 227 ~~l~~L~~L~l~~N~l~~~~p~~~~---~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~ls~N~l~~~~~~l~ 299 (986)
..+.+|+.|+++.|.+.+.....+. ..+++|+.|++++|.+++. ++..+..+++|+.|++++|.+++...
T Consensus 162 ~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~--- 238 (319)
T cd00116 162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGA--- 238 (319)
T ss_pred HhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHH---
Confidence 6667788888888887742211111 1335788888888887633 34456677888888888888764210
Q ss_pred hhhhHhhhhhccCCCCCCCCCCcccccccccccccceeeccccccccCCCcccccccccceEEEccCCccc----ccCCc
Q 046598 300 KLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIF----GNIPA 375 (986)
Q Consensus 300 ~l~~L~~l~l~~n~l~~~~~~~l~~l~~l~~~~~L~~l~l~~n~~~~~~p~~~~~~~~~L~~L~L~~n~l~----~~~~~ 375 (986)
..+.. .+......|+.|++++|.++ ..+..
T Consensus 239 --~~l~~--------------------------------------------~~~~~~~~L~~L~l~~n~i~~~~~~~l~~ 272 (319)
T cd00116 239 --AALAS--------------------------------------------ALLSPNISLLTLSLSCNDITDDGAKDLAE 272 (319)
T ss_pred --HHHHH--------------------------------------------HHhccCCCceEEEccCCCCCcHHHHHHHH
Confidence 00000 00000134666677777665 12334
Q ss_pred cccCCCCCCEEEccCccccCc----CCCcccCC-CCCCEEEccCccc
Q 046598 376 AIGKFVNLQRLDMCSNRLSGT----IPPAIGEL-QNLKDLRLQRNRF 417 (986)
Q Consensus 376 ~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l-~~L~~L~Ls~N~l 417 (986)
.+..+++|+++++++|.++.. ....+... +.|++|++.+|.+
T Consensus 273 ~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 273 VLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred HHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 455667888888888888743 33444455 6788888877753
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.7e-16 Score=158.89 Aligned_cols=143 Identities=22% Similarity=0.151 Sum_probs=111.0
Q ss_pred HHHHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCch----------------------hHHHHHHHHHHH
Q 046598 682 NLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHG----------------------AFKSFIAECNTL 739 (986)
Q Consensus 682 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l 739 (986)
++......|.+.+.||+|+||.||+|... +++.||||+++..... .......|+.++
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 33344445888999999999999999886 5899999987642210 112367788888
Q ss_pred hcCCCC--cceeeeeeccccccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHH
Q 046598 740 KNIRHR--NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLH 817 (986)
Q Consensus 740 ~~l~h~--niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH 817 (986)
.++.|+ .+...++. ...++||||++|++|..... ......++.+++.++.++|
T Consensus 88 ~~l~~~~i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~----------------~~~~~~~~~~i~~~l~~lh 142 (198)
T cd05144 88 KALYEEGFPVPKPIDW---------NRHAVVMEYIDGVELYRVRV----------------LEDPEEVLDEILEEIVKAY 142 (198)
T ss_pred HHHHHcCCCCCceeec---------CCceEEEEEeCCcchhhccc----------------cccHHHHHHHHHHHHHHHH
Confidence 888777 44444433 34589999999999876542 0234678899999999999
Q ss_pred hcCCCCeEeecCCCCCeEecCCCcEEEcccccceec
Q 046598 818 HDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFL 853 (986)
Q Consensus 818 ~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 853 (986)
+. +|+||||||+||++++++.++|+|||.+...
T Consensus 143 ~~---gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 143 KH---GIIHGDLSEFNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred HC---CCCcCCCCcccEEEcCCCcEEEEECCccccC
Confidence 98 9999999999999999999999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.1e-17 Score=187.72 Aligned_cols=167 Identities=26% Similarity=0.331 Sum_probs=122.7
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
..+|..++.|..|+||.||.++++.+.+.+|+|+=+.. . |++ ||..+.+ ..+
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~------l------ilR-----nilt~a~-----------npf 133 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN------L------ILR-----NILTFAG-----------NPF 133 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccc------h------hhh-----ccccccC-----------Ccc
Confidence 46799999999999999999999998999999653211 0 111 1222221 122
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
.| |+-...++ ..+.++... +.+++|+|+. ||+|||+||+|.+|+.-|++|++|
T Consensus 134 vv------gDc~tllk----------~~g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTD 186 (1205)
T KOG0606|consen 134 VV------GDCATLLK----------NIGPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTD 186 (1205)
T ss_pred ee------chhhhhcc----------cCCCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccc
Confidence 22 33333332 112333322 7899999999 999999999999999999999999
Q ss_pred cccceecCCCCC-------------ccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCcc
Q 046598 847 FGLARFLPLSSA-------------QTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIM 908 (986)
Q Consensus 847 FG~a~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~ 908 (986)
||+++..-..-. +-.....+||+.|+|||++....|...+|.|++|+++||.+.|+.||...
T Consensus 187 fgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd 261 (1205)
T KOG0606|consen 187 FGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 261 (1205)
T ss_pred hhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC
Confidence 999975321110 11123457999999999999999999999999999999999999998643
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.1e-15 Score=180.32 Aligned_cols=144 Identities=22% Similarity=0.247 Sum_probs=112.7
Q ss_pred hHHHHHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEe--eccCc------hhHHHHHHHHHHHhcCCCCcceeee
Q 046598 680 YQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVF--NLLHH------GAFKSFIAECNTLKNIRHRNLVKIL 751 (986)
Q Consensus 680 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~--~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~ 751 (986)
+.........|...+.||+|+||+||+|.+... .+++|+. +.... ...+++.+|+++++.++|++++...
T Consensus 325 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~ 402 (535)
T PRK09605 325 WIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPV 402 (535)
T ss_pred eccccccccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeE
Confidence 333344455667789999999999999998653 3444432 21111 1235688999999999999988876
Q ss_pred eeccccccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCC
Q 046598 752 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKP 831 (986)
Q Consensus 752 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 831 (986)
.++. .....++||||+++++|.+++. ....++.|+++++.|||+. +++||||||
T Consensus 403 ~~~~-----~~~~~~lv~E~~~g~~L~~~l~------------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp 456 (535)
T PRK09605 403 IYDV-----DPEEKTIVMEYIGGKDLKDVLE------------------GNPELVRKVGEIVAKLHKA---GIVHGDLTT 456 (535)
T ss_pred EEEE-----eCCCCEEEEEecCCCcHHHHHH------------------HHHHHHHHHHHHHHHHHhC---CCccCCCCh
Confidence 6532 2345789999999999999883 3567999999999999999 999999999
Q ss_pred CCeEecCCCcEEEccccccee
Q 046598 832 SNILLDEDMIAHIGDFGLARF 852 (986)
Q Consensus 832 ~NIll~~~~~~kL~DFG~a~~ 852 (986)
+||++ .++.++|+|||+++.
T Consensus 457 ~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 457 SNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred HHEEE-ECCcEEEEeCccccc
Confidence 99999 678999999999975
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=9.7e-16 Score=158.72 Aligned_cols=134 Identities=19% Similarity=0.235 Sum_probs=108.7
Q ss_pred cccccccceeEEEEEECCCCeEEEEEEeeccCc--------hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 694 NQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH--------GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 694 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
+.||+|++|.||+|.+. +..|++|+...... .....+.+|++++..+.|+++.....++. .....
T Consensus 2 ~~l~~G~~~~vy~~~~~--~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----~~~~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFL--GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFV-----DPENF 74 (211)
T ss_pred cccccCceEEEEEEeeC--CCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEE-----eCCCC
Confidence 67999999999999883 56789998653221 11245788999999999988876665532 33567
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
++||||++|++|.+++.. ... ++..++.+++.++.++|+. +++|||++|+||+++ ++.++++
T Consensus 75 ~lv~e~~~G~~L~~~~~~-------------~~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~li 136 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINS-------------NGM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLI 136 (211)
T ss_pred EEEEEEeCCcCHHHHHHh-------------ccH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEE
Confidence 899999999999999841 112 7889999999999999999 999999999999999 7899999
Q ss_pred cccccee
Q 046598 846 DFGLARF 852 (986)
Q Consensus 846 DFG~a~~ 852 (986)
|||.++.
T Consensus 137 Df~~a~~ 143 (211)
T PRK14879 137 DFGLAEF 143 (211)
T ss_pred ECCcccC
Confidence 9999864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.59 E-value=3.8e-15 Score=152.70 Aligned_cols=130 Identities=20% Similarity=0.241 Sum_probs=101.7
Q ss_pred ccccccceeEEEEEECCCCeEEEEEEeeccCc--------hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 695 QIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH--------GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 695 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
.||+|+||.||+|.+. +..|++|+...... ...+++.+|++++..++|+++.....++ ......+
T Consensus 1 ~ig~G~~~~vy~~~~~--~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~-----~~~~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL--GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYD-----VDPDNKT 73 (199)
T ss_pred CCCCCceEEEEEeecC--CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEE-----EECCCCE
Confidence 3799999999999964 57899998643211 1135677899999999887654433332 1234568
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||++|++|.+++... .. .++.+++.++.++|+. +++|||++|+||+++ ++.++++|
T Consensus 74 lv~e~~~g~~l~~~~~~~----------~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liD 132 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEG----------ND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLID 132 (199)
T ss_pred EEEEEECCccHHHHHhhc----------HH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEE
Confidence 999999999999987410 00 7899999999999999 999999999999999 88999999
Q ss_pred ccccee
Q 046598 847 FGLARF 852 (986)
Q Consensus 847 FG~a~~ 852 (986)
||.++.
T Consensus 133 fg~a~~ 138 (199)
T TIGR03724 133 FGLGKY 138 (199)
T ss_pred CCCCcC
Confidence 999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.6e-16 Score=183.87 Aligned_cols=256 Identities=24% Similarity=0.238 Sum_probs=189.3
Q ss_pred hcCCCCCcccccccceeEEEEEEC-CCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCC-CCcceeeeeeccccccCCC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILD-DGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~ 762 (986)
...|.+.+.||+|+|+.|-.+... +....+|+|.+.... ....+....|..+-+.+. |+|++++++. ..+.
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~-----~~~~ 93 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEP-----SSSP 93 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCc-----cCCC
Confidence 446888889999999999888774 334557777665432 233445556777777776 9999999998 6677
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHH-hcCCCCeEeecCCCCCeEecCCC-
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLH-HDCQPPIAHCDLKPSNILLDEDM- 840 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~~~~ivH~Dlkp~NIll~~~~- 840 (986)
...++++||..|+++.+.+.. ......+...+-.++.|+..++.|+| .. ++.|||+||+|.+++..+
T Consensus 94 ~~~~~~~~~s~g~~~f~~i~~--------~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~ 162 (601)
T KOG0590|consen 94 RSYLLSLSYSDGGSLFSKISH--------PDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGS 162 (601)
T ss_pred cccccccCccccccccccccc--------CCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCC
Confidence 889999999999999988831 11113455566779999999999999 77 999999999999999999
Q ss_pred cEEEcccccceecCC-CCCccccccccc-cccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCccccccccHHH
Q 046598 841 IAHIGDFGLARFLPL-SSAQTSSIGAKG-SIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHN 917 (986)
Q Consensus 841 ~~kL~DFG~a~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~ 917 (986)
..|++|||+|..+.. ..........+| ++.|+|||...+. -..+..|+||.|+++.-+++|..|++.....+..+..
T Consensus 163 ~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~ 242 (601)
T KOG0590|consen 163 ALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSS 242 (601)
T ss_pred cccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccccee
Confidence 999999999988876 555555566778 9999999998884 4567899999999999999999999865554433333
Q ss_pred HHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 918 LARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 918 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
|........ ..+. ........++..+++..+|+.|.+.+++
T Consensus 243 ~~~~~~~~~----------~~~~------------------~~~~~~~~~~l~k~l~~~~~~r~s~~~~ 283 (601)
T KOG0590|consen 243 WKSNKGRFT----------QLPW------------------NSISDQAHDLLHKILKENPSNRLSIEEL 283 (601)
T ss_pred ecccccccc----------cCcc------------------ccCChhhhhcccccccCCchhccccccc
Confidence 332210000 0000 0112234467778888889999887764
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.2e-14 Score=147.46 Aligned_cols=135 Identities=22% Similarity=0.211 Sum_probs=96.0
Q ss_pred CcccccccceeEEEEEECCCCeEEEEEEeeccCchh--HHH----------------------HHHHHHHHhcCCCC--c
Q 046598 693 VNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGA--FKS----------------------FIAECNTLKNIRHR--N 746 (986)
Q Consensus 693 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~E~~~l~~l~h~--n 746 (986)
.+.||+|+||+||+|.+. +++.||||+++...... ... ...|.+.+.++.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 568999999999999987 58899999986432111 111 12445555554332 2
Q ss_pred ceeeeeeccccccCCCceEEEEEEeccCCCHhHh-hccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHh-cCCCCe
Q 046598 747 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEW-LHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHH-DCQPPI 824 (986)
Q Consensus 747 iv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~i 824 (986)
+.+.+++ ...++||||++++++... +... ... .++..++.+++.++.++|+ . +|
T Consensus 81 ~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~-----------~~~-~~~~~~~~~~~~~l~~lh~~~---~i 136 (187)
T cd05119 81 VPKPIDL---------NRHVLVMEFIGGDGIPAPRLKDV-----------RLL-EDPEELYDQILELMRKLYREA---GL 136 (187)
T ss_pred CCceEec---------CCCEEEEEEeCCCCccChhhhhh-----------hhc-ccHHHHHHHHHHHHHHHhhcc---Cc
Confidence 3344333 235899999998554321 1100 001 5678899999999999999 7 99
Q ss_pred EeecCCCCCeEecCCCcEEEcccccceec
Q 046598 825 AHCDLKPSNILLDEDMIAHIGDFGLARFL 853 (986)
Q Consensus 825 vH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 853 (986)
+||||||+||+++ ++.++++|||.+...
T Consensus 137 vH~Dl~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 137 VHGDLSEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred CcCCCChhhEEEE-CCcEEEEECcccccc
Confidence 9999999999999 899999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.5e-15 Score=177.47 Aligned_cols=118 Identities=34% Similarity=0.519 Sum_probs=97.6
Q ss_pred ccchhhccCccccccCcccccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeecc
Q 046598 502 NLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLS 581 (986)
Q Consensus 502 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls 581 (986)
.++.|+|++|.++|.+|..++.+++|+.|+|++|.|+|.+|..++.+++|+.|||++|+++|.+|+.++++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 36778888888888888888888889999999999888888888889999999999999988889888899999999999
Q ss_pred CCccccccCCc--cccccccceeeeCCcccccCCCCCCCCCCC
Q 046598 582 NNDLEGVVPTQ--GVFKNASITSVFGNLKLCGGIPEFQLPTCS 622 (986)
Q Consensus 582 ~N~l~~~~p~~--~~~~~~~~~~~~~n~~lcg~~~~~~~~~~~ 622 (986)
+|+++|.+|.. ..+..+..+++.+|+.+||.+.. +.|.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l---~~C~ 538 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGL---RACG 538 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCCC---CCCc
Confidence 99999888875 12234456789999999996542 3564
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.9e-16 Score=168.66 Aligned_cols=177 Identities=34% Similarity=0.505 Sum_probs=121.1
Q ss_pred CCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCcccccccccEEEecccccCCCCCcccCCCCCCCeee
Q 046598 379 KFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTID 458 (986)
Q Consensus 379 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 458 (986)
.+.--...||+.|++. .+|..++.+..|+.+.|..|.|. .+|..++++..|++||
T Consensus 73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r------------------------~ip~~i~~L~~lt~l~ 127 (722)
T KOG0532|consen 73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR------------------------TIPEAICNLEALTFLD 127 (722)
T ss_pred cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce------------------------ecchhhhhhhHHHHhh
Confidence 3444556677777776 66666666666666666666665 5666677777777777
Q ss_pred cCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccCcccccCCccccEEeccccccc
Q 046598 459 LSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQ 538 (986)
Q Consensus 459 L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 538 (986)
|+.|+++ .+|.. ++.++ |+.|-+++|+++ .+|..++.++.|..||.+.|.+. .+|..++++.+|+.|++..|++.
T Consensus 128 ls~NqlS-~lp~~-lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~ 202 (722)
T KOG0532|consen 128 LSSNQLS-HLPDG-LCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE 202 (722)
T ss_pred hccchhh-cCChh-hhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh
Confidence 7777776 66666 44444 777777777776 56777777777777777777776 66777777777777777777776
Q ss_pred ccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCccccc
Q 046598 539 GPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGV 588 (986)
Q Consensus 539 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~ 588 (986)
..|.++..| .|..||+|.|+++ .+|-.|.+|+.|++|-|.+|+|+..
T Consensus 203 -~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqSP 249 (722)
T KOG0532|consen 203 -DLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQSP 249 (722)
T ss_pred -hCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCCC
Confidence 456666644 4777777777776 5777777777777777777777753
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.54 E-value=3e-14 Score=139.03 Aligned_cols=135 Identities=22% Similarity=0.263 Sum_probs=111.3
Q ss_pred CCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCC--CcceeeeeeccccccCCCceEEEEE
Q 046598 692 SVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRH--RNLVKILTACSGVDYQGNDFKALVF 769 (986)
Q Consensus 692 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~~~~~~lv~ 769 (986)
+++.+|+|.++.||++...+ ..+++|+...... ...+.+|+.+++.++| ..+++++++ ...++..+++|
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~-----~~~~~~~~~v~ 72 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLAS-----GESDGWSYLLM 72 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEE-----cCCCCccEEEE
Confidence 46789999999999999865 6799999865433 4678899999999976 588888877 34446789999
Q ss_pred EeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccccc
Q 046598 770 EFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGL 849 (986)
Q Consensus 770 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~ 849 (986)
||++++.+..+ +......++.+++++++++|....++++|||++|+||+++.++.++++|||.
T Consensus 73 e~~~g~~~~~~-----------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~ 135 (155)
T cd05120 73 EWIEGETLDEV-----------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEY 135 (155)
T ss_pred EecCCeecccC-----------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccc
Confidence 99988766532 3456677899999999999986445799999999999999989999999999
Q ss_pred cee
Q 046598 850 ARF 852 (986)
Q Consensus 850 a~~ 852 (986)
++.
T Consensus 136 ~~~ 138 (155)
T cd05120 136 AGY 138 (155)
T ss_pred ccC
Confidence 864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.7e-13 Score=143.17 Aligned_cols=139 Identities=17% Similarity=0.113 Sum_probs=104.0
Q ss_pred cccc-cccceeEEEEEECCCCeEEEEEEeeccC-------------chhHHHHHHHHHHHhcCCCCcc--eeeeeecccc
Q 046598 694 NQIG-EGSFGSVFKGILDDGRTTIAVKVFNLLH-------------HGAFKSFIAECNTLKNIRHRNL--VKILTACSGV 757 (986)
Q Consensus 694 ~~lg-~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~ 757 (986)
..|| .||.|+||.+... +..+|||.+.... .....++.+|++++.++.|++| ++.++++...
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4687 8999999999886 4678999885311 1223567889999999988774 6666653211
Q ss_pred ccCCCceEEEEEEeccC-CCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEe
Q 046598 758 DYQGNDFKALVFEFMHN-RSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILL 836 (986)
Q Consensus 758 ~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 836 (986)
.......++||||++| .+|.+++.. ..++.. .+.+|+.++.+||+. ||+||||||+|||+
T Consensus 115 -~~~~~~~~lV~e~l~G~~~L~~~l~~-----------~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv 175 (239)
T PRK01723 115 -HGLFYRADILIERIEGARDLVALLQE-----------APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILL 175 (239)
T ss_pred -cCcceeeeEEEEecCCCCCHHHHHhc-----------CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEE
Confidence 1111234699999997 699988842 123333 357899999999999 99999999999999
Q ss_pred cCCCcEEEcccccceec
Q 046598 837 DEDMIAHIGDFGLARFL 853 (986)
Q Consensus 837 ~~~~~~kL~DFG~a~~~ 853 (986)
+.++.++|+|||.++..
T Consensus 176 ~~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 176 DPDGKFWLIDFDRGELR 192 (239)
T ss_pred cCCCCEEEEECCCcccC
Confidence 99999999999999753
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.9e-15 Score=163.46 Aligned_cols=178 Identities=34% Similarity=0.523 Sum_probs=124.3
Q ss_pred ceEEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCcccccccccEEEeccc
Q 046598 359 LEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYN 438 (986)
Q Consensus 359 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N 438 (986)
....+|+.|++. ++|..++.+..|+.+.|..|.+. .+|.+++++..|++|+|+.|+++
T Consensus 77 t~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-------------------- 134 (722)
T KOG0532|consen 77 TVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-------------------- 134 (722)
T ss_pred hhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh--------------------
Confidence 356788889888 78888999999999999999998 89999999998888888888887
Q ss_pred ccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccCc
Q 046598 439 FLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIP 518 (986)
Q Consensus 439 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 518 (986)
..|..++.++ |+.|.+++|+++ .+|+. ++....|..||.+.|.|. .+|..++++.+|+.|.+..|++. .+|
T Consensus 135 ----~lp~~lC~lp-Lkvli~sNNkl~-~lp~~-ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp 205 (722)
T KOG0532|consen 135 ----HLPDGLCDLP-LKVLIVSNNKLT-SLPEE-IGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLP 205 (722)
T ss_pred ----cCChhhhcCc-ceeEEEecCccc-cCCcc-cccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCC
Confidence 3444444443 555555555555 55555 445556666666666665 45666666666666666666666 566
Q ss_pred ccccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhh
Q 046598 519 STLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLI 570 (986)
Q Consensus 519 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 570 (986)
++++. -.|..||+|+|+++ .+|-.|.+|+.|++|-|.+|+|. ..|..+.
T Consensus 206 ~El~~-LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC 254 (722)
T KOG0532|consen 206 EELCS-LPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQIC 254 (722)
T ss_pred HHHhC-CceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHH
Confidence 66663 34666677777766 56667777777777777777776 3454443
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=9.4e-14 Score=140.80 Aligned_cols=158 Identities=24% Similarity=0.394 Sum_probs=123.7
Q ss_pred HhcCCCCcceeeeeeccccccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHh
Q 046598 739 LKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHH 818 (986)
Q Consensus 739 l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~ 818 (986)
+-++.|.|+|++..|+.+..+.+.....++.|||..|++.+++++..+ ....+......+|+.||..||.|||+
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~------~~~a~~~~~wkkw~tqIlsal~yLhs 194 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK------NQKALFQKAWKKWCTQILSALSYLHS 194 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH------hhhhhhHHHHHHHHHHHHhhhhhhhc
Confidence 445579999999999877767677888999999999999999975543 34568888999999999999999999
Q ss_pred cCCCCeEeecCCCCCeEecCCCcEEEccccccee--cCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHH
Q 046598 819 DCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARF--LPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLL 896 (986)
Q Consensus 819 ~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~--~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ 896 (986)
|.|.|+|+++..+-|++..+|-+|++--.-... ..............+-++|.|||+-.....+.++|||+||+...
T Consensus 195 -~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAl 273 (458)
T KOG1266|consen 195 -CDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCAL 273 (458)
T ss_pred -cCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHH
Confidence 589999999999999999999888852111000 00001111122234678999999977777888999999999999
Q ss_pred HHHhCCC
Q 046598 897 ELITRKK 903 (986)
Q Consensus 897 elltg~~ 903 (986)
||..|..
T Consensus 274 emailEi 280 (458)
T KOG1266|consen 274 EMAILEI 280 (458)
T ss_pred HHHHhee
Confidence 9998875
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.37 E-value=5.5e-13 Score=152.22 Aligned_cols=198 Identities=38% Similarity=0.525 Sum_probs=145.9
Q ss_pred EEEccCccccCcCCCcccCCCCCCEEEccCccceeecCcccccc--cccEEEecccccCCCCCcccCCCCCCCeeecCCC
Q 046598 385 RLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNL--KLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNN 462 (986)
Q Consensus 385 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~--~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 462 (986)
.++++.|.+. .....+..++.++.|++.+|.++. ++...... +|+.|++++|.+. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~~-i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNITD-IPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCccccc-Cccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 4566666653 223334444566666666666663 33333332 5667777777776 56667788889999999999
Q ss_pred ccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccCcccccCCccccEEecccccccccCC
Q 046598 463 NLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIP 542 (986)
Q Consensus 463 ~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 542 (986)
+++ .+|.. .+..+.|+.|++++|+++ .+|.....+..|++|++++|++. .++..+.++.++..|.+++|++. ..+
T Consensus 174 ~l~-~l~~~-~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~ 248 (394)
T COG4886 174 DLS-DLPKL-LSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLP 248 (394)
T ss_pred hhh-hhhhh-hhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-ecc
Confidence 998 77765 336678889999999998 57776666677999999999655 57778888888999999999887 347
Q ss_pred ccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCccccccCCc
Q 046598 543 SSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQ 592 (986)
Q Consensus 543 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~ 592 (986)
..++.+++|+.|++++|+++. ++. +..+.+++.|++++|.++..+|..
T Consensus 249 ~~~~~l~~l~~L~~s~n~i~~-i~~-~~~~~~l~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 249 ESIGNLSNLETLDLSNNQISS-ISS-LGSLTNLRELDLSGNSLSNALPLI 296 (394)
T ss_pred chhccccccceeccccccccc-ccc-ccccCccCEEeccCccccccchhh
Confidence 788888889999999999984 444 888889999999999998877765
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.34 E-value=4.2e-12 Score=144.39 Aligned_cols=142 Identities=21% Similarity=0.254 Sum_probs=98.4
Q ss_pred CcccccccceeEEEEEECCCCeEEEEEEeeccCchhH----------------------------------------HHH
Q 046598 693 VNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAF----------------------------------------KSF 732 (986)
Q Consensus 693 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~ 732 (986)
.+.||.|++|.||+|+.++ |+.||||+.++...... -+|
T Consensus 122 ~~plasaSigQVh~A~l~~-G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVD-GKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEecC-CCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 3679999999999999975 78999999864321110 024
Q ss_pred HHHHHHHhcC----CCCcceeeeeeccccccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHH
Q 046598 733 IAECNTLKNI----RHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISID 808 (986)
Q Consensus 733 ~~E~~~l~~l----~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~q 808 (986)
.+|++.+.++ +|.+-+.+-..+ .......++||||++|++|.++..... ... +..+++.+
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~----~~~~~~~vLvmE~i~G~~L~~~~~~~~---------~~~---~~~~ia~~ 264 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVY----WDRTSERVLTMEWIDGIPLSDIAALDE---------AGL---DRKALAEN 264 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEe----hhhcCCceEEEEeECCcccccHHHHHh---------cCC---CHHHHHHH
Confidence 4455555444 222223322222 112245699999999999988764110 011 23456777
Q ss_pred HHH-HHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcccccceecC
Q 046598 809 VAC-ALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLP 854 (986)
Q Consensus 809 i~~-~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 854 (986)
++. .+..+|.. |++|+|++|.||++++++.++++|||++..+.
T Consensus 265 ~~~~~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 265 LARSFLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 766 47888988 99999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.2e-13 Score=136.06 Aligned_cols=137 Identities=28% Similarity=0.355 Sum_probs=115.3
Q ss_pred cCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccCcccccCCccc
Q 046598 448 LGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKL 527 (986)
Q Consensus 448 ~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 527 (986)
....+.|+.+|||+|.|+ .+.++ ....+.++.|++|+|.|+. + ..++.+++|+.||||+|.++ .+-.+-.++-++
T Consensus 280 ~dTWq~LtelDLS~N~I~-~iDES-vKL~Pkir~L~lS~N~i~~-v-~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNI 354 (490)
T KOG1259|consen 280 ADTWQELTELDLSGNLIT-QIDES-VKLAPKLRRLILSQNRIRT-V-QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNI 354 (490)
T ss_pred cchHhhhhhccccccchh-hhhhh-hhhccceeEEeccccceee-e-hhhhhcccceEeecccchhH-hhhhhHhhhcCE
Confidence 344578999999999998 77776 6788999999999999984 3 34889999999999999999 666677788899
Q ss_pred cEEecccccccccCCccccCCCCCCEEeCCCccCcccC-chhhhcccccceeeccCCccccccCC
Q 046598 528 EQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKI-PELLIRLQLVKNLNLSNNDLEGVVPT 591 (986)
Q Consensus 528 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~l~ls~N~l~~~~p~ 591 (986)
+.|.|++|.|.. -..++.+-+|..||+++|+|.... -..++++|-|+++.|-+|++++.+.-
T Consensus 355 KtL~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vdY 417 (490)
T KOG1259|consen 355 KTLKLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVDY 417 (490)
T ss_pred eeeehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccchH
Confidence 999999999974 356788899999999999997422 24688999999999999999986553
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.2e-12 Score=145.36 Aligned_cols=199 Identities=29% Similarity=0.329 Sum_probs=157.4
Q ss_pred cCCCCCccccc--ccceeEEEEEE--CCCCeEEEEEEeec--cCchhHHHHHHHHHHHhcC-CCCcceeeeeeccccccC
Q 046598 688 DRFSSVNQIGE--GSFGSVFKGIL--DDGRTTIAVKVFNL--LHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQ 760 (986)
Q Consensus 688 ~~y~~~~~lg~--G~~g~Vy~~~~--~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 760 (986)
..|.+.+.+|. |.+|.||.+.. ..++..+|+|.-+. .......+-.+|+.....+ .|++.++.+.. +.
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~-----~e 188 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA-----WE 188 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc-----cc
Confidence 35777889999 99999999998 77789999998542 2223334445677666666 59999996665 77
Q ss_pred CCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHH----HHHHHHhcCCCCeEeecCCCCCeEe
Q 046598 761 GNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVAC----ALNYLHHDCQPPIAHCDLKPSNILL 836 (986)
Q Consensus 761 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~----~L~~LH~~~~~~ivH~Dlkp~NIll 836 (986)
..+..++-+|++ +.+|.++.+ .....++....+.+..+... |+.++|+. .++|-|+||.||+.
T Consensus 189 ~~~~lfiqtE~~-~~sl~~~~~---------~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~ 255 (524)
T KOG0601|consen 189 GSGILFIQTELC-GESLQSYCH---------TPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFT 255 (524)
T ss_pred cCCcceeeeccc-cchhHHhhh---------cccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheec
Confidence 788899999988 688988886 33344677788888888888 99999999 99999999999999
Q ss_pred cCC-CcEEEcccccceecCCCCCc---cccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCC
Q 046598 837 DED-MIAHIGDFGLARFLPLSSAQ---TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPT 905 (986)
Q Consensus 837 ~~~-~~~kL~DFG~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf 905 (986)
..+ ...+++|||+...+...... .......|...|++||...+ -++.++|+||+|.++.+..+|..+.
T Consensus 256 ~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~ 327 (524)
T KOG0601|consen 256 TSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLP 327 (524)
T ss_pred ccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccc
Confidence 999 89999999999887544321 11222357889999998654 5789999999999999999987764
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.9e-12 Score=147.81 Aligned_cols=186 Identities=39% Similarity=0.619 Sum_probs=135.4
Q ss_pred ccCCCCCCEEEccCccccCcCCCcccCCC-CCCEEEccCccceeecCccccc-ccccEEEecccccCCCCCcccCCCCCC
Q 046598 377 IGKFVNLQRLDMCSNRLSGTIPPAIGELQ-NLKDLRLQRNRFQGNIPPSIGN-LKLFILYLSYNFLQGSIPSSLGRYETL 454 (986)
Q Consensus 377 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~-~~L~~L~L~~N~l~~~~p~~~~~l~~L 454 (986)
+..++.++.|++.+|.++ .++.....+. +|+.|++++|++.. +|..+.. ..|+.|++++|+++ .+|...+..+.|
T Consensus 112 ~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~~-l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L 188 (394)
T COG4886 112 LLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIES-LPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNL 188 (394)
T ss_pred hhcccceeEEecCCcccc-cCccccccchhhcccccccccchhh-hhhhhhccccccccccCCchhh-hhhhhhhhhhhh
Confidence 333455566666666665 4444444443 56666666666552 2222222 24666666666666 566656678899
Q ss_pred CeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccCcccccCCccccEEeccc
Q 046598 455 TTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQE 534 (986)
Q Consensus 455 ~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 534 (986)
+.|++++|+++ .+|.. .+.+..|++|++++|.+. ..+..+.++.++..|.+++|++. .++..++.++.++.|++++
T Consensus 189 ~~L~ls~N~i~-~l~~~-~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~ 264 (394)
T COG4886 189 NNLDLSGNKIS-DLPPE-IELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSN 264 (394)
T ss_pred hheeccCCccc-cCchh-hhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchhccccccceecccc
Confidence 99999999998 88875 355667999999999655 47778899999999999999998 5588899999999999999
Q ss_pred ccccccCCccccCCCCCCEEeCCCccCcccCchhhhc
Q 046598 535 NFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIR 571 (986)
Q Consensus 535 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 571 (986)
|.++. ++. ++.+.+|+.|++++|.++...|.....
T Consensus 265 n~i~~-i~~-~~~~~~l~~L~~s~n~~~~~~~~~~~~ 299 (394)
T COG4886 265 NQISS-ISS-LGSLTNLRELDLSGNSLSNALPLIALL 299 (394)
T ss_pred ccccc-ccc-ccccCccCEEeccCccccccchhhhcc
Confidence 99995 444 899999999999999999766665443
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.2e-11 Score=135.10 Aligned_cols=170 Identities=22% Similarity=0.221 Sum_probs=130.5
Q ss_pred EEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEEEEeccCCCHhHhhccCC
Q 046598 706 KGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPIT 785 (986)
Q Consensus 706 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~ 785 (986)
.|..+.++.+|.|.+++...........+-++.++.++||+|+++++. ++..+..|+|+|.+ ..|..++.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t-----~e~~~~~ylvTErV--~Pl~~~lk--- 99 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDT-----TEEEGTLYLVTERV--RPLETVLK--- 99 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhh-----hcccCceEEEeecc--ccHHHHHH---
Confidence 466666788899999887665445667788899999999999999998 66678999999998 36777774
Q ss_pred CCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcccccceecCCCCCccccccc
Q 046598 786 REDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGA 865 (986)
Q Consensus 786 ~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~ 865 (986)
.++...+...+.||+.||.|||+.+ +++|++|.-+-|+|++.|+-||++|.++........ .....
T Consensus 100 ----------~l~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~ 165 (690)
T KOG1243|consen 100 ----------ELGKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSL 165 (690)
T ss_pred ----------HhHHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccc
Confidence 2445667778999999999999664 999999999999999999999999998865432221 11111
Q ss_pred cccccccccccccCCCcCcccchhhHHHHHHHHHhC
Q 046598 866 KGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITR 901 (986)
Q Consensus 866 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg 901 (986)
.--..|..|+.+.... -..|.|.||++++|++.|
T Consensus 166 ~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 166 YLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 2223466777544332 346999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.27 E-value=5.4e-11 Score=118.19 Aligned_cols=138 Identities=20% Similarity=0.157 Sum_probs=100.3
Q ss_pred CcccccccceeEEEEEECC------CCeEEEEEEeecc-------------C---------chhHHHHH----HHHHHHh
Q 046598 693 VNQIGEGSFGSVFKGILDD------GRTTIAVKVFNLL-------------H---------HGAFKSFI----AECNTLK 740 (986)
Q Consensus 693 ~~~lg~G~~g~Vy~~~~~~------~~~~vavK~~~~~-------------~---------~~~~~~~~----~E~~~l~ 740 (986)
...||.|--+.||.|...+ .+..+|||+++.. + ....+.+. +|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3468999999999998764 2578999998521 0 01122333 7999998
Q ss_pred cCC--CCcceeeeeeccccccCCCceEEEEEEeccCCCHhH-hhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHH-
Q 046598 741 NIR--HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEE-WLHPITREDETDEAPRSLNLIQRLNISIDVACALNYL- 816 (986)
Q Consensus 741 ~l~--h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~L- 816 (986)
++. .-++.+.+++ ...++||||+.++.+.. .++ ...++..+...+..+++.++..+
T Consensus 82 rl~~~Gv~vP~pi~~---------~~~~lvME~Ig~~~~~~~~Lk-----------d~~~~~~~~~~i~~~i~~~l~~l~ 141 (197)
T cd05146 82 RMQKAGIPCPEVVVL---------KKHVLVMSFIGDDQVPAPKLK-----------DAKLNDEEMKNAYYQVLSMMKQLY 141 (197)
T ss_pred HHHHcCCCCCeEEEe---------cCCEEEEEEcCCCCccchhhh-----------ccccCHHHHHHHHHHHHHHHHHHH
Confidence 884 3466666665 45689999997654322 121 11244556778889999999999
Q ss_pred HhcCCCCeEeecCCCCCeEecCCCcEEEcccccceecC
Q 046598 817 HHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLP 854 (986)
Q Consensus 817 H~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 854 (986)
|+. |+||||+++.||+++ ++.++++|||.|....
T Consensus 142 H~~---glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 142 KEC---NLVHADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HhC---CeecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 888 999999999999997 4689999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.6e-11 Score=139.05 Aligned_cols=149 Identities=19% Similarity=0.181 Sum_probs=95.0
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchh----------------------------------HH---
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGA----------------------------------FK--- 730 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----------------------------------~~--- 730 (986)
..|+. +.||+|++|.||+|+.+++|+.||||+.++.-... .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35766 78999999999999999878999999996431110 01
Q ss_pred ---HHHHHHHHHhcCC----CCcceeeeeeccccccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHH
Q 046598 731 ---SFIAECNTLKNIR----HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRL 803 (986)
Q Consensus 731 ---~~~~E~~~l~~l~----h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~ 803 (986)
++.+|+..+.+++ +...+.+-.++ .+-....++||||++|+++.++-.-... ......+....+.
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~----~d~st~~VLvmE~i~G~~l~d~~~l~~~----g~d~~~la~~~v~ 270 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVY----WDYCSETVMVMERMYGIPVSDVAALRAA----GTDMKLLAERGVE 270 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceee----cccCCCceEEEeeecCccHHhHHHHHhc----CCCHHHHHHHHHH
Confidence 1334444443332 33223222221 1223557899999999999874210000 0011123333344
Q ss_pred HHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCC----cEEEcccccceecCC
Q 046598 804 NISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDM----IAHIGDFGLARFLPL 855 (986)
Q Consensus 804 ~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kL~DFG~a~~~~~ 855 (986)
.++.|+. .. |++|+|+||.||+++.++ .++++|||++..++.
T Consensus 271 ~~~~Qif-------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 271 VFFTQVF-------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHH-------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 4444443 46 999999999999999988 999999999987643
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.17 E-value=6.2e-11 Score=118.04 Aligned_cols=131 Identities=18% Similarity=0.141 Sum_probs=95.3
Q ss_pred CcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcc-eeeeeeccccccCCCceEEEEEEe
Q 046598 693 VNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNL-VKILTACSGVDYQGNDFKALVFEF 771 (986)
Q Consensus 693 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~~~~~~lv~e~ 771 (986)
++.++.|.++.||++... +..|++|+...... ....+.+|+++++.+.+..+ .+++++. ....++||||
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~-------~~~~~lv~e~ 72 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD-------PETGVLITEF 72 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe-------CCCCeEEEEe
Confidence 467899999999999876 57899999754321 22346789999988865444 3444441 1234799999
Q ss_pred ccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcC--CCCeEeecCCCCCeEecCCCcEEEccccc
Q 046598 772 MHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDC--QPPIAHCDLKPSNILLDEDMIAHIGDFGL 849 (986)
Q Consensus 772 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kL~DFG~ 849 (986)
++|.++.+.- . ....++.+++++++.||+.. ..+++|||++|.||+++ ++.++++|||.
T Consensus 73 i~G~~l~~~~---------------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~ 133 (170)
T cd05151 73 IEGSELLTED---------------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEY 133 (170)
T ss_pred cCCCcccccc---------------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccc
Confidence 9998775431 0 11345678999999999982 12359999999999999 67899999999
Q ss_pred cee
Q 046598 850 ARF 852 (986)
Q Consensus 850 a~~ 852 (986)
+..
T Consensus 134 a~~ 136 (170)
T cd05151 134 AGM 136 (170)
T ss_pred ccC
Confidence 863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.9e-11 Score=118.92 Aligned_cols=125 Identities=29% Similarity=0.353 Sum_probs=41.0
Q ss_pred CCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccCcccc-cCCcccc
Q 046598 450 RYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTL-GSCIKLE 528 (986)
Q Consensus 450 ~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~ 528 (986)
+..+++.|+|++|+|+ .|. ..-..+.+|+.|+||+|.|+. ++ .+..++.|+.|++++|+|+ .+++.+ ..+++|+
T Consensus 17 n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~ 91 (175)
T PF14580_consen 17 NPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQ 91 (175)
T ss_dssp ---------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--
T ss_pred cccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCC
Confidence 3445677777777776 443 212245667777777777773 32 4666777777777777777 343333 3567777
Q ss_pred EEecccccccccCC-ccccCCCCCCEEeCCCccCcccC---chhhhcccccceee
Q 046598 529 QLEMQENFLQGPIP-SSLSSLRGLSVLDLSQNNLSGKI---PELLIRLQLVKNLN 579 (986)
Q Consensus 529 ~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~---p~~~~~l~~L~~l~ 579 (986)
+|+|++|+|...-. ..+..+++|+.|+|.+|+++... .-.+..+|+|+.||
T Consensus 92 ~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 92 ELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEET
T ss_pred EEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeC
Confidence 77777777764221 34566777777777777776321 12455667776665
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.8e-11 Score=119.02 Aligned_cols=126 Identities=32% Similarity=0.340 Sum_probs=48.9
Q ss_pred ccccccccEEEecccccCCCCCcccC-CCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCccc-cccc
Q 046598 424 SIGNLKLFILYLSYNFLQGSIPSSLG-RYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEV-GNLK 501 (986)
Q Consensus 424 ~~~~~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~-~~l~ 501 (986)
.....++++|+|.+|.|+. +. .++ .+.+|+.|+|++|.|+ .++. +..++.|+.|++++|+|+. ++..+ ..++
T Consensus 15 ~~n~~~~~~L~L~~n~I~~-Ie-~L~~~l~~L~~L~Ls~N~I~-~l~~--l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp 88 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIST-IE-NLGATLDKLEVLDLSNNQIT-KLEG--LPGLPRLKTLDLSNNRISS-ISEGLDKNLP 88 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---TT------TT--EEE--SS---S--CHHHHHH-T
T ss_pred ccccccccccccccccccc-cc-chhhhhcCCCEEECCCCCCc-cccC--ccChhhhhhcccCCCCCCc-cccchHHhCC
Confidence 3334456677777777763 32 344 5778888888888888 5553 5667888888888888884 44444 3578
Q ss_pred ccchhhccCccccccC-cccccCCccccEEecccccccccCCc----cccCCCCCCEEeC
Q 046598 502 NLEILNVFGNKLKGEI-PSTLGSCIKLEQLEMQENFLQGPIPS----SLSSLRGLSVLDL 556 (986)
Q Consensus 502 ~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~L~L 556 (986)
+|++|+|++|+|...- -..+..+++|+.|+|.+|.++.. +. .+..+|+|+.||-
T Consensus 89 ~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 89 NLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp T--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEETT
T ss_pred cCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeCC
Confidence 8888899998887432 24567788999999999999843 32 4567888998874
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.4e-11 Score=123.41 Aligned_cols=126 Identities=26% Similarity=0.290 Sum_probs=107.4
Q ss_pred CCcceEEEccCCcccccCCcccccccccchhhccCccccccCcccccCCccccEEecccccccccCCccccCCCCCCEEe
Q 046598 476 SSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLD 555 (986)
Q Consensus 476 ~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 555 (986)
...|+.||||+|.|+ .+.++..-+|.++.|++|+|.|. .+- .+..+++|+.||||+|.++ .+..+-..+-+.+.|.
T Consensus 283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~ 358 (490)
T KOG1259|consen 283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLK 358 (490)
T ss_pred Hhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeee
Confidence 467999999999999 68888889999999999999998 343 4899999999999999999 5777778899999999
Q ss_pred CCCccCcccCchhhhcccccceeeccCCccccccCC--ccccccccceeeeCCc
Q 046598 556 LSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPT--QGVFKNASITSVFGNL 607 (986)
Q Consensus 556 Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~--~~~~~~~~~~~~~~n~ 607 (986)
|++|.|.. -..+..+-+|..||+++|++...... -|.++-++.+.+.+||
T Consensus 359 La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NP 410 (490)
T KOG1259|consen 359 LAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNP 410 (490)
T ss_pred hhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCC
Confidence 99999963 24477888999999999999865433 3667778888899886
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.4e-11 Score=130.07 Aligned_cols=62 Identities=24% Similarity=0.312 Sum_probs=38.9
Q ss_pred ccceEEEccCCcccccCC-ccccCCCCCCEEEccCccccCcCC--CcccCCCCCCEEEccCccce
Q 046598 357 TTLEVLLLDNNQIFGNIP-AAIGKFVNLQRLDMCSNRLSGTIP--PAIGELQNLKDLRLQRNRFQ 418 (986)
Q Consensus 357 ~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~Ls~N~l~ 418 (986)
.+|+.+.|++..+..... .....+++++.||||.|-+....+ .....+++|+.|+|+.|++.
T Consensus 121 kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~ 185 (505)
T KOG3207|consen 121 KKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLS 185 (505)
T ss_pred HhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhccccccccc
Confidence 456677777776652211 345567777777777777763222 23456777777777777776
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.06 E-value=7.9e-11 Score=131.17 Aligned_cols=198 Identities=25% Similarity=0.242 Sum_probs=146.2
Q ss_pred HhhcCCCCCcccccccceeEEEEEEC-CCCeEEEEEEeeccCchhH--HHHHHHHHHHhcC-CCCcceeeeeeccccccC
Q 046598 685 NATDRFSSVNQIGEGSFGSVFKGILD-DGRTTIAVKVFNLLHHGAF--KSFIAECNTLKNI-RHRNLVKILTACSGVDYQ 760 (986)
Q Consensus 685 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 760 (986)
....+|..+..||.|.|+.|+....+ .++..+++|.......... ..-..|+.+...+ .|.++++.+.. +.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-----W~ 336 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS-----WS 336 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC-----cc
Confidence 34567889999999999999988766 6788899998753222211 2224455555555 58888887665 44
Q ss_pred CCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCC-
Q 046598 761 GNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED- 839 (986)
Q Consensus 761 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~- 839 (986)
.....|+=-||+++++...... ....+....++++..|++.++.++|+. .++|+|+||+||++..+
T Consensus 337 ~~r~~~ip~e~~~~~s~~l~~~----------~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~ 403 (524)
T KOG0601|consen 337 QLRQGYIPLEFCEGGSSSLRSV----------TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDG 403 (524)
T ss_pred ccccccCchhhhcCcchhhhhH----------HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccch
Confidence 4566779999999998887662 123466677889999999999999998 99999999999999886
Q ss_pred CcEEEcccccceecCCCCCccccccccccccc-cccccccCCCcCcccchhhHHHHHHHHHhCCCC
Q 046598 840 MIAHIGDFGLARFLPLSSAQTSSIGAKGSIGY-IAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904 (986)
Q Consensus 840 ~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p 904 (986)
+..+++|||+++.+.... ......+..| .+|+......+..++|+||||..+.+..+|.+-
T Consensus 404 ~~~~~~~~~~~t~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 404 FFSKLGDFGCWTRLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred hhhhccccccccccceec----ccccccccccccchhhccccccccccccccccccccccccCccc
Confidence 789999999997432111 1111123334 356666667888999999999999999998763
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.5e-11 Score=138.59 Aligned_cols=192 Identities=32% Similarity=0.388 Sum_probs=91.4
Q ss_pred cceEEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCcccccccccEEEecc
Q 046598 358 TLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSY 437 (986)
Q Consensus 358 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~ 437 (986)
+++.|++.+|+|..+ ...+..+++|++|++++|.|+.+. .+..++.|+.|++++|.|+..
T Consensus 96 ~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~~N~i~~~----------------- 155 (414)
T KOG0531|consen 96 SLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNLSGNLISDI----------------- 155 (414)
T ss_pred ceeeeeccccchhhc-ccchhhhhcchheecccccccccc--chhhccchhhheeccCcchhc-----------------
Confidence 455555555555522 222555666666666666665332 244445555556655555521
Q ss_pred cccCCCCCcccCCCCCCCeeecCCCccCCCCCc-ccccCCCcceEEEccCCcccccCCcccccccccchhhccCcccccc
Q 046598 438 NFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPP-QFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGE 516 (986)
Q Consensus 438 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~-~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 516 (986)
..+..++.|+.+++++|+++ .+.. . ...+.+++.+++.+|.+.. ...+..+..+..+++..|+++..
T Consensus 156 --------~~~~~l~~L~~l~l~~n~i~-~ie~~~-~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~i~~~ 223 (414)
T KOG0531|consen 156 --------SGLESLKSLKLLDLSYNRIV-DIENDE-LSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDNKISKL 223 (414)
T ss_pred --------cCCccchhhhcccCCcchhh-hhhhhh-hhhccchHHHhccCCchhc--ccchHHHHHHHHhhcccccceec
Confidence 12333455555555555555 3332 1 1234445555555555542 23344444444455555555522
Q ss_pred CcccccCCc--cccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCccc
Q 046598 517 IPSTLGSCI--KLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLE 586 (986)
Q Consensus 517 ~p~~~~~l~--~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~ 586 (986)
-+ +..+. .|+.+++++|.+. ..+..+..+..+..|++++|+++..- .+...+.+..+.++.|.+.
T Consensus 224 ~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~~--~~~~~~~~~~~~~~~~~~~ 290 (414)
T KOG0531|consen 224 EG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNLE--GLERLPKLSELWLNDNKLA 290 (414)
T ss_pred cC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhccccccc--cccccchHHHhccCcchhc
Confidence 11 11222 2555555555555 23344455555555566655554221 1233444445555555544
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.7e-10 Score=84.13 Aligned_cols=40 Identities=55% Similarity=1.042 Sum_probs=31.6
Q ss_pred HhHHHHHHHHHHhccCCCcCCCCCCCCC--CCCCcceeeEec
Q 046598 19 ETDRLALLELKSKITHDPLGVLASWNES--SHFCQWRGVTCS 58 (986)
Q Consensus 19 ~~~~~~ll~~k~~~~~~~~~~l~~w~~~--~~~c~w~gv~c~ 58 (986)
++|++||++||+++..+|.+.+.+|+.. ++||+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 5799999999999976788999999876 799999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.03 E-value=5.2e-11 Score=125.87 Aligned_cols=210 Identities=19% Similarity=0.160 Sum_probs=129.8
Q ss_pred hccccCceeeceecccCCCCc--cchhcCccccceecccccccCccC--ccccCCCCCCeEEccCCcCCCCccccc-CCC
Q 046598 107 DRLRRLQVLALHYNSIGGAIP--ANISSCSNLIQLRLFHNQLVGKIP--SELSSLSKIEHISVNDNNLTGSIPSSL-GNL 181 (986)
Q Consensus 107 ~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l 181 (986)
.++.+|+...|.+.... ..+ .....|++++.||||+|-|....| .....|++|+.|+|+.|++.....+.. ..+
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 56677777778777776 333 355677788888888887764433 234567788888888887763222211 245
Q ss_pred cCcceeeccCCcccCc-CcchhhccCCCceeecccccccccCCccccCCCCccEEeccccccccccCCcccccccccceE
Q 046598 182 SSIRSLFLSGNNLEGS-IPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFF 260 (986)
Q Consensus 182 ~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L 260 (986)
++|+.|.|+.|.++-. +......+++|+.|+|..|...+.-.....-+..|+.|||++|.+...--......++.|..|
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~L 276 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQL 276 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhh
Confidence 6777888888877622 222334567788888888753323334444556677777777776532211223356777777
Q ss_pred EecCceeccc-CCcc-----ccCCCCCcEEecccccccCCC--chhhhhhhHhhhhhccCCCCCC
Q 046598 261 SVGENQLTGA-IPPT-----ISNASNLEIFHGSVNKLTGAA--PYLEKLQRLLVFGILGNSLGSR 317 (986)
Q Consensus 261 ~L~~N~l~~~-~p~~-----l~~l~~L~~L~ls~N~l~~~~--~~l~~l~~L~~l~l~~n~l~~~ 317 (986)
+++.+.++.. .|+. ....++|+.|+++.|++.... ..+..+.+|..+.+.+|.+...
T Consensus 277 nls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~e 341 (505)
T KOG3207|consen 277 NLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNKE 341 (505)
T ss_pred hccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccccc
Confidence 7777777643 2222 355677888888888875433 3455666666666666666543
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=5e-11 Score=136.13 Aligned_cols=151 Identities=30% Similarity=0.324 Sum_probs=114.0
Q ss_pred cccEEEecccccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcc-cccccccchhh
Q 046598 429 KLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSE-VGNLKNLEILN 507 (986)
Q Consensus 429 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~ 507 (986)
+|++|++++|+|+... .+..++.|+.|++++|.|+ .+.. +..+..|+.+++++|+++..-+ . ...+.+++.++
T Consensus 119 ~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~~N~i~-~~~~--~~~l~~L~~l~l~~n~i~~ie~-~~~~~~~~l~~l~ 192 (414)
T KOG0531|consen 119 NLQVLDLSFNKITKLE--GLSTLTLLKELNLSGNLIS-DISG--LESLKSLKLLDLSYNRIVDIEN-DELSELISLEELD 192 (414)
T ss_pred cchheecccccccccc--chhhccchhhheeccCcch-hccC--CccchhhhcccCCcchhhhhhh-hhhhhccchHHHh
Confidence 3455555555554332 3556677999999999998 5554 5558899999999999995433 2 57889999999
Q ss_pred ccCccccccCcccccCCccccEEecccccccccCCccccCCC--CCCEEeCCCccCcccCchhhhcccccceeeccCCcc
Q 046598 508 VFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLR--GLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDL 585 (986)
Q Consensus 508 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l 585 (986)
+++|.+. ....+..+..+..+++..|.++..-+ +..+. .|+.+++++|++. .++..+..+..+..+++++|.+
T Consensus 193 l~~n~i~--~i~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~ 267 (414)
T KOG0531|consen 193 LGGNSIR--EIEGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRI 267 (414)
T ss_pred ccCCchh--cccchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhccc
Confidence 9999998 33556677778888999999984322 22333 3899999999998 4557788899999999999999
Q ss_pred ccccC
Q 046598 586 EGVVP 590 (986)
Q Consensus 586 ~~~~p 590 (986)
+..-.
T Consensus 268 ~~~~~ 272 (414)
T KOG0531|consen 268 SNLEG 272 (414)
T ss_pred ccccc
Confidence 86543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=2e-09 Score=102.49 Aligned_cols=129 Identities=22% Similarity=0.248 Sum_probs=96.4
Q ss_pred cccccccceeEEEEEECCCCeEEEEEEeec--cC------chhHHHHHHHHHHHhcCCC--CcceeeeeeccccccCCCc
Q 046598 694 NQIGEGSFGSVFKGILDDGRTTIAVKVFNL--LH------HGAFKSFIAECNTLKNIRH--RNLVKILTACSGVDYQGND 763 (986)
Q Consensus 694 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~------~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~~~ 763 (986)
..+++|+-+.+|.+.+.+ .++++|.-.+ .. .-..++..+|++++.+++- -++..++++ +..
T Consensus 2 ~~i~~GAEa~i~~~~~~g--~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv-------D~~ 72 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG--LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV-------DPD 72 (204)
T ss_pred chhhCCcceeEEeeeccC--cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE-------cCC
Confidence 357899999999998754 4577775321 11 1123467789999988753 344444544 345
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
...|+|||++|..|.+++... ...++..+-.-+.-||.. ||||||+.++||.+..+. +.
T Consensus 73 ~~~I~me~I~G~~lkd~l~~~-----------------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~ 131 (204)
T COG3642 73 NGLIVMEYIEGELLKDALEEA-----------------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IY 131 (204)
T ss_pred CCEEEEEEeCChhHHHHHHhc-----------------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EE
Confidence 678999999999999888511 245778888888999999 999999999999998665 99
Q ss_pred Eccccccee
Q 046598 844 IGDFGLARF 852 (986)
Q Consensus 844 L~DFG~a~~ 852 (986)
++|||++..
T Consensus 132 ~IDfGLg~~ 140 (204)
T COG3642 132 FIDFGLGEF 140 (204)
T ss_pred EEECCcccc
Confidence 999999974
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=1.6e-10 Score=134.80 Aligned_cols=206 Identities=24% Similarity=0.292 Sum_probs=148.8
Q ss_pred HhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCC
Q 046598 685 NATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 761 (986)
Q Consensus 685 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 761 (986)
...+.+.+.+-+-+|.++.++.+.-...+...+.|+..... ....+....+-.+.-..++|-+++.... +..
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s-----~~~ 875 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPS-----FPC 875 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCC-----CCC
Confidence 34567778888999999999998887777666666553221 1112222223223323345666655433 445
Q ss_pred CceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCc
Q 046598 762 NDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI 841 (986)
Q Consensus 762 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 841 (986)
....++|++|+.+++|...++... ..+.+..+.....+..+.+|||.. .+.|+|++|.|++...+++
T Consensus 876 rsP~~L~~~~~~~~~~~Skl~~~~----------~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh 942 (1205)
T KOG0606|consen 876 RSPLPLVGHYLNGGDLPSKLHNSG----------CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGH 942 (1205)
T ss_pred CCCcchhhHHhccCCchhhhhcCC----------CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCC
Confidence 678899999999999999987443 234444555667788999999998 7999999999999999999
Q ss_pred EEEcccccceecCCC---------------------C--------CccccccccccccccccccccCCCcCcccchhhHH
Q 046598 842 AHIGDFGLARFLPLS---------------------S--------AQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYG 892 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~---------------------~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG 892 (986)
.+++|||.......- . .........+|+.|.|||...+......+|.|++|
T Consensus 943 ~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g 1022 (1205)
T KOG0606|consen 943 RPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSG 1022 (1205)
T ss_pred cccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhh
Confidence 999999844322100 0 00112345689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCcc
Q 046598 893 ILLLELITRKKPTDIM 908 (986)
Q Consensus 893 vvl~elltg~~pf~~~ 908 (986)
++++|.++|.+||+..
T Consensus 1023 ~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 1023 VCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred hhhhhhhcCCCCCCCc
Confidence 9999999999999743
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.96 E-value=4.8e-09 Score=109.51 Aligned_cols=145 Identities=18% Similarity=0.196 Sum_probs=107.6
Q ss_pred cccccccceeEEEEEECCCCeEEEEEEeeccCc-hhHHHHHHHHHHHhcCCC--CcceeeeeeccccccCCCceEEEEEE
Q 046598 694 NQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH-GAFKSFIAECNTLKNIRH--RNLVKILTACSGVDYQGNDFKALVFE 770 (986)
Q Consensus 694 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~~~~~~lv~e 770 (986)
+.++.|..+.||++...+ +..+++|+...... .....+.+|+++++.+++ ..+.+++.++... ...+..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~--~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDP--SVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCC--CccCCceEEEE
Confidence 578999999999998865 57899998754322 134678899999999865 3456677663221 11235689999
Q ss_pred eccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcC------------------------------
Q 046598 771 FMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDC------------------------------ 820 (986)
Q Consensus 771 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~------------------------------ 820 (986)
|++|.++.+.+.. ..++..+...++.++++++.+||+..
T Consensus 81 ~i~G~~l~~~~~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (223)
T cd05154 81 RVDGRVLRDRLLR-----------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDAS 149 (223)
T ss_pred EeCCEecCCCCCC-----------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhh
Confidence 9999888775520 24667777788888888888888521
Q ss_pred -----------------------CCCeEeecCCCCCeEecC--CCcEEEccccccee
Q 046598 821 -----------------------QPPIAHCDLKPSNILLDE--DMIAHIGDFGLARF 852 (986)
Q Consensus 821 -----------------------~~~ivH~Dlkp~NIll~~--~~~~kL~DFG~a~~ 852 (986)
...++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 150 RTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred cccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246899999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.95 E-value=4.7e-09 Score=99.10 Aligned_cols=143 Identities=20% Similarity=0.212 Sum_probs=99.1
Q ss_pred CCcccccccceeEEEEEECCCCeEEEEEEeec--------cCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 692 SVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL--------LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 692 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--------~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
....+.+|+-+.|+++.+.+ +..+||.-.. ...-..++..+|++.+.+.+--.|.-..-+ +-+..
T Consensus 11 ~l~likQGAEArv~~~~~~G--e~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~-----~~D~~ 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSG--EAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLI-----FIDTY 83 (229)
T ss_pred cceeeeccceeeEeeeccCC--ceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEE-----EEecC
Confidence 56788999999999999875 6666774321 111124567889999988743222211111 11234
Q ss_pred eEEEEEEeccC-CCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCC--
Q 046598 764 FKALVFEFMHN-RSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDM-- 840 (986)
Q Consensus 764 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-- 840 (986)
.-.|+|||++| .++.+++...-.. .........++.+|-+.+.-||.. +|+||||..+||++..++
T Consensus 84 ~~~i~ME~~~g~~~vk~~i~~~~~~--------~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~ 152 (229)
T KOG3087|consen 84 GGQIYMEFIDGASTVKDFILSTMED--------ESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQ 152 (229)
T ss_pred CCeEEEEeccchhHHHHHHHHHccC--------cccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCc
Confidence 45799999976 5788888633211 112222367889999999999999 999999999999997665
Q ss_pred -cEEEccccccee
Q 046598 841 -IAHIGDFGLARF 852 (986)
Q Consensus 841 -~~kL~DFG~a~~ 852 (986)
.+.++|||++..
T Consensus 153 ~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 153 ITPILIDFGLSSV 165 (229)
T ss_pred CceEEEeecchhc
Confidence 468999999964
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=5.3e-11 Score=122.66 Aligned_cols=182 Identities=21% Similarity=0.239 Sum_probs=118.0
Q ss_pred CCCCCEEEccCccceeecCccccc-----ccccEEEecccccCCCCCc-------------ccCCCCCCCeeecCCCccC
Q 046598 404 LQNLKDLRLQRNRFQGNIPPSIGN-----LKLFILYLSYNFLQGSIPS-------------SLGRYETLTTIDLSNNNLT 465 (986)
Q Consensus 404 l~~L~~L~Ls~N~l~~~~~~~~~~-----~~L~~L~L~~N~l~~~~p~-------------~~~~l~~L~~L~L~~N~l~ 465 (986)
.++|++|+||+|-|....+..+.. ..|+.|+|.+|.+...... ..+.-+.|+++..++|++.
T Consensus 91 ~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrle 170 (382)
T KOG1909|consen 91 CPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLE 170 (382)
T ss_pred CCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccc
Confidence 345555555555555433333321 1355555655555422111 1233467888888888886
Q ss_pred CCCCcc----cccCCCcceEEEccCCccccc----CCcccccccccchhhccCcccccc----CcccccCCccccEEecc
Q 046598 466 GTIPPQ----FIGLSSSLIVLDLSRNQLTGS----IPSEVGNLKNLEILNVFGNKLKGE----IPSTLGSCIKLEQLEMQ 533 (986)
Q Consensus 466 ~~ip~~----~~~~~~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~ 533 (986)
.-+.. .+...+.|+.+.++.|.|... +...|..+++|+.|||.+|-|+.. +...+..+++|++|+++
T Consensus 171 -n~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~ 249 (382)
T KOG1909|consen 171 -NGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLG 249 (382)
T ss_pred -cccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccc
Confidence 33322 234457788888888887621 223467788999999999988832 45567778889999999
Q ss_pred cccccccCCccc-----cCCCCCCEEeCCCccCcc----cCchhhhcccccceeeccCCccc
Q 046598 534 ENFLQGPIPSSL-----SSLRGLSVLDLSQNNLSG----KIPELLIRLQLVKNLNLSNNDLE 586 (986)
Q Consensus 534 ~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~l~ls~N~l~ 586 (986)
++.++..-...| ...++|+.|.|.+|.|+. .+...+...+.|..|+|++|.+.
T Consensus 250 dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 250 DCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred ccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 998876544333 236789999999998873 23345566788888999998884
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.94 E-value=3.4e-08 Score=107.39 Aligned_cols=181 Identities=16% Similarity=0.108 Sum_probs=137.1
Q ss_pred cceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEEEEeccC-CCHh
Q 046598 700 SFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHN-RSLE 778 (986)
Q Consensus 700 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-gsL~ 778 (986)
...+.|++....+|..|++|+++............-+++++++.|+|||++.+++... --++...++||+|+++ ++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~-tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTY-TFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhh-ccCcceEEEEEecCCCCchHH
Confidence 3457899999999999999999543333333445668899999999999999987643 2345678999999987 6777
Q ss_pred HhhccCCCCC-----ccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcccccceec
Q 046598 779 EWLHPITRED-----ETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFL 853 (986)
Q Consensus 779 ~~l~~~~~~~-----~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 853 (986)
++-....... .....+...++..+|.++.|+..||.++|+. |+.-+-+.|.+|+++.+.+++|+..|....+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence 7654332221 1234456688999999999999999999999 9999999999999999999999887777655
Q ss_pred CCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCC
Q 046598 854 PLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKK 903 (986)
Q Consensus 854 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~ 903 (986)
..+.. |.+.+ -.+-|.=.||.+++.+.||..
T Consensus 444 ~~d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 444 QEDPT----------------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred cCCCC----------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 43321 11111 235699999999999999964
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.94 E-value=6.3e-09 Score=103.22 Aligned_cols=125 Identities=23% Similarity=0.225 Sum_probs=83.4
Q ss_pred eEEEEEECCCCeEEEEEEeeccC-------------c-------------hhHHHHHHHHHHHhcCCCC--cceeeeeec
Q 046598 703 SVFKGILDDGRTTIAVKVFNLLH-------------H-------------GAFKSFIAECNTLKNIRHR--NLVKILTAC 754 (986)
Q Consensus 703 ~Vy~~~~~~~~~~vavK~~~~~~-------------~-------------~~~~~~~~E~~~l~~l~h~--niv~l~~~~ 754 (986)
.||.|...+ +..+|||+.+... . .......+|++.|.++..- ++.+++++
T Consensus 1 ~Vy~~~~~~-~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~- 78 (188)
T PF01163_consen 1 DVYHAIDPD-GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY- 78 (188)
T ss_dssp EEEEEEECT-TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred CEEEEECCC-CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence 389999876 6899999985210 0 0123467899999999654 56777766
Q ss_pred cccccCCCceEEEEEEecc--CCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHH-HHhcCCCCeEeecCCC
Q 046598 755 SGVDYQGNDFKALVFEFMH--NRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNY-LHHDCQPPIAHCDLKP 831 (986)
Q Consensus 755 ~~~~~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~-LH~~~~~~ivH~Dlkp 831 (986)
...++||||++ |..+..... ..++..+...++.+++..+.. +|+. ||+|||+.+
T Consensus 79 --------~~~~ivME~I~~~G~~~~~l~~------------~~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~ 135 (188)
T PF01163_consen 79 --------NRNVIVMEYIGEDGVPLPRLKD------------VDLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSE 135 (188)
T ss_dssp --------ETTEEEEE--EETTEEGGCHHH------------CGGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-ST
T ss_pred --------eCCEEEEEecCCCccchhhHHh------------ccccchhHHHHHHHHHHHHHHHHHhc---CceecCCCh
Confidence 34579999998 655554432 011133456778888886665 5687 999999999
Q ss_pred CCeEecCCCcEEEcccccceec
Q 046598 832 SNILLDEDMIAHIGDFGLARFL 853 (986)
Q Consensus 832 ~NIll~~~~~~kL~DFG~a~~~ 853 (986)
.||+++++ .+.++|||.+...
T Consensus 136 ~NIlv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 136 YNILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp TSEEEETT-CEEE--GTTEEET
T ss_pred hhEEeecc-eEEEEecCcceec
Confidence 99999987 8999999999754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.9e-09 Score=131.02 Aligned_cols=106 Identities=30% Similarity=0.312 Sum_probs=67.4
Q ss_pred CCCEEEccCCC--ccccCCcchhccccCceeeceecccCCCCccchhcCccccceecccccccCccCccccCCCCCCeEE
Q 046598 87 FLKVLRLYNNS--FNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHIS 164 (986)
Q Consensus 87 ~L~~L~L~~n~--l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 164 (986)
.|++|-+..|. +..+.++.|..++.|++|||++|.=-+.+|..++.|-+|++|+|++..++ .+|..+++|.+|.+|+
T Consensus 546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Ln 624 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLN 624 (889)
T ss_pred ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheec
Confidence 46666666664 44333445666677777777766555566777777777777777776666 6666666667777777
Q ss_pred ccCCcCCCCcccccCCCcCcceeeccCCc
Q 046598 165 VNDNNLTGSIPSSLGNLSSIRSLFLSGNN 193 (986)
Q Consensus 165 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 193 (986)
+..+.-...+|.....|++|++|.+..-.
T Consensus 625 l~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 625 LEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred cccccccccccchhhhcccccEEEeeccc
Confidence 66665544455555566666666665543
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.2e-10 Score=120.14 Aligned_cols=232 Identities=21% Similarity=0.258 Sum_probs=135.3
Q ss_pred eEEEEeccCCCCccc----cCcCccCCCCCCEEEccCC---CccccCCcc-------hhccccCceeeceecccCCCCcc
Q 046598 63 RVTILDLESLKLAGS----ISPHVGNLSFLKVLRLYNN---SFNHEIPSE-------FDRLRRLQVLALHYNSIGGAIPA 128 (986)
Q Consensus 63 ~v~~l~l~~~~l~~~----~~~~~~~l~~L~~L~L~~n---~l~~~~p~~-------~~~l~~L~~L~L~~N~l~~~~p~ 128 (986)
.++.++|++|.+... +.+.+.+.+.|+.-++|+- ++...+|++ +-..++|++||||+|-|.-.-+.
T Consensus 31 s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~~ 110 (382)
T KOG1909|consen 31 SLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGIR 110 (382)
T ss_pred ceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccchH
Confidence 478889998887643 3455667788888888863 233345544 34556888888888888744443
Q ss_pred c----hhcCccccceecccccccCcc-------------CccccCCCCCCeEEccCCcCCCC----cccccCCCcCccee
Q 046598 129 N----ISSCSNLIQLRLFHNQLVGKI-------------PSELSSLSKIEHISVNDNNLTGS----IPSSLGNLSSIRSL 187 (986)
Q Consensus 129 ~----~~~l~~L~~L~Ls~N~l~~~~-------------p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L 187 (986)
. +.++++|++|+|.+|.+.-.- ..-.++-++|+++...+|++..- +...|...+.|+.+
T Consensus 111 ~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leev 190 (382)
T KOG1909|consen 111 GLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEV 190 (382)
T ss_pred HHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhccccceE
Confidence 3 456778888888888775211 11223345666666666666421 22345555666666
Q ss_pred eccCCcccC----cCcchhhccCCCceeecccccccccCCccccCCCCccEEeccccccccccCCcccccccccceEEec
Q 046598 188 FLSGNNLEG----SIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVG 263 (986)
Q Consensus 188 ~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~ 263 (986)
.+..|.|.. .+...|..+++|+.|||..|-++..-...++ .....+++|+.|+++
T Consensus 191 r~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~La---------------------kaL~s~~~L~El~l~ 249 (382)
T KOG1909|consen 191 RLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALA---------------------KALSSWPHLRELNLG 249 (382)
T ss_pred EEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHH---------------------HHhcccchheeeccc
Confidence 666666541 1223455566666666666665532111111 011234566677777
Q ss_pred CceecccCCc----cc-cCCCCCcEEecccccccCCC-----chhhhhhhHhhhhhccCCCC
Q 046598 264 ENQLTGAIPP----TI-SNASNLEIFHGSVNKLTGAA-----PYLEKLQRLLVFGILGNSLG 315 (986)
Q Consensus 264 ~N~l~~~~p~----~l-~~l~~L~~L~ls~N~l~~~~-----~~l~~l~~L~~l~l~~n~l~ 315 (986)
+|.++..-.. .+ ...++|+++.+.+|.++.-. ..+...+.|..|++.+|.++
T Consensus 250 dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 250 DCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred ccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 7766632222 11 22567777777777776321 22344677777888888775
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.87 E-value=3.1e-08 Score=104.77 Aligned_cols=203 Identities=14% Similarity=0.144 Sum_probs=136.2
Q ss_pred CCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcC-CCCcceeeeeeccc--cccCCCceEEE
Q 046598 691 SSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSG--VDYQGNDFKAL 767 (986)
Q Consensus 691 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~--~~~~~~~~~~l 767 (986)
...+.||+|+.+.+|-.-.- ...+.|++......... +.+..|... .||-+-.-+.|=.. ..........+
T Consensus 14 ~~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CCCccccCCccceeeecchh---hchhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 34578999999999965332 23466887643332222 223334433 56644332222100 00122334678
Q ss_pred EEEeccCC-CHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 768 VFEFMHNR-SLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 768 v~e~~~~g-sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
.|..+++. .+..+....++. ..-....|.-.++.++.++.+.+.||.. |.+-||+.++|+||.+++.+.|.|
T Consensus 88 lmP~v~g~~pI~~~y~p~tRR----qs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVd 160 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRR----QSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVD 160 (637)
T ss_pred ecccCCCccchhhhcCchhhc----ccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEc
Confidence 88888764 333333332222 3344578999999999999999999999 999999999999999999999998
Q ss_pred cccceecCCCCCcccccccccccccccccccc-----CCCcCcccchhhHHHHHHHHHhC-CCCCCccc
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGL-----GSEVSISGDVYSYGILLLELITR-KKPTDIMF 909 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg-~~pf~~~~ 909 (986)
=..-... .........+|...|.+||.-. +..-+...|-|.+||++|+++.| ++||.+..
T Consensus 161 sDsfqi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~ 226 (637)
T COG4248 161 SDSFQIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIP 226 (637)
T ss_pred ccceeec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccc
Confidence 5544322 2334445577999999999643 44567889999999999999886 99998653
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.4e-09 Score=130.20 Aligned_cols=125 Identities=27% Similarity=0.339 Sum_probs=55.5
Q ss_pred CCCCEEEccCCCccccCCcchhccccCceeeceecc--cCCCCccchhcCccccceecccccccCccCccccCCCCCCeE
Q 046598 86 SFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNS--IGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHI 163 (986)
Q Consensus 86 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~--l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 163 (986)
...+...+.+|.+. .++....+ ++|++|-+..|. +....++.|..++.|+.||||+|.=-+.+|..+++|-+|++|
T Consensus 523 ~~~rr~s~~~~~~~-~~~~~~~~-~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL 600 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIE-HIAGSSEN-PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYL 600 (889)
T ss_pred hheeEEEEeccchh-hccCCCCC-CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcc
Confidence 44455555555553 22222222 145555555553 332223334445555555555544333444444444444444
Q ss_pred EccCCcCCCCcccccCCCcCcceeeccCCcccCcCcchhhccCCCceeec
Q 046598 164 SVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTM 213 (986)
Q Consensus 164 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 213 (986)
+|++..++ .+|..+++|..|.+|++..+.-...+|.....|++|++|.+
T Consensus 601 ~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l 649 (889)
T KOG4658|consen 601 DLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRL 649 (889)
T ss_pred cccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEe
Confidence 44444444 44444444444444444444433233333334444444443
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.84 E-value=1.7e-08 Score=102.07 Aligned_cols=136 Identities=21% Similarity=0.158 Sum_probs=102.9
Q ss_pred CCCCcccccccceeEEEEEECCCCeEEEEEEeeccC----------------------chhHHHHHHHHHHHhcCCCC--
Q 046598 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH----------------------HGAFKSFIAECNTLKNIRHR-- 745 (986)
Q Consensus 690 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~E~~~l~~l~h~-- 745 (986)
+.+..+||.|--+.||.|.+.. +.++|||.-+... .......++|.++|+++...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~-g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPK-GRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECCC-CCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 4466889999999999999986 7899999754110 01133567899999998654
Q ss_pred cceeeeeeccccccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 046598 746 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIA 825 (986)
Q Consensus 746 niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iv 825 (986)
.|.+.+++ +...+||||++|-.|...- ++.+....|+..|+.-+..+-.. |||
T Consensus 172 ~VP~P~~~---------nRHaVvMe~ieG~eL~~~r---------------~~~en~~~il~~il~~~~~~~~~---GiV 224 (304)
T COG0478 172 KVPKPIAW---------NRHAVVMEYIEGVELYRLR---------------LDVENPDEILDKILEEVRKAYRR---GIV 224 (304)
T ss_pred CCCCcccc---------ccceeeeehcccceeeccc---------------CcccCHHHHHHHHHHHHHHHHHc---Ccc
Confidence 77787777 6779999999886665432 13334455666666666666666 999
Q ss_pred eecCCCCCeEecCCCcEEEcccccceec
Q 046598 826 HCDLKPSNILLDEDMIAHIGDFGLARFL 853 (986)
Q Consensus 826 H~Dlkp~NIll~~~~~~kL~DFG~a~~~ 853 (986)
|||+++-||+++++|.+.++||-.+...
T Consensus 225 HGDlSefNIlV~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 225 HGDLSEFNILVTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred ccCCchheEEEecCCCEEEEeCcccccC
Confidence 9999999999999999999999877543
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.81 E-value=2.9e-09 Score=85.16 Aligned_cols=60 Identities=42% Similarity=0.583 Sum_probs=37.6
Q ss_pred cccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCcc
Q 046598 526 KLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDL 585 (986)
Q Consensus 526 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l 585 (986)
+|++|++++|+|+...+..|..+++|++|++++|+|+...|..|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 556666666666655555666666666666666666655556666666666666666654
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.75 E-value=5e-09 Score=83.78 Aligned_cols=58 Identities=38% Similarity=0.543 Sum_probs=23.3
Q ss_pred ccceecccccccCccCccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeeccCCc
Q 046598 136 LIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNN 193 (986)
Q Consensus 136 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 193 (986)
|++|++++|+++...+.+|.++++|++|++++|+++...|..|.++++|++|++++|+
T Consensus 3 L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 3 LESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp ESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred CcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 3344444444443323334444444444444444443333344444444444444443
|
... |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.69 E-value=2.4e-07 Score=97.86 Aligned_cols=145 Identities=14% Similarity=0.047 Sum_probs=96.8
Q ss_pred ccccccceeEEEEEECCCCeEEEEEEeeccCch-----------hHHHHHHHHHHHhcCCCCc--ceeeeeeccccccCC
Q 046598 695 QIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHG-----------AFKSFIAECNTLKNIRHRN--LVKILTACSGVDYQG 761 (986)
Q Consensus 695 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~ 761 (986)
.+-+.....|+++... |+.|.||........ ....+.+|.+.+.++.... +.+.+++........
T Consensus 29 ~v~~~~~rrvvr~~~~--g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 29 VFRELEGRRTLRFELA--GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred EEecCCCceEEEEEEC--CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444456676664 578999977432211 1114778888887773222 223333321110111
Q ss_pred CceEEEEEEeccCC-CHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecC--
Q 046598 762 NDFKALVFEFMHNR-SLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDE-- 838 (986)
Q Consensus 762 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-- 838 (986)
....++|||++++. +|.+++.... ....+...+..++.+++..+.-||.. ||+|||++++|||++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~--------~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~ 175 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA--------TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPF 175 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc--------ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccc
Confidence 34578999999885 8999884211 12345667788999999999999999 9999999999999975
Q ss_pred -----CCcEEEccccccee
Q 046598 839 -----DMIAHIGDFGLARF 852 (986)
Q Consensus 839 -----~~~~kL~DFG~a~~ 852 (986)
++.+.++||+.++.
T Consensus 176 ~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 176 PGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred cCCCCCceEEEEECCcccc
Confidence 46899999998853
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.68 E-value=5.8e-10 Score=99.32 Aligned_cols=111 Identities=23% Similarity=0.322 Sum_probs=59.0
Q ss_pred cceEEEccCCcccccCCccccc-ccccchhhccCccccccCcccccCCccccEEecccccccccCCccccCCCCCCEEeC
Q 046598 478 SLIVLDLSRNQLTGSIPSEVGN-LKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDL 556 (986)
Q Consensus 478 ~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 556 (986)
.|+..+|++|.+. .+|..|.. .+.++.|+|++|+|+ .+|.++..++.|+.|+++.|.|. ..|..+..|.+|..||.
T Consensus 54 el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds 130 (177)
T KOG4579|consen 54 ELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDS 130 (177)
T ss_pred eEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcC
Confidence 3444555555555 33433332 235555555555555 45555555555555555555555 44555555666666666
Q ss_pred CCccCcccCchhhhcccccceeeccCCccccccCCc
Q 046598 557 SQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQ 592 (986)
Q Consensus 557 s~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~ 592 (986)
.+|.+. .+|-.+.--+.....++.++++.+.-+..
T Consensus 131 ~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~k 165 (177)
T KOG4579|consen 131 PENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKK 165 (177)
T ss_pred CCCccc-cCcHHHhccccHHHHHhcCCcccccCccc
Confidence 666655 34433332333344556777777665554
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.64 E-value=5.9e-10 Score=124.40 Aligned_cols=129 Identities=30% Similarity=0.356 Sum_probs=82.0
Q ss_pred CCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccCcc-cccCCccccEEe
Q 046598 453 TLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPS-TLGSCIKLEQLE 531 (986)
Q Consensus 453 ~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~ 531 (986)
+|.+.+.++|++. .+... +..++.|+.|||++|+++.. +.+..++.|++|||+.|.+. .+|. ....+. |..|.
T Consensus 165 ~L~~a~fsyN~L~-~mD~S-Lqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~ 238 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDES-LQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLN 238 (1096)
T ss_pred hHhhhhcchhhHH-hHHHH-HHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhh-heeee
Confidence 4566666677665 44433 55566677777777777643 25666777777777777776 3442 222333 77777
Q ss_pred cccccccccCCccccCCCCCCEEeCCCccCcccCc-hhhhcccccceeeccCCcccccc
Q 046598 532 MQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIP-ELLIRLQLVKNLNLSNNDLEGVV 589 (986)
Q Consensus 532 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~l~ls~N~l~~~~ 589 (986)
|++|.++.. ..+.+|++|+.|||++|-|++.-. ..+..|..|++|+|.+|++.+.+
T Consensus 239 lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 239 LRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred ecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 777777632 346677777777888877764322 23456777788888888887653
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.52 E-value=5.9e-09 Score=93.01 Aligned_cols=132 Identities=24% Similarity=0.310 Sum_probs=74.9
Q ss_pred eEEEEeccCCCCccccCcCc---cCCCCCCEEEccCCCccccCCcchh-ccccCceeeceecccCCCCccchhcCccccc
Q 046598 63 RVTILDLESLKLAGSISPHV---GNLSFLKVLRLYNNSFNHEIPSEFD-RLRRLQVLALHYNSIGGAIPANISSCSNLIQ 138 (986)
Q Consensus 63 ~v~~l~l~~~~l~~~~~~~~---~~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 138 (986)
..-.+||+++.+. .+++.. .....|+..+|++|.+.. .|+.|. ..+.++.|+|++|+|+ .+|.++..++.|+.
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~-fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~ 104 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKK-FPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRS 104 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhh-CCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhh
Confidence 3445677777654 344433 333455555777777763 444443 3346677777777776 66666777777777
Q ss_pred eecccccccCccCccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeeccCCcccCcCc
Q 046598 139 LRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIP 199 (986)
Q Consensus 139 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 199 (986)
|+++.|.+. ..|..|..|.+|-.|+..+|.+. .+|..+-.-+..-..++.++.+.+.-+
T Consensus 105 lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~ 163 (177)
T KOG4579|consen 105 LNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETK 163 (177)
T ss_pred cccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCc
Confidence 777777766 55666666666666666666665 333333222333334445555554433
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.52 E-value=6.8e-09 Score=116.18 Aligned_cols=172 Identities=25% Similarity=0.267 Sum_probs=124.6
Q ss_pred ccccEEEecccccCCCCCcccCCC-CCCCeeecCCCccC----------CCCCcccccCCCcceEEEccCCcccccCCcc
Q 046598 428 LKLFILYLSYNFLQGSIPSSLGRY-ETLTTIDLSNNNLT----------GTIPPQFIGLSSSLIVLDLSRNQLTGSIPSE 496 (986)
Q Consensus 428 ~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~----------~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~ 496 (986)
.+|+.|.|.++.|.. ...+..+ ..|++|.. +|.+. |.+-..+. ...|...+.+.|.++ .....
T Consensus 109 ~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC-~~Sl~Al~~v~ascggd~~ns~~--Wn~L~~a~fsyN~L~-~mD~S 182 (1096)
T KOG1859|consen 109 RSLRVLELRGCDLST--AKGLQELRHQLEKLIC-HNSLDALRHVFASCGGDISNSPV--WNKLATASFSYNRLV-LMDES 182 (1096)
T ss_pred cceeeEEecCcchhh--hhhhHHHHHhhhhhhh-hccHHHHHHHHHHhccccccchh--hhhHhhhhcchhhHH-hHHHH
Confidence 368899999888873 1222222 24555544 33332 22222211 135788899999998 67888
Q ss_pred cccccccchhhccCccccccCcccccCCccccEEecccccccccCCc-cccCCCCCCEEeCCCccCcccCchhhhccccc
Q 046598 497 VGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPS-SLSSLRGLSVLDLSQNNLSGKIPELLIRLQLV 575 (986)
Q Consensus 497 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 575 (986)
+.-++.|+.|||++|+++.. +.+..+++|+.|||+.|.++. +|. ....+. |+.|.|++|.++.. ..+.+|++|
T Consensus 183 Lqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~-vp~l~~~gc~-L~~L~lrnN~l~tL--~gie~LksL 256 (1096)
T KOG1859|consen 183 LQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRH-VPQLSMVGCK-LQLLNLRNNALTTL--RGIENLKSL 256 (1096)
T ss_pred HHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhcc-ccccchhhhh-heeeeecccHHHhh--hhHHhhhhh
Confidence 88899999999999999954 389999999999999999994 443 334444 99999999999843 347789999
Q ss_pred ceeeccCCccccccCCc--cccccccceeeeCCccccc
Q 046598 576 KNLNLSNNDLEGVVPTQ--GVFKNASITSVFGNLKLCG 611 (986)
Q Consensus 576 ~~l~ls~N~l~~~~p~~--~~~~~~~~~~~~~n~~lcg 611 (986)
+.|||++|-|++.---. +.+..+..+.+.|||.-|.
T Consensus 257 ~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~ 294 (1096)
T KOG1859|consen 257 YGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA 294 (1096)
T ss_pred hccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence 99999999998753222 3455667788999987775
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.51 E-value=2.7e-08 Score=112.46 Aligned_cols=98 Identities=21% Similarity=0.382 Sum_probs=76.6
Q ss_pred HHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcccccceecCCCCCcc-------ccccccccccccccccccC
Q 046598 807 IDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQT-------SSIGAKGSIGYIAPEYGLG 879 (986)
Q Consensus 807 ~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~ 879 (986)
.+++.|+.|+|.. +++||++|.|++|.++..+..||+.|+.+.......... ...-......|.|||++.+
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 3455999999986 699999999999999999999999999986554311111 1111224567999999999
Q ss_pred CCcCcccchhhHHHHHHHHHh-CCCCCC
Q 046598 880 SEVSISGDVYSYGILLLELIT-RKKPTD 906 (986)
Q Consensus 880 ~~~~~~sDvwSlGvvl~ellt-g~~pf~ 906 (986)
...+.++|+||+||++|.+.. |+.-++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~ 211 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIA 211 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhh
Confidence 888999999999999999994 555443
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.47 E-value=2.1e-06 Score=85.49 Aligned_cols=143 Identities=18% Similarity=0.095 Sum_probs=103.2
Q ss_pred cccccceeEEEEEECCCCeEEEEEEeec------cCchhHHHHHHHHHHHhcCCC--CcceeeeeeccccccCCCceEEE
Q 046598 696 IGEGSFGSVFKGILDDGRTTIAVKVFNL------LHHGAFKSFIAECNTLKNIRH--RNLVKILTACSGVDYQGNDFKAL 767 (986)
Q Consensus 696 lg~G~~g~Vy~~~~~~~~~~vavK~~~~------~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~~~~~~l 767 (986)
-|+||-+.|+.....+ ..+-+|.-.. ..+-....|.+|...+.++.. -.+.+.. ++...........+|
T Consensus 26 ~~rgG~SgV~r~~~~g--~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVERNG--KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEeCC--cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 4679999999987765 3678887541 112245789999999988842 2244444 322111223455789
Q ss_pred EEEeccC-CCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCc--EEE
Q 046598 768 VFEFMHN-RSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI--AHI 844 (986)
Q Consensus 768 v~e~~~~-gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kL 844 (986)
|+|-++| .+|.+++... ...+.+..++..+..++++.++-||+. |+.|+|+.+.||+++.++. +++
T Consensus 103 VTe~L~g~~~L~~~l~~~--------~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~l 171 (216)
T PRK09902 103 VTEDMAGFISIADWYAQH--------AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGF 171 (216)
T ss_pred EEEeCCCCccHHHHHhcC--------CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEE
Confidence 9998854 6898887421 122467778889999999999999999 9999999999999986666 999
Q ss_pred ccccccee
Q 046598 845 GDFGLARF 852 (986)
Q Consensus 845 ~DFG~a~~ 852 (986)
+||.-++.
T Consensus 172 IDlEk~r~ 179 (216)
T PRK09902 172 LDLEKSRR 179 (216)
T ss_pred EEhhccch
Confidence 99987754
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.5e-06 Score=87.48 Aligned_cols=156 Identities=21% Similarity=0.167 Sum_probs=104.1
Q ss_pred CCCcChHHHHHhhcCCCCCcccc---cccceeEEEEEECCCCeEEEEEEeeccCchh-------------------H---
Q 046598 675 FPNISYQNLYNATDRFSSVNQIG---EGSFGSVFKGILDDGRTTIAVKVFNLLHHGA-------------------F--- 729 (986)
Q Consensus 675 ~~~~~~~~~~~~~~~y~~~~~lg---~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-------------------~--- 729 (986)
+-..+...+.....+..+....| .|--+.||+|...+ +..||||+++.....- .
T Consensus 32 ~D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~-~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~l 110 (268)
T COG1718 32 FDKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGD-GRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKL 110 (268)
T ss_pred hhhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCC-CceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHH
Confidence 34456667777777777766544 67777899998754 7899999986321110 0
Q ss_pred --HHHHHHHHHHhcC--CCCcceeeeeeccccccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHH
Q 046598 730 --KSFIAECNTLKNI--RHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNI 805 (986)
Q Consensus 730 --~~~~~E~~~l~~l--~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i 805 (986)
.-..+|..-|+++ .+-.+.+.+++ ..-.+||||+.... .-. +.-...++...+...+
T Consensus 111 v~~W~~kEf~NL~R~~eAGVrvP~Pi~~---------~~nVLvMEfIg~~g---~pA-------P~LkDv~~e~~e~~~~ 171 (268)
T COG1718 111 VFAWARKEFRNLKRAYEAGVRVPEPIAF---------RNNVLVMEFIGDDG---LPA-------PRLKDVPLELEEAEGL 171 (268)
T ss_pred HHHHHHHHHHHHHHHHHcCCCCCCceee---------cCCeEEEEeccCCC---CCC-------CCcccCCcCchhHHHH
Confidence 0123466666655 24455555555 34579999995431 100 0011223333467778
Q ss_pred HHHHHHHHHHHHh-cCCCCeEeecCCCCCeEecCCCcEEEcccccceecC
Q 046598 806 SIDVACALNYLHH-DCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLP 854 (986)
Q Consensus 806 ~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 854 (986)
..++++.+.-|-. . ++||+||+.=|||+. ++.+.|+|||.|....
T Consensus 172 ~~~~v~~~~~l~~~a---~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 172 YEDVVEYMRRLYKEA---GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred HHHHHHHHHHHHHhc---CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 8889999888877 5 999999999999999 8899999999997553
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 986 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 5e-46 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 3e-29 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 7e-46 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 4e-29 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 7e-32 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-31 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-22 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-22 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-21 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-20 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-20 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-21 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-21 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-20 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-20 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-20 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 9e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-18 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 9e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 9e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 9e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 9e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-13 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 7e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-13 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-12 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-12 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-12 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-12 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-12 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-12 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-12 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-12 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-12 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-12 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-12 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-12 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-12 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-12 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-12 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-12 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-12 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 8e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 8e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 8e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 8e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 8e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 8e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-11 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-11 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-11 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-11 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 7e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 8e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 8e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 8e-11 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-10 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-10 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-10 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-10 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-10 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-10 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-10 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-10 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-10 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-10 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 7e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 8e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 8e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 8e-10 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-10 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 8e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 9e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 9e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 9e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 9e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 9e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 9e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 9e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-09 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-09 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-09 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-09 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-09 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 8e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 9e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 9e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-08 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-08 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-08 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-08 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-08 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 7e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 8e-08 | ||
| 4fmz_A | 347 | Crystal Structure Of An Internalin (Inlf) From List | 9e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 9e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-07 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-07 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-07 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-07 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-07 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-07 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-07 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-07 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-07 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-07 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-07 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-07 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-07 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-07 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-07 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-07 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-07 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-07 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-07 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-07 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 8e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 8e-07 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-07 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 9e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-06 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-06 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-06 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-06 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-06 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-06 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-06 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-06 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-06 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-06 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-06 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-06 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-06 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-06 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-06 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-06 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-06 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-06 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-06 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-06 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-06 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-06 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-06 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-06 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-06 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-06 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-06 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-06 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-06 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-06 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 4e-06 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-06 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-06 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 7e-06 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-06 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-06 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 8e-06 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-06 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 9e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-05 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-05 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-05 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-05 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-05 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-05 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-05 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-05 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-05 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-05 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-05 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-05 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-05 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-05 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-05 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 4e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-05 | ||
| 4b8c_D | 727 | Nuclease Module Of The Yeast Ccr4-Not Complex Lengt | 5e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 6e-05 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-05 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 6e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-05 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-05 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-05 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-05 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 8e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 9e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-04 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-04 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-04 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-04 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-04 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-04 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-04 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-04 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-04 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-04 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-04 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-04 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-04 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-04 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-04 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-04 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-04 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-04 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-04 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-04 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-04 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-04 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-04 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-04 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-04 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-04 | ||
| 2z7x_B | 520 | Crystal Structure Of The Tlr1-Tlr2 Heterodimer Indu | 4e-04 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-04 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-04 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-04 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-04 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-04 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-04 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-04 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-04 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-04 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-04 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-04 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-04 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-04 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-04 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-04 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-04 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-04 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-04 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-04 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-04 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-04 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-04 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-04 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-04 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-04 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-04 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-04 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 7e-04 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-04 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 7e-04 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-04 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 7e-04 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 7e-04 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-04 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-04 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-04 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 8e-04 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 8e-04 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-04 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 8e-04 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 8e-04 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-04 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-04 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-04 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-04 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 9e-04 | ||
| 2id5_A | 477 | Crystal Structure Of The Lingo-1 Ectodomain Length | 9e-04 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-04 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4FMZ|A Chain A, Crystal Structure Of An Internalin (Inlf) From Listeria Monocytogenes Str. 4b F2365 At 1.91 A Resolution Length = 347 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2Z7X|B Chain B, Crystal Structure Of The Tlr1-Tlr2 Heterodimer Induced By Binding Of A Tri-Acylated Lipopeptide Length = 520 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2ID5|A Chain A, Crystal Structure Of The Lingo-1 Ectodomain Length = 477 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 477 bits (1230), Expect = e-155
Identities = 168/575 (29%), Positives = 259/575 (45%), Gaps = 27/575 (4%)
Query: 65 TILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGG 124
LD+ S + I P +G+ S L+ L + N + + L++L + N G
Sbjct: 203 EFLDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVG 261
Query: 125 AIPANISSCSNLIQLRLFHNQLVGKIPSELS-SLSKIEHISVNDNNLTGSIPSSLGNLSS 183
IP +L L L N+ G+IP LS + + + ++ N+ G++P G+ S
Sbjct: 262 PIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSL 319
Query: 184 IRSLFLSGNNLEGSIP-DTLGWLKNLVNLTMAQNRLSGTIPSSIFNIS-SITGFDAGVNK 241
+ SL LS NN G +P DTL ++ L L ++ N SG +P S+ N+S S+ D N
Sbjct: 320 LESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNN 379
Query: 242 IQGAIPLDYG-FSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAP-YLE 299
G I + LQ + N TG IPPT+SN S L H S N L+G P L
Sbjct: 380 FSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLG 439
Query: 300 KLQRLLVFGILGNSL-GSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTT 358
L +L + N L G L L+ L+++ N+ G +P+ +SN T
Sbjct: 440 SLSKLRDLKLWLNMLEGE-------IPQELMYVKTLETLILDFNDLTGEIPSGLSNC-TN 491
Query: 359 LEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQ 418
L + L NN++ G IP IG+ NL L + +N SG IP +G+ ++L L L N F
Sbjct: 492 LNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFN 551
Query: 419 GNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNN--NLTGTIPPQFIGLS 476
G IP ++ ++ NF+ G + + N G Q +
Sbjct: 552 GTIPAAMFKQSGK---IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQ-LNRL 607
Query: 477 SSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENF 536
S+ +++ G N ++ L++ N L G IP +GS L L + N
Sbjct: 608 STRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHND 667
Query: 537 LQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQGVFK 596
+ G IP + LRGL++LDLS N L G+IP+ + L ++ ++LSNN+L G +P G F+
Sbjct: 668 ISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFE 727
Query: 597 NASITSVFGNLKLCGGIPEFQLPTCSSKKSKHKKS 631
N LCG + LP C +
Sbjct: 728 TFPPAKFLNNPGLCG----YPLPRCDPSNADGYAH 758
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 463 bits (1193), Expect = e-150
Identities = 169/596 (28%), Positives = 258/596 (43%), Gaps = 55/596 (9%)
Query: 10 VTASTVAGNETDRLALLELKSKITHDPLGVLASWNESSHFCQWRGVTCSRRHQRVTILDL 69
AS + L+ K + +L W+ + + C + GVTC +VT +DL
Sbjct: 2 FQASPSQSLYREIHQLISFKDVLPDK--NLLPDWSSNKNPCTFDGVTCR--DDKVTSIDL 57
Query: 70 ESLKLA---GSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAI 126
S L ++S + +L+ L+ L L N+ N + F L L L NS+ G +
Sbjct: 58 SSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPV 116
Query: 127 PA--NISSCSNLIQLRLFHNQLVGKIP-SELSSLSKIEHISVNDNNLTGSIPSSL---GN 180
++ SCS L L + N L S L+ +E + ++ N+++G+
Sbjct: 117 TTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDG 176
Query: 181 LSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVN 240
++ L +SGN + G + + NL L ++ N S IP + + S++ D N
Sbjct: 177 CGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGN 233
Query: 241 KIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEK 300
K+ G + L+ ++ NQ G IPP +L+ + NK TG P
Sbjct: 234 KLSGDFSRAIS-TCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIP---- 286
Query: 301 LQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLE 360
+ G L L ++ N+F G++P + S LE
Sbjct: 287 ------DFLSGAC------------------DTLTGLDLSGNHFYGAVPPFFGSCS-LLE 321
Query: 361 VLLLDNNQIFGNIPA-AIGKFVNLQRLDMCSNRLSGTIPPAIGEL-QNLKDLRLQRNRFQ 418
L L +N G +P + K L+ LD+ N SG +P ++ L +L L L N F
Sbjct: 322 SLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFS 381
Query: 419 GNIPPSIGNLK---LFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGL 475
G I P++ L LYL N G IP +L L ++ LS N L+GTIP L
Sbjct: 382 GPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSL 441
Query: 476 SSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQEN 535
S L L L N L G IP E+ +K LE L + N L GEIPS L +C L + + N
Sbjct: 442 -SKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNN 500
Query: 536 FLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPT 591
L G IP + L L++L LS N+ SG IP L + + L+L+ N G +P
Sbjct: 501 RLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPA 556
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 325 bits (836), Expect = 3e-98
Identities = 130/463 (28%), Positives = 212/463 (45%), Gaps = 48/463 (10%)
Query: 164 SVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIP 223
S N ++ SSL +L+ + SLFLS +++ GS+ +L +L +++N LSG +
Sbjct: 59 SKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLSGPVT 117
Query: 224 S--SIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTI---SNA 278
+ S+ + S + + N + + G L +L+ + N ++GA
Sbjct: 118 TLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGC 177
Query: 279 SNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLL 338
L+ S NK++G ++ L++L
Sbjct: 178 GELKHLAISGNKISGDVD-------------------------------VSRCVNLEFLD 206
Query: 339 ININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIP 398
++ NNF +P + + S L+ L + N++ G+ AI L+ L++ SN+ G IP
Sbjct: 207 VSSNNFSTGIPF-LGDCS-ALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIP 264
Query: 399 PAIGELQNLKDLRLQRNRFQGNIPPSI-GNL-KLFILYLSYNFLQGSIPSSLGRYETLTT 456
P L++L+ L L N+F G IP + G L L LS N G++P G L +
Sbjct: 265 PLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLES 322
Query: 457 IDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLK-NLEILNVFGNKLKG 515
+ LS+NN +G +P + L VLDLS N+ +G +P + NL +L L++ N G
Sbjct: 323 LALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSG 382
Query: 516 EIPSTLGSCIK--LEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQ 573
I L K L++L +Q N G IP +LS+ L L LS N LSG IP L L
Sbjct: 383 PILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLS 442
Query: 574 LVKNLNLSNNDLEGVVPTQGVFKNASITSV-FGNLKLCGGIPE 615
+++L L N LEG +P Q + ++ ++ L G IP
Sbjct: 443 KLRDLKLWLNMLEGEIP-QELMYVKTLETLILDFNDLTGEIPS 484
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 5e-46
Identities = 68/251 (27%), Positives = 107/251 (42%), Gaps = 10/251 (3%)
Query: 378 GKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSY 437
K ++ N + ++ L L+ L L + G++ + L L LS
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSR 109
Query: 438 NFLQGSIPS--SLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPS 495
N L G + + SLG L +++S+N L +SL VLDLS N ++G+
Sbjct: 110 NSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVV 169
Query: 496 EV---GNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLS 552
L+ L + GNK+ G++ + C+ LE L++ N IP L L
Sbjct: 170 GWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQ 226
Query: 553 VLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQGVFKNASITSVFGNLKLCGG 612
LD+S N LSG + +K LN+S+N G +P K+ S+ N K G
Sbjct: 227 HLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP-LKSLQYLSLAEN-KFTGE 284
Query: 613 IPEFQLPTCSS 623
IP+F C +
Sbjct: 285 IPDFLSGACDT 295
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-20
Identities = 37/129 (28%), Positives = 58/129 (44%), Gaps = 1/129 (0%)
Query: 64 VTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIG 123
++ S G SP N + L + N + IP E + L +L L +N I
Sbjct: 610 RNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDIS 669
Query: 124 GAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSS 183
G+IP + L L L N+L G+IP +S+L+ + I +++NNL+G IP G +
Sbjct: 670 GSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM-GQFET 728
Query: 184 IRSLFLSGN 192
N
Sbjct: 729 FPPAKFLNN 737
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 3e-12
Identities = 30/91 (32%), Positives = 48/91 (52%)
Query: 62 QRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNS 121
+ LD+ L+G I +G++ +L +L L +N + IP E LR L +L L N
Sbjct: 632 GSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNK 691
Query: 122 IGGAIPANISSCSNLIQLRLFHNQLVGKIPS 152
+ G IP +S+ + L ++ L +N L G IP
Sbjct: 692 LDGRIPQAMSALTMLTEIDLSNNNLSGPIPE 722
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 295 bits (757), Expect = 2e-92
Identities = 82/285 (28%), Positives = 133/285 (46%), Gaps = 11/285 (3%)
Query: 342 NNFGGSLPACISNLSTTLEVLLLDNNQIFG--NIPAAIGKFVNLQRLDMCS-NRLSGTIP 398
+ G L + + + L L + IP+++ L L + N L G IP
Sbjct: 36 RTWLGVLCDTDTQ-TYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94
Query: 399 PAIGELQNLKDLRLQRNRFQGNIPPSIGNLK-LFILYLSYNFLQGSIPSSLGRYETLTTI 457
PAI +L L L + G IP + +K L L SYN L G++P S+ L I
Sbjct: 95 PAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154
Query: 458 DLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEI 517
N ++G IP + S + +SRN+LTG IP NL NL +++ N L+G+
Sbjct: 155 TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDA 213
Query: 518 PSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKN 577
GS +++ + +N L + + + L+ LDL N + G +P+ L +L+ + +
Sbjct: 214 SVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHS 272
Query: 578 LNLSNNDLEGVVPTQGVFKNASITSVFGNLKLCGGIPEFQLPTCS 622
LN+S N+L G +P G + +++ N LCG LP C+
Sbjct: 273 LNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP----LPACT 313
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 240 bits (616), Expect = 3e-72
Identities = 91/391 (23%), Positives = 145/391 (37%), Gaps = 91/391 (23%)
Query: 18 NETDRLALLELKSKITHDPLGVLASWNESSHFCQ--WRGVTCSRRHQ--RVTILDLESLK 73
N D+ ALL++K + + L+SW ++ C W GV C Q RV LDL L
Sbjct: 4 NPQDKQALLQIKKDLGNPT--TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLN 61
Query: 74 LAGS--ISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANIS 131
L I + NL +L L + N++ G IP I+
Sbjct: 62 LPKPYPIPSSLANLPYLNFLYIGG-----------------------INNLVGPIPPAIA 98
Query: 132 SCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSG 191
+ L L + H + G IP LS + + + + N L+G++P S+ +L ++ + G
Sbjct: 99 KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158
Query: 192 NNLEGSIPDTLGWLKNLVN-LTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDY 250
N + G+IPD+ G L +T+++NRL+G IP + N+
Sbjct: 159 NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL--------------------- 197
Query: 251 GFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGIL 310
NL F + N L G + N + H + N L
Sbjct: 198 -----NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-------------- 238
Query: 311 GNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIF 370
+ + L L + N G+LP ++ L L L + N +
Sbjct: 239 ----------------KVGLSKNLNGLDLRNNRIYGTLPQGLTQL-KFLHSLNVSFNNLC 281
Query: 371 GNIPAAIGKFVNLQRLDMCSNR-LSGTIPPA 400
G IP G +N+ L G+ PA
Sbjct: 282 GEIP-QGGNLQRFDVSAYANNKCLCGSPLPA 311
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 2e-65
Identities = 76/378 (20%), Positives = 133/378 (35%), Gaps = 90/378 (23%)
Query: 125 AIPANISSCSNL----IQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGS--IPSSL 178
I ++ + + L + +G + + ++ ++ ++ NL IPSSL
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72
Query: 179 GNLSSIRSLFLSG-NNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDA 237
NL + L++ G NNL G IP + L L L + +SG IP +
Sbjct: 73 ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ--------- 123
Query: 238 GVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPY 297
++ L N L+G +PP+IS+ NL N+++G
Sbjct: 124 ----------------IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG---- 163
Query: 298 LEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLST 357
++P + S
Sbjct: 164 -------------------------------------------------AIPDSYGSFSK 174
Query: 358 TLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRF 417
+ + N++ G IP NL +D+ N L G G +N + + L +N
Sbjct: 175 LFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSL 233
Query: 418 QGNIPPSIGNLK-LFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLS 476
++ +G K L L L N + G++P L + + L ++++S NNL G IP G
Sbjct: 234 AFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ--GGNL 290
Query: 477 SSLIVLDLSRNQLTGSIP 494
V + N+ P
Sbjct: 291 QRFDVSAYANNKCLCGSP 308
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 198 bits (507), Expect = 3e-57
Identities = 80/329 (24%), Positives = 129/329 (39%), Gaps = 59/329 (17%)
Query: 120 NSIGGAIPANISSCSNLIQLRLFHNQLVG--KIPSELSSLSKIEHISV-NDNNLTGSIPS 176
+ G + + + L L L IPS L++L + + + NNL G IP
Sbjct: 36 RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP 95
Query: 177 SLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFD 236
++ L+ + L+++ N+ G+IPD L +K LV L + N LSGT+P SI ++ ++ G
Sbjct: 96 AIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155
Query: 237 AGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAP 296
N+I GAIP YG + ++ N+LTG IPPT +N NL S N L
Sbjct: 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLE---- 210
Query: 297 YLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLS 356
G +
Sbjct: 211 -------------------------------------------------GDASVLFGSDK 221
Query: 357 TTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNR 416
+ + L N + ++ +G NL LD+ +NR+ GT+P + +L+ L L + N
Sbjct: 222 -NTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN 279
Query: 417 FQGNIPPSIGNLKLFILYLSYNFLQGSIP 445
G IP + + + N P
Sbjct: 280 LCGEIPQGGNLQRFDVSAYANNKCLCGSP 308
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 156 bits (398), Expect = 2e-42
Identities = 48/178 (26%), Positives = 68/178 (38%), Gaps = 14/178 (7%)
Query: 435 LSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIP-PQFIGLSSSLIVLDLS-RNQLTGS 492
G + + + + +DLS NL P P + L L + N L G
Sbjct: 33 CCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGP 92
Query: 493 IPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLS 552
IP + L L L + + G IP L L L+ N L G +P S+SSL L
Sbjct: 93 IPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLV 152
Query: 553 VLDLSQNNLSGKIPELLIRLQ-LVKNLNLSNNDLEGVVPTQGVFKNASITSVFGNLKL 609
+ N +SG IP+ L ++ +S N L G +P F NL L
Sbjct: 153 GITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPT-----------FANLNL 199
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 300 bits (770), Expect = 9e-90
Identities = 118/562 (20%), Positives = 207/562 (36%), Gaps = 30/562 (5%)
Query: 64 VTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIG 123
+T+L+L +L + + S L L + N+ + P +L L+VL L +N +
Sbjct: 27 ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86
Query: 124 GAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSS 183
+ C+NL +L L N + + + + ++ N L+ + + L +
Sbjct: 87 QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLEN 146
Query: 184 IRSLFLSGNNLEGSIPDTLGWLKN--LVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNK 241
++ L LS N ++ + L N L L ++ N++ P I + G +
Sbjct: 147 LQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQ 206
Query: 242 IQGAIP--LDYGFSLQNLQFFSVGENQLTGAIPPTISN--ASNLEIFHGSVNKLTGAAPY 297
+ ++ L + +++ S+ +QL+ T +NL + S N L
Sbjct: 207 LGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGND 266
Query: 298 -LEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTN---ATRLKWLLININNFGGSLPACIS 353
L +L F + N++ L+ L ++ I++ +
Sbjct: 267 SFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQ 326
Query: 354 NLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIG----ELQNLKD 409
L LE L +++N I G +NL+ L + ++ S L
Sbjct: 327 WL-KCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHI 385
Query: 410 LRLQRNRFQGNIPPSIGNLK-LFILYLSYNFLQGSIP-SSLGRYETLTTIDLSNNNLTGT 467
L L +N+ + L L +L L N + + E + I LS N
Sbjct: 386 LNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQL 445
Query: 468 IPPQFIGLSSSLIVLDLSRNQLTG--SIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCI 525
F + SL L L R L S PS L+NL IL++ N + L
Sbjct: 446 TRNSFALV-PSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLE 504
Query: 526 KLEQLEMQENFLQ--------GPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKN 577
KLE L++Q N L G L L L +L+L N E+ L +K
Sbjct: 505 KLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKI 564
Query: 578 LNLSNNDLEGVVPTQGVFKNAS 599
++L N+L + VF N
Sbjct: 565 IDLGLNNLNTLPA--SVFNNQV 584
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 278 bits (712), Expect = 1e-81
Identities = 95/543 (17%), Positives = 189/543 (34%), Gaps = 69/543 (12%)
Query: 65 TILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGG 124
+ D LKL + + + + VL L +N + F R +L L + +N+I
Sbjct: 7 EVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISK 63
Query: 125 AIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSI 184
P L L L HN+L + + + + + N++ + ++
Sbjct: 64 LEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNL 123
Query: 185 RSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQG 244
+L LS N L + T L+NL L ++ N++ +
Sbjct: 124 ITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDI---------------- 167
Query: 245 AIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRL 304
F+ +L+ + NQ+ P L + +L +
Sbjct: 168 -------FANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLT-------- 212
Query: 305 LVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLS-TTLEVLL 363
LC T ++ L ++ + + L T L +L
Sbjct: 213 ------------------EKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLD 254
Query: 364 LDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNI-- 421
L N + + L+ + N + ++ L N++ L L+R+ + +I
Sbjct: 255 LSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISL 314
Query: 422 -------PPSIGNLK-LFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPP--Q 471
S LK L L + N + G + L + LSN+ +
Sbjct: 315 ASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNET 374
Query: 472 FIGLS-SSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIP-STLGSCIKLEQ 529
F+ L+ S L +L+L++N+++ L +LE+L++ N++ E+ + +
Sbjct: 375 FVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFE 434
Query: 530 LEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSG--KIPELLIRLQLVKNLNLSNNDLEG 587
+ + N +S + + L L L + L P L+ + L+LSNN++
Sbjct: 435 IYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIAN 494
Query: 588 VVP 590
+
Sbjct: 495 IND 497
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 5e-81
Identities = 115/564 (20%), Positives = 194/564 (34%), Gaps = 61/564 (10%)
Query: 65 TILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGG 124
T L L S + + L L L +N + +L LQ L L N I
Sbjct: 100 TELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA 159
Query: 125 AIPANISSCSN--LIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLG--- 179
+ +N L +L L NQ+ P ++ ++ + +N+ L S+ L
Sbjct: 160 LKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLEL 219
Query: 180 NLSSIRSLFLSGNNLEGSIPDTLGWLK--NLVNLTMAQNRLSGTIPSSIFNISSITGFDA 237
+SIR+L LS + L + T LK NL L ++ N L+ S + + F
Sbjct: 220 ANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFL 279
Query: 238 GVNKIQGAIP--------LDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVN 289
N IQ + Y ++ S+ L + LE + N
Sbjct: 280 EYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDN 339
Query: 290 KLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLP 349
+ G T LK+L ++ +
Sbjct: 340 DIPGIKS-----------------------------NMFTGLINLKYLSLSNSFTSLRTL 370
Query: 350 ---ACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPP-AIGELQ 405
+S + L +L L N+I A +L+ LD+ N + + L+
Sbjct: 371 TNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLE 430
Query: 406 NLKDLRLQRNRFQGNIPPSIGNL-KLFILYLSYNFLQG--SIPSSLGRYETLTTIDLSNN 462
N+ ++ L N++ S + L L L L+ S PS LT +DLSNN
Sbjct: 431 NIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNN 490
Query: 463 NLTGTIPPQFIGLSSSLIVLDLSRNQLT--------GSIPSEVGNLKNLEILNVFGNKLK 514
N+ GL L +LDL N L G + L +L ILN+ N
Sbjct: 491 NIANINDDMLEGLEK-LEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFD 549
Query: 515 GEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELL-IRLQ 573
+L+ +++ N L S ++ L L+L +N ++ ++ +
Sbjct: 550 EIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFR 609
Query: 574 LVKNLNLSNNDLEGVVPTQGVFKN 597
+ L++ N + + F N
Sbjct: 610 NLTELDMRFNPFDCTCESIAWFVN 633
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-29
Identities = 55/276 (19%), Positives = 94/276 (34%), Gaps = 13/276 (4%)
Query: 42 SWNESSHFCQWRGVTCSRRHQRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHE 101
S + +S S H + IL+L K++ S L L+VL L N E
Sbjct: 361 SNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQE 420
Query: 102 IP-SEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQL--VGKIPSELSSLS 158
+ E+ L + + L YN + + +L +L L L V PS L
Sbjct: 421 LTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLR 480
Query: 159 KIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLE--------GSIPDTLGWLKNLVN 210
+ + +++NN+ L L + L L NNL G L L +L
Sbjct: 481 NLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHI 540
Query: 211 LTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGA 270
L + N ++ + D G+N + +P + +L+ ++ +N +T
Sbjct: 541 LNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNT-LPASVFNNQVSLKSLNLQKNLITSV 599
Query: 271 IPPTISNA-SNLEIFHGSVNKLTGAAPYLEKLQRLL 305
A NL N + +
Sbjct: 600 EKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWI 635
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 7e-07
Identities = 26/126 (20%), Positives = 43/126 (34%), Gaps = 5/126 (3%)
Query: 62 QRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNS 121
+ IL+LES +L LK++ L N+ N S F+ L+ L L N
Sbjct: 536 SHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNL 595
Query: 122 IGGAIPANIS-SCSNLIQLRLFHNQLVGKIPSELSSLSKIE----HISVNDNNLTGSIPS 176
I + NL +L + N S ++ I +I ++ + P
Sbjct: 596 ITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPP 655
Query: 177 SLGNLS 182
Sbjct: 656 HYHGFP 661
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 297 bits (762), Expect = 4e-89
Identities = 103/647 (15%), Positives = 190/647 (29%), Gaps = 114/647 (17%)
Query: 8 LGVTASTVAGNETDRLALLELKS-------KITHDPLGVLASWNESSHFCQWR---GVTC 57
+ + S A D LAL E+ A+WN + W GV+
Sbjct: 18 VPIKLSRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSL 77
Query: 58 SRRHQRVTILDLESLKLAGSISPHVGNLSFLKVLRLY----------------------- 94
+ RVT L LE +G + +G L+ L+VL L
Sbjct: 78 NSN-GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDE 136
Query: 95 --NNSFNHEIPSEFDRLRRLQVLALHYNSIG-----GAIPANISSCSNLIQLRLFHNQLV 147
H + D R L + I +I + Q+ N +
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT 196
Query: 148 GKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKN 207
+ + L+K+ + ++ + + LK+
Sbjct: 197 F-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENEN-----SEYAQQYKTEDLKWDNLKD 250
Query: 208 LVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFS-------LQNLQFF 260
L ++ + +P+ + + + + N+ L + + +Q
Sbjct: 251 LTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQII 310
Query: 261 SVGENQL-TGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGD 319
+G N L T + ++ L + N+L G P
Sbjct: 311 YIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP----------------------- 347
Query: 320 RDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAA--I 377
+ + +L L + N +PA + +E L +N++ IP
Sbjct: 348 -------AFGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKL-KYIPNIFDA 398
Query: 378 GKFVNLQRLDMCSNRLSG-------TIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNL-K 429
+ +D N + + P + N+ + L N+
Sbjct: 399 KSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSP 458
Query: 430 LFILYLSYNFLQG-------SIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVL 482
L + L N L + LT+IDL N LT L+ +
Sbjct: 459 LSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGI 518
Query: 483 DLSRNQLTGSIPSEVGNLKNLEIL------NVFGNKLKGEIPSTLGSCIKLEQLEMQENF 536
DLS N + P++ N L+ + GN+ E P + C L QL++ N
Sbjct: 519 DLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSND 577
Query: 537 LQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNN 583
++ + + +SVLD+ N + L +
Sbjct: 578 IRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYD 621
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 3e-67
Identities = 70/456 (15%), Positives = 147/456 (32%), Gaps = 46/456 (10%)
Query: 164 SVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSG--- 220
+ + SL + + L L G G +PD +G L L L + +
Sbjct: 63 NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER 122
Query: 221 -TIPSSIFNISSITGFDAGVNKIQGAIPLDYGF-SLQNLQFFSVGENQLTGAIPPTISNA 278
P I S Q +L + + +I +
Sbjct: 123 LFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT 182
Query: 279 SNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLL 338
N +T + + +L +L F + + + + +
Sbjct: 183 LKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY-------- 234
Query: 339 ININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRL----- 393
+ NL L + + N +P + +Q +++ NR
Sbjct: 235 ---AQQYKTEDLKWDNL-KDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQ 290
Query: 394 ---SGTIPPAIGELQNLKDLRLQRNRFQ-GNIPPSIGNL-KLFILYLSYNFLQGSIPSSL 448
+ ++ + + N + + S+ + KL +L YN L+G +P +
Sbjct: 291 LKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AF 349
Query: 449 GRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPS--EVGNLKNLEIL 506
G L +++L+ N +T IP F G + + L + N+L IP+ + ++ + +
Sbjct: 350 GSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAI 407
Query: 507 NVFGNKLKG-------EIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQN 559
+ N++ + T I + + + N + S+ LS ++L N
Sbjct: 408 DFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGN 467
Query: 560 NLSG-------KIPELLIRLQLVKNLNLSNNDLEGV 588
L+ E L+ +++L N L +
Sbjct: 468 MLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKL 503
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 233 bits (595), Expect = 7e-66
Identities = 67/473 (14%), Positives = 146/473 (30%), Gaps = 85/473 (17%)
Query: 153 ELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEG----SIPDTLGWLKNL 208
L+S ++ +S+ +G +P ++G L+ + L L + + P + +
Sbjct: 76 SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135
Query: 209 VNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLT 268
+ T +L + +
Sbjct: 136 EQKQKMRMHYQKTFVDYDPRED-----------------------FSDLIKDCINSDPQQ 172
Query: 269 GAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSL 328
+I + N +T + ++
Sbjct: 173 KSIKKSSRITLKDTQIGQLSNNITFVSK------------------------------AV 202
Query: 329 TNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDM 388
T+L+ + + F + Q + +L +++
Sbjct: 203 MRLTKLRQFYMGNSPFVAENICEAWEN------ENSEYAQQYKTEDLKWDNLKDLTDVEV 256
Query: 389 CSNRLSGTIPPAIGELQNLKDLRLQRNRF--------QGNIPPSIGNLK-LFILYLSYNF 439
+ +P + L ++ + + NR + + I+Y+ YN
Sbjct: 257 YNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNN 316
Query: 440 LQ-GSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVG 498
L+ + +SL + + L ++ N L G +P G L L+L+ NQ+T + G
Sbjct: 317 LKTFPVETSLQKMKKLGMLECLYNQLEGKLPA--FGSEIKLASLNLAYNQITEIPANFCG 374
Query: 499 NLKNLEILNVFGNKLKGEIPSTL--GSCIKLEQLEMQENFLQG-------PIPSSLSSLR 549
+ +E L+ NKLK IP+ S + ++ N + P+ +
Sbjct: 375 FTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGI 433
Query: 550 GLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQGVFKNASITS 602
+S ++LS N +S EL + ++NL N L + +N + +
Sbjct: 434 NVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKN 486
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 290 bits (745), Expect = 5e-87
Identities = 100/573 (17%), Positives = 187/573 (32%), Gaps = 38/573 (6%)
Query: 64 VTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIG 123
LDL L S + L+VL L + L L L L N I
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 124 GAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTG-SIPSSLGNLS 182
S S+L +L L + L ++ ++V N + +P NL+
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 183 SIRSLFLSGNNLEGSIPDTLGWLKNL----VNLTMAQNRLSGTIPSSIFNISSITGFDAG 238
++ L LS N ++ L L + ++L ++ N ++ I F +
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLR 208
Query: 239 VNKIQGAIPLDYGFSLQNLQFFSV------GENQLTGAIPPTISNASNLEIFHGSVNKLT 292
N + L L+ + E L + NL I + L
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268
Query: 293 GAAP----YLEKLQRLLVFGILGNSLGSRGDRDL-----------NFLCSLTNATRLKWL 337
L + F ++ ++ D
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLK 328
Query: 338 LININNFGGSLPACISNLSTTLEVLLLDNNQI--FGNIPAAIGKFVNLQRLDMCSNRLSG 395
+ + G +L +LE L L N + G + +L+ LD+ N +
Sbjct: 329 RLTFTSNKGGNAFSEVDL-PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI- 386
Query: 396 TIPPAIGELQNLKDLRLQRNRFQGNIPPSI-GNLK-LFILYLSYNFLQGSIPSSLGRYET 453
T+ L+ L+ L Q + + S+ +L+ L L +S+ + + +
Sbjct: 387 TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 446
Query: 454 LTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKL 513
L + ++ N+ P +L LDLS+ QL P+ +L +L++LN+ N
Sbjct: 447 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNF 506
Query: 514 KGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSL-RGLSVLDLSQNNLSGKIP--ELLI 570
L+ L+ N + L L+ L+L+QN+ + L
Sbjct: 507 FSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQ 566
Query: 571 RLQLVKNLNLSNNDLEGVVPTQGVFKNASITSV 603
++ + L + +E P+ + + S+
Sbjct: 567 WIKDQRQLLVEVERMECATPSD--KQGMPVLSL 597
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 247 bits (633), Expect = 3e-71
Identities = 97/500 (19%), Positives = 173/500 (34%), Gaps = 43/500 (8%)
Query: 125 AIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSI 184
IP N+ + L L N L S +++ + ++ + + +LS +
Sbjct: 21 KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 185 RSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQG 244
+L L+GN ++ L +L L + L+ I ++ ++ + N IQ
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 245 AIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHG----SVNKLTGAAPYLEK 300
+Y +L NL+ + N++ + + + + S+N + P K
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK 198
Query: 301 LQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLE 360
RL + N + + L + L++ G+L + L
Sbjct: 199 EIRLHKLTLRNNFDS--LNVMKTCIQGLAG-LEVHRLVLGEFRNEGNLEKFDKSALEGLC 255
Query: 361 VLLLDNNQI------FGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQR 414
L ++ ++ +I N+ + S + + L L
Sbjct: 256 NLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVN 313
Query: 415 NRF-------------------QGNIPPSIGNLK-LFILYLSYNFLQ--GSIPSSLGRYE 452
+F +G S +L L L LS N L G S
Sbjct: 314 CKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTT 373
Query: 453 TLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEV-GNLKNLEILNVFGN 511
+L +DLS N + T+ F+GL L LD + L V +L+NL L++
Sbjct: 374 SLKYLDLSFNGVI-TMSSNFLGL-EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 431
Query: 512 KLKGEIPSTLGSCIKLEQLEMQENFLQGPI-PSSLSSLRGLSVLDLSQNNLSGKIPELLI 570
+ LE L+M N Q P + LR L+ LDLSQ L P
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 491
Query: 571 RLQLVKNLNLSNNDLEGVVP 590
L ++ LN+S+N+ +
Sbjct: 492 SLSSLQVLNMSHNNFFSLDT 511
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 3e-64
Identities = 102/538 (18%), Positives = 182/538 (33%), Gaps = 63/538 (11%)
Query: 65 TILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSI-G 123
+ L L + LS L+ L + L+ L+ L + +N I
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 124 GAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIE----HISVNDNNLTGSIPSSLG 179
+P S+ +NL L L N++ ++L L ++ + ++ N + P +
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK 198
Query: 180 NLSSIRSLFLSGNNLEGSIPDTLGW----------------------------LKNLVNL 211
+ + L L N ++ T L+ L NL
Sbjct: 199 EIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 212 TMAQNRLS------GTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGEN 265
T+ + RL+ I +++++ F I+ Y F Q+L+ +
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLE---LVNC 314
Query: 266 QLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFL 325
+ + + L L L + N L +G +
Sbjct: 315 KFGQFPTLKLKSLKRLTFTSNKGGNAFS----EVDLPSLEFLDLSRNGLSFKGCCSQSDF 370
Query: 326 CSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPA-AIGKFVNLQ 384
T LK+L ++ N + + L LE L ++ + NL
Sbjct: 371 ----GTTSLKYLDLSFNGVIT-MSSNFLGL-EQLEHLDFQHSNLKQMSEFSVFLSLRNLI 424
Query: 385 RLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSI-GNL-KLFILYLSYNFLQG 442
LD+ L +L+ L++ N FQ N P I L L L LS L+
Sbjct: 425 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ 484
Query: 443 SIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNL-K 501
P++ +L +++S+NN + L+S L VLD S N + S E+ +
Sbjct: 485 LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNS-LQVLDYSLNHIMTSKKQELQHFPS 543
Query: 502 NLEILNVFGNKLKGEIPST--LGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLS 557
+L LN+ N L QL ++ ++ PS +G+ VL L+
Sbjct: 544 SLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDK---QGMPVLSLN 598
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-24
Identities = 33/154 (21%), Positives = 55/154 (35%), Gaps = 14/154 (9%)
Query: 455 TTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLK 514
T N IP L S LDLS N L + L++L++ +++
Sbjct: 10 ITYQCMELNFY-KIPD---NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ 65
Query: 515 GEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQL 574
S L L + N +Q + S L L L + NL+ + L+
Sbjct: 66 TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKT 125
Query: 575 VKNLNLSNNDLEGVVPTQGVFKNASITSVFGNLK 608
+K LN+++N ++ + F NL
Sbjct: 126 LKELNVAHNLIQSF----------KLPEYFSNLT 149
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 7e-11
Identities = 28/124 (22%), Positives = 46/124 (37%), Gaps = 3/124 (2%)
Query: 62 QRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNS 121
+ +T LDL +L +LS L+VL + +N+F + L LQVL N
Sbjct: 470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 529
Query: 122 IGGAIPANISSC-SNLIQLRLFHNQLVGKIPSE--LSSLSKIEHISVNDNNLTGSIPSSL 178
I + + S+L L L N + L + + V + + PS
Sbjct: 530 IMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDK 589
Query: 179 GNLS 182
+
Sbjct: 590 QGMP 593
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 257 bits (658), Expect = 4e-78
Identities = 100/329 (30%), Positives = 159/329 (48%), Gaps = 38/329 (11%)
Query: 664 EKQNPNSPINSFPNISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL 723
+++P + S + L A+D FS+ N +G G FG V+KG L DG T +AVK
Sbjct: 6 AEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADG-TLVAVKRLKE 64
Query: 724 -LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLH 782
G F E + HRNL+++ C + + LV+ +M N S+ L
Sbjct: 65 ERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM----TPTE-RLLVYPYMANGSVASCLR 119
Query: 783 PITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842
E E+ L+ +R I++ A L YLH C P I H D+K +NILLDE+ A
Sbjct: 120 ------ERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173
Query: 843 HIGDFGLARFLPLSSAQTS-SIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITR 901
+GDFGLA+ + T + +G+IG+IAPEY + S DV+ YG++LLELIT
Sbjct: 174 VVGDFGLAKLMD--YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 231
Query: 902 KKPTDIMF---EGDMNLHNLARTALPD-HVMDIVDSTLLNDGEDLIVHGNQRQRQARVKS 957
++ D+ + D+ L + + L + + +VD L + +D
Sbjct: 232 QRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKD---------------- 275
Query: 958 RIECLISMVRIGVACSMESPEDRMSMTNV 986
E + ++++ + C+ SP +R M+ V
Sbjct: 276 --EEVEQLIQVALLCTQSSPMERPKMSEV 302
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 255 bits (654), Expect = 3e-74
Identities = 99/570 (17%), Positives = 183/570 (32%), Gaps = 34/570 (5%)
Query: 41 ASWNESSHFCQWRGVTCSRRH---------QRVTILDLESLKLAGSISPHVGNLSFLKVL 91
+S + + C L+ L + L L L
Sbjct: 3 SSDQKCIEKEVNKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFL 62
Query: 92 RLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIP 151
L F RL L L N + +S L L +
Sbjct: 63 DLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDF 122
Query: 152 SELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNL 211
L + +E + + N+++ ++ L N + + + L+ NL
Sbjct: 123 IPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNL 182
Query: 212 T--MAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFS-LQNLQFFSVGENQLT 268
+ + N ++ I F+ + + G + I S +Q+L + +
Sbjct: 183 SLNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDE 241
Query: 269 GAIPPTISN--ASNLEIFHGSVNKLTGAAPY-LEKLQRLLVFGILGNSLGSRGDRDLNFL 325
P ++E + + + L + L
Sbjct: 242 DISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPS------ 295
Query: 326 CSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNI-PAAIGKFVNLQ 384
L + LK L+++ N F SN +L L + N + + NL+
Sbjct: 296 -GLVGLSTLKKLVLSANKFENLCQISASNF-PSLTHLSIKGNTKRLELGTGCLENLENLR 353
Query: 385 RLDMCSNRL--SGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNL-KLFILYLSYNFLQ 441
LD+ + + S + L +L+ L L N + +L +L L++ L+
Sbjct: 354 ELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLK 413
Query: 442 GSIP-SSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVG-- 498
S L ++LS++ L + F GL + L L+L N +
Sbjct: 414 VKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPA-LQHLNLQGNHFPKGNIQKTNSL 472
Query: 499 -NLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLS 557
L LEIL + L S + +++ N L +LS L+G+ L+L+
Sbjct: 473 QTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLA 531
Query: 558 QNNLSGKIPELLIRLQLVKNLNLSNNDLEG 587
N++S +P LL L + +NL N L+
Sbjct: 532 SNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 252 bits (646), Expect = 3e-73
Identities = 104/521 (19%), Positives = 183/521 (35%), Gaps = 25/521 (4%)
Query: 85 LSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHN 144
+ + L N + F RL L L L I S L L L N
Sbjct: 32 PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91
Query: 145 QLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGW 204
L+ + LS ++H+ ++ L N ++ SL+L N++
Sbjct: 92 PLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFP 151
Query: 205 LKNLVNLTMAQNRLSGTIPSSIFNISSITG--FDAGVNKIQGAIPLDYGFSLQNLQFFSV 262
+ L L N + + ++ T + N I G P F Q +
Sbjct: 152 TEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPG--AFDSAVFQSLNF 209
Query: 263 GENQLTGAIPPTISNAS-----NLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSR 317
G Q I + N++ ++ A + + + +
Sbjct: 210 GGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNI 269
Query: 318 GDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAI 377
+ + L+ L + + LP+ + LS TL+ L+L N+ +
Sbjct: 270 SSN------TFHCFSGLQELDLTATHL-SELPSGLVGLS-TLKKLVLSANKFENLCQISA 321
Query: 378 GKFVNLQRLDMCSNRLSGTIPP-AIGELQNLKDLRLQRNRFQ--GNIPPSIGNL-KLFIL 433
F +L L + N + + L+NL++L L + + + NL L L
Sbjct: 322 SNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSL 381
Query: 434 YLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSI 493
LSYN + L +DL+ L L VL+LS + L S
Sbjct: 382 NLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISS 441
Query: 494 PSEVGNLKNLEILNVFGNKLKGEI---PSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRG 550
L L+ LN+ GN ++L + +LE L + L + +SL+
Sbjct: 442 EQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKM 501
Query: 551 LSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPT 591
++ +DLS N L+ E L L+ + LNL++N + ++P+
Sbjct: 502 MNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPS 541
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 1e-53
Identities = 89/510 (17%), Positives = 171/510 (33%), Gaps = 32/510 (6%)
Query: 65 TILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGG 124
L ++ + N L+ L L +N + + +L+VL N+I
Sbjct: 108 KHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHY 167
Query: 125 AIPANISSCSNL--IQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGN-- 180
++SS + L L N + I + + ++ I L N
Sbjct: 168 LSKEDMSSLQQATNLSLNLNGNDI-AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNST 226
Query: 181 LSSIRSLFLSGNNLEGSIPDTLGWLK--NLVNLTMAQNRLSGTIPSSIFNISSITGFDAG 238
+ S+ + E P L ++ ++ + ++ ++ S + D
Sbjct: 227 IQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLT 286
Query: 239 VNKIQGAIPLDYGFS-LQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPY 297
+ L G L L+ + N+ + SN +L N
Sbjct: 287 ATHLSE---LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGT 343
Query: 298 --LEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNL 355
LE L+ L + + + + +L N + L+ L ++ N
Sbjct: 344 GCLENLENLRELDLSHDDIETSDCCNLQL----RNLSHLQSLNLSYNEPLSLKTEAFKEC 399
Query: 356 STTLEVLLLDNNQIFGNIP-AAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQR 414
LE+L L ++ + L+ L++ + L + L L+ L LQ
Sbjct: 400 -PQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQG 458
Query: 415 NRFQGNIPPSIGNLK----LFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPP 470
N F +L+ L IL LS+ L + + + +DLS+N LT +
Sbjct: 459 NHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIE 518
Query: 471 QFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQL 530
L I L+L+ N ++ +PS + L +N+ N L + LE
Sbjct: 519 ALSHLKG--IYLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNIY----FLEWY 572
Query: 531 EMQENFLQGPIP---SSLSSLRGLSVLDLS 557
+ L+ + LRG+ + D++
Sbjct: 573 KENMQKLEDTEDTLCENPPLLRGVRLSDVT 602
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 4e-47
Identities = 68/417 (16%), Positives = 132/417 (31%), Gaps = 40/417 (9%)
Query: 60 RHQRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSE--FDRLRRLQVLAL 117
+ L+L + I P + + + L I ++ L +
Sbjct: 177 QQATNLSLNLNGNDI-AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTF 235
Query: 118 HYNSIGGAIPANISSCS--NLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIP 175
PA ++ + L + + S ++ + + +L+ +P
Sbjct: 236 EDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELP 294
Query: 176 SSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIF-NISSITG 234
S L LS+++ L LS N E + +L +L++ N + + N+ ++
Sbjct: 295 SGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRE 354
Query: 235 FDAGVNKIQGAIPLDYGFS-LQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTG 293
D + I+ + + L +LQ ++ N+ LE+ + +L
Sbjct: 355 LDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV 414
Query: 294 AAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACIS 353
+ +L LK L ++ + S
Sbjct: 415 KDAQ-------------------------SPFQNLHL---LKVLNLSHSLLDISSEQLFD 446
Query: 354 NLSTTLEVLLLDNNQIFGNIPAAIGKFVN---LQRLDMCSNRLSGTIPPAIGELQNLKDL 410
L L+ L L N L+ L + LS A L+ + +
Sbjct: 447 GLPA-LQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHV 505
Query: 411 RLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGT 467
L NR + ++ +LK L L+ N + +PS L TI+L N L T
Sbjct: 506 DLSHNRLTSSSIEALSHLKGIYLNLASNHISIILPSLLPILSQQRTINLRQNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 7e-27
Identities = 46/205 (22%), Positives = 69/205 (33%), Gaps = 4/205 (1%)
Query: 421 IPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLI 480
IP ++ N L S+N L ++ R LT +DL+ + F L
Sbjct: 27 IPGTLPNS-TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHR-LD 84
Query: 481 VLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGP 540
L L+ N L + + K L+ L + L + LE L + N +
Sbjct: 85 TLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSI 144
Query: 541 IPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKN--LNLSNNDLEGVVPTQGVFKNA 598
L VLD N + E + LQ N LNL+ ND+ G+ P
Sbjct: 145 KLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVF 204
Query: 599 SITSVFGNLKLCGGIPEFQLPTCSS 623
+ G L + T S
Sbjct: 205 QSLNFGGTQNLLVIFKGLKNSTIQS 229
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 258 bits (660), Expect = 6e-73
Identities = 89/625 (14%), Positives = 173/625 (27%), Gaps = 122/625 (19%)
Query: 8 LGVTASTVAGNETDRLALLELKSKI----------THDPLGVLASWNESSHFCQWRGVTC 57
+ + A D AL + + T + +WN + W
Sbjct: 257 VPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPG 316
Query: 58 SRRHQ--RVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVL 115
RVT L L G + +G L+ LKVL +S D +
Sbjct: 317 VDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMS 376
Query: 116 ALHYNSIGGAIPANISS------CSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNN 169
+ I S+L+Q + N + I + K I N
Sbjct: 377 EERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNR 436
Query: 170 LTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNI 229
+T I ++ L+ ++ ++ + + + + + S N
Sbjct: 437 IT-FISKAIQRLTKLQIIYFANSPFTYDNIAV-----DWEDANSDYAKQYENEELSWSN- 489
Query: 230 SSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVN 289
L++L + +P + + L+ + + N
Sbjct: 490 ------------------------LKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACN 525
Query: 290 KLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLP 349
+ AA L
Sbjct: 526 RGISAAQLKADW--------------------------------------------TRLA 541
Query: 350 ACISNLSTTLEVLLLDNNQIFG-NIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLK 408
+++ + N + A++ K V L LD N++ A G L
Sbjct: 542 DDEDTG-PKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLT 598
Query: 409 DLRLQRNRFQGNIPPSIGNL--KLFILYLSYNFLQGSIPS--SLGRYETLTTIDLSNNNL 464
DL+L N+ + IP ++ L S+N L+ IP+ + + ++D S N +
Sbjct: 599 DLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKI 656
Query: 465 TGTIPPQFIGLSS----SLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLK------ 514
+ + + LS N++ + + + N +
Sbjct: 657 GSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENS 716
Query: 515 -GEIPSTLGSCIKLEQLEMQENFLQG-PIPSSLSSLRGLSVLDLSQNNLSGKIPEL---- 568
+ L ++++ N L ++L LS +D+S N S P
Sbjct: 717 LKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNS 775
Query: 569 --LIRLQLVKNLNLSNNDLEGVVPT 591
L + + N + PT
Sbjct: 776 SQLKAFGIRHQRDAEGNRILRQWPT 800
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 220 bits (561), Expect = 7e-60
Identities = 82/543 (15%), Positives = 169/543 (31%), Gaps = 59/543 (10%)
Query: 88 LKVLRLYNNSFNHEIPSEFDRLRRLQ-VLALHYNSIGGAIPANISSCSNLIQ----LRLF 142
+ Y+ S E +R + + + +P + + I+ L+
Sbjct: 218 VVAYTTYSQSGIKRSELETQSVRGESFTVIDNKLTKDANVPIQLKETAEYIKDYKALKAI 277
Query: 143 HNQLVGKIPSELSSLSKIEHISVN------DNNLTGSIPSSLGNLSSIRSLFLSGNNLEG 196
L GK S S+N + L N + L L+G +G
Sbjct: 278 WEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKG 337
Query: 197 SIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQN 256
+PD +G L L L+ + + + + + ++I+ + Q
Sbjct: 338 RVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQR 397
Query: 257 LQFFSVGENQLT-----GAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILG 311
L + ++ + I + N++T + +++L +L +
Sbjct: 398 LNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFAN 457
Query: 312 NSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFG 371
+ A + + + SNL L + L N
Sbjct: 458 SPFTY-----------DNIAVDWEDANSDYAKQYENEELSWSNL-KDLTDVELYNCPNMT 505
Query: 372 NIPAAIGKFVNLQRLDMCSNRLSG---------TIPPAIGELQNLKDLRLQRNRFQGNIP 422
+P + LQ L++ NR + ++ + N + P
Sbjct: 506 QLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEE-FP 564
Query: 423 PS--IGNL-KLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSL 479
S + + KL +L +N + + G LT + L N + IP F + +
Sbjct: 565 ASASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQV 621
Query: 480 IVLDLSRNQLTGSIPS--EVGNLKNLEILNVFGNKLKGEIPSTLGS-----CIKLEQLEM 532
L S N+L IP+ ++ + ++ NK+ E + S I + +
Sbjct: 622 EGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTL 680
Query: 533 QENFLQGPIPSSLSSLRGLSVLDLSQNNLS-------GKIPELLIRLQLVKNLNLSNNDL 585
N +Q ++ +S + LS N ++ L+ ++L N L
Sbjct: 681 SYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKL 740
Query: 586 EGV 588
+
Sbjct: 741 TSL 743
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 8e-12
Identities = 26/150 (17%), Positives = 57/150 (38%), Gaps = 16/150 (10%)
Query: 69 LESLKLAG----SISPH--VGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHY--- 119
L ++ L S+S L +L + + N F+ P++ +L+ + +
Sbjct: 730 LTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRD 788
Query: 120 ---NSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPS 176
N I P I++C +LIQL++ N + K+ +L ++ + + DN +
Sbjct: 789 AEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKL--TPQLYILDIADNPNISIDVT 845
Query: 177 SLGNLSSIRSLFLSGNNLEGSIPDTLGWLK 206
S+ L + + ++
Sbjct: 846 SVCPYIEAGMYVLLYDKTQDIRGCDALGIE 875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 2e-69
Identities = 96/313 (30%), Positives = 140/313 (44%), Gaps = 39/313 (12%)
Query: 678 ISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECN 737
+ +L AT+ F IG G FG V+KG+L DG +A+K + F E
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG-AKVALKRRTPESSQGIEEFETEIE 87
Query: 738 TLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSL 797
TL RH +LV ++ C + L++++M N +L+ L+ +D S+
Sbjct: 88 TLSFCRHPHLVSLIGFCDERNEM-----ILIYKYMENGNLKRHLY------GSDLPTMSM 136
Query: 798 NLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSS 857
+ QRL I I A L+YLH I H D+K NILLDE+ + I DFG+++
Sbjct: 137 SWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELD 193
Query: 858 AQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHN 917
S KG++GYI PEY + ++ DVYS+G++L E++ + +M N
Sbjct: 194 QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREM--VN 251
Query: 918 LARTALPDH----VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACS 973
LA A+ H + IVD L K R E L V C
Sbjct: 252 LAEWAVESHNNGQLEQIVDPNL------------------ADKIRPESLRKFGDTAVKCL 293
Query: 974 MESPEDRMSMTNV 986
S EDR SM +V
Sbjct: 294 ALSSEDRPSMGDV 306
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 9e-69
Identities = 96/523 (18%), Positives = 171/523 (32%), Gaps = 32/523 (6%)
Query: 86 SFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQ 145
S K + L N F LQ L L I +L L L N
Sbjct: 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91
Query: 146 LVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEG-SIPDTLGW 204
+ P S L+ +E++ + L +G L +++ L ++ N + +P
Sbjct: 92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN 151
Query: 205 LKNLVNLTMAQNRLSGTIPSSIFNISSITGF----DAGVNKIQGAIPLDYGFSLQNLQFF 260
L NLV++ ++ N + + + + D +N I F L
Sbjct: 152 LTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQA--FQGIKLHEL 209
Query: 261 SVGENQLTGAIPPT-ISNASNLEIFHGSVNKLTG-------AAPYLEKLQRLLVFGILGN 312
++ N + I T + N + L + + + +E L + +
Sbjct: 210 TLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLT 269
Query: 313 SLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGN 372
D + F C + + + + L + + L + Q+
Sbjct: 270 YTNDFSDDIVKFHCL----ANVSAMSLAGVSIK-YLEDVPKHFK--WQSLSIIRCQL-KQ 321
Query: 373 IPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNL---K 429
P L+ L + N+ S I L +L L L RN + S +L
Sbjct: 322 FPTL--DLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNS 377
Query: 430 LFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQL 489
L L LS+N + ++ E L +D ++ L L+ LD+S
Sbjct: 378 LRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNT 436
Query: 490 TGSIPSEVGNLKNLEILNVFGNKLKGEIPS-TLGSCIKLEQLEMQENFLQGPIPSSLSSL 548
L +L L + GN K S + L L++ + L+ +L
Sbjct: 437 KIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTL 496
Query: 549 RGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPT 591
L +L++S NNL +L + L+ S N +E
Sbjct: 497 HRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGI 539
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 1e-68
Identities = 101/562 (17%), Positives = 183/562 (32%), Gaps = 47/562 (8%)
Query: 64 VTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIG 123
+DL L S N S L+ L L + L L L L N I
Sbjct: 34 TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93
Query: 124 GAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTG-SIPSSLGNLS 182
P + S ++L L +L + L ++ ++V N + +P+ NL+
Sbjct: 94 SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLT 153
Query: 183 SIRSLFLSGNNLEGSIPDTLGWLKNL----VNLTMAQNRLSGTIPSSIFNISSITGFDAG 238
++ + LS N ++ + L +L+ ++L M+ N + I F +
Sbjct: 154 NLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLR 212
Query: 239 VNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLE--------IFHGSVNK 290
N I +L L + + I S +E F +
Sbjct: 213 GNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTN 272
Query: 291 LTGAAPY-LEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLP 349
L + + G S+ +L + + + L I
Sbjct: 273 DFSDDIVKFHCLANVSAMSLAGVSI--------KYLEDVPKHFKWQSLSIIRCQLKQFPT 324
Query: 350 ACISNLST------------------TLEVLLLDNNQI--FGNIPAAIGKFVNLQRLDMC 389
+ L + +L L L N + G + +L+ LD+
Sbjct: 325 LDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLS 384
Query: 390 SNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPS-IGNL-KLFILYLSYNFLQGSIPSS 447
N + L+ L+ L Q + + S +L KL L +SY +
Sbjct: 385 FNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGI 443
Query: 448 LGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILN 507
+L T+ ++ N+ +++L LDLS+ QL L L++LN
Sbjct: 444 FLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLN 503
Query: 508 VFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPE 567
+ N L S L L+ N ++ + L+ +L+ N+++ I E
Sbjct: 504 MSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA-CICE 562
Query: 568 LLIRLQLVKNLNLSNNDLEGVV 589
LQ VK ++E +
Sbjct: 563 HQKFLQWVKEQKQFLVNVEQMT 584
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 3e-58
Identities = 89/482 (18%), Positives = 170/482 (35%), Gaps = 20/482 (4%)
Query: 125 AIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSI 184
+P +I S + + L N L S+ S+++ + ++ + + L +
Sbjct: 25 KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHL 82
Query: 185 RSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQG 244
+L L+GN ++ P + L +L NL + +L+ I + ++ + N I
Sbjct: 83 SNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHS 142
Query: 245 AIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIF----HGSVNKLTGAAPYLEK 300
Y +L NL + N + + S+N + +
Sbjct: 143 CKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQ 202
Query: 301 LQRLLVFGILGNSLGSRGDRD-LNFLCSLTNATRLKWLLININNFGGSLPACISNL-STT 358
+L + GN S + L L L + + N P+ + L T
Sbjct: 203 GIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVT 262
Query: 359 LEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQ 418
++ L F + N+ + + + + + + L + R + +
Sbjct: 263 IDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLK 320
Query: 419 GNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLS-S 477
+ LK L L+ N +GSI +L+ +DLS N L+ + + L +
Sbjct: 321 QFPTLDLPFLK--SLTLTMN--KGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTN 376
Query: 478 SLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIP-STLGSCIKLEQLEMQENF 536
SL LDLS N + + L+ L+ L+ + LK S S KL L++
Sbjct: 377 SLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTN 435
Query: 537 LQGPIPSSLSSLRGLSVLDLSQNNLSGKIP-ELLIRLQLVKNLNLSNNDLEGVVPTQGVF 595
+ L L+ L ++ N+ + + L+LS LE + GVF
Sbjct: 436 TKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISW--GVF 493
Query: 596 KN 597
Sbjct: 494 DT 495
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 7e-57
Identities = 100/554 (18%), Positives = 171/554 (30%), Gaps = 57/554 (10%)
Query: 59 RRHQRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALH 118
+ LDL ++ L L L L N P F L L+ L
Sbjct: 53 SNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAV 112
Query: 119 YNSIGGAIPANISSCSNLIQLRLFHNQLVG-KIPSELSSLSKIEHISVNDNNLTGSIPSS 177
+ I L +L + HN + K+P+ S+L+ + H+ ++ N + +
Sbjct: 113 ETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVND 172
Query: 178 LGNLSSIR----SLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIF-NISSI 232
L L SL +S N ++ I D L LT+ N S I + N++ +
Sbjct: 173 LQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGL 231
Query: 233 TGFDAGVNKIQG-----AIPLDYGFSLQNLQF--FSVGENQLTGAIPPTISNASNLEIFH 285
+ + + L ++ F + +N+
Sbjct: 232 HVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMS 291
Query: 286 GSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSL-------------TNAT 332
+ + + K + I+ L DL FL SL
Sbjct: 292 LAGVSIKYL-EDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALP 350
Query: 333 RLKWLLININNFGGSLPACISNLSTT-LEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSN 391
L +L ++ N S S+L T L L L N + A LQ LD +
Sbjct: 351 SLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHS 409
Query: 392 RLSGTIPP-AIGELQNLKDLRLQRNRFQGNIPPSIGNL-KLFILYLSYNFLQGSIPSS-L 448
L A L+ L L + + + L L L ++ N + + S+
Sbjct: 410 TLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVF 469
Query: 449 GRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNV 508
LT +DLS L F L L +L++S N L S L +L L+
Sbjct: 470 ANTTNLTFLDLSKCQLEQISWGVFDTLHR-LQLLNMSHNNLLFLDSSHYNQLYSLSTLDC 528
Query: 509 FGNKLKGEIPSTLGSCIKLEQLEMQEN-----------------------FLQGPIPSSL 545
N+++ L + N ++ ++
Sbjct: 529 SFNRIETSKGILQHFPKSLAFFNLTNNSVACICEHQKFLQWVKEQKQFLVNVEQMTCATP 588
Query: 546 SSLRGLSVLDLSQN 559
+ VLD + +
Sbjct: 589 VEMNTSLVLDFNNS 602
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-26
Identities = 40/173 (23%), Positives = 66/173 (38%), Gaps = 5/173 (2%)
Query: 419 GNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSS 478
G++ P I + L +P + + IDLS N L F S
Sbjct: 2 GSLNPCIEVVPNITYQCMDQKLS-KVPDDIPS--STKNIDLSFNPLKILKSYSFSNF-SE 57
Query: 479 LIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQ 538
L LDLSR ++ L +L L + GN ++ P + LE L E L
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 539 GPIPSSLSSLRGLSVLDLSQNNLSG-KIPELLIRLQLVKNLNLSNNDLEGVVP 590
+ L L L+++ N + K+P L + +++LS N ++ +
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITV 170
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-21
Identities = 33/156 (21%), Positives = 57/156 (36%), Gaps = 6/156 (3%)
Query: 442 GSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLK 501
GS+ + T + L+ +P + SS +DLS N L N
Sbjct: 2 GSLNPCIE-VVPNITYQCMDQKLS-KVPD---DIPSSTKNIDLSFNPLKILKSYSFSNFS 56
Query: 502 NLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNL 561
L+ L++ +++ L L + N +Q P S S L L L + L
Sbjct: 57 ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKL 116
Query: 562 SGKIPELLIRLQLVKNLNLSNNDLEGVVPTQGVFKN 597
+ + +L +K LN+++N + F N
Sbjct: 117 ASLESFPIGQLITLKKLNVAHNFIHS-CKLPAYFSN 151
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 6e-63
Identities = 90/337 (26%), Positives = 139/337 (41%), Gaps = 54/337 (16%)
Query: 664 EKQNPNSPINSFPNISYQNLYNATDRFSS------VNQIGEGSFGSVFKGILDDGRTTIA 717
E ++ F + S+ L N T+ F N++GEG FG V+KG +++ TT+A
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN--TTVA 58
Query: 718 VKVFNLLHHGAFKS------FIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEF 771
VK L + F E + +H NLV++L S G+D LV+ +
Sbjct: 59 VKK--LAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSS----DGDD-LCLVYVY 111
Query: 772 MHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKP 831
M N SL + L P L+ R I+ A +N+LH + H D+K
Sbjct: 112 MPNGSLLDRLS-----CLDGTPP--LSWHMRCKIAQGAANGINFLHENH---HIHRDIKS 161
Query: 832 SNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSY 891
+NILLDE A I DFGLAR + + G+ Y+APE G E++ D+YS+
Sbjct: 162 ANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSF 220
Query: 892 GILLLELITRKKPTDIMFEGDMNLHNLARTALPD--HVMDIVDSTLLNDGEDLIVHGNQR 949
G++LLE+IT D E L ++ + + D +D + +
Sbjct: 221 GVVLLEIITGLPAVDEHRE-PQLLLDIKEEIEDEEKTIEDYIDKKM----------NDAD 269
Query: 950 QRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986
+M + C E R + V
Sbjct: 270 STSVE---------AMYSVASQCLHEKKNKRPDIKKV 297
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 7e-63
Identities = 74/326 (22%), Positives = 132/326 (40%), Gaps = 37/326 (11%)
Query: 673 NSFPNISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSF 732
+S ++ +NLY + + G FG V+K L + +AVK+F + +++
Sbjct: 9 SSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLN--EYVAVKIFPIQDKQSWQ-N 65
Query: 733 IAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDE 792
E +L ++H N+++ + A D L+ F SL ++L
Sbjct: 66 EYEVYSLPGMKHENILQFIGAEKRGTSVDVDL-WLITAFHEKGSLSDFLKA--------- 115
Query: 793 APRSLNLIQRLNISIDVACALNYLHHD-------CQPPIAHCDLKPSNILLDEDMIAHIG 845
++ + +I+ +A L YLH D +P I+H D+K N+LL ++ A I
Sbjct: 116 --NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173
Query: 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEY-----GLGSEVSISGDVYSYGILLLELIT 900
DFGLA + + G G+ Y+APE + + D+Y+ G++L EL +
Sbjct: 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233
Query: 901 RKKPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIE 960
R D + M LP + L D ++++VH +R +
Sbjct: 234 RCTAADGPVDEYM---------LPFEEEIGQHPS-LEDMQEVVVHKKKRPVLRDYWQKHA 283
Query: 961 CLISMVRIGVACSMESPEDRMSMTNV 986
+ + C E R+S V
Sbjct: 284 GMAMLCETIEECWDHDAEARLSAGCV 309
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 3e-55
Identities = 74/331 (22%), Positives = 126/331 (38%), Gaps = 46/331 (13%)
Query: 678 ISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECN 737
+ D + IG G +G+V+KG LD+ +AVKVF+ + ++FI E N
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDE--RPVAVKVFSFAN---RQNFINEKN 57
Query: 738 --TLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPR 795
+ + H N+ + + V G LV E+ N SL ++L
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-----------H 106
Query: 796 SLNLIQRLNISIDVACALNYLHHD------CQPPIAHCDLKPSNILLDEDMIAHIGDFGL 849
+ + + ++ V L YLH + +P I+H DL N+L+ D I DFGL
Sbjct: 107 TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL 166
Query: 850 ARFL------PLSSAQTSSIGAKGSIGYIAPEY-------GLGSEVSISGDVYSYGILLL 896
+ L ++I G+I Y+APE D+Y+ G++
Sbjct: 167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYW 226
Query: 897 ELITRKKPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQR-QARV 955
E+ R TD+ + + + A V + D + L+ QR +
Sbjct: 227 EIFMRC--TDLFPGESVPEYQM---AFQTEVGNHPT---FEDMQVLVSREKQRPKFPEAW 278
Query: 956 KSRIECLISMVRIGVACSMESPEDRMSMTNV 986
K + S+ C + E R++
Sbjct: 279 KENSLAVRSLKETIEDCWDQDAEARLTAQXA 309
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 7e-55
Identities = 100/517 (19%), Positives = 171/517 (33%), Gaps = 33/517 (6%)
Query: 64 VTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIG 123
LDL L S + L+VL L + L L L L N I
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 124 GAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLT-GSIPSSLGNLS 182
S S+L +L L + L ++ ++V N + +P NL+
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 183 SIRSLFLSGNNLEGSIPDTLGWLKNL----VNLTMAQNRLSGTIPSSIFNISSITGFDAG 238
++ L LS N ++ L L + ++L ++ N ++ I F +
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLR 208
Query: 239 VNKIQGAIPLDYGFSLQNLQFFS------VGENQLTGAIPPTISNASNLEIFHGSVNKLT 292
N + L L+ E L + NL I + L
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268
Query: 293 GAAPYLEKLQRLLVFGILGN-SLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPAC 351
+ +F L N S S + + + + L + F
Sbjct: 269 -----YYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKF-----GQ 318
Query: 352 ISNLS-TTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLS--GTIPPAIGELQNLK 408
L +L+ L +N+ GN + + +L+ LD+ N LS G + +LK
Sbjct: 319 FPTLKLKSLKRLTFTSNKG-GNAFSEVD-LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLK 376
Query: 409 DLRLQRNRFQGNIPPSIGNLK-LFILYLSYNFLQGSIPSS-LGRYETLTTIDLSNNNLTG 466
L L N + + L+ L L ++ L+ S L +D+S+ +
Sbjct: 377 YLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR- 434
Query: 467 TIPPQFIGLSSSLIVLDLSRNQLTGSIPSEV-GNLKNLEILNVFGNKLKGEIPSTLGSCI 525
SSL VL ++ N + ++ L+NL L++ +L+ P+ S
Sbjct: 435 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS 494
Query: 526 KLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLS 562
L+ L M N L+ L L + L N
Sbjct: 495 SLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 1e-54
Identities = 109/515 (21%), Positives = 187/515 (36%), Gaps = 31/515 (6%)
Query: 88 LKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLV 147
K L L N H F LQVL L I S S+L L L N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 148 GKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNL-EGSIPDTLGWLK 206
S LS ++ + + NL +G+L +++ L ++ N + +P+ L
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 207 NLVNLTMAQNRLSGTIPSSIFNISSITGF----DAGVNKIQGAIPLDYGFSLQNLQFFSV 262
NL +L ++ N++ + + + + D +N + I F L ++
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPG-AFKEIRLHKLTL 207
Query: 263 GENQLTGAIPPT-ISNASNLEI-------FHGSVNKLTGAAPYLEKLQRLLVFGILGNSL 314
N + + T I + LE+ F N LE L L + L
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267
Query: 315 GSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIP 374
D ++ LTN + + + LE++ Q
Sbjct: 268 DYYLDDIIDLFNCLTN---VSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTL-- 322
Query: 375 AAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNR--FQGNIPPSIGNL-KLF 431
K +L+RL SN+ + +L +L+ L L RN F+G S L
Sbjct: 323 ----KLKSLKRLTFTSNKGGN--AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLK 376
Query: 432 ILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTG 491
L LS+N + ++ S+ E L +D ++NL +LI LD+S
Sbjct: 377 YLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV 435
Query: 492 SIPSEVGNLKNLEILNVFGNKLKGEIPS-TLGSCIKLEQLEMQENFLQGPIPSSLSSLRG 550
+ L +LE+L + GN + L L++ + L+ P++ +SL
Sbjct: 436 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS 495
Query: 551 LSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDL 585
L VL+++ N L + RL ++ + L N
Sbjct: 496 LQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 1e-47
Identities = 96/504 (19%), Positives = 167/504 (33%), Gaps = 39/504 (7%)
Query: 125 AIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSI 184
IP N+ + L L N L S +++ + ++ + + +LS +
Sbjct: 21 KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 185 RSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQG 244
+L L+GN ++ L +L L + L+ I ++ ++ + N IQ
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 245 AIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHG----SVNKLTGAAPYLEK 300
+Y +L NL+ + N++ + + + + S+N + P K
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK 198
Query: 301 LQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLE 360
RL + N + + RL L
Sbjct: 199 EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLT 258
Query: 361 VLLLDNNQI---FGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGE-------------- 403
+ + +I N+ + S + +
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFG 317
Query: 404 ------LQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQ--GSIPSSLGRYETLT 455
L++LK L N+ N + L L LS N L G S +L
Sbjct: 318 QFPTLKLKSLKRLTFTSNKGG-NAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLK 376
Query: 456 TIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEV-GNLKNLEILNVFGNKLK 514
+DLS N + T+ F+GL L LD + L V +L+NL L++ +
Sbjct: 377 YLDLSFNGVI-TMSSNFLGL-EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 434
Query: 515 GEIPSTLGSCIKLEQLEMQENFLQGPIPS-SLSSLRGLSVLDLSQNNLSGKIPELLIRLQ 573
LE L+M N Q + LR L+ LDLSQ L P L
Sbjct: 435 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS 494
Query: 574 LVKNLNLSNNDLEGVVPTQGVFKN 597
++ LN+++N L+ V G+F
Sbjct: 495 SLQVLNMASNQLKSVPD--GIFDR 516
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-37
Identities = 93/474 (19%), Positives = 162/474 (34%), Gaps = 62/474 (13%)
Query: 69 LESLKLAG----SISPHV-GNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIG 123
L +L L G S++ LS L+ L + L+ L+ L + +N I
Sbjct: 78 LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137
Query: 124 -GAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSK----IEHISVNDNNLTGSIPSSL 178
+P S+ +NL L L N++ ++L L + + ++ N + I
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGA 196
Query: 179 GNLSSIRSLFLSGNNLEGSIPDTL----------------------------GWLKNLVN 210
+ L L N ++ T L+ L N
Sbjct: 197 FKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN 256
Query: 211 LTMAQNRLSG------TIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGE 264
LT+ + RL+ I +++++ F I+ Y F Q+L+ +
Sbjct: 257 LTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKF 316
Query: 265 NQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNF 324
Q +L+ + NK A L L + N L +G
Sbjct: 317 GQFPT------LKLKSLKRLTFTSNKGGNA-FSEVDLPSLEFLDLSRNGLSFKGCCS--- 366
Query: 325 LCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPA-AIGKFVNL 383
S T LK+L ++ N ++ + L LE L ++ + NL
Sbjct: 367 -QSDFGTTSLKYLDLSFNGVI-TMSSNFLGL-EQLEHLDFQHSNLKQMSEFSVFLSLRNL 423
Query: 384 QRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSI-GNL-KLFILYLSYNFLQ 441
LD+ L +L+ L++ N FQ N P I L L L LS L+
Sbjct: 424 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483
Query: 442 GSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPS 495
P++ +L +++++N L ++P +SL + L N S P
Sbjct: 484 QLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 6e-20
Identities = 67/369 (18%), Positives = 114/369 (30%), Gaps = 28/369 (7%)
Query: 67 LDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSE-FDRLRRLQVLALHYNSIGGA 125
LDL + I P L L L NN + + L L+V L
Sbjct: 182 LDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE 240
Query: 126 ---IPANISSCSNLIQLRLFHNQLVG------KIPSELSSLSKIEHISVNDNNLTGSIPS 176
+ S+ L L + +L I + L+ + S+ + +
Sbjct: 241 GNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKD 299
Query: 177 SLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFD 236
N + L L LK+L LT N+ ++ S+ D
Sbjct: 300 FSYN-FGWQHLELVNCKFGQ---FPTLKLKSLKRLTFTSNKGGNAFSEV--DLPSLEFLD 353
Query: 237 AGVNKIQG-AIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAA 295
N + F +L++ + N + + LE + L +
Sbjct: 354 LSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMS 412
Query: 296 PY--LEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACIS 353
+ L+ L+ I + N L + L+ L + N+F + I
Sbjct: 413 EFSVFLSLRNLIYLDISHTHTRVAFNGIFNGL------SSLEVLKMAGNSFQENFLPDIF 466
Query: 354 NLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQ 413
L L L Q+ P A +LQ L+M SN+L L +L+ + L
Sbjct: 467 TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLH 526
Query: 414 RNRFQGNIP 422
N + + P
Sbjct: 527 TNPWDCSCP 535
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 2e-18
Identities = 48/226 (21%), Positives = 85/226 (37%), Gaps = 8/226 (3%)
Query: 84 NLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIG--GAIPANISSCSNLIQLRL 141
L LK L +N + L L+ L L N + G + ++L L L
Sbjct: 323 KLKSLKRLTFTSNKGGNAFS--EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380
Query: 142 FHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSS-LGNLSSIRSLFLSGNNLEGSIPD 200
N ++ + S L ++EH+ +NL S +L ++ L +S + +
Sbjct: 381 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG 439
Query: 201 TLGWLKNLVNLTMAQNRLSGTIPSSIF-NISSITGFDAGVNKIQGAIPLDYGFSLQNLQF 259
L +L L MA N IF + ++T D +++ + SL +LQ
Sbjct: 440 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQV 498
Query: 260 FSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLL 305
++ NQL ++L+ N + P ++ L R L
Sbjct: 499 LNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWL 544
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 7e-17
Identities = 30/131 (22%), Positives = 50/131 (38%), Gaps = 4/131 (3%)
Query: 455 TTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLK 514
T N IP L S LDLS N L + L++L++ +++
Sbjct: 10 ITYQCMELNFY-KIPD---NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ 65
Query: 515 GEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQL 574
S L L + N +Q + S L L L + NL+ + L+
Sbjct: 66 TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKT 125
Query: 575 VKNLNLSNNDL 585
+K LN+++N +
Sbjct: 126 LKELNVAHNLI 136
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 9e-15
Identities = 30/166 (18%), Positives = 65/166 (39%), Gaps = 5/166 (3%)
Query: 65 TILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSE--FDRLRRLQVLALHYNSI 122
LDL + ++S + L L+ L +++ ++ F LR L L + +
Sbjct: 376 KYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNL-KQMSEFSVFLSLRNLIYLDISHTHT 433
Query: 123 GGAIPANISSCSNLIQLRLFHNQLVGKIPSE-LSSLSKIEHISVNDNNLTGSIPSSLGNL 181
A + S+L L++ N + + L + + ++ L P++ +L
Sbjct: 434 RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSL 493
Query: 182 SSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIF 227
SS++ L ++ N L+ L +L + + N + P +
Sbjct: 494 SSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDY 539
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 3e-54
Identities = 73/255 (28%), Positives = 121/255 (47%), Gaps = 25/255 (9%)
Query: 658 LVRKRKEKQNPNSPINSFPNISYQNLYNATD---RFSSV---NQIGEGSFGSVFKGILDD 711
+ + I + N+ +Q + D + + +IG GSFG+V +
Sbjct: 1 MKHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHG 60
Query: 712 GRTTIAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVF 769
+ +AVK+ H F+ E +K +RH N+V + A + Q + ++V
Sbjct: 61 --SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT----QPPNL-SIVT 113
Query: 770 EFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDL 829
E++ SL LH A L+ +RL+++ DVA +NYLH+ PPI H +L
Sbjct: 114 EYLSRGSLYRLLH-------KSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNL 165
Query: 830 KPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVY 889
K N+L+D+ + DFGL+R +S SS A G+ ++APE + DVY
Sbjct: 166 KSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVY 223
Query: 890 SYGILLLELITRKKP 904
S+G++L EL T ++P
Sbjct: 224 SFGVILWELATLQQP 238
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 5e-53
Identities = 103/507 (20%), Positives = 184/507 (36%), Gaps = 67/507 (13%)
Query: 84 NLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFH 143
L+ L + + L ++ L I + +NL Q+ +
Sbjct: 22 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSN 77
Query: 144 NQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLG 203
NQL P L +L+K+ I +N+N + P L NL+++ L L N + P L
Sbjct: 78 NQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LK 131
Query: 204 WLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVG 263
L NL L ++ N +S S++ ++S+ G N++ PL L L+ +
Sbjct: 132 NLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTDLKPLAN---LTTLERLDIS 185
Query: 264 ENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLN 323
N+++ ++ +NLE + N+++ P L L L + GN L +D+
Sbjct: 186 SNKVSD--ISVLAKLTNLESLIATNNQISDITP-LGILTNLDELSLNGNQL-----KDIG 237
Query: 324 FLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNL 383
L SLTN L L L NNQI P + L
Sbjct: 238 TLASLTN----------------------------LTDLDLANNQISNLAP--LSGLTKL 267
Query: 384 QRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGS 443
L + +N++S P + L L +L L N+ + +I P L L L +N +
Sbjct: 268 TELKLGANQISNISP--LAGLTALTNLELNENQLE-DISPISNLKNLTYLTLYFNNISDI 324
Query: 444 IPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNL 503
P + L + NN ++ + +++ L NQ++ P + NL +
Sbjct: 325 SP--VSSLTKLQRLFFYNNKVSD---VSSLANLTNINWLSAGHNQISDLTP--LANLTRI 377
Query: 504 EILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSG 563
L + + + ++ L P+++S + D++ N S
Sbjct: 378 TQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLPS- 434
Query: 564 KIPELLIRLQLVKNLNLSNNDLEGVVP 590
E+ + G V
Sbjct: 435 YTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 7e-49
Identities = 94/462 (20%), Positives = 185/462 (40%), Gaps = 46/462 (9%)
Query: 129 NISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLF 188
++ + ++ L + + + L ++ + + + + L+++ +
Sbjct: 19 TDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQIN 74
Query: 189 LSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPL 248
S N L P L L LV++ M N+++ P + N++++TG N+I PL
Sbjct: 75 FSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDPL 130
Query: 249 DYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFG 308
+L NL + N ++ +S ++L+ N++T P L L L
Sbjct: 131 K---NLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTDLKP-LANLTTLERLD 183
Query: 309 ILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQ 368
I N + D++ L LTN L+ L+ N P + L T L+ L L+ NQ
Sbjct: 184 ISSNKV-----SDISVLAKLTN---LESLIATNNQISDITP--LGIL-TNLDELSLNGNQ 232
Query: 369 IFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNL 428
+ + NL LD+ +N++S P + L L +L+L N+ + L
Sbjct: 233 L--KDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN--ISPLAGL 286
Query: 429 K-LFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRN 487
L L L+ N L+ P + + LT + L NN++ P + + L L N
Sbjct: 287 TALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP---VSSLTKLQRLFFYNN 341
Query: 488 QLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSS 547
+++ S + NL N+ L+ N++ P L + ++ QL + + + ++
Sbjct: 342 KVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKAN 397
Query: 548 LRGLSVLDLSQNNLSGKI-PELLIRLQLVKNLNLSNNDLEGV 588
+S+ + +N I P + +++ N
Sbjct: 398 ---VSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPSYT 436
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 1e-45
Identities = 89/452 (19%), Positives = 171/452 (37%), Gaps = 44/452 (9%)
Query: 64 VTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIG 123
L + ++S +L + L+ + L L + N +
Sbjct: 26 KMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLT 81
Query: 124 GAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSS 183
P + + + L+ + + +NQ+ + L++L+ + +++ +N +T P L NL++
Sbjct: 82 DITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITDIDP--LKNLTN 135
Query: 184 IRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQ 243
+ L LS N + L L +L L+ N+++ P + N++++ D NK+
Sbjct: 136 LNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLDISSNKVS 190
Query: 244 GAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQR 303
L L NL+ NQ++ P + +NL+ + N+L L L
Sbjct: 191 DISVLA---KLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGT-LASLTN 244
Query: 304 LLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLL 363
L + N + +L L LT L L + N P ++ L T L L
Sbjct: 245 LTDLDLANNQI-----SNLAPLSGLTK---LTELKLGANQISNISP--LAGL-TALTNLE 293
Query: 364 LDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPP 423
L+ NQ+ P I NL L + N +S P + L L+ L N+
Sbjct: 294 LNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VS 347
Query: 424 SIGNL-KLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVL 482
S+ NL + L +N + P L +T + L++ T +S V
Sbjct: 348 SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVK 405
Query: 483 DLSRNQLTGSIPSEVGNLKNLEILNVFGNKLK 514
+++ + P+ + + + ++ N
Sbjct: 406 NVTGALIA---PATISDGGSYTEPDITWNLPS 434
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 3e-51
Identities = 95/503 (18%), Positives = 180/503 (35%), Gaps = 40/503 (7%)
Query: 83 GNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANI-SSCSNLIQLRL 141
G + +K L L N + + LQVL L + I I + S +L L L
Sbjct: 23 GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI-NTIEGDAFYSLGSLEHLDL 81
Query: 142 FHNQLVGKIPSELSSLSKIEHISVNDNNLTG-SIPSSLGNLSSIRSLFLSGNNLEGSIP- 199
N L S LS ++++++ N + S NL+++++L + I
Sbjct: 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRR 141
Query: 200 DTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQF 259
L +L L + L S+ +I I +++ + + L ++++
Sbjct: 142 IDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRY 200
Query: 260 FSVGENQLTGAIPPTIS-----------NASNLEIFHGSVNKLTGAAPYLEKLQRLLVFG 308
+ + L + + S N+L Y+ +L +
Sbjct: 201 LELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDD 260
Query: 309 ILGNSLGSRGDRDLNFLCSLTN--ATRLKWLLININNFGGSLPACISNLSTTLEVLLLDN 366
N LG + + + L ++ L I L S L ++ + ++N
Sbjct: 261 CTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLL-EKVKRITVEN 319
Query: 367 NQIFGNIPA-AIGKFVNLQRLDMCSNRLSGTIPP---AIGELQNLKDLRLQRNRFQGNIP 422
+++F +P +L+ LD+ N + G +L+ L L +N + ++
Sbjct: 320 SKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQ 377
Query: 423 PSIGNL----KLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSS 478
+ L L L +S N +P S E + ++LS+ + + + +
Sbjct: 378 KTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKT---CIPQT 432
Query: 479 LIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQ 538
L VLD+S N L S L L+ L + NKLK +P L +++ N L+
Sbjct: 433 LEVLDVSNNNLD-SFSL---FLPRLQELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLK 486
Query: 539 GPIPSSLSSLRGLSVLDLSQNNL 561
L L + L N
Sbjct: 487 SVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-38
Identities = 83/486 (17%), Positives = 177/486 (36%), Gaps = 34/486 (6%)
Query: 125 AIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSI 184
+IP+ +++ + L L N++ +L + + ++ + + + + + +L S+
Sbjct: 19 SIPSGLTA--AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSL 76
Query: 185 RSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIF-NISSITGFDAGVNKIQ 243
L LS N+L G L +L L + N +S+F N++++ G +
Sbjct: 77 EHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETF 136
Query: 244 GAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPY-LEKLQ 302
I L +L + L ++ + ++ +++ + L
Sbjct: 137 SEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILS 196
Query: 303 RLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNF-GGSLPACISNLSTTLEV 361
+ + +L L + +L + + + L + + EV
Sbjct: 197 SVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEV 256
Query: 362 LLLDN--NQIFGNIPAAIGKF--------VNLQRLDMCSNRLSGTIPPAIGELQNLKDLR 411
D N + P+ V ++RL + L + L+ +K +
Sbjct: 257 EFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRIT 316
Query: 412 LQRNRFQGNIPPSI--GNLKLFILYLSYNFLQGSI---PSSLGRYETLTTIDLSNNNLT- 465
++ ++ +P S L L LS N + + G + +L T+ LS N+L
Sbjct: 317 VENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRS 375
Query: 466 -GTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSC 524
+ L +L LD+SRN +P + + LN+ ++ + + +
Sbjct: 376 MQKTGEILLTL-KNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQ- 431
Query: 525 IKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNND 584
LE L++ N L L L+ L +S+N L +P+ + L + +S N
Sbjct: 432 -TLEVLDVSNNNLDS-FSLFLPRLQ---ELYISRNKLK-TLPDASLFPVL-LVMKISRNQ 484
Query: 585 LEGVVP 590
L+ V
Sbjct: 485 LKSVPD 490
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-29
Identities = 69/453 (15%), Positives = 133/453 (29%), Gaps = 73/453 (16%)
Query: 65 TILDLESLKLAGSISPHV-GNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIG 123
L + +++ I L+ L L + S + +R + L LH +
Sbjct: 126 QTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA 185
Query: 124 GAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSS 183
+ S++ L L L S L + + S L
Sbjct: 186 FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLK 245
Query: 184 IRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQ 243
+ L + +E + T+ G S ++ S G
Sbjct: 246 LLRYILELSEVE------------FDDCTLNGL---GDFNPSESDVVSELGK-------- 282
Query: 244 GAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTG-AAPYLEKLQ 302
++ + + L + S ++ +K+ + + L+
Sbjct: 283 --------VETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLK 334
Query: 303 RLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVL 362
L + N + ++ + + L+ L
Sbjct: 335 SLEFLDLSENLMVEEYLKNSACKGAWPS----------------------------LQTL 366
Query: 363 LLDNNQI--FGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGN 420
+L N + + NL LD+ N +P + + ++ L L +
Sbjct: 367 VLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-V 424
Query: 421 IPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLI 480
+ I L +L +S N L S L R L + +S N L T+P L L+
Sbjct: 425 VKTCIPQ-TLEVLDVSNNNLD-SFSLFLPR---LQELYISRNKLK-TLPD--ASLFPVLL 476
Query: 481 VLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKL 513
V+ +SRNQL L +L+ + + N
Sbjct: 477 VMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-25
Identities = 62/434 (14%), Positives = 134/434 (30%), Gaps = 65/434 (14%)
Query: 167 DNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSI 226
+ T SIPS L ++++SL LS N + L NL L + +R++ TI
Sbjct: 14 SRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDA 69
Query: 227 FNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHG 286
F SL +L+ + +N L+ S+L+ +
Sbjct: 70 FY------------------------SLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNL 105
Query: 287 SVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGG 346
N L N T L+ L I
Sbjct: 106 MGNPYQ----------------------------TLGVTSLFPNLTNLQTLRIGNVETFS 137
Query: 347 SLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQN 406
+ T+L L + + ++ ++ L + + + + L +
Sbjct: 138 EIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSS 197
Query: 407 LKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTG 466
++ L L+ S + + +GS+ + + + +
Sbjct: 198 VRYLELRDTNLA-RFQFSPLPVDEVSSPMKKLAFRGSVLTDE----SFNELLKLLRYILE 252
Query: 467 TIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIK 526
+F + + + D + ++ + L++ L ++ + K
Sbjct: 253 LSEVEFDDCTLNGL-GDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEK 311
Query: 527 LEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKI---PELLIRLQLVKNLNLSNN 583
++++ ++ + + S L+ L LDLS+N + + ++ L LS N
Sbjct: 312 VKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQN 371
Query: 584 DLEGVVPTQGVFKN 597
L + T +
Sbjct: 372 HLRSMQKTGEILLT 385
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-23
Identities = 57/379 (15%), Positives = 127/379 (33%), Gaps = 44/379 (11%)
Query: 65 TILDLESLKLAGSISPHV-GNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIG 123
L++++L L + ++ + L L+ + + D L ++ L L ++
Sbjct: 151 NELEIKALSLR-NYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLA 209
Query: 124 GAIPANISSCSNLIQLRLFHNQLVG----------KIPSELSSLSKIEHISVNDNNLTGS 173
+ + ++ + K+ + LS++E N L
Sbjct: 210 RFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDF 269
Query: 174 IPSSLGNLS--------SIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSS 225
PS +S +IR L + L + L+ + +T+ +++ +P S
Sbjct: 270 NPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCS 328
Query: 226 IF-NISSITGFDAGVNKIQGAIPLDYGF--SLQNLQFFSVGENQLT--GAIPPTISNASN 280
++ S+ D N + + + +LQ + +N L + N
Sbjct: 329 FSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKN 388
Query: 281 LEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLIN 340
L S N + +++ + + C L+ L ++
Sbjct: 389 LTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIRV------VKTCIPQT---LEVLDVS 439
Query: 341 INNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPP- 399
NN S + L + L + N++ +P A F L + + N+L ++P
Sbjct: 440 NNNLD-SFSLFLPRL----QELYISRNKL-KTLPDA-SLFPVLLVMKISRNQLK-SVPDG 491
Query: 400 AIGELQNLKDLRLQRNRFQ 418
L +L+ + L N +
Sbjct: 492 IFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 4e-16
Identities = 45/247 (18%), Positives = 82/247 (33%), Gaps = 16/247 (6%)
Query: 64 VTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIG 123
+ L + L +S L +K + + N+ S L+ L+ L L N +
Sbjct: 288 IRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMV 347
Query: 124 GAIPAN---ISSCSNLIQLRLFHNQL--VGKIPSELSSLSKIEHISVNDNNLTGSIPSSL 178
N + +L L L N L + K L +L + + ++ N +P S
Sbjct: 348 EEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSC 406
Query: 179 GNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAG 238
+R L LS + + + L L ++ N L + + +
Sbjct: 407 QWPEKMRFLNLSSTGIR-VVKT--CIPQTLEVLDVSNNNLD-SFSL---FLPRLQELYIS 459
Query: 239 VNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYL 298
NK++ L L + NQL ++L+ N + P +
Sbjct: 460 RNKLKT---LPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 516
Query: 299 EKLQRLL 305
+ L R L
Sbjct: 517 DYLSRWL 523
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 6e-51
Identities = 67/212 (31%), Positives = 92/212 (43%), Gaps = 24/212 (11%)
Query: 694 NQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTA 753
+G G+FG V K +A+K K+FI E L + H N+VK+ A
Sbjct: 14 EVVGRGAFGVVCKAKWRA--KDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 754 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACAL 813
C N LV E+ SL LH E ++ + + +
Sbjct: 70 CL------NPV-CLVMEYAEGGSLYNVLH-------GAEPLPYYTAAHAMSWCLQCSQGV 115
Query: 814 NYLHHDCQPPIAHCDLKPSNILLDEDM-IAHIGDFGLARFLPLSSAQTSSIGAKGSIGYI 872
YLH + H DLKP N+LL + I DFG A + QT KGS ++
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI-----QTHMTNNKGSAAWM 170
Query: 873 APEYGLGSEVSISGDVYSYGILLLELITRKKP 904
APE GS S DV+S+GI+L E+ITR+KP
Sbjct: 171 APEVFEGSNYSEKCDVFSWGIILWEVITRRKP 202
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 3e-50
Identities = 51/219 (23%), Positives = 88/219 (40%), Gaps = 32/219 (14%)
Query: 694 NQIGEGSFGSVFKGILDDGRTTIAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKIL 751
++ E G ++KG I VKV + + F EC L+ H N++ +L
Sbjct: 16 TKLNENHSGELWKGRWQG--NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 752 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVAC 811
AC L+ +M SL LH + ++ Q + ++D+A
Sbjct: 74 GACQS---PPAPHPTLITHWMPYGSLYNVLH--------EGTNFVVDQSQAVKFALDMAR 122
Query: 812 ALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGY 871
+ +LH +P I L ++++DEDM A I + S G + +
Sbjct: 123 GMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAW 174
Query: 872 IAPE------YGLGSEVSISGDVYSYGILLLELITRKKP 904
+APE + D++S+ +LL EL+TR+ P
Sbjct: 175 VAPEALQKKPEDTNRRSA---DMWSFAVLLWELVTREVP 210
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 5e-50
Identities = 65/216 (30%), Positives = 98/216 (45%), Gaps = 26/216 (12%)
Query: 694 NQIGEGSFGSVFKGILDDGRTTIAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKIL 751
+IG GSFG+V+KG +AVK+ N+ ++F E L+ RH N++ +
Sbjct: 30 QRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 752 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVAC 811
+ A+V ++ SL LH + + + ++I+ A
Sbjct: 87 GYSTAPQL------AIVTQWCEGSSLYHHLH---------ASETKFEMKKLIDIARQTAR 131
Query: 812 ALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGY 871
++YLH I H DLK +NI L ED IGDFGLA S GSI +
Sbjct: 132 GMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILW 188
Query: 872 IAPE---YGLGSEVSISGDVYSYGILLLELITRKKP 904
+APE + S DVY++GI+L EL+T + P
Sbjct: 189 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 1e-49
Identities = 61/223 (27%), Positives = 94/223 (42%), Gaps = 34/223 (15%)
Query: 694 NQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH----HGAFKSFIAECNTLKNIRHRNLVK 749
IG G FG V++ +AVK ++ E ++H N++
Sbjct: 13 EIIGIGGFGKVYRAFWIG--DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 750 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDV 809
+ C + + LV EF L L + + +N ++ +
Sbjct: 71 LRGVCL----KEPNL-CLVMEFARGGPLNRVLSG-----------KRIPPDILVNWAVQI 114
Query: 810 ACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH--------IGDFGLARFLPLSSAQTS 861
A +NYLH + PI H DLK SNIL+ + + I DFGLAR +T+
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW----HRTT 170
Query: 862 SIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
+ A G+ ++APE S S DV+SYG+LL EL+T + P
Sbjct: 171 KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-48
Identities = 55/225 (24%), Positives = 92/225 (40%), Gaps = 36/225 (16%)
Query: 694 NQIGEGSFGSVFKGILDDGRTTIAVKVF-------NLLHHGAFKSFIAECNTLKNIRHRN 746
QIG+G FG V KG L ++ +A+K F+ F E + N+ H N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 747 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNIS 806
+VK+ + +V EF+ L L + + +L +
Sbjct: 85 IVKLYGLMH-------NPPRMVMEFVPCGDLYHRLL---------DKAHPIKWSVKLRLM 128
Query: 807 IDVACALNYLHHDCQPPIAHCDLKPSNILLDE-----DMIAHIGDFGLARFLPLSSAQTS 861
+D+A + Y+ + PPI H DL+ NI L + A + DFGL++ S
Sbjct: 129 LDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV-----HS 182
Query: 862 SIGAKGSIGYIAPE--YGLGSEVSISGDVYSYGILLLELITRKKP 904
G G+ ++APE + D YS+ ++L ++T + P
Sbjct: 183 VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 5e-48
Identities = 106/518 (20%), Positives = 194/518 (37%), Gaps = 39/518 (7%)
Query: 84 NLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANI-SSCSNLIQLRLF 142
L+ + L L N S F L +LQ+L L I + NL L L
Sbjct: 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLG 81
Query: 143 HNQLVGKIPSELSSLSKIEHISVNDNNLTGSI--PSSLGNLSSIRSLFLSGNNLEG-SIP 199
+++ P L + + + L+ ++ NL ++ L LS N + +
Sbjct: 82 SSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLH 141
Query: 200 DTLGWLKNLVNLTMAQNRLSGTIPSSIFN---ISSITGFDAGVNKIQGAIPLDYGFSLQN 256
+ G L +L ++ + N++ + +++ F N + + +D+G +
Sbjct: 142 PSFGKLNSLKSIDFSSNQIF-LVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNP 200
Query: 257 LQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTG-AAPYLEKLQRLLVFGILGNSLG 315
+ + ++G N ++I N ++ A L ++ G +++
Sbjct: 201 FRNMVLEILDVSG-------NGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK 253
Query: 316 SRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPA 375
L + ++ L ++ L L+VL L N+I
Sbjct: 254 DPDQNTFAGLARSS----VRHLDLSHGFVFSLNSRVFETL-KDLKVLNLAYNKINKIADE 308
Query: 376 AIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNL-KLFILY 434
A NLQ L++ N L L + + LQ+N + L KL L
Sbjct: 309 AFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLD 368
Query: 435 LSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTG-SI 493
L N L +++ ++ I LS N L T+P ++ + ++ LS N+L I
Sbjct: 369 LRDNAL-----TTIHFIPSIPDIFLSGNKLV-TLPK----INLTANLIHLSENRLENLDI 418
Query: 494 PSEVGNLKNLEILNVFGNKLKG-EIPSTLGSCIKLEQLEMQENFLQGPIPSSL-----SS 547
+ + +L+IL + N+ T LEQL + EN LQ + L
Sbjct: 419 LYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEG 478
Query: 548 LRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDL 585
L L VL L+ N L+ P + L ++ L+L++N L
Sbjct: 479 LSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRL 516
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-32
Identities = 79/424 (18%), Positives = 137/424 (32%), Gaps = 67/424 (15%)
Query: 168 NNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIF 227
NLT +P L++ L LS N + + +L+ L L + TI F
Sbjct: 14 CNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAF 69
Query: 228 NISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGS 287
+L NL+ +G +++ P +L
Sbjct: 70 R------------------------NLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLY 105
Query: 288 VNKLTGAAP---YLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNF 344
L+ A Y L+ L + N + S L S LK + + N
Sbjct: 106 FCGLSDAVLKDGYFRNLKALTRLDLSKNQIRS-----LYLHPSFGKLNSLKSIDFSSNQI 160
Query: 345 GGSLPACISNLS-TTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGE 403
+ L TL L N ++ + GK
Sbjct: 161 FLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKC----------------------- 197
Query: 404 LQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNN 463
+ +++ L+ GN + I N + S SL + +N
Sbjct: 198 MNPFRNMVLEILDVSGN------GWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHN 251
Query: 464 LTGTIPPQFIGL-SSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLG 522
+ F GL SS+ LDLS + LK+L++LN+ NK+
Sbjct: 252 IKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFY 311
Query: 523 SCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSN 582
L+ L + N L S+ L ++ +DL +N+++ + L+ ++ L+L +
Sbjct: 312 GLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRD 371
Query: 583 NDLE 586
N L
Sbjct: 372 NALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 2e-20
Identities = 68/340 (20%), Positives = 129/340 (37%), Gaps = 38/340 (11%)
Query: 85 LSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHN 144
S ++ L L + F+ L+ L+VL L YN I NL L L +N
Sbjct: 265 RSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYN 324
Query: 145 QLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGW 204
L S L K+ +I + N++ + L +++L L N L T+ +
Sbjct: 325 LLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHF 379
Query: 205 LKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGE 264
+ ++ ++ ++ N+L T+P + I N+++ L + + +LQ + +
Sbjct: 380 IPSIPDIFLSGNKLV-TLPKINLTANLI---HLSENRLENLDILYFLLRVPHLQILILNQ 435
Query: 265 NQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNF 324
N+ + + L++L + N L + +L
Sbjct: 436 NRFSS-CSGD-------QTPSE-----------NPSLEQLFLG---ENMLQLAWETELC- 472
Query: 325 LCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQ 384
+ L+ L +N N SLP + + T L L L++N++ + NL+
Sbjct: 473 WDVFEGLSHLQVLYLNHNYL-NSLPPGVFSHLTALRGLSLNSNRLT-VLSHND-LPANLE 529
Query: 385 RLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPS 424
LD+ N+L P + +L L + N+F S
Sbjct: 530 ILDISRNQLL-APNPDV--FVSLSVLDITHNKFICECELS 566
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 6e-48
Identities = 62/309 (20%), Positives = 120/309 (38%), Gaps = 43/309 (13%)
Query: 693 VNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECN--TLKNIRHRNLVKI 750
+ +G+G +G V++G +AVK+F+ KS+ E +RH N++
Sbjct: 13 LECVGKGRYGEVWRGSWQG--ENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGF 67
Query: 751 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVA 810
+ + + L+ + SL ++L +L+ + L I + +A
Sbjct: 68 IASDMTSRHSSTQL-WLITHYHEMGSLYDYLQL-----------TTLDTVSCLRIVLSIA 115
Query: 811 CALNYLHHD-----CQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLP--LSSAQTSSI 863
L +LH + +P IAH DLK NIL+ ++ I D GLA + +
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN 175
Query: 864 GAKGSIGYIAPE------YGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHN 917
G+ Y+APE + D++++G++L E+ R I+ +
Sbjct: 176 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED------- 228
Query: 918 LARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESP 977
P + + D + D ++ QR L S+ ++ C ++P
Sbjct: 229 ---YKPPFYDVVPNDPS-FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNP 284
Query: 978 EDRMSMTNV 986
R++ +
Sbjct: 285 SARLTALRI 293
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 6e-47
Identities = 95/519 (18%), Positives = 184/519 (35%), Gaps = 84/519 (16%)
Query: 78 ISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISS----- 132
I+P + +FL+ ++++ E+P E + ++ ++ P
Sbjct: 3 INPRNVSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 133 --------CSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSI 184
+L L + L +P L E + + N+LT +P +L S+
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLS-SLPELPPHL---ESLVASCNSLT-ELPELPQSLKSL 116
Query: 185 RSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQG 244
+ L P L L ++ N+L +P + N S + D N ++
Sbjct: 117 LVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK- 166
Query: 245 AIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRL 304
+P +L+F + G NQL P + N L + N L L+ +
Sbjct: 167 KLP----DLPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKKLPDLPLSLESI 220
Query: 305 LVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLL 364
+ N L +L L +L L + + N +LP + LE L +
Sbjct: 221 VA---GNNIL-----EELPELQNLPF---LTTIYADNNLL-KTLPDLPPS----LEALNV 264
Query: 365 DNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPS 424
+N + ++P +L LD+ N S + NL L N + ++
Sbjct: 265 RDNYL-TDLPELPQ---SLTFLDVSENIFS-GLSELPP---NLYYLNASSNEIR-SLCDL 315
Query: 425 IGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDL 484
+L+ L +S N L +P+ R L + S N+L +P +L L +
Sbjct: 316 PPSLE--ELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPELP----QNLKQLHV 364
Query: 485 SRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSS 544
N L P ++++L + + E+P + L+QL ++ N L+ P
Sbjct: 365 EYNPLR-EFPDIPESVEDLRMNS-----HLAEVPELPQN---LKQLHVETNPLRE-FPDI 414
Query: 545 LSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNN 583
S+ L ++ + +++ ++
Sbjct: 415 PESVE---DLRMNSERVVDPYEFAHETTDKLEDDVFEHH 450
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 3e-43
Identities = 95/473 (20%), Positives = 166/473 (35%), Gaps = 81/473 (17%)
Query: 127 PANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLS---- 182
P N+S+ L + + L ++P E ++ + + P G
Sbjct: 5 PRNVSNT-FLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62
Query: 183 ---------SIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSIT 233
L L+ L S+P+ +L +L + N L+ +P ++ S+
Sbjct: 63 SRLRDCLDRQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELPQSLKSLL 117
Query: 234 GFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTG 293
+ + + P L++ V NQL P + N+S L+I N L
Sbjct: 118 VDNNNLKALSDLPP--------LLEYLGVSNNQLEKL--PELQNSSFLKIIDVDNNSLKK 167
Query: 294 AAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACIS 353
L+ + N L +L L +L L + + N+ LP
Sbjct: 168 LPDLPPSLEFI---AAGNNQL-----EELPELQNLPF---LTAIYADNNSL-KKLPDLPL 215
Query: 354 NLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQ 413
+ LE ++ NN + + L + +N L T+P L+ L
Sbjct: 216 S----LESIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNY 268
Query: 414 RNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFI 473
++P +L L +S N + L ++ S+N +
Sbjct: 269 LT----DLPELPQSLT--FLDVSENIFS-GLSELPPN---LYYLNASSNEIR-----SLC 313
Query: 474 GLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQ 533
L SL L++S N+L +P+ LE L N L E+P + L+QL ++
Sbjct: 314 DLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPELPQN---LKQLHVE 365
Query: 534 ENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLE 586
N L+ P S+ DL N+ ++PEL L K L++ N L
Sbjct: 366 YNPLRE-FPDIPESVE-----DLRMNSHLAEVPELPQNL---KQLHVETNPLR 409
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-39
Identities = 95/454 (20%), Positives = 161/454 (35%), Gaps = 70/454 (15%)
Query: 60 RHQRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHY 119
++ L+L +L L S+ +L + L NS E+P L+ L V +
Sbjct: 69 LDRQAHELELNNLGL-SSLPELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDNNNL 123
Query: 120 NSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLG 179
++ P L L + +NQL K+P EL + S ++ I V++N+L +P
Sbjct: 124 KALSDLPP-------LLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDLPP 173
Query: 180 NLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGV 239
+L + N LE +P+ L L L + N L +P ++ SI AG
Sbjct: 174 SL---EFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLK-KLPDLPLSLESI---VAGN 224
Query: 240 NKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLE 299
N ++ + +L L N L +P + L + N LT +
Sbjct: 225 NILE--ELPELQ-NLPFLTTIYADNNLLK-TLPDLPPSLEALNVRD---NYLTDLPELPQ 277
Query: 300 KLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTL 359
L L V + + L +L L +N SL +L
Sbjct: 278 SLTFLDVSENIFSGLSE-------LPPNLYY-------LNASSNEIRSLCDLPPSL---- 319
Query: 360 EVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQG 419
E L + NN++ +PA L+RL N L+ +P QNLK L ++ N +
Sbjct: 320 EELNVSNNKL-IELPALPP---RLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLR- 370
Query: 420 NIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSL 479
P +++ L N +P L + + N L P + S+
Sbjct: 371 EFPDIPESVED----LRMNSHLAEVPELPQN---LKQLHVETNPLR-EFPD----IPESV 418
Query: 480 IVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKL 513
L ++ ++ LE +
Sbjct: 419 EDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 7e-29
Identities = 68/340 (20%), Positives = 112/340 (32%), Gaps = 51/340 (15%)
Query: 252 FSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILG 311
S LQ + LT +P N + ++ + ++ AP QR + L
Sbjct: 8 VSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLR 66
Query: 312 NSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFG 371
+ L + L +N SLP +L E L+ N +
Sbjct: 67 DCL----------------DRQAHELELNNLGLS-SLPELPPHL----ESLVASCNSL-T 104
Query: 372 NIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLK-L 430
+P +L + LS P L+ L + N+ + P + N L
Sbjct: 105 ELPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLEKL--PELQNSSFL 155
Query: 431 FILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLT 490
I+ + N L+ +P L I NN L +P + L + N L
Sbjct: 156 KIIDVDNNSLK-KLPDLPPS---LEFIAAGNNQLE-ELPE--LQNLPFLTAIYADNNSLK 208
Query: 491 GSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRG 550
+P +LE + N L E L + L + N L+ +P SL
Sbjct: 209 -KLPDL---PLSLESIVAGNNIL--EELPELQNLPFLTTIYADNNLLKT-LPDLPPSLE- 260
Query: 551 LSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVP 590
L++ N L+ +PEL L + + L + P
Sbjct: 261 --ALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPP 297
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 4e-46
Identities = 70/307 (22%), Positives = 116/307 (37%), Gaps = 39/307 (12%)
Query: 693 VNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILT 752
V QIG+G +G V+ G +AVKVF ++ E +RH N++ +
Sbjct: 42 VKQIGKGRYGEVWMGKWRG--EKVAVKVFFTTEEASWF-RETEIYQTVLMRHENILGFIA 98
Query: 753 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACA 812
A L+ ++ N SL ++L +L+ L ++
Sbjct: 99 ADIKGTGSWTQL-YLITDYHENGSLYDYLKS-----------TTLDAKSMLKLAYSSVSG 146
Query: 813 LNYLH-----HDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQT--SSIGA 865
L +LH +P IAH DLK NIL+ ++ I D GLA + +
Sbjct: 147 LCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR 206
Query: 866 KGSIGYIAPE------YGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLA 919
G+ Y+ PE + I D+YS+G++L E+ R I+ E + H+L
Sbjct: 207 VGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266
Query: 920 RTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPED 979
+ M +++ R S ECL M ++ C +P
Sbjct: 267 PSDPSYEDM-----------REIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPAS 315
Query: 980 RMSMTNV 986
R++ V
Sbjct: 316 RLTALRV 322
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 2e-45
Identities = 51/225 (22%), Positives = 86/225 (38%), Gaps = 35/225 (15%)
Query: 694 NQIGEGSFGSVFKGILDDGRTTIAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKIL 751
IG+G FG V+ G +A+++ ++ + K+F E + RH N+V +
Sbjct: 39 ELIGKGRFGQVYHGRW---HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 752 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVAC 811
AC A++ R+L + +A L++ + I+ ++
Sbjct: 96 GACM----SPPHL-AIITSLCKGRTLYSVVR---------DAKIVLDVNKTRQIAQEIVK 141
Query: 812 ALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARF---LPLSSAQTSSIGAKGS 868
+ YLH I H DLK N+ D + I DFGL L + G
Sbjct: 142 GMGYLH---AKGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGW 197
Query: 869 IGYIAPE---------YGLGSEVSISGDVYSYGILLLELITRKKP 904
+ ++APE S DV++ G + EL R+ P
Sbjct: 198 LCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 3e-45
Identities = 64/309 (20%), Positives = 119/309 (38%), Gaps = 43/309 (13%)
Query: 693 VNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECN--TLKNIRHRNLVKI 750
IG+G FG V++G +AVK+F+ +S+ E +RH N++
Sbjct: 47 QESIGKGRFGEVWRGKWRG--EEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGF 101
Query: 751 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVA 810
+ A + + LV ++ + SL ++L+ ++ + + +++ A
Sbjct: 102 IAADNKDNGTWTQL-WLVSDYHEHGSLFDYLNR-----------YTVTVEGMIKLALSTA 149
Query: 811 CALNYLHHD-----CQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLP--LSSAQTSSI 863
L +LH + +P IAH DLK NIL+ ++ I D GLA + +
Sbjct: 150 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 209
Query: 864 GAKGSIGYIAPEYGLGS------EVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHN 917
G+ Y+APE S E D+Y+ G++ E+ R I +
Sbjct: 210 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED------- 262
Query: 918 LARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESP 977
LP + + D + + + ++ R E L M +I C +
Sbjct: 263 ---YQLPYYDLVPSDPS-VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANG 318
Query: 978 EDRMSMTNV 986
R++ +
Sbjct: 319 AARLTALRI 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 7e-44
Identities = 54/331 (16%), Positives = 114/331 (34%), Gaps = 31/331 (9%)
Query: 269 GAIPPTISNASNLEIFH-GSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCS 327
G+ ++S E + L PY + L + + +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALR---PYHDVLSQWQRHYNADRNR-------WHSAWR 51
Query: 328 LTNATRLKWLLININNFGGSLPACISNL-STTLEVLLLDNNQIFGNIPAAIGKFVNLQRL 386
N+ + + + + L L + + P + +LQ +
Sbjct: 52 QANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPL-PQFPDQAFRLSHLQHM 109
Query: 387 DMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLK-LFILYLSYNFLQGSIP 445
+ + L +P + + L+ L L RN + +P SI +L L L + +P
Sbjct: 110 TIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELP 167
Query: 446 SSLGRYET---------LTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSE 496
L + L ++ L + ++P I +L L + + L+ ++
Sbjct: 168 EPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPAS-IANLQNLKSLKIRNSPLS-ALGPA 224
Query: 497 VGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQE-NFLQGPIPSSLSSLRGLSVLD 555
+ +L LE L++ G P G L++L +++ + L +P + L L LD
Sbjct: 225 IHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQLEKLD 283
Query: 556 LSQNNLSGKIPELLIRLQLVKNLNLSNNDLE 586
L ++P L+ +L + + +
Sbjct: 284 LRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-38
Identities = 55/328 (16%), Positives = 113/328 (34%), Gaps = 30/328 (9%)
Query: 253 SLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGN 312
+NL F G L +S + Q G
Sbjct: 13 GRENLYF--QGSTALR-PYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETR---TGR 66
Query: 313 SLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGN 372
+L + + L T L + P L + L+ + +D +
Sbjct: 67 ALKA----TADLLEDATQ-PGRVALELRSVPLP-QFPDQAFRL-SHLQHMTIDAAGL-ME 118
Query: 373 IPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLK--- 429
+P + +F L+ L + N L +P +I L L++L ++ +P + +
Sbjct: 119 LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASG 177
Query: 430 -------LFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVL 482
L L L + ++ S+P+S+ + L ++ + N+ L+ + P L L L
Sbjct: 178 EHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPK-LEEL 234
Query: 483 DLSRNQLTGSIPSEVGNLKNLEILNVFG-NKLKGEIPSTLGSCIKLEQLEMQENFLQGPI 541
DL + P G L+ L + + L +P + +LE+L+++ +
Sbjct: 235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRL 293
Query: 542 PSSLSSLRGLSVLDLSQNNLSGKIPELL 569
PS ++ L ++ + + +
Sbjct: 294 PSLIAQLPANCIILVPPHLQAQLDQHRP 321
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 8e-36
Identities = 60/388 (15%), Positives = 113/388 (29%), Gaps = 76/388 (19%)
Query: 172 GSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISS 231
GS + S +L+ G+ D L + N + + N ++
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNN 57
Query: 232 ITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKL 291
++ L + + L P S+L+
Sbjct: 58 PQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHM------- 109
Query: 292 TGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPAC 351
++ L LP
Sbjct: 110 -----------------------------TIDA-AGLM-----------------ELPDT 122
Query: 352 ISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIG--------- 402
+ LE L L N + +PA+I L+ L + + +P +
Sbjct: 123 MQQF-AGLETLTLARNPL-RALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQ 180
Query: 403 ELQNLKDLRLQRNRFQGNIPPSIGNLK-LFILYLSYNFLQGSIPSSLGRYETLTTIDLSN 461
L NL+ LRL+ + ++P SI NL+ L L + + L ++ ++ L +DL
Sbjct: 181 GLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRG 238
Query: 462 NNLTGTIPPQFIGLSSSLIVLDLS-RNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPST 520
PP G + L L L + L ++P ++ L LE L++ G +PS
Sbjct: 239 CTALRNYPPI-FGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSL 296
Query: 521 LGSCIKLEQLEMQENFLQGPIPSSLSSL 548
+ + + + +
Sbjct: 297 IAQLPANCIILVPPHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-34
Identities = 67/393 (17%), Positives = 114/393 (29%), Gaps = 83/393 (21%)
Query: 76 GSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSN 135
GS H + S + L ++ + +R + ++ +N
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNN 57
Query: 136 LIQLRLFHNQLVGKIPSELSSLS--KIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNN 193
L L + + + L P LS ++ + +
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 194 LEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFS 253
L +PDT+ L LT+A+N L +P+SI +
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLR-ALPASIAS------------------------- 148
Query: 254 LQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNS 313
L L+ S+ +P +++ G L LQ L
Sbjct: 149 LNRLRELSIRACPELTELPEPLASTDASGEHQG-----------LVNLQSL--------- 188
Query: 314 LGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNI 373
L + + SLPA I+NL L+ L + N+ + +
Sbjct: 189 -------RLEW-TGIR-----------------SLPASIANL-QNLKSLKIRNSPLSA-L 221
Query: 374 PAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLK-LFI 432
AI L+ LD+ PP G LK L L+ +P I L L
Sbjct: 222 GPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEK 281
Query: 433 LYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLT 465
L L +PS + + I + +
Sbjct: 282 LDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 36/228 (15%), Positives = 78/228 (34%), Gaps = 38/228 (16%)
Query: 65 TILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGG 124
+ +++ L + + + L+ L L N +P+ L RL+ L++
Sbjct: 107 QHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPL-RALPASIASLNRLRELSIRACPELT 164
Query: 125 AIPANISSCS---------NLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIP 175
+P ++S NL LRL + +P+ +++L ++ + + ++ L+ ++
Sbjct: 165 ELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALG 222
Query: 176 SSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGF 235
++ +L + L L G + P G L L + T+P I
Sbjct: 223 PAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHR------- 275
Query: 236 DAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEI 283
L L+ + +P I+ I
Sbjct: 276 ------------------LTQLEKLDLRGCVNLSRLPSLIAQLPANCI 305
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 4e-08
Identities = 18/93 (19%), Positives = 32/93 (34%)
Query: 65 TILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGG 124
LDL + P G + LK L L + S +P + RL +L+ L L
Sbjct: 232 EELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLS 291
Query: 125 AIPANISSCSNLIQLRLFHNQLVGKIPSELSSL 157
+P+ I+ + + + +
Sbjct: 292 RLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 6e-43
Identities = 49/223 (21%), Positives = 85/223 (38%), Gaps = 29/223 (13%)
Query: 694 NQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTA 753
+G+G FG K + + +K ++F+ E ++ + H N++K +
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 754 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACAL 813
Y+ + E++ +L + QR++ + D+A +
Sbjct: 76 L----YKDKRL-NFITEYIKGGTLRGIIK---------SMDSQYPWSQRVSFAKDIASGM 121
Query: 814 NYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQT------------S 861
YLH I H DL N L+ E+ + DFGLAR + Q
Sbjct: 122 AYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178
Query: 862 SIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
G+ ++APE G DV+S+GI+L E+I R
Sbjct: 179 RYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-42
Identities = 89/402 (22%), Positives = 158/402 (39%), Gaps = 59/402 (14%)
Query: 65 TILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGG 124
L + I P +L+ L S + + L + L + +
Sbjct: 3 ATLATLPAPI-NQIFP-DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS 58
Query: 125 AIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSI 184
I I +NL L L NQ+ P LS+L K+ ++ + N +T S+L NL+++
Sbjct: 59 -IQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNL 112
Query: 185 RSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQG 244
R L+L+ +N+ P L L + +L + N + S + N++ + +K++
Sbjct: 113 RELYLNEDNISDISP--LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKD 169
Query: 245 AIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRL 304
P+ +L +L S+ NQ+ P +++ ++L F VN++T P + + RL
Sbjct: 170 VTPIA---NLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP-VANMTRL 223
Query: 305 LVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLL 364
I N + DL+ L +L+ L L +
Sbjct: 224 NSLKIGNNKI-----TDLSPLANLSQ----------------------------LTWLEI 250
Query: 365 DNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPS 424
NQI +I A+ L+ L++ SN++S + L L L L N+
Sbjct: 251 GTNQI-SDIN-AVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEV 306
Query: 425 IGNL-KLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLT 465
IG L L L+LS N + P L + + D +N +
Sbjct: 307 IGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-42
Identities = 77/428 (17%), Positives = 154/428 (35%), Gaps = 84/428 (19%)
Query: 136 LIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLE 195
L + +I + L++ + ++T + L SI L ++G +
Sbjct: 2 AATLATLPAPI-NQI-FPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 196 GSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQ 255
SI + +L NL L + N+++ P S +L
Sbjct: 58 -SIQG-IEYLTNLEYLNLNGNQITDISPLS---------------------------NLV 88
Query: 256 NLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLG 315
L +G N++T + N +NL + + + ++
Sbjct: 89 KLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNIS----------------------- 123
Query: 316 SRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPA 375
D++ L +LT + L + N S + +SN+ T L L + +++ ++
Sbjct: 124 -----DISPLANLTK---MYSLNLG-ANHNLSDLSPLSNM-TGLNYLTVTESKV-KDVTP 172
Query: 376 AIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLK-LFILY 434
I +L L + N++ + L +L N+ P + N+ L L
Sbjct: 173 -IANLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLK 227
Query: 435 LSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIP 494
+ N + P L LT +++ N ++ I + + L +L++ NQ++
Sbjct: 228 IGNNKITDLSP--LANLSQLTWLEIGTNQIS-DINA--VKDLTKLKMLNVGSNQISD--I 280
Query: 495 SEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVL 554
S + NL L L + N+L E +G L L + +N + P L+SL +
Sbjct: 281 SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSA 338
Query: 555 DLSQNNLS 562
D + +
Sbjct: 339 DFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 7e-42
Identities = 75/428 (17%), Positives = 145/428 (33%), Gaps = 84/428 (19%)
Query: 112 LQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLT 171
LA I P + + I+ L + + L I + V +
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 172 GSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISS 231
+ L+++ L L+GN + P L L L NL + N++ T S++ N+++
Sbjct: 58 S--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTN 111
Query: 232 ITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKL 291
+ + I PL +L + ++G N +SN + L + +K+
Sbjct: 112 LRELYLNEDNISDISPLA---NLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKV 167
Query: 292 TGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPAC 351
+D+ + +LT+
Sbjct: 168 ----------------------------KDVTPIANLTD--------------------- 178
Query: 352 ISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLR 411
L L L+ NQI P + +L N+++ P + + L L+
Sbjct: 179 -------LYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLK 227
Query: 412 LQRNRFQGNIPPSIGNL-KLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPP 470
+ N+ + NL +L L + N + +++ L +++ +N ++
Sbjct: 228 IGNNKITD--LSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--IS 281
Query: 471 QFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQL 530
LS L L L+ NQL +G L NL L + N + P L S K++
Sbjct: 282 VLNNLSQ-LNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSA 338
Query: 531 EMQENFLQ 538
+ ++
Sbjct: 339 DFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 4e-40
Identities = 85/402 (21%), Positives = 157/402 (39%), Gaps = 60/402 (14%)
Query: 186 SLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGA 245
+L + PD L + + + ++ + + SIT K+
Sbjct: 4 TLATLPAPINQIFPDAD--LAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVASI 59
Query: 246 IPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLL 305
++Y L NL++ ++ NQ+T P +SN L + NK+T
Sbjct: 60 QGIEY---LTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT------------- 101
Query: 306 VFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLD 365
D++ L +LTN L+ L +N +N P ++NL T + L L
Sbjct: 102 ---------------DISALQNLTN---LRELYLNEDNISDISP--LANL-TKMYSLNLG 140
Query: 366 NNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSI 425
N ++ + L L + +++ I L +L L L N+ + P +
Sbjct: 141 ANHNLSDLSP-LSNMTGLNYLTVTESKVKD--VTPIANLTDLYSLSLNYNQIEDISP--L 195
Query: 426 GNL-KLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDL 484
+L L N + P + L ++ + NN +T P + S L L++
Sbjct: 196 ASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP---LANLSQLTWLEI 250
Query: 485 SRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSS 544
NQ++ + V +L L++LNV N++ S L + +L L + N L
Sbjct: 251 GTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEV 306
Query: 545 LSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLE 586
+ L L+ L LSQN+++ P L L + + + +N ++
Sbjct: 307 IGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 7e-38
Identities = 74/352 (21%), Positives = 134/352 (38%), Gaps = 34/352 (9%)
Query: 240 NKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLE 299
I P L + + +T T ++ + K+ +E
Sbjct: 10 APINQIFPDA---DLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVASI-QGIE 63
Query: 300 KLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTL 359
L L + GN + D++ L +L L L I N + + + NL T L
Sbjct: 64 YLTNLEYLNLNGNQI-----TDISPLSNLVK---LTNLYIGTNKI--TDISALQNL-TNL 112
Query: 360 EVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQG 419
L L+ + I P + + L++ +N + + + L L + ++ +
Sbjct: 113 RELYLNEDNISDISP--LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKD 169
Query: 420 NIPPSIGNLK-LFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSS 478
P I NL L+ L L+YN ++ P L +L N +T P + +
Sbjct: 170 VTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP---VANMTR 222
Query: 479 LIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQ 538
L L + N++T P + NL L L + N++ + + KL+ L + N +
Sbjct: 223 LNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQIS 278
Query: 539 GPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVP 590
S L++L L+ L L+ N L + E++ L + L LS N + + P
Sbjct: 279 DI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-34
Identities = 77/353 (21%), Positives = 146/353 (41%), Gaps = 54/353 (15%)
Query: 64 VTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIG 123
+T L + K+A SI + L+ L+ L L N P L +L L + N I
Sbjct: 46 ITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI- 100
Query: 124 GAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSS 183
+ + + +NL +L L + + S L++L+K+ +++ N+ S S L N++
Sbjct: 101 -TDISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNL-SDLSPLSNMTG 156
Query: 184 IRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQ 243
+ L ++ + ++ P + L +L +L++ N++ P + +++S+ F A VN+I
Sbjct: 157 LNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQIT 212
Query: 244 GAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQR 303
P+ ++ L +G N++T P ++N S L N+++
Sbjct: 213 DITPVA---NMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQIS----------- 256
Query: 304 LLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLL 363
D+N + LT LK L + N + ++NL + L L
Sbjct: 257 -----------------DINAVKDLTK---LKMLNVGSNQI-SDISV-LNNL-SQLNSLF 293
Query: 364 LDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNR 416
L+NNQ+ IG NL L + N ++ P + L +
Sbjct: 294 LNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQV 344
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 4e-39
Identities = 94/479 (19%), Positives = 180/479 (37%), Gaps = 30/479 (6%)
Query: 64 VTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIG 123
TIL++ ++ + + +LS L++L + +N + S F + L+ L L +N +
Sbjct: 23 TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV 82
Query: 124 GAIPANISSCSNLIQLRLFHNQL-VGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLS 182
I + NL L L N I E ++S+++ + ++ +L S + +L+
Sbjct: 83 -KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLN 139
Query: 183 SIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKI 242
+ L + G L++ ++ + I ++S T + ++ I
Sbjct: 140 ISKVLLVLGETYGEKED--PEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNI 197
Query: 243 QGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVN-KLTGAAPYLEKL 301
+ + + ++ T SNL + + L
Sbjct: 198 KCVLEDNKCSYFLSILA-----------KLQTNPKLSNLTLNNIETTWNSFIRILQLVWH 246
Query: 302 QRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEV 361
+ F I L + D F S T+ L + + FG + I + + + +
Sbjct: 247 TTVWYFSISNVKLQGQLDFRD-FDYSGTSLKALSIHQVVSDVFG-FPQSYIYEIFSNMNI 304
Query: 362 LLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNI 421
+ K LD +N L+ T+ G L L+ L LQ N+ + +
Sbjct: 305 KNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-EL 363
Query: 422 PPSIGNL----KLFILYLSYNFLQGSIPSSL-GRYETLTTIDLSNNNLTGTIPPQFIGLS 476
L L +S N + ++L ++++S+N LT TI F L
Sbjct: 364 SKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTI---FRCLP 420
Query: 477 SSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQEN 535
+ VLDL N++ SIP +V L+ L+ LNV N+LK L+++ + N
Sbjct: 421 PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-33
Identities = 88/508 (17%), Positives = 166/508 (32%), Gaps = 64/508 (12%)
Query: 88 LKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLV 147
+L + N + S+ L +L++L + +N I + L L L HN+L
Sbjct: 23 TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKL- 81
Query: 148 GKIPSELSSLSKIEHISVNDNNLTGSIPSS--LGNLSSIRSLFLSGNNLEGSIPDTLGWL 205
KI ++H+ ++ N ++P GN+S ++ L LS +LE S + L
Sbjct: 82 VKISCH--PTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHL 138
Query: 206 KNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGEN 265
L + F+ ++L
Sbjct: 139 NISKVLLVLGETYGEKEDPEGLQD----------------------FNTESLHIVFPTNK 176
Query: 266 QLTGAIPPTISNASNLEIFH----GSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRD 321
+ + ++ +NLE+ + NK + L KLQ L +
Sbjct: 177 EFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNS 236
Query: 322 LNFLCSLTNATRLKWLLININNFGGSLPACISNLSTT----LEVLLLDNNQIFGNIPAAI 377
+ L T + + I+ G L + S T L + + ++
Sbjct: 237 FIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIY 296
Query: 378 GKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNL-KLFILYLS 436
F N+ + + ++ L N + + G+L +L L L
Sbjct: 297 EIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQ 356
Query: 437 YNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSE 496
N L+ + + SL LD+S+N ++
Sbjct: 357 MNQLK-ELSKIAEMTTQMK----------------------SLQQLDISQNSVSYDEKKG 393
Query: 497 V-GNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLD 555
K+L LN+ N L I L +++ L++ N ++ IP + L L L+
Sbjct: 394 DCSWTKSLLSLNMSSNILTDTIFRCLPP--RIKVLDLHSNKIKS-IPKQVVKLEALQELN 450
Query: 556 LSQNNLSGKIPELLIRLQLVKNLNLSNN 583
++ N L + RL ++ + L N
Sbjct: 451 VASNQLKSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-31
Identities = 89/493 (18%), Positives = 166/493 (33%), Gaps = 60/493 (12%)
Query: 125 AIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSI 184
+P ++S L + N + S++ SLSK+ + ++ N + S +
Sbjct: 14 HVPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQEL 71
Query: 185 RSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQG 244
L LS N L I NL +L ++ N F
Sbjct: 72 EYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFG---------------- 112
Query: 245 AIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRL 304
++ L+F + L + I++ + ++ E + L
Sbjct: 113 --------NMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYG----EKEDPEGL 160
Query: 305 LVFGILGNSLGSRGDRDLNFL--CSLTNATRLKWLLININNFGGSLPACISNLST----- 357
F + +++ +F+ S+ L+ I +S L+
Sbjct: 161 QDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNP 220
Query: 358 TLEVLLLDNNQIFGNIPAAIGKFV---NLQRLDMCSNRLSG-----TIPPAIGELQNLKD 409
L L L+N + N I + V + + + +L G + L+ L
Sbjct: 221 KLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSI 280
Query: 410 LRLQRNRFQGNIPPSIGNLKLF-ILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTI 468
++ + F I + + + + +D SNN LT T+
Sbjct: 281 HQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTV 340
Query: 469 PPQFIGLSSSLIVLDLSRNQLTGSIPSEVG---NLKNLEILNVFGNKLK-GEIPSTLGSC 524
L+ L L L NQL + +K+L+ L++ N + E
Sbjct: 341 FENCGHLTE-LETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWT 398
Query: 525 IKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNND 584
L L M N L I L + VLDL N + IP+ +++L+ ++ LN+++N
Sbjct: 399 KSLLSLNMSSNILTDTIFRCLPPR--IKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQ 455
Query: 585 LEGVVPTQGVFKN 597
L+ V G+F
Sbjct: 456 LKSV--PDGIFDR 466
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 3e-14
Identities = 67/378 (17%), Positives = 137/378 (36%), Gaps = 38/378 (10%)
Query: 65 TILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGG 124
L L + L S + +L+ KVL + + + + L+ +LH
Sbjct: 118 KFLGLSTTHLEKSSVLPIAHLNISKVLLVLGE--TYGEKEDPEGLQDFNTESLHIVFPTN 175
Query: 125 AIPANISSCSNLIQLRLFHNQLVG-----------KIPSELSSLSKIEHISVNDNNLTGS 173
I S L + + I ++L + K+ ++++N+ T +
Sbjct: 176 KEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWN 235
Query: 174 IPSSLGNL---SSIRSLFLSGNNLEGSIPDTLGW-----LKNLVNLTMAQNRLSGTIPSS 225
+ L +++ +S L+G + LK L + + S
Sbjct: 236 SFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFG-FPQSY 294
Query: 226 IFNI-SSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIF 284
I+ I S++ + V+ + + + + N LT + + + LE
Sbjct: 295 IYEIFSNMNIKNFTVSGTR-MVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETL 353
Query: 285 HGSVNKLT---GAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLINI 341
+N+L A +++ L I NS+ + + L L ++
Sbjct: 354 ILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKG-----DCSWTKSLLSLNMSS 408
Query: 342 NNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPP-A 400
N ++ C L ++VL L +N+I +IP + K LQ L++ SN+L ++P
Sbjct: 409 NILTDTIFRC---LPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGI 463
Query: 401 IGELQNLKDLRLQRNRFQ 418
L +L+ + L N +
Sbjct: 464 FDRLTSLQKIWLHTNPWD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 4e-12
Identities = 33/192 (17%), Positives = 65/192 (33%), Gaps = 10/192 (5%)
Query: 420 NIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSL 479
++ IL +S N++ S + L + +S+N + + + L
Sbjct: 18 DLSQK-----TTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQEL 71
Query: 480 IVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKG-EIPSTLGSCIKLEQLEMQENFLQ 538
LDLS N+L I NL+ L++ N I G+ +L+ L + L+
Sbjct: 72 EYLDLSHNKLV-KISC--HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLE 128
Query: 539 GPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQGVFKNA 598
++ L VL + K ++ ++L++ + V
Sbjct: 129 KSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKT 188
Query: 599 SITSVFGNLKLC 610
N+K
Sbjct: 189 VANLELSNIKCV 200
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 4e-37
Identities = 86/466 (18%), Positives = 170/466 (36%), Gaps = 30/466 (6%)
Query: 88 LKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANI-SSCSNLIQLRLFHNQL 146
K L L NS + + L L+VL L +N I ++ ++ +L L + HN+L
Sbjct: 54 TKALSLSQNSISELRMPDISFLSELRVLRLSHNRI-RSLDFHVFLFNQDLEYLDVSHNRL 112
Query: 147 VGKIPSELSSLSKIEHISVNDNNLTGSIPSS--LGNLSSIRSLFLSGNNLEGSIPDTLGW 204
I ++ + H+ ++ N+ +P GNL+ + L LS +
Sbjct: 113 Q-NISC--CPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAH 168
Query: 205 LK-NLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFS------LQNL 257
L + + L + + G S+ ++ ++ ++ + L N+
Sbjct: 169 LHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNI 228
Query: 258 QFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQ---RLLVFGILGNSL 314
+ +L + + L + + + L + + I ++
Sbjct: 229 KLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTI 288
Query: 315 GSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIP 374
R DR+ + L + F + ++ + + +L +
Sbjct: 289 TERIDREEFTYSETALKS-LMIEHVKNQVF-LFSKEALYSVFAEMNIKMLSISDTPFIHM 346
Query: 375 AAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNL----KL 430
+ L+ N + ++ L+ L+ L LQRN + N L
Sbjct: 347 VCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSL 405
Query: 431 FILYLSYNFLQGSIPSSL-GRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQL 489
L +S N L E++ ++LS+N LTG++ F L + VLDL N++
Sbjct: 406 ETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSV---FRCLPPKVKVLDLHNNRI 462
Query: 490 TGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQEN 535
SIP +V +L+ L+ LNV N+LK L+ + + +N
Sbjct: 463 M-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-26
Identities = 80/485 (16%), Positives = 152/485 (31%), Gaps = 46/485 (9%)
Query: 125 AIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSL-GNLSS 183
+P ++ L L N + ++S LS++ + ++ N + S+ +
Sbjct: 45 HVPKDLPP--RTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQD 101
Query: 184 IRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIF-NISSITGFDAGVNKI 242
+ L +S N L+ +I + +L +L ++ N F N++ +T K
Sbjct: 102 LEYLDVSHNRLQ-NISC--CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKF 158
Query: 243 QGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTG-AAPYLEKL 301
+ + L L + N + H + + + +
Sbjct: 159 R-QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSV 217
Query: 302 QRLLVFGILGNSLGSRGDRDLN--FLCSLTNATRLKWLLININNFGGSLPACISNL-STT 358
L + L + L T L L +I
Sbjct: 218 NALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRP 277
Query: 359 LEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQ 418
+E L + N I I + L++L ++ F
Sbjct: 278 VEYLNIYNLTITERIDREEFTYSETA-------------------LKSLMIEHVKNQVFL 318
Query: 419 GNIPPSIGNL--KLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLS 476
++ ++ ++ I LS + + T ++ + N T ++ L
Sbjct: 319 -FSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLK 377
Query: 477 SSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLK----GEIPSTLGSCIKLEQLEM 532
L L L RN L + KN+ L L T + L +
Sbjct: 378 R-LQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNL 435
Query: 533 QENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQ 592
N L G + L + VLDL N + IP+ + LQ ++ LN+++N L+ V
Sbjct: 436 SSNMLTGSVFRCLPPK--VKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSV--PD 490
Query: 593 GVFKN 597
GVF
Sbjct: 491 GVFDR 495
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 2e-17
Identities = 68/444 (15%), Positives = 140/444 (31%), Gaps = 83/444 (18%)
Query: 65 TILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNH-EIPSEFDRLRRLQVLALHYNSI- 122
LD+ +L +IS ++ L+ L L N F+ + EF L +L L L
Sbjct: 103 EYLDVSHNRLQ-NISC--CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFR 159
Query: 123 -----------------------GGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSK 159
N L L + S++
Sbjct: 160 QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNA 219
Query: 160 IEHISVNDNNLTGSIPSSLGNLS-----SIRSLFLSGNNLEGSIPDTLG-----WLKNLV 209
+ H+ +++ L L L ++ ++E + ++ W + +
Sbjct: 220 LGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVE 279
Query: 210 NLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQG---AIPLDYGFS-LQNLQFFSVGEN 265
L + ++ I F S + ++ + +S + + +
Sbjct: 280 YLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSIS 339
Query: 266 QLTGAIPPTISNASNLEIFHGSVNKLTGAAPY-LEKLQRLLVFGILGNSLGSRGDRDLNF 324
+ S+ + + N T + L+RL + N L + L
Sbjct: 340 DTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVAL-- 397
Query: 325 LCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQI----FGNIPAAIGKF 380
N + L+ L +++N+ + ++ VL L +N + F +P
Sbjct: 398 --MTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPP----- 450
Query: 381 VNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFL 440
++ LD+ +NR+ +IP + LQ L++L + N+ +
Sbjct: 451 -KVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK---------------------- 486
Query: 441 QGSIP-SSLGRYETLTTIDLSNNN 463
S+P R +L I L +N
Sbjct: 487 --SVPDGVFDRLTSLQYIWLHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 1e-11
Identities = 69/455 (15%), Positives = 133/455 (29%), Gaps = 89/455 (19%)
Query: 154 LSSLSKIEHISVN--DNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNL 211
++ S V+ + NLT +P ++L LS N++ + +L L L
Sbjct: 25 MTPFSNELESMVDYSNRNLT-HVPK--DLPPRTKALSLSQNSISELRMPDISFLSELRVL 81
Query: 212 TMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAI 271
++ NR+ ++ +F Q+L++ V N+L I
Sbjct: 82 RLSHNRIR-SLDFHVFL------------------------FNQDLEYLDVSHNRLQ-NI 115
Query: 272 PPTISNASNLEIFHGSVNKLT--GAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLT 329
++L S N L +L G+ L+ L
Sbjct: 116 SC--CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ-----LDLLPVAH 168
Query: 330 NATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMC 389
L + + G + +TT+ L+ N +F L L
Sbjct: 169 LHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQ--VNMSVNALGHL--- 223
Query: 390 SNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLG 449
+L N+K R + L + L + L
Sbjct: 224 -------------QLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLF 270
Query: 450 RY---ETLTTIDLSNNNLTGTIPPQFIGLSS----SLIVLDLSRNQLTGSIPSEVGNLKN 502
++ + +++ N +T I + S SL++ + S +
Sbjct: 271 QFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAE 330
Query: 503 LEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLS 562
+ I + + F+ P S SS L+ +QN +
Sbjct: 331 MNIKMLSISDTP---------------------FIHMVCPPSPSSFT---FLNFTQNVFT 366
Query: 563 GKIPELLIRLQLVKNLNLSNNDLEGVVPTQGVFKN 597
+ + L+ ++ L L N L+ + KN
Sbjct: 367 DSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKN 401
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 1e-09
Identities = 38/212 (17%), Positives = 77/212 (36%), Gaps = 7/212 (3%)
Query: 57 CSRRHQRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLA 116
+ + I +++ S + + + L + L
Sbjct: 300 SETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLN 359
Query: 117 LHYNSIGGAIPANISSCSNLIQLRLFHNQL--VGKIPSELSSLSKIEHISVNDNNLTGSI 174
N ++ S+ L L L N L K+ ++S +E + V+ N+L
Sbjct: 360 FTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHA 419
Query: 175 PSSL-GNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSIT 233
SI L LS N L GS+ L + L + NR+ +IP + ++ ++
Sbjct: 420 YDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM-SIPKDVTHLQALQ 476
Query: 234 GFDAGVNKIQGAIPLDYGFSLQNLQFFSVGEN 265
+ N+++ ++P L +LQ+ + +N
Sbjct: 477 ELNVASNQLK-SVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 29/137 (21%), Positives = 58/137 (42%), Gaps = 10/137 (7%)
Query: 62 QRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRL----RRLQVLAL 117
+R+ L L+ L + + L + S N +DR + VL L
Sbjct: 377 KRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNL 435
Query: 118 HYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIP-S 176
N + G++ + + L L +N++ IP +++ L ++ ++V N L S+P
Sbjct: 436 SSNMLTGSVFRCLPP--KVKVLDLHNNRI-MSIPKDVTHLQALQELNVASNQLK-SVPDG 491
Query: 177 SLGNLSSIRSLFLSGNN 193
L+S++ ++L N
Sbjct: 492 VFDRLTSLQYIWLHDNP 508
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-36
Identities = 88/403 (21%), Positives = 135/403 (33%), Gaps = 77/403 (19%)
Query: 181 LSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVN 240
+ L + + L ++PD L ++ L + N L+ ++P+
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPALPPE------------ 82
Query: 241 KIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEK 300
L+ L V NQLT ++P L IF + L L K
Sbjct: 83 -------------LRTL---EVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSGLCK 125
Query: 301 LQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLE 360
L I GN L S L+ L ++ N SLPA S L
Sbjct: 126 LW------IFGNQLTS-------LPVLPPG---LQELSVSDNQLA-SLPALPSELCK--- 165
Query: 361 VLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGN 420
L NNQ+ ++P LQ L + N+L+ ++P EL L +
Sbjct: 166 -LWAYNNQL-TSLPMLPS---GLQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTS---- 215
Query: 421 IPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLI 480
+P LK L +S N L S+P L + +S N LT ++P L S L+
Sbjct: 216 LPALPSGLK--ELIVSGNRLT-SLPVLPSE---LKELMVSGNRLT-SLPM----LPSGLL 264
Query: 481 VLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGP 540
L + RNQLT +P + +L + +N+ GN L L
Sbjct: 265 SLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMA 323
Query: 541 IPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNN 583
S+ R L + + L +N
Sbjct: 324 GASAPRETRALH--LAAADWLVPAREGEPAPADRWHMFGQEDN 364
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-32
Identities = 68/272 (25%), Positives = 103/272 (37%), Gaps = 52/272 (19%)
Query: 332 TRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSN 391
+ L+I NN SLPA L L + NQ+ ++P + L
Sbjct: 61 AHITTLVIPDNNLT-SLPALPPEL----RTLEVSGNQL-TSLPVLPPGLLELSIFSNPLT 114
Query: 392 RLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRY 451
L L L + N+ ++P L+ L +S N L S+P+
Sbjct: 115 HLPA-------LPSGLCKLWIFGNQLT-SLPVLPPGLQ--ELSVSDNQLA-SLPALPSE- 162
Query: 452 ETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGN 511
L + NN LT ++P S L L +S NQL S+P+ L L N N
Sbjct: 163 --LCKLWAYNNQLT-SLPMLP----SGLQELSVSDNQLA-SLPTLPSELYKLWAYN---N 211
Query: 512 KLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLR-----------------GLSVL 554
+L +P+ L++L + N L +P S L+ GL L
Sbjct: 212 RLT-SLPALPSG---LKELIVSGNRLTS-LPVLPSELKELMVSGNRLTSLPMLPSGLLSL 266
Query: 555 DLSQNNLSGKIPELLIRLQLVKNLNLSNNDLE 586
+ +N L+ ++PE LI L +NL N L
Sbjct: 267 SVYRNQLT-RLPESLIHLSSETTVNLEGNPLS 297
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-31
Identities = 78/428 (18%), Positives = 137/428 (32%), Gaps = 101/428 (23%)
Query: 108 RLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVND 167
VL + + + +P + +++ L + N L +P+ L + V+
Sbjct: 38 LNNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPALPPEL---RTLEVSG 90
Query: 168 NNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIF 227
N LT S+P L + +L L L + N+L+ ++P
Sbjct: 91 NQLT-SLPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQLT-SLPVLP- 140
Query: 228 NISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGS 287
LQ SV +NQL ++P S L ++
Sbjct: 141 ---------------------------PGLQELSVSDNQLA-SLPALPSELCKLWAYN-- 170
Query: 288 VNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGS 347
N+LT L L+ L ++ N S
Sbjct: 171 -NQLTS----------------LPMLPSG-----------------LQELSVSDNQL-AS 195
Query: 348 LPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNL 407
LP S L L NN++ ++PA L+ L + NRL+ ++P EL+
Sbjct: 196 LPTLPSELYK----LWAYNNRL-TSLPALPS---GLKELIVSGNRLT-SLPVLPSELKE- 245
Query: 408 KDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGT 467
L + NR ++P L L + N L +P SL + TT++L N L+
Sbjct: 246 --LMVSGNRLT-SLPMLPSGLL--SLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS-E 298
Query: 468 IPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKL 527
Q + +S + + S + L + + L +
Sbjct: 299 RTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAA--ADWLVPAREGEPAPADRW 356
Query: 528 EQLEMQEN 535
++N
Sbjct: 357 HMFGQEDN 364
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-25
Identities = 74/402 (18%), Positives = 129/402 (32%), Gaps = 97/402 (24%)
Query: 62 QRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNS 121
+T L + L S+ L + L + N +P L L + +
Sbjct: 61 AHITTLVIPDNNLT-SLPALPPEL---RTLEVSGNQL-TSLPVLPPGLLELSIFSNPLTH 115
Query: 122 IGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNL 181
+ + S L +L +F NQL +P L + +SV+DN L S+P+ L
Sbjct: 116 L-------PALPSGLCKLWIFGNQL-TSLPVLPPGL---QELSVSDNQLA-SLPALPSEL 163
Query: 182 SSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNK 241
L+ N L S+P L L+++ N+L+ ++P+
Sbjct: 164 ---CKLWAYNNQLT-SLPMLPS---GLQELSVSDNQLA-SLPTLPSE------------- 202
Query: 242 IQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKL 301
L L N+LT ++P S L+ S N+LT +L
Sbjct: 203 ------------LYKL---WAYNNRLT-SLPALP---SGLKELIVSGNRLTSLPVLPSEL 243
Query: 302 QRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEV 361
+ L+V G N L SL P S L
Sbjct: 244 KELMVSG--------------NRLTSL--------------------PMLPSG----LLS 265
Query: 362 LLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNI 421
L + NQ+ +P ++ + +++ N LS A+ E+ + RF
Sbjct: 266 LSVYRNQL-TRLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFD-MA 323
Query: 422 PPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNN 463
S + + ++L + + +N
Sbjct: 324 GASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNA 365
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 2e-13
Identities = 58/276 (21%), Positives = 95/276 (34%), Gaps = 29/276 (10%)
Query: 65 TILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGG 124
L + +LA S+ L L YNN +P+ L+ L + N +
Sbjct: 184 QELSVSDNQLA-SLPTLPSEL---YKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLT- 234
Query: 125 AIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSI 184
++P S L +L + N+L +P S L +SV N LT +P SL +LSS
Sbjct: 235 SLPVLPS---ELKELMVSGNRLT-SLPMLPSGL---LSLSVYRNQLT-RLPESLIHLSSE 286
Query: 185 RSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPS------SIFNISSITGFDAG 238
++ L GN L L + + + R S ++ ++ A
Sbjct: 287 TTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAR 346
Query: 239 VNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYL 298
+ A N FS+ ++L+ N F ++
Sbjct: 347 EGEPAPADRWHMFGQEDNADAFSLFLDRLS-----ETENFIKDAGFKAQISSWLAQLAED 401
Query: 299 EKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRL 334
E L R F + + S DR FL + N +
Sbjct: 402 EAL-RANTFAMATEATSSCEDRVTFFLHQMKNVQLV 436
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 6e-36
Identities = 68/492 (13%), Positives = 148/492 (30%), Gaps = 76/492 (15%)
Query: 102 IPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIE 161
I R ++ + +S+ A+ + S N+ +L L N L ++L+ +K+E
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 162 HISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGT 221
++++ N L L +LS++R+L L+ N ++ L ++ L A N +S
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-R 113
Query: 222 IPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNL 281
+ S Q + + N++T S +
Sbjct: 114 VSCSRG---------------------------QGKKNIYLANNKITMLRDLDEGCRSRV 146
Query: 282 EIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLINI 341
+ +N++ +NF ++ L+ L +
Sbjct: 147 QYLDLKLNEID----------------------------TVNFAELAASSDTLEHLNLQY 178
Query: 342 NNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAI 401
N + + L+ L L +N++ + + + + +N+L I A+
Sbjct: 179 NFI-YDVKGQVVF--AKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV-LIEKAL 233
Query: 402 GELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSN 461
QNL+ L+ N F + + ++ ++ + T
Sbjct: 234 RFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGA 293
Query: 462 NNLTGTIPPQFIGL----SSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEI 517
P L +L ++ + E N ++ + + I
Sbjct: 294 YCCEDLPAPFADRLIALKRKEHALLSGQGSETE-RLECERENQARQREIDALKEQYRTVI 352
Query: 518 PSTLGSCIKLEQLEMQENFLQGPIP---SSLSSLRGLSVLDLSQNNLSGKIPELLIRLQL 574
LE ++ L + + + L G + Q L E L
Sbjct: 353 DQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLL 412
Query: 575 VKNLNLSNNDLE 586
+
Sbjct: 413 RAIVKRYEEMYV 424
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-34
Identities = 67/488 (13%), Positives = 143/488 (29%), Gaps = 57/488 (11%)
Query: 83 GNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLF 142
N + K+ ++ ++S + S ++ L L N + A+++ + L L L
Sbjct: 7 QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLS 66
Query: 143 HNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTL 202
N L +L SLS + + +N+N + L SI +L + NN+ +
Sbjct: 67 SNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVS--C 116
Query: 203 GWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSV 262
+ N+ +A N+++ S + D +N+I + S L+ ++
Sbjct: 117 SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176
Query: 263 GENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDL 322
N + + + + L+ S NKL P + + + N L
Sbjct: 177 QYNFIY-DVKGQV-VFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKL-------- 226
Query: 323 NFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQI-FGNIPAAIGKFV 381
+ + LE L N G + K
Sbjct: 227 -----------------------VLIEKALRFS-QNLEHFDLRGNGFHCGTLRDFFSKNQ 262
Query: 382 NLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNL------KLFILYL 435
+Q + + E + P L + +L
Sbjct: 263 RVQTVA--KQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSG 320
Query: 436 SYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPS 495
+ + + ID T+ Q + I L+ + L + +
Sbjct: 321 QGSETE-RLECERENQARQREIDALKEQYR-TVIDQVTLRKQAKITLEQKKKALDEQVSN 378
Query: 496 EVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQ-ENFLQGPIPSSLSSLRGLSVL 554
L+ + + E+ L+ L + + + + +
Sbjct: 379 GRRAHAELD-GTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDW 437
Query: 555 DLSQNNLS 562
D+ Q+ +
Sbjct: 438 DMYQHKET 445
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-33
Identities = 49/277 (17%), Positives = 94/277 (33%), Gaps = 27/277 (9%)
Query: 330 NATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMC 389
N R K + ++ +L + + ++ L L N + A + F L+ L++
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSA-WNVKELDLSGNPLSQISAADLAPFTKLELLNLS 66
Query: 390 SNRLSGTIPPAIGELQNLKDLRLQRNRFQ------------------GNIPPSIGNLKLF 431
SN L + L L+ L L N Q + S G
Sbjct: 67 SNVLYE--TLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQ-GKK 123
Query: 432 ILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTG 491
+YL+ N + G + +DL N + + S +L L+L N +
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY- 182
Query: 492 SIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGL 551
+ +V L+ L++ NKL + S + + ++ N L I +L + L
Sbjct: 183 DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNL 239
Query: 552 SVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGV 588
DL N + + ++ ++ +
Sbjct: 240 EHFDLRGNGFHCGTLRDFF-SKNQRVQTVAKQTVKKL 275
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-32
Identities = 60/459 (13%), Positives = 138/459 (30%), Gaps = 31/459 (6%)
Query: 62 QRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNS 121
R I + L +++ + +K L L N + ++ +L++L L N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 122 IGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNL 181
+ + + S S L L L +N + EL IE + +NN++ + S
Sbjct: 70 LYETLD--LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCS--RG 119
Query: 182 SSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIF-NISSITGFDAGVN 240
++++L+ N + G + L + N + + + + ++ + N
Sbjct: 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179
Query: 241 KIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEK 300
I + L+ + N+L + P +A+ + NKL L
Sbjct: 180 FIYD---VKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKALRF 235
Query: 301 LQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLE 360
Q L F + GN RD + R++ + L T
Sbjct: 236 SQNLEHFDLRGNGFHCGTLRDF-----FSKNQRVQTVAKQTVK---KLTGQNEEECTVPT 287
Query: 361 VLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSG----TIPPAIGELQNLKDLRLQRNR 416
+ + + L+R + G + +++ + +
Sbjct: 288 LGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQ 347
Query: 417 FQGNIPPSIGNLK--LFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIG 474
++ + + K L L + + + L
Sbjct: 348 YR-TVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQ 406
Query: 475 LSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKL 513
L+ + R + + + + +++ +K
Sbjct: 407 SPLQLLRAIVKRYEEM-YVEQQSVQNNAIRDWDMYQHKE 444
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 24/95 (25%), Positives = 44/95 (46%), Gaps = 2/95 (2%)
Query: 492 SIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGL 551
+I N +I V + LK + S S +++L++ N L + L+ L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 552 SVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLE 586
+L+LS N L +L L ++ L+L+NN ++
Sbjct: 61 ELLNLSSNVLYE-TLDLE-SLSTLRTLDLNNNYVQ 93
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-35
Identities = 49/277 (17%), Positives = 94/277 (33%), Gaps = 27/277 (9%)
Query: 330 NATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMC 389
N R K + ++ +L + + ++ L L N + A + F L+ L++
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSA-WNVKELDLSGNPLSQISAADLAPFTKLELLNLS 66
Query: 390 SNRLSGTIPPAIGELQNLKDLRLQRNRFQ------------------GNIPPSIGNLKLF 431
SN L + L L+ L L N Q + S G
Sbjct: 67 SNVLYE--TLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQ-GKK 123
Query: 432 ILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTG 491
+YL+ N + G + +DL N + + S +L L+L N +
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY- 182
Query: 492 SIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGL 551
+ +V L+ L++ NKL + S + + ++ N L I +L + L
Sbjct: 183 DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNL 239
Query: 552 SVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGV 588
DL N + + ++ ++ +
Sbjct: 240 EHFDLRGNGFHC-GTLRDFFSKNQRVQTVAKQTVKKL 275
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 51/341 (14%), Positives = 118/341 (34%), Gaps = 28/341 (8%)
Query: 150 IPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLV 209
I + ++ + V D++L ++ S + +++ L LSGN L L L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 210 NLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTG 269
L ++ N L + ++S++ D N +Q + +++ N ++
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-ELL-----VGPSIETLHAANNNIS- 112
Query: 270 AIPPTISNASNLEIFHGSVNKLTGAAPY-LEKLQRLLVFGILGNSLGSRGDRDLNFLCSL 328
+ S + + + NK+T R+ + N + +NF
Sbjct: 113 RVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEI-----DTVNFAELA 165
Query: 329 TNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDM 388
++ L+ L + N + + L+ L L +N++ + + + +
Sbjct: 166 ASSDTLEHLNLQYNFI-YDVKGQVVF--AKLKTLDLSSNKL-AFMGPEFQSAAGVTWISL 221
Query: 389 CSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSL 448
+N+L I A+ QNL+ L+ N F + + ++ ++ +
Sbjct: 222 RNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK-KLTGQN 279
Query: 449 GRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQL 489
T+ T+ +P F ++ L +
Sbjct: 280 EEECTVPTLGHYGAYCCEDLPAPFA-----DRLIALGHHHH 315
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 53/319 (16%), Positives = 105/319 (32%), Gaps = 24/319 (7%)
Query: 62 QRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNS 121
R I + L +++ + +K L L N + ++ +L++L L N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 122 IGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNL 181
+ ++ S S L L L +N + EL IE + +NN++ + S
Sbjct: 70 LYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCS--RG 119
Query: 182 SSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSG-TIPSSIFNISSITGFDAGVN 240
++++L+ N + G + L + N + + ++ + N
Sbjct: 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179
Query: 241 KIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEK 300
I + L+ + N+L + P +A+ + NKL L
Sbjct: 180 FIYD---VKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKALRF 235
Query: 301 LQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLE 360
Q L F + GN RD + R++ + L + T+
Sbjct: 236 SQNLEHFDLRGNGFHCGTLRDF-----FSKNQRVQTVAKQTVK---KLT-GQNEEECTVP 286
Query: 361 VLLLDNNQIFGNIPAAIGK 379
L ++PA
Sbjct: 287 TLGHYGAYCCEDLPAPFAD 305
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 5e-16
Identities = 31/146 (21%), Positives = 59/146 (40%), Gaps = 11/146 (7%)
Query: 443 SIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKN 502
+I +++++L + ++ LDLS N L+ +++
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK 59
Query: 503 LEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLS 562
LE+LN+ N L E L S L L++ N++ L + L + NN+S
Sbjct: 60 LELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS 112
Query: 563 GKIPELLIRLQLVKNLNLSNNDLEGV 588
++ Q KN+ L+NN + +
Sbjct: 113 -RVSCSR--GQGKKNIYLANNKITML 135
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 9e-34
Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 22/219 (10%)
Query: 693 VNQIGEGSFGSVFKGIL---DDGRTTIAVKVFNLLHHG--AFKSFIAECNTLKNIRHRNL 747
+GEG FGSV +G L D +AVK L + + F++E +K+ H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 748 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISI 807
+++L C + QG ++ FM L +L + P+ + L L +
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL----LYSRLETGPKHIPLQTLLKFMV 154
Query: 808 DVACALNYL--HHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGA 865
D+A + YL + H DL N +L +DM + DFGL++ + A
Sbjct: 155 DIALGMEYLSNRN-----FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIA 209
Query: 866 KGSIGYIAPE---YGLGSEVSISGDVYSYGILLLELITR 901
K + +IA E + + S DV+++G+ + E+ TR
Sbjct: 210 KMPVKWIAIESLADRVYTSKS---DVWAFGVTMWEIATR 245
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-33
Identities = 60/216 (27%), Positives = 108/216 (50%), Gaps = 24/216 (11%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAF--KSFIAECNTLKNIRHR 745
+ +++G G +G V++G+ T+AVK L + F+ E +K I+H
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT---LKEDTMEVEEFLKEAAVMKEIKHP 276
Query: 746 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNI 805
NLV++L C+ + F ++ EFM +L ++L RE + ++ + L +
Sbjct: 277 NLVQLLGVCT----REPPFY-IITEFMTYGNLLDYL----RECN----RQEVSAVVLLYM 323
Query: 806 SIDVACALNYLH-HDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIG 864
+ ++ A+ YL + I H +L N L+ E+ + + DFGL+R + T+ G
Sbjct: 324 ATQISSAMEYLEKKNF---I-HRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAG 378
Query: 865 AKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
AK I + APE ++ SI DV+++G+LL E+ T
Sbjct: 379 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 6e-33
Identities = 55/223 (24%), Positives = 94/223 (42%), Gaps = 29/223 (13%)
Query: 693 VNQIGEGSFGSVFKGIL---DDGRTTIAVKVFNLLHHGAF-----KSFIAECNTLKNIRH 744
+G+G FGSV + L D +AVK+ L + F+ E +K H
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKM---LKADIIASSDIEEFLREAACMKEFDH 84
Query: 745 RNLVKILTACSGVDYQGNDFKAL-VFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRL 803
++ K++ +G + + FM + L +L E P +L L +
Sbjct: 85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL----LASRIGENPFNLPLQTLV 140
Query: 804 NISIDVACALNYL--HHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTS 861
+D+AC + YL + H DL N +L EDM + DFGL+R +
Sbjct: 141 RFMVDIACGMEYLSSRN-----FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQ 195
Query: 862 SIGAKGSIGYIAPE---YGLGSEVSISGDVYSYGILLLELITR 901
+K + ++A E L + S DV+++G+ + E++TR
Sbjct: 196 GCASKLPVKWLALESLADNLYTVHS---DVWAFGVTMWEIMTR 235
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 60/219 (27%), Positives = 106/219 (48%), Gaps = 28/219 (12%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAF--KSFIAECNTLKNIRHR 745
+ +++G G +G V++G+ T+AVK L + F+ E +K I+H
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT---LKEDTMEVEEFLKEAAVMKEIKHP 69
Query: 746 NLVKILTACSGVD--YQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRL 803
NLV++L C+ Y ++ EFM +L ++L RE + ++ + L
Sbjct: 70 NLVQLLGVCTREPPFY-------IITEFMTYGNLLDYL----RECN----RQEVSAVVLL 114
Query: 804 NISIDVACALNYL-HHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSS 862
++ ++ A+ YL + H DL N L+ E+ + + DFGL+R + T+
Sbjct: 115 YMATQISSAMEYLEKKNF----IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAH 169
Query: 863 IGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITR 901
GAK I + APE ++ SI DV+++G+LL E+ T
Sbjct: 170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 208
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-32
Identities = 61/216 (28%), Positives = 106/216 (49%), Gaps = 26/216 (12%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAF--KSFIAECNTLKNIRHR 745
+ ++G G FG V+ + T +AVK + G+ ++F+AE N +K ++H
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKT---MKPGSMSVEAFLAEANVMKTLQHD 243
Query: 746 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNI 805
LVK+ + + ++ EFM SL ++L + DE L + ++
Sbjct: 244 KLVKLHAVVTK------EPIYIITEFMAKGSLLDFL----KSDE----GSKQPLPKLIDF 289
Query: 806 SIDVACALNYL-HHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIG 864
S +A + ++ + H DL+ +NIL+ ++ I DFGLAR + + T+ G
Sbjct: 290 SAQIAEGMAFIEQRNY----IHRDLRAANILVSASLVCKIADFGLARVI-EDNEYTAREG 344
Query: 865 AKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
AK I + APE +I DV+S+GILL+E++T
Sbjct: 345 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 64/219 (29%), Positives = 111/219 (50%), Gaps = 32/219 (14%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAF--KSFIAECNTLKNIRHR 745
+ V ++G G FG V+ G + G T +AVK L G+ +F+AE N +K ++H+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKS---LKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 746 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNI 805
LV++ + + ++ E+M N SL ++L + L + + L++
Sbjct: 69 RLVRLYAVVTQ------EPIYIITEYMENGSLVDFL----KTPS----GIKLTINKLLDM 114
Query: 806 SIDVACALNYL-HHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIG 864
+ +A + ++ + H DL+ +NIL+ + + I DFGLAR + + T+ G
Sbjct: 115 AAQIAEGMAFIEERNY----IHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREG 169
Query: 865 AKGSIGYIAPE---YGLGSEVSISGDVYSYGILLLELIT 900
AK I + APE YG +I DV+S+GILL E++T
Sbjct: 170 AKFPIKWTAPEAINYGT---FTIKSDVWSFGILLTEIVT 205
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-32
Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 28/215 (13%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAF-KSFIAECNTLKNIRHRN 746
+ IG+G FG V G +AVK + + A ++F+AE + + +RH N
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYRG--NKVAVKC---IKNDATAQAFLAEASVMTQLRHSN 247
Query: 747 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNIS 806
LV++L + +V E+M SL ++L L L S
Sbjct: 248 LVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLR--------SRGRSVLGGDCLLKFS 295
Query: 807 IDVACALNYL-HHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGA 865
+DV A+ YL ++ + H DL N+L+ ED +A + DFGL + A ++
Sbjct: 296 LDVCEAMEYLEGNNF---V-HRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTG 346
Query: 866 KGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
K + + APE + S DV+S+GILL E+ +
Sbjct: 347 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-32
Identities = 54/228 (23%), Positives = 96/228 (42%), Gaps = 34/228 (14%)
Query: 688 DRFSSVNQIGEGSFGSVFKGIL----DDGRTTIAVKVFNLLHHGA----FKSFIAECNTL 739
F + +G G+FG+V+KG+ + + +A+K L K + E +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE---LREATSPKANKEILDEAYVM 71
Query: 740 KNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNL 799
++ + ++ ++L C Q L+ + M L +++ E ++
Sbjct: 72 ASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVR---------EHKDNIGS 116
Query: 800 IQRLNISIDVACALNYL--HHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSS 857
LN + +A +NYL + H DL N+L+ I DFGLA+ L
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171
Query: 858 AQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITR-KKP 904
+ + G K I ++A E L + DV+SYG+ + EL+T KP
Sbjct: 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-32
Identities = 56/222 (25%), Positives = 87/222 (39%), Gaps = 30/222 (13%)
Query: 693 VNQIGEGSFGSVFKGIL---DDGRTTIAVKVFN---LLHHGAFKSFIAECNTLKNIRHRN 746
+ ++G+GSFG V +G ++AVK L A FI E N + ++ HRN
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 747 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNIS 806
L+++ + +V E SL + L + L +
Sbjct: 83 LIRLYGVVLTPPMK------MVTELAPLGSLLDRLR---------KHQGHFLLGTLSRYA 127
Query: 807 IDVACALNYL--HHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQ-TSSI 863
+ VA + YL H DL N+LL + IGDFGL R LP +
Sbjct: 128 VQVAEGMGYLESKR-----FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 182
Query: 864 GAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITR-KKP 904
K + APE S + D + +G+ L E+ T ++P
Sbjct: 183 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 28/215 (13%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGA-FKSFIAECNTLKNIRHRN 746
+ IG+G FG V G +AVK + + A ++F+AE + + +RH N
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYRG--NKVAVKC---IKNDATAQAFLAEASVMTQLRHSN 75
Query: 747 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNIS 806
LV++L + +V E+M SL ++L L L S
Sbjct: 76 LVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLR--------SRGRSVLGGDCLLKFS 123
Query: 807 IDVACALNYL-HHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGA 865
+DV A+ YL ++ + H DL N+L+ ED +A + DFGL + A ++
Sbjct: 124 LDVCEAMEYLEGNNF---V-HRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTG 174
Query: 866 KGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
K + + APE + S DV+S+GILL E+ +
Sbjct: 175 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 209
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 59/219 (26%), Positives = 92/219 (42%), Gaps = 32/219 (14%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGA--FKSFIAECNTLKNIRHR 745
+ V +IG G FG V G + +A+K + GA + FI E + + H
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKT---IREGAMSEEDFIEEAEVMMKLSHP 63
Query: 746 NLVKILTACSGVD--YQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRL 803
LV++ C LV EFM + L ++L R L
Sbjct: 64 KLVQLYGVCLEQAPIC-------LVTEFMEHGCLSDYL----RTQR-----GLFAAETLL 107
Query: 804 NISIDVACALNYL--HHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTS 861
+ +DV + YL + H DL N L+ E+ + + DFG+ RF+ L TS
Sbjct: 108 GMCLDVCEGMAYLEEAC-----VIHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTS 161
Query: 862 SIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
S G K + + +PE S S DV+S+G+L+ E+ +
Sbjct: 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 200
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-31
Identities = 60/268 (22%), Positives = 101/268 (37%), Gaps = 32/268 (11%)
Query: 323 NFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVN 382
++ + + N N L C L L L+ + ++P +
Sbjct: 28 DYFSAWDKWEKQALPGENRNEAVSLLKEC---LINQFSELQLNRLNL-SSLPDNLPP--Q 81
Query: 383 LQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQG 442
+ L++ N L ++P +L+ L NR +P +LK L + N L
Sbjct: 82 ITVLEITQNALI-SLPELPA---SLEYLDACDNRLS-TLPELPASLK--HLDVDNNQLT- 133
Query: 443 SIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKN 502
+P L I+ NN LT +P +SL VL + NQLT +P ++
Sbjct: 134 MLPELPA---LLEYINADNNQLT-MLPELP----TSLEVLSVRNNQLT-FLPEL---PES 181
Query: 503 LEILNVFGNKLKGEIPSTLGSCIKLEQ----LEMQENFLQGPIPSSLSSLRGLSVLDLSQ 558
LE L+V N L+ +P+ E+ +EN + IP ++ SL + L
Sbjct: 182 LEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILED 239
Query: 559 NNLSGKIPELLIRLQLVKNLNLSNNDLE 586
N LS +I E L + + +
Sbjct: 240 NPLSSRIRESLSQQTAQPDYHGPRIYFS 267
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 105 bits (262), Expect = 2e-23
Identities = 68/440 (15%), Positives = 128/440 (29%), Gaps = 76/440 (17%)
Query: 132 SCSNLIQLR--LFHNQLVG---KIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRS 186
+N L F+N + G S K N N + L ++
Sbjct: 6 PINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSE 63
Query: 187 LFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAI 246
L L+ NL S+PD L + L + QN L ++P
Sbjct: 64 LQLNRLNLS-SLPDNLP--PQITVLEITQNALI-SLPELP-------------------- 99
Query: 247 PLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLV 306
+L++ +N+L+ +P ++ +L++ + N+LT L+ +
Sbjct: 100 --------ASLEYLDACDNRLS-TLPELPASLKHLDVDN---NQLTMLPELPALLEYINA 147
Query: 307 FGILGNSLGSRGDRDLNFLCSLTNA-TRLKWLLININNFGGSLPACISNLSTTLEVLLLD 365
D N L L T L+ L + N LP +L E L +
Sbjct: 148 --------------DNNQLTMLPELPTSLEVLSVRNNQLT-FLPELPESL----EALDVS 188
Query: 366 NNQIFGNIPAAIGKFVNLQR----LDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNI 421
N + ++PA + + + NR++ IP I L + L+ N I
Sbjct: 189 TNLL-ESLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRI 246
Query: 422 PPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIV 481
S+ Y D + +
Sbjct: 247 RESLSQQTAQPDYHGPRIYFSMSDGQQNTLH-RPLADAVTAWFPENKQSDVSQIWHAFEH 305
Query: 482 LDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPI 541
+ + + + + + + F ++ + L +L Q +
Sbjct: 306 EEHANTFS--AFLDRLSDTVSARNTSGFRE----QVAAWLEKLSASAELRQQSFAVAADA 359
Query: 542 PSSLSSLRGLSVLDLSQNNL 561
S L+ +L + L
Sbjct: 360 TESCEDRVALTWNNLRKTLL 379
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 98.1 bits (244), Expect = 3e-21
Identities = 62/395 (15%), Positives = 122/395 (30%), Gaps = 65/395 (16%)
Query: 62 QRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNS 121
+ + L L L L+ S+ ++ + VL + N+ +P L L N
Sbjct: 59 NQFSELQLNRLNLS-SLPDNLPPQ--ITVLEITQNAL-ISLPELPASLEYLD---ACDNR 111
Query: 122 IGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNL 181
+ +P + +L L + +NQL +P + L E+I+ ++N LT +P +L
Sbjct: 112 LS-TLPELPA---SLKHLDVDNNQLT-MLPELPALL---EYINADNNQLT-MLPELPTSL 162
Query: 182 SSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNK 241
L + N L +P+ ++L L ++ N L ++P+
Sbjct: 163 ---EVLSVRNNQLT-FLPE---LPESLEALDVSTNLLE-SLPAVPVRNHH---------- 204
Query: 242 IQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKL 301
S + FF EN++T IP I + N L+
Sbjct: 205 -----------SEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQ 252
Query: 302 QRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEV 361
Q + N F + + +S + E
Sbjct: 253 QTAQPDYHGPRIY-------FSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFE- 304
Query: 362 LLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNI 421
++ F + V+ + +++ + +L +LR Q +
Sbjct: 305 -HEEHANTFSAFLDRLSDTVSARNTSGFREQVAAWLE----KLSASAELRQQSFAVAADA 359
Query: 422 PPSIGNLKLF------ILYLSYNFLQGSIPSSLGR 450
S + L + +G + G
Sbjct: 360 TESCEDRVALTWNNLRKTLLVHQASEGLFDNDTGA 394
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 80.0 bits (197), Expect = 2e-15
Identities = 39/163 (23%), Positives = 63/163 (38%), Gaps = 15/163 (9%)
Query: 424 SIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLD 483
I N YN + G+ ++ L N + L + L
Sbjct: 6 PINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQ 65
Query: 484 LSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPS 543
L+R L+ S+P + + +L + N L +P S LE L+ +N L +P
Sbjct: 66 LNRLNLS-SLPDNLP--PQITVLEITQNALI-SLPELPAS---LEYLDACDNRLST-LPE 117
Query: 544 SLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLE 586
+SL+ LD+ N L+ +PEL L+ +N NN L
Sbjct: 118 LPASLKH---LDVDNNQLT-MLPELPALLE---YINADNNQLT 153
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 54/220 (24%), Positives = 96/220 (43%), Gaps = 28/220 (12%)
Query: 693 VNQIGEGSFGSVFKGIL----DDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNL 747
+ +G G FG+V KG+ + + + +KV +F++ + ++ H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 748 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISI 807
V++L C G Q LV +++ SL + + R+ +L LN +
Sbjct: 78 VRLLGLCPGSSLQ------LVTQYLPLGSLLDHV----RQHR-----GALGPQLLLNWGV 122
Query: 808 DVACALNYL--HHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGA 865
+A + YL H + H +L N+LL + DFG+A LP Q A
Sbjct: 123 QIAKGMYYLEEHG-----MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEA 177
Query: 866 KGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITR-KKP 904
K I ++A E + + DV+SYG+ + EL+T +P
Sbjct: 178 KTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-31
Identities = 64/216 (29%), Positives = 107/216 (49%), Gaps = 26/216 (12%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKS--FIAECNTLKNIRHR 745
+ ++G+G FG V+ G + G T +A+K L G F+ E +K +RH
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKT---LKPGTMSPEAFLQEAQVMKKLRHE 239
Query: 746 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNI 805
LV++ S + +V E+M SL ++L + + + L L Q +++
Sbjct: 240 KLVQLYAVVSE------EPIYIVTEYMSKGSLLDFL----KGET----GKYLRLPQLVDM 285
Query: 806 SIDVACALNYLH-HDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIG 864
+ +A + Y+ + H DL+ +NIL+ E+++ + DFGLAR + + T+ G
Sbjct: 286 AAQIASGMAYVERMNY----VHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQG 340
Query: 865 AKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
AK I + APE L +I DV+S+GILL EL T
Sbjct: 341 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 376
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 28/217 (12%)
Query: 693 VNQIGEGSFGSVFKGIL----DDGRTTIAVKVFNLLHHGA---FKSFIAECNTLKNIRHR 745
+ Q+G+G+FGSV D+ +AVK L H + F E LK+++H
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK---LQHSTEEHLRDFEREIEILKSLQHD 71
Query: 746 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNI 805
N+VK C G L+ E++ SL ++L ++ + ++ I+ L
Sbjct: 72 NIVKYKGVCYS---AGRRNLKLIMEYLPYGSLRDYL----QKHK-----ERIDHIKLLQY 119
Query: 806 SIDVACALNYLH-HDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQ-TSSI 863
+ + + YL H DL NIL++ + IGDFGL + LP
Sbjct: 120 TSQICKGMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKE 175
Query: 864 GAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
+ I + APE S+ S++ DV+S+G++L EL T
Sbjct: 176 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 56/219 (25%), Positives = 100/219 (45%), Gaps = 32/219 (14%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGA--FKSFIAECNTLKNIRHR 745
+ + ++G G FG V G G+ +A+K+ + G+ FI E + N+ H
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKM---IKEGSMSEDEFIEEAKVMMNLSHE 79
Query: 746 NLVKILTACSGVD--YQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRL 803
LV++ C+ + ++ E+M N L +L RE Q L
Sbjct: 80 KLVQLYGVCTKQRPIF-------IITEYMANGCLLNYL----REMR-----HRFQTQQLL 123
Query: 804 NISIDVACALNYL--HHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTS 861
+ DV A+ YL H DL N L+++ + + DFGL+R++ L TS
Sbjct: 124 EMCKDVCEAMEYLESKQ-----FLHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTS 177
Query: 862 SIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
S+G+K + + PE + S+ S D++++G+L+ E+ +
Sbjct: 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 61/224 (27%), Positives = 97/224 (43%), Gaps = 33/224 (14%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGA--FKSFIAECNTLKNIRHR 745
+ + + ++G G FG V G G+ +AVK+ + G+ F E T+ + H
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWK-GQYDVAVKM---IKEGSMSEDEFFQEAQTMMKLSHP 63
Query: 746 NLVKILTACSGVD--YQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRL 803
LVK CS Y +V E++ N L +L + L Q L
Sbjct: 64 KLVKFYGVCSKEYPIY-------IVTEYISNGCLLNYLR---------SHGKGLEPSQLL 107
Query: 804 NISIDVACALNYL--HHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTS 861
+ DV + +L H H DL N L+D D+ + DFG+ R++ L S
Sbjct: 108 EMCYDVCEGMAFLESHQ-----FIHRDLAARNCLVDRDLCVKVSDFGMTRYV-LDDQYVS 161
Query: 862 SIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITR-KKP 904
S+G K + + APE + S DV+++GIL+ E+ + K P
Sbjct: 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 7e-31
Identities = 74/417 (17%), Positives = 140/417 (33%), Gaps = 79/417 (18%)
Query: 173 SIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSI 232
I S+L + + + L N +T + + +P+++ +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLD---- 66
Query: 233 TGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTI-SNASNLEIFHGSVNKL 291
S + ++ ++ + Q+ I + A ++ + N +
Sbjct: 67 --------------------SFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAI 105
Query: 292 TGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPAC 351
P++ N L L++ N+ SLP
Sbjct: 106 RYLPPHV-----------------------------FQNVPLLTVLVLERNDLS-SLPRG 135
Query: 352 ISNLSTTLEVLLLDNNQIFGNIPAAI-GKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDL 410
I + + L L + NN + I +LQ L + SNRL+ + + +L
Sbjct: 136 IFHNTPKLTTLSMSNNNL-ERIEDDTFQATTSLQNLQLSSNRLT-HVDL--SLIPSLFHA 191
Query: 411 RLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPP 470
+ N + I + L S+N + + + LT + L +NNLT
Sbjct: 192 NVSYNLLS-TLAIPI---AVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTD--TA 242
Query: 471 QFIGLSSSLIVLDLSRNQLTGSIPSEV-GNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQ 529
+ L+ +DLS N+L I ++ LE L + N+L + L+
Sbjct: 243 WLLNYPG-LVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKV 299
Query: 530 LEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLE 586
L++ N L + + L L L N++ L KNL LS+ND +
Sbjct: 300 LDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVTLKLSTHHTL---KNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 9e-31
Identities = 71/408 (17%), Positives = 139/408 (34%), Gaps = 54/408 (13%)
Query: 67 LDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAI 126
+ ++ L+ K++ N++ + D R++++L L+ I I
Sbjct: 26 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQI-EEI 84
Query: 127 PANI-SSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIR 185
+ + +L + N + P ++ + + + N+L+ N +
Sbjct: 85 DTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLT 144
Query: 186 SLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGA 245
+L +S NNLE DT +L NL ++ NRL+ + S+
Sbjct: 145 TLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLI------------------ 185
Query: 246 IPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTG-AAPYLEKLQRL 304
+L +V N L+ T++ +E S N + P +L L
Sbjct: 186 ---------PSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVELTIL 231
Query: 305 LVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLL 364
+ N+L L N L + ++ N + LE L +
Sbjct: 232 ---KLQHNNLTDTA--------WLLNYPGLVEVDLSYNEL-EKIMYHPFVKMQRLERLYI 279
Query: 365 DNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPS 424
NN++ + L+ LD+ N L + + L++L L N + S
Sbjct: 280 SNNRL-VALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLS 336
Query: 425 IGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQF 472
+ L L LS+N + +L R + + + + I Q
Sbjct: 337 T-HHTLKNLTLSHNDWDCNSLRALFR--NVARPAVDDADQHCKIDYQL 381
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-30
Identities = 65/391 (16%), Positives = 136/391 (34%), Gaps = 53/391 (13%)
Query: 102 IPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIE 161
I S + + + + +N + ++ + + L S ++E
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 162 HISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGT 221
+++ND + + +I+ L++ N + P + L L + +N LS +
Sbjct: 73 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-S 131
Query: 222 IPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNL 281
+P IF+ + L S+ N L T ++L
Sbjct: 132 LPRGIFH------------------------NTPKLTTLSMSNNNLERIEDDTFQATTSL 167
Query: 282 EIFHGSVNKLTGAAP-YLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLIN 340
+ S N+LT + L + N L +L ++ L +
Sbjct: 168 QNLQLSSNRLTHVDLSLIPSLFHA--------------NVSYNLLSTLAIPIAVEELDAS 213
Query: 341 INNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPA 400
N+ + ++ L +L L +N + A + + L +D+ N L +
Sbjct: 214 HNSI-NVVRG---PVNVELTILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELEKIMYHP 267
Query: 401 IGELQNLKDLRLQRNRFQGNIPPSIGNL-KLFILYLSYNFLQGSIPSSLGRYETLTTIDL 459
++Q L+ L + NR + + L +L LS+N L + + +++ L + L
Sbjct: 268 FVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYL 325
Query: 460 SNNNLTGTIPPQFIGLSSSLIVLDLSRNQLT 490
+N++ T+ +L L LS N
Sbjct: 326 DHNSIV-TLKL---STHHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-24
Identities = 57/266 (21%), Positives = 101/266 (37%), Gaps = 23/266 (8%)
Query: 327 SLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAI-GKFVNLQR 385
L + +++ L +N + + T++ L + N I +P + L
Sbjct: 64 LLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAI-RYLPPHVFQNVPLLTV 121
Query: 386 LDMCSNRLSGTIPPAI-GELQNLKDLRLQRNRFQGNIPPSI--GNLKLFILYLSYNFLQG 442
L + N LS ++P I L L + N + I L L LS N L
Sbjct: 122 LVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT- 178
Query: 443 SIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKN 502
+ L +L ++S N L+ T+ ++ LD S N + + V
Sbjct: 179 HVD--LSLIPSLFHANVSYNLLS-TLAIP-----IAVEELDASHNSIN-VVRGPV--NVE 227
Query: 503 LEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLS 562
L IL + N L + L + L ++++ N L+ + ++ L L +S N L
Sbjct: 228 LTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 285
Query: 563 GKIPELLIRLQLVKNLNLSNNDLEGV 588
+ + +K L+LS+N L V
Sbjct: 286 -ALNLYGQPIPTLKVLDLSHNHLLHV 310
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 6e-08
Identities = 23/125 (18%), Positives = 49/125 (39%), Gaps = 4/125 (3%)
Query: 475 LSSSLIVLDLSRNQLTGSIPS--EVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEM 532
L + D+ + T + E L N +I+ + ++ + L S ++E L +
Sbjct: 17 LQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNL 76
Query: 533 QENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQ 592
+ ++ + + + L + N + P + + L+ L L NDL +
Sbjct: 77 NDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPR-- 134
Query: 593 GVFKN 597
G+F N
Sbjct: 135 GIFHN 139
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-31
Identities = 56/214 (26%), Positives = 80/214 (37%), Gaps = 28/214 (13%)
Query: 693 VNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKS----FIAECNTLKNIRHRNLV 748
QIG G+FG VF G L T +AVK F+ E LK H N+V
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKS---CRETLPPDLKAKFLQEARILKQYSHPNIV 175
Query: 749 KILTACSGVD--YQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNIS 806
+++ C+ Y +V E + +L L + L +
Sbjct: 176 RLIGVCTQKQPIY-------IVMELVQGGDFLTFLR---------TEGARLRVKTLLQMV 219
Query: 807 IDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAK 866
D A + YL H DL N L+ E + I DFG++R S +
Sbjct: 220 GDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQ 276
Query: 867 GSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
+ + APE S DV+S+GILL E +
Sbjct: 277 VPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 9e-31
Identities = 86/435 (19%), Positives = 159/435 (36%), Gaps = 72/435 (16%)
Query: 88 LKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANI-SSCSNLIQLRLFHNQL 146
+ + L NS + F RL+ LQ L + + G I N S+LI L+L +NQ
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91
Query: 147 VGKIPSE-LSSLSKIEHISVNDNNLTGSI--PSSLGNLSSIRSLFLSGNNLEGSIPDTL- 202
+ ++ + + L+ +E +++ NL G++ + L+S+ L L NN++ P +
Sbjct: 92 L-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFF 150
Query: 203 GWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSV 262
++ L + N++ +I F ++ +
Sbjct: 151 LNMRRFHVLDLTFNKVK-SICEEDL----------------------LNFQGKHFTLLRL 187
Query: 263 GENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDL 322
L ++ G+ K T + L + GN +
Sbjct: 188 SSITLQ-----DMNEYWLGWEKCGNPFKNTS----ITTLD------LSGNGFKESMAKRF 232
Query: 323 NFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVN 382
+ T L L + N + N F + A+
Sbjct: 233 FDAIAGTKIQSL-ILSNSYNMGSSFGHTNFKDPD----------NFTFKGLEAS-----G 276
Query: 383 LQRLDMCSNRLSGTIPPAI-GELQNLKDLRLQRNRFQGNIPPSI--GNLKLFILYLSYNF 439
++ D+ +++ + ++ +L+ L L +N I + G L L LS NF
Sbjct: 277 VKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNF 334
Query: 440 LQGSIPS-SLGRYETLTTIDLSNNNLTGTIPPQ-FIGLSSSLIVLDLSRNQLTGSIPSEV 497
L SI S + L +DLS N++ + Q F+GL +L L L NQL S+P +
Sbjct: 335 LG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGL-PNLKELALDTNQLK-SVPDGI 390
Query: 498 -GNLKNLEILNVFGN 511
L +L+ + + N
Sbjct: 391 FDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-23
Identities = 78/427 (18%), Positives = 141/427 (33%), Gaps = 74/427 (17%)
Query: 182 SSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNK 241
+ + + LS N++ + L++L L + Q I ++ F
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFR------------- 76
Query: 242 IQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTI-SNASNLEIFHGSVNKLTGA---APY 297
L +L + NQ + + +NLE+ + L GA +
Sbjct: 77 -----------GLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNF 124
Query: 298 LEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNL-S 356
+ L L + + N++ + N R L + N + N
Sbjct: 125 FKPLTSLEMLVLRDNNIKK-----IQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQG 179
Query: 357 TTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNR 416
+L L + + DM L + ++ L L N
Sbjct: 180 KHFTLLRLSSITL----------------QDMNEYWLGWEKCGNPFKNTSITTLDLSGNG 223
Query: 417 FQ----GNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQF 472
F+ +I K+ L LS ++ GS + N F
Sbjct: 224 FKESMAKRFFDAIAGTKIQSLILSNSYNMGS--------------SFGHTNFKDPDNFTF 269
Query: 473 IGLS-SSLIVLDLSRNQLTGSIPSEV-GNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQL 530
GL S + DLS++++ ++ V + +LE L + N++ + L +L
Sbjct: 270 KGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKL 328
Query: 531 EMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVP 590
+ +NFL +L L VLDLS N++ + + L +K L L N L+ V
Sbjct: 329 NLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSV-- 386
Query: 591 TQGVFKN 597
G+F
Sbjct: 387 PDGIFDR 393
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 4e-21
Identities = 54/263 (20%), Positives = 92/263 (34%), Gaps = 29/263 (11%)
Query: 354 NLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPP-AIGELQNLKDLRL 412
L + + L N I + + +LQ L + I L +L L+L
Sbjct: 27 ELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKL 86
Query: 413 QRNRFQGNIPPSI--GNLKLFILYLSYNFLQGSI--PSSLGRYETLTTIDLSNNNLTGTI 468
N+F + G L +L L+ L G++ + +L + L +NN+
Sbjct: 87 DYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQ 145
Query: 469 PPQFIGLSSSLIVLDLSRNQLTGSIPSEV---GNLKNLEILNVFGNKLKGEIPSTLGSCI 525
P F VLDL+ N++ SI E K+ +L + L
Sbjct: 146 PASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITL------------ 192
Query: 526 KLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEL---LIRLQLVKNLNLSN 582
+M E +L + ++ LDLS N + + I +++L LSN
Sbjct: 193 ----QDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSN 248
Query: 583 NDLEGVVPTQGVFKNASITSVFG 605
+ G FK+ + G
Sbjct: 249 SYNMGSSFGHTNFKDPDNFTFKG 271
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 2e-12
Identities = 31/135 (22%), Positives = 59/135 (43%), Gaps = 8/135 (5%)
Query: 64 VTILDLESLKLAGSISPHV-GNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSI 122
V DL K+ ++ V + + L+ L L N N + F L L L L N +
Sbjct: 277 VKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFL 335
Query: 123 GGAIPANI-SSCSNLIQLRLFHNQLVGKIPSEL-SSLSKIEHISVNDNNLTGSIPSS-LG 179
G +I + + + L L L +N + + + L ++ ++++ N L S+P
Sbjct: 336 G-SIDSRMFENLDKLEVLDLSYNHI-RALGDQSFLGLPNLKELALDTNQLK-SVPDGIFD 392
Query: 180 NLSSIRSLFLSGNNL 194
L+S++ ++L N
Sbjct: 393 RLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 5e-09
Identities = 30/185 (16%), Positives = 60/185 (32%), Gaps = 20/185 (10%)
Query: 60 RHQRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRL---RRLQVLA 116
R +T+ D+ L + + + L L N F + F ++Q L
Sbjct: 186 RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLI 245
Query: 117 LHYNSI-GGAIPANISSC-----------SNLIQLRLFHNQLVGKIPSEL-SSLSKIEHI 163
L + G + S + L +++ + + S + +E +
Sbjct: 246 LSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKI-FALLKSVFSHFTDLEQL 304
Query: 164 SVNDNNLTGSIPS-SLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTI 222
++ N + I + L+ + L LS N L L L L ++ N + +
Sbjct: 305 TLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-AL 362
Query: 223 PSSIF 227
F
Sbjct: 363 GDQSF 367
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 52/221 (23%), Positives = 93/221 (42%), Gaps = 35/221 (15%)
Query: 695 QIGEGSFGSVFKGIL--DDGRTTIAVKVF--NLLHHGAFKSFIAECNTLKNIRHRNLVKI 750
++G G+FG+V KG T+AVK+ +AE N ++ + + +V++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 751 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVA 810
+ C + LV E L ++L +++ R + + + V+
Sbjct: 84 IGICEAESWM------LVMEMAELGPLNKYL----QQN------RHVKDKNIIELVHQVS 127
Query: 811 CALNYL--HHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPL-SSAQTSSIGAKG 867
+ YL + H DL N+LL A I DFGL++ L + + K
Sbjct: 128 MGMKYLEESN-----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 182
Query: 868 SIGYIAPE---YGLGSEVSISGDVYSYGILLLELITR-KKP 904
+ + APE Y + S DV+S+G+L+ E + +KP
Sbjct: 183 PVKWYAPECINYY---KFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 51/223 (22%), Positives = 91/223 (40%), Gaps = 39/223 (17%)
Query: 695 QIGEGSFGSVFKGIL--DDGRTTIAVKVFNLLHHGAFKS----FIAECNTLKNIRHRNLV 748
++G G+FGSV +G+ + +A+KV L G K+ + E + + + +V
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKV---LKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 749 KILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISID 808
+++ C LV E L ++L + + +
Sbjct: 74 RLIGVCQAEALM------LVMEMAGGGPLHKFL----VGKR-----EEIPVSNVAELLHQ 118
Query: 809 VACALNYL--HHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQ-TSSIGA 865
V+ + YL + H DL N+LL A I DFGL++ L + T+
Sbjct: 119 VSMGMKYLEEKN-----FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 173
Query: 866 KGSIGYIAPE---YGLGSEVSISGDVYSYGILLLELITR-KKP 904
K + + APE + + S DV+SYG+ + E ++ +KP
Sbjct: 174 KWPLKWYAPECINFR---KFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 28/217 (12%)
Query: 693 VNQIGEGSFGSVFKGIL----DDGRTTIAVKVFNLLHHGA---FKSFIAECNTLKNIRHR 745
+ Q+G+G+FGSV D+ +AVK L H + F E LK+++H
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK---LQHSTEEHLRDFEREIEILKSLQHD 102
Query: 746 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNI 805
N+VK C + L+ E++ SL ++L ++ + ++ I+ L
Sbjct: 103 NIVKYKGVCYSAGRRN---LKLIMEYLPYGSLRDYL----QKHK-----ERIDHIKLLQY 150
Query: 806 SIDVACALNYLH-HDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQ-TSSI 863
+ + + YL H DL NIL++ + IGDFGL + LP
Sbjct: 151 TSQICKGMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKE 206
Query: 864 GAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
+ I + APE S+ S++ DV+S+G++L EL T
Sbjct: 207 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 29/218 (13%)
Query: 693 VNQIGEGSFGSVFKGIL----DDGRTTIAVKVFNLLHHGA----FKSFIAECNTLKNIRH 744
+ +GEG FG V D+ +AVK L + E L+N+ H
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKS---LKPESGGNHIADLKKEIEILRNLYH 82
Query: 745 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLN 804
N+VK C+ G + L+ EF+ + SL+E+L +++ +NL Q+L
Sbjct: 83 ENIVKYKGICTE---DGGNGIKLIMEFLPSGSLKEYL----PKNK-----NKINLKQQLK 130
Query: 805 ISIDVACALNYLH-HDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPL-SSAQTSS 862
++ + ++YL H DL N+L++ + IGDFGL + + T
Sbjct: 131 YAVQICKGMDYLGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK 186
Query: 863 IGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
+ + APE + S+ I+ DV+S+G+ L EL+T
Sbjct: 187 DDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-30
Identities = 64/216 (29%), Positives = 107/216 (49%), Gaps = 26/216 (12%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKS--FIAECNTLKNIRHR 745
+ ++G+G FG V+ G + G T +A+K L G F+ E +K +RH
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKT---LKPGTMSPEAFLQEAQVMKKLRHE 322
Query: 746 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNI 805
LV++ S + +V E+M SL ++L + + + L L Q +++
Sbjct: 323 KLVQLYAVVSE------EPIYIVTEYMSKGSLLDFL----KGET----GKYLRLPQLVDM 368
Query: 806 SIDVACALNYLH-HDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIG 864
+ +A + Y+ + H DL+ +NIL+ E+++ + DFGLAR + + T+ G
Sbjct: 369 AAQIASGMAYVERMNY----VHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQG 423
Query: 865 AKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
AK I + APE L +I DV+S+GILL EL T
Sbjct: 424 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 459
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-30
Identities = 60/217 (27%), Positives = 91/217 (41%), Gaps = 28/217 (12%)
Query: 693 VNQIGEGSFGSVFKGIL----DDGRTTIAVKVFNLLHHGA---FKSFIAECNTLKNIRHR 745
++Q+G+G+FGSV D+ +AVK L H + F E LK +
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQ---LQHSGPDQQRDFQREIQILKALHSD 84
Query: 746 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNI 805
+VK G G LV E++ + L ++L + L+ + L
Sbjct: 85 FIVKYRGVSYG---PGRQSLRLVMEYLPSGCLRDFL----QRHR-----ARLDASRLLLY 132
Query: 806 SIDVACALNYLH-HDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSS-AQTSSI 863
S + + YL C H DL NIL++ + I DFGLA+ LPL
Sbjct: 133 SSQICKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVRE 188
Query: 864 GAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
+ I + APE + S DV+S+G++L EL T
Sbjct: 189 PGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-30
Identities = 85/532 (15%), Positives = 172/532 (32%), Gaps = 79/532 (14%)
Query: 67 LDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAI 126
+ ++ L+ K++ N++ + D R++++L L+ I I
Sbjct: 32 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQI-EEI 90
Query: 127 PANI-SSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIR 185
+ + +L + N + P ++ + + + N+L+ N +
Sbjct: 91 DTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLT 150
Query: 186 SLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGA 245
+L +S NNLE DT +L NL ++ NRL+ + S+
Sbjct: 151 TLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLI------------------ 191
Query: 246 IPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTG-AAPYLEKLQRL 304
+L +V N L+ T++ +E S N + P +L L
Sbjct: 192 ---------PSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVELTIL 237
Query: 305 LVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLL 364
+ N+L L N L + ++ N + LE L +
Sbjct: 238 ---KLQHNNLTDTA--------WLLNYPGLVEVDLSYNEL-EKIMYHPFVKMQRLERLYI 285
Query: 365 DNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPS 424
NN++ + L+ LD+ N L + + L++L L N + S
Sbjct: 286 SNNRL-VALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLS 342
Query: 425 IGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDL 484
+ L L LS+N + S + + + + + I Q
Sbjct: 343 T-HHTLKNLTLSHNDWDCN--SLRALFRNVARPAVDDADQHCKIDYQL------------ 387
Query: 485 SRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSS 544
+ L + + L+ + + + ++ G C + + ++
Sbjct: 388 -EHGLCCKESDKPYLDRLLQYIAL--TSVVEKVQRAQGRCSATDTINSVQSLSHYITQQG 444
Query: 545 LSSLRGLSVLDLSQNNLSGKIPEL----------LIRLQLVKNLNLSNNDLE 586
L+G L+ N L ++ +L L L + NL L
Sbjct: 445 GVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEIDTNLRRYRLP 496
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-30
Identities = 54/228 (23%), Positives = 96/228 (42%), Gaps = 34/228 (14%)
Query: 688 DRFSSVNQIGEGSFGSVFKGIL----DDGRTTIAVKVFNLLHHGA----FKSFIAECNTL 739
F + +G G+FG+V+KG+ + + +A+K L K + E +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE---LREATSPKANKEILDEAYVM 71
Query: 740 KNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNL 799
++ + ++ ++L C Q L+ + M L +++ E ++
Sbjct: 72 ASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVR---------EHKDNIGS 116
Query: 800 IQRLNISIDVACALNYL--HHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSS 857
LN + +A +NYL + H DL N+L+ I DFGLA+ L
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171
Query: 858 AQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITR-KKP 904
+ + G K I ++A E L + DV+SYG+ + EL+T KP
Sbjct: 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 49/224 (21%), Positives = 94/224 (41%), Gaps = 38/224 (16%)
Query: 693 VNQIGEGSFGSVFKGIL---DDGRTTIAVKVFNLLHHGA----FKSFIAECNTLKNIRHR 745
IGEG FG V +GI ++ +A+K + + F+ E T++ H
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKT---CKNCTSDSVREKFLQEALTMRQFDHP 76
Query: 746 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNI 805
++VK++ + ++ E L +L + + SL+L +
Sbjct: 77 HIVKLIGVITENPVW------IIMELCTLGELRSFL----QVRK-----YSLDLASLILY 121
Query: 806 SIDVACALNYL-HHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIG 864
+ ++ AL YL H D+ N+L+ + +GDFGL+R++ S +
Sbjct: 122 AYQLSTALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASK 176
Query: 865 AKGSIGYIAPE---YGLGSEVSISGDVYSYGILLLELITR-KKP 904
K I ++APE + + + DV+ +G+ + E++ KP
Sbjct: 177 GKLPIKWMAPESINFR---RFTSASDVWMFGVCMWEILMHGVKP 217
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 49/220 (22%), Positives = 88/220 (40%), Gaps = 38/220 (17%)
Query: 696 IGEGSFGSVFKGIL---DDGRTTIAVKVFNLLHHGA----FKSFIAECNTLKNIRHRNLV 748
IG+G FG V+ G R A+K L ++F+ E ++ + H N++
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKS---LSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 749 KILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISID 808
++ ++ +M + L +++ R + R+ + ++ +
Sbjct: 86 ALIGIML----PPEGLPHVLLPYMCHGDLLQFI----RSPQ-----RNPTVKDLISFGLQ 132
Query: 809 VACALNYL--HHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSS--AQTSSIG 864
VA + YL H DL N +LDE + DFGLAR + +
Sbjct: 133 VARGMEYLAEQK-----FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRH 187
Query: 865 AKGSIGYIAPE---YGLGSEVSISGDVYSYGILLLELITR 901
A+ + + A E + DV+S+G+LL EL+TR
Sbjct: 188 ARLPVKWTALESLQTYR---FTTKSDVWSFGVLLWELLTR 224
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 53/228 (23%), Positives = 96/228 (42%), Gaps = 43/228 (18%)
Query: 693 VNQIGEGSFGSVFKGIL---DDGRTTIAVKVFNLLHHGA----FKSFIAECNTLKNIRHR 745
IG G G V G L +A+K L G + F++E + + H
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKA---LKAGYTERQRRDFLSEASIMGQFDHP 110
Query: 746 NLVKILTACSGVD--YQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRL 803
N++++ + +V E+M N SL+ +L R + ++Q +
Sbjct: 111 NIIRLEGVVTRGRLAM-------IVTEYMENGSLDTFL----RTHD-----GQFTIMQLV 154
Query: 804 NISIDVACALNYL--HHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSS-AQT 860
+ V + YL H DL N+L+D +++ + DFGL+R L A
Sbjct: 155 GMLRGVGAGMRYLSDLG-----YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAY 209
Query: 861 SSIGAKGSIGYIAPE---YGLGSEVSISGDVYSYGILLLELITR-KKP 904
++ G K I + APE + S + DV+S+G+++ E++ ++P
Sbjct: 210 TTTGGKIPIRWTAPEAIAFR---TFSSASDVWSFGVVMWEVLAYGERP 254
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 61/251 (24%), Positives = 94/251 (37%), Gaps = 34/251 (13%)
Query: 688 DRFSSVNQIGEGSFGSVFKGI-LDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRN 746
F + IG G FG VFK DG+T +K + E L + H N
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKT-YVIKRVKY----NNEKAEREVKALAKLDHVN 65
Query: 747 LVKILTACSGVDYQGNDFKA-----------LVFEFMHNRSLEEWLHPITREDETDEAPR 795
+V G DY + EF +LE+W+
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE--------KRRGE 117
Query: 796 SLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPL 855
L+ + L + + ++Y+H + + DLKPSNI L + IGDFGL L
Sbjct: 118 KLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN 174
Query: 856 SSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNL 915
+T S G++ Y++PE + D+Y+ G++L EL+ FE
Sbjct: 175 DGKRTRSK---GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT---AFETSKFF 228
Query: 916 HNLARTALPDH 926
+L + D
Sbjct: 229 TDLRDGIISDI 239
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 45/222 (20%), Positives = 95/222 (42%), Gaps = 40/222 (18%)
Query: 696 IGEGSFGSVFKGIL---DDGRTTIAVKVFNLLHHGA----FKSFIAECNTLKNIRHRNLV 748
+GEG FG V++G+ + +AVK + F++E +KN+ H ++V
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKT---CKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 749 KILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISID 808
K++ + ++ E L +L ++ SL ++ + S+
Sbjct: 77 KLIGIIEE------EPTWIIMELYPYGELGHYL----ERNK-----NSLKVLTLVLYSLQ 121
Query: 809 VACALNYL--HHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAK 866
+ A+ YL + H D+ NIL+ +GDFGL+R++ + +
Sbjct: 122 ICKAMAYLESIN-----CVHRDIAVRNILVASPECVKLGDFGLSRYI-EDEDYYKASVTR 175
Query: 867 GSIGYIAPE---YGLGSEVSISGDVYSYGILLLELITR-KKP 904
I +++PE + + + DV+ + + + E+++ K+P
Sbjct: 176 LPIKWMSPESINFR---RFTTASDVWMFAVCMWEILSFGKQP 214
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-29
Identities = 51/221 (23%), Positives = 100/221 (45%), Gaps = 26/221 (11%)
Query: 693 VNQIGEGSFGSVFKGIL-----DDGRTTIAVKVFNLLHHGA----FKSFIAECNTLKNIR 743
++G+GSFG V++G+ D+ T +A+K ++ A F+ E + +K
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKT---VNEAASMRERIEFLNEASVMKEFN 86
Query: 744 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRL 803
++V++L S QG ++ E M L+ +L + + +L + +
Sbjct: 87 CHHVVRLLGVVS----QGQPT-LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 804 NISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSI 863
++ ++A + YL+ H DL N ++ ED IGDFG+ R + +
Sbjct: 142 QMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 198
Query: 864 GAKGSIGYIAPE---YGLGSEVSISGDVYSYGILLLELITR 901
+ +++PE G+ + S DV+S+G++L E+ T
Sbjct: 199 KGLLPVRWMSPESLKDGVFTTYS---DVWSFGVVLWEIATL 236
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 7e-29
Identities = 50/220 (22%), Positives = 90/220 (40%), Gaps = 33/220 (15%)
Query: 695 QIGEGSFGSVFKGIL--DDGRTTIAVKVFNLLHHGAFKS----FIAECNTLKNIRHRNLV 748
++G G+FGSV +G+ + +A+KV L G K+ + E + + + +V
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKV---LKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 749 KILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISID 808
+++ C LV E L ++L + + +
Sbjct: 400 RLIGVCQAEALM------LVMEMAGGGPLHKFLV---------GKREEIPVSNVAELLHQ 444
Query: 809 VACALNYL--HHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQ-TSSIGA 865
V+ + YL + H +L N+LL A I DFGL++ L + T+
Sbjct: 445 VSMGMKYLEEKN-----FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 499
Query: 866 KGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITR-KKP 904
K + + APE + S DV+SYG+ + E ++ +KP
Sbjct: 500 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-29
Identities = 54/252 (21%), Positives = 97/252 (38%), Gaps = 37/252 (14%)
Query: 688 DRFSSVNQIGEGSFGSVFKGI-LDDGRTTIAVKVFNLLHHGAFK-SFIAECNTLKNIRHR 745
F + +G G FG VF+ D A+K L + + + E L + H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCN-YAIKRIRLPNRELAREKVMREVKALAKLEHP 63
Query: 746 NLVKILTACSGVDYQGNDFKA-------LVFEFMHNRSLEEWLHPITREDETDEAPRSLN 798
+V+ A + + + + +L++W++ +E + +
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERS----- 118
Query: 799 LIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFL----- 853
L+I + +A A+ +LH + H DLKPSNI D + +GDFGL +
Sbjct: 119 --VCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEE 173
Query: 854 --PLSSAQTSSIGAKGSIG---YIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIM 908
+ + + G +G Y++PE G+ S D++S G++L EL+
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP------- 226
Query: 909 FEGDMNLHNLAR 920
F M
Sbjct: 227 FSTQMERVRTLT 238
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 55/214 (25%), Positives = 90/214 (42%), Gaps = 22/214 (10%)
Query: 695 QIGEGSFGSVFKGI-LDDGRTTIAVKVFNLLHHGA--FKSFIAECNTLKNIRHRNLVKIL 751
+IG GSF +V+KG+ + +A + F E LK ++H N+V+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVE-VAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 752 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVAC 811
+ LV E M + +L+ +L + + + + + +
Sbjct: 92 DSWESTVKGKKCI-VLVTELMTSGTLKTYL----------KRFKVMKIKVLRSWCRQILK 140
Query: 812 ALNYLHHDCQPPIAHCDLKPSNILLD-EDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIG 870
L +LH PPI H DLK NI + IGD GLA S A+ G+
Sbjct: 141 GLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPE 195
Query: 871 YIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
++APE + S DVY++G+ +LE+ T + P
Sbjct: 196 FMAPEMY-EEKYDESVDVYAFGMCMLEMATSEYP 228
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 57/229 (24%), Positives = 104/229 (45%), Gaps = 44/229 (19%)
Query: 693 VNQIGEGSFGSVFKGIL----DDGRTTIAVKVFNLLHHGA----FKSFIAECNTLKNIRH 744
IG G FG V+KG+L +A+K L G F+ E + H
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT---LKAGYTEKQRVDFLGEAGIMGQFSH 105
Query: 745 RNLVKILTACSGVD--YQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQR 802
N++++ S ++ E+M N +L+++L RE + +++Q
Sbjct: 106 HNIIRLEGVISKYKPMM-------IITEYMENGALDKFL----REKD-----GEFSVLQL 149
Query: 803 LNISIDVACALNYL--HHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLP-LSSAQ 859
+ + +A + YL + H DL NIL++ +++ + DFGL+R L A
Sbjct: 150 VGMLRGIAAGMKYLANMN-----YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT 204
Query: 860 TSSIGAKGSIGYIAPE---YGLGSEVSISGDVYSYGILLLELITR-KKP 904
++ G K I + APE Y + + + DV+S+GI++ E++T ++P
Sbjct: 205 YTTSGGKIPIRWTAPEAISYR---KFTSASDVWSFGIVMWEVMTYGERP 250
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 56/229 (24%), Positives = 99/229 (43%), Gaps = 29/229 (12%)
Query: 688 DRFSSVNQIGEGSFGSVFKGIL-----DDGRTTIAVKVFNLLHHGA----FKSFIAECNT 738
+ +G G+FG V + +D +AVK +L A ++ ++E
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK---MLKSTAHADEKEALMSELKI 102
Query: 739 LKNI-RHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWL----HPITREDETDEA 793
+ ++ +H N+V +L AC+ G ++ E+ L +L + + A
Sbjct: 103 MSHLGQHENIVNLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157
Query: 794 PRSLNLIQRLNISIDVACALNYL--HHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLAR 851
+ + L+ S VA + +L + H D+ N+LL +A IGDFGLAR
Sbjct: 158 NSTASTRDLLHFSSQVAQGMAFLASKN-----CIHRDVAARNVLLTNGHVAKIGDFGLAR 212
Query: 852 FLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
+ S A+ + ++APE ++ DV+SYGILL E+ +
Sbjct: 213 DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 57/218 (26%), Positives = 87/218 (39%), Gaps = 31/218 (14%)
Query: 693 VNQIGEGSFGSVFKGIL----DDGRTTIAVKVFNLLHHGA----FKSFIAECNTLKNIRH 744
+ +GEG FG V D +AVK L A + E + L+ + H
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA---LKADAGPQHRSGWKQEIDILRTLYH 92
Query: 745 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLN 804
+++K C LV E++ SL ++L S+ L Q L
Sbjct: 93 EHIIKYKGCCEDAGAASL---QLVMEYVPLGSLRDYLPR-----------HSIGLAQLLL 138
Query: 805 ISIDVACALNYLH-HDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQ-TSS 862
+ + + YLH H DL N+LLD D + IGDFGLA+ +P
Sbjct: 139 FAQQICEGMAYLHAQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVR 194
Query: 863 IGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
+ + APE + + DV+S+G+ L EL+T
Sbjct: 195 EDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 57/223 (25%), Positives = 91/223 (40%), Gaps = 38/223 (17%)
Query: 693 VNQIGEGSFGSVFKGIL---DDGRTTIAVKVFNLLHHGA----FKSFIAECNTLKNIRHR 745
IG G FG V+ G L D + AVK L+ F+ E +K+ H
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS---LNRITDIGEVSQFLTEGIIMKDFSHP 86
Query: 746 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNI 805
N++ +L C +G+ +V +M + L ++ + + +
Sbjct: 87 NVLSLLGICL--RSEGSPL--VVLPYMKHGDLRNFIR---------NETHNPTVKDLIGF 133
Query: 806 SIDVACALNYL--HHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSS--AQTS 861
+ VA + YL H DL N +LDE + DFGLAR + + +
Sbjct: 134 GLQVAKGMKYLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHN 188
Query: 862 SIGAKGSIGYIAPE---YGLGSEVSISGDVYSYGILLLELITR 901
GAK + ++A E + S DV+S+G+LL EL+TR
Sbjct: 189 KTGAKLPVKWMALESLQTQKFTTKS---DVWSFGVLLWELMTR 228
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-28
Identities = 55/225 (24%), Positives = 99/225 (44%), Gaps = 37/225 (16%)
Query: 693 VNQIGEGSFGSVFKGIL---DDGRTTIAVKVFNLLHHGA----FKSFIAECNTLKNIRHR 745
+G G FG V G L ++A+K L G + F+ E + + H
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKT---LKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 746 NLVKILTACSGVD--YQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRL 803
N++++ + +V E+M N SL+ +L R+ + +IQ +
Sbjct: 107 NIIRLEGVVTKSKPVM-------IVTEYMENGSLDSFL----RKHD-----AQFTVIQLV 150
Query: 804 NISIDVACALNYL--HHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLP-LSSAQT 860
+ +A + YL H DL NIL++ +++ + DFGL R L A
Sbjct: 151 GMLRGIASGMKYLSDMG-----YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAY 205
Query: 861 SSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITR-KKP 904
++ G K I + +PE + + + DV+SYGI+L E+++ ++P
Sbjct: 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 60/224 (26%), Positives = 98/224 (43%), Gaps = 29/224 (12%)
Query: 693 VNQIGEGSFGSVFKGIL-----DDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNL 747
++GEG+FG VF + +AVK A K F E L N++H ++
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 748 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWL------HPITREDETDEAPRSLNLIQ 801
VK C G+ +VFE+M + L ++L I + + +A L L Q
Sbjct: 80 VKFYGVCG----DGDPL-IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 802 RLNISIDVACALNYL--HHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQ 859
L+I+ +A + YL H H DL N L+ +++ IGDFG++R + +
Sbjct: 135 MLHIASQIASGMVYLASQH-----FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY 189
Query: 860 TSSIGAKGSIGYIAPE---YGLGSEVSISGDVYSYGILLLELIT 900
I ++ PE Y + DV+S+G++L E+ T
Sbjct: 190 RVGGHTMLPIRWMPPESIMYRK---FTTESDVWSFGVILWEIFT 230
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 62/228 (27%), Positives = 95/228 (41%), Gaps = 23/228 (10%)
Query: 688 DRFSSVNQIGEGSFGSVFKGIL-----DDGRTTIAVKVFNLLHHGA-FKSFIAECNTLKN 741
+R S +G G+FG V + D T+AVK+ H ++ ++E L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 742 I-RHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWL--------HPITREDETDE 792
+ H N+V +L AC+ G ++ E+ L +L T ++
Sbjct: 83 LGNHMNIVNLLGACT----IGGPT-LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 793 APRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARF 852
+L+L L+ S VA + +L H DL NILL I I DFGLAR
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARD 194
Query: 853 LPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
+ S A+ + ++APE + DV+SYGI L EL +
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-28
Identities = 66/340 (19%), Positives = 120/340 (35%), Gaps = 79/340 (23%)
Query: 617 QLPTCSSKKSKHKKSLALK-------LVLAIISGLIGLSLALSIIVLCLV---------- 659
+ +S+ K L LK L + S I ++A I C +
Sbjct: 271 TIQYSNSEDKDRKGMLQLKIAGAPEPLTVTAPSLTIAENMADLIDGYCRLVNGATQSFII 330
Query: 660 RKRKEKQNPNSPINSFPNISYQNLYNATDRFSSVN------------------------- 694
R +KE + I N Q + + T S +
Sbjct: 331 RPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRE 390
Query: 695 ------QIGEGSFGSVFKGIL---DDGRTTIAVKVFNLLHHGA----FKSFIAECNTLKN 741
IGEG FG V +GI ++ +A+K + + F+ E T++
Sbjct: 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKT---CKNCTSDSVREKFLQEALTMRQ 447
Query: 742 IRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQ 801
H ++VK++ + ++ E L +L SL+L
Sbjct: 448 FDHPHIVKLIGVITENPVW------IIMELCTLGELRSFLQ---------VRKFSLDLAS 492
Query: 802 RLNISIDVACALNYLH-HDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQT 860
+ + ++ AL YL H D+ N+L+ + +GDFGL+R++ S
Sbjct: 493 LILYAYQLSTALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYY 547
Query: 861 SSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
+ K I ++APE + + DV+ +G+ + E++
Sbjct: 548 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-28
Identities = 73/421 (17%), Positives = 139/421 (33%), Gaps = 48/421 (11%)
Query: 167 DNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSI 226
+ + S L+++ SL +++ + + L L L N ++ T+ +
Sbjct: 27 AFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNIT-TLD--L 81
Query: 227 FNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHG 286
+++T NK+ + + L L + + N+LT +S L +
Sbjct: 82 SQNTNLTYLACDSNKLT-NLDVT---PLTKLTYLNCDTNKLTKL---DVSQNPLLTYLNC 134
Query: 287 SVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGG 346
+ N LT + +L N ++ D +T T+L L + N
Sbjct: 135 ARNTLT--EIDVSHNTQLTELDCHLNKKITKLD--------VTPQTQLTTLDCSFNKIT- 183
Query: 347 SLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQN 406
L +S L L D N I + + + + L LD SN+L+ I + L
Sbjct: 184 ELD--VSQN-KLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQ 234
Query: 407 LKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTG 466
L N + S KL L+ L + + L
Sbjct: 235 LTYFDCSVNPLT-ELDVS-TLSKLTTLHCIQTDLLEIDLTHNTQ---LIYFQAEGCRKIK 289
Query: 467 TIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIK 526
+ + ++ L +LD +T + + L L + +L E+ + K
Sbjct: 290 ELD---VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTK 340
Query: 527 LEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLE 586
L+ L +Q SS+ + L+ ++ E L L ++ D
Sbjct: 341 LKSLSCVNAHIQDF--SSVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQF 398
Query: 587 G 587
G
Sbjct: 399 G 399
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-24
Identities = 64/474 (13%), Positives = 138/474 (29%), Gaps = 74/474 (15%)
Query: 112 LQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLT 171
+ + + L L ++ + + + L+ + + NN+T
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSI--TDMTGIEKLTGLTKLICTSNNIT 77
Query: 172 GSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISS 231
++ L +++ L N L ++ + L L L N+L+ + S
Sbjct: 78 -TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLDVS------ 124
Query: 232 ITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKL 291
L + + N LT +S+ + L +NK
Sbjct: 125 ---------------------QNPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKK 160
Query: 292 TGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPAC 351
+ +L N + ++ L L + NN L
Sbjct: 161 IT-KLDVTPQTQLTTLDCSFNKITE---------LDVSQNKLLNRLNCDTNNI-TKLD-- 207
Query: 352 ISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLR 411
++ L L +N++ I + L D N L+ + + L L L
Sbjct: 208 LNQN-IQLTFLDCSSNKL-TEID--VTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLH 260
Query: 412 LQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQ 471
+ I + N +L + + L +D +T +
Sbjct: 261 CIQTDLL-EIDLT-HNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT-ELD-- 313
Query: 472 FIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLE 531
+ + L+ L L+ +LT + V + L+ L+ ++ + S +G L
Sbjct: 314 -LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNF 367
Query: 532 MQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDL 585
E +L++ + + G + I + + N +
Sbjct: 368 EAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNP--MNIEPGDGGVYDQATNTI 419
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-24
Identities = 70/442 (15%), Positives = 144/442 (32%), Gaps = 70/442 (15%)
Query: 67 LDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAI 126
+ ++ + + L+ L L +N+S + ++L L L N+I
Sbjct: 23 EVAAAFEMQATDTISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNITTL- 79
Query: 127 PANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSL-------- 178
++S +NL L N+L + ++ L+K+ +++ + N LT S
Sbjct: 80 --DLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTKLDVSQNPLLTYLNC 134
Query: 179 ----------GNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFN 228
+ + + L N + + L L + N+++ +
Sbjct: 135 ARNTLTEIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE---LDVSQ 189
Query: 229 ISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSV 288
+ + N I + L+ L F N+LT I ++ + L F SV
Sbjct: 190 NKLLNRLNCDTNNIT-KLDLN---QNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSV 242
Query: 289 NKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSL 348
N LT + L +L + L LT+ T+L + L
Sbjct: 243 NPLT--ELDVSTLSKLTTLHCIQTDLLE---------IDLTHNTQLIYFQAEGCRKIKEL 291
Query: 349 PACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLK 408
+++ T L +L I + + + L L + + L+ + + LK
Sbjct: 292 D--VTHN-TQLYLLDCQAAGI-TELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKLK 342
Query: 409 DLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTI 468
L Q + L + + T+ L+NN+LT +
Sbjct: 343 SLSCVNAHIQ-DFSSVGKIPALNNNFEAEGQTI-----------TMPKETLTNNSLTIAV 390
Query: 469 PPQFIGLSSSLIVLDLSRNQLT 490
P + + + ++ +
Sbjct: 391 SPDLLDQFGNPMNIEPGDGGVY 412
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 5e-10
Identities = 32/166 (19%), Positives = 60/166 (36%), Gaps = 15/166 (9%)
Query: 420 NIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSL 479
+ + + +Q + S + TLT++D N+++T + I + L
Sbjct: 10 SFNDWFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG--IEKLTGL 66
Query: 480 IVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQG 539
L + N +T ++ + NL L NKL + + KL L N L
Sbjct: 67 TKLICTSNNIT-TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT- 119
Query: 540 PIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDL 585
+S L+ L+ ++N L+ +L L+ N
Sbjct: 120 --KLDVSQNPLLTYLNCARNTLTEIDVSHNTQLT---ELDCHLNKK 160
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 8e-28
Identities = 67/305 (21%), Positives = 114/305 (37%), Gaps = 50/305 (16%)
Query: 623 SKKSKHKKSLALKLVL-AIISGLIGLSLALSIIVLCLVRKRKEKQNPNSPINSFPNISYQ 681
+ + S+A +++ GL G+ + + E ++S
Sbjct: 12 HHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSAL 71
Query: 682 N--LYNATDRF---------SSVNQIGEGSFGSVFKGIL---DDGRTTIAVKVFNLLHHG 727
N L A IG G FG V+ G L D + AVK L+
Sbjct: 72 NPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS---LNRI 128
Query: 728 A----FKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHP 783
F+ E +K+ H N++ +L C +G+ +V +M + L ++
Sbjct: 129 TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL--RSEGSPL--VVLPYMKHGDLRNFI-- 182
Query: 784 ITREDETDEAPRSLNLIQRLNISIDVACALNYL--HHDCQPPIAHCDLKPSNILLDEDMI 841
R + + + + + VA + +L H DL N +LDE
Sbjct: 183 --RNET-----HNPTVKDLIGFGLQVAKGMKFLASKK-----FVHRDLAARNCMLDEKFT 230
Query: 842 AHIGDFGLARFLPLSS--AQTSSIGAKGSIGYIAPE---YGLGSEVSISGDVYSYGILLL 896
+ DFGLAR + + + GAK + ++A E + S DV+S+G+LL
Sbjct: 231 VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKS---DVWSFGVLLW 287
Query: 897 ELITR 901
EL+TR
Sbjct: 288 ELMTR 292
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 8e-28
Identities = 57/241 (23%), Positives = 95/241 (39%), Gaps = 44/241 (18%)
Query: 688 DRFSSVNQIGEGSFGSVFKGIL-----DDGRTTIAVKVFNLLHHGA----FKSFIAECNT 738
+GEG FG V K G TT+AVK +L A + ++E N
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVK---MLKENASPSELRDLLSEFNV 79
Query: 739 LKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWL--------------HPI 784
LK + H +++K+ ACS Q L+ E+ SL +L
Sbjct: 80 LKQVNHPHVIKLYGACS----QDGPL-LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 785 TREDETDEAPRSLNLIQRLNISIDVACALNYL--HHDCQPPIAHCDLKPSNILLDEDMIA 842
R+L + ++ + ++ + YL + H DL NIL+ E
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK-----LVHRDLAARNILVAEGRKM 189
Query: 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPE---YGLGSEVSISGDVYSYGILLLELI 899
I DFGL+R + + + + ++A E + + DV+S+G+LL E++
Sbjct: 190 KISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI---YTTQSDVWSFGVLLWEIV 246
Query: 900 T 900
T
Sbjct: 247 T 247
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-28
Identities = 53/228 (23%), Positives = 97/228 (42%), Gaps = 36/228 (15%)
Query: 693 VNQIGEGSFGSVFKGIL-----DDGRTTIAVKVFNLLHHGA----FKSFIAECNTLKNIR 743
+ ++GE FG V+KG L + +A+K L A + F E ++
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKT---LKDKAEGPLREEFRHEAMLRARLQ 70
Query: 744 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLH------PITREDETDEAPRSL 797
H N+V +L + + +++F + + L E+L + D+ +L
Sbjct: 71 HPNVVCLLGVVT----KDQPL-SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125
Query: 798 NLIQRLNISIDVACALNYL--HHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPL 855
+++ +A + YL HH + H DL N+L+ + + I D GL R +
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYA 180
Query: 856 SSAQTSSIGAKGSIGYIAPE---YGLGSEVSISGDVYSYGILLLELIT 900
+ + I ++APE YG SI D++SYG++L E+ +
Sbjct: 181 ADYYKLLGNSLLPIRWMAPEAIMYGK---FSIDSDIWSYGVVLWEVFS 225
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 59/223 (26%), Positives = 97/223 (43%), Gaps = 28/223 (12%)
Query: 693 VNQIGEGSFGSVFKGIL-----DDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNL 747
++GEG+FG VF + + +AVK A + F E L ++H+++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 748 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWL-----HPITREDETDEAPRSLNLIQR 802
V+ C+ +G +VFE+M + L +L D AP L L Q
Sbjct: 106 VRFFGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 803 LNISIDVACALNYL--HHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQT 860
L ++ VA + YL H H DL N L+ + ++ IGDFG++R + +
Sbjct: 161 LAVASQVAAGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR 215
Query: 861 SSIGAKGSIGYIAPE---YGLGSEVSISGDVYSYGILLLELIT 900
I ++ PE Y + S DV+S+G++L E+ T
Sbjct: 216 VGGRTMLPIRWMPPESILYRKFTTES---DVWSFGVVLWEIFT 255
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 61/231 (26%), Positives = 95/231 (41%), Gaps = 30/231 (12%)
Query: 688 DRFSSVNQIGEGSFGSVFKGIL-----DDGRTTIAVKVFNLLHHGA----FKSFIAECNT 738
DR +G G+FG V + T+AVK +L GA ++ ++E
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK---MLKEGATHSEHRALMSELKI 83
Query: 739 LKNI-RHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWL------HPITREDETD 791
L +I H N+V +L AC+ + ++ EF +L +L + D
Sbjct: 84 LIHIGHHLNVVNLLGACT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 792 EAPRSLNLIQRLNISIDVACALNYL--HHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGL 849
L L + S VA + +L H DL NILL E + I DFGL
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRK-----CIHRDLAARNILLSEKNVVKICDFGL 194
Query: 850 ARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
AR + A+ + ++APE +I DV+S+G+LL E+ +
Sbjct: 195 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 56/232 (24%), Positives = 103/232 (44%), Gaps = 34/232 (14%)
Query: 688 DRFSSVNQIGEGSFGSVFKG---ILDDGRTTIAVKV--FNLLHHGAFKS-FIAECNTLKN 741
+R+ V+++G G +V+ IL+ +A+K F E +
Sbjct: 11 ERYKIVDKLGGGGMSTVYLAEDTILN--IK-VAIKAIFIPPREKEETLKRFEREVHNSSQ 67
Query: 742 IRHRNLVKILTACSGVDY-QGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLI 800
+ H+N+V ++ D + +D LV E++ +L E++ P L++
Sbjct: 68 LSHQNIVSMI------DVDEEDDCYYLVMEYIEGPTLSEYIE--------SHGP--LSVD 111
Query: 801 QRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQT 860
+N + + + + H I H D+KP NIL+D + I DFG+A+ L ++ T
Sbjct: 112 TAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLT 167
Query: 861 SSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGD 912
+ G++ Y +PE G D+YS GI+L E++ + P F G+
Sbjct: 168 QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP----FNGE 215
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 59/244 (24%), Positives = 95/244 (38%), Gaps = 34/244 (13%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL--LHHGAFKSFIAECNTLKNIRHR 745
+ + + IG GS+G K + K + + + ++E N L+ ++H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 746 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDET-DEAPRSLNLIQRLN 804
N+V+ +D +V E+ L + T+E + DE L
Sbjct: 66 NIVRYYD--RIIDRTNTTLY-IVMEYCEGGDLASVITKGTKERQYLDEE-------FVLR 115
Query: 805 ISIDVACALNYLH--HDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSS 862
+ + AL H D + H DLKP+N+ LD +GDFGLAR L ++ +
Sbjct: 116 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT 175
Query: 863 IGAKGSIGYIAPE------YGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLH 916
G+ Y++PE Y S D++S G LL EL P F +
Sbjct: 176 F--VGTPYYMSPEQMNRMSYNEKS------DIWSLGCLLYELCALMPP----FTAF-SQK 222
Query: 917 NLAR 920
LA
Sbjct: 223 ELAG 226
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 56/239 (23%), Positives = 100/239 (41%), Gaps = 15/239 (6%)
Query: 366 NNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNR--FQGNIPP 423
N++ ++P I + RL++ SN+L +L L L L N F+G
Sbjct: 15 NSKGLTSVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQ 72
Query: 424 SIGNL-KLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQ--FIGLSSSLI 480
S L L LS+N + ++ S+ E L +D ++NL + F+ L + LI
Sbjct: 73 SDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRN-LI 129
Query: 481 VLDLSRNQLTGSIPSEV-GNLKNLEILNVFGNKLKGEIPS-TLGSCIKLEQLEMQENFLQ 538
LD+S + + L +LE+L + GN + L L++ + L+
Sbjct: 130 YLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 188
Query: 539 GPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQGVFKN 597
P++ +SL L VL++S NN L ++ L+ S N + + ++
Sbjct: 189 QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTS--KKQELQH 245
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 48/238 (20%), Positives = 89/238 (37%), Gaps = 11/238 (4%)
Query: 332 TRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQI-FGNIPA-AIGKFVNLQRLDMC 389
+ L + N L T L L L +N + F + + +L+ LD+
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKL-TQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86
Query: 390 SNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSI--GNLKLFILYLSYNFLQGSIPSS 447
N + T+ L+ L+ L Q + + S+ L L +S+ + +
Sbjct: 87 FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 145
Query: 448 LGRYETLTTIDLSNNNLTGTIPPQ-FIGLSSSLIVLDLSRNQLTGSIPSEV-GNLKNLEI 505
+L + ++ N+ P F L + L LDLS+ QL + +L +L++
Sbjct: 146 FNGLSSLEVLKMAGNSFQENFLPDIFTELRN-LTFLDLSQCQLE-QLSPTAFNSLSSLQV 203
Query: 506 LNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSL-RGLSVLDLSQNNLS 562
LN+ N L+ L+ N + L L+ L+L+QN+ +
Sbjct: 204 LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 55/285 (19%), Positives = 93/285 (32%), Gaps = 57/285 (20%)
Query: 88 LKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSI--GGAIPANISSCSNLIQLRLFHNQ 145
L L +N FD+L +L L+L N + G + ++L L L N
Sbjct: 30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89
Query: 146 LVGKIPSELSSLSKIEHISVNDNNLTGSIPSSL-GNLSSIRSLFLSGNNLEGSIPDTLGW 204
++ + S L ++EH+ +NL S+ +L ++ L +S + +
Sbjct: 90 VI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 148
Query: 205 LKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGE 264
L +L L MA N IF L+NL F + +
Sbjct: 149 LSSLEVLKMAGNSFQENFLPDIFT------------------------ELRNLTFLDLSQ 184
Query: 265 NQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNF 324
QL + P F+ L LQ L + N+ S
Sbjct: 185 CQLE-QLSP--------TAFNS-----------LSSLQVLNMSH---NNFFSLDTF---- 217
Query: 325 LCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQI 369
L+ L ++N+ S + + ++L L L N
Sbjct: 218 --PYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-27
Identities = 63/327 (19%), Positives = 122/327 (37%), Gaps = 19/327 (5%)
Query: 264 ENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPY-LEKLQRLLVFGILGNSLGSRGDRDL 322
+ A+P I + + N++ L + N + +
Sbjct: 20 RKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPG-- 74
Query: 323 NFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVN 382
+ N L+ L + N +P + + L L + N+I + N
Sbjct: 75 ----AFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYN 129
Query: 383 LQRLDMCSNRLSGTIPP-AIGELQNLKDLRLQRNRFQGNIPPSI--GNLKLFILYLSYNF 439
L+ L++ N L I A L +L+ L L++ +IP L +L L +
Sbjct: 130 LKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLN 187
Query: 440 LQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEV-G 498
+ S R L +++S+ T+ P + + L L ++ LT ++P
Sbjct: 188 INAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLN-LTSLSITHCNLT-AVPYLAVR 245
Query: 499 NLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQ 558
+L L LN+ N + S L ++L+++++ L P + L L VL++S
Sbjct: 246 HLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSG 305
Query: 559 NNLSGKIPELLIRLQLVKNLNLSNNDL 585
N L+ + + ++ L L +N L
Sbjct: 306 NQLTTLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-26
Identities = 65/267 (24%), Positives = 102/267 (38%), Gaps = 15/267 (5%)
Query: 327 SLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAI-GKFVNLQR 385
+ L+ L +N N P +NL L L L +N++ IP + NL +
Sbjct: 51 EFASFPHLEELELNENIVSAVEPGAFNNL-FNLRTLGLRSNRL-KLIPLGVFTGLSNLTK 108
Query: 386 LDMCSNRLSGTIPPAI-GELQNLKDLRLQRNRFQGNIPPSI--GNLKLFILYLSYNFLQG 442
LD+ N++ + + +L NLK L + N I G L L L L
Sbjct: 109 LDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT- 165
Query: 443 SIPS-SLGRYETLTTIDLSNNNLTGTIPPQ-FIGLSSSLIVLDLSRNQLTGSIPSEVGNL 500
SIP+ +L L + L + N+ I F L L VL++S ++
Sbjct: 166 SIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYR-LKVLEISHWPYLDTMTPNCLYG 223
Query: 501 KNLEILNVFGNKLKGEIPS-TLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQN 559
NL L++ L +P + + L L + N + S L L L + L
Sbjct: 224 LNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGG 282
Query: 560 NLSGKIPELLIRLQLVKNLNLSNNDLE 586
L+ P L ++ LN+S N L
Sbjct: 283 QLAVVEPYAFRGLNYLRVLNVSGNQLT 309
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-26
Identities = 66/313 (21%), Positives = 118/313 (37%), Gaps = 18/313 (5%)
Query: 256 NLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPY-LEKLQRLLVFGILGNSL 314
+ +G+N++ ++ +LE + N ++ P L L G+ N L
Sbjct: 33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRL 92
Query: 315 GSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIP 374
T + L L I+ N L +L L+ L + +N +
Sbjct: 93 KLIPLG------VFTGLSNLTKLDISENKIVILLDYMFQDL-YNLKSLEVGDNDLVYISH 145
Query: 375 AAIGKFVNLQRLDMCSNRLSGTIPP-AIGELQNLKDLRLQRNRFQGNIPPSI--GNLKLF 431
A +L++L + L+ +IP A+ L L LRL+ I +L
Sbjct: 146 RAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLK 203
Query: 432 ILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQ-FIGLSSSLIVLDLSRNQLT 490
+L +S+ ++ + LT++ +++ NLT +P L L L+LS N ++
Sbjct: 204 VLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVY-LRFLNLSYNPIS 261
Query: 491 GSIPSEV-GNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLR 549
+I + L L+ + + G +L P L L + N L S S+
Sbjct: 262 -TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVG 320
Query: 550 GLSVLDLSQNNLS 562
L L L N L+
Sbjct: 321 NLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-25
Identities = 47/221 (21%), Positives = 79/221 (35%), Gaps = 12/221 (5%)
Query: 373 IPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSI--GNLKL 430
+P I + LD+ NR+ +L++L L N + P L
Sbjct: 26 VPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNL 82
Query: 431 FILYLSYNFLQGSIPS-SLGRYETLTTIDLSNNNLTGTIPPQ-FIGLSSSLIVLDLSRNQ 488
L L N L+ IP LT +D+S N + + F L + L L++ N
Sbjct: 83 RTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYN-LKSLEVGDND 139
Query: 489 LTGSIPSEV-GNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSS 547
L I L +LE L + L L L L ++ + S
Sbjct: 140 LV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKR 198
Query: 548 LRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGV 588
L L VL++S + + + +L++++ +L V
Sbjct: 199 LYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAV 239
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 4e-25
Identities = 61/273 (22%), Positives = 98/273 (35%), Gaps = 17/273 (6%)
Query: 332 TRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPA-AIGKFVNLQRLDMCS 390
T + L + N ++ LE L L+ N + + A NL+ L + S
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASF-PHLEELELNENIV-SAVEPGAFNNLFNLRTLGLRS 89
Query: 391 NRLSGTIPPAI-GELQNLKDLRLQRNRFQGNIPPSI--GNLKLFILYLSYNFLQGSIPS- 446
NRL IP + L NL L + N+ + + L L + N L I
Sbjct: 90 NRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV-YISHR 146
Query: 447 SLGRYETLTTIDLSNNNLTGTIPPQ-FIGLSSSLIVLDLSRNQLTGSIPSEV-GNLKNLE 504
+ +L + L NLT +IP + L LIVL L + +I L L+
Sbjct: 147 AFSGLNSLEQLTLEKCNLT-SIPTEALSHLHG-LIVLRLRHLNIN-AIRDYSFKRLYRLK 203
Query: 505 ILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGK 564
+L + + + L L + L ++ L L L+LS N +S
Sbjct: 204 VLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTI 263
Query: 565 IPELLIRLQLVKNLNLSNNDLEGVVPTQGVFKN 597
+L L ++ + L L V F+
Sbjct: 264 EGSMLHELLRLQEIQLVGGQLAVV--EPYAFRG 294
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-25
Identities = 70/363 (19%), Positives = 123/363 (33%), Gaps = 68/363 (18%)
Query: 86 SFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANI-SSCSNLIQLRLFHN 144
+ ++L L N EF L+ L L+ N + A+ ++ NL L L N
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSN 90
Query: 145 QLVGKIPSE-LSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPD-TL 202
+L IP + LS + + +++N + + +L +++SL + N+L I
Sbjct: 91 RLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAF 148
Query: 203 GWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSV 262
L +L LT+ + L+ +IP+ + L L +
Sbjct: 149 SGLNSLEQLTLEKCNLT-SIPTEALS------------------------HLHGLIVLRL 183
Query: 263 GENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDL 322
+ AI F L +L+ L I +
Sbjct: 184 RHLNIN-AIRD--------YSFKR-----------LYRLKVLE---ISHWPYLDTMTPNC 220
Query: 323 NFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPA-AIGKFV 381
+ +LT L I N ++P L L L N I I + + +
Sbjct: 221 LYGLNLT------SLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPI-STIEGSMLHELL 272
Query: 382 NLQRLDMCSNRLSGTIPP-AIGELQNLKDLRLQRNRFQGNIPPSI--GNLKLFILYLSYN 438
LQ + + +L+ + P A L L+ L + N+ + S+ L L L N
Sbjct: 273 RLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSN 330
Query: 439 FLQ 441
L
Sbjct: 331 PLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 2e-20
Identities = 58/250 (23%), Positives = 96/250 (38%), Gaps = 20/250 (8%)
Query: 69 LESLKLAG----SISPHV-GNLSFLKVLRLYNNSFNHEIPSE-FDRLRRLQVLALHYNSI 122
LE L+L ++ P NL L+ L L +N IP F L L L + N I
Sbjct: 58 LEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRL-KLIPLGVFTGLSNLTKLDISENKI 116
Query: 123 GGAIPANI-SSCSNLIQLRLFHNQLVGKIPSE-LSSLSKIEHISVNDNNLTGSIPS-SLG 179
+ + NL L + N LV I S L+ +E +++ NLT SIP+ +L
Sbjct: 117 V-ILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALS 173
Query: 180 NLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGV 239
+L + L L N+ + L L L ++ T+ + ++T
Sbjct: 174 HLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITH 233
Query: 240 NKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTI-SNASNLEIFHGSVNKLT----GA 294
+ A+P L L+F ++ N ++ I ++ L+ +L A
Sbjct: 234 CNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYA 291
Query: 295 APYLEKLQRL 304
L L+ L
Sbjct: 292 FRGLNYLRVL 301
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 1e-12
Identities = 44/181 (24%), Positives = 64/181 (35%), Gaps = 31/181 (17%)
Query: 69 LESLKLAG----SISPHV-GNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIG 123
LE L L SI +L L VLRL + + N F RL RL+VL + +
Sbjct: 154 LEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYL 213
Query: 124 GAIPANISSCSNLIQLRLFHNQLVGKIPSE-------------------------LSSLS 158
+ N NL L + H L +P L L
Sbjct: 214 DTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELL 272
Query: 159 KIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRL 218
+++ I + L P + L+ +R L +SGN L + NL L + N L
Sbjct: 273 RLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332
Query: 219 S 219
+
Sbjct: 333 A 333
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-27
Identities = 62/278 (22%), Positives = 102/278 (36%), Gaps = 49/278 (17%)
Query: 660 RKRKEKQNPNSPINSFPNISYQNLYNATDRFSSVNQIGEGSFGSVFKGI-LDDGRTTIAV 718
R+ + + + S + F ++++G GS+G VFK +DGR AV
Sbjct: 29 RRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRL-YAV 87
Query: 719 KVFNLLHHGAF--KSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVFEF---- 771
K G +AE + + + +H V++ A ++ L E
Sbjct: 88 KRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQA-----WEEGGILYLQTELCGPS 142
Query: 772 MHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKP 831
+ E W + E + D AL +LH + H D+KP
Sbjct: 143 LQQH-CEAWGASLP-EAQV------------WGYLRDTLLALAHLH---SQGLVHLDVKP 185
Query: 832 SNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPE-----YGLGSEVSISG 886
+NI L +GDFGL L ++ +G Y+APE YG +
Sbjct: 186 ANIFLGPRGRCKLGDFGLLVELG-TAGAGEVQ--EGDPRYMAPELLQGSYGTAA------ 236
Query: 887 DVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALP 924
DV+S G+ +LE+ + G+ L + LP
Sbjct: 237 DVFSLGLTILEVACNMEL---PHGGE-GWQQLRQGYLP 270
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-27
Identities = 59/259 (22%), Positives = 104/259 (40%), Gaps = 28/259 (10%)
Query: 668 PNSPINSFPNISYQNLYNATDRFSSVNQIGEGSFGSVFKGI-LDDGRTTIAVKVFNLLHH 726
P + YN F +IG G F V++ L DG +A+K +
Sbjct: 12 PVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVP-VALKKVQIFDL 70
Query: 727 GAFK---SFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHP 783
K I E + LK + H N++K + + ++ +V E L +
Sbjct: 71 MDAKARADCIKEIDLLKQLNHPNVIKYYAS-----FIEDNELNIVLELADAGDLSRMIKH 125
Query: 784 ITREDET-DEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842
++ E + + + AL ++H + H D+KP+N+ + +
Sbjct: 126 FKKQKRLIPE-----RTV--WKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVV 175
Query: 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRK 902
+GD GL RF + S+ G+ Y++PE + + D++S G LL E+ +
Sbjct: 176 KLGDLGLGRFFSSKTTAAHSL--VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 233
Query: 903 KPTDIMFEGD-MNLHNLAR 920
P F GD MNL++L +
Sbjct: 234 SP----FYGDKMNLYSLCK 248
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-27
Identities = 51/235 (21%), Positives = 91/235 (38%), Gaps = 37/235 (15%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILD---DGRTTIAVKVFNLLHHG---AFKSFIAECNTLKN 741
++ I G G ++ LD +GR + +K L+H G A +AE L
Sbjct: 80 GQYEVKGCIAHGGLGWIYLA-LDRNVNGRP-VVLKG--LVHSGDAEAQAMAMAERQFLAE 135
Query: 742 IRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQ 801
+ H ++V+I D G+ +V E++ +SL+ + L + +
Sbjct: 136 VVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG------------QKLPVAE 183
Query: 802 RLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTS 861
+ +++ AL+YLH + + DLKP NI+L E+ + + D G +
Sbjct: 184 AIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEEQLK-LIDLGAVSRI----NSFG 235
Query: 862 SIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLH 916
+ G+ G+ APE + D+Y+ G L L G
Sbjct: 236 YLY--GTPGFQAPEIVRTGPTVAT-DIYTVGRTLAALTLDLPT----RNGRYVDG 283
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-27
Identities = 60/226 (26%), Positives = 97/226 (42%), Gaps = 37/226 (16%)
Query: 693 VNQIGEGSFGSVFKGIL--DDGRTTIAVKVFNLLHHGA----FKSFIAECNTLKNI-RHR 745
+ IGEG+FG V K + D R A+K + A + F E L + H
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKR---MKEYASKDDHRDFAGELEVLCKLGHHP 86
Query: 746 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWL------HPITREDETDEAPRSLNL 799
N++ +L AC Y L E+ + +L ++L + +L+
Sbjct: 87 NIINLLGACEHRGYL-----YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 141
Query: 800 IQRLNISIDVACALNYL--HHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSS 857
Q L+ + DVA ++YL H DL NIL+ E+ +A I DFGL+R
Sbjct: 142 QQLLHFAADVARGMDYLSQKQ-----FIHRDLAARNILVGENYVAKIADFGLSRG---QE 193
Query: 858 AQTSSIGAKGSIGYIAPE---YGLGSEVSISGDVYSYGILLLELIT 900
+ + ++A E Y + + S DV+SYG+LL E+++
Sbjct: 194 VYVKKTMGRLPVRWMAIESLNYSVYTTNS---DVWSYGVLLWEIVS 236
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-27
Identities = 56/228 (24%), Positives = 95/228 (41%), Gaps = 33/228 (14%)
Query: 693 VNQIGEGSFGSVFKGIL-------DDGRTTIAVKVFNLLHHGA----FKSFIAECNTLKN 741
+GEG+FG V + T +AVK +L A I+E +K
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVK---MLKSDATEKDLSDLISEMEMMKM 130
Query: 742 I-RHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWL------HPITREDETDEAP 794
I +H+N++ +L AC+ Q ++ E+ +L E+L + +
Sbjct: 131 IGKHKNIINLLGACT----QDGPL-YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185
Query: 795 RSLNLIQRLNISIDVACALNYL--HHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARF 852
L+ ++ + VA + YL H DL N+L+ ED + I DFGLAR
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKK-----CIHRDLAARNVLVTEDNVMKIADFGLARD 240
Query: 853 LPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
+ + + + ++APE + DV+S+G+LL E+ T
Sbjct: 241 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-27
Identities = 53/236 (22%), Positives = 96/236 (40%), Gaps = 39/236 (16%)
Query: 688 DRFSSVNQIGEGSFGSVFKGIL-------DDGRTTIAVKVFNLLHHGA----FKSFIAEC 736
D+ + +GEG+FG V T+AVK+ L A ++E
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM---LKDDATEKDLSDLVSEM 91
Query: 737 NTLKNI-RHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWL------HPITREDE 789
+K I +H+N++ +L AC+ Q ++ E+ +L E+L D
Sbjct: 92 EMMKMIGKHKNIINLLGACT----QDGPL-YVIVEYASKGNLREYLRARRPPGMEYSYDI 146
Query: 790 TDEAPRSLNLIQRLNISIDVACALNYL--HHDCQPPIAHCDLKPSNILLDEDMIAHIGDF 847
+ ++ + +A + YL H DL N+L+ E+ + I DF
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADF 201
Query: 848 GLARFLPLSSAQTSSIGAKGSIGYIAPE---YGLGSEVSISGDVYSYGILLLELIT 900
GLAR + + + + ++APE + + DV+S+G+L+ E+ T
Sbjct: 202 GLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV---YTHQSDVWSFGVLMWEIFT 254
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 62/235 (26%), Positives = 99/235 (42%), Gaps = 34/235 (14%)
Query: 688 DRFSSVNQIGEGSFGSVFKG---ILDDGRTTIAVKV--FNLLHHGAFKS-FIAECNTLKN 741
DR+ +G G V R +AVKV +L +F F E
Sbjct: 12 DRYELGEILGFGGMSEVHLARDLRDH--RD-VAVKVLRADLARDPSFYLRFRREAQNAAA 68
Query: 742 IRHRNLVKILTACSGVDYQGNDFKA-LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLI 800
+ H +V + +G +V E++ +L + +H E P +
Sbjct: 69 LNHPAIVAVYD--TGEAETPAGPLPYIVMEYVDGVTLRDIVH--------TEGP--MTPK 116
Query: 801 QRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSA-- 858
+ + + D ALN+ H Q I H D+KP+NI++ + DFG+AR + S
Sbjct: 117 RAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV 173
Query: 859 -QTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGD 912
QT+++ G+ Y++PE G V DVYS G +L E++T + P F GD
Sbjct: 174 TQTAAV--IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 56/233 (24%), Positives = 90/233 (38%), Gaps = 38/233 (16%)
Query: 693 VNQIGEGSFGSVFKGIL-----DDGRTTIAVKVFNLLHHGA----FKSFIAECNTLKNI- 742
+G G+FG V +AVK +L A ++ ++E + +
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVK---MLKEKADSSEREALMSELKMMTQLG 106
Query: 743 RHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWL-------------HPITREDE 789
H N+V +L AC+ L+FE+ L +L + + E
Sbjct: 107 SHENIVNLLGACT----LSGPI-YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161
Query: 790 TDEAPRSLNLIQRLNISIDVACALNYL--HHDCQPPIAHCDLKPSNILLDEDMIAHIGDF 847
+E L L + VA + +L H DL N+L+ + I DF
Sbjct: 162 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-----CVHRDLAARNVLVTHGKVVKICDF 216
Query: 848 GLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
GLAR + S A+ + ++APE +I DV+SYGILL E+ +
Sbjct: 217 GLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 61/262 (23%), Positives = 96/262 (36%), Gaps = 55/262 (20%)
Query: 687 TDRFSSVNQIGEGSFGSVFKGI-LDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHR 745
F + +G+G+FG V K D R A+K + ++E L ++ H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRY-YAIKKIRH-TEEKLSTILSEVMLLASLNHQ 62
Query: 746 NLVKILTACSGVDYQGNDFKA--------LVFEFMHNRSLEEWLHPITREDETDEAPRSL 797
+V+ A A + E+ N +L + +H + DE
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY---- 118
Query: 798 NLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSS 857
+ + AL+Y+H I H DLKP NI +DE IGDFGLA+ + S
Sbjct: 119 -----WRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSL 170
Query: 858 AQTSSIG---------AKGSIG---YIAPE-------YGLGSEVSISGDVYSYGILLLEL 898
+IG Y+A E Y ++ D+YS GI+ E+
Sbjct: 171 DILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHY--NEKI----DMYSLGIIFFEM 224
Query: 899 ITRKKPTDIMFEGDMNLHNLAR 920
I F M N+ +
Sbjct: 225 IYP-------FSTGMERVNILK 239
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-26
Identities = 67/236 (28%), Positives = 108/236 (45%), Gaps = 11/236 (4%)
Query: 353 SNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPP-AIGELQNLKDLR 411
+ST +L L NQI + +L+ L + N + TI A L NL L
Sbjct: 60 DGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLE 118
Query: 412 LQRNRFQGNIPPSI--GNLKLFILYLSYNFLQGSIPSSL-GRYETLTTIDLSNNNLTGTI 468
L NR IP KL L+L N ++ SIPS R +L +DL I
Sbjct: 119 LFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYI 176
Query: 469 PPQ-FIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKL 527
F GLS+ L L+L+ L IP+ + L L+ L++ GN L P + + L
Sbjct: 177 SEGAFEGLSN-LRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHL 233
Query: 528 EQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNN 583
++L M ++ +Q ++ +L+ L ++L+ NNL+ +L L ++ ++L +N
Sbjct: 234 QKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-23
Identities = 64/221 (28%), Positives = 98/221 (44%), Gaps = 17/221 (7%)
Query: 373 IPAAIGKFVNLQRLDMCSNRLSGTIPP-AIGELQNLKDLRLQRNRFQGNIPPSI--GNLK 429
+P I N + L++ N++ I + L++L+ L+L RN + I G
Sbjct: 58 VPDGI--STNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLAN 113
Query: 430 LFILYLSYNFLQGSIPSSLGRY-ETLTTIDLSNNNLTGTIPPQ-FIGLSSSLIVLDLSR- 486
L L L N L +IP+ Y L + L NN + +IP F + S L LDL
Sbjct: 114 LNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPS-LRRLDLGEL 170
Query: 487 NQLTGSIPSEV-GNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSL 545
+L+ I L NL LN+ L+ EIP L IKL++L++ N L P S
Sbjct: 171 KRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSF 227
Query: 546 SSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLE 586
L L L + Q+ + LQ + +NL++N+L
Sbjct: 228 QGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT 268
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 4e-22
Identities = 59/236 (25%), Positives = 92/236 (38%), Gaps = 14/236 (5%)
Query: 332 TRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPA-AIGKFVNLQRLDMCS 390
T + L ++ N +L LE+L L N I I A NL L++
Sbjct: 64 TNTRLLNLHENQIQIIKVNSFKHL-RHLEILQLSRNHI-RTIEIGAFNGLANLNTLELFD 121
Query: 391 NRLSGTIPP-AIGELQNLKDLRLQRNRFQGNIPPSI-GNL-KLFILYLS-YNFLQGSIPS 446
NRL+ TIP A L LK+L L+ N + +IP + L L L L
Sbjct: 122 NRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEG 179
Query: 447 SLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEV-GNLKNLEI 505
+ L ++L+ NL IP L L LDLS N L+ +I L +L+
Sbjct: 180 AFEGLSNLRYLNLAMCNLR-EIPN-LTPLIK-LDELDLSGNHLS-AIRPGSFQGLMHLQK 235
Query: 506 LNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNL 561
L + ++++ + + L ++ + N L + L L + L N
Sbjct: 236 LWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 3e-18
Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 15/208 (7%)
Query: 69 LESLKLAG----SISPHV-GNLSFLKVLRLYNNSFNHEIPSE-FDRLRRLQVLALHYNSI 122
LE L+L+ +I L+ L L L++N IP+ F L +L+ L L N I
Sbjct: 90 LEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL-TTIPNGAFVYLSKLKELWLRNNPI 148
Query: 123 GGAIPANI-SSCSNLIQLRLFHNQLVGKIPSE-LSSLSKIEHISVNDNNLTGSIPSSLGN 180
+IP+ + +L +L L + + I LS + ++++ NL IP +L
Sbjct: 149 -ESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTP 205
Query: 181 LSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIF-NISSITGFDAGV 239
L + L LSGN+L P + L +L L M Q+++ I + F N+ S+ +
Sbjct: 206 LIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAH 264
Query: 240 NKIQGAIPLDYGFSLQNLQFFSVGENQL 267
N + +P D L +L+ + N
Sbjct: 265 NNLT-LLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 1e-17
Identities = 57/296 (19%), Positives = 102/296 (34%), Gaps = 62/296 (20%)
Query: 125 AIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSI 184
+P IS+ N L L NQ+ + L +E + ++ N++ + L+++
Sbjct: 57 EVPDGIST--NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANL 114
Query: 185 RSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQG 244
+L L N L +L L L + N + +IPS FN
Sbjct: 115 NTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFN---------------- 157
Query: 245 AIPLDYGFSLQNLQFFSVGE-NQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQR 303
+ +L+ +GE +L+ I F G L L+
Sbjct: 158 --------RIPSLRRLDLGELKRLS-YISE--------GAFEG-----------LSNLRY 189
Query: 304 LLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLL 363
L L L + +LT +L L ++ N+ P L L+ L
Sbjct: 190 L----NLAMCN-------LREIPNLTPLIKLDELDLSGNHLSAIRPGSFQGL-MHLQKLW 237
Query: 364 LDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPP-AIGELQNLKDLRLQRNRFQ 418
+ +QI A +L +++ N L+ +P L +L+ + L N +
Sbjct: 238 MIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 1e-16
Identities = 60/275 (21%), Positives = 99/275 (36%), Gaps = 51/275 (18%)
Query: 50 CQWRG--VTCSRRH---------QRVTILDLESLKLAGSISPHV-GNLSFLKVLRLYNNS 97
C + V C R++ +L+L ++ I + +L L++L+L N
Sbjct: 41 CSNQFSKVICVRKNLREVPDGISTNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNH 99
Query: 98 FNHEIPSEFDRLRRLQVLALHYNSIGGAIPANI-SSCSNLIQLRLFHNQLVGKIPSEL-S 155
F+ L L L L N + IP S L +L L +N + IPS +
Sbjct: 100 IRTIEIGAFNGLANLNTLELFDNRL-TTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFN 157
Query: 156 SLSKIEHISVNDNNLTGSIPS-SLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMA 214
+ + + + + I + LS++R L L+ NL IP L L L L ++
Sbjct: 158 RIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLS 215
Query: 215 QNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPP- 273
N LS I F L +LQ + ++Q+ I
Sbjct: 216 GNHLS-AIRPGSFQ------------------------GLMHLQKLWMIQSQIQ-VIERN 249
Query: 274 TISNASNLEIFHGSVNKLT----GAAPYLEKLQRL 304
N +L + + N LT L L+R+
Sbjct: 250 AFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERI 284
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 2e-13
Identities = 56/274 (20%), Positives = 98/274 (35%), Gaps = 48/274 (17%)
Query: 101 EIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSE-LSSLSK 159
E+P ++L LH N I + +L L+L N + I + L+
Sbjct: 57 EVPDGIST--NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI-RTIEIGAFNGLAN 113
Query: 160 IEHISVNDNNLTGSIPS-SLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQ-NR 217
+ + + DN LT +IP+ + LS ++ L+L N +E + +L L + + R
Sbjct: 114 LNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKR 172
Query: 218 LSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISN 277
LS I F L NL++ ++ L P ++
Sbjct: 173 LS-YISEGAFE------------------------GLSNLRYLNLAMCNLRE--IPNLTP 205
Query: 278 ASNLEIFHGSVNKLT----GAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATR 333
L+ S N L+ G+ L LQ+L + + + + N
Sbjct: 206 LIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMI---QSQIQVIERN------AFDNLQS 256
Query: 334 LKWLLININNFGGSLPACISNLSTTLEVLLLDNN 367
L + + NN LP + LE + L +N
Sbjct: 257 LVEINLAHNNL-TLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 34/136 (25%), Positives = 51/136 (37%), Gaps = 7/136 (5%)
Query: 62 QRVTILDLESLKLAGSISPHV-GNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYN 120
+ LDL LK IS LS L+ L L + IP+ L +L L L N
Sbjct: 160 PSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IPN-LTPLIKLDELDLSGN 217
Query: 121 SIGGAIPANI-SSCSNLIQLRLFHNQLVGKIPSE-LSSLSKIEHISVNDNNLTGSIPSSL 178
+ AI +L +L + +Q+ I +L + I++ NNLT
Sbjct: 218 HLS-AIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLTLLPHDLF 275
Query: 179 GNLSSIRSLFLSGNNL 194
L + + L N
Sbjct: 276 TPLHHLERIHLHHNPW 291
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 61/277 (22%), Positives = 104/277 (37%), Gaps = 23/277 (8%)
Query: 332 TRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSN 391
L + N+ L L L+L NN+I A LQ+L + N
Sbjct: 54 PDTTLLDLQNNDISELRKDDFKGL-QHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112
Query: 392 RLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSI--GNLKLFILYLSYNFLQ-GSIPSSL 448
L IPP + +L +LR+ NR + +P + G + + + N L+
Sbjct: 113 HLV-EIPPNL--PSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGA 168
Query: 449 GRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEV-GNLKNLEILN 507
L + +S LT IP L +L L L N++ +I E L L
Sbjct: 169 FDGLKLNYLRISEAKLT-GIPK---DLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLG 223
Query: 508 VFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPE 567
+ N+++ +L L +L + N L +P+ L L+ L V+ L NN++ K+
Sbjct: 224 LGHNQIRMIENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNIT-KVGV 281
Query: 568 -------LLIRLQLVKNLNLSNNDLEGVVPTQGVFKN 597
++ ++L NN + F+
Sbjct: 282 NDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRC 318
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 64/261 (24%), Positives = 104/261 (39%), Gaps = 18/261 (6%)
Query: 353 SNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPP-AIGELQNLKDLR 411
+S +L L NN I +L L + +N++S I A L+ L+ L
Sbjct: 50 KEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLY 108
Query: 412 LQRNRFQGNIPPSI-GNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGT-IP 469
+ +N IPP++ +L L + N ++ + I++ N L +
Sbjct: 109 ISKNHLV-EIPPNLPSSLV--ELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFE 165
Query: 470 PQ-FIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPS-TLGSCIKL 527
P F GL L L +S +LT IP + L L++ NK++ I L KL
Sbjct: 166 PGAFDGLK--LNYLRISEAKLT-GIPK--DLPETLNELHLDHNKIQ-AIELEDLLRYSKL 219
Query: 528 EQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEG 587
+L + N ++ SLS L L L L N LS ++P L L+L++ + L N++
Sbjct: 220 YRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITK 278
Query: 588 VVPTQGVFKNASITSVFGNLK 608
V F
Sbjct: 279 V--GVNDFCPVGFGVKRAYYN 297
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 5e-19
Identities = 69/357 (19%), Positives = 121/357 (33%), Gaps = 76/357 (21%)
Query: 166 NDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSS 225
+D L ++P + L L N++ D L++L L + N++S I
Sbjct: 41 SDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEK 96
Query: 226 IFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFH 285
F+ L+ LQ + +N L IPP + S+L
Sbjct: 97 AFS------------------------PLRKLQKLYISKNHLV-EIPPNLP--SSLVELR 129
Query: 286 GSVNKLTGAAPY-LEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNF 344
N++ L+ + + GN L + G F + +L +L I+
Sbjct: 130 IHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAF-----DGLKLNYLRISEAKL 184
Query: 345 GGSLPACISNLSTTLEVLLLDNNQIFGNIPA-AIGKFVNLQRLDMCSNRLSGTIPPAIGE 403
+P +L TL L LD+N+I I + ++ L RL + N++ I G
Sbjct: 185 T-GIPK---DLPETLNELHLDHNKI-QAIELEDLLRYSKLYRLGLGHNQIR-MIEN--GS 236
Query: 404 LQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNN 463
L L LR L+L N L +P+ L + L + L NN
Sbjct: 237 LSFLPTLR--------------------ELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNN 275
Query: 464 LTGTIPP-QFIGLS-----SSLIVLDLSRNQLT-GSIPSEV-GNLKNLEILNVFGNK 512
+T + F + + + L N + + + + + K
Sbjct: 276 IT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-18
Identities = 61/343 (17%), Positives = 114/343 (33%), Gaps = 63/343 (18%)
Query: 150 IPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLV 209
+P E+S + + +N+++ L + +L L N + L+ L
Sbjct: 48 VPKEISP--DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQ 105
Query: 210 NLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLT- 268
L +++N L IP ++ SS+ N+I+ +P L+N+ +G N L
Sbjct: 106 KLYISKNHLV-EIPPNLP--SSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLEN 161
Query: 269 GAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSL 328
P + L S KLTG L
Sbjct: 162 SGFEPGAFDGLKLNYLRISEAKLTGIPKDL------------------------------ 191
Query: 329 TNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPA-AIGKFVNLQRLD 387
L L ++ N + + L L L +NQI I ++ L+ L
Sbjct: 192 --PETLNELHLDHNKIQAIELEDLLRY-SKLYRLGLGHNQI-RMIENGSLSFLPTLRELH 247
Query: 388 MCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSS 447
+ +N+LS +P + +L+ L+ + L N + + F + +Y
Sbjct: 248 LDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAY---------- 295
Query: 448 LGRYETLTTIDLSNNNLT-GTIPPQ-FIGLSSSLIVLDLSRNQ 488
I L NN + + P F + + + + +
Sbjct: 296 ------YNGISLFNNPVPYWEVQPATFRCV-TDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 70/335 (20%), Positives = 113/335 (33%), Gaps = 50/335 (14%)
Query: 49 FCQWRGVTCSRRH---------QRVTILDLESLKLAGSISPHV-GNLSFLKVLRLYNNSF 98
C R V CS T+LDL++ ++ + L L L L NN
Sbjct: 32 HCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKI 90
Query: 99 NHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSE-LSSL 157
+ F LR+LQ L + N + IP N+ S+L++LR+ N++ K+P S L
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHL-VEIPPNLP--SSLVELRIHDNRIR-KVPKGVFSGL 146
Query: 158 SKIEHISVNDNNLT-GSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQN 216
+ I + N L + + L +S L IP L + L L + N
Sbjct: 147 RNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHN 203
Query: 217 RLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPP-TI 275
++ I L +G NQ+ I ++
Sbjct: 204 KIQ-AIELEDLL------------------------RYSKLYRLGLGHNQIR-MIENGSL 237
Query: 276 SNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLK 335
S L H NKL+ L L+ L V + N++ G D +
Sbjct: 238 SFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYN 297
Query: 336 WLLININN--FGGSLPACISNLSTTLEVLLLDNNQ 368
+ + N + PA + T + N +
Sbjct: 298 GISLFNNPVPYWEVQPATFRCV-TDRLAIQFGNYK 331
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 55/225 (24%), Positives = 94/225 (41%), Gaps = 36/225 (16%)
Query: 693 VNQIGEGSFGSVFKGIL-----DDGRTTIAVKVFNLLHHGA----FKSFIAECNTLKNIR 743
+ +G G+FG V++G + D +AVK L F+ E +
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT---LPEVCSEQDELDFLMEALIISKFN 91
Query: 744 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRL 803
H+N+V+ + Q ++ E M L+ +L P SL ++ L
Sbjct: 92 HQNIVRCIGVSL----QSLPR-FILMELMAGGDLKSFLR---ETRPRPSQPSSLAMLDLL 143
Query: 804 NISIDVACALNYL--HHDCQPPIAHCDLKPSNILLD---EDMIAHIGDFGLARFLPLSSA 858
+++ D+AC YL +H H D+ N LL +A IGDFG+AR + +S
Sbjct: 144 HVARDIACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 198
Query: 859 QTSSIGAKGSIGYIAPE---YGLGSEVSISGDVYSYGILLLELIT 900
A + ++ PE G+ + D +S+G+LL E+ +
Sbjct: 199 YRKGGCAMLPVKWMPPEAFMEGI---FTSKTDTWSFGVLLWEIFS 240
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 46/235 (19%), Positives = 93/235 (39%), Gaps = 52/235 (22%)
Query: 693 VNQIGEGSFGSVFKGIL-------DDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHR 745
+G+G+F +FKG+ T + +KV + H +SF + + + H+
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 746 NLVKILTACSGVD--YQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRL 803
+LV C D LV EF+ SL+ +L + +N++ +L
Sbjct: 73 HLVLNYGVCVCGDENI-------LVQEFVKFGSLDTYLK---------KNKNCINILWKL 116
Query: 804 NISIDVACALNYL--HHDCQPPIAHCDLKPSNILLD--------EDMIAHIGDFGLARFL 853
++ +A A+++L + + H ++ NILL + D G++ +
Sbjct: 117 EVAKQLAAAMHFLEENT-----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV 171
Query: 854 PLSSAQTSSIGAKGSIGYIAPE---YGLGSEVSISGDVYSYGILLLELITR-KKP 904
+ I ++ PE ++++ D +S+G L E+ + KP
Sbjct: 172 ------LPKDILQERIPWVPPECIEN--PKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-26
Identities = 59/236 (25%), Positives = 94/236 (39%), Gaps = 11/236 (4%)
Query: 353 SNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPP-AIGELQNLKDLR 411
+ + L L N I +L+ L + N + I A L +L L
Sbjct: 71 QGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLE 129
Query: 412 LQRNRFQGNIPPSI--GNLKLFILYLSYNFLQGSIPS-SLGRYETLTTIDLSNNNLTGTI 468
L N IP KL L+L N ++ SIPS + R +L +DL I
Sbjct: 130 LFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYI 187
Query: 469 PPQ-FIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKL 527
F GL + L L+L + +P+ + L LE L + GN P + L
Sbjct: 188 SEGAFEGLFN-LKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSL 244
Query: 528 EQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNN 583
++L + + + ++ L L L+L+ NNLS +L L+ + L+L +N
Sbjct: 245 KKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-24
Identities = 66/243 (27%), Positives = 98/243 (40%), Gaps = 22/243 (9%)
Query: 351 CISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPP-AIGELQNLKD 409
C + S V+ +P I N + L++ N + I L +L+
Sbjct: 52 CSNQFSK---VVCTRRG--LSEVPQGI--PSNTRYLNLMENNIQ-MIQADTFRHLHHLEV 103
Query: 410 LRLQRNRFQGNIPPSI--GNLKLFILYLSYNFLQGSIPSSLGRY-ETLTTIDLSNNNLTG 466
L+L RN + I G L L L N+L IPS Y L + L NN +
Sbjct: 104 LQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE- 160
Query: 467 TIPPQ-FIGLSSSLIVLDLSR-NQLTGSIPSEV-GNLKNLEILNVFGNKLKGEIPSTLGS 523
+IP F + S L+ LDL +L I L NL+ LN+ +K ++P L
Sbjct: 161 SIPSYAFNRVPS-LMRLDLGELKKLE-YISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTP 216
Query: 524 CIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNN 583
+ LE+LEM N P S L L L + + +S L + LNL++N
Sbjct: 217 LVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHN 276
Query: 584 DLE 586
+L
Sbjct: 277 NLS 279
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-23
Identities = 55/236 (23%), Positives = 85/236 (36%), Gaps = 14/236 (5%)
Query: 332 TRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPA-AIGKFVNLQRLDMCS 390
+ ++L + NN +L LEVL L N I I A +L L++
Sbjct: 75 SNTRYLNLMENNIQMIQADTFRHL-HHLEVLQLGRNSI-RQIEVGAFNGLASLNTLELFD 132
Query: 391 NRLSGTIPP-AIGELQNLKDLRLQRNRFQGNIPPSI--GNLKLFILYLS-YNFLQGSIPS 446
N L+ IP A L L++L L+ N + +IP L L L L+
Sbjct: 133 NWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEG 190
Query: 447 SLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEV-GNLKNLEI 505
+ L ++L N+ P L L L++S N I L +L+
Sbjct: 191 AFEGLFNLKYLNLGMCNIKD--MPNLTPLVG-LEELEMSGNHFP-EIRPGSFHGLSSLKK 246
Query: 506 LNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNL 561
L V +++ + L +L + N L + LR L L L N
Sbjct: 247 LWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 7e-18
Identities = 61/296 (20%), Positives = 102/296 (34%), Gaps = 62/296 (20%)
Query: 125 AIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSI 184
+P I S N L L N + L +E + + N++ + L+S+
Sbjct: 68 EVPQGIPS--NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASL 125
Query: 185 RSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQG 244
+L L N L +L L L + N + +IPS FN
Sbjct: 126 NTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFN---------------- 168
Query: 245 AIPLDYGFSLQNLQFFSVGE-NQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQR 303
+ +L +GE +L I F G L L+
Sbjct: 169 --------RVPSLMRLDLGELKKLE-YISE--------GAFEG-----------LFNLKY 200
Query: 304 LLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLL 363
L LG + + +LT L+ L ++ N+F P L ++L+ L
Sbjct: 201 L----NLGMCN-------IKDMPNLTPLVGLEELEMSGNHFPEIRPGSFHGL-SSLKKLW 248
Query: 364 LDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPP-AIGELQNLKDLRLQRNRFQ 418
+ N+Q+ A +L L++ N LS ++P L+ L +L L N +
Sbjct: 249 VMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 4e-16
Identities = 52/230 (22%), Positives = 85/230 (36%), Gaps = 16/230 (6%)
Query: 88 LKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANI-SSCSNLIQLRLFHNQL 146
+ L L N+ F L L+VL L NSI I + ++L L LF N L
Sbjct: 77 TRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI-RQIEVGAFNGLASLNTLELFDNWL 135
Query: 147 VGKIPSE-LSSLSKIEHISVNDNNLTGSIPS-SLGNLSSIRSLFLSGNNLEGSIP-DTLG 203
IPS LSK+ + + +N + SIPS + + S+ L L I
Sbjct: 136 T-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFE 193
Query: 204 WLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVG 263
L NL L + + +P ++ + + + N I L +L+ V
Sbjct: 194 GLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVM 250
Query: 264 ENQLTGAIPP-TISNASNLEIFHGSVNKLT----GAAPYLEKLQRLLVFG 308
+Q++ I ++L + + N L+ L L L +
Sbjct: 251 NSQVS-LIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHH 299
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 1e-15
Identities = 45/167 (26%), Positives = 71/167 (42%), Gaps = 10/167 (5%)
Query: 65 TILDLESLKLAGSISPHV-GNLSFLKVLRLYNNSFNHEIPSE-FDRLRRLQVLAL-HYNS 121
L+L L I LS L+ L L NN IPS F+R+ L L L
Sbjct: 126 NTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPI-ESIPSYAFNRVPSLMRLDLGELKK 183
Query: 122 IGGAIPANI-SSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGN 180
+ I NL L L + +P+ L+ L +E + ++ N+ P S
Sbjct: 184 LE-YISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHG 240
Query: 181 LSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIF 227
LSS++ L++ + + + L +LV L +A N LS ++P +F
Sbjct: 241 LSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLF 286
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 3e-14
Identities = 39/160 (24%), Positives = 63/160 (39%), Gaps = 11/160 (6%)
Query: 433 LYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPP-QFIGLSSSLIVLDLSRNQLTG 491
+ + L +P + ++L NN+ I F L L VL L RN +
Sbjct: 59 VVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQ-MIQADTFRHLHH-LEVLQLGRNSIR- 112
Query: 492 SIPSEV-GNLKNLEILNVFGNKLKGEIPS-TLGSCIKLEQLEMQENFLQGPIPSSLSSLR 549
I L +L L +F N L IPS KL +L ++ N ++ + + +
Sbjct: 113 QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVP 171
Query: 550 GLSVLDLSQNNLSGKIPE-LLIRLQLVKNLNLSNNDLEGV 588
L LDL + I E L +K LNL +++ +
Sbjct: 172 SLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM 211
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 2e-12
Identities = 36/154 (23%), Positives = 60/154 (38%), Gaps = 8/154 (5%)
Query: 69 LESLKLAG----SISPHV-GNLSFLKVLRLYNNSFNHEIPSE-FDRLRRLQVLALHYNSI 122
L L L SI + + L L L I F+ L L+ L L +I
Sbjct: 149 LRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNI 208
Query: 123 GGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLS 182
+P ++ L +L + N P LS ++ + V ++ ++ ++ L+
Sbjct: 209 K-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLA 266
Query: 183 SIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQN 216
S+ L L+ NNL D L+ LV L + N
Sbjct: 267 SLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-26
Identities = 52/228 (22%), Positives = 91/228 (39%), Gaps = 33/228 (14%)
Query: 693 VNQIGEGSFGSVFKGIL-------DDGRTTIAVKVFNLLHHGA----FKSFIAECNTLKN 741
+GEG FG V T+AVK+ L A ++E +K
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM---LKDDATEKDLSDLVSEMEMMKM 142
Query: 742 I-RHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWL------HPITREDETDEAP 794
I +H+N++ +L AC+ Q ++ E+ +L E+L D
Sbjct: 143 IGKHKNIINLLGACT----QDGPL-YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197
Query: 795 RSLNLIQRLNISIDVACALNYL--HHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARF 852
+ ++ + +A + YL H DL N+L+ E+ + I DFGLAR
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARD 252
Query: 853 LPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
+ + + + ++APE + DV+S+G+L+ E+ T
Sbjct: 253 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 65/277 (23%), Positives = 113/277 (40%), Gaps = 22/277 (7%)
Query: 332 TRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSN 391
L + N NL L L+L NN+I P A V L+RL + N
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNL-KNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 110
Query: 392 RLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSI--GNLKLFILYLSYNFLQGSI--PSS 447
+L +P + L++LR+ N + S+ G ++ ++ L N L+ S +
Sbjct: 111 QLK-ELPE--KMPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGA 166
Query: 448 LGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEV-GNLKNLEIL 506
+ L+ I +++ N+T TIP GL SL L L N++T + + L NL L
Sbjct: 167 FQGMKKLSYIRIADTNIT-TIPQ---GLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKL 221
Query: 507 NVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSG--- 563
+ N + +L + L +L + N L +P L+ + + V+ L NN+S
Sbjct: 222 GLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGS 280
Query: 564 ---KIPELLIRLQLVKNLNLSNNDLEGVVPTQGVFKN 597
P + ++L +N ++ F+
Sbjct: 281 NDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 317
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 1e-22
Identities = 63/246 (25%), Positives = 105/246 (42%), Gaps = 19/246 (7%)
Query: 349 PACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPP-AIGELQNL 407
P C L V+ + + +P + + LD+ +N+++ I L+NL
Sbjct: 23 PVCPFRCQCHLRVVQCSDLGL-EKVPKDL--PPDTALLDLQNNKIT-EIKDGDFKNLKNL 78
Query: 408 KDLRLQRNRFQGNIPPSI--GNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLT 465
L L N+ I P +KL LYLS N L+ +P + +TL + + N +T
Sbjct: 79 HTLILINNKIS-KISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEIT 134
Query: 466 GTIPPQ-FIGLSSSLIVLDLSRNQLT-GSIPSEV-GNLKNLEILNVFGNKLKGEIPSTLG 522
+ F GL+ +IV++L N L I + +K L + + + IP L
Sbjct: 135 -KVRKSVFNGLNQ-MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP 191
Query: 523 SCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSN 582
L +L + N + +SL L L+ L LS N++S L ++ L+L+N
Sbjct: 192 P--SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNN 249
Query: 583 NDLEGV 588
N L V
Sbjct: 250 NKLVKV 255
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-21
Identities = 70/361 (19%), Positives = 119/361 (32%), Gaps = 73/361 (20%)
Query: 161 EHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSG 220
+ +D L +P L L L N + LKNL L + N++S
Sbjct: 34 RVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS- 89
Query: 221 TIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASN 280
I F L L+ + +NQL +P +
Sbjct: 90 KISPGAFA------------------------PLVKLERLYLSKNQLK-ELPEKM--PKT 122
Query: 281 LEIFHGSVNKLTGAAPY-LEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLI 339
L+ N++T L +++V + N L S G + F +L ++ I
Sbjct: 123 LQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF----QGMKKLSYIRI 178
Query: 340 NINNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPA-AIGKFVNLQRLDMCSNRLSGTIP 398
N ++P L +L L LD N+I + A ++ NL +L + N +S +
Sbjct: 179 ADTNIT-TIPQ---GLPPSLTELHLDGNKI-TKVDAASLKGLNNLAKLGLSFNSIS-AVD 232
Query: 399 PAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTID 458
G L N LR L+L+ N L +P L ++ + +
Sbjct: 233 N--GSLANTPHLR--------------------ELHLNNNKLV-KVPGGLADHKYIQVVY 269
Query: 459 LSNNNLTGTIPPQFIGLS-----SSLIVLDLSRNQLT-GSIPSEV-GNLKNLEILNVFGN 511
L NNN++ F +S + L N + I + + +
Sbjct: 270 LHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
Query: 512 K 512
K
Sbjct: 330 K 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 3e-21
Identities = 61/333 (18%), Positives = 117/333 (35%), Gaps = 49/333 (14%)
Query: 50 CQWRGVTCSRRH---------QRVTILDLESLKLAGSISPHV-GNLSFLKVLRLYNNSFN 99
C R V CS +LDL++ K+ I NL L L L NN +
Sbjct: 31 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKIS 89
Query: 100 HEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSE-LSSLS 158
P F L +L+ L L N + +P + L +LR+ N++ K+ + L+
Sbjct: 90 KISPGAFAPLVKLERLYLSKNQL-KELPEKMP--KTLQELRVHENEIT-KVRKSVFNGLN 145
Query: 159 KIEHISVNDNNLTGSI--PSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQN 216
++ + + N L S + + + + ++ N+ +IP L +L L + N
Sbjct: 146 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGN 202
Query: 217 RLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPP-TI 275
+++ + ++ L NL + N ++ A+ ++
Sbjct: 203 KIT-KVDAASLK------------------------GLNNLAKLGLSFNSIS-AVDNGSL 236
Query: 276 SNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLK 335
+N +L H + NKL L + + V + N++ + G D T
Sbjct: 237 ANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYS 296
Query: 336 WLLININNFG-GSLPACISNLSTTLEVLLLDNN 367
+ + N + + L N
Sbjct: 297 GVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 5e-20
Identities = 64/350 (18%), Positives = 128/350 (36%), Gaps = 78/350 (22%)
Query: 150 IPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLV 209
+P +L + + +N +T NL ++ +L L N + P L L
Sbjct: 46 VPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 103
Query: 210 NLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTG 269
L +++N+L +P + + LQ V EN++T
Sbjct: 104 RLYLSKNQLK-ELPEKMP---------------------------KTLQELRVHENEIT- 134
Query: 270 AIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLT 329
+ +F+G L ++ + + N L S G + F
Sbjct: 135 KVRK--------SVFNG-----------LNQMIVVELG---TNPLKSSGIENGAF----Q 168
Query: 330 NATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPA-AIGKFVNLQRLDM 388
+L ++ I N ++P L +L L LD N+I + A ++ NL +L +
Sbjct: 169 GMKKLSYIRIADTNI-TTIPQ---GLPPSLTELHLDGNKI-TKVDAASLKGLNNLAKLGL 223
Query: 389 CSNRLSGTIPP-AIGELQNLKDLRLQRNRFQGNIPPSIGNLK-LFILYLSYNFLQGSIPS 446
N +S + ++ +L++L L N+ +P + + K + ++YL N + +I S
Sbjct: 224 SFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGS 280
Query: 447 S-------LGRYETLTTIDLSNNNLTGT-IPPQ-FIGLSSSLIVLDLSRN 487
+ + + + + L +N + I P F + + L
Sbjct: 281 NDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCV-YVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 65/341 (19%), Positives = 113/341 (33%), Gaps = 76/341 (22%)
Query: 88 LKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANI-SSCSNLIQLRLFHNQL 146
+L L NN +F L+ L L L N I I + L +L L NQL
Sbjct: 54 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKNQL 112
Query: 147 VGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSI--PDTLGW 204
++P ++ ++ + V++N +T S L+ + + L N L+ S
Sbjct: 113 K-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQG 169
Query: 205 LKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGE 264
+K L + +A ++ TIP + S+T NKI + L NL +
Sbjct: 170 MKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSF 225
Query: 265 NQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNF 324
N ++ A+
Sbjct: 226 NSIS-AVDNG-------------------------------------------------- 234
Query: 325 LCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQI-------FGNIPAAI 377
SL N L+ L +N N +P +++ ++V+ L NN I F P
Sbjct: 235 --SLANTPHLRELHLNNNKLV-KVPGGLADH-KYIQVVYLHNNNISAIGSNDFCP-PGYN 289
Query: 378 GKFVNLQRLDMCSNRLSGT-IPP-AIGELQNLKDLRLQRNR 416
K + + + SN + I P + ++L +
Sbjct: 290 TKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 60/298 (20%), Positives = 118/298 (39%), Gaps = 44/298 (14%)
Query: 663 KEKQNPNSPINSFPNISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFN 722
+ + N+ +Q++ +S + QIG G VF+ + + + A+K N
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVN 61
Query: 723 L--LHHGAFKSFIAECNTLKNIRHRNL--VKILTACSGVDYQGNDFKALVFEFMHNRSLE 778
L + S+ E L ++ + +++ + +V E N L
Sbjct: 62 LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY----DYEITDQYIY-MVMEC-GNIDLN 115
Query: 779 EWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLH-HDCQPPIAHCDLKPSNILLD 837
WL +S++ +R + ++ A++ +H H I H DLKP+N L+
Sbjct: 116 SWLK----------KKKSIDPWERKSYWKNMLEAVHTIHQHG----IVHSDLKPANFLIV 161
Query: 838 EDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPE-----------YGLGSEVSISG 886
+ M+ + DFG+A + + G++ Y+ PE S++S
Sbjct: 162 DGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKS 220
Query: 887 DVYSYGILLLELITRKKPTDIMFEGDMN-LHNLARTALPDHVMDIVDSTLLNDGEDLI 943
DV+S G +L + K P F+ +N + L P+H ++ D +D++
Sbjct: 221 DVWSLGCILYYMTYGKTP----FQQIINQISKLHAIIDPNHEIEF-PDIPEKDLQDVL 273
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 64/236 (27%), Positives = 99/236 (41%), Gaps = 44/236 (18%)
Query: 693 VNQIGEGSFGSVFKGIL-----DDGRTTIAVKVFNLLHHGA----FKSFIAECNTLKNIR 743
V IGEG+FG VF+ + T +AVK+ L A F E +
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKM---LKEEASADMQADFQREAALMAEFD 108
Query: 744 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWL--------------HPITREDE 789
+ N+VK+L C+ G L+FE+M L E+L TR
Sbjct: 109 NPNIVKLLGVCA----VGKPM-CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 790 TDEAPRSLNLIQRLNISIDVACALNYL--HHDCQPPIAHCDLKPSNILLDEDMIAHIGDF 847
+ P L+ ++L I+ VA + YL H DL N L+ E+M+ I DF
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADF 218
Query: 848 GLARFLPLSSAQTSSIGAKGSIGYIAPE---YGLGSEVSISGDVYSYGILLLELIT 900
GL+R + + + I ++ PE Y + S DV++YG++L E+ +
Sbjct: 219 GLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTES---DVWAYGVVLWEIFS 271
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 54/230 (23%), Positives = 95/230 (41%), Gaps = 36/230 (15%)
Query: 688 DRFSSVNQIGEGSFGSVFKGIL-----DDGRTTIAVKVFNLLHHGA----FKSFIAECNT 738
+ + +G G+FG V++G + D +AVK L F+ E
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT---LPEVCSEQDELDFLMEALI 127
Query: 739 LKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLN 798
+ H+N+V+ + Q ++ E M L+ +L P SL
Sbjct: 128 ISKFNHQNIVRCIGVSL----QSLPR-FILLELMAGGDLKSFLR---ETRPRPSQPSSLA 179
Query: 799 LIQRLNISIDVACALNYL--HHDCQPPIAHCDLKPSNILLD---EDMIAHIGDFGLARFL 853
++ L+++ D+AC YL +H H D+ N LL +A IGDFG+AR +
Sbjct: 180 MLDLLHVARDIACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 234
Query: 854 PLSSAQTSSIGAKGSIGYIAPE---YGLGSEVSISGDVYSYGILLLELIT 900
+ A + ++ PE G+ + + D +S+G+LL E+ +
Sbjct: 235 YRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKT---DTWSFGVLLWEIFS 281
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 43/237 (18%), Positives = 87/237 (36%), Gaps = 30/237 (12%)
Query: 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLV 748
+ + ++GEG F V A+K + E + + H N++
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 749 KILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISID 808
+++ C ++ L+ F +L + + + L Q L + +
Sbjct: 90 RLVAYCLRERGAKHEAW-LLLPFFKRGTLWNEI------ERLKDKGNFLTEDQILWLLLG 142
Query: 809 VACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFL--PLSSAQTSS---- 862
+ L +H AH DLKP+NILL ++ + D G + ++ +
Sbjct: 143 ICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQD 199
Query: 863 -IGAKGSIGYIAPE------YGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGD 912
+ +I Y APE + + E + DV+S G +L ++ + P ++
Sbjct: 200 WAAQRCTISYRAPELFSVQSHCVIDERT---DVWSLGCVLYAMMFGEGP----YDMV 249
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-25
Identities = 62/260 (23%), Positives = 112/260 (43%), Gaps = 32/260 (12%)
Query: 667 NPNSPINSFPNISYQNLYNAT-DRFSSVNQIGEGSFGSVFKGI-LDDGRTTIAVKVFNLL 724
+ + +S ++ +NLY + +++ + +IGEGSFG +DGR +K N+
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQ-YVIKEINIS 60
Query: 725 HHGA--FKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLH 782
+ + E L N++H N+V+ + ++ N +V ++ L +
Sbjct: 61 RMSSKEREESRREVAVLANMKHPNIVQYRES-----FEENGSLYIVMDYCEGGDLFKR-- 113
Query: 783 PITREDET--DEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDM 840
I + E Q L+ + + AL ++H I H D+K NI L +D
Sbjct: 114 -INAQKGVLFQED-------QILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDG 162
Query: 841 IAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
+GDFG+AR L + + G+ Y++PE + D+++ G +L EL T
Sbjct: 163 TVQLGDFGIARVLNSTVELARAC--IGTPYYLSPEICENKPYNNKSDIWALGCVLYELCT 220
Query: 901 RKKPTDIMFEGDMNLHNLAR 920
K FE ++ NL
Sbjct: 221 LKHA----FEAG-SMKNLVL 235
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 51/223 (22%), Positives = 89/223 (39%), Gaps = 32/223 (14%)
Query: 696 IGEGSFGSVFKG---ILDDGRTTIAVKV--FNLLHHGAFKS-FIAECNTLKNIRHRNLVK 749
+G G G V++ + + R +A+K+ L F++ E T ++ ++V
Sbjct: 42 VGRGGMGDVYEAEDTVRE--RI-VALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 750 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDV 809
I G G + + ++ L L + P L + + I +
Sbjct: 99 IHD--FGEI-DGQLY--VDMRLINGVDLAAMLR--------RQGP--LAPPRAVAIVRQI 143
Query: 810 ACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSI 869
AL+ H H D+KP NIL+ D A++ DFG+A T G++
Sbjct: 144 GSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTL 199
Query: 870 GYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGD 912
Y+APE S + D+Y+ +L E +T P ++GD
Sbjct: 200 YYMAPERFSESHATYRADIYALTCVLYECLTGSPP----YQGD 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 58/216 (26%), Positives = 89/216 (41%), Gaps = 11/216 (5%)
Query: 373 IPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSI--GNLKL 430
+P I QR+ + NR+S + +NL L L N I + G L
Sbjct: 26 VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALL 82
Query: 431 FILYLSYNFLQGSIPSS-LGRYETLTTIDLSNNNLTGTIPPQ-FIGLSSSLIVLDLSRNQ 488
L LS N S+ + L T+ L L + P F GL++ L L L N
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAA-LQYLYLQDNA 140
Query: 489 LTGSIPSEV-GNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSS 547
L ++P + +L NL L + GN++ L++L + +N + P +
Sbjct: 141 LQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRD 199
Query: 548 LRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNN 583
L L L L NNLS E L L+ ++ L L++N
Sbjct: 200 LGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 53/215 (24%), Positives = 85/215 (39%), Gaps = 11/215 (5%)
Query: 353 SNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPP-AIGELQNLKDLR 411
+ + + L N+I A+ NL L + SN L+ I A L L+ L
Sbjct: 28 VGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLD 86
Query: 412 LQRNRFQGNIPPSI--GNLKLFILYLSYNFLQGSIPS-SLGRYETLTTIDLSNNNLTGTI 468
L N ++ P+ G +L L+L LQ + L + L +N L +
Sbjct: 87 LSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-AL 144
Query: 469 PPQ-FIGLSSSLIVLDLSRNQLTGSIPSEV-GNLKNLEILNVFGNKLKGEIPSTLGSCIK 526
P F L + L L L N+++ S+P L +L+ L + N++ P +
Sbjct: 145 PDDTFRDLGN-LTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 527 LEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNL 561
L L + N L +L+ LR L L L+ N
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 49/203 (24%), Positives = 76/203 (37%), Gaps = 11/203 (5%)
Query: 389 CSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSI--GNLKLFILYLSYNFLQGSIPS 446
C + +P I + + L NR ++P + L IL+L N L +
Sbjct: 18 CPQQGLQAVPVGI--PAASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAA 74
Query: 447 SLGRYETLTTIDLSNNNLTGTIPPQ-FIGLSSSLIVLDLSRNQLTGSIPSEV-GNLKNLE 504
+ L +DLS+N ++ P F GL L L L R L + + L L+
Sbjct: 75 AFTGLALLEQLDLSDNAQLRSVDPATFHGLGR-LHTLHLDRCGLQ-ELGPGLFRGLAALQ 132
Query: 505 ILNVFGNKLKGEIPS-TLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSG 563
L + N L+ +P T L L + N + + L L L L QN ++
Sbjct: 133 YLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191
Query: 564 KIPELLIRLQLVKNLNLSNNDLE 586
P L + L L N+L
Sbjct: 192 VHPHAFRDLGRLMTLYLFANNLS 214
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 41/227 (18%), Positives = 87/227 (38%), Gaps = 19/227 (8%)
Query: 55 VTCSRRH---------QRVTILDLESLKLAGSISPHV-GNLSFLKVLRLYNNSFNHEIPS 104
+C ++ + L +++ + L +L L++N +
Sbjct: 16 TSCPQQGLQAVPVGIPAASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAA 74
Query: 105 EFDRLRRLQVLALHYNSIGGAIPANI-SSCSNLIQLRLFHNQLVGKIPSE-LSSLSKIEH 162
F L L+ L L N+ ++ L L L L ++ L+ +++
Sbjct: 75 AFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQY 133
Query: 163 ISVNDNNLTGSIPS-SLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGT 221
+ + DN L ++P + +L ++ LFL GN + L +L L + QNR++
Sbjct: 134 LYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-H 191
Query: 222 IPSSIF-NISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQL 267
+ F ++ + N + A+P + L+ LQ+ + +N
Sbjct: 192 VHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 34/186 (18%), Positives = 70/186 (37%), Gaps = 10/186 (5%)
Query: 125 AIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSI 184
A+P I + ++ L N++ + + + + ++ N L ++ L+ +
Sbjct: 25 AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 185 RSLFLSGNNLEGSIP-DTLGWLKNLVNLTMAQNRLSGTIPSSIF-NISSITGFDAGVNKI 242
L LS N S+ T L L L + + L + +F ++++ N +
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNAL 141
Query: 243 QGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLT----GAAPYL 298
Q A+P D L NL + N+++ +L+ N++ A L
Sbjct: 142 Q-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDL 200
Query: 299 EKLQRL 304
+L L
Sbjct: 201 GRLMTL 206
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 27/85 (31%), Positives = 33/85 (38%), Gaps = 7/85 (8%)
Query: 69 LESLKLAG----SISPHV-GNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIG 123
L L L G S+ L L L L+ N H P F L RL L L N++
Sbjct: 155 LTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL- 213
Query: 124 GAIPANI-SSCSNLIQLRLFHNQLV 147
A+P + L LRL N V
Sbjct: 214 SALPTEALAPLRALQYLRLNDNPWV 238
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 51/213 (23%), Positives = 91/213 (42%), Gaps = 22/213 (10%)
Query: 696 IGEGSFGSVFKGI-LDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTAC 754
+G+G++G V+ G L + IA+K + E K+++H+N+V+ L
Sbjct: 30 LGKGTYGIVYAGRDLSNQV-RIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL--- 85
Query: 755 SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALN 814
G + K + E + SL L + +E I + + L
Sbjct: 86 -GSFSENGFIK-IFMEQVPGGSLSALLRSKWGPLKDNE-----QTIG--FYTKQILEGLK 136
Query: 815 YLHHDCQPPIAHCDLKPSNILLDEDM-IAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIA 873
YLH + I H D+K N+L++ + I DFG ++ L + T + G++ Y+A
Sbjct: 137 YLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF--TGTLQYMA 191
Query: 874 PE--YGLGSEVSISGDVYSYGILLLELITRKKP 904
PE + D++S G ++E+ T K P
Sbjct: 192 PEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 4e-24
Identities = 58/259 (22%), Positives = 108/259 (41%), Gaps = 21/259 (8%)
Query: 353 SNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPP-AIGELQNLKDLR 411
S L+ ++ L L NN+I + + + VNLQ L + SN ++ TI + L +L+ L
Sbjct: 48 SGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLD 106
Query: 412 LQRNRFQGNIPPSI--GNLKLFILYLSYNFLQGSIPSSL-GRYETLTTIDLSNNNLTGTI 468
L N N+ S L L L N + +SL L + + N + I
Sbjct: 107 LSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKI 165
Query: 469 PPQ-FIGLSSSLIVLDLSRNQLTGSIPSEV-GNLKNLEILNVFGNKLKGEIPSTLGSCIK 526
+ F GL+ L L++ + L S + +++N+ L + + + +
Sbjct: 166 QRKDFAGLTF-LEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSS 223
Query: 527 LEQLEMQENFLQGPIPSSLSS--------LRGLSVLDLSQNNLSGKIPELLIRLQLVKNL 578
+E LE+++ L S LS+ + ++ +L ++ +LL ++ + L
Sbjct: 224 VECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLEL 282
Query: 579 NLSNNDLEGVVPTQGVFKN 597
S N L+ V G+F
Sbjct: 283 EFSRNQLKSV--PDGIFDR 299
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 4e-22
Identities = 48/268 (17%), Positives = 97/268 (36%), Gaps = 24/268 (8%)
Query: 332 TRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPA-AIGKFVNLQRLDMCS 390
+K L ++ N + + L+ L+L +N I I + +L+ LD+
Sbjct: 52 EAVKSLDLSNNRITYISNSDLQRC-VNLQALVLTSNGI-NTIEEDSFSSLGSLEHLDLSY 109
Query: 391 NRLSGTIPP-AIGELQNLKDLRLQRNRFQGNIPPSI---GNLKLFILYLSYNFLQGSIPS 446
N LS + L +L L L N ++ + + KL IL + I
Sbjct: 110 NYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQR 167
Query: 447 -SLGRYETLTTIDLSNNNLTGTIPPQ-FIGLSSSLIVLDLSRNQLTGSIPSEV-GNLKNL 503
L +++ ++L + P+ + + + L L Q + ++
Sbjct: 168 KDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQN-VSHLILHMKQHI-LLLEIFVDVTSSV 224
Query: 504 EILNVFGNKLKG----EIPS----TLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLD 555
E L + L E+ + +L +++ + L + L+ + GL L+
Sbjct: 225 ECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELE 283
Query: 556 LSQNNLSGKIPELLIRLQLVKNLNLSNN 583
S+N L + RL ++ + L N
Sbjct: 284 FSRNQLKSVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 4e-19
Identities = 61/362 (16%), Positives = 116/362 (32%), Gaps = 97/362 (26%)
Query: 164 SVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIP 223
+ +L SIPS L +++SL LS N + L NL L + N ++ TI
Sbjct: 37 KGSSGSLN-SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIE 92
Query: 224 SSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEI 283
F+ SL +L+ + N L+ + +
Sbjct: 93 EDSFS------------------------SLGSLEHLDLSYNYLS-NLSSSW-------- 119
Query: 284 FHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININN 343
+ L +L + N
Sbjct: 120 --------------------------------------------FKPLSSLTFLNLLGNP 135
Query: 344 FGGSLPACISNLSTTLEVLLLDNNQIFGNIPA-AIGKFVNLQRLDMCSNRLSGTIPPAIG 402
+ + + T L++L + N F I L+ L++ ++ L P ++
Sbjct: 136 YKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLK 195
Query: 403 ELQNLKDLRLQRNRFQGNIPPSI--GNLKLFILYLSYNFLQG----SIPS----SLGRYE 452
+QN+ L L + + + L L L + + SL +
Sbjct: 196 SIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKF 254
Query: 453 TLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEV-GNLKNLEILNVFGN 511
T + +++ +L + + S L+ L+ SRNQL S+P + L +L+ + + N
Sbjct: 255 TFRNVKITDESLF-QVMKLLNQI-SGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTN 311
Query: 512 KL 513
Sbjct: 312 PW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 4e-18
Identities = 61/235 (25%), Positives = 95/235 (40%), Gaps = 21/235 (8%)
Query: 389 CSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSI--GNLKLFILYLSYNFLQGSIP- 445
S+ +IP + + +K L L NR I S + L L L+ N + +I
Sbjct: 38 GSSGSLNSIPSGL--TEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN-TIEE 93
Query: 446 ---SSLGRYETLTTIDLSNNNLTGTIPPQ-FIGLSSSLIVLDLSRNQLTGSIPSEV-GNL 500
SSLG L +DLS N L+ + F LSS L L+L N + + +L
Sbjct: 94 DSFSSLGS---LEHLDLSYNYLS-NLSSSWFKPLSS-LTFLNLLGNPYKTLGETSLFSHL 148
Query: 501 KNLEILNVFGNKLKGEIPS-TLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQN 559
L+IL V +I LE+LE+ + LQ P SL S++ +S L L
Sbjct: 149 TKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMK 208
Query: 560 NLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQ---GVFKNASITSVFGNLKLCG 611
+ + V+ L L + DL+ ++ G + F N+K+
Sbjct: 209 QHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITD 263
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 8e-18
Identities = 47/247 (19%), Positives = 83/247 (33%), Gaps = 18/247 (7%)
Query: 328 LTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPA-AIGKFVNLQRL 386
L L+ L++ N ++ + +LE L L N + N+ + +L L
Sbjct: 72 LQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYL-SNLSSSWFKPLSSLTFL 129
Query: 387 DMCSNRLSGTIPPAI--GELQNLKDLRLQRNRFQGNIPPSI--GNLKLFILYLSYNFLQG 442
++ N T+ L L+ LR+ I G L L + + LQ
Sbjct: 130 NLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQS 188
Query: 443 SIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEV----- 497
P SL + ++ + L + F+ ++SS+ L+L L SE+
Sbjct: 189 YEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGET 247
Query: 498 ---GNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVL 554
+ + L ++ L L +LE N L+ L L +
Sbjct: 248 NSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKI 306
Query: 555 DLSQNNL 561
L N
Sbjct: 307 WLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 3e-17
Identities = 71/393 (18%), Positives = 120/393 (30%), Gaps = 100/393 (25%)
Query: 37 LGVLASWNESSHFCQWRGVTCSRRHQRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNN 96
LGV+ S ++ Q ++C R I S L SI G +K L L NN
Sbjct: 11 LGVIISLSKEESSNQ-ASLSCDRN----GICKGSSGSLN-SIPS--GLTEAVKSLDLSNN 62
Query: 97 SFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANI-SSCSNLIQLRLFHNQLVGKIPSELS 155
+ S+ R LQ L L N I I + SS +L L L +N L S
Sbjct: 63 RITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYL--------S 113
Query: 156 SLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPD--TLGWLKNLVNLTM 213
+LS S LSS+ L L GN + ++ + L L L +
Sbjct: 114 NLS----------------SSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRV 156
Query: 214 AQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPP 273
I F L L+ + + L P
Sbjct: 157 GNMDTFTKIQRKDFA------------------------GLTFLEELEIDASDLQSYEPK 192
Query: 274 TISNASNLEIFHGSVNKLT----GAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLT 329
++ + N+ + + ++ L
Sbjct: 193 SLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECL------------------------- 227
Query: 330 NATRLKWLLININNFGGSLPACISNL---STTLEVLLLDNNQIFGNIPAAIGKFVNLQRL 386
L+ ++ +F L +N T + + + +F + + + L L
Sbjct: 228 ---ELRDTDLDTFHFS-ELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLEL 282
Query: 387 DMCSNRLSGTIPP-AIGELQNLKDLRLQRNRFQ 418
+ N+L ++P L +L+ + L N +
Sbjct: 283 EFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-24
Identities = 25/254 (9%), Positives = 58/254 (22%), Gaps = 30/254 (11%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKILT 752
+ G VF + A+KVF + + + +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 753 AC-------SGVDYQGNDFKALVFEFMHNRSLEEWL----------HPITREDETDEAPR 795
+ F L L + D
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189
Query: 796 SLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPL 855
++ ++ + L + H P N+ + D +GD +
Sbjct: 190 DEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKV-- 244
Query: 856 SSAQTSSIGAKGSIGYIAPEYGLGSEVSISG--DVYSYGILLLELITRKKPTDIMFEGDM 913
+ + + Y E+ S + + + + G+ + + P ++ G
Sbjct: 245 -GTRGPASS--VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301
Query: 914 NLHNLARTALPDHV 927
+P
Sbjct: 302 GSWKRPSLRVPGTD 315
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-24
Identities = 52/233 (22%), Positives = 89/233 (38%), Gaps = 29/233 (12%)
Query: 685 NATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFN-LLHHGAFKSFIAECNTLKNIR 743
+ + + +G+G+ +VF+G A+KVFN + + E LK +
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 744 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRL 803
H+N+VK+ + K L+ EF SL L + E L +++
Sbjct: 66 HKNIVKLFAI---EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPE-SEFLIVLR-- 119
Query: 804 NISIDVACALNYLHHDCQPPIAHCDLKPSNILL----DEDMIAHIGDFGLARFLPLSSAQ 859
DV +N+L + I H ++KP NI+ D + + DFG AR L
Sbjct: 120 ----DVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF 172
Query: 860 TSSIGAKGSIGYIAPEYGLGSEVSISG--------DVYSYGILLLELITRKKP 904
S G+ Y+ P+ + + D++S G+ T P
Sbjct: 173 VSLY---GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-23
Identities = 59/245 (24%), Positives = 100/245 (40%), Gaps = 28/245 (11%)
Query: 680 YQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVK-VFNLLHHGAF-KSFIAECN 737
+ + R+ ++ IG G+ G V +A+K + + K E
Sbjct: 17 GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELV 76
Query: 738 TLKNIRHRNLVKILTACSGVDYQGNDFKA--LVFEFMHNRSLEEWLHPITREDETDEAPR 795
+K + H+N++ +L + +F+ +V E M + L + + + E
Sbjct: 77 LMKCVNHKNIIGLLNVFT-PQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHERMS 130
Query: 796 SLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPL 855
L L Q L C + +LH I H DLKPSNI++ D I DFGLAR
Sbjct: 131 YL-LYQML-------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179
Query: 856 SSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNL 915
S T + + Y APE LG + D++S G ++ E+I ++F G ++
Sbjct: 180 SFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG----VLFPGTDHI 232
Query: 916 HNLAR 920
+
Sbjct: 233 DQWNK 237
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 54/244 (22%), Positives = 88/244 (36%), Gaps = 30/244 (12%)
Query: 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIR-HRNL 747
R + EG F V++ A+K ++ I E +K + H N+
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 748 VKILTACSGV--DYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNI 805
V+ +A S + + L+ + L E+L + E+ L+ L I
Sbjct: 89 VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFL-------KKMESRGPLSCDTVLKI 141
Query: 806 SIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSS--- 862
A+ ++H +PPI H DLK N+LL + DFG A + + S
Sbjct: 142 FYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQR 200
Query: 863 -------IGAKGSIGYIAPE----YGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEG 911
I + Y PE Y + D+++ G +L L R+ P FE
Sbjct: 201 RALVEEEITRNTTPMYRTPEIIDLYS-NFPIGEKQDIWALGCILYLLCFRQHP----FED 255
Query: 912 DMNL 915
L
Sbjct: 256 GAKL 259
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 54/274 (19%), Positives = 93/274 (33%), Gaps = 61/274 (22%)
Query: 688 DRFSSVNQIGEGSFGSVFKGI-LDDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHR 745
F + +G G FG VF+ D A+K L + A + + E L + H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDC-NYAIKRIRLPNRELAREKVMREVKALAKLEHP 64
Query: 746 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAP----------- 794
+V+ A + + + P + + +
Sbjct: 65 GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124
Query: 795 ---------------------RSL-NLIQR------------LNISIDVACALNYLHHDC 820
+L + + R L+I I +A A+ +LH
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184
Query: 821 QPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAK-------GSIG--- 870
+ H DLKPSNI D + +GDFGL + + + + G +G
Sbjct: 185 ---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241
Query: 871 YIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
Y++PE G+ S D++S G++L EL+
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST 275
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 58/272 (21%), Positives = 110/272 (40%), Gaps = 44/272 (16%)
Query: 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL--LHHGAFKSFIAECNTLKNIRHRN 746
+S + QIG G VF+ + + + A+K NL + S+ E L ++ +
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 747 L--VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLN 804
+++ + +V E N L WL +S++ +R +
Sbjct: 69 DKIIRLY----DYEITDQYIY-MVMEC-GNIDLNSWLK----------KKKSIDPWERKS 112
Query: 805 ISIDVACALNYLH-HDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSI 863
++ A++ +H H I H DLKP+N L+ + M+ + DFG+A + +
Sbjct: 113 YWKNMLEAVHTIHQHG----IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKD 167
Query: 864 GAKGSIGYIAPE-----------YGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGD 912
G++ Y+ PE S++S DV+S G +L + K P F+
Sbjct: 168 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQI 223
Query: 913 MN-LHNLARTALPDHVMDIVDSTLLNDGEDLI 943
+N + L P+H ++ D +D++
Sbjct: 224 INQISKLHAIIDPNHEIEF-PDIPEKDLQDVL 254
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 47/214 (21%), Positives = 74/214 (34%), Gaps = 29/214 (13%)
Query: 696 IGEGSFGSVFKGI-LDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTAC 754
+G GSFG V + G AVK L + E + +V +
Sbjct: 66 VGRGSFGEVHRMKDKQTGF-QCAVKKVRLE-----VFRVEELVACAGLSSPRIVPLY--- 116
Query: 755 SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALN 814
G +G + E + SL + + + E + L
Sbjct: 117 -GAVREGPWVN-IFMELLEGGSLGQLIKQMGCLPE--------DRAL--YYLGQALEGLE 164
Query: 815 YLHHDCQPPIAHCDLKPSNILLDED-MIAHIGDFGLARFLPLSSAQTSSIGA---KGSIG 870
YLH I H D+K N+LL D A + DFG A L S + G+
Sbjct: 165 YLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET 221
Query: 871 YIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
++APE +G D++S ++L ++ P
Sbjct: 222 HMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 60/247 (24%), Positives = 100/247 (40%), Gaps = 35/247 (14%)
Query: 679 SYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNT 738
S+ + D + V ++G G + VF+ I + VK+ + K E
Sbjct: 27 SHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKI 83
Query: 739 LKNIR-HRNLVKILTACSGVDYQGNDFK-ALVFEFMHNRSLEEWLHPITREDETDEAPRS 796
L+N+R N++ + + ALVFE ++N ++ +T D R
Sbjct: 84 LENLRGGPNIITLAD----IVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD-----IRF 134
Query: 797 LNLIQRLNISIDVACALNYLH-HDCQPPIAHCDLKPSNILLD-EDMIAHIGDFGLARFLP 854
+ + L AL+Y H I H D+KP N+++D E + D+GLA F
Sbjct: 135 Y-MYEIL-------KALDYCHSMG----IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182
Query: 855 LSSAQTSSIGAKGSIGYIAPEYGLGSEV-SISGDVYSYGILLLELITRKKPTDIMFEGDM 913
+ S + PE + ++ S D++S G +L +I RK+P F G
Sbjct: 183 PGQEYNVRV---ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFHGHD 236
Query: 914 NLHNLAR 920
N L R
Sbjct: 237 NYDQLVR 243
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 7e-23
Identities = 51/232 (21%), Positives = 94/232 (40%), Gaps = 38/232 (16%)
Query: 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL--LHHGAFKSFIAECNTLKNIRHRN 746
+S + QIG G VF+ + + + A+K NL + S+ E L ++ +
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 747 L--VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLN 804
+++ + +V E N L WL +S++ +R +
Sbjct: 116 DKIIRLY----DYEITDQYIY-MVMEC-GNIDLNSWLK----------KKKSIDPWERKS 159
Query: 805 ISIDVACALNYLH-HDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSI 863
++ A++ +H H I H DLKP+N L+ + M+ + DFG+A + +
Sbjct: 160 YWKNMLEAVHTIHQHG----IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKD 214
Query: 864 GAKGSIGYIAPE-----------YGLGSEVSISGDVYSYGILLLELITRKKP 904
G++ Y+ PE S++S DV+S G +L + K P
Sbjct: 215 SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 1e-22
Identities = 58/218 (26%), Positives = 93/218 (42%), Gaps = 22/218 (10%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIA-ECNTLKNIRHRN 746
D F ++++G G+ G VFK +A K+ +L A ++ I E L
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 747 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNIS 806
+V G Y + + E M SL++ L R E +S
Sbjct: 93 IVG----FYGAFYSDGEIS-ICMEHMDGGSLDQVLKKAGRIPEQILGK----------VS 137
Query: 807 IDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAK 866
I V L YL + I H D+KPSNIL++ + DFG++ L S A +
Sbjct: 138 IAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---- 191
Query: 867 GSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
G+ Y++PE G+ S+ D++S G+ L+E+ + P
Sbjct: 192 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 100 bits (249), Expect = 1e-22
Identities = 43/300 (14%), Positives = 88/300 (29%), Gaps = 38/300 (12%)
Query: 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTT-----IAVKVFNLLHHGAFKSFIAECNTLKN 741
+ + +GEG+F V++ D +KV + F LK
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 742 IRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQ 801
+K +A + + LV E +L ++ E + +
Sbjct: 124 SMQHMFMKFYSA-----HLFQNGSVLVGELYSYGTLLNAINLYKNTPE-----KVMPQGL 173
Query: 802 RLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH-----------IGDFGLA 850
++ ++ + + +H I H D+KP N +L + + D G +
Sbjct: 174 VISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQS 230
Query: 851 RFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFE 910
+ L T + G+ E + D + + ++
Sbjct: 231 IDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290
Query: 911 GDMNLH-NLARTALPDHVMDIVDSTLLN-------DGEDLIVHGNQRQRQARVKSRIECL 962
G+ R D + +LN DL+ ++ Q ++I L
Sbjct: 291 GECKPEGLFRRLPHLDMWNEFFH-VMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRAL 349
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 2e-22
Identities = 52/233 (22%), Positives = 89/233 (38%), Gaps = 29/233 (12%)
Query: 685 NATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFN-LLHHGAFKSFIAECNTLKNIR 743
+ + + +G+G+ +VF+G A+KVFN + + E LK +
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 744 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRL 803
H+N+VK+ + K L+ EF SL L + E L +++
Sbjct: 66 HKNIVKLFAI---EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPE-SEFLIVLR-- 119
Query: 804 NISIDVACALNYLHHDCQPPIAHCDLKPSNILL----DEDMIAHIGDFGLARFLPLSSAQ 859
DV +N+L + I H ++KP NI+ D + + DFG AR L
Sbjct: 120 ----DVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF 172
Query: 860 TSSIGAKGSIGYIAPEYGLGSEVSISG--------DVYSYGILLLELITRKKP 904
S G+ Y+ P+ + + D++S G+ T P
Sbjct: 173 VSLY---GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 2e-22
Identities = 60/249 (24%), Positives = 103/249 (41%), Gaps = 52/249 (20%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRT--TIAVKVFNLLH--HGAFKSFIAECNTLKNIR 743
++ + +IGEG++G+VFK + T +A+K L G S + E LK ++
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAK--NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK 59
Query: 744 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRL 803
H+N+V++ V + LVFEF L+++ D L+
Sbjct: 60 HKNIVRLH----DVLHSDKKL-TLVFEFCDQ-DLKKYF---------DSCNGDLDPEIVK 104
Query: 804 NISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSI 863
+ + L + H + H DLKP N+L++ + + +FGLAR
Sbjct: 105 SFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLAR------------ 149
Query: 864 GAKGS-----------IGYIAPEYGLGSEV-SISGDVYSYGILLLELITRKKPTDIMFEG 911
A G + Y P+ G+++ S S D++S G + EL +P +F G
Sbjct: 150 -AFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP---LFPG 205
Query: 912 DMNLHNLAR 920
+ L R
Sbjct: 206 NDVDDQLKR 214
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-22
Identities = 61/248 (24%), Positives = 94/248 (37%), Gaps = 22/248 (8%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFNL-LHHGAFKSFIAECNTLKNIRHRNLVKIL-TA 753
+G G FG V + I D +A+K L + + E +K + H N+V
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 754 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACAL 813
ND L E+ L ++L+ E + D++ AL
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG-------PIRTLLSDISSAL 134
Query: 814 NYLHHDCQPPIAHCDLKPSNILLD---EDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIG 870
YLH + I H DLKP NI+L + +I I D G A+ L T + G++
Sbjct: 135 RYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV---GTLQ 188
Query: 871 YIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVMDI 930
Y+APE + +++ D +S+G L E IT +P F + I
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP----FLPNWQPVQWHGKVREKSNEHI 244
Query: 931 VDSTLLND 938
V L
Sbjct: 245 VVYDDLTG 252
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 3e-22
Identities = 51/230 (22%), Positives = 90/230 (39%), Gaps = 40/230 (17%)
Query: 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIA----ECNTLKNI-R 743
F + +G G+ G++ + D R +AVK + E L+
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRD-VAVKRIL-------PECFSFADREVQLLRESDE 76
Query: 744 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRL 803
H N+++ C+ + F+ + E +L+E+ + ++D + L+Q
Sbjct: 77 HPNVIRYF--CT---EKDRQFQYIAIELCAA-TLQEY---VEQKDFAHLGLEPITLLQ-- 125
Query: 804 NISIDVACALNYLHHDCQPPIAHCDLKPSNILLDE-----DMIAHIGDFGLARFL-PLSS 857
L +LH I H DLKP NIL+ + A I DFGL + L
Sbjct: 126 ----QTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178
Query: 858 AQTSSIGAKGSIGYIAPEY---GLGSEVSISGDVYSYGILLLELITRKKP 904
+ + G G+ G+IAPE + + D++S G + +I+
Sbjct: 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 4e-22
Identities = 47/240 (19%), Positives = 94/240 (39%), Gaps = 34/240 (14%)
Query: 696 IGEGSFGSV---------------FKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLK 740
+ +G F + K +L+ R + + F E +
Sbjct: 39 LNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 741 NIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLI 800
+I++ + G+ D +++E+M N S+ ++ D+ + +I
Sbjct: 99 DIKNEYCLTCE----GI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVI 153
Query: 801 QRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQT 860
+ I V + +Y+H+ + I H D+KPSNIL+D++ + DFG + ++ +
Sbjct: 154 KC--IIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKG 209
Query: 861 SSIGAKGSIGYIAPE--YGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNL 918
S +G+ ++ PE S D++S GI L + P F ++L L
Sbjct: 210 S----RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP----FSLKISLVEL 261
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 4e-22
Identities = 55/240 (22%), Positives = 98/240 (40%), Gaps = 39/240 (16%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTL-KNIRHRN 746
+ S +G GS G+V GR +AVK + + E L ++ H N
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRP-VAVKRMLI---DFCDIALMEIKLLTESDDHPN 70
Query: 747 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNIS 806
+++ CS + F + E N +L++ + ++ +DE + +++
Sbjct: 71 VIRYY--CS---ETTDRFLYIALELC-NLNLQDL---VESKNVSDENLKLQKEYNPISLL 121
Query: 807 IDVACALNYLHHDCQPPIAHCDLKPSNILLD-------------EDMIAHIGDFGLARFL 853
+A + +LH I H DLKP NIL+ E++ I DFGL + L
Sbjct: 122 RQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 178
Query: 854 P--LSSAQTSSIGAKGSIGYIAPEYGLGSEVSISG-------DVYSYGILLLELITRKKP 904
SS +T+ G+ G+ APE S + D++S G + ++++ K
Sbjct: 179 DSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 96.9 bits (241), Expect = 5e-22
Identities = 58/271 (21%), Positives = 98/271 (36%), Gaps = 22/271 (8%)
Query: 334 LKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVN---LQRLDMCS 390
L++LL ++ S +L+ L + +I I + + LQ L + +
Sbjct: 45 LEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLEN 104
Query: 391 NRLSGTIPPAIGELQ--NLKDLRLQRNRFQGNIP-----PSIGNLKLFILYLSYNFLQGS 443
++GT PP + E +L L L+ + L +L ++
Sbjct: 105 LEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNF 164
Query: 444 IPSSLGRYETLTTIDLSNNNLTGTIPPQ---FIGLSSSLIVLDLSRNQLT---GSIPSEV 497
+ + L+T+DLS+N G +L VL L + G +
Sbjct: 165 SCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALA 224
Query: 498 GNLKNLEILNVFGNKLKGEIPSTLGS-CIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDL 556
L+ L++ N L+ + +L L + L+ +P L + LSVLDL
Sbjct: 225 AARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGLPA--KLSVLDL 281
Query: 557 SQNNLSGKIPELLIRLQLVKNLNLSNNDLEG 587
S N L P L V NL+L N
Sbjct: 282 SYNRLDR-NP-SPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 92.3 bits (229), Expect = 2e-20
Identities = 47/246 (19%), Positives = 91/246 (36%), Gaps = 22/246 (8%)
Query: 361 VLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQN---LKDLRLQRNRF 417
+L + + I K ++L+RL + + R+ I + L++L L+
Sbjct: 48 LLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEV 107
Query: 418 QGNIPPSIGNL---KLFILYLSYNFLQG--SIPSSLGRY--ETLTTIDLSNNNLTGTIPP 470
G PP + L IL L + + L ++ L + ++ +
Sbjct: 108 TGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSL-NFSC 166
Query: 471 QFIGLSSSLIVLDLSRNQLTGSIPSE----VGNLKNLEILNVFGNKLK---GEIPSTLGS 523
+ + + +L LDLS N G L++L + ++ G + +
Sbjct: 167 EQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAA 226
Query: 524 CIKLEQLEMQENFLQG-PIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSN 582
++L+ L++ N L+ S L+ L+LS L L +L L+LS
Sbjct: 227 RVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLS---VLDLSY 283
Query: 583 NDLEGV 588
N L+
Sbjct: 284 NRLDRN 289
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 2e-19
Identities = 48/279 (17%), Positives = 88/279 (31%), Gaps = 21/279 (7%)
Query: 276 SNASNLEIFHGSVNKLTGAAPYLEKLQRL-LVFGILGNSLGSRGDRDLNFLCSLTNATRL 334
+LE V+ + + ++ L L + + R L + + L
Sbjct: 40 GGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIP--SRILFGALRVLGISGL 97
Query: 335 KWLLININNFGGSLPACISNLS-TTLEVLLLDNNQI--FGNIPAAIGKFV--NLQRLDMC 389
+ L + G+ P + + L +L L N A + +++ L+ L +
Sbjct: 98 QELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIA 157
Query: 390 SNRLSGTIPPAIGELQNLKDLRLQRNRFQGNI-------PPSIGNLK-LFILYLSYNFLQ 441
+ L L L N G P L+ L +
Sbjct: 158 QAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPS 217
Query: 442 GSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLK 501
G + L +DLS+N+L S L L+LS L +P +
Sbjct: 218 GVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PA 274
Query: 502 NLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGP 540
L +L++ N+L PS ++ L ++ N
Sbjct: 275 KLSVLDLSYNRLD-RNPSPDE-LPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 48/346 (13%), Positives = 96/346 (27%), Gaps = 85/346 (24%)
Query: 83 GNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANIS---SCSNLIQL 139
G S +L+ + + ++ + L+ L + I I S L +L
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 140 RLFHNQLVGKIPSELSSL--SKIEHISVNDNNLTG--SIPSSLGNLS--SIRSLFLSGNN 193
L + ++ G P L + +++ + + + + L ++ L ++ +
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160
Query: 194 LEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFS 253
+ + L L ++ N G + A+ +
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERG------------------LISALCPLKFPT 202
Query: 254 LQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNS 313
LQ L + G +G + L+ S N L
Sbjct: 203 LQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLR--------------------- 241
Query: 314 LGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNI 373
+ A + + L L L + +
Sbjct: 242 --------------------------------DAAGAPSCDWPSQLNSLNLSFTGL-KQV 268
Query: 374 PAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQG 419
P + L LD+ NRL P+ EL + +L L+ N F
Sbjct: 269 PKGL--PAKLSVLDLSYNRLDRN--PSPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 32/252 (12%), Positives = 71/252 (28%), Gaps = 23/252 (9%)
Query: 60 RHQRVTILDLESLKLAGSISPH---VGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLA 116
+ + L + + ++ I V +S L+ L L N P +
Sbjct: 66 KSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNI 125
Query: 117 LHYNSI----GGAIPANISSCS--NLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNL 170
L+ ++ A A + L L + + ++ + + ++DN
Sbjct: 126 LNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPE 185
Query: 171 TGSIPSS----LGNLSSIRSLFLSGNNLE---GSIPDTLGWLKNLVNLTMAQNRLSGTIP 223
G +++ L L +E G L L ++ N L
Sbjct: 186 LGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245
Query: 224 SSIFNI-SSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLE 282
+ + S + + ++ +P L + N+L P+ +
Sbjct: 246 APSCDWPSQLNSLNLSFTGLK-QVP---KGLPAKLSVLDLSYNRLDR--NPSPDELPQVG 299
Query: 283 IFHGSVNKLTGA 294
N +
Sbjct: 300 NLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 63.8 bits (155), Expect = 7e-11
Identities = 34/185 (18%), Positives = 59/185 (31%), Gaps = 13/185 (7%)
Query: 44 NESSHFCQWRGVTCSRRHQRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEI- 102
+ W + +L + V L L L +N E
Sbjct: 131 VSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190
Query: 103 ------PSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSS 156
P +F L+ L + + G A ++ L L L HN L +
Sbjct: 191 LISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCD 250
Query: 157 -LSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQ 215
S++ ++++ L +P L + + L LS N L+ P L + NL++
Sbjct: 251 WPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLD-RNPSPDE-LPQVGNLSLKG 305
Query: 216 NRLSG 220
N
Sbjct: 306 NPFLD 310
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 5e-22
Identities = 61/245 (24%), Positives = 100/245 (40%), Gaps = 28/245 (11%)
Query: 680 YQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVK-VFNLLHHGAF-KSFIAECN 737
+ + R+ ++ IG G+ G V +A+K + + K E
Sbjct: 54 GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV 113
Query: 738 TLKNIRHRNLVKILTACSGVDYQGNDFKA--LVFEFMHNRSLEEWLHPITREDETDEAPR 795
+K + H+N++ +L + +F+ LV E M + L + + + E
Sbjct: 114 LMKCVNHKNIISLLNVFT-PQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMS 167
Query: 796 SLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPL 855
L L Q L C + +LH I H DLKPSNI++ D I DFGLAR
Sbjct: 168 YL-LYQML-------CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216
Query: 856 SSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNL 915
S T + + Y APE LG + D++S G ++ E++ K I+F G +
Sbjct: 217 SFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPGRDYI 269
Query: 916 HNLAR 920
+
Sbjct: 270 DQWNK 274
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 7e-22
Identities = 55/251 (21%), Positives = 101/251 (40%), Gaps = 40/251 (15%)
Query: 684 YNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVK-VFNLLHHGAFKS-FIAECNTLKN 741
DRF G+G+FG+V G ++A+K V F++ + L
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ---DPRFRNRELQIMQDLAV 75
Query: 742 IRHRNLVKILTA-CSGVDYQGND-FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNL 799
+ H N+V++ + + + D + +V E++ + LH R + L
Sbjct: 76 LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-----PDTLHRCCRNYYRRQVAPPPIL 130
Query: 800 IQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLD-EDMIAHIGDFGLARFLPLSSA 858
I+ + ++ LH + H D+KP N+L++ D + DFG A+ L S
Sbjct: 131 IKV--FLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP 187
Query: 859 QTSSIGAKGSIGYI------APEYGLGSE---VSISGDVYSYGILLLELITRKKPTDIMF 909
+ YI APE G++ ++ D++S G + E++ +P +F
Sbjct: 188 NVA---------YICSRYYRAPELIFGNQHYTTAV--DIWSVGCIFAEMMLG-EP---IF 232
Query: 910 EGDMNLHNLAR 920
GD + L
Sbjct: 233 RGDNSAGQLHE 243
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 8e-22
Identities = 61/245 (24%), Positives = 103/245 (42%), Gaps = 40/245 (16%)
Query: 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVK-VFNLLHHGAFKSFIAECNTLKNIRHR 745
++ IG GSFG V++ L D +A+K V FK+ E ++ + H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKN--RELQIMRKLDHC 107
Query: 746 NLVKILTA-CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLN 804
N+V++ S + + + LV +++ E ++ + R + + ++
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAKQTLPVIYVK--L 160
Query: 805 ISIDVACALNYLH-HDCQPPIAHCDLKPSNILLDEDM-IAHIGDFGLARFLPLSSAQTSS 862
+ +L Y+H I H D+KP N+LLD D + + DFG A+ L S
Sbjct: 161 YMYQLFRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS- 215
Query: 863 IGAKGSIGYI------APEYGLGSEV-SISGDVYSYGILLLELITRKKPTDIMFEGDMNL 915
YI APE G+ + S DV+S G +L EL+ +P +F GD +
Sbjct: 216 --------YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QP---IFPGDSGV 263
Query: 916 HNLAR 920
L
Sbjct: 264 DQLVE 268
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 1e-21
Identities = 66/241 (27%), Positives = 105/241 (43%), Gaps = 29/241 (12%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTT---IAVKVFNLLH--HGAFKSFIAECNTLKNI 742
++ V +IGEG++G VFK D + +A+K + G S I E L+++
Sbjct: 11 QQYECVAEIGEGAYGKVFKAR--DLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 743 R---HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNL 799
H N+V++ C+ LVFE + + L +L + E + + +
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDM-M 126
Query: 800 IQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQ 859
Q L L++LH + H DLKP NIL+ + DFGLAR A
Sbjct: 127 FQLLR-------GLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL 176
Query: 860 TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLA 919
TS + + Y APE L S + D++S G + E+ R KP +F G ++ L
Sbjct: 177 TSVVVT---LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR-KP---LFRGSSDVDQLG 229
Query: 920 R 920
+
Sbjct: 230 K 230
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 97.8 bits (243), Expect = 1e-21
Identities = 38/282 (13%), Positives = 82/282 (29%), Gaps = 49/282 (17%)
Query: 696 IGEGSFGSVFKGI-LDDGRTTIAVKVFNLL-------------------------HHGAF 729
+G+ + + + G + V V +
Sbjct: 86 LGQEDPYAYLEATDQETGE-SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 730 KSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDE 789
K + ++ K++ + ++ M +L+ + +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSS 203
Query: 790 TDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGL 849
T + SL RL +++ V L LHH + H L+P +I+LD+ + F
Sbjct: 204 THK---SLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEH 257
Query: 850 ARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSE-----VSISGDVYSYGILLLELITRKKP 904
+SA + A + ++ + D ++ G+ + + P
Sbjct: 258 LVRDG-ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
Query: 905 TDIMFEGDMNLHNLART-----ALPDHVMDIVDSTLLNDGED 941
D L +P V +++ L ED
Sbjct: 317 ----NTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKED 354
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 55/237 (23%), Positives = 90/237 (37%), Gaps = 32/237 (13%)
Query: 353 SNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPP-AIGELQNLKDLR 411
NL + + L L N + + F LQ LD+ + TI A L +L L
Sbjct: 24 DNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLI 82
Query: 412 LQRNRFQGNIPPSI-GNL-KLFILYLSYNFLQGSIPSSL-GRYETLTTIDLSNNNLTGTI 468
L N Q ++ L L L L S+ + G +TL +++++N +
Sbjct: 83 LTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFK 140
Query: 469 PPQ-FIGLSSSLIVLDLSRNQLTGSIPSEV-GNLKNLEILNVFGNKLKGEIPSTLGSCIK 526
P+ F L++ L LDLS N++ SI L + +LN+
Sbjct: 141 LPEYFSNLTN-LEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNL------------------ 180
Query: 527 LEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNN 583
L++ N + P + +R L L L N L + RL ++ + L N
Sbjct: 181 --SLDLSLNPMNFIQPGAFKEIR-LKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 52/187 (27%), Positives = 81/187 (43%), Gaps = 21/187 (11%)
Query: 420 NIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQ-FIGLSSS 478
N+P S NL LS+N L+ S + L +DLS + TI + L S
Sbjct: 25 NLPFSTKNL-----DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSL-SH 77
Query: 479 LIVLDLSRNQLTGSIPSEV-GNLKNLEILNVFGNKLKGEIPS-TLGSCIKLEQLEMQENF 536
L L L+ N + S+ L +L+ L L + + +G L++L + N
Sbjct: 78 LSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNL 135
Query: 537 LQG-PIPSSLSSLRGLSVLDLSQNNLSGKIPE----LLIRLQ-LVKNLNLSNNDLEGVVP 590
+Q +P S+L L LDLS N + I +L ++ L +L+LS N + + P
Sbjct: 136 IQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQP 194
Query: 591 TQGVFKN 597
G FK
Sbjct: 195 --GAFKE 199
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 43/236 (18%), Positives = 77/236 (32%), Gaps = 28/236 (11%)
Query: 50 CQWRGVTC-SRRHQRV--------TILDLESLKLAGSISPHV-GNLSFLKVLRLYNNSFN 99
C ++ LDL L + + + L+VL L
Sbjct: 7 VPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ 65
Query: 100 HEIPSEFDRLRRLQVLALHYNSIGGAIPANI-SSCSNLIQLRLFHNQLVGKIPSEL-SSL 157
+ L L L L N I ++ S S+L +L L + + L
Sbjct: 66 TIEDGAYQSLSHLSTLILTGNPI-QSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHL 123
Query: 158 SKIEHISVNDNNLTGSIPSS--LGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQ 215
++ ++V N + S NL+++ L LS N ++ SI L+ L + +
Sbjct: 124 KTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYC--TDLRVLHQMPLLN 179
Query: 216 NRLS------GTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGEN 265
L I F + N+++ ++P L +LQ + N
Sbjct: 180 LSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 46/266 (17%), Positives = 85/266 (31%), Gaps = 62/266 (23%)
Query: 166 NDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSS 225
+ N IP +L S ++L LS N L + L L +++ + TI
Sbjct: 15 MELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDG 70
Query: 226 IFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTI-SNASNLEIF 284
+ SL +L + N + ++ S S+L+
Sbjct: 71 AYQ------------------------SLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKL 105
Query: 285 HGSVNKLT----GAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNA------TRL 334
L +L+ L+ L ++ N + S T L
Sbjct: 106 VAVETNLASLENFPIGHLKTLKEL--------NVAH------NLIQSFKLPEYFSNLTNL 151
Query: 335 KWLLININNFGGSLPACI----SNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCS 390
+ L ++ N S+ + L L N + I K + L+ L + +
Sbjct: 152 EHLDLSSNKI-QSIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKEIRLKELALDT 209
Query: 391 NRLSGTIPP-AIGELQNLKDLRLQRN 415
N+L ++P L +L+ + L N
Sbjct: 210 NQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 3e-21
Identities = 68/272 (25%), Positives = 107/272 (39%), Gaps = 56/272 (20%)
Query: 663 KEKQNPNSPINSFPNISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFN 722
+ +S + +++ + ++GEG++G V+K GR +A+K
Sbjct: 2 HHHHHHSSGRENLYFQGLM------EKYQKLEKVGEGTYGVVYKAKDSQGRI-VALKRIR 54
Query: 723 LLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEW 780
L G + I E + LK + H N+V ++ LVFEFM L++
Sbjct: 55 LDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI-----HSERCLTLVFEFMEK-DLKKV 108
Query: 781 LHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDM 840
L DE L Q + + + H I H DLKP N+L++ D
Sbjct: 109 L---------DENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDG 156
Query: 841 IAHIGDFGLARFLPLSSAQTSSIGAKGSIG-----------YIAPEYGLGSEV-SISGDV 888
+ DFGLAR A G Y AP+ +GS+ S S D+
Sbjct: 157 ALKLADFGLAR-------------AFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDI 203
Query: 889 YSYGILLLELITRKKPTDIMFEGDMNLHNLAR 920
+S G + E+IT KP +F G + L +
Sbjct: 204 WSIGCIFAEMITG-KP---LFPGVTDDDQLPK 231
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 3e-21
Identities = 63/252 (25%), Positives = 103/252 (40%), Gaps = 43/252 (17%)
Query: 680 YQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVK-VFNLLHHGAF-KSFIAECN 737
+ + + S +G G++GSV I +A+K + F K E
Sbjct: 16 NKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELL 75
Query: 738 TLKNIRHRNLVKILTACSGVDYQGNDFKA--LVFEFMHNRSLEEWLHPITREDETDEAPR 795
LK+++H N++ +L + +F LV FM + L I ++E +
Sbjct: 76 LLKHMQHENVIGLLDVFT-PASSLRNFYDFYLVMPFM-----QTDLQKIMGLKFSEEKIQ 129
Query: 796 SLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPL 855
L + Q L L Y+H + H DLKP N+ ++ED I DFGLAR
Sbjct: 130 YL-VYQML-------KGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR--HA 176
Query: 856 SSAQTSSIGAKGSIGYI------APEYGLGS-EVSISGDVYSYGILLLELITRKKPTDIM 908
+ T GY+ APE L + + D++S G ++ E++T K +
Sbjct: 177 DAEMT---------GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK----TL 223
Query: 909 FEGDMNLHNLAR 920
F+G L L +
Sbjct: 224 FKGKDYLDQLTQ 235
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 5e-21
Identities = 52/270 (19%), Positives = 98/270 (36%), Gaps = 63/270 (23%)
Query: 687 TDRFSSVNQIGEGSFGSVFKGI-LDDGRTTIAVKVFNLLHHGAF--KSFIAECNTLKNI- 742
T F + +IG G FGSVFK + DG A+K G+ ++ + E +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGC-IYAIKRSKKPLAGSVDEQNALREVYAHAVLG 68
Query: 743 RHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDET-DEAPRSLNLIQ 801
+H ++V+ +A + +D + E+ + SL + + R EA +
Sbjct: 69 QHSHVVRYFSA-----WAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEA-------E 116
Query: 802 RLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED-------------------MIA 842
++ + V L Y+H + H D+KPSNI + ++
Sbjct: 117 LKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMF 173
Query: 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPE-------YGLGSEVSISGDVYSYGILL 895
IGD G +SS Q +G ++A E + + D+++ + +
Sbjct: 174 KIGDLGHVT--RISSPQVE----EGDSRFLANEVLQENYTHLPKA------DIFALALTV 221
Query: 896 LELITRKKPTDIMFEGDMNLHNLARTALPD 925
+ + H + + LP
Sbjct: 222 VCAAGAEPL----PRNGDQWHEIRQGRLPR 247
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 6e-21
Identities = 67/245 (27%), Positives = 106/245 (43%), Gaps = 31/245 (12%)
Query: 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRT--TIAVKVFNLLHH-GAFKSF----IAECNT 738
AT R+ V +IG G++G+V+K D + +A+K + + G + E
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKAR--DPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 739 LKNIR---HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPR 795
L+ + H N+V+++ C+ LVFE + + L +L E +
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIK 123
Query: 796 SLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPL 855
L + Q L L++LH +C I H DLKP NIL+ + DFGLAR
Sbjct: 124 DL-MRQFLR-------GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY 172
Query: 856 SSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNL 915
A T + + Y APE L S + D++S G + E+ R KP +F G+
Sbjct: 173 QMALTPVVVT---LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR-KP---LFCGNSEA 225
Query: 916 HNLAR 920
L +
Sbjct: 226 DQLGK 230
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 7e-21
Identities = 67/251 (26%), Positives = 115/251 (45%), Gaps = 47/251 (18%)
Query: 685 NATDRFSSVNQIGEGSFGSVFKGILDDGRT--TIAVKVFNLLH-HGAFKSFIAECNTLKN 741
+++ +F + ++G G++ +V+KG+ + T +A+K L G + I E + +K
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGL--NKTTGVYVALKEVKLDSEEGTPSTAIREISLMKE 59
Query: 742 IRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQ 801
++H N+V++ + LVFEFM N L++++ +R LNL++
Sbjct: 60 LKHENIVRLYDVIHT---ENKLT--LVFEFMDN-DLKKYMD--SRTVGNTPRGLELNLVK 111
Query: 802 RLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTS 861
+ L + H + I H DLKP N+L+++ +GDFGLAR
Sbjct: 112 YF--QWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLAR---------- 156
Query: 862 SIGAKGS-----------IGYIAPEYGLGSEV-SISGDVYSYGILLLELITRKKPTDIMF 909
A G + Y AP+ +GS S S D++S G +L E+IT KP +F
Sbjct: 157 ---AFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITG-KP---LF 209
Query: 910 EGDMNLHNLAR 920
G + L
Sbjct: 210 PGTNDEEQLKL 220
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 9e-21
Identities = 63/247 (25%), Positives = 104/247 (42%), Gaps = 50/247 (20%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHR 745
+++ + +IGEG++G V+K + G T A+K L G + I E + LK ++H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGET-FALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 746 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNI 805
N+VK+ V + LVFE + L++ L D L + +
Sbjct: 61 NIVKLY----DVIHTKKRL-VLVFEHLDQ-DLKKLL---------DVCEGGLESVTAKSF 105
Query: 806 SIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGA 865
+ + + Y H + H DLKP N+L++ + I DFGLAR A
Sbjct: 106 LLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLAR-------------A 149
Query: 866 KGS-----------IGYIAPEYGLGSEV-SISGDVYSYGILLLELITRKKPTDIMFEGDM 913
G + Y AP+ +GS+ S + D++S G + E++ P +F G
Sbjct: 150 FGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG-TP---LFPGVS 205
Query: 914 NLHNLAR 920
L R
Sbjct: 206 EADQLMR 212
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 55/229 (24%), Positives = 91/229 (39%), Gaps = 31/229 (13%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFN---LLHHGAFKSFIAECNTLKNIRH 744
+ F +G+G FG+V+ + +A+KV L G E ++RH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 745 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLN 804
N++++ + L+ E+ ++ L +++ DE R+ I L
Sbjct: 69 PNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDE----QRTATYITEL- 118
Query: 805 ISIDVACALNYLH-HDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSI 863
A AL+Y H + H D+KP N+LL I DFG + P S
Sbjct: 119 -----ANALSYCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC- 168
Query: 864 GAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGD 912
G++ Y+ PE G D++S G+L E + K P FE +
Sbjct: 169 ---GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEAN 210
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 50/224 (22%), Positives = 99/224 (44%), Gaps = 25/224 (11%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGA-FKSFIAECN-TLKNIRHR 745
D + ++G G++G V K +AVK + K + + + +++ +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 746 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDET-DEAPRSLNLIQRLN 804
V G ++ D + E M + SL+++ + + +T E +++ +
Sbjct: 67 FTVT----FYGALFREGDVW-ICMELM-DTSLDKFYKQVIDKGQTIPE-----DILGK-- 113
Query: 805 ISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIG 864
I++ + AL +LH + H D+KPSN+L++ + DFG++ +L A+ G
Sbjct: 114 IAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAG 171
Query: 865 AKGSIGYIAPE----YGLGSEVSISGDVYSYGILLLELITRKKP 904
K Y+APE S+ D++S GI ++EL + P
Sbjct: 172 CK---PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 63/250 (25%), Positives = 99/250 (39%), Gaps = 52/250 (20%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKILT 752
+G+G F F+ D + A K+ LL + E + +++ H+++V
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 753 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACA 812
++ NDF +V E RSL E E EA ++++
Sbjct: 83 F-----FEDNDFVFVVLELCRRRSLLELHKRRKALTE-PEARY---YLRQI------VLG 127
Query: 813 LNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAK-----G 867
YLH + + H DLK N+ L+ED+ IGDFGL + + G + G
Sbjct: 128 CQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGL-------ATKVEYDGERKKVLCG 177
Query: 868 SIGYIAPE----YGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNL----- 918
+ YIAPE G EV DV+S G ++ L+ K P FE L
Sbjct: 178 TPNYIAPEVLSKKGHSFEV----DVWSIGCIMYTLLVGKPP----FE-TSCLKETYLRIK 228
Query: 919 -ARTALPDHV 927
++P H+
Sbjct: 229 KNEYSIPKHI 238
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 93.1 bits (231), Expect = 3e-20
Identities = 39/259 (15%), Positives = 81/259 (31%), Gaps = 65/259 (25%)
Query: 696 IGEGSFGSVFKGI-LDDGRTTIAVKVF----------------------------NLLHH 726
+G+ + + + G + V V N
Sbjct: 81 LGQEDPYAYLEATDQETGES-FEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 727 GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLE--EWLHPI 784
FI + +K+ + + +++ + + + F ++ M + E L
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIR-VRLDERDMWVLSRF--FLYPRMQSNLQTFGEVLLSH 196
Query: 785 TREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844
+ + SL RL +++ V L LHH + H L+P +I+LD+ +
Sbjct: 197 SSTHK------SLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFL 247
Query: 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEY-----------GLGSEVSISGDVYSYGI 893
F + SS S G+ PE + ++ S D ++ G+
Sbjct: 248 TGFEHLV--RDGARVVSS----VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301
Query: 894 LLLELITRKKPTDIMFEGD 912
++ + P D
Sbjct: 302 VIYWIWCADLP----ITKD 316
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-20
Identities = 66/267 (24%), Positives = 111/267 (41%), Gaps = 37/267 (13%)
Query: 684 YNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAF-KSFIAECNTLKNI 742
YN + F + +GEG++G V +A+K F + E LK+
Sbjct: 7 YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF 66
Query: 743 RHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDE-TDEAPRSLNLIQ 801
+H N++ I ++ + ++ E M + LH + +D+ + + Q
Sbjct: 67 KHENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQMLSDDHIQYF-IYQ 120
Query: 802 RLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTS 861
L A+ LH + H DLKPSN+L++ + + DFGLAR + S+A S
Sbjct: 121 TL-------RAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS 170
Query: 862 SIGAKGSI--GYI------APEYGLGS-EVSISGDVYSYGILLLELITRKKPTDIMFEGD 912
+ S ++ APE L S + S + DV+S G +L EL R+ +F G
Sbjct: 171 EPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR----PIFPGR 226
Query: 913 MNLHNLAR------TALPDHVMDIVDS 933
H L T D+ + ++S
Sbjct: 227 DYRHQLLLIFGIIGTPHSDNDLRCIES 253
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 4e-20
Identities = 60/246 (24%), Positives = 104/246 (42%), Gaps = 48/246 (19%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRN 746
+ + ++++GEG++ +V+KG +A+K L H GA + I E + LK+++H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 747 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNIS 806
+V + + + LVFE++ + L+++L D+ +N+
Sbjct: 62 IVTLH----DIIHTEKSL-TLVFEYLD-KDLKQYL---------DDCGNIINMHNVKLFL 106
Query: 807 IDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAK 866
+ L Y H + H DLKP N+L++E + DFGLAR AK
Sbjct: 107 FQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLAR-------------AK 150
Query: 867 GS-----------IGYIAPEYGLGSEV-SISGDVYSYGILLLELITRKKPTDIMFEGDMN 914
+ Y P+ LGS S D++ G + E+ T +P +F G
Sbjct: 151 SIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG-RP---LFPGSTV 206
Query: 915 LHNLAR 920
L
Sbjct: 207 EEQLHF 212
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 4e-20
Identities = 57/243 (23%), Positives = 97/243 (39%), Gaps = 41/243 (16%)
Query: 688 DRFSSVN-QIGEGSFGSVFKGILDDGRT--TIAVKVFNLLHHGAFKSFIAECNTLKNIRH 744
D F ++G G++G V+K DG+ A+K G S E L+ ++H
Sbjct: 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE--GTGISMSACREIALLRELKH 77
Query: 745 RNLVKILTACSGVDYQGNDFKALVFEFM-HNRSLEEWLHPITREDETDEAP-------RS 796
N++ + + L+F++ H+ L + + +S
Sbjct: 78 PNVISLQKVFLS---HADRKVWLLFDYAEHD--LWHIIKFHRASKANKKPVQLPRGMVKS 132
Query: 797 LNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH----IGDFGLARF 852
L L Q L+ ++YLH + + H DLKP+NIL+ + I D G AR
Sbjct: 133 L-LYQILD-------GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
Query: 853 --LPLSSAQTSSIGAKGSIGYIAPEYGLGSEV-SISGDVYSYGILLLELITRKKPTDIMF 909
PL + Y APE LG+ + + D+++ G + EL+T +P +F
Sbjct: 182 FNSPLKP-LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EP---IF 236
Query: 910 EGD 912
Sbjct: 237 HCR 239
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 5e-20
Identities = 63/250 (25%), Positives = 99/250 (39%), Gaps = 52/250 (20%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKILT 752
+G+G F F+ D + A K+ LL + E + +++ H+++V
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 753 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACA 812
++ NDF +V E RSL E E EA ++++
Sbjct: 109 F-----FEDNDFVFVVLELCRRRSLLELHKRRKALTE-PEARY---YLRQI------VLG 153
Query: 813 LNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAK-----G 867
YLH + + H DLK N+ L+ED+ IGDFGL + + G + G
Sbjct: 154 CQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGL-------ATKVEYDGERKKVLCG 203
Query: 868 SIGYIAPEY----GLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNL----- 918
+ YIAPE G EV DV+S G ++ L+ K P FE L
Sbjct: 204 TPNYIAPEVLSKKGHSFEV----DVWSIGCIMYTLLVGKPP----FE-TSCLKETYLRIK 254
Query: 919 -ARTALPDHV 927
++P H+
Sbjct: 255 KNEYSIPKHI 264
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 6e-20
Identities = 55/223 (24%), Positives = 98/223 (43%), Gaps = 22/223 (9%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL-LHHGAFKSFIAECNT-LKNIRHR 745
+ + +IG G++GSV K + +AVK + K + + + +++
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 746 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNI 805
+V+ G ++ D + E M + S +++ + + ++ + I
Sbjct: 82 YIVQ----FYGALFREGDCW-ICMELM-STSFDKFYKYVYS---VLDDVIPEEILGK--I 130
Query: 806 SIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGA 865
++ ALN+L + + I H D+KPSNILLD + DFG++ L S A+T G
Sbjct: 131 TLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGC 188
Query: 866 KGSIGYIAPE----YGLGSEVSISGDVYSYGILLLELITRKKP 904
+ Y+APE + DV+S GI L EL T + P
Sbjct: 189 R---PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 8e-20
Identities = 55/224 (24%), Positives = 88/224 (39%), Gaps = 27/224 (12%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL-LHHGAFKSFIAECNTL-KNIRHR 745
+ ++ ++G G+ G V+K IAVK + K + + + + K+
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 746 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNI 805
+V+ C G D + E M + + E +
Sbjct: 85 YIVQ----CFGTFITNTDVF-IAMELMGTCAEKLKKRMQGPIPERILGK----------M 129
Query: 806 SIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGA 865
++ + AL YL + H D+KPSNILLDE + DFG++ L A+ S G
Sbjct: 130 TVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGC 187
Query: 866 KGSIGYIAPE-----YGLGSEVSISGDVYSYGILLLELITRKKP 904
Y+APE + I DV+S GI L+EL T + P
Sbjct: 188 A---AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 9e-20
Identities = 57/238 (23%), Positives = 95/238 (39%), Gaps = 37/238 (15%)
Query: 680 YQNLYNATD---RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAEC 736
Y+++ D + V ++G+G+FG V+K + A KV + +I E
Sbjct: 8 YEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEI 67
Query: 737 NTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRS 796
L H +VK+L A Y + ++ EF ++ + E R
Sbjct: 68 EILATCDHPYIVKLLGA-----YYHDGKLWIMIEFCPGGAV---------DAIMLELDRG 113
Query: 797 LNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLS 856
L Q + + ALN+LH I H DLK N+L+ + + DFG
Sbjct: 114 LTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFG-------V 163
Query: 857 SAQTSSIGAKGS--IG---YIAPEYGLGSEVSISG-----DVYSYGILLLELITRKKP 904
SA+ K IG ++APE + + + D++S GI L+E+ + P
Sbjct: 164 SAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 9e-20
Identities = 55/251 (21%), Positives = 95/251 (37%), Gaps = 53/251 (21%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKILT 752
+G+GSF V++ +A+K+ + + G + E ++H +++++
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY- 77
Query: 753 ACSGVDYQGNDFKA-LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVAC 811
+Y + LV E HN + +L + +EA + ++
Sbjct: 78 -----NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARH---FMHQI------IT 123
Query: 812 ALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAK----- 866
+ YLH I H DL SN+LL +M I DFGL + Q K
Sbjct: 124 GMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGL-------ATQLKMPHEKHYTLC 173
Query: 867 GSIGYIAPE----YGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNL---- 918
G+ YI+PE G E DV+S G + L+ + P F+ + N
Sbjct: 174 GTPNYISPEIATRSAHGLES----DVWSLGCMFYTLLIGRPP----FD-TDTVKNTLNKV 224
Query: 919 --ARTALPDHV 927
A +P +
Sbjct: 225 VLADYEMPSFL 235
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-19
Identities = 61/240 (25%), Positives = 97/240 (40%), Gaps = 51/240 (21%)
Query: 688 DRFSSVNQIGEGSFGSVFKGI-LDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRH 744
+++ ++ +GEGS+G V K D GR +A+K F K + E LK +RH
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRI-VAIKKFLESDDDKMVKKIAMREIKLLKQLRH 83
Query: 745 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLN 804
NLV +L C + LVFEF+ ++ + L + P L+
Sbjct: 84 ENLVNLLEVC-----KKKKRWYLVFEFVD-HTILDDL---------ELFPNGLDYQVVQK 128
Query: 805 ISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIG 864
+ + + H I H D+KP NIL+ + + + DFG AR
Sbjct: 129 YLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFAR------------- 172
Query: 865 AKGSIG-----------YIAPEYGLGSEV-SISGDVYSYGILLLELITRKKPTDIMFEGD 912
+ G Y APE +G + DV++ G L+ E+ +P +F GD
Sbjct: 173 TLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG-EP---LFPGD 228
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 54/223 (24%), Positives = 92/223 (41%), Gaps = 31/223 (13%)
Query: 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRN 746
S +IGEGS G V +AVK+ +L + E +++ +H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 747 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNIS 806
+V++ + Y + ++ EF+ +L + + R +E A +
Sbjct: 104 VVEMYKS-----YLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIA----------TVC 147
Query: 807 IDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAK 866
V AL YLH + H D+K +ILL D + DFG AQ S K
Sbjct: 148 EAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGF-------CAQISKDVPK 197
Query: 867 -----GSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
G+ ++APE S + D++S GI+++E++ + P
Sbjct: 198 RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 49/187 (26%), Positives = 75/187 (40%), Gaps = 12/187 (6%)
Query: 353 SNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRL 412
+L +L L N ++ A + + L +L++ L T G L L L L
Sbjct: 27 PDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL--TKLQVDGTLPVLGTLDL 84
Query: 413 QRNRFQGNIPPSIGNL-KLFILYLSYNFLQGSIPSSL-GRYETLTTIDLSNNNLTGTIPP 470
N+ Q ++P L L +L +S+N L S+P L + L N L T+PP
Sbjct: 85 SHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPP 141
Query: 471 Q-FIGLSSSLIVLDLSRNQLTGSIPSEV-GNLKNLEILNVFGNKLKGEIPSTLGSCIKLE 528
L L L+ N LT +P+ + L+NL+ L + N L IP L
Sbjct: 142 GLLTPT-PKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLP 198
Query: 529 QLEMQEN 535
+ N
Sbjct: 199 FAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 46/197 (23%), Positives = 73/197 (37%), Gaps = 33/197 (16%)
Query: 88 LKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLV 147
+L L N + RL L L + + + + L L L HNQL
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL-TKLQVD-GTLPVLGTLDLSHNQLQ 90
Query: 148 GKIPSELSSLSKIEHISVNDNNLTGSIPSSL-GNLSSIRSLFLSGNNLEGSIP-DTLGWL 205
+P +L + + V+ N LT S+P L ++ L+L GN L+ ++P L
Sbjct: 91 -SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPT 147
Query: 206 KNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGEN 265
L L++A N L+ +P+ + N L+NL + EN
Sbjct: 148 PKLEKLSLANNNLT-ELPAGLLN------------------------GLENLDTLLLQEN 182
Query: 266 QLTGAIPPTISNASNLE 282
L IP + L
Sbjct: 183 SLY-TIPKGFFGSHLLP 198
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 41/165 (24%), Positives = 68/165 (41%), Gaps = 9/165 (5%)
Query: 433 LYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGS 492
+ L ++P L + T + LS N L + + L L+L R +LT
Sbjct: 15 VNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTR-LTQLNLDRAELT-K 69
Query: 493 IPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLS 552
+ + G L L L++ N+L+ +P + L L++ N L +L L L
Sbjct: 70 LQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQ 127
Query: 553 VLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQGVFKN 597
L L N L P LL ++ L+L+NN+L + G+
Sbjct: 128 ELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPA--GLLNG 170
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 7e-12
Identities = 37/133 (27%), Positives = 59/133 (44%), Gaps = 9/133 (6%)
Query: 454 LTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKL 513
++ NLT +PP L +L LS N L + + L LN+ +L
Sbjct: 12 HLEVNCDKRNLT-ALPP---DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67
Query: 514 KGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPE-LLIRL 572
++ G+ L L++ N LQ +P +L L+VLD+S N L+ +P L L
Sbjct: 68 T-KLQ-VDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLT-SLPLGALRGL 123
Query: 573 QLVKNLNLSNNDL 585
++ L L N+L
Sbjct: 124 GELQELYLKGNEL 136
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 33/130 (25%), Positives = 54/130 (41%), Gaps = 6/130 (4%)
Query: 65 TILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGG 124
LDL +L S+ L L VL + N L LQ L L N +
Sbjct: 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNEL-K 137
Query: 125 AIPANI-SSCSNLIQLRLFHNQLVGKIPSEL-SSLSKIEHISVNDNNLTGSIPSSLGNLS 182
+P + + L +L L +N L ++P+ L + L ++ + + +N+L +IP
Sbjct: 138 TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSH 195
Query: 183 SIRSLFLSGN 192
+ FL GN
Sbjct: 196 LLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 8e-11
Identities = 37/183 (20%), Positives = 74/183 (40%), Gaps = 11/183 (6%)
Query: 112 LQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLT 171
+ ++ A+P ++ + L L N L + L +++ ++++ LT
Sbjct: 12 HLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT 68
Query: 172 GSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIF-NIS 230
+ G L + +L LS N L+ S+P L L L ++ NRL+ ++P +
Sbjct: 69 -KLQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLG 124
Query: 231 SITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTI-SNASNLEIFHGSVN 289
+ N+++ +P L+ S+ N LT +P + + NL+ N
Sbjct: 125 ELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQEN 182
Query: 290 KLT 292
L
Sbjct: 183 SLY 185
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 50/251 (19%), Positives = 72/251 (28%), Gaps = 64/251 (25%)
Query: 166 NDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSS 225
+ NLT ++P L L LS N L TL L L + + L
Sbjct: 18 DKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL------- 67
Query: 226 IFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFH 285
+ + +L L + NQL ++P L +
Sbjct: 68 ----TKLQVDG----------------TLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLD 106
Query: 286 GSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFG 345
S N+LT L+ L + N
Sbjct: 107 VSFNRLTSLPLG--------AL---------------------RGLGELQELYLKGNEL- 136
Query: 346 GSLPACISNLSTTLEVLLLDNNQIFGNIPAAI-GKFVNLQRLDMCSNRLSGTIPPAIGEL 404
+LP + + LE L L NN + +PA + NL L + N L TIP
Sbjct: 137 KTLPPGLLTPTPKLEKLSLANNNL-TELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGS 194
Query: 405 QNLKDLRLQRN 415
L L N
Sbjct: 195 HLLPFAFLHGN 205
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 1e-19
Identities = 58/249 (23%), Positives = 96/249 (38%), Gaps = 53/249 (21%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRT--TIAVKVFNLLH--HGAFKSFIAECNTLKNIR 743
+++ + +IGEGS+G VFK + T +A+K F K + E LK ++
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCR--NRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK 60
Query: 744 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRL 803
H NLV +L V + LVFE+ ++ L D R +
Sbjct: 61 HPNLVNLL----EVFRRKRRL-HLVFEYCD-HTVLHEL---------DRYQRGVPEHLVK 105
Query: 804 NISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSI 863
+I+ A+N+ H H D+KP NIL+ + + + DFG AR
Sbjct: 106 SITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFAR------------ 150
Query: 864 GAKGSIG-----------YIAPEYGLGSEV-SISGDVYSYGILLLELITRKKPTDIMFEG 911
Y +PE +G DV++ G + EL++ P ++ G
Sbjct: 151 -LLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG-VP---LWPG 205
Query: 912 DMNLHNLAR 920
++ L
Sbjct: 206 KSDVDQLYL 214
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-19
Identities = 64/252 (25%), Positives = 104/252 (41%), Gaps = 42/252 (16%)
Query: 680 YQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVK-VFNLLHHGAF-KSFIAECN 737
+ + + + +G G++G+V + +A+K ++ F K E
Sbjct: 17 TKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR 76
Query: 738 TLKNIRHRNLVKILTACSGVDYQGNDFKA--LVFEFMHNRSLEEWLHPITREDETDEAPR 795
LK++RH N++ +L + D +DF LV FM L + + ++ E
Sbjct: 77 LLKHMRHENVIGLLDVFT-PDETLDDFTDFYLVMPFM-----GTDLGKLMKHEKLGEDRI 130
Query: 796 SLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPL 855
+ Q L L Y+H I H DLKP N+ ++ED I DFGLAR
Sbjct: 131 QFLVYQML-------KGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QA 178
Query: 856 SSAQTSSIGAKGSIGYI------APEYGLGS-EVSISGDVYSYGILLLELITRKKPTDIM 908
S T GY+ APE L + + D++S G ++ E+IT K +
Sbjct: 179 DSEMT---------GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK----TL 225
Query: 909 FEGDMNLHNLAR 920
F+G +L L
Sbjct: 226 FKGSDHLDQLKE 237
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 53/223 (23%), Positives = 95/223 (42%), Gaps = 31/223 (13%)
Query: 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRN 746
+++ +IG+G+ G+V+ + +A++ NL + I E ++ ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 747 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNIS 806
+V L + Y D +V E++ SL + + T DE A +
Sbjct: 79 IVNYLDS-----YLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIA----------AVC 122
Query: 807 IDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAK 866
+ AL +LH + + H D+K NILL D + DFG AQ + +K
Sbjct: 123 RECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF-------CAQITPEQSK 172
Query: 867 GS--IG---YIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
S +G ++APE D++S GI+ +E+I + P
Sbjct: 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-19
Identities = 65/269 (24%), Positives = 113/269 (42%), Gaps = 42/269 (15%)
Query: 665 KQNPNSPINSFPNISYQ---NLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVF 721
K NP N + +++ IG GSFG VF+ L + +A+K
Sbjct: 14 KLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESD-EVAIK-- 70
Query: 722 NLLHHGAFKSFIAECNTLKNIRHRNLVKILTA-CSGVDYQGNDFKALVFEFMHNRSLEEW 780
+L FK+ E ++ ++H N+V + S D + F LV E++ E
Sbjct: 71 KVLQDKRFKN--RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-----PET 123
Query: 781 LHPITREDETDEAPRSLNLIQRLNISIDVACALNYLH-HDCQPPIAHCDLKPSNILLDED 839
++ +R + + LI+ + +L Y+H I H D+KP N+LLD
Sbjct: 124 VYRASRHYAKLKQTMPMLLIK--LYMYQLLRSLAYIHSIG----ICHRDIKPQNLLLDPP 177
Query: 840 M-IAHIGDFGLARFLPLSSAQTSSIGAKGSIGYI------APEYGLGSEV-SISGDVYSY 891
+ + DFG A+ L I + ++ YI APE G+ + + D++S
Sbjct: 178 SGVLKLIDFGSAKIL---------IAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWST 228
Query: 892 GILLLELITRKKPTDIMFEGDMNLHNLAR 920
G ++ EL+ +P +F G+ + L
Sbjct: 229 GCVMAELMQG-QP---LFPGESGIDQLVE 253
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-19
Identities = 56/264 (21%), Positives = 95/264 (35%), Gaps = 55/264 (20%)
Query: 680 YQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVK-VFNLLHHGA----FKSFIA 734
L+ ++ I GS+G+V G+ D +A+K VFN + G
Sbjct: 14 IAELHAMQSPYTVQRFISSGSYGAVCAGV-DSEGIPVAIKRVFNTVSDGRTVNILSDSFL 72
Query: 735 ------ECNTLKNIRHRNLVKILTACSGVDYQGNDFKA--LVFEFMHNRSLEEWLHPITR 786
E L + H N++ + V ++ LV E M L +
Sbjct: 73 CKRVLREIRLLNHFHHPNILGLRDIF--VHFEEPAMHKLYLVTELM-----RTDLAQVIH 125
Query: 787 EDE---TDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843
+ + + + + L L+ LH + + H DL P NILL ++
Sbjct: 126 DQRIVISPQHIQYF-MYHIL-------LGLHVLH---EAGVVHRDLHPGNILLADNNDIT 174
Query: 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYI------APEYGLGS-EVSISGDVYSYGILLL 896
I DF LAR + +T Y+ APE + + D++S G ++
Sbjct: 175 ICDFNLAREDTADANKT---------HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMA 225
Query: 897 ELITRKKPTDIMFEGDMNLHNLAR 920
E+ RK +F G + L +
Sbjct: 226 EMFNRK----ALFRGSTFYNQLNK 245
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 3e-19
Identities = 64/251 (25%), Positives = 108/251 (43%), Gaps = 54/251 (21%)
Query: 688 DRFSSVNQIGEGSFGSVFKGI-LDDGRTTIAVKVFNLLHHGAFK-----SFIAECNTLKN 741
R+ ++ +GEG F +V+K + + +A+K L H K + + E L+
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQI-VAIKKIKLGHRSEAKDGINRTALREIKLLQE 68
Query: 742 IRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQ 801
+ H N++ +L ++ +LVF+FM LE + + + + + I+
Sbjct: 69 LSHPNIIGLL----DAFGHKSNI-SLVFDFME-TDLEVII-------KDNSLVLTPSHIK 115
Query: 802 RLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTS 861
+ L YLH I H DLKP+N+LLDE+ + + DFGLA+
Sbjct: 116 AY--MLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK---------- 160
Query: 862 SIGAKGSIG-----------YIAPEYGLGSEV-SISGDVYSYGILLLELITRKKPTDIMF 909
+ GS Y APE G+ + + D+++ G +L EL+ R P
Sbjct: 161 ---SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR-VP---FL 213
Query: 910 EGDMNLHNLAR 920
GD +L L R
Sbjct: 214 PGDSDLDQLTR 224
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 4e-19
Identities = 57/276 (20%), Positives = 93/276 (33%), Gaps = 70/276 (25%)
Query: 688 DRFSSVNQIGEGSFGSVFKGIL-----DDGRTTIAVKVFNLLHHGA----FKSFIAECNT 738
DR +G G+FG V + T+AVK +L GA ++ ++E
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK---MLKEGATHSEHRALMSELKI 78
Query: 739 LKNI-RHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLH--------PITREDE 789
L +I H N+V +L AC+ + ++ EF +L +L T+
Sbjct: 79 LIHIGHHLNVVNLLGACT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGAR 134
Query: 790 TDEAPRSLNLIQR---------------------LNISIDVACALNYLHHDCQPPIA--- 825
+ + I S+ + +
Sbjct: 135 FRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEH 194
Query: 826 ---------------------HCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIG 864
H DL NILL E + I DFGLAR +
Sbjct: 195 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 254
Query: 865 AKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900
A+ + ++APE +I DV+S+G+LL E+ +
Sbjct: 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 4e-19
Identities = 69/254 (27%), Positives = 111/254 (43%), Gaps = 59/254 (23%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRT--TIAVKVFNLLH--HGAFKSFIAECNTLKNIR 743
DR+ + ++GEG++G V+K I D T T+A+K L H G + I E + LK ++
Sbjct: 34 DRYRRITKLGEGTYGEVYKAI--DTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ 91
Query: 744 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRL 803
HRN++++ + V + + L+FE+ L++++ +S L Q +
Sbjct: 92 HRNIIELKS----VIHHNHRL-HLIFEYAE-NDLKKYMDKNPDVSMRVI--KSF-LYQLI 142
Query: 804 NISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH-----IGDFGLARFLPLSSA 858
N +N+ H H DLKP N+LL + IGDFGLAR
Sbjct: 143 N-------GVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR------- 185
Query: 859 QTSSIGAKGS-----------IGYIAPEYGLGSEV-SISGDVYSYGILLLELITRKKPTD 906
A G + Y PE LGS S S D++S + E++ + P
Sbjct: 186 ------AFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMK-TP-- 236
Query: 907 IMFEGDMNLHNLAR 920
+F GD + L +
Sbjct: 237 -LFPGDSEIDQLFK 249
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 4e-19
Identities = 61/248 (24%), Positives = 96/248 (38%), Gaps = 31/248 (12%)
Query: 669 NSPINSFPNISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGA 728
+SP S I L + F V +G G++G V+KG A+KV + +
Sbjct: 5 DSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGDE 63
Query: 729 FKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKA-LVFEFMHNRSLEEWLHPITR 786
+ E N LK HRN+ A + G D + LV EF S+ + +
Sbjct: 64 EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG 123
Query: 787 EDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846
+L I ++ L++LH + H D+K N+LL E+ + D
Sbjct: 124 --------NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVD 172
Query: 847 FGLARFLPLSSAQTSSIGAK--GSIG---YIAPEYGLGSEVSISG-----DVYSYGILLL 896
FG+ SAQ + IG ++APE E + D++S GI +
Sbjct: 173 FGV-------SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAI 225
Query: 897 ELITRKKP 904
E+ P
Sbjct: 226 EMAEGAPP 233
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 5e-19
Identities = 60/252 (23%), Positives = 103/252 (40%), Gaps = 42/252 (16%)
Query: 680 YQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVK-VFNLLHHGAF-KSFIAECN 737
+ ++ +R+ +++ +G G++GSV +AVK + K E
Sbjct: 21 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 80
Query: 738 TLKNIRHRNLVKILTACSGVDYQGNDFKA--LVFEFMHNRSLEEWLHPITREDETDEAPR 795
LK+++H N++ +L + +F LV M L+ I + + +
Sbjct: 81 LLKHMKHENVIGLLDVFT-PARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDDHV 134
Query: 796 SLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPL 855
+ Q L L Y+H I H DLKPSN+ ++ED I DFGLAR
Sbjct: 135 QFLIYQIL-------RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HT 182
Query: 856 SSAQTSSIGAKGSIGYI------APEYGLGS-EVSISGDVYSYGILLLELITRKKPTDIM 908
+ T GY+ APE L + + D++S G ++ EL+T + +
Sbjct: 183 ADEMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR----TL 229
Query: 909 FEGDMNLHNLAR 920
F G ++ L
Sbjct: 230 FPGTDHIDQLKL 241
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 6e-19
Identities = 50/286 (17%), Positives = 106/286 (37%), Gaps = 28/286 (9%)
Query: 320 RDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGK 379
+ +L NA ++ + ++L + L + I +
Sbjct: 10 NVIFPDPALANAIKI-----AAGKSNVTDTVTQADL-DGITTLSAFGTGV-TTIEG-VQY 61
Query: 380 FVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNF 439
NL L++ N+++ + P + L + +L L N + N+ G + L L+
Sbjct: 62 LNNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNPLK-NVSAIAGLQSIKTLDLTSTQ 118
Query: 440 LQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGN 499
+ P L L + L N +T I P + ++L L + Q++ + + + N
Sbjct: 119 ITDVTP--LAGLSNLQVLYLDLNQIT-NISP--LAGLTNLQYLSIGNAQVS-DL-TPLAN 171
Query: 500 LKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQN 559
L L L NK+ +I L S L ++ ++ N + S L++ L ++ L+
Sbjct: 172 LSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQ 227
Query: 560 NLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQ----GVFKNASIT 601
++ + LV + + P G + + ++T
Sbjct: 228 TITN--QPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLT 271
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 6e-18
Identities = 58/303 (19%), Positives = 110/303 (36%), Gaps = 52/303 (17%)
Query: 205 LKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGE 264
L N + + ++ ++ + ++ IT A + + Y L NL + +
Sbjct: 18 LANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTTIEGVQY---LNNLIGLELKD 72
Query: 265 NQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNF 324
NQ+T + P + N + + S N L +++
Sbjct: 73 NQITD-LAP-LKNLTKITELELSGNPLK----------------------------NVSA 102
Query: 325 LCSLTNATRLKWLLININNFGGSLPACISNLS--TTLEVLLLDNNQIFGNIPAAIGKFVN 382
+ L + +K L + ++ L+ + L+VL LD NQI NI + N
Sbjct: 103 IAGLQS---IKTLDLTSTQITD-----VTPLAGLSNLQVLYLDLNQI-TNISP-LAGLTN 152
Query: 383 LQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQG 442
LQ L + + ++S + P + L L L+ N+ +I P L ++L N +
Sbjct: 153 LQYLSIGNAQVS-DLTP-LANLSKLTTLKADDNKIS-DISPLASLPNLIEVHLKNNQI-- 207
Query: 443 SIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKN 502
S S L L + L+N +T L +V S + + S+ G +
Sbjct: 208 SDVSPLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYAS 267
Query: 503 LEI 505
+
Sbjct: 268 PNL 270
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 7e-15
Identities = 54/296 (18%), Positives = 113/296 (38%), Gaps = 32/296 (10%)
Query: 84 NLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFH 143
L+ + ++ L + L+ + + +NLI L L
Sbjct: 17 ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 144 NQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLG 203
NQ+ + L +L+KI + ++ N L S++ L SI++L L+ + P L
Sbjct: 73 NQI--TDLAPLKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQITDVTP--LA 126
Query: 204 WLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVG 263
L NL L + N+++ S + ++++ G ++ PL +L L
Sbjct: 127 GLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLTPLA---NLSKLTTLKAD 181
Query: 264 ENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLN 323
+N+++ I P +++ NL H N+++ +P L L + + ++ ++ N
Sbjct: 182 DNKISD-ISP-LASLPNLIEVHLKNNQISDVSP-LANTSNLFIVTLTNQTITNQPVFYNN 238
Query: 324 FLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGK 379
L ++ + PA IS+ T + + N+ + I
Sbjct: 239 NLVVP--------NVVKGPSGAPIAPATISDNGT------YASPNLTWNLTSFINN 280
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 7e-19
Identities = 55/228 (24%), Positives = 88/228 (38%), Gaps = 29/228 (12%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFN---LLHHGAFKSFIAECNTLKNIRH 744
D F +G+G FG+V+ + +A+KV L G E ++RH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 745 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLN 804
N++++ + L+ EF L + L R DE RS ++ L
Sbjct: 74 PNILRMYNY-----FHDRKRIYLMLEFAPRGELYKELQKHGRFDE----QRSATFMEEL- 123
Query: 805 ISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIG 864
A AL+Y H + H D+KP N+L+ I DFG + P +T
Sbjct: 124 -----ADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC-- 173
Query: 865 AKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGD 912
G++ Y+ PE G D++ G+L E + P F+
Sbjct: 174 --GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP----FDSP 215
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 7e-19
Identities = 61/268 (22%), Positives = 105/268 (39%), Gaps = 36/268 (13%)
Query: 663 KEKQNPNSPINSFPNISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFN 722
+ + + P + +++ R+++++ IGEG++G V + + +A+K +
Sbjct: 2 HHHHHMAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS 61
Query: 723 LLHHGAF-KSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA--LVFEFMHNRSLEE 779
H + + + E L RH N++ I + K +V + M E
Sbjct: 62 PFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE--QMKDVYIVQDLM-----ET 114
Query: 780 WLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED 839
L+ + + L Q L L Y+H + H DLKPSN+LL+
Sbjct: 115 DLYKLLKTQHLSNDHICYFLYQIL-------RGLKYIH---SANVLHRDLKPSNLLLNTT 164
Query: 840 MIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYI------APEYGLGS-EVSISGDVYSYG 892
I DFGLAR A Y+ APE L S + S D++S G
Sbjct: 165 CDLKICDFGLAR-----VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVG 219
Query: 893 ILLLELITRKKPTDIMFEGDMNLHNLAR 920
+L E+++ + +F G L L
Sbjct: 220 CILAEMLSNR----PIFPGKHYLDQLNH 243
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 8e-19
Identities = 61/258 (23%), Positives = 100/258 (38%), Gaps = 59/258 (22%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRT--TIAVKVFNLLHHGAFKSF----IAECNTLKN 741
++ + +IG+G+FG VFK +T +A+K + + F + E L+
Sbjct: 17 SKYEKLAKIGQGTFGEVFKAR--HRKTGQKVALKKVLM--ENEKEGFPITALREIKILQL 72
Query: 742 IRHRNLVKILTACSGVDYQGNDFKA---LVFEFMHNRSLEEWLHPITREDETDEAPRSLN 798
++H N+V ++ C N K LVF+F H + +L+
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE--------HDLAGLLSNVLVKFTLS 124
Query: 799 LI-----QRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFL 853
I LN L Y+H + I H D+K +N+L+ D + + DFGLAR
Sbjct: 125 EIKRVMQMLLN-------GLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAF 174
Query: 854 PLSSAQTSSIGAKGSIG----------YIAPEYGLGSEV-SISGDVYSYGILLLELITRK 902
S+ Y PE LG D++ G ++ E+ TR
Sbjct: 175 --------SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR- 225
Query: 903 KPTDIMFEGDMNLHNLAR 920
P + +G+ H LA
Sbjct: 226 SP---IMQGNTEQHQLAL 240
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 9e-19
Identities = 54/254 (21%), Positives = 90/254 (35%), Gaps = 31/254 (12%)
Query: 660 RKRKEKQNPNSPINSFPNISYQNLYNATDRFSSV----NQIGEGSFGSVFKGILDDGRTT 715
+ + + S + ++G G++G V
Sbjct: 5 HHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVE 64
Query: 716 IAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMH 773
A+K+ + + + E LK + H N++K+ ++ LV E
Sbjct: 65 RAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF-----FEDKRNYYLVMECYK 119
Query: 774 NRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSN 833
L + + + +E D A I V + YLH I H DLKP N
Sbjct: 120 GGELFDEIIHRMKFNEVDAA----------VIIKQVLSGVTYLHKHN---IVHRDLKPEN 166
Query: 834 ILL---DEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYS 890
+LL ++D + I DFGL+ + G+ YIAPE L + DV+S
Sbjct: 167 LLLESKEKDALIKIVDFGLSAVFENQKKMKERL---GTAYYIAPEV-LRKKYDEKCDVWS 222
Query: 891 YGILLLELITRKKP 904
G++L L+ P
Sbjct: 223 IGVILFILLAGYPP 236
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 90.2 bits (223), Expect = 1e-18
Identities = 46/269 (17%), Positives = 104/269 (38%), Gaps = 32/269 (11%)
Query: 296 PYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNL 355
+ + +L + D L + + ++ N ++ + +
Sbjct: 18 DAFAETIKD--------NLKKKSVTDAVTQNELNS---IDQIIANNSDI-----KSVQGI 61
Query: 356 S--TTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQ 413
+ L L+ N++ +I + NL L + N++ + + +L+ LK L L+
Sbjct: 62 QYLPNVTKLFLNGNKL-TDIKP-LTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLE 117
Query: 414 RNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFI 473
N +I + +L LYL N + + + L R L T+ L +N ++ I P +
Sbjct: 118 HNGIS-DINGLVHLPQLESLYLGNN--KITDITVLSRLTKLDTLSLEDNQIS-DIVP--L 171
Query: 474 GLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQ 533
+ L L LS+N ++ + + LKNL++L +F + + + + + ++
Sbjct: 172 AGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNT 229
Query: 534 ENFLQGPIPSSLSSLRGLSVLDLSQNNLS 562
+ L P +S ++ +
Sbjct: 230 DGSLVTPEI--ISDDGDYEKPNVKWHLPE 256
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 80.2 bits (197), Expect = 2e-15
Identities = 52/239 (21%), Positives = 93/239 (38%), Gaps = 22/239 (9%)
Query: 129 NISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLF 188
+ + I+ L + + + L+ I+ I N++++ S+ + L ++ LF
Sbjct: 16 PDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLF 71
Query: 189 LSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPL 248
L+GN L I L LKNL L + +N++ + SS+ ++ + N I L
Sbjct: 72 LNGNKLT-DIKP-LTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGISDINGL 127
Query: 249 DYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFG 308
L L+ +G N++T +S + L+ N+++ P L L +L
Sbjct: 128 V---HLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLY 181
Query: 309 ILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNN 367
+ N + DL L L N L L + SNL V D +
Sbjct: 182 LSKNHI-----SDLRALAGLKN---LDVLELFSQECLNKPINHQSNLVVPNTVKNTDGS 232
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 72.8 bits (178), Expect = 2e-13
Identities = 61/334 (18%), Positives = 117/334 (35%), Gaps = 25/334 (7%)
Query: 407 LKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTG 466
+ + + I P + L + ++ ++ I +N+++
Sbjct: 1 MGETITVSTPIK-QIFPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK- 56
Query: 467 TIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIK 526
++ I ++ L L+ N+LT I + NLKNL L + NK+K ++ S+L K
Sbjct: 57 SVQG--IQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIK-DL-SSLKDLKK 110
Query: 527 LEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLE 586
L+ L ++ N + + L L L L L N ++ +L RL + L+L +N +
Sbjct: 111 LKSLSLEHNGIS--DINGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS 166
Query: 587 GVVPTQGVFK-------NASITSVFGNLKLCGGIPEFQLP--TCSSKKSKHKKSLALKLV 637
+VP G+ K I+ L + +L C +K H+ +L +
Sbjct: 167 DIVPLAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNT 225
Query: 638 LAIISGLIGLSLALSIIVLCLVRKRKEKQNPNSPINSFPNISYQNLYNATDRFSSVNQIG 697
+ G + +S K + SF + A RF
Sbjct: 226 VKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQP 285
Query: 698 EGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKS 731
+V + D V+ + +
Sbjct: 286 LKEVYTVSYDV-DGTVIKTKVEAGTRITAPKPPT 318
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 71.7 bits (175), Expect = 6e-13
Identities = 40/208 (19%), Positives = 78/208 (37%), Gaps = 15/208 (7%)
Query: 84 NLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFH 143
L+ + + N+ + L + L L+ N + +++ NL L L
Sbjct: 41 ELNSIDQIIANNSDIKS-V-QGIQYLPNVTKLFLNGNKLTDI--KPLTNLKNLGWLFLDE 96
Query: 144 NQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLG 203
N++ + S L L K++ +S+ N ++ I + L +L + SL+L N + + L
Sbjct: 97 NKIK-DL-SSLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKI--TDITVLS 150
Query: 204 WLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVG 263
L L L++ N++S I + ++ + N I L L+NL +
Sbjct: 151 RLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHISDLRALA---GLKNLDVLELF 205
Query: 264 ENQLTGAIPPTISNASNLEIFHGSVNKL 291
+ SN + L
Sbjct: 206 SQECLNKPINHQSNLVVPNTVKNTDGSL 233
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 40/224 (17%), Positives = 69/224 (30%), Gaps = 16/224 (7%)
Query: 69 LESLKLAG----SISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGG 124
LESL L I+ + L+ L L L +N + L +LQ L L N I
Sbjct: 133 LESLYLGNNKITDITV-LSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSKNHI-- 187
Query: 125 AIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTG----SIPSSLGN 180
+ ++ NL L LF + + K + S+L + D +L S
Sbjct: 188 SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEK 247
Query: 181 LSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNI---SSITGFDA 237
+ L N + + K + + + +++ T +A
Sbjct: 248 PNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVDGTVIKTKVEA 307
Query: 238 GVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNL 281
G P G+ + G ++ N L
Sbjct: 308 GTRITAPKPPTKQGYVFKGWYTEKNGGHEWNFNTDYMSGNDFTL 351
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 3e-18
Identities = 58/274 (21%), Positives = 103/274 (37%), Gaps = 66/274 (24%)
Query: 685 NATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVK-VFNLLHHGAFKSFIAECNTLKNIR 743
++ ++S +G GSFG V + + A+K V +K E + +K +
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ---DPRYK--NRELDIMKVLD 58
Query: 744 HRNLVKIL------TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSL 797
H N++K++ Q D + + + + L
Sbjct: 59 HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKY-----L 113
Query: 798 NLIQ-----------------RLNISID--------VACALNYLHHDCQPPIAHCDLKPS 832
N+I +I ++ + A+ ++H I H D+KP
Sbjct: 114 NVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQ 170
Query: 833 NILLD-EDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYI------APEYGLGS-EVSI 884
N+L++ +D + DFG A+ L S + YI APE LG+ E +
Sbjct: 171 NLLVNSKDNTLKLCDFGSAKKLIPSEPSVA---------YICSRFYRAPELMLGATEYTP 221
Query: 885 SGDVYSYGILLLELITRKKPTDIMFEGDMNLHNL 918
S D++S G + ELI KP +F G+ ++ L
Sbjct: 222 SIDLWSIGCVFGELILG-KP---LFSGETSIDQL 251
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 59/229 (25%), Positives = 90/229 (39%), Gaps = 23/229 (10%)
Query: 685 NATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGA-FKSFIAECNTLKNIR 743
D + IG G+ V + +A+K NL + E +
Sbjct: 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH 71
Query: 744 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRL 803
H N+V T+ + D LV + + S+ + + I + E + I
Sbjct: 72 HPNIVSYYTS-----FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIA-- 124
Query: 804 NISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSI 863
I +V L YLH + Q I H D+K NILL ED I DFG++ FL T +
Sbjct: 125 TILREVLEGLEYLHKNGQ--I-HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNK 181
Query: 864 GAKGSIG---YIAPE-----YGLGSEVSISGDVYSYGILLLELITRKKP 904
K +G ++APE G + D++S+GI +EL T P
Sbjct: 182 VRKTFVGTPCWMAPEVMEQVRGYDFKA----DIWSFGITAIELATGAAP 226
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-18
Identities = 35/184 (19%), Positives = 71/184 (38%), Gaps = 10/184 (5%)
Query: 334 LKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRL 393
K L + + + + +L + L N + ++ I N++ L + +
Sbjct: 22 FKAYLNGLLGQSSTANITEAQM-NSLTYITLANINV-TDLTG-IEYAHNIKDLTINNIHA 78
Query: 394 SGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNL-KLFILYLSYNFLQGSIPSSLGRYE 452
+ P I L NL+ LR+ + P++ L L +L +S++ SI + +
Sbjct: 79 TNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLP 136
Query: 453 TLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNK 512
+ +IDLS N I P + L L++ + + + + L L F
Sbjct: 137 KVNSIDLSYNGAITDIMP--LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQT 192
Query: 513 LKGE 516
+ G+
Sbjct: 193 IGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-16
Identities = 34/207 (16%), Positives = 74/207 (35%), Gaps = 14/207 (6%)
Query: 358 TLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRF 417
E L +Q NIP + + S T ++ +L + L
Sbjct: 2 AAEQTGLKASQDNVNIPDS-----TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINV 56
Query: 418 QGNIPPSIGNLK-LFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLS 476
++ I + L ++ + + + L + + ++T P GL+
Sbjct: 57 T-DLTG-IEYAHNIKDLTINNI--HATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLT 112
Query: 477 SSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENF 536
S L +LD+S + SI +++ L + +++ N +I L + +L+ L +Q +
Sbjct: 113 S-LTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDG 170
Query: 537 LQGPIPSSLSSLRGLSVLDLSQNNLSG 563
+ + L+ L + G
Sbjct: 171 VHDY--RGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-15
Identities = 31/162 (19%), Positives = 60/162 (37%), Gaps = 7/162 (4%)
Query: 83 GNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLF 142
++ L + L N + + + ++ L ++ P IS SNL +LR+
Sbjct: 41 AQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIM 96
Query: 143 HNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTL 202
+ LS L+ + + ++ + SI + + L + S+ LS N I L
Sbjct: 97 GKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPL 155
Query: 203 GWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQG 244
L L +L + + + I + + A I G
Sbjct: 156 KTLPELKSLNIQFDGVHDY--RGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 3e-15
Identities = 33/164 (20%), Positives = 63/164 (38%), Gaps = 13/164 (7%)
Query: 429 KLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQ 488
L + + + +LT I L+N N+T I + ++ L ++
Sbjct: 24 AYLNGLLGQSSTANITEAQM---NSLTYITLANINVTDLTG---IEYAHNIKDLTINNIH 77
Query: 489 LTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSL 548
T + + L NLE L + G + + L L L++ + I + +++L
Sbjct: 78 ATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTL 135
Query: 549 RGLSVLDLSQNNLSGKIPEL--LIRLQLVKNLNLSNNDLEGVVP 590
++ +DLS N I L L L K+LN+ + +
Sbjct: 136 PKVNSIDLSYNGAITDIMPLKTLPEL---KSLNIQFDGVHDYRG 176
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 9e-14
Identities = 27/142 (19%), Positives = 52/142 (36%), Gaps = 5/142 (3%)
Query: 325 LCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQ 384
L + A +K L IN + P IS L + LE L + + + + +L
Sbjct: 59 LTGIEYAHNIKDLTINNIHATNYNP--ISGL-SNLERLRIMGKDVTSDKIPNLSGLTSLT 115
Query: 385 RLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSI 444
LD+ + +I I L + + L N +I P +L L + ++ +
Sbjct: 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDY- 174
Query: 445 PSSLGRYETLTTIDLSNNNLTG 466
+ + L + + + G
Sbjct: 175 -RGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 2e-13
Identities = 18/130 (13%), Positives = 53/130 (40%), Gaps = 8/130 (6%)
Query: 69 LESLKLAG----SISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGG 124
++ L + + +P + LS L+ LR+ + L L +L + +++
Sbjct: 68 IKDLTINNIHATNYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDD 126
Query: 125 AIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSI 184
+I I++ + + L +N + I L +L +++ +++ + + + + +
Sbjct: 127 SILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDY--RGIEDFPKL 183
Query: 185 RSLFLSGNNL 194
L+ +
Sbjct: 184 NQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 1e-09
Identities = 37/228 (16%), Positives = 72/228 (31%), Gaps = 43/228 (18%)
Query: 189 LSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPL 248
L + +IPD+ K +N + Q+ + + ++S+T + +
Sbjct: 8 LKASQDNVNIPDST--FKAYLNGLLGQSSTANITEA---QMNSLTYITLANINVTDLTGI 62
Query: 249 DYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFG 308
+Y N++ ++ T P IS SNLE +T
Sbjct: 63 EY---AHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVT---------------- 101
Query: 309 ILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQ 368
+ L LT+ L L I+ + S+ I+ L + + L N
Sbjct: 102 ----------SDKIPNLSGLTS---LTLLDISHSAHDDSILTKINTL-PKVNSIDLSYNG 147
Query: 369 IFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNR 416
+I + L+ L++ + + I + L L
Sbjct: 148 AITDIM-PLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQT 192
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 32/230 (13%), Positives = 72/230 (31%), Gaps = 64/230 (27%)
Query: 166 NDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSS 225
+ T +I + ++S+ + L+ N+ + + N+ +LT+ +
Sbjct: 30 LGQSSTANI--TEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHAT------ 79
Query: 226 IFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFH 285
N + I+G L NL+ + +T P +S ++L +
Sbjct: 80 --NYNPISG-------------------LSNLERLRIMGKDVTSDKIPNLSGLTSLTLLD 118
Query: 286 GSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFG 345
S + D L + +L + + ++ N
Sbjct: 119 ISHSAHD--------------------------DSILTKINTLPK---VNSIDLSYNGAI 149
Query: 346 GSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSG 395
+ + L L+ L + + + + I F L +L S + G
Sbjct: 150 TDIMP-LKTL-PELKSLNIQFDGV-HDYR-GIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 12/114 (10%), Positives = 41/114 (35%), Gaps = 7/114 (6%)
Query: 478 SLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFL 537
+ + L ++ + +L + + + ++ + + ++ L +
Sbjct: 24 AYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHA 78
Query: 538 QGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPT 591
+ +S L L L + +++ L L + L++S++ + + T
Sbjct: 79 TNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILT 130
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 4e-18
Identities = 42/238 (17%), Positives = 84/238 (35%), Gaps = 34/238 (14%)
Query: 353 SNLSTTLEVLLLDNNQIFGNIPA-AIGKFVNLQRLDMCSNRLSGTIPP-AIGELQNLKDL 410
S+L L ++ I A F +L+++++ N + I L L ++
Sbjct: 26 SDLPRNAIELRFVLTKL-RVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEI 84
Query: 411 RLQRNRFQGNIPPSI--GNLKLFILYLSYNFLQGSIPSSLGRYET-LTTIDLSNNNLTGT 467
R+++ I P L L +S ++ +P + +D+ +N T
Sbjct: 85 RIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHT 143
Query: 468 IPPQ-FIGLSSSLIVLDLSRNQLTGSIPSEV-GNLKNLEILNVFGNKLKGEIPSTLGSCI 525
I F+GLS ++L L++N + I + + E+ N L+ E+P
Sbjct: 144 IERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELP------- 194
Query: 526 KLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNN 583
G +LD+S+ + L L+ ++ + N
Sbjct: 195 ----------------NDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 236
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 7e-13
Identities = 44/203 (21%), Positives = 76/203 (37%), Gaps = 19/203 (9%)
Query: 406 NLKDLRLQRNRFQ---GNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNN 462
+ + Q ++ ++P + L L+ + + L I++S N
Sbjct: 10 SNRVFLCQESKVTEIPSDLPRN-----AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQN 64
Query: 463 NLTGTIPPQ-FIGLSSSLIVLDLSR-NQLTGSIPSEV-GNLKNLEILNVFGNKLKGEIPS 519
++ I F L L + + + N L I E NL NL+ L + +K +P
Sbjct: 65 DVLEVIEADVFSNL-PKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPD 121
Query: 520 -TLGSCIKLEQLEMQENFLQGPIPS-SLSSLRGLSV-LDLSQNNLSGKIPELLIRLQLVK 576
++ L++Q+N I S L SV L L++N + QL +
Sbjct: 122 VHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDE 181
Query: 577 NLNLSNNDLEGVVPTQGVFKNAS 599
NN+LE + VF AS
Sbjct: 182 LNLSDNNNLEELPN--DVFHGAS 202
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 8e-13
Identities = 34/224 (15%), Positives = 71/224 (31%), Gaps = 11/224 (4%)
Query: 88 LKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANI-SSCSNLIQLRLFHNQL 146
LR F L+ + + N + I A++ S+ L ++R+
Sbjct: 32 AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 91
Query: 147 VGKIPSE-LSSLSKIEHISVNDNNLTGSIPS-SLGNLSSIRSLFLSGNNLEGSIPDTL-- 202
+ I E +L ++++ +++ + +P + L + N +I
Sbjct: 92 LLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFV 150
Query: 203 GWLKNLVNLTMAQNRLSGTIPSSIFN-ISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFS 261
G V L + +N + I +S FN + N ++ +P D
Sbjct: 151 GLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILD 208
Query: 262 VGENQLTGAIPPTI-SNASNLEIFHGSVNKLTGAAPYLEKLQRL 304
+ ++ ++P N L K L L
Sbjct: 209 ISRTRIH-SLPSYGLENLKKLRARSTYNLKKLPTLEKLVALMEA 251
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 43/284 (15%), Positives = 86/284 (30%), Gaps = 43/284 (15%)
Query: 161 EHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSG 220
++ +T IPS L + L L +L + ++QN +
Sbjct: 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68
Query: 221 TIPSSIF-NISSITGFD-AGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPP-TISN 277
I + +F N+ + N + I + +L NLQ+ + + +P +
Sbjct: 69 VIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIH 126
Query: 278 ASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWL 337
+ + N + + + N L+ L
Sbjct: 127 SLQKVLLDIQDNI---------NIHTI----------------ERNSFVGLSF--ESVIL 159
Query: 338 LININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPA-AIGKFVNLQRLDMCSNRLSGT 396
+N N + N + E+ L DNN + +P LD+ R+ +
Sbjct: 160 WLNKNGI-QEIHNSAFNGTQLDELNLSDNNNL-EELPNDVFHGASGPVILDISRTRIH-S 216
Query: 397 IPPAI-GELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNF 439
+P L+ L+ + +P + L L+Y
Sbjct: 217 LPSYGLENLKKLRARSTYNLK---KLPTLEKLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 43/242 (17%), Positives = 78/242 (32%), Gaps = 27/242 (11%)
Query: 50 CQWRGVTCSRRH---------QRVTILDLESLKLAGSISPHV-GNLSFLKVLRLYNNSFN 99
C R C + L KL I L+ + + N
Sbjct: 9 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVL 67
Query: 100 HEIPSE-FDRLRRLQVLAL-HYNSIGGAIPANI-SSCSNLIQLRLFHNQLVGKIPSEL-S 155
I ++ F L +L + + N++ I + NL L + + + +P
Sbjct: 68 EVIEADVFSNLPKLHEIRIEKANNL-LYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKI 125
Query: 156 SLSKIEHISVNDNNLTGSIPS-SLGNLSS-IRSLFLSGNNLEGSIPDTLGWLKNLVNLTM 213
+ + + DN +I S LS L+L+ N ++ +
Sbjct: 126 HSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLS 185
Query: 214 AQNRLSGTIPSSIF-NISSITGFDAGVNKIQGAIPLDYGF-SLQNLQFFSVGENQLTGAI 271
N L +P+ +F S D +I ++P YG +L+ L+ S L +
Sbjct: 186 DNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLP-SYGLENLKKLRARST--YNLK-KL 239
Query: 272 PP 273
P
Sbjct: 240 PT 241
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 5e-18
Identities = 54/254 (21%), Positives = 99/254 (38%), Gaps = 41/254 (16%)
Query: 684 YNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIR 743
++ R+ + +G G G VF + +D +A+K L + K + E ++ +
Sbjct: 7 FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLD 66
Query: 744 HRNLVKIL-------TACSGVDYQGNDFKA--LVFEFMHNRSLEEWLHPITREDETDEAP 794
H N+VK+ + + + + +V E+M E L + + E
Sbjct: 67 HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLLEEH 121
Query: 795 RSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLD-EDMIAHIGDFGLARFL 853
L + Q L L Y+H + H DLKP+N+ ++ ED++ IGDFGLAR
Sbjct: 122 ARLFMYQLL-------RGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLAR-- 169
Query: 854 PLSSAQTSSIGAKGSIGYI------APEYGLGS-EVSISGDVYSYGILLLELITRKKPTD 906
+ +P L + + D+++ G + E++T K
Sbjct: 170 ---IMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK---- 222
Query: 907 IMFEGDMNLHNLAR 920
+F G L +
Sbjct: 223 TLFAGAHELEQMQL 236
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 9e-18
Identities = 54/226 (23%), Positives = 95/226 (42%), Gaps = 32/226 (14%)
Query: 685 NATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIR 743
+ + F+ + +IG+GSFG VFKGI + + +A+K+ +L + E L
Sbjct: 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 78
Query: 744 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRL 803
+ K + Y + ++ E++ S + L P L+ Q
Sbjct: 79 SPYVTKYYGS-----YLKDTKLWIIMEYLGGGSALDLLE-----------PGPLDETQIA 122
Query: 804 NISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSI 863
I ++ L+YLH + H D+K +N+LL E + DFG+ + Q +
Sbjct: 123 TILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGV-------AGQLTDT 172
Query: 864 GAKGS--IG---YIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
K + +G ++APE S D++S GI +EL + P
Sbjct: 173 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 60/226 (26%), Positives = 85/226 (37%), Gaps = 43/226 (19%)
Query: 684 YNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIR 743
N F + +G G+F VF A+K S E LK I+
Sbjct: 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIK 64
Query: 744 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITRE--DETDEAPRSLNLIQ 801
H N+V + Y+ LV + + L + + + R E D + +IQ
Sbjct: 65 HENIVTLEDI-----YESTTHYYLVMQLVSGGELFDRI--LERGVYTEKDAS----LVIQ 113
Query: 802 RLNISIDVACALNYLH-HDCQPPIAHCDLKPSNILL---DEDMIAHIGDFGLARFLPLSS 857
V A+ YLH + I H DLKP N+L +E+ I DFGL++
Sbjct: 114 ------QVLSAVKYLHENG----IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI 163
Query: 858 AQTSSIGAKGSIGYIAPE----YGLGSEVSISGDVYSYG----ILL 895
T A G+ GY+APE V D +S G ILL
Sbjct: 164 MST----ACGTPGYVAPEVLAQKPYSKAV----DCWSIGVITYILL 201
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 56/249 (22%), Positives = 97/249 (38%), Gaps = 33/249 (13%)
Query: 661 KRKEKQNPNSPINSFPNISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKV 720
+ + P + S + F + ++GEGS+GSV+K I + +A+K
Sbjct: 4 TVQLRNPPRRQLKKLDEDSLTK--QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQ 61
Query: 721 FNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEW 780
+ + I E + ++ ++VK + Y N +V E+ S+
Sbjct: 62 VPV--ESDLQEIIKEISIMQQCDSPHVVKYYGS-----YFKNTDLWIVMEYCGAGSV--- 111
Query: 781 LHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDM 840
D ++L + I L YLH H D+K NILL+ +
Sbjct: 112 ------SDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEG 162
Query: 841 IAHIGDFGLARFLPLSSAQTSSIGAKGS--IG---YIAPEYGLGSEVSISGDVYSYGILL 895
A + DFG+ + Q + AK + IG ++APE + D++S GI
Sbjct: 163 HAKLADFGV-------AGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITA 215
Query: 896 LELITRKKP 904
+E+ K P
Sbjct: 216 IEMAEGKPP 224
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 84.2 bits (208), Expect = 2e-17
Identities = 50/249 (20%), Positives = 88/249 (35%), Gaps = 44/249 (17%)
Query: 677 NISYQNLYNATD---RFSSVNQIGEG--SFGSVFKGILDDGRTTIAVKVFNL--LHHGAF 729
N+ +Q + + + + IG+G +V + V+ NL +
Sbjct: 11 NLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMV 70
Query: 730 KSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDE 789
E + K H N+V + ++ +V FM S ++ + D
Sbjct: 71 TFLQGELHVSKLFNHPNIVPYRAT-----FIADNELWVVTSFMAYGSAKDLICT-HFMDG 124
Query: 790 TDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGL 849
+E I I V AL+Y+HH + H +K S+IL+ D ++
Sbjct: 125 MNEL-----AIA--YILQGVLKALDYIHHMGY--V-HRSVKASHILISVDGKVYLSGLR- 173
Query: 850 ARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS------EV---SISG-----DVYSYGILL 895
S+ S G + + + P+Y + EV ++ G D+YS GI
Sbjct: 174 ------SNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITA 227
Query: 896 LELITRKKP 904
EL P
Sbjct: 228 CELANGHVP 236
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 62/223 (27%), Positives = 91/223 (40%), Gaps = 41/223 (18%)
Query: 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFN--LLHHGAFKSFIAECNTLKNIRH 744
+R++ V +G+GSFG V K + AVKV N + + + E LK + H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 745 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLN 804
N++K+ + + +V E L + + R E D A
Sbjct: 81 PNIMKLFEI-----LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA----------R 125
Query: 805 ISIDVACALNYLHHDCQPPIAHCDLKPSNILL---DEDMIAHIGDFGLARFLPLSSAQTS 861
I V + Y+H + I H DLKP NILL ++D I DFGL+ ++
Sbjct: 126 IIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD 182
Query: 862 SIGAKGSIGYIAPE-----YGLGSEVSISGDVYSYG----ILL 895
I G+ YIAPE Y + DV+S G ILL
Sbjct: 183 RI---GTAYYIAPEVLRGTYDE--KC----DVWSAGVILYILL 216
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 3e-17
Identities = 56/227 (24%), Positives = 94/227 (41%), Gaps = 48/227 (21%)
Query: 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFN--LLHHGAFKSFIAECNTLKNIRH 744
+D + ++G+G+F V + + A K+ N L F+ E + ++H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 745 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITRE--DETDEAPRSLNLIQR 802
N+V++ + Q F LVF+ + L E + + RE E D + + IQ
Sbjct: 65 PNIVRLHDS-----IQEESFHYLVFDLVTGGELFEDI--VAREFYSEADAS----HCIQ- 112
Query: 803 LNISIDVACALNYLH-HDCQPPIAHCDLKPSNILL---DEDMIAHIGDFGLARFLPLSSA 858
+ ++ Y H + I H +LKP N+LL + + DFGLA + S A
Sbjct: 113 -----QILESIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163
Query: 859 QTSSIGAKGSIGYIAPE------YGLGSEVSISGDVYSYG----ILL 895
G+ GY++PE Y V D+++ G ILL
Sbjct: 164 WHGFA---GTPGYLSPEVLKKDPYSK--PV----DIWACGVILYILL 201
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-17
Identities = 64/232 (27%), Positives = 93/232 (40%), Gaps = 32/232 (13%)
Query: 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFN---LLHHGAFKSFIAECNTLKNIR 743
+DR+ +G+GSFG V AVKV + + +S + E LK +
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 744 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRL 803
H N++K+ ++ + LV E L + + R E D A
Sbjct: 85 HPNIMKLYEF-----FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA---------- 129
Query: 804 NISIDVACALNYLHHDCQPPIAHCDLKPSNILL---DEDMIAHIGDFGLARFLPLSSAQT 860
I V + Y+H + I H DLKP N+LL +D I DFGL+ S
Sbjct: 130 RIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMK 186
Query: 861 SSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGD 912
I G+ YIAPE L DV+S G++L L++ P F G
Sbjct: 187 DKI---GTAYYIAPEV-LHGTYDEKCDVWSTGVILYILLSGCPP----FNGA 230
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-17
Identities = 50/227 (22%), Positives = 89/227 (39%), Gaps = 47/227 (20%)
Query: 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFN--LLHHGAFKSFIAECNTLKNIRH 744
T+ + ++G+G+F V + + A + N L + E + ++H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 745 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITRE--DETDEAPRSLNLIQR 802
N+V++ + L+F+ + L E + + RE E D + + IQ
Sbjct: 70 PNIVRLHDS-----ISEEGHHYLIFDLVTGGELFEDI--VAREYYSEADAS----HCIQ- 117
Query: 803 LNISIDVACALNYLH-HDCQPPIAHCDLKPSNILL---DEDMIAHIGDFGLARFLPLSSA 858
+ A+ + H + H +LKP N+LL + + DFGLA +
Sbjct: 118 -----QILEAVLHCHQMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168
Query: 859 QTSSIGAKGSIGYIAPE------YGLGSEVSISGDVYSYG----ILL 895
G G+ GY++PE YG V D+++ G ILL
Sbjct: 169 AWF--GFAGTPGYLSPEVLRKDPYGK--PV----DLWACGVILYILL 207
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 3e-17
Identities = 55/289 (19%), Positives = 93/289 (32%), Gaps = 61/289 (21%)
Query: 669 NSPINSFPNISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFN-----L 723
+S +L ++ IG+GS+G V I + R A+K+ N
Sbjct: 7 HSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQ 66
Query: 724 LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSL------ 777
++ + E +K + H N+ ++ Y+ + LV E H L
Sbjct: 67 INPKDVERIKTEVRLMKKLHHPNIARLYEV-----YEDEQYICLVMELCHGGHLLDKLNV 121
Query: 778 ----------------EEWLHPITREDETDEAPRSLNLIQRLNISIDVAC--------AL 813
+ P E+ + + + AL
Sbjct: 122 FIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181
Query: 814 NYLHHDCQPPIAHCDLKPSNILLDEDMIAH--IGDFGLARFLPLSSAQTSSIGAK--GSI 869
+YLH I H D+KP N L + + DFGL++ + G+
Sbjct: 182 HYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTP 238
Query: 870 GYIAPE------YGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGD 912
++APE G + D +S G+LL L+ P F G
Sbjct: 239 YFVAPEVLNTTNESYGPKC----DAWSAGVLLHLLLMGAVP----FPGV 279
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 4e-17
Identities = 64/265 (24%), Positives = 112/265 (42%), Gaps = 61/265 (23%)
Query: 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVK-VFNLLHHGAFKSFIAECNTLKNIR-- 743
++ V ++G+G++G V+K I +AVK +F+ AF++ T + I
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD-----AFQNSTDAQRTFREIMIL 62
Query: 744 -----HRNLVKILTACSGVDYQGNDFKA--LVFEFMHNRSLEEWLHPITREDE-TDEAPR 795
H N+V +L + ++ + LVF++M E LH + R + +
Sbjct: 63 TELSGHENIVNLLNV-----LRADNDRDVYLVFDYM-----ETDLHAVIRANILEPVHKQ 112
Query: 796 SLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPL 855
+ + Q + + YLH + H D+KPSNILL+ + + DFGL+R
Sbjct: 113 YV-VYQLI-------KVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161
Query: 856 SSAQTSSIGAKGSIG-------------------YIAPEYGLGS-EVSISGDVYSYGILL 895
T++I + Y APE LGS + + D++S G +L
Sbjct: 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCIL 221
Query: 896 LELITRKKPTDIMFEGDMNLHNLAR 920
E++ K +F G ++ L R
Sbjct: 222 GEILCGK----PIFPGSSTMNQLER 242
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 5e-17
Identities = 54/276 (19%), Positives = 96/276 (34%), Gaps = 47/276 (17%)
Query: 663 KEKQNPNSPINSFPNISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVK-VF 721
+ + N + + D + + IG GS+G V+ + +A+K V
Sbjct: 3 HHHHHSSGRENLYF--QGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN 60
Query: 722 NLLHHGAF-KSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA--LVFEFMHNRSLE 778
+ K + E L ++ ++++ D F +V E +
Sbjct: 61 RMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDL--LKFDELYIVLEIA-----D 113
Query: 779 EWLHPI--TREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILL 836
L + T T+E +++ L L N++H + I H DLKP+N LL
Sbjct: 114 SDLKKLFKTPIFLTEEHIKTI-LYNLL-------LGENFIH---ESGIIHRDLKPANCLL 162
Query: 837 DEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIG--------------------YIAPEY 876
++D + DFGLAR + + + Y APE
Sbjct: 163 NQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPEL 222
Query: 877 GLGSEV-SISGDVYSYGILLLELITRKKPTDIMFEG 911
L E + S D++S G + EL+ +
Sbjct: 223 ILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 5e-17
Identities = 58/277 (20%), Positives = 103/277 (37%), Gaps = 48/277 (17%)
Query: 660 RKRKEKQNPNSPINSFPNISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVK 719
++ ++++ +S + + + DR+ + IG GS+G V + + +A+K
Sbjct: 25 QEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK 84
Query: 720 -VFNLLHHGAF-KSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSL 777
+ + K + E L + H ++VK+L D + D +V E
Sbjct: 85 KILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA----- 139
Query: 778 EEWLHPITREDE--TDEAPRSLNLIQRLNISIDVACALNYLH-HDCQPPIAHCDLKPSNI 834
+ + R T+ ++L L L + Y+H I H DLKP+N
Sbjct: 140 DSDFKKLFRTPVYLTELHIKTL-LYNLL-------VGVKYVHSAG----ILHRDLKPANC 187
Query: 835 LLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIG------------------------ 870
L+++D + DFGLAR + S +
Sbjct: 188 LVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTR 247
Query: 871 -YIAPEYGLGSEV-SISGDVYSYGILLLELITRKKPT 905
Y APE L E + + DV+S G + EL+ K
Sbjct: 248 WYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 6e-17
Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 14/201 (6%)
Query: 389 CSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSI--GNLKLFILYLSYNFLQGSIPS 446
CS++ IP I + K L LQ N+ ++P KL +LYL+ N LQ ++P+
Sbjct: 23 CSSKKLTAIPSNI--PADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPA 78
Query: 447 SL-GRYETLTTIDLSNNNLTGTIPPQ-FIGLSSSLIVLDLSRNQLTGSIPSEV-GNLKNL 503
+ + L T+ +++N L +P F L + L L L RNQL S+P V +L L
Sbjct: 79 GIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVN-LAELRLDRNQLK-SLPPRVFDSLTKL 135
Query: 504 EILNVFGNKLKGEIPSTL-GSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLS 562
L++ N+L+ +P + L++L + N L+ + L L L L N L
Sbjct: 136 TYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK 194
Query: 563 GKIPELLIRLQLVKNLNLSNN 583
L+ +K L L N
Sbjct: 195 RVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 7e-14
Identities = 46/183 (25%), Positives = 84/183 (45%), Gaps = 11/183 (6%)
Query: 88 LKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANI-SSCSNLIQLRLFHNQL 146
K L L +N + F RL +L++L L+ N + +PA I NL L + N+L
Sbjct: 39 TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTDNKL 97
Query: 147 VGKIPSEL-SSLSKIEHISVNDNNLTGSIPSSL-GNLSSIRSLFLSGNNLEGSIPDTL-G 203
+P + L + + ++ N L S+P + +L+ + L L N L+ S+P +
Sbjct: 98 Q-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFD 154
Query: 204 WLKNLVNLTMAQNRLSGTIPSSIF-NISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSV 262
L +L L + N+L +P F ++ + N+++ +P SL+ L+ +
Sbjct: 155 KLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQL 212
Query: 263 GEN 265
EN
Sbjct: 213 QEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 9e-11
Identities = 50/188 (26%), Positives = 94/188 (50%), Gaps = 15/188 (7%)
Query: 125 AIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSL-GNLSS 183
AIP+NI + + +L L N+L L+K+ + +NDN L ++P+ + L +
Sbjct: 30 AIPSNIPA--DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKN 86
Query: 184 IRSLFLSGNNLEGSIP-DTLGWLKNLVNLTMAQNRLSGTIPSSIF-NISSITGFDAGVNK 241
+ +L+++ N L+ ++P L NL L + +N+L ++P +F +++ +T G N+
Sbjct: 87 LETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNE 144
Query: 242 IQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTI-SNASNLEIFHGSVNKLT----GAAP 296
+Q ++P L +L+ + NQL +P + L+ N+L GA
Sbjct: 145 LQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFD 202
Query: 297 YLEKLQRL 304
LEKL+ L
Sbjct: 203 SLEKLKML 210
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 3e-10
Identities = 35/131 (26%), Positives = 63/131 (48%), Gaps = 6/131 (4%)
Query: 65 TILDLESLKLAGSISPHV-GNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIG 123
L + KL ++ V L L LRL N P FD L +L L+L YN +
Sbjct: 88 ETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNEL- 145
Query: 124 GAIPANI-SSCSNLIQLRLFHNQLVGKIPSEL-SSLSKIEHISVNDNNLTGSIPSSLGNL 181
++P + ++L +LRL++NQL ++P L++++ + +++N L + +L
Sbjct: 146 QSLPKGVFDKLTSLKELRLYNNQL-KRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSL 204
Query: 182 SSIRSLFLSGN 192
++ L L N
Sbjct: 205 EKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 9e-10
Identities = 44/149 (29%), Positives = 72/149 (48%), Gaps = 14/149 (9%)
Query: 451 YETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEV-GNLKNLEILNVF 509
++D S+ LT IP + + LDL N+L+ S+PS+ L L +L +
Sbjct: 15 NNNKNSVDCSSKKLT-AIPS---NIPADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLN 69
Query: 510 GNKLKGEIPSTL-GSCIKLEQLEMQENFLQGPIPSSL-SSLRGLSVLDLSQNNLSGKIPE 567
NKL+ +P+ + LE L + +N LQ +P + L L+ L L +N L +P
Sbjct: 70 DNKLQ-TLPAGIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLK-SLPP 126
Query: 568 -LLIRLQLVKNLNLSNNDLEGVVPTQGVF 595
+ L + L+L N+L+ +P GVF
Sbjct: 127 RVFDSLTKLTYLSLGYNELQ-SLPK-GVF 153
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 52/226 (23%), Positives = 84/226 (37%), Gaps = 48/226 (21%)
Query: 221 TIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASN 280
IPS+I + D NK+ ++P L L+ + +N+L +P I
Sbjct: 30 AIPSNIP--ADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGI----- 80
Query: 281 LEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSL-----TNATRLK 335
F L+ L+ L V N L +L L
Sbjct: 81 ---FKE-----------LKNLETLWVTD--------------NKLQALPIGVFDQLVNLA 112
Query: 336 WLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPA-AIGKFVNLQRLDMCSNRLS 394
L ++ N SLP + + T L L L N++ ++P K +L+ L + +N+L
Sbjct: 113 ELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNEL-QSLPKGVFDKLTSLKELRLYNNQLK 170
Query: 395 GTIPPAIGELQNLKDLRLQRNRFQGNIPPSI--GNLKLFILYLSYN 438
A +L LK L+L N+ + +P KL +L L N
Sbjct: 171 RVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQEN 215
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 7e-17
Identities = 63/278 (22%), Positives = 100/278 (35%), Gaps = 59/278 (21%)
Query: 663 KEKQNPNSPINSFPNISYQ-------NLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTT 715
+ F I+ + + V ++G G++G V +G +
Sbjct: 4 HHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSE 63
Query: 716 IAVKV-------------FNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762
A+KV N + E + LK++ H N++K+ ++
Sbjct: 64 KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV-----FEDK 118
Query: 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQP 822
+ LV EF L E + + DE D A NI + + YLH
Sbjct: 119 KYFYLVTEFYEGGELFEQIINRHKFDECDAA----------NIMKQILSGICYLHKHN-- 166
Query: 823 PIAHCDLKPSNILL---DEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPE---- 875
I H D+KP NILL + + I DFGL+ F + G+ YIAPE
Sbjct: 167 -IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL---GTAYYIAPEVLKK 222
Query: 876 -YGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGD 912
Y + DV+S G+++ L+ P F G
Sbjct: 223 KY--NEKC----DVWSCGVIMYILLCGYPP----FGGQ 250
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 7e-17
Identities = 64/236 (27%), Positives = 96/236 (40%), Gaps = 41/236 (17%)
Query: 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL--LHHGAFKSFIAECNTLKNIRH 744
+R++ V +G+GSFG V K + AVKV N + + + E LK + H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 745 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLN 804
N++K+ + + +V E L + + R E D A
Sbjct: 81 PNIMKLFEI-----LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA----------R 125
Query: 805 ISIDVACALNYLHHDCQPPIAHCDLKPSNILL---DEDMIAHIGDFGLARFLPLSSAQTS 861
I V + Y+H I H DLKP NILL ++D I DFGL+ ++
Sbjct: 126 IIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD 182
Query: 862 SIGAKGSIGYIAPE-----YGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGD 912
I G+ YIAPE Y + DV+S G++L L++ P F G
Sbjct: 183 RI---GTAYYIAPEVLRGTY--DEKC----DVWSAGVILYILLSGTPP----FYGK 225
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 9e-17
Identities = 45/236 (19%), Positives = 94/236 (39%), Gaps = 18/236 (7%)
Query: 352 ISNLS--TTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKD 409
I + L + + + ++ ++ ++ + ++ I L N+
Sbjct: 17 IFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTK 72
Query: 410 LRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIP 469
L L N+ +I P L L+L N ++ + SSL + L ++ L +N ++ I
Sbjct: 73 LFLNGNKLT-DIKPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS-DIN 128
Query: 470 PQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQ 529
+ L L L N++T + + L L+ L++ N++ +I L KL+
Sbjct: 129 G--LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQN 182
Query: 530 LEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDL 585
L + +N + +L+ L+ L VL+L K L + + ++ L
Sbjct: 183 LYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 7e-11
Identities = 49/241 (20%), Positives = 91/241 (37%), Gaps = 22/241 (9%)
Query: 129 NISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLF 188
+ + + I+ L + + L+ I+ I N++++ S+ + L ++ LF
Sbjct: 19 SDDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLF 74
Query: 189 LSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPL 248
L+GN L I L LKNL L + +N++ SS+ ++ + N I L
Sbjct: 75 LNGNKLT-DIKP-LANLKNLGWLFLDENKVKDL--SSLKDLKKLKSLSLEHNGISDINGL 130
Query: 249 DYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFG 308
L L+ +G N++T +S + L+ N+++ P L L +L
Sbjct: 131 V---HLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLY 184
Query: 309 ILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQ 368
+ N + L +L L L + SNL V D +
Sbjct: 185 LSKNHISD--------LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
Query: 369 I 369
+
Sbjct: 237 V 237
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 8e-11
Identities = 40/209 (19%), Positives = 77/209 (36%), Gaps = 15/209 (7%)
Query: 84 NLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFH 143
L+ + + N+ L + L L+ N + +++ NL L L
Sbjct: 44 ELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDI--KPLANLKNLGWLFLDE 99
Query: 144 NQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLG 203
N++ + S L L K++ +S+ N ++ I + L +L + SL+L N + + L
Sbjct: 100 NKVK-DL-SSLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKI--TDITVLS 153
Query: 204 WLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVG 263
L L L++ N++S I + ++ + N I L L+NL +
Sbjct: 154 RLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHISDLRALA---GLKNLDVLELF 208
Query: 264 ENQLTGAIPPTISNASNLEIFHGSVNKLT 292
+ SN + L
Sbjct: 209 SQECLNKPINHQSNLVVPNTVKNTDGSLV 237
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 9e-17
Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 44/225 (19%)
Query: 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFN--LLHHGAFKSFIAECNTLKNIRH 744
+D + ++G+G+F V + + A K+ N L F+ E + ++H
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 745 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITRE--DETDEAPRSLNLIQR 802
N+V++ + Q F LVF+ + L E + + RE E D + + IQ
Sbjct: 88 PNIVRLHDS-----IQEESFHYLVFDLVTGGELFEDI--VAREFYSEADAS----HCIQ- 135
Query: 803 LNISIDVACALNYLH-HDCQPPIAHCDLKPSNILL---DEDMIAHIGDFGLARFLPLSSA 858
+ ++ Y H + I H +LKP N+LL + + DFGLA + S A
Sbjct: 136 -----QILESIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 186
Query: 859 QTSSIGAKGSIGYIAPE----YGLGSEVSISGDVYSYG----ILL 895
G+ GY++PE V D+++ G ILL
Sbjct: 187 WHGFA---GTPGYLSPEVLKKDPYSKPV----DIWACGVILYILL 224
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 52/227 (22%), Positives = 83/227 (36%), Gaps = 44/227 (19%)
Query: 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFN--------LLHHGAFKSFIAECNT 738
D + +G G+ G V +A+K+ + + E
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 739 LKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLN 798
LK + H ++KI + D+ +V E M L + + R E
Sbjct: 69 LKKLNHPCIIKIKNF-----FDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCK----L 118
Query: 799 LIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILL---DEDMIAHIGDFGLARFLPL 855
+ A+ YLH + I H DLKP N+LL +ED + I DFG ++ L
Sbjct: 119 YFY------QMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169
Query: 856 SSAQTSSIGAKGSIGYIAPE-------YGLGSEVSISGDVYSYGILL 895
+S + G+ Y+APE G V D +S G++L
Sbjct: 170 TSLMRTLC---GTPTYLAPEVLVSVGTAGYNRAV----DCWSLGVIL 209
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 1e-16
Identities = 54/223 (24%), Positives = 85/223 (38%), Gaps = 39/223 (17%)
Query: 685 NATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRH 744
+ ++ N IG GS+G V + R A K F E +K++ H
Sbjct: 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDH 65
Query: 745 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLN 804
N++++ ++ N LV E L E + E+D A +++
Sbjct: 66 PNIIRLYET-----FEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA----RIMK--- 113
Query: 805 ISIDVACALNYLHHDCQPPIAHCDLKPSNILL---DEDMIAHIGDFGLARFLPLSSAQTS 861
DV A+ Y H + +AH DLKP N L D + DFGLA +
Sbjct: 114 ---DVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT 167
Query: 862 SIGAKGSIGYIAPE-----YGLGSEVSISGDVYSYG----ILL 895
+ G+ Y++P+ YG E D +S G +LL
Sbjct: 168 KV---GTPYYVSPQVLEGLYGP--EC----DEWSAGVMMYVLL 201
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 52/229 (22%), Positives = 88/229 (38%), Gaps = 45/229 (19%)
Query: 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFN---------LLHHGAFKSFIAECN 737
+ + +G G V + I AVK+ + ++ + E +
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 738 TLKNI-RHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRS 796
L+ + H N++++ Y+ N F LVF+ M L ++L E +
Sbjct: 76 ILRKVSGHPNIIQLKDT-----YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR--- 127
Query: 797 LNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLS 856
+++ + + LH I H DLKP NILLD+DM + DFG + L
Sbjct: 128 -KIMR------ALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG 177
Query: 857 SAQTSSIGAKGSIGYIAPE----------YGLGSEVSISGDVYSYGILL 895
G+ Y+APE G G EV D++S G+++
Sbjct: 178 EKLREVC---GTPSYLAPEIIECSMNDNHPGYGKEV----DMWSTGVIM 219
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 44/174 (25%), Positives = 79/174 (45%), Gaps = 20/174 (11%)
Query: 420 NIPPSIGNLKLFILYLSYNFLQGSIPS--SLGRYETLTTIDLSNNNLTGTIPPQ-FIGLS 476
++P +L LS+N L + + + R L ++ LS+N+L I + F+ +
Sbjct: 36 SLPSYT-----ALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVP 88
Query: 477 SSLIVLDLSRNQLTGSIPSEV-GNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQEN 535
+ L LDLS N L ++ + +L+ LE+L ++ N + + +L++L + +N
Sbjct: 89 N-LRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQN 146
Query: 536 FLQGPIP----SSLSSLRGLSVLDLSQNNLSGKIPELLIRLQ--LVKNLNLSNN 583
+ P + L L +LDLS N L L +L + L L NN
Sbjct: 147 QISR-FPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 3e-15
Identities = 32/150 (21%), Positives = 62/150 (41%), Gaps = 15/150 (10%)
Query: 88 LKVLRLYNNSFNHEIPSE--FDRLRRLQVLALHYNSIGGAIPANI-SSCSNLIQLRLFHN 144
+L L +N+ + +E RL L L L +N + I + NL L L N
Sbjct: 41 TALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSN 98
Query: 145 QLVGKIPSE-LSSLSKIEHISVNDNNLTGSIPS-SLGNLSSIRSLFLSGNNLEGSIP--- 199
L + S L +E + + +N++ + + +++ ++ L+LS N + P
Sbjct: 99 HLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVEL 155
Query: 200 -DTLGWLKNLVNLTMAQNRLSGTIPSSIFN 228
L L+ L ++ N+L +P +
Sbjct: 156 IKDGNKLPKLMLLDLSSNKLK-KLPLTDLQ 184
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 7e-14
Identities = 42/154 (27%), Positives = 68/154 (44%), Gaps = 15/154 (9%)
Query: 443 SIPSSLGRYETLTTIDLSNNNLTGTIPPQ--FIGLSSSLIVLDLSRNQLTGSIPSEV-GN 499
++P SL +DLS+NNL+ + + L++ L L LS N L I SE
Sbjct: 32 NVPQSLPS--YTALLDLSHNNLS-RLRAEWTPTRLTN-LHSLLLSHNHLN-FISSEAFVP 86
Query: 500 LKNLEILNVFGNKLKGEIPS-TLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQ 558
+ NL L++ N L + LE L + N + ++ + L L LSQ
Sbjct: 87 VPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQ 145
Query: 559 NNLSGKIPE----LLIRLQLVKNLNLSNNDLEGV 588
N +S + P +L + L+LS+N L+ +
Sbjct: 146 NQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKL 178
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 3e-13
Identities = 37/181 (20%), Positives = 68/181 (37%), Gaps = 23/181 (12%)
Query: 50 CQWRGVTCSRRH---------QRVTILDLESLKLAGSISPHV--GNLSFLKVLRLYNNSF 98
C ++CS++ +LDL L+ + L+ L L L +N
Sbjct: 18 CASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHL 76
Query: 99 NHEIPSE-FDRLRRLQVLALHYNSIGGAIPANI-SSCSNLIQLRLFHNQLVGKIPSE-LS 155
+ I SE F + L+ L L N + + + S L L L++N +V +
Sbjct: 77 -NFISSEAFVPVPNLRYLDLSSNHL-HTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFE 133
Query: 156 SLSKIEHISVNDNNLTGSIP----SSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNL 211
+++++ + ++ N ++ P L + L LS N L+ L L V
Sbjct: 134 DMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKN 192
Query: 212 T 212
Sbjct: 193 G 193
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 37/139 (26%), Positives = 58/139 (41%), Gaps = 16/139 (11%)
Query: 69 LESLKLAG----SISPHV-GNLSFLKVLRLYNNSFNHEIPSE-FDRLRRLQVLALHYNSI 122
L SL L+ IS + L+ L L +N H + F L+ L+VL L+ N I
Sbjct: 66 LHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHL-HTLDEFLFSDLQALEVLLLYNNHI 124
Query: 123 GGAIPANI-SSCSNLIQLRLFHNQLVGKIPSE----LSSLSKIEHISVNDNNLTGSIPSS 177
+ N + L +L L NQ+ + P E + L K+ + ++ N L +
Sbjct: 125 -VVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTD 182
Query: 178 LGNLSSI--RSLFLSGNNL 194
L L + L+L N L
Sbjct: 183 LQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 7e-07
Identities = 45/191 (23%), Positives = 70/191 (36%), Gaps = 36/191 (18%)
Query: 265 NQLTGAIPPTISNASNLEIFHGSVNKLT-----GAAPYLEKLQRLLVFGILGNSLGS--R 317
QL +P ++ S + S N L+ L L LL+ N L
Sbjct: 28 QQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSH---NHLNFISS 81
Query: 318 GDRDLNFLCSLTNATRLKWLLININNFGGSLPACI-SNLSTTLEVLLLDNNQIFGNIPA- 375
+ L++L ++ N+ +L + S+L LEVLLL NN I +
Sbjct: 82 E--------AFVPVPNLRYLDLSSNHLH-TLDEFLFSDL-QALEVLLLYNNHI-VVVDRN 130
Query: 376 AIGKFVNLQRLDMCSNRLSGTIPP----AIGELQNLKDLRLQRNRFQGNIPP----SIGN 427
A LQ+L + N++S P +L L L L N+ + +P +
Sbjct: 131 AFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK-KLPLTDLQKLPA 188
Query: 428 LKLFILYLSYN 438
LYL N
Sbjct: 189 WVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 4e-06
Identities = 42/211 (19%), Positives = 69/211 (32%), Gaps = 42/211 (19%)
Query: 166 NDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDT-LGWLKNLVNLTMAQNRLSGTIPS 224
+ L ++P SL S L LS NNL + L NL +L ++ N L+ I S
Sbjct: 26 SKQQLP-NVPQSL--PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISS 81
Query: 225 SIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPP-TISNASNLEI 283
F + NL++ + N L + S+ LE+
Sbjct: 82 EAFV------------------------PVPNLRYLDLSSNHLH-TLDEFLFSDLQALEV 116
Query: 284 FHGSVNKLT----GAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLI 339
N + A + +LQ+L + N + + L +L L +
Sbjct: 117 LLLYNNHIVVVDRNAFEDMAQLQKLYLS---QNQISRFPVELIKDGNKL---PKLMLLDL 170
Query: 340 NINNFGGSLPACISNLST-TLEVLLLDNNQI 369
+ N + L L L NN +
Sbjct: 171 SSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 83.4 bits (205), Expect = 3e-16
Identities = 81/589 (13%), Positives = 165/589 (28%), Gaps = 158/589 (26%)
Query: 420 NIPPSIGNLKLFILYLS--YNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLS- 476
PS +++I YN Q ++ R + + L P + + +
Sbjct: 102 QRQPS-MMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKL---RQALLELRPAKNVLIDG 157
Query: 477 ------SSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNK---LKGEIPSTLGSCIKL 527
+ + + +V + ++ K L L +C
Sbjct: 158 VLGSGKTWVAL--------------DV--CLSYKVQCKMDFKIFWL------NLKNCNSP 195
Query: 528 EQ-LEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNL----NLSN 582
E LEM + L P+ S S + L +++ ++ LL L N+ N
Sbjct: 196 ETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQN 255
Query: 583 -NDLEG-------VVPTQGVFKNASITSVFGNLKLCGGIPEFQLPTCSSKKSKHKKSLAL 634
++ T + +T + T + + KSL L
Sbjct: 256 AKAWNAFNLSCKILLTT----RFKQVTDFLSAATTTHISLDHHSMTLTPDEV---KSLLL 308
Query: 635 KLVLAIISGL-----IGLSLALSIIVLCLVRKRKEKQNPNSPINSFPNISYQNLYNATDR 689
K + L LSII + ++ + +++ +++ L +
Sbjct: 309 KYLDCRPQDLPREVLTTNPRRLSIIA-------ESIRDGLATWDNWKHVNCDKLTTIIE- 360
Query: 690 FSSVNQIGEGSFGSVFK--GILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNL 747
SS+N + + +F + I + +L+ ++ ++
Sbjct: 361 -SSLNVLEPAEYRKMFDRLSVFPPS-AHIPTILLSLI--------------WFDVIKSDV 404
Query: 748 VKILTACSGVDYQGNDFKALVFEFMHNRSL-EEW-------LHPITRE-DETDEAPRSLN 798
+ ++ H SL E+ + I E E +L+
Sbjct: 405 MVVVNKL------------------HKYSLVEKQPKESTISIPSIYLELKVKLENEYALH 446
Query: 799 --LIQRLNISIDVACALNYLHHDCQPP---------IAHCDLKPSNILLDEDMIAHI-GD 846
++ NI + D PP I H LK + + D
Sbjct: 447 RSIVDHYNI------PKTFDSDDLIPPYLDQYFYSHIGH-HLKNIEHPERMTLFRMVFLD 499
Query: 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTD 906
F RFL I + GS ++ + Y I P
Sbjct: 500 F---RFL------EQKIRHDST-----AWNASGSILNTLQQLKFYK----PYICDNDPKY 541
Query: 907 IMFEGDM--NLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQA 953
+ L + + D++ L+ + E + + +Q
Sbjct: 542 ERLVNAILDFLPKIEENLICSKYTDLLRIALMAEDEAIF---EEAHKQV 587
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 61.0 bits (147), Expect = 2e-09
Identities = 70/590 (11%), Positives = 162/590 (27%), Gaps = 183/590 (31%)
Query: 242 IQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPY---- 297
++ + ++Y F + ++ + T + + Y
Sbjct: 83 VEEVLRINYKFLMSPIK------TEQRQPSMMTRMYIEQRDRLYNDNQVFA---KYNVSR 133
Query: 298 ----------LEKLQR---LLVFGILG---NSLGSRGDRDLNFLCSLTNATRLKWLLINI 341
L +L+ +L+ G+LG + C + ++ WL
Sbjct: 134 LQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDF--KIFWL---- 187
Query: 342 NNFG-----GSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGT 396
N ++ + L ++ + NI R+ L
Sbjct: 188 -NLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIK---------LRIHSIQAELRRL 237
Query: 397 I-----PPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLF-----ILYLSYNFLQGSIPS 446
+ + L N+++ + F IL + +
Sbjct: 238 LKSKPYENCLLVLLNVQNAKA---------------WNAFNLSCKILLTTRF---KQVTD 279
Query: 447 SL-GRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEI 505
L T ++D + LT P + L LD L P EV N
Sbjct: 280 FLSAATTTHISLDHHSMTLT---PDEVKSLLLK--YLDCRPQDL----PREVLTT-NPRR 329
Query: 506 LNVFGNKLKGEIP--------------STLGSCIK-LEQLEMQENFLQ-------GPIPS 543
L++ ++ + + + S + LE E ++ F + IP+
Sbjct: 330 LSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPT 389
Query: 544 SLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQGVFKNASITSV 603
L LS++ ++ ++ + + +L K ++I+
Sbjct: 390 IL-----LSLI---WFDVIKSDVMVV--VNKLHKYSLVEKQ----------PKESTIS-- 427
Query: 604 FGNLKLCGGIPEFQL---PTCSSKKSKHKKSLAL----------KLVLAIISGLIGLSLA 650
IP L ++ + H+ + L+ + +
Sbjct: 428 ---------IPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIG 478
Query: 651 --LSIIVLCLVRKRKEKQNPNSPINSFPNISYQNLYNATDRFSSVNQIGEGSFGSVFKGI 708
L I + E+ + F + + + RF + + + I
Sbjct: 479 HHLKNI------EHPER------MTLFRMV-FLDF-----RFLEQKIRHDSTAWNASGSI 520
Query: 709 LDDGRTTIAVKVFNLLHHGAF-------KSFIAECNT-LKNIRHRNLVKI 750
L+ + K + + + F+ + L ++ +L++I
Sbjct: 521 LNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRI 570
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 53.7 bits (128), Expect = 3e-07
Identities = 90/511 (17%), Positives = 156/511 (30%), Gaps = 144/511 (28%)
Query: 22 RLALLELKSK---ITHDPLG----VLASWNESSHFCQ--------WRGVTCSRRHQRVTI 66
R ALLEL+ + LG +A S+ Q W + + T+
Sbjct: 141 RQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFW--LNLKNCNSPETV 198
Query: 67 LD-LESLKLAGSISPHVGNLSFLKVLRLYNNSFN--HEIPSEFDRLRRLQVLALHYNSIG 123
L+ L+ L I P+ + S ++S N I S LRRL + N +
Sbjct: 199 LEMLQKLLY--QIDPNWTSRS--------DHSSNIKLRIHSIQAELRRLLKSKPYENCL- 247
Query: 124 GAIPANISS----------CSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGS 173
+ N+ + C L+ R + V ++ S + HIS++ +++T +
Sbjct: 248 -LVLLNVQNAKAWNAFNLSCKILLTTR---FKQV----TDFLSAATTTHISLDHHSMTLT 299
Query: 174 IPSSLGNLS--------SIRSLFLSGNNLEGSI--------PDTLGWLKNLVNLTMAQNR 217
L + L+ N SI T W N + ++
Sbjct: 300 PDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLAT--W-DNW--KHVNCDK 354
Query: 218 LSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISN 277
L+ I SS+ + P +Y L F + IP +
Sbjct: 355 LTTIIESSLNVLE----------------PAEYRKMFDRLSVFPPSAH-----IPTIL-- 391
Query: 278 ASNLEIFHGS---------VNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSL 328
L + VNKL + +EK + I L L
Sbjct: 392 ---LSLIWFDVIKSDVMVVVNKLHKYS-LVEKQPKESTISIP--------SIYLELKVKL 439
Query: 329 TNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDM 388
N L +++ N + S L LD + +I + + +R+ +
Sbjct: 440 ENEYALHRSIVDHYNIPKTFD------SDDLIPPYLD-QYFYSHIGHHLKNIEHPERMTL 492
Query: 389 CSN------------RLSGTIPPAIGELQN-LKDLRLQRNRFQGNIPPS---IGNLKLFI 432
R T A G + N L+ L+ + N P + + F+
Sbjct: 493 FRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFL 552
Query: 433 LYLSYNFLQGSIPSSLGRYETLTTIDLSNNN 463
+ N + +Y L I L +
Sbjct: 553 PKIEENLIC-------SKYTDLLRIALMAED 576
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 3e-16
Identities = 56/258 (21%), Positives = 101/258 (39%), Gaps = 51/258 (19%)
Query: 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVF-NLLHHGAFKSFIAECNTLKNIR---- 743
R+ V ++G G F +V+ T +A+K+ + ++ E L+ +
Sbjct: 20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY--TEAAEDEIKLLQRVNDADN 77
Query: 744 ----HRNLVKILTACSGVDYQGNDFK--ALVFEFMHNRSLEEWLHPITREDETDEAPRSL 797
IL +++G + +VFE + +L + + + L
Sbjct: 78 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLG-ENLLALIK------KYEHRGIPL 130
Query: 798 NLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH------IGDFGLAR 851
+++ IS + L+Y+H C I H D+KP N+L++ I D G A
Sbjct: 131 IYVKQ--ISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 186
Query: 852 FLPL---SSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIM 908
+ +S QT Y +PE LG+ D++S L+ ELIT D +
Sbjct: 187 WYDEHYTNSIQTRE--------YRSPEVLLGAPWGCGADIWSTACLIFELITG----DFL 234
Query: 909 FEGD------MNLHNLAR 920
FE D + ++A+
Sbjct: 235 FEPDEGHSYTKDDDHIAQ 252
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 4e-16
Identities = 50/220 (22%), Positives = 77/220 (35%), Gaps = 36/220 (16%)
Query: 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFN-LLHHGAFKSFIAECNTLKNIRHR 745
D F ++G G+FG V +K N + AE LK++ H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 746 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITRED----ETDEAPRSLNLIQ 801
N++KI ++ +V E L E + E A
Sbjct: 81 NIIKIFEV-----FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVA-------- 127
Query: 802 RLNISIDVACALNYLHHDCQPPIAHCDLKPSNILL---DEDMIAHIGDFGLARFLPLSSA 858
+ + AL Y H + H DLKP NIL I DFGLA
Sbjct: 128 --ELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH 182
Query: 859 QTSSIGAKGSIGYIAPE---YGLGSEVSISGDVYSYGILL 895
T++ G+ Y+APE + + D++S G+++
Sbjct: 183 STNAA---GTALYMAPEVFKRDVTFKC----DIWSAGVVM 215
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 4e-16
Identities = 56/227 (24%), Positives = 91/227 (40%), Gaps = 36/227 (15%)
Query: 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGA---FKSFIAECNTLKNIR 743
FS + +IG GSFG+V+ +A+K + + ++ I E L+ +R
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 744 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRL 803
H N ++ Y LV E+ + D + + L ++
Sbjct: 113 HPNTIQYRGC-----YLREHTAWLVMEYCLGSAS----------DLLEVHKKPLQEVEIA 157
Query: 804 NISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSI 863
++ L YLH + H D+K NILL E + +GDFG S++ +
Sbjct: 158 AVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG-------SASIMAP- 206
Query: 864 GAKGSIG---YIAPEYGLGSEVSISG---DVYSYGILLLELITRKKP 904
A +G ++APE L + DV+S GI +EL RK P
Sbjct: 207 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 5e-16
Identities = 49/227 (21%), Positives = 87/227 (38%), Gaps = 44/227 (19%)
Query: 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKV-----FNLLHHGAFKSFIAECNTLKN 741
D + IG+G F V + I + AVK+ F + + E +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 742 IRHRNLVKILTACSGVDYQGNDFKALVFEFMH-----NRSLEEWLHPITREDETDEAPRS 796
++H ++V++L Y + +VFEFM + + E +
Sbjct: 83 LKHPHIVELLET-----YSSDGMLYMVFEFMDGADLCFE-IVKRADAGFVYSEAVAS--- 133
Query: 797 LNLIQRLNISIDVACALNYLH-HDCQPPIAHCDLKPSNILL---DEDMIAHIGDFGLARF 852
+ ++ + AL Y H ++ I H D+KP +LL + +G FG+A
Sbjct: 134 -HYMR------QILEALRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182
Query: 853 LPLSSAQTSSIGAKGSIGYIAPE----YGLGSEVSISGDVYSYGILL 895
L + + G G+ ++APE G V DV+ G++L
Sbjct: 183 LG--ESGLVAGGRVGTPHFMAPEVVKREPYGKPV----DVWGCGVIL 223
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 7e-16
Identities = 45/217 (20%), Positives = 80/217 (36%), Gaps = 30/217 (13%)
Query: 685 NATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRH 744
+ D + + ++G G+FG V + + K N + + E + + + H
Sbjct: 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH 107
Query: 745 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITRED----ETDEAPRSLNLI 800
L+ + A ++ L+ EF+ S E I ED E + N +
Sbjct: 108 PKLINLHDA-----FEDKYEMVLILEFL---SGGELFDRIAAEDYKMSEAEVI----NYM 155
Query: 801 QRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILL--DEDMIAHIGDFGLARFLPLSSA 858
+ L ++H + I H D+KP NI+ + I DFGLA L
Sbjct: 156 R------QACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206
Query: 859 QTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILL 895
+ + + APE V D+++ G+L
Sbjct: 207 VKVTT---ATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 7e-16
Identities = 49/240 (20%), Positives = 88/240 (36%), Gaps = 24/240 (10%)
Query: 659 VRKRKEKQNPNSPINSFPNISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAV 718
V + + +P + D + ++G G+FG V + A
Sbjct: 128 VSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAA 187
Query: 719 KVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLE 778
K H ++ E T+ +RH LV + A ++ ++ +++EFM L
Sbjct: 188 KFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA-----FEDDNEMVMIYEFMSGGELF 242
Query: 779 EWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILL-- 836
E + ++ E + Q L ++H + H DLKP NI+
Sbjct: 243 EKV--ADEHNKMSEDEAVEYMRQVCK-------GLCHMH---ENNYVHLDLKPENIMFTT 290
Query: 837 -DEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILL 895
+ + + DFGL L + + G+ + APE G V D++S G+L
Sbjct: 291 KRSNELK-LIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 1e-15
Identities = 57/220 (25%), Positives = 90/220 (40%), Gaps = 23/220 (10%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKILT 752
+G G FG VF + A K N L ++ + E L + R +V L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS-LA 251
Query: 753 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACA 812
++ LV M+ + ++ + ++ + PR+ + +
Sbjct: 252 YA----FETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA-----IFYTA-QIVSG 301
Query: 813 LNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYI 872
L +LH Q I + DLKP N+LLD+D I D GLA L +T G+ G++
Sbjct: 302 LEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA--GTPGFM 356
Query: 873 APEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGD 912
APE LG E S D ++ G+ L E+I + P F
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAARGP----FRAR 392
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 80.6 bits (198), Expect = 1e-15
Identities = 42/238 (17%), Positives = 86/238 (36%), Gaps = 12/238 (5%)
Query: 338 LININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTI 397
+ + + + L L + + + + LQ L+ + TI
Sbjct: 331 CVLLKDRPECWCRDSATD-EQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTI 388
Query: 398 PPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTI 457
+ L L + F ++ ++ L + Y + +
Sbjct: 389 ILLMRALDPLLYEKETLQYFSTLK--AVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVL 446
Query: 458 DLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEI 517
L++ +LT + + + LDLS N+L ++P + L+ LE+L N L+ +
Sbjct: 447 HLAHKDLT-VLC--HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NV 501
Query: 518 PSTLGSCIKLEQLEMQENFLQG-PIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQL 574
+ + +L++L + N LQ L S L +L+L N+L + + RL
Sbjct: 502 DG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAE 557
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 70.6 bits (172), Expect = 1e-12
Identities = 39/233 (16%), Positives = 76/233 (32%), Gaps = 17/233 (7%)
Query: 272 PPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNA 331
+ L SV K T LE + L L + +
Sbjct: 342 CRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEP------ENKWCLLTIILLMRAL 395
Query: 332 TRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSN 391
L + + F + ++ ++ ++ +++ L +
Sbjct: 396 DPLLYEKETLQYFSTLKAVDPMRAAYLDDL----RSKFLLENSVLKMEYADVRVLHLAHK 451
Query: 392 RLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNL-KLFILYLSYNFLQGSIPSSLGR 450
L T+ + +L + L L NR + +PP++ L L +L S N L+ ++ +
Sbjct: 452 DL--TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VAN 506
Query: 451 YETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNL 503
L + L NN L + Q + L++L+L N L L +
Sbjct: 507 LPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 70.2 bits (171), Expect = 2e-12
Identities = 50/331 (15%), Positives = 101/331 (30%), Gaps = 33/331 (9%)
Query: 1 MHLASEFLGVTASTVAGNETDRLALLELKSKITHDPLGVLASWNESSHFCQWRGVTCSRR 60
+ A + V+ E + +L +E+ +WR R
Sbjct: 236 LGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNR 295
Query: 61 HQRVTILDLESLKLAGSISPHVGNLSFLKVLRLYN----NSFNHEIPSEFDRLRRLQVLA 116
V + DL + L + H + + + +L
Sbjct: 296 PSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCE 355
Query: 117 LHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEH---ISVNDNNLTGS 173
L + + + SC L +L + + I + +L + + + L
Sbjct: 356 LSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAV 414
Query: 174 IPSSLGNLSSIRS------------------LFLSGNNLEGSIPDTLGWLKNLVNLTMAQ 215
P L +RS L L+ +L + L L + +L ++
Sbjct: 415 DPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSH 472
Query: 216 NRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTG-AIPPT 274
NRL +P ++ + + A N ++ + +L LQ + N+L A
Sbjct: 473 NRLR-ALPPALAALRCLEVLQASDNALENVDGVA---NLPRLQELLLCNNRLQQSAAIQP 528
Query: 275 ISNASNLEIFHGSVNKLTGAAPYLEKLQRLL 305
+ + L + + N L E+L +L
Sbjct: 529 LVSCPRLVLLNLQGNSLCQEEGIQERLAEML 559
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 61.7 bits (149), Expect = 8e-10
Identities = 39/209 (18%), Positives = 68/209 (32%), Gaps = 12/209 (5%)
Query: 380 FVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNF 439
+L + T + K+ L ++R + S + +LF LS
Sbjct: 301 LCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEK 360
Query: 440 LQGSIPSSLGRYETLTTIDLSNNN--LTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEV 497
+ S L + L ++ N LT + + + + L P
Sbjct: 361 ST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRA 419
Query: 498 GNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLS 557
L +L + E + L + L + L L ++ LDLS
Sbjct: 420 AYLDDLRSKFLL------ENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLS 471
Query: 558 QNNLSGKIPELLIRLQLVKNLNLSNNDLE 586
N L +P L L+ ++ L S+N LE
Sbjct: 472 HNRLR-ALPPALAALRCLEVLQASDNALE 499
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 47.8 bits (113), Expect = 2e-05
Identities = 41/273 (15%), Positives = 76/273 (27%), Gaps = 8/273 (2%)
Query: 334 LKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRL 393
+WLL +S L V + + + V+ L +
Sbjct: 232 HRWLLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVG-SRMGTLLLMVDEAPLSVEWRTP 290
Query: 394 SGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYET 453
G P+ L +L L Q + E
Sbjct: 291 DGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQ 350
Query: 454 LTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKL 513
L +LS T + L L+ +I + ++ L+ L L
Sbjct: 351 LFRCELSVEKSTVL--QSELESCKELQELEPENKWCLLTI---ILLMRALDPLLYEKETL 405
Query: 514 KGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQ 573
+ ++ L+ + + VL L+ +L+ + L +L
Sbjct: 406 QYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCHLE-QLL 463
Query: 574 LVKNLNLSNNDLEGVVPTQGVFKNASITSVFGN 606
LV +L+LS+N L + P + + N
Sbjct: 464 LVTHLDLSHNRLRALPPALAALRCLEVLQASDN 496
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-15
Identities = 53/217 (24%), Positives = 82/217 (37%), Gaps = 36/217 (16%)
Query: 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVK 749
S +G G FG V K +A K+ + E + + + H NL++
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 750 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITRED----ETDEAPRSLNLIQRLNI 805
+ A ++ + LV E++ L + I E E D ++
Sbjct: 151 LYDA-----FESKNDIVLVMEYVDGGELFDR---IIDESYNLTELDTI----LFMK---- 194
Query: 806 SIDVACALNYLHHDCQPPIAHCDLKPSNILL---DEDMIAHIGDFGLARFLPLSSAQTSS 862
+ + ++H Q I H DLKP NIL D I I DFGLAR +
Sbjct: 195 --QICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIK-IIDFGLARRYKPREKLKVN 248
Query: 863 IGAKGSIGYIAPEYGLGSEVSISGDVYSYG----ILL 895
G+ ++APE VS D++S G +LL
Sbjct: 249 F---GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLL 282
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 61/243 (25%), Positives = 100/243 (41%), Gaps = 54/243 (22%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFN---LLHHGAFKSFIA-ECNTLKNIRHRNLVKIL 751
+GEGS+G V + + + AVK+ L ++ + E L+ +RH+N+++++
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 752 TACSGVDYQGNDFKA-LVFEFMHNRSLEEWLHPITR----EDETDEAPRSLNLIQRLNIS 806
V Y K +V E+ ++E L + + + +L I
Sbjct: 73 D----VLYNEEKQKMYMVMEYCVC-GMQEMLDSVPEKRFPVCQ------AHGYFCQL-ID 120
Query: 807 IDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSA----QTSS 862
L YLH I H D+KP N+LL I G+A L +A +TS
Sbjct: 121 -----GLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ 172
Query: 863 IGAKGSIGYIAPE-------YGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNL 915
GS + PE + G +V D++S G+ L + T P FEGD N+
Sbjct: 173 ----GSPAFQPPEIANGLDTF-SGFKV----DIWSAGVTLYNITTGLYP----FEGD-NI 218
Query: 916 HNL 918
+ L
Sbjct: 219 YKL 221
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 52/192 (27%), Positives = 79/192 (41%), Gaps = 33/192 (17%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIR-HRNLVKILTAC 754
+GEG+ V I AVK+ E L + HRN+++++
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF- 79
Query: 755 SGVDYQGNDFKALVFEFMHNRSLEEWLHPITRE---DETDEAPRSLNLIQRLNISIDVAC 811
++ D LVFE M S+ L I + +E + + ++Q DVA
Sbjct: 80 ----FEEEDRFYLVFEKMRGGSI---LSHIHKRRHFNELEAS----VVVQ------DVAS 122
Query: 812 ALNYLHHDCQPPIAHCDLKPSNILL---DEDMIAHIGDFGLARFLPLSSAQTSSIGAK-- 866
AL++LH IAH DLKP NIL ++ I DF L + L+ + +
Sbjct: 123 ALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179
Query: 867 ---GSIGYIAPE 875
GS Y+APE
Sbjct: 180 TPCGSAEYMAPE 191
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 60/263 (22%), Positives = 97/263 (36%), Gaps = 43/263 (16%)
Query: 664 EKQNPNSPINSFPNISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL 723
E + + D F +GEGSF +V A+K+
Sbjct: 7 EPRPGAGSLQHAQPPPQPRKKRPED-FKFGKILGEGSFSTVVLARELATSREYAIKILE- 64
Query: 724 LHHGAFKSFI----------AECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMH 773
K I E + + + H VK+ +Q ++ +
Sbjct: 65 ------KRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT-----FQDDEKLYFGLSYAK 113
Query: 774 NRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLH-HDCQPPIAHCDLKPS 832
N L +++ I DE + R + ++ AL YLH I H DLKP
Sbjct: 114 NGELLKYIRKIGSFDE----TCT-----RFYTA-EIVSALEYLHGKG----IIHRDLKPE 159
Query: 833 NILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYG 892
NILL+EDM I DFG A+ L S Q + G+ Y++PE S D+++ G
Sbjct: 160 NILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALG 219
Query: 893 ILLLELITRKKP-----TDIMFE 910
++ +L+ P ++F+
Sbjct: 220 CIIYQLVAGLPPFRAGNEYLIFQ 242
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 2e-15
Identities = 52/227 (22%), Positives = 82/227 (36%), Gaps = 44/227 (19%)
Query: 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFN--------LLHHGAFKSFIAECNT 738
D + +G G+ G V +A+++ + + E
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 739 LKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLN 798
LK + H ++KI DY +V E M L + + R E
Sbjct: 194 LKKLNHPCIIKIKNFFDAEDYY------IVLELMEGGELFDKVVGNKRLKEATCK----- 242
Query: 799 LIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILL---DEDMIAHIGDFGLARFLPL 855
+ A+ YLH + I H DLKP N+LL +ED + I DFG ++ L
Sbjct: 243 -----LYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 294
Query: 856 SSAQTSSIGAKGSIGYIAPE-------YGLGSEVSISGDVYSYGILL 895
+S + G+ Y+APE G V D +S G++L
Sbjct: 295 TSLMRTLC---GTPTYLAPEVLVSVGTAGYNRAV----DCWSLGVIL 334
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-15
Identities = 88/520 (16%), Positives = 168/520 (32%), Gaps = 117/520 (22%)
Query: 88 LKVLRLYNNSFNHE-IPSEFDRLRRLQVLALHYNSIG----GAIPANISSCSNLIQLRLF 142
++ L + + L++ QV+ L + I + + L +L L
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 143 HNQL----VGKIPSELSSLS-KIEHISVNDNNLT----GSIPSSLGNLSSIRSLFLSGNN 193
N+L V + L + S KI+ +S+ + LT G + S+L L +++ L LS N
Sbjct: 65 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 124
Query: 194 LEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFS 253
L DAG+ + + LD
Sbjct: 125 LG----------------------------------------DAGLQLLCEGL-LDPQCR 143
Query: 254 LQNLQFFSVGENQLT----GAIPPTISNASNLEIFHGSVNKL--TGAAPYLEKLQ----R 303
L+ LQ L+ + + + + S N + G + L+ +
Sbjct: 144 LEKLQL---EYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQ 200
Query: 304 LLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGS----LPACISNLSTTL 359
L + + S RDL + + + L+ L + N G L + + S+ L
Sbjct: 201 LEALKLESCGVTSDNCRDLCGI--VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRL 258
Query: 360 EVLLLDNNQI----FGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRN 415
L + I G++ + +L+ L + N L + E L +
Sbjct: 259 RTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCET--LLE------ 310
Query: 416 RFQGNIPPSIGNLKLFILYLSYNFLQG----SIPSSLGRYETLTTIDLSNNNLTGT---- 467
+L L++ S L + L + +SNN L
Sbjct: 311 ----------PGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRE 360
Query: 468 IPPQFIGLSSSLIVLDLSRNQLT----GSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGS 523
+ S L VL L+ ++ S+ + + +L L++ N L L
Sbjct: 361 LCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE 420
Query: 524 CIK-----LEQLEMQENFL----QGPIPSSLSSLRGLSVL 554
++ LEQL + + + + + + L V+
Sbjct: 421 SVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 460
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 4e-14
Identities = 79/457 (17%), Positives = 152/457 (33%), Gaps = 73/457 (15%)
Query: 182 SSIRSLFLSGNNL-EGSIPDTLGWLKNLVNLTMAQNRLSGT----IPSSIFNISSITGFD 236
I+SL + L + + L L+ + + L+ I S++ ++ +
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 237 AGVNKIQ--GAIPLDYGFSLQN--LQFFSVGENQLT----GAIPPTISNASNLEIFHGSV 288
N++ G + G + +Q S+ LT G + T+ L+ H S
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 289 NKLT--GAAPYLEKLQ----RLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININ 342
N L G E L RL + SL + L + L K L ++ N
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASV--LRAKPDFKELTVSNN 180
Query: 343 NFGGS----LPACISNLSTTLEVLLLDNNQI----FGNIPAAIGKFVNLQRLDMCSNRLS 394
+ + L + + LE L L++ + ++ + +L+ L + SN+L
Sbjct: 181 DINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLG 240
Query: 395 GTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQ----GSIPSSLGR 450
+ RL+ L++ + G + L
Sbjct: 241 DVGMAELCPGLLHPSSRLRT------------------LWIWECGITAKGCGDLCRVLRA 282
Query: 451 YETLTTIDLSNNNLTGT----IPPQFIGLSSSLIVLDLSRNQLTG----SIPSEVGNLKN 502
E+L + L+ N L + + L L + T S + +
Sbjct: 283 KESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRF 342
Query: 503 LEILNVFGNKLKGEIPSTLGSCIK-----LEQLEMQENFLQ----GPIPSSLSSLRGLSV 553
L L + N+L+ L + L L + + + + ++L + L
Sbjct: 343 LLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRE 402
Query: 554 LDLSQNNLSGK-IPELLIRLQ----LVKNLNLSNNDL 585
LDLS N L I +L+ ++ L++ L L +
Sbjct: 403 LDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYW 439
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-13
Identities = 58/354 (16%), Positives = 111/354 (31%), Gaps = 48/354 (13%)
Query: 279 SNLEIFHGSVNKLT--GAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKW 336
+++ +L+ A L LQ+ V + L +D++ L L
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSA--LRVNPALAE 60
Query: 337 LLININNFGGS----LPACISNLSTTLEVLLLDNNQI----FGNIPAAIGKFVNLQRLDM 388
L + N G + + S ++ L L N + G + + + LQ L +
Sbjct: 61 LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHL 120
Query: 389 CSNRLSGTIPPAIGELQ-----NLKDLRLQRNRFQGNIPPSIG-----NLKLFILYLSYN 438
N L + E L+ L+L+ + L +S N
Sbjct: 121 SDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNN 180
Query: 439 FLQGSIPSSLGR-----YETLTTIDLSNNNLTGTIPPQF---IGLSSSLIVLDLSRNQLT 490
+ + L + L + L + +T + +SL L L N+L
Sbjct: 181 DINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLG 240
Query: 491 GS-----IPSEVGNLKNLEILNVFGNKLKGE----IPSTLGSCIKLEQLEMQENFLQGPI 541
P + L L ++ + + + L + L++L + N L
Sbjct: 241 DVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEG 300
Query: 542 PSSLSSL-----RGLSVLDLSQNNLSGK----IPELLIRLQLVKNLNLSNNDLE 586
L L L + + + +L + + + L +SNN LE
Sbjct: 301 ARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLE 354
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 5e-10
Identities = 45/268 (16%), Positives = 84/268 (31%), Gaps = 37/268 (13%)
Query: 355 LSTTLEVLLLDNNQI-FGNIPAAIGKFVNLQRLDMCSNRLSGT----IPPAIGELQNLKD 409
+S ++ L + ++ + Q + + L+ I A+ L +
Sbjct: 1 MSLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 60
Query: 410 LRLQRNRFQGNIPPSIG------NLKLFILYLSYNFLQ----GSIPSSLGRYETLTTIDL 459
L L+ N + + K+ L L L G + S+L TL + L
Sbjct: 61 LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHL 120
Query: 460 SNNNLTGT----IPPQFIGLSSSLIVLDLSRNQLT----GSIPSEVGNLKNLEILNVFGN 511
S+N L + + L L L L+ + S + + + L V N
Sbjct: 121 SDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNN 180
Query: 512 KLKGEIPSTLGSCIK-----LEQLEMQENFLQ----GPIPSSLSSLRGLSVLDLSQNNLS 562
+ L +K LE L+++ + + ++S L L L N L
Sbjct: 181 DINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLG 240
Query: 563 GKIPELLIRLQLVKN-----LNLSNNDL 585
L L + L + +
Sbjct: 241 DVGMAELCPGLLHPSSRLRTLWIWECGI 268
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-08
Identities = 64/358 (17%), Positives = 120/358 (33%), Gaps = 51/358 (14%)
Query: 61 HQRVTILDLESLKL----AGSISPHVGNLSFLKVLRLYNNSFNHE-IPSEFDRLR----R 111
++ L L++ L G +S + L L+ L L +N + + L R
Sbjct: 84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCR 143
Query: 112 LQVLALHYNSIG----GAIPANISSCSNLIQLRLFHNQL----VGKIPSEL-SSLSKIEH 162
L+ L L Y S+ + + + + + +L + +N + V + L S ++E
Sbjct: 144 LEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEA 203
Query: 163 ISVNDNNLT----GSIPSSLGNLSSIRSLFLSGNNLEGS-----IPDTLGWLKNLVNLTM 213
+ + +T + + + +S+R L L N L P L L L +
Sbjct: 204 LKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWI 263
Query: 214 AQNRLS----GTIPSSIFNISSITGFDAGVNKIQ--GAIPLDYGFSLQN--LQFFSVGEN 265
+ ++ G + + S+ N++ GA L L+ V
Sbjct: 264 WECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSC 323
Query: 266 QLTGAIPPTISNA----SNLEIFHGSVNKLTGA-----APYLEKLQRLL-VFGILGNSLG 315
T A S+ L S N+L A L + +L V + +
Sbjct: 324 SFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS 383
Query: 316 SRGDRDLNFLCSLTNATRLKWLLININNFGGS----LPACISNLSTTLEVLLLDNNQI 369
L +L L+ L ++ N G + L + LE L+L +
Sbjct: 384 DSSCSSL--AATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYW 439
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 56/249 (22%), Positives = 93/249 (37%), Gaps = 44/249 (17%)
Query: 661 KRKEKQNPNSPINSFPNISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKV 720
+ + I N +D F +++G G+ V++ + A+KV
Sbjct: 26 VTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKV 85
Query: 721 FNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEW 780
K E L + H N++K+ ++ +LV E + L +
Sbjct: 86 LK--KTVDKKIVRTEIGVLLRLSHPNIIKLKEI-----FETPTEISLVLELVTGGELFDR 138
Query: 781 LHPITRE--DETDEAPRSLNLIQRLNISIDVACALNYLH-HDCQPPIAHCDLKPSNILL- 836
+ + + E D A + ++ + A+ YLH + I H DLKP N+L
Sbjct: 139 I--VEKGYYSERDAA----DAVK------QILEAVAYLHENG----IVHRDLKPENLLYA 182
Query: 837 --DEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPE----YGLGSEVSISGDVYS 890
D I DFGL++ + + G+ GY APE G EV D++S
Sbjct: 183 TPAPDAPLKIADFGLSKIVEHQVLMKTVC---GTPGYCAPEILRGCAYGPEV----DMWS 235
Query: 891 YG----ILL 895
G ILL
Sbjct: 236 VGIITYILL 244
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 55/228 (24%), Positives = 89/228 (39%), Gaps = 53/228 (23%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKILT 752
IG+GSFG V +D + A+K N + ++ E ++ + H LV +
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 753 ACSGVDYQGNDFKALVFEFM-------HNRSLEEWLHPITREDETDEAPRSLNLIQRLNI 805
+ +Q + +V + + H + + E +L I
Sbjct: 83 S-----FQDEEDMFMVVDLLLGGDLRYH----------LQQNVHFKE-ETV-----KLFI 121
Query: 806 SIDVACALNYLH-HDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLA-RFLPLSSAQTSSI 863
++ AL+YL I H D+KP NILLDE HI DF +A + T +
Sbjct: 122 C-ELVMALDYLQNQR----IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA- 175
Query: 864 GAKGSIGYIAPE-------YGLGSEVSISGDVYSYGILLLELITRKKP 904
G+ Y+APE G V D +S G+ EL+ ++P
Sbjct: 176 ---GTKPYMAPEMFSSRKGAGYSFAV----DWWSLGVTAYELLRGRRP 216
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-14
Identities = 57/262 (21%), Positives = 99/262 (37%), Gaps = 52/262 (19%)
Query: 661 KRKEKQNPNSPINSFPNISYQNLYNATDRFSSV----NQIGEGSFGSVFKGILDDGRTTI 716
+ K N S + A F + IG G V + +
Sbjct: 63 DAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEF 122
Query: 717 AVKVFNL--------LHHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDFKAL 767
AVK+ + ++ E + L+ + H +++ ++ + Y+ + F L
Sbjct: 123 AVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS-----YESSSFMFL 177
Query: 768 VFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHC 827
VF+ M L ++L E + ++++ + A+++LH + I H
Sbjct: 178 VFDLMRKGELFDYLTEKVALSEKETR----SIMR------SLLEAVSFLHANN---IVHR 224
Query: 828 DLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPE----------YG 877
DLKP NILLD++M + DFG + L G+ GY+APE G
Sbjct: 225 DLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC---GTPGYLAPEILKCSMDETHPG 281
Query: 878 LGSEVSISGDVYSYG----ILL 895
G EV D+++ G LL
Sbjct: 282 YGKEV----DLWACGVILFTLL 299
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 50/218 (22%), Positives = 85/218 (38%), Gaps = 53/218 (24%)
Query: 695 QIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIA----ECNTLKNIR-HRNLVK 749
+GEGSF K + AVK+ + K A E LK H N+VK
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIIS-------KRMEANTQKEITALKLCEGHPNIVK 70
Query: 750 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITRE---DETDEAPRSLNLIQRLNIS 806
+ + LV E ++ L I ++ ET+ + +++
Sbjct: 71 LHEV-----FHDQLHTFLVMELLNGGEL---FERIKKKKHFSETEAS----YIMR----- 113
Query: 807 IDVACALNYLHHDCQPPIAHCDLKPSNILL---DEDMIAHIGDFGLARFLPLSSAQTSSI 863
+ A++++H + H DLKP N+L ++++ I DFG AR P + +
Sbjct: 114 -KLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP 169
Query: 864 GAKGSIGYIAPE------YGLGSEVSISGDVYSYGILL 895
++ Y APE Y D++S G++L
Sbjct: 170 C--FTLHYAAPELLNQNGYDE--SC----DLWSLGVIL 199
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 32/275 (11%), Positives = 69/275 (25%), Gaps = 76/275 (27%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRT--TIAVKV--FNLLHHGAFKS-FIAECNTLKNI 742
R+ + G ++ + D +A+ + ++ L I
Sbjct: 31 GRYRLLIFHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI 88
Query: 743 RHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQR 802
+ ++L V + +V E++ SL+E +T +P
Sbjct: 89 DKPGVARVLDV---VHTRAGGL--VVAEWIRGGSLQEVA-------DTSPSPV-----GA 131
Query: 803 LNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSS 862
+ +A A + H +A PS + + D +
Sbjct: 132 IRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA-------------- 174
Query: 863 IGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLA--- 919
+ + D+ G L L+ + P LA
Sbjct: 175 --------TMPD-------ANPQDDIRGIGASLYALLVNRWP----LPEAGVRSGLAPAE 215
Query: 920 -------------RTALPDHVMDIVDSTLLNDGED 941
+P + + ++ DG
Sbjct: 216 RDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGI 250
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 67/268 (25%), Positives = 105/268 (39%), Gaps = 61/268 (22%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFN--LLHHGAFKSFIAECNTLKNIRHRNLVKILTA 753
IG+G+F V +A+K+ + L+ + + E +K + H N+VK+
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL--- 79
Query: 754 CSGVDYQGNDFKA---LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVA 810
++ + + L+ E+ + ++L R E EA +
Sbjct: 80 -----FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKE-KEARS---------KFRQIV 124
Query: 811 CALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGL-ARFLPLSSAQTSSIGAKGSI 869
A+ Y H I H DLK N+LLD DM I DFG F G+
Sbjct: 125 SAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC----GAP 177
Query: 870 GYIAPE------YGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNL----- 918
Y APE Y G EV DV+S G++L L++ P F+G NL L
Sbjct: 178 PYAAPELFQGKKY-DGPEV----DVWSLGVILYTLVSGSLP----FDGQ-NLKELRERVL 227
Query: 919 -ARTALPDHVMDIVDSTLLNDGEDLIVH 945
+ +P ++ ST D E+L+
Sbjct: 228 RGKYRIPFYM-----ST---DCENLLKR 247
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 51/244 (20%), Positives = 94/244 (38%), Gaps = 23/244 (9%)
Query: 362 LLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNI 421
+ I P N + ++ ++ + EL +++ + Q ++
Sbjct: 2 SIQRPTPINQVFP--DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SL 56
Query: 422 PPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIV 481
L L+LS+N Q S S L L + ++ N L + S+ L
Sbjct: 57 AGMQFFTNLKELHLSHN--QISDLSPLKDLTKLEELSVNRNRLK-NLNG---IPSACLSR 110
Query: 482 LDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPI 541
L L N+L + +LKNLEIL++ NKLK I LG KLE L++ N +
Sbjct: 111 LFLDNNELRD--TDSLIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEITNT- 165
Query: 542 PSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQ----GVFKN 597
L+ L+ ++ +DL+ + + L + + + D + P G + +
Sbjct: 166 -GGLTRLKKVNWIDLTGQKCVNEPVKYQPELYI--TNTVKDPDGRWISPYYISNGGSYVD 222
Query: 598 ASIT 601
+
Sbjct: 223 GCVL 226
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 47/289 (16%), Positives = 107/289 (37%), Gaps = 47/289 (16%)
Query: 129 NISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLF 188
+N ++ L + LS +++ + +++N+ S+ + + ++++ L
Sbjct: 14 PDPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELH 69
Query: 189 LSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNIS--SITGFDAGVNKIQGAI 246
LS N + + L L L L++ +NRL ++ I ++ N+++
Sbjct: 70 LSHNQIS-DL-SPLKDLTKLEELSVNRNRL-----KNLNGIPSACLSRLFLDNNELRDTD 122
Query: 247 PLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLV 306
L L+NL+ S+ N+L +I + S LE+ N++T L +L+++
Sbjct: 123 SLI---HLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEITNTGG-LTRLKKVNW 176
Query: 307 FGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSL--PACISNLSTTLEVLLL 364
+ G + + L ++ + + G P ISN +
Sbjct: 177 IDLTGQKCVNEPVKYQPEL----------YITNTVKDPDGRWISPYYISNGGS------Y 220
Query: 365 DNNQIFGNIPAAIGK----FVNLQRLDMCSNRLSGTIPPAIGELQNLKD 409
+ + +P + F + GT+ Q +K+
Sbjct: 221 VDGCVLWELPVYTDEVSYKFSEYINVGETEAIFDGTVT------QPIKN 263
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 9e-10
Identities = 47/235 (20%), Positives = 89/235 (37%), Gaps = 24/235 (10%)
Query: 275 ISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRL 334
+N + +T ++L + F +++ + L + TN L
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS-QKELSGVQNFNGDNSNI-----QSLAGMQFFTN---L 65
Query: 335 KWLLININNFGGSLPACISNLS--TTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNR 392
K L ++ N + +S L T LE L ++ N++ N+ L RL + +N
Sbjct: 66 KELHLSHNQI-----SDLSPLKDLTKLEELSVNRNRL-KNLNG--IPSACLSRLFLDNNE 117
Query: 393 LSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYE 452
L T + L+NL+ L ++ N+ + +I KL +L L N + + L R +
Sbjct: 118 LRDTDS--LIHLKNLEILSIRNNKLK-SIVMLGFLSKLEVLDLHGNEI--TNTGGLTRLK 172
Query: 453 TLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILN 507
+ IDL+ L + V D ++ S G+ + +L
Sbjct: 173 KVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLW 227
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 8e-08
Identities = 41/185 (22%), Positives = 67/185 (36%), Gaps = 30/185 (16%)
Query: 77 SISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNL 136
+ P L+ L S + L +Q ++I A + +NL
Sbjct: 11 QVFP-DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNI--QSLAGMQFFTNL 65
Query: 137 IQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTG-------------------SIPSS 177
+L L HNQ+ + S L L+K+E +SVN N L S
Sbjct: 66 KELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLKNLNGIPSACLSRLFLDNNELRDTDS 123
Query: 178 LGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDA 237
L +L ++ L + N L+ SI LG+L L L + N ++ + + + D
Sbjct: 124 LIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEITN--TGGLTRLKKVNWIDL 179
Query: 238 GVNKI 242
K
Sbjct: 180 TGQKC 184
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 41/253 (16%), Positives = 79/253 (31%), Gaps = 57/253 (22%)
Query: 164 SVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIP 223
S+ + L++ L ++ + + L + N +
Sbjct: 2 SIQRPTPINQV-FPDPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNS------- 51
Query: 224 SSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEI 283
NI S+ G NL+ + NQ++ + P + + + LE
Sbjct: 52 ----NIQSLAGMQ----------------FFTNLKELHLSHNQIS-DLSP-LKDLTKLEE 89
Query: 284 FHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININN 343
+ N+L + L + N L RD + L L N L+ L I N
Sbjct: 90 LSVNRNRLKNLNG-IPSAC-LSRLFLDNNEL-----RDTDSLIHLKN---LEILSIRNNK 139
Query: 344 FGGSLPACISNLS-----TTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIP 398
+ ++ + LEVL L N+I N + + + +D+ +
Sbjct: 140 --------LKSIVMLGFLSKLEVLDLHGNEI-TNTG-GLTRLKKVNWIDLTGQKCVNEPV 189
Query: 399 PAIGELQNLKDLR 411
EL ++
Sbjct: 190 KYQPELYITNTVK 202
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 3e-14
Identities = 53/223 (23%), Positives = 95/223 (42%), Gaps = 27/223 (12%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVF---NLLHHGAFKSFIAECNTLKNIRHRNLVKILT 752
+G+G+FG V A+K+ ++ + E L+N RH L L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA-LK 214
Query: 753 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACA 812
+Q +D V E+ + L ++RE E R+ R + ++ A
Sbjct: 215 YS----FQTHDRLCFVMEYANGGEL---FFHLSRERVFSE-DRA-----RFYGA-EIVSA 260
Query: 813 LNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYI 872
L+YLH + + + DLK N++LD+D I DFGL + A + G+ Y+
Sbjct: 261 LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC--GTPEYL 316
Query: 873 APEYGLGSEVSISGDVYSYGILLLELITRKKP-----TDIMFE 910
APE ++ + D + G+++ E++ + P + +FE
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 359
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 3e-14
Identities = 55/220 (25%), Positives = 88/220 (40%), Gaps = 26/220 (11%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKILT 752
+G+G FG V + A K + + E L+ + R +V L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS-LA 250
Query: 753 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACA 812
Y+ D LV M+ L+ ++ + + E R+ + ++ C
Sbjct: 251 YA----YETKDALCLVLTLMNGGDLKFHIYHM-GQAGFPE-ARA-----VFYAA-EICCG 298
Query: 813 LNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYI 872
L LH + I + DLKP NILLD+ I D GLA +P +G ++GY+
Sbjct: 299 LEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVG---TVGYM 352
Query: 873 APEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGD 912
APE + S D ++ G LL E+I + P F+
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMIAGQSP----FQQR 388
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 70/286 (24%), Positives = 109/286 (38%), Gaps = 71/286 (24%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFN---LLHHGAFKSFIA------------------ 734
IG+GS+G V ++ T A+KV + L+ F
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 735 -----ECNTLKNIRHRNLVK----ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPIT 785
E LK + H N+VK + Y +VFE ++ + E
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLY-------MVFELVNQGPVMEVPTL-K 132
Query: 786 REDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845
E D+A Q D+ + YLH+ I H D+KPSN+L+ ED I
Sbjct: 133 PLSE-DQARF---YFQ------DLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIA 179
Query: 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISG---DVYSYGILLLELITRK 902
DFG++ S A S+ G+ ++APE + SG DV++ G+ L + +
Sbjct: 180 DFGVSNEFKGSDALLSN--TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
Query: 903 KPTDIMFEGD--MNLHNLARTA---LPDHVMDIVDSTLLNDGEDLI 943
P F + M LH+ ++ PD + D +DLI
Sbjct: 238 CP----FMDERIMCLHSKIKSQALEFPDQP------DIAEDLKDLI 273
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 3e-14
Identities = 50/174 (28%), Positives = 77/174 (44%), Gaps = 18/174 (10%)
Query: 347 SLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAI-GELQ 405
SL + S + E L L + + A L L++ N+L T+ + +L
Sbjct: 25 SLDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLT 83
Query: 406 NLKDLRLQRNRFQGNIPPSI--GNLKLFILYLSYNFLQGSIPS----SLGRYETLTTIDL 459
L L L N+ ++P + +L LYL N L+ S+PS L + L + L
Sbjct: 84 ELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTK---LKELRL 138
Query: 460 SNNNLTGTIPP-QFIGLSSSLIVLDLSRNQLTGSIPSEV-GNLKNLEILNVFGN 511
+ N L +IP F L ++L L LS NQL S+P L L+ + +FGN
Sbjct: 139 NTNQLQ-SIPAGAFDKL-TNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 6e-10
Identities = 41/156 (26%), Positives = 70/156 (44%), Gaps = 22/156 (14%)
Query: 89 KVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANI-SSCSNLIQLRLFHNQLV 147
+ L L + + F L +L L L YN + + A + + L L L +NQL
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQLA 96
Query: 148 GKIPSEL-SSLSKIEHISVNDNNLTGSIPS----SLGNLSSIRSLFLSGNNLEGSIP--- 199
+P + L++++ + + N L S+PS L L + L L+ N L+ SIP
Sbjct: 97 -SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKL---KELRLNTNQLQ-SIPAGA 150
Query: 200 -DTLGWLKNLVNLTMAQNRLSGTIPSSIF-NISSIT 233
D L NL L+++ N+L ++P F + +
Sbjct: 151 FDKLT---NLQTLSLSTNQLQ-SVPHGAFDRLGKLQ 182
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 42/147 (28%), Positives = 73/147 (49%), Gaps = 9/147 (6%)
Query: 65 TILDLESLKLAGSISPHV-GNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIG 123
T L+L+ +L ++S V +L+ L L L NN FD L +L L L N +
Sbjct: 62 TWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLK 120
Query: 124 GAIPANI-SSCSNLIQLRLFHNQLVGKIPSEL-SSLSKIEHISVNDNNLTGSIP-SSLGN 180
++P+ + + L +LRL NQL IP+ L+ ++ +S++ N L S+P +
Sbjct: 121 -SLPSGVFDRLTKLKELRLNTNQL-QSIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDR 177
Query: 181 LSSIRSLFLSGNNLEGSIPDTLGWLKN 207
L ++++ L GN + S + L +L
Sbjct: 178 LGKLQTITLFGNQFDCSRCEIL-YLSQ 203
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 35/142 (24%), Positives = 53/142 (37%), Gaps = 8/142 (5%)
Query: 455 TTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLK 514
+D +L ++P G+ + LDL L + L L LN+ N+L+
Sbjct: 17 KEVDCQGKSLD-SVPS---GIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ 72
Query: 515 GEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPE-LLIRLQ 573
+L L + N L L L L L N L +P + RL
Sbjct: 73 TLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLT 131
Query: 574 LVKNLNLSNNDLEGVVPTQGVF 595
+K L L+ N L+ +P G F
Sbjct: 132 KLKELRLNTNQLQ-SIPA-GAF 151
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 41/174 (23%), Positives = 66/174 (37%), Gaps = 18/174 (10%)
Query: 173 SIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFN-ISS 231
S+PS G + L L L T L L L + N+L T+ + +F+ ++
Sbjct: 28 SVPS--GIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTE 84
Query: 232 ITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTI-SNASNLEIFHGSVNK 290
+ N++ ++PL L L +G NQL ++P + + L+ + N+
Sbjct: 85 LGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQ 142
Query: 291 LT----GAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLIN 340
L GA L LQ L + N L S + L L L N
Sbjct: 143 LQSIPAGAFDKLTNLQTL---SLSTNQLQSVPHGAFDRLGKLQTI----TLFGN 189
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 4e-14
Identities = 47/213 (22%), Positives = 80/213 (37%), Gaps = 23/213 (10%)
Query: 685 NATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRH 744
+++ +G G FG V + + + T K + E + L RH
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARH 60
Query: 745 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLN 804
RN++ + + ++ + ++FEF+ + E + T E +E + Q
Sbjct: 61 RNILHLHES-----FESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCE 113
Query: 805 ISIDVACALNYLHHDCQPPIAHCDLKPSNILL--DEDMIAHIGDFGLARFLPLSSAQTSS 862
AL +LH I H D++P NI+ I +FG AR L
Sbjct: 114 -------ALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL 163
Query: 863 IGAKGSIGYIAPEYGLGSEVSISGDVYSYGILL 895
+ Y APE VS + D++S G L+
Sbjct: 164 F---TAPEYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 4e-14
Identities = 45/219 (20%), Positives = 81/219 (36%), Gaps = 31/219 (14%)
Query: 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFN------LLHHGAFKSFIAECNTLK 740
D + ++G G F V K A K + E + L+
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 741 NIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLI 800
+ H N++ + Y+ L+ E + L ++ + +++ E + +
Sbjct: 71 QVLHPNIITLHDV-----YENRTDVVLILELVSGGELFDF---LAQKESLSEEEATSFIK 122
Query: 801 QRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILL----DEDMIAHIGDFGLARFLPLS 856
Q L+ +NYLH IAH DLKP NI+L + DFGLA +
Sbjct: 123 QILD-------GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 857 SAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILL 895
+ G+ ++APE + + D++S G++
Sbjct: 173 VEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 6e-14
Identities = 45/219 (20%), Positives = 82/219 (37%), Gaps = 31/219 (14%)
Query: 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFN------LLHHGAFKSFIAECNTLK 740
D + ++G G F V K A K + + E + L+
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 741 NIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLI 800
+ H N++ + Y+ L+ E + L ++ + +++ E + +
Sbjct: 71 QVLHHNVITLHDV-----YENRTDVVLILELVSGGELFDF---LAQKESLSEEEATSFIK 122
Query: 801 QRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILL----DEDMIAHIGDFGLARFLPLS 856
Q L+ +NYLH IAH DLKP NI+L + DFGLA +
Sbjct: 123 QILD-------GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 857 SAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILL 895
+ G+ ++APE + + D++S G++
Sbjct: 173 VEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 7e-14
Identities = 60/249 (24%), Positives = 103/249 (41%), Gaps = 49/249 (19%)
Query: 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAF-KSFIAECNTLKNIRHR 745
R+ + IG+GSFG V K +A+K+ + + F + E L+++R +
Sbjct: 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKM--VRNEKRFHRQAAEEIRILEHLRKQ 153
Query: 746 ------NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNL 799
N++ +L ++ + + FE + +L E + + SL L
Sbjct: 154 DKDNTMNVIHMLEN---FTFRNHIC--MTFELLSM-NLYELIK------KNKFQGFSLPL 201
Query: 800 IQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI--GDFGLARFLPLSS 857
+++ + + L+ LH + I HCDLKP NILL + + I DFG + +
Sbjct: 202 VRK--FAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH--- 253
Query: 858 AQTSSIGAKGSIGYI------APEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEG 911
Q YI APE LG+ + D++S G +L EL+T + G
Sbjct: 254 -QRVYT-------YIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY----PLLPG 301
Query: 912 DMNLHNLAR 920
+ LA
Sbjct: 302 EDEGDQLAC 310
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 8e-14
Identities = 41/142 (28%), Positives = 66/142 (46%), Gaps = 10/142 (7%)
Query: 420 NIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQ-FIGLSSS 478
N+P +I + L N ++ P + Y+ L IDLSNN ++ + P F GL S
Sbjct: 29 NLPETITEI-----RLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGL-RS 81
Query: 479 LIVLDLSRNQLTGSIPSEV-GNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFL 537
L L L N++T +P + L +L++L + NK+ L L + +N L
Sbjct: 82 LNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKL 140
Query: 538 QGPIPSSLSSLRGLSVLDLSQN 559
Q + S LR + + L+QN
Sbjct: 141 QTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 3e-13
Identities = 38/143 (26%), Positives = 64/143 (44%), Gaps = 7/143 (4%)
Query: 443 SIPSSLGRYETLTTIDLSNNNLTGTIPPQ-FIGLSSSLIVLDLSRNQLTGSIPSEV-GNL 500
IP++L ET+T I L N + IPP F L +DLS NQ++ + + L
Sbjct: 25 EIPTNLP--ETITEIRLEQNTIK-VIPPGAFSPYKK-LRRIDLSNNQIS-ELAPDAFQGL 79
Query: 501 KNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNN 560
++L L ++GNK+ S L+ L + N + + L L++L L N
Sbjct: 80 RSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNK 139
Query: 561 LSGKIPELLIRLQLVKNLNLSNN 583
L L+ ++ ++L+ N
Sbjct: 140 LQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 8e-13
Identities = 28/131 (21%), Positives = 57/131 (43%), Gaps = 6/131 (4%)
Query: 89 KVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANI-SSCSNLIQLRLFHNQLV 147
+RL N+ P F ++L+ + L N I + + +L L L+ N++
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQI-SELAPDAFQGLRSLNSLVLYGNKIT 93
Query: 148 GKIPSEL-SSLSKIEHISVNDNNLTGSIPS-SLGNLSSIRSLFLSGNNLEGSIPDTLGWL 205
++P L L ++ + +N N + + + +L ++ L L N L+ T L
Sbjct: 94 -ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL 151
Query: 206 KNLVNLTMAQN 216
+ + + +AQN
Sbjct: 152 RAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 35/166 (21%), Positives = 66/166 (39%), Gaps = 32/166 (19%)
Query: 373 IPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFI 432
IP + + + + N + IPP G K LR
Sbjct: 26 IPTNL--PETITEIRLEQNTIK-VIPP--GAFSPYKKLR--------------------R 60
Query: 433 LYLSYNFLQGSIPS-SLGRYETLTTIDLSNNNLTGTIPPQ-FIGLSSSLIVLDLSRNQLT 490
+ LS N + + + +L ++ L N +T +P F GL SL +L L+ N++
Sbjct: 61 IDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGL-FSLQLLLLNANKIN 117
Query: 491 GSIPSEV-GNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQEN 535
+ + +L NL +L+++ NKL+ T ++ + + +N
Sbjct: 118 -CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 8e-14
Identities = 71/269 (26%), Positives = 111/269 (41%), Gaps = 62/269 (23%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKILT 752
+G G+FG V G +AVK+ N + E LK RH +++K+
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL-- 76
Query: 753 ACSGVDYQGNDFKA---LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDV 809
YQ +V E++ L +++ R +E EA R L Q++ +S
Sbjct: 77 ------YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEE-MEARR---LFQQI-LS--- 122
Query: 810 ACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGL-ARFLPLSSAQTSSIGAKGS 868
A++Y H + H DLKP N+LLD M A I DFGL +TS GS
Sbjct: 123 --AVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC----GS 173
Query: 869 IGYIAPE------YGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNL---- 918
Y APE Y G EV D++S G++L L+ P F+ + ++ L
Sbjct: 174 PNYAAPEVISGRLY-AGPEV----DIWSCGVILYALLCGTLP----FDDE-HVPTLFKKI 223
Query: 919 --ARTALPDHVMDIVDSTLLNDGEDLIVH 945
+P+++ + L++H
Sbjct: 224 RGGVFYIPEYL-----NR---SVATLLMH 244
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 54/241 (22%), Positives = 85/241 (35%), Gaps = 71/241 (29%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFN---LLHHGAFKSFIA-----ECNTLKNIRHRNL 747
+G G+FG V+ + + + VK +L + E L + H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 748 VKIL--------------TACSGVDYQGNDFKALVFEF-MHNRSLEEWLHPITREDETDE 792
+K+L SG+D +F F + L+E
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLD---------LFAFIDRHPRLDE-----------PL 131
Query: 793 APRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARF 852
A I + A+ YL I H D+K NI++ ED + DFG A +
Sbjct: 132 ASY---------IFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAY 179
Query: 853 LPLSSA-QTSSIGAKGSIGYIAPE------YGLGSEVSISGDVYSYGILLLELITRKKPT 905
L T G+I Y APE Y G E+ +++S G+ L L+ + P
Sbjct: 180 LERGKLFYTFC----GTIEYCAPEVLMGNPY-RGPEL----EMWSLGVTLYTLVFEENPF 230
Query: 906 D 906
Sbjct: 231 C 231
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 57/270 (21%), Positives = 97/270 (35%), Gaps = 49/270 (18%)
Query: 660 RKRKEKQNPNSPINSFPNISYQNLYNATDRFSSVNQIGEGSFGSVFKGI-LDDGRTTIAV 718
R P + +++ + ++ +G G FGSV+ GI + D +A+
Sbjct: 15 VPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLP-VAI 73
Query: 719 KVFN---LLHHGAFKSFIA---ECNTLKNIRHR--NLVKILTACSGVDYQGNDFKALVFE 770
K + G + E LK + ++++L ++ D L+ E
Sbjct: 74 KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW-----FERPDSFVLILE 128
Query: 771 FMHNR-SLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDL 829
L +++ E + A RS Q V A+ + H+ + H D+
Sbjct: 129 RPEPVQDLFDFITERGALQE-ELA-RSF-FWQ-------VLEAVRHCHNCG---VLHRDI 175
Query: 830 KPSNILLDED-MIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPE------YGLGSEV 882
K NIL+D + + DFG L + G+ Y PE Y G
Sbjct: 176 KDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPPEWIRYHRY-HGRSA 230
Query: 883 SISGDVYSYGILLLELITRKKPTDIMFEGD 912
V+S GILL +++ P FE D
Sbjct: 231 ----AVWSLGILLYDMVCGDIP----FEHD 252
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 3e-13
Identities = 49/226 (21%), Positives = 82/226 (36%), Gaps = 41/226 (18%)
Query: 685 NATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFN------LLHHGAFKSFIAECNT 738
N D + + ++G G F V K A K + + E +
Sbjct: 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 739 LKNIRHRNLVKILTACSGVDYQGNDFKALVFEFM-----HNRSLEEWLHPITREDETDEA 793
LK I+H N++ + Y+ L+ E + + + ++ E
Sbjct: 68 LKEIQHPNVITLHEV-----YENKTDVILILELVAGGELFDF--------LAEKESLTEE 114
Query: 794 PRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILL----DEDMIAHIGDFGL 849
+ L Q LN + YLH IAH DLKP NI+L I DFGL
Sbjct: 115 EATEFLKQILN-------GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 850 ARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILL 895
A + + + G+ ++APE + + D++S G++
Sbjct: 165 AHKIDFGNEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 3e-13
Identities = 45/212 (21%), Positives = 77/212 (36%), Gaps = 35/212 (16%)
Query: 695 QIGEGSFGSVFKGILDDGRTTIAVKVFN--LLHHGAFKSFIAECNTLKNIRHR-NLVKIL 751
++G G F V + I A K + E L+ + ++ +
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 752 TACSGVDYQGNDFKALVFEFM-----HNRSLEEWLHPITREDETDEAPRSLNLIQRLNIS 806
Y+ L+ E+ + L E ++ E D LI+
Sbjct: 96 EV-----YENTSEIILILEYAAGGEIFSLCLPELAEMVS---ENDVI----RLIK----- 138
Query: 807 IDVACALNYLHHDCQPPIAHCDLKPSNILL---DEDMIAHIGDFGLARFLPLSSAQTSSI 863
+ + YLH Q I H DLKP NILL I DFG++R + + +
Sbjct: 139 -QILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM 194
Query: 864 GAKGSIGYIAPEYGLGSEVSISGDVYSYGILL 895
G+ Y+APE ++ + D+++ GI+
Sbjct: 195 ---GTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 4e-13
Identities = 54/238 (22%), Positives = 92/238 (38%), Gaps = 38/238 (15%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFN---LLHHGAFKSFIAECNTLKNIRH 744
D F + IG G+F V + A+K+ N +L G F E + L N
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 745 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLN 804
R + ++ A +Q ++ LV E+ L L +++ E A + R
Sbjct: 121 RWITQLHFA-----FQDENYLYLVMEYYVGGDL---LTLLSKFGERIPAEMA-----RFY 167
Query: 805 ISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI--GDFGLA-RFLPLSSAQTS 861
++ ++ A++ +H + H D+KP NILLD HI DFG + + ++
Sbjct: 168 LA-EIVMAIDSVH---RLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRSL 221
Query: 862 SIGAKGSIGYIAPEYGLGSEVSISGDVY-------SYGILLLELITRKKPTDIMFEGD 912
A G+ Y++PE Y + G+ E+ + P F D
Sbjct: 222 V--AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP----FYAD 273
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 56/280 (20%), Positives = 86/280 (30%), Gaps = 79/280 (28%)
Query: 666 QNPNSPINSFPNISYQNLYNATDRFSSVNQIGEGSFGSVFKGI-LDDGRTTIAVKVFN-- 722
P P P ++ + +G+G FG+VF G L D +A+KV
Sbjct: 9 GPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQ-VAIKVIPRN 67
Query: 723 -LLHHGAFKSFIA---ECNTLKNIR----HRNLVKIL--------------TACSGVDYQ 760
+L + E L + H ++++L D
Sbjct: 68 RVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQD-- 125
Query: 761 GNDFKALVFEF-MHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHD 819
+F++ L E + R Q V A+ + H
Sbjct: 126 -------LFDYITEKGPLGE-----------GPS-RCF-FGQ-------VVAAIQHCHSR 158
Query: 820 CQPPIAHCDLKPSNILLDEDM-IAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPE--- 875
+ H D+K NIL+D A + DFG L G+ Y PE
Sbjct: 159 G---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD----GTRVYSPPEWIS 211
Query: 876 ---YGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGD 912
Y V+S GILL +++ P FE D
Sbjct: 212 RHQY-HALPA----TVWSLGILLYDMVCGDIP----FERD 242
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 40/211 (18%), Positives = 77/211 (36%), Gaps = 15/211 (7%)
Query: 382 NLQRLDMCSNRLSGTIPP-AIGELQNLKDLRLQRNRFQGNIPPSI--GNLKLFILYLSYN 438
+ Q L + L TIP A L N+ + + + + K+ + +
Sbjct: 32 STQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT 90
Query: 439 FLQGSIPSS-LGRYETLTTIDLSNNNLTGTIPPQ-FIGLSSSLIVLDLSRNQLTGSIPSE 496
I L L + + N L P + + +L+++ N SIP
Sbjct: 91 RNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVN 149
Query: 497 V-GNLKN-LEILNVFGNKLKGEIPSTLGSCIKLEQLEMQEN-FLQGPIPSSLSSLR-GLS 552
L N L ++ N + + KL+ + + +N +L + + G S
Sbjct: 150 AFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPS 208
Query: 553 VLDLSQNNLSGKIPELLIRLQLVKNLNLSNN 583
+LD+SQ +++ +P L+ +K L N
Sbjct: 209 LLDVSQTSVT-ALPSKG--LEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 28/172 (16%), Positives = 58/172 (33%), Gaps = 16/172 (9%)
Query: 69 LESLKLAG-----SISPHV-GNLSFLKVLRLYNNSFNHEIPSE-FDRLRRLQVLALHYNS 121
+ + ++ + H NLS + + + N I + L L+ L +
Sbjct: 57 ISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTG 116
Query: 122 IGGAIPAN--ISSCSNLIQLRLFHNQLVGKIPSE-LSSLSK-IEHISVNDNNLTGSIPSS 177
+ P + S L + N + IP L + + +N T S+
Sbjct: 117 L-KMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGY 174
Query: 178 LGNLSSIRSLFLSGNNLEGSIPDTL--GWLKNLVNLTMAQNRLSGTIPSSIF 227
N + + +++L+ N I G L ++Q ++ +PS
Sbjct: 175 AFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGL 225
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 28/196 (14%), Positives = 65/196 (33%), Gaps = 12/196 (6%)
Query: 88 LKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANI-SSCSNLIQLRLFHNQL 146
+ L+L F L + + + + + ++ + S + + + + +
Sbjct: 33 TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRN 92
Query: 147 VGKIPSE-LSSLSKIEHISVNDNNLTGSIP--SSLGNLSSIRSLFLSGNNLEGSIPDTL- 202
+ I + L L ++ + + + L P + + + L ++ N SIP
Sbjct: 93 LTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAF 151
Query: 203 -GWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFS--LQNLQF 259
G + L + N + ++ FN + + NK I F
Sbjct: 152 QGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVID-KDAFGGVYSGPSL 209
Query: 260 FSVGENQLTGAIPPTI 275
V + +T A+P
Sbjct: 210 LDVSQTSVT-ALPSKG 224
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 40/231 (17%), Positives = 71/231 (30%), Gaps = 27/231 (11%)
Query: 51 QWRGVTCSRRH--------QRVTILDLESLKLAGSISPHV-GNLSFLKVLRLYNNSFNHE 101
Q + + L L L +I H NL + + + + +
Sbjct: 12 QEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQ 70
Query: 102 IPSE-FDRLRRLQVLALHYNSIGGAIPANI-SSCSNLIQLRLFHNQLVGKIPSE--LSSL 157
+ S F L ++ + + I + L L +F+ L P + S
Sbjct: 71 LESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYST 129
Query: 158 SKIEHISVNDNNLTGSIP----SSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTM 213
+ + DN SIP L N + +L L N S+ L + +
Sbjct: 130 DIFFILEITDNPYMTSIPVNAFQGLCNET--LTLKLYNNGFT-SVQGYAFNGTKLDAVYL 186
Query: 214 AQNRLSGTIPSSIFN--ISSITGFDAGVNKIQGAIPLDYGF-SLQNLQFFS 261
+N+ I F S + D + A+P G L+ L +
Sbjct: 187 NKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALP-SKGLEHLKELIARN 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 39/261 (14%), Positives = 74/261 (28%), Gaps = 44/261 (16%)
Query: 161 EHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSG 220
E V ++ IPS + ++L L +L L N+ + ++ +
Sbjct: 14 EDFRVTCKDIQ-RIPSLPPST---QTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQ 69
Query: 221 TIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPP-TISNAS 279
+ S F +L + + + I P +
Sbjct: 70 QLESHSFY------------------------NLSKVTHIEIRNTRNLTYIDPDALKELP 105
Query: 280 NLEIFHGSVNKLT--GAAPYLEKLQRLLVFGILGNS-LGSRGDRDLNFLCSLTNATRLKW 336
L+ L + + I N + S LC+
Sbjct: 106 LLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNE-----TLT 160
Query: 337 LLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAI--GKFVNLQRLDMCSNRLS 394
L + N F S+ N + V L N + I G + LD+ ++
Sbjct: 161 LKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYL-TVIDKDAFGGVYSGPSLLDVSQTSVT 218
Query: 395 GTIPPAIGELQNLKDLRLQRN 415
+P L++LK+L +
Sbjct: 219 -ALPSKG--LEHLKELIARNT 236
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 4e-13
Identities = 58/234 (24%), Positives = 93/234 (39%), Gaps = 42/234 (17%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIA-ECNTLKNIRHRNLVKILTAC 754
+GEG++G V + +AVK+ ++ I E K + H N+VK
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 71
Query: 755 SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALN 814
G +GN L E+ L + + P E +A R +L ++ +
Sbjct: 72 -GHRREGNIQ-YLFLEYCSGGELFDRIEPDIGMPE-PDAQR---FFHQL-MA-----GVV 119
Query: 815 YLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSA----QTSSIGAKGSIG 870
YLH I H D+KP N+LLDE I DFGLA ++ G++
Sbjct: 120 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC----GTLP 172
Query: 871 YIAPE------YGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNL 918
Y+APE + V DV+S GI+L ++ + P ++ +
Sbjct: 173 YVAPELLKRREF-HAEPV----DVWSCGIVLTAMLAGELP----WDQPSDSCQE 217
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 5e-13
Identities = 48/230 (20%), Positives = 83/230 (36%), Gaps = 45/230 (19%)
Query: 685 NATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFN------LLHHGAFKSFIAECNT 738
D + ++G G F V K A K + + E N
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 739 LKNIRHRNLVKILTACSGVDYQGNDFKALVFEFM-----HNRSLEEWLHPITREDETDEA 793
L+ IRH N++ + ++ L+ E + + + ++ E
Sbjct: 62 LREIRHPNIITLHDI-----FENKTDVVLILELVSGGELFDF--------LAEKESLTED 108
Query: 794 PRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILL----DEDMIAHIGDFGL 849
+ L Q L+ ++YLH IAH DLKP NI+L + + DFG+
Sbjct: 109 EATQFLKQILD-------GVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158
Query: 850 ARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYG----ILL 895
A + + + G+ ++APE + + D++S G ILL
Sbjct: 159 AHKIEAGNEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 205
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 5e-13
Identities = 61/245 (24%), Positives = 101/245 (41%), Gaps = 39/245 (15%)
Query: 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVF---NLLHHGAFKSFIAECNTLKNIR 743
DR+ + IG+GSFG V K + +A+K+ + A E L+ +
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI----EVRLLELMN 108
Query: 744 HR------NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSL 797
+V + ++ + LVFE + +L + L T+ SL
Sbjct: 109 KHDTEMKYYIVHLKRH---FMFRNHLC--LVFEMLS-YNLYDLL------RNTNFRGVSL 156
Query: 798 NLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG--DFGLARFLPL 855
NL ++ + + AL +L + I HCDLKP NILL + I DFG + L
Sbjct: 157 NLTRK--FAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ--L 211
Query: 856 SSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNL 915
I S Y +PE LG ++ D++S G +L+E+ T + +F G +
Sbjct: 212 GQRIYQYI---QSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE----PLFSGANEV 264
Query: 916 HNLAR 920
+ +
Sbjct: 265 DQMNK 269
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 5e-13
Identities = 52/222 (23%), Positives = 94/222 (42%), Gaps = 32/222 (14%)
Query: 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFN---LLHHGAFKSFIAECNTLKNIRHRN 746
F + IG G+FG V L + A+K+ N +L F E + L N +
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 747 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNIS 806
+ + A +Q ++ LV ++ L L +++ ++ + R ++
Sbjct: 136 ITTLHYA-----FQDDNNLYLVMDYYVGGDL---LTLLSKFEDRLPEEMA-----RFYLA 182
Query: 807 IDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI--GDFGLA-RFLPLSSAQTSSI 863
++ A++ +H Q H D+KP NIL+D + HI DFG + + + Q+S
Sbjct: 183 -EMVIAIDSVH---QLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQSSV- 235
Query: 864 GAKGSIGYIAPEYGLGSEVSISG-----DVYSYGILLLELIT 900
A G+ YI+PE E D +S G+ + E++
Sbjct: 236 -AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 6e-13
Identities = 45/215 (20%), Positives = 81/215 (37%), Gaps = 47/215 (21%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIA--ECNTL-KNIRHRNLVKILT 752
+G G G V + A+K+ S A E + + ++V IL
Sbjct: 37 LGLGVNGKVLECFHRRTGQKCALKLLY-------DSPKARQEVDHHWQASGGPHIVCILD 89
Query: 753 ACSGVDYQGNDFKALVFEFMH-----NRSLEEWLHPITREDETDEAPRSLNLIQRLNISI 807
+ + ++ E M +R E T E + A +++
Sbjct: 90 VYENMHHGKRCL-LIIMECMEGGELFSRIQERGDQAFT---EREAA----EIMR------ 135
Query: 808 DVACALNYLHHDCQPPIAHCDLKPSNILL---DEDMIAHIGDFGLARFLPLSSAQTSSIG 864
D+ A+ +LH IAH D+KP N+L ++D + + DFG A+ ++ QT
Sbjct: 136 DIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT---- 188
Query: 865 AKGSIGYIAPE----YGLGSEVSISGDVYSYGILL 895
+ Y+APE D++S G+++
Sbjct: 189 PCYTPYYVAPEVLGPEKYDKSC----DMWSLGVIM 219
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 6e-13
Identities = 56/262 (21%), Positives = 99/262 (37%), Gaps = 57/262 (21%)
Query: 687 TDRFSSVNQIGEGSFGSVFKGI-LDDGRTTIAVKVF---NLLHHGAFKSFIAECNTLKNI 742
+R+ V +GEG+FG V + + G++ +A+K+ A E N LK I
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL----EINVLKKI 73
Query: 743 RHR------NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRS 796
+ + V + ++ G+ + FE + ++ E+L E + P
Sbjct: 74 KEKDKENKFLCVLMSDW---FNFHGHMC--IAFELLG-KNTFEFL------KENNFQPYP 121
Query: 797 LNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLS 856
L ++ ++ + AL +LH + Q + H DLKP NIL + +
Sbjct: 122 LPHVRH--MAYQLCHALRFLH-ENQ--LTHTDLKPENILFVNS--EFETLYNEHKSCEEK 174
Query: 857 SAQTSSIGAK----GS--------IGYI------APEYGLGSEVSISGDVYSYGILLLEL 898
S + +SI + GS + PE L + DV+S G +L E
Sbjct: 175 SVKNTSI--RVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEY 232
Query: 899 ITRKKPTDIMFEGDMNLHNLAR 920
+F+ N +L
Sbjct: 233 YR----GFTLFQTHENREHLVM 250
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 7e-13
Identities = 57/259 (22%), Positives = 92/259 (35%), Gaps = 48/259 (18%)
Query: 659 VRKRKEKQNPNSPINSFPNISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAV 718
+RK K N S N A D + V IG G+FG V R A+
Sbjct: 41 LRKNKNIDNFLSRYKDTINKIRDLRMKAED-YEVVKVIGRGAFGEVQLVRHKSTRKVYAM 99
Query: 719 KVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNR 775
K+ + ++ F E + + +V++ A +Q + + +V E+M
Sbjct: 100 KLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA-----FQDDRYLYMVMEYMPGG 154
Query: 776 SLEEWLHPITREDETDEAPRSLNLIQRLNISIDVA--------CALNYLHHDCQPPIAHC 827
L +NL+ ++ A AL+ +H H
Sbjct: 155 DL-------------------VNLMSNYDVPEKWARFYTAEVVLALDAIH---SMGFIHR 192
Query: 828 DLKPSNILLDEDMIAHI--GDFGLARFLPLSSAQTSSIGAKGSIGYIAPE----YGLGSE 881
D+KP N+LLD+ H+ DFG + A G+ YI+PE G
Sbjct: 193 DVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGDGY 249
Query: 882 VSISGDVYSYGILLLELIT 900
D +S G+ L E++
Sbjct: 250 YGRECDWWSVGVFLYEMLV 268
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-12
Identities = 52/332 (15%), Positives = 105/332 (31%), Gaps = 50/332 (15%)
Query: 295 APYLEKLQRLLVFGILGNSLGSRGDRDL-NFLCSLTNATRLKWLLININNFGGSLPACIS 353
L + + + GN++G+ R L + S + ++ I +P +
Sbjct: 25 FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALR 84
Query: 354 NLS------TTLEVLLLDNNQIFGNIPAAIGKF----VNLQRLDMCSNRLSGTIPPAIGE 403
L L + L +N + F L+ L + +N L I
Sbjct: 85 LLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIAR 144
Query: 404 LQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQG----SIPSSLGRYETLTTIDL 459
L++L + + + L + N L+ + + L T+ +
Sbjct: 145 A--LQELAVNKK--------AKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKM 194
Query: 460 SNNNLT----GTIPPQFIGLSSSLIVLDLSRNQLTG----SIPSEVGNLKNLEILNVFGN 511
N + + + + L VLDL N T ++ + + NL L +
Sbjct: 195 VQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDC 254
Query: 512 KLKGE----IPSTLGSC--IKLEQLEMQENFLQGPIPSSLSS-----LRGLSVLDLSQNN 560
L + I L+ L +Q N ++ +L + + L L+L+ N
Sbjct: 255 LLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNR 314
Query: 561 LS------GKIPELLIRLQLVKNLNLSNNDLE 586
S +I E+ + L + +
Sbjct: 315 FSEEDDVVDEIREVFSTRGRGELDELDDMEEL 346
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 43/265 (16%), Positives = 88/265 (33%), Gaps = 50/265 (18%)
Query: 358 TLEVLLLDNNQI----FGNIPAAIGKFVNLQRLDMCSNRLSGT----IPPAIGELQNLKD 409
++E L + I ++ A + + +++ + + N + + I ++L+
Sbjct: 5 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64
Query: 410 LRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLT--GT 467
G +K I + +L + L T+ LS+N
Sbjct: 65 AEFSDI--------FTGRVKDEIPEAL-----RLLLQALLKCPKLHTVRLSDNAFGPTAQ 111
Query: 468 IP-PQFIGLSSSLIVLDLSRNQLT-------------GSIPSEVGNLKNLEILNVFGNKL 513
P F+ + L L L N L ++ + N L + N+L
Sbjct: 112 EPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL 171
Query: 514 KGE----IPSTLGSCIKLEQLEMQENFL-----QGPIPSSLSSLRGLSVLDLSQNNLSGK 564
+ T S L ++M +N + + + L+ + L VLDL N +
Sbjct: 172 ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHL 231
Query: 565 ----IPELLIRLQLVKNLNLSNNDL 585
+ L ++ L L++ L
Sbjct: 232 GSSALAIALKSWPNLRELGLNDCLL 256
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 3e-09
Identities = 47/311 (15%), Positives = 98/311 (31%), Gaps = 54/311 (17%)
Query: 112 LQVLALHYNSIGG----AIPANISSCSNLIQLRLFHNQL----VGKIPSELSSLSKIEHI 163
++ +L ++I ++ A + ++ ++ L N + + ++S +E
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 164 SVNDNNL----------TGSIPSSLGNLSSIRSLFLSGNNL--EG--SIPDTLGWLKNLV 209
+D + +L + ++ LS N + D L L
Sbjct: 66 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125
Query: 210 NLTMAQNRLS-------------GTIPSSIFNISSITGFDAGVNKIQ--GAIPLDYGF-S 253
+L + N L + N + G N+++ F S
Sbjct: 126 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 185
Query: 254 LQNLQFFSVGENQLT-----GAIPPTISNASNLEIFHGSVNKLT--GA---APYLEKLQR 303
+ L + +N + + ++ L++ N T G+ A L+
Sbjct: 186 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 245
Query: 304 LLVFGILGNSLGSRGDRDL-NFLCSLTNATRLKWLLININNFGG----SLPACISNLSTT 358
L G+ L +RG + + L N L+ L + N +L I
Sbjct: 246 LRELGLNDCLLSARGAAAVVDAFSKLENIG-LQTLRLQYNEIELDAVRTLKTVIDEKMPD 304
Query: 359 LEVLLLDNNQI 369
L L L+ N+
Sbjct: 305 LLFLELNGNRF 315
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 1e-12
Identities = 71/269 (26%), Positives = 109/269 (40%), Gaps = 62/269 (23%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKILT 752
+G G+FG V G + +AVK+ N + E LK RH +++K+
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL-- 81
Query: 753 ACSGVDYQGNDFKA---LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDV 809
YQ + +V E++ L +++ R DE E+ R L Q++ +S
Sbjct: 82 ------YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDE-KESRR---LFQQI-LS--- 127
Query: 810 ACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGL-ARFLPLSSAQTSSIGAKGS 868
++Y H + H DLKP N+LLD M A I DFGL +TS GS
Sbjct: 128 --GVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC----GS 178
Query: 869 IGYIAPE------YGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNL---- 918
Y APE Y G EV D++S G++L L+ P F+ D ++ L
Sbjct: 179 PNYAAPEVISGRLY-AGPEV----DIWSSGVILYALLCGTLP----FDDD-HVPTLFKKI 228
Query: 919 --ARTALPDHVMDIVDSTLLNDGEDLIVH 945
P ++ + L+ H
Sbjct: 229 CDGIFYTPQYL-----NP---SVISLLKH 249
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 58/234 (24%), Positives = 93/234 (39%), Gaps = 42/234 (17%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIA-ECNTLKNIRHRNLVKILTAC 754
+GEG++G V + +AVK+ ++ I E K + H N+VK
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 71
Query: 755 SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALN 814
G +GN L E+ L + + P E +A R +L ++ +
Sbjct: 72 -GHRREGNIQ-YLFLEYCSGGELFDRIEPDIGMPE-PDAQR---FFHQL-MA-----GVV 119
Query: 815 YLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSA----QTSSIGAKGSIG 870
YLH I H D+KP N+LLDE I DFGLA ++ G++
Sbjct: 120 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC----GTLP 172
Query: 871 YIAPE------YGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNL 918
Y+APE + V DV+S GI+L ++ + P ++ +
Sbjct: 173 YVAPELLKRREF-HAEPV----DVWSCGIVLTAMLAGELP----WDQPSDSCQE 217
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 2e-12
Identities = 50/216 (23%), Positives = 77/216 (35%), Gaps = 29/216 (13%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFN---LLHHGAFKSFIAECNTL---KNIRHRNLVK 749
IG G FG V+ D A+K + + + E L +V
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 750 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDV 809
++ + D + + + M+ L L E R + ++
Sbjct: 257 -MSYA----FHTPDKLSFILDLMNGGDLHYHLSQHGVFSE----ADM-----RFYAA-EI 301
Query: 810 ACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSI 869
L ++H + + DLKP+NILLDE I D GLA S G+
Sbjct: 302 ILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTH 354
Query: 870 GYIAPE-YGLGSEVSISGDVYSYGILLLELITRKKP 904
GY+APE G S D +S G +L +L+ P
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 70/278 (25%), Positives = 108/278 (38%), Gaps = 81/278 (29%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKILT 752
+GEGSFG V + +A+K + L E + LK +RH +++K+
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74
Query: 753 ACSGVDYQGNDFKA---LVFEF---------MHNRSLEEWLHPITREDETDEAPRSLNLI 800
Y +V E+ + + + E DE R
Sbjct: 75 ------YDVITTPTDIVMVIEYAGGELFDYIVEKKRMTE-----------DEGRR---FF 114
Query: 801 QRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSS-AQ 859
Q++ I A+ Y H I H DLKP N+LLD+++ I DFGL+ + + +
Sbjct: 115 QQI-IC-----AIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK 165
Query: 860 TSSIGAKGSIGYIAPE------YGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDM 913
TS GS Y APE Y G EV DV+S GI+L ++ + P F+ +
Sbjct: 166 TSC----GSPNYAAPEVINGKLY-AGPEV----DVWSCGIVLYVMLVGRLP----FDDE- 211
Query: 914 NLHNL------ARTALPDHVMDIVDSTLLNDGEDLIVH 945
+ NL +PD + S + LI
Sbjct: 212 FIPNLFKKVNSCVYVMPDFL-----SP---GAQSLIRR 241
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 68.0 bits (165), Expect = 3e-12
Identities = 39/222 (17%), Positives = 68/222 (30%), Gaps = 59/222 (26%)
Query: 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKV--------FNLLHHGAFKSFIAECN 737
T++ +IGEG FG VF+ I D T +A+K+ N H F+ + E
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 738 TLKNI---------RHRNLVKILTAC-------------------------SGVDYQGND 763
K + R + + + D+ +D
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPP 823
+V EF E + + +L +I + +L +
Sbjct: 136 QLFIVLEFEFGGIDLEQMR-----------TKLSSLATAKSILHQLTASLAVAEASLR-- 182
Query: 824 IAHCDLKPSNILLDEDMIAHIGDFGLAR--FLPLSSAQTSSI 863
H DL N+LL + + + + +P Q S I
Sbjct: 183 FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSII 224
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 5e-12
Identities = 56/262 (21%), Positives = 100/262 (38%), Gaps = 57/262 (21%)
Query: 687 TDRFSSVNQIGEGSFGSVFKGI-LDDGRTTIAVKVF---NLLHHGAFKSFIAECNTLKNI 742
+ R+ V+ +GEG+FG V + I G +AVK+ + A E L+++
Sbjct: 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS----EIQVLEHL 68
Query: 743 RHR------NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRS 796
V++L ++ G+ +VFE + S +++ E P
Sbjct: 69 NTTDPNSTFRCVQMLEW---FEHHGHIC--IVFELLG-LSTYDFI------KENGFLPFR 116
Query: 797 LNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLS 856
L+ I++ ++ + ++N+LH + + H DLKP NIL + + +
Sbjct: 117 LDHIRK--MAYQICKSVNFLH-SNK--LTHTDLKPENILFVQS--DYTEAYNPKIKRDER 169
Query: 857 SAQTSSIGAK----GS--------IGYI------APEYGLGSEVSISGDVYSYGILLLEL 898
+ I K GS + APE L S DV+S G +L+E
Sbjct: 170 TLINPDI--KVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEY 227
Query: 899 ITRKKPTDIMFEGDMNLHNLAR 920
+F + +LA
Sbjct: 228 YL----GFTVFPTHDSKEHLAM 245
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 5e-12
Identities = 57/244 (23%), Positives = 94/244 (38%), Gaps = 66/244 (27%)
Query: 696 IGEGSFGSVF---KGILDDGRTTIAVKVFNLLHHGAFKSFI-----------AECNTLKN 741
+G+G +G VF K + A+KV K+ I AE N L+
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLK-------KAMIVRNAKDTAHTKAERNILEE 77
Query: 742 IRHRNLVKILTACSGVDYQGNDFKALVFE-------FMHNRSLEEWLHPITREDETDEAP 794
++H +V L +Q L+ E FM + RE E
Sbjct: 78 VKHPFIVD-LIYA----FQTGGKLYLILEYLSGGELFMQ----------LEREGIFME-D 121
Query: 795 RSLNLIQRLNISIDVACALNYLH-HDCQPPIAHCDLKPSNILLDEDMIAHI--GDFGLAR 851
+ ++ +++ AL +LH I + DLKP NI+L+ H+ DFGL +
Sbjct: 122 TA-----CFYLA-EISMALGHLHQKG----IIYRDLKPENIMLNHQ--GHVKLTDFGLCK 169
Query: 852 FLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP-----TD 906
T + G+I Y+APE + S + + D +S G L+ +++T P
Sbjct: 170 ESIHDGTVTHTFC--GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK 227
Query: 907 IMFE 910
+
Sbjct: 228 KTID 231
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 6e-12
Identities = 53/225 (23%), Positives = 94/225 (41%), Gaps = 32/225 (14%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVF---NLLHHGAFKSFIAECNTLKNIRHRNLVKILT 752
+G+G+FG V A+K+ ++ + E L+N RH L L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA-LK 71
Query: 753 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACA 812
+Q +D V E+ + L ++RE E R+ R + ++ A
Sbjct: 72 YA----FQTHDRLCFVMEYANGGEL---FFHLSRERVFTE-ERA-----RFYGA-EIVSA 117
Query: 813 LNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI--GDFGLARFLPLSSAQTSSIGAKGSIG 870
L YLH + + D+K N++LD+D HI DFGL + A + G+
Sbjct: 118 LEYLH---SRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFC--GTPE 170
Query: 871 YIAPEYGLGSEVSISGDVYSYGILLLELITRKKP-----TDIMFE 910
Y+APE ++ + D + G+++ E++ + P + +FE
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE 215
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 6e-12
Identities = 62/264 (23%), Positives = 95/264 (35%), Gaps = 57/264 (21%)
Query: 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVF---NLLHHGAFKSFIAECNTLKNIR 743
+ F + ++G+G+FG V D + AVKV A E + LK I+
Sbjct: 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI----EADILKKIQ 89
Query: 744 HR-----NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLN 798
+ N+VK Y + L+FE + SL E + + +
Sbjct: 90 NDDINNNNIVKYHGK---FMYYDHMC--LIFEPLG-PSLYEII------TRNNYNGFHIE 137
Query: 799 LIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSA 858
I+ I++ ALNYL + H DLKP NILLD+ R +
Sbjct: 138 DIKL--YCIEILKALNYLR-KMS--LTHTDLKPENILLDDP--YFEKSLITVRRVTDGKK 190
Query: 859 QTSSIGAKGSI-----G-----------YI------APEYGLGSEVSISGDVYSYGILLL 896
I G I APE L +S D++S+G +L
Sbjct: 191 IQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA 250
Query: 897 ELITRKKPTDIMFEGDMNLHNLAR 920
EL T ++F ++ +LA
Sbjct: 251 ELYT----GSLLFRTHEHMEHLAM 270
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 6e-12
Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 29/204 (14%)
Query: 320 RDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGK 379
+ + + + ++ N N+ S+ I L + L L N++ I
Sbjct: 29 KSVTDAVTQNELNSIDQIIAN-NSDIKSVQG-IQYL-PNVRYLALGGNKL-----HDISA 80
Query: 380 F---VNLQRLDMCSNRLSGTIPPAI-GELQNLKDLRLQRNRFQGNIPPSIGNL--KLFIL 433
NL L + N+L ++P + +L NLK+L L N+ Q ++P + + L L
Sbjct: 81 LKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYL 138
Query: 434 YLSYNFLQGSIPS----SLGRYETLTTIDLSNNNLTGTIPP-QFIGLSSSLIVLDLSRNQ 488
L++N LQ S+P L LT +DLS N L ++P F L + L L L +NQ
Sbjct: 139 NLAHNQLQ-SLPKGVFDKLTN---LTELDLSYNQLQ-SLPEGVFDKL-TQLKDLRLYQNQ 192
Query: 489 LTGSIPSEV-GNLKNLEILNVFGN 511
L S+P V L +L+ + + N
Sbjct: 193 LK-SVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 39/136 (28%), Positives = 59/136 (43%), Gaps = 15/136 (11%)
Query: 84 NLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANI-SSCSNLIQLRLF 142
L+ L L L N FD+L L+ L L N + ++P + +NL L L
Sbjct: 83 ELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQL-QSLPDGVFDKLTNLTYLNLA 141
Query: 143 HNQLVGKIPSEL-SSLSKIEHISVNDNNLTGSIPS----SLGNLSSIRSLFLSGNNLEGS 197
HNQL +P + L+ + + ++ N L S+P L L + L L N L+ S
Sbjct: 142 HNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQL---KDLRLYQNQLK-S 195
Query: 198 IPDTLGWLKNLVNLTM 213
+PD G L +L
Sbjct: 196 VPD--GVFDRLTSLQY 209
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 9e-07
Identities = 45/181 (24%), Positives = 81/181 (44%), Gaps = 26/181 (14%)
Query: 64 VTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIG 123
+ + + + + L ++ L L N H+I + L L L L N +
Sbjct: 43 IDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKL-HDISA-LKELTNLTYLILTGNQL- 97
Query: 124 GAIPANI-SSCSNLIQLRLFHNQLVGKIPSEL-SSLSKIEHISVNDNNLTGSIPS----S 177
++P + +NL +L L NQL +P + L+ + ++++ N L S+P
Sbjct: 98 QSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDK 155
Query: 178 LGNLSSIRSLFLSGNNLEGSIP----DTLGWLKNLVNLTMAQNRLSGTIPSSIF-NISSI 232
L NL+ L LS N L+ S+P D L L +L + QN+L ++P +F ++S+
Sbjct: 156 LTNLT---ELDLSYNQLQ-SLPEGVFDKLT---QLKDLRLYQNQLK-SVPDGVFDRLTSL 207
Query: 233 T 233
Sbjct: 208 Q 208
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 45/226 (19%), Positives = 84/226 (37%), Gaps = 39/226 (17%)
Query: 89 KVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVG 148
L S + + L + + + + I ++ I N+ L L N+L
Sbjct: 22 IKANLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVRYLALGGNKLH- 76
Query: 149 KIPSELSSLSKIEHISVNDNNLTGSIPSSL-GNLSSIRSLFLSGNNLEGSIPDTLGWLKN 207
I + L L+ + ++ + N L S+P+ + L++++ L L N L+ L N
Sbjct: 77 DISA-LKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTN 134
Query: 208 LVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQL 267
L L +A N+L ++P +F+ L NL + NQL
Sbjct: 135 LTYLNLAHNQLQ-SLPKGVFD------------------------KLTNLTELDLSYNQL 169
Query: 268 TGAIPPTI-SNASNLEIFHGSVNKLT----GAAPYLEKLQRLLVFG 308
++P + + L+ N+L G L LQ + +
Sbjct: 170 Q-SLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHD 214
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 7e-12
Identities = 61/242 (25%), Positives = 97/242 (40%), Gaps = 64/242 (26%)
Query: 696 IGEGSFGSVF---KGILDDGRTTIAVKVFNLLHHGAFKSFI---------AECNTLKNIR 743
+G+GSFG VF K D R A+KV K+ + E + L +
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLK-------KATLKVRDRVRTKMERDILVEVN 84
Query: 744 HRNLVKILTACSGVDYQGNDFKALVFE-------FMHNRSLEEWLHPITREDETDEAPRS 796
H +VK L +Q L+ + F +++E E
Sbjct: 85 HPFIVK-LHYA----FQTEGKLYLILDFLRGGDLFTR----------LSKEVMFTE-EDV 128
Query: 797 LNLIQRLNISIDVACALNYLH-HDCQPPIAHCDLKPSNILLDEDMIAHI--GDFGLARFL 853
+ ++ ++A AL++LH I + DLKP NILLDE+ HI DFGL++
Sbjct: 129 -----KFYLA-ELALALDHLHSLG----IIYRDLKPENILLDEE--GHIKLTDFGLSKES 176
Query: 854 PLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP-----TDIM 908
+ S G++ Y+APE + S D +S+G+L+ E++T P
Sbjct: 177 IDHEKKAYSFC--GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET 234
Query: 909 FE 910
Sbjct: 235 MT 236
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 9e-12
Identities = 54/248 (21%), Positives = 96/248 (38%), Gaps = 52/248 (20%)
Query: 681 QNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFI------- 733
QN F + +G GSFG V + A+K+ + K +
Sbjct: 35 QNTAQLDQ-FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-------KQKVVKLKQIE 86
Query: 734 ---AECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDET 790
E L+ + LVK+ + ++ N +V E++ + L I R E
Sbjct: 87 HTLNEKRILQAVNFPFLVKLEFS-----FKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE- 140
Query: 791 DEAPRSLNLIQRLNISIDVACALNYLH-HDCQPPIAHCDLKPSNILLDEDMIAHI--GDF 847
P + R + + YLH D + + DLKP N+L+D+ +I DF
Sbjct: 141 ---PHA-----RFYAA-QIVLTFEYLHSLD----LIYRDLKPENLLIDQQ--GYIQVTDF 185
Query: 848 GLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP--- 904
G A+ + +T ++ G+ +APE L + + D ++ G+L+ E+ P
Sbjct: 186 GFAKRVK---GRTWTLC--GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240
Query: 905 --TDIMFE 910
++E
Sbjct: 241 DQPIQIYE 248
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 50/224 (22%), Positives = 82/224 (36%), Gaps = 49/224 (21%)
Query: 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIA---ECNTL-KNI 742
TD + IG GS+ + I AVK+ + KS E L +
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID-------KSKRDPTEEIEILLRYG 73
Query: 743 RHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQR 802
+H N++ + Y + +V E M L + + E + + ++
Sbjct: 74 QHPNIITLKDV-----YDDGKYVYVVTELMKGGELLDKILRQKFFSEREAS----AVLF- 123
Query: 803 LNISIDVACALNYLHHDCQPPIAHCDLKPSNILL-----DEDMIAHIGDFGLARFLPLSS 857
+ + YLH + H DLKPSNIL + + I I DFG A+ L +
Sbjct: 124 -----TITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIR-ICDFGFAKQLRAEN 174
Query: 858 AQTSSIGAKGSIGYIAPE------YGLGSEVSISGDVYSYGILL 895
+ + ++APE Y D++S G+LL
Sbjct: 175 GLLMTPC--YTANFVAPEVLERQGYDA--AC----DIWSLGVLL 210
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 28/157 (17%), Positives = 59/157 (37%), Gaps = 18/157 (11%)
Query: 50 CQWRGVTCS-RRHQRV--------TILDLESLKLAGSISPHVG--NLSFLKVLRLYNNSF 98
C+ V CS ++ ++ L L + + + L L+ + NN
Sbjct: 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKI 69
Query: 99 NHEIPSEFDRLRRLQVLALHYNSIGGAIPANI-SSCSNLIQLRLFHNQLVGKIPSEL-SS 156
F+ + + L N + + + +L L L N++ + ++
Sbjct: 70 TDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIG 127
Query: 157 LSKIEHISVNDNNLTGSIP-SSLGNLSSIRSLFLSGN 192
LS + +S+ DN +T ++ + L S+ +L L N
Sbjct: 128 LSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 29/144 (20%), Positives = 52/144 (36%), Gaps = 8/144 (5%)
Query: 443 SIPSSLGRYETLTTIDLSNNNLTGTIPPQ--FIGLSSSLIVLDLSRNQLTGSIPSEV-GN 499
IP + + + L+NN T + F L L ++ S N++T I
Sbjct: 25 KIPEHIP--QYTAELRLNNNEFT-VLEATGIFKKLPQ-LRKINFSNNKIT-DIEEGAFEG 79
Query: 500 LKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQN 559
+ + + N+L+ L+ L ++ N + S L + +L L N
Sbjct: 80 ASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDN 139
Query: 560 NLSGKIPELLIRLQLVKNLNLSNN 583
++ P L + LNL N
Sbjct: 140 QITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 7e-11
Identities = 37/163 (22%), Positives = 66/163 (40%), Gaps = 31/163 (19%)
Query: 353 SNLSTTLEVLLLDNNQIFGNIPAAI-GKFVNLQRLDMCSNRLSGTIPP-AIGELQNLKDL 410
++ L L+NN+ I K L++++ +N+++ I A + ++
Sbjct: 28 EHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEI 86
Query: 411 RLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPP 470
L NR + N+ + F L L T+ L +N +T +
Sbjct: 87 LLTSNRLE-NVQHKM-----F--------------KGLES---LKTLMLRSNRIT-CVGN 122
Query: 471 -QFIGLSSSLIVLDLSRNQLTGSIPSEV-GNLKNLEILNVFGN 511
FIGL SS+ +L L NQ+T ++ L +L LN+ N
Sbjct: 123 DSFIGL-SSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 32/132 (24%), Positives = 53/132 (40%), Gaps = 7/132 (5%)
Query: 89 KVLRLYNNSFNH-EIPSEFDRLRRLQVLALHYNSIGGAIPANI-SSCSNLIQLRLFHNQL 146
LRL NN F E F +L +L+ + N I I S + ++ L N+L
Sbjct: 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRL 93
Query: 147 VGKIPSELSSLSKIEHISVNDNNLTGSIPS-SLGNLSSIRSLFLSGNNLEGSIPD-TLGW 204
L ++ + + N +T + + S LSS+R L L N + ++
Sbjct: 94 ENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDT 151
Query: 205 LKNLVNLTMAQN 216
L +L L + N
Sbjct: 152 LHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 9e-06
Identities = 29/144 (20%), Positives = 49/144 (34%), Gaps = 31/144 (21%)
Query: 455 TTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEV-GNLKNLEILNVFGNKL 513
TT+D SN L IP + L L+ N+ T + + L L +N NK+
Sbjct: 14 TTVDCSNQKLN-KIPE---HIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKI 69
Query: 514 KGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQ 573
+I + G++ + L+ N L ++ L+
Sbjct: 70 T-DIE-----------------------EGAFEGASGVNEILLTSNRLENVQHKMFKGLE 105
Query: 574 LVKNLNLSNNDLEGVVPTQGVFKN 597
+K L L +N + V F
Sbjct: 106 SLKTLMLRSNRITCVGN--DSFIG 127
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 21/111 (18%), Positives = 47/111 (42%), Gaps = 8/111 (7%)
Query: 332 TRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAI-GKFVNLQRLDMCS 390
+L+ + + NN + ++ + +LL +N++ N+ + +L+ L + S
Sbjct: 57 PQLRKINFS-NNKITDIEEGAFEGASGVNEILLTSNRL-ENVQHKMFKGLESLKTLMLRS 114
Query: 391 NRLSGTIPP-AIGELQNLKDLRLQRNRFQGNIPPSI--GNLKLFILYLSYN 438
NR++ + + L +++ L L N+ + P L L L N
Sbjct: 115 NRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 51/253 (20%), Positives = 88/253 (34%), Gaps = 52/253 (20%)
Query: 660 RKRKEKQNPNSPINSFPNISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVK 719
+Q P + S I + + S V +G G G V + + A+K
Sbjct: 36 PPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQV--LGLGINGKVLQIFNKRTQEKFALK 93
Query: 720 VFNLLHHGAFKSFIA--ECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVFEFMH--- 773
+ A E + ++V+I+ Y G +V E +
Sbjct: 94 MLQ-------DCPKARREVELHWRASQCPHIVRIVDVYEN-LYAGRKCLLIVMECLDGGE 145
Query: 774 --NRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKP 831
+R + T E + + I + A+ YLH IAH D+KP
Sbjct: 146 LFSRIQDRGDQAFT---EREAS----------EIMKSIGEAIQYLH---SINIAHRDVKP 189
Query: 832 SNILL---DEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPE------YGLGSEV 882
N+L + I + DFG A+ ++ T+ + Y+APE Y
Sbjct: 190 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC---YTPYYVAPEVLGPEKYDK---- 242
Query: 883 SISGDVYSYGILL 895
S D++S G+++
Sbjct: 243 --SCDMWSLGVIM 253
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 63/243 (25%), Positives = 89/243 (36%), Gaps = 60/243 (24%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIA------ECNTLKNIRHRNLVK 749
IG G+FG + +AVK + E +++RH N+V+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIE-------RGAAIDENVQREIINHRSLRHPNIVR 80
Query: 750 ----ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNI 805
ILT A++ E+ L E + R E DEA Q+L +
Sbjct: 81 FKEVILT---------PTHLAIIMEYASGGELYERICNAGRFSE-DEARF---FFQQL-L 126
Query: 806 SIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH--IGDFGLARFLPLSSAQTSSI 863
S ++Y H I H DLK N LLD I DFG ++ L S S++
Sbjct: 127 S-----GVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 178
Query: 864 GAKGSIGYIAPE------YGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHN 917
G+ YIAPE Y G DV+S G+ L ++ P FE
Sbjct: 179 ---GTPAYIAPEVLLRQEYD-GKIA----DVWSCGVTLYVMLVGAYP----FEDP-EEPR 225
Query: 918 LAR 920
R
Sbjct: 226 DYR 228
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 65.8 bits (160), Expect = 4e-11
Identities = 52/226 (23%), Positives = 90/226 (39%), Gaps = 33/226 (14%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVF---NLLHHGAFKSFIAECNTLKNI-RHRNLVKIL 751
+G+GSFG V AVK+ ++ + + E L + L + L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ-L 407
Query: 752 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVAC 811
+C +Q D V E+++ L + + E P + + ++A
Sbjct: 408 HSC----FQTMDRLYFVMEYVNGGDLMYHIQ---QVGRFKE-PHA-----VFYAA-EIAI 453
Query: 812 ALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI--GDFGLARFLPLSSAQTSSIGAKGSI 869
L +L I + DLK N++LD + HI DFG+ + T + G+
Sbjct: 454 GLFFLQ---SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCKENIWDGVTTKTFC--GTP 506
Query: 870 GYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP-----TDIMFE 910
YIAPE S D +++G+LL E++ + P D +F+
Sbjct: 507 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 552
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 7e-11
Identities = 36/134 (26%), Positives = 57/134 (42%), Gaps = 6/134 (4%)
Query: 347 SLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAI-GELQ 405
+ + + T ++L L +NQI P +NL+ L + SN+L +P + L
Sbjct: 30 RHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLT 88
Query: 406 NLKDLRLQRNRFQGNIPPSI-GNL-KLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNN 463
L L L N+ +P ++ L L L++ N L +P + R LT + L N
Sbjct: 89 QLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQ 146
Query: 464 LTGTIPPQFIGLSS 477
L F LSS
Sbjct: 147 LKSIPHGAFDRLSS 160
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 9e-10
Identities = 41/129 (31%), Positives = 62/129 (48%), Gaps = 8/129 (6%)
Query: 89 KVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANI-SSCSNLIQLRLFHNQLV 147
++L L++N P FD L L+ L L N + GA+P + S + L L L NQL
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLTQLTVLDLGTNQLT 101
Query: 148 GKIPSEL-SSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLK 206
+PS + L ++ + + N LT +P + L+ + L L N L+ SIP G
Sbjct: 102 -VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIPH--GAFD 156
Query: 207 NLVNLTMAQ 215
L +LT A
Sbjct: 157 RLSSLTHAY 165
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 39/142 (27%), Positives = 61/142 (42%), Gaps = 6/142 (4%)
Query: 443 SIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEV-GNLK 501
S+P+ G + L +N +T P F L + L L L NQL ++P V +L
Sbjct: 33 SVPA--GIPTNAQILYLHDNQITKLEPGVFDSLIN-LKELYLGSNQLG-ALPVGVFDSLT 88
Query: 502 NLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNL 561
L +L++ N+L + + L++L M N L +P + L L+ L L QN L
Sbjct: 89 QLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQL 147
Query: 562 SGKIPELLIRLQLVKNLNLSNN 583
RL + + L N
Sbjct: 148 KSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 38/151 (25%), Positives = 67/151 (44%), Gaps = 8/151 (5%)
Query: 455 TTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLK 514
TT+D + ++P G+ ++ +L L NQ+T P +L NL+ L + N+L
Sbjct: 22 TTVDCRSKRHA-SVPA---GIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG 77
Query: 515 GEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQL 574
S +L L++ N L + L L L + N L+ ++P + RL
Sbjct: 78 ALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTH 136
Query: 575 VKNLNLSNNDLEGVVPTQGVFKN-ASITSVF 604
+ +L L N L+ + G F +S+T +
Sbjct: 137 LTHLALDQNQLKSI--PHGAFDRLSSLTHAY 165
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 63.3 bits (155), Expect = 1e-10
Identities = 59/233 (25%), Positives = 93/233 (39%), Gaps = 51/233 (21%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFI----------AECNTLKNIRHR 745
+G GSFG V A+KV K + E L + H
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLK-------KEIVVRLKQVEHTNDERLMLSIVTHP 66
Query: 746 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNI 805
++++ +Q ++ +++ L L R P + +
Sbjct: 67 FIIRMWGT-----FQDAQQIFMIMDYIEGGELFSLLRKSQRFPN----PVA-----KFYA 112
Query: 806 SIDVACALNYLH-HDCQPPIAHCDLKPSNILLDEDMIAHI--GDFGLARFLPLSSAQTSS 862
+ +V AL YLH D I + DLKP NILLD++ HI DFG A+++P T +
Sbjct: 113 A-EVCLALEYLHSKD----IIYRDLKPENILLDKN--GHIKITDFGFAKYVP---DVTYT 162
Query: 863 IGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP-----TDIMFE 910
+ G+ YIAPE + S D +S+GIL+ E++ P T +E
Sbjct: 163 LC--GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE 213
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 33/121 (27%), Positives = 51/121 (42%), Gaps = 31/121 (25%)
Query: 809 VACALNYLH-HDCQPPIAHCDLKPSNILLDEDMIAHI--GDFGLA-RFLPLSSAQTSSIG 864
+ AL +LH I + D+K NILLD + H+ DFGL+ F+ + +
Sbjct: 168 IVLALEHLHKLG----IIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETERAYDFC 221
Query: 865 AKGSIGYIAPE------YGLGSEVSISGDVYSYGILLLELIT---------RKKPTDIMF 909
G+I Y+AP+ G V D +S G+L+ EL+T K +
Sbjct: 222 --GTIEYMAPDIVRGGDSGHDKAV----DWWSLGVLMYELLTGASPFTVDGEKNSQAEIS 275
Query: 910 E 910
Sbjct: 276 R 276
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 2e-10
Identities = 58/226 (25%), Positives = 95/226 (42%), Gaps = 33/226 (14%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVF---NLLHHGAFKSFIAECNTL-KNIRHRNLVKIL 751
+G+GSFG VF A+K +L + + E L H L +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH-M 83
Query: 752 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVAC 811
+Q + V E+++ L + + D R+ + ++
Sbjct: 84 FCT----FQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDL-SRA-----TFYAA-EIIL 129
Query: 812 ALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI--GDFGLARFLPLSSAQTSSIGAKGSI 869
L +LH I + DLK NILLD+D HI DFG+ + L A+T++ G+
Sbjct: 130 GLQFLH---SKGIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAKTNTFC--GTP 182
Query: 870 GYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP-----TDIMFE 910
YIAPE LG + + S D +S+G+LL E++ + P + +F
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 228
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 61/305 (20%), Positives = 104/305 (34%), Gaps = 86/305 (28%)
Query: 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIR--- 743
R+ + ++G G F +V+ G+ +A+KV H ++ + E LK++R
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT-ETALDEIRLLKSVRNSD 94
Query: 744 --HRNLVKILTACSGVDYQGNDFK--ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNL 799
N ++ G + +VFE + L +W+ +++ L
Sbjct: 95 PNDPNREMVVQLLDDFKISGVNGTHICMVFEVLG-HHLLKWII------KSNYQGLPLPC 147
Query: 800 IQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILL----------------------- 836
+++ I V L+YLH C+ I H D+KP NILL
Sbjct: 148 VKK--IIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAP 203
Query: 837 --------------------------DEDMIAHIGDFGLARFL---PLSSAQTSSIGAKG 867
E + I D G A ++ QT
Sbjct: 204 PPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ----- 258
Query: 868 SIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHV 927
Y + E +GS + D++S + EL T D +FE T DH+
Sbjct: 259 ---YRSLEVLIGSGYNTPADIWSTACMAFELATG----DYLFEP---HSGEEYTRDEDHI 308
Query: 928 MDIVD 932
I++
Sbjct: 309 ALIIE 313
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 4e-10
Identities = 32/106 (30%), Positives = 50/106 (47%), Gaps = 13/106 (12%)
Query: 809 VACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI--GDFGLARFLPLSSAQTSSIGAK 866
+A L +L I + DLK N++LD + HI DFG+ + T +
Sbjct: 130 IAIGLFFLQ---SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCKENIWDGVTTKTFC-- 182
Query: 867 GSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGD 912
G+ YIAPE S D +++G+LL E++ + P FEG+
Sbjct: 183 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP----FEGE 224
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 5e-10
Identities = 69/227 (30%), Positives = 101/227 (44%), Gaps = 35/227 (15%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVF---NLLHHGAFKSFIAECNTL-KNIRHRNLVKIL 751
IG+GSFG V AVKV +L K ++E N L KN++H LV L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG-L 104
Query: 752 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVAC 811
+Q D V ++++ L + H + RE E PR+ R + ++A
Sbjct: 105 HFS----FQTADKLYFVLDYINGGEL--FYH-LQRERCFLE-PRA-----RFYAA-EIAS 150
Query: 812 ALNYLH-HDCQPPIAHCDLKPSNILLDEDMIAHI--GDFGLARFLPLSSAQTSSIGAKGS 868
AL YLH + I + DLKP NILLD HI DFGL + ++ TS+ G+
Sbjct: 151 ALGYLHSLN----IVYRDLKPENILLDSQ--GHIVLTDFGLCKENIEHNSTTSTFC--GT 202
Query: 869 IGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP-----TDIMFE 910
Y+APE + D + G +L E++ P T M++
Sbjct: 203 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD 249
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 8e-10
Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 9/98 (9%)
Query: 809 VACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI--GDFGLARFLPLSSAQTSSIGAK 866
++ ALNYLH + I + DLK N+LLD + HI D+G+ + TS+
Sbjct: 119 ISLALNYLH---ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTSTFC-- 171
Query: 867 GSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
G+ YIAPE G + S D ++ G+L+ E++ + P
Sbjct: 172 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 9e-10
Identities = 38/169 (22%), Positives = 69/169 (40%), Gaps = 32/169 (18%)
Query: 347 SLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAI-GELQ 405
+ + + L L+ N + + +L +L + N+L ++P + +L
Sbjct: 18 GRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLT 76
Query: 406 NLKDLRLQRNRFQGNIPPSIGN--LKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNN 463
+L L L N+ Q ++P + + +L L L+ N LQ S+P G ++ LT
Sbjct: 77 SLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPD--GVFDKLT-------- 124
Query: 464 LTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEV-GNLKNLEILNVFGN 511
L L L +NQL S+P V L +L+ + + N
Sbjct: 125 --------------QLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 7e-08
Identities = 36/130 (27%), Positives = 61/130 (46%), Gaps = 9/130 (6%)
Query: 89 KVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANI-SSCSNLIQLRLFHNQLV 147
L L NS FD L L L L N + ++P + + ++L L L NQL
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKL-QSLPNGVFNKLTSLTYLNLSTNQLQ 89
Query: 148 GKIPSEL-SSLSKIEHISVNDNNLTGSIPSSL-GNLSSIRSLFLSGNNLEGSIPDTLGWL 205
+P+ + L++++ +++N N L S+P + L+ ++ L L N L+ S+PD G
Sbjct: 90 -SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK-SVPD--GVF 144
Query: 206 KNLVNLTMAQ 215
L +L
Sbjct: 145 DRLTSLQYIW 154
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 37/128 (28%), Positives = 63/128 (49%), Gaps = 13/128 (10%)
Query: 342 NNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAI-GKFVNLQRLDMCSNRLSGTIPPA 400
N SLP + + T+L L L N++ ++P + K +L L++ +N+L ++P
Sbjct: 37 TNSLKSLPNGVFDELTSLTQLYLGGNKL-QSLPNGVFNKLTSLTYLNLSTNQLQ-SLPNG 94
Query: 401 I-GELQNLKDLRLQRNRFQGNIPP----SIGNLKLFILYLSYNFLQGSIPS-SLGRYETL 454
+ +L LK+L L N+ Q ++P + LK L L N L+ S+P R +L
Sbjct: 95 VFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLK--DLRLYQNQLK-SVPDGVFDRLTSL 150
Query: 455 TTIDLSNN 462
I L +N
Sbjct: 151 QYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 34/131 (25%), Positives = 59/131 (45%), Gaps = 6/131 (4%)
Query: 65 TILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGG 124
T LDLE+ L + L+ L L L N F++L L L L N +
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQL-Q 89
Query: 125 AIPANI-SSCSNLIQLRLFHNQLVGKIPSEL-SSLSKIEHISVNDNNLTGSIPS-SLGNL 181
++P + + L +L L NQL +P + L++++ + + N L S+P L
Sbjct: 90 SLPNGVFDKLTQLKELALNTNQL-QSLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRL 147
Query: 182 SSIRSLFLSGN 192
+S++ ++L N
Sbjct: 148 TSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 41/152 (26%), Positives = 63/152 (41%), Gaps = 9/152 (5%)
Query: 455 TTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLK 514
TT++ + T ++P G+ + LDL N L L +L L + GNKL+
Sbjct: 10 TTVECYSQGRT-SVPT---GIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ 65
Query: 515 GEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPE-LLIRLQ 573
L L + N LQ L L L L+ N L +P+ + +L
Sbjct: 66 SLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLT 124
Query: 574 LVKNLNLSNNDLEGVVPTQGVFKN-ASITSVF 604
+K+L L N L+ VP GVF S+ ++
Sbjct: 125 QLKDLRLYQNQLKS-VP-DGVFDRLTSLQYIW 154
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-09
Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 9/98 (9%)
Query: 809 VACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI--GDFGLARFLPLSSAQTSSIGAK 866
++ ALNYLH + I + DLK N+LLD + HI D+G+ + TS+
Sbjct: 162 ISLALNYLH---ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTSTFC-- 214
Query: 867 GSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
G+ YIAPE G + S D ++ G+L+ E++ + P
Sbjct: 215 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 1e-09
Identities = 32/109 (29%), Positives = 50/109 (45%), Gaps = 14/109 (12%)
Query: 809 VACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI--GDFGLARFLPLSSAQTSSIGAK 866
+ AL +LH I + DLK N+LLD + H DFG+ + + T++
Sbjct: 133 IISALMFLH---DKGIIYRDLKLDNVLLDHE--GHCKLADFGMCKEGICNGVTTATFC-- 185
Query: 867 GSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP-----TDIMFE 910
G+ YIAPE + D ++ G+LL E++ P D +FE
Sbjct: 186 GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFE 234
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 34/97 (35%), Positives = 49/97 (50%), Gaps = 11/97 (11%)
Query: 420 NIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQ-FIGLSSS 478
IP + L YL N +P L Y+ LT IDLSNN ++ T+ Q F + +
Sbjct: 28 GIPRDVTEL-----YLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNM-TQ 79
Query: 479 LIVLDLSRNQLTGSIPSEV-GNLKNLEILNVFGNKLK 514
L+ L LS N+L IP LK+L +L++ GN +
Sbjct: 80 LLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS 115
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 26/107 (24%), Positives = 49/107 (45%), Gaps = 7/107 (6%)
Query: 89 KVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANI-SSCSNLIQLRLFHNQLV 147
L L N F +P E + L ++ L N I + S+ + L+ L L +N+L
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRI-STLSNQSFSNMTQLLTLILSYNRL- 90
Query: 148 GKIPSEL-SSLSKIEHISVNDNNLTGSIP-SSLGNLSSIRSLFLSGN 192
IP L + +S++ N+++ +P + +LS++ L + N
Sbjct: 91 RCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 37/151 (24%), Positives = 64/151 (42%), Gaps = 32/151 (21%)
Query: 455 TTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLK 514
T + SN L +P G+ + L L NQ T +P E+ N K+L ++++ N++
Sbjct: 13 TVVRCSNKGLK-VLPK---GIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS 67
Query: 515 GEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQL 574
L S S++ L L LS N L P L+
Sbjct: 68 -----------TLS-------------NQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKS 103
Query: 575 VKNLNLSNNDLEGVVPTQGVFKN-ASITSVF 604
++ L+L ND+ VVP +G F + ++++ +
Sbjct: 104 LRLLSLHGNDIS-VVP-EGAFNDLSALSHLA 132
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 5e-04
Identities = 31/128 (24%), Positives = 51/128 (39%), Gaps = 30/128 (23%)
Query: 329 TNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKF---VNLQR 385
+ T L +L + N F +P +SN L ++ L NN+I + F L
Sbjct: 31 RDVTEL-YL--DGNQFT-LVPKELSNY-KHLTLIDLSNNRI-STLSN--QSFSNMTQLLT 82
Query: 386 LDMCSNRLSGTIPPAI-GELQNLKDLRLQRNRFQGNIP-------PSIGNLKLF------ 431
L + NRL IPP L++L+ L L N +P ++ +L +
Sbjct: 83 LILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPLYC 140
Query: 432 ---ILYLS 436
+ +LS
Sbjct: 141 DCNMQWLS 148
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 47/306 (15%), Positives = 100/306 (32%), Gaps = 50/306 (16%)
Query: 328 LTNATRLKWLLININNFGGS----LPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFV-- 381
+ + L +++NN L +N ++ L L N + + + +
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77
Query: 382 ---NLQRLDMCSNRLSGTIPPAIGEL-----QNLKDLRLQRNRFQGNIPPSIG------N 427
N+ L++ N LS + + + L L N F
Sbjct: 78 IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137
Query: 428 LKLFILYLSYNFLQGSIPSSLGRY-----ETLTTIDLSNNNLTGT----IPPQFIGLSSS 478
+ L L N L L + + +++L NNL + + +S
Sbjct: 138 ASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPAS 197
Query: 479 LIVLDLSRNQLTGSIPSEVG-----NLKNLEILNVFGNKLKGE----IPSTLGSCIKLEQ 529
+ LDLS N L +E+ ++ LN+ N L G + S L+
Sbjct: 198 VTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQT 257
Query: 530 LEMQENFLQGP-------IPSSLSSLRGLSVLDLSQNNLSG----KIPELLIRLQL-VKN 577
+ + + ++ + ++ +++ + ++D + + I L+ L
Sbjct: 258 VYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADV 317
Query: 578 LNLSNN 583
+L N
Sbjct: 318 PSLLNQ 323
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 59.8 bits (144), Expect = 2e-09
Identities = 21/126 (16%), Positives = 41/126 (32%), Gaps = 26/126 (20%)
Query: 389 CSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSL 448
C+ + + +NL +L ++ + ++ L
Sbjct: 15 CTRDGALDSLHHLPGAENLTELYIENQQHLQHLE----------------------LRDL 52
Query: 449 GRYETLTTIDLSNNNLTGTIPPQ-FIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILN 507
L + + + L + P F L L+LS N L S+ + +L+ L
Sbjct: 53 RGLGELRNLTIVKSGLR-FVAPDAFHFT-PRLSRLNLSFNALE-SLSWKTVQGLSLQELV 109
Query: 508 VFGNKL 513
+ GN L
Sbjct: 110 LSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 56.3 bits (135), Expect = 2e-08
Identities = 19/98 (19%), Positives = 35/98 (35%), Gaps = 5/98 (5%)
Query: 443 SIPSSLGRYETLTTIDLSNNNLTGTIPPQ-FIGLSSSLIVLDLSRNQLTGSIPSEV-GNL 500
L E LT + + N + + GL L L + ++ L + +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGL-GELRNLTIVKSGLR-FVAPDAFHFT 79
Query: 501 KNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQ 538
L LN+ N L+ + + L++L + N L
Sbjct: 80 PRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 53.2 bits (127), Expect = 2e-07
Identities = 15/105 (14%), Positives = 32/105 (30%), Gaps = 3/105 (2%)
Query: 132 SCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPS-SLGNLSSIRSLFLS 190
LR + + L + + + + + L L +R+L +
Sbjct: 6 CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64
Query: 191 GNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGF 235
+ L PD + L L ++ N L ++ S+
Sbjct: 65 KSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQEL 108
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.8 bits (126), Expect = 2e-07
Identities = 20/95 (21%), Positives = 40/95 (42%), Gaps = 2/95 (2%)
Query: 125 AIPANISSCSNLIQLRLFHNQLVGKIPSE-LSSLSKIEHISVNDNNLTGSIPSSLGNLSS 183
++ NL +L + + Q + + L L ++ ++++ + L P +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 184 IRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRL 218
+ L LS N LE T+ L +L L ++ N L
Sbjct: 82 LSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.4 bits (125), Expect = 4e-07
Identities = 20/97 (20%), Positives = 33/97 (34%), Gaps = 4/97 (4%)
Query: 347 SLPACISNLSTTLEVLLLDNNQIFGNIPA-AIGKFVNLQRLDMCSNRLSGTIPP-AIGEL 404
+ L L ++N Q ++ + L+ L + + L + P A
Sbjct: 22 DSLHHLPGA-ENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFT 79
Query: 405 QNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQ 441
L L L N + ++ L L L LS N L
Sbjct: 80 PRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.5 bits (107), Expect = 6e-05
Identities = 21/111 (18%), Positives = 39/111 (35%), Gaps = 14/111 (12%)
Query: 50 CQW-RGVTCSRRH-----------QRVTILDLESLKLAGSISPHV-GNLSFLKVLRLYNN 96
G+ C+R + +T L +E+ + + L L+ L + +
Sbjct: 7 PHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 97 SFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLV 147
P F RL L L +N++ ++ +L +L L N L
Sbjct: 67 GLRFVAPDAFHFTPRLSRLNLSFNAL-ESLSWKTVQGLSLQELVLSGNPLH 116
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 31/176 (17%), Positives = 63/176 (35%), Gaps = 34/176 (19%)
Query: 695 QIGEGSFGSVFKGILDDGR-----TTIAVKV-----------FNLLHHGAFKSFIAECNT 738
IG+G FG ++ ++ VKV A I +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 739 LKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLN 798
+ +++ + K D G ++ ++ + L++ + + +
Sbjct: 102 TRKLKYLGVPKYW-GSGLHDKNGKSYRFMIMDRF-GSDLQKIY---------EANAKRFS 150
Query: 799 LIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILL---DEDMIAHIGDFGLAR 851
L +S+ + L Y+H H D+K SN+LL + D + ++ D+GLA
Sbjct: 151 RKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQV-YLVDYGLAY 202
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 29/120 (24%), Positives = 54/120 (45%), Gaps = 7/120 (5%)
Query: 347 SLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAI-GELQ 405
L + + + ++ L L++N++ K L +L + N++ ++P + +L
Sbjct: 18 GLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLT 76
Query: 406 NLKDLRLQRNRFQGNIPPSI-GNL-KLFILYLSYNFLQGSIPS-SLGRYETLTTIDLSNN 462
L L L N+ Q ++P + L +L L L N L+ S+P R +L I L N
Sbjct: 77 KLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 27/107 (25%), Positives = 53/107 (49%), Gaps = 6/107 (5%)
Query: 89 KVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANI-SSCSNLIQLRLFHNQLV 147
L L +N FD+L +L L+L N I ++P + + L L L N+L
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQI-QSLPDGVFDKLTKLTILYLHENKL- 88
Query: 148 GKIPSEL-SSLSKIEHISVNDNNLTGSIPS-SLGNLSSIRSLFLSGN 192
+P+ + L++++ ++++ N L S+P L+S++ ++L N
Sbjct: 89 QSLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 5e-05
Identities = 37/131 (28%), Positives = 58/131 (44%), Gaps = 8/131 (6%)
Query: 455 TTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEV-GNLKNLEILNVFGNKL 513
T I ++ LT ++P G+ SS L+L N+L S+P V L L L++ N++
Sbjct: 10 TEIRCNSKGLT-SVPT---GIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQI 64
Query: 514 KGEIPSTLGSCIKLEQLEMQENFLQGPIPSSL-SSLRGLSVLDLSQNNLSGKIPELLIRL 572
+ KL L + EN LQ +P+ + L L L L N L + RL
Sbjct: 65 QSLPDGVFDKLTKLTILYLHENKLQS-LPNGVFDKLTQLKELALDTNQLKSVPDGIFDRL 123
Query: 573 QLVKNLNLSNN 583
++ + L N
Sbjct: 124 TSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 5e-04
Identities = 32/112 (28%), Positives = 50/112 (44%), Gaps = 11/112 (9%)
Query: 453 TLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEV-GNLKNLEILNVFGN 511
+ T ++L +N L F L+ L L LS+NQ+ S+P V L L IL + N
Sbjct: 29 SATRLELESNKLQSLPHGVFDKLTQ-LTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHEN 86
Query: 512 KLKGEIPS----TLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQN 559
KL+ +P+ L +L++L + N L+ L L + L N
Sbjct: 87 KLQ-SLPNGVFDKLT---QLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 6e-08
Identities = 31/164 (18%), Positives = 58/164 (35%), Gaps = 38/164 (23%)
Query: 424 SIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSS--SLIV 481
+ L+ ++ + ++L + + LS NN+ + LS +L +
Sbjct: 21 VATEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-----KISSLSGMENLRI 74
Query: 482 LDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPI 541
L L RN + I + LE L + N++ L
Sbjct: 75 LSLGRNLIK-KIENLDAVADTLEELWISYNQIA-----------SLS------------- 109
Query: 542 PSSLSSLRGLSVLDLSQNNLSGKIPEL--LIRLQLVKNLNLSNN 583
+ L L VL +S N ++ E+ L L +++L L+ N
Sbjct: 110 --GIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 34/137 (24%), Positives = 57/137 (41%), Gaps = 21/137 (15%)
Query: 385 RLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNL----KLFILYLSYNFL 440
L + + + L+ K L L N + I +L L IL L N +
Sbjct: 29 ELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-----KISSLSGMENLRILSLGRNLI 82
Query: 441 QGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSS--SLIVLDLSRNQLT--GSIPSE 496
+ I + +TL + +S N + ++ G+ +L VL +S N++T G I +
Sbjct: 83 K-KIENLDAVADTLEELWISYNQIA-SLS----GIEKLVNLRVLYMSNNKITNWGEI-DK 135
Query: 497 VGNLKNLEILNVFGNKL 513
+ L LE L + GN L
Sbjct: 136 LAALDKLEDLLLAGNPL 152
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 5e-06
Identities = 35/140 (25%), Positives = 61/140 (43%), Gaps = 14/140 (10%)
Query: 61 HQRVTILDLESLKLAGSISP------HVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQV 114
+ V + E ++L G I P + L K L L N+ +I S + L++
Sbjct: 17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNI-EKI-SSLSGMENLRI 74
Query: 115 LALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLT--G 172
L+L N I I + L +L + +NQ+ + S + L + + +++N +T G
Sbjct: 75 LSLGRNLI-KKIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWG 131
Query: 173 SIPSSLGNLSSIRSLFLSGN 192
I L L + L L+GN
Sbjct: 132 EI-DKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 9e-06
Identities = 30/146 (20%), Positives = 62/146 (42%), Gaps = 12/146 (8%)
Query: 136 LIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLE 195
++L + K+ + LS+L +H++++ NN+ I SSL + ++R L L N ++
Sbjct: 27 KVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK 83
Query: 196 GSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNIS---SITGFDAGVNKIQGAIPLDYGF 252
I + L L ++ N+++ S+ I ++ NKI +D
Sbjct: 84 -KIENLDAVADTLEELWISYNQIA-----SLSGIEKLVNLRVLYMSNNKITNWGEIDKLA 137
Query: 253 SLQNLQFFSVGENQLTGAIPPTISNA 278
+L L+ + N L + +
Sbjct: 138 ALDKLEDLLLAGNPLYNDYKENNATS 163
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 25/105 (23%), Positives = 46/105 (43%), Gaps = 6/105 (5%)
Query: 115 LALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSI 174
L I + A +S+ L L N + KI S LS + + +S+ N + I
Sbjct: 30 LHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KI 85
Query: 175 PSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLS 219
+ ++ L++S N + S+ + L NL L M+ N+++
Sbjct: 86 ENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKIT 128
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 20/88 (22%), Positives = 42/88 (47%), Gaps = 5/88 (5%)
Query: 499 NLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQ 558
+ +E+ + ++ ++ +TL + + L + N ++ I SSLS + L +L L +
Sbjct: 24 EAEKVELHGMI-PPIE-KMDATLSTLKACKHLALSTNNIEK-I-SSLSGMENLRILSLGR 79
Query: 559 NNLSGKIPELLIRLQLVKNLNLSNNDLE 586
N + KI L ++ L +S N +
Sbjct: 80 NLIK-KIENLDAVADTLEELWISYNQIA 106
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 9e-08
Identities = 25/184 (13%), Positives = 60/184 (32%), Gaps = 38/184 (20%)
Query: 689 RFSSVNQIGEGSFGSVFKGI--------LDDGRTTIAVKV----------FNLLHHGAFK 730
++ + + G +++ + ++K+ N A
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKP 102
Query: 731 SFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDET 790
+ + L + + + GV + ++ LV + RSL+ L +
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCM--GFGV--HQDKYRFLVLPSL-GRSLQSALDVSPK---- 153
Query: 791 DEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILL---DEDMIAHIGDF 847
L+ L ++ + AL +LH + H ++ NI + D+ + + +
Sbjct: 154 ----HVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQV-TLAGY 205
Query: 848 GLAR 851
G A
Sbjct: 206 GFAF 209
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 9e-08
Identities = 26/117 (22%), Positives = 56/117 (47%), Gaps = 12/117 (10%)
Query: 353 SNLSTTLEVLLLDNNQIFGNIPAAI-GKFVNLQRLDMCSNRLSGTIPP-AIGELQNLKDL 410
++ LLL++N++ + G+ +L +L++ N+L+ I P A ++++L
Sbjct: 25 RDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQEL 83
Query: 411 RLQRNRFQGNIPPSI----GNLKLFILYLSYNFLQGSIP-SSLGRYETLTTIDLSNN 462
+L N+ + I + LK L L N + + S +LT+++L++N
Sbjct: 84 QLGENKIK-EISNKMFLGLHQLK--TLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 29/109 (26%), Positives = 55/109 (50%), Gaps = 9/109 (8%)
Query: 89 KVLRLYNNSFNHEIPSE--FDRLRRLQVLALHYNSIGGAIPANI-SSCSNLIQLRLFHNQ 145
L L +N I S+ F RL L L L N + I N S++ +L+L N+
Sbjct: 32 TELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQL-TGIEPNAFEGASHIQELQLGENK 89
Query: 146 LVGKIPSEL-SSLSKIEHISVNDNNLTGSIP-SSLGNLSSIRSLFLSGN 192
+ +I +++ L +++ +++ DN ++ + S +L+S+ SL L+ N
Sbjct: 90 I-KEISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 31/145 (21%), Positives = 54/145 (37%), Gaps = 33/145 (22%)
Query: 455 TTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEV-GNLKNLEILNVFGNKL 513
TT+D + L IP + L L+ N+L + G L +L L + N+L
Sbjct: 11 TTVDCTGRGLK-EIPR---DIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQL 66
Query: 514 KGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPE-LLIRL 572
+E P++ + L L +N + +I + + L
Sbjct: 67 T-----------GIE-------------PNAFEGASHIQELQLGENKIK-EISNKMFLGL 101
Query: 573 QLVKNLNLSNNDLEGVVPTQGVFKN 597
+K LNL +N + V G F++
Sbjct: 102 HQLKTLNLYDNQISCV--MPGSFEH 124
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 32/109 (29%), Positives = 52/109 (47%), Gaps = 8/109 (7%)
Query: 455 TTIDLSNNNLTGTIPPQ--FIGLSSSLIVLDLSRNQLTGSIPSEV-GNLKNLEILNVFGN 511
T + L++N L I F L L+ L+L RNQLT I +++ L + N
Sbjct: 32 TELLLNDNELG-RISSDGLFGRLPH-LVKLELKRNQLT-GIEPNAFEGASHIQELQLGEN 88
Query: 512 KLKGEIPS-TLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQN 559
K+K EI + +L+ L + +N + +P S L L+ L+L+ N
Sbjct: 89 KIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 34/165 (20%), Positives = 57/165 (34%), Gaps = 33/165 (20%)
Query: 696 IGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTAC 754
+G G G V + + A+K+ E + ++V+I+
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDVY 80
Query: 755 SGVDYQGNDFKALVFEFMH-----NRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDV 809
Y G +V E + +R + T E + + I +
Sbjct: 81 EN-LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT---EREAS----------EIMKSI 126
Query: 810 ACALNYLH-HDCQPPIAHCDLKPSNILL---DEDMIAHIGDFGLA 850
A+ YLH + IAH D+KP N+L + I + DFG A
Sbjct: 127 GEAIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 30/174 (17%), Positives = 60/174 (34%), Gaps = 33/174 (18%)
Query: 695 QIGEGSFGSVFKGILDDGRTTIAVKV--------------FNLLHHGAFKSFIAECNTLK 740
+IG G FG ++ + A V A K I + K
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 741 NIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLI 800
+ + + +++G ++ +V E L++ +
Sbjct: 104 QLDYLGIPLFY-GSGLTEFKGRSYRFMVME-RLGIDLQKIS----------GQNGTFKKS 151
Query: 801 QRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILL---DEDMIAHIGDFGLAR 851
L + I + L Y+H + H D+K +N+LL + D + ++ D+GL+
Sbjct: 152 TVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQV-YLADYGLSY 201
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 3e-07
Identities = 23/113 (20%), Positives = 46/113 (40%), Gaps = 5/113 (4%)
Query: 105 EFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHIS 164
++ L + N + L L + L I + L L+K++ +
Sbjct: 15 TPSDVKELVLDNSRSNEG--KLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLE 70
Query: 165 VNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEG-SIPDTLGWLKNLVNLTMAQN 216
++DN ++G + ++ L LSGN ++ S + L L+NL +L +
Sbjct: 71 LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 9e-06
Identities = 28/112 (25%), Positives = 47/112 (41%), Gaps = 9/112 (8%)
Query: 427 NLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSS--SLIVLDL 484
++K +L S + +G + +E L + N LT +I L L L+L
Sbjct: 18 DVKELVLDNSRS-NEGKLEGLTDEFEELEFLSTINVGLT-SIA----NLPKLNKLKKLEL 71
Query: 485 SRNQLTGSIPSEVGNLKNLEILNVFGNKLKG-EIPSTLGSCIKLEQLEMQEN 535
S N+++G + NL LN+ GNK+K L L+ L++
Sbjct: 72 SDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 21/89 (23%), Positives = 40/89 (44%), Gaps = 3/89 (3%)
Query: 499 NLKNLEILNVFGNKLK-GEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLS 557
+++ L + ++ G++ +LE L L ++L L L L+LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT--SIANLPKLNKLKKLELS 72
Query: 558 QNNLSGKIPELLIRLQLVKNLNLSNNDLE 586
N +SG + L + + +LNLS N ++
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 22/114 (19%), Positives = 48/114 (42%), Gaps = 3/114 (2%)
Query: 156 SLSKIEHISVNDNNLT-GSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMA 214
+ S ++ + ++++ G + + L L SI + L L L L ++
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELS 72
Query: 215 QNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLT 268
NR+SG + ++T + NKI+ ++ L+NL+ + ++T
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 8e-07
Identities = 40/178 (22%), Positives = 70/178 (39%), Gaps = 44/178 (24%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNL 747
+R+ +IG GSFG ++ G +A+K+ EC +H L
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL--------------EC---VKTKHPQL 51
Query: 748 V------KILTACSG---VDYQG--NDFKALVFEFMHNRSLEEWLHPITREDETDEAPRS 796
K++ G + + G D+ +V E + SLE+ + R
Sbjct: 52 HIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME-LLGPSLEDLF---------NFCSRK 101
Query: 797 LNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILL---DEDMIAHIGDFGLAR 851
+L L ++ + + Y+H H D+KP N L+ + + +I DFGLA+
Sbjct: 102 FSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 1e-06
Identities = 24/128 (18%), Positives = 49/128 (38%), Gaps = 6/128 (4%)
Query: 90 VLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGK 149
+++L +++ R + L L I I ++ + N++ K
Sbjct: 1 MVKLTAELIEQA--AQYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIR-K 56
Query: 150 IPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEG-SIPDTLGWLKNL 208
+ L +++ + VN+N + L + L L+ N+L D L LK+L
Sbjct: 57 L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSL 115
Query: 209 VNLTMAQN 216
L + +N
Sbjct: 116 TYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 19/106 (17%), Positives = 44/106 (41%), Gaps = 5/106 (4%)
Query: 481 VLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGP 540
++ L+ + + ++ N L++ G K+ I + + + + ++ +N ++
Sbjct: 1 MVKLTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-K 56
Query: 541 IPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLE 586
+ LR L L ++ N + L L + L L+NN L
Sbjct: 57 L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 4e-05
Identities = 21/130 (16%), Positives = 48/130 (36%), Gaps = 5/130 (3%)
Query: 139 LRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSI 198
++L L+ + + ++ + + + + I + L ++ S N + +
Sbjct: 2 VKLTAE-LIEQAA-QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL 57
Query: 199 PDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQ 258
D L+ L L + NR+ + +T N + LD SL++L
Sbjct: 58 -DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLT 116
Query: 259 FFSVGENQLT 268
+ + N +T
Sbjct: 117 YLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 22/112 (19%), Positives = 39/112 (34%), Gaps = 11/112 (9%)
Query: 428 LKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSS--SLIVLDLS 485
++ L L + I + + ID S+N + + G L L ++
Sbjct: 19 VRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-----KLDGFPLLRRLKTLLVN 72
Query: 486 RNQLTGSIPSEVGNLKNLEILNVFGNKLK--GEIPSTLGSCIKLEQLEMQEN 535
N++ L +L L + N L G++ L S L L + N
Sbjct: 73 NNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 8e-04
Identities = 28/132 (21%), Positives = 44/132 (33%), Gaps = 33/132 (25%)
Query: 67 LDLESLKLAGSISPHVGNL----SFLKVLRLYNNSFNHEIPS--EFDRLRRLQVLALHYN 120
+ L L G P + NL + +N EI F LRRL+ L ++ N
Sbjct: 19 VRDRELDLRGYKIPVIENLGATLDQFDAIDFSDN----EIRKLDGFPLLRRLKTLLVNNN 74
Query: 121 SIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGN 180
I + +L +L L +N L L ++ L +
Sbjct: 75 RICRIGEGLDQALPDLTELILTNNS--------LVELGDLDP---------------LAS 111
Query: 181 LSSIRSLFLSGN 192
L S+ L + N
Sbjct: 112 LKSLTYLCILRN 123
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 1e-06
Identities = 26/104 (25%), Positives = 48/104 (46%), Gaps = 4/104 (3%)
Query: 114 VLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGS 173
VL ++ G I + NL L L + L+ + + L L K++ + +++N + G
Sbjct: 30 VLDNCKSNDG-KIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENRIFGG 86
Query: 174 IPSSLGNLSSIRSLFLSGNNLEG-SIPDTLGWLKNLVNLTMAQN 216
+ L ++ L LSGN L+ S + L L+ L +L +
Sbjct: 87 LDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 8e-06
Identities = 22/111 (19%), Positives = 35/111 (31%), Gaps = 3/111 (2%)
Query: 450 RYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVF 509
+ + L N +L L L L S+ + + L L+ L +
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELS 79
Query: 510 GNKLKGEIPSTLGSCIKLEQLEMQENFLQGP-IPSSLSSLRGLSVLDLSQN 559
N++ G + L L + N L+ L L L LDL
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 33/134 (24%), Positives = 50/134 (37%), Gaps = 26/134 (19%)
Query: 358 TLEVLLLDNNQI-FGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNR 416
+ L+LDN + G I +FVNL+ L + + L + NL L
Sbjct: 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI--------SVSNLPKLP----- 71
Query: 417 FQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLS 476
KL L LS N + G + + LT ++LS N L + +
Sbjct: 72 ------------KLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKL 119
Query: 477 SSLIVLDLSRNQLT 490
L LDL ++T
Sbjct: 120 ECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 4e-04
Identities = 25/89 (28%), Positives = 39/89 (43%), Gaps = 3/89 (3%)
Query: 499 NLKNLEILNVFGNKLK-GEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLS 557
+ L + K G+I + LE L + L S+L L L L+LS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI--SVSNLPKLPKLKKLELS 79
Query: 558 QNNLSGKIPELLIRLQLVKNLNLSNNDLE 586
+N + G + L +L + +LNLS N L+
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 8e-04
Identities = 25/126 (19%), Positives = 51/126 (40%), Gaps = 7/126 (5%)
Query: 143 HNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTL 202
H +L + P+ + L N + G I ++ L L L S+ + L
Sbjct: 15 HLELRNRTPAAVRELVL-----DNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-L 67
Query: 203 GWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSV 262
L L L +++NR+ G + + ++T + NK++ L+ L+ L+ +
Sbjct: 68 PKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDL 127
Query: 263 GENQLT 268
++T
Sbjct: 128 FNCEVT 133
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 41/173 (23%), Positives = 65/173 (37%), Gaps = 34/173 (19%)
Query: 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLV 748
F +IG G+FG + G +A+K + + L
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIK---------LEPMKSRAPQLH--LEYRFY 58
Query: 749 KILTACSG---VDYQG--NDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRL 803
K L + G V Y G + A+V E + SLE+ D R+ +L L
Sbjct: 59 KQLGSGDGIPQVYYFGPCGKYNAMVLE-LLGPSLEDLF---------DLCDRTFSLKTVL 108
Query: 804 NISIDVACALNYLHHDCQPPIAHCDLKPSNILL-----DEDMIAHIGDFGLAR 851
I+I + + Y+H + + D+KP N L+ + HI DF LA+
Sbjct: 109 MIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 5e-06
Identities = 37/180 (20%), Positives = 64/180 (35%), Gaps = 46/180 (25%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNL 747
+ +IGEGSFG +F+G +A+K E + L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF--------------EP---RRSDAPQL 52
Query: 748 V------KILTACSG---VDYQG--NDFKALVFEFMHNRSLEEWLHPITREDETDEAPRS 796
K+L C+G V Y G LV + + SLE+ L D R
Sbjct: 53 RDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID-LLGPSLEDLL---------DLCGRK 102
Query: 797 LNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDM-----IAHIGDFGLAR 851
++ + + + +H + + D+KP N L+ + ++ DFG+ +
Sbjct: 103 FSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 41/178 (23%), Positives = 70/178 (39%), Gaps = 44/178 (24%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNL 747
++F +IG GSFG ++ G +A+K+ E +H L
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--------------EN---VKTKHPQL 49
Query: 748 V------KILTACSG---VDYQG--NDFKALVFEFMHNRSLEEWLHPITREDETDEAPRS 796
+ +IL +G V + G D+ LV + + SLE+ + R
Sbjct: 50 LYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD-LLGPSLEDLF---------NFCSRK 99
Query: 797 LNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDM---IAHIGDFGLAR 851
L+L L ++ + + ++H H D+KP N L+ +I DFGLA+
Sbjct: 100 LSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 7e-05
Identities = 29/203 (14%), Positives = 68/203 (33%), Gaps = 32/203 (15%)
Query: 395 GTIPPAIGELQNLKDLRLQRN---RFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRY 451
+ P + + L +L+++ P++ +L++ L + ++ + S L
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNL 221
Query: 452 ETLTTIDLSNNNLTGTIPPQFIGLSS-----SLIVLDLSRNQLTGSIPS---EVGNLKNL 503
E L + F L S +L L + + + E L L
Sbjct: 222 EKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQL 281
Query: 504 EILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSG 563
E +++ L E L + ++ L +++ N LS
Sbjct: 282 ETMDISAGVLTDEGARLL--------------------LDHVDKIKHLKFINMKYNYLSD 321
Query: 564 KIPELLIRLQLVKNLNLSNNDLE 586
++ + L + L +++S++
Sbjct: 322 EMKKEL-QKSLPMKIDVSDSQEY 343
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 43.8 bits (102), Expect = 2e-04
Identities = 21/124 (16%), Positives = 44/124 (35%), Gaps = 7/124 (5%)
Query: 294 AAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACI- 352
L L++L+++ + + L S LKWL I +
Sbjct: 214 LGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFL 273
Query: 353 -SNLSTTLEVLLLDNNQI----FGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGE-LQN 406
S++ LE + + + + + K +L+ ++M N LS + + + L
Sbjct: 274 ESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPM 333
Query: 407 LKDL 410
D+
Sbjct: 334 KIDV 337
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 42.6 bits (99), Expect = 4e-04
Identities = 21/169 (12%), Positives = 53/169 (31%), Gaps = 19/169 (11%)
Query: 67 LDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIP-----SEFDRLRRLQVLALHYNS 121
L+ +K ++S LK L + + + S+ L +L + +
Sbjct: 174 LNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDY 233
Query: 122 IGGAIPANIS------SCSNLIQLRLFHNQLVGKIPSELSS---LSKIEHISVNDNNLTG 172
NL L + + + L ++E + ++ LT
Sbjct: 234 GFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTD 293
Query: 173 S----IPSSLGNLSSIRSLFLSGNNLEGSIPDTLG-WLKNLVNLTMAQN 216
+ + + ++ + + N L + L L ++++ +Q
Sbjct: 294 EGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVSDSQE 342
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 1e-04
Identities = 33/108 (30%), Positives = 50/108 (46%), Gaps = 23/108 (21%)
Query: 347 SLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAI-GELQ 405
S+P I TT +VL L +NQI P + L RLD+ +N+L+ +P + +L
Sbjct: 23 SVPTGIP---TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLT 78
Query: 406 NLKDLRLQRNRFQGNIP-------PSIGNLKLF----------ILYLS 436
L L L N+ + +IP S+ ++ L ILYLS
Sbjct: 79 QLTQLSLNDNQLK-SIPRGAFDNLKSLTHIWLLNNPWDCACSDILYLS 125
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 1e-04
Identities = 34/108 (31%), Positives = 49/108 (45%), Gaps = 23/108 (21%)
Query: 347 SLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAI-GELQ 405
S+PA I T + L L+NNQI P VNLQ+L SN+L+ IP + +L
Sbjct: 26 SVPAGIP---TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLT 81
Query: 406 NLKDLRLQRNRFQGNIP-------PSIGNLKLF----------ILYLS 436
L L L N + +IP S+ ++ L+ I+YL
Sbjct: 82 QLTQLDLNDNHLK-SIPRGAFDNLKSLTHIYLYNNPWDCECRDIMYLR 128
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 6e-04
Identities = 45/249 (18%), Positives = 82/249 (32%), Gaps = 46/249 (18%)
Query: 382 NLQRLDMCSNRLSGTIPPAIGEL-----QNLKDLRLQRNRF--QGNIPPSIGNLKLFILY 434
+L++L++ R++ + + L ++ L + G L+ L
Sbjct: 73 SLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLG 132
Query: 435 LSYNFLQ----GSIPSSLGRYE-TLTTIDLSNNNLT--GTIPPQFI--GLSS--SLIVLD 483
L N L + L + +TT+ LSNN LT G + GL+ S+ L
Sbjct: 133 LQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGV---AVLMEGLAGNTSVTHLS 189
Query: 484 LSRNQLT----GSIPSEVGNLKNLEILNVFGNKLKGE----IPSTLGSCIKLEQLEMQEN 535
L L + +++ + L+ LNV N + LE L + N
Sbjct: 190 LLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFN 249
Query: 536 FLQ-------GPIPSSLSSLRGLSVLDLSQNNLS----------GKIPELLIRLQLVKNL 578
L + + + V +S + R ++ ++L
Sbjct: 250 ELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSVILSEVQRNLNSWDRARVQRHL 309
Query: 579 NLSNNDLEG 587
L DLE
Sbjct: 310 ELLLRDLED 318
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* Length = 130 | Back alignment and structure |
|---|
Score = 39.4 bits (92), Expect = 8e-04
Identities = 14/58 (24%), Positives = 21/58 (36%), Gaps = 4/58 (6%)
Query: 455 TTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEV-GNLKNLEILNVFGN 511
T +D LT P L L+ N LT ++P + L L ++ N
Sbjct: 11 TLVDCGRRGLTWASLPT--AFPVDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGAN 65
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 986 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.98 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.98 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.98 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.95 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.95 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.94 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.9 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.9 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.89 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.89 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.88 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.88 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.88 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.87 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.87 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.87 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.86 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.86 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.86 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.85 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.85 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.85 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.85 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.83 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.83 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.82 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.82 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.8 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.8 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.8 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.79 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.78 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.78 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.78 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.78 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.78 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.77 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.75 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.75 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.75 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.74 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.73 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.73 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.73 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.72 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.69 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.68 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.68 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.67 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.66 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.66 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.65 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.64 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.64 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.62 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.58 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.58 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.57 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.57 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.56 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.53 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.52 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.52 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.51 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.49 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.47 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.45 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.35 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.32 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.32 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.29 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.27 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.26 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.23 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 99.0 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.97 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.93 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.93 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.89 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.88 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.87 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.82 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.58 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.52 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.51 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.47 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.35 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.34 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.28 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.01 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.94 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.87 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.68 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.67 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.67 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.64 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.55 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.34 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.33 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.28 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.23 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.07 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.05 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.8 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.78 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.74 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.72 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.69 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.4 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.33 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.16 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.65 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 94.36 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.2 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 91.61 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.46 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 89.82 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 84.74 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 84.08 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 82.49 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-82 Score=782.49 Aligned_cols=600 Identities=31% Similarity=0.462 Sum_probs=497.2
Q ss_pred ccCcCCCHhHHHHHHHHHHhccCCCcCCCCCCCCCCCCCcceeeEecCCCCeEEEEeccCCCCccc---cC---------
Q 046598 12 ASTVAGNETDRLALLELKSKITHDPLGVLASWNESSHFCQWRGVTCSRRHQRVTILDLESLKLAGS---IS--------- 79 (986)
Q Consensus 12 ~~~~~~~~~~~~~ll~~k~~~~~~~~~~l~~w~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~---~~--------- 79 (986)
++++.+.++||+|||+||+++. ||. .+++|+.+++||+|.||+|+ .++|+.+||+++++.|. +|
T Consensus 4 ~~~~~~~~~~~~all~~k~~~~-~~~-~l~~W~~~~~~C~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L 79 (768)
T 3rgz_A 4 ASPSQSLYREIHQLISFKDVLP-DKN-LLPDWSSNKNPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGL 79 (768)
T ss_dssp ----CCHHHHHHHHHHHHTTCS-CTT-SSTTCCTTSCGGGSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTC
T ss_pred CccccCCHHHHHHHHHHHhhCC-Ccc-cccCCCCCCCCcCCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCcc
Confidence 4455567899999999999996 888 99999988899999999998 67999999999999887 44
Q ss_pred --------------cCccCCCCCCEEEccCCCccccCCc--chhccccCceeeceecccCCCCccch-hcCccccceecc
Q 046598 80 --------------PHVGNLSFLKVLRLYNNSFNHEIPS--EFDRLRRLQVLALHYNSIGGAIPANI-SSCSNLIQLRLF 142 (986)
Q Consensus 80 --------------~~~~~l~~L~~L~L~~n~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~Ls 142 (986)
+.|+.+++|++|+|++|.+.+.+|. .|+++++|++|+|++|.+++.+|..+ ..+++|++|+|+
T Consensus 80 ~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls 159 (768)
T 3rgz_A 80 ESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLS 159 (768)
T ss_dssp CEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECC
T ss_pred cccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECC
Confidence 5788889999999999999988888 89999999999999999888887765 667777777777
Q ss_pred cccccCccCcc---c----------------------cCCCCCCeEEccCCcCCCCcccccCCCcCcceeeccCCcccCc
Q 046598 143 HNQLVGKIPSE---L----------------------SSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGS 197 (986)
Q Consensus 143 ~N~l~~~~p~~---~----------------------~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 197 (986)
+|.+++..|.. + ..+++|++|+|++|++++.+|. |+++++|++|+|++|++++.
T Consensus 160 ~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~ 238 (768)
T 3rgz_A 160 ANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGD 238 (768)
T ss_dssp SSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSC
T ss_pred CCccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCc
Confidence 77776555543 3 4556666666667777666665 77777777777777777777
Q ss_pred CcchhhccCCCceeecccccccccCCccccCCCCccEEeccccccccccCCcccccccccceEEecCceecccCCccccC
Q 046598 198 IPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISN 277 (986)
Q Consensus 198 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~ 277 (986)
+|..|+.+++|++|+|++|++++.+|.. .+++|+.|++++|.+.+.+|..++..+++|++|++++|++++.+|..|++
T Consensus 239 ~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~ 316 (768)
T 3rgz_A 239 FSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGS 316 (768)
T ss_dssp HHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGG
T ss_pred ccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhc
Confidence 7777777777777777777777766665 67777777777777777788777655688888888888888888888888
Q ss_pred CCCCcEEecccccccCC-Cch-hhhhhhHhhhhhccCCCCCCCCCCcccc-------------------ccccc--cccc
Q 046598 278 ASNLEIFHGSVNKLTGA-APY-LEKLQRLLVFGILGNSLGSRGDRDLNFL-------------------CSLTN--ATRL 334 (986)
Q Consensus 278 l~~L~~L~ls~N~l~~~-~~~-l~~l~~L~~l~l~~n~l~~~~~~~l~~l-------------------~~l~~--~~~L 334 (986)
+++|+.|++++|++++. +.. +..+++|+.+++++|.+.......+..+ ..+.. ++.|
T Consensus 317 l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L 396 (768)
T 3rgz_A 317 CSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTL 396 (768)
T ss_dssp CTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCC
T ss_pred CCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCc
Confidence 88888888888888743 433 7778888888888887753222221111 11112 5678
Q ss_pred ceeeccccccccCCCcccccccccceEEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccC
Q 046598 335 KWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQR 414 (986)
Q Consensus 335 ~~l~l~~n~~~~~~p~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 414 (986)
+.|+++.|.+++.+|..+..+ ++|+.|++++|++++.+|..|..+++|++|++++|.+++.+|..|..+++|++|+|++
T Consensus 397 ~~L~L~~n~l~~~~p~~l~~l-~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~ 475 (768)
T 3rgz_A 397 QELYLQNNGFTGKIPPTLSNC-SELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDF 475 (768)
T ss_dssp CEEECCSSEEEEECCGGGGGC-TTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCS
T ss_pred cEEECCCCccccccCHHHhcC-CCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecC
Confidence 888888888888888888776 6789999999999888899999999999999999999988999999999999999999
Q ss_pred ccceeecCcccccc-cccEEEecccccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccC
Q 046598 415 NRFQGNIPPSIGNL-KLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSI 493 (986)
Q Consensus 415 N~l~~~~~~~~~~~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~ 493 (986)
|++++.+|..+..+ +|++|+|++|++++.+|.+++.+++|++|+|++|+++|.+|.. ++.+++|+.|++++|+++|.+
T Consensus 476 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-l~~l~~L~~L~Ls~N~l~g~i 554 (768)
T 3rgz_A 476 NDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAE-LGDCRSLIWLDLNTNLFNGTI 554 (768)
T ss_dssp SCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGG-GGGCTTCCEEECCSSEEESBC
T ss_pred CcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHH-HcCCCCCCEEECCCCccCCcC
Confidence 99998888888765 5999999999999999999999999999999999999888887 677889999999999998777
Q ss_pred Cccc----------------------------------------------------------------------cccccc
Q 046598 494 PSEV----------------------------------------------------------------------GNLKNL 503 (986)
Q Consensus 494 p~~~----------------------------------------------------------------------~~l~~L 503 (986)
|..+ ..+++|
T Consensus 555 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L 634 (768)
T 3rgz_A 555 PAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSM 634 (768)
T ss_dssp CGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCC
T ss_pred ChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccc
Confidence 7543 335778
Q ss_pred chhhccCccccccCcccccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCC
Q 046598 504 EILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNN 583 (986)
Q Consensus 504 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N 583 (986)
+.|||++|+++|.+|..|+++++|+.|+|++|+++|.+|..|+++++|+.|||++|+++|.+|..+..+++|++|||++|
T Consensus 635 ~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N 714 (768)
T 3rgz_A 635 MFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNN 714 (768)
T ss_dssp CEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSS
T ss_pred cEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCccccccccceeeeCCcccccCCCCCCCCCCCCc
Q 046598 584 DLEGVVPTQGVFKNASITSVFGNLKLCGGIPEFQLPTCSSK 624 (986)
Q Consensus 584 ~l~~~~p~~~~~~~~~~~~~~~n~~lcg~~~~~~~~~~~~~ 624 (986)
+++|.+|..++|.++...++.||+++||.|.. .|...
T Consensus 715 ~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~----~C~~~ 751 (768)
T 3rgz_A 715 NLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP----RCDPS 751 (768)
T ss_dssp EEEEECCSSSSGGGSCGGGGCSCTEEESTTSC----CCCSC
T ss_pred cccccCCCchhhccCCHHHhcCCchhcCCCCc----CCCCC
Confidence 99999999999999999999999999998743 57544
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-63 Score=612.06 Aligned_cols=521 Identities=33% Similarity=0.497 Sum_probs=452.4
Q ss_pred CeEEEEeccCCCCccccCc--CccCCCCCCEEEccCCCccccCCcch-hccccCceeeceecccCCCCccc---h-----
Q 046598 62 QRVTILDLESLKLAGSISP--HVGNLSFLKVLRLYNNSFNHEIPSEF-DRLRRLQVLALHYNSIGGAIPAN---I----- 130 (986)
Q Consensus 62 ~~v~~l~l~~~~l~~~~~~--~~~~l~~L~~L~L~~n~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~~---~----- 130 (986)
.+++.|||++|.+.|.+|. .++++++|++|+|++|.+.+.+|..+ .++++|++|+|++|++++..|.. +
T Consensus 100 ~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~ 179 (768)
T 3rgz_A 100 ASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGE 179 (768)
T ss_dssp TTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTTCCTT
T ss_pred CCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhccCCC
Confidence 4678899999999988888 88888888888888888888777665 66777777777777766555543 2
Q ss_pred -----------------hcCccccceecccccccCccCccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeeccCCc
Q 046598 131 -----------------SSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNN 193 (986)
Q Consensus 131 -----------------~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 193 (986)
..+++|++|+|++|.+++.+|. ++++++|++|+|++|++++.+|..|+++++|++|+|++|+
T Consensus 180 L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~ 258 (768)
T 3rgz_A 180 LKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQ 258 (768)
T ss_dssp CCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSC
T ss_pred CCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCc
Confidence 5677888888888888887777 9999999999999999999999999999999999999999
Q ss_pred ccCcCcchhhccCCCceeecccccccccCCccccCC-CCccEEeccccccccccCCcccccccccceEEecCceecccCC
Q 046598 194 LEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNI-SSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIP 272 (986)
Q Consensus 194 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l-~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p 272 (986)
+++.+|.. .+++|++|+|++|++++.+|..++.. ++|+.|++++|.+.+.+|..+. .+++|++|++++|++++.+|
T Consensus 259 l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~-~l~~L~~L~L~~n~l~~~ip 335 (768)
T 3rgz_A 259 FVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFG-SCSLLESLALSSNNFSGELP 335 (768)
T ss_dssp CEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGG-GCTTCCEEECCSSEEEEECC
T ss_pred ccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHh-cCCCccEEECCCCcccCcCC
Confidence 98877765 78899999999999998889888876 8899999999999888887654 68899999999999988888
Q ss_pred cc-ccCCCCCcEEeccccccc-CCCchhhhhh-hHhhhhhccCCCCCCCCCC--------c------------ccccccc
Q 046598 273 PT-ISNASNLEIFHGSVNKLT-GAAPYLEKLQ-RLLVFGILGNSLGSRGDRD--------L------------NFLCSLT 329 (986)
Q Consensus 273 ~~-l~~l~~L~~L~ls~N~l~-~~~~~l~~l~-~L~~l~l~~n~l~~~~~~~--------l------------~~l~~l~ 329 (986)
.. +.++++|++|++++|+++ ..+..+..+. +|+.+++++|.+....... + .....+.
T Consensus 336 ~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~ 415 (768)
T 3rgz_A 336 MDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLS 415 (768)
T ss_dssp HHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGG
T ss_pred HHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHh
Confidence 76 888999999999999988 4566677776 7888888888764311111 1 1223577
Q ss_pred cccccceeeccccccccCCCcccccccccceEEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCE
Q 046598 330 NATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKD 409 (986)
Q Consensus 330 ~~~~L~~l~l~~n~~~~~~p~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 409 (986)
++++|+.|+++.|.+++.+|..+..+ ++|+.|++++|++++.+|..+..+++|++|++++|++++.+|..|..+++|++
T Consensus 416 ~l~~L~~L~Ls~N~l~~~~p~~l~~l-~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 494 (768)
T 3rgz_A 416 NCSELVSLHLSFNYLSGTIPSSLGSL-SKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNW 494 (768)
T ss_dssp GCTTCCEEECCSSEEESCCCGGGGGC-TTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCE
T ss_pred cCCCCCEEECcCCcccCcccHHHhcC-CCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCE
Confidence 88999999999999999999999887 68999999999999999999999999999999999999999999999999999
Q ss_pred EEccCccceeecCcccccc-cccEEEecccccCCCCCcccCCCCCCCeeecCCCccCCCCCccccc--------------
Q 046598 410 LRLQRNRFQGNIPPSIGNL-KLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIG-------------- 474 (986)
Q Consensus 410 L~Ls~N~l~~~~~~~~~~~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~-------------- 474 (986)
|+|++|++++.+|..+..+ +|++|+|++|++++.+|..++.+++|+.|++++|+++|.+|..++.
T Consensus 495 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~ 574 (768)
T 3rgz_A 495 ISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKR 574 (768)
T ss_dssp EECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCE
T ss_pred EEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccc
Confidence 9999999999999998766 5999999999999999999999999999999999999999876432
Q ss_pred -------------------------------------------------------CCCcceEEEccCCcccccCCccccc
Q 046598 475 -------------------------------------------------------LSSSLIVLDLSRNQLTGSIPSEVGN 499 (986)
Q Consensus 475 -------------------------------------------------------~~~~L~~L~Ls~N~l~~~~p~~~~~ 499 (986)
.+++|+.|||++|+++|.+|..+++
T Consensus 575 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~ 654 (768)
T 3rgz_A 575 YVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGS 654 (768)
T ss_dssp EEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGG
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhc
Confidence 2467899999999999999999999
Q ss_pred ccccchhhccCccccccCcccccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceee
Q 046598 500 LKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLN 579 (986)
Q Consensus 500 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ 579 (986)
+++|+.|+|++|+++|.+|..|+++++|+.|||++|+++|.+|..++.+++|++|||++|+++|.+|.. ..+.++....
T Consensus 655 l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~-~~~~~~~~~~ 733 (768)
T 3rgz_A 655 MPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM-GQFETFPPAK 733 (768)
T ss_dssp CTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSS-SSGGGSCGGG
T ss_pred cccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCc-hhhccCCHHH
Confidence 999999999999999999999999999999999999999999999999999999999999999999975 4455666677
Q ss_pred ccCCc-cccc
Q 046598 580 LSNND-LEGV 588 (986)
Q Consensus 580 ls~N~-l~~~ 588 (986)
+.+|+ +.|.
T Consensus 734 ~~gN~~Lcg~ 743 (768)
T 3rgz_A 734 FLNNPGLCGY 743 (768)
T ss_dssp GCSCTEEEST
T ss_pred hcCCchhcCC
Confidence 78886 5553
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-60 Score=578.07 Aligned_cols=562 Identities=21% Similarity=0.228 Sum_probs=479.7
Q ss_pred CCcceeeEecCC---------CCeEEEEeccCCCCccccCcCccCCCCCCEEEccCCCccccCCcchhccccCceeecee
Q 046598 49 FCQWRGVTCSRR---------HQRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHY 119 (986)
Q Consensus 49 ~c~w~gv~c~~~---------~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~ 119 (986)
.|.++.|.|+.. ..+++.|||++|++++..+..|+++++|++|+|++|.+++..|.+|+++++|++|+|++
T Consensus 3 ~~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~ 82 (680)
T 1ziw_A 3 TVSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQH 82 (680)
T ss_dssp -CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCS
T ss_pred eeECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCC
Confidence 356666777642 35799999999999988788899999999999999999999999999999999999999
Q ss_pred cccCCCCccchhcCccccceecccccccCccCccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeeccCCcccCcCc
Q 046598 120 NSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIP 199 (986)
Q Consensus 120 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 199 (986)
|++++..+..|+.+++|++|+|++|++++..|..|+++++|++|+|++|.+++..|..|+++++|++|+|++|++++..+
T Consensus 83 n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 162 (680)
T 1ziw_A 83 NELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKS 162 (680)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCH
T ss_pred CccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCH
Confidence 99997666689999999999999999998888999999999999999999999999999999999999999999998888
Q ss_pred chhh--ccCCCceeecccccccccCCccccCC---------------------------CCccEEeccccccccccCCcc
Q 046598 200 DTLG--WLKNLVNLTMAQNRLSGTIPSSIFNI---------------------------SSITGFDAGVNKIQGAIPLDY 250 (986)
Q Consensus 200 ~~~~--~l~~L~~L~L~~N~l~~~~p~~l~~l---------------------------~~L~~L~l~~N~l~~~~p~~~ 250 (986)
..+. .+++|++|+|++|++++..|..+..+ ++|+.|++++|.+.+..|..+
T Consensus 163 ~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~ 242 (680)
T 1ziw_A 163 EELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTF 242 (680)
T ss_dssp HHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTT
T ss_pred HHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHh
Confidence 7765 45899999999999998888877665 456777788888877666554
Q ss_pred ccccc--ccceEEecCceecccCCccccCCCCCcEEecccccccCCCc-hhhhhhhHhhhhhccCCCCCCC-CCCcccc-
Q 046598 251 GFSLQ--NLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAP-YLEKLQRLLVFGILGNSLGSRG-DRDLNFL- 325 (986)
Q Consensus 251 ~~~l~--~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~-~l~~l~~L~~l~l~~n~l~~~~-~~~l~~l- 325 (986)
. +++ +|++|++++|++++..|..|+.+++|+.|++++|++++.++ .+..+++|+.+++.+|...... ...+..+
T Consensus 243 ~-~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~ 321 (680)
T 1ziw_A 243 L-GLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKID 321 (680)
T ss_dssp G-GGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEEC
T ss_pred h-ccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccC
Confidence 3 454 49999999999998888999999999999999999988755 6788889999988876443210 0011111
Q ss_pred -cccccccccceeeccccccccCCCcccccccccceEEEccCCcccc--cCCccccCC--CCCCEEEccCccccCcCCCc
Q 046598 326 -CSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFG--NIPAAIGKF--VNLQRLDMCSNRLSGTIPPA 400 (986)
Q Consensus 326 -~~l~~~~~L~~l~l~~n~~~~~~p~~~~~~~~~L~~L~L~~n~l~~--~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~ 400 (986)
..+..+++|+.++++.|.+++..|..+..+ ++|+.|++++|.+.. .....|..+ ++|+.|++++|++++..|.+
T Consensus 322 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~ 400 (680)
T 1ziw_A 322 DFSFQWLKCLEHLNMEDNDIPGIKSNMFTGL-INLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDA 400 (680)
T ss_dssp TTTTTTCTTCCEEECCSCCBCCCCTTTTTTC-TTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTT
T ss_pred hhhcccCCCCCEEECCCCccCCCChhHhccc-cCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhh
Confidence 146678899999999999998777767665 689999999998542 333445443 58999999999999999999
Q ss_pred ccCCCCCCEEEccCccceeecC-cccccc-cccEEEecccccCCCCCcccCCCCCCCeeecCCCccC--CCCCcccccCC
Q 046598 401 IGELQNLKDLRLQRNRFQGNIP-PSIGNL-KLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLT--GTIPPQFIGLS 476 (986)
Q Consensus 401 ~~~l~~L~~L~Ls~N~l~~~~~-~~~~~~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~ip~~~~~~~ 476 (986)
|..+++|+.|+|++|++.+.+| ..+..+ +|++|++++|++.+..+..|..+++|+.|++++|.++ +.+|.. +..+
T Consensus 401 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~-~~~l 479 (680)
T 1ziw_A 401 FSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSP-FQPL 479 (680)
T ss_dssp TTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCT-TTTC
T ss_pred hhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcc-cccC
Confidence 9999999999999999998776 566555 5999999999999999999999999999999999987 466766 7888
Q ss_pred CcceEEEccCCcccccCCcccccccccchhhccCccccccCc--------ccccCCccccEEecccccccccCCccccCC
Q 046598 477 SSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIP--------STLGSCIKLEQLEMQENFLQGPIPSSLSSL 548 (986)
Q Consensus 477 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--------~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 548 (986)
++|+.|++++|+|++..+..|..+++|++|+|++|++++..+ ..|.++++|++|+|++|+|+...+..|..+
T Consensus 480 ~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l 559 (680)
T 1ziw_A 480 RNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDL 559 (680)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred CCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccc
Confidence 999999999999998778889999999999999999986422 248899999999999999996555679999
Q ss_pred CCCCEEeCCCccCcccCchhhhcccccceeeccCCccccccCCc-c-ccccccceeeeCCcccccCC
Q 046598 549 RGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQ-G-VFKNASITSVFGNLKLCGGI 613 (986)
Q Consensus 549 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~-~-~~~~~~~~~~~~n~~lcg~~ 613 (986)
++|+.|+|++|+|++..+..|..+++|++|+|++|++++.+|.. . .++++..+++.||||.|++.
T Consensus 560 ~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 560 FELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred cCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence 99999999999999877788899999999999999999988764 2 57889999999999999875
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-60 Score=575.46 Aligned_cols=501 Identities=21% Similarity=0.289 Sum_probs=342.2
Q ss_pred CCCHhHHHHHHHHHHhccCCCcC-------CCCCCCCCCCCCcc---eeeEecCCCCeEEEEeccCCCCccccCcCccCC
Q 046598 16 AGNETDRLALLELKSKITHDPLG-------VLASWNESSHFCQW---RGVTCSRRHQRVTILDLESLKLAGSISPHVGNL 85 (986)
Q Consensus 16 ~~~~~~~~~ll~~k~~~~~~~~~-------~l~~w~~~~~~c~w---~gv~c~~~~~~v~~l~l~~~~l~~~~~~~~~~l 85 (986)
+....|++||.+||.++..+++. ..++|+.+++||.| .||+|+.. +||+.|+|+++++.|.+|+++++|
T Consensus 26 ~~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~~l~~L 104 (636)
T 4eco_A 26 AEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPDAIGQL 104 (636)
T ss_dssp CHHHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGGGTTCCTTEEECTT-CCEEEEECTTSCCEEEECGGGGGC
T ss_pred hhHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcccccCCCCeEEcCC-CCEEEEEecCcccCCcCChHHhcC
Confidence 33458999999999998544333 23489988999999 99999865 799999999999999999999999
Q ss_pred CCCCEEEccCCCc------cc------cCCcchhccccCceeeceecccCCCCccchhc-CccccceecccccccCccCc
Q 046598 86 SFLKVLRLYNNSF------NH------EIPSEFDRLRRLQVLALHYNSIGGAIPANISS-CSNLIQLRLFHNQLVGKIPS 152 (986)
Q Consensus 86 ~~L~~L~L~~n~l------~~------~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~ 152 (986)
++|++|+|++|.+ .+ .+|... +..|+ +++++|.+.+.+|..+.. +..+..+++....+..
T Consensus 105 ~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~---- 177 (636)
T 4eco_A 105 TELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK---- 177 (636)
T ss_dssp TTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCC----
T ss_pred ccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCcccccccc----
Confidence 9999999999977 33 456555 67788 999999999988887763 3445555554322221
Q ss_pred cccCCCCCCeEEcc--CCcCCCCcccccCCCcCcceeeccCCcccCc-----------------Ccchhh--ccCCCcee
Q 046598 153 ELSSLSKIEHISVN--DNNLTGSIPSSLGNLSSIRSLFLSGNNLEGS-----------------IPDTLG--WLKNLVNL 211 (986)
Q Consensus 153 ~~~~l~~L~~L~L~--~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-----------------~p~~~~--~l~~L~~L 211 (986)
.....++.+.+. +|++++ +|..|+++++|++|+|++|++++. +|+.++ .+++|++|
T Consensus 178 --~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L 254 (636)
T 4eco_A 178 --SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDV 254 (636)
T ss_dssp --CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEE
T ss_pred --ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEE
Confidence 111122222222 344444 444455555555555555555443 455544 55555555
Q ss_pred ecccccccccCCccccCCCCccEEeccccc-ccc-ccCCcccc-----cccccceEEecCceecccCCc--cccCCCCCc
Q 046598 212 TMAQNRLSGTIPSSIFNISSITGFDAGVNK-IQG-AIPLDYGF-----SLQNLQFFSVGENQLTGAIPP--TISNASNLE 282 (986)
Q Consensus 212 ~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~-l~~-~~p~~~~~-----~l~~L~~L~L~~N~l~~~~p~--~l~~l~~L~ 282 (986)
+|++|++.+.+|..++++++|+.|++++|+ +.+ .+|..+.. .+++|++|++++|+++ .+|. .++++++|+
T Consensus 255 ~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~ 333 (636)
T 4eco_A 255 EVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLG 333 (636)
T ss_dssp EEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCC
T ss_pred EecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCC
Confidence 555555555555555555555555555554 544 44444331 2366777777777777 6666 677777777
Q ss_pred EEecccccccCCCchhhhhhhHhhhhhccCCCCCCCCCCcccccccccccccceeeccccccccCCCcccccccccceEE
Q 046598 283 IFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVL 362 (986)
Q Consensus 283 ~L~ls~N~l~~~~~~l~~l~~L~~l~l~~n~l~~~~~~~l~~l~~l~~~~~L~~l~l~~n~~~~~~p~~~~~~~~~L~~L 362 (986)
.|++++|+++| .+| .+..+ ++|+.|
T Consensus 334 ~L~L~~N~l~g-----------------------------------------------------~ip-~~~~l-~~L~~L 358 (636)
T 4eco_A 334 MLECLYNQLEG-----------------------------------------------------KLP-AFGSE-IKLASL 358 (636)
T ss_dssp EEECCSCCCEE-----------------------------------------------------ECC-CCEEE-EEESEE
T ss_pred EEeCcCCcCcc-----------------------------------------------------chh-hhCCC-CCCCEE
Confidence 77776666652 222 11111 345556
Q ss_pred EccCCcccccCCccccCCCC-CCEEEccCccccCcCCCcccCCC--CCCEEEccCccceeecCcccc-------c-cccc
Q 046598 363 LLDNNQIFGNIPAAIGKFVN-LQRLDMCSNRLSGTIPPAIGELQ--NLKDLRLQRNRFQGNIPPSIG-------N-LKLF 431 (986)
Q Consensus 363 ~L~~n~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~Ls~N~l~~~~~~~~~-------~-~~L~ 431 (986)
++++|+++ .+|..+..+++ |++|++++|.++ .+|..+..++ +|+.|++++|++++.+|..+. . .+|+
T Consensus 359 ~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~ 436 (636)
T 4eco_A 359 NLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVS 436 (636)
T ss_dssp ECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEE
T ss_pred ECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCC
Confidence 66666665 55555666666 666666666666 5555555543 666666666666665555544 2 2577
Q ss_pred EEEecccccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCC-------cceEEEccCCcccccCCcccc--cccc
Q 046598 432 ILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSS-------SLIVLDLSRNQLTGSIPSEVG--NLKN 502 (986)
Q Consensus 432 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~-------~L~~L~Ls~N~l~~~~p~~~~--~l~~ 502 (986)
+|+|++|++++..+..+..+++|++|+|++|+++ .+|...+.... +|+.|+|++|+|+ .+|..+. .+++
T Consensus 437 ~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~ 514 (636)
T 4eco_A 437 SINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPY 514 (636)
T ss_dssp EEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTT
T ss_pred EEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCC
Confidence 7777777777444444566788888888888888 77776555433 7888888888888 6777776 8888
Q ss_pred cchhhccCccccccCcccccCCccccEEec------ccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccc
Q 046598 503 LEILNVFGNKLKGEIPSTLGSCIKLEQLEM------QENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVK 576 (986)
Q Consensus 503 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L------~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 576 (986)
|+.|+|++|+|++ +|..+..+++|++|+| ++|++.+.+|..+..+++|+.|+|++|+| +.+|..+. ++|+
T Consensus 515 L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~ 590 (636)
T 4eco_A 515 LVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNIS 590 (636)
T ss_dssp CCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCC
T ss_pred cCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCC
Confidence 8888888888886 7888888888888888 56888889999999999999999999999 57888766 7999
Q ss_pred eeeccCCccccccCC
Q 046598 577 NLNLSNNDLEGVVPT 591 (986)
Q Consensus 577 ~l~ls~N~l~~~~p~ 591 (986)
+|+|++|++....+.
T Consensus 591 ~L~Ls~N~l~~~~~~ 605 (636)
T 4eco_A 591 VLDIKDNPNISIDLS 605 (636)
T ss_dssp EEECCSCTTCEEECT
T ss_pred EEECcCCCCccccHH
Confidence 999999988876544
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-58 Score=554.53 Aligned_cols=514 Identities=18% Similarity=0.178 Sum_probs=327.6
Q ss_pred CCCCCCCCc--ceeeEecCC---------CCeEEEEeccCCCCccccCcCccCCCCCCEEEccCCCccccCCcchhcccc
Q 046598 43 WNESSHFCQ--WRGVTCSRR---------HQRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRR 111 (986)
Q Consensus 43 w~~~~~~c~--w~gv~c~~~---------~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~ 111 (986)
|.+..+.|. +..|.|... ...++.|||++|.+++..|..|+++++|++|+|++|++.+..|.+|+++++
T Consensus 3 ~~~~~C~~~~~~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~ 82 (606)
T 3t6q_A 3 SSDQKCIEKEVNKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHR 82 (606)
T ss_dssp ---CCCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTT
T ss_pred cccCceecccCCceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccc
Confidence 444444453 566888653 246888999999998877888999999999999999998888888999999
Q ss_pred CceeeceecccCCCCccchhcCccccceecccccccCccCccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeeccC
Q 046598 112 LQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSG 191 (986)
Q Consensus 112 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 191 (986)
|++|+|++|++++..|..|+.+++|++|+|++|++++..|..|+++++|++|+|++|++++..+..+.++++|++|+|++
T Consensus 83 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 162 (606)
T 3t6q_A 83 LDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQN 162 (606)
T ss_dssp CCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCS
T ss_pred cCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEccc
Confidence 99999999999888888899999999999999999877778888999999999999998875545555688999999999
Q ss_pred CcccCcCcchhhccCCCc--eeecccccccccCCccccCCCCccEEecccccccc-------------------------
Q 046598 192 NNLEGSIPDTLGWLKNLV--NLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQG------------------------- 244 (986)
Q Consensus 192 N~l~~~~p~~~~~l~~L~--~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~------------------------- 244 (986)
|++++..|..|+.+++|+ .|++++|++++..|..+. ..+|+.|+++.|....
T Consensus 163 n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~-~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~ 241 (606)
T 3t6q_A 163 NAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFD-SAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDE 241 (606)
T ss_dssp SCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTT-TCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCC
T ss_pred CcccccChhhhhhhcccceeEEecCCCccCccChhHhh-hccccccccCCchhHHHHhhhccccchhheechhhcccccc
Confidence 999887888888898888 888999999876665544 4678888888775210
Q ss_pred ccCCccccccc--ccceEEecCceecccCCccccCCCCCcEEecccccccCCCchhhhhhhHhhhhhccCCCCCCCCCCc
Q 046598 245 AIPLDYGFSLQ--NLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDL 322 (986)
Q Consensus 245 ~~p~~~~~~l~--~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~l~~l~~L~~l~l~~n~l~~~~~~~l 322 (986)
.++...+.++. +|+.|++++|.+++..+..|+.+++|+.|++++|+++.+++.
T Consensus 242 ~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~lp~~------------------------- 296 (606)
T 3t6q_A 242 DISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSG------------------------- 296 (606)
T ss_dssp CCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCSCCCSS-------------------------
T ss_pred ccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccCCCChh-------------------------
Confidence 11111111121 455555555555555555555555555555555555533322
Q ss_pred ccccccccccccceeeccccccccCCCcccccccccceEEEccCCcccccCCc-cccCCCCCCEEEccCccccCcC--CC
Q 046598 323 NFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPA-AIGKFVNLQRLDMCSNRLSGTI--PP 399 (986)
Q Consensus 323 ~~l~~l~~~~~L~~l~l~~n~~~~~~p~~~~~~~~~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~--~~ 399 (986)
+..+++|+.|+++.|.+.+..|..+..+ ++|+.|++++|.+.+.+|. .+..+++|++|++++|.+++.. +.
T Consensus 297 -----l~~l~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 370 (606)
T 3t6q_A 297 -----LVGLSTLKKLVLSANKFENLCQISASNF-PSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNL 370 (606)
T ss_dssp -----CCSCTTCCEEECTTCCCSBGGGGCGGGC-TTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTT
T ss_pred -----hcccccCCEEECccCCcCcCchhhhhcc-CcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcch
Confidence 2333445555555555554444444443 4555666666655544333 3555666666666666655443 45
Q ss_pred cccCCCCCCEEEccCccceeecCcccccc-cccEEEecccccCCCCCcc-cCCCCCCCeeecCCCccCCCCCcccccCCC
Q 046598 400 AIGELQNLKDLRLQRNRFQGNIPPSIGNL-KLFILYLSYNFLQGSIPSS-LGRYETLTTIDLSNNNLTGTIPPQFIGLSS 477 (986)
Q Consensus 400 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~-~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~ 477 (986)
.+..+++|++|++++|++.+..|..+... +|++|++++|.+++..|.. +..+++|++|++++|++++..|.. ++.++
T Consensus 371 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~-~~~l~ 449 (606)
T 3t6q_A 371 QLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQL-FDGLP 449 (606)
T ss_dssp TTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTT-TTTCT
T ss_pred hcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHH-HhCCC
Confidence 55556666666666666655555555433 3556666666555544332 555555666666666555333332 44555
Q ss_pred cceEEEccCCccccc---CCcccccccccchhhccCccccccCcccccCCccccEEecccccccccCCccccCCCCCCEE
Q 046598 478 SLIVLDLSRNQLTGS---IPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVL 554 (986)
Q Consensus 478 ~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 554 (986)
+|++|++++|++++. .+..+..+++|++|+|++|++++..|..|..+++|++|+|++|++++.+|..+..+++| .|
T Consensus 450 ~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L 528 (606)
T 3t6q_A 450 ALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YL 528 (606)
T ss_dssp TCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EE
T ss_pred CCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EE
Confidence 566666666655541 12345555556666666666555555555555666666666666655555555555555 56
Q ss_pred eCCCccCcccCchhhhcccccceeeccCCccccccC
Q 046598 555 DLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVP 590 (986)
Q Consensus 555 ~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p 590 (986)
+|++|++++..|..+..+++|++|++++|+++|..+
T Consensus 529 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 529 NLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp ECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred ECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence 666666655555555555556666666666555444
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-58 Score=560.02 Aligned_cols=485 Identities=20% Similarity=0.206 Sum_probs=307.3
Q ss_pred cCcCCCHhHHHHHHHHHHhccCCCcCCCCCCCCCC-----CC--Ccc------------eeeEecCCCCeEEEEeccCCC
Q 046598 13 STVAGNETDRLALLELKSKITHDPLGVLASWNESS-----HF--CQW------------RGVTCSRRHQRVTILDLESLK 73 (986)
Q Consensus 13 ~~~~~~~~~~~~ll~~k~~~~~~~~~~l~~w~~~~-----~~--c~w------------~gv~c~~~~~~v~~l~l~~~~ 73 (986)
.+.++..+|++||++||+++. +| +|+.+. +| |.| .||+|+. ++||+.|+|++++
T Consensus 262 ~~~~~~~~d~~ALl~~k~~l~-~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~ 334 (876)
T 4ecn_A 262 KETAEYIKDYKALKAIWEALD-GK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFG 334 (876)
T ss_dssp CCCCHHHHHHHHHHHHHHHTT-GG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTC
T ss_pred cccccchHHHHHHHHHHHHcC-CC-----CCCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECccCC
Confidence 344556789999999999994 65 786543 55 999 9999987 6899999999999
Q ss_pred CccccCcCccCCCCCCEEEc-cCCCccccCCcchh---------------------------------------------
Q 046598 74 LAGSISPHVGNLSFLKVLRL-YNNSFNHEIPSEFD--------------------------------------------- 107 (986)
Q Consensus 74 l~~~~~~~~~~l~~L~~L~L-~~n~l~~~~p~~~~--------------------------------------------- 107 (986)
+.|.+|++|++|++|++|+| ++|.+.|..|..-.
T Consensus 335 L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~ 414 (876)
T 4ecn_A 335 AKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEM 414 (876)
T ss_dssp CEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTS
T ss_pred CCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccc
Confidence 99999999999999999999 89988877442211
Q ss_pred ------ccccCceeecee--cccCCCCccchhcCccccceecccccccC-----------------ccCcccc--CCCCC
Q 046598 108 ------RLRRLQVLALHY--NSIGGAIPANISSCSNLIQLRLFHNQLVG-----------------KIPSELS--SLSKI 160 (986)
Q Consensus 108 ------~l~~L~~L~L~~--N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-----------------~~p~~~~--~l~~L 160 (986)
....++.+.++. |++++ +|..|+++++|++|+|++|.|++ .+|..++ ++++|
T Consensus 415 ~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L 493 (876)
T 4ecn_A 415 KPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDL 493 (876)
T ss_dssp CCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTC
T ss_pred cccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCC
Confidence 111233333333 66665 66677777777777777777776 2666665 67777
Q ss_pred CeEEccCCcCCCCcccccCCCcCcceeeccCCc-ccC-cCcchhhccC-------CCceeecccccccccCCc--cccCC
Q 046598 161 EHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNN-LEG-SIPDTLGWLK-------NLVNLTMAQNRLSGTIPS--SIFNI 229 (986)
Q Consensus 161 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~-~~p~~~~~l~-------~L~~L~L~~N~l~~~~p~--~l~~l 229 (986)
++|+|++|++.+.+|..|+++++|++|+|++|+ +++ .+|..++.++ +|++|+|++|+++ .+|. .+.++
T Consensus 494 ~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L 572 (876)
T 4ecn_A 494 TDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKM 572 (876)
T ss_dssp CEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTC
T ss_pred CEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcC
Confidence 777777777666777777777777777777776 666 5666666555 6777777777776 6666 66666
Q ss_pred CCccEEeccccccccccCCcccccccccceEEecCceecccCCccccCCCC-CcEEecccccccCCCchhhhhhhHhhhh
Q 046598 230 SSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASN-LEIFHGSVNKLTGAAPYLEKLQRLLVFG 308 (986)
Q Consensus 230 ~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~-L~~L~ls~N~l~~~~~~l~~l~~L~~l~ 308 (986)
++|+.|++++|.+. .+| .+..+++|+.|+|++|+++ .+|..+.++++ |+.|++++|+++.++
T Consensus 573 ~~L~~L~Ls~N~l~-~lp--~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~~lp------------- 635 (876)
T 4ecn_A 573 VKLGLLDCVHNKVR-HLE--AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIP------------- 635 (876)
T ss_dssp TTCCEEECTTSCCC-BCC--CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCCSCC-------------
T ss_pred CCCCEEECCCCCcc-cch--hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCCcCc-------------
Confidence 66666666666666 566 3345666666666666666 56666666666 666666666655332
Q ss_pred hccCCCCCCCCCCcccccccccccccceeeccccccccCCCccccccc-ccceEEEccCCcccccCCccc---c--CCCC
Q 046598 309 ILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLS-TTLEVLLLDNNQIFGNIPAAI---G--KFVN 382 (986)
Q Consensus 309 l~~n~l~~~~~~~l~~l~~l~~~~~L~~l~l~~n~~~~~~p~~~~~~~-~~L~~L~L~~n~l~~~~~~~~---~--~l~~ 382 (986)
..+.... .+|+.|+|++|++.+.+|... . .+++
T Consensus 636 -----------------------------------------~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~ 674 (876)
T 4ecn_A 636 -----------------------------------------NIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGIN 674 (876)
T ss_dssp -----------------------------------------SCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCC
T ss_pred -----------------------------------------hhhhccccCCCCEEECcCCcCCCccccchhhhccccCCC
Confidence 2222111 235666666666665544221 2 2346
Q ss_pred CCEEEccCccccCcCCCc-ccCCCCCCEEEccCccceeecCcccccccccEEEecccccCCCCCcccCCCCCCCeeecCC
Q 046598 383 LQRLDMCSNRLSGTIPPA-IGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSN 461 (986)
Q Consensus 383 L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 461 (986)
|+.|+|++|.++ .+|.. +..+++|+.|+|++|+|+...+..+... +..+.++++|+.|+|++
T Consensus 675 L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~----------------~~~l~nl~~L~~L~Ls~ 737 (876)
T 4ecn_A 675 ASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMTSIPENSLKPK----------------DGNYKNTYLLTTIDLRF 737 (876)
T ss_dssp EEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCT----------------TSCCTTGGGCCEEECCS
T ss_pred cCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCCccChHHhccc----------------cccccccCCccEEECCC
Confidence 777777777777 34443 3466777777777777662222222211 00122333666666666
Q ss_pred CccCCCCCcccc-cCCCcceEEEccCCcccccCCcccccccccchhhccC------ccccccCcccccCCccccEEeccc
Q 046598 462 NNLTGTIPPQFI-GLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFG------NKLKGEIPSTLGSCIKLEQLEMQE 534 (986)
Q Consensus 462 N~l~~~ip~~~~-~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~------N~l~~~~p~~~~~l~~L~~L~L~~ 534 (986)
|+|+ .+|..+. ..+++|+.|+|++|+|++ +|..+..+++|+.|+|++ |++.+.+|..|..+++|+.|+|++
T Consensus 738 N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~ 815 (876)
T 4ecn_A 738 NKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGS 815 (876)
T ss_dssp SCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCS
T ss_pred CCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCC
Confidence 6666 5665533 255666666666666664 566666666666666655 566666666666666666666666
Q ss_pred ccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCccc
Q 046598 535 NFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLE 586 (986)
Q Consensus 535 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~ 586 (986)
|+| +.+|..+. ++|+.|||++|++....+..+.....+..+.|++|++.
T Consensus 816 N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~ 864 (876)
T 4ecn_A 816 NDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864 (876)
T ss_dssp SCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTS
T ss_pred CCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchheeecCCCcc
Confidence 666 35555544 46666666666665555555554444555555555443
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-57 Score=562.89 Aligned_cols=520 Identities=20% Similarity=0.176 Sum_probs=397.9
Q ss_pred CcceeeEecCCCCeEEEEeccCCCCccccCcCccCCCCCCEEEccCCCccccC-CcchhccccCceeeceecccCCCCcc
Q 046598 50 CQWRGVTCSRRHQRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEI-PSEFDRLRRLQVLALHYNSIGGAIPA 128 (986)
Q Consensus 50 c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~ 128 (986)
|.|++|.+ ...+++.|||++|.+++..+.+|.++++|++|+|++|.+.+.+ |.+|+++++|++|+|++|.+++..|.
T Consensus 14 ~~L~~vP~--lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~ 91 (844)
T 3j0a_A 14 CNLTQVPQ--VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD 91 (844)
T ss_dssp CCSSCCCS--SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT
T ss_pred CCCCCCCC--CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh
Confidence 46777776 4467899999999999888899999999999999999666555 78899999999999999999988899
Q ss_pred chhcCccccceecccccccCccCcc--ccCCCCCCeEEccCCcCCCCcc-cccCCCcCcceeeccCCcccCcCcchhhcc
Q 046598 129 NISSCSNLIQLRLFHNQLVGKIPSE--LSSLSKIEHISVNDNNLTGSIP-SSLGNLSSIRSLFLSGNNLEGSIPDTLGWL 205 (986)
Q Consensus 129 ~~~~l~~L~~L~Ls~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 205 (986)
.|+++++|++|+|++|.+++.+|.. |+++++|++|+|++|.+++..+ ..|+++++|++|+|++|.+++..+..|..+
T Consensus 92 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l 171 (844)
T 3j0a_A 92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPL 171 (844)
T ss_dssp SSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHH
T ss_pred HccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccc
Confidence 9999999999999999999876665 8999999999999999987655 578999999999999999998888999888
Q ss_pred --CCCceeecccccccccCCccccCCCC------ccEEeccccccccccCCccccc--ccccceEEecC---------ce
Q 046598 206 --KNLVNLTMAQNRLSGTIPSSIFNISS------ITGFDAGVNKIQGAIPLDYGFS--LQNLQFFSVGE---------NQ 266 (986)
Q Consensus 206 --~~L~~L~L~~N~l~~~~p~~l~~l~~------L~~L~l~~N~l~~~~p~~~~~~--l~~L~~L~L~~---------N~ 266 (986)
++|+.|+|++|.+++..|..+..+.+ |+.|+++.|.+.+.+|..+... ..+++.|.++. |.
T Consensus 172 ~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~ 251 (844)
T 3j0a_A 172 QGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHN 251 (844)
T ss_dssp HHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSS
T ss_pred cCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccc
Confidence 89999999999999888888777665 8999999998888777665432 24566776663 33
Q ss_pred ecccCCccccCC--CCCcEEecccccccCCCchhhhhhhHhhhhhccCCCCCCCCCCcccccccccccccceeecccccc
Q 046598 267 LTGAIPPTISNA--SNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNF 344 (986)
Q Consensus 267 l~~~~p~~l~~l--~~L~~L~ls~N~l~~~~~~l~~l~~L~~l~l~~n~l~~~~~~~l~~l~~l~~~~~L~~l~l~~n~~ 344 (986)
+.+..+..|..+ ++|+.|++++|.+++..+ ..+..+++|+.|+++.|.+
T Consensus 252 l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~-----------------------------~~~~~l~~L~~L~L~~n~i 302 (844)
T 3j0a_A 252 IKDPDQNTFAGLARSSVRHLDLSHGFVFSLNS-----------------------------RVFETLKDLKVLNLAYNKI 302 (844)
T ss_dssp STTGGGTTTTTTTTSCCCEEECTTCCCCEECS-----------------------------CCSSSCCCCCEEEEESCCC
T ss_pred cCCCChhhhhccccCCccEEECCCCcccccCh-----------------------------hhhhcCCCCCEEECCCCcC
Confidence 333334445554 677778877777765433 1345566777777777777
Q ss_pred ccCCCcccccccccceEEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCcc
Q 046598 345 GGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPS 424 (986)
Q Consensus 345 ~~~~p~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 424 (986)
++..|..+..+ ++|+.|+|++|++++..|..|..+++|++|++++|.+++..+..|..+++|+.|+|++|.+++...
T Consensus 303 ~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~-- 379 (844)
T 3j0a_A 303 NKIADEAFYGL-DNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHF-- 379 (844)
T ss_dssp CEECTTTTTTC-SSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSS--
T ss_pred CCCChHHhcCC-CCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccC--
Confidence 76666666555 578888888888877777788888888888888888877777778888888888888888774322
Q ss_pred cccccccEEEecccccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCc-cccccccc
Q 046598 425 IGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPS-EVGNLKNL 503 (986)
Q Consensus 425 ~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~-~~~~l~~L 503 (986)
..+|+.|++++|+++ .+|.. ..+++.|++++|++++.-...++..+++|+.|+|++|++++..+. .+..+++|
T Consensus 380 --~~~L~~L~l~~N~l~-~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L 453 (844)
T 3j0a_A 380 --IPSIPDIFLSGNKLV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSL 453 (844)
T ss_dssp --CCSCSEEEEESCCCC-CCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTC
T ss_pred --CCCcchhccCCCCcc-ccccc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCcc
Confidence 335778888888887 44543 456778888888887432233345677888888888888754332 35567788
Q ss_pred chhhccCcccc-----ccCcccccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhccccccee
Q 046598 504 EILNVFGNKLK-----GEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNL 578 (986)
Q Consensus 504 ~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l 578 (986)
+.|+|++|.++ +..+..|..+++|+.|+|++|+|++.+|..|..+++|+.|+|++|+|++..|..+. ++|+.|
T Consensus 454 ~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L 531 (844)
T 3j0a_A 454 EQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEIL 531 (844)
T ss_dssp CBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEE
T ss_pred ccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEE
Confidence 88888888876 34455677788888888888888877777788888888888888888876666555 778888
Q ss_pred eccCCccccccCCccccccccceeeeCCcccccCC
Q 046598 579 NLSNNDLEGVVPTQGVFKNASITSVFGNLKLCGGI 613 (986)
Q Consensus 579 ~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lcg~~ 613 (986)
+|++|+|++.+|.. +..+..+++.|||+.|++.
T Consensus 532 ~Ls~N~l~~~~~~~--~~~L~~l~l~~Np~~C~c~ 564 (844)
T 3j0a_A 532 DISRNQLLAPNPDV--FVSLSVLDITHNKFICECE 564 (844)
T ss_dssp EEEEECCCCCCSCC--CSSCCEEEEEEECCCCSSS
T ss_pred ECCCCcCCCCChhH--hCCcCEEEecCCCcccccc
Confidence 88888888877754 5677777888888888654
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-56 Score=547.27 Aligned_cols=522 Identities=21% Similarity=0.226 Sum_probs=461.0
Q ss_pred CeEEEEeccCCCCccccCcCccCCCCCCEEEccCCCccccCCcchhccccCceeeceecccCCCCccchhcCccccceec
Q 046598 62 QRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRL 141 (986)
Q Consensus 62 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 141 (986)
.+++.|||++|.+++..|..|+++++|++|+|++|++++..+.+|+++++|++|+|++|++++..|..|+.+++|++|+|
T Consensus 49 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 128 (680)
T 1ziw_A 49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDL 128 (680)
T ss_dssp TTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEEC
T ss_pred CcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEEC
Confidence 46899999999999988999999999999999999999777778999999999999999999888889999999999999
Q ss_pred ccccccCccCccccCCCCCCeEEccCCcCCCCcccccC--CCcCcceeeccCCcccCcCcchhhcc--------------
Q 046598 142 FHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLG--NLSSIRSLFLSGNNLEGSIPDTLGWL-------------- 205 (986)
Q Consensus 142 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l-------------- 205 (986)
++|.+++..|..|+++++|++|++++|++++..+..+. ++++|++|++++|++++..|..|..+
T Consensus 129 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~ 208 (680)
T 1ziw_A 129 SHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLG 208 (680)
T ss_dssp CSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCH
T ss_pred CCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccC
Confidence 99999999999999999999999999999988887765 56899999999999998888877654
Q ss_pred -------------CCCceeecccccccccCCccccCCCC--ccEEeccccccccccCCcccccccccceEEecCceeccc
Q 046598 206 -------------KNLVNLTMAQNRLSGTIPSSIFNISS--ITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGA 270 (986)
Q Consensus 206 -------------~~L~~L~L~~N~l~~~~p~~l~~l~~--L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~ 270 (986)
++|++|++++|++++..|..+.+++. |+.|++++|.+.+..|.. +..+++|++|++++|++++.
T Consensus 209 ~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~-~~~l~~L~~L~L~~n~l~~~ 287 (680)
T 1ziw_A 209 PSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDS-FAWLPQLEYFFLEYNNIQHL 287 (680)
T ss_dssp HHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTT-TTTCTTCCEEECCSCCBSEE
T ss_pred hhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCccc-ccCcccccEeeCCCCccCcc
Confidence 56788899999999999999998865 999999999999766554 45799999999999999999
Q ss_pred CCccccCCCCCcEEecccccccC------CCc----hhhhhhhHhhhhhccCCCCCCCCCCcccccccccccccceeecc
Q 046598 271 IPPTISNASNLEIFHGSVNKLTG------AAP----YLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLIN 340 (986)
Q Consensus 271 ~p~~l~~l~~L~~L~ls~N~l~~------~~~----~l~~l~~L~~l~l~~n~l~~~~~~~l~~l~~l~~~~~L~~l~l~ 340 (986)
.|..|.++++|+.|++++|...+ ++. .+..+++|+.+++++|.+...... .+.++++|+.++++
T Consensus 288 ~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~------~~~~l~~L~~L~Ls 361 (680)
T 1ziw_A 288 FSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSN------MFTGLINLKYLSLS 361 (680)
T ss_dssp CTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTT------TTTTCTTCCEEECT
T ss_pred ChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChh------HhccccCCcEEECC
Confidence 99999999999999999876553 222 567889999999999999875543 46678899999999
Q ss_pred ccccccC-CCccc-ccc-cccceEEEccCCcccccCCccccCCCCCCEEEccCccccCcCC-CcccCCCCCCEEEccCcc
Q 046598 341 INNFGGS-LPACI-SNL-STTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIP-PAIGELQNLKDLRLQRNR 416 (986)
Q Consensus 341 ~n~~~~~-~p~~~-~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~ 416 (986)
.|.+.+. ++... ..+ ...|+.|++++|++++..|.+|..+++|+.|++++|.+++.+| ..|..+++|++|++++|+
T Consensus 362 ~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~ 441 (680)
T 1ziw_A 362 NSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNK 441 (680)
T ss_dssp TCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCS
T ss_pred CCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCC
Confidence 9986543 33222 222 1479999999999999999999999999999999999987666 689999999999999999
Q ss_pred ceeecCcccccc-cccEEEecccccC--CCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccC
Q 046598 417 FQGNIPPSIGNL-KLFILYLSYNFLQ--GSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSI 493 (986)
Q Consensus 417 l~~~~~~~~~~~-~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~ 493 (986)
+.+..+..+... +|+.|++++|.+. +.+|..|..+++|++|+|++|+|+ .+|+..+..+++|++|+|++|++++..
T Consensus 442 l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~Ls~N~l~~~~ 520 (680)
T 1ziw_A 442 YLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIA-NINDDMLEGLEKLEILDLQHNNLARLW 520 (680)
T ss_dssp EEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCGGGG
T ss_pred cceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCC-cCChhhhccccccCEEeCCCCCccccc
Confidence 999888888765 5999999999997 678999999999999999999999 666666888999999999999998642
Q ss_pred C--------cccccccccchhhccCccccccCcccccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccC
Q 046598 494 P--------SEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKI 565 (986)
Q Consensus 494 p--------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 565 (986)
+ ..|.++++|+.|+|++|+++...+..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..
T Consensus 521 ~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~ 600 (680)
T 1ziw_A 521 KHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVE 600 (680)
T ss_dssp STTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCC
T ss_pred hhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccC
Confidence 2 23789999999999999999554567999999999999999999877788899999999999999999988
Q ss_pred chhhh-cccccceeeccCCccccccCC
Q 046598 566 PELLI-RLQLVKNLNLSNNDLEGVVPT 591 (986)
Q Consensus 566 p~~~~-~l~~L~~l~ls~N~l~~~~p~ 591 (986)
|..+. .+++|+.|++++|++.|..+.
T Consensus 601 ~~~~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 601 KKVFGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp HHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred hhHhcccccccCEEEccCCCcccCCcc
Confidence 88888 899999999999999998875
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-56 Score=538.96 Aligned_cols=512 Identities=19% Similarity=0.161 Sum_probs=295.5
Q ss_pred CeEEEEeccCCCCccccCcCccCCCCCCEEEccCCCccccCCcchhccccCceeeceecccCCCCccchhcCccccceec
Q 046598 62 QRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRL 141 (986)
Q Consensus 62 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 141 (986)
.+++.|||++|.+++..+..|+++++|++|+|++|++++..|.+|+++++|++|+|++|++++..|..|+++++|++|+|
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 34555666666665555555666666666666666665555555666666666666666666555556666666666666
Q ss_pred ccccccCccCccccCCCCCCeEEccCCcCCC-CcccccCCCcCcceeeccCCcccCcCcchhhccCCCc----eeecccc
Q 046598 142 FHNQLVGKIPSELSSLSKIEHISVNDNNLTG-SIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLV----NLTMAQN 216 (986)
Q Consensus 142 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~----~L~L~~N 216 (986)
++|++++..|..|+++++|++|++++|.+++ .+|..|+++++|++|+|++|++++..|..|+.+++|+ +|++++|
T Consensus 112 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n 191 (606)
T 3vq2_A 112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLN 191 (606)
T ss_dssp TTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTC
T ss_pred cCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCC
Confidence 6666655554556666666666666666554 3455566666666666666666555555555555444 4666666
Q ss_pred cccccCCccccCCCCccEEeccccccccccCCcccccccccceEEecCceeccc------CCccccCCC--CCcEEec-c
Q 046598 217 RLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGA------IPPTISNAS--NLEIFHG-S 287 (986)
Q Consensus 217 ~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~------~p~~l~~l~--~L~~L~l-s 287 (986)
++++..+.. +...+|+.|++++|.+.+........++++|+.+++..+.+.+. .+..+..+. .++.+++ .
T Consensus 192 ~l~~~~~~~-~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~ 270 (606)
T 3vq2_A 192 PIDFIQDQA-FQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTY 270 (606)
T ss_dssp CCCEECTTT-TTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECC
T ss_pred CcceeCccc-ccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccc
Confidence 665333332 23335566666665554333333333455555555543332211 111111111 2333333 4
Q ss_pred cccccCCCchhhhhhhHhhhhhccCCCCCCCCCCcccccccccccccceeeccccccccCCCcccccccccceEEEccCC
Q 046598 288 VNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNN 367 (986)
Q Consensus 288 ~N~l~~~~~~l~~l~~L~~l~l~~n~l~~~~~~~l~~l~~l~~~~~L~~l~l~~n~~~~~~p~~~~~~~~~L~~L~L~~n 367 (986)
.|.+++..+.+..+++|+.+++.+|.+...+ .+..+++|+.|+++.|.+ +.+|. + . .++|+.|++++|
T Consensus 271 ~~~~~~~~~~~~~l~~L~~L~l~~~~~~~l~--------~l~~~~~L~~L~l~~n~l-~~lp~-~-~-l~~L~~L~l~~n 338 (606)
T 3vq2_A 271 TNDFSDDIVKFHCLANVSAMSLAGVSIKYLE--------DVPKHFKWQSLSIIRCQL-KQFPT-L-D-LPFLKSLTLTMN 338 (606)
T ss_dssp CTTCCGGGGSCGGGTTCSEEEEESCCCCCCC--------CCCTTCCCSEEEEESCCC-SSCCC-C-C-CSSCCEEEEESC
T ss_pred cccccccccccccCCCCCEEEecCccchhhh--------hccccccCCEEEcccccC-ccccc-C-C-CCccceeeccCC
Confidence 5555555555666666666666666554322 344556666666666666 56663 2 2 356666666666
Q ss_pred cccccCCccccCCCCCCEEEccCccccCc--CCCcccCCCCCCEEEccCccceeecCcccccc-cccEEEecccccCCCC
Q 046598 368 QIFGNIPAAIGKFVNLQRLDMCSNRLSGT--IPPAIGELQNLKDLRLQRNRFQGNIPPSIGNL-KLFILYLSYNFLQGSI 444 (986)
Q Consensus 368 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~-~L~~L~L~~N~l~~~~ 444 (986)
...+.. .+..+++|++|++++|.+++. .|..+..+++|++|++++|.+++. |..+..+ +|++|++++|++.+..
T Consensus 339 ~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~-~~~~~~l~~L~~L~l~~n~l~~~~ 415 (606)
T 3vq2_A 339 KGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIM-SANFMGLEELQHLDFQHSTLKRVT 415 (606)
T ss_dssp SSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEEE-CCCCTTCTTCCEEECTTSEEESTT
T ss_pred cCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccccc-hhhccCCCCCCeeECCCCccCCcc
Confidence 444333 455666666666666666644 256666666666666666666643 3444333 4666666666666665
Q ss_pred C-cccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccc-cCCcccccccccchhhccCccccccCccccc
Q 046598 445 P-SSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTG-SIPSEVGNLKNLEILNVFGNKLKGEIPSTLG 522 (986)
Q Consensus 445 p-~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 522 (986)
| ..+..+++|++|++++|++++.+|.. ++.+++|+.|++++|++++ .+|..|..+++|+.|+|++|++++..|..|.
T Consensus 416 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~ 494 (606)
T 3vq2_A 416 EFSAFLSLEKLLYLDISYTNTKIDFDGI-FLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFD 494 (606)
T ss_dssp TTTTTTTCTTCCEEECTTSCCEECCTTT-TTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTT
T ss_pred ChhhhhccccCCEEECcCCCCCccchhh-hcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhc
Confidence 5 45666666666666666666444444 5556666666666666665 3566666666666666666666666666666
Q ss_pred CCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhccc-ccceeeccCCccccccCC
Q 046598 523 SCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQ-LVKNLNLSNNDLEGVVPT 591 (986)
Q Consensus 523 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~l~ls~N~l~~~~p~ 591 (986)
++++|++|+|++|++++.+|..|..+++|+.|+|++|+|+ .+|..+..++ +|++|++++|++.|..+.
T Consensus 495 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 495 TLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEH 563 (606)
T ss_dssp TCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred ccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence 6666666666666666666666666666666666666666 4555566665 466666666666665554
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-56 Score=537.60 Aligned_cols=534 Identities=18% Similarity=0.150 Sum_probs=453.5
Q ss_pred EEeccCCCCccccCcCccCCCCCCEEEccCCCccccCCcchhccccCceeeceecccCCCCccchhcCccccceeccccc
Q 046598 66 ILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQ 145 (986)
Q Consensus 66 ~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 145 (986)
.+|.++++++ .+|..+. +.|++|+|++|++++..+.+|.++++|++|+|++|++++..|..|+++++|++|+|++|.
T Consensus 15 ~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~ 91 (606)
T 3vq2_A 15 TYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91 (606)
T ss_dssp EEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred ceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCc
Confidence 4666777777 6777665 889999999999999999999999999999999999998889999999999999999999
Q ss_pred ccCccCccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeeccCCcccC-cCcchhhccCCCceeecccccccccCCc
Q 046598 146 LVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEG-SIPDTLGWLKNLVNLTMAQNRLSGTIPS 224 (986)
Q Consensus 146 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 224 (986)
+++..|.+|+++++|++|+|++|++++..+..|+++++|++|+|++|++++ .+|..|+.+++|++|+|++|++++..|.
T Consensus 92 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~ 171 (606)
T 3vq2_A 92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVN 171 (606)
T ss_dssp CCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTT
T ss_pred ccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChh
Confidence 998889999999999999999999998888899999999999999999986 5799999999999999999999998888
Q ss_pred cccCCCCcc----EEeccccccccccCCcccccccccceEEecCceec-ccCCccccCCCCCcEEecccccccCCCch--
Q 046598 225 SIFNISSIT----GFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLT-GAIPPTISNASNLEIFHGSVNKLTGAAPY-- 297 (986)
Q Consensus 225 ~l~~l~~L~----~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~-~~~p~~l~~l~~L~~L~ls~N~l~~~~~~-- 297 (986)
.+..+++|+ .|+++.|.+.+ +|...+.. .+|+.|++++|.++ +..|..+.++++|+.+++..+.+......
T Consensus 172 ~~~~l~~L~~~l~~L~l~~n~l~~-~~~~~~~~-~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~ 249 (606)
T 3vq2_A 172 DLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQG-IKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEI 249 (606)
T ss_dssp TTHHHHHCTTCCCEEECTTCCCCE-ECTTTTTT-CEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSC
T ss_pred hhhhhhccccccceeeccCCCcce-eCcccccC-ceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccc
Confidence 888887765 89999999984 45555533 48999999999997 56788999999999999887766542210
Q ss_pred --hhhhhhHhhhhhccCCCCCCCCCCcccccccccccccceeeccccccccCCCcccccccccceEEEccCCcccccCCc
Q 046598 298 --LEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPA 375 (986)
Q Consensus 298 --l~~l~~L~~l~l~~n~l~~~~~~~l~~l~~l~~~~~L~~l~l~~n~~~~~~p~~~~~~~~~L~~L~L~~n~l~~~~~~ 375 (986)
-..+..+..+.+....+...... ......+..+++|+.++++.|.+. .+| .+..+ ++|+.|++++|++ +.+|
T Consensus 250 ~~~~~~~~l~~l~l~~l~l~~~~~~-~~~~~~~~~l~~L~~L~l~~~~~~-~l~-~l~~~-~~L~~L~l~~n~l-~~lp- 323 (606)
T 3vq2_A 250 FEPSIMEGLCDVTIDEFRLTYTNDF-SDDIVKFHCLANVSAMSLAGVSIK-YLE-DVPKH-FKWQSLSIIRCQL-KQFP- 323 (606)
T ss_dssp CCGGGGTTGGGSEEEEEEECCCTTC-CGGGGSCGGGTTCSEEEEESCCCC-CCC-CCCTT-CCCSEEEEESCCC-SSCC-
T ss_pred cChHHhhhhhhccHhheeccccccc-cccccccccCCCCCEEEecCccch-hhh-hcccc-ccCCEEEcccccC-cccc-
Confidence 11122222222222211111100 112233778889999999999985 566 55554 6899999999999 5778
Q ss_pred cccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeec--Ccccccc-cccEEEecccccCCCCCcccCCCC
Q 046598 376 AIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNI--PPSIGNL-KLFILYLSYNFLQGSIPSSLGRYE 452 (986)
Q Consensus 376 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~~-~L~~L~L~~N~l~~~~p~~~~~l~ 452 (986)
.+ .+++|++|++++|...+.. .+..+++|++|++++|++++.. |..+... +|++|++++|.+++ +|..+..++
T Consensus 324 ~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~ 399 (606)
T 3vq2_A 324 TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLE 399 (606)
T ss_dssp CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCT
T ss_pred cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCC
Confidence 55 9999999999999665444 6789999999999999999773 6666544 69999999999995 678999999
Q ss_pred CCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccc-cCcccccCCccccEEe
Q 046598 453 TLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKG-EIPSTLGSCIKLEQLE 531 (986)
Q Consensus 453 ~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~ 531 (986)
+|+.|++++|++.+..|...+..+++|+.|++++|++++..|..+..+++|++|+|++|++++ .+|..|+.+++|++|+
T Consensus 400 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ 479 (606)
T 3vq2_A 400 ELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLD 479 (606)
T ss_dssp TCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEE
T ss_pred CCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEE
Confidence 999999999999977664568889999999999999999899999999999999999999997 4789999999999999
Q ss_pred cccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCccccccCCccccc-cccceeeeCCcccc
Q 046598 532 MQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQGVFK-NASITSVFGNLKLC 610 (986)
Q Consensus 532 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~~~~-~~~~~~~~~n~~lc 610 (986)
|++|++++.+|..|..+++|++|+|++|++++.+|..+..+++|++|+|++|+++..++....++ +++.+++.+||+.|
T Consensus 480 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c 559 (606)
T 3vq2_A 480 LSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVAC 559 (606)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCC
T ss_pred CCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCccc
Confidence 99999999999999999999999999999999999999999999999999999997766655665 58999999999999
Q ss_pred cCCC
Q 046598 611 GGIP 614 (986)
Q Consensus 611 g~~~ 614 (986)
+++.
T Consensus 560 ~c~~ 563 (606)
T 3vq2_A 560 ICEH 563 (606)
T ss_dssp SSTT
T ss_pred CCcc
Confidence 8753
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-53 Score=509.56 Aligned_cols=531 Identities=21% Similarity=0.197 Sum_probs=464.4
Q ss_pred EEeccCCCCccccCcCccCCCCCCEEEccCCCccccCCcchhccccCceeeceecccCCCCccchhcCccccceeccccc
Q 046598 66 ILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQ 145 (986)
Q Consensus 66 ~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 145 (986)
.+|.++.+++ .+|..+.. .+++|+|++|.+++..|.+|+++++|++|+|++|++++..|..|+++++|++|+|++|+
T Consensus 16 ~~~c~~~~l~-~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~ 92 (606)
T 3t6q_A 16 TYNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP 92 (606)
T ss_dssp EEECTTSCCS-SCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred eEECCCCCcc-cCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCc
Confidence 5778888887 67776654 78999999999999999999999999999999999999899999999999999999999
Q ss_pred ccCccCccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeeccCCcccCcCcchhhccCCCceeecccccccccCCcc
Q 046598 146 LVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSS 225 (986)
Q Consensus 146 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 225 (986)
+++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|++++..+..+..+++|++|+|++|++++..|..
T Consensus 93 l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 172 (606)
T 3t6q_A 93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKED 172 (606)
T ss_dssp CSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHH
T ss_pred ccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhh
Confidence 99889999999999999999999999887899999999999999999999755455556999999999999999888999
Q ss_pred ccCCCCcc--EEeccccccccccCCcccccccccceEEecCceecccCCccccCCCCCcEEecccccccCC-----C-ch
Q 046598 226 IFNISSIT--GFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGA-----A-PY 297 (986)
Q Consensus 226 l~~l~~L~--~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~-----~-~~ 297 (986)
+..+++|+ .|++++|.+.+..|..+ ...+|+.|++++|. ..+..+..+.++....+..+.+... . ..
T Consensus 173 ~~~l~~L~~l~L~l~~n~l~~~~~~~~--~~~~L~~L~l~~~~---~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~ 247 (606)
T 3t6q_A 173 MSSLQQATNLSLNLNGNDIAGIEPGAF--DSAVFQSLNFGGTQ---NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAV 247 (606)
T ss_dssp HHTTTTCCSEEEECTTCCCCEECTTTT--TTCEEEEEECTTCS---CHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGG
T ss_pred hhhhcccceeEEecCCCccCccChhHh--hhccccccccCCch---hHHHHhhhccccchhheechhhccccccccChhH
Confidence 99999999 89999999998776654 35789999999987 3345555666665555444333221 1 12
Q ss_pred hhhhh--hHhhhhhccCCCCCCCCCCcccccccccccccceeeccccccccCCCcccccccccceEEEccCCcccccCCc
Q 046598 298 LEKLQ--RLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPA 375 (986)
Q Consensus 298 l~~l~--~L~~l~l~~n~l~~~~~~~l~~l~~l~~~~~L~~l~l~~n~~~~~~p~~~~~~~~~L~~L~L~~n~l~~~~~~ 375 (986)
+..+. +++.+++.+|.+...... .+..+++|+.|+++.|.++ .+|..+..+ ++|++|++++|++.+..|.
T Consensus 248 ~~~l~~~~L~~L~l~~n~l~~~~~~------~~~~l~~L~~L~l~~n~l~-~lp~~l~~l-~~L~~L~l~~n~l~~~~~~ 319 (606)
T 3t6q_A 248 FEGLCEMSVESINLQKHYFFNISSN------TFHCFSGLQELDLTATHLS-ELPSGLVGL-STLKKLVLSANKFENLCQI 319 (606)
T ss_dssp GGGGGGSEEEEEECTTCCCSSCCTT------TTTTCTTCSEEECTTSCCS-CCCSSCCSC-TTCCEEECTTCCCSBGGGG
T ss_pred hchhhcCceeEEEeecCccCccCHH------HhccccCCCEEeccCCccC-CCChhhccc-ccCCEEECccCCcCcCchh
Confidence 33333 577788888877665543 3667889999999999998 789888776 6899999999999998899
Q ss_pred cccCCCCCCEEEccCccccCcCCC-cccCCCCCCEEEccCccceeec--Ccccccc-cccEEEecccccCCCCCcccCCC
Q 046598 376 AIGKFVNLQRLDMCSNRLSGTIPP-AIGELQNLKDLRLQRNRFQGNI--PPSIGNL-KLFILYLSYNFLQGSIPSSLGRY 451 (986)
Q Consensus 376 ~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~~-~L~~L~L~~N~l~~~~p~~~~~l 451 (986)
.+..+++|++|++++|.+.+.+|. .|..+++|++|++++|++++.. +..+..+ +|++|++++|.+.+..|..|..+
T Consensus 320 ~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 399 (606)
T 3t6q_A 320 SASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKEC 399 (606)
T ss_dssp CGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTC
T ss_pred hhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCC
Confidence 999999999999999999876665 5999999999999999999876 6666655 69999999999999999999999
Q ss_pred CCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCcccccc---CcccccCCcccc
Q 046598 452 ETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGE---IPSTLGSCIKLE 528 (986)
Q Consensus 452 ~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~ 528 (986)
++|++|++++|++++..|...+..+++|+.|++++|.+++..|..+..+++|++|+|++|++++. .+..+..+++|+
T Consensus 400 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~ 479 (606)
T 3t6q_A 400 PQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLE 479 (606)
T ss_dssp TTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCC
T ss_pred ccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCcc
Confidence 99999999999999777777788899999999999999988899999999999999999999873 346799999999
Q ss_pred EEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCccccccCCc-cccccccceeeeCCc
Q 046598 529 QLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQ-GVFKNASITSVFGNL 607 (986)
Q Consensus 529 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~ 607 (986)
+|+|++|++++.+|..|..+++|+.|+|++|++++..|+.+..++.| .|+|++|++++.+|.. ..++.++.+++.|||
T Consensus 480 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 558 (606)
T 3t6q_A 480 ILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNP 558 (606)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCC
T ss_pred EEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCC
Confidence 99999999999999999999999999999999999999999999999 9999999999988875 567888999999999
Q ss_pred ccccCC
Q 046598 608 KLCGGI 613 (986)
Q Consensus 608 ~lcg~~ 613 (986)
+.|.+.
T Consensus 559 ~~c~c~ 564 (606)
T 3t6q_A 559 LDCTCS 564 (606)
T ss_dssp EECSGG
T ss_pred ccccCC
Confidence 999754
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-52 Score=521.30 Aligned_cols=487 Identities=20% Similarity=0.203 Sum_probs=419.3
Q ss_pred CeEEEEeccCCCCcccc-CcCccCCCCCCEEEccCCCccccCCcchhccccCceeeceecccCCCCccc--hhcCccccc
Q 046598 62 QRVTILDLESLKLAGSI-SPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPAN--ISSCSNLIQ 138 (986)
Q Consensus 62 ~~v~~l~l~~~~l~~~~-~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~--~~~l~~L~~ 138 (986)
.+++.|||++|...+.+ |..|+++++|++|+|++|.+.+..|.+|+++++|++|+|++|.+++.+|.. |+++++|++
T Consensus 48 ~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~ 127 (844)
T 3j0a_A 48 EQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTR 127 (844)
T ss_dssp CSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCE
T ss_pred ccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCE
Confidence 46889999999887788 678999999999999999999999999999999999999999999877765 999999999
Q ss_pred eecccccccCccC-ccccCCCCCCeEEccCCcCCCCcccccCCC--cCcceeeccCCcccCcCcchhhccCC------Cc
Q 046598 139 LRLFHNQLVGKIP-SELSSLSKIEHISVNDNNLTGSIPSSLGNL--SSIRSLFLSGNNLEGSIPDTLGWLKN------LV 209 (986)
Q Consensus 139 L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~------L~ 209 (986)
|+|++|.+++..+ ..|+++++|++|+|++|.+++..+..|..+ ++|+.|+|++|.+.+..|..++.+.+ |+
T Consensus 128 L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~ 207 (844)
T 3j0a_A 128 LDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLE 207 (844)
T ss_dssp EEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBS
T ss_pred EECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCcee
Confidence 9999999998765 589999999999999999999999999888 89999999999999988888877766 99
Q ss_pred eeecccccccccCCccccCC---CCccEEecccccc---------ccccCCccccc--ccccceEEecCceecccCCccc
Q 046598 210 NLTMAQNRLSGTIPSSIFNI---SSITGFDAGVNKI---------QGAIPLDYGFS--LQNLQFFSVGENQLTGAIPPTI 275 (986)
Q Consensus 210 ~L~L~~N~l~~~~p~~l~~l---~~L~~L~l~~N~l---------~~~~p~~~~~~--l~~L~~L~L~~N~l~~~~p~~l 275 (986)
+|+|++|++++.+|..+... ++++.++++.+.. .+..+ ..+.+ .++|+.|++++|.+++..|..|
T Consensus 208 ~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~-~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~ 286 (844)
T 3j0a_A 208 ILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQ-NTFAGLARSSVRHLDLSHGFVFSLNSRVF 286 (844)
T ss_dssp EEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGG-TTTTTTTTSCCCEEECTTCCCCEECSCCS
T ss_pred EEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCCh-hhhhccccCCccEEECCCCcccccChhhh
Confidence 99999999999888887654 5678888774332 22111 12222 3789999999999999999999
Q ss_pred cCCCCCcEEecccccccCCCchhhhhhhHhhhhhccCCCCCCCCCCcccccccccccccceeeccccccccCCCcccccc
Q 046598 276 SNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNL 355 (986)
Q Consensus 276 ~~l~~L~~L~ls~N~l~~~~~~l~~l~~L~~l~l~~n~l~~~~~~~l~~l~~l~~~~~L~~l~l~~n~~~~~~p~~~~~~ 355 (986)
..+++|+.|++++|++++.++. .+..+++|+.|+++.|.+++..|..+..+
T Consensus 287 ~~l~~L~~L~L~~n~i~~~~~~-----------------------------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 337 (844)
T 3j0a_A 287 ETLKDLKVLNLAYNKINKIADE-----------------------------AFYGLDNLQVLNLSYNLLGELYSSNFYGL 337 (844)
T ss_dssp SSCCCCCEEEEESCCCCEECTT-----------------------------TTTTCSSCCEEEEESCCCSCCCSCSCSSC
T ss_pred hcCCCCCEEECCCCcCCCCChH-----------------------------HhcCCCCCCEEECCCCCCCccCHHHhcCC
Confidence 9999999999999999876542 34556778888899898887777777776
Q ss_pred cccceEEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCcccccccccEEEe
Q 046598 356 STTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYL 435 (986)
Q Consensus 356 ~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L 435 (986)
++|+.|++++|+|.+..+..|..+++|++|+|++|.+++. + .+++|+.|++++|+++. +|.. ..+++.|++
T Consensus 338 -~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-~----~~~~L~~L~l~~N~l~~-l~~~--~~~l~~L~l 408 (844)
T 3j0a_A 338 -PKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-H----FIPSIPDIFLSGNKLVT-LPKI--NLTANLIHL 408 (844)
T ss_dssp -TTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-S----SCCSCSEEEEESCCCCC-CCCC--CTTCCEEEC
T ss_pred -CCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-c----CCCCcchhccCCCCccc-cccc--ccccceeec
Confidence 6899999999999988899999999999999999999843 2 38899999999999994 4443 346899999
Q ss_pred cccccCCCCC-cccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCccc-----ccCCcccccccccchhhcc
Q 046598 436 SYNFLQGSIP-SSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLT-----GSIPSEVGNLKNLEILNVF 509 (986)
Q Consensus 436 ~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~Ls 509 (986)
++|++++... ..+..+++|+.|+|++|++++..+...+..+++|+.|+|++|.++ +..+..|.++++|+.|+|+
T Consensus 409 s~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls 488 (844)
T 3j0a_A 409 SENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLN 488 (844)
T ss_dssp CSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCC
T ss_pred ccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECC
Confidence 9999996532 235689999999999999996655555667899999999999997 3445678999999999999
Q ss_pred CccccccCcccccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCcccccc
Q 046598 510 GNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVV 589 (986)
Q Consensus 510 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~ 589 (986)
+|+|++..|..|..+++|+.|+|++|+|++..|..+. ++|+.|||++|+|++.+|..+ .+|+.|++++|++.|..
T Consensus 489 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~---~~L~~l~l~~Np~~C~c 563 (844)
T 3j0a_A 489 HNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVF---VSLSVLDITHNKFICEC 563 (844)
T ss_dssp HHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCC---SSCCEEEEEEECCCCSS
T ss_pred CCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHh---CCcCEEEecCCCccccc
Confidence 9999999999999999999999999999987777776 899999999999999999875 47889999999999987
Q ss_pred CCc
Q 046598 590 PTQ 592 (986)
Q Consensus 590 p~~ 592 (986)
+..
T Consensus 564 ~~~ 566 (844)
T 3j0a_A 564 ELS 566 (844)
T ss_dssp SCC
T ss_pred ccH
Confidence 643
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=493.63 Aligned_cols=512 Identities=20% Similarity=0.192 Sum_probs=389.6
Q ss_pred CeEEEEeccCCCCccccCcCccCCCCCCEEEccCCCccccCCcchhccccCceeeceecccCCCCccchhcCccccceec
Q 046598 62 QRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRL 141 (986)
Q Consensus 62 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 141 (986)
.+++.|||++|.+++..+.+|+++++|++|+|++|++++..|.+|+++++|++|+|++|++++..|..|+++++|++|++
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 46788888888888777778888888888888888888777788888888888888888888777788888888888888
Q ss_pred ccccccCccCccccCCCCCCeEEccCCcCCC-CcccccCCCcCcceeeccCCcccCcCcchhhccCCC----ceeecccc
Q 046598 142 FHNQLVGKIPSELSSLSKIEHISVNDNNLTG-SIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNL----VNLTMAQN 216 (986)
Q Consensus 142 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L----~~L~L~~N 216 (986)
++|++++..+..|+++++|++|++++|.+++ .+|..|+++++|++|++++|++++..|..|+.+++| +.|++++|
T Consensus 108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n 187 (570)
T 2z63_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (570)
T ss_dssp TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred cccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCC
Confidence 8888886666678888888888888888876 368888888888888888888887777788888888 78888888
Q ss_pred cccccCCccccCCCCccEEeccccccccccCCcccccccccceEEecCceec------ccCCccccCCCC--CcEEeccc
Q 046598 217 RLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLT------GAIPPTISNASN--LEIFHGSV 288 (986)
Q Consensus 217 ~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~------~~~p~~l~~l~~--L~~L~ls~ 288 (986)
.+++..|..+..+ +|+.|+++.|......-......+++++.+.+..+.+. ......+..+.+ ++.+++++
T Consensus 188 ~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~ 266 (570)
T 2z63_A 188 PMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266 (570)
T ss_dssp CCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEE
T ss_pred CceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhc
Confidence 8887666666555 78888888775432211112223444444444322211 111222333332 23344444
Q ss_pred c-cccCCCchhhhhhhHhhhhhccCCCCCCCCCCcccccccccccccceeeccccccccCCCcccccccccceEEEccCC
Q 046598 289 N-KLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNN 367 (986)
Q Consensus 289 N-~l~~~~~~l~~l~~L~~l~l~~n~l~~~~~~~l~~l~~l~~~~~L~~l~l~~n~~~~~~p~~~~~~~~~L~~L~L~~n 367 (986)
+ .+.+..+ ..+..+++|+.++++.|.+. .+|..+... +|+.|++++|
T Consensus 267 ~~~~~~~~~-----------------------------~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~--~L~~L~l~~n 314 (570)
T 2z63_A 267 LDYYLDDII-----------------------------DLFNCLTNVSSFSLVSVTIE-RVKDFSYNF--GWQHLELVNC 314 (570)
T ss_dssp TTEEESCST-----------------------------TTTGGGTTCSEEEEESCEEC-SCCBCCSCC--CCSEEEEESC
T ss_pred chhhhhhch-----------------------------hhhcCcCcccEEEecCccch-hhhhhhccC--CccEEeeccC
Confidence 4 3332221 12344556666666666665 466666665 7888888888
Q ss_pred cccccCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeec--Cccccc-ccccEEEecccccCCCC
Q 046598 368 QIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNI--PPSIGN-LKLFILYLSYNFLQGSI 444 (986)
Q Consensus 368 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~-~~L~~L~L~~N~l~~~~ 444 (986)
.+. .+|. ..+++|+.|++++|.+.+..+. ..+++|++|++++|++++.. +..+.. .+|++|++++|.+.+..
T Consensus 315 ~~~-~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~ 389 (570)
T 2z63_A 315 KFG-QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMS 389 (570)
T ss_dssp BCS-SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEE
T ss_pred ccc-ccCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccc
Confidence 888 4554 4788899999999988866655 77889999999999988654 444543 36999999999998655
Q ss_pred CcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCcccc-ccCcccccC
Q 046598 445 PSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLK-GEIPSTLGS 523 (986)
Q Consensus 445 p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~ 523 (986)
+. +..+++|++|++++|++++..|...+..+++|++|++++|++++..|..|..+++|++|+|++|+++ +.+|..+..
T Consensus 390 ~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~ 468 (570)
T 2z63_A 390 SN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468 (570)
T ss_dssp EE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTT
T ss_pred cc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhc
Confidence 54 9999999999999999997666566888999999999999999989999999999999999999998 578999999
Q ss_pred CccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCccccccCCcccc-cccc--c
Q 046598 524 CIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQGVF-KNAS--I 600 (986)
Q Consensus 524 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~~~-~~~~--~ 600 (986)
+++|++|+|++|++++..|..|..+++|+.|+|++|++++..|..+..+++|++|++++|+++|.+|....+ ..+. .
T Consensus 469 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~wl~~~~ 548 (570)
T 2z63_A 469 LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNS 548 (570)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTHHHHHHHHHTG
T ss_pred ccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchHHHHHHHHhcc
Confidence 999999999999999988999999999999999999999988889999999999999999999999876433 2221 1
Q ss_pred eeeeCCcccccCC
Q 046598 601 TSVFGNLKLCGGI 613 (986)
Q Consensus 601 ~~~~~n~~lcg~~ 613 (986)
..+.+.+ .|..+
T Consensus 549 ~~~~~~~-~C~~~ 560 (570)
T 2z63_A 549 QKEQGSA-KCSGS 560 (570)
T ss_dssp GGEESCC-BBTTT
T ss_pred ccCCCch-hhCCC
Confidence 2344444 66554
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-52 Score=494.73 Aligned_cols=493 Identities=20% Similarity=0.218 Sum_probs=359.1
Q ss_pred CCCcceeeEecCCCCeEEEEeccCCCCccccCcCccCCCCCCEEEccCCCccccCCcchhccccCceeeceecccCCCCc
Q 046598 48 HFCQWRGVTCSRRHQRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIP 127 (986)
Q Consensus 48 ~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 127 (986)
-.|.|.|| |+. ++++++ .+|+.+. +.|++|+|++|++++..|.+|.++++|++|+|++|++++..|
T Consensus 2 ~~C~~~~~-c~~----------~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~ 67 (549)
T 2z81_A 2 LSCDASGV-CDG----------RSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEG 67 (549)
T ss_dssp CEECTTSE-EEC----------TTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECT
T ss_pred ccCCCCce-EEC----------CCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccCh
Confidence 35999998 854 445555 5666554 678888888888887778888888888888888888887777
Q ss_pred cchhcCccccceecccccccCccCccccCCCCCCeEEccCCcCCCC-cccccCCCcCcceeeccCCcccCcC-cchhhcc
Q 046598 128 ANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGS-IPSSLGNLSSIRSLFLSGNNLEGSI-PDTLGWL 205 (986)
Q Consensus 128 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l 205 (986)
+.|+.+++|++|+|++|++++..|..|+++++|++|+|++|++++. .|..|+++++|++|++++|++.+.+ +..|..+
T Consensus 68 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l 147 (549)
T 2z81_A 68 DAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGL 147 (549)
T ss_dssp TTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTC
T ss_pred hhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcc
Confidence 7888888888888888888877777788888888888888888753 5667888888888888888743344 4678888
Q ss_pred CCCceeecccccccccCCccccCCCCccEEeccccccccccCCcccccccccceEEecCceecccC--C-ccccCCCCCc
Q 046598 206 KNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAI--P-PTISNASNLE 282 (986)
Q Consensus 206 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~--p-~~l~~l~~L~ 282 (986)
++|++|+|++|++++.+|..+.++++|+.|+++.|.+. .+|..++..+++|++|++++|++++.. | .....+++|+
T Consensus 148 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~ 226 (549)
T 2z81_A 148 TSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMK 226 (549)
T ss_dssp CEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCC
T ss_pred cccCeeeccCCcccccChhhhhccccCceEecccCccc-ccchhhHhhcccccEEEccCCccccccccccchhhhhhccc
Confidence 88888888888888888888888888888888888775 455555556788888888888887642 1 2334577888
Q ss_pred EEecccccccCCCchhhhhhhHhhhhhccCCCCCCCCCCcccccccccccccceeeccccccccCC--Cc---ccccccc
Q 046598 283 IFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSL--PA---CISNLST 357 (986)
Q Consensus 283 ~L~ls~N~l~~~~~~l~~l~~L~~l~l~~n~l~~~~~~~l~~l~~l~~~~~L~~l~l~~n~~~~~~--p~---~~~~~~~ 357 (986)
.|++++|.+++..+. .+ ...+..+.+|+.++++.|.+.+.. +. .......
T Consensus 227 ~L~l~~n~l~~~~~~--~l-----------------------~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~ 281 (549)
T 2z81_A 227 KLAFRGSVLTDESFN--EL-----------------------LKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELG 281 (549)
T ss_dssp EEEEESCEEEHHHHH--HH-----------------------HGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCT
T ss_pred ceeccccccchhHHH--HH-----------------------HHHhhhhccccccccccccccccccccccchhhhhhhc
Confidence 888888877643210 00 011223344455555555544311 00 0011124
Q ss_pred cceEEEccCCccccc-----CCccccCCCCCCEEEccCccccCcCCCcc-cCCCCCCEEEccCccceeecCc---cccc-
Q 046598 358 TLEVLLLDNNQIFGN-----IPAAIGKFVNLQRLDMCSNRLSGTIPPAI-GELQNLKDLRLQRNRFQGNIPP---SIGN- 427 (986)
Q Consensus 358 ~L~~L~L~~n~l~~~-----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~---~~~~- 427 (986)
+++.|.+.++.+... ++..+..+.+|+.|++++|.++ .+|..+ ..+++|++|+|++|++++.+|. .+..
T Consensus 282 ~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l 360 (549)
T 2z81_A 282 KVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAW 360 (549)
T ss_dssp TCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSS
T ss_pred ccccccccccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhcc
Confidence 566677766665421 1222344567888888888887 566555 5688888888888888876543 2333
Q ss_pred ccccEEEecccccCCCCC--cccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccch
Q 046598 428 LKLFILYLSYNFLQGSIP--SSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEI 505 (986)
Q Consensus 428 ~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 505 (986)
.+|++|+|++|++++..+ ..+..+++|++|++++|+++ .+|.. +..+++|++|++++|+|+ .+|..+. ++|+.
T Consensus 361 ~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~-~~~~~~L~~L~Ls~N~l~-~l~~~~~--~~L~~ 435 (549)
T 2z81_A 361 PSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDS-CQWPEKMRFLNLSSTGIR-VVKTCIP--QTLEV 435 (549)
T ss_dssp TTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSC-CCCCTTCCEEECTTSCCS-CCCTTSC--TTCSE
T ss_pred ccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChh-hcccccccEEECCCCCcc-cccchhc--CCceE
Confidence 358888888888875432 45788899999999999998 78876 567788999999999988 4555443 68999
Q ss_pred hhccCccccccCcccccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCcc
Q 046598 506 LNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDL 585 (986)
Q Consensus 506 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l 585 (986)
|+|++|+|++.+ ..+++|++|+|++|+|+ .+|. ...+++|+.|+|++|+|++.+|..+..+++|++|++++|++
T Consensus 436 L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~ 509 (549)
T 2z81_A 436 LDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509 (549)
T ss_dssp EECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCB
T ss_pred EECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCc
Confidence 999999998642 57889999999999998 5676 56789999999999999998888899999999999999999
Q ss_pred ccccCCc
Q 046598 586 EGVVPTQ 592 (986)
Q Consensus 586 ~~~~p~~ 592 (986)
+|.+|..
T Consensus 510 ~~~~~~~ 516 (549)
T 2z81_A 510 DCSCPRI 516 (549)
T ss_dssp CCCHHHH
T ss_pred cCCCccH
Confidence 9988853
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=486.72 Aligned_cols=513 Identities=21% Similarity=0.214 Sum_probs=433.5
Q ss_pred EeccCCCCccccCcCccCCCCCCEEEccCCCccccCCcchhccccCceeeceecccCCCCccchhcCccccceecccccc
Q 046598 67 LDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQL 146 (986)
Q Consensus 67 l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 146 (986)
++.++.+++ .+|..+. +.+++|+|++|++++..+.+|.++++|++|+|++|++++..|..|+++++|++|+|++|.+
T Consensus 12 ~~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l 88 (570)
T 2z63_A 12 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88 (570)
T ss_dssp EECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred EEeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcC
Confidence 444455555 5666553 5799999999999998899999999999999999999988888999999999999999999
Q ss_pred cCccCccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeeccCCcccC-cCcchhhccCCCceeecccccccccCCcc
Q 046598 147 VGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEG-SIPDTLGWLKNLVNLTMAQNRLSGTIPSS 225 (986)
Q Consensus 147 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 225 (986)
++..|.+|+++++|++|++++|++++..+..|+++++|++|+|++|.+++ .+|..|+.+++|++|++++|++++..|..
T Consensus 89 ~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~ 168 (570)
T 2z63_A 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168 (570)
T ss_dssp CEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGG
T ss_pred CccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHH
Confidence 98888999999999999999999997777689999999999999999986 47999999999999999999999888888
Q ss_pred ccCCCCc----cEEeccccccccccCCcccccccccceEEecCceec-ccCCccccCCCCCcEEecccccccCCCchhhh
Q 046598 226 IFNISSI----TGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLT-GAIPPTISNASNLEIFHGSVNKLTGAAPYLEK 300 (986)
Q Consensus 226 l~~l~~L----~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~-~~~p~~l~~l~~L~~L~ls~N~l~~~~~~l~~ 300 (986)
+..+.+| +.++++.|.+.+..|..+. ..+|+.|++++|... ..++..+..+++++...+..+.+.....
T Consensus 169 ~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~---- 242 (570)
T 2z63_A 169 LRVLHQMPLLNLSLDLSLNPMNFIQPGAFK--EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN---- 242 (570)
T ss_dssp GHHHHTCTTCCCEEECTTCCCCEECTTTTT--TCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSS----
T ss_pred ccchhccchhhhhcccCCCCceecCHHHhc--cCcceeEecccccccccchhhhhcCccccceeeeccccccCchh----
Confidence 9888888 8999999999866554433 337999999988544 2356677788888877766554432111
Q ss_pred hhhHhhhhhccCCCCCCCCCCcccccccccccccceeecccc-ccccCCCcccccccccceEEEccCCcccccCCccccC
Q 046598 301 LQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININ-NFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGK 379 (986)
Q Consensus 301 l~~L~~l~l~~n~l~~~~~~~l~~l~~l~~~~~L~~l~l~~n-~~~~~~p~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~ 379 (986)
+.......+. .+.++ .++.+++..+ .+.+.+|..+..+ ++|+.|++++|.++ .+|..+..
T Consensus 243 -------------l~~~~~~~~~---~l~~l-~l~~l~l~~~~~~~~~~~~~~~~l-~~L~~L~l~~~~l~-~l~~~~~~ 303 (570)
T 2z63_A 243 -------------LEKFDKSALE---GLCNL-TIEEFRLAYLDYYLDDIIDLFNCL-TNVSSFSLVSVTIE-RVKDFSYN 303 (570)
T ss_dssp -------------CEECCTTTTG---GGGGS-EEEEEEEEETTEEESCSTTTTGGG-TTCSEEEEESCEEC-SCCBCCSC
T ss_pred -------------hhhcchhhhc---ccccc-chhhhhhhcchhhhhhchhhhcCc-CcccEEEecCccch-hhhhhhcc
Confidence 0111111111 22222 3567777777 7778888887766 68999999999998 58888888
Q ss_pred CCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCcccccccccEEEecccccCCCC--CcccCCCCCCCee
Q 046598 380 FVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSI--PSSLGRYETLTTI 457 (986)
Q Consensus 380 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L 457 (986)
+ +|++|++++|.++ .+|. ..+++|+.|++++|.+.+..+. ....+|++|++++|.+++.. |..+..+++|++|
T Consensus 304 ~-~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~~~-~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L 378 (570)
T 2z63_A 304 F-GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAFSE-VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYL 378 (570)
T ss_dssp C-CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCBCCC-CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEE
T ss_pred C-CccEEeeccCccc-ccCc--ccccccCEEeCcCCcccccccc-ccCCCCCEEeCcCCccCccccccccccccCccCEE
Confidence 8 9999999999998 5665 5789999999999999877665 34457999999999998665 7788999999999
Q ss_pred ecCCCccCCCCCcccccCCCcceEEEccCCcccccCC-cccccccccchhhccCccccccCcccccCCccccEEeccccc
Q 046598 458 DLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIP-SEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENF 536 (986)
Q Consensus 458 ~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 536 (986)
++++|+++ .+|.. +..+++|+.|++++|++++..| ..+..+++|++|++++|++++..|..|.++++|++|+|++|.
T Consensus 379 ~l~~n~l~-~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 456 (570)
T 2z63_A 379 DLSFNGVI-TMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNS 456 (570)
T ss_dssp ECCSCSEE-EEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCE
T ss_pred ECCCCccc-ccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCc
Confidence 99999998 56666 7888999999999999997666 578999999999999999999999999999999999999999
Q ss_pred cc-ccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCccccccCCc-cccccccceeeeCCcccccCCC
Q 046598 537 LQ-GPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQ-GVFKNASITSVFGNLKLCGGIP 614 (986)
Q Consensus 537 l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~~lcg~~~ 614 (986)
++ +.+|..+..+++|+.|+|++|++++..|..+..+++|++|++++|++++.+|.. ..++.++.+.+.+|++.|.++.
T Consensus 457 l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 536 (570)
T 2z63_A 457 FQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536 (570)
T ss_dssp EGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred CccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence 98 579999999999999999999999999999999999999999999999998864 6678899999999999987653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=440.56 Aligned_cols=252 Identities=30% Similarity=0.469 Sum_probs=193.5
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc--CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
.++|.+.++||+|+||+||+|++.. .||||+++.. .....++|.+|++++++++|||||+++++|. ++.
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~------~~~ 105 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT------KDN 105 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE------CCe
Confidence 3567889999999999999998764 5999998743 2344678999999999999999999999863 245
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.++|||||++|+|.++++. ....+++.++..|+.|||+||+|||++ +||||||||+|||+++++.+||
T Consensus 106 ~~iVmEy~~gGsL~~~l~~---------~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki 173 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHV---------QETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKI 173 (307)
T ss_dssp CEEEEECCSSCBHHHHHHT---------SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEE
T ss_pred EEEEEEcCCCCCHHHHHhh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEE
Confidence 7999999999999999962 234699999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCccccccccccccccccccccC---CCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHh
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG---SEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLART 921 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~ 921 (986)
+|||+|+..............+||+.|||||++.+ ++|+.++|||||||++|||+||+.||....... ........
T Consensus 174 ~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~-~~~~~~~~ 252 (307)
T 3omv_A 174 GDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD-QIIFMVGR 252 (307)
T ss_dssp CCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHHHT
T ss_pred eeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH-HHHHHHhc
Confidence 99999987654433444455789999999999864 468999999999999999999999996432111 11111111
Q ss_pred hCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 922 ALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 922 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
....+ .+. .....++.++.+++.+||+.||++||||+||
T Consensus 253 ~~~~p-------~~~-------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei 291 (307)
T 3omv_A 253 GYASP-------DLS-------------------KLYKNCPKAMKRLVADCVKKVKEERPLFPQI 291 (307)
T ss_dssp TCCCC-------CST-------------------TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHH
T ss_pred CCCCC-------Ccc-------------------cccccchHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 10000 000 0011345678899999999999999999764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=443.65 Aligned_cols=259 Identities=25% Similarity=0.419 Sum_probs=205.3
Q ss_pred cCCCCCcccccccceeEEEEEECC-----CCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDD-----GRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
++|.+.++||+|+||+||+|++.. +++.||||+++.......++|.+|++++++++|||||+++|+| .++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~-----~~~ 87 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVC-----VEG 87 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEE-----eeC
Confidence 568889999999999999999753 4788999999877666778899999999999999999999995 345
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCC---ccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCC
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITRED---ETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED 839 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~---~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 839 (986)
+..++|||||++|+|.++++...... ........+++.+++.|+.||++||+|||++ +||||||||+|||++++
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN 164 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCC
Confidence 78999999999999999997543110 0112345799999999999999999999999 99999999999999999
Q ss_pred CcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHH
Q 046598 840 MIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNL 918 (986)
Q Consensus 840 ~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~ 918 (986)
+.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||..... .+.
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~-----~~~ 239 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-----NEV 239 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----HHH
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----HHH
Confidence 9999999999987654444344445679999999999999999999999999999999999 9999974321 111
Q ss_pred HHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 919 ARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 919 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.. .+........ +..++.++.+++.+||+.||++||||+||
T Consensus 240 ~~--------~i~~~~~~~~-------------------p~~~~~~~~~li~~cl~~dP~~RPs~~~i 280 (299)
T 4asz_A 240 IE--------CITQGRVLQR-------------------PRTCPQEVYELMLGCWQREPHMRKNIKGI 280 (299)
T ss_dssp HH--------HHHHTCCCCC-------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HH--------HHHcCCCCCC-------------------CccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence 11 0001000000 11345678899999999999999999764
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-51 Score=436.59 Aligned_cols=248 Identities=22% Similarity=0.303 Sum_probs=207.1
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
++|++.+.||+|+||+||+|++..+++.||||+++.. .....+.+.+|++++++++|||||+++++ +++++.
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~-----~~~~~~ 106 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT-----FQDDEK 106 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEE-----EECSSE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEE-----EEeCCE
Confidence 5799999999999999999999999999999999742 23445789999999999999999999999 567789
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.|+||||++||+|.++++. .+.+++.+++.|+.||+.||+|||++ +|+||||||+|||++.++.+||
T Consensus 107 ~yivmEy~~gG~L~~~i~~----------~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl 173 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRK----------IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQI 173 (311)
T ss_dssp EEEEECCCTTEEHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEE
T ss_pred EEEEEecCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEE
Confidence 9999999999999999952 34689999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCC
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALP 924 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 924 (986)
+|||+|+.+............+||+.|||||++.+..|+.++||||+||++|||+||+.||..... .....
T Consensus 174 ~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----~~~~~---- 244 (311)
T 4aw0_A 174 TDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-----GLIFA---- 244 (311)
T ss_dssp CCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH----
T ss_pred EEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHH----
Confidence 999999987655444455567899999999999999999999999999999999999999963211 11111
Q ss_pred CchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 925 DHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 925 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..+...+. . +...+.++.+++.+|++.||++|||++|+
T Consensus 245 --------~i~~~~~~-~---------------p~~~s~~~~dli~~lL~~dp~~R~t~~e~ 282 (311)
T 4aw0_A 245 --------KIIKLEYD-F---------------PEKFFPKARDLVEKLLVLDATKRLGCEEM 282 (311)
T ss_dssp --------HHHHTCCC-C---------------CTTCCHHHHHHHHHHSCSSGGGSTTSGGG
T ss_pred --------HHHcCCCC-C---------------CcccCHHHHHHHHHHccCCHhHCcChHHH
Confidence 11111100 0 00123456789999999999999999873
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=444.03 Aligned_cols=259 Identities=25% Similarity=0.405 Sum_probs=198.3
Q ss_pred cCCCCCcccccccceeEEEEEECC-----CCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDD-----GRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
++|.+.++||+|+||+||+|++.. +++.||||+++.......++|.+|++++++++|||||+++|+| .++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~-----~~~ 115 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVC-----TEG 115 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EEC
Confidence 457778899999999999999753 4789999999877667778899999999999999999999995 345
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCc-----cccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEec
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDE-----TDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLD 837 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~-----~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 837 (986)
+..|+|||||++|+|.++++....... ......++++.+++.|+.|||+||+|||++ +||||||||+|||++
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVG 192 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEEC
Confidence 789999999999999999975543211 112345799999999999999999999999 999999999999999
Q ss_pred CCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHH
Q 046598 838 EDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLH 916 (986)
Q Consensus 838 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~ 916 (986)
+++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||..... .
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~-----~ 267 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-----T 267 (329)
T ss_dssp TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH-----H
T ss_pred CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH-----H
Confidence 999999999999987654444444455679999999999999999999999999999999999 9999964321 1
Q ss_pred HHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 917 NLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 917 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.... .+.. .. +.+.+..++.++.+++.+||+.||++||||+||
T Consensus 268 ~~~~---------~i~~---g~---------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei 310 (329)
T 4aoj_A 268 EAID---------CITQ---GR---------------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDV 310 (329)
T ss_dssp HHHH---------HHHH---TC---------------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHH
T ss_pred HHHH---------HHHc---CC---------------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHH
Confidence 1111 0000 00 000111345678899999999999999999874
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=472.11 Aligned_cols=458 Identities=20% Similarity=0.220 Sum_probs=374.3
Q ss_pred EEEeccCCCCccccCcCccCCCCCCEEEccCCCccccCCcchhccccCceeeceecccCCCCccchhcCccccceecccc
Q 046598 65 TILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHN 144 (986)
Q Consensus 65 ~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 144 (986)
..+|+++|+++ .+|..+. ++|++|+|++|++++..|.+|.++++|++|+|++|++++..|..|+++++|++|+|++|
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 46899999999 6888776 89999999999999888899999999999999999999888999999999999999999
Q ss_pred cccCccCccccCCCCCCeEEccCCcCCC-CcccccCCCcCcceeeccCCcccCcCcchhhccCCC--ceeecccccc--c
Q 046598 145 QLVGKIPSELSSLSKIEHISVNDNNLTG-SIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNL--VNLTMAQNRL--S 219 (986)
Q Consensus 145 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L--~~L~L~~N~l--~ 219 (986)
+++ .+|.. .+++|++|+|++|++++ .+|..|+++++|++|+|++|++++ ..|..+++| ++|+|++|++ .
T Consensus 80 ~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~ 153 (520)
T 2z7x_B 80 KLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGE 153 (520)
T ss_dssp CCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTS
T ss_pred cee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeeccccccc
Confidence 999 67766 89999999999999997 478999999999999999999985 467888888 9999999999 8
Q ss_pred ccCCccccCCC-CccEEeccccccccccCCcccccccccceEEecCce-------ecccCCccccCCCCCcEEecccccc
Q 046598 220 GTIPSSIFNIS-SITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQ-------LTGAIPPTISNASNLEIFHGSVNKL 291 (986)
Q Consensus 220 ~~~p~~l~~l~-~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~-------l~~~~p~~l~~l~~L~~L~ls~N~l 291 (986)
+..|..+..+. +...++++.|.+.+.++...+..+++|+.|++++|. +.+.+| .++.+++|+.|++++|.+
T Consensus 154 ~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l 232 (520)
T 2z7x_B 154 KEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIET 232 (520)
T ss_dssp SCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEE
T ss_pred ccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhcccccccc
Confidence 88899888876 355678899999988888888889999999999997 777666 788899999999888887
Q ss_pred cCCCchhhhhhhHhhhhhccCCCCCCCCCCcccccccccccccceeeccccccccCCCcccccccccceEEEccCCcccc
Q 046598 292 TGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFG 371 (986)
Q Consensus 292 ~~~~~~l~~l~~L~~l~l~~n~l~~~~~~~l~~l~~l~~~~~L~~l~l~~n~~~~~~p~~~~~~~~~L~~L~L~~n~l~~ 371 (986)
++... ..+ +.... ..+|+.|++++|++++
T Consensus 233 ~~~~~--~~~-----------------------------------------------~~~~~--~~~L~~L~l~~n~l~~ 261 (520)
T 2z7x_B 233 TWNSF--IRI-----------------------------------------------LQLVW--HTTVWYFSISNVKLQG 261 (520)
T ss_dssp EHHHH--HHH-----------------------------------------------HHHHH--TSSCSEEEEEEEEEES
T ss_pred CHHHH--HHH-----------------------------------------------HHHhh--hCcccEEEeecccccC
Confidence 63210 000 00000 1245666666666666
Q ss_pred cCCccc-----cCCCCCCEEEccCccccCcCC-CcccCC---CCCCEEEccCccceeecCcccccccccEEEecccccCC
Q 046598 372 NIPAAI-----GKFVNLQRLDMCSNRLSGTIP-PAIGEL---QNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQG 442 (986)
Q Consensus 372 ~~~~~~-----~~l~~L~~L~L~~N~l~~~~~-~~~~~l---~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~ 442 (986)
.+|..+ ..+++|+.+++++|.+ .+| ..+..+ .+|+.|++++|.+..... .-...+|++|++++|++++
T Consensus 262 ~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~Ls~n~l~~ 338 (520)
T 2z7x_B 262 QLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHMLC-PSKISPFLHLDFSNNLLTD 338 (520)
T ss_dssp CCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCCC-CSSCCCCCEEECCSSCCCT
T ss_pred ccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCccccccc-hhhCCcccEEEeECCccCh
Confidence 666666 7777888888888877 344 445444 668888888887764321 0123358888888888888
Q ss_pred CCCcccCCCCCCCeeecCCCccCC--CCCcccccCCCcceEEEccCCcccccCCc-ccccccccchhhccCccccccCcc
Q 046598 443 SIPSSLGRYETLTTIDLSNNNLTG--TIPPQFIGLSSSLIVLDLSRNQLTGSIPS-EVGNLKNLEILNVFGNKLKGEIPS 519 (986)
Q Consensus 443 ~~p~~~~~l~~L~~L~L~~N~l~~--~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~ 519 (986)
.+|..++.+++|++|++++|++++ .+|.. ++.+++|++|++++|++++.+|. .+..+++|+.|+|++|++++.+|.
T Consensus 339 ~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 417 (520)
T 2z7x_B 339 TVFENCGHLTELETLILQMNQLKELSKIAEM-TTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFR 417 (520)
T ss_dssp TTTTTCCCCSSCCEEECCSSCCCBHHHHHHH-HTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGG
T ss_pred hhhhhhccCCCCCEEEccCCccCccccchHH-HhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhh
Confidence 888889999999999999999984 33344 67788999999999999975665 488889999999999999888877
Q ss_pred cccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCch-hhhcccccceeeccCCccccccCC
Q 046598 520 TLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPE-LLIRLQLVKNLNLSNNDLEGVVPT 591 (986)
Q Consensus 520 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~l~ls~N~l~~~~p~ 591 (986)
.+. ++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++ +|. .+..+++|++|++++|+++|..+.
T Consensus 418 ~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~c~~ 486 (520)
T 2z7x_B 418 CLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCSCPR 486 (520)
T ss_dssp SCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred hhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCc-cCHHHhccCCcccEEECcCCCCcccCCc
Confidence 665 78999999999999 788888899999999999999995 555 488999999999999999987764
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=475.39 Aligned_cols=557 Identities=21% Similarity=0.184 Sum_probs=391.4
Q ss_pred CCcCCCCCCCCCCCCCcceeeEecCCCCeEEEEeccCCCCccccCcCccCCCCCCEEEccCCCccccCCcchhccccCce
Q 046598 35 DPLGVLASWNESSHFCQWRGVTCSRRHQRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQV 114 (986)
Q Consensus 35 ~~~~~l~~w~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 114 (986)
|+...+++|+.+ -+..|....|..... .+|-++.+++ .+|+.+- +.+++|||++|+|+++.|.+|.++++|++
T Consensus 8 ~~~~~~~~~~~~-~p~~~~~c~~~~~~~---~~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~ 80 (635)
T 4g8a_A 8 DDDDKLAAANSS-IPESWEPCVEVVPNI---TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQV 80 (635)
T ss_dssp ------------------CCSEEEETTT---EEECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred CCcchhhcccCC-CCCCCCCccccCCCC---EEECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCE
Confidence 334456777543 234565555543322 2344555565 5665442 46788888888888777788888888888
Q ss_pred eeceecccCCCCccchhcCccccceecccccccCccCccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeeccCCcc
Q 046598 115 LALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNL 194 (986)
Q Consensus 115 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 194 (986)
|+|++|+|++..|++|.++++|++|+|++|+|++..+.+|.++++|++|+|++|++++..+..|+++++|++|+|++|.+
T Consensus 81 L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l 160 (635)
T 4g8a_A 81 LDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 160 (635)
T ss_dssp EECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCC
T ss_pred EECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCcc
Confidence 88888888877777888888888888888888866667788888888888888888877777788888888888888888
Q ss_pred cC-cCcchhhccCCCceeecccccccccCCccccCCCCc----cEEeccccccccccCCcccccccccceEEecCceecc
Q 046598 195 EG-SIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSI----TGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTG 269 (986)
Q Consensus 195 ~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L----~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~ 269 (986)
++ ..|..++.+++|++|+|++|++++..|..+..+.++ ..++++.|.+... +...+ ....++.+++.+|....
T Consensus 161 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i-~~~~~-~~~~~~~l~l~~n~~~~ 238 (635)
T 4g8a_A 161 QSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFI-QPGAF-KEIRLHKLTLRNNFDSL 238 (635)
T ss_dssp CCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEE-CTTTT-TTCEEEEEEEESCCSSH
T ss_pred ccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCccccc-Ccccc-cchhhhhhhhhcccccc
Confidence 65 357778888888888888888887777777665543 3677888887643 33333 24456777887776553
Q ss_pred -cCCccccCCCCCcEEecccccccCCC-------chhhhhhhHhhhhhccCCCCCCCCCCcccccccccccccceeeccc
Q 046598 270 -AIPPTISNASNLEIFHGSVNKLTGAA-------PYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLINI 341 (986)
Q Consensus 270 -~~p~~l~~l~~L~~L~ls~N~l~~~~-------~~l~~l~~L~~l~l~~n~l~~~~~~~l~~l~~l~~~~~L~~l~l~~ 341 (986)
..+..+..+..++...+..+...... ..+..+..+....+..+....... .....+.....+..+.+..
T Consensus 239 ~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~---~~~~~~~~~~~l~~l~~~~ 315 (635)
T 4g8a_A 239 NVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLD---GIIDLFNCLTNVSSFSLVS 315 (635)
T ss_dssp HHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEE---ECTTTTGGGTTCSEEEEES
T ss_pred cccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhccccc---chhhhhhhhcccccccccc
Confidence 33445677777777766544432211 122333333333322222111110 1112334455666666666
Q ss_pred cccccCCCcccccccccceEEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeec
Q 046598 342 NNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNI 421 (986)
Q Consensus 342 n~~~~~~p~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 421 (986)
+.+....+ +. ....++.|++.+|.+....+ ..+..|+.++++.|.+... ..+..+++|+.|++++|.+....
T Consensus 316 ~~~~~~~~--~~-~~~~L~~L~l~~~~~~~~~~---~~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~ 387 (635)
T 4g8a_A 316 VTIERVKD--FS-YNFGWQHLELVNCKFGQFPT---LKLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKG 387 (635)
T ss_dssp CEEEECGG--GG-SCCCCSEEEEESCEESSCCC---CBCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEE
T ss_pred cccccccc--cc-cchhhhhhhcccccccCcCc---ccchhhhhcccccccCCCC--cccccccccccchhhcccccccc
Confidence 66654322 11 22467888888888875544 3466788888888887633 34557889999999999886433
Q ss_pred --Cccc-ccccccEEEecccccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccc
Q 046598 422 --PPSI-GNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVG 498 (986)
Q Consensus 422 --~~~~-~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~ 498 (986)
+..+ ...+|++++++.|.+.. .+..+..+++|+.+++++|++....+...+..+.+++.++++.|.+++..+..+.
T Consensus 388 ~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~ 466 (635)
T 4g8a_A 388 CCSQSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN 466 (635)
T ss_dssp ECCHHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTT
T ss_pred ccccchhhhhhhhhhhcccccccc-ccccccccccccchhhhhccccccccccccccccccccccccccccccccccccc
Confidence 3222 34468899999998874 5667888899999999988888777777788888999999999999988888888
Q ss_pred cccccchhhccCcccc-ccCcccccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccce
Q 046598 499 NLKNLEILNVFGNKLK-GEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKN 577 (986)
Q Consensus 499 ~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 577 (986)
.++.|+.|+|++|++. +..|..|..+++|++|+|++|+|++.+|..|.++++|++|+|++|+|++..|..|..+++|++
T Consensus 467 ~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~ 546 (635)
T 4g8a_A 467 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQV 546 (635)
T ss_dssp TCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCE
T ss_pred cchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCE
Confidence 8999999999999754 457788999999999999999999888899999999999999999999888888999999999
Q ss_pred eeccCCccccccCCc-ccc-ccccceeeeCCcccccC
Q 046598 578 LNLSNNDLEGVVPTQ-GVF-KNASITSVFGNLKLCGG 612 (986)
Q Consensus 578 l~ls~N~l~~~~p~~-~~~-~~~~~~~~~~n~~lcg~ 612 (986)
|+|++|+|++.+|.. ..+ ++++.+++.+||+.|+|
T Consensus 547 L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C 583 (635)
T 4g8a_A 547 LDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC 583 (635)
T ss_dssp EECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSG
T ss_pred EECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccC
Confidence 999999999988875 333 56888899999999975
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=439.36 Aligned_cols=248 Identities=22% Similarity=0.289 Sum_probs=205.3
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 767 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 767 (986)
+.|++.++||+|+||+||+|++..+++.||||+++.......+.+.+|++++++++|||||+++++ +.+++..|+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~-----~~~~~~~~i 148 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-----YLVGDELWV 148 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEE-----EEETTEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEE-----EEECCEEEE
Confidence 569999999999999999999999999999999987666666788999999999999999999999 455688999
Q ss_pred EEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccc
Q 046598 768 VFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDF 847 (986)
Q Consensus 768 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DF 847 (986)
|||||+||+|.+++.. ..+++.+++.|+.||+.||+|||++ +||||||||+|||++.++.+||+||
T Consensus 149 vmEy~~gg~L~~~l~~-----------~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DF 214 (346)
T 4fih_A 149 VMEFLEGGALTDIVTH-----------TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDF 214 (346)
T ss_dssp EECCCTTEEHHHHHHH-----------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCC
T ss_pred EEeCCCCCcHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecC
Confidence 9999999999999851 3589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCch
Q 046598 848 GLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHV 927 (986)
Q Consensus 848 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 927 (986)
|+|+.+.... ......+||+.|||||++.+..|+.++||||+||++|||++|+.||...... .....+....+..
T Consensus 215 Gla~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~~~~i~~~~~~~- 289 (346)
T 4fih_A 215 GFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRDNLPPR- 289 (346)
T ss_dssp TTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSSCCC-
T ss_pred cCceecCCCC--CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHHHHcCCCCC-
Confidence 9998764332 2334578999999999999999999999999999999999999999632111 1111111111100
Q ss_pred hHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 928 MDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 928 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.. .....+.++.+++.+||+.||++|||++|+
T Consensus 290 -----------~~----------------~~~~~s~~~~dli~~~L~~dP~~R~ta~e~ 321 (346)
T 4fih_A 290 -----------LK----------------NLHKVSPSLKGFLDRLLVRDPAQRATAAEL 321 (346)
T ss_dssp -----------CS----------------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred -----------CC----------------ccccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 00 001234567799999999999999998764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-51 Score=443.70 Aligned_cols=250 Identities=22% Similarity=0.334 Sum_probs=198.4
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc--CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
.++|++++.||+|+||+||+|++..+++.||||+++.. .....+.+.+|++++++++|||||+++++ +.+++.
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~-----~~~~~~ 97 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES-----FEENGS 97 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEE-----EEETTE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEE-----EEECCE
Confidence 36899999999999999999999999999999999753 33446789999999999999999999999 456688
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.|+|||||+||+|.+++... ....+++.+++.|+.||+.||+|||++ +||||||||+|||++.++.+||
T Consensus 98 ~yiVmEy~~gg~L~~~i~~~--------~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl 166 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINAQ--------KGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQL 166 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHT--------TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEE
T ss_pred EEEEEeCCCCCcHHHHHHHc--------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEE
Confidence 99999999999999999632 234578999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCC
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALP 924 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 924 (986)
+|||+|+.... ........+||+.|||||++.+..|+.++||||+||++|||+||+.||.... .......
T Consensus 167 ~DFGla~~~~~--~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-----~~~~~~~--- 236 (350)
T 4b9d_A 167 GDFGIARVLNS--TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS-----MKNLVLK--- 236 (350)
T ss_dssp CSTTEESCCCH--HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHH---
T ss_pred cccccceeecC--CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-----HHHHHHH---
Confidence 99999986532 1223345679999999999999999999999999999999999999996321 1111111
Q ss_pred CchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 925 DHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 925 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+........+ ...+.++.+++.+||+.||++|||++|+
T Consensus 237 -----i~~~~~~~~~-------------------~~~s~~~~~li~~~L~~dP~~R~s~~e~ 274 (350)
T 4b9d_A 237 -----IISGSFPPVS-------------------LHYSYDLRSLVSQLFKRNPRDRPSVNSI 274 (350)
T ss_dssp -----HHHTCCCCCC-------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -----HHcCCCCCCC-------------------ccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 1110000000 1234457799999999999999998763
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=438.18 Aligned_cols=259 Identities=20% Similarity=0.330 Sum_probs=203.8
Q ss_pred cCCCCCcccccccceeEEEEEEC-----CCCeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCC
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILD-----DGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 761 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 761 (986)
.++++.++||+|+||+||+|++. .+++.||||+++... ....++|.+|+.++++++|||||+++|+|. .
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-----~ 100 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT-----K 100 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEE-----E
Confidence 34667889999999999999974 346889999996432 334578999999999999999999999963 4
Q ss_pred CceEEEEEEeccCCCHhHhhccCCCCCc------cccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeE
Q 046598 762 NDFKALVFEFMHNRSLEEWLHPITREDE------TDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNIL 835 (986)
Q Consensus 762 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIl 835 (986)
++..++|||||++|+|.++++....... .......+++.++..|+.|||+||+|||++ +||||||||+|||
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NIL 177 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVL 177 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceE
Confidence 5778999999999999999965432211 112345799999999999999999999999 9999999999999
Q ss_pred ecCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCcccccccc
Q 046598 836 LDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMN 914 (986)
Q Consensus 836 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~ 914 (986)
+++++.+||+|||+|+.....+.........||+.|||||++.++.|+.++|||||||++|||+| |+.||.....
T Consensus 178 l~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---- 253 (308)
T 4gt4_A 178 VYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---- 253 (308)
T ss_dssp ECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH----
T ss_pred ECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH----
Confidence 99999999999999987654443444455679999999999999999999999999999999999 8999974321
Q ss_pred HHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 915 LHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 915 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..... .+.... +.+.+.+++.++.+++.+||+.||++||||+||
T Consensus 254 -~~~~~---------~i~~~~------------------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei 297 (308)
T 4gt4_A 254 -QDVVE---------MIRNRQ------------------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDI 297 (308)
T ss_dssp -HHHHH---------HHHTTC------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -HHHHH---------HHHcCC------------------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence 11111 111000 000112456678899999999999999999874
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-50 Score=481.69 Aligned_cols=453 Identities=18% Similarity=0.257 Sum_probs=387.7
Q ss_pred CCCCEEEccCCCccccCCcchhccccCceeeceeccc------CC------CCccchhcCccccceecccccccCccCcc
Q 046598 86 SFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSI------GG------AIPANISSCSNLIQLRLFHNQLVGKIPSE 153 (986)
Q Consensus 86 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l------~~------~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 153 (986)
.+++.|+|++|++.|.+|.+|++|++|++|+|++|.+ .+ .+|... +..|+ +++++|.+.+.+|..
T Consensus 81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~ 157 (636)
T 4eco_A 81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPRED 157 (636)
T ss_dssp CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGG
T ss_pred CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhh
Confidence 4678999999999999999999999999999999987 33 455544 67788 999999999988887
Q ss_pred ccC-CCCCCeEEccCCcCCCCcccccCCCcCcceeecc--CCcccCcCcchhhccCCCceeeccccccccc---------
Q 046598 154 LSS-LSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLS--GNNLEGSIPDTLGWLKNLVNLTMAQNRLSGT--------- 221 (986)
Q Consensus 154 ~~~-l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~--~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--------- 221 (986)
+.. +..+..+++....+.. .....++.+++. .|++++ +|..|+.+++|++|+|++|++++.
T Consensus 158 ~~~~~~~l~~~~l~~~~~~~------~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~ 230 (636)
T 4eco_A 158 FSDLIKDCINSDPQQKSIKK------SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENE 230 (636)
T ss_dssp SCHHHHHHHHHCTTSCCCCC------CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCT
T ss_pred HHHHHHHHhhcCcccccccc------ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCcccccccccccccc
Confidence 763 3445555555444431 222345555554 689998 899999999999999999999986
Q ss_pred --------CCcccc--CCCCccEEeccccccccccCCcccccccccceEEecCce-ecc-cCCccccCC------CCCcE
Q 046598 222 --------IPSSIF--NISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQ-LTG-AIPPTISNA------SNLEI 283 (986)
Q Consensus 222 --------~p~~l~--~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~-l~~-~~p~~l~~l------~~L~~ 283 (986)
+|..++ ++++|++|++++|.+.+.+|..+. ++++|++|++++|+ ++| .+|..++.+ ++|+.
T Consensus 231 ~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~ 309 (636)
T 4eco_A 231 NSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLK-ALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQI 309 (636)
T ss_dssp TSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTT-TCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCE
T ss_pred ccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHh-cCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCE
Confidence 999999 999999999999999999997665 79999999999998 998 889888776 77777
Q ss_pred EecccccccCCCchhhhhhhHhhhhhccCCCCCCCCCCcccccccccccccceeeccccccccCCCc--ccccccccceE
Q 046598 284 FHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPA--CISNLSTTLEV 361 (986)
Q Consensus 284 L~ls~N~l~~~~~~l~~l~~L~~l~l~~n~l~~~~~~~l~~l~~l~~~~~L~~l~l~~n~~~~~~p~--~~~~~~~~L~~ 361 (986)
|++++|+++. +|. .+..+ ++|+.
T Consensus 310 L~L~~n~l~~------------------------------------------------------ip~~~~l~~l-~~L~~ 334 (636)
T 4eco_A 310 IYIGYNNLKT------------------------------------------------------FPVETSLQKM-KKLGM 334 (636)
T ss_dssp EECCSSCCSS------------------------------------------------------CCCHHHHTTC-TTCCE
T ss_pred EECCCCcCCc------------------------------------------------------cCchhhhccC-CCCCE
Confidence 7777777663 343 33333 57899
Q ss_pred EEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCCC-CCEEEccCccceeecCcccccc---cccEEEecc
Q 046598 362 LLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQN-LKDLRLQRNRFQGNIPPSIGNL---KLFILYLSY 437 (986)
Q Consensus 362 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~~~~~~~~---~L~~L~L~~ 437 (986)
|++++|+++|.+| .|..+++|++|++++|+++ .+|..|..+++ |++|++++|+++ .+|..+... +|++|++++
T Consensus 335 L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~ 411 (636)
T 4eco_A 335 LECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSY 411 (636)
T ss_dssp EECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCS
T ss_pred EeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcC
Confidence 9999999999999 9999999999999999999 88999999999 999999999999 778777654 599999999
Q ss_pred cccCCCCCcccC-------CCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCccccc--------ccc
Q 046598 438 NFLQGSIPSSLG-------RYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGN--------LKN 502 (986)
Q Consensus 438 N~l~~~~p~~~~-------~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~--------l~~ 502 (986)
|.+++.+|..|. .+++|++|+|++|+++ .+|..++..+++|+.|+|++|+|+ .+|..+.. +++
T Consensus 412 N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~ 489 (636)
T 4eco_A 412 NEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQIS-KFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYL 489 (636)
T ss_dssp SCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCC-SCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGG
T ss_pred CcCCCcchhhhcccccccccCCCCCEEECcCCccC-cCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCC
Confidence 999999999998 8889999999999999 889887888899999999999999 56654433 239
Q ss_pred cchhhccCccccccCccccc--CCccccEEecccccccccCCccccCCCCCCEEeC------CCccCcccCchhhhcccc
Q 046598 503 LEILNVFGNKLKGEIPSTLG--SCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDL------SQNNLSGKIPELLIRLQL 574 (986)
Q Consensus 503 L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L------s~N~l~~~~p~~~~~l~~ 574 (986)
|+.|+|++|+++ .+|..+. .+++|++|+|++|+|++ +|..+..+++|+.|+| ++|++.+.+|..+..+++
T Consensus 490 L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~ 567 (636)
T 4eco_A 490 LTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPS 567 (636)
T ss_dssp CCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSS
T ss_pred ccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCC
Confidence 999999999999 7888887 99999999999999997 8999999999999999 568899999999999999
Q ss_pred cceeeccCCccccccCCccccccccceeeeCCcccccCC
Q 046598 575 VKNLNLSNNDLEGVVPTQGVFKNASITSVFGNLKLCGGI 613 (986)
Q Consensus 575 L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lcg~~ 613 (986)
|++|+|++|++ +.+|.. .++.++.+.+.+|+..|-..
T Consensus 568 L~~L~Ls~N~l-~~ip~~-~~~~L~~L~Ls~N~l~~~~~ 604 (636)
T 4eco_A 568 LTQLQIGSNDI-RKVNEK-ITPNISVLDIKDNPNISIDL 604 (636)
T ss_dssp CCEEECCSSCC-CBCCSC-CCTTCCEEECCSCTTCEEEC
T ss_pred CCEEECCCCcC-CccCHh-HhCcCCEEECcCCCCccccH
Confidence 99999999999 556654 34789999999999888543
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=484.19 Aligned_cols=461 Identities=19% Similarity=0.263 Sum_probs=333.4
Q ss_pred CCCCEEEccCCCccccCCcchhccccCceeec-eecccCCCCccchhcC----c-----cccceec-------ccccccC
Q 046598 86 SFLKVLRLYNNSFNHEIPSEFDRLRRLQVLAL-HYNSIGGAIPANISSC----S-----NLIQLRL-------FHNQLVG 148 (986)
Q Consensus 86 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L-~~N~l~~~~p~~~~~l----~-----~L~~L~L-------s~N~l~~ 148 (986)
.+++.|+|++|++.|.+|++|++|++|++|+| ++|.++|..|..-... . .++..++ ....+.+
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 56889999999999999999999999999999 9999887744321111 0 0000000 0000000
Q ss_pred -----------ccCccccCCCCCCeEEccC--CcCCCCcccccCCCcCcceeeccCCcccC-----------------cC
Q 046598 149 -----------KIPSELSSLSKIEHISVND--NNLTGSIPSSLGNLSSIRSLFLSGNNLEG-----------------SI 198 (986)
Q Consensus 149 -----------~~p~~~~~l~~L~~L~L~~--N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-----------------~~ 198 (986)
..+........++.+.+.. |++++ +|..|+++++|++|+|++|+|++ .+
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~i 481 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE 481 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccC
Confidence 0011111222333333333 55554 55556666666666666666655 36
Q ss_pred cchhh--ccCCCceeecccccccccCCccccCCCCccEEeccccc-ccc-ccCCccc------ccccccceEEecCceec
Q 046598 199 PDTLG--WLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNK-IQG-AIPLDYG------FSLQNLQFFSVGENQLT 268 (986)
Q Consensus 199 p~~~~--~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~-l~~-~~p~~~~------~~l~~L~~L~L~~N~l~ 268 (986)
|+.++ .+++|++|+|++|++.+.+|..++++++|+.|++++|+ +++ .+|..+. ..+++|+.|+|++|+++
T Consensus 482 P~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~ 561 (876)
T 4ecn_A 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE 561 (876)
T ss_dssp TSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC
T ss_pred ChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC
Confidence 66655 67777777777777666777777777777777777776 666 5665432 23458999999999998
Q ss_pred ccCCc--cccCCCCCcEEecccccccCCCchhhhhhhHhhhhhccCCCCCCCCCCcccccccccccccceeecccccccc
Q 046598 269 GAIPP--TISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGG 346 (986)
Q Consensus 269 ~~~p~--~l~~l~~L~~L~ls~N~l~~~~~~l~~l~~L~~l~l~~n~l~~~~~~~l~~l~~l~~~~~L~~l~l~~n~~~~ 346 (986)
.+|. .++++++|+.|++++|+++.++ .
T Consensus 562 -~ip~~~~l~~L~~L~~L~Ls~N~l~~lp-~------------------------------------------------- 590 (876)
T 4ecn_A 562 -EFPASASLQKMVKLGLLDCVHNKVRHLE-A------------------------------------------------- 590 (876)
T ss_dssp -BCCCHHHHTTCTTCCEEECTTSCCCBCC-C-------------------------------------------------
T ss_pred -ccCChhhhhcCCCCCEEECCCCCcccch-h-------------------------------------------------
Confidence 7888 8999999999999888877322 1
Q ss_pred CCCcccccccccceEEEccCCcccccCCccccCCCC-CCEEEccCccccCcCCCcccCCCC--CCEEEccCccceeecCc
Q 046598 347 SLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVN-LQRLDMCSNRLSGTIPPAIGELQN--LKDLRLQRNRFQGNIPP 423 (986)
Q Consensus 347 ~~p~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~--L~~L~Ls~N~l~~~~~~ 423 (986)
+..+ ++|+.|+|++|+++ .+|..+..+++ |+.|+|++|.++ .+|..+..++. |+.|+|++|++.+.+|.
T Consensus 591 -----~~~L-~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~ 662 (876)
T 4ecn_A 591 -----FGTN-VKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRN 662 (876)
T ss_dssp -----CCTT-SEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSS
T ss_pred -----hcCC-CcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCcccc
Confidence 1111 45677777777777 67777777777 888888888887 67777766654 88888888888776654
Q ss_pred cc------ccccccEEEecccccCCCCCcc-cCCCCCCCeeecCCCccCCCCCcccccCC-------CcceEEEccCCcc
Q 046598 424 SI------GNLKLFILYLSYNFLQGSIPSS-LGRYETLTTIDLSNNNLTGTIPPQFIGLS-------SSLIVLDLSRNQL 489 (986)
Q Consensus 424 ~~------~~~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~ip~~~~~~~-------~~L~~L~Ls~N~l 489 (986)
.. ...+|+.|+|++|.++ .+|.. +..+++|+.|+|++|+|+ .+|...+... ++|+.|+|++|+|
T Consensus 663 l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L 740 (876)
T 4ecn_A 663 ISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKL 740 (876)
T ss_dssp CSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCC
T ss_pred chhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCC
Confidence 33 2336899999999999 55555 458999999999999999 8898866544 3899999999999
Q ss_pred cccCCcccc--cccccchhhccCccccccCcccccCCccccEEeccc------ccccccCCccccCCCCCCEEeCCCccC
Q 046598 490 TGSIPSEVG--NLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQE------NFLQGPIPSSLSSLRGLSVLDLSQNNL 561 (986)
Q Consensus 490 ~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~------N~l~~~~p~~~~~l~~L~~L~Ls~N~l 561 (986)
+ .+|..+. .+++|+.|+|++|+|++ +|..+..+++|+.|+|++ |++.+.+|..|..+++|+.|+|++|+|
T Consensus 741 ~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L 818 (876)
T 4ecn_A 741 T-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI 818 (876)
T ss_dssp C-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC
T ss_pred c-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC
Confidence 9 7888887 99999999999999996 899999999999999976 889999999999999999999999999
Q ss_pred cccCchhhhcccccceeeccCCccccccCCc-cccccccceeeeCCcccc--cCC
Q 046598 562 SGKIPELLIRLQLVKNLNLSNNDLEGVVPTQ-GVFKNASITSVFGNLKLC--GGI 613 (986)
Q Consensus 562 ~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~~lc--g~~ 613 (986)
+.+|..+. ++|+.|+|++|++....+.. ..........+.+|+..| ||+
T Consensus 819 -~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~~I~gC~ 870 (876)
T 4ecn_A 819 -RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCD 870 (876)
T ss_dssp -CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTSEEESCG
T ss_pred -CccCHhhc--CCCCEEECCCCCCCccChHHccccccchheeecCCCccccCCCC
Confidence 68888866 69999999999998876654 112233456677776543 553
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-50 Score=427.67 Aligned_cols=251 Identities=25% Similarity=0.369 Sum_probs=196.4
Q ss_pred CC-CCCcccccccceeEEEEEECCCCeEEEEEEeecc--CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 689 RF-SSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 689 ~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
+| ++.++||+|+||+||+|.+..+++.||+|++... .....+++.+|++++++++|||||+++++|... ...+...
T Consensus 26 r~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~-~~~~~~~ 104 (290)
T 3fpq_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCI 104 (290)
T ss_dssp SEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE-ETTEEEE
T ss_pred ceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeec-cCCCcEE
Confidence 44 5667899999999999999999999999999643 334457799999999999999999999986432 2345678
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEec-CCCcEEE
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLD-EDMIAHI 844 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kL 844 (986)
|+|||||+||+|.++++. .+.+++.+++.|+.||+.||+|||++ .++||||||||+|||++ .++.+||
T Consensus 105 ~lvmEy~~gg~L~~~l~~----------~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl 173 (290)
T 3fpq_A 105 VLVTELMTSGTLKTYLKR----------FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKI 173 (290)
T ss_dssp EEEEECCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEE
T ss_pred EEEEeCCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEE
Confidence 999999999999999952 34689999999999999999999998 12299999999999998 4789999
Q ss_pred cccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCC
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALP 924 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 924 (986)
+|||+|+.... ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||.... ...........
T Consensus 174 ~DFGla~~~~~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~----~~~~~~~~i~~ 244 (290)
T 3fpq_A 174 GDLGLATLKRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ----NAAQIYRRVTS 244 (290)
T ss_dssp CCTTGGGGCCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS----SHHHHHHHHTT
T ss_pred EeCcCCEeCCC----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC----cHHHHHHHHHc
Confidence 99999986432 22334679999999999875 69999999999999999999999996321 11111111111
Q ss_pred CchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 925 DHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 925 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
... +.. .....+.++.+++.+||+.||++|||++|+
T Consensus 245 ~~~-----------~~~---------------~~~~~~~~~~~li~~~L~~dP~~R~s~~e~ 280 (290)
T 3fpq_A 245 GVK-----------PAS---------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDL 280 (290)
T ss_dssp TCC-----------CGG---------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CCC-----------CCC---------------CCccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 000 000 000122357789999999999999998764
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=471.55 Aligned_cols=523 Identities=20% Similarity=0.172 Sum_probs=431.4
Q ss_pred eeeEecCC---------CCeEEEEeccCCCCccccCcCccCCCCCCEEEccCCCccccCCcchhccccCceeeceecccC
Q 046598 53 RGVTCSRR---------HQRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIG 123 (986)
Q Consensus 53 ~gv~c~~~---------~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~ 123 (986)
..|.|... +..++.|||++|+|++..+.+|.++++|++|+|++|+|+++.|.+|.++++|++|+|++|+|+
T Consensus 34 ~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~ 113 (635)
T 4g8a_A 34 ITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 113 (635)
T ss_dssp TEEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred CEEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCC
Confidence 35778753 246899999999999777789999999999999999999988999999999999999999999
Q ss_pred CCCccchhcCccccceecccccccCccCccccCCCCCCeEEccCCcCCC-CcccccCCCcCcceeeccCCcccCcCcchh
Q 046598 124 GAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTG-SIPSSLGNLSSIRSLFLSGNNLEGSIPDTL 202 (986)
Q Consensus 124 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 202 (986)
+..|..|.++++|++|+|++|++++..+..|+++++|++|+|++|++++ ..|..++++++|++|+|++|+|++..+..|
T Consensus 114 ~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l 193 (635)
T 4g8a_A 114 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL 193 (635)
T ss_dssp EECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGG
T ss_pred CCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccc
Confidence 8778889999999999999999998888889999999999999999986 468889999999999999999999889999
Q ss_pred hccCCCc----eeecccccccccCCccccCCCCccEEeccccccccccCCcccccccccceEEecCce------ecccCC
Q 046598 203 GWLKNLV----NLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQ------LTGAIP 272 (986)
Q Consensus 203 ~~l~~L~----~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~------l~~~~p 272 (986)
..+.+++ .++++.|.++. ++........+..+++..|.....++...+.++..++...+..+. +.....
T Consensus 194 ~~L~~l~~~~~~~~ls~n~l~~-i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~ 272 (635)
T 4g8a_A 194 RVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDK 272 (635)
T ss_dssp HHHHTCTTCCCEEECTTCCCCE-ECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCT
T ss_pred cchhhhhhhhhhhhcccCcccc-cCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccc
Confidence 8887655 68899999985 455555556788899999887766666666667777777665443 333344
Q ss_pred ccccCCCCCcEEeccccccc----CCCchhhhhhhHhhhhhccCCCCCCCCCCcccccccccccccceeeccccccccCC
Q 046598 273 PTISNASNLEIFHGSVNKLT----GAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSL 348 (986)
Q Consensus 273 ~~l~~l~~L~~L~ls~N~l~----~~~~~l~~l~~L~~l~l~~n~l~~~~~~~l~~l~~l~~~~~L~~l~l~~n~~~~~~ 348 (986)
..+..+..+....+..+... +....+..+..+..+.+..+.+.. +..+.....++.+++..|.+.+..
T Consensus 273 ~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~--------~~~~~~~~~L~~L~l~~~~~~~~~ 344 (635)
T 4g8a_A 273 SALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIER--------VKDFSYNFGWQHLELVNCKFGQFP 344 (635)
T ss_dssp TTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEE--------CGGGGSCCCCSEEEEESCEESSCC
T ss_pred cccccccchhhhhhhhhhhcccccchhhhhhhhccccccccccccccc--------ccccccchhhhhhhcccccccCcC
Confidence 55666667777766655443 333445556666666666665432 234555677888999999887544
Q ss_pred CcccccccccceEEEccCCcccccCCccccCCCCCCEEEccCcccc--CcCCCcccCCCCCCEEEccCccceeecCcccc
Q 046598 349 PACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLS--GTIPPAIGELQNLKDLRLQRNRFQGNIPPSIG 426 (986)
Q Consensus 349 p~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 426 (986)
+..+ ..++.+.+.+|.+... .....+++|+.|++++|.+. +..+..+..+.+|+.|+++.|.+....+....
T Consensus 345 ~~~l----~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~ 418 (635)
T 4g8a_A 345 TLKL----KSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLG 418 (635)
T ss_dssp CCBC----TTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTT
T ss_pred cccc----hhhhhcccccccCCCC--cccccccccccchhhccccccccccccchhhhhhhhhhhccccccccccccccc
Confidence 4332 4678899999987643 34568999999999999986 34566778899999999999999876665555
Q ss_pred cccccEEEecccccCCCCC-cccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCccc-ccCCcccccccccc
Q 046598 427 NLKLFILYLSYNFLQGSIP-SSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLT-GSIPSEVGNLKNLE 504 (986)
Q Consensus 427 ~~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~ 504 (986)
..+|+.++++.|+.....+ ..|..+++++.+++++|++.+..+ ..+..++.|+.|++++|++. +..|..|..+++|+
T Consensus 419 l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~-~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~ 497 (635)
T 4g8a_A 419 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN-GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT 497 (635)
T ss_dssp CTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCT-TTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCC
T ss_pred cccccchhhhhccccccccccccccccccccccccccccccccc-cccccchhhhhhhhhhcccccccCchhhhhccccC
Confidence 6679999999888776654 468889999999999999995544 44788899999999999854 45788999999999
Q ss_pred hhhccCccccccCcccccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcc-cccceeeccCC
Q 046598 505 ILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRL-QLVKNLNLSNN 583 (986)
Q Consensus 505 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~l~ls~N 583 (986)
+|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|||++|+|++..|..+..+ ++|++|+|++|
T Consensus 498 ~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~N 577 (635)
T 4g8a_A 498 FLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 577 (635)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTC
T ss_pred EEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999998 68999999999
Q ss_pred ccccccCC
Q 046598 584 DLEGVVPT 591 (986)
Q Consensus 584 ~l~~~~p~ 591 (986)
+++|....
T Consensus 578 p~~C~C~~ 585 (635)
T 4g8a_A 578 DFACTCEH 585 (635)
T ss_dssp CBCCSGGG
T ss_pred CCcccCCc
Confidence 99997654
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=470.44 Aligned_cols=481 Identities=19% Similarity=0.193 Sum_probs=399.2
Q ss_pred CCcceeeEecCC--CCeEEEEeccCCCCccccCcCccCCCCCCEEEccCCCccccCCcchhccccCceeeceecccCCCC
Q 046598 49 FCQWRGVTCSRR--HQRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAI 126 (986)
Q Consensus 49 ~c~w~gv~c~~~--~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 126 (986)
-|++.+++.-+. ..+++.|||++|++++..|..|+++++|++|+|++|++++..|.+|+++++|++|+|++|++++..
T Consensus 11 ~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~ 90 (549)
T 2z81_A 11 DGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLS 90 (549)
T ss_dssp ECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCC
T ss_pred ECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccC
Confidence 356777665442 357999999999999888999999999999999999999999999999999999999999999888
Q ss_pred ccchhcCccccceecccccccC-ccCccccCCCCCCeEEccCCcCCCCcc-cccCCCcCcceeeccCCcccCcCcchhhc
Q 046598 127 PANISSCSNLIQLRLFHNQLVG-KIPSELSSLSKIEHISVNDNNLTGSIP-SSLGNLSSIRSLFLSGNNLEGSIPDTLGW 204 (986)
Q Consensus 127 p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 204 (986)
|..|+.+++|++|+|++|.+++ .+|..|+++++|++|++++|.+.+.+| ..|+++++|++|++++|++++..|..++.
T Consensus 91 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~ 170 (549)
T 2z81_A 91 SSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKS 170 (549)
T ss_dssp HHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTT
T ss_pred HHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhc
Confidence 8889999999999999999997 367889999999999999999555555 68999999999999999999999999999
Q ss_pred cCCCceeecccccccccCCccc-cCCCCccEEecccccccccc--CCcccccccccceEEecCceecccCC----ccccC
Q 046598 205 LKNLVNLTMAQNRLSGTIPSSI-FNISSITGFDAGVNKIQGAI--PLDYGFSLQNLQFFSVGENQLTGAIP----PTISN 277 (986)
Q Consensus 205 l~~L~~L~L~~N~l~~~~p~~l-~~l~~L~~L~l~~N~l~~~~--p~~~~~~l~~L~~L~L~~N~l~~~~p----~~l~~ 277 (986)
+++|++|++++|.+. .+|..+ ..+++|+.|++++|.+.+.. |......+++|+.|++++|++++..+ ..+..
T Consensus 171 l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~ 249 (549)
T 2z81_A 171 IRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRY 249 (549)
T ss_dssp CSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGG
T ss_pred cccCceEecccCccc-ccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhh
Confidence 999999999999987 455544 57899999999999998742 33444567899999999999987554 34577
Q ss_pred CCCCcEEecccccccCCCchhhhhhhHhhhhhccCCCCCCCCCCcccccccccccccceeeccccccccC-----CCccc
Q 046598 278 ASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGS-----LPACI 352 (986)
Q Consensus 278 l~~L~~L~ls~N~l~~~~~~l~~l~~L~~l~l~~n~l~~~~~~~l~~l~~l~~~~~L~~l~l~~n~~~~~-----~p~~~ 352 (986)
+++|+.+++++|.+.+....- ... ...+..+.+++.+.+..+.+... ++. +
T Consensus 250 ~~~L~~l~l~~~~~~~~~~~~--------------------~~~---~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~-~ 305 (549)
T 2z81_A 250 ILELSEVEFDDCTLNGLGDFN--------------------PSE---SDVVSELGKVETVTIRRLHIPQFYLFYDLST-V 305 (549)
T ss_dssp CTTCCEEEEESCEEECCSCCC--------------------CCT---TTCCCCCTTCCEEEEESCBCSCGGGSCCCCH-H
T ss_pred hcccccccccccccccccccc--------------------ccc---hhhhhhhcccccccccccccchhhhcccchh-h
Confidence 899999999999988754210 000 11233445556666665544321 111 1
Q ss_pred ccccccceEEEccCCcccccCCccc-cCCCCCCEEEccCccccCcCC---CcccCCCCCCEEEccCccceeecC--cccc
Q 046598 353 SNLSTTLEVLLLDNNQIFGNIPAAI-GKFVNLQRLDMCSNRLSGTIP---PAIGELQNLKDLRLQRNRFQGNIP--PSIG 426 (986)
Q Consensus 353 ~~~~~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~Ls~N~l~~~~~--~~~~ 426 (986)
.....+|+.|++++|++. .+|..+ ..+++|++|++++|++++..| ..++.+++|++|+|++|++++..+ ..+.
T Consensus 306 ~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~ 384 (549)
T 2z81_A 306 YSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILL 384 (549)
T ss_dssp HHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGG
T ss_pred hhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhh
Confidence 233467899999999998 566655 679999999999999997664 457889999999999999986543 3454
Q ss_pred cc-cccEEEecccccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccch
Q 046598 427 NL-KLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEI 505 (986)
Q Consensus 427 ~~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 505 (986)
.+ +|++|++++|+++ .+|..+..+++|++|++++|+++ .+|..+ .++|++|+|++|+|++. +..+++|++
T Consensus 385 ~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~---~~~L~~L~Ls~N~l~~~----~~~l~~L~~ 455 (549)
T 2z81_A 385 TLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI---PQTLEVLDVSNNNLDSF----SLFLPRLQE 455 (549)
T ss_dssp GCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTS---CTTCSEEECCSSCCSCC----CCCCTTCCE
T ss_pred cCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchh---cCCceEEECCCCChhhh----cccCChhcE
Confidence 44 6999999999999 68889999999999999999998 677653 36899999999999964 257899999
Q ss_pred hhccCccccccCcccccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCc
Q 046598 506 LNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIP 566 (986)
Q Consensus 506 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 566 (986)
|+|++|+|+ .+|. ...+++|++|+|++|+|++.+|..+..+++|+.|+|++|++++..|
T Consensus 456 L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 456 LYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp EECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred EECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 999999999 6776 5789999999999999999999999999999999999999998776
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=432.64 Aligned_cols=247 Identities=21% Similarity=0.248 Sum_probs=197.1
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
.+.|++.++||+|+||+||+|+++.+++.||||+++.... ..+|+.++++++|||||+++++ +.+++..|
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~-----~~~~~~~~ 126 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGA-----VREGPWVN 126 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEE-----EEETTEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEE-----EEECCEEE
Confidence 3568888999999999999999999999999999975322 2469999999999999999999 45568899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCC-cEEEc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDM-IAHIG 845 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~ 845 (986)
+|||||+||+|.++++. .+.+++.+++.|+.||+.||+|||++ +||||||||+|||++.++ ++||+
T Consensus 127 ivmEy~~gg~L~~~l~~----------~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~ 193 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQ----------MGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALC 193 (336)
T ss_dssp EEECCCTTCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEEC
T ss_pred EEEeccCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEe
Confidence 99999999999999952 34699999999999999999999999 999999999999999988 69999
Q ss_pred ccccceecCCCCCc---cccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 046598 846 DFGLARFLPLSSAQ---TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 846 DFG~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 922 (986)
|||+|+.+...... ......+||+.|||||++.+..|+.++||||+||++|||+||+.||........ ........
T Consensus 194 DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~i~~~~ 272 (336)
T 4g3f_A 194 DFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-CLKIASEP 272 (336)
T ss_dssp CCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC-HHHHHHSC
T ss_pred eCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHHcCC
Confidence 99999877543221 122345799999999999999999999999999999999999999974333221 11111100
Q ss_pred CCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 923 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.... ..+..++.++.+++.+||+.||++|||++||
T Consensus 273 --~~~~---------------------------~~~~~~s~~~~~li~~~L~~dP~~R~sa~el 307 (336)
T 4g3f_A 273 --PPIR---------------------------EIPPSCAPLTAQAIQEGLRKEPVHRASAMEL 307 (336)
T ss_dssp --CGGG---------------------------GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred --CCch---------------------------hcCccCCHHHHHHHHHHccCCHhHCcCHHHH
Confidence 0000 0011234567899999999999999998763
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-49 Score=440.61 Aligned_cols=249 Identities=22% Similarity=0.296 Sum_probs=205.7
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
.+.|++.++||+|+||.||+|++..+++.||||+++.......+.+.+|+.+|++++|||||+++++ +.+++..|
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~-----~~~~~~~~ 224 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-----YLVGDELW 224 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEE-----EEETTEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEE-----EEECCEEE
Confidence 3569999999999999999999999999999999987666667789999999999999999999999 45568899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+|||||+||+|.++++. ..+++.++..|+.||+.||+|||++ +||||||||+|||++.+|.+||+|
T Consensus 225 iVmEy~~gG~L~~~i~~-----------~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~D 290 (423)
T 4fie_A 225 VVMEFLEGGALTDIVTH-----------TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSD 290 (423)
T ss_dssp EEEECCTTEEHHHHHHH-----------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECC
T ss_pred EEEeCCCCCcHHHHHhc-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEec
Confidence 99999999999999851 3589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCc
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDH 926 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 926 (986)
||+|+.+.... ......+||+.|||||++.+..|+.++|||||||++|||++|+.||...... .....+....+..
T Consensus 291 FGla~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~~~~i~~~~~~~ 366 (423)
T 4fie_A 291 FGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRDNLPPR 366 (423)
T ss_dssp CTTCEECCSSC--CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSCCCC
T ss_pred CccceECCCCC--ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHHHHcCCCCC
Confidence 99998764332 2334578999999999999999999999999999999999999999632111 1111111111100
Q ss_pred hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 927 VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 927 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
. . .....+.++.+++.+||+.||++|||++|+
T Consensus 367 ~------------~----------------~~~~~s~~~~dli~~~L~~dP~~R~ta~el 398 (423)
T 4fie_A 367 L------------K----------------NLHKVSPSLKGFLDRLLVRDPAQRATAAEL 398 (423)
T ss_dssp C------------S----------------CTTSSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred C------------c----------------ccccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 0 0 001233457799999999999999998764
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=416.87 Aligned_cols=245 Identities=24% Similarity=0.347 Sum_probs=186.8
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
.++|++.+.||+|+||+||+|++..+++.||||+++.. .....+++.+|++++++++|||||+++++ +.+++
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~-----~~~~~ 86 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDV-----IKSKD 86 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEE-----EECSS
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEE-----EEECC
Confidence 36899999999999999999999999999999999643 23345679999999999999999999999 56678
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..|+||||+ +|+|.+++.. .+.+++.+++.++.||+.||+|||++ +|+||||||+|||+++++++|
T Consensus 87 ~~~ivmEy~-~g~L~~~l~~----------~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vk 152 (275)
T 3hyh_A 87 EIIMVIEYA-GNELFDYIVQ----------RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVK 152 (275)
T ss_dssp EEEEEEECC-CEEHHHHHHH----------SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEE
T ss_pred EEEEEEeCC-CCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEE
Confidence 899999999 7899999852 34699999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccCCCc-CcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEV-SISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 922 (986)
|+|||+|+..... ......+||+.|||||++.+..+ +.++||||+||++|||+||+.||... +.......
T Consensus 153 l~DFGla~~~~~~---~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~-----~~~~~~~~- 223 (275)
T 3hyh_A 153 IADFGLSNIMTDG---NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE-----SIPVLFKN- 223 (275)
T ss_dssp ECCSSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHH-
T ss_pred EeecCCCeecCCC---CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC-----CHHHHHHH-
Confidence 9999999865322 22334679999999999998876 58999999999999999999999632 11111111
Q ss_pred CCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 923 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+..... .-| ...+.++.+++.+|++.||++|||++|+
T Consensus 224 -------i~~~~~-~~p-------------------~~~s~~~~~li~~~L~~dP~~R~s~~ei 260 (275)
T 3hyh_A 224 -------ISNGVY-TLP-------------------KFLSPGAAGLIKRMLIVNPLNRISIHEI 260 (275)
T ss_dssp -------HHHTCC-CCC-------------------TTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred -------HHcCCC-CCC-------------------CCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 000000 000 0123456789999999999999998764
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=455.41 Aligned_cols=458 Identities=21% Similarity=0.225 Sum_probs=368.6
Q ss_pred CEEEccCCCccccCCcchhccccCceeeceecccCCCCccchhcCccccceecccccccCccCccccCCCCCCeEEccCC
Q 046598 89 KVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDN 168 (986)
Q Consensus 89 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 168 (986)
++||+++|+++ .+|..+. ++|++|+|++|++++..|..|..+++|++|+|++|++++..|..|+++++|++|+|++|
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 57999999998 5777666 89999999999999888899999999999999999999888999999999999999999
Q ss_pred cCCCCcccccCCCcCcceeeccCCcccC-cCcchhhccCCCceeecccccccccCCccccCCCCc--cEEecccccc--c
Q 046598 169 NLTGSIPSSLGNLSSIRSLFLSGNNLEG-SIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSI--TGFDAGVNKI--Q 243 (986)
Q Consensus 169 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L--~~L~l~~N~l--~ 243 (986)
+++ .+|.. .+++|++|+|++|++++ .+|..|+.+++|++|+|++|++++ ..+..+++| +.|+++.|.+ .
T Consensus 80 ~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~ 153 (520)
T 2z7x_B 80 KLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGE 153 (520)
T ss_dssp CCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTS
T ss_pred cee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeeccccccc
Confidence 999 67766 89999999999999987 478999999999999999999986 456667777 8888888888 6
Q ss_pred cccCCccccccc-ccceEEecCceecccCCc-cccCCCCCcEEecccccccCCCchhhhhhhHhhhhhccCCCCCCCCCC
Q 046598 244 GAIPLDYGFSLQ-NLQFFSVGENQLTGAIPP-TISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRD 321 (986)
Q Consensus 244 ~~~p~~~~~~l~-~L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~ls~N~l~~~~~~l~~l~~L~~l~l~~n~l~~~~~~~ 321 (986)
+..|..+. .+. +...+++++|++.+.++. .+.++++|+.+++++|........
T Consensus 154 ~~~~~~l~-~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~------------------------ 208 (520)
T 2z7x_B 154 KEDPEGLQ-DFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSY------------------------ 208 (520)
T ss_dssp SCCTTTTT-TCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHH------------------------
T ss_pred cccccccc-ccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccce------------------------
Confidence 66665443 222 334567777777665543 566677777777777652110000
Q ss_pred cccccccccccccceeeccccccccCCCcccccccccceEEEccCCcccccCCcccc---CCCCCCEEEccCccccCcCC
Q 046598 322 LNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIG---KFVNLQRLDMCSNRLSGTIP 398 (986)
Q Consensus 322 l~~l~~l~~~~~L~~l~l~~n~~~~~~p~~~~~~~~~L~~L~L~~n~l~~~~~~~~~---~l~~L~~L~L~~N~l~~~~~ 398 (986)
+.+.+| .+..+ ++|+.|++++|.+++..+..+. ..++|++|++++|+++|.+|
T Consensus 209 ----------------------~~~~~~-~l~~l-~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p 264 (520)
T 2z7x_B 209 ----------------------FLSILA-KLQTN-PKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLD 264 (520)
T ss_dssp ----------------------HHHHHH-GGGGC-TTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCC
T ss_pred ----------------------eecchh-hhccc-cchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccc
Confidence 112222 22222 3455666666665543222111 24689999999999999999
Q ss_pred Ccc-----cCCCCCCEEEccCccceeecC-ccc----ccccccEEEecccccCCCCCcccCCCCCCCeeecCCCccCCCC
Q 046598 399 PAI-----GELQNLKDLRLQRNRFQGNIP-PSI----GNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTI 468 (986)
Q Consensus 399 ~~~-----~~l~~L~~L~Ls~N~l~~~~~-~~~----~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~i 468 (986)
..+ ..+++|+.+++++|.+ .+| ..+ ...+|+.|++++|.+.+.. .+..+++|++|++++|++++.+
T Consensus 265 ~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~ 340 (520)
T 2z7x_B 265 FRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTV 340 (520)
T ss_dssp CCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTT
T ss_pred cchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhh
Confidence 998 9999999999999999 455 333 2346999999999987533 2368899999999999999878
Q ss_pred CcccccCCCcceEEEccCCcccc--cCCcccccccccchhhccCccccccCcc-cccCCccccEEecccccccccCCccc
Q 046598 469 PPQFIGLSSSLIVLDLSRNQLTG--SIPSEVGNLKNLEILNVFGNKLKGEIPS-TLGSCIKLEQLEMQENFLQGPIPSSL 545 (986)
Q Consensus 469 p~~~~~~~~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~ 545 (986)
|.. ++.+++|++|++++|++++ .+|..+..+++|++|+|++|++++.+|. .+..+++|++|+|++|++++.+|..+
T Consensus 341 ~~~-~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l 419 (520)
T 2z7x_B 341 FEN-CGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL 419 (520)
T ss_dssp TTT-CCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSC
T ss_pred hhh-hccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhh
Confidence 877 6888999999999999996 4567899999999999999999985665 48899999999999999998888776
Q ss_pred cCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCccccccCC-ccccccccceeeeCCcccccC
Q 046598 546 SSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPT-QGVFKNASITSVFGNLKLCGG 612 (986)
Q Consensus 546 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~-~~~~~~~~~~~~~~n~~lcg~ 612 (986)
. ++|+.|+|++|+|+ .+|..+..+++|++|+|++|++++.++. ...++.++.+++.+|++.|.+
T Consensus 420 ~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c 484 (520)
T 2z7x_B 420 P--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 484 (520)
T ss_dssp C--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred c--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccC
Confidence 5 79999999999999 7888888999999999999999976665 466788899999999999864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-49 Score=432.19 Aligned_cols=263 Identities=25% Similarity=0.338 Sum_probs=207.1
Q ss_pred hhcCCCCCcccccccceeEEEEEECCC-----CeEEEEEEeeccC-chhHHHHHHHHHHHhcCCC-Ccceeeeeeccccc
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDG-----RTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRH-RNLVKILTACSGVD 758 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~ 758 (986)
..++|++.+.||+|+||+||+|.+... .+.||||+++... ....+++.+|++++++++| ||||+++|+|.
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~--- 138 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT--- 138 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE---
Confidence 357899999999999999999998643 3689999997543 3445779999999999965 89999999963
Q ss_pred cCCCceEEEEEEeccCCCHhHhhccCCCCCc------cccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCC
Q 046598 759 YQGNDFKALVFEFMHNRSLEEWLHPITREDE------TDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPS 832 (986)
Q Consensus 759 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~ 832 (986)
..+...++|||||++|+|.++++....... .......+++.++..|+.|||+||+|||++ +||||||||+
T Consensus 139 -~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~ 214 (353)
T 4ase_A 139 -KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAAR 214 (353)
T ss_dssp -CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred -ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCcc
Confidence 344678999999999999999975432110 112245699999999999999999999999 9999999999
Q ss_pred CeEecCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccc
Q 046598 833 NILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEG 911 (986)
Q Consensus 833 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~ 911 (986)
|||+++++.+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||++|||+| |+.||......
T Consensus 215 NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~ 294 (353)
T 4ase_A 215 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 294 (353)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999997765555455556779999999999999999999999999999999998 99999743221
Q ss_pred cccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 912 DMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
. .+....... .. .+.+..++.++.+++.+||+.||++||||+||
T Consensus 295 ~-~~~~~i~~g------------~~------------------~~~p~~~~~~~~~li~~c~~~dP~~RPt~~ei 338 (353)
T 4ase_A 295 E-EFCRRLKEG------------TR------------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL 338 (353)
T ss_dssp H-HHHHHHHHT------------CC------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred H-HHHHHHHcC------------CC------------------CCCCccCCHHHHHHHHHHcCcChhHCcCHHHH
Confidence 1 111111110 00 00011234568899999999999999999764
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=422.55 Aligned_cols=269 Identities=23% Similarity=0.294 Sum_probs=195.1
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 767 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 767 (986)
++|.+.++||+|+||+||+|++. ++.||||+++..... ...+..|+..+.+++|||||+++++|... .......|+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~-~~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKD-NGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEE-CSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEec-CCCceEEEE
Confidence 46788899999999999999985 689999999754322 22334566666788999999999997532 112246899
Q ss_pred EEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEeecCCCCCeEecCCCcE
Q 046598 768 VFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHD-----CQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 768 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
|||||++|+|.++++. ..+++.++.+|+.|+++||+|||++ ..++||||||||+|||++.++++
T Consensus 79 V~Ey~~~gsL~~~l~~-----------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~ 147 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNR-----------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 147 (303)
T ss_dssp EEECCTTCBHHHHHHH-----------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred EecCCCCCcHHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCE
Confidence 9999999999999962 3589999999999999999999975 24589999999999999999999
Q ss_pred EEcccccceecCCCCCc--cccccccccccccccccccCC------CcCcccchhhHHHHHHHHHhCCCCCCcccccccc
Q 046598 843 HIGDFGLARFLPLSSAQ--TSSIGAKGSIGYIAPEYGLGS------EVSISGDVYSYGILLLELITRKKPTDIMFEGDMN 914 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~ 914 (986)
||+|||+|+........ ......+||+.|||||++.+. .++.++|||||||++|||+||++||.........
T Consensus 148 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p 227 (303)
T 3hmm_A 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227 (303)
T ss_dssp EECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred EEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc
Confidence 99999999876543322 122346799999999998764 4788999999999999999999887643332222
Q ss_pred HHHHHHhhCCCchhHHh----hhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 915 LHNLARTALPDHVMDIV----DSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 915 ~~~~~~~~~~~~~~~~~----d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+....... ....++. +..+..... ......+++..+.+++.+||+.||++||||+||
T Consensus 228 ~~~~~~~~--~~~~~~~~~~~~~~~rp~~p-------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei 288 (303)
T 3hmm_A 228 YYDLVPSD--PSVEEMRKVVCEQKLRPNIP-------------NRWQSCEALRVMAKIMRECWYANGAARLTALRI 288 (303)
T ss_dssp TTTTSCSS--CCHHHHHHHHTTSCCCCCCC-------------GGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHH
T ss_pred chhccccc--chHHHHHHHHhcccCCCCCC-------------ccccchHHHHHHHHHHHHHcccCHhHCcCHHHH
Confidence 21111000 0011111 111111100 011122566778899999999999999999864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-49 Score=420.61 Aligned_cols=244 Identities=25% Similarity=0.275 Sum_probs=191.4
Q ss_pred cCCCCCcccccccceeEEEEEEC---CCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILD---DGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
++|++.+.||+|+||+||+|++. .+++.||||+++... .....++.+|++++++++|||||+++++ +.++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~-----~~~~ 98 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYA-----FQTE 98 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEE-----EEET
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEE-----EEEC
Confidence 57999999999999999999984 457899999996422 2234578899999999999999999999 4566
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
+..|+|||||+||+|.+++.. .+.+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~~----------~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~v 165 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLSK----------EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHI 165 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHHH----------HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCE
T ss_pred CEEEEEEEcCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCE
Confidence 889999999999999999952 34689999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 046598 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 922 (986)
||+|||+|+...... ......+||+.|||||++.+..|+.++||||+||++|||+||+.||..... ......
T Consensus 166 Kl~DFGla~~~~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-----~~~~~~- 237 (304)
T 3ubd_A 166 KLTDFGLSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR-----KETMTM- 237 (304)
T ss_dssp EEESSEEEEC-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH-
T ss_pred EecccccceeccCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH-----HHHHHH-
Confidence 999999998653222 223456799999999999999999999999999999999999999963211 111111
Q ss_pred CCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 046598 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMT 984 (986)
Q Consensus 923 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 984 (986)
+..... ..| ...+.++.+++.+||+.||++|||+.
T Consensus 238 -------i~~~~~-~~p-------------------~~~s~~~~~li~~~L~~dP~~R~ta~ 272 (304)
T 3ubd_A 238 -------ILKAKL-GMP-------------------QFLSPEAQSLLRMLFKRNPANRLGAG 272 (304)
T ss_dssp -------HHHCCC-CCC-------------------TTSCHHHHHHHHHHTCSSGGGSTTCS
T ss_pred -------HHcCCC-CCC-------------------CcCCHHHHHHHHHHcccCHHHCCCCC
Confidence 111000 000 01234577999999999999999974
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=449.97 Aligned_cols=459 Identities=20% Similarity=0.177 Sum_probs=360.5
Q ss_pred EEEeccCCCCccccCcCccCCCCCCEEEccCCCccccCCcchhccccCceeeceecccCCCCccchhcCccccceecccc
Q 046598 65 TILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHN 144 (986)
Q Consensus 65 ~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 144 (986)
..+|++++++++ +|..+. +.|++|+|++|++++..|.+|.++++|++|+|++|++++..|+.|.++++|++|+|++|
T Consensus 34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 110 (562)
T 3a79_B 34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN 110 (562)
T ss_dssp CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence 689999999995 887665 89999999999999888899999999999999999999888999999999999999999
Q ss_pred cccCccCccccCCCCCCeEEccCCcCCCC-cccccCCCcCcceeeccCCcccCcCcchhhccCCC--ceeecccccc--c
Q 046598 145 QLVGKIPSELSSLSKIEHISVNDNNLTGS-IPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNL--VNLTMAQNRL--S 219 (986)
Q Consensus 145 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L--~~L~L~~N~l--~ 219 (986)
+++ .+|.. .+++|++|+|++|++++. .|..|+++++|++|+|++|++++ ..|..+++| ++|+|++|++ +
T Consensus 111 ~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~L~~n~l~~~ 184 (562)
T 3a79_B 111 RLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ---LDLLPVAHLHLSCILLDLVSYHIK 184 (562)
T ss_dssp CCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCT---TTTGGGTTSCEEEEEEEESSCCCC
T ss_pred cCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCcccc---CchhhhhhceeeEEEeeccccccc
Confidence 999 67766 899999999999999963 56899999999999999999985 356666776 9999999999 8
Q ss_pred ccCCccccCCC-CccEEeccccccccccCCcccccccccceEEecCce-----ecccCCccccCCCCCcEEecccccccC
Q 046598 220 GTIPSSIFNIS-SITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQ-----LTGAIPPTISNASNLEIFHGSVNKLTG 293 (986)
Q Consensus 220 ~~~p~~l~~l~-~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~-----l~~~~p~~l~~l~~L~~L~ls~N~l~~ 293 (986)
+..|..+.++. +...++++.|.+.+.++...+..+++|+.|++++|+ +.+ .+..+..+++|+.++++++.+++
T Consensus 185 ~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~-~~~~l~~l~~L~~L~L~~~~l~~ 263 (562)
T 3a79_B 185 GGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMT-FLSELTRGPTLLNVTLQHIETTW 263 (562)
T ss_dssp SSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHH-HHHHHHSCSSCEEEEEEEEEECH
T ss_pred ccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHH-HHHHHhccCcceEEEecCCcCcH
Confidence 88899888775 223568889998888887777788899999998885 222 23356777777777777766642
Q ss_pred CCchhhhhhhHhhhhhccCCCCCCCCCCcccccccccccccceeeccccccccCCCcccccccccceEEEccCCcccccC
Q 046598 294 AAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNI 373 (986)
Q Consensus 294 ~~~~l~~l~~L~~l~l~~n~l~~~~~~~l~~l~~l~~~~~L~~l~l~~n~~~~~~p~~~~~~~~~L~~L~L~~n~l~~~~ 373 (986)
.. +.+ ++..+. ..+|++|++++|++++.+
T Consensus 264 ~~------------------------------------------------~~~-~~~~~~--~~~L~~L~l~~n~l~~~i 292 (562)
T 3a79_B 264 KC------------------------------------------------SVK-LFQFFW--PRPVEYLNIYNLTITERI 292 (562)
T ss_dssp HH------------------------------------------------HHH-HHHHHT--TSSEEEEEEEEEEECSCC
T ss_pred HH------------------------------------------------HHH-HHHhhh--cccccEEEEeccEeeccc
Confidence 11 000 011110 125666666666666666
Q ss_pred Cccc-----cCCCCCCEEEccCccccCcCC-CcccC---CCCCCEEEccCccceeecCcccccccccEEEecccccCCCC
Q 046598 374 PAAI-----GKFVNLQRLDMCSNRLSGTIP-PAIGE---LQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSI 444 (986)
Q Consensus 374 ~~~~-----~~l~~L~~L~L~~N~l~~~~~-~~~~~---l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~ 444 (986)
|..+ .+++.|+.++++.|.+ .+| ..+.. ..+|++|++++|.+..... .-...+|++|++++|++++.+
T Consensus 293 p~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~-~~~l~~L~~L~l~~n~l~~~~ 369 (562)
T 3a79_B 293 DREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSISDTPFIHMVC-PPSPSSFTFLNFTQNVFTDSV 369 (562)
T ss_dssp CCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEESSCCCCCCC-CSSCCCCCEEECCSSCCCTTT
T ss_pred cchhhhcccccchheehhhccccee--ecChhhhhhhhccCcceEEEccCCCcccccC-ccCCCCceEEECCCCccccch
Confidence 6655 5666666666666666 234 22322 2568888888887753221 012235888888888888888
Q ss_pred CcccCCCCCCCeeecCCCccCCCCCc--ccccCCCcceEEEccCCcccccCCc-ccccccccchhhccCccccccCcccc
Q 046598 445 PSSLGRYETLTTIDLSNNNLTGTIPP--QFIGLSSSLIVLDLSRNQLTGSIPS-EVGNLKNLEILNVFGNKLKGEIPSTL 521 (986)
Q Consensus 445 p~~~~~l~~L~~L~L~~N~l~~~ip~--~~~~~~~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~ 521 (986)
|..+..+++|++|+|++|+++ .++. ..++.+++|+.|++++|++++.+|. .+..+++|++|+|++|++++.+|..+
T Consensus 370 ~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l 448 (562)
T 3a79_B 370 FQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL 448 (562)
T ss_dssp TTTCCSCSSCCEEECCSSCCC-BTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSC
T ss_pred hhhhcccCCCCEEECCCCCcC-CcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhh
Confidence 888999999999999999998 4442 3367788999999999999874554 58888999999999999988777665
Q ss_pred cCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchh-hhcccccceeeccCCccccccCCc
Q 046598 522 GSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPEL-LIRLQLVKNLNLSNNDLEGVVPTQ 592 (986)
Q Consensus 522 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~l~ls~N~l~~~~p~~ 592 (986)
. ++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++ +|.. +..+++|+.|++++|+++|.+|..
T Consensus 449 ~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~c~~~ 516 (562)
T 3a79_B 449 P--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS-VPDGVFDRLTSLQYIWLHDNPWDCTCPGI 516 (562)
T ss_dssp C--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCC-CCTTSTTTCTTCCCEECCSCCBCCCHHHH
T ss_pred c--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCC-CCHHHHhcCCCCCEEEecCCCcCCCcchH
Confidence 5 68999999999998 677777799999999999999995 5554 889999999999999999887754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=413.00 Aligned_cols=255 Identities=23% Similarity=0.345 Sum_probs=187.3
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc-hhHHHHHHHHHHHhcCCCCcceeeeeeccccc-------c
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTACSGVD-------Y 759 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------~ 759 (986)
++|++++.||+|+||+||+|+++.+++.||||+++.... ...+.+.+|++++++++|||||++++++.... .
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 468999999999999999999999999999999975443 34567899999999999999999999864321 1
Q ss_pred CCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCC
Q 046598 760 QGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED 839 (986)
Q Consensus 760 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 839 (986)
..+...|+|||||++|+|.+++..... ....++..++.|+.||+.||+|||++ +|+||||||+|||++.+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-------~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~ 154 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCT-------IEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMD 154 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCS-------GGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCC-------CChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCC
Confidence 223457999999999999999964321 12346677899999999999999999 99999999999999999
Q ss_pred CcEEEcccccceecCCCCCc----------cccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccc
Q 046598 840 MIAHIGDFGLARFLPLSSAQ----------TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMF 909 (986)
Q Consensus 840 ~~~kL~DFG~a~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~ 909 (986)
+.+||+|||+|+........ ......+||+.|||||++.+..|+.++|||||||++|||++ ||....
T Consensus 155 ~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~ 231 (299)
T 4g31_A 155 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM 231 (299)
T ss_dssp CCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc
Confidence 99999999999876433221 12334679999999999999999999999999999999996 775211
Q ss_pred cccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 910 EGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+ ...... .+.+ ... .+...+......+++.+||+.||++|||++|+
T Consensus 232 ~----~~~~~~--------~~~~----~~~---------------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~ei 277 (299)
T 4g31_A 232 E----RVRTLT--------DVRN----LKF---------------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINI 277 (299)
T ss_dssp H----HHHHHH--------HHHT----TCC---------------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred H----HHHHHH--------HHhc----CCC---------------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 1 000000 0000 000 01111233445689999999999999998763
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=438.65 Aligned_cols=460 Identities=19% Similarity=0.219 Sum_probs=362.2
Q ss_pred CCEEEccCCCccccCCcchhccccCceeeceecccCCCCccchhcCccccceecccccccCccCccccCCCCCCeEEccC
Q 046598 88 LKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVND 167 (986)
Q Consensus 88 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 167 (986)
.+++++++|++++ +|..+. ++|++|+|++|++++..|..|..+++|++|+|++|++++..|.+|+++++|++|+|++
T Consensus 33 ~~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 109 (562)
T 3a79_B 33 ESMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSH 109 (562)
T ss_dssp CCEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTT
T ss_pred CcEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCC
Confidence 3799999999995 776654 8999999999999988889999999999999999999988899999999999999999
Q ss_pred CcCCCCcccccCCCcCcceeeccCCcccC-cCcchhhccCCCceeecccccccccCCccccCCCCc--cEEecccccc--
Q 046598 168 NNLTGSIPSSLGNLSSIRSLFLSGNNLEG-SIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSI--TGFDAGVNKI-- 242 (986)
Q Consensus 168 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L--~~L~l~~N~l-- 242 (986)
|+++ .+|.. .+++|++|+|++|++++ .+|..|+.+++|++|+|++|++++. .+..+++| +.|+++.|.+
T Consensus 110 N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~ 183 (562)
T 3a79_B 110 NRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHI 183 (562)
T ss_dssp SCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCC
T ss_pred CcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccc
Confidence 9999 67766 89999999999999996 3468999999999999999999863 45555555 9999999998
Q ss_pred ccccCCccccccc-ccceEEecCceecccCCc-cccCCCCCcEEecccccccCCCchhhhhhhHhhhhhccCCCCCCCCC
Q 046598 243 QGAIPLDYGFSLQ-NLQFFSVGENQLTGAIPP-TISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDR 320 (986)
Q Consensus 243 ~~~~p~~~~~~l~-~L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~ls~N~l~~~~~~l~~l~~L~~l~l~~n~l~~~~~~ 320 (986)
.+..|..+. .+. ..-.+++++|.+.+.++. .+..+++|+.+++++|+.. ...+..
T Consensus 184 ~~~~~~~l~-~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~-----~~~l~~----------------- 240 (562)
T 3a79_B 184 KGGETESLQ-IPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDEN-----CQRLMT----------------- 240 (562)
T ss_dssp CSSSCCEEE-ECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTT-----HHHHHH-----------------
T ss_pred cccCccccc-ccCcceEEEEecCccchhhhhhhcccccceEEEecccccccc-----cchHHH-----------------
Confidence 766665543 222 122568888888876654 4667888888888887521 000000
Q ss_pred CcccccccccccccceeeccccccccCCCcccccccccceEEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCc
Q 046598 321 DLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPA 400 (986)
Q Consensus 321 ~l~~l~~l~~~~~L~~l~l~~n~~~~~~p~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 400 (986)
.+..+..++.|+.+++.. +.+++|.+.+..+ .+ ..++|++|++++|.++|.+|..
T Consensus 241 ---~~~~l~~l~~L~~L~L~~--------------------~~l~~~~~~~~~~-~~-~~~~L~~L~l~~n~l~~~ip~~ 295 (562)
T 3a79_B 241 ---FLSELTRGPTLLNVTLQH--------------------IETTWKCSVKLFQ-FF-WPRPVEYLNIYNLTITERIDRE 295 (562)
T ss_dssp ---HHHHHHSCSSCEEEEEEE--------------------EEECHHHHHHHHH-HH-TTSSEEEEEEEEEEECSCCCCC
T ss_pred ---HHHHHhccCcceEEEecC--------------------CcCcHHHHHHHHH-hh-hcccccEEEEeccEeeccccch
Confidence 001122223333333322 2233333332222 22 2459999999999999999988
Q ss_pred c-----cCCCCCCEEEccCccceeecCc-c----cccccccEEEecccccCCCCCcccCCCCCCCeeecCCCccCCCCCc
Q 046598 401 I-----GELQNLKDLRLQRNRFQGNIPP-S----IGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPP 470 (986)
Q Consensus 401 ~-----~~l~~L~~L~Ls~N~l~~~~~~-~----~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~ 470 (986)
+ ..++.|+.++++.|.+ .+|. . +...+|++|++++|.+.... ....+++|++|++++|++++.+|.
T Consensus 296 ~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~ 371 (562)
T 3a79_B 296 EFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQ 371 (562)
T ss_dssp CCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTT
T ss_pred hhhcccccchheehhhccccee--ecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhh
Confidence 7 6677777777777776 3442 2 23356999999999987432 226889999999999999977777
Q ss_pred ccccCCCcceEEEccCCccccc--CCcccccccccchhhccCccccccCcc-cccCCccccEEecccccccccCCccccC
Q 046598 471 QFIGLSSSLIVLDLSRNQLTGS--IPSEVGNLKNLEILNVFGNKLKGEIPS-TLGSCIKLEQLEMQENFLQGPIPSSLSS 547 (986)
Q Consensus 471 ~~~~~~~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 547 (986)
. ++.+++|+.|+|++|++++. +|..+..+++|++|+|++|++++.+|. .+..+++|++|+|++|++++.+|..+.
T Consensus 372 ~-~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~- 449 (562)
T 3a79_B 372 G-CSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP- 449 (562)
T ss_dssp T-CCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC-
T ss_pred h-hcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc-
Confidence 6 78889999999999999963 356799999999999999999985664 588999999999999999988777665
Q ss_pred CCCCCEEeCCCccCcccCchhhhcccccceeeccCCccccccCC-ccccccccceeeeCCcccccC
Q 046598 548 LRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPT-QGVFKNASITSVFGNLKLCGG 612 (986)
Q Consensus 548 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~-~~~~~~~~~~~~~~n~~lcg~ 612 (986)
++|+.|+|++|+|+ .+|..+..+++|++|+|++|++++.++. ...++.++.+++.+|++.|++
T Consensus 450 -~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c 513 (562)
T 3a79_B 450 -PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTC 513 (562)
T ss_dssp -TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCH
T ss_pred -CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCc
Confidence 79999999999999 6888778999999999999999987666 567788899999999999965
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=416.53 Aligned_cols=207 Identities=27% Similarity=0.356 Sum_probs=177.2
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeecccc-ccCCCc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGV-DYQGND 763 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~~~ 763 (986)
.++|++++.||+|+||+||+|++..+++.||||+++... ....+.+.+|+++|++++|||||++++++... .+.+.+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 468999999999999999999999999999999996432 23456788999999999999999999987543 245667
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..|+|||||+ |+|.+++. ..+.+++.+++.|+.||+.||+|||++ |||||||||+|||++.++.+|
T Consensus 133 ~~~ivmE~~~-g~L~~~i~----------~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~K 198 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIH----------SSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELK 198 (398)
T ss_dssp CEEEEEECCS-EEHHHHHT----------SSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEE
T ss_pred EEEEEEeCCC-CCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEE
Confidence 8999999995 68999995 235699999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCC--CccccccccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 844 IGDFGLARFLPLSS--AQTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 844 L~DFG~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
|+|||+|+.+.... ........+||+.|||||++.+. .++.++||||+||++|||++|++||..
T Consensus 199 i~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g 265 (398)
T 4b99_A 199 IGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPG 265 (398)
T ss_dssp ECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred EeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCC
Confidence 99999998764322 12234457899999999998875 569999999999999999999999974
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=395.52 Aligned_cols=294 Identities=29% Similarity=0.453 Sum_probs=276.6
Q ss_pred cCCCHhHHHHHHHHHHhccCCCcCCCCCCCCCCCCCc--ceeeEecCCC--CeEEEEeccCCCCcc--ccCcCccCCCCC
Q 046598 15 VAGNETDRLALLELKSKITHDPLGVLASWNESSHFCQ--WRGVTCSRRH--QRVTILDLESLKLAG--SISPHVGNLSFL 88 (986)
Q Consensus 15 ~~~~~~~~~~ll~~k~~~~~~~~~~l~~w~~~~~~c~--w~gv~c~~~~--~~v~~l~l~~~~l~~--~~~~~~~~l~~L 88 (986)
+.|.++|++||++||+++. ||. .+++|+.+++||. |.||+|+..+ ++|+.|+|++++++| .+|+.|+++++|
T Consensus 1 ~~c~~~~~~aL~~~k~~~~-~~~-~l~~W~~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L 78 (313)
T 1ogq_A 1 ELCNPQDKQALLQIKKDLG-NPT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL 78 (313)
T ss_dssp CCSCHHHHHHHHHHHHHTT-CCG-GGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred CCCCHHHHHHHHHHHHhcC-Ccc-cccCCCCCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCC
Confidence 3699999999999999994 776 7899988889998 9999998765 799999999999999 999999999999
Q ss_pred CEEEccC-CCccccCCcchhccccCceeeceecccCCCCccchhcCccccceecccccccCccCccccCCCCCCeEEccC
Q 046598 89 KVLRLYN-NSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVND 167 (986)
Q Consensus 89 ~~L~L~~-n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 167 (986)
++|+|++ |.+.+.+|..|+++++|++|+|++|++++.+|..|..+++|++|+|++|.+++.+|..|.++++|++|+|++
T Consensus 79 ~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 158 (313)
T 1ogq_A 79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158 (313)
T ss_dssp SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCS
T ss_pred CeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcC
Confidence 9999995 999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCcccccCCCc-CcceeeccCCcccCcCcchhhccCCCceeecccccccccCCccccCCCCccEEecccccccccc
Q 046598 168 NNLTGSIPSSLGNLS-SIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAI 246 (986)
Q Consensus 168 N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~ 246 (986)
|++++.+|..+++++ +|++|+|++|++++.+|..|..++ |++|+|++|++++.+|..+..+++|+.|++++|.+.+.+
T Consensus 159 N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 237 (313)
T 1ogq_A 159 NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL 237 (313)
T ss_dssp SCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBG
T ss_pred CcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeec
Confidence 999999999999998 999999999999999999999998 999999999999999999999999999999999999887
Q ss_pred CCcccccccccceEEecCceecccCCccccCCCCCcEEecccccccCCCchhhhhhhHhhhhhccCC
Q 046598 247 PLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNS 313 (986)
Q Consensus 247 p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~l~~l~~L~~l~l~~n~ 313 (986)
|. +..+++|++|++++|++++.+|..+..+++|+.|++++|++++..|....+++|+.+++.+|.
T Consensus 238 ~~--~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 238 GK--VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302 (313)
T ss_dssp GG--CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSS
T ss_pred Cc--ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCC
Confidence 76 446899999999999999999999999999999999999999877776778888888777774
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=406.00 Aligned_cols=200 Identities=24% Similarity=0.338 Sum_probs=170.8
Q ss_pred HhhcCCCCCcccccccceeEEEEEEC---CCCeEEEEEEeeccCchhHHHHHHHHHHHhcC-CCCcceeeeeeccccccC
Q 046598 685 NATDRFSSVNQIGEGSFGSVFKGILD---DGRTTIAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQ 760 (986)
Q Consensus 685 ~~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 760 (986)
...++|++.++||+|+||+||+|+++ .+++.||||++.... ...++.+|+++++.+ +|||||+++++ +.
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~-----~~ 90 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYC-----FR 90 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEE-----EE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEE-----EE
Confidence 45688999999999999999999874 357889999986543 346788999999988 69999999998 55
Q ss_pred CCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCC-
Q 046598 761 GNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED- 839 (986)
Q Consensus 761 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~- 839 (986)
++++.|+||||+++|+|.+++. .+++.+++.++.||+.||+|||++ ||+||||||+|||++.+
T Consensus 91 ~~~~~~lvmE~~~g~~L~~~~~-------------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~ 154 (361)
T 4f9c_A 91 KNDHVVIAMPYLEHESFLDILN-------------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRL 154 (361)
T ss_dssp ETTEEEEEEECCCCCCHHHHHT-------------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTT
T ss_pred ECCEEEEEEeCCCcccHHHHHc-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCC
Confidence 6689999999999999999984 488999999999999999999999 99999999999999877
Q ss_pred CcEEEcccccceecCCCCCc--------------------------cccccccccccccccccccCC-CcCcccchhhHH
Q 046598 840 MIAHIGDFGLARFLPLSSAQ--------------------------TSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYG 892 (986)
Q Consensus 840 ~~~kL~DFG~a~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG 892 (986)
+.+||+|||+|+........ ......+||+.|||||++.+. .|+.++||||+|
T Consensus 155 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG 234 (361)
T 4f9c_A 155 KKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAG 234 (361)
T ss_dssp TEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHH
T ss_pred CeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhH
Confidence 79999999999865432211 112345799999999998876 489999999999
Q ss_pred HHHHHHHhCCCCCCc
Q 046598 893 ILLLELITRKKPTDI 907 (986)
Q Consensus 893 vvl~elltg~~pf~~ 907 (986)
|++|||+||+.||..
T Consensus 235 ~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 235 VIFLSLLSGRYPFYK 249 (361)
T ss_dssp HHHHHHHHTCSSSSC
T ss_pred HHHHHHHHCCCCCCC
Confidence 999999999999953
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=410.33 Aligned_cols=377 Identities=19% Similarity=0.202 Sum_probs=281.1
Q ss_pred CCCCEEEccCCCccccCCcchhccccCceeeceecccCCCC-ccchhcCccccceecccccccCccCccccCCCCCCeEE
Q 046598 86 SFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAI-PANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHIS 164 (986)
Q Consensus 86 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 164 (986)
++|++|+|++|.+++..|..|+++++|++|+|++|.+.+.+ |..|.++++|++|+|++|++++..|..|+++++|++|+
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 109 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT 109 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence 78999999999999888999999999999999999997655 56789999999999999999988889999999999999
Q ss_pred ccCCcCCCCcccc--cCCCcCcceeeccCCcccCcCcch-hhccCCCceeecccccccccCCccccCCCCccEEeccccc
Q 046598 165 VNDNNLTGSIPSS--LGNLSSIRSLFLSGNNLEGSIPDT-LGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNK 241 (986)
Q Consensus 165 L~~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~ 241 (986)
|++|++++..|.. |+++++|++|+|++|++++..|.. |..+++|++|+|++|++++..|..+.++.
T Consensus 110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~----------- 178 (455)
T 3v47_A 110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQ----------- 178 (455)
T ss_dssp CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGT-----------
T ss_pred CCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhccc-----------
Confidence 9999998766655 888999999999999998777766 78888888888888888876666655431
Q ss_pred cccccCCcccccccccceEEecCceecccCCccccCCCCCcEEecccccccCCCchhhhhhhHhhhhhccCCCCCCCCCC
Q 046598 242 IQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRD 321 (986)
Q Consensus 242 l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~l~~l~~L~~l~l~~n~l~~~~~~~ 321 (986)
..+|+.|++++|.+++..+..++.
T Consensus 179 ------------~~~L~~L~l~~n~l~~~~~~~~~~-------------------------------------------- 202 (455)
T 3v47_A 179 ------------GKHFTLLRLSSITLQDMNEYWLGW-------------------------------------------- 202 (455)
T ss_dssp ------------TCEEEEEECTTCBCTTCSTTCTTH--------------------------------------------
T ss_pred ------------cccccccccccCcccccchhhccc--------------------------------------------
Confidence 134455555555544322111100
Q ss_pred cccccccccccccceeeccccccccCCCcccccccccceEEEccCCcccccCCccccCC---CCCCEEEccCccccCcCC
Q 046598 322 LNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKF---VNLQRLDMCSNRLSGTIP 398 (986)
Q Consensus 322 l~~l~~l~~~~~L~~l~l~~n~~~~~~p~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l---~~L~~L~L~~N~l~~~~~ 398 (986)
.....++.. ++|+.|++++|++++..|..+..+ ++|+.|++++|.+.+...
T Consensus 203 -------------------------~~~~~~~~~-~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~ 256 (455)
T 3v47_A 203 -------------------------EKCGNPFKN-TSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSF 256 (455)
T ss_dssp -------------------------HHHCCTTTT-CEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCT
T ss_pred -------------------------ccccccccc-ceeeeEecCCCcccccchhhhhccccccceeeEeecccccccccc
Confidence 000000111 356666777776666655555433 556666666665442210
Q ss_pred CcccCCCCCCEEEccCccceeecCcccccccccEEEecccccCCCCCcccCC--CCCCCeeecCCCccCCCCCcccccCC
Q 046598 399 PAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGR--YETLTTIDLSNNNLTGTIPPQFIGLS 476 (986)
Q Consensus 399 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~--l~~L~~L~L~~N~l~~~ip~~~~~~~ 476 (986)
..+.+.+..+..+.. .++|+.|++++|++++.+|.. ++.+
T Consensus 257 -------------------------------------~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~-~~~l 298 (455)
T 3v47_A 257 -------------------------------------GHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSV-FSHF 298 (455)
T ss_dssp -------------------------------------TCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTT-TTTC
T ss_pred -------------------------------------chhhhccCcccccccccccCceEEEecCccccccchhh-cccC
Confidence 111122122222222 357888888888888555544 6777
Q ss_pred CcceEEEccCCcccccCCcccccccccchhhccCccccccCcccccCCccccEEecccccccccCCccccCCCCCCEEeC
Q 046598 477 SSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDL 556 (986)
Q Consensus 477 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 556 (986)
++|+.|+|++|++++..|..|..+++|++|+|++|++++..|..|..+++|++|+|++|++++..|..|..+++|++|+|
T Consensus 299 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 378 (455)
T 3v47_A 299 TDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELAL 378 (455)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEEC
Confidence 88888888888888777888888889999999999998777888899999999999999999888889999999999999
Q ss_pred CCccCcccCchhhhcccccceeeccCCccccccCCcc
Q 046598 557 SQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQG 593 (986)
Q Consensus 557 s~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~ 593 (986)
++|+|++..+..+..+++|++|+|++|+++|.+|...
T Consensus 379 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 415 (455)
T 3v47_A 379 DTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID 415 (455)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTH
T ss_pred CCCccccCCHhHhccCCcccEEEccCCCcccCCCcch
Confidence 9999998777788899999999999999999988653
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=403.25 Aligned_cols=387 Identities=25% Similarity=0.332 Sum_probs=214.3
Q ss_pred CCCCCCEEEccCCCccccCCcchhccccCceeeceecccCCCCccchhcCccc-------------cceecccccccCcc
Q 046598 84 NLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNL-------------IQLRLFHNQLVGKI 150 (986)
Q Consensus 84 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L-------------~~L~Ls~N~l~~~~ 150 (986)
..++|++|++++|++ +.+|.+|+++++|++|++++|+++|.+|..++.+++| ++|++++|.+++ +
T Consensus 9 ~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-l 86 (454)
T 1jl5_A 9 SNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-L 86 (454)
T ss_dssp --------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-C
T ss_pred ccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-C
Confidence 456677777777777 5677777777777777777777777777777776665 777777777764 3
Q ss_pred CccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeeccCCcccCcCcchhhccCCCceeecccccccccCCccccCCC
Q 046598 151 PSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNIS 230 (986)
Q Consensus 151 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 230 (986)
|.. .++|++|++++|++++ +|.. +++|++|++++|++++ +|.. .++|++|++++|++++ +| .+.+++
T Consensus 87 p~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~ 153 (454)
T 1jl5_A 87 PEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSS 153 (454)
T ss_dssp CSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCT
T ss_pred CCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCC
Confidence 432 2567777777777775 4543 3667777777777764 3321 1567777777777774 56 477777
Q ss_pred CccEEeccccccccccCCcccccccccceEEecCceecccCCccccCCCCCcEEecccccccCCCchhhhhhhHhhhhhc
Q 046598 231 SITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGIL 310 (986)
Q Consensus 231 ~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~l~~l~~L~~l~l~ 310 (986)
+|+.|++++|++.+ +|.. ..+|++|++++|++++ +| .++++++|+.|++++|++++++.
T Consensus 154 ~L~~L~l~~N~l~~-lp~~----~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l~~-------------- 212 (454)
T 1jl5_A 154 FLKIIDVDNNSLKK-LPDL----PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKLPD-------------- 212 (454)
T ss_dssp TCCEEECCSSCCSC-CCCC----CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSCCC--------------
T ss_pred CCCEEECCCCcCcc-cCCC----cccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcCCC--------------
Confidence 77777777777764 4432 2467777777777775 44 46777777777777776654331
Q ss_pred cCCCCCCCCCCcccccccccccccceeeccccccccCCCcccccccccceEEEccCCcccccCCccccCCCCCCEEEccC
Q 046598 311 GNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCS 390 (986)
Q Consensus 311 ~n~l~~~~~~~l~~l~~l~~~~~L~~l~l~~n~~~~~~p~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 390 (986)
. ..+|+.|++++|+++ .+| .++.+++|++|++++
T Consensus 213 ----------------------------------------~----~~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~ 246 (454)
T 1jl5_A 213 ----------------------------------------L----PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADN 246 (454)
T ss_dssp ----------------------------------------C----CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCS
T ss_pred ----------------------------------------C----cCcccEEECcCCcCC-ccc-ccCCCCCCCEEECCC
Confidence 1 135667777777777 455 377777777777777
Q ss_pred ccccCcCCCcccCCCCCCEEEccCccceeecCcccccccccEEEecccccCCCCCcccCCCCCCCeeecCCCccCCCCCc
Q 046598 391 NRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPP 470 (986)
Q Consensus 391 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~ 470 (986)
|++++ +|.. +++|++|++++|++++ +|... .+|++|++++|++++. |.. .++|++|++++|++++ ++.
T Consensus 247 N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~~--~~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~-i~~ 314 (454)
T 1jl5_A 247 NLLKT-LPDL---PPSLEALNVRDNYLTD-LPELP--QSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRS-LCD 314 (454)
T ss_dssp SCCSS-CCSC---CTTCCEEECCSSCCSC-CCCCC--TTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSE-ECC
T ss_pred CcCCc-cccc---ccccCEEECCCCcccc-cCccc--CcCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCCc-ccC
Confidence 77774 4432 3677777777777775 33332 3567777777777652 211 1467777777777763 332
Q ss_pred ccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccCcccccCCccccEEecccccccc--cCCccccCC
Q 046598 471 QFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQG--PIPSSLSSL 548 (986)
Q Consensus 471 ~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l 548 (986)
..++|+.|++++|++++ +|.. +++|+.|++++|+++ .+|. .+++|++|++++|++++ .+|.++..+
T Consensus 315 ----~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L 382 (454)
T 1jl5_A 315 ----LPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVEDL 382 (454)
T ss_dssp ----CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCEE
T ss_pred ----CcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHhh
Confidence 12467777777777774 5543 466777777777777 4555 35677777777777776 455554432
Q ss_pred CCCCEEeCCCccCcccCchhhhcccccceeeccCCcccc
Q 046598 549 RGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEG 587 (986)
Q Consensus 549 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~ 587 (986)
+.|.+.+.+|.. +++|++|++++|++++
T Consensus 383 --------~~n~~~~~i~~~---~~~L~~L~ls~N~l~~ 410 (454)
T 1jl5_A 383 --------RMNSHLAEVPEL---PQNLKQLHVETNPLRE 410 (454)
T ss_dssp --------ECCC---------------------------
T ss_pred --------hhcccccccccc---cCcCCEEECCCCcCCc
Confidence 345555555553 3677778888888877
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=409.61 Aligned_cols=245 Identities=22% Similarity=0.240 Sum_probs=194.5
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHH---HHHHHHHhcCCCCcceeeeeeccccccC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSF---IAECNTLKNIRHRNLVKILTACSGVDYQ 760 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~ 760 (986)
.++|++.+.||+|+||+||+|+++.+++.||||+++... ....... ..++.+++.++|||||+++++ ++
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~-----f~ 262 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA-----FH 262 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEE-----EE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEE-----EE
Confidence 357999999999999999999999999999999996421 1122223 344677788899999999999 66
Q ss_pred CCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCC
Q 046598 761 GNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDM 840 (986)
Q Consensus 761 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 840 (986)
+.+..|+||||++||+|.+++.. .+.+++..++.|+.||+.||+|||++ |||||||||+|||++.+|
T Consensus 263 ~~~~lylVmEy~~GGdL~~~l~~----------~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G 329 (689)
T 3v5w_A 263 TPDKLSFILDLMNGGDLHYHLSQ----------HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHG 329 (689)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHH----------HCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTS
T ss_pred ECCEEEEEEecCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCC
Confidence 77899999999999999999952 34699999999999999999999999 999999999999999999
Q ss_pred cEEEcccccceecCCCCCccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHH
Q 046598 841 IAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLA 919 (986)
Q Consensus 841 ~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~ 919 (986)
++||+|||+|+.+.... ....+||+.|||||++.+ ..|+.++||||+||++|||++|++||......+ .....
T Consensus 330 ~vKL~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~--~~~i~ 403 (689)
T 3v5w_A 330 HVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEID 403 (689)
T ss_dssp CEEECCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC--HHHHH
T ss_pred CEEecccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHH
Confidence 99999999998764332 234689999999999964 579999999999999999999999996432211 11111
Q ss_pred HhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 046598 920 RTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSM 983 (986)
Q Consensus 920 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 983 (986)
.. .+...+. .+...+.++.+++.+|++.||++|++.
T Consensus 404 ~~------------i~~~~~~----------------~p~~~S~~a~dLI~~lL~~dP~~Rl~~ 439 (689)
T 3v5w_A 404 RM------------TLTMAVE----------------LPDSFSPELRSLLEGLLQRDVNRRLGC 439 (689)
T ss_dssp HH------------HHHCCCC----------------CCTTSCHHHHHHHHHHTCSCGGGCTTC
T ss_pred Hh------------hcCCCCC----------------CCccCCHHHHHHHHHHccCCHhHCCCC
Confidence 10 0000000 000123456799999999999999984
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=415.29 Aligned_cols=250 Identities=21% Similarity=0.294 Sum_probs=204.8
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
.++|++.+.||+|+||+||+|+++.+++.||+|++........+.+.+|+++|+.++|||||+++++ +.++...|
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~-----~~~~~~~~ 230 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA-----FEDDNEMV 230 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEE-----EECSSEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEE-----EEECCEEE
Confidence 4689999999999999999999999999999999987666667789999999999999999999999 56678999
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCC--CcEEE
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED--MIAHI 844 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kL 844 (986)
+|||||+||+|.+++. .....+++.+++.++.||+.||+|||++ +|+||||||+|||++.+ +.+||
T Consensus 231 iv~E~~~gg~L~~~i~---------~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl 298 (573)
T 3uto_A 231 MIYEFMSGGELFEKVA---------DEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKL 298 (573)
T ss_dssp EEEECCCCCBHHHHHT---------CTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEE
T ss_pred EEEeecCCCcHHHHHH---------HhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEE
Confidence 9999999999999995 2234699999999999999999999999 99999999999999854 89999
Q ss_pred cccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCC
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALP 924 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 924 (986)
+|||+|+.+.... .....+||+.|||||++.+..|+.++||||+||++|||++|+.||..... ......
T Consensus 299 ~DFG~a~~~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~-----~~~~~~--- 367 (573)
T 3uto_A 299 IDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-----DETLRN--- 367 (573)
T ss_dssp CCCSSCEECCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHHHH---
T ss_pred eeccceeEccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----HHHHHH---
Confidence 9999999875332 23346799999999999999999999999999999999999999963221 111110
Q ss_pred CchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCC
Q 046598 925 DHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTN 985 (986)
Q Consensus 925 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 985 (986)
+....... +.. .....+.++.+|+.+||+.||++|||++|
T Consensus 368 -----i~~~~~~~-~~~---------------~~~~~s~~~~dli~~~L~~dp~~R~t~~e 407 (573)
T 3uto_A 368 -----VKSCDWNM-DDS---------------AFSGISEDGKDFIRKLLLADPNTRMTIHQ 407 (573)
T ss_dssp -----HHTTCCCC-CSG---------------GGTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred -----HHhCCCCC-Ccc---------------cccCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 00000000 000 00012345678999999999999999876
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=393.50 Aligned_cols=403 Identities=23% Similarity=0.284 Sum_probs=255.8
Q ss_pred CcchhccccCceeeceecccCCCCccchhcCccccceecccccccCccCccccCCCCCCeEEccCCcCCCCcccccCCCc
Q 046598 103 PSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLS 182 (986)
Q Consensus 103 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 182 (986)
|+.+. .++|++|++++|.+ |.+|.+|+++++|++|++++|.+.|.+|..++++++|+.+++.+|.. .
T Consensus 5 p~~~~-~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~ 71 (454)
T 1jl5_A 5 PRNVS-NTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------R 71 (454)
T ss_dssp -------------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------H
T ss_pred ccccc-cccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------c
Confidence 45554 58999999999999 69999999999999999999999999999999999886666655532 3
Q ss_pred CcceeeccCCcccCcCcchhhccCCCceeecccccccccCCccccCCCCccEEeccccccccccCCcccccccccceEEe
Q 046598 183 SIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSV 262 (986)
Q Consensus 183 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L 262 (986)
++++|++++|.+++ +|.. .++|++|++++|++++ +|.. +++|+.|++++|.+.+ +|.. .++|++|++
T Consensus 72 ~l~~L~l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~----~~~L~~L~L 138 (454)
T 1jl5_A 72 QAHELELNNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL----PPLLEYLGV 138 (454)
T ss_dssp TCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC----CTTCCEEEC
T ss_pred CCCEEEecCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC----CCCCCEEEC
Confidence 56666666666663 3331 3566666676666664 5543 2566667777666653 2221 256778888
Q ss_pred cCceecccCCccccCCCCCcEEecccccccCCCchhhhhhhHhhhhhccCCCCCCCCCCcccccccccccccceeecccc
Q 046598 263 GENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININ 342 (986)
Q Consensus 263 ~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~l~~l~~L~~l~l~~n~l~~~~~~~l~~l~~l~~~~~L~~l~l~~n 342 (986)
++|++++ +| .++++++|++|++++|++++++... .+|+.|+++.|
T Consensus 139 ~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~lp~~~---------------------------------~~L~~L~L~~n 183 (454)
T 1jl5_A 139 SNNQLEK-LP-ELQNSSFLKIIDVDNNSLKKLPDLP---------------------------------PSLEFIAAGNN 183 (454)
T ss_dssp CSSCCSS-CC-CCTTCTTCCEEECCSSCCSCCCCCC---------------------------------TTCCEEECCSS
T ss_pred cCCCCCC-Cc-ccCCCCCCCEEECCCCcCcccCCCc---------------------------------ccccEEECcCC
Confidence 8888775 56 5788888888888888777654321 25666667777
Q ss_pred ccccCCCcccccccccceEEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecC
Q 046598 343 NFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIP 422 (986)
Q Consensus 343 ~~~~~~p~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 422 (986)
.+++ +| .+..+ ++|+.|++++|++++ +|... ++|++|++++|.++ .+| .|..+++|++|++++|++++ +|
T Consensus 184 ~l~~-l~-~~~~l-~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~ 253 (454)
T 1jl5_A 184 QLEE-LP-ELQNL-PFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LP 253 (454)
T ss_dssp CCSS-CC-CCTTC-TTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CC
T ss_pred cCCc-Cc-cccCC-CCCCEEECCCCcCCc-CCCCc---CcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cc
Confidence 6665 55 34444 678999999999986 44332 58999999999998 666 48899999999999999986 44
Q ss_pred cccccccccEEEecccccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccc
Q 046598 423 PSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKN 502 (986)
Q Consensus 423 ~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~ 502 (986)
... .+|++|++++|++++ +|.. +++|+.|++++|++++ +|. ..++|+.|++++|++++ ++.. .++
T Consensus 254 ~~~--~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~-l~~----~~~~L~~L~l~~N~l~~-i~~~---~~~ 318 (454)
T 1jl5_A 254 DLP--PSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSG-LSE----LPPNLYYLNASSNEIRS-LCDL---PPS 318 (454)
T ss_dssp SCC--TTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSE-ESC----CCTTCCEEECCSSCCSE-ECCC---CTT
T ss_pred ccc--cccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCc-ccC----cCCcCCEEECcCCcCCc-ccCC---cCc
Confidence 432 468999999999986 5553 3789999999999984 332 12679999999999985 3321 258
Q ss_pred cchhhccCccccccCcccccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcc--cCchhhhcccccceeec
Q 046598 503 LEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSG--KIPELLIRLQLVKNLNL 580 (986)
Q Consensus 503 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~l~l 580 (986)
|++|++++|++++ +|.. +++|++|++++|++++ +|. .+++|++|+|++|++++ .+|..+.. |
T Consensus 319 L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~--------L 382 (454)
T 1jl5_A 319 LEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE-VPE---LPQNLKQLHVEYNPLREFPDIPESVED--------L 382 (454)
T ss_dssp CCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCE--------E
T ss_pred CCEEECCCCcccc-cccc---CCcCCEEECCCCcccc-ccc---hhhhccEEECCCCCCCcCCCChHHHHh--------h
Confidence 9999999999985 6654 5789999999999984 666 47899999999999998 67776553 3
Q ss_pred cCCccccccCCccccccccceeeeCCccc
Q 046598 581 SNNDLEGVVPTQGVFKNASITSVFGNLKL 609 (986)
Q Consensus 581 s~N~l~~~~p~~~~~~~~~~~~~~~n~~l 609 (986)
+.|.+.|.+|.. .++++.+++.+|+..
T Consensus 383 ~~n~~~~~i~~~--~~~L~~L~ls~N~l~ 409 (454)
T 1jl5_A 383 RMNSHLAEVPEL--PQNLKQLHVETNPLR 409 (454)
T ss_dssp ECCC-------------------------
T ss_pred hhcccccccccc--cCcCCEEECCCCcCC
Confidence 457788888764 577888889888654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=371.10 Aligned_cols=249 Identities=21% Similarity=0.279 Sum_probs=203.9
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
.++|++.+.||+|+||+||+|.+..+++.||||++........+.+.+|+.++++++||||+++++++ ..++..+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~ 93 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDELW 93 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEE-----EECCEEE
Confidence 46899999999999999999999988999999999876666678899999999999999999999984 4457899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+++|+|.+++.. ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 94 lv~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~D 159 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTE-----------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTD 159 (297)
T ss_dssp EEEECCTTCBHHHHHHH-----------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECC
T ss_pred EEEECCCCCCHHHHHhh-----------cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEee
Confidence 99999999999999952 2488999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCc
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDH 926 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 926 (986)
||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .........+.
T Consensus 160 fg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~- 235 (297)
T 3fxz_A 160 FGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTPE- 235 (297)
T ss_dssp CTTCEECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHHCSCC-
T ss_pred CCCceecCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCCCC-
Confidence 999987643322 23346799999999999999999999999999999999999999963211100 00000000000
Q ss_pred hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 927 VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 927 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
. ......+..+.+++.+||+.||++|||++|+
T Consensus 236 ------------~----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el 267 (297)
T 3fxz_A 236 ------------L----------------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKEL 267 (297)
T ss_dssp ------------C----------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred ------------C----------------CCccccCHHHHHHHHHHccCChhHCcCHHHH
Confidence 0 0011234457799999999999999998764
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=375.85 Aligned_cols=275 Identities=33% Similarity=0.486 Sum_probs=215.9
Q ss_pred ChHHHHHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 046598 679 SYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD 758 (986)
Q Consensus 679 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 758 (986)
++.++...+++|++.+.||+|+||.||+|++.. ++.||||++........+.+.+|++++++++||||++++++|
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~---- 104 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD-GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC---- 104 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTT-CCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEEC----
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEECC-CCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEE----
Confidence 334555678899999999999999999999764 789999998776666678899999999999999999999994
Q ss_pred cCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecC
Q 046598 759 YQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDE 838 (986)
Q Consensus 759 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 838 (986)
..++..++||||+++|+|.+++.... .....+++.+++.++.|++.||+|||++ +|+||||||+||+++.
T Consensus 105 -~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~ 174 (321)
T 2qkw_B 105 -DERNEMILIYKYMENGNLKRHLYGSD------LPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDE 174 (321)
T ss_dssp -CCTTCCEEEEECCTTCBTGGGSSSSC------CCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECT
T ss_pred -cCCCeEEEEEEcCCCCcHHHHHhccC------CCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECC
Confidence 45678999999999999999996332 2234689999999999999999999999 9999999999999999
Q ss_pred CCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCcccccc-ccHHH
Q 046598 839 DMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGD-MNLHN 917 (986)
Q Consensus 839 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~-~~~~~ 917 (986)
++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .....
T Consensus 175 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~ 254 (321)
T 2qkw_B 175 NFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAE 254 (321)
T ss_dssp TCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHH
T ss_pred CCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHH
Confidence 99999999999987543333333344568999999999988899999999999999999999999997543322 12222
Q ss_pred HHHh-hCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 918 LART-ALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 918 ~~~~-~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+... .....+...+++.+. .....+++.++.+++.+||+.||++|||++||
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 306 (321)
T 2qkw_B 255 WAVESHNNGQLEQIVDPNLA------------------DKIRPESLRKFGDTAVKCLALSSEDRPSMGDV 306 (321)
T ss_dssp HTHHHHTTTCCCSSSSSSCT------------------TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HhhhccccccHHHhcChhhc------------------cccCHHHHHHHHHHHHHHcCCCcccCcCHHHH
Confidence 2111 111111111111111 01123567788999999999999999999764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=374.38 Aligned_cols=283 Identities=34% Similarity=0.557 Sum_probs=221.8
Q ss_pred CCCCCcChHHHHHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc-hhHHHHHHHHHHHhcCCCCcceeee
Q 046598 673 NSFPNISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKIL 751 (986)
Q Consensus 673 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~ 751 (986)
.....+++.++....++|++.+.||+|+||.||+|.+.. ++.||||+++.... .....+.+|++++++++||||++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 93 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD-GTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSS-SCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecC-CCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceE
Confidence 345678999999999999999999999999999998654 78999999865332 2234789999999999999999999
Q ss_pred eeccccccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCC
Q 046598 752 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKP 831 (986)
Q Consensus 752 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 831 (986)
++| ......++||||+++|+|.+++.... .....+++..+..|+.|++.||+|||+.+.++|+||||||
T Consensus 94 ~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp 162 (326)
T 3uim_A 94 GFC-----MTPTERLLVYPYMANGSVASCLRERP------ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKA 162 (326)
T ss_dssp EEE-----CCSSCCEEEEECCTTCBHHHHHHCCS------TTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSG
T ss_pred EEE-----ecCCceEEEEEeccCCCHHHHHHhcc------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCch
Confidence 995 45577899999999999999997433 2234699999999999999999999998777999999999
Q ss_pred CCeEecCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccc--
Q 046598 832 SNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMF-- 909 (986)
Q Consensus 832 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~-- 909 (986)
+||+++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||+...
T Consensus 163 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 241 (326)
T 3uim_A 163 ANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA 241 (326)
T ss_dssp GGEEECTTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHT
T ss_pred hhEEECCCCCEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccc
Confidence 999999999999999999987643322 22334569999999999988899999999999999999999999996321
Q ss_pred -cccccHHHHHHhhCCCc-hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 910 -EGDMNLHNLARTALPDH-VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 910 -~~~~~~~~~~~~~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
........+........ .....+..+.. ....+.+..+.+++.+||+.||++|||++||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~el 302 (326)
T 3uim_A 242 NDDDVMLLDWVKGLLKEKKLEALVDVDLQG------------------NYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302 (326)
T ss_dssp TTSCSBHHHHHTTTTSSCCSTTSSCTTCTT------------------SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHH
T ss_pred cccchhHHHHHHHHhhchhhhhhcChhhcc------------------ccCHHHHHHHHHHHHHHhCcCCccCCCHHHH
Confidence 12222333333222221 22222221111 1123566789999999999999999999764
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=389.44 Aligned_cols=384 Identities=21% Similarity=0.233 Sum_probs=275.3
Q ss_pred CCCccee--eEecCCC--------CeEEEEeccCCCCccccCcCccCCCCCCEEEccCCCccccC-CcchhccccCceee
Q 046598 48 HFCQWRG--VTCSRRH--------QRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEI-PSEFDRLRRLQVLA 116 (986)
Q Consensus 48 ~~c~w~g--v~c~~~~--------~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~ 116 (986)
..|.|.+ |.|+... .+++.|||++|.+++..|..|+++++|++|+|++|.+.+.+ |..|.++++|++|+
T Consensus 6 ~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~ 85 (455)
T 3v47_A 6 SECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILK 85 (455)
T ss_dssp -CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEE
T ss_pred ceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEe
Confidence 4466666 8887643 56999999999999888999999999999999999998655 67899999999999
Q ss_pred ceecccCCCCccchhcCccccceecccccccCccCcc--ccCCCCCCeEEccCCcCCCCcccc-cCCCcCcceeeccCCc
Q 046598 117 LHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSE--LSSLSKIEHISVNDNNLTGSIPSS-LGNLSSIRSLFLSGNN 193 (986)
Q Consensus 117 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~ 193 (986)
|++|++++..|..|+.+++|++|+|++|.+++.+|.. |+++++|++|+|++|++++..|.. |.++++|++|+|++|+
T Consensus 86 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~ 165 (455)
T 3v47_A 86 LDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK 165 (455)
T ss_dssp CTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCC
T ss_pred CCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCc
Confidence 9999999888999999999999999999999866655 999999999999999999888876 8999999999999999
Q ss_pred ccCcCcchhhcc--CCCceeecccccccccCCccccCCCCccEEeccccccccccCCcccccccccceEEecCceecccC
Q 046598 194 LEGSIPDTLGWL--KNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAI 271 (986)
Q Consensus 194 l~~~~p~~~~~l--~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~ 271 (986)
+++..|..+..+ .+|+.|++++|.+++..+..+.. .... ....+++|++|++++|++++..
T Consensus 166 l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~----------------~~~~-~~~~~~~L~~L~Ls~n~l~~~~ 228 (455)
T 3v47_A 166 VKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGW----------------EKCG-NPFKNTSITTLDLSGNGFKESM 228 (455)
T ss_dssp BSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTH----------------HHHC-CTTTTCEEEEEECTTSCCCHHH
T ss_pred ccccChhhhhccccccccccccccCcccccchhhccc----------------cccc-cccccceeeeEecCCCcccccc
Confidence 999999999887 78999999999998654433220 0000 0112445666666666666555
Q ss_pred CccccCC---CCCcEEecccccccCCCchhhhhhhHhhhhhccCCCCCCCCCCcccccccccccccceeeccccccccCC
Q 046598 272 PPTISNA---SNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSL 348 (986)
Q Consensus 272 p~~l~~l---~~L~~L~ls~N~l~~~~~~l~~l~~L~~l~l~~n~l~~~~~~~l~~l~~l~~~~~L~~l~l~~n~~~~~~ 348 (986)
|..+... ++|+.+++++|.+.+.... . +.+.+..
T Consensus 229 ~~~~~~~~~~~~L~~L~l~~~~~~~~~~~-------------~------------------------------~~~~~~~ 265 (455)
T 3v47_A 229 AKRFFDAIAGTKIQSLILSNSYNMGSSFG-------------H------------------------------TNFKDPD 265 (455)
T ss_dssp HHHHHHHTTTCCEEEEECTTCTTTSCCTT-------------C------------------------------CSSCCCC
T ss_pred hhhhhccccccceeeEeeccccccccccc-------------h------------------------------hhhccCc
Confidence 5554433 6666666666655432110 0 0000001
Q ss_pred Ccccccc-cccceEEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCccccc
Q 046598 349 PACISNL-STTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGN 427 (986)
Q Consensus 349 p~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 427 (986)
+..+..+ ..+|+.|++++|++++..|..|..+++|++|++++|.+++..|..|..+++|++|+|++|++++..|..+..
T Consensus 266 ~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 345 (455)
T 3v47_A 266 NFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFEN 345 (455)
T ss_dssp TTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTT
T ss_pred ccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcC
Confidence 1111111 145777888888887777777888888888888888888777777777887777777777777655555543
Q ss_pred c-cccEEEecccccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCccccc
Q 046598 428 L-KLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGS 492 (986)
Q Consensus 428 ~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~ 492 (986)
+ +|++|+|++|++++..|..|..+++|++|+|++|+|+ .+|...+..+++|+.|++++|++++.
T Consensus 346 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~ 410 (455)
T 3v47_A 346 LDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCS 410 (455)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred cccCCEEECCCCcccccChhhccccccccEEECCCCccc-cCCHhHhccCCcccEEEccCCCcccC
Confidence 3 3666666666665555555666666666666666665 34444445555555555555555543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=371.77 Aligned_cols=253 Identities=24% Similarity=0.372 Sum_probs=204.3
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
.++|.+.+.||+|+||+||+|.+..+++.||+|++........+.+.+|++++++++||||+++++++ .++...+
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~ 83 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL-----YKDKRLN 83 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEE-----ecCCeeE
Confidence 46799999999999999999999999999999998776667778899999999999999999999995 4457899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+++++|.++++. ....+++.++..|+.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 84 lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~D 151 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKS---------MDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVAD 151 (310)
T ss_dssp EEEECCTTCBHHHHHHH---------CCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECC
T ss_pred EEEEecCCCcHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEee
Confidence 99999999999999963 234689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcc------------ccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCcccccccc
Q 046598 847 FGLARFLPLSSAQT------------SSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMN 914 (986)
Q Consensus 847 FG~a~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~ 914 (986)
||+++......... ......||+.|+|||++.+..++.++|||||||++|||++|..||.........
T Consensus 152 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~ 231 (310)
T 3s95_A 152 FGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD 231 (310)
T ss_dssp CTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT
T ss_pred cccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH
Confidence 99998764332211 111456999999999999999999999999999999999999998643322111
Q ss_pred HHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 915 LHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 915 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.. .......+.... ..++.++.+++.+||+.||++|||++||
T Consensus 232 ~~--------~~~~~~~~~~~~----------------------~~~~~~l~~li~~~l~~dP~~Rps~~~l 273 (310)
T 3s95_A 232 FG--------LNVRGFLDRYCP----------------------PNCPPSFFPITVRCCDLDPEKRPSFVKL 273 (310)
T ss_dssp SS--------BCHHHHHHHTCC----------------------TTCCTTHHHHHHHHTCSSGGGSCCHHHH
T ss_pred Hh--------hhhhccccccCC----------------------CCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 10 011111111110 1223457789999999999999998764
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=370.61 Aligned_cols=252 Identities=21% Similarity=0.300 Sum_probs=201.0
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc-hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
.++|++.+.||+|+||+||+|++..+++.||||++..... ...+.+.+|+.+++.++||||++++++ +..++..
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~-----~~~~~~~ 80 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH-----RREGNIQ 80 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEE-----EECSSEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEE-----EecCCeE
Confidence 4689999999999999999999998899999999864332 234668899999999999999999999 4556889
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
++||||+++|+|.+++. ....+++.+++.++.||+.||+|||+. ||+||||||+||+++.++.+||+
T Consensus 81 ~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~ 147 (323)
T 3tki_A 81 YLFLEYCSGGELFDRIE----------PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKIS 147 (323)
T ss_dssp EEEEECCTTEEGGGGSB----------TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEcCCCCcHHHHHh----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEE
Confidence 99999999999999984 234589999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccCCCc-CcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCC
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEV-SISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALP 924 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 924 (986)
|||+++.+.............||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.........+..+......
T Consensus 148 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 227 (323)
T 3tki_A 148 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY 227 (323)
T ss_dssp CCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT
T ss_pred EeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc
Confidence 9999987643333333445679999999999988775 789999999999999999999997433322222111111000
Q ss_pred CchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 925 DHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 925 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..+ ....+.++.+++.+||+.||++|||++|+
T Consensus 228 ------------~~~------------------~~~~~~~~~~li~~~L~~dP~~R~t~~ei 259 (323)
T 3tki_A 228 ------------LNP------------------WKKIDSAPLALLHKILVENPSARITIPDI 259 (323)
T ss_dssp ------------STT------------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred ------------CCc------------------cccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 000 01223456789999999999999998763
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=370.28 Aligned_cols=247 Identities=21% Similarity=0.299 Sum_probs=201.3
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc--CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
..++|++.+.||+|+||.||+|++..+++.||||++... .....+++.+|+++++.++||||+++++++ ...+
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-----~~~~ 87 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI-----ETEK 87 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECC
Confidence 457899999999999999999999988999999999753 334456788999999999999999999994 5568
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..|+||||+++|+|.+++.. .+.+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+|
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~----------~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~k 154 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVA----------HGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIK 154 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHH----------HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred EEEEEEECCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEE
Confidence 89999999999999999952 24589999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccCCCcC-cccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVS-ISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 922 (986)
|+|||+++...... .....+||+.|+|||++.+..++ .++||||+||++|||++|+.||.... ......
T Consensus 155 l~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~-- 224 (328)
T 3fe3_A 155 IADFGFSNEFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-----LKELRE-- 224 (328)
T ss_dssp ECSTTCCGGGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHH--
T ss_pred EeeccCceecCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC-----HHHHHH--
Confidence 99999998654322 23446799999999999888765 89999999999999999999996321 111111
Q ss_pred CCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 923 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
......+.. +...+.++.+++.+||+.||++|||++|+
T Consensus 225 ----------~i~~~~~~~----------------p~~~s~~~~~li~~~L~~dP~~R~t~~ei 262 (328)
T 3fe3_A 225 ----------RVLRGKYRI----------------PFYMSTDCENLLKRFLVLNPIKRGTLEQI 262 (328)
T ss_dssp ----------HHHHCCCCC----------------CTTSCHHHHHHHHHHCCSSTTTSCCHHHH
T ss_pred ----------HHHhCCCCC----------------CCCCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 111010000 00123456789999999999999998763
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=363.40 Aligned_cols=260 Identities=21% Similarity=0.268 Sum_probs=209.2
Q ss_pred CCcChHHHHHhhcC----------CCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCC
Q 046598 676 PNISYQNLYNATDR----------FSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHR 745 (986)
Q Consensus 676 ~~~~~~~~~~~~~~----------y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 745 (986)
+.++++++..+++. |+..+.||+|+||.||+|++..+++.||||+++.......+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45778888777764 67778999999999999999988999999999876666678899999999999999
Q ss_pred cceeeeeeccccccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 046598 746 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIA 825 (986)
Q Consensus 746 niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iv 825 (986)
||+++++++ ...+..++||||+++++|.+++.. ..+++.++..++.|++.||+|||+. +|+
T Consensus 103 niv~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~-----------~~l~~~~~~~i~~qi~~~L~~LH~~---~iv 163 (321)
T 2c30_A 103 NVVEMYKSY-----LVGEELWVLMEFLQGGALTDIVSQ-----------VRLNEEQIATVCEAVLQALAYLHAQ---GVI 163 (321)
T ss_dssp TBCCEEEEE-----EETTEEEEEECCCCSCBHHHHHTT-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred CcceEEEEE-----EECCEEEEEEecCCCCCHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHHC---Cee
Confidence 999999985 345789999999999999999851 3589999999999999999999999 999
Q ss_pred eecCCCCCeEecCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCC
Q 046598 826 HCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPT 905 (986)
Q Consensus 826 H~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf 905 (986)
||||||+||+++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 164 H~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf 241 (321)
T 2c30_A 164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPY 241 (321)
T ss_dssp CCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred cCCCCHHHEEECCCCcEEEeeeeeeeecccCc--cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999998764322 2223457999999999999999999999999999999999999998
Q ss_pred CccccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCC
Q 046598 906 DIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTN 985 (986)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 985 (986)
...... ..........+... ......+.++.+++.+||+.||++|||++|
T Consensus 242 ~~~~~~--~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e 291 (321)
T 2c30_A 242 FSDSPV--QAMKRLRDSPPPKL----------------------------KNSHKVSPVLRDFLERMLVRDPQERATAQE 291 (321)
T ss_dssp TTSCHH--HHHHHHHHSSCCCC----------------------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCCCHH--HHHHHHhcCCCCCc----------------------------CccccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 632111 00001110000000 000122345778999999999999999876
Q ss_pred C
Q 046598 986 V 986 (986)
Q Consensus 986 V 986 (986)
|
T Consensus 292 l 292 (321)
T 2c30_A 292 L 292 (321)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=367.85 Aligned_cols=275 Identities=23% Similarity=0.310 Sum_probs=204.7
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
..++|++.+.||+|+||+||+|++. ++.||||+++... .......+|+.++++++||||+++++++... .......
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~~~~ 97 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRG-TSVDVDL 97 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE-CSSSEEE
T ss_pred chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccC-CCCCceE
Confidence 3578999999999999999999987 5899999997543 3335567799999999999999999997543 1224568
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhc-------CCCCeEeecCCCCCeEecC
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHD-------CQPPIAHCDLKPSNILLDE 838 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-------~~~~ivH~Dlkp~NIll~~ 838 (986)
++||||+++|+|.++++. ..+++.+++.++.|++.||+|||+. +.++|+||||||+||+++.
T Consensus 98 ~lv~e~~~~g~L~~~l~~-----------~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~ 166 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKA-----------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN 166 (322)
T ss_dssp EEEEECCTTCBHHHHHHH-----------CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECT
T ss_pred EEEEecCCCCCHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECC
Confidence 999999999999999952 2489999999999999999999975 1348999999999999999
Q ss_pred CCcEEEcccccceecCCCCCccccccccccccccccccccC-----CCcCcccchhhHHHHHHHHHhCCCCCCccccccc
Q 046598 839 DMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-----SEVSISGDVYSYGILLLELITRKKPTDIMFEGDM 913 (986)
Q Consensus 839 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~ 913 (986)
++.+||+|||+++...............||+.|+|||++.+ ..++.++|||||||++|||+||+.||........
T Consensus 167 ~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~ 246 (322)
T 3soc_A 167 NLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246 (322)
T ss_dssp TCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCC
T ss_pred CCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhc
Confidence 99999999999987765444434445679999999999887 3567889999999999999999999975433221
Q ss_pred -cHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 914 -NLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 914 -~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+..... . .....++.+......... ..........++.++.+++.+||+.||++||||+||
T Consensus 247 ~~~~~~~~-~-~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el 309 (322)
T 3soc_A 247 LPFEEEIG-Q-HPSLEDMQEVVVHKKKRP---------VLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCV 309 (322)
T ss_dssp CTTHHHHC-S-SCCHHHHHHHHTTSCCCC---------CCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred cchhhhhc-c-CCchhhhhhhhhcccCCC---------CccccccccchHHHHHHHHHHHccCChhhCcCHHHH
Confidence 1111100 0 111112211111111000 000011112455678899999999999999999764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=366.67 Aligned_cols=251 Identities=20% Similarity=0.248 Sum_probs=202.0
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCch------hHHHHHHHHHHHhcCCCCcceeeeeecccccc
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHG------AFKSFIAECNTLKNIRHRNLVKILTACSGVDY 759 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 759 (986)
..++|++.+.||+|+||.||+|++..+++.||+|+++..... ..+.+.+|+.++++++||||++++++ +
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~-----~ 84 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDV-----Y 84 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEE-----E
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEE-----E
Confidence 356899999999999999999999999999999999753322 34678999999999999999999999 4
Q ss_pred CCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCC
Q 046598 760 QGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED 839 (986)
Q Consensus 760 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 839 (986)
.+....++||||+++|+|.+++.. ...+++.++..++.||+.||+|||+. ||+||||||+||+++.+
T Consensus 85 ~~~~~~~lv~e~~~gg~L~~~l~~----------~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~ 151 (361)
T 2yab_A 85 ENRTDVVLILELVSGGELFDFLAQ----------KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDK 151 (361)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHTT----------CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCT
T ss_pred EeCCEEEEEEEcCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCC
Confidence 566889999999999999999942 34689999999999999999999999 99999999999999887
Q ss_pred C----cEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccH
Q 046598 840 M----IAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNL 915 (986)
Q Consensus 840 ~----~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~ 915 (986)
+ .+||+|||+++...... ......||+.|+|||++.+..++.++||||+||++|+|++|..||.....
T Consensus 152 ~~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~----- 223 (361)
T 2yab_A 152 NIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK----- 223 (361)
T ss_dssp TSSSCCEEECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-----
T ss_pred CCCccCEEEEecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-----
Confidence 7 79999999998764322 22345699999999999999999999999999999999999999963211
Q ss_pred HHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 916 HNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 916 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
...... +..... ... .......+.++.+++.+|+..||++|||++|+
T Consensus 224 ~~~~~~--------i~~~~~--~~~--------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~ 270 (361)
T 2yab_A 224 QETLAN--------ITAVSY--DFD--------------EEFFSQTSELAKDFIRKLLVKETRKRLTIQEA 270 (361)
T ss_dssp HHHHHH--------HHTTCC--CCC--------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred HHHHHH--------HHhcCC--CCC--------------chhccCCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 111110 000000 000 00011234457799999999999999998763
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=356.46 Aligned_cols=275 Identities=31% Similarity=0.479 Sum_probs=216.8
Q ss_pred CCCCcChHHHHHhhcCCCCC------cccccccceeEEEEEECCCCeEEEEEEeecc----CchhHHHHHHHHHHHhcCC
Q 046598 674 SFPNISYQNLYNATDRFSSV------NQIGEGSFGSVFKGILDDGRTTIAVKVFNLL----HHGAFKSFIAECNTLKNIR 743 (986)
Q Consensus 674 ~~~~~~~~~~~~~~~~y~~~------~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~ 743 (986)
....+++.++..++++|... +.||+|+||.||+|.+. ++.||||++... .....+.+.+|++++++++
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 88 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS--SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC--CceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence 45678999999999998877 89999999999999874 689999998642 2334578999999999999
Q ss_pred CCcceeeeeeccccccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 046598 744 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPP 823 (986)
Q Consensus 744 h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ 823 (986)
||||+++++++ ..++..++||||+++++|.+++.... ....+++..++.++.||+.||+|||+. +
T Consensus 89 h~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ 153 (307)
T 2nru_A 89 HENLVELLGFS-----SDGDDLCLVYVYMPNGSLLDRLSCLD-------GTPPLSWHMRCKIAQGAANGINFLHEN---H 153 (307)
T ss_dssp CTTBCCEEEEE-----CSSSSCEEEEECCTTCBHHHHHHTGG-------GCCCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred CCCeEEEEEEE-----ecCCceEEEEEecCCCcHHHHHHhcc-------CCCCCCHHHHHHHHHHHHHHHHHHhcC---C
Confidence 99999999994 45578899999999999999996321 234689999999999999999999999 9
Q ss_pred eEeecCCCCCeEecCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCC
Q 046598 824 IAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKK 903 (986)
Q Consensus 824 ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~ 903 (986)
|+||||||+||+++.++.+||+|||+++...............|++.|+|||++.+ .++.++||||||+++|+|++|+.
T Consensus 154 i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~ 232 (307)
T 2nru_A 154 HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLP 232 (307)
T ss_dssp EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCC
T ss_pred eecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCC
Confidence 99999999999999999999999999987654433333444678999999998765 58999999999999999999999
Q ss_pred CCCccccccccHHHHHHh--hCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCC
Q 046598 904 PTDIMFEGDMNLHNLART--ALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRM 981 (986)
Q Consensus 904 pf~~~~~~~~~~~~~~~~--~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 981 (986)
||........ ...+... .....+.+.+++.+... ....+..+.+++.+||+.||++||
T Consensus 233 p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~l~~li~~cl~~~p~~Rp 292 (307)
T 2nru_A 233 AVDEHREPQL-LLDIKEEIEDEEKTIEDYIDKKMNDA-------------------DSTSVEAMYSVASQCLHEKKNKRP 292 (307)
T ss_dssp SBCTTBSSSB-TTHHHHHHHTTSCCHHHHSCSSCSCC-------------------CHHHHHHHHHHHHHHTCSSTTTSC
T ss_pred CcccCcchHH-HHHHHHHhhhhhhhhhhhcccccccc-------------------chHHHHHHHHHHHHHcCCCcccCc
Confidence 9975433221 1111111 11112333333322111 124566788999999999999999
Q ss_pred CCCCC
Q 046598 982 SMTNV 986 (986)
Q Consensus 982 t~~eV 986 (986)
|++||
T Consensus 293 s~~~l 297 (307)
T 2nru_A 293 DIKKV 297 (307)
T ss_dssp CHHHH
T ss_pred CHHHH
Confidence 98764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=362.77 Aligned_cols=250 Identities=21% Similarity=0.291 Sum_probs=202.3
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
.++|++.+.||+|+||.||+|.+..+++.||+|+++... .....+.+|+++++.++||||+++++++ .+.+..+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~~~ 77 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESF-----ESMEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEE-----EETTEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEE-----ecCCEEE
Confidence 578999999999999999999999999999999987543 3456788999999999999999999994 4567899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecC--CCcEEE
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDE--DMIAHI 844 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kL 844 (986)
+||||+++|+|.+++.. ....+++.++..++.||+.||+|||+. ||+||||||+||+++. ++.+||
T Consensus 78 lv~e~~~g~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl 145 (321)
T 1tki_A 78 MIFEFISGLDIFERINT---------SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKI 145 (321)
T ss_dssp EEECCCCCCBHHHHHTS---------SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEE
T ss_pred EEEEeCCCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEE
Confidence 99999999999999952 234689999999999999999999999 9999999999999987 789999
Q ss_pred cccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCC
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALP 924 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 924 (986)
+|||+++...... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||...... ....
T Consensus 146 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~---- 213 (321)
T 1tki_A 146 IEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-----QIIE---- 213 (321)
T ss_dssp CCCTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHH----
T ss_pred EECCCCeECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH-----HHHH----
Confidence 9999998765332 223456899999999999988999999999999999999999999632211 1110
Q ss_pred CchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 925 DHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 925 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+....... + .......+.++.+++.+|++.||++|||++|+
T Consensus 214 ----~i~~~~~~~-~---------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~ 255 (321)
T 1tki_A 214 ----NIMNAEYTF-D---------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255 (321)
T ss_dssp ----HHHHTCCCC-C---------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred ----HHHcCCCCC-C---------------hhhhccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 011100000 0 00111234567899999999999999998763
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=375.27 Aligned_cols=358 Identities=19% Similarity=0.203 Sum_probs=236.9
Q ss_pred cCccCCCCCCEEEccCCCccccCCcchhccccCceeeceecccCCCCccchhcCccccceecccccccCccCccccCCCC
Q 046598 80 PHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSK 159 (986)
Q Consensus 80 ~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 159 (986)
..++++++|++|+|++|.+++. | .|+.+++|++|+|++|++++. | ++.+++|++|+|++|.+++. | ++++++
T Consensus 36 ~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~ 107 (457)
T 3bz5_A 36 ISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTK 107 (457)
T ss_dssp EEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTT
T ss_pred cChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCc
Confidence 3444555555555555555542 3 455555555555555555542 2 55555555555555555532 2 555555
Q ss_pred CCeEEccCCcCCCCcccccCCCcCcceeeccCCcccCcCcchhhccCCCceeecccccccccCCccccCCCCccEEeccc
Q 046598 160 IEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGV 239 (986)
Q Consensus 160 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~ 239 (986)
|++|++++|++++. | ++++++|++|++++|++++. + ++.+++|++|++++|+.
T Consensus 108 L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~--------------------- 160 (457)
T 3bz5_A 108 LTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKK--------------------- 160 (457)
T ss_dssp CCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSC---------------------
T ss_pred CCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCc---------------------
Confidence 55555555555532 2 45555555555555555532 1 44455555555555533
Q ss_pred cccccccCCcccccccccceEEecCceecccCCccccCCCCCcEEecccccccCCCchhhhhhhHhhhhhccCCCCCCCC
Q 046598 240 NKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGD 319 (986)
Q Consensus 240 N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~l~~l~~L~~l~l~~n~l~~~~~ 319 (986)
.+.++ +..+++|++|++++|++++ +| ++.+++|+.|++++|++++.+
T Consensus 161 ---~~~~~---~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~~------------------------ 207 (457)
T 3bz5_A 161 ---ITKLD---VTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKLD------------------------ 207 (457)
T ss_dssp ---CCCCC---CTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCCC------------------------
T ss_pred ---ccccc---cccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCeec------------------------
Confidence 33332 2245666777777777765 33 667777777777777766421
Q ss_pred CCcccccccccccccceeeccccccccCCCcccccccccceEEEccCCcccccCCccccCCCCCCEEEccCccccCcCCC
Q 046598 320 RDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPP 399 (986)
Q Consensus 320 ~~l~~l~~l~~~~~L~~l~l~~n~~~~~~p~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 399 (986)
+.. .++|+.|++++|++++ +| +..+++|+.|++++|++++..
T Consensus 208 --------------------------------l~~-l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~-- 249 (457)
T 3bz5_A 208 --------------------------------LNQ-NIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELD-- 249 (457)
T ss_dssp --------------------------------CTT-CTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCC--
T ss_pred --------------------------------ccc-CCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcC--
Confidence 001 1456777888888876 44 778888999999999998653
Q ss_pred cccCCCCCCEEEccCccceeecCcccccccccEEEecccccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcc
Q 046598 400 AIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSL 479 (986)
Q Consensus 400 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L 479 (986)
+..+++|+.|++++|++ +.|++++|.+.+.+| ++.+++|+.|++++|++.+.+|.. ..+|
T Consensus 250 -~~~l~~L~~L~l~~n~L-------------~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~----~~~L 309 (457)
T 3bz5_A 250 -VSTLSKLTTLHCIQTDL-------------LEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQ----AAGI 309 (457)
T ss_dssp -CTTCTTCCEEECTTCCC-------------SCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECT----TCCC
T ss_pred -HHHCCCCCEEeccCCCC-------------CEEECCCCccCCccc--ccccccCCEEECCCCcccceeccC----CCcc
Confidence 45678888888888754 477888998887777 567899999999999988777642 3456
Q ss_pred eEEEccCCcccccCCcccccccccchhhccCccccccCcccccCCccccEEecccccccccCCccccCCCCCCEEeCCCc
Q 046598 480 IVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQN 559 (986)
Q Consensus 480 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 559 (986)
+.|++++| ++|++|+|++|+|++. + ++.+++|+.|++++|+|++ ++.|..|++++|
T Consensus 310 ~~L~l~~~-------------~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n 365 (457)
T 3bz5_A 310 TELDLSQN-------------PKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNN 365 (457)
T ss_dssp SCCCCTTC-------------TTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGT
T ss_pred eEechhhc-------------ccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC--------ccccccccccCC
Confidence 65555554 6889999999999974 3 8899999999999999986 246677789999
Q ss_pred cCcccCchhhhcccccceeeccCCccccccCCc
Q 046598 560 NLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQ 592 (986)
Q Consensus 560 ~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~ 592 (986)
+++|. ..+..|..+++++|+++|.+|..
T Consensus 366 ~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~ 393 (457)
T 3bz5_A 366 NFEAE-----GQTITMPKETLTNNSLTIAVSPD 393 (457)
T ss_dssp SEEEE-----EEEEECCCBCCBTTBEEEECCTT
T ss_pred cEEec-----ceeeecCccccccCcEEEEcChh
Confidence 99886 36677888999999999999875
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=364.62 Aligned_cols=200 Identities=24% Similarity=0.324 Sum_probs=177.1
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
.++|++.+.||+|+||.||+|++..+++.||+|+++.. .....+.+.+|+++++.++||||++++++ +...+
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~-----~~~~~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYA-----FQTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEE-----EECSS
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEE-----EEeCC
Confidence 46799999999999999999999999999999999753 23345678999999999999999999998 45668
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..|+||||+++|+|.+++.. .+.+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+|
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vk 145 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSR----------ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIK 145 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHH----------HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEE
T ss_pred EEEEEEeCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEE
Confidence 89999999999999999852 24689999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCC
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTD 906 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~ 906 (986)
|+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 146 L~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~ 206 (337)
T 1o6l_A 146 ITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 206 (337)
T ss_dssp ECCCTTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred EeeccchhhcccCC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCC
Confidence 99999998543222 22334679999999999999999999999999999999999999996
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=370.07 Aligned_cols=260 Identities=22% Similarity=0.369 Sum_probs=203.4
Q ss_pred hcCCCCCcccccccceeEEEEEEC-------CCCeEEEEEEeeccC-chhHHHHHHHHHHHhcC-CCCcceeeeeecccc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILD-------DGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKILTACSGV 757 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 757 (986)
.++|++.+.||+|+||.||+|++. .++..||||+++... ....+++.+|+++++++ +||||++++++|
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~--- 156 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC--- 156 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE---
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE---
Confidence 468999999999999999999974 245689999997543 33457899999999999 899999999994
Q ss_pred ccCCCceEEEEEEeccCCCHhHhhccCCCCCc------cccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCC
Q 046598 758 DYQGNDFKALVFEFMHNRSLEEWLHPITREDE------TDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKP 831 (986)
Q Consensus 758 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 831 (986)
..++..|+||||+++|+|.+++........ .......+++.+++.++.||+.||+|||++ +|+||||||
T Consensus 157 --~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp 231 (370)
T 2psq_A 157 --TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA 231 (370)
T ss_dssp --CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCG
T ss_pred --ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccch
Confidence 455779999999999999999975432100 011234689999999999999999999999 999999999
Q ss_pred CCeEecCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCcccc
Q 046598 832 SNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFE 910 (986)
Q Consensus 832 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~ 910 (986)
+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 232 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~ 311 (370)
T 2psq_A 232 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311 (370)
T ss_dssp GGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred hhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999999999999999987654443333444567889999999999999999999999999999999 9999864221
Q ss_pred ccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 911 GDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
. ..... +....... .+..++.++.+++.+||+.||++|||++||
T Consensus 312 ~--~~~~~------------~~~~~~~~------------------~~~~~~~~l~~li~~~l~~dP~~Rpt~~el 355 (370)
T 2psq_A 312 E--ELFKL------------LKEGHRMD------------------KPANCTNELYMMMRDCWHAVPSQRPTFKQL 355 (370)
T ss_dssp G--GHHHH------------HHTTCCCC------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred H--HHHHH------------HhcCCCCC------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 1 11111 11000000 001234567899999999999999998764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=360.01 Aligned_cols=207 Identities=29% Similarity=0.472 Sum_probs=162.6
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
.++|++.+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|++++++++||||++++++ +..++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~-----~~~~~~~ 78 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDV-----IHTENKL 78 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEE-----ECCTTEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEE-----EEECCeE
Confidence 468999999999999999999999889999999997543 2334678899999999999999999999 4556789
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
++||||++ |+|.+++...... .....+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+
T Consensus 79 ~lv~e~~~-~~L~~~l~~~~~~----~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~ 150 (317)
T 2pmi_A 79 TLVFEFMD-NDLKKYMDSRTVG----NTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLG 150 (317)
T ss_dssp EEEEECCC-CBHHHHHHHHHSS----SCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred EEEEEecC-CCHHHHHHhcccc----ccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEEC
Confidence 99999997 6999998633211 2234589999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCcc
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDIM 908 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~ 908 (986)
|||+++...... .......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 151 Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 212 (317)
T 2pmi_A 151 DFGLARAFGIPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT 212 (317)
T ss_dssp CCSSCEETTSCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cCccceecCCCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999998764322 12234568999999999876 46899999999999999999999999743
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=363.02 Aligned_cols=249 Identities=24% Similarity=0.321 Sum_probs=200.4
Q ss_pred HhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcC-CCCcceeeeeeccccccC
Q 046598 685 NATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQ 760 (986)
Q Consensus 685 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 760 (986)
...++|.+.+.||+|+||.||+|+++.+++.||||+++... ....+.+..|.++++.+ +||||++++++ +.
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~-----~~ 88 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCT-----FQ 88 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEE-----EE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEE-----EE
Confidence 35678999999999999999999999999999999997532 23456788899999877 99999999998 45
Q ss_pred CCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCC
Q 046598 761 GNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDM 840 (986)
Q Consensus 761 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 840 (986)
+.+..|+||||+++|+|.+++.. .+.+++.+++.++.||+.||+|||++ ||+||||||+||+++.++
T Consensus 89 ~~~~~~lv~E~~~gg~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g 155 (345)
T 1xjd_A 89 TKENLFFVMEYLNGGDLMYHIQS----------CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDG 155 (345)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTS
T ss_pred eCCEEEEEEeCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCC
Confidence 66889999999999999999952 24589999999999999999999999 999999999999999999
Q ss_pred cEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHH
Q 046598 841 IAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLAR 920 (986)
Q Consensus 841 ~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~ 920 (986)
.+||+|||+++...... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||..... .....
T Consensus 156 ~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~ 228 (345)
T 1xjd_A 156 HIKIADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-----EELFH 228 (345)
T ss_dssp CEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH
T ss_pred CEEEeEChhhhhcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH-----HHHHH
Confidence 99999999998643222 223456799999999999999999999999999999999999999963211 11111
Q ss_pred hhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCC-CC
Q 046598 921 TALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMT-NV 986 (986)
Q Consensus 921 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~-eV 986 (986)
......+.- +...+.++.+++.+||+.||++||++. ||
T Consensus 229 ------------~i~~~~~~~----------------p~~~s~~~~~li~~lL~~dp~~R~~~~~~i 267 (345)
T 1xjd_A 229 ------------SIRMDNPFY----------------PRWLEKEAKDLLVKLFVREPEKRLGVRGDI 267 (345)
T ss_dssp ------------HHHHCCCCC----------------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCG
T ss_pred ------------HHHhCCCCC----------------CcccCHHHHHHHHHHhcCCHhHcCCChHHH
Confidence 000000000 001234577899999999999999987 53
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=357.20 Aligned_cols=260 Identities=24% Similarity=0.367 Sum_probs=198.0
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhc--CCCCcceeeeeeccccccCCCc
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKN--IRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~~~~~~ 763 (986)
..++|++.+.||+|+||+||+|++. ++.||||++... ..+.+.+|.+++.. ++||||+++++++... .....
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~-~~~~~ 79 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSWQ--GENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTS-RHSST 79 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE-ETTEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEEC--CEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccc-cCCCc
Confidence 3578999999999999999999984 689999998653 33555666666665 7999999999986543 34456
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEeecCCCCCeE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLH--------HDCQPPIAHCDLKPSNIL 835 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~~~~~ivH~Dlkp~NIl 835 (986)
..++||||+++|+|.++++. ..+++.+++.++.||+.||+||| +. +|+||||||+||+
T Consensus 80 ~~~lv~e~~~~g~L~~~l~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nil 145 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQL-----------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNIL 145 (301)
T ss_dssp EEEEEECCCTTCBHHHHHTT-----------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEE
T ss_pred eeEEehhhccCCCHHHHHhh-----------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEE
Confidence 78999999999999999951 35899999999999999999999 77 9999999999999
Q ss_pred ecCCCcEEEcccccceecCCCCCcc--ccccccccccccccccccCC------CcCcccchhhHHHHHHHHHhC------
Q 046598 836 LDEDMIAHIGDFGLARFLPLSSAQT--SSIGAKGSIGYIAPEYGLGS------EVSISGDVYSYGILLLELITR------ 901 (986)
Q Consensus 836 l~~~~~~kL~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvvl~elltg------ 901 (986)
++.++.+||+|||+++......... ......||+.|+|||++.+. .++.++|||||||++|||+||
T Consensus 146 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~ 225 (301)
T 3q4u_A 146 VKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI 225 (301)
T ss_dssp ECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred EcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccc
Confidence 9999999999999998664332221 12334799999999998876 566899999999999999999
Q ss_pred ----CCCCCccccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCC
Q 046598 902 ----KKPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESP 977 (986)
Q Consensus 902 ----~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP 977 (986)
+.||....................... ...+ .......++.++.+++.+||+.||
T Consensus 226 ~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~-------~~~~--------------~~~~~~~~~~~l~~li~~cl~~dP 284 (301)
T 3q4u_A 226 VEDYKPPFYDVVPNDPSFEDMRKVVCVDQQR-------PNIP--------------NRWFSDPTLTSLAKLMKECWYQNP 284 (301)
T ss_dssp CCCCCCTTTTTSCSSCCHHHHHHHHTTSCCC-------CCCC--------------GGGGGSHHHHHHHHHHHHHCCSSG
T ss_pred cccccccccccCCCCcchhhhhHHHhccCCC-------CCCC--------------hhhccCccHHHHHHHHHHHhhcCh
Confidence 777764443333332222211111000 0000 000112456778999999999999
Q ss_pred CCCCCCCCC
Q 046598 978 EDRMSMTNV 986 (986)
Q Consensus 978 ~~RPt~~eV 986 (986)
++||||+||
T Consensus 285 ~~Rps~~~i 293 (301)
T 3q4u_A 285 SARLTALRI 293 (301)
T ss_dssp GGSCCHHHH
T ss_pred hhCCCHHHH
Confidence 999999764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=359.46 Aligned_cols=250 Identities=22% Similarity=0.268 Sum_probs=200.8
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCch------hHHHHHHHHHHHhcCCCCcceeeeeeccccccC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHG------AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ 760 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 760 (986)
.++|.+.+.||+|+||.||+|.+..+++.||+|+++..... ..+.+.+|+.++++++||||+++++++ .
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~ 84 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----E 84 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence 45799999999999999999999999999999999753321 357789999999999999999999994 5
Q ss_pred CCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCC
Q 046598 761 GNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDM 840 (986)
Q Consensus 761 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 840 (986)
.+...++||||+++++|.+++.. ...+++.+++.++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~ 151 (326)
T 2y0a_A 85 NKTDVILILELVAGGELFDFLAE----------KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRN 151 (326)
T ss_dssp CSSEEEEEEECCCSCBHHHHHTT----------SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSS
T ss_pred eCCEEEEEEEcCCCCCHHHHHHh----------cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCC
Confidence 56789999999999999999952 34689999999999999999999999 999999999999999887
Q ss_pred ----cEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHH
Q 046598 841 ----IAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLH 916 (986)
Q Consensus 841 ----~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~ 916 (986)
.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......+ ...
T Consensus 152 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~ 227 (326)
T 2y0a_A 152 VPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLA 227 (326)
T ss_dssp SSSCCEEECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHH
T ss_pred CCCCCEEEEECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-HHH
Confidence 899999999987643322 234569999999999999999999999999999999999999996321110 000
Q ss_pred HHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 917 NLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 917 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
...... .. .. .......+..+.+++.+||+.||++|||++|+
T Consensus 228 ~~~~~~-~~-------------~~--------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~ 269 (326)
T 2y0a_A 228 NVSAVN-YE-------------FE--------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 269 (326)
T ss_dssp HHHHTC-CC-------------CC--------------HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHhcC-CC-------------cC--------------ccccccCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 000000 00 00 00011234557799999999999999998763
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=375.15 Aligned_cols=251 Identities=25% Similarity=0.337 Sum_probs=199.8
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
.++|.+.+.||+|+||.||+|.+..+++.||||+++... ....+++.+|++++++++||||++++++| ..++..
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~~ 187 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC-----TQKQPI 187 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEE-----CSSSSC
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----ecCCCc
Confidence 467899999999999999999999889999999987532 23345788999999999999999999995 445778
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
++||||+++|+|.++++. ....+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 188 ~lv~e~~~~g~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~ 255 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRT---------EGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKIS 255 (377)
T ss_dssp EEEEECCTTCBHHHHHHH---------HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEcCCCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEEC
Confidence 999999999999999962 234589999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCC
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALP 924 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 924 (986)
|||+++...............++..|+|||++.+..++.++|||||||++|||+| |+.||...... .
T Consensus 256 DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~-----~------- 323 (377)
T 3cbl_A 256 DFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ-----Q------- 323 (377)
T ss_dssp CGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH-----H-------
T ss_pred cCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----H-------
Confidence 9999986533221111122345778999999998899999999999999999999 99998642211 1
Q ss_pred CchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 925 DHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 925 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..+.+...... +.+..++.++.+++.+||+.||++|||++||
T Consensus 324 --~~~~~~~~~~~------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i 365 (377)
T 3cbl_A 324 --TREFVEKGGRL------------------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTI 365 (377)
T ss_dssp --HHHHHHTTCCC------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred --HHHHHHcCCCC------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 11111110000 0011234567899999999999999998764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=356.59 Aligned_cols=249 Identities=23% Similarity=0.393 Sum_probs=194.1
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
.++|++.+.||+|+||.||+|++..+++.||+|++... .....+.+.+|+.++++++||||++++++ +..++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~-----~~~~~ 84 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDV-----DEEDD 84 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEE-----EECSS
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEe-----eeeCC
Confidence 46899999999999999999999998999999998542 23345678999999999999999999999 45668
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..++||||+++++|.+++.. .+.+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~k 151 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIES----------HGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLK 151 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEE
T ss_pred eEEEEEeCCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEE
Confidence 89999999999999999952 24689999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhC
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTAL 923 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 923 (986)
|+|||+++...... ........||+.|+|||++.+..++.++||||+||++|||++|+.||...... .......
T Consensus 152 l~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-----~~~~~~~ 225 (294)
T 4eqm_A 152 IFDFGIAKALSETS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV-----SIAIKHI 225 (294)
T ss_dssp ECCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH-----HHHHHHH
T ss_pred EEeCCCcccccccc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHh
Confidence 99999997653222 12233456899999999999999999999999999999999999999632211 1111000
Q ss_pred CCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCC
Q 046598 924 PDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMS 982 (986)
Q Consensus 924 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt 982 (986)
....... ........+..+.+++.+|++.||++||+
T Consensus 226 ~~~~~~~-----------------------~~~~~~~~~~~l~~li~~~l~~dp~~R~~ 261 (294)
T 4eqm_A 226 QDSVPNV-----------------------TTDVRKDIPQSLSNVILRATEKDKANRYK 261 (294)
T ss_dssp SSCCCCH-----------------------HHHSCTTSCHHHHHHHHHHSCSSGGGSCS
T ss_pred hccCCCc-----------------------chhcccCCCHHHHHHHHHHhcCCHhHccc
Confidence 0000000 00001123456789999999999999994
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=364.07 Aligned_cols=251 Identities=22% Similarity=0.386 Sum_probs=197.3
Q ss_pred hcCCCCCcccccccceeEEEEEECCC---CeEEEEEEeecc-CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDG---RTTIAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
.++|++.+.||+|+||.||+|.+..+ +..||||+++.. .....+.+.+|++++++++||||+++++++ ..+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~ 122 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV-----TRG 122 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CGG
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeC
Confidence 45788999999999999999999744 456999999754 334457799999999999999999999995 445
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
...++||||+++|+|.++++. ....+++.+++.|+.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~ 190 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRT---------HDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVC 190 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHT---------TTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred CccEEEeeCCCCCcHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCE
Confidence 778999999999999999952 234689999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCC-ccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHH
Q 046598 843 HIGDFGLARFLPLSSA-QTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLAR 920 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~ 920 (986)
||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... ....
T Consensus 191 kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-----~~~~ 265 (325)
T 3kul_A 191 KVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR-----DVIS 265 (325)
T ss_dssp EECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-----HHHH
T ss_pred EECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH-----HHHH
Confidence 9999999987654322 122233456788999999998999999999999999999999 99998632211 1111
Q ss_pred hhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 921 TALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 921 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+....... ....++.++.+++.+||+.||++|||++||
T Consensus 266 ---------~~~~~~~~~------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ei 304 (325)
T 3kul_A 266 ---------SVEEGYRLP------------------APMGCPHALHQLMLDCWHKDRAQRPRFSQI 304 (325)
T ss_dssp ---------HHHTTCCCC------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ---------HHHcCCCCC------------------CCCCcCHHHHHHHHHHccCChhhCcCHHHH
Confidence 000000000 001234567899999999999999998764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=367.67 Aligned_cols=245 Identities=23% Similarity=0.301 Sum_probs=194.6
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcC-CCCcceeeeeeccccccCC
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQG 761 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 761 (986)
..++|++.+.||+|+||.||+|++..+++.||||+++.. .....+.+.+|.++++.+ +||||++++++ +..
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~-----~~~ 95 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCC-----FQT 95 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEE-----EEC
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEE-----EEe
Confidence 357899999999999999999999999999999999743 233456788999999988 79999999999 556
Q ss_pred CceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCc
Q 046598 762 NDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI 841 (986)
Q Consensus 762 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 841 (986)
.+..|+||||+++|+|.++++. .+.+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.
T Consensus 96 ~~~~~lv~E~~~gg~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ 162 (353)
T 3txo_A 96 PDRLFFVMEFVNGGDLMFHIQK----------SRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGH 162 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSC
T ss_pred CCEEEEEEeCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCC
Confidence 6889999999999999999952 24689999999999999999999999 9999999999999999999
Q ss_pred EEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHh
Q 046598 842 AHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLART 921 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~ 921 (986)
+||+|||+|+..... .......+||+.|+|||++.+..++.++||||+||++|||++|+.||..... .....
T Consensus 163 ikL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~~~~~- 234 (353)
T 3txo_A 163 CKLADFGMCKEGICN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE-----DDLFE- 234 (353)
T ss_dssp EEECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH-
T ss_pred EEEccccceeecccC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH-----HHHHH-
Confidence 999999999854322 2233446799999999999988999999999999999999999999963211 11111
Q ss_pred hCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 046598 922 ALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSM 983 (986)
Q Consensus 922 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 983 (986)
.+...... .+ .....++.+++.+|++.||++||++
T Consensus 235 -------~i~~~~~~-~p-------------------~~~~~~~~~li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 235 -------AILNDEVV-YP-------------------TWLHEDATGILKSFMTKNPTMRLGS 269 (353)
T ss_dssp -------HHHHCCCC-CC-------------------TTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred -------HHHcCCCC-CC-------------------CCCCHHHHHHHHHHhhhCHHHccCC
Confidence 11110000 00 0123456789999999999999998
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=366.33 Aligned_cols=251 Identities=19% Similarity=0.253 Sum_probs=202.6
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
.++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+|++++++++||||++++++ +.++...+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~-----~~~~~~~~ 124 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA-----FEDKYEMV 124 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEE-----EECSSEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEE-----EEeCCEEE
Confidence 4689999999999999999999999999999999986655566789999999999999999999999 45568899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecC--CCcEEE
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDE--DMIAHI 844 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kL 844 (986)
+||||+++|+|.+++.. ....+++.++..++.||+.||+|||+. +|+||||||+||+++. ++.+||
T Consensus 125 lv~E~~~gg~L~~~l~~---------~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL 192 (387)
T 1kob_A 125 LILEFLSGGELFDRIAA---------EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKI 192 (387)
T ss_dssp EEEECCCCCBHHHHTTC---------TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEE
T ss_pred EEEEcCCCCcHHHHHHh---------hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEE
Confidence 99999999999999952 234689999999999999999999999 9999999999999974 468999
Q ss_pred cccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCC
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALP 924 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 924 (986)
+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .........
T Consensus 193 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-~~~~~i~~~--- 265 (387)
T 1kob_A 193 IDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ETLQNVKRC--- 265 (387)
T ss_dssp CCCTTCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHHC---
T ss_pred EecccceecCCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH-HHHHHHHhC---
Confidence 99999987643322 23346899999999999999999999999999999999999999632111 000011000
Q ss_pred CchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 925 DHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 925 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.....+. .....+.++.+++.+||+.||++|||++|+
T Consensus 266 ---------~~~~~~~----------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~el 302 (387)
T 1kob_A 266 ---------DWEFDED----------------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 302 (387)
T ss_dssp ---------CCCCCSS----------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred ---------CCCCCcc----------------ccccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 0000000 000234457899999999999999998763
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=365.36 Aligned_cols=246 Identities=26% Similarity=0.366 Sum_probs=198.8
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
.++|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+++++.++||||++++++ +.+..
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~-----~~~~~ 88 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYS-----FQDEE 88 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEE-----EECSS
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEE-----EEeCC
Confidence 46799999999999999999999999999999999642 23345778899999999999999999998 45668
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..|+||||+++|+|.+++.. ...+++..++.++.||+.||+|||+. ||+||||||+||+++.++.+|
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~----------~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vk 155 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQ----------NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVH 155 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHT----------TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEE
T ss_pred EEEEEEecCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEE
Confidence 89999999999999999952 34689999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccC---CCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHH
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG---SEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLAR 920 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~ 920 (986)
|+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .......
T Consensus 156 L~DFG~a~~~~~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~--~~~~~~~ 230 (384)
T 4fr4_A 156 ITDFNIAAMLPRE---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST--SSKEIVH 230 (384)
T ss_dssp ECCCTTCEECCTT---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS--CHHHHHH
T ss_pred EeccceeeeccCC---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc--cHHHHHH
Confidence 9999999876432 22344679999999999874 45899999999999999999999999633221 1111111
Q ss_pred hhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 046598 921 TALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSM 983 (986)
Q Consensus 921 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 983 (986)
.+.......+ ...+.++.+++.+||+.||++||++
T Consensus 231 ---------~~~~~~~~~p-------------------~~~s~~~~~li~~lL~~dP~~R~s~ 265 (384)
T 4fr4_A 231 ---------TFETTVVTYP-------------------SAWSQEMVSLLKKLLEPNPDQRFSQ 265 (384)
T ss_dssp ---------HHHHCCCCCC-------------------TTSCHHHHHHHHHHSCSSGGGSCCS
T ss_pred ---------HHhhcccCCC-------------------CcCCHHHHHHHHHHhcCCHhHhccc
Confidence 0000000001 0123457899999999999999983
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=365.29 Aligned_cols=251 Identities=20% Similarity=0.278 Sum_probs=200.4
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
..++|++.+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|++++++++||||++++++ +.+++
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~-----~~~~~ 101 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS-----IQEES 101 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEE-----EECSS
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEE-----EEeCC
Confidence 4578999999999999999999999999999999997532 3345678999999999999999999999 45668
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCC---
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDM--- 840 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--- 840 (986)
..|+||||+++|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~----------~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~ 168 (362)
T 2bdw_A 102 FHYLVFDLVTGGELFEDIVA----------REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGA 168 (362)
T ss_dssp EEEEEECCCCSCBHHHHHTT----------CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTC
T ss_pred EEEEEEecCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCC
Confidence 89999999999999999852 24689999999999999999999999 999999999999998654
Q ss_pred cEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHH
Q 046598 841 IAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLAR 920 (986)
Q Consensus 841 ~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~ 920 (986)
.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .......
T Consensus 169 ~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~--~~~~~i~ 243 (362)
T 2bdw_A 169 AVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYAQIK 243 (362)
T ss_dssp CEEECCCTTCBCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHH
T ss_pred CEEEeecCcceEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHH
Confidence 59999999998764322 223457999999999999999999999999999999999999998632110 1111110
Q ss_pred hhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 921 TALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 921 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.. ... .+.. .....+.++.+++.+||+.||++|||++|+
T Consensus 244 ~~-----------~~~-~~~~---------------~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 282 (362)
T 2bdw_A 244 AG-----------AYD-YPSP---------------EWDTVTPEAKSLIDSMLTVNPKKRITADQA 282 (362)
T ss_dssp HT-----------CCC-CCTT---------------GGGGSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred hC-----------CCC-CCcc---------------cccCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 00 000 0000 001234457799999999999999998753
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=359.36 Aligned_cols=267 Identities=25% Similarity=0.407 Sum_probs=200.3
Q ss_pred hcCCCCCcccccccceeEEEEE----ECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGI----LDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
.++|++.+.||+|+||+||+|+ +..+++.||||+++.......+.+.+|++++++++||||++++++|.. .+.
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~ 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGR 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH---HHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCC
Confidence 4689999999999999999999 456789999999987666667889999999999999999999998642 223
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
...++||||+++|+|.+++.. ....+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~ 153 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQK---------HKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRV 153 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHH---------CGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEE
T ss_pred CceEEEEEeCCCCCHHHHHHh---------cccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeE
Confidence 558999999999999999962 234589999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCc-cccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHh
Q 046598 843 HIGDFGLARFLPLSSAQ-TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLART 921 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~ 921 (986)
||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||+||..||...... .......
T Consensus 154 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~ 230 (295)
T 3ugc_A 154 KIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGN 230 (295)
T ss_dssp EECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH---HHHHHCT
T ss_pred EEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH---HHhhhcC
Confidence 99999999876433221 2223345778899999999999999999999999999999999998632111 1111111
Q ss_pred hCCCc--hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 922 ALPDH--VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 922 ~~~~~--~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..... .....+. +.... +.+.+..++.++.+++.+||+.||++|||++||
T Consensus 231 ~~~~~~~~~~~~~~-~~~~~--------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el 282 (295)
T 3ugc_A 231 DKQGQMIVFHLIEL-LKNNG--------------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 282 (295)
T ss_dssp TCCTHHHHHHHHHH-HHTTC--------------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred ccccchhHHHHHHH-HhccC--------------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 00000 0011111 00000 001112345678899999999999999998764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=366.67 Aligned_cols=254 Identities=22% Similarity=0.279 Sum_probs=198.0
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcC-CCCcceeeeeeccccccCCC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~ 762 (986)
.++|++.+.||+|+||+||+|+++.+++.||+|+++.. .....+.+.+|..++.++ +||||++++++ +..+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~-----~~~~ 125 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC-----FQTE 125 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEE-----EECS
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEE-----EEEC
Confidence 46799999999999999999999999999999999753 223345688899999887 89999999998 4566
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
...|+||||+++|+|..++.. .+.+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+
T Consensus 126 ~~~~lV~E~~~gg~L~~~l~~----------~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~i 192 (396)
T 4dc2_A 126 SRLFFVIEYVNGGDLMFHMQR----------QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHI 192 (396)
T ss_dssp SEEEEEEECCTTCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCE
T ss_pred CEEEEEEEcCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCE
Confidence 889999999999999999952 24689999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 046598 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 922 (986)
||+|||+|+..... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+....
T Consensus 193 kL~DFGla~~~~~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~------ 264 (396)
T 4dc2_A 193 KLTDYGMCKEGLRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ------ 264 (396)
T ss_dssp EECCCTTCBCCCCT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------------
T ss_pred EEeecceeeecccC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch------
Confidence 99999999853222 2223456799999999999999999999999999999999999999964322111000
Q ss_pred CCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 046598 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMT 984 (986)
Q Consensus 923 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 984 (986)
.....+.......... .+...+.++.+++.+||+.||++||++.
T Consensus 265 --~~~~~~~~~i~~~~~~----------------~p~~~s~~~~~li~~lL~~dP~~R~~~~ 308 (396)
T 4dc2_A 265 --NTEDYLFQVILEKQIR----------------IPRSLSVKAASVLKSFLNKDPKERLGCH 308 (396)
T ss_dssp --CCHHHHHHHHHHCCCC----------------CCTTSCHHHHHHHHHHTCSCTTTSTTCS
T ss_pred --hhHHHHHHHHhccccC----------------CCCcCCHHHHHHHHHHhcCCHhHcCCCC
Confidence 0000000101100000 0002234577999999999999999973
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=365.46 Aligned_cols=254 Identities=22% Similarity=0.273 Sum_probs=200.6
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC-----chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-----HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 761 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 761 (986)
.++|++.+.||+|+||+||+|.+..+++.||||+++... ....+.+.+|+++++.++||||+++++++ ..
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~ 97 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETY-----SS 97 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEE-----Ee
Confidence 467999999999999999999999999999999986421 12357789999999999999999999984 45
Q ss_pred CceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCc
Q 046598 762 NDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI 841 (986)
Q Consensus 762 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 841 (986)
++..|+||||+++++|.+++.... .....+++..+..++.||+.||+|||++ +|+||||||+||+++.++.
T Consensus 98 ~~~~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~ 168 (351)
T 3c0i_A 98 DGMLYMVFEFMDGADLCFEIVKRA------DAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKEN 168 (351)
T ss_dssp TTEEEEEEECCSSCBHHHHHHHHH------HTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSST
T ss_pred CCEEEEEEeCCCCCCHHHHHHHhc------ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCC
Confidence 678999999999999998885221 1234589999999999999999999999 9999999999999987654
Q ss_pred ---EEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHH
Q 046598 842 ---AHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNL 918 (986)
Q Consensus 842 ---~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~ 918 (986)
+||+|||+++...... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||..... ..
T Consensus 169 ~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~ 240 (351)
T 3c0i_A 169 SAPVKLGGFGVAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE------RL 240 (351)
T ss_dssp TCCEEECCCTTCEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH------HH
T ss_pred CCcEEEecCcceeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH------HH
Confidence 9999999998765332 223345799999999999999999999999999999999999999963211 00
Q ss_pred HHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 919 ARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 919 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
. ..+........ .......+.++.+++.+||+.||++|||+.|+
T Consensus 241 ~--------~~i~~~~~~~~----------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~ 284 (351)
T 3c0i_A 241 F--------EGIIKGKYKMN----------------PRQWSHISESAKDLVRRMLMLDPAERITVYEA 284 (351)
T ss_dssp H--------HHHHHTCCCCC----------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred H--------HHHHcCCCCCC----------------ccccccCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 0 01111000000 00011234567899999999999999998763
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=372.76 Aligned_cols=253 Identities=17% Similarity=0.210 Sum_probs=200.4
Q ss_pred HhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 685 NATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 685 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
...++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||++++++ +.++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~-----~~~~ 82 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS-----ISEE 82 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEE-----EECS
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEE-----EEEC
Confidence 34678999999999999999999999999999999997533 2345678999999999999999999999 4566
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEec---CC
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLD---ED 839 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~ 839 (986)
+..++||||+++|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+||+++ .+
T Consensus 83 ~~~~lv~E~~~gg~L~~~i~~----------~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~ 149 (444)
T 3soa_A 83 GHHYLIFDLVTGGELFEDIVA----------REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKG 149 (444)
T ss_dssp SEEEEEECCCBCCBHHHHHHH----------CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTT
T ss_pred CEEEEEEEeCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCC
Confidence 889999999999999999852 34689999999999999999999999 999999999999998 46
Q ss_pred CcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHH
Q 046598 840 MIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLA 919 (986)
Q Consensus 840 ~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~ 919 (986)
+.+||+|||+++...... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||...... ......
T Consensus 150 ~~vkL~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~--~~~~~i 225 (444)
T 3soa_A 150 AAVKLADFGLAIEVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH--RLYQQI 225 (444)
T ss_dssp CCEEECCCSSCBCCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHH
T ss_pred CcEEEccCceeEEecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH--HHHHHH
Confidence 789999999998664322 2233467999999999999999999999999999999999999999632111 111111
Q ss_pred HhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 920 RTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 920 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
... .... +.. .....+.++.+++.+||+.||++|||++|+
T Consensus 226 ~~~-----------~~~~-~~~---------------~~~~~s~~~~~li~~~L~~dP~~Rpta~e~ 265 (444)
T 3soa_A 226 KAG-----------AYDF-PSP---------------EWDTVTPEAKDLINKMLTINPSKRITAAEA 265 (444)
T ss_dssp HHT-----------CCCC-CTT---------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred HhC-----------CCCC-Ccc---------------ccccCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 000 0000 000 001223457799999999999999998763
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=354.85 Aligned_cols=274 Identities=21% Similarity=0.286 Sum_probs=198.7
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
++|++.+.||+|+||+||+|++..+++.||||+++... ....+.+.+|++++++++||||+++++++ .+++..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEE-----EeCCEE
Confidence 57999999999999999999999999999999997533 23347788999999999999999999994 456789
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
++||||+++ ++.+++. ...+.+++.+++.++.|++.||+|||++ ||+||||||+||+++.++.+||+
T Consensus 77 ~lv~e~~~~-~l~~~~~---------~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~ 143 (292)
T 3o0g_A 77 TLVFEFCDQ-DLKKYFD---------SCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLA 143 (292)
T ss_dssp EEEEECCSE-EHHHHHH---------HTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred EEEEecCCC-CHHHHHH---------hCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEe
Confidence 999999965 6666654 2234689999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccCCC-cCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCC
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSE-VSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALP 924 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 924 (986)
|||+++..... ........||+.|+|||++.+.. ++.++||||+||++|||++|..||...................
T Consensus 144 Dfg~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~ 221 (292)
T 3o0g_A 144 NFGLARAFGIP--VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT 221 (292)
T ss_dssp CCTTCEECCSC--CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCC
T ss_pred ecccceecCCc--cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCC
Confidence 99999876422 22233456899999999988765 8999999999999999999888864222211122222111111
Q ss_pred Cc--hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 925 DH--VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 925 ~~--~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.. ........-...+... ................++.+++.+|++.||++|||++|+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 280 (292)
T 3o0g_A 222 PTEEQWPSMTKLPDYKPYPM-----YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280 (292)
T ss_dssp CCTTTCTTGGGSTTCCCCCC-----CCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CChhhhhhhccccccccccc-----ccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHH
Confidence 00 0000000000000000 000000000111234567799999999999999998764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=361.91 Aligned_cols=245 Identities=23% Similarity=0.325 Sum_probs=197.3
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
.++|.+.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+++++.++||||+++++++ ....
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-----~~~~ 82 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVI-----TTPT 82 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCC
Confidence 468999999999999999999999999999999986421 22346789999999999999999999994 4567
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..++||||+ +|+|.+++.. .+.+++.+++.++.||+.||+|||+. ||+||||||+||+++.++.+|
T Consensus 83 ~~~lv~E~~-~g~l~~~l~~----------~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~k 148 (336)
T 3h4j_B 83 DIVMVIEYA-GGELFDYIVE----------KKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVK 148 (336)
T ss_dssp EEEEEECCC-CEEHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEE
T ss_pred EEEEEEECC-CCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEE
Confidence 899999999 7899998842 24689999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccCCCc-CcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEV-SISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 922 (986)
|+|||++...... ......+||+.|+|||++.+..+ ++++||||+||++|+|++|+.||+....... .. .
T Consensus 149 l~DFG~s~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-----~~-~ 219 (336)
T 3h4j_B 149 IADFGLSNIMTDG---NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-----FK-K 219 (336)
T ss_dssp ECCSSCTBTTTTS---BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-----BC-C
T ss_pred EEEeccceeccCC---cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-----HH-H
Confidence 9999999865432 22334579999999999988876 7899999999999999999999964221110 00 0
Q ss_pred CCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 923 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+.......+ ...+.++.+++.+||+.||++|||++|+
T Consensus 220 --------i~~~~~~~p-------------------~~~s~~~~~li~~~L~~dP~~Rpt~~ei 256 (336)
T 3h4j_B 220 --------VNSCVYVMP-------------------DFLSPGAQSLIRRMIVADPMQRITIQEI 256 (336)
T ss_dssp --------CCSSCCCCC-------------------TTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred --------HHcCCCCCc-------------------ccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 000000000 0123456789999999999999998764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=355.75 Aligned_cols=250 Identities=24% Similarity=0.320 Sum_probs=194.4
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc--------------------------hhHHHHHHHHHHHh
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH--------------------------GAFKSFIAECNTLK 740 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 740 (986)
.++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 4689999999999999999999999999999999864321 12356889999999
Q ss_pred cCCCCcceeeeeeccccccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcC
Q 046598 741 NIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDC 820 (986)
Q Consensus 741 ~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ 820 (986)
+++||||+++++++.. ......++||||+++++|.+++. ...+++.+++.++.||+.||+|||++
T Consensus 92 ~l~h~~iv~~~~~~~~---~~~~~~~lv~e~~~~~~l~~~~~-----------~~~~~~~~~~~~~~qi~~~l~~lH~~- 156 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDD---PNEDHLYMVFELVNQGPVMEVPT-----------LKPLSEDQARFYFQDLIKGIEYLHYQ- 156 (298)
T ss_dssp TCCCTTBCCEEEEEEC---SSSSEEEEEEECCTTCBSCCSSC-----------SSCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred hCCCCCCCeEEEEEEc---CCCCEEEEEEecCCCCcHHHHhh-----------cCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 9999999999998642 23578999999999999988653 23689999999999999999999999
Q ss_pred CCCeEeecCCCCCeEecCCCcEEEcccccceecCCCCCccccccccccccccccccccCCC---cCcccchhhHHHHHHH
Q 046598 821 QPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSE---VSISGDVYSYGILLLE 897 (986)
Q Consensus 821 ~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvvl~e 897 (986)
+|+||||||+||+++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++||
T Consensus 157 --~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~ 232 (298)
T 2zv2_A 157 --KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYC 232 (298)
T ss_dssp --TEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHH
T ss_pred --CeeccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHH
Confidence 999999999999999999999999999987643322 223457999999999988765 4788999999999999
Q ss_pred HHhCCCCCCccccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCC
Q 046598 898 LITRKKPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESP 977 (986)
Q Consensus 898 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP 977 (986)
|++|+.||.... ...... .+..... ..+. ....+.++.+++.+||+.||
T Consensus 233 l~~g~~pf~~~~-----~~~~~~--------~~~~~~~-~~~~-----------------~~~~~~~l~~li~~~l~~dp 281 (298)
T 2zv2_A 233 FVFGQCPFMDER-----IMCLHS--------KIKSQAL-EFPD-----------------QPDIAEDLKDLITRMLDKNP 281 (298)
T ss_dssp HHHSSCSSCCSS-----HHHHHH--------HHHHCCC-CCCS-----------------SSCCCHHHHHHHHHHTCSCT
T ss_pred HHHCCCCCCCcc-----HHHHHH--------HHhcccC-CCCC-----------------ccccCHHHHHHHHHHhhcCh
Confidence 999999996321 111110 0000000 0000 00223457899999999999
Q ss_pred CCCCCCCCC
Q 046598 978 EDRMSMTNV 986 (986)
Q Consensus 978 ~~RPt~~eV 986 (986)
++|||++||
T Consensus 282 ~~R~s~~e~ 290 (298)
T 2zv2_A 282 ESRIVVPEI 290 (298)
T ss_dssp TTSCCHHHH
T ss_pred hhCCCHHHH
Confidence 999998764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=357.98 Aligned_cols=251 Identities=27% Similarity=0.386 Sum_probs=190.2
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
..++|++.+.||+|+||+||+|++. ++.||||++.... ....+++.+|++++++++||||+++++++ ....
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~ 107 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV-----TQPP 107 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSTT
T ss_pred ChhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECC
Confidence 4568999999999999999999884 6889999986533 33456789999999999999999999994 4557
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeecCCCCCeEecCCCc
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPP--IAHCDLKPSNILLDEDMI 841 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~ 841 (986)
..++||||+++|+|.+++.... ....+++.+++.++.||+.||+|||+. + |+||||||+||+++.++.
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~ 177 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSG-------AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYT 177 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTT-------HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCC
T ss_pred ceEEEEecCCCCcHHHHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCc
Confidence 7899999999999999996321 123489999999999999999999999 8 999999999999999999
Q ss_pred EEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHh
Q 046598 842 AHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLART 921 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~ 921 (986)
+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......
T Consensus 178 ~kL~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~--~~~~~~~ 253 (309)
T 3p86_A 178 VKVCDFGLSRLKAST--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ--VVAAVGF 253 (309)
T ss_dssp EEECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH--HHHHHHH
T ss_pred EEECCCCCCcccccc--ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHh
Confidence 999999999754322 122334568999999999999999999999999999999999999996432110 0000000
Q ss_pred hCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 922 ALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 922 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.... .. .+...+.++.+++.+||+.||++|||++||
T Consensus 254 ~~~~-----------~~------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l 289 (309)
T 3p86_A 254 KCKR-----------LE------------------IPRNLNPQVAAIIEGCWTNEPWKRPSFATI 289 (309)
T ss_dssp SCCC-----------CC------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred cCCC-----------CC------------------CCccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 0000 00 001233457899999999999999998764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=355.37 Aligned_cols=198 Identities=26% Similarity=0.350 Sum_probs=176.3
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
.++|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|+.+++.++||||++++++ +.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~-----~~~~~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGT-----FQDAQ 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEE-----EECSS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEE-----EEeCC
Confidence 467999999999999999999999999999999997532 2345678899999999999999999998 45668
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..|+||||+++|+|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+|
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~k 146 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRK----------SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIK 146 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHH----------TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEE
T ss_pred EEEEEEeCCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEE
Confidence 89999999999999999952 24589999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
|+|||+++..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 147 L~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 205 (318)
T 1fot_A 147 ITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD 205 (318)
T ss_dssp ECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred EeecCcceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence 9999999875321 2345799999999999999999999999999999999999999963
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=354.47 Aligned_cols=249 Identities=21% Similarity=0.263 Sum_probs=178.3
Q ss_pred CcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCC-CCcceeeeeeccccccCCCceEEEEEEe
Q 046598 693 VNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDFKALVFEF 771 (986)
Q Consensus 693 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~e~ 771 (986)
.+.||+|+||.||+|.+..+++.||||++... ....+.+|+.+++.+. ||||++++++ +.++...|+||||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~-----~~~~~~~~lv~e~ 87 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEV-----FHDQLHTFLVMEL 87 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEE-----EECSSEEEEEECC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEE-----EEcCCEEEEEEEc
Confidence 47899999999999999999999999998643 3467789999999996 9999999999 4566889999999
Q ss_pred ccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCC---cEEEcccc
Q 046598 772 MHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDM---IAHIGDFG 848 (986)
Q Consensus 772 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kL~DFG 848 (986)
+++|+|.+++.. ...+++.++..|+.||+.||+|||++ +|+||||||+||+++.++ .+||+|||
T Consensus 88 ~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg 154 (325)
T 3kn6_A 88 LNGGELFERIKK----------KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFG 154 (325)
T ss_dssp CCSCBHHHHHHH----------CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCT
T ss_pred cCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccc
Confidence 999999999952 34689999999999999999999999 999999999999998766 89999999
Q ss_pred cceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCchh
Q 046598 849 LARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVM 928 (986)
Q Consensus 849 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 928 (986)
+++...... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||........ .....
T Consensus 155 ~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----------~~~~~ 222 (325)
T 3kn6_A 155 FARLKPPDN--QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT----------CTSAV 222 (325)
T ss_dssp TCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-----------------CCCHH
T ss_pred cceecCCCC--CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc----------cccHH
Confidence 998654322 223345689999999999999999999999999999999999999974322100 00111
Q ss_pred HHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 929 DIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 929 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+............ ........+.++.+++.+||+.||++|||++||
T Consensus 223 ~~~~~i~~~~~~~------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~el 268 (325)
T 3kn6_A 223 EIMKKIKKGDFSF------------EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGL 268 (325)
T ss_dssp HHHHHHTTTCCCC------------CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTS
T ss_pred HHHHHHHcCCCCC------------CcccccCCCHHHHHHHHHHCCCChhHCCCHHHH
Confidence 1111111111100 001112345567899999999999999999986
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=357.42 Aligned_cols=278 Identities=21% Similarity=0.257 Sum_probs=205.1
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
.++|.+.+.||+|+||+||+|++..+++.||||+++... ....+.+.+|++++++++||||+++++++.. ......
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~~ 84 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE---TTTRHK 84 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---TTTCCE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeec---CCCceE
Confidence 467999999999999999999999989999999997533 2345778899999999999999999998532 234578
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEe----cCCCc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILL----DEDMI 841 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~ 841 (986)
++||||+++++|.+++.... ....+++.+++.++.||+.||+|||+. +|+||||||+||++ +.++.
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~ 154 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPS-------NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSV 154 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGG-------GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEE
T ss_pred EEEEeCCCCCCHHHHHHHhc-------cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCce
Confidence 99999999999999996322 123489999999999999999999999 99999999999999 78888
Q ss_pred EEEcccccceecCCCCCcccccccccccccccccccc--------CCCcCcccchhhHHHHHHHHHhCCCCCCccccccc
Q 046598 842 AHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGL--------GSEVSISGDVYSYGILLLELITRKKPTDIMFEGDM 913 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~ 913 (986)
+||+|||+++....... .....||+.|+|||++. +..++.++|||||||++|||++|+.||........
T Consensus 155 ~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 231 (319)
T 4euu_A 155 YKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231 (319)
T ss_dssp EEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG
T ss_pred EEEccCCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch
Confidence 99999999987643322 23356899999999876 57899999999999999999999999964332221
Q ss_pred cHHHH--HHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 914 NLHNL--ARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 914 ~~~~~--~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..... .....+......+.... ..+.+ +.. ...............+.+++.+||+.||++|||++|+
T Consensus 232 ~~~~~~~~~~~~p~~~~~~~~~~~-~~~~~--~~~---~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~el 300 (319)
T 4euu_A 232 NKEVMYKIITGKPSGAISGVQKAE-NGPID--WSG---DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300 (319)
T ss_dssp CHHHHHHHHHHCCTTCCEEEECST-TCCEE--EES---SCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHH
T ss_pred hHHHHHHHhcCCCcccchhhhccc-CCccc--cCc---cCCcccccchhHHHHhHHHHHHhccCChhhhccHHHh
Confidence 11111 11111111000000000 00000 000 0000011223556678899999999999999998763
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=361.71 Aligned_cols=257 Identities=22% Similarity=0.323 Sum_probs=193.7
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
..++|++.+.||+|+||.||+|++..+++.||||+++... ....+.+.+|++++++++||||+++++++... ....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~ 88 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE-TPAG 88 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEE-ETTE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeecc-CCCC
Confidence 3578999999999999999999999889999999997532 23346789999999999999999999986432 1222
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
...|+||||+++++|.++++. .+.+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~ 155 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHT----------EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAV 155 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCE
T ss_pred cccEEEEecCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCE
Confidence 356999999999999999952 24689999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCc-cccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHh
Q 046598 843 HIGDFGLARFLPLSSAQ-TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLART 921 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~ 921 (986)
||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....
T Consensus 156 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-----~~~~ 230 (311)
T 3ork_A 156 KVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-----VAYQ 230 (311)
T ss_dssp EECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHH
T ss_pred EEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-----HHHH
Confidence 99999999866433221 22334568999999999999999999999999999999999999996422111 1000
Q ss_pred hCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCC
Q 046598 922 ALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTN 985 (986)
Q Consensus 922 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 985 (986)
.....+.. ........+.++.+++.+||+.||++||++.+
T Consensus 231 ------------~~~~~~~~------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~ 270 (311)
T 3ork_A 231 ------------HVREDPIP------------PSARHEGLSADLDAVVLKALAKNPENRYQTAA 270 (311)
T ss_dssp ------------HHHCCCCC------------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHH
T ss_pred ------------HhcCCCCC------------cccccCCCCHHHHHHHHHHHhcCHhhChhhHH
Confidence 00000000 00001123456789999999999999998754
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=357.71 Aligned_cols=254 Identities=22% Similarity=0.282 Sum_probs=198.9
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcC-CCCcceeeeeeccccccCCC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~ 762 (986)
.++|++.+.||+|+||.||+|++..+++.||+|+++.. .....+.+.+|..+++++ +||||++++++ +..+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~-----~~~~ 82 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC-----FQTE 82 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEE-----EECS
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEE-----EEeC
Confidence 36799999999999999999999999999999999753 233456688999999988 89999999999 4556
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
...|+||||+++|+|.+++.. .+.+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~----------~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~ 149 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQR----------QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHI 149 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCE
T ss_pred CEEEEEEeCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCE
Confidence 889999999999999999952 24589999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 046598 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 922 (986)
||+|||+++...... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||......+....
T Consensus 150 kL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~------ 221 (345)
T 3a8x_A 150 KLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ------ 221 (345)
T ss_dssp EECCGGGCBCSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC------------
T ss_pred EEEeccccccccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc------
Confidence 999999998543221 223446799999999999999999999999999999999999999964221110000
Q ss_pred CCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 046598 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMT 984 (986)
Q Consensus 923 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 984 (986)
.....+.......... .+...+.++.+++.+||+.||++||++.
T Consensus 222 --~~~~~~~~~i~~~~~~----------------~p~~~s~~~~~li~~lL~~dP~~R~~~~ 265 (345)
T 3a8x_A 222 --NTEDYLFQVILEKQIR----------------IPRSLSVKAASVLKSFLNKDPKERLGCH 265 (345)
T ss_dssp ---CHHHHHHHHHHCCCC----------------CCTTSCHHHHHHHHHHTCSSTTTSTTCC
T ss_pred --ccHHHHHHHHHcCCCC----------------CCCCCCHHHHHHHHHHhcCCHhHCCCCC
Confidence 0000000000000000 0012234577899999999999999973
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=367.32 Aligned_cols=265 Identities=15% Similarity=0.215 Sum_probs=201.2
Q ss_pred hhcCCCCCcccccccceeEEEEEECCC-----CeEEEEEEeeccCchh-----------HHHHHHHHHHHhcCCCCccee
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDG-----RTTIAVKVFNLLHHGA-----------FKSFIAECNTLKNIRHRNLVK 749 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~ 749 (986)
..++|++.+.||+|+||.||+|.+..+ ++.||||++....... .....+|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 356899999999999999999999764 4789999987543211 123445666777889999999
Q ss_pred eeeeccccccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecC
Q 046598 750 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDL 829 (986)
Q Consensus 750 l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dl 829 (986)
+++++... .......++||||+ +++|.+++.. ....+++.+++.|+.||+.||+|||+. +|+||||
T Consensus 113 ~~~~~~~~-~~~~~~~~lv~e~~-g~~L~~~~~~---------~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDl 178 (364)
T 3op5_A 113 YWGSGLHD-KNGKSYRFMIMDRF-GSDLQKIYEA---------NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDI 178 (364)
T ss_dssp EEEEEEEE-ETTEEEEEEEEECE-EEEHHHHHHH---------TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred EEeeeeec-cCCcceEEEEEeCC-CCCHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecC
Confidence 99996542 23346689999999 9999999962 235699999999999999999999999 9999999
Q ss_pred CCCCeEec--CCCcEEEcccccceecCCCCCc-----cccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCC
Q 046598 830 KPSNILLD--EDMIAHIGDFGLARFLPLSSAQ-----TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRK 902 (986)
Q Consensus 830 kp~NIll~--~~~~~kL~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~ 902 (986)
||+|||++ .++.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||+||+
T Consensus 179 kp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~ 258 (364)
T 3op5_A 179 KASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258 (364)
T ss_dssp CGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSC
T ss_pred CHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999 8899999999999876432211 1123345999999999999999999999999999999999999
Q ss_pred CCCCccccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCC
Q 046598 903 KPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMS 982 (986)
Q Consensus 903 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt 982 (986)
.||...... ..............+.+++++.+... .++.++.+++..||+.||++||+
T Consensus 259 ~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~li~~cl~~~p~~RP~ 316 (364)
T 3op5_A 259 LPWEDNLKD-PKYVRDSKIRYRENIASLMDKCFPAA---------------------NAPGEIAKYMETVKLLDYTEKPL 316 (364)
T ss_dssp CTTGGGTTC-HHHHHHHHHHHHHCHHHHHHHHSCTT---------------------CCCHHHHHHHHHHHTCCTTCCCC
T ss_pred CCccccccC-HHHHHHHHHHhhhhHHHHHHHhcccc---------------------cCHHHHHHHHHHHhcCCCCCCCC
Confidence 999743222 11222222222223344444433211 23456889999999999999999
Q ss_pred CCCC
Q 046598 983 MTNV 986 (986)
Q Consensus 983 ~~eV 986 (986)
+++|
T Consensus 317 ~~~l 320 (364)
T 3op5_A 317 YENL 320 (364)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8763
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=348.09 Aligned_cols=253 Identities=22% Similarity=0.307 Sum_probs=202.8
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
..++|++.+.||+|+||.||+|.+..+++.||||+++... ....+.+.+|+.+++.++||||+++++++ ..++.
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 79 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNI 79 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EETTE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEE-----EcCCE
Confidence 3567999999999999999999999889999999997533 33457889999999999999999999984 45578
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.++||||+++++|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 80 ~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl 146 (276)
T 2yex_A 80 QYLFLEYCSGGELFDRIEP----------DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKI 146 (276)
T ss_dssp EEEEEECCTTEEGGGGSBT----------TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred EEEEEEecCCCcHHHHHhh----------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEE
Confidence 8999999999999999842 24689999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCccccccccccccccccccccCCCc-CcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhC
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEV-SISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTAL 923 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 923 (986)
+|||.+................|++.|+|||++.+..+ +.++||||||+++|||++|+.||.........+..+....
T Consensus 147 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~- 225 (276)
T 2yex_A 147 SDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK- 225 (276)
T ss_dssp CCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTC-
T ss_pred eeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcc-
Confidence 99999986543332233345678999999999988765 7899999999999999999999975333221111111100
Q ss_pred CCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 924 PDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 924 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
....+ ....+..+.+++.+||+.||++|||++||
T Consensus 226 -----------~~~~~------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~i 259 (276)
T 2yex_A 226 -----------TYLNP------------------WKKIDSAPLALLHKILVENPSARITIPDI 259 (276)
T ss_dssp -----------TTSTT------------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred -----------cccCc------------------hhhcCHHHHHHHHHHCCCCchhCCCHHHH
Confidence 00000 01223456789999999999999998764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=368.65 Aligned_cols=269 Identities=24% Similarity=0.322 Sum_probs=206.8
Q ss_pred hHHHHHhhcCCCCCcccccccceeEEEEE-----ECCCCeEEEEEEeeccC-chhHHHHHHHHHHHhcC-CCCcceeeee
Q 046598 680 YQNLYNATDRFSSVNQIGEGSFGSVFKGI-----LDDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKILT 752 (986)
Q Consensus 680 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~ 752 (986)
..+.....++|++.+.||+|+||.||+|+ ...+++.||||+++... ....+.+.+|+++++++ +||||+++++
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~ 93 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 93 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence 34444567899999999999999999999 44557899999997533 33456799999999999 8999999999
Q ss_pred eccccccCCCceEEEEEEeccCCCHhHhhccCCCCCc-------------------------------------------
Q 046598 753 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDE------------------------------------------- 789 (986)
Q Consensus 753 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------------------------------------------- 789 (986)
+|. ..+...++||||+++|+|.++++.......
T Consensus 94 ~~~----~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (359)
T 3vhe_A 94 ACT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169 (359)
T ss_dssp EEC----STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred eee----cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence 963 334568999999999999999975432100
Q ss_pred -------------cccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcccccceecCCC
Q 046598 790 -------------TDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLS 856 (986)
Q Consensus 790 -------------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~ 856 (986)
.......+++..++.|+.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 246 (359)
T 3vhe_A 170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246 (359)
T ss_dssp --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence 000123389999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCchhHHhhhhc
Q 046598 857 SAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALPDHVMDIVDSTL 935 (986)
Q Consensus 857 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 935 (986)
..........||+.|+|||++.+..++.++|||||||++|||+| |+.||....... ............
T Consensus 247 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~~~~~~~~~~~~---------- 315 (359)
T 3vhe_A 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLKEGTRM---------- 315 (359)
T ss_dssp TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-HHHHHHHHTCCC----------
T ss_pred ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH-HHHHHHHcCCCC----------
Confidence 44444455678999999999999999999999999999999998 999996432211 111111110000
Q ss_pred ccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 936 LNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 936 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..+ ...+.++.+++.+||+.||++|||++||
T Consensus 316 -~~~-------------------~~~~~~l~~li~~~l~~dP~~Rps~~el 346 (359)
T 3vhe_A 316 -RAP-------------------DYTTPEMYQTMLDCWHGEPSQRPTFSEL 346 (359)
T ss_dssp -CCC-------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -CCC-------------------CCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 000 0123457899999999999999998764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=358.42 Aligned_cols=245 Identities=21% Similarity=0.265 Sum_probs=198.7
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcC-CCCcceeeeeeccccccCC
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQG 761 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 761 (986)
..++|++.+.||+|+||.||+|++..+++.||||+++.. .....+.+..|.++++.+ +||+|++++++ +..
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~-----~~~ 92 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC-----FQT 92 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEE-----EEC
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEE-----EEc
Confidence 356899999999999999999999998999999999753 223456788999999988 89999999998 456
Q ss_pred CceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCc
Q 046598 762 NDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI 841 (986)
Q Consensus 762 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 841 (986)
.+..|+||||++||+|.+++.. .+.+++.+++.++.||+.||+|||++ ||+||||||+||+++.++.
T Consensus 93 ~~~~~lv~E~~~gg~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ 159 (353)
T 2i0e_A 93 MDRLYFVMEYVNGGDLMYHIQQ----------VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGH 159 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSC
T ss_pred CCEEEEEEeCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCc
Confidence 6889999999999999999952 23589999999999999999999999 9999999999999999999
Q ss_pred EEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHh
Q 046598 842 AHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLART 921 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~ 921 (986)
+||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .....
T Consensus 160 vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~~~~~- 231 (353)
T 2i0e_A 160 IKIADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DELFQ- 231 (353)
T ss_dssp EEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH-
T ss_pred EEEEeCCcccccccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH-----HHHHH-
Confidence 9999999998543221 223446799999999999999999999999999999999999999963211 11111
Q ss_pred hCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 046598 922 ALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSM 983 (986)
Q Consensus 922 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 983 (986)
.+...... -+ ...+.++.+++.+|++.||++||++
T Consensus 232 -------~i~~~~~~-~p-------------------~~~s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 232 -------SIMEHNVA-YP-------------------KSMSKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp -------HHHHCCCC-CC-------------------TTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred -------HHHhCCCC-CC-------------------CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 11110000 00 0223457799999999999999976
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=354.72 Aligned_cols=275 Identities=23% Similarity=0.315 Sum_probs=199.0
Q ss_pred HhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 685 NATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 685 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
...++|++.++||+|+||+||+|++.. ++.||+|+++... ....+.+.+|++++++++||||++++++ +..+
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~-----~~~~ 91 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV-----IHSE 91 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEE-----ECCS
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeE-----EccC
Confidence 346789999999999999999999975 8899999986432 2334678899999999999999999999 4566
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
...++||||++ ++|.+++.. ....+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 92 ~~~~lv~e~~~-~~l~~~~~~---------~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~ 158 (311)
T 3niz_A 92 RCLTLVFEFME-KDLKKVLDE---------NKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGAL 158 (311)
T ss_dssp SCEEEEEECCS-EEHHHHHHT---------CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCE
T ss_pred CEEEEEEcCCC-CCHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCE
Confidence 78999999997 588888852 234589999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHh
Q 046598 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLART 921 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~ 921 (986)
||+|||+++...... .......+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||......+ ........
T Consensus 159 kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~ 235 (311)
T 3niz_A 159 KLADFGLARAFGIPV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD-QLPKIFSI 235 (311)
T ss_dssp EECCCTTCEETTSCC--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT-HHHHHHHH
T ss_pred EEccCcCceecCCCc--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHH
Confidence 999999998764322 22334568999999999876 568999999999999999999999997543322 12222111
Q ss_pred hC---CCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 922 AL---PDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 922 ~~---~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.. +.......+......... .. ...............++.+++.+|++.||++|||++|+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~---~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 298 (311)
T 3niz_A 236 LGTPNPREWPQVQELPLWKQRTF---QV--FEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDA 298 (311)
T ss_dssp HCCCCTTTSGGGTTSHHHHSCCC---CC--CCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred HCCCChHHhhhhhccchhhhccc---cc--ccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 11 111111000000000000 00 00000000111234567899999999999999998764
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=380.94 Aligned_cols=387 Identities=20% Similarity=0.218 Sum_probs=224.8
Q ss_pred CCcCCCCCCCCCCCCCc----ceeeEecCCCCeEEEEeccCCCCccccCcCccCCCCCCEEEccCCCccccCCcchhccc
Q 046598 35 DPLGVLASWNESSHFCQ----WRGVTCSRRHQRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLR 110 (986)
Q Consensus 35 ~~~~~l~~w~~~~~~c~----w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~ 110 (986)
+....+++|.++.+||. |.++.|+. .++....... ....-..++.++.|++++|.+....+..|.+++
T Consensus 4 ~~~~~l~~~~~~~~C~~~~~~~~c~~~~~------~i~~~~~~~~--~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~ 75 (597)
T 3oja_B 4 QQRYNVKPRQPEYKCIDSNLQYDCVFYDV------HIDMQTQDVY--FGFEDITLNNQKIVTFKNSTMRKLPAALLDSFR 75 (597)
T ss_dssp -------CCCSEECCCCC--CCSEEECSC------EECSSCCCCE--ESCSSGGGCCCSEEEESSCEESEECTHHHHHCC
T ss_pred cccccccCCCCCCcCcccCcCceeEecCc------eecccccccc--cCcccccCCCceEEEeeCCCCCCcCHHHHccCC
Confidence 44556899998888874 66666541 1221111111 111122356677777777777665556667777
Q ss_pred cCceeeceecccCCCCccchhcCccccceecccccccCccCccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeecc
Q 046598 111 RLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLS 190 (986)
Q Consensus 111 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 190 (986)
+|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|+++++|++|+|++|.+++..+..|+++++|++|+|+
T Consensus 76 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls 155 (597)
T 3oja_B 76 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMS 155 (597)
T ss_dssp CCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEee
Confidence 77777777777776666667777777777777777766666666666666666666666665444455666666666666
Q ss_pred CCcccCcCcchhhccCCCceeecccccccccCCccccCCCCccEEeccccccccccCCcccccccccceEEecCceeccc
Q 046598 191 GNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGA 270 (986)
Q Consensus 191 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~ 270 (986)
+|.+++..|..|+.+++|++|+|++|++++. +
T Consensus 156 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~----------------------------------------------- 187 (597)
T 3oja_B 156 NNNLERIEDDTFQATTSLQNLQLSSNRLTHV-D----------------------------------------------- 187 (597)
T ss_dssp SSCCCBCCTTTTTTCTTCCEEECTTSCCSBC-C-----------------------------------------------
T ss_pred CCcCCCCChhhhhcCCcCcEEECcCCCCCCc-C-----------------------------------------------
Confidence 6666655555566666666666555555421 0
Q ss_pred CCccccCCCCCcEEecccccccCCCchhhhhhhHhhhhhccCCCCCCCCCCcccccccccccccceeeccccccccCCCc
Q 046598 271 IPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPA 350 (986)
Q Consensus 271 ~p~~l~~l~~L~~L~ls~N~l~~~~~~l~~l~~L~~l~l~~n~l~~~~~~~l~~l~~l~~~~~L~~l~l~~n~~~~~~p~ 350 (986)
++.+++|+.|+
T Consensus 188 ----~~~l~~L~~L~----------------------------------------------------------------- 198 (597)
T 3oja_B 188 ----LSLIPSLFHAN----------------------------------------------------------------- 198 (597)
T ss_dssp ----GGGCTTCSEEE-----------------------------------------------------------------
T ss_pred ----hhhhhhhhhhh-----------------------------------------------------------------
Confidence 01111122222
Q ss_pred ccccccccceEEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCcccccccc
Q 046598 351 CISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKL 430 (986)
Q Consensus 351 ~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L 430 (986)
+++|.+++ +....+|+.|++++|.++...+. +
T Consensus 199 -------------l~~n~l~~-----l~~~~~L~~L~ls~n~l~~~~~~-~----------------------------- 230 (597)
T 3oja_B 199 -------------VSYNLLST-----LAIPIAVEELDASHNSINVVRGP-V----------------------------- 230 (597)
T ss_dssp -------------CCSSCCSE-----EECCTTCSEEECCSSCCCEEECS-C-----------------------------
T ss_pred -------------cccCcccc-----ccCCchhheeeccCCcccccccc-c-----------------------------
Confidence 22222211 01112344444444444311110 0
Q ss_pred cEEEecccccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccC
Q 046598 431 FILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFG 510 (986)
Q Consensus 431 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 510 (986)
.++|+.|+|++|.+++. . .++.+++|+.|+|++|.|++..|..|..+++|+.|+|++
T Consensus 231 --------------------~~~L~~L~L~~n~l~~~--~-~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 287 (597)
T 3oja_B 231 --------------------NVELTILKLQHNNLTDT--A-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISN 287 (597)
T ss_dssp --------------------CSCCCEEECCSSCCCCC--G-GGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTT
T ss_pred --------------------CCCCCEEECCCCCCCCC--h-hhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCC
Confidence 12455555555555531 2 244556666666666666666666666667777777777
Q ss_pred ccccccCcccccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCccccccC
Q 046598 511 NKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVP 590 (986)
Q Consensus 511 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p 590 (986)
|++++ +|..+..+++|+.|+|++|.++ .+|..+..+++|+.|+|++|+|++. | +..+++|+.|+|++|+++|...
T Consensus 288 N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~~~ 362 (597)
T 3oja_B 288 NRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSL 362 (597)
T ss_dssp SCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHH
T ss_pred CCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCChhH
Confidence 77763 5666666777777777777777 4666677777888888888887754 2 5667788888888888887643
Q ss_pred CccccccccceeeeCCcccccCCCCCCCCCCCC
Q 046598 591 TQGVFKNASITSVFGNLKLCGGIPEFQLPTCSS 623 (986)
Q Consensus 591 ~~~~~~~~~~~~~~~n~~lcg~~~~~~~~~~~~ 623 (986)
. ..+..+....+.+++..|+.+.......|..
T Consensus 363 ~-~~~~~~~~~~~~~~~~~C~~~~~~~~~~cc~ 394 (597)
T 3oja_B 363 R-ALFRNVARPAVDDADQHCKIDYQLEHGLCCK 394 (597)
T ss_dssp H-HHTTTCCTTTBCCCCCCCCTTCEEETTEEEE
T ss_pred H-HHHHHHhhhccccccccCCcchhccCCcccc
Confidence 3 3455566667788999999866554455543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=369.57 Aligned_cols=257 Identities=24% Similarity=0.393 Sum_probs=199.0
Q ss_pred hcCCCCCcccccccceeEEEEEE-----CCCCeEEEEEEeecc-CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGIL-----DDGRTTIAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ 760 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 760 (986)
.++|++.+.||+|+||.||+|++ ..+++.||||+++.. ......++.+|+.++++++||||+++++++ .
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~ 144 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS-----L 144 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----C
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----e
Confidence 46799999999999999999995 345778999998643 334456789999999999999999999994 4
Q ss_pred CCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCC
Q 046598 761 GNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDM 840 (986)
Q Consensus 761 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 840 (986)
.....++||||+++|+|.+++...... ......+++.+++.++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~---~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~ 218 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPR---PSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPG 218 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCC---SSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSS
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccc---cCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCC
Confidence 557789999999999999999744322 12335689999999999999999999999 999999999999999555
Q ss_pred ---cEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHH
Q 046598 841 ---IAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLH 916 (986)
Q Consensus 841 ---~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~ 916 (986)
.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... .
T Consensus 219 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~-----~ 293 (367)
T 3l9p_A 219 PGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-----Q 293 (367)
T ss_dssp TTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----H
T ss_pred CCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----H
Confidence 599999999975532222233334567899999999999999999999999999999998 9999863211 1
Q ss_pred HHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 917 NLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 917 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.... .+.......+ ...++.++.+++.+||+.||++|||++||
T Consensus 294 ~~~~---------~i~~~~~~~~------------------~~~~~~~l~~li~~~l~~dP~~Rps~~ei 336 (367)
T 3l9p_A 294 EVLE---------FVTSGGRMDP------------------PKNCPGPVYRIMTQCWQHQPEDRPNFAII 336 (367)
T ss_dssp HHHH---------HHHTTCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHH---------HHHcCCCCCC------------------CccCCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 1111 1110000000 01234457899999999999999998764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=367.33 Aligned_cols=251 Identities=23% Similarity=0.424 Sum_probs=188.1
Q ss_pred hcCCCCCcccccccceeEEEEEEC---CCCeEEEEEEeecc-CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILD---DGRTTIAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
.++|++.+.||+|+||.||+|++. ..+..||||+++.. .....+++.+|++++++++||||++++++| ...
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~ 118 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV-----TKS 118 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CSS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----eeC
Confidence 458999999999999999999986 45678999999754 334456899999999999999999999995 445
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
...++||||+++|+|.++++. ....+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~---------~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~ 186 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRK---------HDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVC 186 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHT---------TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCE
T ss_pred CceEEEEeCCCCCcHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCE
Confidence 788999999999999999962 234689999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCc-cccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHH
Q 046598 843 HIGDFGLARFLPLSSAQ-TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLAR 920 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~ 920 (986)
||+|||+++........ .......+++.|+|||++.+..++.++|||||||++|||++ |+.||..... ...
T Consensus 187 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~-----~~~-- 259 (373)
T 2qol_A 187 KVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-----QDV-- 259 (373)
T ss_dssp EECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH-----HHH--
T ss_pred EECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH-----HHH--
Confidence 99999999876433221 11222345778999999999999999999999999999998 9999863221 111
Q ss_pred hhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 921 TALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 921 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+.+........ ...++.++.+++.+||+.||++||+++||
T Consensus 260 -------~~~i~~~~~~~~------------------~~~~~~~l~~li~~cl~~dp~~RPs~~~i 300 (373)
T 2qol_A 260 -------IKAVDEGYRLPP------------------PMDCPAALYQLMLDCWQKDRNNRPKFEQI 300 (373)
T ss_dssp -------HHHHHTTEECCC------------------CTTCBHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -------HHHHHcCCCCCC------------------CccccHHHHHHHHHHhCcChhhCcCHHHH
Confidence 111111110000 01234567899999999999999998764
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=359.39 Aligned_cols=240 Identities=19% Similarity=0.248 Sum_probs=197.7
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
.++|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|+++++.++||||++++++ +.++.
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~-----~~~~~ 114 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS-----FKDNS 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEE-----EECSS
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEE-----EEcCC
Confidence 468999999999999999999999989999999996432 2345678899999999999999999998 45668
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..|+||||+++|+|.+++.. .+.+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+|
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~k 181 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRR----------IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQ 181 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHH----------HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEE
T ss_pred EEEEEEcCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEE
Confidence 89999999999999999952 23589999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhC
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTAL 923 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 923 (986)
|+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .....
T Consensus 182 L~DFg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~--- 248 (350)
T 1rdq_E 182 VTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-----IQIYE--- 248 (350)
T ss_dssp ECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH---
T ss_pred EcccccceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH-----HHHHH---
Confidence 9999999876422 2345799999999999999999999999999999999999999963211 11111
Q ss_pred CCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCC
Q 046598 924 PDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMS 982 (986)
Q Consensus 924 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt 982 (986)
.+..... .-+ ...+.++.+++.+||+.||++||+
T Consensus 249 -----~i~~~~~-~~p-------------------~~~~~~~~~li~~lL~~dp~~R~~ 282 (350)
T 1rdq_E 249 -----KIVSGKV-RFP-------------------SHFSSDLKDLLRNLLQVDLTKRFG 282 (350)
T ss_dssp -----HHHHCCC-CCC-------------------TTCCHHHHHHHHHHSCSCTTTCTT
T ss_pred -----HHHcCCC-CCC-------------------CCCCHHHHHHHHHHhhcCHHhccC
Confidence 0111000 000 012345779999999999999998
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=370.55 Aligned_cols=203 Identities=26% Similarity=0.295 Sum_probs=170.5
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc--CchhHHHHHHHHHHHhcCCCCcceeeeeeccccc-cCCC
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-YQGN 762 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~ 762 (986)
..++|++.+.||+|+||+||+|++..+++.||||++... .....+++.+|+.+++.++||||+++++++.... ....
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 357899999999999999999999999999999999743 3345678899999999999999999999975432 2344
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
...|+||||+++ ++.+.+. ..+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~------------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~ 203 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQ------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTL 203 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHT------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCE
T ss_pred CeEEEEEeCCCC-CHHHHHh------------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCE
Confidence 678999999965 5666663 2488999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
||+|||+|+..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 204 kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g 265 (464)
T 3ttj_A 204 KILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 265 (464)
T ss_dssp EECCCCCC-----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EEEEEEeeeecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999865432 223446799999999999999999999999999999999999999974
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=371.61 Aligned_cols=207 Identities=24% Similarity=0.324 Sum_probs=172.9
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc--CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
..++|++.+.||+|+||.||+|++..+++.||||+++.. .....+++.+|++++++++||||+++++++.........
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 457899999999999999999999999999999999642 334457889999999999999999999997554444447
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..|+||||++ ++|.+++.. ...+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+|
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~----------~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~k 169 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKT----------PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVK 169 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHS----------SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEE
T ss_pred eEEEEEecCC-cCHHHHHhc----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEE
Confidence 7999999995 699999952 34689999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCc--------------------cccccccccccccccccc-cCCCcCcccchhhHHHHHHHHHhCC
Q 046598 844 IGDFGLARFLPLSSAQ--------------------TSSIGAKGSIGYIAPEYG-LGSEVSISGDVYSYGILLLELITRK 902 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGvvl~elltg~ 902 (986)
|+|||+|+........ ......+||+.|+|||++ .+..++.++||||+||++|||++|.
T Consensus 170 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~ 249 (432)
T 3n9x_A 170 VCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNML 249 (432)
T ss_dssp ECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTC
T ss_pred EccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcc
Confidence 9999999876433211 123556799999999985 5567999999999999999999976
Q ss_pred CCCC
Q 046598 903 KPTD 906 (986)
Q Consensus 903 ~pf~ 906 (986)
.||.
T Consensus 250 ~p~~ 253 (432)
T 3n9x_A 250 QSHI 253 (432)
T ss_dssp TTTC
T ss_pred cccc
Confidence 6654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=356.44 Aligned_cols=257 Identities=22% Similarity=0.319 Sum_probs=197.8
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeecccccc-----
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY----- 759 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 759 (986)
..++|++.+.||+|+||.||+|++..+++.||||+++... ....+.+.+|++++++++||||++++++|.....
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 3567999999999999999999999889999999997533 3355789999999999999999999998643210
Q ss_pred -----------------------------------------------CCCceEEEEEEeccCCCHhHhhccCCCCCcccc
Q 046598 760 -----------------------------------------------QGNDFKALVFEFMHNRSLEEWLHPITREDETDE 792 (986)
Q Consensus 760 -----------------------------------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~ 792 (986)
..+...++||||+++++|.+++.....
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~------ 157 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS------ 157 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS------
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC------
Confidence 122348999999999999999974322
Q ss_pred CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcccccceecCCCCCc----------ccc
Q 046598 793 APRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQ----------TSS 862 (986)
Q Consensus 793 ~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~----------~~~ 862 (986)
....++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++........ ...
T Consensus 158 -~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T 3qd2_B 158 -LEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATH 233 (332)
T ss_dssp -GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CC
T ss_pred -ccchhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccc
Confidence 23456778999999999999999999 9999999999999999999999999999876543221 122
Q ss_pred ccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCchhHHhhhhcccCCcch
Q 046598 863 IGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDL 942 (986)
Q Consensus 863 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 942 (986)
....||+.|+|||++.+..++.++|||||||++|||++|..|+... ...... ... ..
T Consensus 234 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-------~~~~~~--------~~~----~~---- 290 (332)
T 3qd2_B 234 TGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-------VRIITD--------VRN----LK---- 290 (332)
T ss_dssp CSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-------HHHHHH--------HHT----TC----
T ss_pred cccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-------HHHHHH--------hhc----cC----
Confidence 3456999999999999999999999999999999999987764210 000000 000 00
Q ss_pred hhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 943 IVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..........++.+++.+||+.||++|||++|+
T Consensus 291 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 323 (332)
T 3qd2_B 291 -----------FPLLFTQKYPQEHMMVQDMLSPSPTERPEATDI 323 (332)
T ss_dssp -----------CCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHH
T ss_pred -----------CCcccccCChhHHHHHHHHccCCCCcCCCHHHH
Confidence 001112334456789999999999999998764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=368.61 Aligned_cols=208 Identities=23% Similarity=0.291 Sum_probs=179.6
Q ss_pred HHHHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 046598 682 NLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVD 758 (986)
Q Consensus 682 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 758 (986)
++....++|++.++||+|+||+||+|++..+++.||+|+++... ....+.+.+|+.++..++||||++++++
T Consensus 68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~----- 142 (437)
T 4aw2_A 68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYA----- 142 (437)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEE-----
T ss_pred cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEE-----
Confidence 33445689999999999999999999999999999999997422 2223458899999999999999999998
Q ss_pred cCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecC
Q 046598 759 YQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDE 838 (986)
Q Consensus 759 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 838 (986)
+.+++..|+||||+++|+|.+++.. ....+++..++.++.||+.||+|||+. +|+||||||+|||++.
T Consensus 143 ~~~~~~~~lV~Ey~~gg~L~~~l~~---------~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~ 210 (437)
T 4aw2_A 143 FQDDNNLYLVMDYYVGGDLLTLLSK---------FEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDM 210 (437)
T ss_dssp EECSSEEEEEECCCTTCBHHHHHHT---------TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECT
T ss_pred EeeCCEEEEEEecCCCCcHHHHHHH---------ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcC
Confidence 4566889999999999999999963 234689999999999999999999999 9999999999999999
Q ss_pred CCcEEEcccccceecCCCCCcccccccccccccccccccc-----CCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 839 DMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGL-----GSEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 839 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
++.+||+|||+|+....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 211 ~g~vkL~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~ 283 (437)
T 4aw2_A 211 NGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA 283 (437)
T ss_dssp TSCEEECCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCCEEEcchhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC
Confidence 99999999999987643322 2233467999999999987 56799999999999999999999999963
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=377.05 Aligned_cols=201 Identities=26% Similarity=0.373 Sum_probs=160.6
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc--CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
.++|++.+.||+|+||+||+|++..+++.||||++... .....+++.+|++++++++||||+++++++..........
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 47899999999999999999999999999999998642 3344578899999999999999999999976554456678
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.|+||||+ +++|.+++. ....+++..++.|+.||+.||+|||+. +|+||||||+|||++.++.+||
T Consensus 132 ~~lv~e~~-~~~L~~~~~----------~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl 197 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFR----------TPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKV 197 (458)
T ss_dssp EEEEECCC-SEEHHHHHH----------SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEE
T ss_pred EEEEEecc-ccchhhhcc----------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEee
Confidence 99999998 679999985 234689999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCc-------------------------cccccccccccccccccc-cCCCcCcccchhhHHHHHHHH
Q 046598 845 GDFGLARFLPLSSAQ-------------------------TSSIGAKGSIGYIAPEYG-LGSEVSISGDVYSYGILLLEL 898 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGvvl~el 898 (986)
+|||+|+........ ......+||+.|+|||++ .+..++.++|||||||++|||
T Consensus 198 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~el 277 (458)
T 3rp9_A 198 CDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277 (458)
T ss_dssp CCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred cccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHH
Confidence 999999876422211 123456789999999976 566799999999999999999
Q ss_pred HhC
Q 046598 899 ITR 901 (986)
Q Consensus 899 ltg 901 (986)
++|
T Consensus 278 ltg 280 (458)
T 3rp9_A 278 LNM 280 (458)
T ss_dssp HTT
T ss_pred HHh
Confidence 994
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=371.80 Aligned_cols=206 Identities=23% Similarity=0.315 Sum_probs=178.3
Q ss_pred HHHHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 046598 682 NLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD 758 (986)
Q Consensus 682 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 758 (986)
++....++|++.+.||+|+||+||+|++..+++.||+|+++.. .....+.+.+|+.+++.++||||++++++
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~----- 137 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA----- 137 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEE-----
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEE-----
Confidence 3344567899999999999999999999999999999999642 12233558899999999999999999999
Q ss_pred cCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecC
Q 046598 759 YQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDE 838 (986)
Q Consensus 759 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 838 (986)
+.++...|+||||++||+|.++++. ..+++..++.++.||+.||+|||++ +|+||||||+||+++.
T Consensus 138 ~~~~~~~~lV~E~~~gg~L~~~l~~-----------~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~ 203 (410)
T 3v8s_A 138 FQDDRYLYMVMEYMPGGDLVNLMSN-----------YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDK 203 (410)
T ss_dssp EECSSEEEEEECCCTTEEHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECT
T ss_pred EEECCEEEEEEeCCCCCcHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECC
Confidence 4566889999999999999999852 2488999999999999999999999 9999999999999999
Q ss_pred CCcEEEcccccceecCCCCCccccccccccccccccccccCCC----cCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 839 DMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSE----VSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 839 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
++.+||+|||+|+...... .......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||..
T Consensus 204 ~g~ikL~DFG~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 275 (410)
T 3v8s_A 204 SGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 275 (410)
T ss_dssp TSCEEECCCTTCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCCEEEeccceeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCC
Confidence 9999999999998764332 22233567999999999988765 88999999999999999999999963
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=361.16 Aligned_cols=250 Identities=21% Similarity=0.248 Sum_probs=185.3
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
..++|++.+.||+|+||.||+|++..+++.||||+++... ..+.+.+|++++++++||||++++++| ......
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~ 123 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIF-----ETPTEI 123 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEE-----ECSSEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeE-----ecCCeE
Confidence 4578999999999999999999999889999999997543 346788999999999999999999994 456789
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecC---CCcE
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDE---DMIA 842 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~ 842 (986)
++||||+++++|.+++.. .+.+++.+++.++.||+.||+|||+. +|+||||||+||+++. ++.+
T Consensus 124 ~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~ 190 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIVE----------KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPL 190 (349)
T ss_dssp EEEECCCCSCBHHHHHTT----------CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCE
T ss_pred EEEEEeCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCE
Confidence 999999999999999952 24589999999999999999999999 9999999999999975 8899
Q ss_pred EEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 046598 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 922 (986)
||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........+.....
T Consensus 191 kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~-- 265 (349)
T 2w4o_A 191 KIADFGLSKIVEHQ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILN-- 265 (349)
T ss_dssp EECCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHT--
T ss_pred EEccCccccccCcc---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHh--
Confidence 99999999865322 2223456899999999999999999999999999999999999998632221111111110
Q ss_pred CCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 923 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..... +. +...+.+.++.+++.+||+.||++|||+.|+
T Consensus 266 ----------~~~~~-~~---------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~ 303 (349)
T 2w4o_A 266 ----------CEYYF-IS---------------PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQA 303 (349)
T ss_dssp ----------TCCCC-CT---------------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred ----------CCCcc-CC---------------chhhhCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 00000 00 0001234457799999999999999998763
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=360.20 Aligned_cols=262 Identities=23% Similarity=0.399 Sum_probs=185.0
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCe---EEEEEEeecc--CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccC
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRT---TIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ 760 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 760 (986)
..++|++.+.||+|+||.||+|.+..++. .||||+++.. .....+++.+|++++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 45789999999999999999999877654 8999998753 345567899999999999999999999986432111
Q ss_pred -CCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCC
Q 046598 761 -GNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED 839 (986)
Q Consensus 761 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 839 (986)
.....++||||+++|+|.+++...... .....+++.+++.|+.||+.||+|||++ +|+||||||+||+++.+
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIG----ENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAED 173 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC-------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhcc----ccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCC
Confidence 112349999999999999999633211 2223689999999999999999999999 99999999999999999
Q ss_pred CcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHH
Q 046598 840 MIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNL 918 (986)
Q Consensus 840 ~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~ 918 (986)
+.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+ ....
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~ 251 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE--IYNY 251 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHH
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH--HHHH
Confidence 9999999999987654433333444557889999999999999999999999999999999 999987432211 1111
Q ss_pred HHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 919 ARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 919 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+........+ ...+.++.+++.+||+.||++|||++||
T Consensus 252 -----------~~~~~~~~~~-------------------~~~~~~l~~li~~~l~~dp~~Rps~~~l 289 (323)
T 3qup_A 252 -----------LIGGNRLKQP-------------------PECMEEVYDLMYQCWSADPKQRPSFTCL 289 (323)
T ss_dssp -----------HHTTCCCCCC-------------------TTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred -----------HhcCCCCCCC-------------------CccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 0000000000 1233467899999999999999997653
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=358.81 Aligned_cols=254 Identities=19% Similarity=0.210 Sum_probs=199.2
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcC-CCCcceeeeeeccccccCCCceE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
.++|++.+.||+|+||.||+|++..+++.||||++..... .+.+.+|+++++++ +||||+++++++ ..+...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~-----~~~~~~ 80 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFG-----PCGKYN 80 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEE-----EETTEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEE-----ecCCcc
Confidence 4679999999999999999999988899999999875432 35688999999999 999999999984 445789
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCc----
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI---- 841 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---- 841 (986)
++||||+ +++|.+++... ...+++.+++.|+.||+.||+|||+. +|+||||||+||+++.++.
T Consensus 81 ~lv~e~~-~~~L~~~~~~~---------~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~ 147 (330)
T 2izr_A 81 AMVLELL-GPSLEDLFDLC---------DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQ 147 (330)
T ss_dssp EEEEECC-CCBHHHHHHHT---------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTT
T ss_pred EEEEEeC-CCCHHHHHHHc---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCc
Confidence 9999999 99999999632 34689999999999999999999999 9999999999999998887
Q ss_pred -EEEcccccceecCCCCCcc-----ccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccH
Q 046598 842 -AHIGDFGLARFLPLSSAQT-----SSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNL 915 (986)
Q Consensus 842 -~kL~DFG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~ 915 (986)
+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..
T Consensus 148 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~--~~ 225 (330)
T 2izr_A 148 VIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD--TL 225 (330)
T ss_dssp SEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS--SH
T ss_pred eEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccc--cH
Confidence 9999999998764332211 123567999999999999999999999999999999999999999743221 11
Q ss_pred HHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 916 HNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 916 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
...... +.+.... .+. .......+ ++.+++.+||+.||++||++++|
T Consensus 226 ~~~~~~--------i~~~~~~-~~~--------------~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l 272 (330)
T 2izr_A 226 KERYQK--------IGDTKRA-TPI--------------EVLCENFP-EMATYLRYVRRLDFFEKPDYDYL 272 (330)
T ss_dssp HHHHHH--------HHHHHHH-SCH--------------HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHH
T ss_pred HHHHHH--------HHhhhcc-CCH--------------HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHH
Confidence 111100 0000000 000 00000123 78899999999999999998653
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=355.08 Aligned_cols=275 Identities=24% Similarity=0.300 Sum_probs=196.9
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc--hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
.++|++.+.||+|+||+||+|++..+++.||||++..... ...+.+.+|++++++++||||+++++++ ...+.
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~ 76 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVF-----RRKRR 76 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhhee-----ecCCe
Confidence 3689999999999999999999999899999999864332 2356788999999999999999999994 45578
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.++||||+++++|.+++. ....+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||
T Consensus 77 ~~lv~e~~~~~~l~~~~~----------~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl 143 (311)
T 4agu_A 77 LHLVFEYCDHTVLHELDR----------YQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKL 143 (311)
T ss_dssp EEEEEECCSEEHHHHHHH----------TSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEE
T ss_pred EEEEEEeCCCchHHHHHh----------hhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEE
Confidence 999999999999999874 234589999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhC
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTAL 923 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 923 (986)
+|||.++...... .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||......+ .........
T Consensus 144 ~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~ 219 (311)
T 4agu_A 144 CDFGFARLLTGPS--DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD--QLYLIRKTL 219 (311)
T ss_dssp CCCTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHH
T ss_pred eeCCCchhccCcc--cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHh
Confidence 9999998764322 22234568999999999876 678999999999999999999999997432221 111111111
Q ss_pred CCc---hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 924 PDH---VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 924 ~~~---~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
... ........-............... ........+.++.+++.+||+.||++|||++||
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 282 (311)
T 4agu_A 220 GDLIPRHQQVFSTNQYFSGVKIPDPEDMEP---LELKFPNISYPALGLLKGCLHMDPTERLTCEQL 282 (311)
T ss_dssp CSCCHHHHHHHHTCGGGTTCCCCCCSSCCC---HHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHH
T ss_pred cccccccccccccccccccCcCCCccccch---hhhhcccccHHHHHHHHHHccCChhhcCCHHHH
Confidence 110 111111000000000000000000 000111345567899999999999999998764
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=361.12 Aligned_cols=250 Identities=24% Similarity=0.388 Sum_probs=191.7
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeE----EEEEEeecc-CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTT----IAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 761 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 761 (986)
.++|++.+.||+|+||+||+|++..+++. ||+|.++.. .....+++.+|+.++++++||||++++++|..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----- 88 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT----- 88 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES-----
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----
Confidence 46799999999999999999998766554 577776532 23445789999999999999999999999642
Q ss_pred CceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCc
Q 046598 762 NDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI 841 (986)
Q Consensus 762 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 841 (986)
...++|+||+++|+|.+++.. ....+++..++.|+.||+.||+|||++ +|+||||||+||+++.++.
T Consensus 89 -~~~~~v~e~~~~g~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~ 155 (327)
T 3poz_A 89 -STVQLITQLMPFGCLLDYVRE---------HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQH 155 (327)
T ss_dssp -SSEEEEEECCTTCBHHHHHHH---------STTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTE
T ss_pred -CCeEEEEEecCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCC
Confidence 347899999999999999963 234689999999999999999999999 9999999999999999999
Q ss_pred EEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHH
Q 046598 842 AHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLAR 920 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~ 920 (986)
+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||+| |+.||...... ....
T Consensus 156 ~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~--- 230 (327)
T 3poz_A 156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISS--- 230 (327)
T ss_dssp EEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHH---
T ss_pred EEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH--HHHH---
Confidence 99999999987755444444445567889999999999999999999999999999999 99999743221 1111
Q ss_pred hhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 921 TALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 921 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+........ ...++.++.+++.+||+.||++|||++||
T Consensus 231 ---------~~~~~~~~~~------------------~~~~~~~~~~li~~~l~~~p~~Rps~~el 269 (327)
T 3poz_A 231 ---------ILEKGERLPQ------------------PPICTIDVYMIMVKCWMIDADSRPKFREL 269 (327)
T ss_dssp ---------HHHTTCCCCC------------------CTTBCHHHHHHHHHHTCSCGGGSCCHHHH
T ss_pred ---------HHHcCCCCCC------------------CccCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 1111110000 01233457899999999999999998764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=345.13 Aligned_cols=250 Identities=22% Similarity=0.278 Sum_probs=201.8
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
..++|++.+.||+|+||.||+|.+..++..||+|++........+.+.+|++++++++||||+++++++ ..+...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~ 81 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF-----EDNTDI 81 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCeE
Confidence 456799999999999999999999999999999999876566678899999999999999999999994 456889
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEe---cCCCcE
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILL---DEDMIA 842 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~ 842 (986)
++||||+++++|.+++.. ...+++.+++.++.|++.||+|||+. +|+||||||+||++ +.++.+
T Consensus 82 ~lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~ 148 (277)
T 3f3z_A 82 YLVMELCTGGELFERVVH----------KRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPL 148 (277)
T ss_dssp EEEEECCCSCBHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCE
T ss_pred EEEEeccCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcE
Confidence 999999999999999852 34589999999999999999999999 99999999999999 788899
Q ss_pred EEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 046598 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 922 (986)
||+|||.+....... ......||+.|+|||++.+. ++.++||||||+++|||++|+.||......+ .........
T Consensus 149 ~l~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~ 223 (277)
T 3f3z_A 149 KLIDFGLAARFKPGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-VMLKIREGT 223 (277)
T ss_dssp EECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCC
T ss_pred EEEecccceeccCcc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhCC
Confidence 999999998764332 22345689999999998664 8999999999999999999999996422110 000000000
Q ss_pred CCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 923 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.. .+. ......+.++.+++.+|++.||++|||+.|+
T Consensus 224 ~~-------------~~~---------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~ 259 (277)
T 3f3z_A 224 FT-------------FPE---------------KDWLNVSPQAESLIRRLLTKSPKQRITSLQA 259 (277)
T ss_dssp CC-------------CCH---------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CC-------------CCc---------------hhhhcCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 00 000 0001234567899999999999999998753
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=346.53 Aligned_cols=248 Identities=25% Similarity=0.399 Sum_probs=198.9
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
.++|++.+.||+|+||.||+|.+.. +..||+|+++.... ..+++.+|++++++++||||+++++++ ..+...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 79 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVC-----SKEYPIY 79 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSEE
T ss_pred hhheeeeeeeccCCCceEEEEEecC-ceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCceE
Confidence 5689999999999999999998875 67899999975433 346789999999999999999999994 5567899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+++++|.+++.. ....+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 80 lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~D 147 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRS---------HGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSD 147 (268)
T ss_dssp EEEECCTTCBHHHHHHH---------HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECC
T ss_pred EEEEccCCCcHHHHHHH---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEcc
Confidence 99999999999999962 234589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCC
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALPD 925 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 925 (986)
||.++....... .......+|+.|+|||++.+..++.++||||+|+++|+|++ |+.||...... .....
T Consensus 148 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~---- 217 (268)
T 3sxs_A 148 FGMTRYVLDDQY-VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS-----EVVLK---- 217 (268)
T ss_dssp TTCEEECCTTCE-EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH-----HHHHH----
T ss_pred Cccceecchhhh-hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH-----HHHHH----
Confidence 999987644322 22334556788999999998899999999999999999999 99998632211 11000
Q ss_pred chhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 926 HVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 926 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+........+ ...+.++.+++.+||+.||++|||++||
T Consensus 218 ----~~~~~~~~~~-------------------~~~~~~l~~li~~~l~~~p~~Rps~~~l 255 (268)
T 3sxs_A 218 ----VSQGHRLYRP-------------------HLASDTIYQIMYSCWHELPEKRPTFQQL 255 (268)
T ss_dssp ----HHTTCCCCCC-------------------TTSCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred ----HHcCCCCCCC-------------------CcChHHHHHHHHHHcCCChhhCcCHHHH
Confidence 0000000000 0123457799999999999999998764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=347.65 Aligned_cols=248 Identities=27% Similarity=0.417 Sum_probs=198.1
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
.++|++.+.||+|+||.||+|.+.. ++.||+|++..... ..+++.+|++++++++||||+++++++ .++...+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 81 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVC-----LEQAPIC 81 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSEE
T ss_pred hhhceeeheecCCCccEEEEEEecC-CCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCceE
Confidence 4678999999999999999999975 67899999975432 346799999999999999999999994 4567799
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+++++|.+++.. ....+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 82 lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~D 149 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLRT---------QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSD 149 (269)
T ss_dssp EEEECCTTCBHHHHHHT---------TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECC
T ss_pred EEEEeCCCCcHHHHHHh---------cCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecc
Confidence 99999999999999962 234689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCC
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALPD 925 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 925 (986)
||+++...... ........+++.|+|||++.+..++.++||||+|+++|+|++ |+.||...... .....
T Consensus 150 fg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~-----~~~~~---- 219 (269)
T 4hcu_A 150 FGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----EVVED---- 219 (269)
T ss_dssp TTGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHH----
T ss_pred ccccccccccc-cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH-----HHHHH----
Confidence 99998654221 222334456788999999998999999999999999999999 99998632111 11110
Q ss_pred chhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 926 HVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 926 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+........+ ...+.++.+++.+||+.||++|||++|+
T Consensus 220 ----~~~~~~~~~~-------------------~~~~~~~~~li~~~l~~~p~~Rps~~~l 257 (269)
T 4hcu_A 220 ----ISTGFRLYKP-------------------RLASTHVYQIMNHCWRERPEDRPAFSRL 257 (269)
T ss_dssp ----HHTTCCCCCC-------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ----HhcCccCCCC-------------------CcCCHHHHHHHHHHccCCcccCcCHHHH
Confidence 0000000000 0123457899999999999999998764
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=364.98 Aligned_cols=207 Identities=20% Similarity=0.192 Sum_probs=177.3
Q ss_pred hhcCCCCCcccccc--cceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCC
Q 046598 686 ATDRFSSVNQIGEG--SFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 761 (986)
Q Consensus 686 ~~~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 761 (986)
..++|++.+.||+| +||.||+|++..+++.||||+++... ....+.+.+|++++++++||||+++++++ ..
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~ 97 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF-----IA 97 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEE-----EE
Confidence 35789999999999 99999999999889999999997533 33456788999999999999999999994 45
Q ss_pred CceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCc
Q 046598 762 NDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI 841 (986)
Q Consensus 762 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 841 (986)
++..++||||+++|+|.+++.... ...+++..++.|+.||+.||+|||++ +|+||||||+||+++.++.
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~ 166 (389)
T 3gni_B 98 DNELWVVTSFMAYGSAKDLICTHF--------MDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGK 166 (389)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTC--------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCC
T ss_pred CCEEEEEEEccCCCCHHHHHhhhc--------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCC
Confidence 678999999999999999996321 24589999999999999999999999 9999999999999999999
Q ss_pred EEEcccccceecCCCCC-----ccccccccccccccccccccC--CCcCcccchhhHHHHHHHHHhCCCCCCcc
Q 046598 842 AHIGDFGLARFLPLSSA-----QTSSIGAKGSIGYIAPEYGLG--SEVSISGDVYSYGILLLELITRKKPTDIM 908 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~pf~~~ 908 (986)
+||+|||.+........ ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 167 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 240 (389)
T 3gni_B 167 VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240 (389)
T ss_dssp EEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred EEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence 99999999865422111 111223468999999999987 67999999999999999999999999743
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=359.97 Aligned_cols=350 Identities=31% Similarity=0.448 Sum_probs=220.7
Q ss_pred hccccCceeeceecccCCCCccchhcCccccceecccccccCccCccccCCCCCCeEEccCCcCCCCcccccCCCcCcce
Q 046598 107 DRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRS 186 (986)
Q Consensus 107 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 186 (986)
..+++|+.|++++|.++ .+| .+..+++|++|+|++|.+++..| +.++++|++|++++|.+++..+ ++++++|++
T Consensus 43 ~~l~~l~~L~l~~~~i~-~l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~ 116 (466)
T 1o6v_A 43 TDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTG 116 (466)
T ss_dssp HHHHTCCEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred hHhccccEEecCCCCCc-cCc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCE
Confidence 34556666666666665 344 25566666666666666664433 6666666666666666664443 666666666
Q ss_pred eeccCCcccCcCcchhhccCCCceeecccccccccCCccccCCCCccEEeccccccccccCCcccccccccceEEecCce
Q 046598 187 LFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQ 266 (986)
Q Consensus 187 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~ 266 (986)
|+|++|.+++..+ +..+++|++|+|++|++++ ++ .+.++++ |+.|+++ |.
T Consensus 117 L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~-------------------------L~~L~l~-~~ 166 (466)
T 1o6v_A 117 LTLFNNQITDIDP--LKNLTNLNRLELSSNTISD-IS-ALSGLTS-------------------------LQQLSFG-NQ 166 (466)
T ss_dssp EECCSSCCCCCGG--GTTCTTCSEEEEEEEEECC-CG-GGTTCTT-------------------------CSEEEEE-ES
T ss_pred EECCCCCCCCChH--HcCCCCCCEEECCCCccCC-Ch-hhccCCc-------------------------ccEeecC-Cc
Confidence 6666666664322 6666666666666666653 22 2333333 3333332 22
Q ss_pred ecccCCccccCCCCCcEEecccccccCCCchhhhhhhHhhhhhccCCCCCCCCCCcccccccccccccceeecccccccc
Q 046598 267 LTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGG 346 (986)
Q Consensus 267 l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~l~~l~~L~~l~l~~n~l~~~~~~~l~~l~~l~~~~~L~~l~l~~n~~~~ 346 (986)
+.+.. .+.++++|+.|++++|++++.+.
T Consensus 167 ~~~~~--~~~~l~~L~~L~l~~n~l~~~~~-------------------------------------------------- 194 (466)
T 1o6v_A 167 VTDLK--PLANLTTLERLDISSNKVSDISV-------------------------------------------------- 194 (466)
T ss_dssp CCCCG--GGTTCTTCCEEECCSSCCCCCGG--------------------------------------------------
T ss_pred ccCch--hhccCCCCCEEECcCCcCCCChh--------------------------------------------------
Confidence 22111 14555555555555555442210
Q ss_pred CCCcccccccccceEEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCcccc
Q 046598 347 SLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIG 426 (986)
Q Consensus 347 ~~p~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 426 (986)
+.. .++|+.|++++|++++..| ++.+++|++|++++|.+++. +.+..+++|+.|++++|+++
T Consensus 195 -----l~~-l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~-------- 256 (466)
T 1o6v_A 195 -----LAK-LTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQIS-------- 256 (466)
T ss_dssp -----GGG-CTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCC--------
T ss_pred -----hcc-CCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccc--------
Confidence 000 1234555555555554433 55566666666666666632 34555666666655555554
Q ss_pred cccccEEEecccccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchh
Q 046598 427 NLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEIL 506 (986)
Q Consensus 427 ~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 506 (986)
+..| +..+++|+.|++++|+++ .++. +..+++|+.|++++|++++..+ +..+++|+.|
T Consensus 257 ---------------~~~~--~~~l~~L~~L~l~~n~l~-~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L 314 (466)
T 1o6v_A 257 ---------------NLAP--LSGLTKLTELKLGANQIS-NISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYL 314 (466)
T ss_dssp ---------------CCGG--GTTCTTCSEEECCSSCCC-CCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEE
T ss_pred ---------------cchh--hhcCCCCCEEECCCCccC-cccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEE
Confidence 3333 667778888888888887 3443 5667788888888888876433 7788888888
Q ss_pred hccCccccccCcccccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCccc
Q 046598 507 NVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLE 586 (986)
Q Consensus 507 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~ 586 (986)
+|++|++++..| +..+++|++|++++|++++. ..+..+++|+.|++++|++++..| +..+++|+.|++++|+++
T Consensus 315 ~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~ 388 (466)
T 1o6v_A 315 TLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT 388 (466)
T ss_dssp ECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEE
T ss_pred ECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCccc
Confidence 888888886655 77888888888888888864 468888888888888888887776 788888888999999888
Q ss_pred cccC
Q 046598 587 GVVP 590 (986)
Q Consensus 587 ~~~p 590 (986)
+.+.
T Consensus 389 ~~p~ 392 (466)
T 1o6v_A 389 NAPV 392 (466)
T ss_dssp CCCB
T ss_pred CCch
Confidence 8543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=361.64 Aligned_cols=210 Identities=29% Similarity=0.353 Sum_probs=180.8
Q ss_pred CCCcChHHHHHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCC-----CCccee
Q 046598 675 FPNISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIR-----HRNLVK 749 (986)
Q Consensus 675 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~ 749 (986)
...+++.+.....++|.+.++||+|+||+||+|++..+++.||||+++.. ....+.+..|+++++.+. ||||++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 34556666666788999999999999999999999988999999998742 234466788999999886 999999
Q ss_pred eeeeccccccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecC
Q 046598 750 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDL 829 (986)
Q Consensus 750 l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dl 829 (986)
+++++ ...+..++||||+ +++|.+++.... ...+++.+++.++.||+.||+|||+. +|+||||
T Consensus 101 ~~~~~-----~~~~~~~lv~e~~-~~~L~~~~~~~~--------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDl 163 (360)
T 3llt_A 101 YHGKF-----MYYDHMCLIFEPL-GPSLYEIITRNN--------YNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDL 163 (360)
T ss_dssp EEEEE-----EETTEEEEEECCC-CCBHHHHHHHTT--------TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred cccee-----eECCeeEEEEcCC-CCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCC
Confidence 99984 4457899999999 999999996322 23589999999999999999999999 9999999
Q ss_pred CCCCeEecC-------------------------CCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCc
Q 046598 830 KPSNILLDE-------------------------DMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSI 884 (986)
Q Consensus 830 kp~NIll~~-------------------------~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 884 (986)
||+||+++. ++.+||+|||+|+..... .....||+.|+|||++.+..++.
T Consensus 164 kp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~ 238 (360)
T 3llt_A 164 KPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDV 238 (360)
T ss_dssp SGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCT
T ss_pred CcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCC
Confidence 999999975 789999999999865322 22356899999999999999999
Q ss_pred ccchhhHHHHHHHHHhCCCCCCc
Q 046598 885 SGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 885 ~sDvwSlGvvl~elltg~~pf~~ 907 (986)
++|||||||++|||++|+.||..
T Consensus 239 ~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 239 SSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp THHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccchHHHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999974
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=360.55 Aligned_cols=245 Identities=21% Similarity=0.247 Sum_probs=192.7
Q ss_pred CcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEEEEec
Q 046598 693 VNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFM 772 (986)
Q Consensus 693 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 772 (986)
.+.||+|+||.||+|.+..+++.||+|+++.......+.+.+|++++++++||||+++++++ ...+..++||||+
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~~~lv~E~~ 168 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF-----ESKNDIVLVMEYV 168 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEEEEEEECC
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEEEEEeCC
Confidence 56899999999999999988999999999876656678899999999999999999999994 4567899999999
Q ss_pred cCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEe--cCCCcEEEcccccc
Q 046598 773 HNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILL--DEDMIAHIGDFGLA 850 (986)
Q Consensus 773 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll--~~~~~~kL~DFG~a 850 (986)
++++|.+++. .....+++.+++.++.||+.||+|||+. +|+||||||+||++ +.++.+||+|||++
T Consensus 169 ~~~~L~~~l~---------~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a 236 (373)
T 2x4f_A 169 DGGELFDRII---------DESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLA 236 (373)
T ss_dssp TTCEEHHHHH---------HTGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSC
T ss_pred CCCcHHHHHH---------hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCc
Confidence 9999999885 2234689999999999999999999999 99999999999999 56789999999999
Q ss_pred eecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCchhHH
Q 046598 851 RFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVMDI 930 (986)
Q Consensus 851 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (986)
+....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+.. +
T Consensus 237 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~------------i 300 (373)
T 2x4f_A 237 RRYKPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE-TLNN------------I 300 (373)
T ss_dssp EECCTTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHH------------H
T ss_pred eecCCccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH------------H
Confidence 87643322 223469999999999999999999999999999999999999996322110 1111 1
Q ss_pred hhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 931 VDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 931 ~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.......... .....+.++.+++.+|++.||++|||++|+
T Consensus 301 ~~~~~~~~~~----------------~~~~~~~~~~~li~~~L~~dp~~Rps~~e~ 340 (373)
T 2x4f_A 301 LACRWDLEDE----------------EFQDISEEAKEFISKLLIKEKSWRISASEA 340 (373)
T ss_dssp HHTCCCSCSG----------------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred HhccCCCChh----------------hhccCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 1111000000 001234567899999999999999998763
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=362.05 Aligned_cols=252 Identities=22% Similarity=0.257 Sum_probs=190.5
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
..++|++.+.||+|+||+||+|++..+++.||||++.... ...+.+.+|+.+++.++||||+++++++ ......
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~~ 91 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVI-----LTPTHL 91 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEE-----eeCCEE
Confidence 3578999999999999999999999999999999997543 2346788999999999999999999994 456789
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCc--EE
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI--AH 843 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~k 843 (986)
++||||+++|+|.+++.. .+.+++.+++.++.|++.||+|||++ ||+||||||+||+++.++. +|
T Consensus 92 ~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~k 158 (361)
T 3uc3_A 92 AIIMEYASGGELYERICN----------AGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLK 158 (361)
T ss_dssp EEEEECCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEE
T ss_pred EEEEEeCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEE
Confidence 999999999999999842 24589999999999999999999999 9999999999999987765 99
Q ss_pred EcccccceecCCCCCccccccccccccccccccccCCCcCcc-cchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSIS-GDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 922 (986)
|+|||+++..... .......||+.|+|||++.+..++.+ +||||+||++|+|++|+.||....... .+.......
T Consensus 159 l~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~~~~~~ 234 (361)
T 3uc3_A 159 ICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR-DYRKTIQRI 234 (361)
T ss_dssp ECCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC-CHHHHHHHH
T ss_pred EeecCcccccccc---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH-HHHHHHHHH
Confidence 9999999743222 22234569999999999988887655 899999999999999999997432221 111111110
Q ss_pred CCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 923 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
...... .+. ....+.++.+++.+||+.||++|||++|+
T Consensus 235 --------~~~~~~-~~~-----------------~~~~s~~~~~li~~~L~~dP~~Rps~~el 272 (361)
T 3uc3_A 235 --------LSVKYS-IPD-----------------DIRISPECCHLISRIFVADPATRISIPEI 272 (361)
T ss_dssp --------HTTCCC-CCT-----------------TSCCCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred --------hcCCCC-CCC-----------------cCCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 000000 000 00123457799999999999999998763
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=354.36 Aligned_cols=260 Identities=24% Similarity=0.386 Sum_probs=203.5
Q ss_pred hcCCCCCcccccccceeEEEEEEC-----CCCeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILD-----DGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ 760 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 760 (986)
.++|.+.+.||+|+||.||+|.+. .+++.||||+++... ....+.+.+|++++++++||||+++++++ .
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~ 96 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC-----S 96 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----C
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE-----e
Confidence 568999999999999999999983 445899999997533 34457889999999999999999999994 4
Q ss_pred CCceEEEEEEeccCCCHhHhhccCCCCC--------------ccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 046598 761 GNDFKALVFEFMHNRSLEEWLHPITRED--------------ETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAH 826 (986)
Q Consensus 761 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH 826 (986)
.++..++||||+++++|.+++....... ........+++.+++.++.||+.||+|||++ +|+|
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH 173 (314)
T 2ivs_A 97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVH 173 (314)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcc
Confidence 5677999999999999999997543210 0001234589999999999999999999999 9999
Q ss_pred ecCCCCCeEecCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCC
Q 046598 827 CDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPT 905 (986)
Q Consensus 827 ~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf 905 (986)
|||||+||+++.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |+.||
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 253 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999987754444434445567889999999999999999999999999999999 99998
Q ss_pred CccccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCC
Q 046598 906 DIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTN 985 (986)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 985 (986)
...... ..... +........ ...++.++.+++.+||+.||++|||++|
T Consensus 254 ~~~~~~--~~~~~------------~~~~~~~~~------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~ 301 (314)
T 2ivs_A 254 PGIPPE--RLFNL------------LKTGHRMER------------------PDNCSEEMYRLMLQCWKQEPDKRPVFAD 301 (314)
T ss_dssp TTCCGG--GHHHH------------HHTTCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCHH--HHHHH------------hhcCCcCCC------------------CccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 643221 11111 111000000 0123456789999999999999999876
Q ss_pred C
Q 046598 986 V 986 (986)
Q Consensus 986 V 986 (986)
|
T Consensus 302 l 302 (314)
T 2ivs_A 302 I 302 (314)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=351.84 Aligned_cols=253 Identities=30% Similarity=0.461 Sum_probs=186.7
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
..++|++.++||+|+||+||+|++.. .||||+++... ....+.+.+|++++++++||||+++++++ ...
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~------~~~ 92 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS------TAP 92 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE------CSS
T ss_pred CccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec------cCC
Confidence 35689999999999999999998754 59999987433 34457799999999999999999999973 235
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..++||||+++++|.+++. .....+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 93 ~~~lv~e~~~~~~L~~~l~---------~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~k 160 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLH---------ASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVK 160 (289)
T ss_dssp SCEEEEECCCEEEHHHHHT---------TC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEE
T ss_pred ccEEEEEecCCCcHHHHHh---------hccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEE
Confidence 6799999999999999995 2234689999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCcccccccccccccccccccc---CCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHH
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGL---GSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLAR 920 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~ 920 (986)
|+|||+++...............||+.|+|||++. +..++.++|||||||++|||++|+.||......+........
T Consensus 161 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 240 (289)
T 3og7_A 161 IGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR 240 (289)
T ss_dssp ECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHH
T ss_pred EccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcc
Confidence 99999998654333333334467899999999986 567899999999999999999999999743221111111111
Q ss_pred hhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 921 TALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 921 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
......... ....++.++.+++.+||+.||++|||++||
T Consensus 241 ~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~el 279 (289)
T 3og7_A 241 GSLSPDLSK---------------------------VRSNCPKRMKRLMAECLKKKRDERPSFPRI 279 (289)
T ss_dssp TSCCCCTTS---------------------------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred cccCcchhh---------------------------ccccCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 111110000 001234568899999999999999998764
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=351.04 Aligned_cols=255 Identities=16% Similarity=0.179 Sum_probs=200.4
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcC-CCCcceeeeeeccccccCCCceE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
.++|++.+.||+|+||.||+|.+..+++.||||++.... ..+.+.+|+++++.+ +|+++++++++ +..+...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~-----~~~~~~~ 81 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYF-----GQEGLHN 81 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEE-----EEETTEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEee-----cCCCcee
Confidence 467999999999999999999998889999999986432 335678899999999 89999999998 4456789
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCc----
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI---- 841 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---- 841 (986)
++||||+ +++|.+++... ...+++.++..++.||+.||+|||++ +|+||||||+||+++.++.
T Consensus 82 ~lv~e~~-~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~ 148 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLC---------GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNAN 148 (298)
T ss_dssp EEEEECC-CCBHHHHHHHT---------TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTT
T ss_pred EEEEEec-CCCHHHHHHHh---------ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCC
Confidence 9999999 99999999632 34589999999999999999999999 9999999999999987776
Q ss_pred -EEEcccccceecCCCCCc-----cccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccH
Q 046598 842 -AHIGDFGLARFLPLSSAQ-----TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNL 915 (986)
Q Consensus 842 -~kL~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~ 915 (986)
+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 149 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-- 226 (298)
T 1csn_A 149 MIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN-- 226 (298)
T ss_dssp CEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH--
T ss_pred eEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcccc--
Confidence 999999999876543221 123446699999999999999999999999999999999999999975322111
Q ss_pred HHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 916 HNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 916 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..... .+....... + .......++.++.+++.+||+.||++|||+++|
T Consensus 227 ~~~~~--------~~~~~~~~~-~--------------~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l 274 (298)
T 1csn_A 227 KQKYE--------RIGEKKQST-P--------------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYL 274 (298)
T ss_dssp HHHHH--------HHHHHHHHS-C--------------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHH
T ss_pred HHHHH--------HHHhhccCc-c--------------HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHH
Confidence 11000 000000000 0 000011245678899999999999999998764
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=361.06 Aligned_cols=345 Identities=24% Similarity=0.379 Sum_probs=191.9
Q ss_pred CCCCCCEEEccCCCccccCCcchhccccCceeeceecccCCCCccchhcCccccceecccccccCccCccccCCCCCCeE
Q 046598 84 NLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHI 163 (986)
Q Consensus 84 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 163 (986)
.+++|+.|++++|.+.. +| .+..+++|++|+|++|.+++..| +..+++|++|++++|.+++..+ ++++++|++|
T Consensus 44 ~l~~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L 117 (466)
T 1o6v_A 44 DLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGL 117 (466)
T ss_dssp HHHTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred HhccccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEE
Confidence 45667778888877764 44 37778888888888888875443 7788888888888888875544 7788888888
Q ss_pred EccCCcCCCCcccccCCCcCcceeeccCCcccCcCcchhhccCCCceeecccccccccCCccccCCCCccEEeccccccc
Q 046598 164 SVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQ 243 (986)
Q Consensus 164 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~ 243 (986)
++++|++++..+ +.++++|++|++++|.+++ ++ .++.+++|++|+++ |.+.+.. .+.++++|+.|++++|.+.
T Consensus 118 ~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~ 190 (466)
T 1o6v_A 118 TLFNNQITDIDP--LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKVS 190 (466)
T ss_dssp ECCSSCCCCCGG--GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred ECCCCCCCCChH--HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcCC
Confidence 888888875543 7788888888888888874 33 47788888888886 4444322 2555555555555555544
Q ss_pred cccCCcccccccccceEEecCceecccCCccccCCCCCcEEecccccccCCCchhhhhhhHhhhhhccCCCCCCCCCCcc
Q 046598 244 GAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLN 323 (986)
Q Consensus 244 ~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~l~~l~~L~~l~l~~n~l~~~~~~~l~ 323 (986)
+. + .+..+++|++|++++|++++..| ++.+++
T Consensus 191 ~~-~--~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~------------------------------------------- 222 (466)
T 1o6v_A 191 DI-S--VLAKLTNLESLIATNNQISDITP--LGILTN------------------------------------------- 222 (466)
T ss_dssp CC-G--GGGGCTTCSEEECCSSCCCCCGG--GGGCTT-------------------------------------------
T ss_pred CC-h--hhccCCCCCEEEecCCccccccc--ccccCC-------------------------------------------
Confidence 21 1 12234444444444444443322 333333
Q ss_pred cccccccccccceeeccccccccCCCcccccccccceEEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccC
Q 046598 324 FLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGE 403 (986)
Q Consensus 324 ~l~~l~~~~~L~~l~l~~n~~~~~~p~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 403 (986)
|+.|++++|++++. ..+..+++|++|++++|.+++..+ +..
T Consensus 223 -----------------------------------L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~ 263 (466)
T 1o6v_A 223 -----------------------------------LDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSG 263 (466)
T ss_dssp -----------------------------------CCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTT
T ss_pred -----------------------------------CCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhc
Confidence 44444444444432 245556666666666666664433 555
Q ss_pred CCCCCEEEccCccceeecCcccccccccEEEecccccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEE
Q 046598 404 LQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLD 483 (986)
Q Consensus 404 l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~ 483 (986)
+++|+.|++++|++++..+ .....+|++|++++|++++..+ +..+++|+.|++++|++++..| +..+++|+.|+
T Consensus 264 l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~---~~~l~~L~~L~ 337 (466)
T 1o6v_A 264 LTKLTELKLGANQISNISP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP---VSSLTKLQRLF 337 (466)
T ss_dssp CTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG---GGGCTTCCEEE
T ss_pred CCCCCEEECCCCccCcccc-ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh---hccCccCCEeE
Confidence 6666666666555553221 1111123333333333332222 3444455555555555543222 33444455555
Q ss_pred ccCCcccccCCcccccccccchhhccCccccccCcccccCCccccEEeccccccc
Q 046598 484 LSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQ 538 (986)
Q Consensus 484 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 538 (986)
+++|++++. ..+..+++|+.|++++|++++..| +..+++|+.|++++|.++
T Consensus 338 l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~ 388 (466)
T 1o6v_A 338 FYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT 388 (466)
T ss_dssp CCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEE
T ss_pred CCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCccc
Confidence 555555432 234444555555555555544333 444455555555555544
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=347.43 Aligned_cols=247 Identities=26% Similarity=0.410 Sum_probs=194.9
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchh-------HHHHHHHHHHHhcCCCCcceeeeeecccccc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGA-------FKSFIAECNTLKNIRHRNLVKILTACSGVDY 759 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 759 (986)
.++|++.+.||+|+||+||+|++..+++.||+|++....... .+.+.+|++++++++||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---- 93 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH---- 93 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET----
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec----
Confidence 468999999999999999999999889999999986432211 167899999999999999999999853
Q ss_pred CCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeecCCCCCeEec
Q 046598 760 QGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPP--IAHCDLKPSNILLD 837 (986)
Q Consensus 760 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dlkp~NIll~ 837 (986)
+. .++||||+++|+|.+++. .....+++..++.++.|++.||+|||++ + |+||||||+||+++
T Consensus 94 -~~--~~lv~e~~~~~~L~~~l~---------~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~ 158 (287)
T 4f0f_A 94 -NP--PRMVMEFVPCGDLYHRLL---------DKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQ 158 (287)
T ss_dssp -TT--TEEEEECCTTCBHHHHHH---------CTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEES
T ss_pred -CC--CeEEEEecCCCCHHHHHh---------cccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEe
Confidence 22 269999999999999885 2334689999999999999999999999 8 99999999999998
Q ss_pred CCCc-----EEEcccccceecCCCCCcccccccccccccccccccc--CCCcCcccchhhHHHHHHHHHhCCCCCCcccc
Q 046598 838 EDMI-----AHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGL--GSEVSISGDVYSYGILLLELITRKKPTDIMFE 910 (986)
Q Consensus 838 ~~~~-----~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~ 910 (986)
.++. +||+|||+++.... ......||+.|+|||++. ...++.++||||+||++|||++|+.||.....
T Consensus 159 ~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 233 (287)
T 4f0f_A 159 SLDENAPVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY 233 (287)
T ss_dssp CCCTTCSCCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred ccCCCCceeEEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc
Confidence 8776 99999999975422 233456899999999984 45688999999999999999999999974333
Q ss_pred ccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 911 GDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
............ ...... ...++.++.+++.+||+.||++|||++||
T Consensus 234 ~~~~~~~~~~~~-----------~~~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l 280 (287)
T 4f0f_A 234 GKIKFINMIREE-----------GLRPTI------------------PEDCPPRLRNVIELCWSGDPKKRPHFSYI 280 (287)
T ss_dssp CHHHHHHHHHHS-----------CCCCCC------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred cHHHHHHHHhcc-----------CCCCCC------------------CcccCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 221111111110 000000 01234567899999999999999998764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=353.28 Aligned_cols=280 Identities=24% Similarity=0.294 Sum_probs=199.3
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc-----hhHHHHHHHHHHHhcC---CCCcceeeeeecccc
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH-----GAFKSFIAECNTLKNI---RHRNLVKILTACSGV 757 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~ 757 (986)
..++|++.+.||+|+||+||+|++..+++.||||+++.... .....+.+|+++++++ +||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 46799999999999999999999998899999999874321 1234667788777766 499999999997544
Q ss_pred ccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEec
Q 046598 758 DYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLD 837 (986)
Q Consensus 758 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 837 (986)
........++||||+. ++|.+++.... ...+++.+++.|+.||+.||+|||++ +|+||||||+||+++
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~--------~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~ 154 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP--------PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVT 154 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC--------TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc--------CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEc
Confidence 3333346899999996 69999996322 23489999999999999999999999 999999999999999
Q ss_pred CCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHH
Q 046598 838 EDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHN 917 (986)
Q Consensus 838 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~ 917 (986)
.++.+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....
T Consensus 155 ~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~ 230 (308)
T 3g33_A 155 SGGTVKLADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGK 230 (308)
T ss_dssp TTSCEEECSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH-HHHH
T ss_pred CCCCEEEeeCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH
Confidence 9999999999999865422 22234578999999999999999999999999999999999999997432211 1111
Q ss_pred HHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 918 LARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 918 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
...........++ .... ..+.........+. ......+...++.+++.+|++.||++|||++|+
T Consensus 231 i~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 294 (308)
T 3g33_A 231 IFDLIGLPPEDDW-PRDV-SLPRGAFPPRGPRP---VQSVVPEMEESGAQLLLEMLTFNPHKRISAFRA 294 (308)
T ss_dssp HHHHHCCCCTTTS-CSSC-SSCGGGSCCCCCCC---HHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HHHHhCCCChhhc-cchh-hccccccCCCCCCc---HHHhCccccHHHHHHHHHHhcCCCccCCCHHHH
Confidence 1111000000000 0000 00000000000000 001112344567899999999999999998763
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=359.30 Aligned_cols=246 Identities=25% Similarity=0.280 Sum_probs=190.1
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHH-HhcCCCCcceeeeeeccccccCCC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNT-LKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
.++|++.+.||+|+||.||+|+++.+++.||||+++... ....+.+.+|..+ ++.++||||++++++ +...
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~-----~~~~ 111 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFS-----FQTA 111 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEE-----EECS
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEE-----EEeC
Confidence 467999999999999999999999999999999997533 2234556777776 577899999999998 4566
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
+..|+||||++||+|.++++. ...+++..++.++.||+.||+|||++ +|+||||||+||+++.++++
T Consensus 112 ~~~~lv~E~~~gg~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~i 178 (373)
T 2r5t_A 112 DKLYFVLDYINGGELFYHLQR----------ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHI 178 (373)
T ss_dssp SEEEEEEECCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCE
T ss_pred CEEEEEEeCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCE
Confidence 889999999999999999952 24588999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 046598 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 922 (986)
||+|||+++..... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .....
T Consensus 179 kL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~~~~~-- 249 (373)
T 2r5t_A 179 VLTDFGLCKENIEH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-----AEMYD-- 249 (373)
T ss_dssp EECCCCBCGGGBCC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH-----HHHHH--
T ss_pred EEeeCccccccccC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----HHHHH--
Confidence 99999999753222 1223446799999999999999999999999999999999999999963211 11111
Q ss_pred CCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCC
Q 046598 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTN 985 (986)
Q Consensus 923 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 985 (986)
.++...+.. + ...+.++.+++.+|++.||++||++.+
T Consensus 250 ------~i~~~~~~~-~-------------------~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 250 ------NILNKPLQL-K-------------------PNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp ------HHHHSCCCC-C-------------------SSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred ------HHHhcccCC-C-------------------CCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 111111100 0 012345678999999999999999853
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=368.69 Aligned_cols=246 Identities=24% Similarity=0.330 Sum_probs=199.8
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
.++|.+.+.||+|+||.||+|++..+++.||||+++... ....+.+.+|+++++.++||||+++++++ ....
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~-----~~~~ 89 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI-----STPS 89 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECC
Confidence 467999999999999999999999889999999997432 23356789999999999999999999994 4567
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..++||||+++|+|.+++.. .+.+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+|
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~----------~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vk 156 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICK----------NGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAK 156 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTS----------SSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEE
T ss_pred EEEEEEeCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeE
Confidence 89999999999999999952 34689999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccCCCc-CcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEV-SISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 922 (986)
|+|||+++...... .....+||+.|+|||++.+..+ +.++||||+||++|||++|+.||..... .....
T Consensus 157 L~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-----~~~~~-- 226 (476)
T 2y94_A 157 IADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV-----PTLFK-- 226 (476)
T ss_dssp ECCCSSCEECCTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS-----HHHHH--
T ss_pred EEeccchhhccccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH-----HHHHH--
Confidence 99999998764322 2234579999999999988766 7899999999999999999999963211 11111
Q ss_pred CCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 923 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+.+... ..+. ..+.++.+++.+||+.||++|||++||
T Consensus 227 ------~i~~~~~-~~p~-------------------~~s~~~~~Li~~~L~~dP~~Rpt~~ei 264 (476)
T 2y94_A 227 ------KICDGIF-YTPQ-------------------YLNPSVISLLKHMLQVDPMKRATIKDI 264 (476)
T ss_dssp ------HHHTTCC-CCCT-------------------TCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred ------HHhcCCc-CCCc-------------------cCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 1111100 0010 123457789999999999999998764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=351.29 Aligned_cols=251 Identities=19% Similarity=0.232 Sum_probs=201.2
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCch------hHHHHHHHHHHHhcCCCCcceeeeeecccccc
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHG------AFKSFIAECNTLKNIRHRNLVKILTACSGVDY 759 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 759 (986)
..++|++.+.||+|+||.||+|++..+++.||+|+++..... ..+.+.+|+.++++++||||+++++++
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~----- 84 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY----- 84 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEE-----
Confidence 356799999999999999999999998999999999753321 357799999999999999999999994
Q ss_pred CCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCC
Q 046598 760 QGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED 839 (986)
Q Consensus 760 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 839 (986)
..+...++||||+++++|.+++.. ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.+
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~ 151 (321)
T 2a2a_A 85 ENRTDVVLILELVSGGELFDFLAQ----------KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDK 151 (321)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHT----------CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCT
T ss_pred ecCCEEEEEEEcCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecC
Confidence 556789999999999999999952 24689999999999999999999999 99999999999999988
Q ss_pred C----cEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccH
Q 046598 840 M----IAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNL 915 (986)
Q Consensus 840 ~----~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~ 915 (986)
+ .+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 152 ~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----- 223 (321)
T 2a2a_A 152 NIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK----- 223 (321)
T ss_dssp TSSSCCEEECCCTTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-----
T ss_pred CCCcCCEEEccCccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH-----
Confidence 8 79999999998764322 22345689999999999999999999999999999999999999963211
Q ss_pred HHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 916 HNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 916 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
...... +..... ..+ .......+..+.+++.+||+.||++|||++|+
T Consensus 224 ~~~~~~--------i~~~~~-~~~---------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~ 270 (321)
T 2a2a_A 224 QETLAN--------ITSVSY-DFD---------------EEFFSHTSELAKDFIRKLLVKETRKRLTIQEA 270 (321)
T ss_dssp HHHHHH--------HHTTCC-CCC---------------HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHH
T ss_pred HHHHHH--------HHhccc-ccC---------------hhhhcccCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 111100 000000 000 00011234457899999999999999998763
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=363.15 Aligned_cols=208 Identities=19% Similarity=0.198 Sum_probs=181.9
Q ss_pred CeEEEEeccCCCCccccCcCccCCCCCCEEEccCCCccccCCcchhccccCceeeceecccCCCCccchhcCccccceec
Q 046598 62 QRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRL 141 (986)
Q Consensus 62 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 141 (986)
.+++.||+++|.+++. | .++.+++|++|+|++|++++. | |+.+++|++|+|++|++++. | ++.+++|++|++
T Consensus 42 ~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L 113 (457)
T 3bz5_A 42 ATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNC 113 (457)
T ss_dssp TTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEEC
T ss_pred CCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEEC
Confidence 4688999999999974 4 799999999999999999974 4 99999999999999999975 4 899999999999
Q ss_pred ccccccCccCccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeeccCCcccCcCcchhhccCCCceeeccccccccc
Q 046598 142 FHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGT 221 (986)
Q Consensus 142 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 221 (986)
++|++++ +| ++.+++|++|++++|++++. .++++++|++|++++|+..+.+ .++.+++|++|++++|++++
T Consensus 114 ~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~- 184 (457)
T 3bz5_A 114 DTNKLTK-LD--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE- 184 (457)
T ss_dssp CSSCCSC-CC--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-
T ss_pred CCCcCCe-ec--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-
Confidence 9999996 45 89999999999999999974 3899999999999999665555 48899999999999999996
Q ss_pred CCccccCCCCccEEeccccccccccCCcccccccccceEEecCceecccCCccccCCCCCcEEecccccccCCC
Q 046598 222 IPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAA 295 (986)
Q Consensus 222 ~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~ 295 (986)
+| +..+++|+.|+++.|.+.+. + +..+++|++|++++|++++ +| ++.+++|+.|++++|++++.+
T Consensus 185 l~--l~~l~~L~~L~l~~N~l~~~-~---l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~ 249 (457)
T 3bz5_A 185 LD--VSQNKLLNRLNCDTNNITKL-D---LNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELD 249 (457)
T ss_dssp CC--CTTCTTCCEEECCSSCCSCC-C---CTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCC
T ss_pred ec--cccCCCCCEEECcCCcCCee-c---cccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcC
Confidence 55 88889999999999999864 3 3467889999999999987 45 888889999999988887654
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=358.72 Aligned_cols=377 Identities=20% Similarity=0.204 Sum_probs=200.6
Q ss_pred CCCCCCCCCCCCc-ceeeEecCCCCeEEEEeccCCCCccccCcCccCCCCCCEEEccCCCccccCCcchhccccCceeec
Q 046598 39 VLASWNESSHFCQ-WRGVTCSRRHQRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLAL 117 (986)
Q Consensus 39 ~l~~w~~~~~~c~-w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 117 (986)
.+++|..+.+||. |.+..|.....++ +... ........-..+++++.|++++|.+....+..|..+++|++|+|
T Consensus 2 ~~~~~~~~~~C~~~~~~~~c~~~~~~i---~~~~--~~~~~~~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L 76 (390)
T 3o6n_A 2 NVKPRQPEYKCIDSNLQYDCVFYDVHI---DMQT--QDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNL 76 (390)
T ss_dssp -----CCEECBCC------EEEESCEE---CSSC--CCCEESCSSGGGCCCSEEEEESCEESEECTHHHHHCCCCSEEEC
T ss_pred CcCCCCCccceehhhhhhccceeeeee---eccc--ccccccccccccCCceEEEecCCchhhCChhHhcccccCcEEEC
Confidence 3688988777774 5555554322222 1111 11112222234566777777777776555555666777777777
Q ss_pred eecccCCCCccchhcCccccceecccccccCccCccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeeccCCcccCc
Q 046598 118 HYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGS 197 (986)
Q Consensus 118 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 197 (986)
++|++++..|..|..+++|++|+|++|.+++..|..|+++++|++|+|++|+++...+..|+++++|++|+|++|++++.
T Consensus 77 ~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~ 156 (390)
T 3o6n_A 77 NDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERI 156 (390)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBC
T ss_pred CCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCcc
Confidence 77776655555666666666666666666655555666666666666666666643334445566666666666665554
Q ss_pred CcchhhccCCCceeecccccccccCCccccCCCCccEEeccccccccccCCcccccccccceEEecCceecccCCccccC
Q 046598 198 IPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISN 277 (986)
Q Consensus 198 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~ 277 (986)
.|..|..+++|++|+|++|++++. + +..
T Consensus 157 ~~~~~~~l~~L~~L~l~~n~l~~~-~---------------------------------------------------~~~ 184 (390)
T 3o6n_A 157 EDDTFQATTSLQNLQLSSNRLTHV-D---------------------------------------------------LSL 184 (390)
T ss_dssp CTTTTSSCTTCCEEECCSSCCSBC-C---------------------------------------------------GGG
T ss_pred ChhhccCCCCCCEEECCCCcCCcc-c---------------------------------------------------ccc
Confidence 455555555555555555544411 0 111
Q ss_pred CCCCcEEecccccccCCCchhhhhhhHhhhhhccCCCCCCCCCCcccccccccccccceeeccccccccCCCcccccccc
Q 046598 278 ASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLST 357 (986)
Q Consensus 278 l~~L~~L~ls~N~l~~~~~~l~~l~~L~~l~l~~n~l~~~~~~~l~~l~~l~~~~~L~~l~l~~n~~~~~~p~~~~~~~~ 357 (986)
+++|+.++
T Consensus 185 l~~L~~L~------------------------------------------------------------------------ 192 (390)
T 3o6n_A 185 IPSLFHAN------------------------------------------------------------------------ 192 (390)
T ss_dssp CTTCSEEE------------------------------------------------------------------------
T ss_pred ccccceee------------------------------------------------------------------------
Confidence 11222222
Q ss_pred cceEEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCcccccccccEEEecc
Q 046598 358 TLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSY 437 (986)
Q Consensus 358 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~ 437 (986)
+++|.+++ +...++|++|++++|.++.. |..+
T Consensus 193 ------l~~n~l~~-----~~~~~~L~~L~l~~n~l~~~-~~~~------------------------------------ 224 (390)
T 3o6n_A 193 ------VSYNLLST-----LAIPIAVEELDASHNSINVV-RGPV------------------------------------ 224 (390)
T ss_dssp ------CCSSCCSE-----EECCSSCSEEECCSSCCCEE-ECCC------------------------------------
T ss_pred ------cccccccc-----cCCCCcceEEECCCCeeeec-cccc------------------------------------
Confidence 22222211 01112344444444444421 1110
Q ss_pred cccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccC
Q 046598 438 NFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEI 517 (986)
Q Consensus 438 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 517 (986)
.++|+.|++++|++++ ++ .+..+++|+.|++++|++++..|..|..+++|+.|+|++|+++ .+
T Consensus 225 -------------~~~L~~L~l~~n~l~~-~~--~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~ 287 (390)
T 3o6n_A 225 -------------NVELTILKLQHNNLTD-TA--WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-AL 287 (390)
T ss_dssp -------------CSSCCEEECCSSCCCC-CG--GGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCC-EE
T ss_pred -------------cccccEEECCCCCCcc-cH--HHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCc-cc
Confidence 1345555555555542 21 2444555666666666666555566666666666666666666 34
Q ss_pred cccccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCccccccCCcccccc
Q 046598 518 PSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQGVFKN 597 (986)
Q Consensus 518 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~~~~~ 597 (986)
|..+..+++|++|+|++|+++ .+|..+..+++|+.|+|++|+|++. | +..+++|++|++++|++++.... ..+..
T Consensus 288 ~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~~~~~-~~~~~ 362 (390)
T 3o6n_A 288 NLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLR-ALFRN 362 (390)
T ss_dssp ECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHH-HHTTT
T ss_pred CcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCcccee-C--chhhccCCEEEcCCCCccchhHH-HHHHH
Confidence 555566667777777777776 4555666677777777777777643 3 55677777778888877764332 23445
Q ss_pred ccceeeeCCcccccCCC
Q 046598 598 ASITSVFGNLKLCGGIP 614 (986)
Q Consensus 598 ~~~~~~~~n~~lcg~~~ 614 (986)
+....+.+++..|+.+.
T Consensus 363 ~~~~~~~~~~~~c~~~~ 379 (390)
T 3o6n_A 363 VARPAVDDADQHCKIDY 379 (390)
T ss_dssp CCTTTBCCCCSCCCTTC
T ss_pred HHhhcccccCceecccc
Confidence 55556677777787543
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=368.41 Aligned_cols=137 Identities=21% Similarity=0.187 Sum_probs=76.6
Q ss_pred cceEEEccCCcccccCCcccccccccchhhccCccccccCcccccCCccccEEecccccccccCCccccCCCCCCEEeCC
Q 046598 478 SLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLS 557 (986)
Q Consensus 478 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 557 (986)
+|+.|++++|+|++..+..|..+++|+.|+|++|++++..+..|..+++|++|+|++|++++..|..|..+++|+.|+|+
T Consensus 225 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 304 (477)
T 2id5_A 225 NLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVS 304 (477)
T ss_dssp CCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECC
T ss_pred cccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECC
Confidence 44455555555543222344555555555555555554444555555666666666666665556666666666666666
Q ss_pred CccCcccCchhhhcccccceeeccCCccccccCCccccccccceeeeCCcccccCCC
Q 046598 558 QNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQGVFKNASITSVFGNLKLCGGIP 614 (986)
Q Consensus 558 ~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lcg~~~ 614 (986)
+|+|++..+..|..+++|++|+|++|++++..+....+.......+.++...|+.|.
T Consensus 305 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p~ 361 (477)
T 2id5_A 305 GNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATPE 361 (477)
T ss_dssp SSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEESG
T ss_pred CCcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCch
Confidence 666665555566666666666666666666554333233333345556666666543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=364.53 Aligned_cols=205 Identities=25% Similarity=0.376 Sum_probs=166.2
Q ss_pred HhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeec--cCchhHHHHHHHHHHHhcCC-CCcceeeeeeccccccCC
Q 046598 685 NATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL--LHHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQG 761 (986)
Q Consensus 685 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 761 (986)
...++|++.+.||+|+||.||+|.+..+++.||||++.. ......+++.+|+.+++++. ||||+++++++.. .+
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---~~ 82 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRA---DN 82 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC---TT
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEec---CC
Confidence 356789999999999999999999999999999999853 23345567889999999997 9999999999642 34
Q ss_pred CceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCc
Q 046598 762 NDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI 841 (986)
Q Consensus 762 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 841 (986)
....|+||||++ ++|.+++.. ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.
T Consensus 83 ~~~~~lv~e~~~-~~L~~~~~~-----------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~ 147 (388)
T 3oz6_A 83 DRDVYLVFDYME-TDLHAVIRA-----------NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECH 147 (388)
T ss_dssp SSCEEEEEECCS-EEHHHHHHH-----------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCC
T ss_pred CCEEEEEecccC-cCHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCC
Confidence 457899999996 699999852 3588999999999999999999999 9999999999999999999
Q ss_pred EEEcccccceecCCCC-------------------CccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhC
Q 046598 842 AHIGDFGLARFLPLSS-------------------AQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITR 901 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg 901 (986)
+||+|||+|+.+.... ........+||+.|+|||++.+ ..++.++||||+||++|||++|
T Consensus 148 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g 227 (388)
T 3oz6_A 148 VKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG 227 (388)
T ss_dssp EEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHS
T ss_pred EEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhC
Confidence 9999999998653211 1122344679999999999887 6799999999999999999999
Q ss_pred CCCCCc
Q 046598 902 KKPTDI 907 (986)
Q Consensus 902 ~~pf~~ 907 (986)
++||..
T Consensus 228 ~~pf~~ 233 (388)
T 3oz6_A 228 KPIFPG 233 (388)
T ss_dssp SCSCCC
T ss_pred CCCCCC
Confidence 999974
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=348.54 Aligned_cols=200 Identities=27% Similarity=0.436 Sum_probs=167.9
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc--hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
++|++.+.||+|+||+||+|++ .+++.||+|+++.... ...+.+.+|++++++++||||+++++++ ..++..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI-----HTKKRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE-----ECSSCE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEE-----ccCCeE
Confidence 5799999999999999999999 4588999999864332 2346788999999999999999999994 455789
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
++||||+++ +|.+++.. ....+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 76 ~lv~e~~~~-~l~~~~~~---------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~ 142 (288)
T 1ob3_A 76 VLVFEHLDQ-DLKKLLDV---------CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIA 142 (288)
T ss_dssp EEEEECCSE-EHHHHHHT---------STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred EEEEEecCC-CHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEe
Confidence 999999965 99999862 234689999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCcc
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDIM 908 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~ 908 (986)
|||+++...... .......+|+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 143 Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 204 (288)
T 1ob3_A 143 DFGLARAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (288)
T ss_dssp CTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ECccccccCccc--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999998654221 122335689999999998764 5899999999999999999999999743
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=358.21 Aligned_cols=268 Identities=20% Similarity=0.267 Sum_probs=202.0
Q ss_pred HHHHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc-----CchhHHHHHHHHHHHhcCCCCcceeeeeeccc
Q 046598 682 NLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL-----HHGAFKSFIAECNTLKNIRHRNLVKILTACSG 756 (986)
Q Consensus 682 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 756 (986)
++....++|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|++++++++||||+++++++
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-- 97 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY-- 97 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE--
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh--
Confidence 4566788999999999999999999999999999999998643 234567899999999999999999999994
Q ss_pred cccCCCceEEEEEEeccCCCHhHhhccCCCCCc------------------------------cccCCCccCHHHHHHHH
Q 046598 757 VDYQGNDFKALVFEFMHNRSLEEWLHPITREDE------------------------------TDEAPRSLNLIQRLNIS 806 (986)
Q Consensus 757 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------------------------------~~~~~~~l~~~~~~~i~ 806 (986)
.+++..++||||+++|+|.+++........ .......+++..++.|+
T Consensus 98 ---~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 174 (345)
T 3hko_A 98 ---EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIM 174 (345)
T ss_dssp ---ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHH
T ss_pred ---ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHH
Confidence 556889999999999999999953211100 00112345788899999
Q ss_pred HHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCC--cEEEcccccceecCCCCC--ccccccccccccccccccccC--C
Q 046598 807 IDVACALNYLHHDCQPPIAHCDLKPSNILLDEDM--IAHIGDFGLARFLPLSSA--QTSSIGAKGSIGYIAPEYGLG--S 880 (986)
Q Consensus 807 ~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~kL~DFG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~ 880 (986)
.||+.||+|||+. +|+||||||+||+++.++ .+||+|||+++.+..... ........||+.|+|||++.+ .
T Consensus 175 ~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 251 (345)
T 3hko_A 175 RQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNE 251 (345)
T ss_dssp HHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSS
T ss_pred HHHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCC
Confidence 9999999999999 999999999999998776 899999999986532221 122345669999999999875 6
Q ss_pred CcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHH
Q 046598 881 EVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIE 960 (986)
Q Consensus 881 ~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 960 (986)
.++.++|||||||++|||++|+.||......+ .. ..+......... +....
T Consensus 252 ~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~--------~~~~~~~~~~~~----------------~~~~~ 302 (345)
T 3hko_A 252 SYGPKCDAWSAGVLLHLLLMGAVPFPGVNDAD-----TI--------SQVLNKKLCFEN----------------PNYNV 302 (345)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HH--------HHHHHCCCCTTS----------------GGGGG
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCCCCCChHH-----HH--------HHHHhcccccCC----------------ccccc
Confidence 78999999999999999999999996432211 10 111111110000 00012
Q ss_pred HHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 961 CLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 961 ~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+.++.+++.+||+.||++|||+.|+
T Consensus 303 ~~~~~~~li~~~l~~~p~~Rps~~~~ 328 (345)
T 3hko_A 303 LSPLARDLLSNLLNRNVDERFDAMRA 328 (345)
T ss_dssp SCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 34467799999999999999998763
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=352.69 Aligned_cols=244 Identities=24% Similarity=0.275 Sum_probs=190.0
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcC-CCCcceeeeeeccccccCCCc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 763 (986)
.++|++.++||+|+||+||+|++..+++.||||++.... .....+...|+..+.++ +||||++++++| .+++
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~-----~~~~ 130 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW-----EEGG 130 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETT
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEE-----EeCC
Confidence 367999999999999999999999889999999986432 23334555666666555 899999999995 4568
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..++||||+ +++|.+++.. ....+++.+++.|+.||+.||+|||+. +|+||||||+||+++.++.+|
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~---------~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~k 197 (311)
T 3p1a_A 131 ILYLQTELC-GPSLQQHCEA---------WGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCK 197 (311)
T ss_dssp EEEEEEECC-CCBHHHHHHH---------HCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEE
T ss_pred EEEEEEecc-CCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEE
Confidence 899999999 7799998852 234699999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhC
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTAL 923 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 923 (986)
|+|||+++...... ......||+.|+|||++.+ .++.++|||||||++|||++|..|+... ...........
T Consensus 198 l~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----~~~~~~~~~~~ 269 (311)
T 3p1a_A 198 LGDFGLLVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----EGWQQLRQGYL 269 (311)
T ss_dssp ECCCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----HHHHHHTTTCC
T ss_pred EccceeeeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----cHHHHHhccCC
Confidence 99999998764322 2234568999999999876 7999999999999999999997765421 11111110000
Q ss_pred CCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 924 PDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 924 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+. ......+.++.+++.+||+.||++|||++||
T Consensus 270 ~~------------------------------~~~~~~~~~l~~li~~~L~~dP~~Rpt~~el 302 (311)
T 3p1a_A 270 PP------------------------------EFTAGLSSELRSVLVMMLEPDPKLRATAEAL 302 (311)
T ss_dssp CH------------------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred Cc------------------------------ccccCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 00 0111234568899999999999999998764
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=366.04 Aligned_cols=208 Identities=23% Similarity=0.308 Sum_probs=179.2
Q ss_pred HHHHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 046598 682 NLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVD 758 (986)
Q Consensus 682 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 758 (986)
+.....++|++.+.||+|+||+||+|+++.+++.||||+++... ....+.+.+|..++..++||||++++++
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~----- 129 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFA----- 129 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEE-----
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEE-----
Confidence 33345688999999999999999999999899999999997422 2234568899999999999999999998
Q ss_pred cCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecC
Q 046598 759 YQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDE 838 (986)
Q Consensus 759 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 838 (986)
+.+++..|+||||+++|+|.+++.. ....+++..++.++.||+.||+|||+. +|+||||||+||+++.
T Consensus 130 ~~~~~~~~lVmE~~~gg~L~~~l~~---------~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~ 197 (412)
T 2vd5_A 130 FQDENYLYLVMEYYVGGDLLTLLSK---------FGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDR 197 (412)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHH---------HSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECT
T ss_pred EeeCCEEEEEEcCCCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecC
Confidence 4566889999999999999999962 223689999999999999999999999 9999999999999999
Q ss_pred CCcEEEcccccceecCCCCCcccccccccccccccccccc-------CCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 839 DMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGL-------GSEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 839 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
++++||+|||+++....... ......+||+.|+|||++. +..++.++|||||||++|||++|+.||..
T Consensus 198 ~g~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 272 (412)
T 2vd5_A 198 CGHIRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA 272 (412)
T ss_dssp TSCEEECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCCEEEeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC
Confidence 99999999999987653322 2223457999999999987 45789999999999999999999999963
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=361.23 Aligned_cols=262 Identities=26% Similarity=0.414 Sum_probs=201.9
Q ss_pred HhhcCCCCCcccccccceeEEEEEECC-----CCeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 046598 685 NATDRFSSVNQIGEGSFGSVFKGILDD-----GRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVD 758 (986)
Q Consensus 685 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 758 (986)
...++|++.+.||+|+||.||+|++.. +++.||||+++... ....+.+.+|++++++++||||++++++|
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~---- 119 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC---- 119 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE----
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE----
Confidence 346789999999999999999999973 45899999997543 33457799999999999999999999994
Q ss_pred cCCCceEEEEEEeccCCCHhHhhccCCCCC--------------ccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 046598 759 YQGNDFKALVFEFMHNRSLEEWLHPITRED--------------ETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPI 824 (986)
Q Consensus 759 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i 824 (986)
..++..++||||+++|+|.+++....... ........+++.+++.++.||++||+|||++ +|
T Consensus 120 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~i 195 (343)
T 1luf_A 120 -AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 195 (343)
T ss_dssp -CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred -ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 44578899999999999999997532110 0001125799999999999999999999999 99
Q ss_pred EeecCCCCCeEecCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCC
Q 046598 825 AHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKK 903 (986)
Q Consensus 825 vH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~ 903 (986)
+||||||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.
T Consensus 196 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence 9999999999999999999999999986643332233344568899999999998899999999999999999999 999
Q ss_pred CCCccccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 046598 904 PTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSM 983 (986)
Q Consensus 904 pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 983 (986)
||..... ...... +.+......+ ..++.++.+++.+||+.||++|||+
T Consensus 276 p~~~~~~-----~~~~~~--------~~~~~~~~~~-------------------~~~~~~l~~li~~~l~~~p~~Rps~ 323 (343)
T 1luf_A 276 PYYGMAH-----EEVIYY--------VRDGNILACP-------------------ENCPLELYNLMRLCWSKLPADRPSF 323 (343)
T ss_dssp TTTTSCH-----HHHHHH--------HHTTCCCCCC-------------------TTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred cCCCCCh-----HHHHHH--------HhCCCcCCCC-------------------CCCCHHHHHHHHHHcccCcccCCCH
Confidence 9863211 111110 0000000000 1234467899999999999999998
Q ss_pred CCC
Q 046598 984 TNV 986 (986)
Q Consensus 984 ~eV 986 (986)
+||
T Consensus 324 ~~~ 326 (343)
T 1luf_A 324 CSI 326 (343)
T ss_dssp HHH
T ss_pred HHH
Confidence 764
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=362.02 Aligned_cols=286 Identities=19% Similarity=0.243 Sum_probs=205.5
Q ss_pred HHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 684 YNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 684 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
....++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|++++++++||||+++++++........
T Consensus 23 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 102 (364)
T 3qyz_A 23 FDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 102 (364)
T ss_dssp CCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred ccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcccc
Confidence 344678999999999999999999999999999999997533 3344778999999999999999999999765544555
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
...++||||++ ++|.+++.. ..+++.+++.|+.||+.||+|||+. ||+||||||+||+++.++.+
T Consensus 103 ~~~~iv~e~~~-~~L~~~l~~-----------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~ 167 (364)
T 3qyz_A 103 KDVYIVQDLME-TDLYKLLKT-----------QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDL 167 (364)
T ss_dssp CCEEEEEECCS-EEHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCE
T ss_pred ceEEEEEcccC-cCHHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCE
Confidence 67999999996 599998851 3589999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCc-cccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHH
Q 046598 843 HIGDFGLARFLPLSSAQ-TSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLAR 920 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~ 920 (986)
||+|||+++........ .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||......+ .......
T Consensus 168 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~ 246 (364)
T 3qyz_A 168 KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QLNHILG 246 (364)
T ss_dssp EECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-HHHHHHH
T ss_pred EEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHH
Confidence 99999999876433221 11234579999999998655 458999999999999999999999997432221 1111111
Q ss_pred hhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 921 TALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 921 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.......+.+................................++.+++.+|++.||++|||++|+
T Consensus 247 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 311 (364)
T 3qyz_A 247 -ILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 311 (364)
T ss_dssp -HHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred -HhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 11111111110000000000000000000000000011234567899999999999999998763
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=344.69 Aligned_cols=250 Identities=21% Similarity=0.287 Sum_probs=199.8
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc--CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
.++|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|++++++++||||+++++++ ..+..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 79 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF 79 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE-----EcCCE
Confidence 57899999999999999999999999999999999753 233456788999999999999999999994 55678
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCc---
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI--- 841 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--- 841 (986)
.++||||+++++|.+++. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 80 ~~~v~e~~~~~~l~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~ 146 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIV----------AREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAA 146 (284)
T ss_dssp EEEEECCCCSCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCC
T ss_pred EEEEEecCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCc
Confidence 899999999999999884 224689999999999999999999999 9999999999999986665
Q ss_pred EEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHh
Q 046598 842 AHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLART 921 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~ 921 (986)
+||+|||.+....... ......|++.|+|||++.+..++.++||||+|+++|+|++|+.||...... ........
T Consensus 147 ~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~ 221 (284)
T 3kk8_A 147 VKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYAQIKA 221 (284)
T ss_dssp EEECCCTTCEECCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH
T ss_pred EEEeeceeeEEcccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh--HHHHHHHh
Confidence 9999999998764322 223456899999999999999999999999999999999999998632111 11111100
Q ss_pred hCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 922 ALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 922 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.. . ..+.. .....+.++.+++.+|++.||++|||++|+
T Consensus 222 ~~-----------~-~~~~~---------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~ 259 (284)
T 3kk8_A 222 GA-----------Y-DYPSP---------------EWDTVTPEAKSLIDSMLTVNPKKRITADQA 259 (284)
T ss_dssp TC-----------C-CCCTT---------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred cc-----------c-cCCch---------------hhcccCHHHHHHHHHHcccChhhCCCHHHH
Confidence 00 0 00000 001223457799999999999999998763
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=345.53 Aligned_cols=248 Identities=24% Similarity=0.363 Sum_probs=179.6
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
.++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++ .+.+
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 84 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF-----EDSN 84 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEE-----ECSS
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEE-----ccCC
Confidence 467999999999999999999998889999999996432 22346789999999999999999999994 4567
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..++||||+++++|.+++.. ....+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~k 152 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKN---------RVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIK 152 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHT---------CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEE
T ss_pred eEEEEEecCCCCcHHHHHhh---------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEE
Confidence 89999999999999999962 234689999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhC
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTAL 923 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 923 (986)
|+|||.+........ ......|++.|+|||++.+..++.++||||||+++|||++|+.||....... ...
T Consensus 153 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~--- 222 (278)
T 3cok_A 153 IADFGLATQLKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN-----TLN--- 222 (278)
T ss_dssp ECCCTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------
T ss_pred EEeecceeeccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH-----HHH---
Confidence 999999987643222 2223568999999999999999999999999999999999999996422110 000
Q ss_pred CCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 924 PDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 924 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.....+... +...+.++.+++.+||+.||++|||++||
T Consensus 223 ---------~~~~~~~~~----------------~~~~~~~~~~li~~~l~~dp~~Rps~~~~ 260 (278)
T 3cok_A 223 ---------KVVLADYEM----------------PSFLSIEAKDLIHQLLRRNPADRLSLSSV 260 (278)
T ss_dssp ----------CCSSCCCC----------------CTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred ---------HHhhcccCC----------------ccccCHHHHHHHHHHcccCHhhCCCHHHH
Confidence 000000000 00123457799999999999999998764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=356.00 Aligned_cols=241 Identities=22% Similarity=0.349 Sum_probs=198.3
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc--------hhHHHHHHHHHHHhcCCCCcceeeeeecccc
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH--------GAFKSFIAECNTLKNIRHRNLVKILTACSGV 757 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 757 (986)
..++|++.+.||+|+||.||+|++..+++.||||+++.... ...+.+.+|++++++++||||++++++
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~---- 97 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDI---- 97 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEE----
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEE----
Confidence 45789999999999999999999999999999999975321 133467889999999999999999999
Q ss_pred ccCCCceEEEEEEeccCC-CHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEe
Q 046598 758 DYQGNDFKALVFEFMHNR-SLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILL 836 (986)
Q Consensus 758 ~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 836 (986)
+...+..++||||+.+| +|.+++.. ...+++..++.|+.||+.||+|||+. +|+||||||+||++
T Consensus 98 -~~~~~~~~lv~e~~~~g~~l~~~~~~----------~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll 163 (335)
T 3dls_A 98 -FENQGFFQLVMEKHGSGLDLFAFIDR----------HPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVI 163 (335)
T ss_dssp -EECSSEEEEEEECCTTSCBHHHHHHT----------CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred -EeeCCEEEEEEEeCCCCccHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEE
Confidence 45668899999999777 99999952 34589999999999999999999999 99999999999999
Q ss_pred cCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCc-CcccchhhHHHHHHHHHhCCCCCCccccccccH
Q 046598 837 DEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEV-SISGDVYSYGILLLELITRKKPTDIMFEGDMNL 915 (986)
Q Consensus 837 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~ 915 (986)
+.++.+||+|||+++....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||......
T Consensus 164 ~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---- 236 (335)
T 3dls_A 164 AEDFTIKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---- 236 (335)
T ss_dssp CTTSCEEECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----
T ss_pred cCCCcEEEeecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----
Confidence 9999999999999987643322 234568999999999988877 88999999999999999999999632110
Q ss_pred HHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 916 HNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 916 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..... ..+. ..+.++.+++.+||+.||++|||++||
T Consensus 237 ---------------~~~~~-~~~~-------------------~~~~~l~~li~~~L~~dP~~Rps~~el 272 (335)
T 3dls_A 237 ---------------VEAAI-HPPY-------------------LVSKELMSLVSGLLQPVPERRTTLEKL 272 (335)
T ss_dssp ---------------TTTCC-CCSS-------------------CCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ---------------Hhhcc-CCCc-------------------ccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 00000 0000 123457799999999999999998764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=358.23 Aligned_cols=268 Identities=24% Similarity=0.318 Sum_probs=205.8
Q ss_pred hcCCCCCcccccccceeEEEEEE----CCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGIL----DDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
.++|++.+.||+|+||.||+|++ ..+++.||||++........+.+.+|++++++++||||+++++++. ..+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~~ 98 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSY---GPGR 98 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE---CSSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEe---cCCC
Confidence 46899999999999999999994 5678999999998766666778999999999999999999999853 2355
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
...++||||+++++|.+++.. ....+++.+++.|+.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~ 166 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQR---------HRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHV 166 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHH---------HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEE
T ss_pred ceEEEEEeecCCCCHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCE
Confidence 778999999999999999962 224589999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCc-cccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHh
Q 046598 843 HIGDFGLARFLPLSSAQ-TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLART 921 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~ 921 (986)
||+|||+++........ .......+|..|+|||++.+..++.++|||||||++|+|++|+.||....... .......
T Consensus 167 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~--~~~~~~~ 244 (327)
T 3lxl_A 167 KIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF--LRMMGCE 244 (327)
T ss_dssp EECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH--HHHCC--
T ss_pred EEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchh--hhhcccc
Confidence 99999999876543322 22334558888999999999999999999999999999999999986321110 0000000
Q ss_pred hCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 922 ALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 922 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..........+...... +......++.++.+++.+||+.||++|||++||
T Consensus 245 ~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 294 (327)
T 3lxl_A 245 RDVPALSRLLELLEEGQ---------------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 294 (327)
T ss_dssp --CCHHHHHHHHHHTTC---------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred cccccHHHHHHHhhccc---------------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHH
Confidence 00011111111111000 000112345668899999999999999998764
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=346.37 Aligned_cols=250 Identities=23% Similarity=0.332 Sum_probs=197.5
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc--CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
+.|.+.+.||+|+||.||+|.+..++..||+|++... .....+.+.+|+.++++++||||+++++++... ...+...
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~~~ 104 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCI 104 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccc-cCCCceE
Confidence 4578888999999999999999999999999998743 334567789999999999999999999986543 3456778
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeecCCCCCeEec-CCCcE
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPP--IAHCDLKPSNILLD-EDMIA 842 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~ 842 (986)
++||||+++++|.+++.. ...+++..++.|+.||+.||+|||+. + |+||||||+||+++ .++.+
T Consensus 105 ~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~ 171 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKR----------FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSV 171 (290)
T ss_dssp EEEEECCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCE
T ss_pred EEEEEecCCCCHHHHHHH----------ccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCE
Confidence 999999999999999952 24589999999999999999999998 7 99999999999997 78999
Q ss_pred EEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 046598 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 922 (986)
||+|||++...... ......|++.|+|||++.+ .++.++||||+||++|+|++|+.||...... .......
T Consensus 172 kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~~~~~ 242 (290)
T 1t4h_A 172 KIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA----AQIYRRV 242 (290)
T ss_dssp EECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH----HHHHHHH
T ss_pred EEeeCCCccccccc----ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH----HHHHHHH
Confidence 99999999754322 2233568999999998874 5899999999999999999999999632221 1111111
Q ss_pred CCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 923 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..... +.. .....+.++.+++.+||+.||++|||++||
T Consensus 243 ~~~~~-----------~~~---------------~~~~~~~~l~~li~~~l~~dp~~Rps~~el 280 (290)
T 1t4h_A 243 TSGVK-----------PAS---------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDL 280 (290)
T ss_dssp TTTCC-----------CGG---------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred hccCC-----------ccc---------------cCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 10000 000 000112357899999999999999998764
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=352.38 Aligned_cols=268 Identities=25% Similarity=0.274 Sum_probs=196.5
Q ss_pred hcCCCCC-cccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcC-CCCcceeeeeeccccccCCCce
Q 046598 687 TDRFSSV-NQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 687 ~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~ 764 (986)
.++|++. +.||+|+||.||+|.+..+++.||||+++.......+.+.+|++++.++ +||||+++++++ .+++.
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~-----~~~~~ 85 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF-----EEEDR 85 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EETTE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEE-----eeCCE
Confidence 4678885 7899999999999999988999999999866555667899999999885 799999999994 45578
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCc---
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI--- 841 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--- 841 (986)
.++||||+++++|.+++.. ...+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.
T Consensus 86 ~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~ 152 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHK----------RRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSP 152 (316)
T ss_dssp EEEEEECCTTCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCS
T ss_pred EEEEEEcCCCCcHHHHHhc----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCc
Confidence 9999999999999999952 24689999999999999999999999 9999999999999998776
Q ss_pred EEEcccccceecCCCCC-----ccccccccccccccccccccC-----CCcCcccchhhHHHHHHHHHhCCCCCCccccc
Q 046598 842 AHIGDFGLARFLPLSSA-----QTSSIGAKGSIGYIAPEYGLG-----SEVSISGDVYSYGILLLELITRKKPTDIMFEG 911 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~ 911 (986)
+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 153 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 232 (316)
T 2ac3_A 153 VKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGS 232 (316)
T ss_dssp EEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCS
T ss_pred eEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccc
Confidence 99999999976532211 112223458999999999875 56889999999999999999999999754332
Q ss_pred cccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 912 DMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+..+... ...+.....+.......... .+ .......+.++.+++.+||+.||++|||++|+
T Consensus 233 ~~~~~~~--~~~~~~~~~~~~~i~~~~~~---------~~---~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 293 (316)
T 2ac3_A 233 DCGWDRG--EACPACQNMLFESIQEGKYE---------FP---DKDWAHISCAAKDLISKLLVRDAKQRLSAAQV 293 (316)
T ss_dssp CSCC------CCHHHHHHHHHHHHHCCCC---------CC---HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred ccccccc--ccchhHHHHHHHHHhccCcc---------cC---chhcccCCHHHHHHHHHHhhCChhhCCCHHHH
Confidence 2111000 00000000111111000000 00 00011234568899999999999999998764
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=358.27 Aligned_cols=250 Identities=23% Similarity=0.353 Sum_probs=194.7
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeE----EEEEEeecc-CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTT----IAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 761 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 761 (986)
.++|++.+.||+|+||+||+|.+..+++. ||+|++... .....+.+.+|+.++++++||||++++++|.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------ 85 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP------ 85 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC------
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc------
Confidence 35789999999999999999999776655 777776432 2333456788999999999999999999852
Q ss_pred CceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCc
Q 046598 762 NDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI 841 (986)
Q Consensus 762 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 841 (986)
+...++||||+++|+|.+++.. ....+++..++.|+.||+.||+|||+. +|+||||||+||+++.++.
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~ 153 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQ---------HRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQ 153 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHS---------SGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSC
T ss_pred CCccEEEEEeCCCCCHHHHHHH---------ccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCe
Confidence 3568999999999999999962 234688899999999999999999999 9999999999999999999
Q ss_pred EEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHH
Q 046598 842 AHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLAR 920 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~ 920 (986)
+||+|||+++...............++..|+|||++.+..++.++|||||||++|||+| |+.||...... ...
T Consensus 154 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~---- 227 (325)
T 3kex_A 154 VQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA--EVP---- 227 (325)
T ss_dssp EEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT--HHH----
T ss_pred EEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH--HHH----
Confidence 99999999988765544444455668889999999998999999999999999999999 99999743211 111
Q ss_pred hhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 921 TALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 921 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+.+......... ..++.++.+++.+||+.||++|||++||
T Consensus 228 --------~~~~~~~~~~~~------------------~~~~~~~~~li~~~l~~dp~~Rps~~el 267 (325)
T 3kex_A 228 --------DLLEKGERLAQP------------------QICTIDVYMVMVKCWMIDENIRPTFKEL 267 (325)
T ss_dssp --------HHHHTTCBCCCC------------------TTBCTTTTHHHHHHTCSCTTTSCCHHHH
T ss_pred --------HHHHcCCCCCCC------------------CcCcHHHHHHHHHHcCCChhhCcCHHHH
Confidence 111110000000 0122346689999999999999998764
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=358.66 Aligned_cols=262 Identities=24% Similarity=0.343 Sum_probs=200.4
Q ss_pred hhcCCCCCcccccccceeEEEEEE-----CCCCeEEEEEEeecc-CchhHHHHHHHHHHHhcC-CCCcceeeeeeccccc
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGIL-----DDGRTTIAVKVFNLL-HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVD 758 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 758 (986)
..++|.+.+.||+|+||.||+|.+ ..+++.||||+++.. .....+.+.+|+++++++ +||||+++++++
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~---- 118 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC---- 118 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE----
Confidence 457899999999999999999997 335678999999743 233457899999999999 899999999994
Q ss_pred cCCCceEEEEEEeccCCCHhHhhccCCCCC-------------ccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 046598 759 YQGNDFKALVFEFMHNRSLEEWLHPITRED-------------ETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIA 825 (986)
Q Consensus 759 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-------------~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iv 825 (986)
..++..++||||+++|+|.+++....... ........+++.+++.++.||+.||+|||+. ||+
T Consensus 119 -~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iv 194 (344)
T 1rjb_A 119 -TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCV 194 (344)
T ss_dssp -CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred -eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 44577999999999999999997543210 0011124589999999999999999999999 999
Q ss_pred eecCCCCCeEecCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCC
Q 046598 826 HCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKP 904 (986)
Q Consensus 826 H~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p 904 (986)
||||||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||+| |+.|
T Consensus 195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred cCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999999999987654433333445567889999999998999999999999999999998 9999
Q ss_pred CCccccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 046598 905 TDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMT 984 (986)
Q Consensus 905 f~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 984 (986)
|...... ......... ...... +..++.++.+++.+||+.||++|||++
T Consensus 275 ~~~~~~~-~~~~~~~~~------------~~~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ 323 (344)
T 1rjb_A 275 YPGIPVD-ANFYKLIQN------------GFKMDQ------------------PFYATEEIYIIMQSCWAFDSRKRPSFP 323 (344)
T ss_dssp STTCCCS-HHHHHHHHT------------TCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred cccCCcH-HHHHHHHhc------------CCCCCC------------------CCCCCHHHHHHHHHHcCCCchhCcCHH
Confidence 9643221 111111111 110000 002244678999999999999999987
Q ss_pred CC
Q 046598 985 NV 986 (986)
Q Consensus 985 eV 986 (986)
||
T Consensus 324 ~l 325 (344)
T 1rjb_A 324 NL 325 (344)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=359.43 Aligned_cols=253 Identities=20% Similarity=0.227 Sum_probs=190.4
Q ss_pred hcCCCCC-cccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhc-CCCCcceeeeeeccccccCCCce
Q 046598 687 TDRFSSV-NQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKN-IRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 687 ~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
.++|.+. +.||+|+||+||+|.+..+++.||||+++.. ..+.+|++++.+ .+||||+++++++... +.++..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~-~~~~~~ 133 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC 133 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeec-ccCCcE
Confidence 4567776 6899999999999999999999999998632 456788888744 5899999999986432 344677
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecC---CCc
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDE---DMI 841 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~ 841 (986)
.|+||||+++|+|.+++.... ...+++.+++.|+.||+.||+|||+. +|+||||||+||+++. ++.
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~ 202 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRG--------DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAI 202 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC-----------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCC
T ss_pred EEEEEEeCCCCcHHHHHHHhC--------CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCcc
Confidence 899999999999999996321 23589999999999999999999999 9999999999999997 789
Q ss_pred EEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCcccccccc--HHHHH
Q 046598 842 AHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMN--LHNLA 919 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~--~~~~~ 919 (986)
+||+|||+++..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... .....
T Consensus 203 ~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i 279 (400)
T 1nxk_A 203 LKLTDFGFAKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 279 (400)
T ss_dssp EEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH
T ss_pred EEEEecccccccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH
Confidence 999999999865422 2233467899999999999999999999999999999999999999743222110 11111
Q ss_pred HhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 920 RTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 920 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
. ..... .+. .....++.++.+++.+||+.||++|||++||
T Consensus 280 ~-----------~~~~~-~~~---------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ei 319 (400)
T 1nxk_A 280 R-----------MGQYE-FPN---------------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 319 (400)
T ss_dssp H-----------HTCCC-CCT---------------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred H-----------cCccc-CCC---------------cccccCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 0 00000 000 0001234567899999999999999998764
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=353.82 Aligned_cols=276 Identities=23% Similarity=0.330 Sum_probs=199.0
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc--hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
.++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+.+|++++++++||||++++++| .....
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~ 98 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVC-----KKKKR 98 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEe-----ecCCE
Confidence 4689999999999999999999999899999999864332 2345678999999999999999999995 45578
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.++||||+++++|.++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 99 ~~lv~e~~~~~~l~~~~~----------~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl 165 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLEL----------FPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKL 165 (331)
T ss_dssp EEEEEECCSEEHHHHHHH----------STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEE
T ss_pred EEEEEecCCcchHHHHHh----------hccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEE
Confidence 999999999999998864 234589999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCccccccccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHh--
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLART-- 921 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~-- 921 (986)
+|||.++...... .......|++.|+|||++.+. .++.++||||+||++|+|++|+.||......+. .......
T Consensus 166 ~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~ 242 (331)
T 4aaa_A 166 CDFGFARTLAAPG--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ-LYHIMMCLG 242 (331)
T ss_dssp CCCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHC
T ss_pred EeCCCceeecCCc--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhC
Confidence 9999997654322 222345689999999998875 789999999999999999999999974322211 1111111
Q ss_pred hCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 922 ALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 922 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.......+.+...-....... ... .............+.++.+++.+||+.||++|||++||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~el 304 (331)
T 4aaa_A 243 NLIPRHQELFNKNPVFAGVRL-PEI--KEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAEL 304 (331)
T ss_dssp SCCHHHHHHHHHCGGGTTCCC-CCC--SSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGG
T ss_pred CCChhhhhHhhhccccccccC-ccc--cccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHH
Confidence 011111111111000000000 000 00000011111345678899999999999999999875
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=367.03 Aligned_cols=253 Identities=24% Similarity=0.354 Sum_probs=202.6
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
.++|.+.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|++++++++||||++++++ +....
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~-----~~~~~ 258 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYA-----FETKT 258 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEE-----EECSS
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEE-----EeeCC
Confidence 367999999999999999999999889999999996432 2335678899999999999999999998 45668
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..|+||||++||+|.+++.... .....+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+|
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~------~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vk 329 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVD------EDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVR 329 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSS------TTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEE
T ss_pred EEEEEEEeccCCCHHHHHHHhh------cccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEE
Confidence 8999999999999999986432 1234689999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhC
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTAL 923 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 923 (986)
|+|||+++.+..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........
T Consensus 330 L~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~-~~~~~~~~-- 404 (543)
T 3c4z_A 330 ISDLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQR-- 404 (543)
T ss_dssp ECCCTTCEECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC-CHHHHHHH--
T ss_pred EeecceeeeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch-hHHHHHHH--
Confidence 999999987643322 2234579999999999999999999999999999999999999997432211 11111110
Q ss_pred CCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 046598 924 PDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMT 984 (986)
Q Consensus 924 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 984 (986)
+..... ..+ ...+.++.+++.+||+.||++||++.
T Consensus 405 ------i~~~~~-~~p-------------------~~~s~~~~~li~~lL~~dP~~R~~~~ 439 (543)
T 3c4z_A 405 ------VLEQAV-TYP-------------------DKFSPASKDFCEALLQKDPEKRLGFR 439 (543)
T ss_dssp ------HHHCCC-CCC-------------------TTSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred ------Hhhccc-CCC-------------------cccCHHHHHHHHHhccCCHhHCCCCc
Confidence 111000 000 12244577899999999999999874
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=361.49 Aligned_cols=260 Identities=24% Similarity=0.375 Sum_probs=203.9
Q ss_pred hcCCCCCcccccccceeEEEEEECC-------CCeEEEEEEeeccC-chhHHHHHHHHHHHhcC-CCCcceeeeeecccc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDD-------GRTTIAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKILTACSGV 757 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 757 (986)
.++|.+.+.||+|+||.||+|++.. .+..||||+++... ....+++.+|+++++++ +||||++++++|
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~--- 144 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC--- 144 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee---
Confidence 4689999999999999999999743 34689999997543 33457789999999999 999999999994
Q ss_pred ccCCCceEEEEEEeccCCCHhHhhccCCCCC------ccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCC
Q 046598 758 DYQGNDFKALVFEFMHNRSLEEWLHPITRED------ETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKP 831 (986)
Q Consensus 758 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 831 (986)
..++..++||||+++|+|.+++....... ........+++.+++.|+.||+.||+|||+. +|+||||||
T Consensus 145 --~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp 219 (382)
T 3tt0_A 145 --TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA 219 (382)
T ss_dssp --CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCG
T ss_pred --ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCc
Confidence 45577899999999999999997543210 0112235699999999999999999999999 999999999
Q ss_pred CCeEecCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCcccc
Q 046598 832 SNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFE 910 (986)
Q Consensus 832 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~ 910 (986)
+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~ 299 (382)
T 3tt0_A 220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 299 (382)
T ss_dssp GGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred ceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654443344445567889999999999999999999999999999999 9999863211
Q ss_pred ccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 911 GDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..... .+........ ...++.++.+++.+||+.||++|||++||
T Consensus 300 -----~~~~~---------~~~~~~~~~~------------------~~~~~~~l~~li~~~l~~dP~~Rps~~el 343 (382)
T 3tt0_A 300 -----EELFK---------LLKEGHRMDK------------------PSNCTNELYMMMRDCWHAVPSQRPTFKQL 343 (382)
T ss_dssp -----HHHHH---------HHHTTCCCCC------------------CSSCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -----HHHHH---------HHHcCCCCCC------------------CccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 11111 1111000000 01234567899999999999999998764
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=356.12 Aligned_cols=263 Identities=17% Similarity=0.218 Sum_probs=194.7
Q ss_pred hcCCCCCcccccccceeEEEEEECC---CCeEEEEEEeeccCch-----------hHHHHHHHHHHHhcCCCCcceeeee
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDD---GRTTIAVKVFNLLHHG-----------AFKSFIAECNTLKNIRHRNLVKILT 752 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~ 752 (986)
.++|.+.+.||+|+||.||+|.+.. ++..||||+....... ..+.+.+|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 4689999999999999999999986 6889999998754321 1234667888999999999999999
Q ss_pred eccccccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCC
Q 046598 753 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPS 832 (986)
Q Consensus 753 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~ 832 (986)
++... +......++||||+ +++|.+++.. .+.+++.+++.|+.||+.||+|||+. +|+||||||+
T Consensus 116 ~~~~~-~~~~~~~~lv~e~~-~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~ 180 (345)
T 2v62_A 116 SGLTE-FKGRSYRFMVMERL-GIDLQKISGQ----------NGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAA 180 (345)
T ss_dssp EEEEE-SSSCEEEEEEEECE-EEEHHHHCBG----------GGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred ccccc-cCCCcEEEEEEecc-CCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHH
Confidence 96543 34468899999999 9999999952 23689999999999999999999999 9999999999
Q ss_pred CeEecCCC--cEEEcccccceecCCCCC-----ccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCC
Q 046598 833 NILLDEDM--IAHIGDFGLARFLPLSSA-----QTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPT 905 (986)
Q Consensus 833 NIll~~~~--~~kL~DFG~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf 905 (986)
||+++.++ .+||+|||+++.+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 181 NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf 260 (345)
T 2v62_A 181 NLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPW 260 (345)
T ss_dssp GEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred HEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999887 999999999987643211 11123457999999999999999999999999999999999999999
Q ss_pred CccccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCC
Q 046598 906 DIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTN 985 (986)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 985 (986)
................. .....+.+..... ....+.++.+++.+||+.||++|||++|
T Consensus 261 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~---------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ 318 (345)
T 2v62_A 261 EQNLKDPVAVQTAKTNL-LDELPQSVLKWAP---------------------SGSSCCEIAQFLVCAHSLAYDEKPNYQA 318 (345)
T ss_dssp GGGTTCHHHHHHHHHHH-HHTTTHHHHHHSC---------------------TTSCCHHHHHHHHHHHTCCTTCCCCHHH
T ss_pred cccccccHHHHHHHHhh-cccccHHHHhhcc---------------------ccccHHHHHHHHHHHhhcCcccCCCHHH
Confidence 63322211111111100 0000000000000 0023456889999999999999999876
Q ss_pred C
Q 046598 986 V 986 (986)
Q Consensus 986 V 986 (986)
|
T Consensus 319 l 319 (345)
T 2v62_A 319 L 319 (345)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=359.09 Aligned_cols=249 Identities=23% Similarity=0.370 Sum_probs=189.1
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc--CchhHHHHHHHHHHHhcCCC--CcceeeeeeccccccCCC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRH--RNLVKILTACSGVDYQGN 762 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~~ 762 (986)
.++|++.+.||+|+||.||+|.+.. ++.||||++... .....+.+.+|+.++++++| |||+++++++ ..+
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~-----~~~ 81 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----ITD 81 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTT-SCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECS
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCC-CCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeE-----eeC
Confidence 4679999999999999999999865 889999998743 23345778999999999976 9999999994 456
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
...++|||+ .+++|.+++.. ...+++.++..|+.||+.||+|||+. +|+||||||+||+++ ++.+
T Consensus 82 ~~~~lv~e~-~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~ 146 (343)
T 3dbq_A 82 QYIYMVMEC-GNIDLNSWLKK----------KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGML 146 (343)
T ss_dssp SEEEEEECC-CSEEHHHHHHH----------SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEE
T ss_pred CEEEEEEeC-CCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcE
Confidence 789999995 58899999952 34689999999999999999999999 999999999999997 6789
Q ss_pred EEcccccceecCCCCCccccccccccccccccccccC-----------CCcCcccchhhHHHHHHHHHhCCCCCCccccc
Q 046598 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-----------SEVSISGDVYSYGILLLELITRKKPTDIMFEG 911 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~ 911 (986)
||+|||+++...............||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 147 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 226 (343)
T 3dbq_A 147 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 226 (343)
T ss_dssp EECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH
T ss_pred EEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH
Confidence 9999999987654433333445679999999999864 67899999999999999999999999643221
Q ss_pred cccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 912 DMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
... ....++........+ ..+.++.+++.+||+.||++|||++||
T Consensus 227 ~~~------------~~~~~~~~~~~~~~~------------------~~~~~l~~li~~~L~~dp~~Rpt~~e~ 271 (343)
T 3dbq_A 227 ISK------------LHAIIDPNHEIEFPD------------------IPEKDLQDVLKCCLKRDPKQRISIPEL 271 (343)
T ss_dssp HHH------------HHHHHCTTSCCCCCC------------------CSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HHH------------HHHHhcCCcccCCcc------------------cCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 111 111111111111000 112356789999999999999998764
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=346.02 Aligned_cols=249 Identities=24% Similarity=0.384 Sum_probs=196.0
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
..++|++.+.||+|+||.||+|.+.. +..||+|+++.... ..+++.+|++++++++||||+++++++ ..+...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~ 94 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQRPI 94 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETT-TEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcC-CCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEE-----ecCCCe
Confidence 35689999999999999999999875 77899999975433 347789999999999999999999994 556789
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
++||||+++++|.+++.. ....+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 95 ~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~ 162 (283)
T 3gen_A 95 FIITEYMANGCLLNYLRE---------MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVS 162 (283)
T ss_dssp EEEECCCTTCBHHHHHHC---------GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEEC
T ss_pred EEEEeccCCCcHHHHHHH---------hccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEc
Confidence 999999999999999962 234589999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCC
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALP 924 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 924 (986)
|||.++...... ........+|+.|+|||++.+..++.++||||+|+++|||+| |+.||...... ....
T Consensus 163 Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~-----~~~~---- 232 (283)
T 3gen_A 163 DFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-----ETAE---- 232 (283)
T ss_dssp STTGGGGBCCHH-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-----HHHH----
T ss_pred cccccccccccc-cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh-----HHHH----
Confidence 999998654221 222333456788999999998899999999999999999998 99998642211 1110
Q ss_pred CchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 925 DHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 925 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+......... ...+..+.+++.+||+.||++|||++||
T Consensus 233 -----~~~~~~~~~~~------------------~~~~~~l~~li~~~l~~~p~~Rps~~~l 271 (283)
T 3gen_A 233 -----HIAQGLRLYRP------------------HLASEKVYTIMYSCWHEKADERPTFKIL 271 (283)
T ss_dssp -----HHHTTCCCCCC------------------TTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred -----HHhcccCCCCC------------------CcCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 00000000000 0113457799999999999999998764
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=362.71 Aligned_cols=252 Identities=19% Similarity=0.259 Sum_probs=190.9
Q ss_pred HhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--------chhHHHHHHHHHHHhcCCCCcceeeeeeccc
Q 046598 685 NATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--------HGAFKSFIAECNTLKNIRHRNLVKILTACSG 756 (986)
Q Consensus 685 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 756 (986)
...++|.+.+.||+|+||+||+|.+..+++.||||++.... ......+.+|++++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 45678999999999999999999999999999999987432 112235789999999999999999999842
Q ss_pred cccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEe
Q 046598 757 VDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILL 836 (986)
Q Consensus 757 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 836 (986)
.+..++||||+++|+|.+++. ....+++.+++.++.|++.||+|||++ +|+||||||+||++
T Consensus 211 -----~~~~~lv~e~~~~g~L~~~l~----------~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll 272 (419)
T 3i6u_A 211 -----AEDYYIVLELMEGGELFDKVV----------GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLL 272 (419)
T ss_dssp -----SSEEEEEEECCTTCBGGGGTS----------SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred -----cCceEEEEEcCCCCcHHHHHh----------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEE
Confidence 245799999999999999884 234689999999999999999999999 99999999999999
Q ss_pred cCCC---cEEEcccccceecCCCCCccccccccccccccccccccC---CCcCcccchhhHHHHHHHHHhCCCCCCcccc
Q 046598 837 DEDM---IAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG---SEVSISGDVYSYGILLLELITRKKPTDIMFE 910 (986)
Q Consensus 837 ~~~~---~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~pf~~~~~ 910 (986)
+.++ .+||+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....
T Consensus 273 ~~~~~~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~ 349 (419)
T 3i6u_A 273 SSQEEDCLIKITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 349 (419)
T ss_dssp SSSSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS
T ss_pred ecCCCcceEEEeecccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc
Confidence 7544 5999999999875422 22334679999999999863 6788999999999999999999999974322
Q ss_pred ccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 911 GDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.. ............... ......+.++.+++.+||+.||++|||++|+
T Consensus 350 ~~-~~~~~i~~~~~~~~~---------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 397 (419)
T 3i6u_A 350 QV-SLKDQITSGKYNFIP---------------------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEA 397 (419)
T ss_dssp SC-CHHHHHHTTCCCCCH---------------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred hH-HHHHHHhcCCCCCCc---------------------------hhhcccCHHHHHHHHHHccCChhHCcCHHHH
Confidence 21 111111111100000 0111234567899999999999999998763
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=350.88 Aligned_cols=245 Identities=22% Similarity=0.242 Sum_probs=187.5
Q ss_pred hcCCCCCcccccccceeEEEEEEC---CCCeEEEEEEeeccC----chhHHHHHHHHHHHhcCCCCcceeeeeecccccc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILD---DGRTTIAVKVFNLLH----HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY 759 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 759 (986)
.++|++.+.||+|+||.||+|++. .+++.||+|+++... ......+.+|++++++++||||++++++ +
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~-----~ 90 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYA-----F 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEE-----E
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEE-----E
Confidence 468999999999999999999985 568999999997532 2334567899999999999999999998 4
Q ss_pred CCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCC
Q 046598 760 QGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED 839 (986)
Q Consensus 760 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 839 (986)
..++..|+||||+++++|.+++.. .+.+++.+++.++.||+.||+|||++ +|+||||||+||+++.+
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~ 157 (327)
T 3a62_A 91 QTGGKLYLILEYLSGGELFMQLER----------EGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQ 157 (327)
T ss_dssp ECSSCEEEEEECCTTEEHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTT
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHh----------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCC
Confidence 556789999999999999999952 24588999999999999999999999 99999999999999999
Q ss_pred CcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHH
Q 046598 840 MIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLA 919 (986)
Q Consensus 840 ~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~ 919 (986)
+.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....
T Consensus 158 ~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~ 230 (327)
T 3a62_A 158 GHVKLTDFGLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR-----KKTI 230 (327)
T ss_dssp SCEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHH
T ss_pred CcEEEEeCCcccccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH-----HHHH
Confidence 999999999997543221 223345689999999999999999999999999999999999999963211 1111
Q ss_pred HhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 046598 920 RTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMT 984 (986)
Q Consensus 920 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 984 (986)
. .+...... .+ ...+.++.+++.+||+.||++||++.
T Consensus 231 ~--------~i~~~~~~-~p-------------------~~~~~~~~~li~~~L~~dp~~R~~~~ 267 (327)
T 3a62_A 231 D--------KILKCKLN-LP-------------------PYLTQEARDLLKKLLKRNAASRLGAG 267 (327)
T ss_dssp H--------HHHHTCCC-CC-------------------TTSCHHHHHHHHHHSCSCGGGSTTSS
T ss_pred H--------HHHhCCCC-CC-------------------CCCCHHHHHHHHHHHhcCHhhccCCC
Confidence 0 11111000 00 01234577899999999999999654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=352.33 Aligned_cols=262 Identities=26% Similarity=0.354 Sum_probs=204.2
Q ss_pred hhcCCCCCcccccccceeEEEEEE-----CCCCeEEEEEEeeccCc-hhHHHHHHHHHHHhcC-CCCcceeeeeeccccc
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGIL-----DDGRTTIAVKVFNLLHH-GAFKSFIAECNTLKNI-RHRNLVKILTACSGVD 758 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 758 (986)
..++|++.+.||+|+||.||+|.+ ..+++.||||+++.... ...+.+.+|+++++++ +||||+++++++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~---- 96 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC---- 96 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE----
Confidence 356899999999999999999995 45678999999975433 3457899999999999 999999999994
Q ss_pred cCCCceEEEEEEeccCCCHhHhhccCCCCC--------ccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCC
Q 046598 759 YQGNDFKALVFEFMHNRSLEEWLHPITRED--------ETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLK 830 (986)
Q Consensus 759 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlk 830 (986)
..++..++||||+++|+|.+++....... ........+++.+++.++.||+.||+|||++ +|+|||||
T Consensus 97 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlk 172 (313)
T 1t46_A 97 -TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLA 172 (313)
T ss_dssp -CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred -ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCc
Confidence 45577899999999999999997543210 0012234589999999999999999999999 99999999
Q ss_pred CCCeEecCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccc
Q 046598 831 PSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMF 909 (986)
Q Consensus 831 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~ 909 (986)
|+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||+| |+.||....
T Consensus 173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 9999999999999999999987755444333444567889999999999999999999999999999999 999986432
Q ss_pred cccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 910 EGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
... ..... +........ ....+.++.+++.+||+.||++|||++||
T Consensus 253 ~~~-~~~~~------------~~~~~~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~el 298 (313)
T 1t46_A 253 VDS-KFYKM------------IKEGFRMLS------------------PEHAPAEMYDIMKTCWDADPLKRPTFKQI 298 (313)
T ss_dssp SSH-HHHHH------------HHHTCCCCC------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred chh-HHHHH------------hccCCCCCC------------------cccCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 211 11111 111110000 01224567899999999999999998764
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=350.49 Aligned_cols=263 Identities=24% Similarity=0.386 Sum_probs=191.7
Q ss_pred HhhcCCCCCcccccccceeEEEEEECC---CCeEEEEEEeecc--CchhHHHHHHHHHHHhcCCCCcceeeeeecccccc
Q 046598 685 NATDRFSSVNQIGEGSFGSVFKGILDD---GRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY 759 (986)
Q Consensus 685 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 759 (986)
...++|.+.+.||+|+||.||+|.+.. +++.||+|+++.. .....+.+.+|++++++++||||+++++++.....
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 356789999999999999999998754 4568999998743 23445778999999999999999999999754322
Q ss_pred CCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCC
Q 046598 760 QGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED 839 (986)
Q Consensus 760 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 839 (986)
......++||||+++++|.+++...... .....+++.+++.++.||+.||.|||+. +|+||||||+||+++.+
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLE----TGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDD 183 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBT----TSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTT
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhh----cCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCC
Confidence 3334579999999999999998533221 2345699999999999999999999999 99999999999999999
Q ss_pred CcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHH
Q 046598 840 MIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNL 918 (986)
Q Consensus 840 ~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~ 918 (986)
+.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|+|++ |..||...... .....
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~ 261 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH--EMYDY 261 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHH
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH--HHHHH
Confidence 9999999999987644333333344557889999999999999999999999999999999 88998643221 11111
Q ss_pred HHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 919 ARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 919 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.... .....+ ..++.++.+++.+||+.||++|||++||
T Consensus 262 ~~~~-----------~~~~~~-------------------~~~~~~l~~li~~~l~~dp~~Rps~~~l 299 (313)
T 3brb_A 262 LLHG-----------HRLKQP-------------------EDCLDELYEIMYSCWRTDPLDRPTFSVL 299 (313)
T ss_dssp HHTT-----------CCCCCB-------------------TTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred HHcC-----------CCCCCC-------------------ccccHHHHHHHHHHcCCChhhCcCHHHH
Confidence 1000 000000 1233467899999999999999998764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=373.01 Aligned_cols=250 Identities=26% Similarity=0.438 Sum_probs=202.5
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
.++|++.+.||+|+||.||+|.+..++..||||+++... ...+++.+|++++++++||||++++++| ..+...+
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~-----~~~~~~~ 292 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPFY 292 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSCE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEE-----ecCCcEE
Confidence 457889999999999999999999888999999997543 3467899999999999999999999995 4457789
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+++|+|.++++... ...+++..++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 293 lv~E~~~~g~L~~~l~~~~--------~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~D 361 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECN--------RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVAD 361 (495)
T ss_dssp EEEECCTTCBHHHHHHHSC--------TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECC
T ss_pred EEEEccCCCCHHHHHHhcC--------cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEee
Confidence 9999999999999996322 23589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCC
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALPD 925 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 925 (986)
||+++...... ........++..|+|||++.+..++.++|||||||++|||+| |+.||...... .
T Consensus 362 FG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--~----------- 427 (495)
T 1opk_A 362 FGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--Q----------- 427 (495)
T ss_dssp TTCEECCTTCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--G-----------
T ss_pred cccceeccCCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--H-----------
Confidence 99998764322 222334456789999999998999999999999999999999 99998643211 1
Q ss_pred chhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 926 HVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 926 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+.+.+....... .+..++.++.+++.+||+.||++|||++||
T Consensus 428 -~~~~~~~~~~~~------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~el 469 (495)
T 1opk_A 428 -VYELLEKDYRME------------------RPEGCPEKVYELMRACWQWNPSDRPSFAEI 469 (495)
T ss_dssp -HHHHHHTTCCCC------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -HHHHHHcCCCCC------------------CCCCCCHHHHHHHHHHcCcChhHCcCHHHH
Confidence 111111111000 011344568899999999999999998764
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=346.70 Aligned_cols=256 Identities=19% Similarity=0.278 Sum_probs=196.9
Q ss_pred HhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 685 NATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 685 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
...++|++.+.||+|+||.||+|++..+++.||||+...... .+.+.+|+++++.++|++++..+.+| ...+..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~----~~~~~~ 79 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWC----GAEGDY 79 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEE----EEETTE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeee----cCCCCc
Confidence 346789999999999999999999988899999998764322 24578899999999998888887775 345678
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEe---cCCCc
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILL---DEDMI 841 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~ 841 (986)
.++||||+ +++|.+++.. ....+++.+++.++.||+.||+|||++ +|+||||||+||++ +.++.
T Consensus 80 ~~lv~e~~-~~~L~~~~~~---------~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~ 146 (296)
T 4hgt_A 80 NVMVMELL-GPSLEDLFNF---------CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNL 146 (296)
T ss_dssp EEEEEECC-CCBHHHHHHH---------TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTC
T ss_pred eEEEEEcc-CCCHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCe
Confidence 89999999 9999999962 234589999999999999999999999 99999999999999 78899
Q ss_pred EEEcccccceecCCCCCc-----cccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccc--c
Q 046598 842 AHIGDFGLARFLPLSSAQ-----TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDM--N 914 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~--~ 914 (986)
+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .
T Consensus 147 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 226 (296)
T 4hgt_A 147 VYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK 226 (296)
T ss_dssp EEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSH
T ss_pred EEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhh
Confidence 999999999876443221 122345789999999999999999999999999999999999999975332211 1
Q ss_pred HHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 915 LHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 915 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.............. ......+.++.+++.+||+.||++|||++||
T Consensus 227 ~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l 271 (296)
T 4hgt_A 227 YERISEKKMSTPIE---------------------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYL 271 (296)
T ss_dssp HHHHHHHHHHSCHH---------------------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHH
T ss_pred hhhhhcccccchhh---------------------------hhhccCCHHHHHHHHHHHhcCCCCCCCHHHH
Confidence 11111100000000 0001234568899999999999999998764
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=353.20 Aligned_cols=260 Identities=18% Similarity=0.205 Sum_probs=201.7
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
.++|++.+.||+|+||.||+|++..+++.||||++........+.+.+|+++++.++||||+++++++... .......+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~~~~ 106 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRE-RGAKHEAW 106 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE-ETTEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec-cCCCceeE
Confidence 46899999999999999999999888999999999776666778899999999999999999999986432 22446789
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+++|+|.+++.... .....+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 107 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~d 177 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLK------DKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMD 177 (317)
T ss_dssp EEEECCTTCBHHHHHHHHH------TTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECC
T ss_pred EEEEeCCCCcHHHHHHHHH------hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEe
Confidence 9999999999999996321 1245689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCc-------cccccccccccccccccccCCC---cCcccchhhHHHHHHHHHhCCCCCCccccccccHH
Q 046598 847 FGLARFLPLSSAQ-------TSSIGAKGSIGYIAPEYGLGSE---VSISGDVYSYGILLLELITRKKPTDIMFEGDMNLH 916 (986)
Q Consensus 847 FG~a~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~ 916 (986)
||.++........ .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...........
T Consensus 178 fg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 257 (317)
T 2buj_A 178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA 257 (317)
T ss_dssp CSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHH
T ss_pred cCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhh
Confidence 9998765321111 0112345799999999987654 68999999999999999999999863322221111
Q ss_pred HHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 917 NLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 917 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..... .... + .....+.++.+++.+||+.||++|||++||
T Consensus 258 ~~~~~------------~~~~-~-----------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 297 (317)
T 2buj_A 258 LAVQN------------QLSI-P-----------------QSPRHSSALWQLLNSMMTVDPHQRPHIPLL 297 (317)
T ss_dssp HHHHC------------C--C-C-----------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHhhc------------cCCC-C-----------------ccccCCHHHHHHHHHHhhcChhhCCCHHHH
Confidence 11111 0000 0 001223467899999999999999998764
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=343.89 Aligned_cols=248 Identities=23% Similarity=0.280 Sum_probs=201.5
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
..++|.+.+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.++++++||||+++++++ ..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~ 87 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-----EDN 87 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECS
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee-----ccC
Confidence 356899999999999999999999999999999998753 233456788999999999999999999994 456
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
+..++||||+++++|.+++.. ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 88 ~~~~lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~ 154 (294)
T 2rku_A 88 DFVFVVLELCRRRSLLELHKR----------RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEV 154 (294)
T ss_dssp SEEEEEEECCTTCBHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCE
T ss_pred CEEEEEEecCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCE
Confidence 789999999999999998842 24689999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 046598 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 922 (986)
||+|||.++....... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||...... ....
T Consensus 155 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~-- 225 (294)
T 2rku_A 155 KIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-----ETYL-- 225 (294)
T ss_dssp EECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHH--
T ss_pred EEEeccCceecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHH--
Confidence 9999999987643222 223356899999999999999999999999999999999999999632211 1100
Q ss_pred CCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 923 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+..... ..+ ...+..+.+++.+||+.||++|||++|+
T Consensus 226 ------~~~~~~~-~~~-------------------~~~~~~~~~li~~~l~~~p~~Rps~~~l 263 (294)
T 2rku_A 226 ------RIKKNEY-SIP-------------------KHINPVAASLIQKMLQTDPTARPTINEL 263 (294)
T ss_dssp ------HHHTTCC-CCC-------------------TTSCHHHHHHHHHHTCSSGGGSCCGGGG
T ss_pred ------HHhhccC-CCc-------------------cccCHHHHHHHHHHcccChhhCcCHHHH
Confidence 0000000 000 0123456789999999999999999875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=345.49 Aligned_cols=255 Identities=19% Similarity=0.279 Sum_probs=200.5
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
..++|++.+.||+|+||.||+|++..+++.||||++..... .+++.+|+++++.++|++++..+.++ ...+...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~----~~~~~~~ 80 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWC----GAEGDYN 80 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEE----EEETTEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccc----cCCCCce
Confidence 35789999999999999999999988899999999875432 35688999999999998888777665 3455788
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEe---cCCCcE
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILL---DEDMIA 842 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~ 842 (986)
++||||+ +++|.+++.. ....+++.+++.++.||+.||+|||++ +|+||||||+||++ +.++.+
T Consensus 81 ~lv~e~~-~~~L~~~~~~---------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~ 147 (296)
T 3uzp_A 81 VMVMELL-GPSLEDLFNF---------CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLV 147 (296)
T ss_dssp EEEEECC-CCBHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCE
T ss_pred EEEEEec-CCCHHHHHHh---------hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeE
Confidence 9999999 9999999962 234689999999999999999999999 99999999999999 488899
Q ss_pred EEcccccceecCCCCCc-----cccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCcccccc--ccH
Q 046598 843 HIGDFGLARFLPLSSAQ-----TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGD--MNL 915 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~--~~~ 915 (986)
||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+
T Consensus 148 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 227 (296)
T 3uzp_A 148 YIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 227 (296)
T ss_dssp EECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHH
T ss_pred EEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhh
Confidence 99999999876543221 11234579999999999999999999999999999999999999997532221 111
Q ss_pred HHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 916 HNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 916 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
............. ......+.++.+++.+||+.||++|||++||
T Consensus 228 ~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 271 (296)
T 3uzp_A 228 ERISEKKMSTPIE---------------------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYL 271 (296)
T ss_dssp HHHHHHHHHSCHH---------------------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHH
T ss_pred hhhcccccCCchH---------------------------HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHH
Confidence 1111110000000 0001234568899999999999999998764
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=358.56 Aligned_cols=202 Identities=26% Similarity=0.321 Sum_probs=168.3
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc--CchhHHHHHHHHHHHhcCCCCcceeeeeeccccc-cCCC
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-YQGN 762 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~ 762 (986)
..++|++.+.||+|+||.||+|.+..+++.||||++... .....+++.+|+++++.++||||+++++++.... ....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 357899999999999999999999999999999998542 2334567899999999999999999999964321 1223
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
...|+||||+ +++|.++++. ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~-----------~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~ 167 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH-----------EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCEL 167 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCE
T ss_pred ceEEEEEecC-CCCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCE
Confidence 5679999999 8899999852 3588999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
||+|||+++..... .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus 168 kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 228 (367)
T 1cm8_A 168 KILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 228 (367)
T ss_dssp EECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EEEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999875321 234568999999999887 6899999999999999999999999974
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=343.90 Aligned_cols=246 Identities=21% Similarity=0.287 Sum_probs=196.4
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|++++++++||||+++++++ .+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 81 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDA 81 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheE-----ecC
Confidence 3578999999999999999999999999999999986422 22346788999999999999999999994 456
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
...++||||+++++|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~ 148 (279)
T 3fdn_A 82 TRVYLILEYAPLGTVYRELQK----------LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGEL 148 (279)
T ss_dssp SEEEEEECCCTTEEHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCE
T ss_pred CEEEEEEecCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCE
Confidence 789999999999999999852 24589999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 046598 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 922 (986)
||+|||++...... ......|++.|+|||++.+..++.++||||+|+++|+|++|+.||..... .....
T Consensus 149 ~l~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~-- 217 (279)
T 3fdn_A 149 KIADFGWSVHAPSS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-----QETYK-- 217 (279)
T ss_dssp EECSCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHH--
T ss_pred EEEeccccccCCcc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH-----HHHHH--
Confidence 99999998654322 22345689999999999999999999999999999999999999963211 11110
Q ss_pred CCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 923 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+.. .....+ ...+..+.+++.+||+.||++|||++||
T Consensus 218 ------~~~~-~~~~~~-------------------~~~~~~~~~li~~~l~~~p~~Rps~~e~ 255 (279)
T 3fdn_A 218 ------RISR-VEFTFP-------------------DFVTEGARDLISRLLKHNPSQRPMLREV 255 (279)
T ss_dssp ------HHHH-TCCCCC-------------------TTSCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred ------HHHh-CCCCCC-------------------CcCCHHHHHHHHHHhccChhhCCCHHHH
Confidence 0000 000000 0123456789999999999999998764
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=356.46 Aligned_cols=273 Identities=21% Similarity=0.303 Sum_probs=192.6
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCch-hHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHG-AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
++|.+.+.||+|+||+||+|++..+++.||||+++..... ....+.+|++++++++||||+++++++ ..+...+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII-----HTEKSLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEE-----ECSSCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEE-----eeCCEEE
Confidence 5799999999999999999999988999999998643322 122456799999999999999999994 4567899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||++ |+|.+++.. ....+++.+++.++.||+.||+|||+. ||+||||||+||+++.++.+||+|
T Consensus 77 lv~e~~~-~~l~~~~~~---------~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~D 143 (324)
T 3mtl_A 77 LVFEYLD-KDLKQYLDD---------CGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLAD 143 (324)
T ss_dssp EEEECCS-EEHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECS
T ss_pred EEecccc-cCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEcc
Confidence 9999996 599998862 234689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhC--
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTAL-- 923 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~-- 923 (986)
||+++..... ........||+.|+|||++.+ ..++.++||||+||++|+|++|+.||......+ .........-
T Consensus 144 fg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~ 220 (324)
T 3mtl_A 144 FGLARAKSIP--TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE-QLHFIFRILGTP 220 (324)
T ss_dssp SSEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCC
T ss_pred CcccccccCC--ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCC
Confidence 9999865322 222234568999999999876 568999999999999999999999997432211 1111111100
Q ss_pred -CCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 924 -PDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 924 -~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
...+.......-...... .................++.+++.+|++.||++|||++|+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 279 (324)
T 3mtl_A 221 TEETWPGILSNEEFKTYNY-----PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDA 279 (324)
T ss_dssp CTTTSTTGGGCHHHHHTCC-----CCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred ChHhchhhhcchhhccccc-----ccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHH
Confidence 000111100000000000 0000000011112334567899999999999999998764
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=361.92 Aligned_cols=248 Identities=23% Similarity=0.370 Sum_probs=189.8
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc--CchhHHHHHHHHHHHhcCC--CCcceeeeeeccccccCCCc
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIR--HRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~~~ 763 (986)
++|++.+.||+|+||.||+|.+.. ++.||||++... .....+.+.+|++++++++ ||||+++++++ ..++
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~-----~~~~ 129 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----ITDQ 129 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSS
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEE-----ecCC
Confidence 469999999999999999999876 889999999753 2344578899999999996 59999999984 4457
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..|+||| +.+++|.+++.. ...+++.++..|+.||+.||+|||+. +|+||||||+|||++ ++.+|
T Consensus 130 ~~~lv~E-~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~k 194 (390)
T 2zmd_A 130 YIYMVME-CGNIDLNSWLKK----------KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLK 194 (390)
T ss_dssp EEEEEEE-CCSEEHHHHHHH----------CSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEE
T ss_pred EEEEEEe-cCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEE
Confidence 7999999 568899999952 23688899999999999999999999 999999999999995 58999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccC-----------CCcCcccchhhHHHHHHHHHhCCCCCCcccccc
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-----------SEVSISGDVYSYGILLLELITRKKPTDIMFEGD 912 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~ 912 (986)
|+|||+++.+.............||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......
T Consensus 195 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~ 274 (390)
T 2zmd_A 195 LIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 274 (390)
T ss_dssp ECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH
T ss_pred EEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH
Confidence 999999987654333333345679999999999865 468999999999999999999999996432111
Q ss_pred ccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 913 MNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.. +..+++........+ ..+.++.+++.+||+.||++|||++||
T Consensus 275 ~~------------~~~~~~~~~~~~~~~------------------~~~~~~~~li~~~L~~dP~~Rps~~el 318 (390)
T 2zmd_A 275 SK------------LHAIIDPNHEIEFPD------------------IPEKDLQDVLKCCLKRDPKQRISIPEL 318 (390)
T ss_dssp HH------------HHHHHCTTSCCCCCC------------------CSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HH------------HHHHhCccccCCCCc------------------cchHHHHHHHHHHcccChhhCCCHHHH
Confidence 01 111111111110000 112357789999999999999998764
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=346.29 Aligned_cols=252 Identities=25% Similarity=0.288 Sum_probs=194.4
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
.++|.+.++||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||+++++++ ......
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~ 95 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHNM 95 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhe-----ecCCeE
Confidence 467999999999999999999999989999999997543 33457899999999999999999999994 456789
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEe---cCCCcE
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILL---DEDMIA 842 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~ 842 (986)
++||||+++|+|.+++.... .....+++..++.|+.|++.||+|||+. +|+||||||+||++ +.++.+
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~ 166 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQ------ARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPI 166 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHH------HHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCE
T ss_pred EEEEEeCCCCcHHHHHHhhh------hcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCE
Confidence 99999999999999985221 1235689999999999999999999999 99999999999999 456789
Q ss_pred EEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 046598 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 922 (986)
||+|||+++..... .......|++.|+|||++. ..++.++|||||||++|||++|+.||......+ ........
T Consensus 167 kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~--~~~~~~~~ 240 (285)
T 3is5_A 167 KIIDFGLAELFKSD---EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE--VQQKATYK 240 (285)
T ss_dssp EECCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHC
T ss_pred EEEeeecceecCCc---ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH--HHhhhccC
Confidence 99999999765432 2223456899999999875 568999999999999999999999996422111 00000000
Q ss_pred CCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 923 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+.. ... ....+.++.+++.+||+.||++|||++||
T Consensus 241 ~~~~---------~~~-------------------~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 276 (285)
T 3is5_A 241 EPNY---------AVE-------------------CRPLTPQAVDLLKQMLTKDPERRPSAAQV 276 (285)
T ss_dssp CCCC---------CC---------------------CCCCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred Cccc---------ccc-------------------cCcCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 0000 000 00123456789999999999999998764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=354.26 Aligned_cols=250 Identities=24% Similarity=0.380 Sum_probs=190.0
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeE----EEEEEeec-cCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTT----IAVKVFNL-LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 761 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~----vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 761 (986)
.++|++.+.||+|+||.||+|++..+++. ||+|.+.. ......+.+.+|+.++++++||||++++++|..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----- 88 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT----- 88 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES-----
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec-----
Confidence 46799999999999999999999776665 46666643 233456789999999999999999999999632
Q ss_pred CceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCc
Q 046598 762 NDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI 841 (986)
Q Consensus 762 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 841 (986)
...++|+||+++|+|.+++.. ....+++.+++.|+.||+.||+|||++ +|+||||||+||+++.++.
T Consensus 89 -~~~~~v~~~~~~g~L~~~l~~---------~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~ 155 (327)
T 3lzb_A 89 -STVQLITQLMPFGCLLDYVRE---------HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQH 155 (327)
T ss_dssp -SSEEEEECCCSSCBHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTE
T ss_pred -CCceEEEEecCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCC
Confidence 347899999999999999963 234689999999999999999999999 9999999999999999999
Q ss_pred EEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHH
Q 046598 842 AHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLAR 920 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~ 920 (986)
+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .....
T Consensus 156 ~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~-- 231 (327)
T 3lzb_A 156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSI-- 231 (327)
T ss_dssp EEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHH--
T ss_pred EEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHH--
Confidence 99999999987654444344444567889999999999999999999999999999999 99999743221 11111
Q ss_pred hhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 921 TALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 921 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+........ ...++.++.+++.+||+.||++|||++||
T Consensus 232 ----------~~~~~~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~el 269 (327)
T 3lzb_A 232 ----------LEKGERLPQ------------------PPICTIDVYMIMRKCWMIDADSRPKFREL 269 (327)
T ss_dssp ----------HHTTCCCCC------------------CTTBCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ----------HHcCCCCCC------------------CccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 111100000 01233457899999999999999998764
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=346.17 Aligned_cols=250 Identities=23% Similarity=0.365 Sum_probs=187.4
Q ss_pred hhcCCCCCcccccccceeEEEEEECCC---CeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCC
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDG---RTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 761 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 761 (986)
..++|++.+.||+|+||.||+|.+..+ +..||+|+.+... ....+.+.+|+.++++++||||+++++++.
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------ 86 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------ 86 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC------
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc------
Confidence 356899999999999999999998643 4679999986532 334567899999999999999999999842
Q ss_pred CceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCc
Q 046598 762 NDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI 841 (986)
Q Consensus 762 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 841 (986)
++..++||||+++++|.+++.. ....+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 154 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQV---------RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDC 154 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHH---------TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTE
T ss_pred cCccEEEEecCCCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCC
Confidence 3567999999999999999962 234689999999999999999999999 9999999999999999999
Q ss_pred EEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHH
Q 046598 842 AHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLAR 920 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~ 920 (986)
+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||......+ ......
T Consensus 155 ~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--~~~~i~ 231 (281)
T 1mp8_A 155 VKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRIE 231 (281)
T ss_dssp EEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHH
T ss_pred EEECccccccccCcccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--HHHHHH
Confidence 99999999987643222 12233456789999999998899999999999999999997 999997432211 111110
Q ss_pred hhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 921 TALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 921 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
....... ...++.++.+++.+||+.||++|||++||
T Consensus 232 -----------~~~~~~~-------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l 267 (281)
T 1mp8_A 232 -----------NGERLPM-------------------PPNCPPTLYSLMTKCWAYDPSRRPRFTEL 267 (281)
T ss_dssp -----------TTCCCCC-------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -----------cCCCCCC-------------------CCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 0000000 01234567899999999999999998764
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=350.12 Aligned_cols=248 Identities=23% Similarity=0.280 Sum_probs=201.7
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
..++|.+.+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.+++.++||||+++++++ .++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~ 113 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-----EDN 113 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECS
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecC
Confidence 357899999999999999999999999999999998753 234457789999999999999999999994 456
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
+..++||||+++++|.+++.. ...+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+
T Consensus 114 ~~~~lv~e~~~~~~L~~~~~~----------~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 180 (335)
T 2owb_A 114 DFVFVVLELCRRRSLLELHKR----------RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEV 180 (335)
T ss_dssp SEEEEEECCCTTCBHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCE
T ss_pred CeEEEEEecCCCCCHHHHHhc----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCE
Confidence 789999999999999999852 24689999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 046598 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 922 (986)
||+|||+++....... ......|+..|+|||++.+..++.++|||||||++|||++|+.||...... ....
T Consensus 181 kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~-- 251 (335)
T 2owb_A 181 KIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-----ETYL-- 251 (335)
T ss_dssp EECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHH--
T ss_pred EEeeccCceecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH-----HHHH--
Confidence 9999999987643222 223456899999999999999999999999999999999999999632111 1100
Q ss_pred CCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 923 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+..... ..+ ......+.+++.+||+.||++|||++|+
T Consensus 252 ------~~~~~~~-~~~-------------------~~~~~~~~~li~~~l~~dp~~Rps~~el 289 (335)
T 2owb_A 252 ------RIKKNEY-SIP-------------------KHINPVAASLIQKMLQTDPTARPTINEL 289 (335)
T ss_dssp ------HHHHTCC-CCC-------------------TTSCHHHHHHHHHHTCSSGGGSCCGGGG
T ss_pred ------HHhcCCC-CCC-------------------ccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 0000000 000 0123356789999999999999999875
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=354.47 Aligned_cols=251 Identities=21% Similarity=0.273 Sum_probs=195.3
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcC-CCCcceeeeeeccccccCCCce
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~ 764 (986)
..++|++.+.||+|+||.||+|.++.+++.||||+++.... ...+|++++.++ +||||++++++ +.++..
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~-----~~~~~~ 90 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDV-----YDDGKY 90 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEE-----EECSSE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEE-----EEcCCE
Confidence 46789999999999999999999999999999999975432 235688888887 79999999999 456688
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCC----C
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED----M 840 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~ 840 (986)
.|+||||+++|+|.+++.. .+.+++.++..++.||+.||+|||++ ||+||||||+||++..+ +
T Consensus 91 ~~lv~E~~~gg~L~~~i~~----------~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~ 157 (342)
T 2qr7_A 91 VYVVTELMKGGELLDKILR----------QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPE 157 (342)
T ss_dssp EEEEECCCCSCBHHHHHHT----------CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGG
T ss_pred EEEEEeCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcC
Confidence 9999999999999999952 24689999999999999999999999 99999999999998543 3
Q ss_pred cEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHH
Q 046598 841 IAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLAR 920 (986)
Q Consensus 841 ~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~ 920 (986)
.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........
T Consensus 158 ~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~~~ 233 (342)
T 2qr7_A 158 SIRICDFGFAKQLRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD--DTPEEILA 233 (342)
T ss_dssp GEEECCCTTCEECBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT--SCHHHHHH
T ss_pred eEEEEECCCcccCcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc--CCHHHHHH
Confidence 59999999998764332 223345789999999999888899999999999999999999999974211 11111111
Q ss_pred hhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 921 TALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 921 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
. +......... . .....+.++.+++.+||+.||++|||++||
T Consensus 234 ~--------i~~~~~~~~~-~---------------~~~~~s~~~~~li~~~L~~dP~~R~t~~~i 275 (342)
T 2qr7_A 234 R--------IGSGKFSLSG-G---------------YWNSVSDTAKDLVSKMLHVDPHQRLTAALV 275 (342)
T ss_dssp H--------HHHCCCCCCS-T---------------TTTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred H--------HccCCcccCc-c---------------ccccCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 0 0000000000 0 001233457799999999999999998753
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=365.16 Aligned_cols=244 Identities=26% Similarity=0.371 Sum_probs=195.4
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
.++|++.+.||+|+||.||+|.+. ++.||||+++... ..+.+.+|++++++++||||++++++|. ..+...+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~----~~~~~~~ 263 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLY 263 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEE----CTTSCEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEE----cCCCceE
Confidence 467889999999999999999986 5799999997543 4578999999999999999999999863 3345789
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+++|+|.++++... ...+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 264 iv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~D 332 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSRG--------RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSD 332 (450)
T ss_dssp EEEECCTTCBHHHHHHHHC--------TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECC
T ss_pred EEEEecCCCcHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEee
Confidence 9999999999999996321 22478999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCC
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALPD 925 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 925 (986)
||+++..... .....++..|+|||++.+..++.++|||||||++|||+| |+.||......+ ....
T Consensus 333 fG~a~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~------- 398 (450)
T 1k9a_A 333 FGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPR------- 398 (450)
T ss_dssp CTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--HHHH-------
T ss_pred CCCccccccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH-------
Confidence 9999864321 112357889999999999999999999999999999999 999996432211 1111
Q ss_pred chhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 926 HVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 926 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+...... ..+..++.++.+++.+||+.||++|||++||
T Consensus 399 -----i~~~~~~------------------~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l 436 (450)
T 1k9a_A 399 -----VEKGYKM------------------DAPDGCPPAVYDVMKNCWHLDAATRPTFLQL 436 (450)
T ss_dssp -----HHTTCCC------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -----HHcCCCC------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 1100000 0011345678899999999999999998764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=370.29 Aligned_cols=201 Identities=23% Similarity=0.304 Sum_probs=166.5
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
.++|++.+.||+|+||.||+|.+..+++.||||+++.. .......+.+|+++++.++||||++++++| ...+
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~-----~~~~ 221 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHD 221 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEE-----EETT
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEE-----eeCC
Confidence 46799999999999999999999999999999999742 334456778999999999999999999994 4557
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCCeEecCCCcE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHH-DCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ . ||+||||||+|||++.++.+
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~ 288 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSR----------ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHI 288 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHH----------HSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCE
T ss_pred EEEEEEeeCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCE
Confidence 89999999999999999852 3468999999999999999999998 7 99999999999999999999
Q ss_pred EEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
||+|||+|+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 289 kl~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 351 (446)
T 4ejn_A 289 KITDFGLCKEGIKD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 351 (446)
T ss_dssp EECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EEccCCCceeccCC--CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCC
Confidence 99999999754322 2223446799999999999999999999999999999999999999963
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=349.71 Aligned_cols=264 Identities=20% Similarity=0.257 Sum_probs=205.5
Q ss_pred CCCcChHHHHHhhcCCCCC-cccccccceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcC-CCCcceee
Q 046598 675 FPNISYQNLYNATDRFSSV-NQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNI-RHRNLVKI 750 (986)
Q Consensus 675 ~~~~~~~~~~~~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l 750 (986)
.++..++......++|.+. +.||+|+||.||+|.+..+++.||+|+++... ......+.+|+.+++.+ +||||+++
T Consensus 15 ~~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~ 94 (327)
T 3lm5_A 15 TENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94 (327)
T ss_dssp -CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred chhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEE
Confidence 4566677777788889988 89999999999999999999999999987432 33457889999999999 56999999
Q ss_pred eeeccccccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCC
Q 046598 751 LTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLK 830 (986)
Q Consensus 751 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlk 830 (986)
+++ +......++||||+++|+|.+++.. .....+++.+++.++.|++.||+|||+. ||+|||||
T Consensus 95 ~~~-----~~~~~~~~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dik 158 (327)
T 3lm5_A 95 HEV-----YENTSEIILILEYAAGGEIFSLCLP--------ELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLK 158 (327)
T ss_dssp EEE-----EECSSEEEEEEECCTTEEGGGGGSS--------CC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCC
T ss_pred EEE-----EEeCCeEEEEEEecCCCcHHHHHHH--------hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCC
Confidence 999 4566889999999999999999852 2234689999999999999999999999 99999999
Q ss_pred CCCeEecC---CCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 831 PSNILLDE---DMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 831 p~NIll~~---~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
|+||+++. ++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 159 p~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 235 (327)
T 3lm5_A 159 PQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVG 235 (327)
T ss_dssp GGGEEESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred hHHEEEecCCCCCcEEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999998 7899999999998764322 22345699999999999999999999999999999999999999963
Q ss_pred cccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 908 MFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
....+ ....... .... .+.+ .....+..+.+++.+||+.||++|||++|+
T Consensus 236 ~~~~~-~~~~i~~-~~~~------------~~~~---------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~~l 285 (327)
T 3lm5_A 236 EDNQE-TYLNISQ-VNVD------------YSEE---------------TFSSVSQLATDFIQSLLVKNPEKRPTAEIC 285 (327)
T ss_dssp SSHHH-HHHHHHH-TCCC------------CCTT---------------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CCchH-HHHHHHh-cccc------------cCch---------------hhcccCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 22110 0000000 0000 0000 001234457789999999999999998763
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=354.70 Aligned_cols=245 Identities=26% Similarity=0.351 Sum_probs=194.3
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
.++|.+.+.||+|+||+||+|++..+++.||||++.... ....+++.+|++++++++||||+++++++ ..+.
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~ 127 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY-----LREH 127 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETT
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECC
Confidence 356889999999999999999998889999999997532 23346789999999999999999999995 4457
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..++||||++ |++.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 128 ~~~lv~e~~~-g~l~~~l~~---------~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~k 194 (348)
T 1u5q_A 128 TAWLVMEYCL-GSASDLLEV---------HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVK 194 (348)
T ss_dssp EEEEEEECCS-EEHHHHHHH---------HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEE
T ss_pred eEEEEEecCC-CCHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEE
Confidence 8999999996 688888752 234689999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCcccccccccccccccccccc---CCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHH
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGL---GSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLAR 920 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~ 920 (986)
|+|||+++.... .....||+.|+|||++. +..++.++|||||||++|||++|+.||....... .......
T Consensus 195 L~DfG~a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-~~~~~~~ 267 (348)
T 1u5q_A 195 LGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQ 267 (348)
T ss_dssp ECCCTTCBSSSS------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHH
T ss_pred EeeccCceecCC------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHh
Confidence 999999976532 12356899999999874 5679999999999999999999999986321110 0001110
Q ss_pred hhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 921 TALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 921 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
...+. . . ....+..+.+++.+||+.||++|||++||
T Consensus 268 ~~~~~---------~---~------------------~~~~~~~l~~li~~~l~~dP~~Rps~~~l 303 (348)
T 1u5q_A 268 NESPA---------L---Q------------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVL 303 (348)
T ss_dssp SCCCC---------C---C------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred cCCCC---------C---C------------------CCCCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 00000 0 0 00123457789999999999999998763
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=354.72 Aligned_cols=277 Identities=24% Similarity=0.353 Sum_probs=194.3
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHH--HhcCCCCcceeeeeeccccccCCCce
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNT--LKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
.++|++.+.||+|+||.||+|++. ++.||||+++... ...+..|.++ +..++||||+++++++..........
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEET--TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hHHhheeeecccCCCeEEEEEEEC--CeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 468999999999999999999874 6899999997543 2334444444 55589999999998765544566677
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcC------CCCeEeecCCCCCeEecC
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDC------QPPIAHCDLKPSNILLDE 838 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~------~~~ivH~Dlkp~NIll~~ 838 (986)
.++||||+++|+|.+++.. ...++..+..++.||+.||+|||+.+ .++|+||||||+||+++.
T Consensus 87 ~~lv~e~~~~g~L~~~l~~-----------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~ 155 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSL-----------HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKN 155 (336)
T ss_dssp EEEEECCCTTCBHHHHHHH-----------CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECT
T ss_pred EEEEEecCCCCcHHHHHhh-----------cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcC
Confidence 8999999999999999952 23588899999999999999999862 338999999999999999
Q ss_pred CCcEEEcccccceecCCCCC------ccccccccccccccccccccC-------CCcCcccchhhHHHHHHHHHhCCCCC
Q 046598 839 DMIAHIGDFGLARFLPLSSA------QTSSIGAKGSIGYIAPEYGLG-------SEVSISGDVYSYGILLLELITRKKPT 905 (986)
Q Consensus 839 ~~~~kL~DFG~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvvl~elltg~~pf 905 (986)
++.+||+|||+++.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||
T Consensus 156 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~ 235 (336)
T 3g2f_A 156 DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235 (336)
T ss_dssp TSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred CCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence 99999999999987643221 122234569999999999887 46778999999999999999997776
Q ss_pred CccccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCC
Q 046598 906 DIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTN 985 (986)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 985 (986)
............+..........+.+......... .............++.++.+++.+||+.||++|||++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 308 (336)
T 3g2f_A 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQ-------RPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQX 308 (336)
T ss_dssp STTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCC-------CCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCccchhHHHHhhhcccCCCchHHHHHhhhccccc-------CCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHH
Confidence 42221111000111101111111111111100000 00000111112245667899999999999999999976
Q ss_pred C
Q 046598 986 V 986 (986)
Q Consensus 986 V 986 (986)
|
T Consensus 309 ~ 309 (336)
T 3g2f_A 309 A 309 (336)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=340.94 Aligned_cols=250 Identities=20% Similarity=0.250 Sum_probs=197.3
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc------hhHHHHHHHHHHHhcCCCCcceeeeeeccccccC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH------GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ 760 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 760 (986)
.++|++.+.||+|+||.||+|++..+++.||+|+++.... ...+.+.+|++++++++||||+++++++ .
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~ 78 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIF-----E 78 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhhee-----c
Confidence 3579999999999999999999998899999999875322 1357899999999999999999999994 4
Q ss_pred CCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCC
Q 046598 761 GNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDM 840 (986)
Q Consensus 761 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 840 (986)
.....++||||+++++|.+++.. ...+++.++..++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~ 145 (283)
T 3bhy_A 79 NKTDVVLILELVSGGELFDFLAE----------KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKN 145 (283)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSS
T ss_pred CCCeEEEEEeecCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCC
Confidence 56789999999999999999952 24689999999999999999999999 999999999999998877
Q ss_pred ----cEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHH
Q 046598 841 ----IAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLH 916 (986)
Q Consensus 841 ----~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~ 916 (986)
.+||+|||.++...... ......+++.|+|||++.+..++.++||||||+++|+|++|+.||......
T Consensus 146 ~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----- 217 (283)
T 3bhy_A 146 VPNPRIKLIDFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ----- 217 (283)
T ss_dssp SSSCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----
T ss_pred CCCCceEEEecccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH-----
Confidence 89999999998764322 223356899999999999999999999999999999999999998632211
Q ss_pred HHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 917 NLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 917 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..... +.. ..... ........+..+.+++.+||+.||++|||++|+
T Consensus 218 ~~~~~--------~~~----~~~~~------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~ 263 (283)
T 3bhy_A 218 ETLTN--------ISA----VNYDF------------DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQS 263 (283)
T ss_dssp HHHHH--------HHT----TCCCC------------CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred HHHHH--------hHh----cccCC------------cchhcccCCHHHHHHHHHHccCCHhHCcCHHHH
Confidence 11000 000 00000 000111234567899999999999999998763
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=368.55 Aligned_cols=249 Identities=24% Similarity=0.350 Sum_probs=199.8
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
.++|++.+.||+|+||.||+|++..+++.||+|++... .......+.+|++++++++||||++++++ +.+++
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~-----~~~~~ 257 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYA-----YETKD 257 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEE-----EECSS
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEE-----EeeCC
Confidence 46799999999999999999999999999999999642 22334678899999999999999999998 45668
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..|+||||++||+|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+|
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~--------~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vK 326 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMG--------QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIR 326 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSS--------SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeE
Confidence 8999999999999999996322 23589999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhC
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTAL 923 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 923 (986)
|+|||+++....... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......
T Consensus 327 L~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~-~~~~i~~--- 399 (576)
T 2acx_A 327 ISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREEVER--- 399 (576)
T ss_dssp ECCCTTCEECCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC-CHHHHHH---
T ss_pred EEecccceecccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch-hHHHHHH---
Confidence 999999987643322 234579999999999999999999999999999999999999997432211 1111110
Q ss_pred CCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 046598 924 PDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSM 983 (986)
Q Consensus 924 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 983 (986)
.+.. .+... ....+.++.+++.+||+.||++||++
T Consensus 400 ------~i~~----~~~~~---------------p~~~s~~~~dLI~~lL~~dP~~R~g~ 434 (576)
T 2acx_A 400 ------LVKE----VPEEY---------------SERFSPQARSLCSQLLCKDPAERLGC 434 (576)
T ss_dssp ------HHHH----CCCCC---------------CTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred ------Hhhc----ccccC---------------CccCCHHHHHHHHHhccCCHHHcCCC
Confidence 0000 00000 00123457799999999999999953
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=351.32 Aligned_cols=264 Identities=25% Similarity=0.396 Sum_probs=199.5
Q ss_pred hcCCCCCcccccccceeEEEEE----ECCCCeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGI----LDDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 761 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 761 (986)
.++|++.+.||+|+||.||+|+ +..+++.||||+++... ....+.+.+|++++++++||||+++++++.. ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~ 96 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DG 96 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEec---CC
Confidence 3568999999999999999999 45678999999997432 3345788999999999999999999998642 23
Q ss_pred CceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCc
Q 046598 762 NDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI 841 (986)
Q Consensus 762 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 841 (986)
....++||||+++++|.+++.. ....+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~ 164 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPK---------NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQ 164 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHH---------HTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTE
T ss_pred CceEEEEEEeCCCCcHHHHHHh---------ccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCC
Confidence 3668999999999999999952 234589999999999999999999999 9999999999999999999
Q ss_pred EEEcccccceecCCCCCc-cccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHH
Q 046598 842 AHIGDFGLARFLPLSSAQ-TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLAR 920 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~ 920 (986)
+||+|||+++........ .......+|..|+|||++.+..++.++||||+|+++|+|++|+.|+.... .....
T Consensus 165 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~ 238 (302)
T 4e5w_A 165 VKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM------ALFLK 238 (302)
T ss_dssp EEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH------HHHHH
T ss_pred EEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchh------hHHhh
Confidence 999999999877544322 22334568888999999999999999999999999999999999864221 11111
Q ss_pred hhCCC---c-hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 921 TALPD---H-VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 921 ~~~~~---~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
...+. . ............ +.+....++.++.+++.+||+.||++|||++||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 293 (302)
T 4e5w_A 239 MIGPTHGQMTVTRLVNTLKEGK---------------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNL 293 (302)
T ss_dssp HHCSCCGGGHHHHHHHHHHTTC---------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred ccCCcccccCHHHHHHHHhccC---------------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHH
Confidence 10010 0 111111100000 000111334568899999999999999998764
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=353.59 Aligned_cols=277 Identities=26% Similarity=0.354 Sum_probs=191.5
Q ss_pred HHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc--hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCC
Q 046598 684 YNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 761 (986)
Q Consensus 684 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 761 (986)
....++|++.+.||+|+||+||+|++..+++.||||+++.... ...+.+.+|++++++++||||+++++++ ..
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 104 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVI-----HH 104 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEE-----EE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEE-----ec
Confidence 3456789999999999999999999999999999999964332 2345678999999999999999999994 45
Q ss_pred CceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEe-----
Q 046598 762 NDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILL----- 836 (986)
Q Consensus 762 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll----- 836 (986)
+...++||||++ |+|.+++.. ...+++.+++.|+.||+.||+|||+. +|+||||||+||++
T Consensus 105 ~~~~~lv~e~~~-~~L~~~~~~----------~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~ 170 (329)
T 3gbz_A 105 NHRLHLIFEYAE-NDLKKYMDK----------NPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDA 170 (329)
T ss_dssp TTEEEEEEECCS-EEHHHHHHH----------CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC---
T ss_pred CCEEEEEEecCC-CCHHHHHhh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCC
Confidence 678999999997 599999952 23589999999999999999999999 99999999999999
Q ss_pred cCCCcEEEcccccceecCCCCCccccccccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCccccccccH
Q 046598 837 DEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDIMFEGDMNL 915 (986)
Q Consensus 837 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~ 915 (986)
+.++.+||+|||+++...... .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||......+. .
T Consensus 171 ~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~ 247 (329)
T 3gbz_A 171 SETPVLKIGDFGLARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ-L 247 (329)
T ss_dssp --CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-H
T ss_pred CccceEEECcCCCccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH-H
Confidence 455569999999998654221 223345689999999998874 589999999999999999999999974322111 1
Q ss_pred HHHHHh-hCCCc-hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 916 HNLART-ALPDH-VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 916 ~~~~~~-~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
...... ..+.. ....... .......... .+..............++.+++.+||+.||++|||++|+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 316 (329)
T 3gbz_A 248 FKIFEVLGLPDDTTWPGVTA--LPDWKQSFPK--FRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNA 316 (329)
T ss_dssp HHHHHHHCCCCTTTSTTGGG--STTCCTTCCC--CCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHhCCCchhhhhhhhh--hhhhhhhhhh--hccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHH
Confidence 111111 11110 0000000 0000000000 000000000111234567899999999999999998764
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=356.89 Aligned_cols=266 Identities=21% Similarity=0.373 Sum_probs=204.3
Q ss_pred HHHHHhhcCCCCCcccccccceeEEEEEEC-----CCCeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeec
Q 046598 681 QNLYNATDRFSSVNQIGEGSFGSVFKGILD-----DGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTAC 754 (986)
Q Consensus 681 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 754 (986)
++.....++|++.+.||+|+||.||+|++. .+++.||||++.... .....++.+|++++++++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 344456788999999999999999999886 346889999987533 23456789999999999999999999994
Q ss_pred cccccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCe
Q 046598 755 SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNI 834 (986)
Q Consensus 755 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NI 834 (986)
..+...++||||+++|+|.+++...............+++.+++.++.||+.||+|||++ +|+||||||+||
T Consensus 98 -----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NI 169 (322)
T 1p4o_A 98 -----SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNC 169 (322)
T ss_dssp -----CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGE
T ss_pred -----ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceE
Confidence 455778999999999999999963221100011124578999999999999999999999 999999999999
Q ss_pred EecCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccc
Q 046598 835 LLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDM 913 (986)
Q Consensus 835 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~ 913 (986)
+++.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 170 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--- 246 (322)
T 1p4o_A 170 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--- 246 (322)
T ss_dssp EECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---
T ss_pred EEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH---
Confidence 999999999999999986543333333334557889999999998899999999999999999999 8999863211
Q ss_pred cHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 914 NLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
...... +........+ ..++.++.+++.+||+.||++|||+.||
T Consensus 247 --~~~~~~--------~~~~~~~~~~-------------------~~~~~~l~~li~~~l~~dp~~Rps~~e~ 290 (322)
T 1p4o_A 247 --EQVLRF--------VMEGGLLDKP-------------------DNCPDMLFELMRMCWQYNPKMRPSFLEI 290 (322)
T ss_dssp --HHHHHH--------HHTTCCCCCC-------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred --HHHHHH--------HHcCCcCCCC-------------------CCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 111110 0000000000 1234557899999999999999998764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=369.51 Aligned_cols=249 Identities=27% Similarity=0.438 Sum_probs=198.8
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
..++|.+.+.||+|+||.||+|.+.. +..||||+++... ...+.+.+|++++++++||||+++++++. .+..
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~------~~~~ 257 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT------KEPI 257 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSSC
T ss_pred chHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe------CCcc
Confidence 35678999999999999999999975 6789999997643 34678999999999999999999999852 3568
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
++||||+++|+|.++++.. ....+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 258 ~lv~e~~~~g~L~~~l~~~--------~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~ 326 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSD--------EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIA 326 (454)
T ss_dssp EEEECCCTTCBHHHHHHSH--------HHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEEC
T ss_pred EEEEeecCCCcHHHHHHhc--------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEe
Confidence 9999999999999999622 123578899999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCC
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALP 924 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 924 (986)
|||+++...... ........++..|+|||++.+..++.++|||||||++|||+| |+.||...... ...
T Consensus 327 DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~-----~~~----- 395 (454)
T 1qcf_A 327 DFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-----EVI----- 395 (454)
T ss_dssp STTGGGGBCCHH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----HHH-----
T ss_pred eCCCceEcCCCc-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH-----HHH-----
Confidence 999998754221 122233456789999999998899999999999999999999 99999632211 111
Q ss_pred CchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 925 DHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 925 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..+..... .+.+..++.++.+++.+||+.||++|||+++|
T Consensus 396 ----~~i~~~~~------------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i 435 (454)
T 1qcf_A 396 ----RALERGYR------------------MPRPENCPEELYNIMMRCWKNRPEERPTFEYI 435 (454)
T ss_dssp ----HHHHHTCC------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ----HHHHcCCC------------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 01110000 00011345568899999999999999998764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=347.07 Aligned_cols=247 Identities=28% Similarity=0.376 Sum_probs=187.6
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
.++|++.+.||+|+||.||+|++. ++.||||++... ...+.+.+|++++++++||||+++++++. +..+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-------~~~~ 75 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL-------NPVC 75 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT-------TTTE
T ss_pred HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc-------CCcE
Confidence 357899999999999999999986 588999998643 34578999999999999999999999853 3378
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCc-EEEc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI-AHIG 845 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-~kL~ 845 (986)
+||||+++|+|.+++.... ....+++.+++.++.|+++||+|||+....+|+||||||+||+++.++. +||+
T Consensus 76 lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~ 148 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAE-------PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKIC 148 (307)
T ss_dssp EEEECCTTCBHHHHHHCSS-------SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEEC
T ss_pred EEEEcCCCCCHHHHHhccC-------CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEc
Confidence 9999999999999996322 1234788999999999999999999932229999999999999998886 7999
Q ss_pred ccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCC
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPD 925 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 925 (986)
|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...................
T Consensus 149 Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~- 222 (307)
T 2eva_A 149 DFGTACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR- 222 (307)
T ss_dssp CCCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC-
T ss_pred ccccccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC-
Confidence 99999754321 223458999999999999999999999999999999999999997432211111100000000
Q ss_pred chhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 926 HVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 926 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+. ....++..+.+++.+||+.||++|||++||
T Consensus 223 -------------~~----------------~~~~~~~~l~~li~~~l~~dp~~Rps~~el 254 (307)
T 2eva_A 223 -------------PP----------------LIKNLPKPIESLMTRCWSKDPSQRPSMEEI 254 (307)
T ss_dssp -------------CC----------------CBTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -------------CC----------------cccccCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 00 000223457789999999999999998764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=358.31 Aligned_cols=250 Identities=25% Similarity=0.391 Sum_probs=185.9
Q ss_pred CCCCCcccccccceeEEEEEECCC---CeEEEEEEeecc-CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDG---RTTIAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
.|++.+.||+|+||.||+|.+... ...||||+++.. .....+++.+|+.++++++||||++++++| +..++.
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~----~~~~~~ 165 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC----LRSEGS 165 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEE----CCCSSC
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE----EcCCCC
Confidence 466778999999999999997532 346899998643 334567899999999999999999999986 334567
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.++||||+++|+|.++++. ....+++.+++.++.||++||+|||+. +|+||||||+||+++.++.+||
T Consensus 166 ~~lv~e~~~~g~L~~~l~~---------~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL 233 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRN---------ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKV 233 (373)
T ss_dssp CEEEEECCTTCBHHHHHHC---------TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEE
T ss_pred eEEEEECCCCCCHHHHHhh---------cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEE
Confidence 8999999999999999962 234588999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCc--cccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHh
Q 046598 845 GDFGLARFLPLSSAQ--TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLART 921 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~ 921 (986)
+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|||+| |.+||......+ .......
T Consensus 234 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~--~~~~~~~ 311 (373)
T 3c1x_A 234 ADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYLLQ 311 (373)
T ss_dssp CCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC--HHHHHHT
T ss_pred eeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH--HHHHHHc
Confidence 999999865432211 12234457889999999999999999999999999999999 677776332211 1111110
Q ss_pred hCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 922 ALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 922 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
. .....+ ..++..+.+++.+||+.||++|||++||
T Consensus 312 ~-----------~~~~~p-------------------~~~~~~l~~li~~cl~~dp~~RPs~~el 346 (373)
T 3c1x_A 312 G-----------RRLLQP-------------------EYCPDPLYEVMLKCWHPKAEMRPSFSEL 346 (373)
T ss_dssp T-----------CCCCCC-------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred C-----------CCCCCC-------------------CCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 0 000000 1234467899999999999999998764
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=358.32 Aligned_cols=202 Identities=26% Similarity=0.338 Sum_probs=158.3
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc--CchhHHHHHHHHHHHhcCCCCcceeeeeecccc-ccCCC
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGV-DYQGN 762 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~~ 762 (986)
..++|++.+.||+|+||.||+|.+..+++.||||++... .....+++.+|+++++.++||||+++++++... .....
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 457899999999999999999999999999999998642 234457788999999999999999999986432 12334
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
...++||||+ +++|.+++.. ..+++..+..++.||++||+|||+. ||+||||||+||+++.++.+
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~ 171 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC-----------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 171 (367)
T ss_dssp CCCEEEEECC-CEECC----------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred CeEEEEeccc-CCCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCE
Confidence 6689999999 7899988851 3589999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
||+|||+++.... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus 172 kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 232 (367)
T 2fst_X 172 KILDFGLARHTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232 (367)
T ss_dssp EECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred EEeeccccccccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999986432 1234578999999999887 6899999999999999999999999964
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=347.13 Aligned_cols=244 Identities=20% Similarity=0.328 Sum_probs=193.2
Q ss_pred hcCCCCCcccccccceeEEEEEECCCC-------eEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeecccccc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGR-------TTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY 759 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 759 (986)
.++|.+.+.||+|+||.||+|.+..++ ..||+|+++.......+.+.+|++++++++||||+++++++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~----- 81 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVC----- 81 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEE-----
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEE-----
Confidence 467999999999999999999987655 57999999876666778899999999999999999999994
Q ss_pred CCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCC
Q 046598 760 QGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED 839 (986)
Q Consensus 760 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 839 (986)
..++..++||||+++++|.+++.. ....+++..++.++.||+.||+|||++ +|+||||||+||+++.+
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~ 149 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKK---------NKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIRE 149 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHH---------TGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEEC
T ss_pred EeCCCCEEEEECCCCCCHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecC
Confidence 445778999999999999999962 233489999999999999999999999 99999999999999988
Q ss_pred Cc--------EEEcccccceecCCCCCccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCcccc
Q 046598 840 MI--------AHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDIMFE 910 (986)
Q Consensus 840 ~~--------~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~ 910 (986)
+. +||+|||.+..... .....+++.|+|||++.+ ..++.++|||||||++|||++|..|+.....
T Consensus 150 ~~~~~~~~~~~kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~ 223 (289)
T 4fvq_A 150 EDRKTGNPPFIKLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD 223 (289)
T ss_dssp CBGGGTBCCEEEECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred CcccccccceeeeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc
Confidence 87 99999999965421 122457889999999987 6799999999999999999996554331111
Q ss_pred ccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 911 GDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
... ....... .. ..+. ..+.++.+++.+||+.||++|||++||
T Consensus 224 ~~~-~~~~~~~------------~~-~~~~-------------------~~~~~l~~li~~~l~~dp~~Rps~~~l 266 (289)
T 4fvq_A 224 SQR-KLQFYED------------RH-QLPA-------------------PKAAELANLINNCMDYEPDHRPSFRAI 266 (289)
T ss_dssp HHH-HHHHHHT------------TC-CCCC-------------------CSSCTTHHHHHHHSCSSGGGSCCHHHH
T ss_pred hHH-HHHHhhc------------cC-CCCC-------------------CCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 100 0000000 00 0000 012246789999999999999998764
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=348.14 Aligned_cols=275 Identities=20% Similarity=0.270 Sum_probs=201.5
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCC-CCcceeeeeeccccccCCCceE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~ 765 (986)
.++|++.+.||+|+||+||+|++..+++.||||+++.. ..+.+.+|++++++++ ||||+++++++.. ......
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~---~~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeecc---CCCCce
Confidence 46799999999999999999999988999999998743 3467899999999997 9999999998642 235678
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCC-cEEE
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDM-IAHI 844 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL 844 (986)
++||||+++++|.++++ .+++.+++.++.||+.||+|||+. +|+||||||+||+++.++ .+||
T Consensus 109 ~lv~e~~~~~~l~~~~~-------------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl 172 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQ-------------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRL 172 (330)
T ss_dssp EEEEECCCCCCHHHHGG-------------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEE
T ss_pred EEEEeccCchhHHHHHH-------------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEE
Confidence 99999999999999984 478899999999999999999999 999999999999999777 8999
Q ss_pred cccccceecCCCCCccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhC
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTAL 923 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 923 (986)
+|||+++....... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||.................-
T Consensus 173 ~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~ 249 (330)
T 3nsz_A 173 IDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 249 (330)
T ss_dssp CCCTTCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHC
T ss_pred EeCCCceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcC
Confidence 99999987643322 233568999999999877 67899999999999999999999998533222212222111111
Q ss_pred CCchhHHhhhhcccCCcch---hhcc--chhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 924 PDHVMDIVDSTLLNDGEDL---IVHG--NQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 924 ~~~~~~~~d~~l~~~~~~~---~~~~--~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.....+.++..-....... .... ...............+.++.+++.+||+.||++|||++|+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~ 317 (330)
T 3nsz_A 250 TEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 317 (330)
T ss_dssp HHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred CchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHH
Confidence 1112222111110000000 0000 0000000000111235568899999999999999998764
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=350.85 Aligned_cols=283 Identities=22% Similarity=0.330 Sum_probs=201.2
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeecccccc---CC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY---QG 761 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~~ 761 (986)
.++|++.+.||+|+||.||+|++..+++.||||++.... ......+.+|++++++++||||+++++++..... ..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 478999999999999999999999889999999986432 2234678899999999999999999999754311 12
Q ss_pred CceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCc
Q 046598 762 NDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI 841 (986)
Q Consensus 762 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 841 (986)
.+..++||||+++ +|.+.+.. ....+++.+++.|+.||+.||+|||+. ||+||||||+||+++.++.
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~---------~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~ 162 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSN---------VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGV 162 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHC---------TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSC
T ss_pred CceEEEEEeccCC-CHHHHHhh---------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCC
Confidence 4678999999965 77777752 234589999999999999999999999 9999999999999999999
Q ss_pred EEEcccccceecCCCCC--ccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHH
Q 046598 842 AHIGDFGLARFLPLSSA--QTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNL 918 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~ 918 (986)
+||+|||+++.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .....
T Consensus 163 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i 241 (351)
T 3mi9_A 163 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALI 241 (351)
T ss_dssp EEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHH
T ss_pred EEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHH
Confidence 99999999987643222 222344568999999999876 468999999999999999999999997432211 11111
Q ss_pred HH--hhCCCc-hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 919 AR--TALPDH-VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 919 ~~--~~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.. ...+.. ....-........ .. .....+....+. .......++.+++.+|++.||++|||++|+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 309 (351)
T 3mi9_A 242 SQLCGSITPEVWPNVDNYELYEKL-EL-VKGQKRKVKDRL-KAYVRDPYALDLIDKLLVLDPAQRIDSDDA 309 (351)
T ss_dssp HHHHCCCCTTTSTTGGGCGGGTSS-CC-CSSCCCCHHHHH-HHHHCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHhCCCChhhccccccchhhccc-cc-ccccccCHHHHh-hhccCChHHHHHHHHHhcCChhhCCCHHHH
Confidence 11 111111 1111000000000 00 000001111111 111124567899999999999999998764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=351.37 Aligned_cols=260 Identities=22% Similarity=0.368 Sum_probs=200.7
Q ss_pred hcCCCCCcccccccceeEEEEEEC-------CCCeEEEEEEeeccC-chhHHHHHHHHHHHhcC-CCCcceeeeeecccc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILD-------DGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKILTACSGV 757 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 757 (986)
.++|++.+.||+|+||.||+|.+. .+++.||||+++... ....+++.+|+++++++ +||||++++++|
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~--- 110 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC--- 110 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE---
Confidence 578999999999999999999985 346789999997543 34457789999999999 899999999994
Q ss_pred ccCCCceEEEEEEeccCCCHhHhhccCCCCCc------cccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCC
Q 046598 758 DYQGNDFKALVFEFMHNRSLEEWLHPITREDE------TDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKP 831 (986)
Q Consensus 758 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 831 (986)
..++..++||||+++|+|.+++........ .......+++.+++.++.||+.||+|||+. +|+||||||
T Consensus 111 --~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp 185 (334)
T 2pvf_A 111 --TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA 185 (334)
T ss_dssp --CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSG
T ss_pred --ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCcc
Confidence 455788999999999999999975432100 001234589999999999999999999999 999999999
Q ss_pred CCeEecCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCcccc
Q 046598 832 SNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFE 910 (986)
Q Consensus 832 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~ 910 (986)
+||+++.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 265 (334)
T 2pvf_A 186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265 (334)
T ss_dssp GGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred ceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence 999999999999999999987754443333444567889999999988899999999999999999999 9999863211
Q ss_pred ccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 911 GDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..... .+........ ...++.++.+++.+||+.||++|||++||
T Consensus 266 -----~~~~~---------~~~~~~~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~el 309 (334)
T 2pvf_A 266 -----EELFK---------LLKEGHRMDK------------------PANCTNELYMMMRDCWHAVPSQRPTFKQL 309 (334)
T ss_dssp -----HHHHH---------HHHHTCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -----HHHHH---------HHhcCCCCCC------------------CccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 11110 0100000000 01234467899999999999999998764
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=346.51 Aligned_cols=250 Identities=22% Similarity=0.238 Sum_probs=197.4
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
..++|.+.+.||+|+||.||+|++..+++.||+|+++.......+.+.+|++++++++||||+++++++ ......
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 81 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY-----ESTTHY 81 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhc-----ccCCEE
Confidence 356799999999999999999999988999999999865544556789999999999999999999984 456789
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEe---cCCCcE
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILL---DEDMIA 842 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~ 842 (986)
++||||+++++|.+++.. .+.+++.++..++.|++.||+|||+. +|+||||||+||++ +.++.+
T Consensus 82 ~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~ 148 (304)
T 2jam_A 82 YLVMQLVSGGELFDRILE----------RGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKI 148 (304)
T ss_dssp EEEECCCCSCBHHHHHHH----------HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCE
T ss_pred EEEEEcCCCccHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCE
Confidence 999999999999999842 24589999999999999999999999 99999999999999 788899
Q ss_pred EEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 046598 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 922 (986)
||+|||.++.... .......|++.|+|||++.+..++.++||||+||++|+|++|+.||...... .......
T Consensus 149 kl~Dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~i~-- 220 (304)
T 2jam_A 149 MITDFGLSKMEQN----GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES--KLFEKIK-- 220 (304)
T ss_dssp EBCSCSTTCCCCC----BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHH--
T ss_pred EEccCCcceecCC----CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHH--
Confidence 9999999975432 1223356899999999999999999999999999999999999998632211 0101110
Q ss_pred CCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 923 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
...... +. +.....+.++.+++.+|++.||++|||++|+
T Consensus 221 ---------~~~~~~-~~---------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~ 259 (304)
T 2jam_A 221 ---------EGYYEF-ES---------------PFWDDISESAKDFICHLLEKDPNERYTCEKA 259 (304)
T ss_dssp ---------HCCCCC-CT---------------TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHH
T ss_pred ---------cCCCCC-Cc---------------cccccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 000000 00 0001234567899999999999999998763
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=351.12 Aligned_cols=268 Identities=24% Similarity=0.319 Sum_probs=205.5
Q ss_pred HHHHHhhcCCCCCcccccccceeEEEEEE-----CCCCeEEEEEEeeccCc-hhHHHHHHHHHHHhcC-CCCcceeeeee
Q 046598 681 QNLYNATDRFSSVNQIGEGSFGSVFKGIL-----DDGRTTIAVKVFNLLHH-GAFKSFIAECNTLKNI-RHRNLVKILTA 753 (986)
Q Consensus 681 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~ 753 (986)
.+.....++|++.+.||+|+||.||+|++ ..+++.||||+++.... ...+.+.+|+++++++ +||||++++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 34444568899999999999999999985 34578999999975432 3456789999999999 79999999998
Q ss_pred ccccccCCCceEEEEEEeccCCCHhHhhccCCCCCcc------ccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEee
Q 046598 754 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDET------DEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHC 827 (986)
Q Consensus 754 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~ 827 (986)
|. ..+...++||||+++++|.+++......... ......+++.+++.++.||+.||+|||+. +|+||
T Consensus 100 ~~----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~ 172 (316)
T 2xir_A 100 CT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR 172 (316)
T ss_dssp EC----CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred Ee----cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Ccccc
Confidence 63 3345689999999999999999754321000 01123489999999999999999999999 99999
Q ss_pred cCCCCCeEecCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCC
Q 046598 828 DLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTD 906 (986)
Q Consensus 828 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~ 906 (986)
||||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||+| |+.||.
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 9999999999999999999999987654444344445668899999999999999999999999999999998 999986
Q ss_pred ccccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 907 IMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
...... ............ ..+ ...+.++.+++.+||+.||++|||++||
T Consensus 253 ~~~~~~-~~~~~~~~~~~~-----------~~~-------------------~~~~~~l~~li~~~l~~dp~~Rps~~el 301 (316)
T 2xir_A 253 GVKIDE-EFCRRLKEGTRM-----------RAP-------------------DYTTPEMYQTMLDCWHGEPSQRPTFSEL 301 (316)
T ss_dssp TCCCSH-HHHHHHHHTCCC-----------CCC-------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ccchhH-HHHHHhccCccC-----------CCC-------------------CCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 432211 111111110000 000 0123457899999999999999998764
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=342.10 Aligned_cols=244 Identities=28% Similarity=0.397 Sum_probs=185.0
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc----hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH----GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
.++|++.+.||+|+||.||+|.+. ++.||||+++.... ...+.+.+|+++++.++||||+++++++ ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 78 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC-----LKE 78 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCC
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----ecC
Confidence 467999999999999999999986 68899999864322 2346789999999999999999999994 455
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCC---eEeecCCCCCeEecC-
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPP---IAHCDLKPSNILLDE- 838 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~---ivH~Dlkp~NIll~~- 838 (986)
+..++||||+++++|.+++. ...+++.+++.++.|++.||+|||++ + |+||||||+||+++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~-----------~~~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~ 144 (271)
T 3dtc_A 79 PNLCLVMEFARGGPLNRVLS-----------GKRIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQK 144 (271)
T ss_dssp --CEEEEECCTTEEHHHHHT-----------SSCCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSC
T ss_pred CceEEEEEcCCCCCHHHHhh-----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecc
Confidence 77899999999999999984 23589999999999999999999999 7 999999999999986
Q ss_pred -------CCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccc
Q 046598 839 -------DMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEG 911 (986)
Q Consensus 839 -------~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~ 911 (986)
++.+||+|||.++...... .....|++.|+|||++.+..++.++||||||+++|+|++|+.||......
T Consensus 145 ~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 220 (271)
T 3dtc_A 145 VENGDLSNKILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL 220 (271)
T ss_dssp CSSSCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH
T ss_pred cccccccCcceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 6789999999998654322 22356899999999999999999999999999999999999999642211
Q ss_pred cccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 912 DMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
. .... .......... +..++.++.+++.+||+.||++|||++||
T Consensus 221 ~-----~~~~--------~~~~~~~~~~------------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~ 264 (271)
T 3dtc_A 221 A-----VAYG--------VAMNKLALPI------------------PSTCPEPFAKLMEDCWNPDPHSRPSFTNI 264 (271)
T ss_dssp H-----HHHH--------HHTSCCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred H-----HHHh--------hhcCCCCCCC------------------CcccCHHHHHHHHHHhcCCcccCcCHHHH
Confidence 1 0000 0000000000 01234567899999999999999998764
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=343.44 Aligned_cols=247 Identities=24% Similarity=0.339 Sum_probs=200.7
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.++++++||||+++++++ ..+...
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 95 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKDTKL 95 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEE-----ecCCeE
Confidence 467999999999999999999999889999999997543 34467899999999999999999999984 345789
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
++||||+++++|.+++.. ..+++.++..++.|++.||.|||+. +|+||||||+||+++.++.+||+
T Consensus 96 ~lv~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~ 161 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLEP-----------GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLA 161 (303)
T ss_dssp EEEEECCTTEEHHHHHTT-----------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred EEEEEeCCCCcHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEe
Confidence 999999999999999851 3589999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCC
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPD 925 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 925 (986)
|||.+....... .......|++.|+|||++.+..++.++||||||+++|+|++|+.||....... .........+.
T Consensus 162 Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~ 237 (303)
T 3a7i_A 162 DFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK--VLFLIPKNNPP 237 (303)
T ss_dssp CCTTCEECBTTB--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHSCCC
T ss_pred ecccceecCccc--cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH--HHHHhhcCCCC
Confidence 999998764322 22234568999999999999999999999999999999999999986322110 00000000000
Q ss_pred chhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 926 HVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 926 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
... ...+..+.+++.+||+.||++|||++||
T Consensus 238 ------------~~~------------------~~~~~~l~~li~~~l~~dp~~Rps~~~l 268 (303)
T 3a7i_A 238 ------------TLE------------------GNYSKPLKEFVEACLNKEPSFRPTAKEL 268 (303)
T ss_dssp ------------CCC------------------SSCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred ------------CCc------------------cccCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 000 0123457799999999999999998764
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=344.16 Aligned_cols=251 Identities=25% Similarity=0.434 Sum_probs=203.8
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
..++|++.+.||+|+||.||+|.+..++..||+|+++... ...+.+.+|++++++++||||+++++++ ..+...
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~ 84 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPF 84 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCCE
Confidence 4678999999999999999999999889999999997533 4457899999999999999999999994 456789
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
++||||+++++|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~ 153 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLRECN--------RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVA 153 (288)
T ss_dssp EEEEECCTTEEHHHHHHHCC--------TTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEEEEcCCCCcHHHHHHhcc--------cCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEc
Confidence 99999999999999996322 34589999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCC
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALP 924 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 924 (986)
|||.++...... ........+++.|+|||++.+..++.++||||||+++|+|++ |..||...... ...
T Consensus 154 Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~--~~~-------- 222 (288)
T 3kfa_A 154 DFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVY-------- 222 (288)
T ss_dssp CCCGGGTSCSSS-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHH--------
T ss_pred cCccceeccCCc-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHH--------
Confidence 999998764332 223344557889999999998999999999999999999999 99998643211 111
Q ss_pred CchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 925 DHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 925 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+.+........ ...++.++.+++.+|++.||++|||++||
T Consensus 223 ----~~~~~~~~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~~ 262 (288)
T 3kfa_A 223 ----ELLEKDYRMER------------------PEGCPEKVYELMRACWQWNPSDRPSFAEI 262 (288)
T ss_dssp ----HHHHTTCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ----HHHhccCCCCC------------------CCCCCHHHHHHHHHHhCCChhhCcCHHHH
Confidence 11111110000 01234567899999999999999998764
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=342.32 Aligned_cols=251 Identities=21% Similarity=0.283 Sum_probs=193.9
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEE
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALV 768 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 768 (986)
+|.....||+|+||.||+|.+..+++.||||+++.......+.+.+|+.+++.++||||+++++++ ...+..++|
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv 97 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF-----SENGFIKIF 97 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEE-----EETTEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEE-----EeCCcEEEE
Confidence 345556899999999999999988999999999876666678899999999999999999999994 445789999
Q ss_pred EEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecC-CCcEEEccc
Q 046598 769 FEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDE-DMIAHIGDF 847 (986)
Q Consensus 769 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~DF 847 (986)
|||+++++|.+++.... ....+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+||
T Consensus 98 ~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Df 167 (295)
T 2clq_A 98 MEQVPGGSLSALLRSKW-------GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDF 167 (295)
T ss_dssp EECCSEEEHHHHHHHTT-------CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCT
T ss_pred EEeCCCCCHHHHHHhhc-------cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeec
Confidence 99999999999996321 123467889999999999999999999 9999999999999987 899999999
Q ss_pred ccceecCCCCCccccccccccccccccccccCCC--cCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCC
Q 046598 848 GLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSE--VSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPD 925 (986)
Q Consensus 848 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 925 (986)
|.++...... .......|++.|+|||++.+.. ++.++||||||+++|+|++|+.||...................
T Consensus 168 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~- 244 (295)
T 2clq_A 168 GTSKRLAGIN--PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVH- 244 (295)
T ss_dssp TTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCC-
T ss_pred ccccccCCCC--CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccc-
Confidence 9998764322 2223456899999999987653 7899999999999999999999986322111000000000000
Q ss_pred chhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 926 HVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 926 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
... ....+.++.+++.+||+.||++|||++|+
T Consensus 245 -----------~~~------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~l 276 (295)
T 2clq_A 245 -----------PEI------------------PESMSAEAKAFILKCFEPDPDKRACANDL 276 (295)
T ss_dssp -----------CCC------------------CTTSCHHHHHHHHHTTCSSTTTSCCHHHH
T ss_pred -----------ccc------------------cccCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 000 01233457789999999999999998763
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=345.34 Aligned_cols=267 Identities=25% Similarity=0.352 Sum_probs=194.4
Q ss_pred HHHHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcC--CCCcceeeeeecccccc
Q 046598 682 NLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNI--RHRNLVKILTACSGVDY 759 (986)
Q Consensus 682 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~~ 759 (986)
......++|++.+.||+|+||.||+|++. ++.||||++.... ...+.+|.+++... +||||+++++++... .
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~-~ 104 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKG-T 104 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEES-C
T ss_pred cccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccC-C
Confidence 33445678999999999999999999986 6899999986432 34455566666554 999999999986432 1
Q ss_pred CCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEeecCCCCCe
Q 046598 760 QGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDC-----QPPIAHCDLKPSNI 834 (986)
Q Consensus 760 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----~~~ivH~Dlkp~NI 834 (986)
......++||||+++|+|.++++. ..+++.+++.++.|++.||+|||+.. .++|+||||||+||
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Ni 173 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKS-----------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNI 173 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHH-----------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGE
T ss_pred CCCCceEEEEeccCCCcHHHHhhc-----------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHE
Confidence 222678999999999999999952 25899999999999999999999751 34899999999999
Q ss_pred EecCCCcEEEcccccceecCCCCCcc--ccccccccccccccccccCCCcCcc------cchhhHHHHHHHHHhCC----
Q 046598 835 LLDEDMIAHIGDFGLARFLPLSSAQT--SSIGAKGSIGYIAPEYGLGSEVSIS------GDVYSYGILLLELITRK---- 902 (986)
Q Consensus 835 ll~~~~~~kL~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------sDvwSlGvvl~elltg~---- 902 (986)
+++.++.+||+|||+++......... ......||+.|+|||++.+..++.+ +|||||||++|||+||.
T Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~ 253 (337)
T 3mdy_A 174 LVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG 253 (337)
T ss_dssp EECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred EECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccc
Confidence 99999999999999998764332211 1224569999999999988766655 99999999999999994
Q ss_pred ------CCCCccccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCC
Q 046598 903 ------KPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMES 976 (986)
Q Consensus 903 ------~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~d 976 (986)
.||.................... ....... ......+++.++.+++.+||+.|
T Consensus 254 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~-------------~~~~~~~~~~~l~~li~~~l~~d 312 (337)
T 3mdy_A 254 IVEEYQLPYHDLVPSDPSYEDMREIVCIK--------KLRPSFP-------------NRWSSDECLRQMGKLMTECWAHN 312 (337)
T ss_dssp BCCCCCCTTTTTSCSSCCHHHHHHHHTTS--------CCCCCCC-------------GGGGGSHHHHHHHHHHHHHSCSS
T ss_pred ccccccccHhhhcCCCCchhhhHHHHhhh--------ccCcccc-------------ccchhhHHHHHHHHHHHHhhhhC
Confidence 44443322222222211111000 0000000 01112256778999999999999
Q ss_pred CCCCCCCCCC
Q 046598 977 PEDRMSMTNV 986 (986)
Q Consensus 977 P~~RPt~~eV 986 (986)
|++|||++||
T Consensus 313 P~~Rps~~el 322 (337)
T 3mdy_A 313 PASRLTALRV 322 (337)
T ss_dssp GGGSCCHHHH
T ss_pred hhhCCCHHHH
Confidence 9999998764
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=351.21 Aligned_cols=202 Identities=25% Similarity=0.285 Sum_probs=165.8
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc--CchhHHHHHHHHHHHhcCCCCcceeeeeeccccc-cCCCc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-YQGND 763 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~ 763 (986)
.++|++.+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.+++.++||||+++++++.... .....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46899999999999999999999988999999999753 2344567889999999999999999999864321 23345
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..++||||++ ++|.+++. ..+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+|
T Consensus 104 ~~~lv~e~~~-~~l~~~~~------------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~k 167 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLK 167 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred ceEEEEEcCC-CCHHHHHh------------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEE
Confidence 7899999996 57888874 2478999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
|+|||+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 168 l~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 228 (371)
T 2xrw_A 168 ILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 228 (371)
T ss_dssp ECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EEEeecccccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999865322 122345689999999999999999999999999999999999999974
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=354.69 Aligned_cols=278 Identities=20% Similarity=0.192 Sum_probs=200.6
Q ss_pred hHHHHHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc-----------hhHHHHHHHHHHHhcCCCCcce
Q 046598 680 YQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH-----------GAFKSFIAECNTLKNIRHRNLV 748 (986)
Q Consensus 680 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~niv 748 (986)
..++....++|.+.+.||+|+||.||+|.+.. ++.||||++..... ...+.+.+|++++++++||||+
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 45777889999999999999999999999876 89999999854221 1237789999999999999999
Q ss_pred eeeeeccccccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeec
Q 046598 749 KILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCD 828 (986)
Q Consensus 749 ~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~D 828 (986)
++++++...........++||||++ |+|.+++. .....+++.++..++.||+.||+|||+. +|+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---------~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~D 159 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIH---------DQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRD 159 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHH---------CTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCC
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHH---------hcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecC
Confidence 9999975443345567899999996 68888885 2234689999999999999999999999 999999
Q ss_pred CCCCCeEecCCCcEEEcccccceecCCCCCccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 829 LKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 829 lkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
|||+||+++.++.+||+|||+++..... .......+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||..
T Consensus 160 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 236 (362)
T 3pg1_A 160 LHPGNILLADNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRG 236 (362)
T ss_dssp CCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CChHHEEEcCCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999754322 22334568999999999877 6799999999999999999999999974
Q ss_pred cccccccHHHHHHhhCCCc-----------hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCC
Q 046598 908 MFEGDMNLHNLARTALPDH-----------VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMES 976 (986)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~-----------~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~d 976 (986)
....+ ............. ..+.+.......+.. ............+.+++.+|++.|
T Consensus 237 ~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~li~~~L~~d 304 (362)
T 3pg1_A 237 STFYN-QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPAR-----------AWTAVVPTADPVALDLIAKMLEFN 304 (362)
T ss_dssp SSHHH-HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCC-----------CHHHHSTTSCHHHHHHHHHHTCSS
T ss_pred CCHHH-HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChh-----------hHHhhCCCCCHHHHHHHHHHhcCC
Confidence 32211 1111111111111 111111111111100 001111123456789999999999
Q ss_pred CCCCCCCCCC
Q 046598 977 PEDRMSMTNV 986 (986)
Q Consensus 977 P~~RPt~~eV 986 (986)
|++|||++|+
T Consensus 305 P~~Rpt~~el 314 (362)
T 3pg1_A 305 PQRRISTEQA 314 (362)
T ss_dssp GGGSCCHHHH
T ss_pred hhhCCCHHHH
Confidence 9999998763
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=344.03 Aligned_cols=254 Identities=22% Similarity=0.283 Sum_probs=199.4
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||+++++++.. ..+..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~~ 81 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTT 81 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---GGGTE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEec---CCCce
Confidence 568999999999999999999999889999999997532 3445678999999999999999999998532 23567
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCC-----eEeecCCCCCeEecCC
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPP-----IAHCDLKPSNILLDED 839 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~-----ivH~Dlkp~NIll~~~ 839 (986)
.++||||+++++|.+++.... .....+++.+++.++.|++.||+|||+. + |+||||||+||+++.+
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~ 152 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGT------KERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGK 152 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHH------HTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSS
T ss_pred EEEEEeCCCCCCHHHHHHhhc------ccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCC
Confidence 899999999999999996322 1234589999999999999999999999 7 9999999999999999
Q ss_pred CcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHH
Q 046598 840 MIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLA 919 (986)
Q Consensus 840 ~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~ 919 (986)
+.+||+|||.++...... .......|++.|+|||++.+..++.++||||||+++|+|++|+.||...... ......
T Consensus 153 ~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~i 228 (279)
T 2w5a_A 153 QNVKLGDFGLARILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--ELAGKI 228 (279)
T ss_dssp SCEEECCCCHHHHC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH
T ss_pred CCEEEecCchheeecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH--HHHHHH
Confidence 999999999998654322 1223356899999999999999999999999999999999999998743211 111111
Q ss_pred HhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 920 RTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 920 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
. .......+ ...+.++.+++.+||+.||++|||++||
T Consensus 229 ~-----------~~~~~~~~-------------------~~~~~~l~~li~~~l~~~p~~Rps~~~l 265 (279)
T 2w5a_A 229 R-----------EGKFRRIP-------------------YRYSDELNEIITRMLNLKDYHRPSVEEI 265 (279)
T ss_dssp H-----------HTCCCCCC-------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred h-----------hcccccCC-------------------cccCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 0 00000000 0223467899999999999999998764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=358.03 Aligned_cols=278 Identities=21% Similarity=0.255 Sum_probs=204.1
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
.++|.+.+.||+|+||+||+|++..+++.||||+++... ....+.+.+|++++++++||||+++++++.. ......
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---~~~~~~ 84 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE---TTTRHK 84 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---TTTCCE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeecc---CCCCee
Confidence 467999999999999999999999999999999997533 2345678899999999999999999998542 234578
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEe----cCCCc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILL----DEDMI 841 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~ 841 (986)
++||||+++|+|.+++.... ....+++.+++.++.||+.||+|||+. +|+||||||+||++ +.++.
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~-------~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~ 154 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPS-------NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSV 154 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGG-------GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEE
T ss_pred EEEEecCCCCCHHHHHHhhh-------cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCcee
Confidence 99999999999999996322 123489999999999999999999999 99999999999999 77888
Q ss_pred EEEcccccceecCCCCCccccccccccccccccccccC--------CCcCcccchhhHHHHHHHHHhCCCCCCccccccc
Q 046598 842 AHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG--------SEVSISGDVYSYGILLLELITRKKPTDIMFEGDM 913 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~ 913 (986)
+||+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........
T Consensus 155 ~kL~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~ 231 (396)
T 4eut_A 155 YKLTDFGAARELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231 (396)
T ss_dssp EEECCGGGCEECCCG---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT
T ss_pred EEEecCCCceEccCC---CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc
Confidence 999999999876432 22234569999999998765 5678999999999999999999999974332222
Q ss_pred cHHHHHH--hhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 914 NLHNLAR--TALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 914 ~~~~~~~--~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
....... ...+......+..... .+.+ +... ..............+.+++.+||+.||++|||++|+
T Consensus 232 ~~~~~~~~~~~~p~~~~~~~~~~~~-~~~~--~~~~---~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~ 300 (396)
T 4eut_A 232 NKEVMYKIITGKPSGAISGVQKAEN-GPID--WSGD---MPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300 (396)
T ss_dssp CHHHHHHHHHSCCTTCCEEEECSTT-CCEE--EESS---CCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHH
T ss_pred hHHHHHHHhcCCCcccchhheeccC-CCcc--cCcc---CCcccccchHHHhhchHHHHHhhccChhhhccHHHH
Confidence 2111111 1111100000000000 0000 0000 000011123566778899999999999999998753
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=339.74 Aligned_cols=245 Identities=22% Similarity=0.293 Sum_probs=199.0
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||+++++++ .+++
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 87 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF-----HDRK 87 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE-----EcCC
Confidence 467999999999999999999999889999999986432 22346789999999999999999999994 4567
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..++||||+++++|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~k 154 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQK----------HGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELK 154 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEE
T ss_pred EEEEEEEeCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEE
Confidence 89999999999999999952 23589999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhC
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTAL 923 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 923 (986)
|+|||.+...... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||...... ....
T Consensus 155 l~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~--- 222 (284)
T 2vgo_A 155 IADFGWSVHAPSL----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT-----ETHR--- 222 (284)
T ss_dssp ECCCTTCEECSSS----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHH---
T ss_pred EecccccccCccc----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh-----HHHH---
Confidence 9999999765322 123356899999999999999999999999999999999999999632111 1110
Q ss_pred CCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 924 PDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 924 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+..... ..+ ...+.++.+++.+|++.||++|||++||
T Consensus 223 -----~~~~~~~-~~~-------------------~~~~~~~~~li~~~l~~~p~~Rps~~~l 260 (284)
T 2vgo_A 223 -----RIVNVDL-KFP-------------------PFLSDGSKDLISKLLRYHPPQRLPLKGV 260 (284)
T ss_dssp -----HHHTTCC-CCC-------------------TTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred -----HHhcccc-CCC-------------------CcCCHHHHHHHHHHhhcCHhhCCCHHHH
Confidence 0000000 000 0123456789999999999999998763
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=347.66 Aligned_cols=252 Identities=23% Similarity=0.304 Sum_probs=195.1
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
..++|++.+.||+|+||.||+|.+..+++.||+|++........+.+.+|++++++++||||+++++++ ..++..
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 91 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY-----YHDGKL 91 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECC-CE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeee-----eeCCeE
Confidence 457899999999999999999999988999999999776666678899999999999999999999984 445789
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
++||||+++++|.+++.. ....+++.+++.++.||+.||.|||+. +++||||||+||+++.++.+||+
T Consensus 92 ~lv~e~~~~~~l~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~ 159 (302)
T 2j7t_A 92 WIMIEFCPGGAVDAIMLE---------LDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLA 159 (302)
T ss_dssp EEEEECCTTEEHHHHHHH---------HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEEC
T ss_pred EEEEEeCCCCcHHHHHHh---------hccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEE
Confidence 999999999999999852 234589999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccc-----cCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHH
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYG-----LGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLAR 920 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~ 920 (986)
|||++..... .........|++.|+|||++ .+..++.++||||||+++|+|++|+.||....... .......
T Consensus 160 Dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~ 236 (302)
T 2j7t_A 160 DFGVSAKNLK--TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIAK 236 (302)
T ss_dssp CCHHHHHHHH--HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHH
T ss_pred ECCCCccccc--cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-HHHHHhc
Confidence 9999853211 11112234689999999987 46778999999999999999999999986432110 0000000
Q ss_pred hhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 921 TALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 921 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..+... ......+.++.+++.+||+.||++|||++||
T Consensus 237 ----------------~~~~~~-------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 273 (302)
T 2j7t_A 237 ----------------SDPPTL-------------LTPSKWSVEFRDFLKIALDKNPETRPSAAQL 273 (302)
T ss_dssp ----------------SCCCCC-------------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred ----------------cCCccc-------------CCccccCHHHHHHHHHHcccChhhCCCHHHH
Confidence 000000 0001223457899999999999999998763
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=352.70 Aligned_cols=264 Identities=23% Similarity=0.316 Sum_probs=202.7
Q ss_pred HHhhcCCCCCcccccccceeEEEEEECCCC-----eEEEEEEeeccC-chhHHHHHHHHHHHhcC-CCCcceeeeeeccc
Q 046598 684 YNATDRFSSVNQIGEGSFGSVFKGILDDGR-----TTIAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKILTACSG 756 (986)
Q Consensus 684 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 756 (986)
....++|++.+.||+|+||.||+|.+..++ ..||+|+++... ....+.+.+|+++++++ +||||++++++|
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-- 119 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC-- 119 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE--
Confidence 334678999999999999999999987654 479999997543 33457789999999999 899999999994
Q ss_pred cccCCCceEEEEEEeccCCCHhHhhccCCCCC----ccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCC
Q 046598 757 VDYQGNDFKALVFEFMHNRSLEEWLHPITRED----ETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPS 832 (986)
Q Consensus 757 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~ 832 (986)
..++..++||||+++|+|.+++....... ........+++.+++.++.||+.||+|||+. +|+||||||+
T Consensus 120 ---~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~ 193 (333)
T 2i1m_A 120 ---THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAAR 193 (333)
T ss_dssp ---CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred ---ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccc
Confidence 45577999999999999999996322100 0001134689999999999999999999999 9999999999
Q ss_pred CeEecCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccc
Q 046598 833 NILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEG 911 (986)
Q Consensus 833 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~ 911 (986)
||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||+| |..||......
T Consensus 194 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 273 (333)
T 2i1m_A 194 NVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN 273 (333)
T ss_dssp GCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS
T ss_pred eEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh
Confidence 99999999999999999986644333333344567889999999998899999999999999999999 99998643221
Q ss_pred cccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 912 DMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
. ....... ....... +...+..+.+++.+||+.||++|||++||
T Consensus 274 ~-~~~~~~~------------~~~~~~~------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l 317 (333)
T 2i1m_A 274 S-KFYKLVK------------DGYQMAQ------------------PAFAPKNIYSIMQACWALEPTHRPTFQQI 317 (333)
T ss_dssp H-HHHHHHH------------HTCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred H-HHHHHHh------------cCCCCCC------------------CCCCCHHHHHHHHHHhccChhhCcCHHHH
Confidence 1 1111111 1110000 00123457889999999999999998764
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=343.79 Aligned_cols=252 Identities=25% Similarity=0.382 Sum_probs=193.3
Q ss_pred hcCCCCCcccccccceeEEEEEECCC---CeEEEEEEeecc-CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDG---RTTIAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
..+|++.+.||+|+||.||+|.+..+ ...||+|+++.. .....+.+.+|+.++++++||||++++++| +..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~----~~~~ 99 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC----LRSE 99 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEE----CCSS
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEE----EcCC
Confidence 35688899999999999999997543 346899998653 334457889999999999999999999986 3445
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
+..++||||+++|+|.+++.. ....+++.+++.|+.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~ 167 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRN---------ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTV 167 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHC---------TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCE
T ss_pred CceEEEEeCCCCCCHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCE
Confidence 678999999999999999962 234589999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCC--ccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHH
Q 046598 843 HIGDFGLARFLPLSSA--QTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLA 919 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~ 919 (986)
||+|||.++....... ........+|+.|+|||.+.+..++.++||||+|+++|+|++ |.+||...... ......
T Consensus 168 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~--~~~~~~ 245 (298)
T 3f66_A 168 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYL 245 (298)
T ss_dssp EECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT--THHHHH
T ss_pred EECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH--HHHHHH
Confidence 9999999986643221 122334557889999999999999999999999999999999 55565432211 111111
Q ss_pred HhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 920 RTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 920 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
... .....+ ..++..+.+++.+||+.||++|||++||
T Consensus 246 ~~~-----------~~~~~~-------------------~~~~~~l~~li~~~l~~~p~~Rps~~el 282 (298)
T 3f66_A 246 LQG-----------RRLLQP-------------------EYCPDPLYEVMLKCWHPKAEMRPSFSEL 282 (298)
T ss_dssp HTT-----------CCCCCC-------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hcC-----------CCCCCC-------------------ccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 100 000000 0123457899999999999999998764
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=354.57 Aligned_cols=199 Identities=26% Similarity=0.362 Sum_probs=173.9
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc-CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.. .....+.+.+|++++++++||||+++++++ ..++..
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 106 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGEI 106 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEE-----EETTEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEE-----EECCEE
Confidence 46799999999999999999999988999999999754 334457789999999999999999999984 445789
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHH-DCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
++||||+++++|.+++.. ...+++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+||
T Consensus 107 ~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl 173 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKK----------AGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKL 173 (360)
T ss_dssp EEEECCCTTCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEE
T ss_pred EEEEECCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEcCCccHHHEEECCCCCEEE
Confidence 999999999999999952 2358999999999999999999998 5 8999999999999999999999
Q ss_pred cccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
+|||+++.... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 174 ~Dfg~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 174 CDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp CCCCCCHHHHH----HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred EECCCCccccc----ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999965421 122345689999999999999999999999999999999999999974
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=349.93 Aligned_cols=255 Identities=20% Similarity=0.296 Sum_probs=200.7
Q ss_pred HHHHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc--------hhHHHHHHHHHHHhcC-CCCcceeeee
Q 046598 682 NLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH--------GAFKSFIAECNTLKNI-RHRNLVKILT 752 (986)
Q Consensus 682 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~l~~ 752 (986)
......++|++.+.||+|+||.||+|.+..+++.||||+++.... ...+.+.+|+.+++++ +||||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 344556789999999999999999999998899999999875431 1245678999999999 8999999999
Q ss_pred eccccccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCC
Q 046598 753 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPS 832 (986)
Q Consensus 753 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~ 832 (986)
++ ......++||||+++++|.+++.. ...+++..+..++.||+.||.|||+. ||+||||||+
T Consensus 168 ~~-----~~~~~~~lv~e~~~g~~L~~~l~~----------~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~ 229 (365)
T 2y7j_A 168 SY-----ESSSFMFLVFDLMRKGELFDYLTE----------KVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPE 229 (365)
T ss_dssp EE-----EBSSEEEEEECCCTTCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred EE-----eeCCEEEEEEEeCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHH
Confidence 84 456789999999999999999952 24689999999999999999999999 9999999999
Q ss_pred CeEecCCCcEEEcccccceecCCCCCccccccccccccccccccccC------CCcCcccchhhHHHHHHHHHhCCCCCC
Q 046598 833 NILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG------SEVSISGDVYSYGILLLELITRKKPTD 906 (986)
Q Consensus 833 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlGvvl~elltg~~pf~ 906 (986)
||+++.++.+||+|||++..+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 230 NIl~~~~~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~ 306 (365)
T 2y7j_A 230 NILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFW 306 (365)
T ss_dssp GEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred HEEECCCCCEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCC
Confidence 99999999999999999987653322 234578999999998753 368899999999999999999999996
Q ss_pred ccccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 907 IMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..... ............. ..+.....+.++.+++.+||+.||++|||++|+
T Consensus 307 ~~~~~--~~~~~i~~~~~~~---------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~el 357 (365)
T 2y7j_A 307 HRRQI--LMLRMIMEGQYQF---------------------------SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQA 357 (365)
T ss_dssp CSSHH--HHHHHHHHTCCCC---------------------------CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCCHH--HHHHHHHhCCCCC---------------------------CCcccccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 32110 0000000000000 000011234457899999999999999998764
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=344.25 Aligned_cols=251 Identities=20% Similarity=0.250 Sum_probs=194.2
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--------chhHHHHHHHHHHHhcCCCCcceeeeeecccc
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--------HGAFKSFIAECNTLKNIRHRNLVKILTACSGV 757 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 757 (986)
..++|.+.+.||+|+||.||+|.+..+++.||||++.... ......+.+|++++++++||||+++++++.
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-- 85 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-- 85 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE--
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc--
Confidence 4568999999999999999999999999999999986422 122345889999999999999999999852
Q ss_pred ccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEec
Q 046598 758 DYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLD 837 (986)
Q Consensus 758 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 837 (986)
. ...++||||+++++|.+++.. ...+++.+++.++.||+.||+|||++ +|+||||||+||+++
T Consensus 86 ---~-~~~~lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~ 148 (322)
T 2ycf_A 86 ---A-EDYYIVLELMEGGELFDKVVG----------NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLS 148 (322)
T ss_dssp ---S-SSEEEEEECCTTEETHHHHST----------TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEES
T ss_pred ---C-CceEEEEecCCCCcHHHHHhc----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEe
Confidence 2 338999999999999999852 34689999999999999999999999 999999999999998
Q ss_pred CCCc---EEEcccccceecCCCCCcccccccccccccccccccc---CCCcCcccchhhHHHHHHHHHhCCCCCCccccc
Q 046598 838 EDMI---AHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGL---GSEVSISGDVYSYGILLLELITRKKPTDIMFEG 911 (986)
Q Consensus 838 ~~~~---~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~ 911 (986)
.++. +||+|||+++..... .......||+.|+|||++. ...++.++|||||||++|+|++|+.||......
T Consensus 149 ~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 225 (322)
T 2ycf_A 149 SQEEDCLIKITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ 225 (322)
T ss_dssp SSSSSCCEEECCCTTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS
T ss_pred cCCCCCeEEEccCccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH
Confidence 7664 999999999876422 2223456899999999863 567899999999999999999999999743222
Q ss_pred cccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 912 DMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
. ............... ......+.++.+++.+||+.||++|||++|+
T Consensus 226 ~-~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~ 272 (322)
T 2ycf_A 226 V-SLKDQITSGKYNFIP---------------------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEA 272 (322)
T ss_dssp S-CHHHHHHHTCCCCCH---------------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred H-HHHHHHHhCccccCc---------------------------hhhhhcCHHHHHHHHHHcccCHhhCCCHHHH
Confidence 1 111111111000000 0011234567899999999999999998763
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=346.20 Aligned_cols=251 Identities=20% Similarity=0.226 Sum_probs=188.5
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
..++|++.+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|+.++++++||||+++++++ ..+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~ 106 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFG-----EID 106 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EET
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEE-----eeC
Confidence 3578999999999999999999999889999999986532 22347789999999999999999999994 445
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
+..++||||+++++|.+++.. ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~ 173 (309)
T 2h34_A 107 GQLYVDMRLINGVDLAAMLRR----------QGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFA 173 (309)
T ss_dssp TEEEEEEECCCCEEHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCE
T ss_pred CeEEEEEEecCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCE
Confidence 789999999999999999952 23589999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 046598 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 922 (986)
||+|||++....... ........|++.|+|||++.+..++.++||||||+++|||++|+.||...... .........
T Consensus 174 kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~ 250 (309)
T 2h34_A 174 YLVDFGIASATTDEK-LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHINQA 250 (309)
T ss_dssp EECSCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHHSC
T ss_pred EEecCccCccccccc-cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhccC
Confidence 999999997654322 12223456899999999999999999999999999999999999999632111 011111100
Q ss_pred CCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCC-CCCC
Q 046598 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRM-SMTN 985 (986)
Q Consensus 923 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~e 985 (986)
.+.. . ......+.++.+++.+||+.||++|| |+++
T Consensus 251 ~~~~-------------~---------------~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~ 286 (309)
T 2h34_A 251 IPRP-------------S---------------TVRPGIPVAFDAVIARGMAKNPEDRYVTCGD 286 (309)
T ss_dssp CCCG-------------G---------------GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHH
T ss_pred CCCc-------------c---------------ccCCCCCHHHHHHHHHhccCCHHHHHHhHHH
Confidence 0000 0 00012344577899999999999999 6654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=338.00 Aligned_cols=248 Identities=27% Similarity=0.403 Sum_probs=197.3
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
.++|++.+.||+|+||.||+|.+.. ++.||+|+++.... ..+.+.+|++++++++||||+++++++ ..++..+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 79 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVC-----LEQAPIC 79 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSCE
T ss_pred hhheeeeeEecCCCceeEEEEEecC-CCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCCeE
Confidence 4678999999999999999999975 68899999976433 346789999999999999999999994 4457799
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+++++|.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 80 lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~d 147 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRT---------QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSD 147 (267)
T ss_dssp EEECCCTTCBHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECC
T ss_pred EEEeCCCCCcHHHHHhh---------CcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcc
Confidence 99999999999999962 234589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCC
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALPD 925 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 925 (986)
||.++..... .........++..|+|||++.+..++.++||||+|+++|+|++ |+.||..... ......
T Consensus 148 fg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~---- 217 (267)
T 3t9t_A 148 FGMTRFVLDD-QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-----SEVVED---- 217 (267)
T ss_dssp TTGGGGBCCH-HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHH----
T ss_pred cccccccccc-cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH-----HHHHHH----
Confidence 9999865322 1122233457789999999998899999999999999999999 8999863211 111110
Q ss_pred chhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 926 HVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 926 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+........+ ...+..+.+++.+||+.||++|||++|+
T Consensus 218 ----i~~~~~~~~~-------------------~~~~~~l~~li~~~l~~~p~~Rps~~~l 255 (267)
T 3t9t_A 218 ----ISTGFRLYKP-------------------RLASTHVYQIMNHCWRERPEDRPAFSRL 255 (267)
T ss_dssp ----HHTTCCCCCC-------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ----HhcCCcCCCC-------------------ccCcHHHHHHHHHHccCChhhCcCHHHH
Confidence 0000000000 0123457799999999999999998764
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=374.50 Aligned_cols=245 Identities=21% Similarity=0.255 Sum_probs=200.2
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcC-CCCcceeeeeeccccccCC
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQG 761 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 761 (986)
..++|++.+.||+|+||.||+|++..+++.||||+++.. .....+.+..|.+++..+ +||+|++++++ +++
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~-----~~~ 413 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC-----FQT 413 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEE-----CBC
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE-----EEe
Confidence 356799999999999999999999999999999999742 234456788999999988 79999999998 566
Q ss_pred CceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCc
Q 046598 762 NDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI 841 (986)
Q Consensus 762 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 841 (986)
.+..|+||||+++|+|.++++. .+.+++.+++.|+.||+.||+|||++ +|+||||||+|||++.+++
T Consensus 414 ~~~~~lV~E~~~gg~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ 480 (674)
T 3pfq_A 414 MDRLYFVMEYVNGGDLMYHIQQ----------VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGH 480 (674)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSC
T ss_pred CCEEEEEEeCcCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCc
Confidence 7889999999999999999952 24689999999999999999999999 9999999999999999999
Q ss_pred EEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHh
Q 046598 842 AHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLART 921 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~ 921 (986)
+||+|||+|+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .....
T Consensus 481 ikL~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~-----~~~~~- 552 (674)
T 3pfq_A 481 IKIADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DELFQ- 552 (674)
T ss_dssp EEECCCTTCEECCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH-
T ss_pred EEEeecceeeccccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH-----HHHHH-
Confidence 9999999998643222 223456799999999999999999999999999999999999999963211 11111
Q ss_pred hCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 046598 922 ALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSM 983 (986)
Q Consensus 922 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 983 (986)
..+.....- +...+.++.+++.+||+.||++||++
T Consensus 553 -----------~i~~~~~~~----------------p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 553 -----------SIMEHNVAY----------------PKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp -----------HHHSSCCCC----------------CTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred -----------HHHhCCCCC----------------CccCCHHHHHHHHHHccCCHHHCCCC
Confidence 111110000 00223457799999999999999997
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=349.97 Aligned_cols=278 Identities=23% Similarity=0.275 Sum_probs=193.9
Q ss_pred HHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCch-----hHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 046598 684 YNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHG-----AFKSFIAECNTLKNIRHRNLVKILTACSGVD 758 (986)
Q Consensus 684 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 758 (986)
....++|++.+.||+|+||.||+|++..+++.||||+++..... ..+.+.+|++++++++||||+++++++
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~---- 81 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF---- 81 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEE----
Confidence 34567899999999999999999999988999999998643221 135688999999999999999999994
Q ss_pred cCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecC
Q 046598 759 YQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDE 838 (986)
Q Consensus 759 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 838 (986)
......++||||+++ +|.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.
T Consensus 82 -~~~~~~~lv~e~~~~-~l~~~~~~---------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~ 147 (346)
T 1ua2_A 82 -GHKSNISLVFDFMET-DLEVIIKD---------NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDE 147 (346)
T ss_dssp -CCTTCCEEEEECCSE-EHHHHHTT---------CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT
T ss_pred -eeCCceEEEEEcCCC-CHHHHHHh---------cCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcC
Confidence 456789999999975 89988852 234588889999999999999999999 9999999999999999
Q ss_pred CCcEEEcccccceecCCCCCccccccccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCccccccccHHH
Q 046598 839 DMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHN 917 (986)
Q Consensus 839 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~ 917 (986)
++.+||+|||+++...... .......+|+.|+|||++.+. .++.++|||||||++|||++|.+||......+ .+..
T Consensus 148 ~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~-~~~~ 224 (346)
T 1ua2_A 148 NGVLKLADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTR 224 (346)
T ss_dssp TCCEEECCCGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHH
T ss_pred CCCEEEEecccceeccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHH
Confidence 9999999999998654222 223345689999999998764 58999999999999999999999986432211 1111
Q ss_pred HHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 918 LARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 918 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
............+.+. ...+.. +........ .........+.++.+++.+||+.||++|||++|+
T Consensus 225 i~~~~~~~~~~~~~~~--~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 289 (346)
T 1ua2_A 225 IFETLGTPTEEQWPDM--CSLPDY-VTFKSFPGI-PLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 289 (346)
T ss_dssp HHHHHCCCCTTTSSST--TSSTTC-CCCCCCCCC-CHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHH
T ss_pred HHHHcCCCChhhhhhh--ccCccc-ccccccCCC-ChHHhhccCCHHHHHHHHHHhccChhhCCCHHHH
Confidence 1111100000000000 000000 000000000 0000011234568899999999999999998764
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=348.67 Aligned_cols=251 Identities=22% Similarity=0.426 Sum_probs=190.3
Q ss_pred hcCCCCCcccccccceeEEEEEECCC----CeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDG----RTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 761 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 761 (986)
.++|.+.+.||+|+||.||+|.+..+ +..||||+++... ......+.+|++++++++||||+++++++ ..
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 117 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-----SK 117 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----CS
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----ec
Confidence 35677889999999999999998653 3469999997543 33456789999999999999999999994 45
Q ss_pred CceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCc
Q 046598 762 NDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI 841 (986)
Q Consensus 762 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 841 (986)
.+..++||||+++++|.+++.. ....+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~ 185 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLRE---------KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLV 185 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHH---------TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCC
T ss_pred CCCcEEEEeCCCCCcHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCc
Confidence 6789999999999999999962 234689999999999999999999999 9999999999999999999
Q ss_pred EEEcccccceecCCCCCc-cccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHH
Q 046598 842 AHIGDFGLARFLPLSSAQ-TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLA 919 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~ 919 (986)
+||+|||+++........ .......+++.|+|||++.+..++.++|||||||++|||++ |+.||..... ....
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-----~~~~ 260 (333)
T 1mqb_A 186 CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-----HEVM 260 (333)
T ss_dssp EEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHH
T ss_pred EEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH-----HHHH
Confidence 999999999876433221 12223446789999999999999999999999999999999 9999863221 1111
Q ss_pred HhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 920 RTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 920 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
. .+...... + ....++.++.+++.+||+.||++||+++||
T Consensus 261 ~---------~~~~~~~~-~-----------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 300 (333)
T 1mqb_A 261 K---------AINDGFRL-P-----------------TPMDCPSAIYQLMMQCWQQERARRPKFADI 300 (333)
T ss_dssp H---------HHHTTCCC-C-----------------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred H---------HHHCCCcC-C-----------------CcccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 1 00000000 0 001234567899999999999999998764
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=362.19 Aligned_cols=250 Identities=15% Similarity=0.132 Sum_probs=188.6
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeec---cCchhHHHHHHHH---HHHhcCCCCcceeeeeeccccc--
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL---LHHGAFKSFIAEC---NTLKNIRHRNLVKILTACSGVD-- 758 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~---~~l~~l~h~niv~l~~~~~~~~-- 758 (986)
.++|.+.+.||+|+||+||+|++..+++.||||+++. ......+.+.+|+ +++++++||||+++++.+....
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 4679999999999999999999988899999999973 3334567889999 4555668999999985432100
Q ss_pred cCCCc-----------------eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCC
Q 046598 759 YQGND-----------------FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQ 821 (986)
Q Consensus 759 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ 821 (986)
+..++ ..|+||||+ +|+|.+++...... ......+++..++.|+.||+.||+|||++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~---~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-- 225 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSH---SSTHKSLVHHARLQLTLQVIRLLASLHHY-- 225 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHT---TTTTHHHHHHHHHHHHHHHHHHHHHHHHT--
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcccc---ccccccccHHHHHHHHHHHHHHHHHHHhC--
Confidence 11111 378999999 68999999643211 11224566789999999999999999999
Q ss_pred CCeEeecCCCCCeEecCCCcEEEcccccceecCCCCCccccccccccccccccccccCC-----------CcCcccchhh
Q 046598 822 PPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS-----------EVSISGDVYS 890 (986)
Q Consensus 822 ~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwS 890 (986)
+|+||||||+|||++.++.+||+|||+|+.... ......| +.|+|||++.+. .++.++||||
T Consensus 226 -~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwS 298 (377)
T 3byv_A 226 -GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298 (377)
T ss_dssp -TEECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHH
T ss_pred -CeecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHH
Confidence 999999999999999999999999999986321 2234557 999999999887 8999999999
Q ss_pred HHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHh
Q 046598 891 YGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGV 970 (986)
Q Consensus 891 lGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 970 (986)
|||++|||++|+.||........ ...+.. .+ ...+.++.+++.
T Consensus 299 lG~il~elltg~~Pf~~~~~~~~-------------~~~~~~-----~~-------------------~~~~~~~~~li~ 341 (377)
T 3byv_A 299 LGLVIYWIWCADLPITKDAALGG-------------SEWIFR-----SC-------------------KNIPQPVRALLE 341 (377)
T ss_dssp HHHHHHHHHHSSCCC------CC-------------SGGGGS-----SC-------------------CCCCHHHHHHHH
T ss_pred HHHHHHHHHHCCCCCcccccccc-------------hhhhhh-----hc-------------------cCCCHHHHHHHH
Confidence 99999999999999963221110 000000 00 012345779999
Q ss_pred cccCCCCCCCCCCCCC
Q 046598 971 ACSMESPEDRMSMTNV 986 (986)
Q Consensus 971 ~Cl~~dP~~RPt~~eV 986 (986)
+||+.||++|||+.|+
T Consensus 342 ~~L~~dp~~Rpt~~e~ 357 (377)
T 3byv_A 342 GFLRYPKEDRLLPLQA 357 (377)
T ss_dssp HHTCSSGGGCCCHHHH
T ss_pred HHcCCCchhCCCHHHH
Confidence 9999999999998764
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=343.18 Aligned_cols=250 Identities=23% Similarity=0.298 Sum_probs=195.3
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ..+.+.+|++++++++||||+++++++ ......
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 99 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSY-----FKNTDL 99 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEE-----EETTEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEE-----EeCCEE
Confidence 4578999999999999999999999889999999997543 346789999999999999999999985 345789
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
++||||+++++|.+++. .....+++.++..++.|++.||.|||+. +++||||||+||+++.++.+||+
T Consensus 100 ~lv~e~~~~~~L~~~~~---------~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~ 167 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIR---------LRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLA 167 (314)
T ss_dssp EEEEECCTTEEHHHHHH---------HHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEEC
T ss_pred EEEeecCCCCCHHHHHH---------hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEe
Confidence 99999999999999985 2234689999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCC
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPD 925 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 925 (986)
|||.+....... .......|++.|+|||++.+..++.++||||||+++|+|++|+.||....... .........+.
T Consensus 168 dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~ 243 (314)
T 3com_A 168 DFGVAGQLTDTM--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR--AIFMIPTNPPP 243 (314)
T ss_dssp CCTTCEECBTTB--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHSCCC
T ss_pred ecccchhhhhhc--cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHhcCCCc
Confidence 999998764321 22234568999999999999999999999999999999999999986322110 00000000000
Q ss_pred chhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 926 HVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 926 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
. . ......+.++.+++.+||+.||++|||++|+
T Consensus 244 ~------------~----------------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~l 276 (314)
T 3com_A 244 T------------F----------------RKPELWSDNFTDFVKQCLVKSPEQRATATQL 276 (314)
T ss_dssp C------------C----------------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred c------------c----------------CCcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 0 0 0001123457799999999999999998763
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=337.77 Aligned_cols=246 Identities=23% Similarity=0.325 Sum_probs=193.3
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
.++|++.+.||+|+||.||+|++. ++.||||+++... ....+.+.+|+.++++++||||+++++++.. .....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~ 83 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQS---PPAPH 83 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECT---TTSSS
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEcc---CCCCC
Confidence 467999999999999999999996 6889999997532 3445679999999999999999999999632 22367
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeecCCCCCeEecCCCcE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPP--IAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~ 842 (986)
.++||||+++|+|.+++.... ...+++.+++.|+.|++.||+|||+. + |+||||||+||+++.++.+
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~ 152 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGT--------NFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTA 152 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCS--------SCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCE
T ss_pred eEeeecccCCCcHHHHHhhcc--------cCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcce
Confidence 899999999999999996321 23589999999999999999999998 7 9999999999999999999
Q ss_pred EEcccccceecCCCCCccccccccccccccccccccCCCcCc---ccchhhHHHHHHHHHhCCCCCCccccccccHHHHH
Q 046598 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSI---SGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLA 919 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~ 919 (986)
+|+|||++..... ....||+.|+|||++.+..++. ++|||||||++|||++|+.||....... ..
T Consensus 153 ~l~~~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~ 220 (271)
T 3kmu_A 153 RISMADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME-----IG 220 (271)
T ss_dssp EEEGGGSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH-----HH
T ss_pred eEEeccceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH-----HH
Confidence 9999998754321 2245899999999998765554 7999999999999999999996332211 10
Q ss_pred HhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 920 RTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 920 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
. ........... +...+.++.+++.+||+.||++|||++||
T Consensus 221 ~--------~~~~~~~~~~~------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~i 261 (271)
T 3kmu_A 221 M--------KVALEGLRPTI------------------PPGISPHVSKLMKICMNEDPAKRPKFDMI 261 (271)
T ss_dssp H--------HHHHSCCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred H--------HHHhcCCCCCC------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 0 00000000000 01234457899999999999999998764
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=364.22 Aligned_cols=250 Identities=22% Similarity=0.296 Sum_probs=197.1
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc-------------hhHHHHHHHHHHHhcCCCCcceeeee
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH-------------GAFKSFIAECNTLKNIRHRNLVKILT 752 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~ 752 (986)
..++|.+.++||+|+||+||+|++..+++.||||+++.... ...+.+.+|++++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 46789999999999999999999999999999999874321 23467899999999999999999999
Q ss_pred eccccccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCC
Q 046598 753 ACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPS 832 (986)
Q Consensus 753 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~ 832 (986)
+ +.++...++||||+++|+|.+++.. ...+++.++..|+.||+.||+|||+. +|+||||||+
T Consensus 114 ~-----~~~~~~~~lv~e~~~gg~L~~~l~~----------~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~ 175 (504)
T 3q5i_A 114 V-----FEDKKYFYLVTEFYEGGELFEQIIN----------RHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPE 175 (504)
T ss_dssp E-----EECSSEEEEEEECCTTCBHHHHHHH----------HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred E-----EEcCCEEEEEEecCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHH
Confidence 9 4566889999999999999999842 24689999999999999999999999 9999999999
Q ss_pred CeEecCCC---cEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccc
Q 046598 833 NILLDEDM---IAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMF 909 (986)
Q Consensus 833 NIll~~~~---~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~ 909 (986)
||+++.++ .+||+|||+++...... ......||+.|+|||++. +.++.++||||+||++|+|++|+.||....
T Consensus 176 Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 251 (504)
T 3q5i_A 176 NILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN 251 (504)
T ss_dssp GEEESSTTCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HEEEecCCCCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99998776 69999999998764332 223456999999999987 469999999999999999999999996322
Q ss_pred cccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 910 EGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.. .... ......... ..+.....+.++.+++.+|++.||++|||++|+
T Consensus 252 ~~-----~~~~------------~i~~~~~~~------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~ 299 (504)
T 3q5i_A 252 DQ-----DIIK------------KVEKGKYYF------------DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEA 299 (504)
T ss_dssp HH-----HHHH------------HHHHCCCCC------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HH-----HHHH------------HHHcCCCCC------------CccccCCCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 11 1111 000000000 000111234567899999999999999998763
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=365.19 Aligned_cols=250 Identities=26% Similarity=0.292 Sum_probs=197.2
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc--CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
..++|++.+.||+|+||+||+|++..+++.||||++... .......+.+|++++++++||||++++++ +....
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~-----~~~~~ 94 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI-----LEDSS 94 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEE-----EECSS
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEE-----EEcCC
Confidence 457899999999999999999999988999999998642 23345788999999999999999999999 45568
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEec---CCC
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLD---EDM 840 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~ 840 (986)
..++||||+++|+|.+++.. ...+++.++..|+.||+.||.|||+. +|+||||||+||+++ .++
T Consensus 95 ~~~lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 161 (486)
T 3mwu_A 95 SFYIVGELYTGGELFDEIIK----------RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDC 161 (486)
T ss_dssp EEEEEECCCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTC
T ss_pred EEEEEEEcCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCC
Confidence 89999999999999998842 24689999999999999999999999 999999999999995 456
Q ss_pred cEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHH
Q 046598 841 IAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLAR 920 (986)
Q Consensus 841 ~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~ 920 (986)
.+||+|||+++...... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||......+ .......
T Consensus 162 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~ 236 (486)
T 3mwu_A 162 DIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-ILKRVET 236 (486)
T ss_dssp CEEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH
T ss_pred CEEEEECCcCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHh
Confidence 89999999998654322 2334569999999999876 59999999999999999999999996321110 0001100
Q ss_pred hhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 921 TALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 921 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..... .. +.....+.++.+++.+||+.||++|||+.|+
T Consensus 237 ~~~~~------------~~----------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~ 274 (486)
T 3mwu_A 237 GKYAF------------DL----------------PQWRTISDDAKDLIRKMLTFHPSLRITATQC 274 (486)
T ss_dssp TCCCS------------CS----------------GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CCCCC------------CC----------------cccCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 00000 00 0001234457799999999999999998763
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=344.78 Aligned_cols=256 Identities=21% Similarity=0.316 Sum_probs=190.1
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
..++|++.+.||+|+||.||+|.+..+++.||||+++.. .....+++.+|++++++++||||+++++++ ..+
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~ 104 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF-----IED 104 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EET
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcC
Confidence 346799999999999999999999888999999999742 334457789999999999999999999995 345
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
+..++||||+++++|.+++.... .....+++.+++.++.|++.||.|||+. +|+||||||+||+++.++.+
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~ 175 (310)
T 2wqm_A 105 NELNIVLELADAGDLSRMIKHFK------KQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVV 175 (310)
T ss_dssp TEEEEEEECCCSCBHHHHHHHHH------HTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCE
T ss_pred CcEEEEEecCCCCCHHHHHHHhc------ccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCE
Confidence 78999999999999999985321 1234689999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 046598 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 922 (986)
||+|||+++...... .......|++.|+|||++.+..++.++||||||+++|+|++|+.||...... ........
T Consensus 176 kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~ 250 (310)
T 2wqm_A 176 KLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKKI 250 (310)
T ss_dssp EECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC---HHHHHHHH
T ss_pred EEEeccceeeecCCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh---HHHHHHHh
Confidence 999999997654322 2223356899999999999999999999999999999999999998632211 11111100
Q ss_pred CCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 923 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
........+ ....+.++.+++.+||+.||++|||++||
T Consensus 251 --------~~~~~~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~i 288 (310)
T 2wqm_A 251 --------EQCDYPPLP------------------SDHYSEELRQLVNMCINPDPEKRPDVTYV 288 (310)
T ss_dssp --------HTTCSCCCC------------------TTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred --------hcccCCCCc------------------ccccCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 000000000 00223467899999999999999998764
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=353.02 Aligned_cols=207 Identities=14% Similarity=0.139 Sum_probs=174.0
Q ss_pred HhhcCCCCCcccccccceeEEEEE-----ECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCC---CCcceeeeeeccc
Q 046598 685 NATDRFSSVNQIGEGSFGSVFKGI-----LDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIR---HRNLVKILTACSG 756 (986)
Q Consensus 685 ~~~~~y~~~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 756 (986)
...++|.+.+.||+|+||+||+|. ...+++.||||+++... ..++.+|+++++.++ |+||+++++++
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~-- 136 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAH-- 136 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEE--
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheee--
Confidence 345789999999999999999994 55668899999987543 356677777777775 99999999994
Q ss_pred cccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEe
Q 046598 757 VDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILL 836 (986)
Q Consensus 757 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 836 (986)
..++..++||||+++|+|.+++..... .....+++.+++.|+.||+.||+|||+. +|+||||||+|||+
T Consensus 137 ---~~~~~~~lv~e~~~~g~L~~~l~~~~~-----~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll 205 (365)
T 3e7e_A 137 ---LFQNGSVLVGELYSYGTLLNAINLYKN-----TPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFIL 205 (365)
T ss_dssp ---ECSSCEEEEECCCCSCBHHHHHHHHHT-----STTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEE
T ss_pred ---ecCCCcEEEEeccCCCcHHHHHHHhhc-----ccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEe
Confidence 455788999999999999999963221 1235699999999999999999999999 99999999999999
Q ss_pred cC-----------CCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCC
Q 046598 837 DE-----------DMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPT 905 (986)
Q Consensus 837 ~~-----------~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf 905 (986)
+. ++.+||+|||+|+.+.............||+.|+|||++.+..++.++|||||||++|||+||+.||
T Consensus 206 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 285 (365)
T 3e7e_A 206 GNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMK 285 (365)
T ss_dssp CGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCC
T ss_pred cccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcc
Confidence 98 8999999999998654333344445567999999999999999999999999999999999999998
Q ss_pred Cc
Q 046598 906 DI 907 (986)
Q Consensus 906 ~~ 907 (986)
..
T Consensus 286 ~~ 287 (365)
T 3e7e_A 286 VK 287 (365)
T ss_dssp EE
T ss_pred cc
Confidence 64
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=349.32 Aligned_cols=259 Identities=24% Similarity=0.367 Sum_probs=198.1
Q ss_pred cCC-CCCcccccccceeEEEEEE----CCCCeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCC
Q 046598 688 DRF-SSVNQIGEGSFGSVFKGIL----DDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 761 (986)
Q Consensus 688 ~~y-~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 761 (986)
++| ++.+.||+|+||+||++.+ ..+++.||||+++... ....+.+.+|++++++++||||+++++++.. ..
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~ 106 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCED---AG 106 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---TT
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEec---CC
Confidence 345 8999999999999988765 3468899999997543 2445778999999999999999999999642 23
Q ss_pred CceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCc
Q 046598 762 NDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI 841 (986)
Q Consensus 762 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 841 (986)
....++||||+++++|.+++.. ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~-----------~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~ 172 (318)
T 3lxp_A 107 AASLQLVMEYVPLGSLRDYLPR-----------HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRL 172 (318)
T ss_dssp TTEEEEEECCCTTCBHHHHGGG-----------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred CceEEEEEecccCCcHHHHHhh-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCC
Confidence 4678999999999999999952 2489999999999999999999999 9999999999999999999
Q ss_pred EEEcccccceecCCCCCc-cccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHH
Q 046598 842 AHIGDFGLARFLPLSSAQ-TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLAR 920 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~ 920 (986)
+||+|||.++........ .......++..|+|||++.+..++.++|||||||++|+|++|+.||....... ...
T Consensus 173 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-----~~~ 247 (318)
T 3lxp_A 173 VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-----LEL 247 (318)
T ss_dssp EEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-----HHH
T ss_pred EEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-----hhh
Confidence 999999999877543322 22334557888999999999999999999999999999999999986321110 000
Q ss_pred hhCCCc------hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 921 TALPDH------VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 921 ~~~~~~------~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
...... ..+.++..... +....++.++.+++.+||+.||++|||++||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 301 (318)
T 3lxp_A 248 IGIAQGQMTVLRLTELLERGERL------------------PRPDKCPAEVYHLMKNCWETEASFRPTFENL 301 (318)
T ss_dssp HCSCCHHHHHHHHHHHHHTTCCC------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hcccccchhHHHHHHHHhcccCC------------------CCCccccHHHHHHHHHHcCCCcccCcCHHHH
Confidence 011110 11111111100 0111345678899999999999999998764
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=339.42 Aligned_cols=246 Identities=19% Similarity=0.241 Sum_probs=195.1
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc--CchhHHHHHHHHHHHhcC-CCCcceeeeeeccccccCCC
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~ 762 (986)
..++|++.+.||+|+||+||+|.+..+++.||||+++.. ......++.+|+..+..+ +||||+++++++ ..+
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~-----~~~ 83 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAW-----AED 83 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEE-----EET
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeee-----ecC
Confidence 457899999999999999999999988999999999753 334457788999999999 999999999994 455
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCC---
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED--- 839 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--- 839 (986)
+..++||||+++++|.+++.... .....+++.+++.|+.||+.||+|||++ +|+||||||+||+++.+
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~ 154 (289)
T 1x8b_A 84 DHMLIQNEYCNGGSLADAISENY------RIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIP 154 (289)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHH------HHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----
T ss_pred CeEEEEEEecCCCcHHHHHHhhc------ccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCC
Confidence 78999999999999999996321 1124689999999999999999999999 99999999999999844
Q ss_pred ----------------CcEEEcccccceecCCCCCccccccccccccccccccccCC-CcCcccchhhHHHHHHHHHhCC
Q 046598 840 ----------------MIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRK 902 (986)
Q Consensus 840 ----------------~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~ 902 (986)
..+||+|||.+....... ...||+.|+|||++.+. .+++++|||||||++|+|++|.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~ 228 (289)
T 1x8b_A 155 NAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228 (289)
T ss_dssp ---------------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCC
T ss_pred cccccccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCC
Confidence 479999999998764322 23589999999998876 6778999999999999999999
Q ss_pred CCCCccccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCC
Q 046598 903 KPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMS 982 (986)
Q Consensus 903 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt 982 (986)
+|+... ......... .....+. ..+.++.+++.+||+.||++|||
T Consensus 229 ~~~~~~----~~~~~~~~~------------~~~~~~~-------------------~~~~~~~~li~~~l~~dp~~Rps 273 (289)
T 1x8b_A 229 PLPRNG----DQWHEIRQG------------RLPRIPQ-------------------VLSQEFTELLKVMIHPDPERRPS 273 (289)
T ss_dssp CCCSSS----HHHHHHHTT------------CCCCCSS-------------------CCCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCcch----hHHHHHHcC------------CCCCCCc-------------------ccCHHHHHHHHHHhCCCcccCCC
Confidence 876421 111111111 1100000 12345789999999999999999
Q ss_pred CCCC
Q 046598 983 MTNV 986 (986)
Q Consensus 983 ~~eV 986 (986)
++|+
T Consensus 274 ~~~l 277 (289)
T 1x8b_A 274 AMAL 277 (289)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=349.10 Aligned_cols=258 Identities=24% Similarity=0.391 Sum_probs=194.4
Q ss_pred hhcCCCCCcccccccceeEEEEE-----ECCCCeEEEEEEeecc-CchhHHHHHHHHHHHhcCCCCcceeeeeecccccc
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGI-----LDDGRTTIAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY 759 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 759 (986)
..++|++.+.||+|+||.||+|+ ...+++.||||++... ......++.+|+.++++++||||+++++++
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~----- 102 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS----- 102 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEE-----
Confidence 35789999999999999999999 4456788999998643 334456789999999999999999999994
Q ss_pred CCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecC-
Q 046598 760 QGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDE- 838 (986)
Q Consensus 760 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~- 838 (986)
......++||||+++++|.+++...... ......+++.+++.++.||+.||.|||+. +|+||||||+||+++.
T Consensus 103 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~ 176 (327)
T 2yfx_A 103 LQSLPRFILMELMAGGDLKSFLRETRPR---PSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP 176 (327)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTSCC---SSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCS
T ss_pred cCCCCcEEEEecCCCCcHHHHHHhhccc---ccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecC
Confidence 4556789999999999999999754322 12234689999999999999999999999 9999999999999984
Q ss_pred --CCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccH
Q 046598 839 --DMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNL 915 (986)
Q Consensus 839 --~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~ 915 (986)
+..+||+|||+++...............+++.|+|||++.+..++.++|||||||++|+|+| |+.||.....
T Consensus 177 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----- 251 (327)
T 2yfx_A 177 GPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN----- 251 (327)
T ss_dssp STTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred CCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH-----
Confidence 44699999999976543333333334567899999999988899999999999999999998 9999863211
Q ss_pred HHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 916 HNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 916 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..... .+.......+. ..++..+.+++.+||+.||++|||++||
T Consensus 252 ~~~~~---------~~~~~~~~~~~------------------~~~~~~l~~li~~~l~~dp~~Rps~~~l 295 (327)
T 2yfx_A 252 QEVLE---------FVTSGGRMDPP------------------KNCPGPVYRIMTQCWQHQPEDRPNFAII 295 (327)
T ss_dssp HHHHH---------HHHTTCCCCCC------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHH---------HHhcCCCCCCC------------------CCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 11110 01000000000 1233457899999999999999998764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=339.38 Aligned_cols=250 Identities=23% Similarity=0.361 Sum_probs=197.2
Q ss_pred hcCCCCCc-ccccccceeEEEEEEC--CCCeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 687 TDRFSSVN-QIGEGSFGSVFKGILD--DGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 687 ~~~y~~~~-~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
.++|.+.+ .||+|+||.||+|.+. .+++.||||+++... ....+++.+|++++++++||||+++++++. .
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~ 81 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ------A 81 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE------S
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec------C
Confidence 45677776 9999999999999864 457889999997643 345678999999999999999999999852 3
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
+..++||||+++++|.+++.. ....+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~ 149 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVG---------KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYA 149 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTT---------CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEE
T ss_pred CCcEEEEEeCCCCCHHHHHHh---------CCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCE
Confidence 458999999999999999952 234689999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCc-cccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHH
Q 046598 843 HIGDFGLARFLPLSSAQ-TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLAR 920 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~ 920 (986)
||+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .......
T Consensus 150 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~i~ 227 (287)
T 1u59_A 150 KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIE 227 (287)
T ss_dssp EECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHHHH
T ss_pred EECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHh
Confidence 99999999876533322 22233456889999999988899999999999999999999 99999643211 1111111
Q ss_pred hhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 921 TALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 921 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
. ..... .+..++.++.+++.+||+.||++|||++||
T Consensus 228 ~------------~~~~~------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 263 (287)
T 1u59_A 228 Q------------GKRME------------------CPPECPPELYALMSDCWIYKWEDRPDFLTV 263 (287)
T ss_dssp T------------TCCCC------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred c------------CCcCC------------------CCCCcCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 0 00000 001234568899999999999999998764
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=340.30 Aligned_cols=251 Identities=22% Similarity=0.345 Sum_probs=192.8
Q ss_pred CCCCCcccccccceeEEEEEECCCC---eEEEEEEeeccCc-hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGR---TTIAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
.|.+.+.||+|+||+||+|.+..++ ..||+|+++.... ...+.+.+|++++++++||||+++++++. ..+..
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~~~~ 97 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIML----PPEGL 97 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEC----CSSSC
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEe----cCCCC
Confidence 4666789999999999999975443 3799999875333 44578899999999999999999999953 23345
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.++||||+.+|+|.+++.. ....+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 98 ~~~v~e~~~~~~L~~~~~~---------~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl 165 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIRS---------PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKV 165 (298)
T ss_dssp CEEEECCCTTCBHHHHHHC---------TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEE
T ss_pred cEEEEecccCCCHHHHHhc---------cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEe
Confidence 5999999999999999963 234689999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCC--ccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 046598 845 GDFGLARFLPLSSA--QTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 845 ~DFG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 922 (986)
+|||+++....... ........+++.|+|||.+.+..++.++|||||||++|+|++|..|+...... ..........
T Consensus 166 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~-~~~~~~~~~~ 244 (298)
T 3pls_A 166 ADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-FDLTHFLAQG 244 (298)
T ss_dssp CCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG-GGHHHHHHTT
T ss_pred CcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH-HHHHHHhhcC
Confidence 99999986533221 12223456788999999999999999999999999999999966554321111 1111111110
Q ss_pred CCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 923 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
... ..+ ...+.++.+++.+||+.||++|||++||
T Consensus 245 ~~~-----------~~~-------------------~~~~~~l~~li~~~l~~~p~~Rps~~~l 278 (298)
T 3pls_A 245 RRL-----------PQP-------------------EYCPDSLYQVMQQCWEADPAVRPTFRVL 278 (298)
T ss_dssp CCC-----------CCC-------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCC-----------CCC-------------------ccchHHHHHHHHHHccCChhhCcCHHHH
Confidence 000 000 0123457899999999999999998763
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=350.22 Aligned_cols=268 Identities=25% Similarity=0.390 Sum_probs=202.0
Q ss_pred hcCCCCCcccccccceeEEEEEE----CCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGIL----DDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
.++|++.+.||+|+||.||+|++ ..+++.||||++........+.+.+|++++++++||||+++++++.. ...
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~ 116 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGR 116 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC------
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe---cCC
Confidence 45789999999999999999994 55689999999987666667889999999999999999999998532 233
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
...++||||+++++|.+++.. ....+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~ 184 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQK---------HKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRV 184 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHH---------STTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEE
T ss_pred CceEEEEECCCCCCHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcE
Confidence 478999999999999999963 224589999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCc-cccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHh
Q 046598 843 HIGDFGLARFLPLSSAQ-TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLART 921 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~ 921 (986)
||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||+||..||..... .+......
T Consensus 185 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~---~~~~~~~~ 261 (326)
T 2w1i_A 185 KIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA---EFMRMIGN 261 (326)
T ss_dssp EECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH---HHHHHHCT
T ss_pred EEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH---HHHHhhcc
Confidence 99999999876543322 112334577889999999988999999999999999999999998752211 01111100
Q ss_pred hCCCc-hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 922 ALPDH-VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 922 ~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..... ....+...+.... +.+....++.++.+++.+||+.||++|||++||
T Consensus 262 ~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el 313 (326)
T 2w1i_A 262 DKQGQMIVFHLIELLKNNG--------------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 313 (326)
T ss_dssp TCCTHHHHHHHHHHHHTTC--------------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred ccchhhhHHHHHHHhhcCC--------------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHH
Confidence 00000 0000000000000 000111345668899999999999999998764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=343.97 Aligned_cols=268 Identities=23% Similarity=0.334 Sum_probs=202.0
Q ss_pred cChHHHHHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhc--CCCCcceeeeeecc
Q 046598 678 ISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKN--IRHRNLVKILTACS 755 (986)
Q Consensus 678 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~ 755 (986)
.+........++|.+.+.||+|+||.||+|++. ++.||||++... ..+.+.+|++++.. ++||||+++++++.
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~ 106 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADN 106 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence 344444556789999999999999999999985 689999998643 34667888888887 79999999999964
Q ss_pred ccccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEee
Q 046598 756 GVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLH--------HDCQPPIAHC 827 (986)
Q Consensus 756 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~~~~~ivH~ 827 (986)
.. .......++||||+++|+|.+++.. ..+++.+++.++.|++.||+||| +. +|+||
T Consensus 107 ~~-~~~~~~~~lv~e~~~~g~L~~~l~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~ 171 (342)
T 1b6c_B 107 KD-NGTWTQLWLVSDYHEHGSLFDYLNR-----------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHR 171 (342)
T ss_dssp CC-CSSCCCEEEEECCCTTCBHHHHHHH-----------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECS
T ss_pred cc-CCccceeEEEEeecCCCcHHHHHhc-----------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeC
Confidence 32 1112378999999999999999952 25899999999999999999999 77 99999
Q ss_pred cCCCCCeEecCCCcEEEcccccceecCCCCCcc--ccccccccccccccccccCC------CcCcccchhhHHHHHHHHH
Q 046598 828 DLKPSNILLDEDMIAHIGDFGLARFLPLSSAQT--SSIGAKGSIGYIAPEYGLGS------EVSISGDVYSYGILLLELI 899 (986)
Q Consensus 828 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvvl~ell 899 (986)
||||+||+++.++.+||+|||+++......... ......||+.|+|||++.+. .++.++|||||||++|||+
T Consensus 172 Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~ 251 (342)
T 1b6c_B 172 DLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251 (342)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHH
Confidence 999999999999999999999998764333211 22345689999999998775 3457899999999999999
Q ss_pred hC----------CCCCCccccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHH
Q 046598 900 TR----------KKPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIG 969 (986)
Q Consensus 900 tg----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 969 (986)
|| +.||............+...... ..+...... +. ...+++..+.+++
T Consensus 252 tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~------------~~-~~~~~~~~l~~li 310 (342)
T 1b6c_B 252 RRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE--------QKLRPNIPN------------RW-QSCEALRVMAKIM 310 (342)
T ss_dssp TTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTT--------SCCCCCCCG------------GG-GTSHHHHHHHHHH
T ss_pred hccCcCCcccccccCccccCcCcccHHHHHHHHHH--------HHhCCCCcc------------cc-cchhHHHHHHHHH
Confidence 99 66775443333222222221111 111111000 00 1125667789999
Q ss_pred hcccCCCCCCCCCCCCC
Q 046598 970 VACSMESPEDRMSMTNV 986 (986)
Q Consensus 970 ~~Cl~~dP~~RPt~~eV 986 (986)
.+||+.||++|||++||
T Consensus 311 ~~cl~~dp~~Rps~~~i 327 (342)
T 1b6c_B 311 RECWYANGAARLTALRI 327 (342)
T ss_dssp HHHCCSSGGGSCCHHHH
T ss_pred HHHhccChhhCCCHHHH
Confidence 99999999999998764
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=364.19 Aligned_cols=249 Identities=22% Similarity=0.287 Sum_probs=193.6
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
.++|++.+.||+|+||+||+|++..++..||+|+++... ......+.+|+++++.++||||++++++| .....
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~ 110 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF-----EDKRN 110 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence 457999999999999999999999999999999997532 23357789999999999999999999994 55688
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCC---Cc
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED---MI 841 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~ 841 (986)
.|+||||+++|+|.+++.. ...+++.++..|+.||+.||+|||+. +|+||||||+||+++.. +.
T Consensus 111 ~~lv~e~~~~g~L~~~~~~----------~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~ 177 (494)
T 3lij_A 111 YYLVMECYKGGELFDEIIH----------RMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDAL 177 (494)
T ss_dssp EEEEEECCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCC
T ss_pred EEEEEecCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCc
Confidence 9999999999999998842 24589999999999999999999999 99999999999999764 45
Q ss_pred EEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHh
Q 046598 842 AHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLART 921 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~ 921 (986)
+||+|||+++...... ......||+.|+|||++. ..++.++||||+||++|+|++|+.||...... .....
T Consensus 178 ~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~~ 248 (494)
T 3lij_A 178 IKIVDFGLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ-----EILRK 248 (494)
T ss_dssp EEECCCTTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHH
T ss_pred EEEEECCCCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHH
Confidence 9999999998764322 233456999999999976 56999999999999999999999999642211 11110
Q ss_pred hCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 922 ALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 922 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+.......... .....+.++.+++.+||+.||++|||++|+
T Consensus 249 --------i~~~~~~~~~~----------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~ 289 (494)
T 3lij_A 249 --------VEKGKYTFDSP----------------EWKNVSEGAKDLIKQMLQFDSQRRISAQQA 289 (494)
T ss_dssp --------HHHTCCCCCSG----------------GGTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred --------HHhCCCCCCch----------------hcccCCHHHHHHHHHHCCCChhhCccHHHH
Confidence 00000000000 001223457799999999999999998763
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=366.16 Aligned_cols=250 Identities=25% Similarity=0.305 Sum_probs=199.8
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
..++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+.+|++++++++||||++++++ +...
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~-----~~~~ 98 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEF-----FEDK 98 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEE-----EECS
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEE-----EEeC
Confidence 3467999999999999999999999889999999986432 3446789999999999999999999999 4556
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEe---cCC
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILL---DED 839 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~ 839 (986)
...++||||+.+|+|.+++.. ...+++.++..|+.||+.||+|||++ +|+||||||+||++ +.+
T Consensus 99 ~~~~lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~ 165 (484)
T 3nyv_A 99 GYFYLVGEVYTGGELFDEIIS----------RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKD 165 (484)
T ss_dssp SEEEEEECCCCSCBHHHHHHT----------CSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTT
T ss_pred CEEEEEEecCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCC
Confidence 889999999999999999852 34689999999999999999999999 99999999999999 567
Q ss_pred CcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHH
Q 046598 840 MIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLA 919 (986)
Q Consensus 840 ~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~ 919 (986)
+.+||+|||+++.+..... .....||+.|+|||++.+ .++.++||||+||++|+|++|++||...... ......
T Consensus 166 ~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i 239 (484)
T 3nyv_A 166 ANIRIIDFGLSTHFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY--DILKKV 239 (484)
T ss_dssp CCEEECCTTHHHHBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH
T ss_pred CcEEEEeeeeeEEcccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH--HHHHHH
Confidence 8999999999987643322 234569999999999876 6999999999999999999999999642211 000110
Q ss_pred HhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 920 RTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 920 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
. ........ +.....+.++.+++.+||+.||++|||++|+
T Consensus 240 ~-----------~~~~~~~~----------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~ 279 (484)
T 3nyv_A 240 E-----------KGKYTFEL----------------PQWKKVSESAKDLIRKMLTYVPSMRISARDA 279 (484)
T ss_dssp H-----------HCCCCCCS----------------GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred H-----------cCCCCCCC----------------cccccCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 0 00000000 0001234557799999999999999998763
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=339.29 Aligned_cols=253 Identities=21% Similarity=0.293 Sum_probs=196.9
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC----chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCC
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH----HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 761 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 761 (986)
..++|++.+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|++++++++||||+++++++. ..+
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~ 79 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLY---NEE 79 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE---CC-
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEE---cCC
Confidence 3578999999999999999999999889999999997432 234578999999999999999999999853 234
Q ss_pred CceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCc
Q 046598 762 NDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI 841 (986)
Q Consensus 762 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 841 (986)
....++||||++++ +.+++... ....+++.++..++.||+.||+|||++ +|+||||||+||+++.++.
T Consensus 80 ~~~~~lv~e~~~~~-l~~~~~~~--------~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~ 147 (305)
T 2wtk_C 80 KQKMYMVMEYCVCG-MQEMLDSV--------PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGT 147 (305)
T ss_dssp --CEEEEEECCSEE-HHHHHHHS--------TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred CCeEEEEehhccCC-HHHHHHhC--------cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCc
Confidence 56789999999776 77777532 234689999999999999999999999 9999999999999999999
Q ss_pred EEEcccccceecCCCCCccccccccccccccccccccCCC--cCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHH
Q 046598 842 AHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSE--VSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLA 919 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~ 919 (986)
+||+|||.+................|++.|+|||++.+.. ++.++||||||+++|||++|+.||.... .....
T Consensus 148 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~ 222 (305)
T 2wtk_C 148 LKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-----IYKLF 222 (305)
T ss_dssp EEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHH
T ss_pred EEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch-----HHHHH
Confidence 9999999998765433333344566899999999987654 4789999999999999999999996321 11111
Q ss_pred HhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 920 RTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 920 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
. .+.......+ ..++..+.+++.+||+.||++|||++|+
T Consensus 223 ~---------~i~~~~~~~~-------------------~~~~~~l~~li~~~l~~dp~~Rps~~~l 261 (305)
T 2wtk_C 223 E---------NIGKGSYAIP-------------------GDCGPPLSDLLKGMLEYEPAKRFSIRQI 261 (305)
T ss_dssp H---------HHHHCCCCCC-------------------SSSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred H---------HHhcCCCCCC-------------------CccCHHHHHHHHHHccCChhhCCCHHHH
Confidence 1 0000000000 0223457789999999999999998764
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=365.15 Aligned_cols=249 Identities=29% Similarity=0.469 Sum_probs=193.0
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
..++|++.+.||+|+||.||+|.+.. +..||||+++... ...+++.+|++++++++||||+++++++. + +..
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~-~~~ 253 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-----E-EPI 253 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S-SSC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEc-----C-Cce
Confidence 34678899999999999999999986 5679999997543 33578999999999999999999999853 2 568
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
++||||+++|+|.++++.. ....+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 254 ~iv~e~~~~gsL~~~l~~~--------~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~ 322 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGE--------TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVA 322 (452)
T ss_dssp EEEECCCTTCBHHHHHSHH--------HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEEehhhcCCCHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEEC
Confidence 9999999999999999521 224589999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCC
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALP 924 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 924 (986)
|||+++...... ........++..|+|||++.+..++.++|||||||++|||++ |+.||...... ....
T Consensus 323 DfG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-----~~~~---- 392 (452)
T 1fmk_A 323 DFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVLD---- 392 (452)
T ss_dssp CCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHHH----
T ss_pred CCccceecCCCc-eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH-----HHHH----
Confidence 999998764322 122233457889999999998999999999999999999999 99998632211 1111
Q ss_pred CchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 925 DHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 925 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+..... .+.+..++..+.+++.+||+.||++|||+++|
T Consensus 393 -----~i~~~~~------------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l 431 (452)
T 1fmk_A 393 -----QVERGYR------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYL 431 (452)
T ss_dssp -----HHHTTCC------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -----HHHcCCC------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 0100000 00011345568899999999999999998764
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=340.16 Aligned_cols=250 Identities=21% Similarity=0.344 Sum_probs=194.1
Q ss_pred hhcCCCCCcccccccceeEEEEEECC---CCeEEEEEEeecc-CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCC
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDD---GRTTIAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 761 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 761 (986)
..++|.+.+.||+|+||.||+|.+.. .+..||+|+++.. .....+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------ 83 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE------ 83 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC------
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc------
Confidence 35789999999999999999999753 3456999998754 3345678999999999999999999999852
Q ss_pred CceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCc
Q 046598 762 NDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI 841 (986)
Q Consensus 762 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 841 (986)
++..++||||+++++|.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 84 ~~~~~~v~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 151 (281)
T 3cc6_A 84 EEPTWIIMELYPYGELGHYLER---------NKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPEC 151 (281)
T ss_dssp SSSCEEEEECCTTCBHHHHHHH---------HTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTE
T ss_pred CCCCEEEEecCCCCCHHHHHHh---------ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCc
Confidence 2346899999999999999962 234589999999999999999999999 9999999999999999999
Q ss_pred EEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHH
Q 046598 842 AHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLAR 920 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~ 920 (986)
+||+|||.++....... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||...... .......
T Consensus 152 ~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~--~~~~~~~ 228 (281)
T 3cc6_A 152 VKLGDFGLSRYIEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK--DVIGVLE 228 (281)
T ss_dssp EEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG--GHHHHHH
T ss_pred EEeCccCCCcccccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH--HHHHHHh
Confidence 99999999986543221 12233457889999999988899999999999999999998 99998632221 1111111
Q ss_pred hhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 921 TALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 921 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.... ...+ ..++..+.+++.+||+.||++|||++||
T Consensus 229 ~~~~-----------~~~~-------------------~~~~~~l~~li~~~l~~~p~~Rps~~el 264 (281)
T 3cc6_A 229 KGDR-----------LPKP-------------------DLCPPVLYTLMTRCWDYDPSDRPRFTEL 264 (281)
T ss_dssp HTCC-----------CCCC-------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred cCCC-----------CCCC-------------------CCCCHHHHHHHHHHccCCchhCcCHHHH
Confidence 0000 0000 0123457899999999999999998764
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=343.05 Aligned_cols=250 Identities=23% Similarity=0.352 Sum_probs=195.3
Q ss_pred hhcCCCCCc-ccccccceeEEEEEE--CCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeeccccccC
Q 046598 686 ATDRFSSVN-QIGEGSFGSVFKGIL--DDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ 760 (986)
Q Consensus 686 ~~~~y~~~~-~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 760 (986)
..++|.+.+ .||+|+||.||+|.+ ..+++.||||+++... ....+++.+|++++++++||||+++++++
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~------ 87 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC------ 87 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE------
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE------
Confidence 456788888 999999999999955 5557899999997532 23357899999999999999999999985
Q ss_pred CCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCC
Q 046598 761 GNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDM 840 (986)
Q Consensus 761 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 840 (986)
..+..++||||+++++|.+++.. ...+++.+++.++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~ 154 (291)
T 1xbb_A 88 EAESWMLVMEMAELGPLNKYLQQ----------NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQH 154 (291)
T ss_dssp ESSSEEEEEECCTTEEHHHHHHH----------CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETT
T ss_pred CCCCcEEEEEeCCCCCHHHHHHh----------CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCC
Confidence 23568999999999999999952 23589999999999999999999999 999999999999999999
Q ss_pred cEEEcccccceecCCCCCc-cccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHH
Q 046598 841 IAHIGDFGLARFLPLSSAQ-TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNL 918 (986)
Q Consensus 841 ~~kL~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~ 918 (986)
.+||+|||+++........ .......+++.|+|||++.+..++.++||||||+++|+|++ |+.||...... .....
T Consensus 155 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~ 232 (291)
T 1xbb_A 155 YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAM 232 (291)
T ss_dssp EEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHH
T ss_pred cEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHH
Confidence 9999999999876543322 22233446789999999988899999999999999999999 99998642211 11111
Q ss_pred HHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 919 ARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 919 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
. ....... .+..++.++.+++.+||+.||++|||++||
T Consensus 233 ~------------~~~~~~~------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 270 (291)
T 1xbb_A 233 L------------EKGERMG------------------CPAGCPREMYDLMNLCWTYDVENRPGFAAV 270 (291)
T ss_dssp H------------HTTCCCC------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred H------------HcCCCCC------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 1 1000000 001234567899999999999999998764
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=336.46 Aligned_cols=246 Identities=23% Similarity=0.310 Sum_probs=190.7
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
.++|.+.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+++++.++||||+++++++ ...+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 84 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI-----STPT 84 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE-----ecCC
Confidence 468999999999999999999999889999999996432 23356789999999999999999999994 4567
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..++||||+++++|.+++.. ...+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+|
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~ 151 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICK----------HGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAK 151 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEE
T ss_pred eEEEEEeccCCCcHHHHHhc----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEE
Confidence 89999999999999999952 23589999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccCCCc-CcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEV-SISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 922 (986)
|+|||.+....... ......+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||..... .....
T Consensus 152 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~-- 221 (276)
T 2h6d_A 152 IADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV-----PTLFK-- 221 (276)
T ss_dssp ECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH--
T ss_pred EeecccccccCCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH-----HHHHH--
Confidence 99999998654322 2233568999999999988765 6899999999999999999999863211 11110
Q ss_pred CCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 923 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+.......+ ...+.++.+++.+|++.||++|||++||
T Consensus 222 -------~~~~~~~~~~-------------------~~~~~~l~~li~~~l~~~p~~Rps~~~~ 259 (276)
T 2h6d_A 222 -------KIRGGVFYIP-------------------EYLNRSVATLLMHMLQVDPLKRATIKDI 259 (276)
T ss_dssp -------HHHHCCCCCC-------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -------HhhcCcccCc-------------------hhcCHHHHHHHHHHccCChhhCCCHHHH
Confidence 0000000000 0123457789999999999999998764
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=352.75 Aligned_cols=282 Identities=21% Similarity=0.205 Sum_probs=197.0
Q ss_pred HHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeecccccc----
Q 046598 684 YNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY---- 759 (986)
Q Consensus 684 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 759 (986)
....++|++.+.||+|+||+||+|.+..+++.||||++.... ....+|+++++.++||||+++++++.....
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 345678999999999999999999999999999999986432 223479999999999999999998743211
Q ss_pred -----------------------------CCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHH
Q 046598 760 -----------------------------QGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVA 810 (986)
Q Consensus 760 -----------------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~ 810 (986)
......++||||++ |+|.+.+.... .....+++..++.++.||+
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~------~~~~~l~~~~~~~i~~qi~ 151 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFI------RSGRSIPMNLISIYIYQLF 151 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHH------HTTCCCCHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHH------hcCCCCCHHHHHHHHHHHH
Confidence 34456899999997 58877775321 2245689999999999999
Q ss_pred HHHHHHHhcCCCCeEeecCCCCCeEec-CCCcEEEcccccceecCCCCCccccccccccccccccccccCC-CcCcccch
Q 046598 811 CALNYLHHDCQPPIAHCDLKPSNILLD-EDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS-EVSISGDV 888 (986)
Q Consensus 811 ~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv 888 (986)
+||+|||+. ||+||||||+||+++ .++.+||+|||+|+....... .....+|+.|+|||++.+. .++.++||
T Consensus 152 ~aL~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di 225 (383)
T 3eb0_A 152 RAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDL 225 (383)
T ss_dssp HHHHHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHH
T ss_pred HHHHHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhh
Confidence 999999999 999999999999998 688999999999987643322 2335689999999998775 48999999
Q ss_pred hhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHH
Q 046598 889 YSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRI 968 (986)
Q Consensus 889 wSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 968 (986)
||+||++|||++|+.||......+ .+.......-......+. ..- ....+.. .........+...+...+.++.++
T Consensus 226 wslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~g~p~~~~~~-~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l 301 (383)
T 3eb0_A 226 WSIGCVFGELILGKPLFSGETSID-QLVRIIQIMGTPTKEQMI-RMN-PHYTEVR-FPTLKAKDWRKILPEGTPSLAIDL 301 (383)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHH-HHC-TTC--CC-CCCCCCCCHHHHSCTTCCHHHHHH
T ss_pred hhHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHH-HhC-ccccccc-CCccCcccHHhhCCCCCCHHHHHH
Confidence 999999999999999997432211 111221111111111110 000 0000000 000000000111111244567899
Q ss_pred HhcccCCCCCCCCCCCCC
Q 046598 969 GVACSMESPEDRMSMTNV 986 (986)
Q Consensus 969 ~~~Cl~~dP~~RPt~~eV 986 (986)
+.+||+.||++|||+.|+
T Consensus 302 i~~~L~~dP~~R~t~~e~ 319 (383)
T 3eb0_A 302 LEQILRYEPDLRINPYEA 319 (383)
T ss_dssp HHHHCCSSGGGSCCHHHH
T ss_pred HHHHccCChhhCCCHHHH
Confidence 999999999999998763
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=350.75 Aligned_cols=207 Identities=25% Similarity=0.320 Sum_probs=175.3
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
..++|++.+.||+|+||.||+|.+..+++.||||+++... .....++.+|++++++++||||+++++++....+.....
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 3578999999999999999999999889999999996433 234567889999999999999999999976544556678
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.++||||++ ++|.+++.. ..+++.++..++.|++.||+|||+. ||+||||||+||+++.++.+||
T Consensus 89 ~~lv~e~~~-~~L~~~~~~-----------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl 153 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST-----------QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKV 153 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEE
T ss_pred EEEEEeccC-ccHHHHHhh-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEE
Confidence 999999996 699998852 3589999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCcc--------ccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 845 GDFGLARFLPLSSAQT--------SSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 154 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 225 (353)
T 2b9h_A 154 CDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPG 225 (353)
T ss_dssp CCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred EecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999998764322111 1223468999999998754 7799999999999999999999999974
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=348.35 Aligned_cols=267 Identities=22% Similarity=0.290 Sum_probs=197.8
Q ss_pred CCCcChHHHHHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcC-CCCcceeeeee
Q 046598 675 FPNISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTA 753 (986)
Q Consensus 675 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 753 (986)
.+.+.+.++....++|++.+.||+|+||.||+|++..+++.||||++.... ...+.+.+|+.+++++ +||||++++++
T Consensus 11 ~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 89 (326)
T 2x7f_A 11 LDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGA 89 (326)
T ss_dssp -----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEE
T ss_pred chhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeE
Confidence 344555566667889999999999999999999998889999999997543 3447889999999998 89999999999
Q ss_pred cccccc-CCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCC
Q 046598 754 CSGVDY-QGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPS 832 (986)
Q Consensus 754 ~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~ 832 (986)
+..... ......++||||+++++|.+++... ....+++..++.++.||+.||+|||+. +|+||||||+
T Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~ 158 (326)
T 2x7f_A 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT--------KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQ 158 (326)
T ss_dssp EEECC--CCCCEEEEEEECCTTEEHHHHHHHS--------GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGG
T ss_pred EeeccCccccceEEEEEEcCCCCcHHHHHHhc--------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHH
Confidence 643211 1256789999999999999999632 124689999999999999999999999 9999999999
Q ss_pred CeEecCCCcEEEcccccceecCCCCCcccccccccccccccccccc-----CCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 833 NILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGL-----GSEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 833 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
||+++.++.+||+|||++....... .......|++.|+|||++. +..++.++|||||||++|+|++|+.||..
T Consensus 159 NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 236 (326)
T 2x7f_A 159 NVLLTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 236 (326)
T ss_dssp GEEECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred HEEEcCCCCEEEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999997653221 1223456899999999987 56789999999999999999999999863
Q ss_pred cccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 908 MFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..... ..........+ ... . ...+..+.+++.+||+.||++|||++||
T Consensus 237 ~~~~~-~~~~~~~~~~~---------~~~--~-------------------~~~~~~l~~li~~~l~~dp~~Rps~~~l 284 (326)
T 2x7f_A 237 MHPMR-ALFLIPRNPAP---------RLK--S-------------------KKWSKKFQSFIESCLVKNHSQRPATEQL 284 (326)
T ss_dssp SCHHH-HHHHHHHSCCC---------CCS--C-------------------SCSCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred CcHHH-HHHHhhcCccc---------cCC--c-------------------cccCHHHHHHHHHHhccChhhCCCHHHH
Confidence 22110 00000000000 000 0 0123457799999999999999998763
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=342.39 Aligned_cols=282 Identities=21% Similarity=0.253 Sum_probs=197.1
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeecccc---------
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGV--------- 757 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------- 757 (986)
.++|++.+.||+|+||.||+|.+..+++.||||++........+++.+|++++++++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 46899999999999999999999998999999999876666778899999999999999999999986322
Q ss_pred ccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEec
Q 046598 758 DYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLD 837 (986)
Q Consensus 758 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 837 (986)
........++||||++ |+|.+++.. +.+++.+++.++.|++.||+|||++ +|+||||||+||+++
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~ 154 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ-----------GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFIN 154 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc-----------CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEc
Confidence 1244578899999997 699999851 3588999999999999999999999 999999999999997
Q ss_pred -CCCcEEEcccccceecCCCCC-ccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCcccccccc
Q 046598 838 -EDMIAHIGDFGLARFLPLSSA-QTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDIMFEGDMN 914 (986)
Q Consensus 838 -~~~~~kL~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~ 914 (986)
+++.+||+|||.++....... ........++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+ .
T Consensus 155 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~ 233 (320)
T 2i6l_A 155 TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE-Q 233 (320)
T ss_dssp TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-H
T ss_pred CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH-H
Confidence 567999999999986543211 122233457899999998765 678999999999999999999999997432211 1
Q ss_pred HHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 915 LHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 915 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
... .....+....+........-+.. ...................+.++.+++.+||+.||++|||++|+
T Consensus 234 ~~~-~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 303 (320)
T 2i6l_A 234 MQL-ILESIPVVHEEDRQELLSVIPVY-IRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEA 303 (320)
T ss_dssp HHH-HHHHSCCCCHHHHHHHHTTSCHH-HHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred HHH-HHHhcCCCchhhhhhhhhcCccc-ccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHH
Confidence 111 11111111100000000000000 00000000000000111345678899999999999999998764
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=340.51 Aligned_cols=253 Identities=19% Similarity=0.243 Sum_probs=183.1
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc--hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
.++|++.+.||+|+||+||+|++..+++.||||+++.... ...+.+.++...++.++||||+++++++ ..++.
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-----~~~~~ 80 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGAL-----FREGD 80 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSS
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeee-----eccCC
Confidence 5789999999999999999999998899999999975322 2223344555568888999999999994 45678
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.++||||++ |+|.+++.... .....+++.+++.|+.|++.||+|||++ .||+||||||+||+++.++.+||
T Consensus 81 ~~lv~e~~~-~~l~~~l~~~~------~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl 151 (290)
T 3fme_A 81 VWICMELMD-TSLDKFYKQVI------DKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKM 151 (290)
T ss_dssp EEEEEECCS-EEHHHHHHHHH------HTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEB
T ss_pred EEEEEehhc-cchHHHHHHHH------hcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEE
Confidence 999999996 58888875221 2345699999999999999999999984 28999999999999999999999
Q ss_pred cccccceecCCCCCccccccccccccccccccc----cCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHH
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYG----LGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLAR 920 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~ 920 (986)
+|||+++...... ......||+.|+|||++ .+..++.++||||+||++|+|++|+.||...............
T Consensus 152 ~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 228 (290)
T 3fme_A 152 CDFGISGYLVDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE 228 (290)
T ss_dssp CCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHH
T ss_pred eecCCcccccccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhc
Confidence 9999998654322 22234689999999995 5667899999999999999999999999632211111111111
Q ss_pred hhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 921 TALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 921 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
......+. ...+.++.+++.+||+.||++|||++||
T Consensus 229 ------------~~~~~~~~------------------~~~~~~~~~li~~~l~~~p~~Rpt~~e~ 264 (290)
T 3fme_A 229 ------------EPSPQLPA------------------DKFSAEFVDFTSQCLKKNSKERPTYPEL 264 (290)
T ss_dssp ------------SCCCCCCT------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ------------cCCCCccc------------------ccCCHHHHHHHHHHhhcChhhCcCHHHH
Confidence 10000000 0223457899999999999999998764
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=358.17 Aligned_cols=254 Identities=20% Similarity=0.285 Sum_probs=197.1
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
.++|++.++||+|+||.||+|++..+++.||||+++.... .+++.+|+++++.++|++.+..+.++ ....+..+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~----~~~~~~~~ 79 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWF----GVEGDYNV 79 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEE----EEETTEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEE----EeeCCEEE
Confidence 4789999999999999999999998899999999875432 24578999999999875544444443 34557889
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEe---cCCCcEE
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILL---DEDMIAH 843 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~k 843 (986)
+||||+ +++|.+++... ...+++.+++.|+.||+.||+|||++ +|+||||||+|||+ +.++.+|
T Consensus 80 lvme~~-g~sL~~ll~~~---------~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vk 146 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFC---------SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVY 146 (483)
T ss_dssp EEEECC-CCBHHHHHHHT---------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEE
T ss_pred EEEECC-CCCHHHHHHhh---------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEE
Confidence 999999 99999999632 34689999999999999999999999 99999999999999 6889999
Q ss_pred EcccccceecCCCCCc-----cccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccc--cHH
Q 046598 844 IGDFGLARFLPLSSAQ-----TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDM--NLH 916 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~--~~~ 916 (986)
|+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .+.
T Consensus 147 L~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 226 (483)
T 3sv0_A 147 IIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE 226 (483)
T ss_dssp ECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHH
T ss_pred EEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHH
Confidence 9999999876543321 122356799999999999999999999999999999999999999975332211 011
Q ss_pred HHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 917 NLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 917 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
............ .....++.++.+++.+||+.+|++||++++|
T Consensus 227 ~i~~~~~~~~~~---------------------------~l~~~~p~~l~~li~~cl~~dP~~RPs~~el 269 (483)
T 3sv0_A 227 KISEKKVATSIE---------------------------ALCRGYPTEFASYFHYCRSLRFDDKPDYSYL 269 (483)
T ss_dssp HHHHHHHHSCHH---------------------------HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHH
T ss_pred HHhhccccccHH---------------------------HHhcCCcHHHHHHHHHHhcCChhhCcCHHHH
Confidence 111110000000 0111335678899999999999999998754
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=337.11 Aligned_cols=252 Identities=21% Similarity=0.283 Sum_probs=199.2
Q ss_pred HhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---------chhHHHHHHHHHHHhcCC-CCcceeeeeec
Q 046598 685 NATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---------HGAFKSFIAECNTLKNIR-HRNLVKILTAC 754 (986)
Q Consensus 685 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~ 754 (986)
...++|++.+.||+|+||.||+|.+..+++.||||+++... ....+.+.+|+++++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34678999999999999999999999999999999997543 122456889999999995 99999999994
Q ss_pred cccccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCe
Q 046598 755 SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNI 834 (986)
Q Consensus 755 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NI 834 (986)
..+...++||||+++++|.+++.. ...+++.++..++.||+.||+|||+. +|+||||||+||
T Consensus 94 -----~~~~~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Ni 155 (298)
T 1phk_A 94 -----ETNTFFFLVFDLMKKGELFDYLTE----------KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENI 155 (298)
T ss_dssp -----ECSSEEEEEEECCTTCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred -----ccCCeEEEEEeccCCCcHHHHHhc----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceE
Confidence 556889999999999999999952 24689999999999999999999999 999999999999
Q ss_pred EecCCCcEEEcccccceecCCCCCcccccccccccccccccccc------CCCcCcccchhhHHHHHHHHHhCCCCCCcc
Q 046598 835 LLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGL------GSEVSISGDVYSYGILLLELITRKKPTDIM 908 (986)
Q Consensus 835 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlGvvl~elltg~~pf~~~ 908 (986)
+++.++.+||+|||.+........ .....+++.|+|||++. ...++.++||||||+++|+|++|+.||...
T Consensus 156 l~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 232 (298)
T 1phk_A 156 LLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 232 (298)
T ss_dssp EECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEcCCCcEEEecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc
Confidence 999999999999999987643322 23356899999999875 457889999999999999999999998632
Q ss_pred ccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 909 FEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.. ..... .+......... +.....+.++.+++.+||+.||++|||++|+
T Consensus 233 ~~-----~~~~~--------~~~~~~~~~~~----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 281 (298)
T 1phk_A 233 KQ-----MLMLR--------MIMSGNYQFGS----------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 281 (298)
T ss_dssp SH-----HHHHH--------HHHHTCCCCCT----------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred cH-----HHHHH--------HHhcCCcccCc----------------ccccccCHHHHHHHHHHccCCcccCCCHHHH
Confidence 11 11100 00000000000 0001234567899999999999999998763
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=344.90 Aligned_cols=267 Identities=23% Similarity=0.309 Sum_probs=181.8
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ....+++.+|++++++++||||+++++++ ..++.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 87 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF-----VVKDE 87 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEE-----ESSSC
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEE-----eecCC
Confidence 4578999999999999999999998888999999986432 23456788999999999999999999984 44567
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.++||||+++++|.+++...... .......+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl 162 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAK--GEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQI 162 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHT--TTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEE
T ss_pred cEEEehhccCCchHHHHHHHhhc--cccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEE
Confidence 99999999999999998632111 011235689999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCC---ccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHH
Q 046598 845 GDFGLARFLPLSSA---QTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLAR 920 (986)
Q Consensus 845 ~DFG~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~ 920 (986)
+|||.+........ ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .....
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~ 240 (303)
T 2vwi_A 163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV--LMLTL 240 (303)
T ss_dssp CCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--HHHHH
T ss_pred EeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH--HHHHh
Confidence 99999976543221 112234568999999999876 5689999999999999999999999974322111 00000
Q ss_pred hhCCCchh-HHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 921 TALPDHVM-DIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 921 ~~~~~~~~-~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
...+.... ...+... ....+.++.+++.+||+.||++|||++||
T Consensus 241 ~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~l 285 (303)
T 2vwi_A 241 QNDPPSLETGVQDKEM----------------------LKKYGKSFRKMISLCLQKDPEKRPTAAEL 285 (303)
T ss_dssp TSSCCCTTC-----CC----------------------CCCCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred ccCCCccccccccchh----------------------hhhhhHHHHHHHHHHccCChhhCcCHHHH
Confidence 00000000 0000000 00123457789999999999999998764
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=351.14 Aligned_cols=201 Identities=25% Similarity=0.321 Sum_probs=168.5
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc--CchhHHHHHHHHHHHhcCCCCcceeeeeecccccc-CCC
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY-QGN 762 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~ 762 (986)
..++|.+.+.||+|+||.||+|.+..+++.||||++... .....+++.+|+.+++.++||||+++++++..... ...
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 357899999999999999999999999999999999753 23335778899999999999999999999643211 112
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
...++||||+. ++|.+++. ..+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~------------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~ 183 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG------------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCEL 183 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCE
T ss_pred eeEEEEEcccc-ccHHHHhh------------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCE
Confidence 23499999996 68988873 2489999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
||+|||+++.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus 184 kL~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 244 (371)
T 4exu_A 184 KILDFGLARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 244 (371)
T ss_dssp EECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred EEEecCccccccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999986432 2234568999999999887 6899999999999999999999999974
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=353.43 Aligned_cols=200 Identities=26% Similarity=0.334 Sum_probs=171.6
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcC------CCCcceeeeeecccccc
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNI------RHRNLVKILTACSGVDY 759 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~ 759 (986)
...+|++.+.||+|+||+||+|.+..+++.||||+++.. ....+.+.+|+++++.+ +|+||+++++++
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~----- 168 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF----- 168 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE-----
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeec-----
Confidence 356899999999999999999999999999999999753 23346677888888776 577999999984
Q ss_pred CCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCC
Q 046598 760 QGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED 839 (986)
Q Consensus 760 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 839 (986)
......++||||+. ++|.+++.... ...+++..++.|+.||+.||+|||+. +|+||||||+|||++.+
T Consensus 169 ~~~~~~~lv~e~~~-~~L~~~l~~~~--------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~ 236 (429)
T 3kvw_A 169 TFRNHICMTFELLS-MNLYELIKKNK--------FQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQ 236 (429)
T ss_dssp EETTEEEEEECCCC-CBHHHHHHHTT--------TCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESST
T ss_pred ccCCeEEEEEeccC-CCHHHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccC
Confidence 44578999999995 69999986322 23589999999999999999999999 99999999999999999
Q ss_pred Cc--EEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCcc
Q 046598 840 MI--AHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIM 908 (986)
Q Consensus 840 ~~--~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~ 908 (986)
+. +||+|||+|+..... .....||+.|+|||++.+..++.++|||||||++|||++|++||...
T Consensus 237 ~~~~vkL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 237 GRSGIKVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp TSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCcceEEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 87 999999999764322 22356899999999999999999999999999999999999999743
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=347.58 Aligned_cols=255 Identities=22% Similarity=0.246 Sum_probs=184.5
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCC-CCcceeeeeeccccc---cCC
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVD---YQG 761 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~---~~~ 761 (986)
...+|++.+.||+|+||.||+|++..+++.||||++........+.+.+|+.+++++. ||||+++++++.... ...
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 4568999999999999999999999889999999997766666778999999999995 999999999863211 244
Q ss_pred CceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeecCCCCCeEecCC
Q 046598 762 NDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPP--IAHCDLKPSNILLDED 839 (986)
Q Consensus 762 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~ 839 (986)
....++||||+. |+|.+++... .....+++.+++.|+.||+.||+|||+. + |+||||||+||+++.+
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~-------~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~ 174 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKM-------ESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQ 174 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHH-------HTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTT
T ss_pred CceEEEEEEecC-CCHHHHHHHh-------hccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCC
Confidence 567899999995 7999988532 1234689999999999999999999998 8 9999999999999999
Q ss_pred CcEEEcccccceecCCCCCcc----------ccccccccccccccccc---cCCCcCcccchhhHHHHHHHHHhCCCCCC
Q 046598 840 MIAHIGDFGLARFLPLSSAQT----------SSIGAKGSIGYIAPEYG---LGSEVSISGDVYSYGILLLELITRKKPTD 906 (986)
Q Consensus 840 ~~~kL~DFG~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlGvvl~elltg~~pf~ 906 (986)
+.+||+|||+++......... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||.
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 254 (337)
T 3ll6_A 175 GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254 (337)
T ss_dssp SCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred CCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence 999999999998764332211 11234589999999998 56778999999999999999999999986
Q ss_pred ccccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 907 IMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..... .. ........+.+ ..+..+.+++.+||+.||++|||++||
T Consensus 255 ~~~~~-----~~------------~~~~~~~~~~~------------------~~~~~~~~li~~~l~~~p~~Rps~~e~ 299 (337)
T 3ll6_A 255 DGAKL-----RI------------VNGKYSIPPHD------------------TQYTVFHSLIRAMLQVNPEERLSIAEV 299 (337)
T ss_dssp ----------------------------CCCCTTC------------------CSSGGGHHHHHHHSCSSGGGSCCHHHH
T ss_pred chhHH-----Hh------------hcCcccCCccc------------------ccchHHHHHHHHHccCChhhCcCHHHH
Confidence 32111 00 01000000000 111235689999999999999998764
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=335.72 Aligned_cols=248 Identities=27% Similarity=0.446 Sum_probs=196.7
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
.++|++.+.||+|+||.||+|.+.. +..||||+++... ...+.+.+|++++++++||||+++++++. ++..+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~ 83 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIY 83 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSSCE
T ss_pred HHhhhheeeecCCCCeEEEEEEEcC-CcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc------CCCcE
Confidence 4679999999999999999999875 6789999987543 34578999999999999999999999852 34589
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+++++|.+++... ....+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|
T Consensus 84 ~v~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~D 152 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTP--------SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIAD 152 (279)
T ss_dssp EEEECCTTCBHHHHTTSH--------HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECC
T ss_pred EEEecCCCCCHHHHHhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECC
Confidence 999999999999999521 123589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCC
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALPD 925 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 925 (986)
||.++...... ........++..|+|||++.+..++.++||||||+++|||++ |+.||...... ....
T Consensus 153 fg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----~~~~----- 221 (279)
T 1qpc_A 153 FGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----EVIQ----- 221 (279)
T ss_dssp CTTCEECSSSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHHH-----
T ss_pred CcccccccCcc-cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH-----HHHH-----
Confidence 99998764332 222233456789999999988899999999999999999999 99998632211 1111
Q ss_pred chhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 926 HVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 926 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+........ ...++.++.+++.+|++.||++|||+++|
T Consensus 222 ----~~~~~~~~~~------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l 260 (279)
T 1qpc_A 222 ----NLERGYRMVR------------------PDNCPEELYQLMRLCWKERPEDRPTFDYL 260 (279)
T ss_dssp ----HHHTTCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ----HHhcccCCCC------------------cccccHHHHHHHHHHhccChhhCCCHHHH
Confidence 0000000000 01234567899999999999999998763
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=337.65 Aligned_cols=246 Identities=24% Similarity=0.376 Sum_probs=197.4
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeecccccc------
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY------ 759 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------ 759 (986)
..++|++.+.||+|+||.||+|++..+++.||+|+++... +.+.+|++++++++||||+++++++....+
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4567999999999999999999999889999999997543 456789999999999999999998643211
Q ss_pred -----CCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCe
Q 046598 760 -----QGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNI 834 (986)
Q Consensus 760 -----~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NI 834 (986)
......++||||+++++|.+++... ....+++..++.++.||+.||.|||+. +|+||||||+||
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Ni 153 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--------RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNI 153 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG--------GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc--------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHE
Confidence 2245689999999999999999632 134689999999999999999999999 999999999999
Q ss_pred EecCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCcccccccc
Q 046598 835 LLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMN 914 (986)
Q Consensus 835 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~ 914 (986)
+++.++.+||+|||+++....... .....|++.|+|||++.+..++.++||||||+++|||++|..||...
T Consensus 154 l~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~------ 224 (284)
T 2a19_B 154 FLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET------ 224 (284)
T ss_dssp EEEETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH------
T ss_pred EEcCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH------
Confidence 999999999999999987643322 23356899999999999999999999999999999999999886311
Q ss_pred HHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 915 LHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 915 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.... ..+.+..+.. ..+.++.+++.+||+.||++|||+.||
T Consensus 225 -~~~~--------~~~~~~~~~~----------------------~~~~~~~~li~~~l~~dp~~Rps~~e~ 265 (284)
T 2a19_B 225 -SKFF--------TDLRDGIISD----------------------IFDKKEKTLLQKLLSKKPEDRPNTSEI 265 (284)
T ss_dssp -HHHH--------HHHHTTCCCT----------------------TSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -HHHH--------HHhhcccccc----------------------cCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 0000 0010100000 122346789999999999999998764
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=345.53 Aligned_cols=290 Identities=19% Similarity=0.203 Sum_probs=192.7
Q ss_pred HHHHHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeecccccc-
Q 046598 681 QNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY- 759 (986)
Q Consensus 681 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~- 759 (986)
.+.....++|++.+.||+|+||.||+|++..+++.||||++.... .....+.+|++.++.++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 456677899999999999999999999999889999999986432 334567788888899999999999999754321
Q ss_pred -CCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHH--hcCCCCeEeecCCCCCeEe
Q 046598 760 -QGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLH--HDCQPPIAHCDLKPSNILL 836 (986)
Q Consensus 760 -~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--~~~~~~ivH~Dlkp~NIll 836 (986)
......++||||+++ +|.+.+.... .....+++..+..++.|++.||.||| +. +|+||||||+||++
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~------~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll 164 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYY------RRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLV 164 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHH------TTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHh------hcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEE
Confidence 223347899999976 5544443111 23456889999999999999999999 87 99999999999999
Q ss_pred cC-CCcEEEcccccceecCCCCCccccccccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCcccccccc
Q 046598 837 DE-DMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDIMFEGDMN 914 (986)
Q Consensus 837 ~~-~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~ 914 (986)
+. ++.+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..
T Consensus 165 ~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-~~ 240 (360)
T 3e3p_A 165 NEADGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA-GQ 240 (360)
T ss_dssp ETTTTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HH
T ss_pred eCCCCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH-HH
Confidence 97 89999999999987643322 2335689999999998765 4899999999999999999999999743221 11
Q ss_pred HHHHHHhhCCCchhHHhhhhcccCCc-chhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 915 LHNLARTALPDHVMDIVDSTLLNDGE-DLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 915 ~~~~~~~~~~~~~~~~~d~~l~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+....+... ....+.+...-..... +....................+.++.+++.+||+.||++|||++||
T Consensus 241 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~ 312 (360)
T 3e3p_A 241 LHEIVRVLG-CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEA 312 (360)
T ss_dssp HHHHHHHHC-CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHcC-CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHH
Confidence 122221111 1111111111000000 0000000000000001111245678899999999999999998764
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=355.08 Aligned_cols=257 Identities=11% Similarity=0.026 Sum_probs=177.3
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc---hhHHHHHHHHH---HHhcCCCCcceeeeeecc---cc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH---GAFKSFIAECN---TLKNIRHRNLVKILTACS---GV 757 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~h~niv~l~~~~~---~~ 757 (986)
..+|.+.+.||+|+||.||+|++..+++.||||+++.... ...+.+.+|+. +++. +||||++++..+. +.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence 3458999999999999999999998899999999986432 33456777854 5555 7999888653321 00
Q ss_pred -ccCC---------------CceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHH------HHHHHHHHHHHHH
Q 046598 758 -DYQG---------------NDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQR------LNISIDVACALNY 815 (986)
Q Consensus 758 -~~~~---------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~------~~i~~qi~~~L~~ 815 (986)
.... ....|+||||++ |+|.+++... ...+++..+ ..++.||+.||+|
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---------~~~~~~~~~~~~~vk~~i~~qi~~aL~~ 209 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---------DFVYVFRGDEGILALHILTAQLIRLAAN 209 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---------HHSCCCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---------ccccchhhhhhhhhHHHHHHHHHHHHHH
Confidence 0000 145899999998 8999999632 122344445 6788999999999
Q ss_pred HHhcCCCCeEeecCCCCCeEecCCCcEEEcccccceecCCCCCccccccccccccccccccccC--CCcCcccchhhHHH
Q 046598 816 LHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG--SEVSISGDVYSYGI 893 (986)
Q Consensus 816 LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGv 893 (986)
||++ +|+||||||+|||++.++.+||+|||+|+..... .....+|+.|+|||++.+ ..++.++|||||||
T Consensus 210 LH~~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~ 281 (371)
T 3q60_A 210 LQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGL 281 (371)
T ss_dssp HHHT---TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHH
T ss_pred HHHC---CCccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHH
Confidence 9999 9999999999999999999999999999875321 113456799999999987 68999999999999
Q ss_pred HHHHHHhCCCCCCccccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhccc
Q 046598 894 LLLELITRKKPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACS 973 (986)
Q Consensus 894 vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl 973 (986)
++|||++|+.||.......... +.... ......... ..+.....+..+.+++.+||
T Consensus 282 il~elltg~~Pf~~~~~~~~~~-------~~~~~---~~~~~~~~~--------------~~~~~~~~~~~~~~li~~~L 337 (371)
T 3q60_A 282 SIYRVWCLFLPFGLVTPGIKGS-------WKRPS---LRVPGTDSL--------------AFGSCTPLPDFVKTLIGRFL 337 (371)
T ss_dssp HHHHHHHSSCSTTBCCTTCTTC-------CCBCC---TTSCCCCSC--------------CCTTSSCCCHHHHHHHHHHT
T ss_pred HHHHHHhCCCCCCCcCcccccc-------hhhhh---hhhcccccc--------------chhhccCCCHHHHHHHHHHc
Confidence 9999999999997543221100 00000 000000000 00000123456789999999
Q ss_pred CCCCCCCCCCCCC
Q 046598 974 MESPEDRMSMTNV 986 (986)
Q Consensus 974 ~~dP~~RPt~~eV 986 (986)
+.||++|||++|+
T Consensus 338 ~~dP~~Rpt~~e~ 350 (371)
T 3q60_A 338 NFDRRRRLLPLEA 350 (371)
T ss_dssp CSSTTTCCCHHHH
T ss_pred CCChhhCCCHHHH
Confidence 9999999998763
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=337.15 Aligned_cols=244 Identities=27% Similarity=0.375 Sum_probs=187.7
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
.++|++.+.||+|+||.||+|.+. ++.||||+++... ..+.+.+|++++++++||||+++++++ ...++..+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~----~~~~~~~~ 91 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVI----VEEKGGLY 91 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEE----CCC--CCE
T ss_pred hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEE----EcCCCceE
Confidence 468999999999999999999886 6899999987532 457889999999999999999999985 23445789
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+++++|.+++... ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 92 lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~D 160 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRSR--------GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSD 160 (278)
T ss_dssp EEECCCTTEEHHHHHHHH--------HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECC
T ss_pred EEEecCCCCCHHHHHHhc--------ccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEee
Confidence 999999999999999521 122478999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCC
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALPD 925 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 925 (986)
||+++..... .....+++.|+|||++.+..++.++||||||+++|||+| |+.||...... ....
T Consensus 161 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-----~~~~----- 225 (278)
T 1byg_A 161 FGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----DVVP----- 225 (278)
T ss_dssp CCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-----GHHH-----
T ss_pred cccccccccc-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHH-----
Confidence 9999754322 122357889999999998899999999999999999998 99998643211 1111
Q ss_pred chhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 926 HVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 926 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+........ ...++.++.+++.+||+.||++|||++||
T Consensus 226 ----~~~~~~~~~~------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l 264 (278)
T 1byg_A 226 ----RVEKGYKMDA------------------PDGCPPAVYEVMKNCWHLDAAMRPSFLQL 264 (278)
T ss_dssp ----HHTTTCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ----HHhcCCCCCC------------------cccCCHHHHHHHHHHhcCChhhCCCHHHH
Confidence 0000000000 01234567899999999999999998764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=344.90 Aligned_cols=256 Identities=25% Similarity=0.395 Sum_probs=194.5
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEE--EEEEeecc-CchhHHHHHHHHHHHhcC-CCCcceeeeeeccccccCCCc
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTI--AVKVFNLL-HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~v--avK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 763 (986)
++|++.+.||+|+||.||+|++..++..+ |+|+++.. .....+.+.+|+++++++ +||||+++++++ ..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----~~~~ 99 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRG 99 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE-----EETT
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceee-----eeCC
Confidence 67999999999999999999998777755 99988642 234456789999999999 999999999994 4557
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCc------cccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEec
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDE------TDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLD 837 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 837 (986)
..++||||+++++|.+++........ .......+++.+++.++.||+.||+|||++ +|+||||||+||+++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG 176 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEc
Confidence 89999999999999999964321000 001234689999999999999999999999 999999999999999
Q ss_pred CCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHH
Q 046598 838 EDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLH 916 (986)
Q Consensus 838 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~ 916 (986)
.++.+||+|||+++.... ........+++.|+|||++.+..++.++|||||||++|||++ |+.||..... .
T Consensus 177 ~~~~~kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-----~ 248 (327)
T 1fvr_A 177 ENYVAKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----A 248 (327)
T ss_dssp GGGCEEECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----H
T ss_pred CCCeEEEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH-----H
Confidence 999999999999974321 112223457889999999988899999999999999999998 9999863211 1
Q ss_pred HHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 917 NLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 917 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..... +........ ...++.++.+++.+||+.||++|||++|+
T Consensus 249 ~~~~~---------~~~~~~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~el 291 (327)
T 1fvr_A 249 ELYEK---------LPQGYRLEK------------------PLNCDDEVYDLMRQCWREKPYERPSFAQI 291 (327)
T ss_dssp HHHHH---------GGGTCCCCC------------------CTTBCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHH---------hhcCCCCCC------------------CCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 11110 000000000 01223457899999999999999998763
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=349.01 Aligned_cols=247 Identities=23% Similarity=0.279 Sum_probs=192.0
Q ss_pred hcCCCCCcccccccceeEEEEEEC---CCCeEEEEEEeeccC----chhHHHHHHHHHHHhcC-CCCcceeeeeeccccc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILD---DGRTTIAVKVFNLLH----HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVD 758 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 758 (986)
.++|++.+.||+|+||.||+|++. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~---- 128 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF---- 128 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE----
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE----
Confidence 468999999999999999999984 468999999986422 23345677899999999 699999999984
Q ss_pred cCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecC
Q 046598 759 YQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDE 838 (986)
Q Consensus 759 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 838 (986)
..+...++||||+++++|.+++.. ...+++.+++.++.||+.||+|||+. +|+||||||+||+++.
T Consensus 129 -~~~~~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~ 194 (355)
T 1vzo_A 129 -QTETKLHLILDYINGGELFTHLSQ----------RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDS 194 (355)
T ss_dssp -EETTEEEEEECCCCSCBHHHHHHH----------HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT
T ss_pred -eeCceEEEEeecCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECC
Confidence 455789999999999999999952 23589999999999999999999999 9999999999999999
Q ss_pred CCcEEEcccccceecCCCCCccccccccccccccccccccC--CCcCcccchhhHHHHHHHHHhCCCCCCccccccccHH
Q 046598 839 DMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG--SEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLH 916 (986)
Q Consensus 839 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~ 916 (986)
++.+||+|||+++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ...
T Consensus 195 ~~~~kl~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~ 272 (355)
T 1vzo_A 195 NGHVVLTDFGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQA 272 (355)
T ss_dssp TSCEEESCSSEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-CHH
T ss_pred CCcEEEeeCCCCeecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc-hHH
Confidence 9999999999998654222 222334579999999999886 357899999999999999999999996432211 111
Q ss_pred HHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCC
Q 046598 917 NLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRM 981 (986)
Q Consensus 917 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 981 (986)
.... ......+. ...+.+..+.+++.+||+.||++||
T Consensus 273 ~~~~------------~~~~~~~~----------------~~~~~~~~~~~li~~~L~~dP~~R~ 309 (355)
T 1vzo_A 273 EISR------------RILKSEPP----------------YPQEMSALAKDLIQRLLMKDPKKRL 309 (355)
T ss_dssp HHHH------------HHHHCCCC----------------CCTTSCHHHHHHHHHHTCSSGGGST
T ss_pred HHHH------------HHhccCCC----------------CCcccCHHHHHHHHHHhhhCHHHhc
Confidence 1111 11101000 0012234577899999999999999
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=354.73 Aligned_cols=301 Identities=19% Similarity=0.182 Sum_probs=184.1
Q ss_pred CCCCEEEccCCCccccCCcchhccccCceeeceecccCCCCccchhcCccccceecccccccCccCccccCCCCCCeEEc
Q 046598 86 SFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISV 165 (986)
Q Consensus 86 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 165 (986)
+.++.|+|++|++++..|..|.++++|++|+|++|.+++..|..|.++++|++|+|++|++++..+..|.++++|++|+|
T Consensus 32 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 111 (477)
T 2id5_A 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDI 111 (477)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEEC
T ss_pred CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEEC
Confidence 45666666666666666666666666666666666666666666666666666666666666555555666666666666
Q ss_pred cCCcCCCCcccccCCCcCcceeeccCCcccCcCcchhhccCCCceeecccccccccCCccccCCCCccEEeccccccccc
Q 046598 166 NDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGA 245 (986)
Q Consensus 166 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~ 245 (986)
++|++++..|..|.++++|++|+|++|.+++..+..|..+++|++|+|++|++++..+..+.++++|+.|+++.|.+.+.
T Consensus 112 s~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~ 191 (477)
T 2id5_A 112 SENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAI 191 (477)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEE
T ss_pred CCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEe
Confidence 66666666666666666666666666666666666666666666666666666655455566666666666666666643
Q ss_pred cCCcccccccccceEEecCceecccCCccccCCCCCcEEecccccccCCCchhhhhhhHhhhhhccCCCCCCCCCCcccc
Q 046598 246 IPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFL 325 (986)
Q Consensus 246 ~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~l~~l~~L~~l~l~~n~l~~~~~~~l~~l 325 (986)
. ...+..+++|+.|++++|.+.+.+|.......+|+.|++++|+++.+++.
T Consensus 192 ~-~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~---------------------------- 242 (477)
T 2id5_A 192 R-DYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYL---------------------------- 242 (477)
T ss_dssp C-TTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHH----------------------------
T ss_pred C-hhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHH----------------------------
Confidence 3 33334566777777777666666666655556777777777766644321
Q ss_pred cccccccccceeeccccccccCCCcccccccccceEEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCC
Q 046598 326 CSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQ 405 (986)
Q Consensus 326 ~~l~~~~~L~~l~l~~n~~~~~~p~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 405 (986)
.+..+ ++|+.|+|++|.|++..+..|..+++|++|+|++|++++..|..|..++
T Consensus 243 -~~~~l-------------------------~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 296 (477)
T 2id5_A 243 -AVRHL-------------------------VYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLN 296 (477)
T ss_dssp -HHTTC-------------------------TTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCT
T ss_pred -HhcCc-------------------------cccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcc
Confidence 01111 3345555555555555555555555555555555555555555555555
Q ss_pred CCCEEEccCccceeecCcccccc-cccEEEecccccC
Q 046598 406 NLKDLRLQRNRFQGNIPPSIGNL-KLFILYLSYNFLQ 441 (986)
Q Consensus 406 ~L~~L~Ls~N~l~~~~~~~~~~~-~L~~L~L~~N~l~ 441 (986)
+|+.|+|++|+|++..+..|..+ +|++|+|++|.+.
T Consensus 297 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 333 (477)
T 2id5_A 297 YLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333 (477)
T ss_dssp TCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEE
T ss_pred cCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCcc
Confidence 55555555555555444444433 3555666666554
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=370.05 Aligned_cols=248 Identities=22% Similarity=0.366 Sum_probs=190.9
Q ss_pred CCCCCc-ccccccceeEEEEEEC--CCCeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 689 RFSSVN-QIGEGSFGSVFKGILD--DGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 689 ~y~~~~-~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
++.+.+ .||+|+||.||+|.+. .++..||||+++... ....+++.+|++++++++||||++++++|. . +.
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~-----~-~~ 409 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-----A-EA 409 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEE-----S-SS
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEec-----c-CC
Confidence 344444 7999999999999885 346779999997542 345678999999999999999999999963 2 45
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.++||||+++|+|.+++.. ....+++.++..|+.||+.||+|||++ +|+||||||+|||++.++.+||
T Consensus 410 ~~lv~E~~~~g~L~~~l~~---------~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL 477 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVG---------KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKI 477 (613)
T ss_dssp EEEEEECCTTCBHHHHHTT---------CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEE
T ss_pred eEEEEEeCCCCcHHHHHhh---------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEE
Confidence 8999999999999999952 234689999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCC-ccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhh
Q 046598 845 GDFGLARFLPLSSA-QTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 845 ~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~ 922 (986)
+|||+++....... ........+++.|+|||++.+..++.++|||||||++|||++ |+.||...... ....
T Consensus 478 ~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~----- 550 (613)
T 2ozo_A 478 SDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMA----- 550 (613)
T ss_dssp CCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--HHHH-----
T ss_pred eeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHH-----
Confidence 99999987643222 112223346789999999998999999999999999999998 99999743221 1111
Q ss_pred CCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 923 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+..... ...+..++.++.+++.+||+.||++|||+++|
T Consensus 551 -------~i~~~~~------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l 589 (613)
T 2ozo_A 551 -------FIEQGKR------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTV 589 (613)
T ss_dssp -------HHHTTCC------------------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHH
T ss_pred -------HHHcCCC------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 1110000 00011345678899999999999999998764
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=344.53 Aligned_cols=269 Identities=16% Similarity=0.239 Sum_probs=198.9
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchh-----------------HHHHHHHHHHHhcCCCCccee
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGA-----------------FKSFIAECNTLKNIRHRNLVK 749 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~ 749 (986)
.++|++.+.||+|+||.||+|.+ +++.||||++....... .+.+.+|++++++++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 46899999999999999999999 58999999997432111 178999999999999999999
Q ss_pred eeeeccccccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeec
Q 046598 750 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHH-DCQPPIAHCD 828 (986)
Q Consensus 750 l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~D 828 (986)
+++++ ...+..++||||+++++|.+++...... .......+++..++.++.|++.||+|||+ . ||+|||
T Consensus 108 ~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~~~~l--~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~d 177 (348)
T 2pml_X 108 CEGII-----TNYDEVYIIYEYMENDSILKFDEYFFVL--DKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRD 177 (348)
T ss_dssp CSEEE-----ESSSEEEEEEECCTTCBSSEESSSEESS--CSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCC
T ss_pred EEEEE-----eeCCeEEEEEeccCCCcHHHHHHHhhhh--hhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecC
Confidence 99994 4557899999999999999994321100 01124579999999999999999999999 8 999999
Q ss_pred CCCCCeEecCCCcEEEcccccceecCCCCCccccccccccccccccccccCC-CcCc-ccchhhHHHHHHHHHhCCCCCC
Q 046598 829 LKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS-EVSI-SGDVYSYGILLLELITRKKPTD 906 (986)
Q Consensus 829 lkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDvwSlGvvl~elltg~~pf~ 906 (986)
|||+||+++.++.+||+|||.+...... ......|+..|+|||++.+. .++. ++|||||||++|||++|+.||.
T Consensus 178 l~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 253 (348)
T 2pml_X 178 VKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253 (348)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999875332 23345689999999999887 6766 9999999999999999999997
Q ss_pred ccccccccHHHHHHhhC--CCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 046598 907 IMFEGDMNLHNLARTAL--PDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMT 984 (986)
Q Consensus 907 ~~~~~~~~~~~~~~~~~--~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 984 (986)
................. +........+. ............+.++.+++.+||+.||++|||++
T Consensus 254 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ 318 (348)
T 2pml_X 254 LKISLVELFNNIRTKNIEYPLDRNHFLYPL---------------TNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSE 318 (348)
T ss_dssp CSSCSHHHHHHHTSCCCCCCCSSSSSTTTT---------------CC--------CCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred CCCcHHHHHHHHhccCcCCccchhhhhccc---------------cccccccchhhcCHHHHHHHHHHccCChhhCCCHH
Confidence 43221111111111000 00000000000 00000011123455688999999999999999987
Q ss_pred CC
Q 046598 985 NV 986 (986)
Q Consensus 985 eV 986 (986)
|+
T Consensus 319 e~ 320 (348)
T 2pml_X 319 DA 320 (348)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=350.79 Aligned_cols=261 Identities=14% Similarity=0.153 Sum_probs=194.2
Q ss_pred hcCCCCCcccccccceeEEEEEECC--------CCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccc--
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDD--------GRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSG-- 756 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-- 756 (986)
.++|++.+.||+|+||.||+|++.. .++.||||++... +.+.+|++++++++||||+++++....
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3689999999999999999999987 3789999998743 467899999999999999984332110
Q ss_pred ---------cccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEee
Q 046598 757 ---------VDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHC 827 (986)
Q Consensus 757 ---------~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~ 827 (986)
.....+...++||||+ +++|.+++... ....+++.+++.|+.||+.||+|||++ +|+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--------~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~ 183 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--------PKHVLSERSVLQVACRLLDALEFLHEN---EYVHG 183 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--------GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCS
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--------CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCC
Confidence 0122367899999999 99999999632 135699999999999999999999999 99999
Q ss_pred cCCCCCeEecCCC--cEEEcccccceecCCCCCc-----cccccccccccccccccccCCCcCcccchhhHHHHHHHHHh
Q 046598 828 DLKPSNILLDEDM--IAHIGDFGLARFLPLSSAQ-----TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900 (986)
Q Consensus 828 Dlkp~NIll~~~~--~~kL~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt 900 (986)
||||+||+++.++ .+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 184 Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 263 (352)
T 2jii_A 184 NVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLY 263 (352)
T ss_dssp CCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHh
Confidence 9999999999998 9999999999866432211 11233479999999999999999999999999999999999
Q ss_pred CCCCCCccccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCC
Q 046598 901 RKKPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDR 980 (986)
Q Consensus 901 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R 980 (986)
|+.||................. . ..+....... ......+.++.+++.+||+.||++|
T Consensus 264 g~~pf~~~~~~~~~~~~~~~~~--------~-----~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~R 321 (352)
T 2jii_A 264 GFLPWTNCLPNTEDIMKQKQKF--------V-----DKPGPFVGPC---------GHWIRPSETLQKYLKVVMALTYEEK 321 (352)
T ss_dssp SCCTTGGGTTCHHHHHHHHHHH--------H-----HSCCCEECTT---------SCEECCCHHHHHHHHHHHTCCTTCC
T ss_pred CCCCcccCCcCHHHHHHHHHhc--------c-----CChhhhhhhc---------cccCCCcHHHHHHHHHHHhCChhhC
Confidence 9999974432211111111100 0 0000000000 0000123567899999999999999
Q ss_pred CCCCCC
Q 046598 981 MSMTNV 986 (986)
Q Consensus 981 Pt~~eV 986 (986)
||++||
T Consensus 322 ps~~~l 327 (352)
T 2jii_A 322 PPYAML 327 (352)
T ss_dssp CCHHHH
T ss_pred CCHHHH
Confidence 998764
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=350.50 Aligned_cols=282 Identities=21% Similarity=0.255 Sum_probs=202.3
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCC--------CCcceeeeeeccccc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIR--------HRNLVKILTACSGVD 758 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~~~~ 758 (986)
.++|++.++||+|+||+||+|++..+++.||||+++.. ....+.+.+|+++++.++ |+||+++++++...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~- 113 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS- 113 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE-
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec-
Confidence 47899999999999999999999999999999999743 334577889999999885 78899999986422
Q ss_pred cCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecC
Q 046598 759 YQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDE 838 (986)
Q Consensus 759 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 838 (986)
.......++||||+ ++++.+++... ....+++.+++.|+.||+.||+|||+++ ||+||||||+|||++.
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~--------~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~ 182 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKS--------NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSV 182 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHT--------TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECC
T ss_pred CCCCceEEEEEecc-CccHHHHHHhc--------ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEec
Confidence 22556899999999 66666666421 2246899999999999999999999852 8999999999999997
Q ss_pred CC-------------------------------------------------cEEEcccccceecCCCCCccccccccccc
Q 046598 839 DM-------------------------------------------------IAHIGDFGLARFLPLSSAQTSSIGAKGSI 869 (986)
Q Consensus 839 ~~-------------------------------------------------~~kL~DFG~a~~~~~~~~~~~~~~~~gt~ 869 (986)
++ .+||+|||.++..... .....||+
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~ 257 (397)
T 1wak_A 183 NEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTR 257 (397)
T ss_dssp CHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCG
T ss_pred cchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCC
Confidence 75 7999999999876422 23356899
Q ss_pred cccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccH----HHHHHhhCCCchhHHh-hhhcc-----cCC
Q 046598 870 GYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNL----HNLARTALPDHVMDIV-DSTLL-----NDG 939 (986)
Q Consensus 870 ~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~----~~~~~~~~~~~~~~~~-d~~l~-----~~~ 939 (986)
.|+|||++.+..++.++|||||||++|||++|+.||.......... ...............+ ..... ...
T Consensus 258 ~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 337 (397)
T 1wak_A 258 QYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKG 337 (397)
T ss_dssp GGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTS
T ss_pred cccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcc
Confidence 9999999999999999999999999999999999997543322111 0111111111000000 00000 000
Q ss_pred -----cchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 940 -----EDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 940 -----~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+..................+...++.+++.+||+.||++|||++||
T Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~ 389 (397)
T 1wak_A 338 DLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAEC 389 (397)
T ss_dssp SBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHH
T ss_pred ccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHH
Confidence 00000000000111112234567789999999999999999999764
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=353.72 Aligned_cols=279 Identities=20% Similarity=0.228 Sum_probs=195.0
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeecccccc-CCCceE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY-QGNDFK 765 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~~~ 765 (986)
..+|++.+.||+|+||.||+|++..+++.||||++.... +...+|++++++++||||++++++|..... .+....
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 447999999999999999999999889999999986432 223479999999999999999998754321 233456
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCC-CcEEE
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED-MIAHI 844 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kL 844 (986)
++||||+++ ++.+.+.... .....+++..++.++.||++||+|||++ +|+||||||+|||++.+ +.+||
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~------~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl 198 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYS------RAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKL 198 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHH------HTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEE
T ss_pred Eeehhcccc-cHHHHHHHHh------hccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEe
Confidence 799999975 6666654211 2235689999999999999999999999 99999999999999965 57899
Q ss_pred cccccceecCCCCCccccccccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhC
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTAL 923 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 923 (986)
+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+.......
T Consensus 199 ~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~-~~l~~i~~~l- 273 (420)
T 1j1b_A 199 CDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVL- 273 (420)
T ss_dssp CCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHH-
T ss_pred ccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHh-
Confidence 99999987643222 2335689999999998765 7999999999999999999999999743221 1122222111
Q ss_pred CCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 924 PDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 924 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.....+.+... .....+...... .............+.++.+++.+||+.||++|||+.|+
T Consensus 274 g~p~~~~~~~~-~~~~~~~~~p~~-~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~ 334 (420)
T 1j1b_A 274 GTPTREQIREM-NPNYTEFKFPQI-KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 334 (420)
T ss_dssp CSCCHHHHHHH-CSCCCCCCCCCC-CCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CCCCHHHHHhh-ChhhhhhccCcc-CCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHH
Confidence 11111111111 000000000000 00000000001234567899999999999999998753
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=367.17 Aligned_cols=249 Identities=29% Similarity=0.463 Sum_probs=197.7
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
..++|++.++||+|+||.||+|.+.. +..||||+++... ...+++.+|++++++++||||++++++|. + +..
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~-~~~ 336 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-----E-EPI 336 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S-SSC
T ss_pred chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEe-----e-ccc
Confidence 35678899999999999999999986 5779999997643 33578999999999999999999999853 2 568
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
++||||+++|+|.++++.. ....+++.+++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 337 ~lv~e~~~~gsL~~~l~~~--------~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~ 405 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGE--------TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVA 405 (535)
T ss_dssp EEEECCCTTEEHHHHHSHH--------HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEEC
T ss_pred eEeeehhcCCcHHHHHhhc--------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEc
Confidence 9999999999999999521 224589999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCC
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALP 924 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 924 (986)
|||+++..... .........++..|+|||++.+..++.++|||||||++|||++ |+.||...... ....
T Consensus 406 DFG~a~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~-----~~~~---- 475 (535)
T 2h8h_A 406 DFGLARLIEDN-EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVLD---- 475 (535)
T ss_dssp CTTSTTTCCCH-HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH-----HHHH----
T ss_pred ccccceecCCC-ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHH----
Confidence 99999865321 1122233456789999999998899999999999999999999 99998632211 1111
Q ss_pred CchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 925 DHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 925 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+...... +....++.++.+++.+||+.||++|||+++|
T Consensus 476 -----~i~~~~~~------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l 514 (535)
T 2h8h_A 476 -----QVERGYRM------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYL 514 (535)
T ss_dssp -----HHHTTCCC------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -----HHHcCCCC------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 11100000 0011344567899999999999999998764
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=337.01 Aligned_cols=198 Identities=25% Similarity=0.353 Sum_probs=170.2
Q ss_pred hcCCCCCcccccccceeEEEEEE-CCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCc------ceeeeeecccccc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGIL-DDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRN------LVKILTACSGVDY 759 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~ 759 (986)
.++|++.+.||+|+||.||+|.+ ..+++.||||+++.. ....+.+.+|+++++.++|++ ++++++++
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~----- 86 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF----- 86 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE-----
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc-----
Confidence 46899999999999999999998 557899999999753 234567889999999887654 89999984
Q ss_pred CCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecC-
Q 046598 760 QGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDE- 838 (986)
Q Consensus 760 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~- 838 (986)
...+..++||||+ +++|.+++.... ...+++.+++.++.||+.||+|||++ +|+||||||+||+++.
T Consensus 87 ~~~~~~~lv~e~~-~~~l~~~l~~~~--------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~ 154 (339)
T 1z57_A 87 EHHGHICIVFELL-GLSTYDFIKENG--------FLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQS 154 (339)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTT--------TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCC
T ss_pred ccCCcEEEEEcCC-CCCHHHHHHhcC--------CCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEecc
Confidence 4557899999999 899999996322 23588999999999999999999999 9999999999999987
Q ss_pred ------------------CCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh
Q 046598 839 ------------------DMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900 (986)
Q Consensus 839 ------------------~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt 900 (986)
++.+||+|||.++..... .....||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 229 (339)
T 1z57_A 155 DYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL 229 (339)
T ss_dssp CEEEEEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHH
T ss_pred ccccccCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHh
Confidence 668999999999864322 223568999999999999999999999999999999999
Q ss_pred CCCCCCc
Q 046598 901 RKKPTDI 907 (986)
Q Consensus 901 g~~pf~~ 907 (986)
|+.||..
T Consensus 230 g~~pf~~ 236 (339)
T 1z57_A 230 GFTVFPT 236 (339)
T ss_dssp SSCSCCC
T ss_pred CCCCCCC
Confidence 9999974
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=334.91 Aligned_cols=279 Identities=17% Similarity=0.221 Sum_probs=254.6
Q ss_pred hhccCcCCCHhHHHHHHHHHHhccCCCcCCCCCC----CCCCCCCcceeeEecC--------CCCeEEEEeccCCCCccc
Q 046598 10 VTASTVAGNETDRLALLELKSKITHDPLGVLASW----NESSHFCQWRGVTCSR--------RHQRVTILDLESLKLAGS 77 (986)
Q Consensus 10 ~~~~~~~~~~~~~~~ll~~k~~~~~~~~~~l~~w----~~~~~~c~w~gv~c~~--------~~~~v~~l~l~~~~l~~~ 77 (986)
+.+-..++..+|++||++||+++..||.+++++| ....++|.|.||.|+. ...+|+.|||++++++ .
T Consensus 17 ~~~~~~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~ 95 (328)
T 4fcg_A 17 LYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-Q 95 (328)
T ss_dssp CCCC--CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-S
T ss_pred eeeeccccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-h
Confidence 3344455678999999999999977998899999 4567899999999953 3468999999999999 8
Q ss_pred cCcCccCCCCCCEEEccCCCccccCCcchhccccCceeeceecccCCCCccchhcCccccceecccccccCccCccccC-
Q 046598 78 ISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSS- 156 (986)
Q Consensus 78 ~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~- 156 (986)
+|+.++.+++|++|+|++|.++ .+|..|+++++|++|+|++|+++ .+|..|+.+++|++|+|++|.+.+.+|..+..
T Consensus 96 lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~ 173 (328)
T 4fcg_A 96 FPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST 173 (328)
T ss_dssp CCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEE
T ss_pred cChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhc
Confidence 8999999999999999999999 89999999999999999999999 88999999999999999999999999988765
Q ss_pred --------CCCCCeEEccCCcCCCCcccccCCCcCcceeeccCCcccCcCcchhhccCCCceeecccccccccCCccccC
Q 046598 157 --------LSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFN 228 (986)
Q Consensus 157 --------l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~ 228 (986)
+++|++|+|++|+++ .+|..++++++|++|+|++|++++ +|..|+.+++|++|+|++|++.+.+|..+.+
T Consensus 174 ~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~ 251 (328)
T 4fcg_A 174 DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGG 251 (328)
T ss_dssp C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTC
T ss_pred cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcC
Confidence 999999999999999 889999999999999999999994 6778999999999999999999999999999
Q ss_pred CCCccEEeccccccccccCCcccccccccceEEecCceecccCCccccCCCCCcEEecccccccCC
Q 046598 229 ISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGA 294 (986)
Q Consensus 229 l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~ 294 (986)
+++|+.|++++|.+.+.+|..+. .+++|++|+|++|.+.+.+|..++++++|+.+++..|.+...
T Consensus 252 l~~L~~L~L~~n~~~~~~p~~~~-~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~~l 316 (328)
T 4fcg_A 252 RAPLKRLILKDCSNLLTLPLDIH-RLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQL 316 (328)
T ss_dssp CCCCCEEECTTCTTCCBCCTTGG-GCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSCC-
T ss_pred CCCCCEEECCCCCchhhcchhhh-cCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHHHH
Confidence 99999999999999999998764 799999999999999999999999999999999998877643
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=335.77 Aligned_cols=257 Identities=24% Similarity=0.309 Sum_probs=190.9
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccc-------
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD------- 758 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------- 758 (986)
..++|++.+.||+|+||.||+|++..+++.||||+++.. ....+.+.+|++++++++||||+++++++....
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 356799999999999999999999988999999999653 344578899999999999999999999864321
Q ss_pred -cCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEec
Q 046598 759 -YQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLD 837 (986)
Q Consensus 759 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 837 (986)
.......++||||+++++|.+++.. ....+++.+++.++.|++.||+|||++ +|+||||||+||+++
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~ 150 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHS---------ENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFID 150 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHH---------SCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhc---------cccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEc
Confidence 1335778999999999999999962 234578899999999999999999999 999999999999999
Q ss_pred CCCcEEEcccccceecCCCCC------------ccccccccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCC
Q 046598 838 EDMIAHIGDFGLARFLPLSSA------------QTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKP 904 (986)
Q Consensus 838 ~~~~~kL~DFG~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p 904 (986)
.++.+||+|||.++....... ........|++.|+|||++.+. .++.++|||||||++|||++ |
T Consensus 151 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p 227 (303)
T 1zy4_A 151 ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---P 227 (303)
T ss_dssp TTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---C
T ss_pred CCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---c
Confidence 999999999999986542210 1122345689999999998764 78999999999999999998 5
Q ss_pred CCccccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 046598 905 TDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMT 984 (986)
Q Consensus 905 f~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 984 (986)
|...... ...... +.......+.+ .....+..+.+++.+||+.||++|||++
T Consensus 228 ~~~~~~~----~~~~~~---------~~~~~~~~~~~---------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ 279 (303)
T 1zy4_A 228 FSTGMER----VNILKK---------LRSVSIEFPPD---------------FDDNKMKVEKKIIRLLIDHDPNKRPGAR 279 (303)
T ss_dssp CSSHHHH----HHHHHH---------HHSTTCCCCTT---------------CCTTTSHHHHHHHHHHTCSSGGGSCCHH
T ss_pred cCCchhH----HHHHHh---------ccccccccCcc---------------ccccchHHHHHHHHHHHhcCcccCcCHH
Confidence 4321110 011000 00000000000 0012234567899999999999999987
Q ss_pred CC
Q 046598 985 NV 986 (986)
Q Consensus 985 eV 986 (986)
|+
T Consensus 280 ~l 281 (303)
T 1zy4_A 280 TL 281 (303)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=344.83 Aligned_cols=200 Identities=26% Similarity=0.327 Sum_probs=167.6
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc--CchhHHHHHHHHHHHhcCCCCcceeeeeeccccc-cCCCc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-YQGND 763 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~ 763 (986)
.++|.+.+.||+|+||.||+|.+..+++.||||++... .....+++.+|+.+++.++||||+++++++.... .....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 46899999999999999999999999999999998643 2233567889999999999999999999864321 11123
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..++||||++ ++|.+++. ..+++.++..++.||+.||+|||++ ||+||||||+||+++.++.+|
T Consensus 103 ~~~lv~e~~~-~~l~~~~~------------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~k 166 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG------------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELK 166 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEE
T ss_pred eEEEEecccc-CCHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEE
Confidence 4699999996 68888773 2489999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
|+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus 167 l~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 226 (353)
T 3coi_A 167 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 226 (353)
T ss_dssp ECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBS
T ss_pred EeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999764321 234568999999999877 6789999999999999999999999974
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-37 Score=338.18 Aligned_cols=207 Identities=28% Similarity=0.435 Sum_probs=173.6
Q ss_pred hhcCCCCCcccccccceeEEEEEEC-CCCeEEEEEEeeccCc--hhHHHHHHHHHHHhcC---CCCcceeeeeecccccc
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILD-DGRTTIAVKVFNLLHH--GAFKSFIAECNTLKNI---RHRNLVKILTACSGVDY 759 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~ 759 (986)
+.++|++.+.||+|+||.||+|++. .+++.||+|+++.... .....+.+|+.+++.+ +||||++++++|.....
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4678999999999999999999995 6689999999864322 2234566777777666 89999999999753333
Q ss_pred CCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCC
Q 046598 760 QGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED 839 (986)
Q Consensus 760 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 839 (986)
......++||||++ |+|.+++.... ...+++.+++.++.||+.||+|||+. ||+||||||+||+++.+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~--------~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~ 156 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP--------EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSS 156 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC--------TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc--------cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCC
Confidence 45678999999997 69999996322 23589999999999999999999999 99999999999999999
Q ss_pred CcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 840 MIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 840 ~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
+.+||+|||.++.... ........|++.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 157 ~~~kl~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 221 (326)
T 1blx_A 157 GQIKLADFGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG 221 (326)
T ss_dssp CCEEECSCCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCEEEecCcccccccC---CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCC
Confidence 9999999999976532 2223345689999999999999999999999999999999999999974
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=338.82 Aligned_cols=258 Identities=22% Similarity=0.365 Sum_probs=192.0
Q ss_pred cChHHHHHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc--CchhHHHHHHHHHHHhcCC--CCcceeeeee
Q 046598 678 ISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIR--HRNLVKILTA 753 (986)
Q Consensus 678 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~ 753 (986)
+.++.+....++|++.+.||+|+||.||+|.+.. ++.||||++... .....+.+.+|++++++++ ||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 96 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 96 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence 3344444456789999999999999999999875 788999999643 3344578899999999997 5999999998
Q ss_pred ccccccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCC
Q 046598 754 CSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSN 833 (986)
Q Consensus 754 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~N 833 (986)
+ ..+...++||| +.+++|.+++.. ...+++.+++.++.|++.||+|||+. +|+||||||+|
T Consensus 97 ~-----~~~~~~~lv~e-~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~N 157 (313)
T 3cek_A 97 E-----ITDQYIYMVME-CGNIDLNSWLKK----------KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPAN 157 (313)
T ss_dssp E-----ECSSEEEEEEC-CCSEEHHHHHHH----------CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGG
T ss_pred e-----ecCCEEEEEEe-cCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCccc
Confidence 4 45578999999 558899999952 24688999999999999999999999 99999999999
Q ss_pred eEecCCCcEEEcccccceecCCCCCccccccccccccccccccccC-----------CCcCcccchhhHHHHHHHHHhCC
Q 046598 834 ILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-----------SEVSISGDVYSYGILLLELITRK 902 (986)
Q Consensus 834 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlGvvl~elltg~ 902 (986)
|++++ +.+||+|||+++...............|++.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 158 Il~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~ 236 (313)
T 3cek_A 158 FLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236 (313)
T ss_dssp EEEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSS
T ss_pred EEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCC
Confidence 99964 8999999999987644333333344568999999999875 47889999999999999999999
Q ss_pred CCCCccccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCC
Q 046598 903 KPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMS 982 (986)
Q Consensus 903 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt 982 (986)
.||.......... ...++......... ..+.++.+++.+||+.||++|||
T Consensus 237 ~pf~~~~~~~~~~------------~~~~~~~~~~~~~~------------------~~~~~l~~li~~~l~~dp~~Rps 286 (313)
T 3cek_A 237 TPFQQIINQISKL------------HAIIDPNHEIEFPD------------------IPEKDLQDVLKCCLKRDPKQRIS 286 (313)
T ss_dssp CTTTTCCSHHHHH------------HHHHCTTSCCCCCC------------------CSCHHHHHHHHHHTCSSTTTSCC
T ss_pred CchhhHHHHHHHH------------HHHHhcccccCCcc------------------cchHHHHHHHHHHccCCcccCcC
Confidence 9996432211111 11111111100000 11345778999999999999999
Q ss_pred CCCC
Q 046598 983 MTNV 986 (986)
Q Consensus 983 ~~eV 986 (986)
++||
T Consensus 287 ~~el 290 (313)
T 3cek_A 287 IPEL 290 (313)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8764
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=368.41 Aligned_cols=242 Identities=24% Similarity=0.370 Sum_probs=188.0
Q ss_pred cccccccceeEEEEEE--CCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEEE
Q 046598 694 NQIGEGSFGSVFKGIL--DDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVF 769 (986)
Q Consensus 694 ~~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 769 (986)
+.||+|+||.||+|.+ ...++.||||+++... ....+++.+|++++++++||||++++++|. .+..++||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~------~~~~~lv~ 448 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE------AESWMLVM 448 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE------SSSEEEEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe------cCCEEEEE
Confidence 4799999999999965 4456889999997532 234578999999999999999999999863 24578999
Q ss_pred EeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccccc
Q 046598 770 EFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGL 849 (986)
Q Consensus 770 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~ 849 (986)
||+++|+|.++++. ...+++.+++.|+.||+.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 449 E~~~~g~L~~~l~~----------~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGl 515 (635)
T 4fl3_A 449 EMAELGPLNKYLQQ----------NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGL 515 (635)
T ss_dssp ECCTTEEHHHHHHH----------CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTH
T ss_pred EccCCCCHHHHHhh----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCC
Confidence 99999999999952 24689999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCC-ccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCch
Q 046598 850 ARFLPLSSA-QTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALPDHV 927 (986)
Q Consensus 850 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 927 (986)
++.+..... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... ..
T Consensus 516 a~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-----~~--------- 581 (635)
T 4fl3_A 516 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-----EV--------- 581 (635)
T ss_dssp HHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HH---------
T ss_pred ccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----HH---------
Confidence 987643322 122333457889999999999999999999999999999998 99999643221 11
Q ss_pred hHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 928 MDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 928 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+.+....... .+..++.++.+++.+||+.||++|||+++|
T Consensus 582 ~~~i~~~~~~~------------------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l 622 (635)
T 4fl3_A 582 TAMLEKGERMG------------------CPAGCPREMYDLMNLCWTYDVENRPGFAAV 622 (635)
T ss_dssp HHHHHTTCCCC------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HHHHHcCCCCC------------------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 11111100000 001345668899999999999999998764
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=347.24 Aligned_cols=275 Identities=20% Similarity=0.241 Sum_probs=191.2
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeecccccc-CCCceE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY-QGNDFK 765 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~~~ 765 (986)
..+|++.+.||+|+||.||+|++..+++ ||+|++.... +...+|+++++.++||||+++++++..... .+....
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 4579999999999999999999987655 8888775322 122469999999999999999999754322 334458
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEec-CCCcEEE
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLD-EDMIAHI 844 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kL 844 (986)
++||||++++.+..... .. .....+++..++.++.||++||+|||+. +|+||||||+||+++ .++.+||
T Consensus 114 ~lv~e~~~~~l~~~~~~-~~------~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL 183 (394)
T 4e7w_A 114 NLVLEYVPETVYRASRH-YA------KLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKL 183 (394)
T ss_dssp EEEEECCSEEHHHHHHH-HH------HTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEE
T ss_pred EEEeeccCccHHHHHHH-HH------hhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEE
Confidence 89999997654433321 11 2234689999999999999999999999 999999999999999 7999999
Q ss_pred cccccceecCCCCCccccccccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhC
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTAL 923 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 923 (986)
+|||+|+....... .....+|+.|+|||++.+. .++.++||||+||++|||++|+.||......+ .+.......-
T Consensus 184 ~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~l~~i~~~~g 259 (394)
T 4e7w_A 184 IDFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID-QLVEIIKVLG 259 (394)
T ss_dssp CCCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHC
T ss_pred eeCCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhC
Confidence 99999987643322 2345689999999998765 58999999999999999999999997432211 1111111111
Q ss_pred CCchh--HHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCC
Q 046598 924 PDHVM--DIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTN 985 (986)
Q Consensus 924 ~~~~~--~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 985 (986)
..... ....+........ ..+............+.++.+++.+||+.||++|||+.|
T Consensus 260 ~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 318 (394)
T 4e7w_A 260 TPSREQIKTMNPNYMEHKFP-----QIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIE 318 (394)
T ss_dssp CCCHHHHHHHCGGGSSSCCC-----CCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred CCCHHHHHhhChhhhhhccc-----cccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHH
Confidence 11100 0011100000000 000000000001123456889999999999999999865
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-37 Score=331.37 Aligned_cols=251 Identities=24% Similarity=0.282 Sum_probs=197.4
Q ss_pred HhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 685 NATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 685 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
...++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++ ...
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 93 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDS 93 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECS
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEE-----eCC
Confidence 34678999999999999999999999889999999996532 33467889999999999999999999994 456
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCC---
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED--- 839 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--- 839 (986)
...++||||+++++|.+++.. ...+++.+++.++.||+.||+|||+. +|+||||||+||+++.+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~ 160 (287)
T 2wei_A 94 SSFYIVGELYTGGELFDEIIK----------RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKD 160 (287)
T ss_dssp SEEEEEECCCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTT
T ss_pred CeEEEEEEccCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCc
Confidence 789999999999999998842 23589999999999999999999999 99999999999999754
Q ss_pred CcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHH
Q 046598 840 MIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLA 919 (986)
Q Consensus 840 ~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~ 919 (986)
+.+||+|||+++....... .....+++.|+|||++.+ .++.++||||||+++|+|++|+.||...... ...
T Consensus 161 ~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~ 231 (287)
T 2wei_A 161 CDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-----DIL 231 (287)
T ss_dssp CCEEECSTTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHH
T ss_pred ccEEEeccCcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH-----HHH
Confidence 4799999999986543221 223458899999999876 4899999999999999999999998642211 111
Q ss_pred HhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 920 RTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 920 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
. .+......... +.....+.++.+++.+||+.||++|||++|+
T Consensus 232 ~--------~~~~~~~~~~~----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el 274 (287)
T 2wei_A 232 K--------RVETGKYAFDL----------------PQWRTISDDAKDLIRKMLTFHPSLRITATQC 274 (287)
T ss_dssp H--------HHHHCCCCCCS----------------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred H--------HHHcCCCCCCc----------------hhhhhcCHHHHHHHHHHcccChhhCcCHHHH
Confidence 0 00000000000 0001234457899999999999999998764
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=337.03 Aligned_cols=251 Identities=25% Similarity=0.363 Sum_probs=187.5
Q ss_pred hcCCCCCcccccccceeEEEEEECC-C--CeEEEEEEeecc---CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDD-G--RTTIAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ 760 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 760 (986)
.++|++.+.||+|+||+||+|++.. + +..||||+++.. .....+.+.+|++++++++||||+++++++.
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----- 91 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL----- 91 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEc-----
Confidence 4679999999999999999998643 2 236999998643 3345678999999999999999999999853
Q ss_pred CCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCC
Q 046598 761 GNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDM 840 (986)
Q Consensus 761 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 840 (986)
. ...++||||+++++|.+++.. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 92 ~-~~~~~v~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~ 158 (291)
T 1u46_A 92 T-PPMKMVTELAPLGSLLDRLRK---------HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRD 158 (291)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHH---------HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETT
T ss_pred c-CCceeeEecccCCCHHHHHHh---------ccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCC
Confidence 2 237899999999999999962 234689999999999999999999999 999999999999999999
Q ss_pred cEEEcccccceecCCCCCc-cccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHH
Q 046598 841 IAHIGDFGLARFLPLSSAQ-TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNL 918 (986)
Q Consensus 841 ~~kL~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~ 918 (986)
.+||+|||+++........ .......++..|+|||++.+..++.++||||||+++|+|++ |+.||..... ...
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~ 233 (291)
T 1u46_A 159 LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-----SQI 233 (291)
T ss_dssp EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHH
T ss_pred CEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH-----HHH
Confidence 9999999999877543322 12233457889999999998899999999999999999999 9999863321 111
Q ss_pred HHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 919 ARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 919 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.... ..... ..+ ....++.++.+++.+||+.||++|||++||
T Consensus 234 ~~~~--------~~~~~-~~~-----------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 275 (291)
T 1u46_A 234 LHKI--------DKEGE-RLP-----------------RPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 275 (291)
T ss_dssp HHHH--------HTSCC-CCC-----------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHH--------HccCC-CCC-----------------CCcCcCHHHHHHHHHHccCCcccCcCHHHH
Confidence 1100 00000 000 001234567899999999999999998764
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=349.35 Aligned_cols=212 Identities=22% Similarity=0.303 Sum_probs=157.3
Q ss_pred hcCCCC-CcccccccceeEEEEEEC--CCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 687 TDRFSS-VNQIGEGSFGSVFKGILD--DGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 687 ~~~y~~-~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
.+.|++ .++||+|+||+||+|++. .+++.||||+++... ....+.+|++++++++||||+++++++.. ..+.
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~ 93 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLS---HADR 93 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEE---TTTT
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEec---CCCC
Confidence 344666 458999999999999976 457889999986432 23578899999999999999999998532 3467
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEe----cCC
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILL----DED 839 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~ 839 (986)
..++||||++ ++|.+++....... .......+++..++.|+.||+.||+|||+. +|+||||||+||++ +.+
T Consensus 94 ~~~lv~e~~~-~~l~~~~~~~~~~~-~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~ 168 (405)
T 3rgf_A 94 KVWLLFDYAE-HDLWHIIKFHRASK-ANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPER 168 (405)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHHHC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTT
T ss_pred eEEEEEeCCC-CCHHHHHHHhcccc-ccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCC
Confidence 8999999995 58888875221110 011223589999999999999999999999 99999999999999 677
Q ss_pred CcEEEcccccceecCCCCC-ccccccccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCcc
Q 046598 840 MIAHIGDFGLARFLPLSSA-QTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDIM 908 (986)
Q Consensus 840 ~~~kL~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~ 908 (986)
+.+||+|||+|+....... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 169 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 169 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp TCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred CcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 8999999999987643211 1223446789999999998874 5899999999999999999999999643
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=337.13 Aligned_cols=256 Identities=19% Similarity=0.209 Sum_probs=172.4
Q ss_pred hhcCCCCCc-ccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 686 ATDRFSSVN-QIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 686 ~~~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
..++|.+.+ .||+|+||.||+|.+..+++.||||++.... ....+....++.++||||+++++++... ...+..
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~-~~~~~~ 100 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENM-HHGKRC 100 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhc-cCCCce
Confidence 467899865 5999999999999999889999999986421 2222233345667999999999986532 233566
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecC---CCc
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDE---DMI 841 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~ 841 (986)
.++||||+++|+|.+++.... ...+++.+++.++.||+.||+|||+. +|+||||||+||+++. ++.
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~--------~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~ 169 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERG--------DQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAV 169 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC---------CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCC
T ss_pred EEEEEeccCCCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCce
Confidence 899999999999999996322 24689999999999999999999999 9999999999999976 455
Q ss_pred EEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHh
Q 046598 842 AHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLART 921 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~ 921 (986)
+||+|||+++..... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||...........
T Consensus 170 ~kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----- 240 (336)
T 3fhr_A 170 LKLTDFGFAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG----- 240 (336)
T ss_dssp EEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------
T ss_pred EEEeccccceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh-----
Confidence 999999999865422 22335689999999999999999999999999999999999999964322111000
Q ss_pred hCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 922 ALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 922 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
....+.......+. +.....+.++.+++.+||+.||++|||++|+
T Consensus 241 -----~~~~~~~~~~~~~~---------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 285 (336)
T 3fhr_A 241 -----MKRRIRLGQYGFPN---------------PEWSEVSEDAKQLIRLLLKTDPTERLTITQF 285 (336)
T ss_dssp ---------------CCCT---------------TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred -----HHHhhhccccccCc---------------hhhccCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 00000000000000 0001234567899999999999999998764
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=356.00 Aligned_cols=277 Identities=22% Similarity=0.246 Sum_probs=198.8
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc-CchhHHHHHHHHHHHhcCCCCcceeeeeeccccc-cCCCce
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-YQGNDF 764 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~~ 764 (986)
.++|++.+.||+|+||.||+|.+..+++.||||+++.. .....+++.+|++++++++||||+++++++.... +..++.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 47899999999999999999999988999999998653 3344577999999999999999999999865421 234677
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCc---
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI--- 841 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--- 841 (986)
.++||||+++|+|.+++.... ....+++..++.|+.|++.||+|||+. ||+||||||+||+++.++.
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~-------~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~ 162 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFE-------NCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLI 162 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSS-------CTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCE
T ss_pred EEEEEEeCCCCCHHHHHHhcc-------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCcee
Confidence 899999999999999996432 123588889999999999999999999 9999999999999997764
Q ss_pred EEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHh
Q 046598 842 AHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLART 921 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~ 921 (986)
+||+|||.++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ...+...
T Consensus 163 vKL~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~----~~~~~~~ 235 (676)
T 3qa8_A 163 HKIIDLGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ----PVQWHGK 235 (676)
T ss_dssp EEECSCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH----HHHSSTT
T ss_pred EEEccccccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc----hhhhhhh
Confidence 9999999998764332 22345789999999999999999999999999999999999999963211 1111110
Q ss_pred hCCCchhH-HhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 922 ALPDHVMD-IVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 922 ~~~~~~~~-~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
........ ........... .......+ .......+..+.+++.+|+++||++|||++|+
T Consensus 236 i~~~~~~~~~~~~~l~g~~~---~~~~lp~p---~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 236 VREKSNEHIVVYDDLTGAVK---FSSVLPTP---NHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp CC------CCSCCCCSSSCC---CCSSSCCS---CCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhcccchhhhhhhhhccccc---cccccCCc---hhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 00000000 00000000000 00000000 00011245668899999999999999999874
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=340.52 Aligned_cols=204 Identities=27% Similarity=0.316 Sum_probs=170.6
Q ss_pred HHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCC-CC-----cceeeeeecccc
Q 046598 684 YNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIR-HR-----NLVKILTACSGV 757 (986)
Q Consensus 684 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~ 757 (986)
....++|++.+.||+|+||+||+|.+..+++.||||+++.. ....+++..|+++++.++ |+ +|+++++++
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~--- 125 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF--- 125 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE---
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee---
Confidence 34568999999999999999999999998999999999743 233466778888888774 44 489998884
Q ss_pred ccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEec
Q 046598 758 DYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLD 837 (986)
Q Consensus 758 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 837 (986)
..++..++||||++ ++|.+++.... ...+++..++.++.|++.||.|||++ ..+|+||||||+||+++
T Consensus 126 --~~~~~~~lv~e~~~-~~L~~~l~~~~--------~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~ 193 (382)
T 2vx3_A 126 --MFRNHLCLVFEMLS-YNLYDLLRNTN--------FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLC 193 (382)
T ss_dssp --EETTEEEEEEECCC-CBHHHHHHHTT--------TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEES
T ss_pred --ccCCceEEEEecCC-CCHHHHHhhcC--------cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEe
Confidence 44578999999995 59999996322 23589999999999999999999952 23999999999999995
Q ss_pred --CCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCcc
Q 046598 838 --EDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIM 908 (986)
Q Consensus 838 --~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~ 908 (986)
.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 194 ~~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 194 NPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp STTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCCCcEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 4778999999999876422 22356899999999999999999999999999999999999999743
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=336.92 Aligned_cols=241 Identities=20% Similarity=0.241 Sum_probs=194.8
Q ss_pred HhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCch------hHHHHHHHHHHHhcCC--CCcceeeeeeccc
Q 046598 685 NATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHG------AFKSFIAECNTLKNIR--HRNLVKILTACSG 756 (986)
Q Consensus 685 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~ 756 (986)
...++|++.+.||+|+||.||+|++..+++.||||+++..... ..+.+.+|+.++++++ ||||+++++++
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~-- 117 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF-- 117 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE--
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE--
Confidence 3567899999999999999999999988999999999753221 2245678999999995 59999999994
Q ss_pred cccCCCceEEEEEEeccC-CCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeE
Q 046598 757 VDYQGNDFKALVFEFMHN-RSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNIL 835 (986)
Q Consensus 757 ~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIl 835 (986)
..++..++||||+.+ ++|.+++.. ...+++..++.++.||+.||+|||+. +|+||||||+||+
T Consensus 118 ---~~~~~~~lv~e~~~~~~~L~~~l~~----------~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIl 181 (320)
T 3a99_A 118 ---ERPDSFVLILERPEPVQDLFDFITE----------RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENIL 181 (320)
T ss_dssp ---ECSSEEEEEEECCSSEEEHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEE
T ss_pred ---ecCCcEEEEEEcCCCCccHHHHHhc----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEE
Confidence 456789999999976 899999952 34689999999999999999999999 9999999999999
Q ss_pred ec-CCCcEEEcccccceecCCCCCccccccccccccccccccccCCCc-CcccchhhHHHHHHHHHhCCCCCCccccccc
Q 046598 836 LD-EDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEV-SISGDVYSYGILLLELITRKKPTDIMFEGDM 913 (986)
Q Consensus 836 l~-~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~pf~~~~~~~~ 913 (986)
++ .++.+||+|||+++..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||....
T Consensus 182 l~~~~~~~kL~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---- 253 (320)
T 3a99_A 182 IDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---- 253 (320)
T ss_dssp EETTTTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----
T ss_pred EeCCCCCEEEeeCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh----
Confidence 99 7889999999999876432 1223568999999999887665 788999999999999999999986311
Q ss_pred cHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 914 NLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
... ...... + ...+.++.+++.+||+.||++|||++||
T Consensus 254 ---~~~------------~~~~~~-~-------------------~~~~~~~~~li~~~l~~dp~~Rps~~~l 291 (320)
T 3a99_A 254 ---EII------------RGQVFF-R-------------------QRVSSECQHLIRWCLALRPSDRPTFEEI 291 (320)
T ss_dssp ---HHH------------HCCCCC-S-------------------SCCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ---hhh------------cccccc-c-------------------ccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 010 000000 0 0123457799999999999999998764
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=335.95 Aligned_cols=198 Identities=24% Similarity=0.359 Sum_probs=168.3
Q ss_pred hcCCCCCcccccccceeEEEEEECCCC-eEEEEEEeeccCchhHHHHHHHHHHHhcCCCCc------ceeeeeecccccc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGR-TTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRN------LVKILTACSGVDY 759 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~ 759 (986)
.++|++.+.||+|+||+||+|.+..++ +.||+|+++.. ....+.+.+|++++++++|++ ++.++++ +
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~-----~ 91 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDW-----F 91 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEE-----E
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeee-----e
Confidence 478999999999999999999997665 79999999743 234567888999999987665 8888887 4
Q ss_pred CCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEe---
Q 046598 760 QGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILL--- 836 (986)
Q Consensus 760 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll--- 836 (986)
...+..++||||+ ++++.+++... ....+++.+++.++.||+.||+|||+. +|+||||||+||++
T Consensus 92 ~~~~~~~lv~e~~-~~~l~~~l~~~--------~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~ 159 (355)
T 2eu9_A 92 NFHGHMCIAFELL-GKNTFEFLKEN--------NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNS 159 (355)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHT--------TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCC
T ss_pred eeCCeEEEEEecc-CCChHHHHHhc--------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecc
Confidence 4557899999999 66777777522 124689999999999999999999999 99999999999999
Q ss_pred ----------------cCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh
Q 046598 837 ----------------DEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT 900 (986)
Q Consensus 837 ----------------~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt 900 (986)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 234 (355)
T 2eu9_A 160 EFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234 (355)
T ss_dssp CEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHh
Confidence 56789999999999864322 223568999999999999999999999999999999999
Q ss_pred CCCCCCc
Q 046598 901 RKKPTDI 907 (986)
Q Consensus 901 g~~pf~~ 907 (986)
|+.||..
T Consensus 235 g~~pf~~ 241 (355)
T 2eu9_A 235 GFTLFQT 241 (355)
T ss_dssp SSCSCCC
T ss_pred CCCCCCC
Confidence 9999974
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=334.60 Aligned_cols=245 Identities=21% Similarity=0.274 Sum_probs=187.3
Q ss_pred HHHHHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc------hhHHHHHHHHHHHhcC----CCCcceee
Q 046598 681 QNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH------GAFKSFIAECNTLKNI----RHRNLVKI 750 (986)
Q Consensus 681 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~l 750 (986)
.+.....++|++.+.||+|+||.||+|++..+++.||||+++.... .....+.+|+.++.++ +||||+++
T Consensus 24 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~ 103 (312)
T 2iwi_A 24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL 103 (312)
T ss_dssp ---------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred cchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence 3445567889999999999999999999988899999999864322 1223456788888888 89999999
Q ss_pred eeeccccccCCCceEEEEEEe-ccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecC
Q 046598 751 LTACSGVDYQGNDFKALVFEF-MHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDL 829 (986)
Q Consensus 751 ~~~~~~~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dl 829 (986)
++++ ...+..++|||| +.+++|.+++.. ...+++.+++.++.||+.||+|||+. +|+||||
T Consensus 104 ~~~~-----~~~~~~~~v~e~~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl 165 (312)
T 2iwi_A 104 LDWF-----ETQEGFMLVLERPLPAQDLFDYITE----------KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDI 165 (312)
T ss_dssp EEEC----------CEEEEECCSSEEEHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCC
T ss_pred EEEE-----ecCCeEEEEEEecCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCC
Confidence 9994 455778999999 789999999952 23589999999999999999999999 9999999
Q ss_pred CCCCeEec-CCCcEEEcccccceecCCCCCccccccccccccccccccccCCCc-CcccchhhHHHHHHHHHhCCCCCCc
Q 046598 830 KPSNILLD-EDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEV-SISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 830 kp~NIll~-~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
||+||+++ .++.+||+|||+++...... .....|+..|+|||++.+..+ +.++|||||||++|||++|+.||..
T Consensus 166 kp~Nil~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 166 KDENILIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp SGGGEEEETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred ChhhEEEeCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 99999999 88999999999998764322 234568999999999877666 4589999999999999999999863
Q ss_pred cccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 908 MFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.. . ..+..... + ...+.++.+++.+||+.||++|||++||
T Consensus 242 ~~-------~------------~~~~~~~~-~-------------------~~~~~~~~~li~~~l~~~p~~Rps~~e~ 281 (312)
T 2iwi_A 242 DQ-------E------------ILEAELHF-P-------------------AHVSPDCCALIRRCLAPKPSSRPSLEEI 281 (312)
T ss_dssp HH-------H------------HHHTCCCC-C-------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred hH-------H------------HhhhccCC-c-------------------ccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 11 0 11100000 0 0123457789999999999999998764
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=324.49 Aligned_cols=256 Identities=30% Similarity=0.487 Sum_probs=240.6
Q ss_pred ccceEEEccCCcccc--cCCccccCCCCCCEEEccC-ccccCcCCCcccCCCCCCEEEccCccceeecCcccccc-cccE
Q 046598 357 TTLEVLLLDNNQIFG--NIPAAIGKFVNLQRLDMCS-NRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNL-KLFI 432 (986)
Q Consensus 357 ~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~-~L~~ 432 (986)
..++.|+|++|++++ .+|..|.++++|++|++++ |.+.+.+|..|..+++|++|+|++|++++.+|..+..+ +|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 468999999999998 8999999999999999995 99999999999999999999999999999999988766 5999
Q ss_pred EEecccccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCC-cceEEEccCCcccccCCcccccccccchhhccCc
Q 046598 433 LYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSS-SLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGN 511 (986)
Q Consensus 433 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 511 (986)
|+|++|.+++.+|..|..+++|++|++++|++++.+|.. ++.++ +|+.|++++|++++.+|..+..++ |+.|+|++|
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N 207 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDS-YGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRN 207 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGG-GGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSS
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHH-HhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCC
Confidence 999999999999999999999999999999999899988 44555 999999999999999999999997 999999999
Q ss_pred cccccCcccccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCccccccCC
Q 046598 512 KLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPT 591 (986)
Q Consensus 512 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~ 591 (986)
++++.+|..|..+++|++|+|++|++++.+|. +..+++|++|+|++|+|++.+|..+..+++|++|+|++|+++|.+|.
T Consensus 208 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~ 286 (313)
T 1ogq_A 208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286 (313)
T ss_dssp EEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC
T ss_pred cccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCC
Confidence 99999999999999999999999999977665 88999999999999999999999999999999999999999999999
Q ss_pred ccccccccceeeeCCcccccCCCC
Q 046598 592 QGVFKNASITSVFGNLKLCGGIPE 615 (986)
Q Consensus 592 ~~~~~~~~~~~~~~n~~lcg~~~~ 615 (986)
.+.+++++.+++.||+++||.|..
T Consensus 287 ~~~l~~L~~l~l~~N~~lc~~p~~ 310 (313)
T 1ogq_A 287 GGNLQRFDVSAYANNKCLCGSPLP 310 (313)
T ss_dssp STTGGGSCGGGTCSSSEEESTTSS
T ss_pred CccccccChHHhcCCCCccCCCCC
Confidence 988999999999999999997653
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=340.90 Aligned_cols=204 Identities=24% Similarity=0.332 Sum_probs=170.4
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCC-----------CCcceeeeeecc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIR-----------HRNLVKILTACS 755 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~ 755 (986)
.++|++.+.||+|+||+||+|++..+++.||||+++.. ....+.+.+|++++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 46899999999999999999999988999999998743 234567889999998886 899999999864
Q ss_pred ccccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeE
Q 046598 756 GVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNIL 835 (986)
Q Consensus 756 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIl 835 (986)
.. .......++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+++ +|+||||||+||+
T Consensus 97 ~~-~~~~~~~~lv~e~~-~~~L~~~~~~~~--------~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIl 164 (373)
T 1q8y_A 97 HK-GPNGVHVVMVFEVL-GENLLALIKKYE--------HRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVL 164 (373)
T ss_dssp EE-ETTEEEEEEEECCC-CEEHHHHHHHTT--------TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEE
T ss_pred cc-CCCCceEEEEEecC-CCCHHHHHHHhh--------ccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeE
Confidence 32 12334789999999 999999996322 235899999999999999999999942 8999999999999
Q ss_pred ec------CCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCcc
Q 046598 836 LD------EDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIM 908 (986)
Q Consensus 836 l~------~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~ 908 (986)
++ ..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 165 l~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 238 (373)
T 1q8y_A 165 MEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 238 (373)
T ss_dssp EEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 94 4458999999999876422 22346899999999999999999999999999999999999999743
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=334.98 Aligned_cols=257 Identities=23% Similarity=0.252 Sum_probs=174.7
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC-chhHHHHHHHHH-HHhcCCCCcceeeeeeccccccCCCce
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-HGAFKSFIAECN-TLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
.++|++.+.||+|+||.||+|.+..+++.||||+++... .....++..|+. +++.++||||+++++++ ..++.
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~-----~~~~~ 95 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGAL-----FREGD 95 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEE-----ECSSE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEE-----EeCCc
Confidence 468999999999999999999999889999999997543 233445666666 77788999999999994 44578
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.++||||+++ +|.+++..... .....+++..+..++.|++.||.|||+. .+|+||||||+||+++.++.+||
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl 167 (327)
T 3aln_A 96 CWICMELMST-SFDKFYKYVYS-----VLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKL 167 (327)
T ss_dssp EEEEECCCSE-EHHHHHHHHHH-----TTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEE
T ss_pred eEEEEeecCC-ChHHHHHHHHh-----hhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEE
Confidence 9999999975 88887742110 1235689999999999999999999984 28999999999999999999999
Q ss_pred cccccceecCCCCCccccccccccccccccccc----cCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHH
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYG----LGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLAR 920 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~ 920 (986)
+|||+++...... ......|++.|+|||++ .+..++.++|||||||++|+|++|+.||........ ...
T Consensus 168 ~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~ 240 (327)
T 3aln_A 168 CDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD----QLT 240 (327)
T ss_dssp CCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------C
T ss_pred ccCCCceeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH----HHH
Confidence 9999997654322 12234689999999998 456789999999999999999999999964221100 000
Q ss_pred hhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 921 TALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 921 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
......+..... ......+.++.+++.+||+.||++|||++||
T Consensus 241 ------------~~~~~~~~~~~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~el 283 (327)
T 3aln_A 241 ------------QVVKGDPPQLSN-----------SEEREFSPSFINFVNLCLTKDESKRPKYKEL 283 (327)
T ss_dssp ------------CCCCSCCCCCCC-----------CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ------------HHhcCCCCCCCC-----------cccccCCHHHHHHHHHHhhCChhhCcCHHHH
Confidence 000000000000 0000123457899999999999999998764
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=361.68 Aligned_cols=250 Identities=23% Similarity=0.364 Sum_probs=194.2
Q ss_pred hhcCCCCCcccccccceeEEEEEECCC---CeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCC
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDG---RTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 761 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 761 (986)
..++|++.+.||+|+||.||+|.+..+ +..||||+++... ....+.+.+|+.++++++||||+++++++.
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~------ 461 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------ 461 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC------
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe------
Confidence 457899999999999999999998643 5679999986533 334577999999999999999999999852
Q ss_pred CceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCc
Q 046598 762 NDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI 841 (986)
Q Consensus 762 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 841 (986)
++..++||||+++|+|.++++. ....+++..++.++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~---------~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~ 529 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQV---------RKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDC 529 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHH---------TTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTE
T ss_pred cCceEEEEEcCCCCcHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCC
Confidence 2458999999999999999962 234589999999999999999999999 9999999999999999999
Q ss_pred EEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHH
Q 046598 842 AHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLAR 920 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~ 920 (986)
+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||......+ ......
T Consensus 530 vkL~DFG~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~~~i~ 606 (656)
T 2j0j_A 530 VKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRIE 606 (656)
T ss_dssp EEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHH
T ss_pred EEEEecCCCeecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHH
Confidence 99999999987643322 22233457789999999998899999999999999999997 999986432111 000000
Q ss_pred hhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 921 TALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 921 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
....... +..++.++.+++.+||+.||++|||+.||
T Consensus 607 -----------~~~~~~~-------------------~~~~~~~l~~li~~~l~~dP~~RPs~~el 642 (656)
T 2j0j_A 607 -----------NGERLPM-------------------PPNCPPTLYSLMTKCWAYDPSRRPRFTEL 642 (656)
T ss_dssp -----------HTCCCCC-------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -----------cCCCCCC-------------------CccccHHHHHHHHHHcCCChhHCcCHHHH
Confidence 0000000 01234567899999999999999998764
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=331.20 Aligned_cols=250 Identities=22% Similarity=0.251 Sum_probs=175.8
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCch-h-HHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHG-A-FKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
.++|++.+.||+|+||.||+|.+..+++.||||++...... . .+.+.++..+++.++||||+++++++ ..++.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~-----~~~~~ 98 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTF-----ITNTD 98 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSSE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEE-----ecCCc
Confidence 56799999999999999999999988999999999754322 2 23344555678888999999999994 45578
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCCeEecCCCcEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHH-DCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
.++||||+ ++.+..+.. .....+++..++.++.|++.||+|||+ . +|+||||||+||+++.++.+|
T Consensus 99 ~~lv~e~~-~~~~~~l~~---------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~k 165 (318)
T 2dyl_A 99 VFIAMELM-GTCAEKLKK---------RMQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIK 165 (318)
T ss_dssp EEEEECCC-SEEHHHHHH---------HHTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEE
T ss_pred EEEEEecc-CCcHHHHHH---------HhccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEE
Confidence 99999999 556665553 123468999999999999999999998 6 899999999999999999999
Q ss_pred EcccccceecCCCCCcccccccccccccccccccc-----CCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHH
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGL-----GSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNL 918 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~ 918 (986)
|+|||+++...... ......+++.|+|||++. +..++.++|||||||++|||++|+.||.............
T Consensus 166 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 242 (318)
T 2dyl_A 166 LCDFGISGRLVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV 242 (318)
T ss_dssp ECCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred EEECCCchhccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHH
Confidence 99999997654322 223356899999999984 4578899999999999999999999996322111111111
Q ss_pred HHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 919 ARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 919 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.... +. ..+. ....+.++.+++.+||+.||++|||++||
T Consensus 243 ~~~~-~~-----------~~~~-----------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l 281 (318)
T 2dyl_A 243 LQEE-PP-----------LLPG-----------------HMGFSGDFQSFVKDCLTKDHRKRPKYNKL 281 (318)
T ss_dssp HHSC-CC-----------CCCS-----------------SSCCCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred hccC-CC-----------CCCc-----------------cCCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 1100 00 0000 00123457799999999999999998764
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=332.65 Aligned_cols=250 Identities=23% Similarity=0.326 Sum_probs=188.4
Q ss_pred HhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 685 NATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 685 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
...++|++.+.||+|+||.||+|.+.. .||+|+++... ....+.+.+|+.++++++||||+++++++ ...
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~ 101 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC-----MSP 101 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEE-----ECS
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEE-----ecC
Confidence 346789999999999999999999865 48999986432 23345678899999999999999999995 445
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
...++||||+++++|.+++.. ....+++.+++.++.||+.||+|||+. +|+||||||+||+++ ++.+
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~ 168 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRD---------AKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKV 168 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTS---------SCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CC
T ss_pred CceEEEeecccCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCE
Confidence 679999999999999999962 234688999999999999999999999 999999999999998 6799
Q ss_pred EEcccccceecCCCC---CccccccccccccccccccccC---------CCcCcccchhhHHHHHHHHHhCCCCCCcccc
Q 046598 843 HIGDFGLARFLPLSS---AQTSSIGAKGSIGYIAPEYGLG---------SEVSISGDVYSYGILLLELITRKKPTDIMFE 910 (986)
Q Consensus 843 kL~DFG~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDvwSlGvvl~elltg~~pf~~~~~ 910 (986)
||+|||+++...... .........|++.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 169 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 248 (319)
T 2y4i_B 169 VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA 248 (319)
T ss_dssp EECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH
T ss_pred EEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999987543211 1122233458999999999864 4578999999999999999999999963221
Q ss_pred ccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 911 GDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.. ........... .... ...+.++.+++.+||+.||++|||++||
T Consensus 249 ~~--~~~~~~~~~~~--------~~~~---------------------~~~~~~l~~li~~~l~~~p~~Rpt~~~l 293 (319)
T 2y4i_B 249 EA--IIWQMGTGMKP--------NLSQ---------------------IGMGKEISDILLFCWAFEQEERPTFTKL 293 (319)
T ss_dssp HH--HHHHHHTTCCC--------CCCC---------------------SSCCTTHHHHHHHHHCSSTTTSCCHHHH
T ss_pred HH--HHHHhccCCCC--------CCCc---------------------CCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 10 00000000000 0000 0122346789999999999999998764
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=337.88 Aligned_cols=255 Identities=21% Similarity=0.256 Sum_probs=180.3
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcC-CCCcceeeeeeccccccCCCceEE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
+.|.+.+.||+|+||+||.+... +++.||||++... ..+.+.+|+++++++ +||||++++++ +..+...+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~-~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~-----~~~~~~~~ 85 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSF-QGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCS-----ETTDRFLY 85 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEES-SSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEE-----EECSSEEE
T ss_pred heeeccCeEeeCCCeEEEEEEEE-CCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEE-----EecCCeEE
Confidence 34556788999999999876544 4899999998653 235678899999876 89999999998 45668899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCC-------
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED------- 839 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~------- 839 (986)
+||||++ |+|.+++....... ......++.+++.++.||+.||+|||+. +|+||||||+||+++.+
T Consensus 86 lv~E~~~-gsL~~~l~~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~ 158 (434)
T 2rio_A 86 IALELCN-LNLQDLVESKNVSD---ENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQ 158 (434)
T ss_dssp EEECCCS-EEHHHHHHTC---------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCC
T ss_pred EEEecCC-CCHHHHHhccCCCc---hhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCccccccc
Confidence 9999995 69999997433211 1111123445678999999999999999 99999999999999754
Q ss_pred ------CcEEEcccccceecCCCCCc--cccccccccccccccccccC-------CCcCcccchhhHHHHHHHHHh-CCC
Q 046598 840 ------MIAHIGDFGLARFLPLSSAQ--TSSIGAKGSIGYIAPEYGLG-------SEVSISGDVYSYGILLLELIT-RKK 903 (986)
Q Consensus 840 ------~~~kL~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvvl~ellt-g~~ 903 (986)
+.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||+| |+.
T Consensus 159 ~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~ 238 (434)
T 2rio_A 159 QTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238 (434)
T ss_dssp TTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCC
T ss_pred ccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCC
Confidence 48999999999876543221 12234579999999999876 678999999999999999999 999
Q ss_pred CCCccccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 046598 904 PTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSM 983 (986)
Q Consensus 904 pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 983 (986)
||....... ....... ....... .......+.++.+++.+||+.||++|||+
T Consensus 239 Pf~~~~~~~---~~i~~~~------------~~~~~~~-------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~ 290 (434)
T 2rio_A 239 PFGDKYSRE---SNIIRGI------------FSLDEMK-------------CLHDRSLIAEATDLISQMIDHDPLKRPTA 290 (434)
T ss_dssp TTCSTTTHH---HHHHHTC------------CCCCCCT-------------TCCCHHHHHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCchhhH---HHHhcCC------------CCccccc-------------ccccccchHHHHHHHHHHhhCChhhCCCH
Confidence 986322111 1111110 0000000 00012345678899999999999999998
Q ss_pred CCC
Q 046598 984 TNV 986 (986)
Q Consensus 984 ~eV 986 (986)
+||
T Consensus 291 ~ei 293 (434)
T 2rio_A 291 MKV 293 (434)
T ss_dssp HHH
T ss_pred HHH
Confidence 764
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-35 Score=335.52 Aligned_cols=248 Identities=21% Similarity=0.272 Sum_probs=177.7
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcC-CCCcceeeeeeccccccCCCceE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
..+|.+.+.||+|+||+||.... .+++.||||++..... ..+.+|+++++++ +||||++++++ +.++...
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~-~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~-----~~~~~~~ 93 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGM-FDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCT-----EKDRQFQ 93 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEE-SSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEE-----EEETTEE
T ss_pred cEEEecCCeeecCcCEEEEEEEE-eCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEE-----EecCCEE
Confidence 34688899999999999764333 3478999999865332 3356899999999 89999999998 4456789
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecC-----CC
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDE-----DM 840 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~~ 840 (986)
|+||||++ |+|.+++.... ...+..++..++.||+.||+|||+. +|+||||||+||+++. ..
T Consensus 94 ~lv~E~~~-g~L~~~l~~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~ 160 (432)
T 3p23_A 94 YIAIELCA-ATLQEYVEQKD---------FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKI 160 (432)
T ss_dssp EEEEECCS-EEHHHHHHSSS---------CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBC
T ss_pred EEEEECCC-CCHHHHHHhcC---------CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCce
Confidence 99999995 69999996332 2234445678999999999999999 9999999999999953 23
Q ss_pred cEEEcccccceecCCCCC-cccccccccccccccccccc---CCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccH
Q 046598 841 IAHIGDFGLARFLPLSSA-QTSSIGAKGSIGYIAPEYGL---GSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNL 915 (986)
Q Consensus 841 ~~kL~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~ 915 (986)
.+||+|||+|+....... ........||+.|+|||++. ...++.++|||||||++|||++ |..||...... .
T Consensus 161 ~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~---~ 237 (432)
T 3p23_A 161 KAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR---Q 237 (432)
T ss_dssp CEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH---H
T ss_pred eEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH---H
Confidence 688999999987643321 12334467999999999987 4567889999999999999999 99998532111 0
Q ss_pred HHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 916 HNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 916 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.... .... ..... .........+.+++.+||+.||++|||++||
T Consensus 238 ~~~~---~~~~---------~~~~~---------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ev 281 (432)
T 3p23_A 238 ANIL---LGAC---------SLDCL---------------HPEKHEDVIARELIEKMIAMDPQKRPSAKHV 281 (432)
T ss_dssp HHHH---TTCC---------CCTTS---------------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHH---hccC---------Ccccc---------------CccccccHHHHHHHHHHHhCCHhhCCCHHHH
Confidence 0000 0000 00000 0001233446789999999999999998764
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-34 Score=323.20 Aligned_cols=200 Identities=21% Similarity=0.216 Sum_probs=162.5
Q ss_pred cCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCcccccccccEEEecccccCCCCCcccCCC
Q 046598 372 NIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRY 451 (986)
Q Consensus 372 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l 451 (986)
..+..|..+++|++|++++|.+++. .+..+++|+.|++++|.+++. ...
T Consensus 156 ~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~~----------------------------~~~ 204 (390)
T 3o6n_A 156 IEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLSTL----------------------------AIP 204 (390)
T ss_dssp CCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSEE----------------------------ECC
T ss_pred cChhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccccc----------------------------CCC
Confidence 3344555666777777777777643 255566777777777766521 122
Q ss_pred CCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccCcccccCCccccEEe
Q 046598 452 ETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLE 531 (986)
Q Consensus 452 ~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 531 (986)
++|+.|++++|+++ .+|.. ..++|+.|++++|++++. ..+..+++|++|+|++|++++..|..|..+++|++|+
T Consensus 205 ~~L~~L~l~~n~l~-~~~~~---~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 278 (390)
T 3o6n_A 205 IAVEELDASHNSIN-VVRGP---VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLY 278 (390)
T ss_dssp SSCSEEECCSSCCC-EEECC---CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEE
T ss_pred CcceEEECCCCeee-ecccc---ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEE
Confidence 47888999999987 55554 347899999999999953 5789999999999999999988899999999999999
Q ss_pred cccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCccccccCCccccccccceeeeCCccccc
Q 046598 532 MQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQGVFKNASITSVFGNLKLCG 611 (986)
Q Consensus 532 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lcg 611 (986)
|++|++++ +|..+..+++|+.|+|++|+++ .+|..+..+++|++|+|++|+++... ...++.++.+++.+|++-|.
T Consensus 279 L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~~--~~~~~~L~~L~l~~N~~~~~ 354 (390)
T 3o6n_A 279 ISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK--LSTHHTLKNLTLSHNDWDCN 354 (390)
T ss_dssp CCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC--CCTTCCCSEEECCSSCEEHH
T ss_pred CCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccceeC--chhhccCCEEEcCCCCccch
Confidence 99999995 6777889999999999999999 57888999999999999999999875 34588899999999999886
Q ss_pred C
Q 046598 612 G 612 (986)
Q Consensus 612 ~ 612 (986)
+
T Consensus 355 ~ 355 (390)
T 3o6n_A 355 S 355 (390)
T ss_dssp H
T ss_pred h
Confidence 4
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-35 Score=354.06 Aligned_cols=236 Identities=20% Similarity=0.294 Sum_probs=187.5
Q ss_pred hcCCCCCcccccccceeEEEEEECC-CCeEEEEEEeecc-CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDD-GRTTIAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
.++|++.+.||+|+||.||+|.+.. +++.||||++... .....+.+.+|++++++++||||++++++|..........
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 4789999999999999999999975 6899999998643 2344567899999999999999999999975432222233
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.|+||||+++++|.+++. ..+++.+++.|+.||+.||.|||++ ||+||||||+||+++.+ .+||
T Consensus 159 ~~lv~E~~~g~~L~~~~~------------~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl 222 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKG------------QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKL 222 (681)
T ss_dssp EEEEEECCCCEECC----------------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEE
T ss_pred eEEEEEeCCCCcHHHHHh------------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEE
Confidence 799999999999998774 2589999999999999999999999 99999999999999985 8999
Q ss_pred cccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCC
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALP 924 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 924 (986)
+|||+++..... ....||+.|+|||++.+.. +.++|||||||++|+|++|.+||........ +
T Consensus 223 ~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------~ 285 (681)
T 2pzi_A 223 IDLGAVSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------P 285 (681)
T ss_dssp CCCTTCEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------C
T ss_pred EecccchhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc----------c
Confidence 999999876432 3356999999999987654 8999999999999999999988763211100 0
Q ss_pred CchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 046598 925 DHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMT 984 (986)
Q Consensus 925 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 984 (986)
.. .........+.+++.+||+.||++||+..
T Consensus 286 ~~-----------------------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~ 316 (681)
T 2pzi_A 286 ED-----------------------------DPVLKTYDSYGRLLRRAIDPDPRQRFTTA 316 (681)
T ss_dssp TT-----------------------------CHHHHHCHHHHHHHHHHTCSSGGGSCSSH
T ss_pred cc-----------------------------ccccccCHHHHHHHhhhccCChhhCCCHH
Confidence 00 00112334577899999999999999764
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=334.12 Aligned_cols=249 Identities=15% Similarity=0.127 Sum_probs=181.9
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc---hhHHHHHHHHHHHhcCCC-Ccceeeeee---------
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH---GAFKSFIAECNTLKNIRH-RNLVKILTA--------- 753 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~niv~l~~~--------- 753 (986)
+..|...+.||+|+||+||+|++..+++.||||+++.... ...+.+.+|+.+++.++| ++......+
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 3457788999999999999999998899999999873222 235789999999999977 322111111
Q ss_pred c------------cccccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCC
Q 046598 754 C------------SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQ 821 (986)
Q Consensus 754 ~------------~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ 821 (986)
+ ...........+++|+++ +++|.++++..... ......+++..++.|+.||++||+|||++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~---~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-- 230 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSH---SSTHKSLVHHARLQLTLQVIRLLASLHHY-- 230 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHH---TTTSHHHHHHHHHHHHHHHHHHHHHHHHT--
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcc---cccCCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 0 000000123467788866 78999998422110 12245688999999999999999999999
Q ss_pred CCeEeecCCCCCeEecCCCcEEEcccccceecCCCCCccccccccccccccccccc----------cCCCcCcccchhhH
Q 046598 822 PPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYG----------LGSEVSISGDVYSY 891 (986)
Q Consensus 822 ~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDvwSl 891 (986)
+|+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||
T Consensus 231 -~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSl 303 (413)
T 3dzo_A 231 -GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL 303 (413)
T ss_dssp -TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHH
T ss_pred -CcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHH
Confidence 9999999999999999999999999999864321 334567 999999998 66678999999999
Q ss_pred HHHHHHHHhCCCCCCccccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhc
Q 046598 892 GILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVA 971 (986)
Q Consensus 892 Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 971 (986)
||++|||++|+.||........ .+..+.... ..+.++.+++.+
T Consensus 304 Gvil~elltg~~Pf~~~~~~~~-----------------~~~~~~~~~--------------------~~~~~~~~li~~ 346 (413)
T 3dzo_A 304 GLAIYWIWCADLPNTDDAALGG-----------------SEWIFRSCK--------------------NIPQPVRALLEG 346 (413)
T ss_dssp HHHHHHHHHSSCCCCTTGGGSC-----------------SGGGGSSCC--------------------CCCHHHHHHHHH
T ss_pred HHHHHHHHHCCCCCCCcchhhh-----------------HHHHHhhcc--------------------cCCHHHHHHHHH
Confidence 9999999999999964321110 000000000 123457899999
Q ss_pred ccCCCCCCCCCCCC
Q 046598 972 CSMESPEDRMSMTN 985 (986)
Q Consensus 972 Cl~~dP~~RPt~~e 985 (986)
||+.||++|||+.|
T Consensus 347 ~l~~dP~~Rpt~~~ 360 (413)
T 3dzo_A 347 FLRYPKEDRLLPLQ 360 (413)
T ss_dssp HTCSSGGGSCCHHH
T ss_pred HccCChhhCcCHHH
Confidence 99999999999765
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-33 Score=310.74 Aligned_cols=174 Identities=25% Similarity=0.396 Sum_probs=116.2
Q ss_pred ccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCcccccccccEEEecccccCCCCCcccCCCCCCCe
Q 046598 377 IGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTT 456 (986)
Q Consensus 377 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 456 (986)
+..+++|++|++++|.+++..+ +..+++|+.|++++|.+.+..+ +..+++|++
T Consensus 173 ~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~-------------------------~~~~~~L~~ 225 (347)
T 4fmz_A 173 IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP-------------------------VANMTRLNS 225 (347)
T ss_dssp GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG-------------------------GGGCTTCCE
T ss_pred hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch-------------------------hhcCCcCCE
Confidence 5667788888888888874433 7777777777777777663322 445566666
Q ss_pred eecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccCcccccCCccccEEeccccc
Q 046598 457 IDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENF 536 (986)
Q Consensus 457 L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 536 (986)
|++++|+++ .++. +..+++|++|++++|++++ + ..+..+++|++|++++|++++. ..+..+++|++|++++|+
T Consensus 226 L~l~~n~l~-~~~~--~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~ 298 (347)
T 4fmz_A 226 LKIGNNKIT-DLSP--LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQ 298 (347)
T ss_dssp EECCSSCCC-CCGG--GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSC
T ss_pred EEccCCccC-CCcc--hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCc
Confidence 666666665 3333 4556666666666666664 2 3466666777777777777643 346677777777777777
Q ss_pred ccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCccc
Q 046598 537 LQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLE 586 (986)
Q Consensus 537 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~ 586 (986)
+++..|..+..+++|+.|+|++|++++..| +..+++|++|++++|+++
T Consensus 299 l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 299 LGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp CCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred CCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 776667777777777777777777776555 667777777777777765
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=338.26 Aligned_cols=200 Identities=21% Similarity=0.209 Sum_probs=162.6
Q ss_pred cCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCcccccccccEEEecccccCCCCCcccCCC
Q 046598 372 NIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRY 451 (986)
Q Consensus 372 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l 451 (986)
..|..|..+++|++|+|++|.+++. .+..+++|+.|++++|.+++. ...
T Consensus 162 ~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~l~~L~~L~l~~n~l~~l----------------------------~~~ 210 (597)
T 3oja_B 162 IEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLSTL----------------------------AIP 210 (597)
T ss_dssp CCTTTTTTCTTCCEEECTTSCCSBC---CGGGCTTCSEEECCSSCCSEE----------------------------ECC
T ss_pred CChhhhhcCCcCcEEECcCCCCCCc---ChhhhhhhhhhhcccCccccc----------------------------cCC
Confidence 3444555666677777777777643 245566677777776666531 123
Q ss_pred CCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccCcccccCCccccEEe
Q 046598 452 ETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLE 531 (986)
Q Consensus 452 ~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 531 (986)
++|+.|++++|.++ .+|... .++|+.|+|++|.+++ +..+..+++|+.|+|++|.+++.+|..|+.+++|+.|+
T Consensus 211 ~~L~~L~ls~n~l~-~~~~~~---~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 284 (597)
T 3oja_B 211 IAVEELDASHNSIN-VVRGPV---NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLY 284 (597)
T ss_dssp TTCSEEECCSSCCC-EEECSC---CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEE
T ss_pred chhheeeccCCccc-cccccc---CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEE
Confidence 46888899999887 555442 3689999999999996 47899999999999999999999999999999999999
Q ss_pred cccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCccccccCCccccccccceeeeCCccccc
Q 046598 532 MQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQGVFKNASITSVFGNLKLCG 611 (986)
Q Consensus 532 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lcg 611 (986)
|++|.+++ +|..+..+++|+.|+|++|+++ .+|..+..+++|++|+|++|++++.++ ..++.+..+.+.+|++-|.
T Consensus 285 Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~~--~~~~~L~~L~l~~N~~~~~ 360 (597)
T 3oja_B 285 ISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKL--STHHTLKNLTLSHNDWDCN 360 (597)
T ss_dssp CTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCCC--CTTCCCSEEECCSSCEEHH
T ss_pred CCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcCh--hhcCCCCEEEeeCCCCCCh
Confidence 99999996 6778888999999999999999 688889999999999999999998753 4578899999999999886
Q ss_pred C
Q 046598 612 G 612 (986)
Q Consensus 612 ~ 612 (986)
+
T Consensus 361 ~ 361 (597)
T 3oja_B 361 S 361 (597)
T ss_dssp H
T ss_pred h
Confidence 4
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=312.38 Aligned_cols=235 Identities=19% Similarity=0.268 Sum_probs=178.7
Q ss_pred hhcCCCCC-cccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHH-hcCCCCcceeeeeeccccccCCCc
Q 046598 686 ATDRFSSV-NQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTL-KNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 686 ~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
..++|.+. +.||+|+||.||+|.+..+++.||+|+++.. ..+.+|+.++ +..+||||+++++++... ...+.
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~-~~~~~ 88 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENL-YAGRK 88 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhh-cCCCc
Confidence 34678777 7799999999999999988999999998642 4567888887 556999999999986432 33467
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecC---CC
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDE---DM 840 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~ 840 (986)
..++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++. ++
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 157 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDRG--------DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNA 157 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHCT--------TCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTC
T ss_pred eEEEEEeecCCCcHHHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCC
Confidence 7999999999999999996322 23689999999999999999999999 9999999999999998 78
Q ss_pred cEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHH
Q 046598 841 IAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLAR 920 (986)
Q Consensus 841 ~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~ 920 (986)
.+||+|||++.... +..++.++||||+||++|||++|+.||......... .
T Consensus 158 ~~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----~ 208 (299)
T 3m2w_A 158 ILKLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----P 208 (299)
T ss_dssp CEEECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------C
T ss_pred cEEEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----H
Confidence 99999999997532 245788999999999999999999999632211000 0
Q ss_pred hhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 921 TALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 921 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
...... ..... .. ........+.++.+++.+||+.||++|||++|+
T Consensus 209 -~~~~~~-------~~~~~---------~~---~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~ 254 (299)
T 3m2w_A 209 -GMKTRI-------RMGQY---------EF---PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 254 (299)
T ss_dssp -CSCCSS-------CTTCC---------SS---CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred -HHHHHH-------hhccc---------cC---CchhcccCCHHHHHHHHHHcccChhhCCCHHHH
Confidence 000000 00000 00 000112345568899999999999999998764
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-33 Score=309.59 Aligned_cols=108 Identities=24% Similarity=0.356 Sum_probs=66.9
Q ss_pred cCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccCcccccCCccc
Q 046598 448 LGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKL 527 (986)
Q Consensus 448 ~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 527 (986)
+..+++|++|++++|+++ .++ . +..+++|+.|++++|++++. ..+..+++|+.|++++|++++..|..++.+++|
T Consensus 239 ~~~l~~L~~L~l~~n~l~-~~~-~-~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L 313 (347)
T 4fmz_A 239 LANLSQLTWLEIGTNQIS-DIN-A-VKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNL 313 (347)
T ss_dssp GTTCTTCCEEECCSSCCC-CCG-G-GTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTC
T ss_pred hhcCCCCCEEECCCCccC-CCh-h-HhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccC
Confidence 344455555555555555 232 1 44555666666666666642 346666677777777777776666677777777
Q ss_pred cEEecccccccccCCccccCCCCCCEEeCCCccCc
Q 046598 528 EQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLS 562 (986)
Q Consensus 528 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 562 (986)
++|+|++|++++..| +..+++|+.|++++|+|+
T Consensus 314 ~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 314 TTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp SEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred CEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 777777777776544 667777777777777765
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=310.90 Aligned_cols=224 Identities=12% Similarity=0.081 Sum_probs=173.6
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
.++|++.+.||+|+||.||+|++..+++.||||+++... ....+.+.+|+.++++++||||+++++++ ..++
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~~ 104 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVV-----HTRA 104 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EETT
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEE-----EECC
Confidence 468999999999999999999999889999999997543 23347889999999999999999999994 4457
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..|+||||++|++|.++++. .....++.+|+.|++.||+|||++ ||+||||||+||+++.++.+|
T Consensus 105 ~~~lv~e~~~g~~L~~~l~~------------~~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~k 169 (286)
T 3uqc_A 105 GGLVVAEWIRGGSLQEVADT------------SPSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVV 169 (286)
T ss_dssp EEEEEEECCCEEEHHHHHTT------------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEE
T ss_pred cEEEEEEecCCCCHHHHHhc------------CCChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEE
Confidence 89999999999999999941 134557889999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhC
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTAL 923 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 923 (986)
|+++| |++ +++.++|||||||++|||+||+.||......... ... ....
T Consensus 170 l~~~~----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~-~~~-~~~~ 218 (286)
T 3uqc_A 170 LAYPA----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL-APA-ERDT 218 (286)
T ss_dssp ECSCC----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS-EEC-CBCT
T ss_pred EEecc----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh-HHH-HHHh
Confidence 97543 333 3688999999999999999999999743221100 000 0000
Q ss_pred CCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 924 PDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 924 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.. .+.. ........+.++.+++.+||+.||++| |++|+
T Consensus 219 ~~------------~~~~------------~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el 256 (286)
T 3uqc_A 219 AG------------QPIE------------PADIDRDIPFQISAVAARSVQGDGGIR-SASTL 256 (286)
T ss_dssp TS------------CBCC------------HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHH
T ss_pred cc------------CCCC------------hhhcccCCCHHHHHHHHHHcccCCccC-CHHHH
Confidence 00 0000 000011234567899999999999999 88653
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-32 Score=303.07 Aligned_cols=197 Identities=22% Similarity=0.235 Sum_probs=102.9
Q ss_pred ceEEEccCCcccccCCccccCCCCCCEEEccCcccc--CcCCCcccCCCCCCEEEccCccceeecCcccccccccEEEec
Q 046598 359 LEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLS--GTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLS 436 (986)
Q Consensus 359 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~ 436 (986)
|++|++++|++++..+..|..+++|++|++++|.++ +..+..|..+ +|+.|++++|++++ +|..+. .+|++|+++
T Consensus 125 L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~-~~L~~L~l~ 201 (332)
T 2ft3_A 125 LVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP-ETLNELHLD 201 (332)
T ss_dssp CCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC-SSCSCCBCC
T ss_pred CCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc-CCCCEEECC
Confidence 334444444444444445666666777777777664 3555566665 66666666666653 222111 234444444
Q ss_pred ccccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCcccccc
Q 046598 437 YNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGE 516 (986)
Q Consensus 437 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 516 (986)
+|.+++..+..|..+++|++|+|++|+++ +..+..+..+++|+.|+|++|+++ .
T Consensus 202 ~n~i~~~~~~~l~~l~~L~~L~L~~N~l~-------------------------~~~~~~~~~l~~L~~L~L~~N~l~-~ 255 (332)
T 2ft3_A 202 HNKIQAIELEDLLRYSKLYRLGLGHNQIR-------------------------MIENGSLSFLPTLRELHLDNNKLS-R 255 (332)
T ss_dssp SSCCCCCCTTSSTTCTTCSCCBCCSSCCC-------------------------CCCTTGGGGCTTCCEEECCSSCCC-B
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCC-------------------------cCChhHhhCCCCCCEEECCCCcCe-e
Confidence 44444444444445555555555555554 433334444444555555555544 4
Q ss_pred CcccccCCccccEEecccccccccCCccccC------CCCCCEEeCCCccCc--ccCchhhhcccccceeeccCCc
Q 046598 517 IPSTLGSCIKLEQLEMQENFLQGPIPSSLSS------LRGLSVLDLSQNNLS--GKIPELLIRLQLVKNLNLSNND 584 (986)
Q Consensus 517 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~------l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~l~ls~N~ 584 (986)
+|..+..+++|++|++++|+|++..+..|.. ..+|+.|++++|+++ +..|..|..+++|+.+++++|.
T Consensus 256 lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 256 VPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred cChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 4444555555555555555555444444433 245677777777766 5566667777777777777763
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=318.16 Aligned_cols=196 Identities=20% Similarity=0.226 Sum_probs=159.6
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--------chhHHHHHHHHHHHhcCC---------CCccee
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--------HGAFKSFIAECNTLKNIR---------HRNLVK 749 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~ 749 (986)
.++|++.+.||+|+||+||+|++ +++.||||+++... ....+.+.+|+++++.++ ||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 46799999999999999999998 46999999997542 223477889999988886 555555
Q ss_pred eee-----------------ecccc--------ccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHH
Q 046598 750 ILT-----------------ACSGV--------DYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLN 804 (986)
Q Consensus 750 l~~-----------------~~~~~--------~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~ 804 (986)
+.+ ++... ++.++...|+||||+++|++.+.+.. ..+++.+++.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----------~~~~~~~~~~ 165 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----------KLSSLATAKS 165 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----------TCCCHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----------cCCCHHHHHH
Confidence 544 43210 01136789999999999977766631 3579999999
Q ss_pred HHHHHHHHHHHHH-hcCCCCeEeecCCCCCeEecCCC--------------------cEEEcccccceecCCCCCccccc
Q 046598 805 ISIDVACALNYLH-HDCQPPIAHCDLKPSNILLDEDM--------------------IAHIGDFGLARFLPLSSAQTSSI 863 (986)
Q Consensus 805 i~~qi~~~L~~LH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kL~DFG~a~~~~~~~~~~~~~ 863 (986)
|+.||+.||+||| +. +|+||||||+|||++.++ .+||+|||+|+.... .
T Consensus 166 i~~qi~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~ 235 (336)
T 2vuw_A 166 ILHQLTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------G 235 (336)
T ss_dssp HHHHHHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------T
T ss_pred HHHHHHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------C
Confidence 9999999999999 89 999999999999999887 999999999986532 1
Q ss_pred cccccccccccccccCCCcCcccchhhHHHH-HHHHHhCCCCCC
Q 046598 864 GAKGSIGYIAPEYGLGSEVSISGDVYSYGIL-LLELITRKKPTD 906 (986)
Q Consensus 864 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvv-l~elltg~~pf~ 906 (986)
...||+.|+|||++.+.. +.++||||+|++ .+++++|..||.
T Consensus 236 ~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 236 IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 346999999999998776 899999998777 788899999974
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-31 Score=296.02 Aligned_cols=289 Identities=19% Similarity=0.286 Sum_probs=163.6
Q ss_pred ccCceeeceecccCCCCccchhcCccccceecccccccCccCccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeec
Q 046598 110 RRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFL 189 (986)
Q Consensus 110 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 189 (986)
.+|++++++++.++ .+|..+. ++|++|+|++|.+++..+..|+++++|++|+|++|++++..|..|+++++|++|+|
T Consensus 31 c~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (330)
T 1xku_A 31 CHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 107 (330)
T ss_dssp EETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CCCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEEC
Confidence 35667777777666 4555443 45666666666666555556666666666666666666555666666666666666
Q ss_pred cCCcccCcCcchhhccCCCceeecccccccccCCccccCCCCccEEeccccccccccCCcccccccccceEEecCceec-
Q 046598 190 SGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLT- 268 (986)
Q Consensus 190 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~- 268 (986)
++|+++ .+|..+. ++|++|++++|++++..+..+.++ ++|++|++++|+++
T Consensus 108 s~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l-------------------------~~L~~L~l~~n~l~~ 159 (330)
T 1xku_A 108 SKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGL-------------------------NQMIVVELGTNPLKS 159 (330)
T ss_dssp CSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTC-------------------------TTCCEEECCSSCCCG
T ss_pred CCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCC-------------------------ccccEEECCCCcCCc
Confidence 666665 3444332 456666666666554433344443 34444444444443
Q ss_pred -ccCCccccCCCCCcEEecccccccCCCchhhhhhhHhhhhhccCCCCCCCCCCcccccccccccccceeeccccccccC
Q 046598 269 -GAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGS 347 (986)
Q Consensus 269 -~~~p~~l~~l~~L~~L~ls~N~l~~~~~~l~~l~~L~~l~l~~n~l~~~~~~~l~~l~~l~~~~~L~~l~l~~n~~~~~ 347 (986)
+..+..+.++++|+.|++++|.++.++.
T Consensus 160 ~~~~~~~~~~l~~L~~L~l~~n~l~~l~~--------------------------------------------------- 188 (330)
T 1xku_A 160 SGIENGAFQGMKKLSYIRIADTNITTIPQ--------------------------------------------------- 188 (330)
T ss_dssp GGBCTTGGGGCTTCCEEECCSSCCCSCCS---------------------------------------------------
T ss_pred cCcChhhccCCCCcCEEECCCCccccCCc---------------------------------------------------
Confidence 2445556666666666666655543221
Q ss_pred CCcccccccccceEEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCccccc
Q 046598 348 LPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGN 427 (986)
Q Consensus 348 ~p~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 427 (986)
.+. ++|+.|++++|++++..|..|..+++|++|++++|.+++..+..|..+++|++|+|++|+++
T Consensus 189 ---~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~--------- 253 (330)
T 1xku_A 189 ---GLP---PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV--------- 253 (330)
T ss_dssp ---SCC---TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS---------
T ss_pred ---ccc---ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc---------
Confidence 111 34556666666666555666666666666666666666555555655555555555555544
Q ss_pred ccccEEEecccccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccC------CCcceEEEccCCcccc--cCCccccc
Q 046598 428 LKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGL------SSSLIVLDLSRNQLTG--SIPSEVGN 499 (986)
Q Consensus 428 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~------~~~L~~L~Ls~N~l~~--~~p~~~~~ 499 (986)
.+|..+..+++|++|++++|+|+ .+|...+.. ...|+.|++++|.+.. ..|..|..
T Consensus 254 ---------------~lp~~l~~l~~L~~L~l~~N~i~-~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~ 317 (330)
T 1xku_A 254 ---------------KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 317 (330)
T ss_dssp ---------------SCCTTTTTCSSCCEEECCSSCCC-CCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTT
T ss_pred ---------------cCChhhccCCCcCEEECCCCcCC-ccChhhcCCcccccccccccceEeecCcccccccCcccccc
Confidence 55666777777777777777777 455443432 2445566666665542 33444555
Q ss_pred ccccchhhccCc
Q 046598 500 LKNLEILNVFGN 511 (986)
Q Consensus 500 l~~L~~L~Ls~N 511 (986)
+++|+.++|++|
T Consensus 318 ~~~l~~l~L~~N 329 (330)
T 1xku_A 318 VYVRAAVQLGNY 329 (330)
T ss_dssp CCCGGGEEC---
T ss_pred ccceeEEEeccc
Confidence 555555555555
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.98 E-value=6.3e-32 Score=299.85 Aligned_cols=130 Identities=21% Similarity=0.253 Sum_probs=77.3
Q ss_pred cceEEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCcccccccccEEEecc
Q 046598 358 TLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSY 437 (986)
Q Consensus 358 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~ 437 (986)
+|+.|++++|++++..+..|..+++|++|++++|.+++..+..|..+++|++|+|++|+++
T Consensus 194 ~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~------------------- 254 (332)
T 2ft3_A 194 TLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS------------------- 254 (332)
T ss_dssp SCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-------------------
T ss_pred CCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-------------------
Confidence 4556666666666666666777777777777777777666666666666666666666555
Q ss_pred cccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccC------CCcceEEEccCCccc--ccCCcccccccccchhhcc
Q 046598 438 NFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGL------SSSLIVLDLSRNQLT--GSIPSEVGNLKNLEILNVF 509 (986)
Q Consensus 438 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~------~~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~Ls 509 (986)
.+|..+..+++|++|++++|+|+ .+|...+.. ...|+.|++++|.+. +..|..|..+++|+.|+++
T Consensus 255 -----~lp~~l~~l~~L~~L~l~~N~l~-~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~ 328 (332)
T 2ft3_A 255 -----RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFG 328 (332)
T ss_dssp -----BCCTTGGGCTTCCEEECCSSCCC-BCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC-
T ss_pred -----ecChhhhcCccCCEEECCCCCCC-ccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhcc
Confidence 45555666666777777777776 444333332 234566666666555 3445555556666666665
Q ss_pred Ccc
Q 046598 510 GNK 512 (986)
Q Consensus 510 ~N~ 512 (986)
+|+
T Consensus 329 ~n~ 331 (332)
T 2ft3_A 329 NYK 331 (332)
T ss_dssp ---
T ss_pred ccc
Confidence 553
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.8e-31 Score=294.49 Aligned_cols=198 Identities=19% Similarity=0.235 Sum_probs=119.5
Q ss_pred ceEEEccCCcccccCCccccCCCCCCEEEccCcccc--CcCCCcccCCCCCCEEEccCccceeecCcccccccccEEEec
Q 046598 359 LEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLS--GTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLS 436 (986)
Q Consensus 359 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~ 436 (986)
|+.|++++|++++..+..|..+++|++|++++|.++ +..+..|..+++|++|++++|+++. +
T Consensus 123 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-l--------------- 186 (330)
T 1xku_A 123 LQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-I--------------- 186 (330)
T ss_dssp CCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-C---------------
T ss_pred ccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc-C---------------
Confidence 444555555555555556666777777777777775 3566677777777777777777663 2
Q ss_pred ccccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCcccccc
Q 046598 437 YNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGE 516 (986)
Q Consensus 437 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 516 (986)
|..+. ++|++|++++|++++..|.. +..+++|+.|+|++|++++..+..+..+++|++|+|++|+++ .
T Consensus 187 --------~~~~~--~~L~~L~l~~n~l~~~~~~~-~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~ 254 (330)
T 1xku_A 187 --------PQGLP--PSLTELHLDGNKITKVDAAS-LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-K 254 (330)
T ss_dssp --------CSSCC--TTCSEEECTTSCCCEECTGG-GTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-S
T ss_pred --------Ccccc--ccCCEEECCCCcCCccCHHH-hcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-c
Confidence 22111 34555555555555322222 445555555555555555544455556666666666666665 5
Q ss_pred CcccccCCccccEEecccccccccCCccccC------CCCCCEEeCCCccCcc--cCchhhhcccccceeeccCCc
Q 046598 517 IPSTLGSCIKLEQLEMQENFLQGPIPSSLSS------LRGLSVLDLSQNNLSG--KIPELLIRLQLVKNLNLSNND 584 (986)
Q Consensus 517 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~------l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~l~ls~N~ 584 (986)
+|..+..+++|++|+|++|+|++..+..|.. ...|+.|++++|++.. ..|..|..+..++.++|++|+
T Consensus 255 lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 255 VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp CCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred CChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 5666666666666666666666555555543 3677888888888753 566778888888888888874
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-35 Score=342.89 Aligned_cols=385 Identities=20% Similarity=0.164 Sum_probs=194.3
Q ss_pred CCCEEEccCCCccccCCc-chhccccCceeeceecccCC----CCccchhcCccccceecccccccCccCcccc-CCC--
Q 046598 87 FLKVLRLYNNSFNHEIPS-EFDRLRRLQVLALHYNSIGG----AIPANISSCSNLIQLRLFHNQLVGKIPSELS-SLS-- 158 (986)
Q Consensus 87 ~L~~L~L~~n~l~~~~p~-~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~-- 158 (986)
.|++|||++|+++..... .|..+++|++|+|++|++++ .++..+..+++|++|+|++|.+.+..+..+. .++
T Consensus 4 ~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~ 83 (461)
T 1z7x_W 4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 83 (461)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred cceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhC
Confidence 455555555555433222 25555666666666666553 2344455556666666666665543332222 233
Q ss_pred --CCCeEEccCCcCCC----CcccccCCCcCcceeeccCCcccCcCcchhhc-----cCCCceeeccccccccc----CC
Q 046598 159 --KIEHISVNDNNLTG----SIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGW-----LKNLVNLTMAQNRLSGT----IP 223 (986)
Q Consensus 159 --~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~L~~N~l~~~----~p 223 (986)
+|++|+|++|+++. .++..|.++++|++|+|++|.+++..+..+.. .++|++|+|++|++++. ++
T Consensus 84 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~ 163 (461)
T 1z7x_W 84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 163 (461)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHH
Confidence 46666666666652 34555666666666666666665433333322 34566666666666542 23
Q ss_pred ccccCCCCccEEeccccccccccCCcccc----cccccceEEecCceeccc----CCccccCCCCCcEEecccccccCCC
Q 046598 224 SSIFNISSITGFDAGVNKIQGAIPLDYGF----SLQNLQFFSVGENQLTGA----IPPTISNASNLEIFHGSVNKLTGAA 295 (986)
Q Consensus 224 ~~l~~l~~L~~L~l~~N~l~~~~p~~~~~----~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~ls~N~l~~~~ 295 (986)
..+..+++|+.|++++|.+....+..+.. ..++|++|++++|.+++. ++..+..+++|+.|++++|+++...
T Consensus 164 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~ 243 (461)
T 1z7x_W 164 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 243 (461)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred HHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHH
Confidence 34444455555555555544322222211 233666666666666642 3455555666666666666554210
Q ss_pred chhhhhhhHhhhhhccCCCCCCCCCCcccccccccccccceeeccccccccCCCcccccccccceEEEccCCccccc---
Q 046598 296 PYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGN--- 372 (986)
Q Consensus 296 ~~l~~l~~L~~l~l~~n~l~~~~~~~l~~l~~l~~~~~L~~l~l~~n~~~~~~p~~~~~~~~~L~~L~L~~n~l~~~--- 372 (986)
... +...+....++|+.|++++|++++.
T Consensus 244 -----~~~--------------------------------------------l~~~~~~~~~~L~~L~L~~n~l~~~~~~ 274 (461)
T 1z7x_W 244 -----MAE--------------------------------------------LCPGLLHPSSRLRTLWIWECGITAKGCG 274 (461)
T ss_dssp -----HHH--------------------------------------------HHHHHTSTTCCCCEEECTTSCCCHHHHH
T ss_pred -----HHH--------------------------------------------HHHHHhcCCCCceEEECcCCCCCHHHHH
Confidence 000 0000000112344444444444432
Q ss_pred -CCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCccccc-ccccEEEecccccCCC----CCc
Q 046598 373 -IPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGN-LKLFILYLSYNFLQGS----IPS 446 (986)
Q Consensus 373 -~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-~~L~~L~L~~N~l~~~----~p~ 446 (986)
++..+..+++|++|++++|.+++..+..+... .... .+|++|++++|.+++. ++.
T Consensus 275 ~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~-------------------l~~~~~~L~~L~L~~n~l~~~~~~~l~~ 335 (461)
T 1z7x_W 275 DLCRVLRAKESLKELSLAGNELGDEGARLLCET-------------------LLEPGCQLESLWVKSCSFTAACCSHFSS 335 (461)
T ss_dssp HHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHH-------------------HTSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred HHHHHHhhCCCcceEECCCCCCchHHHHHHHHH-------------------hccCCccceeeEcCCCCCchHHHHHHHH
Confidence 23334444444444444444443222222211 0000 1355555555555433 344
Q ss_pred ccCCCCCCCeeecCCCccCCCCCccccc----CCCcceEEEccCCcccc----cCCcccccccccchhhccCccccccCc
Q 046598 447 SLGRYETLTTIDLSNNNLTGTIPPQFIG----LSSSLIVLDLSRNQLTG----SIPSEVGNLKNLEILNVFGNKLKGEIP 518 (986)
Q Consensus 447 ~~~~l~~L~~L~L~~N~l~~~ip~~~~~----~~~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p 518 (986)
.+..+++|++|++++|++++..+..+.. ..++|+.|++++|++++ .+|..+..+++|++|+|++|++++...
T Consensus 336 ~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~ 415 (461)
T 1z7x_W 336 VLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGI 415 (461)
T ss_dssp HHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHH
T ss_pred HHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHH
Confidence 5556677777777777776433322111 14578888888888875 567777777888888888888775322
Q ss_pred cccc-----CCccccEEecccccccc
Q 046598 519 STLG-----SCIKLEQLEMQENFLQG 539 (986)
Q Consensus 519 ~~~~-----~l~~L~~L~L~~N~l~~ 539 (986)
..+. ...+|+.|++.++.+..
T Consensus 416 ~~l~~~l~~~~~~L~~L~~~~~~~~~ 441 (461)
T 1z7x_W 416 LQLVESVRQPGCLLEQLVLYDIYWSE 441 (461)
T ss_dssp HHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred HHHHHHhccCCcchhheeecccccCH
Confidence 2211 13356666666665553
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=300.90 Aligned_cols=292 Identities=20% Similarity=0.216 Sum_probs=219.0
Q ss_pred CCCCCCCCCCcceeeEecCCCCeEEEEeccCCCCccccCcCccCCCCCCEEEccCCCccccCCcchhccccCceeeceec
Q 046598 41 ASWNESSHFCQWRGVTCSRRHQRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYN 120 (986)
Q Consensus 41 ~~w~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N 120 (986)
..|.....+|.|.|+ |+ +++++++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|
T Consensus 21 ~~~~~~~~~C~~~~~-c~----------~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n 86 (353)
T 2z80_A 21 ESSNQASLSCDRNGI-CK----------GSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSN 86 (353)
T ss_dssp ------CCEECTTSE-EE----------CCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cCCCccCCCCCCCeE-ee----------CCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCC
Confidence 456667788999998 74 4566676 6676655 58999999999999877779999999999999999
Q ss_pred ccCCCCccchhcCccccceecccccccCccCccccCCCCCCeEEccCCcCCCCcc-cccCCCcCcceeeccCC-cccCcC
Q 046598 121 SIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIP-SSLGNLSSIRSLFLSGN-NLEGSI 198 (986)
Q Consensus 121 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N-~l~~~~ 198 (986)
++++..|..|.++++|++|+|++|++++..+..|+++++|++|+|++|++++..+ ..|.++++|++|++++| .+++..
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~ 166 (353)
T 2z80_A 87 GINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQ 166 (353)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEEC
T ss_pred ccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccC
Confidence 9998888889999999999999999996666669999999999999999995444 47899999999999999 577677
Q ss_pred cchhhccCCCceeecccccccccCCccccCCCCccEEeccccccccccCCcccccccccceEEecCceecccCCccccCC
Q 046598 199 PDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNA 278 (986)
Q Consensus 199 p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l 278 (986)
+..|+.+++|++|++++|++++..|..+.++++|+.|++++|.+. .+|..++..+++|+.|++++|++++..+..+...
T Consensus 167 ~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 245 (353)
T 2z80_A 167 RKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTG 245 (353)
T ss_dssp TTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST-THHHHHHHHTTTEEEEEEESCBCTTCCCC-----
T ss_pred HHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc-cchhhhhhhcccccEEECCCCccccccccccccc
Confidence 788999999999999999999888888888888888888877764 4454444456666666666666664433222110
Q ss_pred CCCcEEecccccccCCCchhhhhhhHhhhhhccCCCCCCCCCCcccccccccccccceeeccccccccCCCccccccccc
Q 046598 279 SNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTT 358 (986)
Q Consensus 279 ~~L~~L~ls~N~l~~~~~~l~~l~~L~~l~l~~n~l~~~~~~~l~~l~~l~~~~~L~~l~l~~n~~~~~~p~~~~~~~~~ 358 (986)
... ..
T Consensus 246 --------------------------------------------------~~~-------------------------~~ 250 (353)
T 2z80_A 246 --------------------------------------------------ETN-------------------------SL 250 (353)
T ss_dssp ---------------------------------------------------CC-------------------------CC
T ss_pred --------------------------------------------------ccc-------------------------ch
Confidence 000 12
Q ss_pred ceEEEccCCcccc----cCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecC
Q 046598 359 LEVLLLDNNQIFG----NIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIP 422 (986)
Q Consensus 359 L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 422 (986)
++.++|+++.+.+ .+|..+..+++|++|++++|+++...+..|..+++|++|+|++|.+.+..|
T Consensus 251 l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 251 IKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp CCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred hhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 3333444444432 356778889999999999999984444446889999999999998886544
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-34 Score=333.74 Aligned_cols=362 Identities=21% Similarity=0.192 Sum_probs=178.5
Q ss_pred CCCCeEEccCCcCCCCcccc-cCCCcCcceeeccCCcccC----cCcchhhccCCCceeecccccccccCCccccCCCCc
Q 046598 158 SKIEHISVNDNNLTGSIPSS-LGNLSSIRSLFLSGNNLEG----SIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSI 232 (986)
Q Consensus 158 ~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L 232 (986)
++|++|+|++|+++...... +..+++|++|+|++|+++. .++..+..+++|++|+|++|++++..+..+
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l------ 76 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCV------ 76 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHH------
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHH------
Confidence 45666666666665333222 5556666666666666653 234455555666666666666554322222
Q ss_pred cEEeccccccccccCCccccccc----ccceEEecCceecc----cCCccccCCCCCcEEecccccccCCCchhhhhhhH
Q 046598 233 TGFDAGVNKIQGAIPLDYGFSLQ----NLQFFSVGENQLTG----AIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRL 304 (986)
Q Consensus 233 ~~L~l~~N~l~~~~p~~~~~~l~----~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~ls~N~l~~~~~~l~~l~~L 304 (986)
...++ +|++|++++|+++. .++..+..+++|+.|++++|.++.... ..+
T Consensus 77 ------------------~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~-----~~l 133 (461)
T 1z7x_W 77 ------------------LQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGL-----QLL 133 (461)
T ss_dssp ------------------HHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHH-----HHH
T ss_pred ------------------HHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHH-----HHH
Confidence 22233 57777777777763 457777788888888888877653211 000
Q ss_pred hhhhhccCCCCCCCCCCcccccccccccccceeeccccccccCC----CcccccccccceEEEccCCcccccCCcccc--
Q 046598 305 LVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSL----PACISNLSTTLEVLLLDNNQIFGNIPAAIG-- 378 (986)
Q Consensus 305 ~~l~l~~n~l~~~~~~~l~~l~~l~~~~~L~~l~l~~n~~~~~~----p~~~~~~~~~L~~L~L~~n~l~~~~~~~~~-- 378 (986)
... -.....+|+.|+++.|.+++.. +..+..+ ++|+.|++++|.+.+..+..+.
T Consensus 134 ~~~-------------------l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~-~~L~~L~L~~n~i~~~~~~~l~~~ 193 (461)
T 1z7x_W 134 CEG-------------------LLDPQCRLEKLQLEYCSLSAASCEPLASVLRAK-PDFKELTVSNNDINEAGVRVLCQG 193 (461)
T ss_dssp HHH-------------------HTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHC-TTCCEEECCSSBCHHHHHHHHHHH
T ss_pred HHH-------------------HhcCCCcceEEECCCCCCCHHHHHHHHHHHhhC-CCCCEEECcCCCcchHHHHHHHHH
Confidence 000 0011223444444444444321 2222222 3455555555555443333332
Q ss_pred ---CCCCCCEEEccCccccCc----CCCcccCCCCCCEEEccCccceeecCcccccccccEEEecccccCCCCCcccCCC
Q 046598 379 ---KFVNLQRLDMCSNRLSGT----IPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRY 451 (986)
Q Consensus 379 ---~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l 451 (986)
..++|++|++++|.+++. ++..+..+++|++|+|++|++.+.....+. +..+..+
T Consensus 194 l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~------------------~~~~~~~ 255 (461)
T 1z7x_W 194 LKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELC------------------PGLLHPS 255 (461)
T ss_dssp HHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHH------------------HHHTSTT
T ss_pred HhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHH------------------HHHhcCC
Confidence 234555555555555532 244444555555555555555432111000 1112234
Q ss_pred CCCCeeecCCCccCCC----CCcccccCCCcceEEEccCCcccccCCcccccc-----cccchhhccCcccccc----Cc
Q 046598 452 ETLTTIDLSNNNLTGT----IPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNL-----KNLEILNVFGNKLKGE----IP 518 (986)
Q Consensus 452 ~~L~~L~L~~N~l~~~----ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~----~p 518 (986)
++|++|++++|++++. ++.. +..+++|+.|++++|.+++..+..+... ++|+.|+|++|.+++. ++
T Consensus 256 ~~L~~L~L~~n~l~~~~~~~l~~~-l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~ 334 (461)
T 1z7x_W 256 SRLRTLWIWECGITAKGCGDLCRV-LRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFS 334 (461)
T ss_dssp CCCCEEECTTSCCCHHHHHHHHHH-HHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCceEEECcCCCCCHHHHHHHHHH-HhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHH
Confidence 4555555555555421 2322 2334455555555555543322222221 3555555555555533 34
Q ss_pred ccccCCccccEEecccccccccCCccccC-----CCCCCEEeCCCccCcc----cCchhhhcccccceeeccCCcccc
Q 046598 519 STLGSCIKLEQLEMQENFLQGPIPSSLSS-----LRGLSVLDLSQNNLSG----KIPELLIRLQLVKNLNLSNNDLEG 587 (986)
Q Consensus 519 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~l~ls~N~l~~ 587 (986)
..+..+++|++|+|++|.+++..+..+.. .++|+.|+|++|++++ .+|..+..+++|++|+|++|++++
T Consensus 335 ~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~ 412 (461)
T 1z7x_W 335 SVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 412 (461)
T ss_dssp HHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred HHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCH
Confidence 44455555666666666555443333332 4456666666666654 455555556666666666665554
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-29 Score=274.76 Aligned_cols=249 Identities=21% Similarity=0.242 Sum_probs=217.8
Q ss_pred CCCCCcceeeEecCCC---------CeEEEEeccCCCCccccCcCccCCCCCCEEEccCCCccc--cCCcchhccccCce
Q 046598 46 SSHFCQWRGVTCSRRH---------QRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNH--EIPSEFDRLRRLQV 114 (986)
Q Consensus 46 ~~~~c~w~gv~c~~~~---------~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~--~~p~~~~~l~~L~~ 114 (986)
..+.|.|++|.|+... ..++.|+|++|+++...+..|+++++|++|+|++|+++. ..|..+..+++|++
T Consensus 3 ~~C~C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~ 82 (306)
T 2z66_A 3 SRCSCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKY 82 (306)
T ss_dssp TTCEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCE
T ss_pred CCCeeCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCE
Confidence 3456899999998642 468999999999985444458999999999999999984 34778888999999
Q ss_pred eeceecccCCCCccchhcCccccceecccccccCccC-ccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeeccCCc
Q 046598 115 LALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIP-SELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNN 193 (986)
Q Consensus 115 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 193 (986)
|+|++|.++ .+|..+..+++|++|++++|++++..+ ..+..+++|++|++++|.+++..+..|.++++|++|+|++|.
T Consensus 83 L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 161 (306)
T 2z66_A 83 LDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNS 161 (306)
T ss_dssp EECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCE
T ss_pred EECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCc
Confidence 999999998 678889999999999999999996655 689999999999999999998889999999999999999999
Q ss_pred ccC-cCcchhhccCCCceeecccccccccCCccccCCCCccEEeccccccccccCCcccccccccceEEecCceecccCC
Q 046598 194 LEG-SIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIP 272 (986)
Q Consensus 194 l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p 272 (986)
+++ ..|..|..+++|++|+|++|++++..|..+.++++|+.|++++|.+.+..+ ..+..+++|++|++++|++++..|
T Consensus 162 l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~ 240 (306)
T 2z66_A 162 FQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT-FPYKCLNSLQVLDYSLNHIMTSKK 240 (306)
T ss_dssp EGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCS-GGGTTCTTCCEEECTTSCCCBCSS
T ss_pred cccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccCh-hhccCcccCCEeECCCCCCcccCH
Confidence 986 588899999999999999999998889999999999999999999985444 345578999999999999999999
Q ss_pred ccccCC-CCCcEEecccccccCCCc
Q 046598 273 PTISNA-SNLEIFHGSVNKLTGAAP 296 (986)
Q Consensus 273 ~~l~~l-~~L~~L~ls~N~l~~~~~ 296 (986)
..+..+ ++|+.|++++|.+++..+
T Consensus 241 ~~~~~~~~~L~~L~L~~N~~~~~c~ 265 (306)
T 2z66_A 241 QELQHFPSSLAFLNLTQNDFACTCE 265 (306)
T ss_dssp SSCCCCCTTCCEEECTTCCEECSGG
T ss_pred HHHHhhhccCCEEEccCCCeecccC
Confidence 999998 499999999999987643
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=6e-32 Score=325.58 Aligned_cols=475 Identities=14% Similarity=0.103 Sum_probs=254.3
Q ss_pred HhHHHHHHHHHHhccCCCcCCCCCCCCCCCCCcceeeEecCCCCeEEEEeccCCCCccccCcCccCCCCCCEEEccCCCc
Q 046598 19 ETDRLALLELKSKITHDPLGVLASWNESSHFCQWRGVTCSRRHQRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSF 98 (986)
Q Consensus 19 ~~~~~~ll~~k~~~~~~~~~~l~~w~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l 98 (986)
|+| .|..+.+.+. ++ ..+..+ +.-|++|.++.+... +... +.+ ......+..+..++.|+.|+|+++..
T Consensus 17 Pde--il~~I~~~L~-~~-~d~~~~--s~vck~W~~~~~~~~--~~l~--~~~-~~~~~~~~~~~~~~~L~~L~L~~~~~ 85 (592)
T 3ogk_B 17 VDD--VIEQVMTYIT-DP-KDRDSA--SLVCRRWFKIDSETR--EHVT--MAL-CYTATPDRLSRRFPNLRSLKLKGKPR 85 (592)
T ss_dssp GGG--THHHHHTTCC-CH-HHHHHH--TTSCHHHHHHHHHHC--CEEE--ESC-GGGSCHHHHHHHCTTCSEEEEECSCG
T ss_pred CHH--HHHHHHHhcC-CH-HHHHHH--HHHhHHHHHhhhccc--cEEE--Eee-ccccChHHHHHhCCCCeEEEecCCcc
Confidence 444 5677776662 21 111222 223458999965322 2222 222 12223344566788899999987533
Q ss_pred ---cccCCcchh------------ccccCceeeceecccCCCCccchhcC--ccccceeccccc-ccC-ccCccccCCCC
Q 046598 99 ---NHEIPSEFD------------RLRRLQVLALHYNSIGGAIPANISSC--SNLIQLRLFHNQ-LVG-KIPSELSSLSK 159 (986)
Q Consensus 99 ---~~~~p~~~~------------~l~~L~~L~L~~N~l~~~~p~~~~~l--~~L~~L~Ls~N~-l~~-~~p~~~~~l~~ 159 (986)
.+.+|..++ .+++|++|+|++|.+++..+..++.. .+|++|+|++|. ++. .++..+.++++
T Consensus 86 ~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~ 165 (592)
T 3ogk_B 86 AAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRK 165 (592)
T ss_dssp GGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTT
T ss_pred hhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCC
Confidence 133443332 67888888888888876666666653 448888888776 221 12223346778
Q ss_pred CCeEEccCCcCCCC----cccccCCCcCcceeeccCCcccC----cCcchhhccCCCceeecccccccccCCccccCCCC
Q 046598 160 IEHISVNDNNLTGS----IPSSLGNLSSIRSLFLSGNNLEG----SIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISS 231 (986)
Q Consensus 160 L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 231 (986)
|++|+|++|.+++. ++..+.++++|++|+|++|.+++ .++..+..+++|++|+|++|.+.+ +|..+.++++
T Consensus 166 L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~ 244 (592)
T 3ogk_B 166 IKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAAN 244 (592)
T ss_dssp CSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTT
T ss_pred CCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhH
Confidence 88888888877655 44445667788888888887762 334445667778888887777764 5566666666
Q ss_pred ccEEeccccccccccCCcccccccccceEEecCceecccCCccccCCCCCcEEecccccccCCCchhhhhhhHhhhhhcc
Q 046598 232 ITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILG 311 (986)
Q Consensus 232 L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~l~~l~~L~~l~l~~ 311 (986)
|+.|+++..... ++ .+..+..+..+++|+.++++++....
T Consensus 245 L~~L~l~~~~~~--~~--------------------~~~~~~~l~~~~~L~~L~l~~~~~~~------------------ 284 (592)
T 3ogk_B 245 LEEFCGGSLNED--IG--------------------MPEKYMNLVFPRKLCRLGLSYMGPNE------------------ 284 (592)
T ss_dssp CCEEEECBCCCC--TT--------------------CTTSSSCCCCCTTCCEEEETTCCTTT------------------
T ss_pred HHhhcccccccc--cc--------------------hHHHHHHhhccccccccCccccchhH------------------
Confidence 666665532211 00 01223344555555555554432211
Q ss_pred CCCCCCCCCCcccccccccccccceeeccccccccCCCcccccccccceEEEccCCcccccCC-ccccCCCCCCEEEccC
Q 046598 312 NSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIP-AAIGKFVNLQRLDMCS 390 (986)
Q Consensus 312 n~l~~~~~~~l~~l~~l~~~~~L~~l~l~~n~~~~~~p~~~~~~~~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~ 390 (986)
+|..+.. .++|+.|+|++|.+++... ..+..+++|++|++++
T Consensus 285 ------------------------------------l~~~~~~-~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~ 327 (592)
T 3ogk_B 285 ------------------------------------MPILFPF-AAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRN 327 (592)
T ss_dssp ------------------------------------GGGGGGG-GGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEG
T ss_pred ------------------------------------HHHHHhh-cCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccC
Confidence 1111111 1345555555555443322 2345566666666663
Q ss_pred ccccCcCCCcccCCCCCCEEEccC-----------ccceeecCcc-cc-cccccEEEecccccCCCCCcccCC-CCCCCe
Q 046598 391 NRLSGTIPPAIGELQNLKDLRLQR-----------NRFQGNIPPS-IG-NLKLFILYLSYNFLQGSIPSSLGR-YETLTT 456 (986)
Q Consensus 391 N~l~~~~~~~~~~l~~L~~L~Ls~-----------N~l~~~~~~~-~~-~~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~ 456 (986)
+...+.++..+..+++|++|+|++ |.+++..... .. ..+|++|+++.|.+++..+..++. +++|+.
T Consensus 328 ~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~ 407 (592)
T 3ogk_B 328 VIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCD 407 (592)
T ss_dssp GGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCE
T ss_pred ccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcE
Confidence 322222333334566666666662 4444321111 11 124556666555555544444444 566666
Q ss_pred eecC----CCccCCC-----CCcccccCCCcceEEEccCC--cccccCCccccc-ccccchhhccCccccc-cCcccccC
Q 046598 457 IDLS----NNNLTGT-----IPPQFIGLSSSLIVLDLSRN--QLTGSIPSEVGN-LKNLEILNVFGNKLKG-EIPSTLGS 523 (986)
Q Consensus 457 L~L~----~N~l~~~-----ip~~~~~~~~~L~~L~Ls~N--~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~-~~p~~~~~ 523 (986)
|+++ .|++++. ++. .+..+++|+.|++++| .+++..+..+.. +++|+.|+|++|++++ .++..+..
T Consensus 408 L~l~~~~~~n~l~~~p~~~~~~~-~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~ 486 (592)
T 3ogk_B 408 FRLVLLDREERITDLPLDNGVRS-LLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRG 486 (592)
T ss_dssp EEEEECSCCSCCSSCCCHHHHHH-HHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTC
T ss_pred EEEeecCCCccccCchHHHHHHH-HHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhc
Confidence 6664 5566532 111 1334566666666543 244433333332 5666666666666664 23444556
Q ss_pred CccccEEeccccccccc-CCccccCCCCCCEEeCCCccCcccCchhh-hcccccceeeccCC
Q 046598 524 CIKLEQLEMQENFLQGP-IPSSLSSLRGLSVLDLSQNNLSGKIPELL-IRLQLVKNLNLSNN 583 (986)
Q Consensus 524 l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~l~ls~N 583 (986)
+++|++|+|++|.+++. ++..+..+++|+.|+|++|+++..--..+ ..++.+....+..+
T Consensus 487 ~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~ 548 (592)
T 3ogk_B 487 CPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSR 548 (592)
T ss_dssp CTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred CcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecCc
Confidence 66666777776666543 22333456667777777776664422222 23455554444443
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-29 Score=275.06 Aligned_cols=275 Identities=23% Similarity=0.199 Sum_probs=228.0
Q ss_pred eeeccccccccCCCcccccccccceEEEccCCcccccCCccccCCCCCCEEEccCccccCc--CCCcccCCCCCCEEEcc
Q 046598 336 WLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGT--IPPAIGELQNLKDLRLQ 413 (986)
Q Consensus 336 ~l~l~~n~~~~~~p~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~Ls 413 (986)
.++++.+.++ .+|..+. ++++.|+|++|+++...+..|.++++|++|+|++|.++.. .+..+..+++|++|+|+
T Consensus 11 ~l~c~~~~l~-~ip~~~~---~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls 86 (306)
T 2z66_A 11 EIRCNSKGLT-SVPTGIP---SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86 (306)
T ss_dssp EEECCSSCCS-SCCSCCC---TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECC
T ss_pred EEEcCCCCcc-cCCCCCC---CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECC
Confidence 4556666654 5666543 6799999999999976667789999999999999999833 36778889999999999
Q ss_pred CccceeecCcccccccccEEEecccccCCCCC-cccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccc-
Q 046598 414 RNRFQGNIPPSIGNLKLFILYLSYNFLQGSIP-SSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTG- 491 (986)
Q Consensus 414 ~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~- 491 (986)
+|.+.+..+......+|++|++++|.+++..+ ..+..+++|++|++++|++++..|. .+..+++|++|++++|.+++
T Consensus 87 ~n~i~~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~l~~n~l~~~ 165 (306)
T 2z66_A 87 FNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG-IFNGLSSLEVLKMAGNSFQEN 165 (306)
T ss_dssp SCSEEEEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTT-TTTTCTTCCEEECTTCEEGGG
T ss_pred CCccccChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchh-hcccCcCCCEEECCCCccccc
Confidence 99999644333334469999999999997665 6899999999999999999855554 47888999999999999986
Q ss_pred cCCcccccccccchhhccCccccccCcccccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhc
Q 046598 492 SIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIR 571 (986)
Q Consensus 492 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 571 (986)
.+|..+..+++|++|+|++|++++..|..|..+++|++|+|++|++++..+..+..+++|+.|+|++|++++..|..+..
T Consensus 166 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 245 (306)
T 2z66_A 166 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQH 245 (306)
T ss_dssp EECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCC
T ss_pred cchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHh
Confidence 57899999999999999999999888999999999999999999999888888999999999999999999999999999
Q ss_pred cc-ccceeeccCCccccccCCcc---ccccccceeeeCCcccccCCCC
Q 046598 572 LQ-LVKNLNLSNNDLEGVVPTQG---VFKNASITSVFGNLKLCGGIPE 615 (986)
Q Consensus 572 l~-~L~~l~ls~N~l~~~~p~~~---~~~~~~~~~~~~n~~lcg~~~~ 615 (986)
++ +|++|+|++|++++..+... .+.....+....+...|..|..
T Consensus 246 ~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~ 293 (306)
T 2z66_A 246 FPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSD 293 (306)
T ss_dssp CCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESGG
T ss_pred hhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCchh
Confidence 85 99999999999998765431 1223334445566667766543
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-30 Score=283.25 Aligned_cols=204 Identities=17% Similarity=0.208 Sum_probs=123.5
Q ss_pred cCCCCCCEEEccCCCccccCCcchhccccCceeeceeccc-CCCCccchh-------cCccccceecccccccCccCccc
Q 046598 83 GNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSI-GGAIPANIS-------SCSNLIQLRLFHNQLVGKIPSEL 154 (986)
Q Consensus 83 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l-~~~~p~~~~-------~l~~L~~L~Ls~N~l~~~~p~~~ 154 (986)
+..++|++|++++|.+ .+|..+... |++|+|++|++ .+.+|..+. .+++|++|+|++|++++.+|..+
T Consensus 40 ~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 115 (312)
T 1wwl_A 40 GGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPL 115 (312)
T ss_dssp EEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCS
T ss_pred ccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHH
Confidence 3445667777777777 566655544 77777777777 344565554 57777777777777777677665
Q ss_pred --cCCCCCCeEEccCCcCCCCcccccCCC-----cCcceeeccCCcccCcCcchhhccCCCceeeccccccccc--CCcc
Q 046598 155 --SSLSKIEHISVNDNNLTGSIPSSLGNL-----SSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGT--IPSS 225 (986)
Q Consensus 155 --~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~ 225 (986)
+.+++|++|+|++|++++. |..++++ ++|++|+|++|++++..|..|+.+++|++|+|++|++.+. +|..
T Consensus 116 ~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 194 (312)
T 1wwl_A 116 LEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISA 194 (312)
T ss_dssp SSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHH
T ss_pred HHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHH
Confidence 6777777777777777755 6666665 6777777777777766667777777777777777776554 2333
Q ss_pred c--cCCCCccEEecccccccc--ccCCcccccccccceEEecCceecccCC-ccccCCCCCcEEecccccc
Q 046598 226 I--FNISSITGFDAGVNKIQG--AIPLDYGFSLQNLQFFSVGENQLTGAIP-PTISNASNLEIFHGSVNKL 291 (986)
Q Consensus 226 l--~~l~~L~~L~l~~N~l~~--~~p~~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~ls~N~l 291 (986)
+ .++++|+.|++++|++.+ .++..++..+++|++|++++|++++..| ..+..+++|+.|++++|++
T Consensus 195 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l 265 (312)
T 1wwl_A 195 LCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGL 265 (312)
T ss_dssp SCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCC
T ss_pred HHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCcc
Confidence 3 555556666665555542 2222333344555555555555554443 2333344444444444443
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.5e-30 Score=296.69 Aligned_cols=244 Identities=23% Similarity=0.191 Sum_probs=197.7
Q ss_pred ccceEEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCcccccccccEEEec
Q 046598 357 TTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLS 436 (986)
Q Consensus 357 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~ 436 (986)
++|+.|+|++|+|++..|..|..+++|++|+|++|.+++..| |..+++|++|+|++|.|++..+. .+|++|+++
T Consensus 34 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~----~~L~~L~L~ 107 (487)
T 3oja_A 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVG----PSIETLHAA 107 (487)
T ss_dssp GGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEEC----TTCCEEECC
T ss_pred CCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCC----CCcCEEECc
Confidence 478999999999998888899999999999999999987665 88999999999999999875543 578999999
Q ss_pred ccccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccc-cccccchhhccCccccc
Q 046598 437 YNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVG-NLKNLEILNVFGNKLKG 515 (986)
Q Consensus 437 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~ 515 (986)
+|.|++..+. .+++|+.|+|++|+|++..|.. ++.+++|+.|+|++|.|++..|..+. .+++|+.|+|++|.|++
T Consensus 108 ~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~ 183 (487)
T 3oja_A 108 NNNISRVSCS---RGQGKKNIYLANNKITMLRDLD-EGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD 183 (487)
T ss_dssp SSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBC-GGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE
T ss_pred CCcCCCCCcc---ccCCCCEEECCCCCCCCCCchh-hcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcccc
Confidence 9999977665 3578999999999998555544 67788999999999999988888776 78999999999999986
Q ss_pred cCcccccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCccc-cccCCc-c
Q 046598 516 EIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLE-GVVPTQ-G 593 (986)
Q Consensus 516 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~-~~~p~~-~ 593 (986)
. | .+..+++|+.|+|++|.|++. |..+..+++|+.|+|++|+|++ +|..+..+++|+.|++++|++. +.+|.. .
T Consensus 184 ~-~-~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~ 259 (487)
T 3oja_A 184 V-K-GQVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFS 259 (487)
T ss_dssp E-E-CCCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHT
T ss_pred c-c-ccccCCCCCEEECCCCCCCCC-CHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHH
Confidence 5 3 344689999999999999964 4458899999999999999995 7878888999999999999998 333332 3
Q ss_pred ccccccceeee-------CCcccccCCC
Q 046598 594 VFKNASITSVF-------GNLKLCGGIP 614 (986)
Q Consensus 594 ~~~~~~~~~~~-------~n~~lcg~~~ 614 (986)
.++.+..+.+. +|+..|.++.
T Consensus 260 ~l~~L~~l~~~~~~~~~~~~~~~c~~~~ 287 (487)
T 3oja_A 260 KNQRVQTVAKQTVKKLTGQNEEECTVPT 287 (487)
T ss_dssp TCHHHHHHHHHHHHHHTSSSSCCCSSTT
T ss_pred hCCCCcEEeccccccccCCCcccccCCc
Confidence 44445545444 5666666543
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-28 Score=264.71 Aligned_cols=251 Identities=22% Similarity=0.194 Sum_probs=179.0
Q ss_pred eEEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCcccccc-cccEEEeccc
Q 046598 360 EVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNL-KLFILYLSYN 438 (986)
Q Consensus 360 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~-~L~~L~L~~N 438 (986)
+.++.+++.++ .+|..+ .++|++|++++|.+++..+..|..+++|++|+|++|++++..|..+..+ +|++|++++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 34556666665 334322 3466666666666665555666666666666666666666656655544 4667777777
Q ss_pred c-cCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccC
Q 046598 439 F-LQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEI 517 (986)
Q Consensus 439 ~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 517 (986)
. +....|..|..+++|++|++++|++++ +++..+..+++|++|++++|++++..+..|..+++|++|+|++|++++..
T Consensus 91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 169 (285)
T 1ozn_A 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP 169 (285)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred CCccccCHHHhcCCcCCCEEECCCCcCCE-ECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccC
Confidence 5 665667778888888888888888874 44444677788888888888888666666788888888888888888666
Q ss_pred cccccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCccccccCCcccccc
Q 046598 518 PSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQGVFKN 597 (986)
Q Consensus 518 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~~~~~ 597 (986)
+..|..+++|++|+|++|.+++..|..|..+++|+.|+|++|++++..+..+..+++|++|++++|++.+..+....+..
T Consensus 170 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~~~~ 249 (285)
T 1ozn_A 170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAW 249 (285)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHH
T ss_pred HHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcHHHHHH
Confidence 66788888888888888888887788888888888888888888877777788888888888888888877665544444
Q ss_pred ccceeeeCCcccccCCC
Q 046598 598 ASITSVFGNLKLCGGIP 614 (986)
Q Consensus 598 ~~~~~~~~n~~lcg~~~ 614 (986)
++......|...|..|.
T Consensus 250 l~~~~~~~~~~~c~~p~ 266 (285)
T 1ozn_A 250 LQKFRGSSSEVPCSLPQ 266 (285)
T ss_dssp HHHCCSEECCCBEEESG
T ss_pred HHhcccccCccccCCch
Confidence 55555566666666554
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-28 Score=282.22 Aligned_cols=251 Identities=21% Similarity=0.207 Sum_probs=207.9
Q ss_pred ceeeccccccccCCCcccccccccceEEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccC
Q 046598 335 KWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQR 414 (986)
Q Consensus 335 ~~l~l~~n~~~~~~p~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 414 (986)
..++.+...++ .+|..+. ++++.|+|++|+|++..+..|.++++|++|+|++|.|++..+..|.++++|++|+|++
T Consensus 57 ~~v~c~~~~l~-~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~ 132 (452)
T 3zyi_A 57 SKVVCTRRGLS-EVPQGIP---SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD 132 (452)
T ss_dssp CEEECCSSCCS-SCCSCCC---TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred cEEEECCCCcC-ccCCCCC---CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCC
Confidence 44556655555 5666543 5788899999999988888999999999999999999988888899999999999999
Q ss_pred ccceeecCcccccc-cccEEEecccccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccC
Q 046598 415 NRFQGNIPPSIGNL-KLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSI 493 (986)
Q Consensus 415 N~l~~~~~~~~~~~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~ 493 (986)
|+|++..+..+..+ +|++|+|++|.|++..+..|..+++|+.|++++|+..+.++...+..+++|+.|+|++|++++ +
T Consensus 133 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~ 211 (452)
T 3zyi_A 133 NWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-M 211 (452)
T ss_dssp SCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-C
T ss_pred CcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-c
Confidence 99987777777655 588999999998877777888889999999988544447777778888889999999998884 4
Q ss_pred CcccccccccchhhccCccccccCcccccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhccc
Q 046598 494 PSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQ 573 (986)
Q Consensus 494 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 573 (986)
| .+..+++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..+..++
T Consensus 212 ~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 290 (452)
T 3zyi_A 212 P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLR 290 (452)
T ss_dssp C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCT
T ss_pred c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhcccc
Confidence 4 578888899999999999888888888889999999999999888888888888999999999998877777888888
Q ss_pred ccceeeccCCccccccCC
Q 046598 574 LVKNLNLSNNDLEGVVPT 591 (986)
Q Consensus 574 ~L~~l~ls~N~l~~~~p~ 591 (986)
+|+.|+|++|++.+...-
T Consensus 291 ~L~~L~L~~Np~~CdC~~ 308 (452)
T 3zyi_A 291 YLVELHLHHNPWNCDCDI 308 (452)
T ss_dssp TCCEEECCSSCEECSTTT
T ss_pred CCCEEEccCCCcCCCCCc
Confidence 888888888888876543
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-28 Score=282.03 Aligned_cols=248 Identities=24% Similarity=0.266 Sum_probs=161.5
Q ss_pred eeeccccccccCCCcccccccccceEEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCc
Q 046598 336 WLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRN 415 (986)
Q Consensus 336 ~l~l~~n~~~~~~p~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 415 (986)
.++...++++ .+|..+. ..++.|+|++|+|++..+..|.++++|++|+|++|.|++..+..|.++++|++|+|++|
T Consensus 47 ~v~c~~~~l~-~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n 122 (440)
T 3zyj_A 47 KVICVRKNLR-EVPDGIS---TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN 122 (440)
T ss_dssp EEECCSCCCS-SCCSCCC---TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSS
T ss_pred EEEeCCCCcC-cCCCCCC---CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCC
Confidence 4444444444 4555443 45677777777777766777777777777777777777666667777777777777777
Q ss_pred cceeecCcccccc-cccEEEecccccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCC
Q 046598 416 RFQGNIPPSIGNL-KLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIP 494 (986)
Q Consensus 416 ~l~~~~~~~~~~~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p 494 (986)
+|++..+..+..+ +|++|+|++|.|++..+..|..+++|++|+|++|+..+.++...+..+++|+.|+|++|+|+ .+|
T Consensus 123 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~ 201 (440)
T 3zyj_A 123 RLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP 201 (440)
T ss_dssp CCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC
T ss_pred cCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc
Confidence 7775555555544 46677777777666555666666677777776643333556555666666677777776666 344
Q ss_pred cccccccccchhhccCccccccCcccccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccc
Q 046598 495 SEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQL 574 (986)
Q Consensus 495 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 574 (986)
.+..+++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++
T Consensus 202 -~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 280 (440)
T 3zyj_A 202 -NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHH 280 (440)
T ss_dssp -CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTT
T ss_pred -ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccC
Confidence 3566666666666666666666666666666666666666666666666666666666666666666655566666666
Q ss_pred cceeeccCCcccccc
Q 046598 575 VKNLNLSNNDLEGVV 589 (986)
Q Consensus 575 L~~l~ls~N~l~~~~ 589 (986)
|+.|+|++|++.+..
T Consensus 281 L~~L~L~~Np~~CdC 295 (440)
T 3zyj_A 281 LERIHLHHNPWNCNC 295 (440)
T ss_dssp CCEEECCSSCEECSS
T ss_pred CCEEEcCCCCccCCC
Confidence 666666666666543
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-28 Score=292.95 Aligned_cols=292 Identities=22% Similarity=0.346 Sum_probs=187.3
Q ss_pred CCcCCCCCCCCCCCCCcceeeEec------CCCCeEEEEeccCCCCccccCcCccCCCCCCEEEccCCCccccCCcchhc
Q 046598 35 DPLGVLASWNESSHFCQWRGVTCS------RRHQRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDR 108 (986)
Q Consensus 35 ~~~~~l~~w~~~~~~c~w~gv~c~------~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~ 108 (986)
|....+++|..+.+||.|+|..|. .....++.+++++++++ .+|..+. ++|++|+|++|+++ .+|. .
T Consensus 7 ~~~~~w~~W~~~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~ 79 (622)
T 3g06_A 7 EYDAVWSAWRRAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---L 79 (622)
T ss_dssp ---CHHHHHHHTCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---C
T ss_pred HHHHHHHHHHhcCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---c
Confidence 444567789878889999774321 11234788899999988 7777766 78899999999888 4555 5
Q ss_pred cccCceeeceecccCCCCccchhcCccccceecccccccCccCccccCCCCCCeEEccCCcCCCCcccccCCCcCcceee
Q 046598 109 LRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLF 188 (986)
Q Consensus 109 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 188 (986)
+++|++|+|++|+|+ .+|. .+++|++|+|++|.+++ +|. .+++|++|++++|++++ +|.. +++|++|+
T Consensus 80 l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~ 147 (622)
T 3g06_A 80 PPELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELS 147 (622)
T ss_dssp CTTCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEE
T ss_pred CCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEE
Confidence 688889999999888 4555 67888888888888884 444 56788888888888884 4543 47888888
Q ss_pred ccCCcccCcCcchhhccCCCceeecccccccccCCccccCCCCccEEeccccccccccCCcccccccccceEEecCceec
Q 046598 189 LSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLT 268 (986)
Q Consensus 189 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~ 268 (986)
|++|++++ +|. .+++|+.|++++|++++ +| ..+++|+.|++++|.+.+ +|. .+++|+.|++++|.++
T Consensus 148 Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~----~~~~L~~L~L~~N~l~ 214 (622)
T 3g06_A 148 VSDNQLAS-LPA---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPT----LPSELYKLWAYNNRLT 214 (622)
T ss_dssp CCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC----CCTTCCEEECCSSCCS
T ss_pred CcCCcCCC-cCC---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCC----ccchhhEEECcCCccc
Confidence 88888874 443 34677888888888873 45 334556666666666553 332 1244555555555554
Q ss_pred ccCCccccCCCCCcEEecccccccCCCchhhhhhhHhhhhhccCCCCCCCCCCcccccccccccccceeeccccccccCC
Q 046598 269 GAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSL 348 (986)
Q Consensus 269 ~~~p~~l~~l~~L~~L~ls~N~l~~~~~~l~~l~~L~~l~l~~n~l~~~~~~~l~~l~~l~~~~~L~~l~l~~n~~~~~~ 348 (986)
.+|.. +++|+.|++++|++++ +
T Consensus 215 -~l~~~---~~~L~~L~Ls~N~L~~------------------------------------------------------l 236 (622)
T 3g06_A 215 -SLPAL---PSGLKELIVSGNRLTS------------------------------------------------------L 236 (622)
T ss_dssp -SCCCC---CTTCCEEECCSSCCSC------------------------------------------------------C
T ss_pred -ccCCC---CCCCCEEEccCCccCc------------------------------------------------------C
Confidence 22221 2344444444444432 2
Q ss_pred CcccccccccceEEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCccc
Q 046598 349 PACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSI 425 (986)
Q Consensus 349 p~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 425 (986)
| ...++|+.|+|++|+|+. +|. .+++|+.|+|++|+|+ .+|..|..+++|+.|+|++|.+++..|..+
T Consensus 237 p----~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l 304 (622)
T 3g06_A 237 P----VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL 304 (622)
T ss_dssp C----CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHH
T ss_pred C----CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHH
Confidence 2 111345666666666663 333 4566667777777776 556666666666666666666665554443
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.8e-28 Score=278.79 Aligned_cols=250 Identities=24% Similarity=0.250 Sum_probs=225.6
Q ss_pred cceEEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCcccccc-cccEEEec
Q 046598 358 TLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNL-KLFILYLS 436 (986)
Q Consensus 358 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~-~L~~L~L~ 436 (986)
....++.++++++ .+|..+. ++++.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+ +|++|+|+
T Consensus 44 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~ 120 (440)
T 3zyj_A 44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF 120 (440)
T ss_dssp TSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECC
T ss_pred CCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECC
Confidence 4567889999998 5666655 689999999999998888999999999999999999999888888766 59999999
Q ss_pred ccccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccC-CcccccCCcccccccccchhhccCccccc
Q 046598 437 YNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSR-NQLTGSIPSEVGNLKNLEILNVFGNKLKG 515 (986)
Q Consensus 437 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 515 (986)
+|+|++..+..|..+++|++|+|++|+|+ .+|...+..+++|+.|+|++ |.++...+..|.++++|++|+|++|+++
T Consensus 121 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~- 198 (440)
T 3zyj_A 121 DNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR- 198 (440)
T ss_dssp SSCCSSCCTTTSCSCSSCCEEECCSCCCC-EECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-
T ss_pred CCcCCeeCHhHhhccccCceeeCCCCccc-ccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-
Confidence 99999888888999999999999999998 77777789999999999999 5566445557999999999999999999
Q ss_pred cCcccccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCccccccCCc-cc
Q 046598 516 EIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQ-GV 594 (986)
Q Consensus 516 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~-~~ 594 (986)
.+| .+..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|+|++.++.. ..
T Consensus 199 ~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 277 (440)
T 3zyj_A 199 EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTP 277 (440)
T ss_dssp SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSS
T ss_pred ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhcc
Confidence 566 5899999999999999999999999999999999999999999999999999999999999999999988765 56
Q ss_pred cccccceeeeCCcccccCC
Q 046598 595 FKNASITSVFGNLKLCGGI 613 (986)
Q Consensus 595 ~~~~~~~~~~~n~~lcg~~ 613 (986)
++.++.+++.+||+.|++.
T Consensus 278 l~~L~~L~L~~Np~~CdC~ 296 (440)
T 3zyj_A 278 LHHLERIHLHHNPWNCNCD 296 (440)
T ss_dssp CTTCCEEECCSSCEECSST
T ss_pred ccCCCEEEcCCCCccCCCC
Confidence 7888999999999999763
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-30 Score=283.92 Aligned_cols=267 Identities=16% Similarity=0.166 Sum_probs=221.2
Q ss_pred CCCCCCCCCCCCcceeeEecCCCCeEEEEeccCCCCccccCcCccCCCCCCEEEccCCCc-cccCCcchh-------ccc
Q 046598 39 VLASWNESSHFCQWRGVTCSRRHQRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSF-NHEIPSEFD-------RLR 110 (986)
Q Consensus 39 ~l~~w~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l-~~~~p~~~~-------~l~ 110 (986)
...+|.....|+.|..+.......+++.+++++|.+ .+|..+... |+.|+|++|.+ ...+|..+. +++
T Consensus 20 ~~~~~~~~~~c~~~~~~~~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~ 95 (312)
T 1wwl_A 20 PKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGIS 95 (312)
T ss_dssp SSCCGGGGGGSSSCSEEEEEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTS
T ss_pred cccchHHHhhhhccccEEEEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcC
Confidence 356887666788887776544456788999999999 778776655 99999999999 456787776 799
Q ss_pred cCceeeceecccCCCCccch--hcCccccceecccccccCccCccccCC-----CCCCeEEccCCcCCCCcccccCCCcC
Q 046598 111 RLQVLALHYNSIGGAIPANI--SSCSNLIQLRLFHNQLVGKIPSELSSL-----SKIEHISVNDNNLTGSIPSSLGNLSS 183 (986)
Q Consensus 111 ~L~~L~L~~N~l~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~ 183 (986)
+|++|+|++|++++.+|..+ +.+++|++|+|++|++++. |..++.+ ++|++|+|++|++++..|..|+++++
T Consensus 96 ~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~ 174 (312)
T 1wwl_A 96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPA 174 (312)
T ss_dssp CCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSS
T ss_pred CccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCC
Confidence 99999999999999999886 8999999999999999977 8888887 99999999999999888899999999
Q ss_pred cceeeccCCcccCc--Ccchh--hccCCCceeecccccccc--cCC-ccccCCCCccEEeccccccccccCCcccccccc
Q 046598 184 IRSLFLSGNNLEGS--IPDTL--GWLKNLVNLTMAQNRLSG--TIP-SSIFNISSITGFDAGVNKIQGAIPLDYGFSLQN 256 (986)
Q Consensus 184 L~~L~L~~N~l~~~--~p~~~--~~l~~L~~L~L~~N~l~~--~~p-~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~ 256 (986)
|++|+|++|++.+. .|..+ +.+++|++|+|++|++++ .++ ..+.++++|+.|++++|.+.+..|...+..+++
T Consensus 175 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~ 254 (312)
T 1wwl_A 175 LSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQ 254 (312)
T ss_dssp CCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTT
T ss_pred CCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCC
Confidence 99999999998765 34444 889999999999999983 233 344578999999999999998887666667899
Q ss_pred cceEEecCceecccCCccccCCCCCcEEecccccccCCCchhhhhhhHhhhhhccCCC
Q 046598 257 LQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSL 314 (986)
Q Consensus 257 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~l~~l~~L~~l~l~~n~l 314 (986)
|++|+|++|+++ .+|..+. ++|+.|++++|++++.+. +..+++|+.+++++|.+
T Consensus 255 L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~p~-~~~l~~L~~L~L~~N~l 308 (312)
T 1wwl_A 255 LNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRNPS-PDELPQVGNLSLKGNPF 308 (312)
T ss_dssp CCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSCCC-TTTSCEEEEEECTTCTT
T ss_pred CCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCChh-HhhCCCCCEEeccCCCC
Confidence 999999999999 7788777 899999999999998743 54444444444444433
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=6.5e-28 Score=279.44 Aligned_cols=250 Identities=23% Similarity=0.242 Sum_probs=225.6
Q ss_pred cceEEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCcccccc-cccEEEec
Q 046598 358 TLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNL-KLFILYLS 436 (986)
Q Consensus 358 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~-~L~~L~L~ 436 (986)
....++.++++++ .+|..+. +++++|+|++|.|++..|..|..+++|++|+|++|+|++..+..|..+ +|++|+|+
T Consensus 55 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~ 131 (452)
T 3zyi_A 55 QFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELF 131 (452)
T ss_dssp SSCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECC
Confidence 3467889999998 5666554 689999999999999999999999999999999999999988888766 69999999
Q ss_pred ccccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccC-CcccccCCcccccccccchhhccCccccc
Q 046598 437 YNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSR-NQLTGSIPSEVGNLKNLEILNVFGNKLKG 515 (986)
Q Consensus 437 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 515 (986)
+|+|++..+..|..+++|++|+|++|+|+ .+|...+..+++|+.|++++ |.+....+..|.++++|++|+|++|++++
T Consensus 132 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~ 210 (452)
T 3zyi_A 132 DNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD 210 (452)
T ss_dssp SSCCSBCCTTTSSSCTTCCEEECCSCCCC-EECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS
T ss_pred CCcCCccChhhhcccCCCCEEECCCCCcc-eeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc
Confidence 99999888888999999999999999998 77777789999999999999 56665455579999999999999999995
Q ss_pred cCcccccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCccccccCCc-cc
Q 046598 516 EIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQ-GV 594 (986)
Q Consensus 516 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~-~~ 594 (986)
+| .+..+++|++|+|++|+|++..|..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|+|++.++.. ..
T Consensus 211 -~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 288 (452)
T 3zyi_A 211 -MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTP 288 (452)
T ss_dssp -CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTT
T ss_pred -cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhcc
Confidence 45 5899999999999999999999999999999999999999999999999999999999999999999888765 56
Q ss_pred cccccceeeeCCcccccCC
Q 046598 595 FKNASITSVFGNLKLCGGI 613 (986)
Q Consensus 595 ~~~~~~~~~~~n~~lcg~~ 613 (986)
++++..+++.+||+.|++.
T Consensus 289 l~~L~~L~L~~Np~~CdC~ 307 (452)
T 3zyi_A 289 LRYLVELHLHHNPWNCDCD 307 (452)
T ss_dssp CTTCCEEECCSSCEECSTT
T ss_pred ccCCCEEEccCCCcCCCCC
Confidence 7888999999999999864
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-28 Score=275.55 Aligned_cols=273 Identities=19% Similarity=0.159 Sum_probs=218.6
Q ss_pred ceeeccccccccCCCcccccccccceEEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccC
Q 046598 335 KWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQR 414 (986)
Q Consensus 335 ~~l~l~~n~~~~~~p~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 414 (986)
...+++.+.++ .+|..+. ++|++|++++|+|++..+..|.++++|++|++++|.+++..|..|.++++|++|+|++
T Consensus 34 ~~c~~~~~~l~-~iP~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 109 (353)
T 2z80_A 34 GICKGSSGSLN-SIPSGLT---EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSY 109 (353)
T ss_dssp SEEECCSTTCS-SCCTTCC---TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred eEeeCCCCCcc-ccccccc---ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCC
Confidence 34566666666 5676554 5789999999999988777899999999999999999988888899999999999999
Q ss_pred ccceeecCcccccc-cccEEEecccccCCCCC-cccCCCCCCCeeecCCCc-cCCCCCcccccCCCcceEEEccCCcccc
Q 046598 415 NRFQGNIPPSIGNL-KLFILYLSYNFLQGSIP-SSLGRYETLTTIDLSNNN-LTGTIPPQFIGLSSSLIVLDLSRNQLTG 491 (986)
Q Consensus 415 N~l~~~~~~~~~~~-~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~-l~~~ip~~~~~~~~~L~~L~Ls~N~l~~ 491 (986)
|++++..+..+..+ +|++|+|++|++++..+ ..|..+++|++|++++|+ +. .++...++.+++|+.|++++|++++
T Consensus 110 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~-~~~~~~~~~l~~L~~L~l~~n~l~~ 188 (353)
T 2z80_A 110 NYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFT-KIQRKDFAGLTFLEELEIDASDLQS 188 (353)
T ss_dssp SCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCC-EECTTTTTTCCEEEEEEEEETTCCE
T ss_pred CcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCcccc-ccCHHHccCCCCCCEEECCCCCcCc
Confidence 99997666656654 69999999999995444 478899999999999984 65 6655557888999999999999998
Q ss_pred cCCcccccccccchhhccCccccccCcccccCCccccEEecccccccccCCcccc---CCCCCCEEeCCCccCcc----c
Q 046598 492 SIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLS---SLRGLSVLDLSQNNLSG----K 564 (986)
Q Consensus 492 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~----~ 564 (986)
..|..+..+++|++|++++|+++...+..+..+++|++|+|++|++++..+..+. ....++.++|++|.+++ .
T Consensus 189 ~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~ 268 (353)
T 2z80_A 189 YEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQ 268 (353)
T ss_dssp ECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHH
T ss_pred cCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhh
Confidence 8889999999999999999999744334455689999999999999876655443 35678888888888875 4
Q ss_pred CchhhhcccccceeeccCCccccccCCc-cccccccceeeeCCcccccC
Q 046598 565 IPELLIRLQLVKNLNLSNNDLEGVVPTQ-GVFKNASITSVFGNLKLCGG 612 (986)
Q Consensus 565 ~p~~~~~l~~L~~l~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~~lcg~ 612 (986)
+|+.+..+++|++|+|++|+++..++.. ..+++++.+++.+|++.|.+
T Consensus 269 l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~ 317 (353)
T 2z80_A 269 VMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 317 (353)
T ss_dssp HHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred hHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcC
Confidence 7778888888888888888888655543 56778888888888888764
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-28 Score=268.46 Aligned_cols=226 Identities=20% Similarity=0.283 Sum_probs=190.2
Q ss_pred ccceEEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCcccccc-cccEEEe
Q 046598 357 TTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNL-KLFILYL 435 (986)
Q Consensus 357 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~-~L~~L~L 435 (986)
..++.|+|++|+++ .+|..+.++++|++|+|++|.++ .+|..|+.+++|++|+|++|+++ .+|..+..+ +|++|+|
T Consensus 81 ~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L 157 (328)
T 4fcg_A 81 PGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSI 157 (328)
T ss_dssp TTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEE
T ss_pred cceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEEC
Confidence 45677777777777 56666777777888888888777 67777777778888888887777 556666554 4777788
Q ss_pred cccccCCCCCcccCC---------CCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchh
Q 046598 436 SYNFLQGSIPSSLGR---------YETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEIL 506 (986)
Q Consensus 436 ~~N~l~~~~p~~~~~---------l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 506 (986)
++|++.+.+|..+.. +++|++|+|++|+++ .+|.. ++.+++|++|+|++|++++ +|..+..+++|++|
T Consensus 158 ~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~-l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L 234 (328)
T 4fcg_A 158 RACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPAS-IANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEEL 234 (328)
T ss_dssp EEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGG-GGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEE
T ss_pred CCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHh-hcCCCCCCEEEccCCCCCc-CchhhccCCCCCEE
Confidence 777777777776654 899999999999998 88887 7778899999999999995 67789999999999
Q ss_pred hccCccccccCcccccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCccc
Q 046598 507 NVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLE 586 (986)
Q Consensus 507 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~ 586 (986)
+|++|++.+.+|..|+.+++|++|+|++|++.+.+|..+..+++|+.|+|++|++.+.+|..+.++++|+.+++..|.+.
T Consensus 235 ~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp ECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred ECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999988776
Q ss_pred cc
Q 046598 587 GV 588 (986)
Q Consensus 587 ~~ 588 (986)
..
T Consensus 315 ~l 316 (328)
T 4fcg_A 315 QL 316 (328)
T ss_dssp C-
T ss_pred HH
Confidence 43
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-30 Score=314.69 Aligned_cols=330 Identities=14% Similarity=0.074 Sum_probs=223.7
Q ss_pred ccCCCceeeccccccccc----CCccccCCCCccEEecccccccc----ccCCcccccccccceEEecCceecccCCccc
Q 046598 204 WLKNLVNLTMAQNRLSGT----IPSSIFNISSITGFDAGVNKIQG----AIPLDYGFSLQNLQFFSVGENQLTGAIPPTI 275 (986)
Q Consensus 204 ~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~l~~N~l~~----~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l 275 (986)
.+++|++|+|++|.+++. ++..+.++++|+.|+++.|.+.+ .++ .+..++++|+.|++++|.+.+ +|..+
T Consensus 162 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~-~~~~~~~~L~~L~L~~~~~~~-l~~~~ 239 (592)
T 3ogk_B 162 HCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLE-TIARNCRSLVSVKVGDFEILE-LVGFF 239 (592)
T ss_dssp HCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHH-HHHHHCTTCCEEECSSCBGGG-GHHHH
T ss_pred hCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHH-HHHhhCCCCcEEeccCccHHH-HHHHH
Confidence 344444555544444333 22223344445555555554431 111 122356778888888888775 66778
Q ss_pred cCCCCCcEEecccccccCCCchhhhhhhHhhhhhccCCCCCCCCCCcccccccccccccceeeccccccccCCCcccccc
Q 046598 276 SNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNL 355 (986)
Q Consensus 276 ~~l~~L~~L~ls~N~l~~~~~~l~~l~~L~~l~l~~n~l~~~~~~~l~~l~~l~~~~~L~~l~l~~n~~~~~~p~~~~~~ 355 (986)
..+++|+.|+++......... ..+..+..+
T Consensus 240 ~~~~~L~~L~l~~~~~~~~~~--------------------------------------------------~~~~~l~~~ 269 (592)
T 3ogk_B 240 KAAANLEEFCGGSLNEDIGMP--------------------------------------------------EKYMNLVFP 269 (592)
T ss_dssp HHCTTCCEEEECBCCCCTTCT--------------------------------------------------TSSSCCCCC
T ss_pred hhhhHHHhhcccccccccchH--------------------------------------------------HHHHHhhcc
Confidence 888888888887522110000 011111111
Q ss_pred cccceEEEccCCcccccCCccccCCCCCCEEEccCccccCcCC-CcccCCCCCCEEEccCcccee-ecCccccc-ccccE
Q 046598 356 STTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIP-PAIGELQNLKDLRLQRNRFQG-NIPPSIGN-LKLFI 432 (986)
Q Consensus 356 ~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~-~~L~~ 432 (986)
.+|+.|.++++.. +.+|..+..+++|++|+|++|.+++... ..+..+++|++|+++ |.+.. .++..... .+|++
T Consensus 270 -~~L~~L~l~~~~~-~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~ 346 (592)
T 3ogk_B 270 -RKLCRLGLSYMGP-NEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKR 346 (592)
T ss_dssp -TTCCEEEETTCCT-TTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCE
T ss_pred -ccccccCccccch-hHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCE
Confidence 4567777777543 3677788899999999999999875443 346889999999999 44443 33333333 35999
Q ss_pred EEec-----------ccccCCCCC-cccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEcc----CCccccc----
Q 046598 433 LYLS-----------YNFLQGSIP-SSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLS----RNQLTGS---- 492 (986)
Q Consensus 433 L~L~-----------~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls----~N~l~~~---- 492 (986)
|+++ .|.+++... ..+..+++|++|+++.|++++..+..+...+++|+.|+++ .|++++.
T Consensus 347 L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~ 426 (592)
T 3ogk_B 347 LRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDN 426 (592)
T ss_dssp EEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHH
T ss_pred EEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHH
Confidence 9999 466664422 2245589999999999999876665544447899999996 7888853
Q ss_pred -CCcccccccccchhhccCc--cccccCcccccC-CccccEEecccccccc-cCCccccCCCCCCEEeCCCccCccc-Cc
Q 046598 493 -IPSEVGNLKNLEILNVFGN--KLKGEIPSTLGS-CIKLEQLEMQENFLQG-PIPSSLSSLRGLSVLDLSQNNLSGK-IP 566 (986)
Q Consensus 493 -~p~~~~~l~~L~~L~Ls~N--~l~~~~p~~~~~-l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~-~p 566 (986)
++..+.++++|+.|+|++| .+++..+..+.. +++|++|+|++|++++ .++..+..+++|+.|+|++|++++. ++
T Consensus 427 ~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~ 506 (592)
T 3ogk_B 427 GVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIA 506 (592)
T ss_dssp HHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHH
T ss_pred HHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHH
Confidence 3344677999999999854 477666655554 8999999999999986 3455668899999999999999865 45
Q ss_pred hhhhcccccceeeccCCccccc
Q 046598 567 ELLIRLQLVKNLNLSNNDLEGV 588 (986)
Q Consensus 567 ~~~~~l~~L~~l~ls~N~l~~~ 588 (986)
..+..+++|++|+|++|+++..
T Consensus 507 ~~~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 507 AAVTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp HHHHHCSSCCEEEEESCBCCTT
T ss_pred HHHHhcCccCeeECcCCcCCHH
Confidence 5567899999999999998865
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=259.53 Aligned_cols=252 Identities=21% Similarity=0.201 Sum_probs=221.0
Q ss_pred ceeeccccccccCCCcccccccccceEEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccC
Q 046598 335 KWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQR 414 (986)
Q Consensus 335 ~~l~l~~n~~~~~~p~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 414 (986)
+.++.+.+.++ .+|..+ +++++.|++++|+|++..+..|..+++|++|++++|.+++..|..|..+++|++|+|++
T Consensus 14 ~~~~c~~~~l~-~ip~~~---~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 89 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89 (285)
T ss_dssp CEEECCSSCCS-SCCTTC---CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred eEEEcCcCCcc-cCCcCC---CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence 45666666665 466544 36899999999999998889999999999999999999988899999999999999999
Q ss_pred cc-ceeecCcccccc-cccEEEecccccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCccccc
Q 046598 415 NR-FQGNIPPSIGNL-KLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGS 492 (986)
Q Consensus 415 N~-l~~~~~~~~~~~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~ 492 (986)
|+ +....|..+..+ +|++|++++|.+++..|..|..+++|++|++++|+++ .++...++.+++|+.|+|++|++++.
T Consensus 90 n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~ 168 (285)
T 1ozn_A 90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSV 168 (285)
T ss_dssp CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCEE
T ss_pred CCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCccc-ccCHhHhccCCCccEEECCCCccccc
Confidence 98 887778888765 6999999999999988999999999999999999998 66666688899999999999999976
Q ss_pred CCcccccccccchhhccCccccccCcccccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcc
Q 046598 493 IPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRL 572 (986)
Q Consensus 493 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 572 (986)
.+..|..+++|+.|+|++|++++..|..|..+++|++|+|++|++++..+..+..+++|+.|+|++|+++...+.. .-.
T Consensus 169 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~~~ 247 (285)
T 1ozn_A 169 PERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLW 247 (285)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHH
T ss_pred CHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-HHH
Confidence 6677999999999999999999888999999999999999999999877788999999999999999998644432 223
Q ss_pred cccceeeccCCccccccCCc
Q 046598 573 QLVKNLNLSNNDLEGVVPTQ 592 (986)
Q Consensus 573 ~~L~~l~ls~N~l~~~~p~~ 592 (986)
..++.+..+.|.+.+..|..
T Consensus 248 ~~l~~~~~~~~~~~c~~p~~ 267 (285)
T 1ozn_A 248 AWLQKFRGSSSEVPCSLPQR 267 (285)
T ss_dssp HHHHHCCSEECCCBEEESGG
T ss_pred HHHHhcccccCccccCCchH
Confidence 45667778899999998875
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-26 Score=274.78 Aligned_cols=108 Identities=31% Similarity=0.355 Sum_probs=68.5
Q ss_pred CCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccCcccccCCccccEEe
Q 046598 452 ETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLE 531 (986)
Q Consensus 452 ~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 531 (986)
++|+.|++++|+++ .+|.. +++|+.|+|++|+|++ +| ..+++|+.|+|++|+|+ .+|. .+++|+.|+
T Consensus 201 ~~L~~L~L~~N~l~-~l~~~----~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~ 267 (622)
T 3g06_A 201 SELYKLWAYNNRLT-SLPAL----PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLS 267 (622)
T ss_dssp TTCCEEECCSSCCS-SCCCC----CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEE
T ss_pred chhhEEECcCCccc-ccCCC----CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEe
Confidence 45666666666666 45532 3556667777776664 44 33456666666666666 3444 456666777
Q ss_pred cccccccccCCccccCCCCCCEEeCCCccCcccCchhhhccc
Q 046598 532 MQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQ 573 (986)
Q Consensus 532 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 573 (986)
|++|+|+ .+|..+.++++|+.|+|++|++++.+|..+..++
T Consensus 268 Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 268 VYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp CCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred CCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence 7777776 5566677777777777777777766666666554
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-28 Score=270.08 Aligned_cols=222 Identities=19% Similarity=0.207 Sum_probs=164.2
Q ss_pred cceEEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCcccccccccEEEecc
Q 046598 358 TLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSY 437 (986)
Q Consensus 358 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~ 437 (986)
+|+.|+|++|++++..+ +..+++|++|++++|.+++.. ..++|++|++++|++++..+..+ .+|++|++++
T Consensus 59 ~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~~--~~L~~L~l~~ 129 (317)
T 3o53_A 59 KLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIETLHAANNNISRVSCSRG--QGKKNIYLAN 129 (317)
T ss_dssp TCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEE-----ECTTCCEEECCSSCCSEEEECCC--SSCEEEECCS
T ss_pred cCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccccc-----CCCCcCEEECCCCccCCcCcccc--CCCCEEECCC
Confidence 44555555555554333 666777777777777776432 23677777777777776665543 2477888888
Q ss_pred cccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccC
Q 046598 438 NFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEI 517 (986)
Q Consensus 438 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 517 (986)
|++++..+..+..+++|++|+|++|++++..+..++..+++|++|+|++|+|++. |. ...+++|++|+|++|++++ +
T Consensus 130 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~-l 206 (317)
T 3o53_A 130 NKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAF-M 206 (317)
T ss_dssp SCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCE-E
T ss_pred CCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCc-c
Confidence 8888777778888888888888888888555565555678888888888888854 33 3357888888888888884 5
Q ss_pred cccccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCc-ccCchhhhcccccceeecc-CCccccccCCc
Q 046598 518 PSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLS-GKIPELLIRLQLVKNLNLS-NNDLEGVVPTQ 592 (986)
Q Consensus 518 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~l~ls-~N~l~~~~p~~ 592 (986)
|..+..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+++ +.+|..+..+++|+.|+++ .+.++|..|..
T Consensus 207 ~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~~ 282 (317)
T 3o53_A 207 GPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEE 282 (317)
T ss_dssp CGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSCC
T ss_pred hhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchhc
Confidence 555888888888888888888 46777888888888888888888 7788888888888888888 55677766654
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.1e-28 Score=266.16 Aligned_cols=157 Identities=22% Similarity=0.248 Sum_probs=85.6
Q ss_pred cceEEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCccc-CCCCCCEEEccCccceeecCcccccccccEEEec
Q 046598 358 TLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIG-ELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLS 436 (986)
Q Consensus 358 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~ 436 (986)
+|+.|++++|++++..+..+..+++|++|++++|.+++..+..+. .+++|++|+|++|+|++. +..
T Consensus 121 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~------------ 187 (317)
T 3o53_A 121 GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KGQ------------ 187 (317)
T ss_dssp SCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-ECC------------
T ss_pred CCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-ccc------------
Confidence 355666666666655566666667777777777777665555553 566666666666666643 111
Q ss_pred ccccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCcccc-c
Q 046598 437 YNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLK-G 515 (986)
Q Consensus 437 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~ 515 (986)
..+++|++|+|++|+|+ .+|+. +..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|.+. +
T Consensus 188 ------------~~l~~L~~L~Ls~N~l~-~l~~~-~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~ 252 (317)
T 3o53_A 188 ------------VVFAKLKTLDLSSNKLA-FMGPE-FQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCG 252 (317)
T ss_dssp ------------CCCTTCCEEECCSSCCC-EECGG-GGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHH
T ss_pred ------------cccccCCEEECCCCcCC-cchhh-hcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCc
Confidence 12444555555555554 33333 334455555555555555 34444555555555555555555 4
Q ss_pred cCcccccCCccccEEecc-cccccccCC
Q 046598 516 EIPSTLGSCIKLEQLEMQ-ENFLQGPIP 542 (986)
Q Consensus 516 ~~p~~~~~l~~L~~L~L~-~N~l~~~~p 542 (986)
.+|..+..+++|+.|+++ .+.+++..|
T Consensus 253 ~~~~~~~~~~~L~~l~l~~~~~l~~~~~ 280 (317)
T 3o53_A 253 TLRDFFSKNQRVQTVAKQTVKKLTGQNE 280 (317)
T ss_dssp HHHHHHHTCHHHHHHHHHHHHHHHSSSS
T ss_pred CHHHHHhccccceEEECCCchhccCCch
Confidence 455555555555555555 333444333
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-28 Score=289.79 Aligned_cols=185 Identities=17% Similarity=0.034 Sum_probs=129.2
Q ss_pred cccccceeEEEEEECCCCeEEEEEEeeccC----------chhHHHHHHHHHHHhcC-CCCcceeeeeeccccccCCCce
Q 046598 696 IGEGSFGSVFKGILDDGRTTIAVKVFNLLH----------HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 696 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~ 764 (986)
.+.|+.|.+..++..-.++.||+|++.... ....+++.+|+++|+++ .|+||++++++ ++++..
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~-----~ed~~~ 316 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAH-----GENAQS 316 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEE-----EECSSE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEE-----EEECCE
Confidence 455666666666655557889999996421 22346799999999999 79999999999 677899
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.||||||++|++|.+++.. .++++.. +|+.||+.||+|+|++ |||||||||+|||++++|.+||
T Consensus 317 ~yLVMEyv~G~~L~d~i~~----------~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL 380 (569)
T 4azs_A 317 GWLVMEKLPGRLLSDMLAA----------GEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARL 380 (569)
T ss_dssp EEEEEECCCSEEHHHHHHT----------TCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEE
T ss_pred EEEEEecCCCCcHHHHHHh----------CCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEE
Confidence 9999999999999999953 2345543 5899999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCC
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p 904 (986)
+|||+|+...... ......+||+.|||||++.+ .+..++|+||+|++.+++.++..+
T Consensus 381 ~DFGlAr~~~~~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 381 IDFGSIVTTPQDC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp CCCTTEESCC-----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred eecccCeeCCCCC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 9999998764332 22345679999999999876 467889999999998887665444
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=7.9e-27 Score=250.41 Aligned_cols=220 Identities=20% Similarity=0.265 Sum_probs=175.3
Q ss_pred CCCCcceeeEecCCCCeEEEEeccCCCCccccCcCccCCCCCCEEEccCCCccccCCcchhccccCceeeceecccCCCC
Q 046598 47 SHFCQWRGVTCSRRHQRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAI 126 (986)
Q Consensus 47 ~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 126 (986)
.++|.|.|+.|+... .++.+|+++++++ .+|..+. +.|++|+|++|++++..+.+|.++++|++|+|++|+++...
T Consensus 2 ~~~C~~~~~~C~c~~-~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~ 77 (270)
T 2o6q_A 2 EALCKKDGGVCSCNN-NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLP 77 (270)
T ss_dssp CCCBGGGTCSBEEET-TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCC
T ss_pred CccCCCCCCCCEeCC-CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeC
Confidence 478999999886532 3567999999998 5776665 67999999999999877788999999999999999999666
Q ss_pred ccchhcCccccceecccccccCccCccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeeccCCcccCcCcchhhccC
Q 046598 127 PANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLK 206 (986)
Q Consensus 127 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 206 (986)
+..|..+++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|+++++|++|+|++|++++..+..|..++
T Consensus 78 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~ 157 (270)
T 2o6q_A 78 AGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLT 157 (270)
T ss_dssp TTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred hhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCc
Confidence 66778899999999999999977777888999999999999999988888888999999999999999876667788889
Q ss_pred CCceeecccccccccCCccccCCCCccEEeccccccccccCCcccccccccceEEecCceecccCCccccCCCCCcEEec
Q 046598 207 NLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHG 286 (986)
Q Consensus 207 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l 286 (986)
+|++|+|++|++++..+..+.+++ +|++|++++|++++..+..|..+++|+.|++
T Consensus 158 ~L~~L~L~~n~l~~~~~~~~~~l~-------------------------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 212 (270)
T 2o6q_A 158 SLKELRLYNNQLKRVPEGAFDKLT-------------------------ELKTLKLDNNQLKRVPEGAFDSLEKLKMLQL 212 (270)
T ss_dssp TCCEEECCSSCCSCCCTTTTTTCT-------------------------TCCEEECCSSCCSCCCTTTTTTCTTCCEEEC
T ss_pred ccceeEecCCcCcEeChhHhccCC-------------------------CcCEEECCCCcCCcCCHHHhccccCCCEEEe
Confidence 999999999988865555555544 4555555555555555555667777777777
Q ss_pred ccccccCCC
Q 046598 287 SVNKLTGAA 295 (986)
Q Consensus 287 s~N~l~~~~ 295 (986)
++|.+....
T Consensus 213 ~~N~~~c~c 221 (270)
T 2o6q_A 213 QENPWDCTC 221 (270)
T ss_dssp CSSCBCCSS
T ss_pred cCCCeeCCC
Confidence 777775543
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.2e-30 Score=306.66 Aligned_cols=455 Identities=15% Similarity=0.131 Sum_probs=257.9
Q ss_pred CCCcceeeEecCCCCeEEEEeccCCCCccccCcCccCCCCCCEEEccCCCccc---cCC------------cchhccccC
Q 046598 48 HFCQWRGVTCSRRHQRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNH---EIP------------SEFDRLRRL 112 (986)
Q Consensus 48 ~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~---~~p------------~~~~~l~~L 112 (986)
-|++|+++... ....++++..... .....+..++.|+.|+|+++.... ..| ..+..+++|
T Consensus 33 vck~W~~~~~~----~~~~l~~~~~~~~-~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L 107 (594)
T 2p1m_B 33 VCKSWYEIERW----CRRKVFIGNCYAV-SPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWL 107 (594)
T ss_dssp SCHHHHHHHHH----HCCEEEESSTTSS-CHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTC
T ss_pred HHHHHHHhhhh----hceEEeecccccc-CHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCC
Confidence 35589998321 2234555543321 112335677889999999875321 122 224567788
Q ss_pred ceeeceecccCCCCccchh-cCccccceecccc-cccCc-cCccccCCCCCCeEEccCCcCCCCcccccC----CCcCcc
Q 046598 113 QVLALHYNSIGGAIPANIS-SCSNLIQLRLFHN-QLVGK-IPSELSSLSKIEHISVNDNNLTGSIPSSLG----NLSSIR 185 (986)
Q Consensus 113 ~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~----~l~~L~ 185 (986)
++|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+. .+++|+
T Consensus 108 ~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~ 187 (594)
T 2p1m_B 108 EEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLV 187 (594)
T ss_dssp CEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCC
T ss_pred CeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCc
Confidence 8888888888876666665 6888888888888 44432 444455788888888888887765544443 566888
Q ss_pred eeeccCCc--ccC-cCcchhhccCCCceeecccc-cccccCCccccCCCCccEEeccccccccccCCcccccccccceEE
Q 046598 186 SLFLSGNN--LEG-SIPDTLGWLKNLVNLTMAQN-RLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFS 261 (986)
Q Consensus 186 ~L~L~~N~--l~~-~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~ 261 (986)
+|+|++|. ++. .++..+..+++|++|+|++| .++ .+|..+.++++|+.|+++.+.. +
T Consensus 188 ~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~-~l~~~~~~~~~L~~L~l~~~~~------------------~ 248 (594)
T 2p1m_B 188 SLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLE-KLATLLQRAPQLEELGTGGYTA------------------E 248 (594)
T ss_dssp EEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHH-HHHHHHHHCTTCSEEECSBCCC------------------C
T ss_pred EEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHH-HHHHHHhcCCcceEcccccccC------------------c
Confidence 88888886 221 11122244578888888877 344 3666666666666666543321 1
Q ss_pred ecCceecccCCccccCCCCCcEEe-cccccccCCCchhhhhhhHhhhhhccCCCCCCCCCCcccccccccccccceeecc
Q 046598 262 VGENQLTGAIPPTISNASNLEIFH-GSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLIN 340 (986)
Q Consensus 262 L~~N~l~~~~p~~l~~l~~L~~L~-ls~N~l~~~~~~l~~l~~L~~l~l~~n~l~~~~~~~l~~l~~l~~~~~L~~l~l~ 340 (986)
++.|.+.+ ++..+.++++|+.+. +......
T Consensus 249 ~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~~~------------------------------------------------ 279 (594)
T 2p1m_B 249 VRPDVYSG-LSVALSGCKELRCLSGFWDAVPA------------------------------------------------ 279 (594)
T ss_dssp CCHHHHHH-HHHHHHTCTTCCEEECCBTCCGG------------------------------------------------
T ss_pred cchhhHHH-HHHHHhcCCCcccccCCcccchh------------------------------------------------
Confidence 22333443 233555666666552 2111110
Q ss_pred ccccccCCCcccccccccceEEEccCCcccccCC-ccccCCCCCCEEEccCccccCc-CCCcccCCCCCCEEEccC----
Q 046598 341 INNFGGSLPACISNLSTTLEVLLLDNNQIFGNIP-AAIGKFVNLQRLDMCSNRLSGT-IPPAIGELQNLKDLRLQR---- 414 (986)
Q Consensus 341 ~n~~~~~~p~~~~~~~~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~---- 414 (986)
.+|..+.. .++|+.|++++|.+++... ..+..+++|++|++++| ++.. ++.....+++|++|+|++
T Consensus 280 ------~l~~~~~~-~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~ 351 (594)
T 2p1m_B 280 ------YLPAVYSV-CSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPF 351 (594)
T ss_dssp ------GGGGGHHH-HTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTT
T ss_pred ------hHHHHHHh-hCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCccc
Confidence 11111111 1456666666666543322 22456677777777776 3322 222223467777777733
Q ss_pred -----ccceeecCcccc--cccccEEEecccccCCCCCcccC-CCCCCCeeecC--C----CccCCCCCc-----ccccC
Q 046598 415 -----NRFQGNIPPSIG--NLKLFILYLSYNFLQGSIPSSLG-RYETLTTIDLS--N----NNLTGTIPP-----QFIGL 475 (986)
Q Consensus 415 -----N~l~~~~~~~~~--~~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~--~----N~l~~~ip~-----~~~~~ 475 (986)
|.+++.....+. ..+|++|.++.|.+++..+..+. .+++|+.|+++ + |.++ ..|. ..+..
T Consensus 352 g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~-~~~~~~~~~~l~~~ 430 (594)
T 2p1m_B 352 VMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLT-LEPLDIGFGAIVEH 430 (594)
T ss_dssp CSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTT-CCCTHHHHHHHHHH
T ss_pred ccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCccccc-CCchhhHHHHHHhh
Confidence 344432222211 22466666666666654444443 36677777777 3 4554 2221 11344
Q ss_pred CCcceEEEccCCcccccCCccccc-ccccchhhccCccccccCcccc-cCCccccEEecccccccccCCc-cccCCCCCC
Q 046598 476 SSSLIVLDLSRNQLTGSIPSEVGN-LKNLEILNVFGNKLKGEIPSTL-GSCIKLEQLEMQENFLQGPIPS-SLSSLRGLS 552 (986)
Q Consensus 476 ~~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~ 552 (986)
+++|+.|+|++ .+++..+..+.. +++|+.|+|++|.+++..+..+ ..+++|++|+|++|.+++..+. .+..+++|+
T Consensus 431 ~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~ 509 (594)
T 2p1m_B 431 CKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMR 509 (594)
T ss_dssp CTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSS
T ss_pred CCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCC
Confidence 56777777766 555544444444 6677777777777765544444 5577777777777777544333 334467777
Q ss_pred EEeCCCccCcccCchhh-hcccccceeeccCCcc
Q 046598 553 VLDLSQNNLSGKIPELL-IRLQLVKNLNLSNNDL 585 (986)
Q Consensus 553 ~L~Ls~N~l~~~~p~~~-~~l~~L~~l~ls~N~l 585 (986)
.|+|++|+++......+ ..++.|+...+..+.-
T Consensus 510 ~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~~ 543 (594)
T 2p1m_B 510 SLWMSSCSVSFGACKLLGQKMPKLNVEVIDERGA 543 (594)
T ss_dssp EEEEESSCCBHHHHHHHHHHCTTEEEEEECSSSC
T ss_pred EEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCCc
Confidence 77777777754333334 4456666655655543
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-26 Score=270.42 Aligned_cols=247 Identities=20% Similarity=0.206 Sum_probs=215.7
Q ss_pred cccccceeeccccccccCCCcccccccccceEEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCE
Q 046598 330 NATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKD 409 (986)
Q Consensus 330 ~~~~L~~l~l~~n~~~~~~p~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 409 (986)
.+++|+.|++++|.+++..|..+..+ ++|++|+|++|.|++..| |..+++|++|+|++|.|++..+ .++|+.
T Consensus 32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~ 103 (487)
T 3oja_A 32 SAWNVKELDLSGNPLSQISAADLAPF-TKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIET 103 (487)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGGTTC-TTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCE
T ss_pred cCCCccEEEeeCCcCCCCCHHHHhCC-CCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCE
Confidence 45588999999999998777777666 689999999999997766 9999999999999999995443 389999
Q ss_pred EEccCccceeecCcccccccccEEEecccccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcc
Q 046598 410 LRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQL 489 (986)
Q Consensus 410 L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l 489 (986)
|++++|.|++..+..+ .+|++|+|++|.+++..|..|+.+++|++|+|++|+|++.+|..+...+++|+.|+|++|.|
T Consensus 104 L~L~~N~l~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l 181 (487)
T 3oja_A 104 LHAANNNISRVSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181 (487)
T ss_dssp EECCSSCCCCEEECCC--SSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCC
T ss_pred EECcCCcCCCCCcccc--CCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcc
Confidence 9999999998877655 36999999999999999999999999999999999999878877666789999999999999
Q ss_pred cccCCcccccccccchhhccCccccccCcccccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCc-ccCchh
Q 046598 490 TGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLS-GKIPEL 568 (986)
Q Consensus 490 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~ 568 (986)
++. | .+..+++|+.|+|++|+|++ +|..+..+++|+.|+|++|.|++ +|..+..+++|+.|+|++|+++ +.+|..
T Consensus 182 ~~~-~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~ 257 (487)
T 3oja_A 182 YDV-K-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDF 257 (487)
T ss_dssp CEE-E-CCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHH
T ss_pred ccc-c-ccccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHH
Confidence 975 3 34469999999999999996 45569999999999999999995 7888999999999999999998 788899
Q ss_pred hhcccccceeecc-------CCccccccC
Q 046598 569 LIRLQLVKNLNLS-------NNDLEGVVP 590 (986)
Q Consensus 569 ~~~l~~L~~l~ls-------~N~l~~~~p 590 (986)
+..++.|+.++++ .|+..+..+
T Consensus 258 ~~~l~~L~~l~~~~~~~~~~~~~~~c~~~ 286 (487)
T 3oja_A 258 FSKNQRVQTVAKQTVKKLTGQNEEECTVP 286 (487)
T ss_dssp HTTCHHHHHHHHHHHHHHTSSSSCCCSST
T ss_pred HHhCCCCcEEeccccccccCCCcccccCC
Confidence 9999999999997 555554443
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-25 Score=240.58 Aligned_cols=209 Identities=22% Similarity=0.233 Sum_probs=142.3
Q ss_pred CCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCcccccc-cccEEEecccccCCCCCcccCCCCCCCeeecC
Q 046598 382 NLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNL-KLFILYLSYNFLQGSIPSSLGRYETLTTIDLS 460 (986)
Q Consensus 382 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 460 (986)
+|++|++++|.+++..+..|..+++|++|+|++|++++..+..+..+ +|++|+|++|.+++..+..|.++++|++|+++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 44455555555544444444445555555555555544444444332 35555555555555556667777777777777
Q ss_pred CCccCCCCCcccccCCCcceEEEccCCccccc-CCcccccccccchhhccCccccccCcccccCCcccc----EEecccc
Q 046598 461 NNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGS-IPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLE----QLEMQEN 535 (986)
Q Consensus 461 ~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~----~L~L~~N 535 (986)
+|+++ .++...++.+++|++|++++|++++. +|..|..+++|++|+|++|++++..+..+..+++|+ +|++++|
T Consensus 109 ~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n 187 (276)
T 2z62_A 109 ETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (276)
T ss_dssp TSCCC-CSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSS
T ss_pred CCCcc-ccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCC
Confidence 77777 44443366777788888888877753 477788888888888888888876667777766666 8888899
Q ss_pred cccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCccccccCCc
Q 046598 536 FLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQ 592 (986)
Q Consensus 536 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~ 592 (986)
.+++..+..+.. .+|+.|+|++|+|++..+..+..+++|++|+|++|+++|..|..
T Consensus 188 ~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~l 243 (276)
T 2z62_A 188 PMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 243 (276)
T ss_dssp CCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTTT
T ss_pred cccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCch
Confidence 888655555544 48999999999998777777888999999999999999887754
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4e-25 Score=238.12 Aligned_cols=221 Identities=20% Similarity=0.226 Sum_probs=190.2
Q ss_pred ccCcCccCCCCCCEEEccCCCccccCCcchhccccCceeeceecccCCCCccchhcCccccceecccccccCccCccccC
Q 046598 77 SISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSS 156 (986)
Q Consensus 77 ~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 156 (986)
.+|..+. +.|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|.+++..+..|.+
T Consensus 21 ~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 98 (276)
T 2z62_A 21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG 98 (276)
T ss_dssp SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTT
T ss_pred ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcC
Confidence 4555543 57899999999999888889999999999999999999777788999999999999999999888889999
Q ss_pred CCCCCeEEccCCcCCCCcccccCCCcCcceeeccCCcccCc-CcchhhccCCCceeecccccccccCCccccCCCCcc--
Q 046598 157 LSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGS-IPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSIT-- 233 (986)
Q Consensus 157 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~-- 233 (986)
+++|++|++++|++++..+..++++++|++|+|++|++++. +|..|+.+++|++|+|++|++++..+..+..+.+|+
T Consensus 99 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l 178 (276)
T 2z62_A 99 LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL 178 (276)
T ss_dssp CTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTC
T ss_pred CccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhcccc
Confidence 99999999999999987777899999999999999999864 589999999999999999999987778888777777
Q ss_pred --EEeccccccccccCCcccccccccceEEecCceecccCCccccCCCCCcEEecccccccCCCchhhhh
Q 046598 234 --GFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKL 301 (986)
Q Consensus 234 --~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~l~~l 301 (986)
.|++++|.+.+..+ ..+ ...+|+.|++++|++++..+..|..+++|+.|++++|.++...+.+..+
T Consensus 179 ~l~L~ls~n~l~~~~~-~~~-~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~l~~l 246 (276)
T 2z62_A 179 NLSLDLSLNPMNFIQP-GAF-KEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYL 246 (276)
T ss_dssp CEEEECCSSCCCEECT-TSS-CSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTTTHHH
T ss_pred ceeeecCCCcccccCc-ccc-CCCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCchHHH
Confidence 89999999985444 333 2458999999999999887778899999999999999999776654444
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-28 Score=295.94 Aligned_cols=213 Identities=15% Similarity=0.093 Sum_probs=149.1
Q ss_pred cCCccccCCCCCCEEEccCccccCcCCC-cccCCCCCCEEEccCccceee-cCcccc-cccccEEEecc---------cc
Q 046598 372 NIPAAIGKFVNLQRLDMCSNRLSGTIPP-AIGELQNLKDLRLQRNRFQGN-IPPSIG-NLKLFILYLSY---------NF 439 (986)
Q Consensus 372 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~-~~~~~~-~~~L~~L~L~~---------N~ 439 (986)
.++..+..+++|++|+|++|.+++.... .+..+++|++|++++| +... ++.... ..+|++|+++. |.
T Consensus 280 ~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~ 358 (594)
T 2p1m_B 280 YLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVA 358 (594)
T ss_dssp GGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSC
T ss_pred hHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCC
Confidence 3455556789999999999998743322 3568899999999988 4422 222222 23689998843 45
Q ss_pred cCCCCCcccC-CCCCCCeeecCCCccCCCCCcccccCCCcceEEEcc--C----Cccccc-----CCcccccccccchhh
Q 046598 440 LQGSIPSSLG-RYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLS--R----NQLTGS-----IPSEVGNLKNLEILN 507 (986)
Q Consensus 440 l~~~~p~~~~-~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls--~----N~l~~~-----~p~~~~~l~~L~~L~ 507 (986)
+++.....+. .+++|+.|+++.|++++..+..+...+++|+.|+++ + |.+++. ++..+..+++|+.|+
T Consensus 359 l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~ 438 (594)
T 2p1m_B 359 LTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLS 438 (594)
T ss_dssp CCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEE
T ss_pred CCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEe
Confidence 5543333333 378899998888888755444433457889999998 4 566621 122256678899999
Q ss_pred ccCccccccCcccccC-CccccEEecccccccccCCccc-cCCCCCCEEeCCCccCcccCch-hhhcccccceeeccCCc
Q 046598 508 VFGNKLKGEIPSTLGS-CIKLEQLEMQENFLQGPIPSSL-SSLRGLSVLDLSQNNLSGKIPE-LLIRLQLVKNLNLSNND 584 (986)
Q Consensus 508 Ls~N~l~~~~p~~~~~-l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~l~ls~N~ 584 (986)
|++ .+++..+..++. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|++++.... .+..+++|++|++++|+
T Consensus 439 L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~ 517 (594)
T 2p1m_B 439 LSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCS 517 (594)
T ss_dssp CCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSC
T ss_pred ecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCC
Confidence 977 677666666665 8889999999999876655555 6688999999999998655444 44558899999999998
Q ss_pred cc
Q 046598 585 LE 586 (986)
Q Consensus 585 l~ 586 (986)
++
T Consensus 518 ~~ 519 (594)
T 2p1m_B 518 VS 519 (594)
T ss_dssp CB
T ss_pred CC
Confidence 84
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.3e-24 Score=229.96 Aligned_cols=206 Identities=24% Similarity=0.286 Sum_probs=149.9
Q ss_pred cceEEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCcccccccccEEEecc
Q 046598 358 TLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSY 437 (986)
Q Consensus 358 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~ 437 (986)
..+.+++++++++ .+|..+. ++|++|+|++|.+++..+..|..+++|++|+|++|+++.
T Consensus 17 ~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~------------------ 75 (270)
T 2o6q_A 17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT------------------ 75 (270)
T ss_dssp TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSC------------------
T ss_pred CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCe------------------
Confidence 4567777777777 3554443 567777777777776666677777777777666666652
Q ss_pred cccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccC
Q 046598 438 NFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEI 517 (986)
Q Consensus 438 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 517 (986)
..+..|..+++|++|++++|+++ .+|...+..+++|++|++++|++++..+..|..+++|++|+|++|++++..
T Consensus 76 -----i~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~ 149 (270)
T 2o6q_A 76 -----LPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLP 149 (270)
T ss_dssp -----CCTTTTSSCTTCCEEECCSSCCC-CCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred -----eChhhhcCCCCCCEEECCCCcCC-cCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccC
Confidence 33444566777777777777776 555555667777777777777777666666777788888888888887655
Q ss_pred cccccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCccccccC
Q 046598 518 PSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVP 590 (986)
Q Consensus 518 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p 590 (986)
+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..+..+++|+.|+|++|++.+..+
T Consensus 150 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 150 KGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred HhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 5667778888888888888887666677888888888888888887666677778888888888888877655
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.92 E-value=8.4e-25 Score=231.85 Aligned_cols=192 Identities=19% Similarity=0.243 Sum_probs=170.5
Q ss_pred CCCcceeeEecCCCCeEEEEeccCCCCccccCcCccCCCCCCEEEccCCCccccCCcchhccccCceeeceecccCCCCc
Q 046598 48 HFCQWRGVTCSRRHQRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIP 127 (986)
Q Consensus 48 ~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 127 (986)
+||.|.|++|... ...+|+++++++ .+|..+. +.|+.|+|++|++.+..+..|.++++|++|+|++|++++..|
T Consensus 3 ~Cp~~~gC~C~~~---~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 76 (251)
T 3m19_A 3 TCETVTGCTCNEG---KKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSA 76 (251)
T ss_dssp -CHHHHSSEEEGG---GTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCT
T ss_pred cCCCCCceEcCCC---CeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCH
Confidence 5889999999643 346889999988 6777665 689999999999999999999999999999999999998888
Q ss_pred cchhcCccccceecccccccCccCccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeeccCCcccCcCcchhhccCC
Q 046598 128 ANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKN 207 (986)
Q Consensus 128 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 207 (986)
..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|+|++..+..|+.+++
T Consensus 77 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 156 (251)
T 3m19_A 77 GVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTN 156 (251)
T ss_dssp TTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred hHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcC
Confidence 88999999999999999999888888999999999999999999888888899999999999999999777778999999
Q ss_pred CceeecccccccccCCccccCCCCccEEeccccccccc
Q 046598 208 LVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGA 245 (986)
Q Consensus 208 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~ 245 (986)
|++|+|++|++++..+..+..+++|+.|++++|.+...
T Consensus 157 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 157 LQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 99999999999977777888888888888888887654
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-24 Score=235.79 Aligned_cols=205 Identities=27% Similarity=0.288 Sum_probs=105.7
Q ss_pred ccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCcccccccccEEEecccccCCCCCcccCCCCCCCe
Q 046598 377 IGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTT 456 (986)
Q Consensus 377 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 456 (986)
+.++++++++++++|.++ .+|..+. ++++.|+|++|+|++..+.. |..+++|++
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~-----------------------~~~l~~L~~ 59 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLAT-----------------------LMPYTRLTQ 59 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGG-----------------------GTTCTTCCE
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHH-----------------------hhcCCCCCE
Confidence 556677777777777776 4454443 45666666666666544444 444444555
Q ss_pred eecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccCcccccCCccccEEeccccc
Q 046598 457 IDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENF 536 (986)
Q Consensus 457 L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 536 (986)
|+|++|+|+ .++.. +.+++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|++..|..|..+++|++|+|++|+
T Consensus 60 L~L~~n~l~-~~~~~--~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~ 135 (290)
T 1p9a_G 60 LNLDRAELT-KLQVD--GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNE 135 (290)
T ss_dssp EECTTSCCC-EEECC--SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSC
T ss_pred EECCCCccC-cccCC--CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCC
Confidence 555555544 22221 33444555555555554 344444455555555555555554444445555555555555555
Q ss_pred ccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCccccccCCccccccccceeeeCCccccc
Q 046598 537 LQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQGVFKNASITSVFGNLKLCG 611 (986)
Q Consensus 537 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lcg 611 (986)
|++..+..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|+|+..++.......+..+.+.||||.|+
T Consensus 136 l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~ 210 (290)
T 1p9a_G 136 LKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCN 210 (290)
T ss_dssp CCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred CCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCc
Confidence 554444444555555555555555554444444455555555555555554433333334444555555555554
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=4.7e-24 Score=230.67 Aligned_cols=203 Identities=26% Similarity=0.266 Sum_probs=140.5
Q ss_pred cccceEEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCcccccccccEEEe
Q 046598 356 STTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYL 435 (986)
Q Consensus 356 ~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L 435 (986)
.++++.+++++|+++ .+|..+. ++++.|+|++|.+++..+..|..+++|++|+|++|+|++..+.
T Consensus 9 l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~------------ 73 (290)
T 1p9a_G 9 VASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD------------ 73 (290)
T ss_dssp STTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC------------
T ss_pred cCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC------------
Confidence 367899999999999 4555554 6899999999999988889999999999999999998854321
Q ss_pred cccccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccc
Q 046598 436 SYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKG 515 (986)
Q Consensus 436 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 515 (986)
+.+++|++|+|++|+|+ .+|.. +..+++|++|+|++|+|++..|..|..+++|++|+|++|+|++
T Consensus 74 -------------~~l~~L~~L~Ls~N~l~-~l~~~-~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ 138 (290)
T 1p9a_G 74 -------------GTLPVLGTLDLSHNQLQ-SLPLL-GQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT 138 (290)
T ss_dssp -------------SCCTTCCEEECCSSCCS-SCCCC-TTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCC
T ss_pred -------------CCCCcCCEEECCCCcCC-cCchh-hccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCc
Confidence 34455666666666665 55544 4455566666666666665445556666666666666666665
Q ss_pred cCcccccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCcccccc
Q 046598 516 EIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVV 589 (986)
Q Consensus 516 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~ 589 (986)
..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+.+|+.|+|++|++.+..
T Consensus 139 ~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 139 LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp CCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred cChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcC
Confidence 55555666666666666666666555555566667777777777766 45666666666777777777766543
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-24 Score=232.78 Aligned_cols=220 Identities=20% Similarity=0.217 Sum_probs=178.8
Q ss_pred ceEEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCccccc-ccccEEEecc
Q 046598 359 LEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGN-LKLFILYLSY 437 (986)
Q Consensus 359 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-~~L~~L~L~~ 437 (986)
+..+.+.++.+.+. ..+..+++|+.|++++|.++. ...+..+++|++|+|++|++++. + .+.. .+|++|+|++
T Consensus 21 l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~--~~~l~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~L~~ 94 (272)
T 3rfs_A 21 TIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIKS--VQGIQYLPNVRYLALGGNKLHDI-S-ALKELTNLTYLILTG 94 (272)
T ss_dssp HHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCC--CTTGGGCTTCCEEECTTSCCCCC-G-GGTTCTTCCEEECTT
T ss_pred HHHHHhcCcccccc--cccccccceeeeeeCCCCccc--ccccccCCCCcEEECCCCCCCCc-h-hhcCCCCCCEEECCC
Confidence 34455556655533 335667778888888888762 23577788888888888887753 3 3333 3588888888
Q ss_pred cccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccC
Q 046598 438 NFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEI 517 (986)
Q Consensus 438 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 517 (986)
|.+++..+..|..+++|++|++++|+++ .+|...++.+++|++|++++|++++..+..|..+++|+.|+|++|++++..
T Consensus 95 n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 173 (272)
T 3rfs_A 95 NQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLP 173 (272)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CccCccChhHhcCCcCCCEEECCCCcCC-ccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccC
Confidence 8888788888899999999999999998 566666788899999999999999777777899999999999999999877
Q ss_pred cccccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCccccccCCc
Q 046598 518 PSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQ 592 (986)
Q Consensus 518 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~ 592 (986)
+..|+.+++|++|+|++|++++..|..+..+++|+.|+|++|++++. ++.|+.|+++.|.++|.+|..
T Consensus 174 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~ 241 (272)
T 3rfs_A 174 EGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNS 241 (272)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCT
T ss_pred HHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCc
Confidence 77889999999999999999988888899999999999999999865 446888999999999999976
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.90 E-value=5.2e-24 Score=228.60 Aligned_cols=206 Identities=18% Similarity=0.190 Sum_probs=168.3
Q ss_pred eEEEEeccCCCCccccCcCccCCCCCCEEEccCCCccccCCcchhccccCceeeceecccCCCCccchhcCccccceecc
Q 046598 63 RVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLF 142 (986)
Q Consensus 63 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 142 (986)
+++.++++++.+.. .+.++.+++|++|+|++|.+.+. ..+..+++|++|+|++|++++..|..|+.+++|++|+|+
T Consensus 42 ~L~~L~l~~~~i~~--~~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 117 (272)
T 3rfs_A 42 SIDQIIANNSDIKS--VQGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLV 117 (272)
T ss_dssp TCCEEECTTSCCCC--CTTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred ceeeeeeCCCCccc--ccccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECC
Confidence 47778888887763 24578888888888888888753 478888888888888888887777778888888888888
Q ss_pred cccccCccCccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeeccCCcccCcCcchhhccCCCceeecccccccccC
Q 046598 143 HNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTI 222 (986)
Q Consensus 143 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 222 (986)
+|++++..+..|+++++|++|+|++|++++..+..|+++++|++|+|++|++++..+..|+.+++|++|+|++|++++..
T Consensus 118 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 197 (272)
T 3rfs_A 118 ENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVP 197 (272)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccC
Confidence 88888777777888888888888888888777777888888888888888888777777888888888888888888777
Q ss_pred CccccCCCCccEEeccccccccccCCcccccccccceEEecCceecccCCccccCCCC
Q 046598 223 PSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASN 280 (986)
Q Consensus 223 p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 280 (986)
|..+.++++|+.|++++|.+.+. +++|+.|+++.|.++|.+|.+++.+..
T Consensus 198 ~~~~~~l~~L~~L~l~~N~~~~~--------~~~l~~l~~~~n~~~g~ip~~~~~~~~ 247 (272)
T 3rfs_A 198 DGVFDRLTSLQYIWLHDNPWDCT--------CPGIRYLSEWINKHSGVVRNSAGSVAP 247 (272)
T ss_dssp TTTTTTCTTCCEEECCSSCBCCC--------TTTTHHHHHHHHHTGGGBBCTTSCBCG
T ss_pred HHHHhCCcCCCEEEccCCCcccc--------CcHHHHHHHHHHhCCCcccCcccccCC
Confidence 77788888888888888887754 346788888888888888888776654
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.7e-24 Score=253.83 Aligned_cols=190 Identities=15% Similarity=0.121 Sum_probs=142.3
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc--------hhHHHHHHHHHHHhcCCCCcceeeeeeccccc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH--------GAFKSFIAECNTLKNIRHRNLVKILTACSGVD 758 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 758 (986)
...+...+.||+|+||.||+|... ++.+|+|+...... ...+++.+|++++++++||||+++..++.
T Consensus 335 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~--- 409 (540)
T 3en9_A 335 KKRKIPEHLIGKGAEADIKRDSYL--DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDV--- 409 (540)
T ss_dssp -------------CCEEEEEEECS--SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEE---
T ss_pred cccCCCCCEEeeCCCEEEEEEEEC--CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEE---
Confidence 333455678999999999999554 57889998643111 11355899999999999999995544422
Q ss_pred cCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecC
Q 046598 759 YQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDE 838 (986)
Q Consensus 759 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 838 (986)
..+..|+||||+++++|.++++. +..|+.|+++||+|||++ +|+||||||+||+++.
T Consensus 410 --~~~~~~lVmE~~~ggsL~~~l~~------------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~ 466 (540)
T 3en9_A 410 --DLDNKRIMMSYINGKLAKDVIED------------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK 466 (540)
T ss_dssp --ETTTTEEEEECCCSEEHHHHSTT------------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS
T ss_pred --eCCccEEEEECCCCCCHHHHHHH------------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC
Confidence 23456999999999999999952 458999999999999999 9999999999999998
Q ss_pred CCcEEEcccccceecCCCCCcc-----ccccccccccccccccccC--CCcCcccchhhHHHHHHHHHhCCCCCC
Q 046598 839 DMIAHIGDFGLARFLPLSSAQT-----SSIGAKGSIGYIAPEYGLG--SEVSISGDVYSYGILLLELITRKKPTD 906 (986)
Q Consensus 839 ~~~~kL~DFG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~pf~ 906 (986)
.+||+|||+|+......... ......||+.|||||++.+ ..|+..+|+|+..+-..+.+.++.+|.
T Consensus 467 --~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 467 --DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp --SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred --eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 99999999999875332211 1235679999999999887 568888999999999999888877653
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.3e-23 Score=220.89 Aligned_cols=203 Identities=15% Similarity=0.195 Sum_probs=166.0
Q ss_pred ccCcCccCCCCCCEEEccCCCccccCCcchhccccCceeeceecc-cCCCCccchhcCccccceeccc-ccccCccCccc
Q 046598 77 SISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNS-IGGAIPANISSCSNLIQLRLFH-NQLVGKIPSEL 154 (986)
Q Consensus 77 ~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~ 154 (986)
.+|. +. +.|++|+|++|++++..+.+|.++++|++|+|++|+ +++..+..|..+++|++|++++ |++++..+..|
T Consensus 25 ~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f 101 (239)
T 2xwt_C 25 RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDAL 101 (239)
T ss_dssp SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSE
T ss_pred ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHh
Confidence 4555 33 379999999999998888899999999999999997 8866677899999999999998 99997777889
Q ss_pred cCCCCCCeEEccCCcCCCCcccccCCCcCcc---eeeccCC-cccCcCcchhhccCCCc-eeecccccccccCCccccCC
Q 046598 155 SSLSKIEHISVNDNNLTGSIPSSLGNLSSIR---SLFLSGN-NLEGSIPDTLGWLKNLV-NLTMAQNRLSGTIPSSIFNI 229 (986)
Q Consensus 155 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~---~L~L~~N-~l~~~~p~~~~~l~~L~-~L~L~~N~l~~~~p~~l~~l 229 (986)
.++++|++|++++|++++ +|. |.++++|+ +|++++| ++++..+..|..+++|+ +|++++|+++ .+|...+..
T Consensus 102 ~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~ 178 (239)
T 2xwt_C 102 KELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNG 178 (239)
T ss_dssp ECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTT
T ss_pred CCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCC
Confidence 999999999999999985 665 88888888 9999999 99877777899999999 9999999998 666655555
Q ss_pred CCccEEeccccc-cccccCCcccccc-cccceEEecCceecccCCccccCCCCCcEEecccc
Q 046598 230 SSITGFDAGVNK-IQGAIPLDYGFSL-QNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVN 289 (986)
Q Consensus 230 ~~L~~L~l~~N~-l~~~~p~~~~~~l-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N 289 (986)
++|+.|++++|+ +. .+|...+.++ ++|+.|++++|++++. |.. .+++|+.|+++++
T Consensus 179 ~~L~~L~L~~n~~l~-~i~~~~~~~l~~~L~~L~l~~N~l~~l-~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 179 TKLDAVYLNKNKYLT-VIDKDAFGGVYSGPSLLDVSQTSVTAL-PSK--GLEHLKELIARNT 236 (239)
T ss_dssp CEEEEEECTTCTTCC-EECTTTTTTCSBCCSEEECTTCCCCCC-CCT--TCTTCSEEECTTC
T ss_pred CCCCEEEcCCCCCcc-cCCHHHhhccccCCcEEECCCCccccC-Chh--HhccCceeeccCc
Confidence 788888888885 66 5555555567 7888888888888744 333 5667777777654
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=4.9e-24 Score=233.62 Aligned_cols=223 Identities=21% Similarity=0.242 Sum_probs=162.7
Q ss_pred ceEEEccCCcccccCCc---cccCCCCCCEEEccCccccCcCCCcc--cCCCCCCEEEccCccceeecCcc----c-ccc
Q 046598 359 LEVLLLDNNQIFGNIPA---AIGKFVNLQRLDMCSNRLSGTIPPAI--GELQNLKDLRLQRNRFQGNIPPS----I-GNL 428 (986)
Q Consensus 359 L~~L~L~~n~l~~~~~~---~~~~l~~L~~L~L~~N~l~~~~~~~~--~~l~~L~~L~Ls~N~l~~~~~~~----~-~~~ 428 (986)
++.+.+.++.++...-. .+..+++|++|++++|.+++..|..+ ..+++|++|+|++|++++..+.. + ...
T Consensus 66 l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~ 145 (310)
T 4glp_A 66 VRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKP 145 (310)
T ss_dssp CCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCS
T ss_pred eeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhcc
Confidence 45556666555421110 12234568888888888888888777 78888888888888888654421 1 233
Q ss_pred cccEEEecccccCCCCCcccCCCCCCCeeecCCCccCCC--C-CcccccCCCcceEEEccCCcccccCCc----cccccc
Q 046598 429 KLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGT--I-PPQFIGLSSSLIVLDLSRNQLTGSIPS----EVGNLK 501 (986)
Q Consensus 429 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--i-p~~~~~~~~~L~~L~Ls~N~l~~~~p~----~~~~l~ 501 (986)
+|++|+|++|++.+..|..|..+++|++|+|++|++.+. + +..+++.+++|++|+|++|+++. ++. .+..++
T Consensus 146 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~ 224 (310)
T 4glp_A 146 GLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAGV 224 (310)
T ss_dssp CCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHTC
T ss_pred CCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcCC
Confidence 688888888888878888888888888999988887642 2 22334667888888888888873 333 246778
Q ss_pred ccchhhccCccccccCcccccCC---ccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhccccccee
Q 046598 502 NLEILNVFGNKLKGEIPSTLGSC---IKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNL 578 (986)
Q Consensus 502 ~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l 578 (986)
+|++|+|++|+|++..|..+..+ ++|++|+|++|+|+ .+|..+. ++|+.|||++|+|++. |. +..+++|++|
T Consensus 225 ~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L 299 (310)
T 4glp_A 225 QPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNL 299 (310)
T ss_dssp CCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCE
T ss_pred CCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEE
Confidence 88888888888887778777776 58888888888888 5677664 7888888988888864 33 6778888888
Q ss_pred eccCCcccc
Q 046598 579 NLSNNDLEG 587 (986)
Q Consensus 579 ~ls~N~l~~ 587 (986)
+|++|+|+.
T Consensus 300 ~L~~N~l~~ 308 (310)
T 4glp_A 300 TLDGNPFLV 308 (310)
T ss_dssp ECSSTTTSC
T ss_pred ECcCCCCCC
Confidence 888888874
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-24 Score=243.73 Aligned_cols=231 Identities=19% Similarity=0.169 Sum_probs=186.2
Q ss_pred EEeccCCCCccccCcCccCCCCCCEEEccCCCccccCC----cchhccc-cCceeeceecccCCCCccchhcC-----cc
Q 046598 66 ILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIP----SEFDRLR-RLQVLALHYNSIGGAIPANISSC-----SN 135 (986)
Q Consensus 66 ~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p----~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~ 135 (986)
..+++.++++|.+|..+...+.|++|+|++|.+.+..+ ..|.+++ +|++|+|++|++++..+..|..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 35788999999999888888889999999999998777 7888898 89999999999998888888876 99
Q ss_pred ccceecccccccCccCccccC----C-CCCCeEEccCCcCCCCccccc----CCC-cCcceeeccCCcccCcCc----ch
Q 046598 136 LIQLRLFHNQLVGKIPSELSS----L-SKIEHISVNDNNLTGSIPSSL----GNL-SSIRSLFLSGNNLEGSIP----DT 201 (986)
Q Consensus 136 L~~L~Ls~N~l~~~~p~~~~~----l-~~L~~L~L~~N~l~~~~p~~~----~~l-~~L~~L~L~~N~l~~~~p----~~ 201 (986)
|++|+|++|++++..+..+.. + ++|++|+|++|++++..+..+ ..+ ++|++|+|++|++++..+ ..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 999999999999777765444 4 899999999999987766554 343 699999999999986444 34
Q ss_pred hhccC-CCceeecccccccccCCcccc----CC-CCccEEeccccccccc----cCCcccccccccceEEecCceecccC
Q 046598 202 LGWLK-NLVNLTMAQNRLSGTIPSSIF----NI-SSITGFDAGVNKIQGA----IPLDYGFSLQNLQFFSVGENQLTGAI 271 (986)
Q Consensus 202 ~~~l~-~L~~L~L~~N~l~~~~p~~l~----~l-~~L~~L~l~~N~l~~~----~p~~~~~~l~~L~~L~L~~N~l~~~~ 271 (986)
+..++ +|++|+|++|++++..+..+. .+ ++|+.||+++|.+.+. ++..+....++|++|+|++|++++..
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~ 241 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence 45555 999999999999977765544 34 6999999999998863 33333322458999999999998654
Q ss_pred C----ccccCCCCCcEEecccccccCCCc
Q 046598 272 P----PTISNASNLEIFHGSVNKLTGAAP 296 (986)
Q Consensus 272 p----~~l~~l~~L~~L~ls~N~l~~~~~ 296 (986)
+ ..+..+++|+.|++++|.+.++.+
T Consensus 242 ~~~l~~~~~~l~~L~~L~L~~n~l~~i~~ 270 (362)
T 3goz_A 242 LENLKLLKDSLKHLQTVYLDYDIVKNMSK 270 (362)
T ss_dssp HHHHHHTTTTTTTCSEEEEEHHHHTTCCH
T ss_pred HHHHHHHHhcCCCccEEEeccCCccccCH
Confidence 4 345778899999999998776554
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.7e-23 Score=227.67 Aligned_cols=201 Identities=17% Similarity=0.148 Sum_probs=96.7
Q ss_pred ccCceeeceecccCCCCccch--hcCccccceecccccccCccC----ccccCCCCCCeEEccCCcCCCCcccccCCCcC
Q 046598 110 RRLQVLALHYNSIGGAIPANI--SSCSNLIQLRLFHNQLVGKIP----SELSSLSKIEHISVNDNNLTGSIPSSLGNLSS 183 (986)
Q Consensus 110 ~~L~~L~L~~N~l~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 183 (986)
++|++|+|++|.+++..|..+ ..+++|++|+|++|.+++..+ ..+..+++|++|+|++|++++..|..|+++++
T Consensus 91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~ 170 (310)
T 4glp_A 91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA 170 (310)
T ss_dssp SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence 445555555555555555544 455555555555555554333 22334555555555555555444455555555
Q ss_pred cceeeccCCcccCc--C--cchhhccCCCceeecccccccccCCc----cccCCCCccEEeccccccccccCCccccc--
Q 046598 184 IRSLFLSGNNLEGS--I--PDTLGWLKNLVNLTMAQNRLSGTIPS----SIFNISSITGFDAGVNKIQGAIPLDYGFS-- 253 (986)
Q Consensus 184 L~~L~L~~N~l~~~--~--p~~~~~l~~L~~L~L~~N~l~~~~p~----~l~~l~~L~~L~l~~N~l~~~~p~~~~~~-- 253 (986)
|++|+|++|++.+. + +..++.+++|++|+|++|+++ .+|. .+.++++|++||+++|++.+..|..+..-
T Consensus 171 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ 249 (310)
T 4glp_A 171 LTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMW 249 (310)
T ss_dssp CCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCC
T ss_pred CCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccC
Confidence 55555555554321 1 122244555555555555554 1121 12344555555555555554444333211
Q ss_pred ccccceEEecCceecccCCccccCCCCCcEEecccccccCCCchhhhhhhHhhhhhccCCCC
Q 046598 254 LQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLG 315 (986)
Q Consensus 254 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~l~~l~~L~~l~l~~n~l~ 315 (986)
+++|++|+|++|+++ .+|..+. ++|+.|++++|++++++. +..+++|+.+++++|.+.
T Consensus 250 ~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~~~-~~~l~~L~~L~L~~N~l~ 307 (310)
T 4glp_A 250 SSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRAPQ-PDELPEVDNLTLDGNPFL 307 (310)
T ss_dssp CTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSCCC-TTSCCCCSCEECSSTTTS
T ss_pred cCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCCch-hhhCCCccEEECcCCCCC
Confidence 245555555555555 3344442 455555555555554422 444455555555555544
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.89 E-value=6.7e-23 Score=217.14 Aligned_cols=161 Identities=24% Similarity=0.223 Sum_probs=111.3
Q ss_pred ccEEEecccccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhcc
Q 046598 430 LFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVF 509 (986)
Q Consensus 430 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 509 (986)
++.|+|++|.+++..+..|.++++|++|+|++|+|++ +++..+..+++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus 37 l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 115 (251)
T 3m19_A 37 TEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLG 115 (251)
T ss_dssp CCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCc-cCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcC
Confidence 4455555555555556666677777777777777763 444446666777777777777776555666777777777777
Q ss_pred CccccccCcccccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCcccccc
Q 046598 510 GNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVV 589 (986)
Q Consensus 510 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~ 589 (986)
+|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..+..+++|++|+|++|++++..
T Consensus 116 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~ 195 (251)
T 3m19_A 116 GNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSR 195 (251)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTTS
T ss_pred CCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCCc
Confidence 77777555556677777777777777777666667777777777777777777766667777777777777777777764
Q ss_pred CC
Q 046598 590 PT 591 (986)
Q Consensus 590 p~ 591 (986)
..
T Consensus 196 ~~ 197 (251)
T 3m19_A 196 CE 197 (251)
T ss_dssp TT
T ss_pred cc
Confidence 33
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.89 E-value=4.9e-25 Score=245.00 Aligned_cols=207 Identities=17% Similarity=0.201 Sum_probs=136.2
Q ss_pred HHHHHHHhccCCCcCCCCCCCCCCCCCcceeeEecCCCCeEEEEeccCCCCccccCcCccCC--CCCCEEEccCCCcccc
Q 046598 24 ALLELKSKITHDPLGVLASWNESSHFCQWRGVTCSRRHQRVTILDLESLKLAGSISPHVGNL--SFLKVLRLYNNSFNHE 101 (986)
Q Consensus 24 ~ll~~k~~~~~~~~~~l~~w~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~~~~l--~~L~~L~L~~n~l~~~ 101 (986)
.|..+-+.+. ..... . .+.-|.+|+++.|+.. .++.+|++++.+. +..+..+ +.++.|++++|.+.+.
T Consensus 16 il~~If~~L~--~~d~~-~--~~~vc~~W~~~~~~~~--~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~ 85 (336)
T 2ast_B 16 LLLGIFSCLC--LPELL-K--VSGVCKRWYRLASDES--LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQP 85 (336)
T ss_dssp HHHHHHTTSC--HHHHH-H--TTSSCHHHHHHHTCST--TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSC
T ss_pred HHHHHHHhCC--HHHHH-H--HHHHHHHHHHHhcCch--hheeeccccccCC---HHHHHhhhhccceEEEcCCcccccc
Confidence 5666666552 22111 1 2334568999998643 3567788877765 3445555 7777888888877766
Q ss_pred CCcchhccccCceeeceecccCCC-CccchhcCccccceecccccccCccCccccCCCCCCeEEccCC-cCCCC-ccccc
Q 046598 102 IPSEFDRLRRLQVLALHYNSIGGA-IPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDN-NLTGS-IPSSL 178 (986)
Q Consensus 102 ~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~ 178 (986)
.+. +..+++|++|+|++|.+++. +|..+..+++|++|+|++|.+++..|..++.+++|++|+|++| .+++. ++..+
T Consensus 86 ~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~ 164 (336)
T 2ast_B 86 LAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLL 164 (336)
T ss_dssp CCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHH
T ss_pred chh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHH
Confidence 555 44677788888887777654 6667777777777777777777777777777777777777777 56542 55666
Q ss_pred CCCcCcceeeccCC-cccCc-CcchhhccC-CCceeecccc--ccc-ccCCccccCCCCccEEeccccc
Q 046598 179 GNLSSIRSLFLSGN-NLEGS-IPDTLGWLK-NLVNLTMAQN--RLS-GTIPSSIFNISSITGFDAGVNK 241 (986)
Q Consensus 179 ~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~-~L~~L~L~~N--~l~-~~~p~~l~~l~~L~~L~l~~N~ 241 (986)
.++++|++|+|++| .+++. ++..+..++ +|++|+|++| .++ +.+|..+.++++|+.|++++|.
T Consensus 165 ~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~ 233 (336)
T 2ast_B 165 SSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSV 233 (336)
T ss_dssp HHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCT
T ss_pred hcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCC
Confidence 77777777777777 77643 466667777 7777777777 343 3344444555555555555444
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.4e-22 Score=213.15 Aligned_cols=197 Identities=18% Similarity=0.236 Sum_probs=122.5
Q ss_pred ccceEEEccCCcccccCCccccCCCCCCEEEccCcc-ccCcCCCcccCCCCCCEEEccC-ccceeecCcccccccccEEE
Q 046598 357 TTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNR-LSGTIPPAIGELQNLKDLRLQR-NRFQGNIPPSIGNLKLFILY 434 (986)
Q Consensus 357 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~~~L~~L~ 434 (986)
.+++.|++++|+|++..+..|..+++|++|++++|. +++..+..|..+++|++|++++ |++++
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~--------------- 95 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTY--------------- 95 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCE---------------
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeE---------------
Confidence 356666666666665555566666666666666664 5544455566666666555555 55553
Q ss_pred ecccccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcce---EEEccCC-cccccCCcccccccccc-hhhcc
Q 046598 435 LSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLI---VLDLSRN-QLTGSIPSEVGNLKNLE-ILNVF 509 (986)
Q Consensus 435 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~---~L~Ls~N-~l~~~~p~~~~~l~~L~-~L~Ls 509 (986)
..+..|..+++|++|++++|+++ .+|. +..+++|+ .|++++| ++++..+..|..+++|+ .|+++
T Consensus 96 --------i~~~~f~~l~~L~~L~l~~n~l~-~lp~--~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~ 164 (239)
T 2xwt_C 96 --------IDPDALKELPLLKFLGIFNTGLK-MFPD--LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLY 164 (239)
T ss_dssp --------ECTTSEECCTTCCEEEEEEECCC-SCCC--CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECC
T ss_pred --------cCHHHhCCCCCCCEEeCCCCCCc-cccc--cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcC
Confidence 44445556666666666666666 3554 44555555 7777777 67655555567777777 77777
Q ss_pred CccccccCcccccCCccccEEeccccc-ccccCCccccCC-CCCCEEeCCCccCcccCchhhhcccccceeeccCC
Q 046598 510 GNKLKGEIPSTLGSCIKLEQLEMQENF-LQGPIPSSLSSL-RGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNN 583 (986)
Q Consensus 510 ~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N 583 (986)
+|+++ .+|......++|++|+|++|+ +++..+..|..+ ++|+.|+|++|+|++ +|.. .+++|+.|+++++
T Consensus 165 ~n~l~-~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~-l~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 165 NNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSK--GLEHLKELIARNT 236 (239)
T ss_dssp SCCCC-EECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCC-CCCT--TCTTCSEEECTTC
T ss_pred CCCCc-ccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCcccc-CChh--HhccCceeeccCc
Confidence 77776 444433333677777777774 776556667777 777777777777774 3332 4566667777665
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.88 E-value=3.2e-24 Score=240.52 Aligned_cols=261 Identities=14% Similarity=0.110 Sum_probs=155.0
Q ss_pred EEEccCCCccccCCcchhccccCceeeceecccCCCCc----cchhcCc-cccceecccccccCccCccccCC-----CC
Q 046598 90 VLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIP----ANISSCS-NLIQLRLFHNQLVGKIPSELSSL-----SK 159 (986)
Q Consensus 90 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p----~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l-----~~ 159 (986)
+++|+.|++++.+|..+...++|++|+|++|.+++..+ ..|..++ +|++|+|++|.+++..+..|..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 46778888888777777777778888888888886666 6667777 78888888888877666666664 77
Q ss_pred CCeEEccCCcCCCCcccccC----CC-cCcceeeccCCcccCcCcchhhc-----cCCCceeecccccccccCCccccCC
Q 046598 160 IEHISVNDNNLTGSIPSSLG----NL-SSIRSLFLSGNNLEGSIPDTLGW-----LKNLVNLTMAQNRLSGTIPSSIFNI 229 (986)
Q Consensus 160 L~~L~L~~N~l~~~~p~~~~----~l-~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~L~~N~l~~~~p~~l~~l 229 (986)
|++|+|++|++++..+..+. .+ ++|++|+|++|++++..+..+.. .++|++|+|++|++++..+..+..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~- 160 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQ- 160 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHH-
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHH-
Confidence 77777777777766555433 33 67777777777777655554433 246777777777766432222110
Q ss_pred CCccEEeccccccccccCCcccccc-cccceEEecCceecccCCcccc----CC-CCCcEEecccccccCCCchhhhhhh
Q 046598 230 SSITGFDAGVNKIQGAIPLDYGFSL-QNLQFFSVGENQLTGAIPPTIS----NA-SNLEIFHGSVNKLTGAAPYLEKLQR 303 (986)
Q Consensus 230 ~~L~~L~l~~N~l~~~~p~~~~~~l-~~L~~L~L~~N~l~~~~p~~l~----~l-~~L~~L~ls~N~l~~~~~~l~~l~~ 303 (986)
.+ ..+ ++|++|+|++|++++..+..++ .. ++|+.|++++|.++.....
T Consensus 161 -------------------~l-~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~------ 214 (362)
T 3goz_A 161 -------------------IL-AAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYA------ 214 (362)
T ss_dssp -------------------HH-HTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHH------
T ss_pred -------------------HH-hcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHH------
Confidence 00 011 2455555555555544443322 22 3566666666655431110
Q ss_pred HhhhhhccCCCCCCCCCCcccccccccccccceeeccccccccCCCcccccccccceEEEccCCcccccCC----ccccC
Q 046598 304 LLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIP----AAIGK 379 (986)
Q Consensus 304 L~~l~l~~n~l~~~~~~~l~~l~~l~~~~~L~~l~l~~n~~~~~~p~~~~~~~~~L~~L~L~~n~l~~~~~----~~~~~ 379 (986)
.++..+....++|+.|+|++|.|++..+ ..+..
T Consensus 215 -------------------------------------------~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~ 251 (362)
T 3goz_A 215 -------------------------------------------ELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDS 251 (362)
T ss_dssp -------------------------------------------HHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTT
T ss_pred -------------------------------------------HHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhc
Confidence 1222222222456666666666665433 33456
Q ss_pred CCCCCEEEccCccccCcC-------CCcccCCCCCCEEEccCccceee
Q 046598 380 FVNLQRLDMCSNRLSGTI-------PPAIGELQNLKDLRLQRNRFQGN 420 (986)
Q Consensus 380 l~~L~~L~L~~N~l~~~~-------~~~~~~l~~L~~L~Ls~N~l~~~ 420 (986)
+++|++|+|++|.+.+.. +..+..+++|+.|++++|++...
T Consensus 252 l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~ 299 (362)
T 3goz_A 252 LKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS 299 (362)
T ss_dssp TTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred CCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence 677777777777744322 23455566666666666666544
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.5e-22 Score=208.00 Aligned_cols=188 Identities=20% Similarity=0.238 Sum_probs=140.5
Q ss_pred CCCCCcceeeEecCCCCeEEEEeccCCCCccccCcCccCCCCCCEEEccCCCccccCCcchhccccCceeeceecccCCC
Q 046598 46 SSHFCQWRGVTCSRRHQRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGA 125 (986)
Q Consensus 46 ~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 125 (986)
..+.|+|++|.|+... ++ .+|..+ .++|++|+|++|++++..+..|.++++|++|+|++|++++.
T Consensus 3 ~~C~C~~~~v~c~~~~------------l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 67 (208)
T 2o6s_A 3 SRCSCSGTTVECYSQG------------RT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSL 67 (208)
T ss_dssp TTCEEETTEEECCSSC------------CS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCC
T ss_pred CCCEECCCEEEecCCC------------cc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCcc
Confidence 4466899999997532 22 344333 35788899999988877777788888888888888888866
Q ss_pred CccchhcCccccceecccccccCccCccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeeccCCcccCcCcchhhcc
Q 046598 126 IPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWL 205 (986)
Q Consensus 126 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 205 (986)
.+..|..+++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+
T Consensus 68 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l 147 (208)
T 2o6s_A 68 PNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRL 147 (208)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTC
T ss_pred ChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccC
Confidence 66677888888888888888886666677888888888888888887666677888888888888888876666667777
Q ss_pred CCCceeecccccccccCCccccCCCCccEEeccccccccccCCcccccccccceEEecCceecccCCccccCCCC
Q 046598 206 KNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASN 280 (986)
Q Consensus 206 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 280 (986)
++|++|+|++|.+.+. +++|++|+++.|+++|.+|.+++.++.
T Consensus 148 ~~L~~L~l~~N~~~~~--------------------------------~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 148 TSLQYIWLHDNPWDCT--------------------------------CPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp TTCCEEECCSCCBCCC--------------------------------TTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred CCccEEEecCCCeecC--------------------------------CCCHHHHHHHHHhCCceeeccCccccC
Confidence 7888888877766532 345666667777777777776665543
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=7.3e-23 Score=228.26 Aligned_cols=220 Identities=15% Similarity=0.133 Sum_probs=171.5
Q ss_pred CCCcceeeEecCCCCeEEEEeccCCCCccccCcCccCCCCCCEEEccCCCccccCCcchhccccCceeeceecccCCCCc
Q 046598 48 HFCQWRGVTCSRRHQRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIP 127 (986)
Q Consensus 48 ~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 127 (986)
+.|+|+.|.|++ ++++ .+|..+ .+.+++|+|++|+|+.+.+.+|.++++|++|+|++|++.+.+|
T Consensus 7 C~C~~~~v~C~~------------~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~ 71 (350)
T 4ay9_X 7 CHCSNRVFLCQE------------SKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIE 71 (350)
T ss_dssp SEEETTEEEEES------------TTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEEC
T ss_pred cEeeCCEEEecC------------CCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccC
Confidence 347888888864 3444 566655 3678999999999987667789999999999999999876665
Q ss_pred -cchhcCccccc-eecccccccCccCccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeeccC-CcccCcCcchhhc
Q 046598 128 -ANISSCSNLIQ-LRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSG-NNLEGSIPDTLGW 204 (986)
Q Consensus 128 -~~~~~l~~L~~-L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~ 204 (986)
..|.++++|++ +.++.|+++...|..|..+++|++|++++|++++..+..+.+..++..|++.+ |++....+..|..
T Consensus 72 ~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~ 151 (350)
T 4ay9_X 72 ADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVG 151 (350)
T ss_dssp TTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTT
T ss_pred hhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhh
Confidence 46788888765 66777999977788999999999999999999977777777888888899866 5777666667777
Q ss_pred cC-CCceeecccccccccCCccccCCCCccEEeccccccccccCCcccccccccceEEecCceecccCCccccCCCCCcE
Q 046598 205 LK-NLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEI 283 (986)
Q Consensus 205 l~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 283 (986)
+. .++.|+|++|+|+ .+|...+...+|+.++++.|...+.+|.+.+.++++|++|+|++|+|+...+..|.++++|+.
T Consensus 152 ~~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~ 230 (350)
T 4ay9_X 152 LSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRA 230 (350)
T ss_dssp SBSSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEEC
T ss_pred cchhhhhhcccccccc-CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhh
Confidence 65 6888999999998 667777777888888887655555888887778888888888888888655555555554443
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.87 E-value=2.1e-24 Score=244.64 Aligned_cols=243 Identities=19% Similarity=0.247 Sum_probs=175.6
Q ss_pred CCCcccccccccceEEEccCCcccccCC----ccccCCCCCCEEEccCc---cccCcCCCcc-------cCCCCCCEEEc
Q 046598 347 SLPACISNLSTTLEVLLLDNNQIFGNIP----AAIGKFVNLQRLDMCSN---RLSGTIPPAI-------GELQNLKDLRL 412 (986)
Q Consensus 347 ~~p~~~~~~~~~L~~L~L~~n~l~~~~~----~~~~~l~~L~~L~L~~N---~l~~~~~~~~-------~~l~~L~~L~L 412 (986)
.++..+..+ ++|+.|+|++|+|++..+ ..+..+++|++|+|++| ++++.+|..+ ..+++|++|+|
T Consensus 23 ~l~~~l~~~-~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~L 101 (386)
T 2ca6_A 23 SVFAVLLED-DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRL 101 (386)
T ss_dssp TTSHHHHHC-SCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEEC
T ss_pred HHHHHHhcC-CCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEEC
Confidence 344444444 457778888887775533 34667788888888775 3444455444 57778888888
Q ss_pred cCcccee----ecCccccc-ccccEEEecccccCCCCCcccCC----C---------CCCCeeecCCCccC-CCCCc--c
Q 046598 413 QRNRFQG----NIPPSIGN-LKLFILYLSYNFLQGSIPSSLGR----Y---------ETLTTIDLSNNNLT-GTIPP--Q 471 (986)
Q Consensus 413 s~N~l~~----~~~~~~~~-~~L~~L~L~~N~l~~~~p~~~~~----l---------~~L~~L~L~~N~l~-~~ip~--~ 471 (986)
++|++.+ .+|..+.. .+|++|+|++|.+++..+..+.. + ++|++|+|++|+++ +.+|. .
T Consensus 102 s~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~ 181 (386)
T 2ca6_A 102 SDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAK 181 (386)
T ss_dssp CSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHH
T ss_pred CCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHH
Confidence 8888776 34444443 35788888888776444433333 3 78999999999987 33442 2
Q ss_pred cccCCCcceEEEccCCcccc-----cCCcccccccccchhhccCcccc----ccCcccccCCccccEEeccccccccc--
Q 046598 472 FIGLSSSLIVLDLSRNQLTG-----SIPSEVGNLKNLEILNVFGNKLK----GEIPSTLGSCIKLEQLEMQENFLQGP-- 540 (986)
Q Consensus 472 ~~~~~~~L~~L~Ls~N~l~~-----~~p~~~~~l~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L~L~~N~l~~~-- 540 (986)
.+..+++|+.|+|++|+|+. ..|..+..+++|+.|+|++|+++ +.+|..+..+++|++|+|++|.|++.
T Consensus 182 ~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~ 261 (386)
T 2ca6_A 182 TFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGA 261 (386)
T ss_dssp HHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHH
T ss_pred HHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhH
Confidence 24566789999999998872 34447888899999999999986 56788888999999999999999865
Q ss_pred --CCccc--cCCCCCCEEeCCCccCcc----cCchhh-hcccccceeeccCCccccccC
Q 046598 541 --IPSSL--SSLRGLSVLDLSQNNLSG----KIPELL-IRLQLVKNLNLSNNDLEGVVP 590 (986)
Q Consensus 541 --~p~~~--~~l~~L~~L~Ls~N~l~~----~~p~~~-~~l~~L~~l~ls~N~l~~~~p 590 (986)
+|..+ +.+++|+.|+|++|+|++ .+|..+ .++++|++|+|++|++++..+
T Consensus 262 ~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 262 AAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp HHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred HHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 55666 348899999999999987 477777 668999999999999887654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1e-22 Score=218.63 Aligned_cols=152 Identities=18% Similarity=0.104 Sum_probs=120.2
Q ss_pred HHHHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc------------------hhHHHHHHHHHHHhcCC
Q 046598 682 NLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH------------------GAFKSFIAECNTLKNIR 743 (986)
Q Consensus 682 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~ 743 (986)
.+......|.+.+.||+|+||.||+|.+ .+++.||||+++.... .....+.+|++++++++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 3344455677889999999999999999 6689999999864221 13457899999999998
Q ss_pred CCcceeeeeeccccccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 046598 744 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPP 823 (986)
Q Consensus 744 h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ 823 (986)
| +++.+++. .+..++||||++|++|.+ +.. .+...++.|++.||+|||+. |
T Consensus 163 ~---~~v~~~~~------~~~~~lvmE~~~g~~L~~-l~~----------------~~~~~i~~qi~~~l~~lH~~---g 213 (282)
T 1zar_A 163 G---LAVPKVYA------WEGNAVLMELIDAKELYR-VRV----------------ENPDEVLDMILEEVAKFYHR---G 213 (282)
T ss_dssp T---SSSCCEEE------EETTEEEEECCCCEEGGG-CCC----------------SCHHHHHHHHHHHHHHHHHT---T
T ss_pred C---CCcCeEEe------ccceEEEEEecCCCcHHH-cch----------------hhHHHHHHHHHHHHHHHHHC---C
Confidence 4 55555421 145699999999999998 520 12346999999999999999 9
Q ss_pred eEeecCCCCCeEecCCCcEEEcccccceecCCCCCccccccccccccccccccccC
Q 046598 824 IAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG 879 (986)
Q Consensus 824 ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 879 (986)
|+||||||+||+++ ++.+||+|||+|+. +..|+|||++..
T Consensus 214 iiHrDlkp~NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 214 IVHGDLSQYNVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp EECSCCSTTSEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred CEeCCCCHHHEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence 99999999999999 99999999999973 345788998643
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.87 E-value=4.7e-23 Score=241.22 Aligned_cols=208 Identities=23% Similarity=0.333 Sum_probs=155.4
Q ss_pred CCCCCCCCCCCC-----cceee-EecCCCCeEEEEeccCCCCccccCcCccCCCCCCEEEccCCCccccCCcchhccccC
Q 046598 39 VLASWNESSHFC-----QWRGV-TCSRRHQRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRL 112 (986)
Q Consensus 39 ~l~~w~~~~~~c-----~w~gv-~c~~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L 112 (986)
.+.+|..+.++| .|.|+ .|.. .+++.|+|++|++++ +|+.+. ++|++|+|++|+|+ .+| ..+++|
T Consensus 32 ~l~~W~~~~~~~~~~~~~~~~l~~C~~--~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L 102 (571)
T 3cvr_A 32 AWDKWEKQALPGENRNEAVSLLKECLI--NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASL 102 (571)
T ss_dssp HHHHHHTTCCTTCCHHHHHHHHHHHHH--TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTC
T ss_pred HHHHHhccCCccccccchhhhcccccc--CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCC
Confidence 456786666778 79999 7864 368899999999986 777664 78999999999998 566 457889
Q ss_pred ceeeceecccCCCCccchhcCccccceecccccccCccCccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeeccCC
Q 046598 113 QVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGN 192 (986)
Q Consensus 113 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 192 (986)
++|+|++|+|++ +|. |.. +|++|+|++|.|++ +|. .+++|++|+|++|++++ +|. .+++|++|+|++|
T Consensus 103 ~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N 170 (571)
T 3cvr_A 103 EYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNN 170 (571)
T ss_dssp CEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSS
T ss_pred CEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCC
Confidence 999999999986 676 655 89999999999886 665 67888999999998885 554 5678888888888
Q ss_pred cccCcCcchhhccCCCceeecccccccccCCccccCCCCccEEeccccccccccCCcccccccccceEEecCceecccCC
Q 046598 193 NLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIP 272 (986)
Q Consensus 193 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p 272 (986)
+|++ +|. |. ++|+.|+|++|+|+ .+|. +.. +| ....+.|+.|+|++|+|+ .+|
T Consensus 171 ~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L------------------~~~~~~L~~L~Ls~N~l~-~lp 223 (571)
T 3cvr_A 171 QLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RN------------------HHSEETEIFFRCRENRIT-HIP 223 (571)
T ss_dssp CCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------------------------CCEEEECCSSCCC-CCC
T ss_pred CCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hh------------------hcccccceEEecCCCcce-ecC
Confidence 8885 666 65 78888888888887 5565 432 33 001233467777777776 466
Q ss_pred ccccCCCCCcEEecccccccCC
Q 046598 273 PTISNASNLEIFHGSVNKLTGA 294 (986)
Q Consensus 273 ~~l~~l~~L~~L~ls~N~l~~~ 294 (986)
..+..+++|+.|++++|++++.
T Consensus 224 ~~l~~l~~L~~L~L~~N~l~~~ 245 (571)
T 3cvr_A 224 ENILSLDPTCTIILEDNPLSSR 245 (571)
T ss_dssp GGGGGSCTTEEEECCSSSCCHH
T ss_pred HHHhcCCCCCEEEeeCCcCCCc
Confidence 6666677777777777777654
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=3.9e-22 Score=217.89 Aligned_cols=194 Identities=27% Similarity=0.372 Sum_probs=128.5
Q ss_pred CCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCccccc-ccccEEEecccccCCCCCcccCCCCCCCeee
Q 046598 380 FVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGN-LKLFILYLSYNFLQGSIPSSLGRYETLTTID 458 (986)
Q Consensus 380 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 458 (986)
+++|++|++++|.++. ++ .+..+++|++|+|++|++++..+ +.. .+|++|+|++|.+++ + ..+..+++|++|+
T Consensus 40 l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~-~-~~~~~l~~L~~L~ 113 (308)
T 1h6u_A 40 LDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-V-SAIAGLQSIKTLD 113 (308)
T ss_dssp HHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-C-GGGTTCTTCCEEE
T ss_pred cCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC-c-hhhcCCCCCCEEE
Confidence 3444444444444442 22 34444444444444444443222 222 234455555555543 2 2577788888888
Q ss_pred cCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccCcccccCCccccEEeccccccc
Q 046598 459 LSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQ 538 (986)
Q Consensus 459 L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 538 (986)
+++|+++ .++. +..+++|+.|++++|++++..+ +..+++|+.|+|++|++++ ++. +..+++|+.|+|++|+++
T Consensus 114 l~~n~l~-~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~ 186 (308)
T 1h6u_A 114 LTSTQIT-DVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADDNKIS 186 (308)
T ss_dssp CTTSCCC-CCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC
T ss_pred CCCCCCC-Cchh--hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCC-Chh-hcCCCCCCEEECCCCccC
Confidence 8888887 4553 6777888888888888885433 7788888888888888885 333 888888888888888888
Q ss_pred ccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCccccccC
Q 046598 539 GPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVP 590 (986)
Q Consensus 539 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p 590 (986)
+..+ +..+++|+.|+|++|++++..| +..+++|+.|+|++|++++.+.
T Consensus 187 ~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~~~~ 234 (308)
T 1h6u_A 187 DISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPV 234 (308)
T ss_dssp CCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEECCCE
T ss_pred cChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeecCCe
Confidence 6443 7888888888888888886543 7888888888888888887443
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=7.1e-22 Score=215.81 Aligned_cols=198 Identities=26% Similarity=0.353 Sum_probs=149.6
Q ss_pred ccCCCCCCEEEccCCCccccCCcchhccccCceeeceecccCCCCccchhcCccccceecccccccCccCccccCCCCCC
Q 046598 82 VGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIE 161 (986)
Q Consensus 82 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 161 (986)
+..+++|++|++++|.+.. +| .+..+++|++|+|++|++++..+ +..+++|++|+|++|++++. + .+..+++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~ 110 (308)
T 1h6u_A 37 QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV-S-AIAGLQSIK 110 (308)
T ss_dssp HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC-G-GGTTCTTCC
T ss_pred HHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc-h-hhcCCCCCC
Confidence 3456778888888888764 44 57778888888888888875443 77888888888888887753 3 577888888
Q ss_pred eEEccCCcCCCCcccccCCCcCcceeeccCCcccCcCcchhhccCCCceeecccccccccCCccccCCCCccEEeccccc
Q 046598 162 HISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNK 241 (986)
Q Consensus 162 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~ 241 (986)
+|+|++|++++. +. +.++++|++|+|++|++++..+ ++.+++|++|+|++|++++. +. +.++++|+.|++++|.
T Consensus 111 ~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~ 184 (308)
T 1h6u_A 111 TLDLTSTQITDV-TP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDL-TP-LANLSKLTTLKADDNK 184 (308)
T ss_dssp EEECTTSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSC
T ss_pred EEECCCCCCCCc-hh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCC-hh-hcCCCCCCEEECCCCc
Confidence 888888888754 32 7888888888888888875433 77888888888888888753 33 7778888888888888
Q ss_pred cccccCCcccccccccceEEecCceecccCCccccCCCCCcEEecccccccCCCc
Q 046598 242 IQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAP 296 (986)
Q Consensus 242 l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~ 296 (986)
+.+..+ +..+++|++|++++|++++..+ +..+++|+.|++++|++++.+.
T Consensus 185 l~~~~~---l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~~~~ 234 (308)
T 1h6u_A 185 ISDISP---LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPV 234 (308)
T ss_dssp CCCCGG---GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEECCCE
T ss_pred cCcChh---hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeecCCe
Confidence 875443 4467888888999988886553 8888999999999999887554
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.3e-21 Score=218.23 Aligned_cols=242 Identities=19% Similarity=0.203 Sum_probs=146.7
Q ss_pred EEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecC-cccccc-cc-cEEEecc
Q 046598 361 VLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIP-PSIGNL-KL-FILYLSY 437 (986)
Q Consensus 361 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~~-~L-~~L~L~~ 437 (986)
+++.++++++ .+|..+ .+++++|+|++|+|+.+.+.+|.++++|++|+|++|++.+.+| ..|..+ ++ +.+.+++
T Consensus 13 ~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~ 89 (350)
T 4ay9_X 13 VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89 (350)
T ss_dssp EEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEE
T ss_pred EEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccC
Confidence 3455555555 344443 2456666666666664444566666666666666666655444 344443 33 3455666
Q ss_pred cccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccC-CcccccCCccccccc-ccchhhccCccccc
Q 046598 438 NFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSR-NQLTGSIPSEVGNLK-NLEILNVFGNKLKG 515 (986)
Q Consensus 438 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~-N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~ 515 (986)
|+++...|..|..+++|++|++++|+|+ .+|+..+....++..|++++ |+++...+..|..+. .++.|+|++|+|+
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~- 167 (350)
T 4ay9_X 90 NNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ- 167 (350)
T ss_dssp TTCCEECTTSBCCCTTCCEEEEEEECCS-SCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-
T ss_pred CcccccCchhhhhccccccccccccccc-cCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc-
Confidence 7777666777777777777777777777 45544444555677777754 566654455566654 5777788888877
Q ss_pred cCcccccCCccccEEeccc-ccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCccccccCCccc
Q 046598 516 EIPSTLGSCIKLEQLEMQE-NFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQGV 594 (986)
Q Consensus 516 ~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~~ 594 (986)
.+|.......+|++|++++ |.++...+..|..+++|+.|||++|+|+...+..+.++++|+.+++ +.+. .+|....
T Consensus 168 ~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~--~~l~-~lP~l~~ 244 (350)
T 4ay9_X 168 EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLPTLEK 244 (350)
T ss_dssp EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTC--TTCC-CCCCTTT
T ss_pred CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccC--CCcC-cCCCchh
Confidence 4555555567777787764 5666444456777888888888888887554445555554444333 3344 3444555
Q ss_pred cccccceeeeCCccccc
Q 046598 595 FKNASITSVFGNLKLCG 611 (986)
Q Consensus 595 ~~~~~~~~~~~n~~lcg 611 (986)
++++..+.+ +|++.|.
T Consensus 245 l~~L~~l~l-~~~~~c~ 260 (350)
T 4ay9_X 245 LVALMEASL-TYPSHCC 260 (350)
T ss_dssp CCSCCEEEC-SCHHHHH
T ss_pred CcChhhCcC-CCCcccc
Confidence 666665554 3555553
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.86 E-value=1.9e-23 Score=236.76 Aligned_cols=238 Identities=15% Similarity=0.240 Sum_probs=195.2
Q ss_pred CeEEEEeccCCCCccc----cCcCccCCCCCCEEEccCC---CccccCCcch-------hccccCceeeceecccCC---
Q 046598 62 QRVTILDLESLKLAGS----ISPHVGNLSFLKVLRLYNN---SFNHEIPSEF-------DRLRRLQVLALHYNSIGG--- 124 (986)
Q Consensus 62 ~~v~~l~l~~~~l~~~----~~~~~~~l~~L~~L~L~~n---~l~~~~p~~~-------~~l~~L~~L~L~~N~l~~--- 124 (986)
.+++.|+|++|++++. ++..+..+++|++|+|++| ++.+.+|..+ ..+++|++|+|++|.+++
T Consensus 32 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~ 111 (386)
T 2ca6_A 32 DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQ 111 (386)
T ss_dssp SCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTH
T ss_pred CCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHH
Confidence 4588999999999876 4455788999999999996 5556667655 788999999999999997
Q ss_pred -CCccchhcCccccceecccccccCccCccccC----C---------CCCCeEEccCCcCC-CCcc---cccCCCcCcce
Q 046598 125 -AIPANISSCSNLIQLRLFHNQLVGKIPSELSS----L---------SKIEHISVNDNNLT-GSIP---SSLGNLSSIRS 186 (986)
Q Consensus 125 -~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~----l---------~~L~~L~L~~N~l~-~~~p---~~~~~l~~L~~ 186 (986)
.+|..+..+++|++|+|++|.+++..+..+.. + ++|++|+|++|+++ +.++ ..+..+++|++
T Consensus 112 ~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~ 191 (386)
T 2ca6_A 112 EPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHT 191 (386)
T ss_dssp HHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCE
T ss_pred HHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCE
Confidence 47888999999999999999997554444443 4 89999999999997 4455 46778899999
Q ss_pred eeccCCccc--C---cCcchhhccCCCceeeccccccc----ccCCccccCCCCccEEeccccccccc----cCCccc-c
Q 046598 187 LFLSGNNLE--G---SIPDTLGWLKNLVNLTMAQNRLS----GTIPSSIFNISSITGFDAGVNKIQGA----IPLDYG-F 252 (986)
Q Consensus 187 L~L~~N~l~--~---~~p~~~~~l~~L~~L~L~~N~l~----~~~p~~l~~l~~L~~L~l~~N~l~~~----~p~~~~-~ 252 (986)
|+|++|+++ + ..|..+..+++|++|+|++|+++ +.+|..+..+++|+.|++++|.+.+. +|..+. .
T Consensus 192 L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~ 271 (386)
T 2ca6_A 192 VKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKL 271 (386)
T ss_dssp EECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTC
T ss_pred EECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhc
Confidence 999999997 2 34558889999999999999996 67888999999999999999999865 333321 2
Q ss_pred cccccceEEecCceecc----cCCccc-cCCCCCcEEecccccccCCCchhh
Q 046598 253 SLQNLQFFSVGENQLTG----AIPPTI-SNASNLEIFHGSVNKLTGAAPYLE 299 (986)
Q Consensus 253 ~l~~L~~L~L~~N~l~~----~~p~~l-~~l~~L~~L~ls~N~l~~~~~~l~ 299 (986)
.+++|+.|+|++|.+++ .+|..+ .++++|+.|++++|++++..+.+.
T Consensus 272 ~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~~~~ 323 (386)
T 2ca6_A 272 ENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVD 323 (386)
T ss_dssp SSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSHHHH
T ss_pred cCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchhHHH
Confidence 37899999999999997 478777 678999999999999998775433
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.7e-21 Score=228.09 Aligned_cols=189 Identities=29% Similarity=0.370 Sum_probs=149.1
Q ss_pred cceEEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCcccccccccEEEecc
Q 046598 358 TLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSY 437 (986)
Q Consensus 358 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~ 437 (986)
+++.|+|++|+|++ +|..+ +++|++|+|++|.|+ .+| ..+++|++|+|++|+|++ +|. +.. +|++|+|++
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~-~L~~L~Ls~ 129 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA-SLKHLDVDN 129 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT-TCCEEECCS
T ss_pred CccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc-CCCEEECCC
Confidence 67788888888886 55544 377888888888888 566 446888888888888887 555 544 788888888
Q ss_pred cccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccC
Q 046598 438 NFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEI 517 (986)
Q Consensus 438 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 517 (986)
|+|++ +|. .+++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|++ +|. |. ++|+.|+|++|+|+ .+
T Consensus 130 N~l~~-lp~---~l~~L~~L~Ls~N~l~-~lp~----~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~l 195 (571)
T 3cvr_A 130 NQLTM-LPE---LPALLEYINADNNQLT-MLPE----LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SL 195 (571)
T ss_dssp SCCSC-CCC---CCTTCCEEECCSSCCS-CCCC----CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SC
T ss_pred CcCCC-CCC---cCccccEEeCCCCccC-cCCC----cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-ch
Confidence 88886 555 5788999999999998 4776 45788999999999986 666 65 88999999999998 66
Q ss_pred cccccCCccc-------cEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccc
Q 046598 518 PSTLGSCIKL-------EQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQL 574 (986)
Q Consensus 518 p~~~~~l~~L-------~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 574 (986)
|. |.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+|..+..++.
T Consensus 196 p~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 196 PA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp CC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred hh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence 76 654 77 89999999998 57888888999999999999998888888887755
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.85 E-value=1.2e-22 Score=225.76 Aligned_cols=199 Identities=16% Similarity=0.176 Sum_probs=151.5
Q ss_pred CCCEEEccCCCccccCCcchhcc--ccCceeeceecccCCCCccchhcCccccceecccccccCc-cCccccCCCCCCeE
Q 046598 87 FLKVLRLYNNSFNHEIPSEFDRL--RRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGK-IPSELSSLSKIEHI 163 (986)
Q Consensus 87 ~L~~L~L~~n~l~~~~p~~~~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L 163 (986)
.++.+++++|.+. |..+..+ ++++.|++++|.+++..+. +..+++|++|+|++|.+++. +|..+..+++|++|
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L 123 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 123 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence 4778999998886 6778888 8899999999999877665 55789999999999998866 78888899999999
Q ss_pred EccCCcCCCCcccccCCCcCcceeeccCC-cccCc-CcchhhccCCCceeecccc-ccccc-CCccccCCC-CccEEecc
Q 046598 164 SVNDNNLTGSIPSSLGNLSSIRSLFLSGN-NLEGS-IPDTLGWLKNLVNLTMAQN-RLSGT-IPSSIFNIS-SITGFDAG 238 (986)
Q Consensus 164 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~l~~l~-~L~~L~l~ 238 (986)
+|++|.+++..+..++++++|++|+|++| .+++. ++..+..+++|++|+|++| .+++. ++..+..++ +|+.|+++
T Consensus 124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~ 203 (336)
T 2ast_B 124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS 203 (336)
T ss_dssp ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECC
T ss_pred eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeC
Confidence 99999988888888999999999999999 67753 6777888999999999999 88754 566677777 77777777
Q ss_pred ccc--cc-cccCCcccccccccceEEecCce-ecccCCccccCCCCCcEEeccccc
Q 046598 239 VNK--IQ-GAIPLDYGFSLQNLQFFSVGENQ-LTGAIPPTISNASNLEIFHGSVNK 290 (986)
Q Consensus 239 ~N~--l~-~~~p~~~~~~l~~L~~L~L~~N~-l~~~~p~~l~~l~~L~~L~ls~N~ 290 (986)
+|. +. +.+|. ....+++|+.|++++|. +++..+..+.++++|+.|++++|.
T Consensus 204 ~~~~~~~~~~l~~-~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~ 258 (336)
T 2ast_B 204 GYRKNLQKSDLST-LVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY 258 (336)
T ss_dssp SCGGGSCHHHHHH-HHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCT
T ss_pred CCcccCCHHHHHH-HHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCC
Confidence 773 33 22332 22345666666666666 555555555556666665555553
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.6e-21 Score=201.58 Aligned_cols=182 Identities=16% Similarity=0.122 Sum_probs=148.1
Q ss_pred ccEEEecccccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhcc
Q 046598 430 LFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVF 509 (986)
Q Consensus 430 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 509 (986)
-+.+++++|.++ .+|..+. +.+++|+|++|+|++..|..++..+++|+.|+|++|+|++..+..|..+++|++|+|+
T Consensus 13 ~~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 89 (220)
T 2v70_A 13 GTTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLT 89 (220)
T ss_dssp TTEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECC
Confidence 356777777777 4666553 3578999999999865566668888999999999999998777789999999999999
Q ss_pred CccccccCcccccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCcccccc
Q 046598 510 GNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVV 589 (986)
Q Consensus 510 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~ 589 (986)
+|+|++..|..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|..|..+++|++|+|++|++++..
T Consensus 90 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 169 (220)
T 2v70_A 90 SNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNC 169 (220)
T ss_dssp SSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSG
T ss_pred CCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCC
Confidence 99999888888999999999999999999988999999999999999999999988999999999999999999999887
Q ss_pred CCccccccccceeeeCCcccccCCC
Q 046598 590 PTQGVFKNASITSVFGNLKLCGGIP 614 (986)
Q Consensus 590 p~~~~~~~~~~~~~~~n~~lcg~~~ 614 (986)
+-......+....+......|+.|.
T Consensus 170 ~l~~l~~~~~~~~~~~~~~~C~~P~ 194 (220)
T 2v70_A 170 YLAWLGEWLRKKRIVTGNPRCQKPY 194 (220)
T ss_dssp GGHHHHHHHHHSCCBCCCCEEEESG
T ss_pred chHHHHHHHHhcCccccCCccCCCh
Confidence 6543222222222223334677654
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.2e-22 Score=247.14 Aligned_cols=257 Identities=20% Similarity=0.193 Sum_probs=137.4
Q ss_pred CCHhHHHHHHHHHHhccCCCcCCCCCCC-CCCCCCcceeeEecCCCCeEEEEeccCCCCccccCcCccCCCCCCEEEccC
Q 046598 17 GNETDRLALLELKSKITHDPLGVLASWN-ESSHFCQWRGVTCSRRHQRVTILDLESLKLAGSISPHVGNLSFLKVLRLYN 95 (986)
Q Consensus 17 ~~~~~~~~ll~~k~~~~~~~~~~l~~w~-~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~ 95 (986)
....++++|++++.+........-..|. ..+.++.|.+++++. .+++.++|.++.+.. ++..+ |+.++|+.
T Consensus 129 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~--~~~~~l~L~~n~~~~-~~~~~-----l~~l~Ls~ 200 (727)
T 4b8c_D 129 LVDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVST--PLTPKIELFANGKDE-ANQAL-----LQHKKLSQ 200 (727)
T ss_dssp ---CCCHHHHHHHHHHHHHHTTC---------------------------------------------------------
T ss_pred ccccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecC--CccceEEeeCCCCCc-chhhH-----hhcCccCc
Confidence 3467889999999887555555556774 334567899999875 579999999998875 33333 33444444
Q ss_pred CCccc---------cCCcchhccccCceeeceecccCCCCccchhcCccccceecccccccCccCccccCCCCCCeEEcc
Q 046598 96 NSFNH---------EIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVN 166 (986)
Q Consensus 96 n~l~~---------~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 166 (986)
|.|.+ ..|..|..+++|+.|+|++|.+. .+|..+..+++|++|+|++|.|+ .+|..|++|++|++|+|+
T Consensus 201 ~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls 278 (727)
T 4b8c_D 201 YSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLS 278 (727)
T ss_dssp ---------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECT
T ss_pred ccccCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCc
Confidence 44432 45788999999999999999998 77878889999999999999999 889999999999999999
Q ss_pred CCcCCCCcccccCCCcCcceeeccCCcccCcCcchhhccCCCceeecccccccccCCccccCCCCc-cEEeccccccccc
Q 046598 167 DNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSI-TGFDAGVNKIQGA 245 (986)
Q Consensus 167 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L-~~L~l~~N~l~~~ 245 (986)
+|+|+ .+|..|++|++|++|+|++|.|+ .+|..|+.|++|++|+|++|+|++.+|..+..+... ..++++.|.+.+.
T Consensus 279 ~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~ 356 (727)
T 4b8c_D 279 HNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIP 356 (727)
T ss_dssp TSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCC
T ss_pred CCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCc
Confidence 99999 77999999999999999999998 778889999999999999999998888887765332 3477888888887
Q ss_pred cCCcccccccccceEEecCc--------eecccCCccccCCCCCcEEeccccccc
Q 046598 246 IPLDYGFSLQNLQFFSVGEN--------QLTGAIPPTISNASNLEIFHGSVNKLT 292 (986)
Q Consensus 246 ~p~~~~~~l~~L~~L~L~~N--------~l~~~~p~~l~~l~~L~~L~ls~N~l~ 292 (986)
+|. .|+.|+++.| .+++..+..+..+..+....+++|.+.
T Consensus 357 ~p~-------~l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~ 404 (727)
T 4b8c_D 357 LPH-------ERRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLC 404 (727)
T ss_dssp CCC-------C-----------------------------------------CCC
T ss_pred Ccc-------ccceeEeecccccccccCCccccccchhhcccccceeeeeccccc
Confidence 774 3566777766 333344444455555555566666553
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.85 E-value=5.3e-21 Score=199.15 Aligned_cols=165 Identities=23% Similarity=0.276 Sum_probs=135.6
Q ss_pred CCCCCCCCCCcceeeEecCCCCeEEEEeccCCCCccccCcCccCCCCCCEEEccCCCccccCCcchhccccCceeeceec
Q 046598 41 ASWNESSHFCQWRGVTCSRRHQRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYN 120 (986)
Q Consensus 41 ~~w~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N 120 (986)
.-|..+.+.|+|++|.|+.. +++ .+|..+. +.|++|+|++|++++..|..|.++++|++|+|++|
T Consensus 10 ~~~~~~~~~Cs~~~v~c~~~------------~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N 74 (229)
T 3e6j_A 10 SAACPSQCSCSGTTVDCRSK------------RHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSN 74 (229)
T ss_dssp -CCCCTTCEEETTEEECTTS------------CCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred hccCCCCCEEeCCEeEccCC------------CcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCC
Confidence 44556778999999999753 232 5555443 78999999999999888889999999999999999
Q ss_pred ccCCCCccchhcCccccceecccccccCccCccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeeccCCcccCcCcc
Q 046598 121 SIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPD 200 (986)
Q Consensus 121 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 200 (986)
+|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+++ .+|..+.++++|++|+|++|+|++..+.
T Consensus 75 ~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~ 153 (229)
T 3e6j_A 75 QLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHG 153 (229)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTT
T ss_pred CCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHH
Confidence 998666677888999999999999998777777888889999999999888 7788888888888888888888876667
Q ss_pred hhhccCCCceeeccccccccc
Q 046598 201 TLGWLKNLVNLTMAQNRLSGT 221 (986)
Q Consensus 201 ~~~~l~~L~~L~L~~N~l~~~ 221 (986)
.|..+++|+.|+|++|.+.+.
T Consensus 154 ~~~~l~~L~~L~l~~N~~~c~ 174 (229)
T 3e6j_A 154 AFDRLSSLTHAYLFGNPWDCE 174 (229)
T ss_dssp TTTTCTTCCEEECTTSCBCTT
T ss_pred HHhCCCCCCEEEeeCCCccCC
Confidence 788888888888888888743
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.83 E-value=3.3e-20 Score=190.31 Aligned_cols=149 Identities=23% Similarity=0.247 Sum_probs=70.1
Q ss_pred EEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCcccccc-cccEEEecccc
Q 046598 361 VLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNL-KLFILYLSYNF 439 (986)
Q Consensus 361 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~-~L~~L~L~~N~ 439 (986)
.++++++.++. +|..+ .++|++|++++|.+++..+..|..+++|++|+|++|++++..+..+..+ +|++|+|++|+
T Consensus 11 ~v~c~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 87 (208)
T 2o6s_A 11 TVECYSQGRTS-VPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQ 87 (208)
T ss_dssp EEECCSSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEecCCCccC-CCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCc
Confidence 45555666552 33322 3466666777666665555556666666666666666654333333222 23444444444
Q ss_pred cCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccc
Q 046598 440 LQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKL 513 (986)
Q Consensus 440 l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 513 (986)
+++..+..|..+++|++|++++|+|+ .+|...+..+++|+.|++++|++++..+..|..+++|+.|+|++|.+
T Consensus 88 l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~ 160 (208)
T 2o6s_A 88 LQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPW 160 (208)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCB
T ss_pred CCccCHhHhcCccCCCEEEcCCCcCc-ccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCe
Confidence 44333333444444444444444444 23333333444444444444444433333344444444444444433
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.83 E-value=1.4e-20 Score=194.59 Aligned_cols=156 Identities=26% Similarity=0.333 Sum_probs=128.7
Q ss_pred cEEEecccccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccC
Q 046598 431 FILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFG 510 (986)
Q Consensus 431 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 510 (986)
+.+++++|.++ .+|..+. ++|+.|+|++|+|+ .++...+..+++|+.|+|++|+|++..|..|.++++|++|+|++
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~-~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~ 89 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYG 89 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCC-EECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCC-CcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCC
Confidence 45666777776 4565543 57888888888888 56655577888889999999998877788888899999999999
Q ss_pred ccccccCcccccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCccccccC
Q 046598 511 NKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVP 590 (986)
Q Consensus 511 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p 590 (986)
|+|++..+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|++.+...
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 169 (220)
T 2v9t_B 90 NKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCH 169 (220)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred CcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCc
Confidence 99986656667889999999999999998888889999999999999999998888888889999999999999987654
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.82 E-value=3e-20 Score=192.06 Aligned_cols=159 Identities=21% Similarity=0.295 Sum_probs=132.3
Q ss_pred CCCCCcceeeEecCCCCeEEEEeccCCCCccccCcCccCCCCCCEEEccCCCccccCCcchhccccCceeeceecccCCC
Q 046598 46 SSHFCQWRGVTCSRRHQRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGA 125 (986)
Q Consensus 46 ~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 125 (986)
..+.|.|..|.|.. ++++ .+|..+. +.|+.|+|++|++++..+..|..+++|++|+|++|++++.
T Consensus 7 ~~C~C~~~~v~c~~------------~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~ 71 (220)
T 2v9t_B 7 AACTCSNNIVDCRG------------KGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISEL 71 (220)
T ss_dssp TTSEEETTEEECTT------------SCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEE
T ss_pred CCCEECCCEEEcCC------------CCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCc
Confidence 34457777777753 4444 4566554 6889999999999988888899999999999999999988
Q ss_pred CccchhcCccccceecccccccCccCccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeeccCCcccCcCcchhhcc
Q 046598 126 IPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWL 205 (986)
Q Consensus 126 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 205 (986)
.|..|.++++|++|+|++|+|+...+..|.++++|++|+|++|++++..|..|.++++|++|+|++|+|++..+..|..+
T Consensus 72 ~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 151 (220)
T 2v9t_B 72 APDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL 151 (220)
T ss_dssp CTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTC
T ss_pred CHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCC
Confidence 88899999999999999999996666678889999999999999988888888888999999999999887777778888
Q ss_pred CCCceeeccccccc
Q 046598 206 KNLVNLTMAQNRLS 219 (986)
Q Consensus 206 ~~L~~L~L~~N~l~ 219 (986)
++|++|+|++|.+.
T Consensus 152 ~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 152 RAIQTMHLAQNPFI 165 (220)
T ss_dssp TTCCEEECCSSCEE
T ss_pred CCCCEEEeCCCCcC
Confidence 88888888888876
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=5.1e-20 Score=190.34 Aligned_cols=153 Identities=24% Similarity=0.303 Sum_probs=119.8
Q ss_pred EEeccCCCCccccCcCccCCCCCCEEEccCCCccccCC-cchhccccCceeeceecccCCCCccchhcCccccceecccc
Q 046598 66 ILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIP-SEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHN 144 (986)
Q Consensus 66 ~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 144 (986)
.++++++.++ .+|..+. ..+++|+|++|++++..| ..|..+++|++|+|++|+|++..|..|..+++|++|+|++|
T Consensus 15 ~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 3555566666 4676654 346789999999887755 45888888888888888888777778888888888888888
Q ss_pred cccCccCccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeeccCCcccCcCcchhhccCCCceeeccccccccc
Q 046598 145 QLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGT 221 (986)
Q Consensus 145 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 221 (986)
++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+++.
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence 88877777788888888888888888877778888888888888888888877777888888888888888877643
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.80 E-value=7.7e-20 Score=204.60 Aligned_cols=157 Identities=27% Similarity=0.239 Sum_probs=97.8
Q ss_pred EEEecccccCCCCCcccC-CCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccC
Q 046598 432 ILYLSYNFLQGSIPSSLG-RYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFG 510 (986)
Q Consensus 432 ~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 510 (986)
.|+|++|+|++..+..|. .+++|+.|+|++|+|+ .++...+..+++|+.|+|++|+|++..+..|..+++|+.|+|++
T Consensus 43 ~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~-~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 121 (361)
T 2xot_A 43 LLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYN 121 (361)
T ss_dssp EEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred EEECCCCCCCccChhhhhhcccccCEEECCCCcCC-ccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCC
Confidence 344444444434444454 5666666666666666 44444455666666666666666655555666667777777777
Q ss_pred ccccccCcccccCCccccEEecccccccccCCccc---cCCCCCCEEeCCCccCcccCchhhhccccc--ceeeccCCcc
Q 046598 511 NKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSL---SSLRGLSVLDLSQNNLSGKIPELLIRLQLV--KNLNLSNNDL 585 (986)
Q Consensus 511 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L--~~l~ls~N~l 585 (986)
|+|++..|..|..+++|+.|+|++|+|++..+..| ..+++|+.|||++|+|++..+..+..++.+ +.|+|++|++
T Consensus 122 N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~ 201 (361)
T 2xot_A 122 NHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCE
T ss_pred CcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCc
Confidence 77766666667777777777777777775433444 457777777777777776665667776653 6677777777
Q ss_pred cccc
Q 046598 586 EGVV 589 (986)
Q Consensus 586 ~~~~ 589 (986)
.+..
T Consensus 202 ~C~C 205 (361)
T 2xot_A 202 ECDC 205 (361)
T ss_dssp ECCH
T ss_pred cCCc
Confidence 6543
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.80 E-value=7.1e-20 Score=204.86 Aligned_cols=178 Identities=26% Similarity=0.222 Sum_probs=150.3
Q ss_pred cEEEecccccCCCCCcccCCCCCCCeeecCCCccCCCCCccccc-CCCcceEEEccCCcccccCCcccccccccchhhcc
Q 046598 431 FILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIG-LSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVF 509 (986)
Q Consensus 431 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~-~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 509 (986)
+.+++++|.++ .+|..+. +.++.|+|++|+|+ .++...+. .+++|+.|+|++|+|++..+..|..+++|++|+|+
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~-~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 96 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS 96 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCC-EECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCC-ccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECC
Confidence 46777777777 4666554 46899999999999 55555565 88999999999999998777889999999999999
Q ss_pred CccccccCcccccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhh---hcccccceeeccCCccc
Q 046598 510 GNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELL---IRLQLVKNLNLSNNDLE 586 (986)
Q Consensus 510 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~l~ls~N~l~ 586 (986)
+|+|++..+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..| ..+++|+.|+|++|+|+
T Consensus 97 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~ 176 (361)
T 2xot_A 97 SNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK 176 (361)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred CCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence 999998778889999999999999999999889999999999999999999997555555 67999999999999999
Q ss_pred cccCCc-ccccc--ccceeeeCCcccccC
Q 046598 587 GVVPTQ-GVFKN--ASITSVFGNLKLCGG 612 (986)
Q Consensus 587 ~~~p~~-~~~~~--~~~~~~~~n~~lcg~ 612 (986)
+.++.. ..++. +..+.+.+||+.|++
T Consensus 177 ~l~~~~~~~l~~~~l~~l~l~~N~~~C~C 205 (361)
T 2xot_A 177 KLPLTDLQKLPAWVKNGLYLHNNPLECDC 205 (361)
T ss_dssp CCCHHHHHHSCHHHHTTEECCSSCEECCH
T ss_pred ccCHHHhhhccHhhcceEEecCCCccCCc
Confidence 876543 23333 366899999999975
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=8.2e-22 Score=232.29 Aligned_cols=226 Identities=18% Similarity=0.161 Sum_probs=156.9
Q ss_pred cceeeEecCCCCeEEEEeccCCCCcc-------------------------ccCc---CccCCCCCCEEEccCCCccccC
Q 046598 51 QWRGVTCSRRHQRVTILDLESLKLAG-------------------------SISP---HVGNLSFLKVLRLYNNSFNHEI 102 (986)
Q Consensus 51 ~w~gv~c~~~~~~v~~l~l~~~~l~~-------------------------~~~~---~~~~l~~L~~L~L~~n~l~~~~ 102 (986)
.|+++.|+....+|-.+++..-.+.- ..+. +++..++|+.|+|++|+++ .+
T Consensus 286 ~W~~~~~~~~~~~vw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~L~~L~Ls~n~L~-~L 364 (567)
T 1dce_A 286 EWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST-VL 364 (567)
T ss_dssp CCBCTTSSCCSEEEEEEECCGGGTSTTSSEEEEEEEETTTTEEEEEEEETTCSEEEEECCSTTTTSSSCCCCHHHHH-HH
T ss_pred eeccCCcccccceeEEeecCccccccccccceEEEeeccCCCCccccccCCCchhhhcccccCccceeccCChhhHH-hh
Confidence 58877777766777777765433210 1111 2356788888888888886 67
Q ss_pred CcchhccccCceeeceecc-------------cCCCCccchhcCcccccee-cccccccCccCccccCCCCCCeEEccCC
Q 046598 103 PSEFDRLRRLQVLALHYNS-------------IGGAIPANISSCSNLIQLR-LFHNQLVGKIPSELSSLSKIEHISVNDN 168 (986)
Q Consensus 103 p~~~~~l~~L~~L~L~~N~-------------l~~~~p~~~~~l~~L~~L~-Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 168 (986)
|..++++++|+.|++++|. +.+.+|..++.+++|+.|+ ++.|.+. +|+.+.+++|
T Consensus 365 p~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~-----------~L~~l~l~~n 433 (567)
T 1dce_A 365 QSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD-----------DLRSKFLLEN 433 (567)
T ss_dssp HHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-----------HHHHHHHHHH
T ss_pred HHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-----------hhhhhhhhcc
Confidence 8888888888888887775 5567777788888888887 6666543 3444445555
Q ss_pred cCCCCcccccCCCcCcceeeccCCcccCcCcchhhccCCCceeecccccccccCCccccCCCCccEEeccccccccccCC
Q 046598 169 NLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPL 248 (986)
Q Consensus 169 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~ 248 (986)
.++...+ ..|++|+|++|+|++ +|. |+.+++|+.|+|++|+|+ .+|..++++++|+.|++++|.+++ +|
T Consensus 434 ~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp- 502 (567)
T 1dce_A 434 SVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD- 502 (567)
T ss_dssp HHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-
T ss_pred cccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-
Confidence 5542221 136677777777764 454 777777777777777776 667777777777777777777765 55
Q ss_pred cccccccccceEEecCceecccC-CccccCCCCCcEEecccccccCCCchhhh
Q 046598 249 DYGFSLQNLQFFSVGENQLTGAI-PPTISNASNLEIFHGSVNKLTGAAPYLEK 300 (986)
Q Consensus 249 ~~~~~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~ls~N~l~~~~~~l~~ 300 (986)
.+..+++|+.|+|++|++++.. |..++.+++|+.|++++|++++.++....
T Consensus 503 -~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~ 554 (567)
T 1dce_A 503 -GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQER 554 (567)
T ss_dssp -GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTH
T ss_pred -ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHH
Confidence 3346788888888888888776 88888899999999999999888775443
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.79 E-value=5.2e-19 Score=191.26 Aligned_cols=172 Identities=21% Similarity=0.317 Sum_probs=85.4
Q ss_pred CCCCCCEEEccCCCccccCCcchhccccCceeeceecccCCCCccchhcCccccceecccccccCccCccccCCCCCCeE
Q 046598 84 NLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHI 163 (986)
Q Consensus 84 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 163 (986)
.+++|++|++++|.+... | .+..+++|++|+|++|++++..| +..+++|++|+|++|.+++ +| .+..+++|++|
T Consensus 44 ~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L 117 (291)
T 1h6t_A 44 ELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSL 117 (291)
T ss_dssp HHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEE
T ss_pred hcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEE
Confidence 444455555555555422 2 24445555555555555553322 4455555555555555543 22 24445555555
Q ss_pred EccCCcCCCCcccccCCCcCcceeeccCCcccCcCcchhhccCCCceeecccccccccCCccccCCCCccEEeccccccc
Q 046598 164 SVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQ 243 (986)
Q Consensus 164 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~ 243 (986)
+|++|++++. ..+.++++|++|+|++|++++. ..+..+++|++|+|++|+++
T Consensus 118 ~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~------------------------ 169 (291)
T 1h6t_A 118 SLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS------------------------ 169 (291)
T ss_dssp ECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCC------------------------
T ss_pred ECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccc------------------------
Confidence 5555555432 2344445555555555555432 34444445555555555444
Q ss_pred cccCCcccccccccceEEecCceecccCCccccCCCCCcEEecccccccCC
Q 046598 244 GAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGA 294 (986)
Q Consensus 244 ~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~ 294 (986)
+..| +..+++|+.|++++|++++. + .+..+++|+.|++++|+++..
T Consensus 170 ~~~~---l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~~ 215 (291)
T 1h6t_A 170 DIVP---LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLNK 215 (291)
T ss_dssp CCGG---GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEECC
T ss_pred cchh---hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccCC
Confidence 3322 23455566666666666542 2 366667777777777766643
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.78 E-value=2.4e-19 Score=181.06 Aligned_cols=156 Identities=24% Similarity=0.289 Sum_probs=98.3
Q ss_pred CeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCc-ccccccccchhhccCccccccCcccccCCccccEEecc
Q 046598 455 TTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPS-EVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQ 533 (986)
Q Consensus 455 ~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 533 (986)
+.+++++|+++ .+|..+. .+|+.|++++|+|++..+. .|..+++|++|+|++|+|++..|..|.++++|++|+|+
T Consensus 11 ~~l~~s~~~l~-~ip~~~~---~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 86 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIP---LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC---TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CEEEcCCCCcC-cCccCCC---CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECC
Confidence 55666666665 5665432 2566666666666644433 36666677777777777766666667777777777777
Q ss_pred cccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCccccccCCccccccccceeeeCCcccccCC
Q 046598 534 ENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQGVFKNASITSVFGNLKLCGGI 613 (986)
Q Consensus 534 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lcg~~ 613 (986)
+|+|++..|..|..+++|++|+|++|+|++..|..+..+++|++|+|++|+++|..+.......+....+.++...|+.|
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P 166 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCC
Confidence 77777666666677777777777777777666777777777777777777777665543222223333445555566654
Q ss_pred C
Q 046598 614 P 614 (986)
Q Consensus 614 ~ 614 (986)
.
T Consensus 167 ~ 167 (192)
T 1w8a_A 167 S 167 (192)
T ss_dssp T
T ss_pred h
Confidence 4
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.78 E-value=5.1e-19 Score=191.30 Aligned_cols=168 Identities=20% Similarity=0.306 Sum_probs=143.4
Q ss_pred CeEEEEeccCCCCccccCcCccCCCCCCEEEccCCCccccCCcchhccccCceeeceecccCCCCccchhcCccccceec
Q 046598 62 QRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRL 141 (986)
Q Consensus 62 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 141 (986)
.+++.++++++.+... +.+..+++|++|+|++|++++..+ +.++++|++|+|++|++++ +| .+..+++|++|+|
T Consensus 46 ~~L~~L~l~~~~i~~~--~~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L 119 (291)
T 1h6t_A 46 NSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSL 119 (291)
T ss_dssp HTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEEC
T ss_pred CcccEEEccCCCcccC--hhHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEEC
Confidence 3588999999999854 458999999999999999997655 9999999999999999985 44 4999999999999
Q ss_pred ccccccCccCccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeeccCCcccCcCcchhhccCCCceeeccccccccc
Q 046598 142 FHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGT 221 (986)
Q Consensus 142 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 221 (986)
++|++++. ..+..+++|++|++++|++++. ..++++++|++|+|++|++++..| +..+++|++|+|++|++++
T Consensus 120 ~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~- 192 (291)
T 1h6t_A 120 EHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD- 192 (291)
T ss_dssp TTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-
T ss_pred CCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCC-
Confidence 99999964 5789999999999999999965 679999999999999999996555 9999999999999999984
Q ss_pred CCccccCCCCccEEeccccccc
Q 046598 222 IPSSIFNISSITGFDAGVNKIQ 243 (986)
Q Consensus 222 ~p~~l~~l~~L~~L~l~~N~l~ 243 (986)
+| .+..+++|+.|++++|.+.
T Consensus 193 l~-~l~~l~~L~~L~l~~n~i~ 213 (291)
T 1h6t_A 193 LR-ALAGLKNLDVLELFSQECL 213 (291)
T ss_dssp CG-GGTTCTTCSEEEEEEEEEE
T ss_pred Ch-hhccCCCCCEEECcCCccc
Confidence 34 3666666666666666554
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.78 E-value=9.1e-19 Score=182.21 Aligned_cols=156 Identities=22% Similarity=0.189 Sum_probs=110.5
Q ss_pred ccEEEecccccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhcc
Q 046598 430 LFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVF 509 (986)
Q Consensus 430 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 509 (986)
.+.++.+++.++ .+|..+. ++|++|+|++|+|++..|. .+..+++|+.|+|++|+|++..+..|..+++|+.|+|+
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls 96 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPG-VFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLG 96 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTT-TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHH-HhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECC
Confidence 445666666665 4554433 6677777777777743343 36666777777777777765545556777777777777
Q ss_pred CccccccCcccccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCcccccc
Q 046598 510 GNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVV 589 (986)
Q Consensus 510 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~ 589 (986)
+|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..|..+++|++|+|++|++++..
T Consensus 97 ~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 175 (229)
T 3e6j_A 97 TNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCEC 175 (229)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred CCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCc
Confidence 77777665666777777788888888777 56777777888888888888887666667777888888888888887766
Q ss_pred C
Q 046598 590 P 590 (986)
Q Consensus 590 p 590 (986)
+
T Consensus 176 ~ 176 (229)
T 3e6j_A 176 R 176 (229)
T ss_dssp G
T ss_pred c
Confidence 5
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.78 E-value=6.6e-19 Score=208.66 Aligned_cols=173 Identities=21% Similarity=0.342 Sum_probs=85.1
Q ss_pred CCCCCCEEEccCCCccccCCcchhccccCceeeceecccCCCCccchhcCccccceecccccccCccCccccCCCCCCeE
Q 046598 84 NLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHI 163 (986)
Q Consensus 84 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 163 (986)
.|+.|+.|+|++|.+.. +| .|..+++|+.|+|++|+|++..| +..+++|++|+|++|.+++ +| .+..+++|++|
T Consensus 41 ~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L 114 (605)
T 1m9s_A 41 ELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSL 114 (605)
T ss_dssp HHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEE
T ss_pred cCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEE
Confidence 44445555555555442 22 34455555555555555543332 4455555555555555442 22 34445555555
Q ss_pred EccCCcCCCCcccccCCCcCcceeeccCCcccCcCcchhhccCCCceeecccccccccCCccccCCCCccEEeccccccc
Q 046598 164 SVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQ 243 (986)
Q Consensus 164 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~ 243 (986)
+|++|.+++. ..+.++++|+.|+|++|+|++. ..|..+++|+.|+|++|++++..| +.
T Consensus 115 ~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~---------------- 172 (605)
T 1m9s_A 115 SLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LA---------------- 172 (605)
T ss_dssp ECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GT----------------
T ss_pred EecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hc----------------
Confidence 5555554432 2344444555555555544432 344444444444444444443322 33
Q ss_pred cccCCcccccccccceEEecCceecccCCccccCCCCCcEEecccccccCCC
Q 046598 244 GAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAA 295 (986)
Q Consensus 244 ~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~ 295 (986)
.+++|+.|+|++|+|++. ..+..+++|+.|++++|++++.+
T Consensus 173 ---------~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p 213 (605)
T 1m9s_A 173 ---------GLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKP 213 (605)
T ss_dssp ---------TCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCC
T ss_pred ---------cCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCc
Confidence 455556666666665543 34666666666666666666543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=6.4e-22 Score=233.16 Aligned_cols=191 Identities=20% Similarity=0.227 Sum_probs=113.0
Q ss_pred cCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCcc-------------ceeecCcccccc-cccEEE-ecccccCC
Q 046598 378 GKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNR-------------FQGNIPPSIGNL-KLFILY-LSYNFLQG 442 (986)
Q Consensus 378 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-------------l~~~~~~~~~~~-~L~~L~-L~~N~l~~ 442 (986)
..+++|+.|+|++|+++ .+|..++.+++|+.|++++|. +.+.+|..+..+ +|+.|+ ++.|.+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~- 423 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD- 423 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-
Confidence 44566666666666665 556666666666666665554 222333333322 244444 3333321
Q ss_pred CCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccCccccc
Q 046598 443 SIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLG 522 (986)
Q Consensus 443 ~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 522 (986)
.|+.+.+++|.|+ .+|. ..|+.|+|++|+|++ +|. |+.+++|+.|+|++|+|+ .+|..|+
T Consensus 424 ----------~L~~l~l~~n~i~-~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~ 483 (567)
T 1dce_A 424 ----------DLRSKFLLENSVL-KMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALA 483 (567)
T ss_dssp ----------HHHHHHHHHHHHH-HHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGG
T ss_pred ----------hhhhhhhhccccc-ccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhh
Confidence 2333444444554 2222 136667777777764 454 666667777777777776 5666677
Q ss_pred CCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccC-chhhhcccccceeeccCCccccccCCc
Q 046598 523 SCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKI-PELLIRLQLVKNLNLSNNDLEGVVPTQ 592 (986)
Q Consensus 523 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~l~ls~N~l~~~~p~~ 592 (986)
.+++|+.|+|++|+|++ +| .++.+++|+.|+|++|+|++.. |..+..+++|++|+|++|++++.+|..
T Consensus 484 ~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~ 552 (567)
T 1dce_A 484 ALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQ 552 (567)
T ss_dssp GCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCT
T ss_pred cCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHH
Confidence 77777777777777765 45 6666777777777777776655 666777777777777777777666543
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.77 E-value=5e-19 Score=209.70 Aligned_cols=193 Identities=21% Similarity=0.305 Sum_probs=122.6
Q ss_pred EEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCccccc-ccccEEEecccc
Q 046598 361 VLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGN-LKLFILYLSYNF 439 (986)
Q Consensus 361 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-~~L~~L~L~~N~ 439 (986)
.+.+..+.+.+..+ +..+++|+.|++++|.++. ++ .|..+++|+.|+|++|+|++..+ +.. .+|+.|+|++|.
T Consensus 25 ~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~ 98 (605)
T 1m9s_A 25 KDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENK 98 (605)
T ss_dssp HHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSC
T ss_pred HHhccCCCcccccc--hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCC
Confidence 34455555553332 4556667777777777663 22 46666777777777776665443 322 246666666666
Q ss_pred cCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccCcc
Q 046598 440 LQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPS 519 (986)
Q Consensus 440 l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 519 (986)
|++ +| .+..+++|+.|+|++|+|+ .++. +..+++|+.|+|++|+|++. ..+..+++|+.|+|++|+|++..|
T Consensus 99 l~~-l~-~l~~l~~L~~L~Ls~N~l~-~l~~--l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~- 170 (605)
T 1m9s_A 99 IKD-LS-SLKDLKKLKSLSLEHNGIS-DING--LVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP- 170 (605)
T ss_dssp CCC-CT-TSTTCTTCCEEECTTSCCC-CCGG--GGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG-
T ss_pred CCC-Ch-hhccCCCCCEEEecCCCCC-CCcc--ccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh-
Confidence 653 22 5677777777777777776 3432 55667777777777777753 457777777777777777775544
Q ss_pred cccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhh
Q 046598 520 TLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLI 570 (986)
Q Consensus 520 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 570 (986)
+..+++|+.|+|++|+|++. ..+..+++|+.|+|++|++++.....+.
T Consensus 171 -l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~~~~~ 218 (605)
T 1m9s_A 171 -LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQS 218 (605)
T ss_dssp -GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCCCCCS
T ss_pred -hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCcccccc
Confidence 77777777777777777753 3567777777777777777654333333
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=9e-19 Score=185.69 Aligned_cols=137 Identities=22% Similarity=0.184 Sum_probs=106.8
Q ss_pred CCCCcccccccceeEEEEEECCCCeE--EEEEEeeccCch------------------------hHHHHHHHHHHHhcCC
Q 046598 690 FSSVNQIGEGSFGSVFKGILDDGRTT--IAVKVFNLLHHG------------------------AFKSFIAECNTLKNIR 743 (986)
Q Consensus 690 y~~~~~lg~G~~g~Vy~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 743 (986)
|.+.+.||+|+||.||+|.+..+++. ||||+++..... ....+.+|+++++++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 66788999999999999999555788 999997532111 1136789999999998
Q ss_pred CCcc--eeeeeeccccccCCCceEEEEEEeccC-C----CHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHH
Q 046598 744 HRNL--VKILTACSGVDYQGNDFKALVFEFMHN-R----SLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYL 816 (986)
Q Consensus 744 h~ni--v~l~~~~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~L 816 (986)
|+++ ..++++ ...++||||+.+ | +|.++... .++.++..++.|++.|+.||
T Consensus 129 ~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~-------------~~~~~~~~i~~qi~~~l~~l 186 (258)
T 1zth_A 129 EAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE-------------LKELDVEGIFNDVVENVKRL 186 (258)
T ss_dssp HTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG-------------GGGSCHHHHHHHHHHHHHHH
T ss_pred hCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc-------------cChHHHHHHHHHHHHHHHHH
Confidence 8754 333332 346899999942 3 67666521 22446778999999999999
Q ss_pred H-hcCCCCeEeecCCCCCeEecCCCcEEEcccccceec
Q 046598 817 H-HDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFL 853 (986)
Q Consensus 817 H-~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 853 (986)
| +. ||+||||||+|||++. .++|+|||+|...
T Consensus 187 H~~~---givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 187 YQEA---ELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp HHTS---CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HHHC---CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9 88 9999999999999998 9999999999764
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.75 E-value=3.5e-18 Score=172.49 Aligned_cols=179 Identities=20% Similarity=0.242 Sum_probs=138.6
Q ss_pred ccEEEecccccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhcc
Q 046598 430 LFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVF 509 (986)
Q Consensus 430 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 509 (986)
-+++++++|.++ .+|..+.. +|++|++++|+|++..+..+++.+++|++|+|++|+|++..|..|..+++|++|+|+
T Consensus 10 ~~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 86 (192)
T 1w8a_A 10 GTTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECC
Confidence 356777788776 56765543 899999999999855444567888999999999999998889999999999999999
Q ss_pred CccccccCcccccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCcccccc
Q 046598 510 GNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVV 589 (986)
Q Consensus 510 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~ 589 (986)
+|+|++..|..|..+++|++|+|++|+|++.+|..|..+++|+.|+|++|++++..+... -...++...+..+...+..
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~-~~~~l~~~~~~~~~~~C~~ 165 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW-FAEWLRKKSLNGGAARCGA 165 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHH-HHHHHHHHCCSGGGCBBCS
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchH-HHHHHHHcCCCCCCCCCCC
Confidence 999998888889999999999999999999999999999999999999999997655321 1112333455566666655
Q ss_pred CCccccccccceeeeCCcccccCCC
Q 046598 590 PTQGVFKNASITSVFGNLKLCGGIP 614 (986)
Q Consensus 590 p~~~~~~~~~~~~~~~n~~lcg~~~ 614 (986)
|.. +......++..+.-.|....
T Consensus 166 P~~--l~~~~l~~l~~~~~~C~~~~ 188 (192)
T 1w8a_A 166 PSK--VRDVQIKDLPHSEFKCSSEN 188 (192)
T ss_dssp STT--TTTSBGGGSCTTTCCCCCC-
T ss_pred ChH--HcCCChhhCcHhhcCcCCCC
Confidence 543 44444445566666676543
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=2.8e-18 Score=174.18 Aligned_cols=151 Identities=19% Similarity=0.239 Sum_probs=87.5
Q ss_pred cCCCCCCEEEccCCCccccCCcchhccccCceeeceecccCCCCccchhcCccccceecccccccCccCccccCCCCCCe
Q 046598 83 GNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEH 162 (986)
Q Consensus 83 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 162 (986)
+.+++|++|++++|.+. .+| .+..+++|++|++++|.++ . +..+..+++|++|++++|++++..|..|+.+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~-~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-N-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-C-CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-c-chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 34555666666666665 344 4666666666666666554 2 235666666666666666666555666666666666
Q ss_pred EEccCCcCCCCcccccCCCcCcceeeccCCc-ccCcCcchhhccCCCceeecccccccccCCccccCCCCccEEeccccc
Q 046598 163 ISVNDNNLTGSIPSSLGNLSSIRSLFLSGNN-LEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNK 241 (986)
Q Consensus 163 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~ 241 (986)
|+|++|++++..|..|+++++|++|+|++|+ ++ .+| .+..+++|++|++++|++++ ++ .+..+++|+.|++++|+
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC-
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcc
Confidence 6666666665556666666666666666665 44 333 45666666666666666653 22 34444444444444443
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=4.6e-18 Score=172.51 Aligned_cols=149 Identities=15% Similarity=0.200 Sum_probs=116.7
Q ss_pred ccEEEecccccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhcc
Q 046598 430 LFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVF 509 (986)
Q Consensus 430 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 509 (986)
|++|++++|.++ .+| .+..+++|++|++++|.++ .++ . +..+++|++|++++|++++..|..++.+++|++|+|+
T Consensus 46 L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~~~-~-l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls 120 (197)
T 4ezg_A 46 LTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-NYN-P-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDIS 120 (197)
T ss_dssp CCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-CCG-G-GTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECC
T ss_pred ccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-cch-h-hhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEec
Confidence 444444444444 444 5777888888888888776 443 3 6778889999999999987778888999999999999
Q ss_pred CccccccCcccccCCccccEEeccccc-ccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCcccc
Q 046598 510 GNKLKGEIPSTLGSCIKLEQLEMQENF-LQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEG 587 (986)
Q Consensus 510 ~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~ 587 (986)
+|++++..|..++.+++|++|+|++|+ ++ .+| .+..+++|+.|+|++|++++ ++ .+..+++|++|++++|++.+
T Consensus 121 ~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 121 HSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp SSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC----
T ss_pred CCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcccCC
Confidence 999988788889999999999999998 65 455 68889999999999999985 44 78889999999999998865
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=4.3e-18 Score=181.00 Aligned_cols=163 Identities=20% Similarity=0.262 Sum_probs=85.5
Q ss_pred EEeccCCCCccccCcCccCCCCCCEEEccCCCccccCCcchhccccCceeeceecccCCCCccchhcCccccceeccccc
Q 046598 66 ILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQ 145 (986)
Q Consensus 66 ~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 145 (986)
.++++.+.+++.. .+..+++|++|++++|+++. +| .+..+++|++|+|++|++++..| +..+++|++|+|++|+
T Consensus 23 ~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~ 96 (263)
T 1xeu_A 23 KQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNR 96 (263)
T ss_dssp HHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSC
T ss_pred HHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCc
Confidence 3444455544322 34555556666666665552 33 45555666666666666654333 5555666666666666
Q ss_pred ccCccCccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeeccCCcccCcCcchhhccCCCceeecccccccccCCcc
Q 046598 146 LVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSS 225 (986)
Q Consensus 146 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 225 (986)
+++ +|... . ++|++|+|++|++++. + .+.++++|++|+|++|++++. + .+..+++|++|+|++|++++. ..
T Consensus 97 l~~-l~~~~-~-~~L~~L~L~~N~l~~~-~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~--~~ 167 (263)
T 1xeu_A 97 LKN-LNGIP-S-ACLSRLFLDNNELRDT-D-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT--GG 167 (263)
T ss_dssp CSC-CTTCC-C-SSCCEEECCSSCCSBS-G-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC--TT
T ss_pred cCC-cCccc-c-CcccEEEccCCccCCC-h-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch--HH
Confidence 553 22221 2 5566666666655532 2 355555666666666655532 2 455555566666666655543 44
Q ss_pred ccCCCCccEEeccccccc
Q 046598 226 IFNISSITGFDAGVNKIQ 243 (986)
Q Consensus 226 l~~l~~L~~L~l~~N~l~ 243 (986)
+..+++|+.|++++|.+.
T Consensus 168 l~~l~~L~~L~l~~N~~~ 185 (263)
T 1xeu_A 168 LTRLKKVNWIDLTGQKCV 185 (263)
T ss_dssp STTCCCCCEEEEEEEEEE
T ss_pred hccCCCCCEEeCCCCccc
Confidence 445555555555555544
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=3.5e-18 Score=181.67 Aligned_cols=169 Identities=24% Similarity=0.297 Sum_probs=112.8
Q ss_pred CCCCCCEEEccCCCccccCCcchhccccCceeeceecccCCCCccchhcCccccceecccccccCccCccccCCCCCCeE
Q 046598 84 NLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHI 163 (986)
Q Consensus 84 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 163 (986)
.+..+..+++++|.+++.. .+..+++|++|++++|+++ .+| .+..+++|++|+|++|++++..+ +.++++|++|
T Consensus 17 ~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence 4566677778888776433 5777888888888888887 445 67778888888888888875444 7778888888
Q ss_pred EccCCcCCCCcccccCCCcCcceeeccCCcccCcCcchhhccCCCceeecccccccccCCccccCCCCccEEeccccccc
Q 046598 164 SVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQ 243 (986)
Q Consensus 164 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~ 243 (986)
+|++|++++. |. +.. ++|++|+|++|++++ ++ .+..+++|++|+|++|++++. | .+..+++|+.|++++|.+.
T Consensus 91 ~L~~N~l~~l-~~-~~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~ 163 (263)
T 1xeu_A 91 SVNRNRLKNL-NG-IPS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEIT 163 (263)
T ss_dssp ECCSSCCSCC-TT-CCC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCC
T ss_pred ECCCCccCCc-Cc-ccc-CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCc
Confidence 8888888753 33 223 778888888888774 33 577777788888888877743 3 4556666666666666555
Q ss_pred cccCCcccccccccceEEecCceec
Q 046598 244 GAIPLDYGFSLQNLQFFSVGENQLT 268 (986)
Q Consensus 244 ~~~p~~~~~~l~~L~~L~L~~N~l~ 268 (986)
+. ..+..+++|+.|++++|.++
T Consensus 164 ~~---~~l~~l~~L~~L~l~~N~~~ 185 (263)
T 1xeu_A 164 NT---GGLTRLKKVNWIDLTGQKCV 185 (263)
T ss_dssp BC---TTSTTCCCCCEEEEEEEEEE
T ss_pred ch---HHhccCCCCCEEeCCCCccc
Confidence 43 22234455555555555554
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.73 E-value=8.3e-19 Score=213.35 Aligned_cols=189 Identities=25% Similarity=0.269 Sum_probs=95.3
Q ss_pred EccCccccCcCCCcccCCCCCCEEEccCccceeecCcccccccccEEEecccccCCCCCcccCCCCCCCeeecCCCccCC
Q 046598 387 DMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTG 466 (986)
Q Consensus 387 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 466 (986)
+++.|.+. ..+..|..+++|+.|+|++|++....+..+...+|++|+|++|.|+ .+|..|+.+++|++|+|++|+|+
T Consensus 207 ~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~- 283 (727)
T 4b8c_D 207 DDIENRMV-MPKDSKYDDQLWHALDLSNLQIFNISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT- 283 (727)
T ss_dssp ----------------CCCCCCEEECTTSCCSCCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-
T ss_pred ccccccee-cChhhhccCCCCcEEECCCCCCCCCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-
Confidence 33444444 4566777777777777777777733333343345777777777777 66777777777777777777777
Q ss_pred CCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccCcccccCCcc-ccEEecccccccccCCccc
Q 046598 467 TIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIK-LEQLEMQENFLQGPIPSSL 545 (986)
Q Consensus 467 ~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~p~~~ 545 (986)
.+|.. ++.+++|++|+|++|.|+ .+|..|+.+++|+.|+|++|+|++.+|..+..+.. +..|+|++|.+++.+|..
T Consensus 284 ~lp~~-~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~- 360 (727)
T 4b8c_D 284 SLPAE-LGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE- 360 (727)
T ss_dssp SCCSS-GGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-
T ss_pred ccChh-hcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc-
Confidence 66666 566677777777777776 56666777777777777777777777766655432 234677777777766653
Q ss_pred cCCCCCCEEeCCCc--------cCcccCchhhhcccccceeeccCCccc
Q 046598 546 SSLRGLSVLDLSQN--------NLSGKIPELLIRLQLVKNLNLSNNDLE 586 (986)
Q Consensus 546 ~~l~~L~~L~Ls~N--------~l~~~~p~~~~~l~~L~~l~ls~N~l~ 586 (986)
|..|++++| .|.+..+..+.++..+....+++|-+.
T Consensus 361 -----l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~ 404 (727)
T 4b8c_D 361 -----RRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLC 404 (727)
T ss_dssp ----------------------------------------------CCC
T ss_pred -----cceeEeecccccccccCCccccccchhhcccccceeeeeccccc
Confidence 344555555 333333333444444444555555444
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.72 E-value=8.4e-18 Score=169.55 Aligned_cols=132 Identities=23% Similarity=0.320 Sum_probs=113.0
Q ss_pred CeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccCcccccCCccccEEeccc
Q 046598 455 TTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQE 534 (986)
Q Consensus 455 ~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 534 (986)
+.+++++|+++ .+|..+ .++|+.|+|++|+|+ .+|..|.++++|+.|+|++|+|++..+..|.++++|++|+|++
T Consensus 13 ~~l~~~~~~l~-~ip~~~---~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~ 87 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGI---PRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSY 87 (193)
T ss_dssp TEEECTTSCCS-SCCSCC---CTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCCC-cCCCCC---CCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCC
Confidence 57888888887 788653 357888999999998 6778888899999999999999977778899999999999999
Q ss_pred ccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCccccccCC
Q 046598 535 NFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPT 591 (986)
Q Consensus 535 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~ 591 (986)
|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++.+...-
T Consensus 88 N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~l 144 (193)
T 2wfh_A 88 NRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCNM 144 (193)
T ss_dssp SCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGGG
T ss_pred CccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCcC
Confidence 999988888899999999999999999977777888999999999999999876543
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.69 E-value=5.7e-17 Score=159.87 Aligned_cols=137 Identities=20% Similarity=0.215 Sum_probs=108.1
Q ss_pred CCCCCEEEccCCCcc-ccCCcchhccccCceeeceecccCCCCccchhcCccccceecccccccCccCccccCCCCCCeE
Q 046598 85 LSFLKVLRLYNNSFN-HEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHI 163 (986)
Q Consensus 85 l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 163 (986)
.+.|+.|+|++|+++ +.+|..|..+++|++|+|++|.+++. ..|..+++|++|+|++|++++.+|..+.++++|++|
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 367888888888887 67787788888888888888888855 677888888888888888887777777778888888
Q ss_pred EccCCcCCCCc-ccccCCCcCcceeeccCCcccCcCc---chhhccCCCceeecccccccccCCc
Q 046598 164 SVNDNNLTGSI-PSSLGNLSSIRSLFLSGNNLEGSIP---DTLGWLKNLVNLTMAQNRLSGTIPS 224 (986)
Q Consensus 164 ~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~L~~N~l~~~~p~ 224 (986)
+|++|++++.. +..+.++++|++|++++|.+++..+ ..|..+++|++|++++|.+. .+|.
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~ 164 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPD 164 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCS
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hccc
Confidence 88888888543 2678888888888888888885544 47788888888888888876 4443
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.68 E-value=3.7e-17 Score=180.36 Aligned_cols=134 Identities=11% Similarity=0.145 Sum_probs=76.4
Q ss_pred cccCcCccC--CCCCCEEEccCCCccccCCcchhc-cccCceeeceecccCCCCccchhcCccccceecccccccCccCc
Q 046598 76 GSISPHVGN--LSFLKVLRLYNNSFNHEIPSEFDR-LRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPS 152 (986)
Q Consensus 76 ~~~~~~~~~--l~~L~~L~L~~n~l~~~~p~~~~~-l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 152 (986)
|.++..+.. +..++.|.++++ +....-..+.. +++|++|||++|++. .....-+.++.++.+.+..|. +.+.
T Consensus 13 g~l~~~l~~~~~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~-~~~~~~~~~~~~~~~~~~~~~---I~~~ 87 (329)
T 3sb4_A 13 GTLISMMTEEEANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIK-MYSGKAGTYPNGKFYIYMANF---VPAY 87 (329)
T ss_dssp TCGGGGSCHHHHHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEEC-CEEESSSSSGGGCCEEECTTE---ECTT
T ss_pred CcHHhhccchhhCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeE-EecCccccccccccccccccc---cCHH
Confidence 344444443 667888888764 22111123333 666888888888887 111111222234555555553 2234
Q ss_pred cccC--------CCCCCeEEccCCcCCCCcccccCCCcCcceeeccCCcccCcCcchhhccCCCceeeccc
Q 046598 153 ELSS--------LSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQ 215 (986)
Q Consensus 153 ~~~~--------l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 215 (986)
+|.+ +++|+.|+|.+ .++.+.+.+|.++++|+.|++++|.+..+.+..|..+.++..+.+..
T Consensus 88 aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~ 157 (329)
T 3sb4_A 88 AFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGS 157 (329)
T ss_dssp TTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTC
T ss_pred HhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcc
Confidence 5555 77777777777 66655556677777777777777777656666666666666555544
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.3e-16 Score=158.84 Aligned_cols=139 Identities=22% Similarity=0.324 Sum_probs=104.9
Q ss_pred CCCCCcceeeEecCCCCeEEEEeccCCCCccccCcCccCCCCCCEEEccCCCccccCCcchhccccCceeeceecccCCC
Q 046598 46 SSHFCQWRGVTCSRRHQRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGA 125 (986)
Q Consensus 46 ~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 125 (986)
..+.|+|++|.|+.. +++ .+|..+ .+.|++|+|++|++++..+..|+.+++|++|+|++|++++.
T Consensus 3 ~~C~C~~~~l~~~~~------------~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 67 (177)
T 2o6r_A 3 SRCSCSGTEIRCNSK------------GLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSL 67 (177)
T ss_dssp TTCEEETTEEECCSS------------CCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCC
T ss_pred CCCEeCCCEEEecCC------------CCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEe
Confidence 345688999988643 333 344433 26788899999888877777788888888888888888866
Q ss_pred CccchhcCccccceecccccccCccCccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeeccCCcccCcCc
Q 046598 126 IPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIP 199 (986)
Q Consensus 126 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 199 (986)
.+..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|.+.+..|
T Consensus 68 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 68 PDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred ChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 66677888888888888888887666677788888888888888886666666777888888888887775433
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.67 E-value=5.1e-17 Score=179.25 Aligned_cols=123 Identities=10% Similarity=0.076 Sum_probs=79.7
Q ss_pred ccccCceeeceecccCCCCccchhc-Cccccceeccccccc--CccCccccCCCCCCeEEccCCcCCCCcccccCC----
Q 046598 108 RLRRLQVLALHYNSIGGAIPANISS-CSNLIQLRLFHNQLV--GKIPSELSSLSKIEHISVNDNNLTGSIPSSLGN---- 180 (986)
Q Consensus 108 ~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~---- 180 (986)
.+.+++.|.++++- ....-..+.. +++|++|||++|++. ...+.. ++.+..+.+..|.+ .+..|.+
T Consensus 23 ~~~~l~~L~l~g~i-~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~---~~~~~~~~~~~~~I---~~~aF~~~~~~ 95 (329)
T 3sb4_A 23 EANSITHLTLTGKL-NAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGT---YPNGKFYIYMANFV---PAYAFSNVVNG 95 (329)
T ss_dssp HHHHCSEEEEEEEE-CHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSS---SGGGCCEEECTTEE---CTTTTEEEETT
T ss_pred hhCceeEEEEeccc-cHHHHHHHHHhhccCeEEecCcceeEEecCcccc---cccccccccccccc---CHHHhcccccc
Confidence 47789999998752 2111223444 778999999999987 222222 22345555655533 2445666
Q ss_pred ----CcCcceeeccCCcccCcCcchhhccCCCceeecccccccccCCccccCCCCccEEecc
Q 046598 181 ----LSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAG 238 (986)
Q Consensus 181 ----l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~ 238 (986)
+++|+.|+|.+ .++.+.+.+|.++++|+.|++++|.++...+..|.++.++..+..+
T Consensus 96 ~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~ 156 (329)
T 3sb4_A 96 VTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLG 156 (329)
T ss_dssp EEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTT
T ss_pred cccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCc
Confidence 88888888888 7776777778888888888888888875555666665555544443
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.66 E-value=1.1e-16 Score=157.71 Aligned_cols=136 Identities=19% Similarity=0.171 Sum_probs=104.0
Q ss_pred CCCCeeecCCCccC-CCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccCcccccCCccccEE
Q 046598 452 ETLTTIDLSNNNLT-GTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQL 530 (986)
Q Consensus 452 ~~L~~L~L~~N~l~-~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 530 (986)
++|+.|++++|+++ +.+|.. +..+++|+.|++++|.|++. ..+..+++|++|+|++|++++.+|..+..+++|++|
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~-~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGL-TAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSC-CGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred ccCCEEECCCCCCChhhHHHH-HHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 56777888888776 666665 56677788888888888754 667778888888888888886677777778888888
Q ss_pred ecccccccccC-CccccCCCCCCEEeCCCccCcccCc---hhhhcccccceeeccCCccccccC
Q 046598 531 EMQENFLQGPI-PSSLSSLRGLSVLDLSQNNLSGKIP---ELLIRLQLVKNLNLSNNDLEGVVP 590 (986)
Q Consensus 531 ~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~l~ls~N~l~~~~p 590 (986)
+|++|+|++.. +..+..+++|+.|+|++|++++..+ ..+..+++|++|++++|.+...+.
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~ 164 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEAPD 164 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBCCS
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhccc
Confidence 88888887542 2678888888888888888886555 478888888888888888876544
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.66 E-value=2.6e-16 Score=156.60 Aligned_cols=134 Identities=25% Similarity=0.275 Sum_probs=102.6
Q ss_pred CCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccCcccccCCccccEEecc
Q 046598 454 LTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQ 533 (986)
Q Consensus 454 L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 533 (986)
.+.+++++|+++ .+|..+ .++|+.|++++|++++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus 9 ~~~l~~~~~~l~-~~p~~~---~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 84 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGI---PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLH 84 (177)
T ss_dssp TTEEECCSSCCS-SCCTTC---CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCEEEecCCCCc-cCCCCC---CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECC
Confidence 466777777776 666542 3567888888888876555667778888888888888876666667888888888888
Q ss_pred cccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCccccccCC
Q 046598 534 ENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPT 591 (986)
Q Consensus 534 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~ 591 (986)
+|+|++..+..+..+++|++|+|++|+|++..+..+..+++|++|+|++|+++|.+|.
T Consensus 85 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 142 (177)
T 2o6r_A 85 ENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 142 (177)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred CCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCcc
Confidence 8888877667778888888888888888876666677888888888888888887764
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.65 E-value=1.1e-16 Score=154.42 Aligned_cols=127 Identities=20% Similarity=0.230 Sum_probs=80.1
Q ss_pred CCCCEEEccCCCcc-ccCCcchhccccCceeeceecccCCCCccchhcCccccceecccccccCccCccccCCCCCCeEE
Q 046598 86 SFLKVLRLYNNSFN-HEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHIS 164 (986)
Q Consensus 86 ~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 164 (986)
++|+.|++++|.++ +.+|..+..+++|++|+|++|.+++. ..++.+++|++|+|++|.+++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 55666666666666 56666666666666666666666644 5566666666666666666655666666666666666
Q ss_pred ccCCcCCCC-cccccCCCcCcceeeccCCcccCcCc---chhhccCCCceeecc
Q 046598 165 VNDNNLTGS-IPSSLGNLSSIRSLFLSGNNLEGSIP---DTLGWLKNLVNLTMA 214 (986)
Q Consensus 165 L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~L~ 214 (986)
+++|++++. .+..++++++|++|++++|.+++..+ ..+..+++|++|+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 666666642 23556666666666666666664443 356666666666654
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=5.1e-16 Score=156.48 Aligned_cols=125 Identities=21% Similarity=0.299 Sum_probs=72.5
Q ss_pred EeccCCCCccccCcCccCCCCCCEEEccCCCccccCCcchhccccCceeeceecccCCCCccchhcCccccceecccccc
Q 046598 67 LDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQL 146 (986)
Q Consensus 67 l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 146 (986)
+++++++++ .+|..+. +.|++|+|++|+++ .+|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|
T Consensus 15 l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l 90 (193)
T 2wfh_A 15 VRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL 90 (193)
T ss_dssp EECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCcc
Confidence 334445555 4554432 45666666666665 4556666666666666666666655555566666666666666666
Q ss_pred cCccCccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeeccCCccc
Q 046598 147 VGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLE 195 (986)
Q Consensus 147 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 195 (986)
++..|..|.++++|++|+|++|++++..+..|.++++|++|+|++|.+.
T Consensus 91 ~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 91 RCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 6555555555555555555555555444444555555555555555554
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.64 E-value=1.8e-16 Score=152.87 Aligned_cols=128 Identities=19% Similarity=0.236 Sum_probs=90.8
Q ss_pred CCCCeeecCCCccC-CCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccCcccccCCccccEE
Q 046598 452 ETLTTIDLSNNNLT-GTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQL 530 (986)
Q Consensus 452 ~~L~~L~L~~N~l~-~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 530 (986)
++|+.|++++|+++ +.+|.. +..+++|+.|++++|++++. ..+..+++|++|+|++|++++.+|..+..+++|++|
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~-~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGL-TDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSC-CTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred ccCeEEEccCCcCChhHHHHH-HhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 45667777777766 556654 55666777777777777643 566777777777777777776677777777777777
Q ss_pred eccccccccc-CCccccCCCCCCEEeCCCccCcccCc---hhhhcccccceeeccC
Q 046598 531 EMQENFLQGP-IPSSLSSLRGLSVLDLSQNNLSGKIP---ELLIRLQLVKNLNLSN 582 (986)
Q Consensus 531 ~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~l~ls~ 582 (986)
++++|++++. .+..+..+++|+.|++++|++++..+ ..+..+++|+.|++++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 7777777753 34677778888888888888876555 5677788888887764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.62 E-value=2.6e-16 Score=172.35 Aligned_cols=146 Identities=13% Similarity=0.099 Sum_probs=99.0
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc--------------hhHHHHHHHHHHHhcCCCCcceeeeeec
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH--------------GAFKSFIAECNTLKNIRHRNLVKILTAC 754 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l~~~~ 754 (986)
-|.+.++||+|++|.||+|.+.. |+.||||+++.... ........+.++.....|+|+.+++...
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~-G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEK-GKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTT-CCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECCC-CCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 48999999999999999999875 88999999753110 0011222223332223344444433221
Q ss_pred cccc-cCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCC
Q 046598 755 SGVD-YQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSN 833 (986)
Q Consensus 755 ~~~~-~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~N 833 (986)
.... .......++||||++|++|.++.. . .+...++.|++.++.|||+. |||||||||.|
T Consensus 175 v~vp~p~~~~~~~LVME~i~G~~L~~l~~--------------~--~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~N 235 (397)
T 4gyi_A 175 FPVPEPIAQSRHTIVMSLVDALPMRQVSS--------------V--PDPASLYADLIALILRLAKH---GLIHGDFNEFN 235 (397)
T ss_dssp CSCCCEEEEETTEEEEECCSCEEGGGCCC--------------C--SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTS
T ss_pred CCCCeeeeccCceEEEEecCCccHhhhcc--------------c--HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHH
Confidence 0000 000022379999999998876542 0 12356889999999999999 99999999999
Q ss_pred eEecCCC----------cEEEcccccceecC
Q 046598 834 ILLDEDM----------IAHIGDFGLARFLP 854 (986)
Q Consensus 834 Ill~~~~----------~~kL~DFG~a~~~~ 854 (986)
||+++++ .+.|+||+.+....
T Consensus 236 ILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 236 ILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred EEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 9998776 38999999987643
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.58 E-value=3.4e-17 Score=166.23 Aligned_cols=130 Identities=25% Similarity=0.359 Sum_probs=68.6
Q ss_pred EEEEeccCCCCccccCc------CccCCCCCCEEEccCCCccccCCcchhccccCceeeceecccCCCCccchhcCcccc
Q 046598 64 VTILDLESLKLAGSISP------HVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLI 137 (986)
Q Consensus 64 v~~l~l~~~~l~~~~~~------~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 137 (986)
++.++++.+.+.|.+|+ .+..+++|++|+|++|++++ +| .|.++++|++|+|++|+++ .+|..+..+++|+
T Consensus 20 l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~ 96 (198)
T 1ds9_A 20 VVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96 (198)
T ss_dssp CCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCS
T ss_pred ccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCC
Confidence 44455555555555544 55555555555555555554 34 5555555555555555555 4455555555555
Q ss_pred ceecccccccCccCccccCCCCCCeEEccCCcCCCCcc-cccCCCcCcceeeccCCcccCcC
Q 046598 138 QLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIP-SSLGNLSSIRSLFLSGNNLEGSI 198 (986)
Q Consensus 138 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~ 198 (986)
+|+|++|++++ +| .+..+++|++|++++|++++..+ ..+.++++|++|++++|.+++..
T Consensus 97 ~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~ 156 (198)
T 1ds9_A 97 ELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDY 156 (198)
T ss_dssp EEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHH
T ss_pred EEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccccc
Confidence 55555555553 33 35555555555555555553221 24555555555555555554433
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.58 E-value=3e-17 Score=166.63 Aligned_cols=138 Identities=23% Similarity=0.282 Sum_probs=101.6
Q ss_pred ccCCCCCCEEEccCCCccccCCc------chhccccCceeeceecccCCCCccchhcCccccceecccccccCccCcccc
Q 046598 82 VGNLSFLKVLRLYNNSFNHEIPS------EFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELS 155 (986)
Q Consensus 82 ~~~l~~L~~L~L~~n~l~~~~p~------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 155 (986)
+.....++.++++.+.+.+.+|. .|..+++|++|+|++|++++ +| .+..+++|++|+|++|.++ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 44556677777777777777766 78888888888888888875 56 7778888888888888887 5677777
Q ss_pred CCCCCCeEEccCCcCCCCcccccCCCcCcceeeccCCcccCcCc-chhhccCCCceeecccccccccCCc
Q 046598 156 SLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIP-DTLGWLKNLVNLTMAQNRLSGTIPS 224 (986)
Q Consensus 156 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~ 224 (986)
.+++|++|+|++|++++ +| .+.++++|++|+|++|++++..+ ..+..+++|++|++++|++++.+|.
T Consensus 91 ~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 91 VADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp HHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred cCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccccccc
Confidence 77788888888888774 44 57777778888888887774322 4677777777777777777765554
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.57 E-value=2e-15 Score=149.91 Aligned_cols=133 Identities=14% Similarity=0.138 Sum_probs=89.3
Q ss_pred CccCCCCCCEEEccCCCccccCCcchhccc-cCceeeceecccCCCCccchhcCccccceecccccccCccCccccCCCC
Q 046598 81 HVGNLSFLKVLRLYNNSFNHEIPSEFDRLR-RLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSK 159 (986)
Q Consensus 81 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 159 (986)
.+.+.+.|+.|+|++|+++. +|. +..+. +|++|+|++|++++. ..|+.+++|++|+|++|++++..+..|..+++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp EEECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred hcCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 35566777777777777773 343 44444 777777777777754 56777777777777777777544445577777
Q ss_pred CCeEEccCCcCCCCccc--ccCCCcCcceeeccCCcccCcCcch----hhccCCCceeeccccccc
Q 046598 160 IEHISVNDNNLTGSIPS--SLGNLSSIRSLFLSGNNLEGSIPDT----LGWLKNLVNLTMAQNRLS 219 (986)
Q Consensus 160 L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~----~~~l~~L~~L~L~~N~l~ 219 (986)
|++|+|++|+++ .+|. .+.++++|++|++++|.++ .+|.. +..+++|+.|++++|.+.
T Consensus 90 L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 90 LTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 777777777775 4444 6677777777777777776 44543 667777777777777654
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.57 E-value=2.2e-15 Score=149.68 Aligned_cols=137 Identities=18% Similarity=0.188 Sum_probs=109.5
Q ss_pred ccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccCcccccCCcc
Q 046598 447 SLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIK 526 (986)
Q Consensus 447 ~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 526 (986)
.+.++++|+.|++++|+++ .+|. +....++|+.|++++|+|++. ..|..+++|++|+|++|+|++..+..|..+++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred hcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 4566778888888888888 5654 344445889999999998864 67888899999999999998655555688999
Q ss_pred ccEEecccccccccCCc--cccCCCCCCEEeCCCccCcccCch----hhhcccccceeeccCCcccccc
Q 046598 527 LEQLEMQENFLQGPIPS--SLSSLRGLSVLDLSQNNLSGKIPE----LLIRLQLVKNLNLSNNDLEGVV 589 (986)
Q Consensus 527 L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~l~ls~N~l~~~~ 589 (986)
|++|+|++|+|+ .+|. .+..+++|+.|+|++|+++ .+|. .+..+++|+.||+++|.+....
T Consensus 90 L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~~~ 156 (176)
T 1a9n_A 90 LTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKERQ 156 (176)
T ss_dssp CCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHHHH
T ss_pred CCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHHHH
Confidence 999999999997 4555 7888999999999999998 4565 4888999999999999887543
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.56 E-value=5.5e-14 Score=158.21 Aligned_cols=268 Identities=9% Similarity=0.048 Sum_probs=141.0
Q ss_pred CCCCEEEccCCCccccCCcchhccccCceeeceecccCCCCccchhcCccccceecccccccCccCccccCCCCCCeEEc
Q 046598 86 SFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISV 165 (986)
Q Consensus 86 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 165 (986)
..++.+.+.+ .++.+.+.+|.++ +|+.+.|..| ++.+-..+|.++ +|+.+.+.. .++.+.+.+|.++++|+.+++
T Consensus 113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l 187 (401)
T 4fdw_A 113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADL 187 (401)
T ss_dssp SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEEC
T ss_pred CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeec
Confidence 4555555543 3444555566664 5666766655 554444556553 566666664 455455566666666666666
Q ss_pred cCCcCCCCcccccCCCcCcceeeccCCcccCcCcchhhccCCCceeecccccccccCCccccCCCCccEEeccccccccc
Q 046598 166 NDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGA 245 (986)
Q Consensus 166 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~ 245 (986)
.+|+++......|. .++|+.+.|.++ ++.+...+|.++++|+.++|..| ++ .
T Consensus 188 ~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~-------------------------~ 239 (401)
T 4fdw_A 188 SKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VS-------------------------T 239 (401)
T ss_dssp TTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CC-------------------------E
T ss_pred CCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-cc-------------------------C
Confidence 66666644444444 366666666633 55455566666666666666553 33 2
Q ss_pred cCCcccccccccceEEecCceecccCCccccCCCCCcEEecccccccCCCchhhhhhhHhhhhhccCCCCCCCCCCcccc
Q 046598 246 IPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFL 325 (986)
Q Consensus 246 ~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~l~~l~~L~~l~l~~n~l~~~~~~~l~~l 325 (986)
++...|.+ .+|+.+.+. +.++......|.++++|+.+++..|.+.....
T Consensus 240 I~~~aF~~-~~L~~i~lp-~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~----------------------------- 288 (401)
T 4fdw_A 240 IGQEAFRE-SGITTVKLP-NGVTNIASRAFYYCPELAEVTTYGSTFNDDPE----------------------------- 288 (401)
T ss_dssp ECTTTTTT-CCCSEEEEE-TTCCEECTTTTTTCTTCCEEEEESSCCCCCTT-----------------------------
T ss_pred cccccccc-CCccEEEeC-CCccEEChhHhhCCCCCCEEEeCCccccCCcc-----------------------------
Confidence 22333322 345555552 33443445556666666666655554431000
Q ss_pred cccccccccceeeccccccccCCCcccccccccceEEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCC
Q 046598 326 CSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQ 405 (986)
Q Consensus 326 ~~l~~~~~L~~l~l~~n~~~~~~p~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 405 (986)
..++...+....+|+.+.|. +.++.+...+|.++++|+.++|..| ++.+...+|.++
T Consensus 289 --------------------~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~- 345 (401)
T 4fdw_A 289 --------------------AMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT- 345 (401)
T ss_dssp --------------------CEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-
T ss_pred --------------------cEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-
Confidence 01111122222344444444 2344445556666666666666443 444555566666
Q ss_pred CCCEEEccCccceeecCcccccc--cccEEEeccccc
Q 046598 406 NLKDLRLQRNRFQGNIPPSIGNL--KLFILYLSYNFL 440 (986)
Q Consensus 406 ~L~~L~Ls~N~l~~~~~~~~~~~--~L~~L~L~~N~l 440 (986)
+|+.+++++|.+....+..|... .+..|++..+.+
T Consensus 346 ~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~ 382 (401)
T 4fdw_A 346 GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESV 382 (401)
T ss_dssp CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGH
T ss_pred CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHH
Confidence 66666666666655555555443 355666665554
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.53 E-value=2.1e-13 Score=153.45 Aligned_cols=265 Identities=12% Similarity=0.114 Sum_probs=154.4
Q ss_pred CccccceecccccccCccCccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeeccCCcccCcCcchhhccCCCceee
Q 046598 133 CSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLT 212 (986)
Q Consensus 133 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 212 (986)
+..++.+.+.+ .++.+.+.+|.+. +|+.+.+.+| ++.+...+|.+ .+|+.+.+.+ .++.+.+..|.++++|+.++
T Consensus 112 ~~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~ 186 (401)
T 4fdw_A 112 LKGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKAD 186 (401)
T ss_dssp CSSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEE
T ss_pred cCCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeee
Confidence 35555555543 3443445566653 5666666655 54444555655 3566666664 45545556666666677777
Q ss_pred cccccccccCCccccCCCCccEEeccccccccccCCcccccccccceEEecCceecccCCccccCCCCCcEEeccccccc
Q 046598 213 MAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLT 292 (986)
Q Consensus 213 L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~ 292 (986)
|++|+++ .+|...+..++|+.+.+..+ ++..-...|.++++|+.+++..| ++
T Consensus 187 l~~n~l~-~I~~~aF~~~~L~~l~lp~~--------------------------l~~I~~~aF~~~~~L~~l~l~~~-l~ 238 (401)
T 4fdw_A 187 LSKTKIT-KLPASTFVYAGIEEVLLPVT--------------------------LKEIGSQAFLKTSQLKTIEIPEN-VS 238 (401)
T ss_dssp CTTSCCS-EECTTTTTTCCCSEEECCTT--------------------------CCEECTTTTTTCTTCCCEECCTT-CC
T ss_pred cCCCcce-EechhhEeecccCEEEeCCc--------------------------hheehhhHhhCCCCCCEEecCCC-cc
Confidence 7666666 33333333445555444422 33333444555555555554432 11
Q ss_pred CCCchhhhhhhHhhhhhccCCCCCCCCCCcccccccccccccceeeccccccccCCCcccccccccceEEEccCCccccc
Q 046598 293 GAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGN 372 (986)
Q Consensus 293 ~~~~~l~~l~~L~~l~l~~n~l~~~~~~~l~~l~~l~~~~~L~~l~l~~n~~~~~~p~~~~~~~~~L~~L~L~~n~l~~~ 372 (986)
.+ +...+.. .+|+.+.+ .+.++.+
T Consensus 239 ~I------------------------------------------------------~~~aF~~-~~L~~i~l-p~~i~~I 262 (401)
T 4fdw_A 239 TI------------------------------------------------------GQEAFRE-SGITTVKL-PNGVTNI 262 (401)
T ss_dssp EE------------------------------------------------------CTTTTTT-CCCSEEEE-ETTCCEE
T ss_pred Cc------------------------------------------------------ccccccc-CCccEEEe-CCCccEE
Confidence 11 0111111 23444444 2344545
Q ss_pred CCccccCCCCCCEEEccCcccc-----CcCCCcccCCCCCCEEEccCccceeecCccccc-ccccEEEecccccCCCCCc
Q 046598 373 IPAAIGKFVNLQRLDMCSNRLS-----GTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGN-LKLFILYLSYNFLQGSIPS 446 (986)
Q Consensus 373 ~~~~~~~l~~L~~L~L~~N~l~-----~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-~~L~~L~L~~N~l~~~~p~ 446 (986)
...+|.++++|+.+++.+|.+. .+.+.+|.++++|+.+.|. +.++......|.. .+|+.+.|..| ++.+.+.
T Consensus 263 ~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~ 340 (401)
T 4fdw_A 263 ASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFS 340 (401)
T ss_dssp CTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTT
T ss_pred ChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHH
Confidence 5667777777777777776654 3555677777777777777 3466666666665 35777777554 6656677
Q ss_pred ccCCCCCCCeeecCCCccCCCCCcccccCC-CcceEEEccCCccc
Q 046598 447 SLGRYETLTTIDLSNNNLTGTIPPQFIGLS-SSLIVLDLSRNQLT 490 (986)
Q Consensus 447 ~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~-~~L~~L~Ls~N~l~ 490 (986)
+|.++ +|+.+++++|.+. .++...|..+ .+++.|++..+.+.
T Consensus 341 aF~~~-~L~~l~l~~n~~~-~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 341 AFNNT-GIKEVKVEGTTPP-QVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp SSSSS-CCCEEEECCSSCC-BCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred hCCCC-CCCEEEEcCCCCc-ccccccccCCCCCccEEEeCHHHHH
Confidence 88888 8999999988887 5655556555 47888888887665
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.52 E-value=1.4e-13 Score=155.74 Aligned_cols=67 Identities=10% Similarity=0.070 Sum_probs=33.5
Q ss_pred ccccCCcchhccccCceeeceecccCCCCccchhcCccccceecccccccCccCccccCCCCCCeEEcc
Q 046598 98 FNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVN 166 (986)
Q Consensus 98 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 166 (986)
++.+-..+|.++++|+.+.|.. .++.+-..+|.++++|+.++|.++ ++.+...+|.++.+|+.+.+.
T Consensus 59 VtsIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p 125 (394)
T 4fs7_A 59 VVSIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLP 125 (394)
T ss_dssp EEEECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCC
T ss_pred EeEhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhccc
Confidence 3334445566666666666643 244333445555555555555433 332333455555555554443
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.52 E-value=2e-14 Score=141.61 Aligned_cols=90 Identities=19% Similarity=0.271 Sum_probs=44.1
Q ss_pred cccchhhccCccccccCcccccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeec
Q 046598 501 KNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNL 580 (986)
Q Consensus 501 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l 580 (986)
++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|++|+|
T Consensus 30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 109 (170)
T 3g39_A 30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWL 109 (170)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEe
Confidence 34444444444444444444444444444444444444444444455555555555555555444444555555555555
Q ss_pred cCCccccccC
Q 046598 581 SNNDLEGVVP 590 (986)
Q Consensus 581 s~N~l~~~~p 590 (986)
++|++++.++
T Consensus 110 ~~N~~~c~c~ 119 (170)
T 3g39_A 110 LNNPWDCACS 119 (170)
T ss_dssp CSSCBCTTBG
T ss_pred CCCCCCCCch
Confidence 5555555444
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.51 E-value=3.1e-13 Score=152.91 Aligned_cols=113 Identities=10% Similarity=0.005 Sum_probs=66.4
Q ss_pred ccCCCCccchhcCccccceecccccccCccCccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeeccCCcccCcCcc
Q 046598 121 SIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPD 200 (986)
Q Consensus 121 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 200 (986)
.++.+-..+|.++++|+.+.|..+ ++.+...+|.++++|+.+++.++ ++......|.++++|+.+.+..+ +......
T Consensus 58 ~VtsIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~ 134 (394)
T 4fs7_A 58 DVVSIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVE 134 (394)
T ss_dssp EEEEECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTT
T ss_pred eEeEhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecce
Confidence 344444567888888888888643 66555677888888888888655 55455567777778877776654 3334555
Q ss_pred hhhccCCCceeecccccccccCCccccCCCCccEEecc
Q 046598 201 TLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAG 238 (986)
Q Consensus 201 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~ 238 (986)
.|.....++........ ......|.++++|+.+.+.
T Consensus 135 aF~~~~~~~~~~~~~~~--~i~~~aF~~c~~L~~i~l~ 170 (394)
T 4fs7_A 135 AFKGCDFKEITIPEGVT--VIGDEAFATCESLEYVSLP 170 (394)
T ss_dssp TTTTCCCSEEECCTTCC--EECTTTTTTCTTCCEEECC
T ss_pred eeecccccccccCcccc--ccchhhhcccCCCcEEecC
Confidence 56555433333222221 1223344555555555544
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.49 E-value=4.4e-14 Score=139.54 Aligned_cols=104 Identities=25% Similarity=0.321 Sum_probs=51.6
Q ss_pred CeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccCcccccCCccccEEeccc
Q 046598 455 TTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQE 534 (986)
Q Consensus 455 ~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 534 (986)
+.+++++|+++ .+|..+ .++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 15 ~~l~~~~n~l~-~iP~~~---~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGI---PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SEEECCSSCCS-SCCSCC---CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred cEEEeCCCCCC-ccCCCc---CCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 45556666554 555442 14455555555555544455555555555555555555533333344444555555555
Q ss_pred ccccccCCccccCCCCCCEEeCCCccCc
Q 046598 535 NFLQGPIPSSLSSLRGLSVLDLSQNNLS 562 (986)
Q Consensus 535 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 562 (986)
|+|++..+..|..+++|+.|+|++|+++
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred CccceeCHHHhccccCCCEEEeCCCCcc
Confidence 5544333333444444444444444444
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.47 E-value=8.6e-14 Score=136.97 Aligned_cols=109 Identities=25% Similarity=0.291 Sum_probs=96.3
Q ss_pred CCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccCcccccCCccccEEec
Q 046598 453 TLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEM 532 (986)
Q Consensus 453 ~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 532 (986)
..+.+++++|+++ .+|..+ .++|+.|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|++|+|
T Consensus 10 ~~~~l~~s~n~l~-~ip~~~---~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L 85 (170)
T 3g39_A 10 SGTTVDCSGKSLA-SVPTGI---PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSL 85 (170)
T ss_dssp ETTEEECTTSCCS-SCCSCC---CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEEeCCCCcC-ccCccC---CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEEC
Confidence 3578899999998 788763 378999999999999887888999999999999999999777777899999999999
Q ss_pred ccccccccCCccccCCCCCCEEeCCCccCcccC
Q 046598 533 QENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKI 565 (986)
Q Consensus 533 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 565 (986)
++|+|++..+..|..+++|+.|+|++|+++...
T Consensus 86 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 86 NDNQLKSIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred CCCccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 999999877778999999999999999998653
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.45 E-value=1.6e-13 Score=135.50 Aligned_cols=85 Identities=26% Similarity=0.335 Sum_probs=40.0
Q ss_pred cCceeeceecccCCCCccchhcCccccceecccccccCccCccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeecc
Q 046598 111 RLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLS 190 (986)
Q Consensus 111 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 190 (986)
+|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus 34 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~ 113 (174)
T 2r9u_A 34 DKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLY 113 (174)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECC
T ss_pred CCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEeC
Confidence 34444444444443334444444444444444444443333334445555555555555554433445555555555555
Q ss_pred CCccc
Q 046598 191 GNNLE 195 (986)
Q Consensus 191 ~N~l~ 195 (986)
+|.+.
T Consensus 114 ~N~~~ 118 (174)
T 2r9u_A 114 NNPWD 118 (174)
T ss_dssp SSCBC
T ss_pred CCCcc
Confidence 55554
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.35 E-value=1.4e-11 Score=139.17 Aligned_cols=107 Identities=19% Similarity=0.297 Sum_probs=43.0
Q ss_pred cCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccCcccccCCccc
Q 046598 448 LGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKL 527 (986)
Q Consensus 448 ~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 527 (986)
|.+++.|+.+.+. +.++ .|+...|..+.+|+.+++..+ ++.+....|.++.+|+.+.+..+ ++..-..+|.++.+|
T Consensus 284 F~~c~~L~~i~l~-~~i~-~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L 359 (394)
T 4gt6_A 284 FMNCPALQDIEFS-SRIT-ELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTAL 359 (394)
T ss_dssp TTTCTTCCEEECC-TTCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTC
T ss_pred cccccccccccCC-Cccc-ccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCC
Confidence 3344444444443 2233 344444444445555554432 33233344555555555555433 332333445555555
Q ss_pred cEEecccccccccCCccccCCCCCCEEeCCCccC
Q 046598 528 EQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNL 561 (986)
Q Consensus 528 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 561 (986)
+.+++.+|.... ..+....+|+.+.+..|.+
T Consensus 360 ~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 360 NNIEYSGSRSQW---NAISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp CEEEESSCHHHH---HTCBCCCCC----------
T ss_pred CEEEECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence 555555544331 2344445555555544433
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.32 E-value=1.3e-12 Score=145.15 Aligned_cols=132 Identities=17% Similarity=0.147 Sum_probs=82.9
Q ss_pred eeecCCC-ccCCCCCcccccCCCcceEEEccC-CcccccCCcccccccccchhhccCccccccCcccccCCccccEEecc
Q 046598 456 TIDLSNN-NLTGTIPPQFIGLSSSLIVLDLSR-NQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQ 533 (986)
Q Consensus 456 ~L~L~~N-~l~~~ip~~~~~~~~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 533 (986)
.++++++ +|+ .+|. +..+++|+.|+|++ |+|++..+..|.++++|+.|+|++|+|++..|..|.++++|++|+|+
T Consensus 12 ~v~~~~~n~l~-~ip~--l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH--LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp CEECCSSCCCT-TTTT--SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred EEEcCCCCCCC-ccCC--CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 4577776 776 5666 56666777777775 77776666667777777777777777777666677777777777777
Q ss_pred cccccccCCccccCCCCCCEEeCCCccCcccCc-hhhhcccccceeeccCCccccccCC
Q 046598 534 ENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIP-ELLIRLQLVKNLNLSNNDLEGVVPT 591 (986)
Q Consensus 534 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~l~ls~N~l~~~~p~ 591 (986)
+|+|++..+..|..++ |+.|+|++|++...-. .+|..+.......+..+.+++..|.
T Consensus 89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~~ 146 (347)
T 2ifg_A 89 FNALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG 146 (347)
T ss_dssp SSCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred CCccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCCh
Confidence 7777765555555554 7777777777763221 2233333333334444555555444
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.32 E-value=3.4e-14 Score=158.35 Aligned_cols=137 Identities=16% Similarity=0.144 Sum_probs=89.5
Q ss_pred CCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCccc-----ccccccchhhccCccccc----cCccccc
Q 046598 452 ETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEV-----GNLKNLEILNVFGNKLKG----EIPSTLG 522 (986)
Q Consensus 452 ~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~----~~p~~~~ 522 (986)
++|+.|+|++|.|+......+...+++|+.|+|++|+|+......+ ...++|++|+|++|.|+. .++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 4666777777766532222333334567777777777764433333 234667778888887764 2444556
Q ss_pred CCccccEEecccccccccC----CccccCCCCCCEEeCCCccCccc----CchhhhcccccceeeccCCccccc
Q 046598 523 SCIKLEQLEMQENFLQGPI----PSSLSSLRGLSVLDLSQNNLSGK----IPELLIRLQLVKNLNLSNNDLEGV 588 (986)
Q Consensus 523 ~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~l~ls~N~l~~~ 588 (986)
.+++|++|+|++|.|++.. +..+...++|+.|+|++|.|+.. ++..+...++|++|+|++|+|+..
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~ 254 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSE 254 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHH
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHH
Confidence 7778888888888887532 45566777888888888888753 344455668888888888888753
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.29 E-value=3.5e-12 Score=141.69 Aligned_cols=107 Identities=24% Similarity=0.194 Sum_probs=86.3
Q ss_pred EEEccCC-cccccCCcccccccccchhhccC-ccccccCcccccCCccccEEecccccccccCCccccCCCCCCEEeCCC
Q 046598 481 VLDLSRN-QLTGSIPSEVGNLKNLEILNVFG-NKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQ 558 (986)
Q Consensus 481 ~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 558 (986)
.++++++ +|+ .+|. +..+++|+.|+|++ |+|++..|..|.++++|+.|+|++|+|++.+|..|.+|++|+.|||++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 4678887 887 4777 88888888888886 888877777888888888888888888888888888888888888888
Q ss_pred ccCcccCchhhhcccccceeeccCCccccccC
Q 046598 559 NNLSGKIPELLIRLQLVKNLNLSNNDLEGVVP 590 (986)
Q Consensus 559 N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p 590 (986)
|+|++..+..+..++ |+.|+|++|+|.+...
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~ 120 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLHCSCA 120 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCCCCGG
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCccCCCc
Confidence 888876666666665 8888888888887654
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.27 E-value=1.7e-13 Score=152.60 Aligned_cols=135 Identities=19% Similarity=0.163 Sum_probs=75.7
Q ss_pred CCCCEEEccCCCccccCCcchhcc-----ccCceeeceecccCCCCccch-hcCccccceecccccccCccCccc-----
Q 046598 86 SFLKVLRLYNNSFNHEIPSEFDRL-----RRLQVLALHYNSIGGAIPANI-SSCSNLIQLRLFHNQLVGKIPSEL----- 154 (986)
Q Consensus 86 ~~L~~L~L~~n~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~~----- 154 (986)
+.|+.|+|++|.++......|... ++|++|+|++|.++......+ ..+++|++|+|++|.++......+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 456677777777664444444333 567777777776653322222 245566677777776654433333
Q ss_pred cCCCCCCeEEccCCcCCC----CcccccCCCcCcceeeccCCcccCc----CcchhhccCCCceeecccccccc
Q 046598 155 SSLSKIEHISVNDNNLTG----SIPSSLGNLSSIRSLFLSGNNLEGS----IPDTLGWLKNLVNLTMAQNRLSG 220 (986)
Q Consensus 155 ~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~ 220 (986)
...++|++|+|++|.++. .++..+..+++|++|+|++|.|+.. ++..+...++|++|+|++|.+++
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~ 225 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGD 225 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCH
Confidence 234566666666666653 1333445566666666666666532 23444555666666666666653
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.26 E-value=3.2e-10 Score=128.07 Aligned_cols=134 Identities=16% Similarity=0.148 Sum_probs=66.2
Q ss_pred cCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCcccccccccEEEecccccCCCCCcccCCC
Q 046598 372 NIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRY 451 (986)
Q Consensus 372 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l 451 (986)
+...+|..+.+|+.+.+.++..+ +...+|.++++|+.+.+. +.++..... +|.++
T Consensus 256 i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~-----------------------aF~~c 310 (394)
T 4gt6_A 256 IETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPES-----------------------VFAGC 310 (394)
T ss_dssp ECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTT-----------------------TTTTC
T ss_pred cccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCce-----------------------eecCC
Confidence 44567788888888888766554 666777788888877775 334433333 34444
Q ss_pred CCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccCcccccCCccccEEe
Q 046598 452 ETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLE 531 (986)
Q Consensus 452 ~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 531 (986)
.+|+.+++..+ ++ .|....|..+.+|+.+.+..+ ++.+....|.++++|+.+++.+|.... ..+....+|+.+.
T Consensus 311 ~~L~~i~lp~~-v~-~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~ 384 (394)
T 4gt6_A 311 ISLKSIDIPEG-IT-QILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLP 384 (394)
T ss_dssp TTCCEEECCTT-CC-EECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC----
T ss_pred CCcCEEEeCCc-cc-EehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEE
Confidence 44444444432 33 344444444445555555332 333333445555555555555444321 2344445555555
Q ss_pred ccccc
Q 046598 532 MQENF 536 (986)
Q Consensus 532 L~~N~ 536 (986)
+..|.
T Consensus 385 i~~~~ 389 (394)
T 4gt6_A 385 VAPGS 389 (394)
T ss_dssp -----
T ss_pred eCCCC
Confidence 54443
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=2e-11 Score=129.60 Aligned_cols=149 Identities=15% Similarity=0.130 Sum_probs=113.9
Q ss_pred HHHHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCC-CCcceeeeeeccccccC
Q 046598 682 NLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQ 760 (986)
Q Consensus 682 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 760 (986)
.+....+.|.+....+.|+.+.||++... ++.+++|+...........+.+|+++++.+. +..+.++++++ .
T Consensus 8 ~l~~~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~-----~ 80 (263)
T 3tm0_A 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE-----R 80 (263)
T ss_dssp HHHHHHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----E
T ss_pred HHHHHhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEE-----e
Confidence 34455678988889999999999999764 5789999987532233356888999998884 67788888874 3
Q ss_pred CCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhc---------------------
Q 046598 761 GNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHD--------------------- 819 (986)
Q Consensus 761 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--------------------- 819 (986)
..+..|+||||++|.++.+... +..+...++.+++++++.||+.
T Consensus 81 ~~~~~~lv~e~i~G~~l~~~~~---------------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~ 145 (263)
T 3tm0_A 81 HDGWSNLLMSEADGVLCSEEYE---------------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYL 145 (263)
T ss_dssp ETTEEEEEEECCSSEEHHHHCC---------------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHH
T ss_pred cCCceEEEEEecCCeehhhccC---------------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHH
Confidence 4577899999999999987642 1112346889999999999981
Q ss_pred -----------------------------------CCCCeEeecCCCCCeEecCCCcEEEccccccee
Q 046598 820 -----------------------------------CQPPIAHCDLKPSNILLDEDMIAHIGDFGLARF 852 (986)
Q Consensus 820 -----------------------------------~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~ 852 (986)
..+.++|||++|.||+++++..+.|+||+.+..
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 146 LNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 013699999999999998766677999998853
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=99.00 E-value=4.7e-12 Score=132.14 Aligned_cols=24 Identities=17% Similarity=0.115 Sum_probs=17.5
Q ss_pred CCCcceeeEecCCCCeEEEEeccC
Q 046598 48 HFCQWRGVTCSRRHQRVTILDLES 71 (986)
Q Consensus 48 ~~c~w~gv~c~~~~~~v~~l~l~~ 71 (986)
..|+|.|+.|+....+|+.+-..+
T Consensus 76 ~l~~~~g~i~~~~~~ki~~~v~~~ 99 (267)
T 3rw6_A 76 ALKAVNYKILDRENRRISIIINSS 99 (267)
T ss_dssp HHHHTTSSCBCTTSCBCCCEEEEC
T ss_pred HHHhcCcEEECCCCCEEEEEEecC
Confidence 358999999998766776665443
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.97 E-value=4.2e-10 Score=119.29 Aligned_cols=139 Identities=18% Similarity=0.090 Sum_probs=97.0
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCc--ceeeeeeccccccCCCce
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRN--LVKILTACSGVDYQGNDF 764 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~~~~ 764 (986)
...|.+....+.|..+.||++... ++..+++|+.... ....+.+|+++++.+.+.. +.+++++. ..++.
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~-~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~-----~~~~~ 89 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVV-----TEAGR 89 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECT-TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEE-----ECSSC
T ss_pred cCCCceEecccCCCCceEEEEecC-CCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEec-----cCCCC
Confidence 344554333345666999999764 3677999997543 2355778999998885434 45577763 33466
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcC------------------------
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDC------------------------ 820 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~------------------------ 820 (986)
.++||||++|.++. ... .+ ...++.++++.+..||+..
T Consensus 90 ~~~v~e~i~G~~l~--~~~-------------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (264)
T 1nd4_A 90 DWLLLGEVPGQDLL--SSH-------------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAG 151 (264)
T ss_dssp EEEEEECCSSEETT--TSC-------------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTT
T ss_pred CEEEEEecCCcccC--cCc-------------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcC
Confidence 89999999998884 210 11 1256777888888888641
Q ss_pred -------------------------------CCCeEeecCCCCCeEecCCCcEEEccccccee
Q 046598 821 -------------------------------QPPIAHCDLKPSNILLDEDMIAHIGDFGLARF 852 (986)
Q Consensus 821 -------------------------------~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~ 852 (986)
.+.++|||++|.||++++++.+.|+|||.+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 152 LVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11399999999999998776677999998853
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.93 E-value=3.5e-08 Score=110.68 Aligned_cols=145 Identities=14% Similarity=0.087 Sum_probs=71.4
Q ss_pred CccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCcccccc-cccEEEecccccCCCCCcccCCCC
Q 046598 374 PAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNL-KLFILYLSYNFLQGSIPSSLGRYE 452 (986)
Q Consensus 374 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~-~L~~L~L~~N~l~~~~p~~~~~l~ 452 (986)
...+....+|+.+.+..+ +..+...+|.+..+|+.+.+..+ ++......|... +|+.+.+..+ +.......|.+++
T Consensus 210 ~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~ 286 (379)
T 4h09_A 210 AYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCS 286 (379)
T ss_dssp TTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCT
T ss_pred ecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccccc
Confidence 344555555555555444 22244455555555665555443 332222333222 2333433322 2223344556666
Q ss_pred CCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccCcccccCC
Q 046598 453 TLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSC 524 (986)
Q Consensus 453 ~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 524 (986)
+|+.+.+.++.++ .|++..|..+.+|+.+.|..+ ++.+...+|.++.+|+.+.+..+ ++.+-..+|.++
T Consensus 287 ~L~~i~l~~~~i~-~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c 355 (379)
T 4h09_A 287 NLTKVVMDNSAIE-TLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGS 355 (379)
T ss_dssp TCCEEEECCTTCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTS
T ss_pred ccccccccccccc-eehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCC
Confidence 6666666666665 555555666666666666543 44344455666666666655443 332333444443
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.93 E-value=2.8e-08 Score=111.47 Aligned_cols=165 Identities=12% Similarity=0.112 Sum_probs=85.4
Q ss_pred ccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCcccccccccEEEecccccCCCCCcccCCCCCCCe
Q 046598 377 IGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTT 456 (986)
Q Consensus 377 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 456 (986)
+.....+..+.+..+.-. .....+....+|+.+.+..+ +.. .....|.++..|+.
T Consensus 190 ~~~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~-----------------------i~~~~f~~~~~L~~ 244 (379)
T 4h09_A 190 YPAAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTT-----------------------LGDGAFYGMKALDE 244 (379)
T ss_dssp CCTTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCE-----------------------ECTTTTTTCSSCCE
T ss_pred ccccccccccccccceeE-Eeecccccccccceeeeccc-eeE-----------------------EccccccCCccceE
Confidence 444555666655544333 45566677777777766544 221 22334445555555
Q ss_pred eecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccCcccccCCccccEEeccccc
Q 046598 457 IDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENF 536 (986)
Q Consensus 457 L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 536 (986)
+.+..+ ++ .|....|..+.+|+.+.+..+ ++......|.++++|+.+.+.++.++......|.++.+|+.+.|..+
T Consensus 245 i~lp~~-v~-~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~- 320 (379)
T 4h09_A 245 IAIPKN-VT-SIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA- 320 (379)
T ss_dssp EEECTT-CC-EECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-
T ss_pred EEcCCC-cc-EeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-
Confidence 555443 33 444444555555555555433 33233445555556666666555555444455556666666666543
Q ss_pred ccccCCccccCCCCCCEEeCCCccCcccCchhhhc
Q 046598 537 LQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIR 571 (986)
Q Consensus 537 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 571 (986)
++.....+|.++.+|+.+.+..+ ++..-...|.+
T Consensus 321 l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~ 354 (379)
T 4h09_A 321 LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEG 354 (379)
T ss_dssp CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTT
T ss_pred ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhC
Confidence 44344455666666666666443 44333344443
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.89 E-value=2.9e-10 Score=125.35 Aligned_cols=156 Identities=12% Similarity=0.170 Sum_probs=77.0
Q ss_pred CeEEEEeccCCCCcc-c-------cCcCccCCCCCCEEEccCCCcc---------ccCCcchhccccCceeeceecccCC
Q 046598 62 QRVTILDLESLKLAG-S-------ISPHVGNLSFLKVLRLYNNSFN---------HEIPSEFDRLRRLQVLALHYNSIGG 124 (986)
Q Consensus 62 ~~v~~l~l~~~~l~~-~-------~~~~~~~l~~L~~L~L~~n~l~---------~~~p~~~~~l~~L~~L~L~~N~l~~ 124 (986)
.+|+.|.+...+..| . +..++..+++|+.|.+..+... +.++..+..+++|+.|+|++|.-.
T Consensus 107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l- 185 (362)
T 2ra8_A 107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL- 185 (362)
T ss_dssp GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-
T ss_pred hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-
Confidence 356666666555442 1 2344556777778877654331 123344566667777777666211
Q ss_pred CCccchhcCccccceecccccccCccCcccc--CCCCCCeEEccC--CcCCCC-----ccccc--CCCcCcceeeccCCc
Q 046598 125 AIPANISSCSNLIQLRLFHNQLVGKIPSELS--SLSKIEHISVND--NNLTGS-----IPSSL--GNLSSIRSLFLSGNN 193 (986)
Q Consensus 125 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~L~~--N~l~~~-----~p~~~--~~l~~L~~L~L~~N~ 193 (986)
.++. + .+++|++|+|..|.+.......++ .+++|++|+|+. |...+. +...+ ..+++|++|+|++|.
T Consensus 186 ~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~ 263 (362)
T 2ra8_A 186 SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAE 263 (362)
T ss_dssp BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCT
T ss_pred eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCC
Confidence 1222 2 256666666666665533333333 566666666642 111111 00111 134556666666655
Q ss_pred ccCcCcchhh---ccCCCceeecccccccc
Q 046598 194 LEGSIPDTLG---WLKNLVNLTMAQNRLSG 220 (986)
Q Consensus 194 l~~~~p~~~~---~l~~L~~L~L~~N~l~~ 220 (986)
+....+..+. .+++|++|+|+.|.+++
T Consensus 264 i~~~~~~~la~a~~~~~L~~LdLs~n~L~d 293 (362)
T 2ra8_A 264 EQNVVVEMFLESDILPQLETMDISAGVLTD 293 (362)
T ss_dssp THHHHHHHHHHCSSGGGCSEEECCSSCCBH
T ss_pred CchHHHHHHHhCccCCCCCEEECCCCCCCh
Confidence 5432222222 34555555555555543
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.88 E-value=6e-10 Score=120.90 Aligned_cols=190 Identities=17% Similarity=0.130 Sum_probs=122.9
Q ss_pred CcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcC-CCCc--ceeeeeeccccccCCCceEEEEE
Q 046598 693 VNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNI-RHRN--LVKILTACSGVDYQGNDFKALVF 769 (986)
Q Consensus 693 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~n--iv~l~~~~~~~~~~~~~~~~lv~ 769 (986)
++.++.|.+..||++. ..+++|+.... .....+.+|+++++.+ .+.. +.+++..+.. .......|+||
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~--~~~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMP--SETYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCC--CSSCSCSCEEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCC--CCCCCcceEEE
Confidence 4568999999999873 45889986432 3456788999999887 3322 3444444211 11112458999
Q ss_pred EeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhc------------------------------
Q 046598 770 EFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHD------------------------------ 819 (986)
Q Consensus 770 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~------------------------------ 819 (986)
|+++|.++.+... ..++..++..++.++++.++.||+.
T Consensus 96 ~~i~G~~l~~~~~------------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (304)
T 3sg8_A 96 TKIKGVPLTPLLL------------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSR 163 (304)
T ss_dssp ECCCCEECCHHHH------------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTT
T ss_pred cccCCeECCcccc------------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcc
Confidence 9999988875331 2467777888888888888888861
Q ss_pred -------------------------CCCCeEeecCCCCCeEecC--CCcEEEcccccceecCCCCCcccccc--------
Q 046598 820 -------------------------CQPPIAHCDLKPSNILLDE--DMIAHIGDFGLARFLPLSSAQTSSIG-------- 864 (986)
Q Consensus 820 -------------------------~~~~ivH~Dlkp~NIll~~--~~~~kL~DFG~a~~~~~~~~~~~~~~-------- 864 (986)
..+.++|+|++|.||++++ +..+.++||+.+..-....+......
T Consensus 164 ~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~ 243 (304)
T 3sg8_A 164 ELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGME 243 (304)
T ss_dssp TSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHH
T ss_pred cCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHH
Confidence 1246899999999999998 45688999999875432111110000
Q ss_pred ----ccccccccc-cccccCCCcCcccchhhHHHHHHHHHhCCCCC
Q 046598 865 ----AKGSIGYIA-PEYGLGSEVSISGDVYSYGILLLELITRKKPT 905 (986)
Q Consensus 865 ----~~gt~~y~a-PE~~~~~~~~~~sDvwSlGvvl~elltg~~pf 905 (986)
.....++.. |+... ......+.|++|.++|.+.+|+.+|
T Consensus 244 ~~~~~l~~Y~~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 244 FVSKILNHYKHKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHTCSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHcCCCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 000011111 22211 1123368999999999999998875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.87 E-value=4.5e-09 Score=116.98 Aligned_cols=145 Identities=16% Similarity=0.183 Sum_probs=106.0
Q ss_pred CCcccccccceeEEEEEECCCCeEEEEEEee--ccCc-hhHHHHHHHHHHHhcCC--CCcceeeeeeccccccCCCceEE
Q 046598 692 SVNQIGEGSFGSVFKGILDDGRTTIAVKVFN--LLHH-GAFKSFIAECNTLKNIR--HRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 692 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~-~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
.++.++.|.++.||++...+ ..+++|+.. .... .....+.+|+++++.+. +..+.++++++... ...+..+
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~--~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~--~~~g~~~ 117 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG--QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE--SVIGRAF 117 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS--CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT--TTTSSCE
T ss_pred eEEEcCCcccceEEEEEECC--ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC--CccCCeE
Confidence 45778999999999998764 578888875 3221 22356788999999886 45678888875432 1124579
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcC--------------------------
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDC-------------------------- 820 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-------------------------- 820 (986)
+||||++|..+.+.. ...++..++..++.++++.|+.||+..
T Consensus 118 ~vme~v~G~~l~~~~------------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQS------------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQ 185 (359)
T ss_dssp EEEECCCCBCCCCTT------------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHH
T ss_pred EEEEecCCeecCCCc------------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHH
Confidence 999999997775422 123678888999999999999999831
Q ss_pred -----------------------------CCCeEeecCCCCCeEecCCCc--EEEccccccee
Q 046598 821 -----------------------------QPPIAHCDLKPSNILLDEDMI--AHIGDFGLARF 852 (986)
Q Consensus 821 -----------------------------~~~ivH~Dlkp~NIll~~~~~--~kL~DFG~a~~ 852 (986)
.+.++|||++|.||+++.++. +.|+||+.+..
T Consensus 186 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 186 YKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999997753 68999999975
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.82 E-value=1.4e-09 Score=119.83 Aligned_cols=182 Identities=12% Similarity=0.153 Sum_probs=93.9
Q ss_pred CCCCEEEccCCCccc-c-------CCcchhccccCceeeceecccC---------CCCccchhcCccccceecccccccC
Q 046598 86 SFLKVLRLYNNSFNH-E-------IPSEFDRLRRLQVLALHYNSIG---------GAIPANISSCSNLIQLRLFHNQLVG 148 (986)
Q Consensus 86 ~~L~~L~L~~n~l~~-~-------~p~~~~~l~~L~~L~L~~N~l~---------~~~p~~~~~l~~L~~L~Ls~N~l~~ 148 (986)
+.++.|.+......+ . +..+...+++|+.|.+..+... +.++..+..+++|+.|+|++|.-.
T Consensus 107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l- 185 (362)
T 2ra8_A 107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL- 185 (362)
T ss_dssp GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-
T ss_pred hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-
Confidence 456777777665542 2 2344667888999988765432 123444556667777777666311
Q ss_pred ccCccccCCCCCCeEEccCCcCCCCcccccC--CCcCcceeeccC--CcccCc-----Ccchh--hccCCCceeeccccc
Q 046598 149 KIPSELSSLSKIEHISVNDNNLTGSIPSSLG--NLSSIRSLFLSG--NNLEGS-----IPDTL--GWLKNLVNLTMAQNR 217 (986)
Q Consensus 149 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~L~~--N~l~~~-----~p~~~--~~l~~L~~L~L~~N~ 217 (986)
.++. +. +++|++|+|..|.++......+. .+++|++|+|+. |...+. +...+ ..+++|++|+|++|.
T Consensus 186 ~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~ 263 (362)
T 2ra8_A 186 SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAE 263 (362)
T ss_dssp BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCT
T ss_pred eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCC
Confidence 1222 32 56667777666665533333332 566666666642 111110 00111 124555555555555
Q ss_pred ccccCCccccCCCCccEEeccccccccccCCcccccccccceEEecCceeccc----CCccccCCCCCcEEeccccccc
Q 046598 218 LSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGA----IPPTISNASNLEIFHGSVNKLT 292 (986)
Q Consensus 218 l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~ls~N~l~ 292 (986)
+++..+..++. ...+++|++|+|+.|.+++. ++..+..+++|+.|++++|.++
T Consensus 264 i~~~~~~~la~----------------------a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~ 320 (362)
T 2ra8_A 264 EQNVVVEMFLE----------------------SDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320 (362)
T ss_dssp THHHHHHHHHH----------------------CSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred CchHHHHHHHh----------------------CccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence 54322222221 01245666666666666542 2333445566777777766654
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.58 E-value=3.2e-09 Score=110.65 Aligned_cols=63 Identities=25% Similarity=0.331 Sum_probs=25.7
Q ss_pred ccccchhhccCccccc--cCcccccCCccccEEecccccccccCCccccCCC--CCCEEeCCCccCccc
Q 046598 500 LKNLEILNVFGNKLKG--EIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLR--GLSVLDLSQNNLSGK 564 (986)
Q Consensus 500 l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~ 564 (986)
+++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|++++.
T Consensus 169 l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~ 235 (267)
T 3rw6_A 169 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDT 235 (267)
T ss_dssp CTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGG
T ss_pred CCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccc
Confidence 3344444444444443 2223333444444444444444432 1222222 444445555544443
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.52 E-value=6.2e-09 Score=103.51 Aligned_cols=121 Identities=12% Similarity=0.081 Sum_probs=60.1
Q ss_pred CcCccCCCCCCEEEccCC-Ccccc----CCcchhccccCceeeceecccCCC----CccchhcCccccceecccccccCc
Q 046598 79 SPHVGNLSFLKVLRLYNN-SFNHE----IPSEFDRLRRLQVLALHYNSIGGA----IPANISSCSNLIQLRLFHNQLVGK 149 (986)
Q Consensus 79 ~~~~~~l~~L~~L~L~~n-~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~ 149 (986)
...+...+.|++|+|++| .+... +...+...++|++|+|++|+|+.. +...+...++|++|+|++|.|...
T Consensus 29 ~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~ 108 (185)
T 1io0_A 29 KRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGS 108 (185)
T ss_dssp HHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHH
T ss_pred HHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHH
Confidence 344555666777777766 66532 233444455666666666666521 222333334455555555554422
Q ss_pred cCccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeec--cCCcccCc----CcchhhccCCCceeeccccccc
Q 046598 150 IPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFL--SGNNLEGS----IPDTLGWLKNLVNLTMAQNRLS 219 (986)
Q Consensus 150 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L--~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~ 219 (986)
--. .+...+...++|++|+| ++|.|+.. +...+...++|++|+|++|.+.
T Consensus 109 g~~--------------------~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 109 GIL--------------------ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHH--------------------HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHH--------------------HHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 100 12334444455566666 55555532 2233344466666666666654
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.47 E-value=2.2e-08 Score=99.55 Aligned_cols=87 Identities=16% Similarity=0.271 Sum_probs=49.0
Q ss_pred ccccchhhccCcccccc----CcccccCCccccEEeccccccccc----CCccccCCCCCCEEeC--CCccCccc----C
Q 046598 500 LKNLEILNVFGNKLKGE----IPSTLGSCIKLEQLEMQENFLQGP----IPSSLSSLRGLSVLDL--SQNNLSGK----I 565 (986)
Q Consensus 500 l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L--s~N~l~~~----~ 565 (986)
.++|++|+|++|+|... +...+...+.|++|+|++|.|.+. +...+...++|++|+| ++|.|+.. +
T Consensus 64 ~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l 143 (185)
T 1io0_A 64 NTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEI 143 (185)
T ss_dssp CCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHH
T ss_pred CCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHH
Confidence 34444455555544421 223344445566666666666542 2345555667777777 66777643 3
Q ss_pred chhhhcccccceeeccCCccc
Q 046598 566 PELLIRLQLVKNLNLSNNDLE 586 (986)
Q Consensus 566 p~~~~~l~~L~~l~ls~N~l~ 586 (986)
.+.+...++|++|+|++|.+.
T Consensus 144 ~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 144 ANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHhCCCcCEEeccCCCCC
Confidence 344445577777777777765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=1.5e-06 Score=92.31 Aligned_cols=137 Identities=17% Similarity=0.091 Sum_probs=96.4
Q ss_pred cccccccce-eEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCC-CCcceeeeeeccccccCCCceEEEEEEe
Q 046598 694 NQIGEGSFG-SVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDFKALVFEF 771 (986)
Q Consensus 694 ~~lg~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~e~ 771 (986)
+.+..|..+ .||+.....++..+++|+.+.. ....+.+|...++.+. +--|.++++++ .+.+..++|||+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~-----~~~~~~~lvme~ 101 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFI-----RTPDDAWLLTTA 101 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEEEEEEEC
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEE-----EECCeEEEEEEe
Confidence 345556665 6999888777788999987542 3456788999888773 33366677764 334678999999
Q ss_pred ccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcC-------------------------------
Q 046598 772 MHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDC------------------------------- 820 (986)
Q Consensus 772 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~------------------------------- 820 (986)
++|.++.+.... ...+...++.+++..|..||+.-
T Consensus 102 l~G~~~~~~~~~--------------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (272)
T 4gkh_A 102 IPGKTAFQVLEE--------------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDF 167 (272)
T ss_dssp CCSEEHHHHHHH--------------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGC
T ss_pred eCCccccccccC--------------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhc
Confidence 999888776531 11123345666666666666421
Q ss_pred ------------------------CCCeEeecCCCCCeEecCCCcEEEccccccee
Q 046598 821 ------------------------QPPIAHCDLKPSNILLDEDMIAHIGDFGLARF 852 (986)
Q Consensus 821 ------------------------~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~ 852 (986)
.+.++|+|+.+.||++++++.+-|+||+.+..
T Consensus 168 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 168 DDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp CGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12389999999999999877778999998864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=3.1e-06 Score=91.35 Aligned_cols=138 Identities=17% Similarity=0.132 Sum_probs=94.5
Q ss_pred CcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCC---cceeeeeeccccccCCCceEEEEE
Q 046598 693 VNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHR---NLVKILTACSGVDYQGNDFKALVF 769 (986)
Q Consensus 693 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~~~~~~~~lv~ 769 (986)
++.++.|....||+. +..+++|+.. .......+.+|+++++.+.+. .|.+++.++. ...+..++||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~----~~~g~~~~v~ 92 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK----RSDGNPFVGY 92 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE----CTTSCEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc----cCCCceEEEE
Confidence 456888888999998 3567888843 223456789999999998642 3555555532 2345678999
Q ss_pred EeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhc------------------------------
Q 046598 770 EFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHD------------------------------ 819 (986)
Q Consensus 770 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~------------------------------ 819 (986)
||++|.++.+... ..++..+...++.++++.|+.||+.
T Consensus 93 e~i~G~~l~~~~~------------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~ 160 (306)
T 3tdw_A 93 RKVQGQILGEDGM------------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQV 160 (306)
T ss_dssp ECCCSEECHHHHH------------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHT
T ss_pred eccCCeECchhhh------------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhc
Confidence 9999988876321 1234445555555555555555542
Q ss_pred ---------------------------CCCCeEeecCCCCCeEecC---CCc-EEEcccccceec
Q 046598 820 ---------------------------CQPPIAHCDLKPSNILLDE---DMI-AHIGDFGLARFL 853 (986)
Q Consensus 820 ---------------------------~~~~ivH~Dlkp~NIll~~---~~~-~kL~DFG~a~~~ 853 (986)
..+.++|+|++|.||+++. ++. +.|+||+.+..-
T Consensus 161 ~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 161 FPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp GGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred ccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2335799999999999987 455 589999988753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.94 E-value=1.2e-05 Score=89.15 Aligned_cols=85 Identities=4% Similarity=-0.054 Sum_probs=54.8
Q ss_pred Cccc-ccccceeEEEEEEC---C---CCeEEEEEEeeccC---chhHHHHHHHHHHHhcCC-C--Ccceeeeeecccccc
Q 046598 693 VNQI-GEGSFGSVFKGILD---D---GRTTIAVKVFNLLH---HGAFKSFIAECNTLKNIR-H--RNLVKILTACSGVDY 759 (986)
Q Consensus 693 ~~~l-g~G~~g~Vy~~~~~---~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~ 759 (986)
.+.| +.|....+|+.... + ++..+++|+..... ......+.+|+++++.+. + -.+.++++++...
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~-- 102 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG-- 102 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS--
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC--
Confidence 3567 88889999998764 1 14678899865422 101245678888888773 2 3566777764321
Q ss_pred CCCceEEEEEEeccCCCHhH
Q 046598 760 QGNDFKALVFEFMHNRSLEE 779 (986)
Q Consensus 760 ~~~~~~~lv~e~~~~gsL~~ 779 (986)
...+..++||||++|.++.+
T Consensus 103 ~~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TTTSSCEEEEECCCCBCCCB
T ss_pred CccCCceEEEEecCCCChhh
Confidence 11145689999999877654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.87 E-value=2.3e-05 Score=88.14 Aligned_cols=76 Identities=13% Similarity=0.148 Sum_probs=49.0
Q ss_pred CcccccccceeEEEEEECCCCeEEEEEEeeccCc-------hhHHHHHHHHHHHhcCCC--C-cceeeeeeccccccCCC
Q 046598 693 VNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH-------GAFKSFIAECNTLKNIRH--R-NLVKILTACSGVDYQGN 762 (986)
Q Consensus 693 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-niv~l~~~~~~~~~~~~ 762 (986)
.+.+|.|..+.||++....+++.|+||....... ....++..|.++++.+.. | .+.+++.+. .
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d-------~ 107 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-------T 107 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-------T
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc-------C
Confidence 4679999999999998765567899998643211 123456788888887632 3 344555441 2
Q ss_pred ceEEEEEEeccCC
Q 046598 763 DFKALVFEFMHNR 775 (986)
Q Consensus 763 ~~~~lv~e~~~~g 775 (986)
+..++||||+++.
T Consensus 108 ~~~~lvmE~l~g~ 120 (397)
T 2olc_A 108 EMAVTVMEDLSHL 120 (397)
T ss_dssp TTTEEEECCCTTS
T ss_pred CccEEEEEeCCCc
Confidence 3458999999764
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.68 E-value=1.2e-05 Score=77.56 Aligned_cols=34 Identities=15% Similarity=0.081 Sum_probs=16.9
Q ss_pred CcceeeccCCc-ccCcCcchhhccCCCceeecccc
Q 046598 183 SIRSLFLSGNN-LEGSIPDTLGWLKNLVNLTMAQN 216 (986)
Q Consensus 183 ~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~N 216 (986)
+|++|+|++|. |+...-..+..+++|++|+|+++
T Consensus 115 ~L~~L~Ls~C~~ITD~Gl~~L~~~~~L~~L~L~~c 149 (176)
T 3e4g_A 115 SMLEMEIISCGNVTDKGIIALHHFRNLKYLFLSDL 149 (176)
T ss_dssp HCCEEEEESCTTCCHHHHHHGGGCTTCCEEEEESC
T ss_pred CCCEEEcCCCCcCCHHHHHHHhcCCCCCEEECCCC
Confidence 45555555543 44333334445555555555554
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.67 E-value=0.0001 Score=78.74 Aligned_cols=79 Identities=19% Similarity=0.164 Sum_probs=56.5
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCC---CcceeeeeeccccccCCCceE
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRH---RNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~~~~~ 765 (986)
+...++.+|.|..+.||+....+ |+.|+||+...........+..|++.|+.+.- --+.+++++ +..
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~D-G~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~---------~~~ 85 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELAD-GTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW---------DDR 85 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETT-SCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE---------ETT
T ss_pred CeEEEEecCCCCCeEEEEEEECC-CCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec---------cCc
Confidence 34456789999999999999876 68899998764443334567889998887732 235555554 234
Q ss_pred EEEEEeccCCCH
Q 046598 766 ALVFEFMHNRSL 777 (986)
Q Consensus 766 ~lv~e~~~~gsL 777 (986)
++||||++++..
T Consensus 86 ~lv~e~l~~~~~ 97 (288)
T 3f7w_A 86 TLAMEWVDERPP 97 (288)
T ss_dssp EEEEECCCCCCC
T ss_pred eEEEEeecccCC
Confidence 799999987643
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.67 E-value=9e-06 Score=78.33 Aligned_cols=84 Identities=13% Similarity=0.089 Sum_probs=57.1
Q ss_pred CcceEEEccCCcccccCCcccccccccchhhccCcc-ccccCcccccCC----ccccEEeccccc-ccccCCccccCCCC
Q 046598 477 SSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNK-LKGEIPSTLGSC----IKLEQLEMQENF-LQGPIPSSLSSLRG 550 (986)
Q Consensus 477 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~L~~N~-l~~~~p~~~~~l~~ 550 (986)
..|+.||++++.|+..--..+..+++|+.|+|++|. +++.--..++.+ ++|++|+|+++. |++.--..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 358888888888876555566777888888888874 664444445554 367777777764 66554455666777
Q ss_pred CCEEeCCCcc
Q 046598 551 LSVLDLSQNN 560 (986)
Q Consensus 551 L~~L~Ls~N~ 560 (986)
|+.|+|+++.
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 7777777764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00046 Score=75.63 Aligned_cols=153 Identities=17% Similarity=0.140 Sum_probs=81.4
Q ss_pred cccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCC--Ccceeeeeeccccc-cCCCceEEEEEE
Q 046598 694 NQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRH--RNLVKILTACSGVD-YQGNDFKALVFE 770 (986)
Q Consensus 694 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~-~~~~~~~~lv~e 770 (986)
+.++.|..+.||++...+ ..+++|+.... ..+...|+.+++.+.. -.+.+++....+.. ....+..++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~--~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDS--GAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEETT--EEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeCC--CCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 456667789999998754 35899998642 1334445555555421 12334433211100 123456899999
Q ss_pred eccCCCHh--------------HhhccCCCCC----ccccCCCccCHHH-------------------------------
Q 046598 771 FMHNRSLE--------------EWLHPITRED----ETDEAPRSLNLIQ------------------------------- 801 (986)
Q Consensus 771 ~~~~gsL~--------------~~l~~~~~~~----~~~~~~~~l~~~~------------------------------- 801 (986)
|++|.++. ..++...... ........-.|..
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986542 1112111100 0000000111211
Q ss_pred HHHHHHHHHHHHHHHHh----------cCCCCeEeecCCCCCeEecCCCcEEEccccccee
Q 046598 802 RLNISIDVACALNYLHH----------DCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARF 852 (986)
Q Consensus 802 ~~~i~~qi~~~L~~LH~----------~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~ 852 (986)
...+..++.+++++|++ ...+.++|||+++.||+++.++.+.|+||+.+..
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 11122234456666663 1245899999999999998888999999998864
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.55 E-value=5.2e-05 Score=85.80 Aligned_cols=80 Identities=10% Similarity=0.141 Sum_probs=50.9
Q ss_pred CCCeEeecCCCCCeEecCCCcEEEcccccceecCCCCCccccccccccccccccccccC---CCcCcccchhhHHHHHHH
Q 046598 821 QPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG---SEVSISGDVYSYGILLLE 897 (986)
Q Consensus 821 ~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~e 897 (986)
.+.++|||++|.||+++.++ ++++||+.+..-+..-+-.... ..-...|++|+.... .......++.+....+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYL-GNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHH-HHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHH-HHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 34899999999999998876 9999999997532111111000 001235677765432 122334566788888898
Q ss_pred HHhCC
Q 046598 898 LITRK 902 (986)
Q Consensus 898 lltg~ 902 (986)
.++++
T Consensus 309 ~y~~~ 313 (420)
T 2pyw_A 309 LFNKR 313 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 88764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.34 E-value=0.00095 Score=71.47 Aligned_cols=145 Identities=15% Similarity=0.125 Sum_probs=90.0
Q ss_pred CcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCC---CCcceeeeeeccccccCCCceEEEEE
Q 046598 693 VNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIR---HRNLVKILTACSGVDYQGNDFKALVF 769 (986)
Q Consensus 693 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~~~~~~lv~ 769 (986)
.+.++.|....+|+.... +..+++|+.... ....+..|++.++.+. ...+.++++++. ..+..++||
T Consensus 41 ~~~l~gG~~n~~y~v~~~--~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~-----~~g~~~lvm 110 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDE--VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGN-----SQGHSFLLL 110 (312)
T ss_dssp EEEECCSSSSEEEEEESS--SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEE-----CSSEEEEEE
T ss_pred eEEeCCccceeeeEEEEC--CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEee-----cCCceEEEE
Confidence 467899999999999863 567889987643 3467888988888873 356777877742 346789999
Q ss_pred EeccCCCHhH-----------hhccCCC-CCccc-----------cCCCccCHHHHH---HHH----------------H
Q 046598 770 EFMHNRSLEE-----------WLHPITR-EDETD-----------EAPRSLNLIQRL---NIS----------------I 807 (986)
Q Consensus 770 e~~~~gsL~~-----------~l~~~~~-~~~~~-----------~~~~~l~~~~~~---~i~----------------~ 807 (986)
||+++..+.. .++.... ..... .....-+|.+.. ++. .
T Consensus 111 e~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~ 190 (312)
T 3jr1_A 111 EALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNID 190 (312)
T ss_dssp ECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHH
T ss_pred EeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHH
Confidence 9999876521 2232221 00000 001112444321 111 1
Q ss_pred HHHHH-HHHHHh-cCCCCeEeecCCCCCeEecCCCcEEEcccc
Q 046598 808 DVACA-LNYLHH-DCQPPIAHCDLKPSNILLDEDMIAHIGDFG 848 (986)
Q Consensus 808 qi~~~-L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG 848 (986)
++... ...|.. ...+.++|+|+.+.|++++.++ +.|.||+
T Consensus 191 ~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 191 LIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 11111 223321 1256899999999999999887 8899984
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.33 E-value=0.0009 Score=72.53 Aligned_cols=173 Identities=15% Similarity=0.123 Sum_probs=92.5
Q ss_pred CCcChHHHHHhhcCCCC-----CcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCc--ce
Q 046598 676 PNISYQNLYNATDRFSS-----VNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRN--LV 748 (986)
Q Consensus 676 ~~~~~~~~~~~~~~y~~-----~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv 748 (986)
+.++.+++.....+|.+ .+.|+.|....+|+....+ + .+++|+.... ...+.+..|+.+++.+.... +.
T Consensus 5 ~~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP 80 (322)
T 2ppq_A 5 TDITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCP 80 (322)
T ss_dssp CCCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCC
T ss_pred ccCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCC-c-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCC
Confidence 44666777777777765 2346678889999998765 3 5889988652 12245566777777663212 33
Q ss_pred eeeeeccccc-cCCCceEEEEEEeccCCCHhH--------------hhccCCCCCcccc--CCCccCHHHHHH-------
Q 046598 749 KILTACSGVD-YQGNDFKALVFEFMHNRSLEE--------------WLHPITREDETDE--APRSLNLIQRLN------- 804 (986)
Q Consensus 749 ~l~~~~~~~~-~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~~~~~~~--~~~~l~~~~~~~------- 804 (986)
+++....+.. ....+..++||+|++|..+.. .++.....-.... ......|.....
T Consensus 81 ~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~ 160 (322)
T 2ppq_A 81 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD 160 (322)
T ss_dssp CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred cccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHH
Confidence 3332211000 011356789999998865421 1111110000000 000011221100
Q ss_pred -----HHHHHHHHHHHHHhc----CCCCeEeecCCCCCeEecCCCcEEEccccccee
Q 046598 805 -----ISIDVACALNYLHHD----CQPPIAHCDLKPSNILLDEDMIAHIGDFGLARF 852 (986)
Q Consensus 805 -----i~~qi~~~L~~LH~~----~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~ 852 (986)
+...+.+.++++++. ..++++|+|+.+.||+++++..+.++||+.+..
T Consensus 161 ~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 161 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011234455555532 234799999999999999876668999998864
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.28 E-value=6e-05 Score=74.00 Aligned_cols=86 Identities=12% Similarity=0.164 Sum_probs=45.1
Q ss_pred ccccchhhccCccccc----cCcccccCCccccEEecccccccccC----CccccCCCCCCEEeCCCc---cCcc----c
Q 046598 500 LKNLEILNVFGNKLKG----EIPSTLGSCIKLEQLEMQENFLQGPI----PSSLSSLRGLSVLDLSQN---NLSG----K 564 (986)
Q Consensus 500 l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~Ls~N---~l~~----~ 564 (986)
-+.|+.|+|++|+|.. .+.+.+..-+.|++|+|++|.|.+.. -..+..-+.|++|+|++| .+.. .
T Consensus 69 N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ 148 (197)
T 1pgv_A 69 SKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMD 148 (197)
T ss_dssp CSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHH
T ss_pred CCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHH
Confidence 3445555555555542 12333444555666666666665422 233444556777777654 3332 2
Q ss_pred CchhhhcccccceeeccCCcc
Q 046598 565 IPELLIRLQLVKNLNLSNNDL 585 (986)
Q Consensus 565 ~p~~~~~l~~L~~l~ls~N~l 585 (986)
+.+.+..-+.|+.|+++.|.+
T Consensus 149 ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 149 MMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHhCCCcCeEeccCCCc
Confidence 334455566777777766643
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.23 E-value=4e-05 Score=75.29 Aligned_cols=66 Identities=15% Similarity=0.140 Sum_probs=36.5
Q ss_pred ccCCCCCCEEEccCC-Cccc----cCCcchhccccCceeeceecccCCC----CccchhcCccccceeccccccc
Q 046598 82 VGNLSFLKVLRLYNN-SFNH----EIPSEFDRLRRLQVLALHYNSIGGA----IPANISSCSNLIQLRLFHNQLV 147 (986)
Q Consensus 82 ~~~l~~L~~L~L~~n-~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 147 (986)
+.+-+.|++|+|++| +|.. .+-+++..-+.|+.|+|++|+|+.. +.+.+..-+.|++|+|++|.|.
T Consensus 37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence 334466777777764 6542 1334455556667777777766522 2333344455666666666554
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0014 Score=70.21 Aligned_cols=73 Identities=8% Similarity=0.115 Sum_probs=44.1
Q ss_pred CCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcc-eeeeeeccccccCCCceEEEEE
Q 046598 691 SSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNL-VKILTACSGVDYQGNDFKALVF 769 (986)
Q Consensus 691 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~~~~~~lv~ 769 (986)
.-++.|+.|....+|++ ..+++|+....... .....+|+.+++.+....+ .++++++ .+.-++|+
T Consensus 21 ~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~-------~~~~~~v~ 86 (301)
T 3dxq_A 21 TGPLERLGGLTNLVFRA------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD-------PATGVMVT 86 (301)
T ss_dssp CSCEEEESCSSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC-------TTTCCEEE
T ss_pred cceeEcCCcccccccee------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE-------CCCCEEEE
Confidence 33688999999999999 34888987542211 1223567777766632222 4555442 22346899
Q ss_pred Eec-cCCCH
Q 046598 770 EFM-HNRSL 777 (986)
Q Consensus 770 e~~-~~gsL 777 (986)
||+ +|.++
T Consensus 87 e~i~~g~~l 95 (301)
T 3dxq_A 87 RYIAGAQTM 95 (301)
T ss_dssp ECCTTCEEC
T ss_pred eecCCCccC
Confidence 999 66554
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.05 E-value=0.002 Score=69.92 Aligned_cols=171 Identities=17% Similarity=0.172 Sum_probs=92.0
Q ss_pred CCCcChHHHHHhhcCCCC-----CcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCC--cc
Q 046598 675 FPNISYQNLYNATDRFSS-----VNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHR--NL 747 (986)
Q Consensus 675 ~~~~~~~~~~~~~~~y~~-----~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--ni 747 (986)
+...+.+++....+.|.+ ++.++ |....||++...+ ++.+++|+..... .....+..|..+++.+... .+
T Consensus 8 ~~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~-g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~v 84 (328)
T 1zyl_A 8 FQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDED-RRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPV 84 (328)
T ss_dssp CCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTT-CCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSB
T ss_pred CCCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCC-CCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCee
Confidence 445566666666555543 23466 8888999887654 5578999986432 1235667788887776321 23
Q ss_pred eeeeeeccccc-cCCCceEEEEEEeccCCCHhH-----------h---hccCCCCCccccCCCccCHHH-----------
Q 046598 748 VKILTACSGVD-YQGNDFKALVFEFMHNRSLEE-----------W---LHPITREDETDEAPRSLNLIQ----------- 801 (986)
Q Consensus 748 v~l~~~~~~~~-~~~~~~~~lv~e~~~~gsL~~-----------~---l~~~~~~~~~~~~~~~l~~~~----------- 801 (986)
.+++.. .+.. ...++..++||||++|..+.. . ++...... .......+++..
T Consensus 85 p~~~~~-~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~ 162 (328)
T 1zyl_A 85 AAPVAF-NGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQ-LFIHRPTIGLNEYLIEPRKLFED 162 (328)
T ss_dssp CCCCCB-TTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSS-CCSSSCBCSHHHHTHHHHHHHHT
T ss_pred cceeec-CCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccC-CCccCCCCCHHHHHhhHHHHHhh
Confidence 444432 1100 112456789999998855321 0 11110000 000001111111
Q ss_pred -----------HHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCCeEecCCCcEEEccccccee
Q 046598 802 -----------RLNISIDVACALNYLHH-DCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARF 852 (986)
Q Consensus 802 -----------~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~ 852 (986)
....+.+++..++..-. ...+.++|||+++.||+++ + .+.++||+.+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 163 ATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred cCcCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 11122222222222211 1234789999999999999 4 899999998864
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0015 Score=71.93 Aligned_cols=148 Identities=12% Similarity=0.162 Sum_probs=83.8
Q ss_pred CcccccccceeEEEEEECC-------CCeEEEEEEeeccCchhHHHHHHHHHHHhcCC-CCcceeeeeeccccccCCCce
Q 046598 693 VNQIGEGSFGSVFKGILDD-------GRTTIAVKVFNLLHHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 693 ~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~ 764 (986)
++.+..|-...+|++.... .++.+++|+..... .......+|.++++.+. +.-..++++++ .+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-----~~--- 125 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVF-----PE--- 125 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-----TT---
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEc-----CC---
Confidence 3567778889999998742 34789999863321 23455678999888773 32235566653 21
Q ss_pred EEEEEEeccCCCHhHh--------------hccCCCCCccccCCCcc--CHHHHHHHHHHHHH-----------------
Q 046598 765 KALVFEFMHNRSLEEW--------------LHPITREDETDEAPRSL--NLIQRLNISIDVAC----------------- 811 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~--------------l~~~~~~~~~~~~~~~l--~~~~~~~i~~qi~~----------------- 811 (986)
.+||||++|.++..- +.+....+. ...+.. -+.++.++..++..
T Consensus 126 -g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~--~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l 202 (379)
T 3feg_A 126 -GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEM--PFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSL 202 (379)
T ss_dssp -EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCC--SSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTH
T ss_pred -ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCC--CCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHH
Confidence 299999998665321 000000000 011112 24455555544422
Q ss_pred --HHHHHHh----c-CCCCeEeecCCCCCeEecCC----CcEEEccccccee
Q 046598 812 --ALNYLHH----D-CQPPIAHCDLKPSNILLDED----MIAHIGDFGLARF 852 (986)
Q Consensus 812 --~L~~LH~----~-~~~~ivH~Dlkp~NIll~~~----~~~kL~DFG~a~~ 852 (986)
.+..|.+ . ....++|+|+.+.||+++.+ +.+.++||..|..
T Consensus 203 ~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 203 KDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2333322 1 23479999999999999876 7899999998864
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0017 Score=59.51 Aligned_cols=38 Identities=29% Similarity=0.316 Sum_probs=22.5
Q ss_pred CCCEEeCCCccCcccCchhhhcccccceeeccCCcccc
Q 046598 550 GLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEG 587 (986)
Q Consensus 550 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~ 587 (986)
+|+.|+|++|+|+...+..|..+++|++|+|++|++.+
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~C 69 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRC 69 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBC
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCeec
Confidence 45666666666665555555566666666666665554
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0022 Score=72.23 Aligned_cols=74 Identities=18% Similarity=0.255 Sum_probs=49.1
Q ss_pred CcccccccceeEEEEEECC-------CCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCc-ceeeeeeccccccCCCce
Q 046598 693 VNQIGEGSFGSVFKGILDD-------GRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRN-LVKILTACSGVDYQGNDF 764 (986)
Q Consensus 693 ~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~~~~ 764 (986)
++.|+.|....||++...+ .+..+++|+.... .....+.+|..+++.+...+ ..++++.+ .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~--- 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIF-----SG--- 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT---
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC---
Confidence 4568888889999998753 2468999998431 11245567888888774322 35566652 21
Q ss_pred EEEEEEeccCCCH
Q 046598 765 KALVFEFMHNRSL 777 (986)
Q Consensus 765 ~~lv~e~~~~gsL 777 (986)
.+||||++|.++
T Consensus 148 -g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 -GRLEEYIPSRPL 159 (429)
T ss_dssp -EEEECCCCEEEC
T ss_pred -CEEEEEeCCccc
Confidence 389999987544
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.72 E-value=0.004 Score=70.43 Aligned_cols=75 Identities=15% Similarity=0.110 Sum_probs=47.6
Q ss_pred CcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcc-eeeeeeccccccCCCceEEEEEEe
Q 046598 693 VNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNL-VKILTACSGVDYQGNDFKALVFEF 771 (986)
Q Consensus 693 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~~~~~~lv~e~ 771 (986)
++.|+.|-...+|++...+.+..+++|+....... .-...+|..+++.+...++ .++++++ . + .+||||
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~-----~--~--G~v~e~ 182 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFF-----T--N--GRIEEF 182 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEE-----T--T--EEEEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEe-----C--C--eEEEEe
Confidence 45788888999999988654578999987532211 1122578888888754333 4566653 1 1 359999
Q ss_pred ccCCCH
Q 046598 772 MHNRSL 777 (986)
Q Consensus 772 ~~~gsL 777 (986)
++|.++
T Consensus 183 I~G~~l 188 (458)
T 2qg7_A 183 MDGYAL 188 (458)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 988555
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.69 E-value=0.0065 Score=66.03 Aligned_cols=33 Identities=21% Similarity=0.215 Sum_probs=28.6
Q ss_pred CCCeEeecCCCCCeEecCC----CcEEEcccccceec
Q 046598 821 QPPIAHCDLKPSNILLDED----MIAHIGDFGLARFL 853 (986)
Q Consensus 821 ~~~ivH~Dlkp~NIll~~~----~~~kL~DFG~a~~~ 853 (986)
.+.++|||+.+.||+++.+ +.+.++||+.+..-
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 3489999999999999875 68999999999754
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.40 E-value=0.0032 Score=57.66 Aligned_cols=35 Identities=29% Similarity=0.418 Sum_probs=15.5
Q ss_pred CCeEEccCCcCCCCcccccCCCcCcceeeccCCcc
Q 046598 160 IEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNL 194 (986)
Q Consensus 160 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 194 (986)
|++|+|++|+|+...+..|..+++|++|+|++|.+
T Consensus 33 l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 33 TTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp CSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred CCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 44444444444433333444444444444444443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.33 E-value=0.0048 Score=68.20 Aligned_cols=75 Identities=19% Similarity=0.272 Sum_probs=43.9
Q ss_pred CcccccccceeEEEEEECCC--------CeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCc-ceeeeeeccccccCCCc
Q 046598 693 VNQIGEGSFGSVFKGILDDG--------RTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRN-LVKILTACSGVDYQGND 763 (986)
Q Consensus 693 ~~~lg~G~~g~Vy~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~~~ 763 (986)
.+.++.|....+|++...++ +..+++|+...... .......|.++++.+.... +.++++.. .
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~--- 108 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF-----N--- 108 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE-----T---
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec-----C---
Confidence 35677888899999987541 26788998754221 1122356777777774223 44565541 1
Q ss_pred eEEEEEEeccCCCH
Q 046598 764 FKALVFEFMHNRSL 777 (986)
Q Consensus 764 ~~~lv~e~~~~gsL 777 (986)
-++||||++|.++
T Consensus 109 -~~~v~e~i~G~~l 121 (369)
T 3c5i_A 109 -GGRIEEWLYGDPL 121 (369)
T ss_dssp -TEEEEECCCSEEC
T ss_pred -CcEEEEEecCCcC
Confidence 2689999988654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.16 E-value=0.031 Score=60.73 Aligned_cols=32 Identities=19% Similarity=0.287 Sum_probs=28.5
Q ss_pred CCeEeecCCCCCeEecCCCcEEEcccccceec
Q 046598 822 PPIAHCDLKPSNILLDEDMIAHIGDFGLARFL 853 (986)
Q Consensus 822 ~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 853 (986)
..++|+|+.+.||++++++.+.++||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 47999999999999998888999999888653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=94.36 E-value=0.13 Score=50.60 Aligned_cols=103 Identities=19% Similarity=0.160 Sum_probs=68.3
Q ss_pred CCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcccccceecC
Q 046598 775 RSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLP 854 (986)
Q Consensus 775 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 854 (986)
.+|.+.++ ..+.++++++++.++.|.+.+|.-.-.... . ..+=+.|..|++..+|.|...+ +.+.
T Consensus 33 vSL~eIL~---------~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~--- 97 (229)
T 2yle_A 33 LSLEEILR---------LYNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD--- 97 (229)
T ss_dssp EEHHHHHH---------HHTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C------
T ss_pred ccHHHHHH---------HcCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc---
Confidence 47889886 456789999999999999999887622101 1 1233457899999999888864 1110
Q ss_pred CCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCC
Q 046598 855 LSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904 (986)
Q Consensus 855 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p 904 (986)
.....+.|||... ...+.+.=|||+|+++|..+--..|
T Consensus 98 -----------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -----------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp --------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -----------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1233567888753 3456788999999999999985555
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.20 E-value=0.033 Score=62.12 Aligned_cols=149 Identities=16% Similarity=0.205 Sum_probs=84.3
Q ss_pred CcccccccceeEEEEEECCC-------CeEEEEEEeeccCchhHHHHHHHHHHHhcCC-CCcceeeeeeccccccCCCce
Q 046598 693 VNQIGEGSFGSVFKGILDDG-------RTTIAVKVFNLLHHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 693 ~~~lg~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~ 764 (986)
++.+..|-...+|+...... +..+++|+..... ...-...+|.++++.+. +.-..++++.+ .
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~-----~---- 144 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF-----P---- 144 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE-----T----
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc-----C----
Confidence 45677788899999987631 4778999864322 11223357888877773 22244555442 1
Q ss_pred EEEEEEeccCCCHhHh-----------------hccCCCCC-cccc--CCCccCHHHHHHHHHHHH--------------
Q 046598 765 KALVFEFMHNRSLEEW-----------------LHPITRED-ETDE--APRSLNLIQRLNISIDVA-------------- 810 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~-----------------l~~~~~~~-~~~~--~~~~l~~~~~~~i~~qi~-------------- 810 (986)
-+.||||++|.++..- ++...... .... ...+--+.++.++..++-
T Consensus 145 ~~~I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~ 224 (424)
T 3mes_A 145 EGRIEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKEL 224 (424)
T ss_dssp TEEEEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHH
T ss_pred CCEEEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhcccc
Confidence 2689999998664210 11000000 0000 111112444444433321
Q ss_pred -----HHHHHHHh---------------------cCCCCeEeecCCCCCeEecCCCcEEEccccccee
Q 046598 811 -----CALNYLHH---------------------DCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARF 852 (986)
Q Consensus 811 -----~~L~~LH~---------------------~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~ 852 (986)
..+..|.+ .....++|+|+.+.||+ +.++.+.++||..|..
T Consensus 225 ~~~l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 225 YSKILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 22333321 11336899999999999 7888999999999864
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.61 E-value=0.14 Score=35.68 Aligned_cols=28 Identities=21% Similarity=0.255 Sum_probs=14.8
Q ss_pred HHHHHHHHHHHHHHHHHHHHhhheeeec
Q 046598 634 LKLVLAIISGLIGLSLALSIIVLCLVRK 661 (986)
Q Consensus 634 ~~~~~~~~~~~~~~~~v~~~~~~~~~~~ 661 (986)
..++.++++|++++++++..++++++||
T Consensus 10 ~aIA~gVVgGv~~v~ii~~~~~~~~RRR 37 (44)
T 2l2t_A 10 PLIAAGVIGGLFILVIVGLTFAVYVRRK 37 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ceEEEeehHHHHHHHHHHHHHHHHhhhh
Confidence 3466666666666555554433333333
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.46 E-value=0.069 Score=59.44 Aligned_cols=30 Identities=30% Similarity=0.429 Sum_probs=25.5
Q ss_pred CeEeecCCCCCeEe------cCCCcEEEccccccee
Q 046598 823 PIAHCDLKPSNILL------DEDMIAHIGDFGLARF 852 (986)
Q Consensus 823 ~ivH~Dlkp~NIll------~~~~~~kL~DFG~a~~ 852 (986)
.++|+|+.+.||++ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 4566899999998864
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.82 E-value=0.12 Score=36.19 Aligned_cols=26 Identities=19% Similarity=0.247 Sum_probs=13.3
Q ss_pred HHHHHHHHHHHHHHHHHHhhheeeec
Q 046598 636 LVLAIISGLIGLSLALSIIVLCLVRK 661 (986)
Q Consensus 636 ~~~~~~~~~~~~~~v~~~~~~~~~~~ 661 (986)
++.++++|++++++++..++++++||
T Consensus 13 IA~gVVgGv~~~~ii~~~~~~~~RRr 38 (44)
T 2ks1_B 13 IATGMVGALLLLLVVALGIGLFMRRR 38 (44)
T ss_dssp STHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEeehhHHHHHHHHHHHHHHHHhhhh
Confidence 45566666666555554433333333
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=84.74 E-value=0.68 Score=32.25 Aligned_cols=25 Identities=20% Similarity=0.616 Sum_probs=9.5
Q ss_pred HHHHHHHHHHHHHHHHhhheeeeccc
Q 046598 638 LAIISGLIGLSLALSIIVLCLVRKRK 663 (986)
Q Consensus 638 ~~~~~~~~~~~~v~~~~~~~~~~~~~ 663 (986)
++.++|++ +++++++.+++++|||+
T Consensus 15 a~~vVGvl-l~vi~~l~~~~~~RRR~ 39 (44)
T 2jwa_A 15 ISAVVGIL-LVVVLGVVFGILIKRRQ 39 (44)
T ss_dssp HHHHHHHH-HHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHH-HHHHHHHHHHhheehhh
Confidence 33344433 33333333333444433
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=84.08 E-value=1.6 Score=42.88 Aligned_cols=91 Identities=18% Similarity=0.261 Sum_probs=66.9
Q ss_pred CccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcccccceecCCCCCcccccccccccccccc
Q 046598 795 RSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAP 874 (986)
Q Consensus 795 ~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aP 874 (986)
+..+...+++++.+|+....+++++ +|--+.|+||+++.++.+++.-.|.-..+ +|
T Consensus 76 k~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL~f~~~~~p~i~~RGik~~l-------------------~P 131 (215)
T 4ann_A 76 KSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDELFFTRDGLPIAKTRGLQNVV-------------------DP 131 (215)
T ss_dssp GGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGEEECTTSCEEESCCEETTTB-------------------SC
T ss_pred HhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceEEEcCCCCEEEEEccCccCC-------------------CC
Confidence 3578899999999999988777655 78889999999999999999877764322 22
Q ss_pred ccccCCCcCcccchhhHHHHHHHHHhCCCCCCcccccccc
Q 046598 875 EYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMN 914 (986)
Q Consensus 875 E~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~ 914 (986)
. .++...=.-.+=+++..+++++..|+....|...
T Consensus 132 ~-----~~~ee~fL~qyKAliiall~~K~~Fe~l~~G~le 166 (215)
T 4ann_A 132 L-----PVSEAEFLTRYKALVICAFNEKQSFDALVEGNLE 166 (215)
T ss_dssp C-----CCCHHHHHHHHHHHHHHHHCTTCCHHHHHHSCGG
T ss_pred C-----CCCHHHHHHHHHHHHHHHHcCCCCHHHHHcChHh
Confidence 1 1122222445778899999999998766555433
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=82.49 E-value=1.1 Score=30.32 Aligned_cols=9 Identities=44% Similarity=0.719 Sum_probs=3.6
Q ss_pred HHHHHHHHH
Q 046598 636 LVLAIISGL 644 (986)
Q Consensus 636 ~~~~~~~~~ 644 (986)
.+.+++++.
T Consensus 12 aIAGiVvG~ 20 (38)
T 2k1k_A 12 EIVAVIFGL 20 (38)
T ss_dssp HHHHHHHHH
T ss_pred ceeeeehHH
Confidence 334444433
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 986 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-55 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-50 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-48 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-48 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-48 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-47 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-47 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-46 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-46 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-45 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-45 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-45 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-44 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-44 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-44 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-44 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-43 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-43 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-43 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-43 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-43 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-43 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-43 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-42 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-42 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-41 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-41 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-41 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-40 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-39 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-38 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-38 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-38 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-37 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-37 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-36 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-35 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-35 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-35 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-35 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-34 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-34 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-34 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-34 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-34 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-33 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-33 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-32 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-32 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-32 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-31 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-30 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-30 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-17 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-12 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-05 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-30 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-30 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-29 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-29 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-29 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-28 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-28 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-28 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-27 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-25 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-24 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-17 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-10 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-07 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-23 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-17 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-15 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-15 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-14 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-11 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-17 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-15 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 9e-15 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-14 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-13 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-12 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-10 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-10 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 6e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.001 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 9e-09 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 1e-07 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 3e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 5e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 2e-08 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 1e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 4e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 8e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 7e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 9e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 1e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 3e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.002 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 9e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (485), Expect = 2e-55
Identities = 77/304 (25%), Positives = 122/304 (40%), Gaps = 53/304 (17%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGA--FKSFIAECNTLKNIRHR 745
+ + +IG GSFG+V+KG +AVK+ N+ ++F E L+ RH
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 746 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNI 805
N++ + + A+V ++ SL LH +I+ ++I
Sbjct: 65 NILLFMGYSTA------PQLAIVTQWCEGSSLYHHLH---------IIETKFEMIKLIDI 109
Query: 806 SIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGA 865
+ A ++YLH I H DLK +NI L ED+ IGDFGLA S
Sbjct: 110 ARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 166
Query: 866 KGSIGYIAPEYGLGSE---VSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTA 922
GSI ++APE + S DVY++GI+L EL+T + P + N
Sbjct: 167 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP----YSNINN-------- 214
Query: 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMS 982
D ++ +V G K R C +M R+ C + ++R
Sbjct: 215 -RDQIIFMV--------------GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPL 259
Query: 983 MTNV 986
+
Sbjct: 260 FPQI 263
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 2e-50
Identities = 62/313 (19%), Positives = 107/313 (34%), Gaps = 33/313 (10%)
Query: 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL-LHHGAFKSFIAECNTLKNIRH 744
D F ++++G G+ G VFK +A K+ +L + I E L
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 745 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLN 804
+V A + ++ E M SL++ L R +
Sbjct: 64 PYIVGFYGAF-----YSDGEISICMEHMDGGSLDQVLKKAGR----------IPEQILGK 108
Query: 805 ISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIG 864
+SI V L YL I H D+KPSNIL++ + DFG++ L S A +
Sbjct: 109 VSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF--- 163
Query: 865 AKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALP 924
G+ Y++PE G+ S+ D++S G+ L+E+ + P ++ L +
Sbjct: 164 -VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 222
Query: 925 DHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSME--------- 975
T + + I S+E
Sbjct: 223 AAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCL 282
Query: 976 --SPEDRMSMTNV 986
+P +R + +
Sbjct: 283 IKNPAERADLKQL 295
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 1e-48
Identities = 63/305 (20%), Positives = 117/305 (38%), Gaps = 39/305 (12%)
Query: 695 QIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTAC 754
IG+G FG V++G +AVK+F+ ++ AE +RH N++ + A
Sbjct: 10 SIGKGRFGEVWRGKWRG--EEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAAD 66
Query: 755 SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALN 814
+ + LV ++ + SL ++L+ ++ + + +++ A L
Sbjct: 67 NKDNGTWTQL-WLVSDYHEHGSLFDYLNR-----------YTVTVEGMIKLALSTASGLA 114
Query: 815 YLHHDC-----QPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLP--LSSAQTSSIGAKG 867
+LH + +P IAH DLK NIL+ ++ I D GLA + + G
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 868 SIGYIAPEYGLGS------EVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLART 921
+ Y+APE S E D+Y+ G++ E+ R I + + ++L +
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234
Query: 922 ALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRM 981
M ++ R E L M +I C + R+
Sbjct: 235 DPSVEEM-----------RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 283
Query: 982 SMTNV 986
+ +
Sbjct: 284 TALRI 288
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 2e-48
Identities = 67/299 (22%), Positives = 121/299 (40%), Gaps = 51/299 (17%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNL 747
+ V ++G G FG V+ G + +AVK + +F+AE N +K ++H+ L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRL 70
Query: 748 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISI 807
V++ + + ++ E+M N SL ++L + L + + L+++
Sbjct: 71 VRLYAVVT------QEPIYIITEYMENGSLVDFLK--------TPSGIKLTINKLLDMAA 116
Query: 808 DVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKG 867
+A + ++ H DL+ +NIL+ + + I DFGLAR + + GAK
Sbjct: 117 QIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKF 172
Query: 868 SIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHV 927
I + APE +I DV+S+GILL E++T + M + + +
Sbjct: 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI----PYPGMTNPEVIQNLERGYR 228
Query: 928 MDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986
M D C + ++ C E PEDR + +
Sbjct: 229 MVRPD---------------------------NCPEELYQLMRLCWKERPEDRPTFDYL 260
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 7e-48
Identities = 62/264 (23%), Positives = 107/264 (40%), Gaps = 24/264 (9%)
Query: 694 NQIGEGSFGSVFKGILDDGRTTIAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKIL 751
+IG GSF +V+KG+ + +A L + F E LK ++H N+V+
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 752 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVAC 811
+ +G LV E M + +L+ +L + + + + +
Sbjct: 75 DSWESTV-KGKKCIVLVTELMTSGTLKTYLK----------RFKVMKIKVLRSWCRQILK 123
Query: 812 ALNYLHHDCQPPIAHCDLKPSNILL-DEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIG 870
L +LH PPI H DLK NI + IGD GLA S A+ G+
Sbjct: 124 GLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPE 178
Query: 871 YIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVMDI 930
++APE + S DVY++G+ +LE+ T + P + N + R
Sbjct: 179 FMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYP----YSECQNAAQIYRRVTSGVKPAS 233
Query: 931 VDSTLLNDGEDLIVHGNQRQRQAR 954
D + + +++I ++ + R
Sbjct: 234 FDKVAIPEVKEIIEGCIRQNKDER 257
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 3e-47
Identities = 54/246 (21%), Positives = 96/246 (39%), Gaps = 17/246 (6%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL--LHHGAFKSFIAECNTLKNIRHR 745
+ + + IG GS+G K + K + + + ++E N L+ ++H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 746 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNI 805
N+V+ + N +V E+ L + T+E + L+ L +
Sbjct: 64 NIVRYYDRIID---RTNTTLYIVMEYCEGGDLASVITKGTKE------RQYLDEEFVLRV 114
Query: 806 SIDVACALNYLH--HDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSI 863
+ AL H D + H DLKP+N+ LD +GDFGLAR L ++ +
Sbjct: 115 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAF 174
Query: 864 GAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDM--NLHNLART 921
G+ Y++PE + D++S G LL EL P + ++ +
Sbjct: 175 --VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR 232
Query: 922 ALPDHV 927
+P
Sbjct: 233 RIPYRY 238
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 4e-47
Identities = 73/299 (24%), Positives = 126/299 (42%), Gaps = 51/299 (17%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNL 747
+ ++G+G FG V+ G + +A+K ++F+ E +K +RH L
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKL 74
Query: 748 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISI 807
V++ S + +V E+M SL ++L E + L L Q ++++
Sbjct: 75 VQLYAVVS------EEPIYIVTEYMSKGSLLDFLK--------GETGKYLRLPQLVDMAA 120
Query: 808 DVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKG 867
+A + Y+ H DL+ +NIL+ E+++ + DFGLAR + + T+ GAK
Sbjct: 121 QIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKF 176
Query: 868 SIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHV 927
I + APE L +I DV+S+GILL EL T+ + M V
Sbjct: 177 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV----PYPGMV---------NREV 223
Query: 928 MDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986
+D V+ R+ EC S+ + C + PE+R + +
Sbjct: 224 LDQVERGY------------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYL 264
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 166 bits (421), Expect = 2e-46
Identities = 63/324 (19%), Positives = 126/324 (38%), Gaps = 64/324 (19%)
Query: 679 SYQNLYNATDRFSS---------VNQIGEGSFGSVFKGIL-DDGRTTIAVKVFNL---LH 725
++++ A F+ IG G FG V G L G+ I V + L
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 726 HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPIT 785
+ F++E + + H N++ + + ++ EFM N SL+ +L
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVV-----TKSTPVMIITEFMENGSLDSFLR--- 119
Query: 786 REDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845
+ +IQ + + +A + YL H DL NIL++ +++ +
Sbjct: 120 ------QNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVS 170
Query: 846 DFGLARFLPLSSAQ---TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRK 902
DFGL+RFL ++ TS++G K I + APE + + + DV+SYGI++ E+++
Sbjct: 171 DFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG 230
Query: 903 KPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECL 962
+ + V++ ++ R+ ++C
Sbjct: 231 ER---PYWDMT----------NQDVINAIEQDY------------------RLPPPMDCP 259
Query: 963 ISMVRIGVACSMESPEDRMSMTNV 986
++ ++ + C + R +
Sbjct: 260 SALHQLMLDCWQKDRNHRPKFGQI 283
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 3e-46
Identities = 66/299 (22%), Positives = 108/299 (36%), Gaps = 55/299 (18%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNL 747
+ IG+G FG V G +AVK + ++F+AE + + +RH NL
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYRG--NKVAVKCIK--NDATAQAFLAEASVMTQLRHSNL 62
Query: 748 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISI 807
V++L + +V E+M SL ++L L L S+
Sbjct: 63 VQLLGVI----VEEKGGLYIVTEYMAKGSLVDYLR--------SRGRSVLGGDCLLKFSL 110
Query: 808 DVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKG 867
DV A+ YL H DL N+L+ ED +A + DFGL + ++ K
Sbjct: 111 DVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-----STQDTGKL 162
Query: 868 SIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHV 927
+ + APE + S DV+S+GILL E+ + + + L ++ +
Sbjct: 163 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV----PYPRIPLKDVVPRVEKGYK 218
Query: 928 MDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986
MD D C ++ + C R S +
Sbjct: 219 MDAPD---------------------------GCPPAVYEVMKNCWHLDAAMRPSFLQL 250
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 6e-45
Identities = 61/272 (22%), Positives = 107/272 (39%), Gaps = 31/272 (11%)
Query: 680 YQNLY---NATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAEC 736
Y+++ N D + + ++G+G+FG V+K + A KV + + ++ E
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60
Query: 737 NTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRS 796
+ L + H N+VK+L A + ++ EF +++ + E R
Sbjct: 61 DILASCDHPNIVKLLDAF-----YYENNLWILIEFCAGGAVDAVML---------ELERP 106
Query: 797 LNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLS 856
L Q + ALNYLH I H DLK NIL D + DFG++ +
Sbjct: 107 LTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 163
Query: 857 SAQTSSIGAKGSIGYIAPEY-----GLGSEVSISGDVYSYGILLLELITRKKPTDIMFEG 911
+ S G+ ++APE DV+S GI L+E+ + P
Sbjct: 164 IQRRDSF--IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP----HHE 217
Query: 912 DMNLHNLARTALPDHVMDIVDSTLLNDGEDLI 943
+ L + A + S ++ +D +
Sbjct: 218 LNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFL 249
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (409), Expect = 7e-45
Identities = 71/330 (21%), Positives = 121/330 (36%), Gaps = 59/330 (17%)
Query: 677 NISYQNLYNATDRFSSVNQIGEGSFGSVFKGIL-----DDGRTTIAVKVFNL-LHHGAFK 730
N +L + V IGEG+FG VF+ + T +AVK+
Sbjct: 2 NPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA 61
Query: 731 SFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLH-------- 782
F E + + N+VK+L C L+FE+M L E+L
Sbjct: 62 DFQREAALMAEFDNPNIVKLLGVC-----AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVC 116
Query: 783 ------PITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILL 836
TR + P L+ ++L I+ VA + YL H DL N L+
Sbjct: 117 SLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLV 173
Query: 837 DEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLL 896
E+M+ I DFGL+R + + + I ++ PE + + DV++YG++L
Sbjct: 174 GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLW 233
Query: 897 ELITRKKPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVK 956
E+ + + G + + + + D +L E+
Sbjct: 234 EIFSYGLQ---PYYGMAH---------EEVIYYVRDGNILACPEN--------------- 266
Query: 957 SRIECLISMVRIGVACSMESPEDRMSMTNV 986
C + + + C + P DR S ++
Sbjct: 267 ----CPLELYNLMRLCWSKLPADRPSFCSI 292
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 9e-45
Identities = 64/319 (20%), Positives = 103/319 (32%), Gaps = 58/319 (18%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTT-----IAVKVFNL-LHHGAFKSFIAECNTLKN 741
+ +G G+FG V T +AVK+ ++ ++E +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 742 I-RHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLH-------------PITRE 787
+ H N+V +L AC + L+FE+ L +L +
Sbjct: 97 LGSHENIVNLLGAC-----TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 151
Query: 788 DETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDF 847
E +E L L + VA + +L H DL N+L+ + I DF
Sbjct: 152 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDF 208
Query: 848 GLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDI 907
GLAR + S A+ + ++APE +I DV+SYGILL E+ +
Sbjct: 209 GLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN--- 265
Query: 908 MFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVR 967
+ G N + MD +
Sbjct: 266 PYPGIPVDANFYKLIQNGFKMDQPF---------------------------YATEEIYI 298
Query: 968 IGVACSMESPEDRMSMTNV 986
I +C R S N+
Sbjct: 299 IMQSCWAFDSRKRPSFPNL 317
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 1e-44
Identities = 58/311 (18%), Positives = 105/311 (33%), Gaps = 54/311 (17%)
Query: 681 QNLYNATDRFSSVN-QIGEGSFGSVFKGIL--DDGRTTIAVKVFNL-LHHGAFKSFIAEC 736
+ L+ D + ++G G+FGSV +G+ + +A+KV + + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 737 NTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRS 796
+ + + +V+++ C LV E L ++L
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAEAL------MLVMEMAGGGPLHKFLV---------GKREE 105
Query: 797 LNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFL-PL 855
+ + + V+ + YL H DL N+LL A I DFGL++ L
Sbjct: 106 IPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162
Query: 856 SSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNL 915
S T+ K + + APE + S DV+SYG+ + E ++ + ++ M
Sbjct: 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP---YKK-MKG 218
Query: 916 HNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSME 975
+ M+ EC + + C +
Sbjct: 219 PEVMAFIEQGKRMECPP---------------------------ECPPELYALMSDCWIY 251
Query: 976 SPEDRMSMTNV 986
EDR V
Sbjct: 252 KWEDRPDFLTV 262
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 161 bits (407), Expect = 1e-44
Identities = 67/299 (22%), Positives = 122/299 (40%), Gaps = 49/299 (16%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNL 747
+ +++G G +G V++G+ T+AVK + F+ E +K I+H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNL 75
Query: 748 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISI 807
V++L C ++ EFM +L ++L R + ++ + L ++
Sbjct: 76 VQLLGVC-----TREPPFYIITEFMTYGNLLDYLRECNR--------QEVSAVVLLYMAT 122
Query: 808 DVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKG 867
++ A+ YL + H DL N L+ E+ + + DFGL+R + T+ GAK
Sbjct: 123 QISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKF 178
Query: 868 SIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHV 927
I + APE ++ SI DV+++G+LL E+ T ++L + D+
Sbjct: 179 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS----PYPGIDLSQVYELLEKDYR 234
Query: 928 MDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986
M+ + C + + AC +P DR S +
Sbjct: 235 MERPE---------------------------GCPEKVYELMRACWQWNPSDRPSFAEI 266
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 3e-44
Identities = 63/299 (21%), Positives = 111/299 (37%), Gaps = 51/299 (17%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNL 747
+ V +IG G FG V G + +A+K + FI E + + H L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSE-EDFIEEAEVMMKLSHPKL 62
Query: 748 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISI 807
V++ C LVFEFM + L ++L + L + +
Sbjct: 63 VQLYGVC-----LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE---------TLLGMCL 108
Query: 808 DVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKG 867
DV + + + + H DL N L+ E+ + + DFG+ RF+ TSS G K
Sbjct: 109 DVCEGM---AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKF 164
Query: 868 SIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHV 927
+ + +PE S S DV+S+G+L+ E+ + K + + +
Sbjct: 165 PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI----PYENRSNSEVVE------- 213
Query: 928 MDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986
I G + + + + +++ C E PEDR + + +
Sbjct: 214 --------------DISTGFRLYKPRLASTHVYQIMNH------CWKERPEDRPAFSRL 252
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 3e-44
Identities = 63/299 (21%), Positives = 105/299 (35%), Gaps = 53/299 (17%)
Query: 694 NQIGEGSFGSVFKGILDDGRTT---IAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVK 749
IG G FG V+ G L D AVK N + G F+ E +K+ H N++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 750 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDV 809
+L C + +V +M + L ++ + + + + V
Sbjct: 93 LLGIC----LRSEGSPLVVLPYMKHGDLRNFIRN---------ETHNPTVKDLIGFGLQV 139
Query: 810 ACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQ--TSSIGAKG 867
A + H DL N +LDE + DFGLAR + + GAK
Sbjct: 140 AKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 196
Query: 868 SIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHV 927
+ ++A E + + DV+S+G+LL EL+TR P D+N ++ L
Sbjct: 197 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVYLLQGRR 252
Query: 928 MDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986
+ + C + + + C E R S + +
Sbjct: 253 LLQPE---------------------------YCPDPLYEVMLKCWHPKAEMRPSFSEL 284
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 1e-43
Identities = 56/266 (21%), Positives = 100/266 (37%), Gaps = 38/266 (14%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFN---LLHHGAFKSFIAECNTLKNIRH 744
+ F +G+G FG+V+ + +A+KV L G E ++RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 745 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLN 804
N++++ L+ E+ ++ L +++ DE +
Sbjct: 66 PNILRLYGYF-----HDATRVYLILEYAPLGTVYRELQKLSKFDEQ----------RTAT 110
Query: 805 ISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIG 864
++A AL+Y H + H D+KP N+LL I DFG + P S T
Sbjct: 111 YITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL--- 164
Query: 865 AKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTA-- 922
G++ Y+ PE G D++S G+L E + K P FE + R +
Sbjct: 165 -CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRV 219
Query: 923 -------LPDHVMDIVDSTLLNDGED 941
+ + D++ L ++
Sbjct: 220 EFTFPDFVTEGARDLISRLLKHNPSQ 245
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 2e-43
Identities = 58/298 (19%), Positives = 104/298 (34%), Gaps = 55/298 (18%)
Query: 694 NQIGEGSFGSVFKGILDDGRT--TIAVKVFN--LLHHGAFKSFIAECNTLKNIRHRNLVK 749
++G G+FG+V KG + T+AVK+ +AE N ++ + + +V+
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 750 ILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDV 809
++ C + LV E L ++L R + + + V
Sbjct: 73 MIGICE------AESWMLVMEMAELGPLNKYLQQ----------NRHVKDKNIIELVHQV 116
Query: 810 ACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLS-SAQTSSIGAKGS 868
+ + YL H DL N+LL A I DFGL++ L + + K
Sbjct: 117 SMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 173
Query: 869 IGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHVM 928
+ + APE + S DV+S+G+L+ E + + + G V
Sbjct: 174 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK---PYRGMK----------GSEVT 220
Query: 929 DIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986
++ ++ R+ C M + C E+R V
Sbjct: 221 AML------------------EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAV 260
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 2e-43
Identities = 64/322 (19%), Positives = 118/322 (36%), Gaps = 59/322 (18%)
Query: 675 FPNISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL---LHHGAFKS 731
+P + + + + IGEG+FG V K + + + + +
Sbjct: 4 YPVLDW-------NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 56
Query: 732 FIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDE- 789
F E L + H N++ +L AC + + L E+ + +L ++L +
Sbjct: 57 FAGELEVLCKLGHHPNIINLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETD 111
Query: 790 -----TDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844
+ +L+ Q L+ + DVA ++YL Q H DL NIL+ E+ +A I
Sbjct: 112 PAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKI 168
Query: 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
DFGL+R + +T + + ++A E S + + DV+SYG+LL E+++
Sbjct: 169 ADFGLSRGQEVYVKKTMG---RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 225
Query: 905 TDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLIS 964
M L + ++ C
Sbjct: 226 ----PYCGMTCAELYEKLPQGYRLEKPL---------------------------NCDDE 254
Query: 965 MVRIGVACSMESPEDRMSMTNV 986
+ + C E P +R S +
Sbjct: 255 VYDLMRQCWREKPYERPSFAQI 276
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 3e-43
Identities = 55/252 (21%), Positives = 96/252 (38%), Gaps = 20/252 (7%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRN 746
+ + V +GEG++G V + +AVK+ ++ ++ E K + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 747 LVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNIS 806
+VK + + + L E+ L + + P +
Sbjct: 65 VVKFYGHR-----REGNIQYLFLEYCSGGELFDRIEP----------DIGMPEPDAQRFF 109
Query: 807 IDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAK 866
+ + YLH I H D+KP N+LLDE I DFGLA ++ +
Sbjct: 110 HQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 166
Query: 867 GSIGYIAPEYGLGSEV-SISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPD 925
G++ Y+APE E + DV+S GI+L ++ + P D + +
Sbjct: 167 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 226
Query: 926 HVMDIVDSTLLN 937
+ +DS L
Sbjct: 227 NPWKKIDSAPLA 238
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 3e-43
Identities = 55/305 (18%), Positives = 118/305 (38%), Gaps = 54/305 (17%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDG----RTTIAVKVFNL-LHHGAFKSFIAECNTLKNI 742
+ IG G FG V+KG+L +A+K F+ E +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 743 RHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQR 802
H N++++ ++ E+M N +L+++L E +++Q
Sbjct: 67 SHHNIIRLEGVI-----SKYKPMMIITEYMENGALDKFLR---------EKDGEFSVLQL 112
Query: 803 LNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQT-S 861
+ + +A + + H DL NIL++ +++ + DFGL+R L T +
Sbjct: 113 VGMLRGIAAGM---KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 169
Query: 862 SIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLART 921
+ G K I + APE + + + DV+S+GI++ E++T + +++
Sbjct: 170 TSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER----PYWELS------- 218
Query: 922 ALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRM 981
VM ++ R+ + ++C ++ ++ + C + R
Sbjct: 219 --NHEVMKAINDGF------------------RLPTPMDCPSAIYQLMMQCWQQERARRP 258
Query: 982 SMTNV 986
++
Sbjct: 259 KFADI 263
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 5e-43
Identities = 52/265 (19%), Positives = 104/265 (39%), Gaps = 25/265 (9%)
Query: 679 SYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNT 738
S ++ + +++ +IG+G+ G+V+ + +A++ NL + I E
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 739 LKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLN 798
++ ++ N+V L + D +V E++ SL + + ++
Sbjct: 71 MRENKNPNIVNYLDSY-----LVGDELWVVMEYLAGGSLTDVVTETCMDEG--------- 116
Query: 799 LIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSA 858
Q + + AL +LH + H D+K NILL D + DFG + +
Sbjct: 117 --QIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171
Query: 859 QTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNL 918
+ S++ G+ ++APE D++S GI+ +E+I + P + + L L
Sbjct: 172 KRSTM--VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP----YLNENPLRAL 225
Query: 919 ARTALPDHVMDIVDSTLLNDGEDLI 943
A L D +
Sbjct: 226 YLIATNGTPELQNPEKLSAIFRDFL 250
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 8e-43
Identities = 60/299 (20%), Positives = 110/299 (36%), Gaps = 51/299 (17%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNL 747
+ + ++G G FG V G +A+K+ FI E + N+ H L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKL 61
Query: 748 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISI 807
V++ C ++ E+M N L +L Q L +
Sbjct: 62 VQLYGVC-----TKQRPIFIITEYMANGCLLNYLRE---------MRHRFQTQQLLEMCK 107
Query: 808 DVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKG 867
DV A+ YL H DL N L+++ + + DFGL+R++ TSS+G+K
Sbjct: 108 DVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKF 163
Query: 868 SIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHV 927
+ + PE + S+ S D++++G+L+ E+ + K +E N
Sbjct: 164 PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP---YERFTNSETA--------- 211
Query: 928 MDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986
+ I G + R ++ ++ C E ++R + +
Sbjct: 212 -------------EHIAQGLRLYRPHLASEKVYTIMYS------CWHEKADERPTFKIL 251
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (394), Expect = 1e-42
Identities = 55/263 (20%), Positives = 95/263 (36%), Gaps = 35/263 (13%)
Query: 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL---LHHGAFKSFIAECNTLKNIR 743
FS + +IG GSFG+V+ +A+K + + ++ I E L+ +R
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 744 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRL 803
H N ++ LV E+ + + + L ++
Sbjct: 74 HPNTIQYRGCY-----LREHTAWLVMEYCLGSASDLLEV----------HKKPLQEVEIA 118
Query: 804 NISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSI 863
++ L YLH + H D+K NILL E + +GDFG A + +
Sbjct: 119 AVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APAN 169
Query: 864 GAKGSIGYIAPEYGLGS---EVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLAR 920
G+ ++APE L + DV+S GI +EL RK P +MN +
Sbjct: 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-----NMNAMSALY 224
Query: 921 TALPDHVMDIVDSTLLNDGEDLI 943
+ + + +
Sbjct: 225 HIAQNESPALQSGHWSEYFRNFV 247
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 3e-42
Identities = 69/314 (21%), Positives = 107/314 (34%), Gaps = 53/314 (16%)
Query: 688 DRFSSVNQIGEGSFGSVFKGIL-----DDGRTTIAVKVFNLLHH-GAFKSFIAECNTLKN 741
+R S +G G+FG V + D T+AVK+ H ++ ++E L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 742 I-RHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLH--------PITREDETDE 792
+ H N+V +L AC ++ E+ L +L T ++
Sbjct: 83 LGNHMNIVNLLGAC-----TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 793 APRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARF 852
+L+L L+ S VA + +L H DL NILL I I DFGLAR
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARD 194
Query: 853 LPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGD 912
+ S A+ + ++APE + DV+SYGI L EL + D
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254
Query: 913 MNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVAC 972
+ + + R+ S M I C
Sbjct: 255 SKFYKMIKEGF------------------------------RMLSPEHAPAEMYDIMKTC 284
Query: 973 SMESPEDRMSMTNV 986
P R + +
Sbjct: 285 WDADPLKRPTFKQI 298
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 1e-41
Identities = 53/228 (23%), Positives = 86/228 (37%), Gaps = 25/228 (10%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFN---LLHHGAFKSFIAECNTLKNIRH 744
+ F +GEGSF +V A+K+ ++ E + + + H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 745 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLN 804
VK+ Q ++ + N L +++ I DET
Sbjct: 68 PFFVKLYFTF-----QDDEKLYFGLSYAKNGELLKYIRKIGSFDETC------------- 109
Query: 805 ISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIG 864
A ++ L + I H DLKP NILL+EDM I DFG A+ L S Q +
Sbjct: 110 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS 169
Query: 865 AKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGD 912
G+ Y++PE S D+++ G ++ +L+ P F
Sbjct: 170 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAG 213
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 2e-41
Identities = 55/305 (18%), Positives = 118/305 (38%), Gaps = 45/305 (14%)
Query: 688 DRFSSVNQIGEGSFGSVFKGIL-----DDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKN 741
++ + ++G+GSFG V++G+ D+ T +A+K N F+ E + +K
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 742 IRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQ 801
++V++L ++ E M L+ +L + + +L +
Sbjct: 80 FNCHHVVRLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134
Query: 802 RLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTS 861
+ ++ ++A + YL+ H DL N ++ ED IGDFG+ R + +
Sbjct: 135 MIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 191
Query: 862 SIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLART 921
+ +++PE + DV+S+G++L E+ T + ++G ++ + R
Sbjct: 192 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP---YQG-LSNEQVLRF 247
Query: 922 ALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRM 981
+ ++D D C + + C +P+ R
Sbjct: 248 VMEGGLLDKPD---------------------------NCPDMLFELMRMCWQYNPKMRP 280
Query: 982 SMTNV 986
S +
Sbjct: 281 SFLEI 285
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 7e-41
Identities = 63/307 (20%), Positives = 115/307 (37%), Gaps = 55/307 (17%)
Query: 685 NATDRFSSVNQIGEGSFGSVFKGI-LDDGRTT---IAVKVFNLLHHG-AFKSFIAECNTL 739
T+ F + +G G+FG+V+KG+ + +G +A+K A K + E +
Sbjct: 7 KETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 740 KNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNL 799
++ + ++ ++L C L+ + M L +++ E ++
Sbjct: 66 ASVDNPHVCRLLGICL------TSTVQLITQLMPFGCLLDYVR---------EHKDNIGS 110
Query: 800 IQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQ 859
LN + +A +NYL + H DL N+L+ I DFGLA+ L +
Sbjct: 111 QYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 167
Query: 860 TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLA 919
+ G K I ++A E L + DV+SYG+ + EL+T ++G
Sbjct: 168 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK---PYDGIPA----- 219
Query: 920 RTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPED 979
+ I++ R+ C I + I V C M +
Sbjct: 220 -----SEISSILEKGE------------------RLPQPPICTIDVYMIMVKCWMIDADS 256
Query: 980 RMSMTNV 986
R +
Sbjct: 257 RPKFREL 263
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 150 bits (379), Expect = 3e-40
Identities = 54/259 (20%), Positives = 96/259 (37%), Gaps = 31/259 (11%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNL 747
D + ++G G+FG V + A K H ++ E T+ +RH L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 748 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISI 807
V + A + ++ +++EFM L E + + ++ + +
Sbjct: 86 VNLHDAF-----EDDNEMVMIYEFMSGGELFEKVA---------DEHNKMSEDEAVEYMR 131
Query: 808 DVACALNYLHHDCQPPIAHCDLKPSNILL--DEDMIAHIGDFGLARFLPLSSAQTSSIGA 865
V L ++H + H DLKP NI+ + DFGL L + S
Sbjct: 132 QVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVT 185
Query: 866 KGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP---------TDIMFEGDMNLH 916
G+ + APE G V D++S G+L L++ P + D N+
Sbjct: 186 TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD 245
Query: 917 NLARTALPDHVMDIVDSTL 935
+ A + + + D + L
Sbjct: 246 DSAFSGISEDGKDFIRKLL 264
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-39
Identities = 67/306 (21%), Positives = 105/306 (34%), Gaps = 55/306 (17%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILD--DGRTT-IAVKVFN---LLHHGAFKSFIAECNTLKN 741
+ ++G+GSFG V +G D G+T +AVK L A FI E N + +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 742 IRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQ 801
+ HRNL+++ +V E SL + L + L
Sbjct: 68 LDHRNLIRLYGVVL------TPPMKMVTELAPLGSLLDRLR---------KHQGHFLLGT 112
Query: 802 RLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQ-T 860
++ VA + YL H DL N+LL + IGDFGL R LP +
Sbjct: 113 LSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV 169
Query: 861 SSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLAR 920
K + APE S + D + +G+ L E+ T + + G L +
Sbjct: 170 MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE---PWIGLNGSQILHK 226
Query: 921 TALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDR 980
+ + +C + + V C PEDR
Sbjct: 227 IDKEGERLPRPE---------------------------DCPQDIYNVMVQCWAHKPEDR 259
Query: 981 MSMTNV 986
+ +
Sbjct: 260 PTFVAL 265
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 2e-38
Identities = 65/311 (20%), Positives = 102/311 (32%), Gaps = 48/311 (15%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGR-----TTIAVKVFNL-LHHGAFKSFIAECNTLKN 741
DR +G G+FG V + T+AVK+ H ++ ++E L +
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 742 IRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLH------PITREDETDEAPR 795
I H V L G + ++ EF +L +L + D
Sbjct: 73 IGHHLNVVNLL---GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 796 SLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPL 855
L L + S VA + +L H DL NILL E + I DFGLAR +
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186
Query: 856 SSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNL 915
A+ + ++APE +I DV+S+G+LL E+ + + G
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS---PYPGVKID 243
Query: 916 HNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSME 975
R M D M + + C
Sbjct: 244 EEFCRRLKEGTRMRAPD---------------------------YTTPEMYQTMLDCWHG 276
Query: 976 SPEDRMSMTNV 986
P R + + +
Sbjct: 277 EPSQRPTFSEL 287
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 141 bits (356), Expect = 6e-38
Identities = 62/287 (21%), Positives = 111/287 (38%), Gaps = 23/287 (8%)
Query: 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFN---LLHHGAFKSFIAECNTLKNIR 743
+DR+ +G G V +AVKV + F E +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 744 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRL 803
H +V + G +V E++ +L + +H + + +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLP-YIVMEYVDGVTLRDIVHT----------EGPMTPKRAI 114
Query: 804 NISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLS-SAQTSS 862
+ D ALN+ Q I H D+KP+NI++ + DFG+AR + S ++ T +
Sbjct: 115 EVIADACQALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 171
Query: 863 IGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTA 922
G+ Y++PE G V DVYS G +L E++T + P F GD + +
Sbjct: 172 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHV 227
Query: 923 LPDHVMDI-VDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRI 968
D + L D + +++ + + R ++ E +VR+
Sbjct: 228 REDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 7e-38
Identities = 57/303 (18%), Positives = 110/303 (36%), Gaps = 54/303 (17%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTT---IAVKVFNLLHHGAFKS-FIAECNTLKNIR 743
+R IGEG FG V +GI +A+K + + F+ E T++
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 744 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRL 803
H ++VK++ + + ++ E L +L SL+L +
Sbjct: 67 HPHIVKLIGVIT------ENPVWIIMELCTLGELRSFLQ---------VRKYSLDLASLI 111
Query: 804 NISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSI 863
+ ++ AL YL H D+ N+L+ + +GDFGL+R++ S+ +S
Sbjct: 112 LYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 168
Query: 864 GAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTAL 923
G K I ++APE + + DV+ +G+ + E++ + +++
Sbjct: 169 G-KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK----PFQGVKNNDVIG--- 220
Query: 924 PDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSM 983
I +G + + L++ C P R
Sbjct: 221 ------------------RIENGERLPMPPNCPPTLYSLMTK------CWAYDPSRRPRF 256
Query: 984 TNV 986
T +
Sbjct: 257 TEL 259
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 5e-37
Identities = 63/306 (20%), Positives = 110/306 (35%), Gaps = 22/306 (7%)
Query: 682 NLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH-GAFKSFIAECNTLK 740
+++ R+++++ IGEG++G V + + +A+K + H + + E L
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 741 NIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLI 800
RH N++ I + LV M L + L + L+
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLLKT-----------QHLSND 109
Query: 801 QRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQT 860
+ L Y+H + H DLKPSN+LL+ I DFGLAR T
Sbjct: 110 HICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 166
Query: 861 SSIGAK-GSIGYIAPEYGLGSEVSI-SGDVYSYGILLLELITRKKPTDIMFEGDMNLHNL 918
+ + Y APE L S+ S D++S G +L E+++ + D H L
Sbjct: 167 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 226
Query: 919 ARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRI-ECLISMVRIGVACSMESP 977
P L L + + R+ + ++ +P
Sbjct: 227 GILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLD---KMLTFNP 283
Query: 978 EDRMSM 983
R+ +
Sbjct: 284 HKRIEV 289
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 7e-37
Identities = 63/314 (20%), Positives = 109/314 (34%), Gaps = 54/314 (17%)
Query: 688 DRFSSVNQIGEGSFGSVFKGIL-------DDGRTTIAVKVFNL-LHHGAFKSFIAECNTL 739
DR +GEG+FG V + T +AVK+ I+E +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 740 KNI-RHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHP------ITREDETDE 792
K I +H+N++ +L AC + ++ E+ +L E+L + +
Sbjct: 73 KMIGKHKNIINLLGAC-----TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 127
Query: 793 APRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARF 852
L+ ++ + VA + YL H DL N+L+ ED + I DFGLAR
Sbjct: 128 PEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARD 184
Query: 853 LPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGD 912
+ + + + ++APE + DV+S+G+LL E+ T
Sbjct: 185 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS----PYPG 240
Query: 913 MNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVAC 972
+ + L + H MD C + + C
Sbjct: 241 VPVEELFKLLKEGHRMDKPS---------------------------NCTNELYMMMRDC 273
Query: 973 SMESPEDRMSMTNV 986
P R + +
Sbjct: 274 WHAVPSQRPTFKQL 287
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 138 bits (349), Expect = 2e-36
Identities = 46/235 (19%), Positives = 87/235 (37%), Gaps = 26/235 (11%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNL 747
D + + ++G G+FG V + + K N + + E + + + H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 748 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISI 807
+ + A + L+ EF+ L + + ++ + +N
Sbjct: 89 INLHDAF-----EDKYEMVLILEFLSGGELFDRIA---------AEDYKMSEAEVINYMR 134
Query: 808 DVACALNYLHHDCQPPIAHCDLKPSNILLD--EDMIAHIGDFGLARFLPLSSAQTSSIGA 865
L ++H + I H D+KP NI+ + + I DFGLA L +
Sbjct: 135 QACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL---NPDEIVKVT 188
Query: 866 KGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLAR 920
+ + APE V D+++ G+L L++ P F G+ +L L
Sbjct: 189 TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP----FAGEDDLETLQN 239
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (339), Expect = 2e-35
Identities = 67/307 (21%), Positives = 109/307 (35%), Gaps = 27/307 (8%)
Query: 686 ATDRFSSVNQIGEGSFGSVFKGI-LDDGRTTIAVKVFNLLH-----HGAFKSFIAECNTL 739
A ++ V +IGEG++G VFK L +G +A+K + + +A L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 740 KNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNL 799
+ H N+V++ C+ LVFE + +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK---------VPEPGVPT 115
Query: 800 IQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQ 859
++ + L++LH + H DLKP NIL+ + DFGLAR A
Sbjct: 116 ETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL 172
Query: 860 TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLA 919
TS + ++ Y APE L S + D++S G + E+ RK + D L
Sbjct: 173 TSVV---VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 229
Query: 920 RTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPED 979
LP D L + + + L+ C +P
Sbjct: 230 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLL------KCLTFNPAK 283
Query: 980 RMSMTNV 986
R+S +
Sbjct: 284 RISAYSA 290
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 132 bits (334), Expect = 5e-35
Identities = 59/279 (21%), Positives = 105/279 (37%), Gaps = 46/279 (16%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAF---------KSFIAECNT 738
+ + +G G V + I AVK+ ++ G+F ++ + E +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 739 LKNIR-HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSL 797
L+ + H N++++ + N F LVF+ M L ++L +L
Sbjct: 63 LRKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLT----------EKVTL 107
Query: 798 NLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSS 857
+ + I + + LH + I H DLKP NILLD+DM + DFG + L
Sbjct: 108 SEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE 164
Query: 858 AQTSSIGAKGSIGYIAPEYGLGSEVSISG------DVYSYGILLLELITRKKP------- 904
G+ Y+APE S D++S G+++ L+ P
Sbjct: 165 KLREVC---GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM 221
Query: 905 --TDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGED 941
++ G+ + D V D+V L+ +
Sbjct: 222 LMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQK 260
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 134 bits (337), Expect = 5e-35
Identities = 49/220 (22%), Positives = 80/220 (36%), Gaps = 26/220 (11%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFN---LLHHGAFKSFIAECNTLKNIRH 744
F + +G GSFG V A+KV ++ + E L + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 745 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLN 804
++++ Q ++ +++ L L R
Sbjct: 64 PFIIRMWGTF-----QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPV------------- 105
Query: 805 ISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIG 864
A L + I + DLKP NILLD++ I DFG A+++P +
Sbjct: 106 AKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYT 160
Query: 865 AKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
G+ YIAPE + S D +S+GIL+ E++ P
Sbjct: 161 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 200
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 133 bits (336), Expect = 6e-35
Identities = 46/266 (17%), Positives = 87/266 (32%), Gaps = 28/266 (10%)
Query: 680 YQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL-LHHGAFKSFIAECNT 738
++ + D + + +G G+F V + +A+K G S E
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 739 LKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLN 798
L I+H N+V + + L+ + + L + +
Sbjct: 61 LHKIKHPNIVALDDIY-----ESGGHLYLIMQLVSGGELFDRIV----------EKGFYT 105
Query: 799 LIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSA 858
+ V A+ YLH LDED I DFGL++ S
Sbjct: 106 ERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV 165
Query: 859 QTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPT---------DIMF 909
+++ G+ GY+APE S + D +S G++ L+ P + +
Sbjct: 166 LSTAC---GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQIL 222
Query: 910 EGDMNLHNLARTALPDHVMDIVDSTL 935
+ + + + D D + +
Sbjct: 223 KAEYEFDSPYWDDISDSAKDFIRHLM 248
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 1e-34
Identities = 66/279 (23%), Positives = 112/279 (40%), Gaps = 31/279 (11%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFN---LLHHGAFKSFIAECNTL-KNIR 743
+ F +G+GSFG VF A+K +L + + E L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 744 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRL 803
H L + Q + V E+++ L + + +L +
Sbjct: 62 HPFLTHMFCTF-----QTKENLFFVMEYLNGGDLMYHIQ----------SCHKFDLSRAT 106
Query: 804 NISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSI 863
+ ++ L +L I + DLK NILLD+D I DFG+ + L A+T++
Sbjct: 107 FYAAEIILGLQFL---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF 163
Query: 864 GAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTAL 923
G+ YIAPE LG + + S D +S+G+LL E++ + P F G + L +
Sbjct: 164 --CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP----FHGQ-DEEELFHSIR 216
Query: 924 PDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECL 962
D+ L + +DL+V R+ + R+ R +
Sbjct: 217 MDNPF--YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 253
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 1e-34
Identities = 63/313 (20%), Positives = 126/313 (40%), Gaps = 34/313 (10%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL--LHHGAFKSFIAECNTLKNIRHR 745
++ + +IG+G+FG VFK +A+K + G + + E L+ ++H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 746 NLVKILTACSGVDYQGNDFKA---LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQR 802
N+V ++ C N K LVF+F + + + + ++ I+R
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE--------IKR 121
Query: 803 LNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLS--SAQT 860
+ + LN L++ + I H D+K +N+L+ D + + DFGLAR L+ S
Sbjct: 122 V-----MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 176
Query: 861 SSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLA 919
++ Y PE LG + D++ G ++ E+ TR +G+ H LA
Sbjct: 177 RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI----MQGNTEQHQLA 232
Query: 920 R------TALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACS 973
+ P+ ++ + L E + + + + + R + ++
Sbjct: 233 LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLID---KLL 289
Query: 974 MESPEDRMSMTNV 986
+ P R+ +
Sbjct: 290 VLDPAQRIDSDDA 302
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 1e-34
Identities = 54/265 (20%), Positives = 99/265 (37%), Gaps = 32/265 (12%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNL 747
+++ +G G FG V + + + T K + E + L RHRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNI 63
Query: 748 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISI 807
+ + + + + ++FEF+ + E ++ + LN + ++
Sbjct: 64 LHLHESF-----ESMEELVMIFEFISGLDIFERIN---------TSAFELNEREIVSYVH 109
Query: 808 DVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH--IGDFGLARFLPLSSAQTSSIGA 865
V AL +LH I H D++P NI+ + I +FG AR L
Sbjct: 110 QVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF-- 164
Query: 866 KGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP---------TDIMFEGDMNLH 916
+ Y APE VS + D++S G L+ L++ P + + +
Sbjct: 165 -TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD 223
Query: 917 NLARTALPDHVMDIVDSTLLNDGED 941
A + MD VD L+ + +
Sbjct: 224 EEAFKEISIEAMDFVDRLLVKERKS 248
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 130 bits (328), Expect = 3e-34
Identities = 62/302 (20%), Positives = 115/302 (38%), Gaps = 28/302 (9%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL--LHHGAFKSFIAECNTLKNIRHR 745
+++ + +IGEG++G V+K + G T A+K L G + I E + LK ++H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGET-FALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 746 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNI 805
N+VK+ LVFE + + +
Sbjct: 61 NIVKLYDVI-----HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVT-------------A 102
Query: 806 SIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGA 865
+ LN + + + H DLKP N+L++ + I DFGLAR + + +
Sbjct: 103 KSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV 162
Query: 866 KGSIGYIAPEYGLGSE-VSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALP 924
+ Y AP+ +GS+ S + D++S G + E++ + E D L + R
Sbjct: 163 T--LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILGT 219
Query: 925 DHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMT 984
+ + + T L + ++ +K E I ++ P R++
Sbjct: 220 PNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLS---KMLKLDPNQRITAK 276
Query: 985 NV 986
Sbjct: 277 QA 278
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 132 bits (333), Expect = 5e-34
Identities = 54/263 (20%), Positives = 86/263 (32%), Gaps = 33/263 (12%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH------HGAFKSFIAECNTLKN 741
+ FS IG G FG V+ D A+K + + + +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 742 IRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQ 801
+V + A D + + + M+ L L E
Sbjct: 64 GDCPFIVCMSYAF-----HTPDKLSFILDLMNGGDLHYHLSQHGVFSEA----------D 108
Query: 802 RLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTS 861
+ ++ L ++H + + DLKP+NILLDE I D GLA S
Sbjct: 109 MRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 165
Query: 862 SIGAKGSIGYIAPEYGL-GSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLAR 920
G+ GY+APE G S D +S G +L +L+ P D + +
Sbjct: 166 ----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 221
Query: 921 TALPDHVMDIVDSTLLNDGEDLI 943
+ + D L L+
Sbjct: 222 LTMAVELPDSFSPEL----RSLL 240
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 4e-33
Identities = 65/301 (21%), Positives = 111/301 (36%), Gaps = 35/301 (11%)
Query: 694 NQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-----HGAFKSFIAECNTLKNIRHRNLV 748
+ +GEG F +V+K + +A+K L H G ++ + E L+ + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 749 KILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISID 808
+L A +LVF+FM + I
Sbjct: 64 GLLDAF-----GHKSNISLVFDFMETDLEVIIKDNSLVLTPSH-------------IKAY 105
Query: 809 VACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGS 868
+ L L + Q I H DLKP+N+LLDE+ + + DFGLA+ S + +
Sbjct: 106 MLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS--FGSPNRAYTHQVVT 163
Query: 869 IGYIAPEYGLGSEV-SISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHV 927
Y APE G+ + + D+++ G +L EL+ R GD +L L R
Sbjct: 164 RWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF----LPGDSDLDQLTRIF---ET 216
Query: 928 MDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSM--ESPEDRMSMTN 985
+ D L + + I + + + +P R++ T
Sbjct: 217 LGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQ 276
Query: 986 V 986
Sbjct: 277 A 277
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 5e-33
Identities = 58/236 (24%), Positives = 99/236 (41%), Gaps = 24/236 (10%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNL 747
++ IG GSFG V++ L D +A+K + E ++ + H N+
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNI 75
Query: 748 VKILTAC-SGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNIS 806
V++ S + + + LV +++ H + ++L +I
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-------QTLPVIYVKLYM 128
Query: 807 IDVACALNYLHHDCQPPIAHCDLKPSNILLDED-MIAHIGDFGLARFLPLSSAQTSSIGA 865
+ +L Y+H I H D+KP N+LLD D + + DFG A+ L S I +
Sbjct: 129 YQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 185
Query: 866 KGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLAR 920
+ Y APE G+ + + S DV+S G +L EL+ + F GD + L
Sbjct: 186 R---YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI----FPGDSGVDQLVE 234
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 2e-32
Identities = 58/301 (19%), Positives = 104/301 (34%), Gaps = 24/301 (7%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL--LHHGAFKSFIAECNTLKNIRHR 745
++ + +IGEG++G+VFK + +A+K L G S + E LK ++H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 746 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNI 805
N+V++ + LVFEF + + D +
Sbjct: 62 NIVRLHDVL-----HSDKKLTLVFEFCDQDLKKYFDSCNGDLDPE----------IVKSF 106
Query: 806 SIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGA 865
+ L + H + H DLKP N+L++ + + +FGLAR + + S
Sbjct: 107 LFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCYSAEV 162
Query: 866 KGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPD 925
S S D++S G + EL +P + D L + R
Sbjct: 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP 222
Query: 926 HVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTN 985
T L D + ++ V +++ +P R+S
Sbjct: 223 TEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQ---NLLKCNPVQRISAEE 279
Query: 986 V 986
Sbjct: 280 A 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 4e-32
Identities = 70/302 (23%), Positives = 111/302 (36%), Gaps = 26/302 (8%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNL--LHHGAFKSFIAECNTLKNIRHR 745
+ F V +IGEG++G V+K +A+K L G + I E + LK + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 746 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNI 805
N+VK+L + LVFEF+H + +
Sbjct: 62 NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLI---------KSY 107
Query: 806 SIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGA 865
+ L + H + H DLKP N+L++ + + DFGLAR + +
Sbjct: 108 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV- 163
Query: 866 KGSIGYIAPEYGLGSE-VSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALP 924
++ Y APE LG + S + D++S G + E++TR+ F GD + L R
Sbjct: 164 -VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL----FPGDSEIDQLFRIFRT 218
Query: 925 DHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMT 984
D V + D + RQ K + P R+S
Sbjct: 219 LGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAK 278
Query: 985 NV 986
Sbjct: 279 AA 280
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 7e-32
Identities = 53/246 (21%), Positives = 91/246 (36%), Gaps = 35/246 (14%)
Query: 685 NATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH------HGAFKSFIAECNT 738
N D + + ++G G F V K A K + + E +
Sbjct: 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66
Query: 739 LKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLN 798
LK I+H N++ + + L+ E + L ++L SL
Sbjct: 67 LKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLA----------EKESLT 111
Query: 799 LIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA----HIGDFGLARFLP 854
+ + LN +++ IAH DLKP NI+L + + I DFGLA +
Sbjct: 112 EEEATEF---LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168
Query: 855 LSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMN 914
+ + G+ ++APE + + D++S G++ L++ P F GD
Sbjct: 169 FGNEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTK 221
Query: 915 LHNLAR 920
LA
Sbjct: 222 QETLAN 227
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 123 bits (310), Expect = 1e-31
Identities = 44/234 (18%), Positives = 81/234 (34%), Gaps = 27/234 (11%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNL 747
+R+ +IG GSFG ++ G +A+K+ + E K ++
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVG 64
Query: 748 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISI 807
+ + C D+ +V E + + + R +L L ++
Sbjct: 65 IPTIRWC----GAEGDYNVMVMELLGPSLEDLFNFC----------SRKFSLKTVLLLAD 110
Query: 808 DVACALNYLHHDCQPPIAHCDLKPSNIL---LDEDMIAHIGDFGLARFLPLSSAQT---- 860
+ + Y+H H D+KP N L + + +I DFGLA+ +
Sbjct: 111 QMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY 167
Query: 861 -SSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDM 913
+ G+ Y + LG E S D+ S G +L+ P +
Sbjct: 168 RENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK 221
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 119 bits (300), Expect = 2e-30
Identities = 40/236 (16%), Positives = 77/236 (32%), Gaps = 29/236 (12%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNL 747
+ +IGEGSFG +F+G +A+K E T K +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 748 VKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISI 807
+ + Q LV + + + ED D R ++ +
Sbjct: 63 IPNVYYF----GQEGLHNVLVIDLLGP----------SLEDLLDLCGRKFSVKTVAMAAK 108
Query: 808 DVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG-----DFGLARFLPLSSAQTSS 862
+ + +H + + + D+KP N L+ + DFG+ +F +
Sbjct: 109 QMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHI 165
Query: 863 IGAK-----GSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDM 913
+ G+ Y++ LG E S D+ + G + + + P +
Sbjct: 166 PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN 221
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 119 bits (298), Expect = 4e-30
Identities = 82/341 (24%), Positives = 129/341 (37%), Gaps = 39/341 (11%)
Query: 18 NETDRLALLELKSKITHDPLGVLASWNESSHFCQ--WRGVTCSR--RHQRVTILDLESLK 73
N D+ ALL++K + + L+SW ++ C W GV C + RV LDL L
Sbjct: 4 NPQDKQALLQIKKDLGNPT--TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLN 61
Query: 74 LAG--SISPHVGNLSFLKVLRLYNN-SFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANI 130
L I + NL +L L + + IP +L +L L + + ++ GAIP +
Sbjct: 62 LPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFL 121
Query: 131 SSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLS 190
S L+ L +N L G +P +SSL + I+ + N ++G+IP S G+ S + +
Sbjct: 122 SQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTI 181
Query: 191 GNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDY 250
N NL + +++N L G + + N + +
Sbjct: 182 SRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVG 241
Query: 251 GFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGIL 310
N N++ G +P ++ L + S N L G P LQR V
Sbjct: 242 LSKNLNGLDLR--NNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYA 299
Query: 311 GNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPAC 351
N LC G LPAC
Sbjct: 300 NN----------KCLC------------------GSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 81.7 bits (200), Expect = 2e-17
Identities = 65/272 (23%), Positives = 113/272 (41%), Gaps = 32/272 (11%)
Query: 378 GKFVNLQRLDMCSNRLSG--TIPPAIGELQNLKDLRLQ--RNRFQGNIPPSIGNLKLFIL 433
+ + LD+ L IP ++ L L L + N P +L L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 434 YLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSI 493
Y+++ + G+IP L + +TL T+D S N L+GT+PP L + + + N+++G+I
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNL-VGITFDGNRISGAI 165
Query: 494 PSEVGNLKNLEI-LNVFGNKLKGEIPSTLGSCIKLEQL---------------------- 530
P G+ L + + N+L G+IP T +
Sbjct: 166 PDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQK 225
Query: 531 EMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVP 590
+ + L+ LDL N + G +P+ L +L+ + +LN+S N+L G +P
Sbjct: 226 IHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285
Query: 591 TQGVFKNASITSVFGNLKLCGGIPEFQLPTCS 622
G + +++ N LCG LP C+
Sbjct: 286 QGGNLQRFDVSAYANNKCLCG----SPLPACT 313
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 65.9 bits (159), Expect = 4e-12
Identities = 71/276 (25%), Positives = 112/276 (40%), Gaps = 13/276 (4%)
Query: 129 NISSCSNLIQLRLFHNQLVGK--IPSELSSLSKIEHISVNDN-NLTGSIPSSLGNLSSIR 185
+ + L L L IPS L++L + + + NL G IP ++ L+ +
Sbjct: 45 TDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLH 104
Query: 186 SLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGA 245
L+++ N+ G+IPD L +K LV L + N LSGT+P SI ++ ++ G N+I GA
Sbjct: 105 YLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGA 164
Query: 246 IPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLL 305
IP YG + ++ N+LTG IPPT L
Sbjct: 165 IPDSYGSFSKLFTSMTISRNRLTGKIPPTF-------ANLNLAFVDLSRNMLEGDASVLF 217
Query: 306 VFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLD 365
+ + L + + L L + N G+LP ++ L L L +
Sbjct: 218 GSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQL-KFLHSLNVS 276
Query: 366 NNQIFGNIPAAIGKFVNLQRLDMCSNR-LSGTIPPA 400
N + G IP G +N+ L G+ PA
Sbjct: 277 FNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPLPA 311
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 44.0 bits (102), Expect = 6e-05
Identities = 36/124 (29%), Positives = 51/124 (41%), Gaps = 2/124 (1%)
Query: 446 SSLGRYETLTTIDLSNNNLTGTIP-PQFIGLSSSLIVLDLSRN-QLTGSIPSEVGNLKNL 503
+ + + +DLS NL P P + L L + L G IP + L L
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 504 EILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSG 563
L + + G IP L L L+ N L G +P S+SSL L + N +SG
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 564 KIPE 567
IP+
Sbjct: 164 AIPD 167
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 8e-30
Identities = 46/222 (20%), Positives = 83/222 (37%), Gaps = 25/222 (11%)
Query: 688 DRFSSVNQ-IGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNI-RHR 745
D + +Q +G G G V + + A+K+ E +
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCP 65
Query: 746 NLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNI 805
++V+I+ + Y G +V E + L + D ++ + I
Sbjct: 66 HIVRIVDVYENL-YAGRKCLLIVMECLDGGELFSRIQ--------DRGDQAFTEREASEI 116
Query: 806 SIDVACALNYLHHDCQPPIAHCDLKPSNILLD---EDMIAHIGDFGLARFLPLSSAQTSS 862
+ A+ YLH IAH D+KP N+L + I + DFG A+ ++ S
Sbjct: 117 MKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET---TSHNSL 170
Query: 863 IGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
+ Y+APE + S D++S G+++ L+ P
Sbjct: 171 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 212
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 9e-30
Identities = 45/220 (20%), Positives = 83/220 (37%), Gaps = 23/220 (10%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFN---LLHHGAFKSFIAECNTLKNIRH 744
+ F + +G+G+FG V A+K+ ++ + E L+N RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 745 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLN 804
L + A Q +D V E+ + L L E
Sbjct: 65 PFLTALKYAF-----QTHDRLCFVMEYANGGELFFHLSRERVFTEER------------- 106
Query: 805 ISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIG 864
A ++ L + + + D+K N++LD+D I DFGL + A +
Sbjct: 107 ARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF- 165
Query: 865 AKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKP 904
G+ Y+APE ++ + D + G+++ E++ + P
Sbjct: 166 -CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 118 bits (297), Expect = 1e-29
Identities = 65/325 (20%), Positives = 127/325 (39%), Gaps = 33/325 (10%)
Query: 667 NPNSPINSFPNISYQNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH 726
N + P + S+ + D + V ++G G + VF+ I + VK+ +
Sbjct: 14 NTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK 73
Query: 727 GAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPIT 785
K E L+N+R N++ + + ALVFE ++N ++ +T
Sbjct: 74 ---KKIKREIKILENLRGGPNIITLADIV---KDPVSRTPALVFEHVNNTDFKQLYQTLT 127
Query: 786 REDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLD-EDMIAHI 844
D ++ AL+Y H I H D+KP N+++D E +
Sbjct: 128 DYD-------------IRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRL 171
Query: 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSE-VSISGDVYSYGILLLELITRKK 903
D+GLA F + S + PE + + S D++S G +L +I RK+
Sbjct: 172 IDWGLAEFYHPGQEYNVRV---ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 228
Query: 904 PTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLN---DGEDLIVHGNQRQRQARVKSRIE 960
P + L +A+ + + D +D + D++ ++++ + V S +
Sbjct: 229 PFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQ 288
Query: 961 CLISMVRIGVACSM--ESPEDRMSM 983
L+S + + + R++
Sbjct: 289 HLVSPEALDFLDKLLRYDHQSRLTA 313
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (290), Expect = 3e-29
Identities = 49/267 (18%), Positives = 83/267 (31%), Gaps = 38/267 (14%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAF------KSFIAECNTLKN 741
++ +G G FGSV+ GI +A+K + E LK
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 742 IR--HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNL 799
+ ++++L + D L+ E +L
Sbjct: 64 VSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFI---------TERGALQE 109
Query: 800 IQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED-MIAHIGDFGLARFLPLSSA 858
+ V A+ + + H D+K NIL+D + + DFG L +
Sbjct: 110 ELARSFFWQVLEAVRHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 166
Query: 859 QTSSIGAKGSIGYIAPEYGLGSEV-SISGDVYSYGILLLELITRKKPTDIMFEGD---MN 914
G+ Y PE+ S V+S GILL +++ P FE D +
Sbjct: 167 TDF----DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP----FEHDEEIIR 218
Query: 915 LHNLARTALPDHVMDIVDSTLLNDGED 941
R + ++ L D
Sbjct: 219 GQVFFRQRVSSECQHLIRWCLALRPSD 245
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 8e-29
Identities = 55/242 (22%), Positives = 93/242 (38%), Gaps = 31/242 (12%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTT---IAVKVFNLLH----HGAFKSFIAECNTLK 740
+ F + +G G++G VF G T A+KV + E L+
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 741 NIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLI 800
+IR + L +Q L+ ++++ L L R E +
Sbjct: 84 HIRQSPFLVTLHYA----FQTETKLHLILDYINGGELFTHLSQRERFTEHE--------- 130
Query: 801 QRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQT 860
+ I V + L H + I + D+K NILLD + + DFGL++ +
Sbjct: 131 ----VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV-ADETE 185
Query: 861 SSIGAKGSIGYIAPEYGLGSEVSISG--DVYSYGILLLELITRKKPTDIMFEGDMNLHNL 918
+ G+I Y+AP+ G + D +S G+L+ EL+T P F D ++
Sbjct: 186 RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP----FTVDGEKNSQ 241
Query: 919 AR 920
A
Sbjct: 242 AE 243
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 1e-28
Identities = 56/301 (18%), Positives = 107/301 (35%), Gaps = 28/301 (9%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFN--LLHHGAFKSFIAECNTLKNIRHR 745
+ + +G G++G+V + +A+K K E LK++RH
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 746 NLVKILTACSGVDYQGNDFK-ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLN 804
N++ +L + + + LV FM + H L +
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH------------EKLGEDRIQF 125
Query: 805 ISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIG 864
+ + L Y+H H DLKP N+ ++ED I DFGLAR + G
Sbjct: 126 LVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQA-----DSEMTG 177
Query: 865 AKGSIGYIAPEYGLGSE-VSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNL-ARTA 922
+ Y APE L + + D++S G ++ E+IT K D +
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237
Query: 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMS 982
P + + S + + ++ + + + ++++ + E R++
Sbjct: 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE---KMLVLDAEQRVT 294
Query: 983 M 983
Sbjct: 295 A 295
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 2e-28
Identities = 54/311 (17%), Positives = 108/311 (34%), Gaps = 34/311 (10%)
Query: 681 QNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFN--LLHHGAFKSFIAECNT 738
+ ++ +R+ +++ +G G++GSV +AVK + K E
Sbjct: 11 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 739 LKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLN 798
LK+++H N++ +L + + + L + + L
Sbjct: 71 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----------CQKLT 119
Query: 799 LIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSA 858
+ + L Y+H H DLKPSN+ ++ED I DFGLAR
Sbjct: 120 DDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHT----- 171
Query: 859 QTSSIGAKGSIGYIAPEYGLGSE-VSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHN 917
G + Y APE L + + D++S G ++ EL+T + F G ++
Sbjct: 172 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL----FPGTDHIDQ 227
Query: 918 LAR-----TALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVAC 972
L ++ + S + + + + ++
Sbjct: 228 LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLE---KM 284
Query: 973 SMESPEDRMSM 983
+ + R++
Sbjct: 285 LVLDSDKRITA 295
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 115 bits (288), Expect = 2e-28
Identities = 47/228 (20%), Positives = 85/228 (37%), Gaps = 30/228 (13%)
Query: 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFN---LLHHGAFKSFIAECNTLKNIRH 744
D+F + +G GSFG V + A+K+ + ++ + + E L+ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 745 RNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLN 804
LVK+ + V E++ + L I R E
Sbjct: 101 PFLVKLEFSFKDNSNLYM-----VMEYVAGGEMFSHLRRIGRFSEP----------HARF 145
Query: 805 ISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIG 864
+ + YLH + + DLKP N+L+D+ + DFG A+ + +
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWT 197
Query: 865 AKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGD 912
G+ +APE L + + D ++ G+L+ E+ P F D
Sbjct: 198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----FFAD 241
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 6e-28
Identities = 53/240 (22%), Positives = 90/240 (37%), Gaps = 26/240 (10%)
Query: 684 YNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFN--LLHHGAFKSFIAECNTLKN 741
+ R+ ++ IG G+ G V +A+K + + K E +K
Sbjct: 13 FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKC 72
Query: 742 IRHRNLVKILTACSGVD-YQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLI 800
+ H+N++ +L + + LV E M + + E
Sbjct: 73 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE------------- 119
Query: 801 QRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQT 860
+ + + C + +LH H DLKPSNI++ D I DFGLAR S T
Sbjct: 120 RMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 176
Query: 861 SSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLAR 920
+ + Y APE LG + D++S G ++ E++ K F G + +
Sbjct: 177 PYV---VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL----FPGRDYIDQWNK 229
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 111 bits (277), Expect = 8e-27
Identities = 48/231 (20%), Positives = 85/231 (36%), Gaps = 19/231 (8%)
Query: 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLV 748
R+ V ++G G F +V+ T +A+K+ ++ E L+ + +
Sbjct: 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNT 72
Query: 749 KILTACSGVDYQGNDFKAL-VFEFMHNRSLEEWLHPITREDETDE-----APRSLNLIQR 802
K + + + K L F + + + R + LI
Sbjct: 73 KEDSMGAN-----HILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 127
Query: 803 LNISIDVACALNYLHHDCQPPIAHCDLKPSNILLD-EDMIAHIGDFGLARFLPLSSAQTS 861
IS + L+Y+H C I H D+KP N+L++ D ++ +A
Sbjct: 128 KQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH 185
Query: 862 SIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGD 912
+ + Y +PE LG+ D++S L+ ELIT FE D
Sbjct: 186 YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL----FEPD 232
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 107 bits (267), Expect = 2e-25
Identities = 79/386 (20%), Positives = 148/386 (38%), Gaps = 26/386 (6%)
Query: 155 SSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMA 214
++L++ + N+T ++ + +L + +L ++ SI D + +L NL + +
Sbjct: 19 TALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFS 74
Query: 215 QNRLSGTIP-SSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPP 273
N+L+ P ++ + I + + I L L + L
Sbjct: 75 NNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134
Query: 274 TISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNS----LGSRGDRDLNFLCSLT 329
S+ I S + L ++ L N ++ + L
Sbjct: 135 NRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA 194
Query: 330 NATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMC 389
T L+ L+ N P I T L+ L L+ NQ+ + NL LD+
Sbjct: 195 KLTNLESLIATNNQISDITPLGI---LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 390 SNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLG 449
+N++S P + L L +L+L N+ I P G L L L+ N L+ P S
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISN-ISPLAGLTALTNLELNENQLEDISPIS-- 304
Query: 450 RYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVF 509
+ LT + L NN++ P + + L L + N+++ S + NL N+ L+
Sbjct: 305 NLKNLTYLTLYFNNISDISP---VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAG 359
Query: 510 GNKLKGEIPSTLGSCIKLEQLEMQEN 535
N++ P L + ++ QL + +
Sbjct: 360 HNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 103 bits (257), Expect = 4e-24
Identities = 80/390 (20%), Positives = 151/390 (38%), Gaps = 38/390 (9%)
Query: 205 LKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGE 264
L + + + ++ T+ + ++ +T A I+ ++Y L NL +
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSIDGVEY---LNNLTQINFSN 75
Query: 265 NQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLV----------FGILGNSL 314
NQLT P + N + L + N++ P + + +
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 315 GSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIP 374
+R + N + ++ + L L + ++NL+T + + N ++
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 375 AAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLK-LFIL 433
K NL+ L +N++S P I NL +L L N+ + ++ +L L L
Sbjct: 194 ---AKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDL 246
Query: 434 YLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSI 493
L+ N + P L LT + L N ++ P L+ + +L N+
Sbjct: 247 DLANNQISNLAP--LSGLTKLTELKLGANQISNISP-----LAGLTALTNLELNENQLED 299
Query: 494 PSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSV 553
S + NLKNL L ++ N + P + S KL++L N + SSL++L ++
Sbjct: 300 ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV--SSLANLTNINW 355
Query: 554 LDLSQNNLSGKIPELLIRLQLVKNLNLSNN 583
L N +S P L L + L L++
Sbjct: 356 LSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 82.4 bits (202), Expect = 4e-17
Identities = 80/393 (20%), Positives = 138/393 (35%), Gaps = 43/393 (10%)
Query: 84 NLSFLKVLRLYNNSFNHEIP-SEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLF 142
L+ L + + ++ D++ LQ L SI G + +NL Q+
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFS 74
Query: 143 HNQLVGKIPSELSSLSKIEHISVNDN------------NLTGSIPSSLGNLSSIRSLFLS 190
+NQL P L +L+K+ I +N+N NLTG + L+
Sbjct: 75 NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132
Query: 191 GNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDY 250
N +T+ + L LT Q G + + ++++T + +
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192
Query: 251 GFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGIL 310
L NL+ NQ++ P I +NL+ + N+L L L L +
Sbjct: 193 LAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD-IGTLASLTNLTDLDLA 249
Query: 311 GNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIF 370
N + + L L+ T+L L + N P T L+ N+
Sbjct: 250 NNQISN--------LAPLSGLTKLTELKLGANQISNISPLAGLTALT-----NLELNENQ 296
Query: 371 GNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLK- 429
+ I NL L + N +S P + L L+ L N+ S+ NL
Sbjct: 297 LEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTN 352
Query: 430 LFILYLSYNFLQGSIPSSLGRYETLTTIDLSNN 462
+ L +N + P L +T + L++
Sbjct: 353 INWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 75.0 bits (183), Expect = 1e-14
Identities = 77/380 (20%), Positives = 141/380 (37%), Gaps = 43/380 (11%)
Query: 62 QRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNS 121
+VT L + L + SI V L+ L + NN P L +L + ++ N
Sbjct: 44 DQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ 99
Query: 122 IGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNL 181
I P + + L + + + + + + ++ N ++ + L
Sbjct: 100 IADITPLANLTNLTGLTLFNNQITDIDPLKNL----TNLNRLELSSNTIS-----DISAL 150
Query: 182 SSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNK 241
S + SL + + L L L L ++ N+ + S + ++++ A N+
Sbjct: 151 SGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNK--VSDISVLAKLTNLESLIATNNQ 208
Query: 242 IQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAP--YLE 299
I PL +L L NQL T+++ +NL + N+++ AP L
Sbjct: 209 ISDITPLGILTNLDELSLNG---NQLKD--IGTLASLTNLTDLDLANNQISNLAPLSGLT 263
Query: 300 KLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTL 359
KL L LG+ +++ L LT T L+ + + + L
Sbjct: 264 KLTEL--------KLGANQISNISPLAGLTALTNLELNENQLEDI------SPISNLKNL 309
Query: 360 EVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQG 419
L L N I P + LQRL +N++S ++ L N+ L N+
Sbjct: 310 TYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISD 365
Query: 420 NIPPSIGNL-KLFILYLSYN 438
P + NL ++ L L+
Sbjct: 366 LTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 72.0 bits (175), Expect = 8e-14
Identities = 46/223 (20%), Positives = 79/223 (35%), Gaps = 17/223 (7%)
Query: 43 WNESSHFCQWRGVTCSRRHQRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEI 102
+ ++ + + L + +++ L+ L L L N
Sbjct: 178 ERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD-- 233
Query: 103 PSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEH 162
L L L L N I P +S + L +L+L NQ+ P +
Sbjct: 234 IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLE 291
Query: 163 ISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTI 222
++ N I NL ++ L L NN+ P + L L L A N++S
Sbjct: 292 LNENQLEDISPIS----NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-- 343
Query: 223 PSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGEN 265
SS+ N+++I AG N+I PL +L + + +
Sbjct: 344 VSSLANLTNINWLSAGHNQISDLTPLA---NLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 61.9 bits (149), Expect = 2e-10
Identities = 64/351 (18%), Positives = 118/351 (33%), Gaps = 36/351 (10%)
Query: 238 GVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPY 297
G + + + LQ +G + G + +NL + S N+LT P
Sbjct: 30 GKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSNNQLTDITP- 83
Query: 298 LEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLST 357
L+ L +L+ + N + + + I+ +L
Sbjct: 84 LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRL------ 137
Query: 358 TLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRF 417
++ N + I L L S T + L L+ L + N+
Sbjct: 138 ----------ELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKV 187
Query: 418 QGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSS 477
+ L L + N + P + L + L+ N L + +
Sbjct: 188 SDISVLA-KLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD---IGTLASLT 241
Query: 478 SLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFL 537
+L LDL+ NQ++ P + L L L + N++ P + + +L +
Sbjct: 242 NLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLED 299
Query: 538 QGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGV 588
PI + L+ L+ L L NN+S P + L ++ L +NN + V
Sbjct: 300 ISPISN----LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV 344
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 50.8 bits (120), Expect = 5e-07
Identities = 34/135 (25%), Positives = 63/135 (46%), Gaps = 11/135 (8%)
Query: 456 TIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKG 515
++ +NN ++ P + ++L L L+ NQL + +L NL L++ N++
Sbjct: 201 SLIATNNQISDITPLGIL---TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN 255
Query: 516 EIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLV 575
P L KL +L++ N + P L+ L L+ L+L++N L P L+ +
Sbjct: 256 LAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPI--SNLKNL 309
Query: 576 KNLNLSNNDLEGVVP 590
L L N++ + P
Sbjct: 310 TYLTLYFNNISDISP 324
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 98.2 bits (243), Expect = 6e-23
Identities = 59/271 (21%), Positives = 105/271 (38%), Gaps = 12/271 (4%)
Query: 332 TRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSN 391
L + N NL L L+L NN+I P A V L+RL + N
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNL-KNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89
Query: 392 RLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRY 451
+L LQ L+ + + + ++ + + + L + G +
Sbjct: 90 QLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM 149
Query: 452 ETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGN 511
+ L+ I +++ N+T TIP GL SL L L N++T + + L NL L + N
Sbjct: 150 KKLSYIRIADTNIT-TIPQ---GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFN 205
Query: 512 KLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSG------KI 565
+ +L + L +L + N L +P L+ + + V+ L NN+S
Sbjct: 206 SISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCP 264
Query: 566 PELLIRLQLVKNLNLSNNDLEGVVPTQGVFK 596
P + ++L +N ++ F+
Sbjct: 265 PGYNTKKASYSGVSLFSNPVQYWEIQPSTFR 295
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 81.6 bits (200), Expect = 2e-17
Identities = 64/296 (21%), Positives = 108/296 (36%), Gaps = 24/296 (8%)
Query: 50 CQWRGVTCSRRHQRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRL 109
C R V CS LE + + P +L L NN +F L
Sbjct: 10 CHLRVVQCSDLG-------LEKV--PKDLPPD------TALLDLQNNKITEIKDGDFKNL 54
Query: 110 RRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNN 169
+ L L L N I P + L +L L NQL ++P ++ ++ + V++N
Sbjct: 55 KNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL-KELPEKMP--KTLQELRVHENE 111
Query: 170 LTGSIPSSLGNLSSIRSLFLSGNNLE--GSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIF 227
+T S L+ + + L N L+ G +K L + +A ++ TIP +
Sbjct: 112 ITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP 170
Query: 228 NISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGS 287
S+T NKI L NL + N ++ +++N +L H +
Sbjct: 171 --PSLTELHLDGNKITKVDA-ASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLN 227
Query: 288 VNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININN 343
NKL L + + V + N++ + G D T + + N
Sbjct: 228 NNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNP 283
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 75.8 bits (185), Expect = 2e-15
Identities = 51/275 (18%), Positives = 91/275 (33%), Gaps = 18/275 (6%)
Query: 221 TIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASN 280
+P + D NKI D+ +L+NL + N+++ P +
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFK-NLKNLHTLILINNKISKISPGAFAPLVK 80
Query: 281 LEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLIN 340
LE + S N+L + K + L N + N L + L N
Sbjct: 81 LERLYLSKNQLKELPEKMPKTLQELRV--HENEITKVRKSVFNGLNQ----MIVVELGTN 134
Query: 341 INNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPA 400
G + L + + + I IP + +L L + N+++ +
Sbjct: 135 PLKSSGIENGAFQGM-KKLSYIRIADTNI-TTIPQGL--PPSLTELHLDGNKITKVDAAS 190
Query: 401 IGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLS 460
+ L NL L L N S+ N N +P L ++ + + L
Sbjct: 191 LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLH 250
Query: 461 NNNLTG-----TIPPQFIGLSSSLIVLDLSRNQLT 490
NNN++ PP + +S + L N +
Sbjct: 251 NNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 75.5 bits (184), Expect = 3e-15
Identities = 45/229 (19%), Positives = 71/229 (31%), Gaps = 8/229 (3%)
Query: 389 CSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLK-LFILYLSYNFLQGSIPSS 447
CS+ +P + + L LQ N+ NLK L L L N + P +
Sbjct: 17 CSDLGLEKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA 74
Query: 448 LGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILN 507
L + LS N L +P + L V + ++ S+ + + + +E L
Sbjct: 75 FAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LG 132
Query: 508 VFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPE 567
K G KL + + + + SL L L N ++
Sbjct: 133 TNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLT---ELHLDGNKITKVDAA 189
Query: 568 LLIRLQLVKNLNLSNNDLEGVVPTQGVFKNASITSVFGNLKLCGGIPEF 616
L L + L LS N + V N KL
Sbjct: 190 SLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGL 238
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 72.0 bits (175), Expect = 4e-14
Identities = 54/297 (18%), Positives = 111/297 (37%), Gaps = 24/297 (8%)
Query: 125 AIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSI 184
+P ++ + L L +N++ + +L + + + +N ++ P + L +
Sbjct: 24 KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 185 RSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQG 244
L+LS N L+ +P+ + L + +N ++ S ++ + + G N ++
Sbjct: 82 ERLYLSKNQLK-ELPEKMPKTLQ--ELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS 138
Query: 245 AIPLDYGF-SLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQR 303
+ + F ++ L + + + +T IP + +L H NK+T L+
Sbjct: 139 SGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDA--ASLKG 193
Query: 304 LLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLL 363
L LG S S D L N L+ L +N N + ++V+
Sbjct: 194 LNNLAKLGLSFNSISAVDNGSLA---NTPHLRELHLNNNKLVKVPGGLADHKY--IQVVY 248
Query: 364 LDNNQIFG------NIPAAIGKFVNLQRLDMCSNRLS-GTIPP-AIGELQNLKDLRL 412
L NN I P K + + + SN + I P + ++L
Sbjct: 249 LHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 62.7 bits (151), Expect = 5e-11
Identities = 34/144 (23%), Positives = 59/144 (40%), Gaps = 7/144 (4%)
Query: 454 LTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKL 513
L + S+ L +P L +LDL N++T + NLKNL L + NK+
Sbjct: 12 LRVVQCSDLGLE-KVPK---DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 514 KGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQ 573
P +KLE+L + +N L+ +P + L + +N ++ + L
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKE-LPEKMPKTL--QELRVHENEITKVRKSVFNGLN 124
Query: 574 LVKNLNLSNNDLEGVVPTQGVFKN 597
+ + L N L+ G F+
Sbjct: 125 QMIVVELGTNPLKSSGIENGAFQG 148
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 81.4 bits (200), Expect = 4e-18
Identities = 28/177 (15%), Positives = 47/177 (26%), Gaps = 33/177 (18%)
Query: 694 NQIGEGSFGSVFKGILDDGRTTIAVKVFNL----------LHHGAFKSFIAECNTLKNIR 743
+GEG +VF + VK + F
Sbjct: 6 KLMGEGKESAVFNCYSEKFG-ECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 744 HRNLVKILTACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRL 803
R L K+ Y A++ E + + L E
Sbjct: 65 FRALQKLQGLAVPKVYAWEGN-AVLMELIDAKELYRVRVENPDE---------------- 107
Query: 804 NISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQT 860
+ + + +H I H DL N+L+ E+ I I DF + + +
Sbjct: 108 -VLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGWRE 159
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.4 bits (199), Expect = 3e-17
Identities = 53/261 (20%), Positives = 93/261 (35%), Gaps = 6/261 (2%)
Query: 345 GGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGEL 404
L A + + + L N+I A+ NL L + SN L+ A L
Sbjct: 20 QQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGL 79
Query: 405 QNLKDLRLQRNRFQGNIPPSI--GNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNN 462
L+ L L N ++ P+ G +L L+L LQ P L + L +N
Sbjct: 80 ALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDN 139
Query: 463 NLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLG 522
L +P +L L L N+++ L +L+ L + N++ P
Sbjct: 140 ALQA-LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFR 198
Query: 523 SCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSN 582
+L L + N L +L+ LR L L L+ N ++ S+
Sbjct: 199 DLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC-DCRARPLWAWLQKFRGSS 257
Query: 583 NDLEGVVPTQGVFKNASITSV 603
+++ +P + + +
Sbjct: 258 SEVPCSLPQR--LAGRDLKRL 276
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.1 bits (180), Expect = 6e-15
Identities = 53/305 (17%), Positives = 96/305 (31%), Gaps = 36/305 (11%)
Query: 162 HISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGT 221
S L ++P + ++ + +FL GN + + +NL L + N L+
Sbjct: 15 TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71
Query: 222 IPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNL 281
++ ++ + D N ++ L L + L P + L
Sbjct: 72 DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAAL 131
Query: 282 EIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLINI 341
+ + N L + + L L ++
Sbjct: 132 QYLYLQDNALQALPD-----------------------------DTFRDLGNLTHLFLHG 162
Query: 342 NNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAI 401
N L +L+ LLL N++ P A L L + +N LS A+
Sbjct: 163 NRISSVPERAFRGL-HSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEAL 221
Query: 402 GELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSN 461
L+ L+ LRL N + + L S + + S+P L L+
Sbjct: 222 APLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLAG---RDLKRLAA 278
Query: 462 NNLTG 466
N+L G
Sbjct: 279 NDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.7 bits (179), Expect = 9e-15
Identities = 44/234 (18%), Positives = 74/234 (31%), Gaps = 6/234 (2%)
Query: 37 LGVLASWNESSHFCQWRGVTCSRRHQRVTILDLESLKLAGSISPHV-GNLSFLKVLRLYN 95
L S+ + LDL S+ P L L L L
Sbjct: 55 CRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDR 114
Query: 96 NSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELS 155
P F L LQ L L N++ NL L L N++
Sbjct: 115 CGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFR 174
Query: 156 SLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQ 215
L ++ + ++ N + P + +L + +L+L NNL + L L+ L L +
Sbjct: 175 GLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLND 234
Query: 216 NRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTG 269
N + + + F +++ ++P L + N L G
Sbjct: 235 NPWVCDCRARPL-WAWLQKFRGSSSEVPCSLPQ----RLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.4 bits (173), Expect = 5e-14
Identities = 55/320 (17%), Positives = 92/320 (28%), Gaps = 62/320 (19%)
Query: 245 AIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRL 304
A+P+ + Q + + N+++ + NL I N
Sbjct: 25 AVPVGIPAASQRI---FLHGNRISHVPAASFRACRNLTILWLHSNV-------------- 67
Query: 305 LVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLL 364
+ T L+ L ++ N S+ + L L L
Sbjct: 68 ---------------LARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112
Query: 365 DNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPS 424
D + P LQ L + N L +L NL L L NR +
Sbjct: 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERA 172
Query: 425 IGNLK-LFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLD 483
L L L L N + P + L T+ L NNL+ +P + + +L L
Sbjct: 173 FRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLR 231
Query: 484 LSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPS 543
L+ N + L+ +++ +P
Sbjct: 232 LNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLP------------------------- 265
Query: 544 SLSSLRGLSVLDLSQNNLSG 563
L G + L+ N+L G
Sbjct: 266 --QRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.1 bits (167), Expect = 4e-13
Identities = 50/247 (20%), Positives = 84/247 (34%), Gaps = 5/247 (2%)
Query: 373 IPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFI 432
+P I QR+ + NR+S + +NL L L N + L L
Sbjct: 26 VPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 433 LYLSYN--FLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLT 490
+ L+ P++ L T+ L + P ++L L L N L
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCG-LQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 491 GSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRG 550
+L NL L + GN++ L++L + +N + P + L
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 551 LSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQGVFKNASITSVFGNLKLC 610
L L L NNLS E L L+ ++ L L++N + ++ + C
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPC 262
Query: 611 GGIPEFQ 617
Sbjct: 263 SLPQRLA 269
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.2 bits (157), Expect = 5e-12
Identities = 51/283 (18%), Positives = 98/283 (34%), Gaps = 32/283 (11%)
Query: 57 CSRRHQRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLA 116
C ++ L ++ + + + L+ N +H + F R L +L
Sbjct: 6 CVCYNEPKVTTSCPQQGLQ-AVPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILW 62
Query: 117 LHYNS-------------------------IGGAIPANISSCSNLIQLRLFHNQLVGKIP 151
LH N + PA L L L L P
Sbjct: 63 LHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGP 122
Query: 152 SELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNL 211
L+ ++++ + DN L + +L ++ LFL GN + L +L L
Sbjct: 123 GLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRL 182
Query: 212 TMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAI 271
+ QNR++ P + ++ + N A+P + L+ LQ+ + +N
Sbjct: 183 LLHQNRVAHVHPHAFRDLGRLMTLYLFAN-NLSALPTEALAPLRALQYLRLNDNPWVCDC 241
Query: 272 PPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSL 314
+ L+ F GS +++ + P ++L + + N L
Sbjct: 242 RA-RPLWAWLQKFRGSSSEVPCSLP--QRLAGRDLKRLAANDL 281
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 55.9 bits (134), Expect = 5e-10
Identities = 23/120 (19%), Positives = 45/120 (37%), Gaps = 5/120 (4%)
Query: 384 QRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGS 443
+ L + L T+ + +L + L L NR + PP++ L+ + + + +
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNALEN 57
Query: 444 IPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNL 503
+ L + L NN L + Q + L++L+L N L L +
Sbjct: 58 VDGV-ANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 50.9 bits (121), Expect = 3e-08
Identities = 29/125 (23%), Positives = 56/125 (44%), Gaps = 7/125 (5%)
Query: 456 TIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKG 515
+ L++ +LT + L + LDLS N+L P+ + L+ LE+L N
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLL-VTHLDLSHNRLRALPPA-LAALRCLEVLQASDNA--L 55
Query: 516 EIPSTLGSCIKLEQLEMQENFLQG-PIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQL 574
E + + +L++L + N LQ L S L +L+L N+L + ++
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
Query: 575 VKNLN 579
+ +++
Sbjct: 116 LPSVS 120
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.6 bits (115), Expect = 2e-07
Identities = 26/109 (23%), Positives = 43/109 (39%), Gaps = 6/109 (5%)
Query: 481 VLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGP 540
VL L+ LT + + L + L++ N+L+ P+ L + LE L+ +N L+
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENV 58
Query: 541 IPSSLSSLRGLSVLDLSQNNL-SGKIPELLIRLQLVKNLNLSNNDLEGV 588
+ L L N L + L+ + LNL N L
Sbjct: 59 DGVANLPRLQ--ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.4 bits (112), Expect = 5e-07
Identities = 23/127 (18%), Positives = 53/127 (41%), Gaps = 9/127 (7%)
Query: 89 KVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVG 148
+VL L + + ++L + L L +N + P +++ L L+ N
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNA--L 55
Query: 149 KIPSELSSLSKIEHISVNDNNLTG-SIPSSLGNLSSIRSLFLSGNNL---EGSIPDTLGW 204
+ +++L +++ + + +N L + L + + L L GN+L EG
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
Query: 205 LKNLVNL 211
L ++ ++
Sbjct: 116 LPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.2 bits (101), Expect = 1e-05
Identities = 25/122 (20%), Positives = 48/122 (39%), Gaps = 7/122 (5%)
Query: 185 RSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQG 244
R L L+ +L ++ L L + +L ++ NRL P+ + + + A N ++
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALEN 57
Query: 245 AIPLDYGFSLQNLQFFSVGENQLTG-AIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQR 303
+ LQ L + N+L A + + L + + N L E+L
Sbjct: 58 VDGVANLPRLQEL---LLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAE 114
Query: 304 LL 305
+L
Sbjct: 115 ML 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.2 bits (96), Expect = 7e-05
Identities = 27/127 (21%), Positives = 50/127 (39%), Gaps = 9/127 (7%)
Query: 66 ILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGA 125
+L L L ++ H+ L + L L +N P+ LR L+V L +
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEV--LQASDNALE 56
Query: 126 IPANISSCSNLIQLRLFHNQLVG-KIPSELSSLSKIEHISVNDNNLT---GSIPSSLGNL 181
+++ L +L L +N+L L S ++ +++ N+L G L
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
Query: 182 SSIRSLF 188
S+ S+
Sbjct: 117 PSVSSIL 123
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 60.2 bits (144), Expect = 5e-10
Identities = 49/324 (15%), Positives = 89/324 (27%), Gaps = 17/324 (5%)
Query: 158 SKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNR 217
+ + +N+ L+ S+P +L SL S N+L +P+ LK+L+
Sbjct: 38 RQAHELELNNLGLS-SLPELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 218 LSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISN 277
LS P + S + + +L+ L
Sbjct: 93 LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152
Query: 278 ASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWL 337
E+ + A K L + G+ +L L +L T +
Sbjct: 153 EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYAD 212
Query: 338 LI----NINNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRL 393
+ + + T L + L N
Sbjct: 213 NNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNAS 272
Query: 394 SGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYET 453
S I +L++L + N+ +P L+ L S+N L +P
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE--RLIASFNHLA-EVPELPQN--- 325
Query: 454 LTTIDLSNNNLTGTIPPQFIGLSS 477
L + + N L P +
Sbjct: 326 LKQLHVEYNPLR-EFPDIPESVED 348
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 55.2 bits (131), Expect = 2e-08
Identities = 25/94 (26%), Positives = 35/94 (37%), Gaps = 10/94 (10%)
Query: 434 YLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSI 493
N I S +L +++SNN L +P L L S N L +
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP----PRLERLIASFNHLA-EV 319
Query: 494 PSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKL 527
P +NL+ L+V N L+ E P S L
Sbjct: 320 PEL---PQNLKQLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.7 bits (122), Expect = 2e-07
Identities = 25/91 (27%), Positives = 44/91 (48%), Gaps = 10/91 (10%)
Query: 342 NNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAI 401
N + + +L +LE L + NN++ +PA L+RL N L+ +P
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKL-IELPALPP---RLERLIASFNHLA-EVPE-- 321
Query: 402 GELQNLKDLRLQRNRFQG--NIPPSIGNLKL 430
QNLK L ++ N + +IP S+ +L++
Sbjct: 322 -LPQNLKQLHVEYNPLREFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.4 bits (121), Expect = 3e-07
Identities = 25/99 (25%), Positives = 43/99 (43%), Gaps = 12/99 (12%)
Query: 484 LSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPS 543
N + I S +LE LNV NKL E+P+ LE+L N L +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLAE-VPE 321
Query: 544 SLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSN 582
+L+ L + N L + P++ ++ +L +++
Sbjct: 322 LPQNLK---QLHVEYNPLR-EFPDIPESVE---DLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.4 bits (116), Expect = 1e-06
Identities = 20/98 (20%), Positives = 39/98 (39%), Gaps = 11/98 (11%)
Query: 364 LDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPP 423
N I + +L+ L++ +N+L +P L+ L N +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPE 321
Query: 424 SIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSN 461
NLK L++ YN L+ P E++ + +++
Sbjct: 322 LPQNLK--QLHVEYNPLR-EFPDIP---ESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.8 bits (104), Expect = 4e-05
Identities = 21/113 (18%), Positives = 35/113 (30%), Gaps = 9/113 (7%)
Query: 48 HFCQWRGVTCSRRHQRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFD 107
+ + I L+ L + NN E+P+
Sbjct: 246 LTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP 304
Query: 108 RLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKI 160
RL RL +N + +P NL QL + +N L + P S+ +
Sbjct: 305 RLERLI---ASFNHLA-EVP---ELPQNLKQLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 43.7 bits (101), Expect = 7e-05
Identities = 23/78 (29%), Positives = 33/78 (42%), Gaps = 8/78 (10%)
Query: 511 NKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLI 570
N EI S LE+L + N L +P+ L L S N+L+ ++PEL
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLE---RLIASFNHLA-EVPELPQ 324
Query: 571 RLQLVKNLNLSNNDLEGV 588
L K L++ N L
Sbjct: 325 NL---KQLHVEYNPLREF 339
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.2 bits (92), Expect = 0.001
Identities = 20/98 (20%), Positives = 35/98 (35%), Gaps = 10/98 (10%)
Query: 162 HISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGT 221
N + I S S+ L +S N L +P L L + N L+
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-E 318
Query: 222 IPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQF 259
+P N+ + N ++ P D S+++L+
Sbjct: 319 VPELPQNLKQL---HVEYNPLRE-FP-DIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.4 bits (90), Expect = 0.002
Identities = 17/69 (24%), Positives = 23/69 (33%), Gaps = 5/69 (7%)
Query: 475 LSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQE 534
L L+L+ L+ S+P +LE L N L E+P S L
Sbjct: 36 LDRQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNL 90
Query: 535 NFLQGPIPS 543
L P
Sbjct: 91 KALSDLPPL 99
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.0 bits (89), Expect = 0.002
Identities = 18/96 (18%), Positives = 32/96 (33%), Gaps = 10/96 (10%)
Query: 188 FLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIP 247
N I +L L ++ N+L +P+ + + A N + +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVP 320
Query: 248 LDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEI 283
QNL+ V N L P + +L +
Sbjct: 321 ----ELPQNLKQLHVEYNPLRE-FPDIPESVEDLRM 351
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.4 bits (137), Expect = 2e-09
Identities = 47/211 (22%), Positives = 77/211 (36%), Gaps = 8/211 (3%)
Query: 325 LCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQ 384
+C ++ + + N +LP +L +L L N ++ A + + L
Sbjct: 3 ICEVSKVASHLEVNCDKRNLT-ALP---PDLPKDTTILHLSENLLYTFSLATLMPYTRLT 58
Query: 385 RLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSI 444
+L++ +R T G L L L L N+ Q L +L +S+N L +
Sbjct: 59 QLNL--DRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTS-L 115
Query: 445 PSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLE 504
P R N T+PP + + L L L+ N LT + L+NL+
Sbjct: 116 PLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLD 175
Query: 505 ILNVFGNKLKGEIPSTLGSCIKLEQLEMQEN 535
L + N L IP L + N
Sbjct: 176 TLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.9 bits (120), Expect = 3e-07
Identities = 39/209 (18%), Positives = 63/209 (30%), Gaps = 49/209 (23%)
Query: 447 SLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEIL 506
+ + + ++ NLT +PP L +L LS N L + + L L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPP---DLPKDTTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 507 NVFGNK---------------------------------------------LKGEIPSTL 521
N+ + L L
Sbjct: 61 NLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120
Query: 522 GSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLS 581
+L++L ++ N L+ P L+ L L L+ NNL+ LL L+ + L L
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180
Query: 582 NNDLEGVVPTQGVFKNASITSVFGNLKLC 610
N L + + GN LC
Sbjct: 181 ENSLYTIPKGFFGSHLLPFAFLHGNPWLC 209
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.9 bits (107), Expect = 1e-05
Identities = 45/241 (18%), Positives = 67/241 (27%), Gaps = 38/241 (15%)
Query: 153 ELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLT 212
E+S ++ ++ + NLT ++P L L LS N L TL L L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 213 MAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIP 272
+ + L +L L + NQL
Sbjct: 62 LDRAE---------------------------LTKLQVDGTLPVLGTLDLSHNQLQSLPL 94
Query: 273 PTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNAT 332
+ + + + L L L + GN L T
Sbjct: 95 LGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGN-------ELKTLPPGLLTPT 147
Query: 333 RLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNR 392
L NN LPA + N L+ LLL N ++ IP L + N
Sbjct: 148 PKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNP 206
Query: 393 L 393
Sbjct: 207 W 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.5 bits (106), Expect = 2e-05
Identities = 41/194 (21%), Positives = 63/194 (32%), Gaps = 31/194 (15%)
Query: 55 VTCSRRH---------QRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEI--- 102
V C +R+ + TIL L L + + L L L
Sbjct: 15 VNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDG 74
Query: 103 ------------------PSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHN 144
P L L VL + +N + + L +L L N
Sbjct: 75 TLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGN 134
Query: 145 QLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGW 204
+L P L+ K+E +S+ +NNLT L L ++ +L L N+L +IP
Sbjct: 135 ELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFG 193
Query: 205 LKNLVNLTMAQNRL 218
L + N
Sbjct: 194 SHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.6 bits (101), Expect = 6e-05
Identities = 37/242 (15%), Positives = 68/242 (28%), Gaps = 38/242 (15%)
Query: 177 SLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFD 236
+ ++S + NL ++P L K+ L +++N L +++ + +T +
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 237 AGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAP 296
++ L +L L + NQL + + + +
Sbjct: 62 LDRAELT---KLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTS---- 114
Query: 297 YLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLS 356
L N +LP + +
Sbjct: 115 ---------------------------LPLGALRGLGELQELYLKGNELKTLPPGLLTPT 147
Query: 357 TTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNR 416
LE L L NN + + NL L + N L TIP L L N
Sbjct: 148 PKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNP 206
Query: 417 FQ 418
+
Sbjct: 207 WL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.7 bits (91), Expect = 0.001
Identities = 36/212 (16%), Positives = 63/212 (29%), Gaps = 10/212 (4%)
Query: 81 HVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLR 140
V ++ + + +P + + +L L N + A + + L QL
Sbjct: 5 EVSKVASHLEVNCDKRNL-TALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 141 LFHNQ-LVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIP 199
L + ++ L L ++ +L L ++ L +S N L
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQ----TLPALTVLDVSFNRLTSLPL 117
Query: 200 DTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQF 259
L L L L + N L P + + N + L+NL
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLN-GLENLDT 176
Query: 260 FSVGENQLTGAIPPTISNASNLEIFHGSVNKL 291
+ EN L IP + L N
Sbjct: 177 LLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 54.0 bits (128), Expect = 9e-09
Identities = 33/172 (19%), Positives = 77/172 (44%), Gaps = 7/172 (4%)
Query: 353 SNLSTTLEVLLLDNNQIFGNIPAAI-GKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLR 411
++ LLL++N++ + G+ +L +L++ N+L+G P A ++++L+
Sbjct: 25 RDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQ 84
Query: 412 LQRNRFQGNIPPSIGNLK-LFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPP 470
L N+ + L L L L N + +P S +LT+++L++N
Sbjct: 85 LGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL 144
Query: 471 QFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLG 522
+ + L L+ PS+ +++++I ++ ++ K ++ G
Sbjct: 145 AW--FAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEFKCSSENSEG 191
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 50.6 bits (119), Expect = 1e-07
Identities = 37/164 (22%), Positives = 64/164 (39%), Gaps = 5/164 (3%)
Query: 455 TTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSI-PSEVGNLKNLEILNVFGNKL 513
TT+D + L IP + L L+ N+L G L +L L + N+L
Sbjct: 11 TTVDCTGRGLK-EIPR---DIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQL 66
Query: 514 KGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQ 573
G P+ +++L++ EN ++ L L L+L N +S +P L
Sbjct: 67 TGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLN 126
Query: 574 LVKNLNLSNNDLEGVVPTQGVFKNASITSVFGNLKLCGGIPEFQ 617
+ +LNL++N + S+ G CG + +
Sbjct: 127 SLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVR 170
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 44.0 bits (102), Expect = 3e-05
Identities = 34/186 (18%), Positives = 60/186 (32%), Gaps = 14/186 (7%)
Query: 50 CQWRGVTCSRRH---------QRVTILDLESLKLAGSI-SPHVGNLSFLKVLRLYNNSFN 99
C+ V C+ R T L L +L G L L L L N
Sbjct: 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67
Query: 100 HEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSK 159
P+ F+ +Q L L N I L L L+ NQ+ +P L+
Sbjct: 68 GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127
Query: 160 IEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLS 219
+ +++ N + + +R L+G P ++++ + +
Sbjct: 128 LTSLNLASNPFNCNCHLA-WFAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEFK 183
Query: 220 GTIPSS 225
+ +S
Sbjct: 184 CSSENS 189
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 43.3 bits (100), Expect = 5e-05
Identities = 26/177 (14%), Positives = 51/177 (28%), Gaps = 31/177 (17%)
Query: 433 LYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSL------------- 479
+ + L+ IP + T + L++N L G L
Sbjct: 13 VDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGI 69
Query: 480 -----------IVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLE 528
L L N++ L L+ LN++ N++ +P + L
Sbjct: 70 EPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLT 129
Query: 529 QLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDL 585
L + N L L+ P + +Q+ +L +++
Sbjct: 130 SLNLASNPFNC-NCHLAWFAEWLRKKSLNGGAARCGAPSKVRDVQI---KDLPHSEF 182
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.5 bits (132), Expect = 1e-08
Identities = 17/98 (17%), Positives = 36/98 (36%), Gaps = 1/98 (1%)
Query: 410 LRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIP 469
L L ++ + + + +F+ + + + +DLSN+ + +
Sbjct: 5 LDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVSTL 63
Query: 470 PQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILN 507
+ S L L L +L+ I + + NL LN
Sbjct: 64 HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.3 bits (129), Expect = 3e-08
Identities = 20/102 (19%), Positives = 45/102 (44%), Gaps = 4/102 (3%)
Query: 455 TTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLK 514
T+DL+ NL + + LS +I R+ + + + ++ +++ + ++
Sbjct: 3 QTLDLTGKNLHPDVTGRL--LSQGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIE 59
Query: 515 GE-IPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLD 555
+ L C KL+ L ++ L PI ++L+ L L+
Sbjct: 60 VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.0 bits (128), Expect = 3e-08
Identities = 38/230 (16%), Positives = 67/230 (29%), Gaps = 37/230 (16%)
Query: 334 LKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGN-IPAAIGKFVNLQRLDMCSNR 392
+ + L S ++ + L N+ I + + + + LQ L + R
Sbjct: 25 VIAFRCPRSFMDQPLAEHFSPFR--VQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLR 82
Query: 393 LSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILY------------------ 434
LS I + + NL L L L
Sbjct: 83 LSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVA 142
Query: 435 ---------------LSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSL 479
N + + + + R L +DLS++ + Q + L
Sbjct: 143 VAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYL 202
Query: 480 IVLDLSR-NQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLE 528
L LSR + E+G + L+ L VFG G + + L+
Sbjct: 203 QHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQ 252
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.3 bits (121), Expect = 2e-07
Identities = 44/296 (14%), Positives = 86/296 (29%), Gaps = 33/296 (11%)
Query: 139 LRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEG-S 197
L L L + L S I + + + ++ + LS + +E +
Sbjct: 5 LDLTGKNLHPDVTGRLLSQGVI-AFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVST 62
Query: 198 IPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVN-KIQGAIPLDYGFSLQN 256
+ L L NL++ RLS I +++ S++ + S
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122
Query: 257 LQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGS 316
L ++ + A E + +L + G N S
Sbjct: 123 LDELNLSWCF-----------------DFTEKHVQVAVAHVSETITQLNLSGYRKNLQKS 165
Query: 317 RGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAA 376
+ +L + L + L+ + L I
Sbjct: 166 DLSTLVRRCPNLVH-----LDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLE 220
Query: 377 IGKFVNLQRLDMCSNRLSGTIPPAIGE--LQNLKDLRLQRNRFQGNIPPSIGNLKL 430
+G+ L+ L + G +P + + L L++ + F P+IGN K
Sbjct: 221 LGEIPTLKTLQ-----VFGIVPDGTLQLLKEALPHLQINCSHFTTIARPTIGNKKN 271
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.2 bits (113), Expect = 2e-06
Identities = 20/106 (18%), Positives = 42/106 (39%), Gaps = 3/106 (2%)
Query: 65 TILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSI-G 123
LDL L ++ + + + R + + + F R+Q + L + I
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEV 60
Query: 124 GAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNN 169
+ +S CS L L L +L I + L+ S + ++++ +
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCS 106
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.8 bits (112), Expect = 3e-06
Identities = 45/302 (14%), Positives = 90/302 (29%), Gaps = 36/302 (11%)
Query: 185 RSLFLSGNNLEGSIPDTLGWL--KNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKI 242
++L L+G NL PD G L + ++ ++ + + F+ + D + I
Sbjct: 3 QTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEH-FSPFRVQHMDLSNSVI 58
Query: 243 QGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKL---TGAAPYLE 299
+ + LQ S+ +L+ I T++ SNL + S L
Sbjct: 59 EVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLS 118
Query: 300 KLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTL 359
RL + + + T+L N L + +
Sbjct: 119 SCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLV 178
Query: 360 EVLLLDNNQIFGNIPAAIGKFVNLQRLDMCS-NRLSGTIPPAIGELQNLKDLRLQRNRFQ 418
+ L D+ + + + LQ L + + +GE+ LK L++
Sbjct: 179 HLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPD 238
Query: 419 GNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSS 478
G + E L + ++ ++ T P +
Sbjct: 239 GTLQLLK--------------------------EALPHLQINCSHFTTIARPTIGNKKNQ 272
Query: 479 LI 480
I
Sbjct: 273 EI 274
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.6 bits (101), Expect = 6e-05
Identities = 34/258 (13%), Positives = 77/258 (29%), Gaps = 16/258 (6%)
Query: 355 LSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAI-GELQNLKDLRLQ 413
LS + + + + +Q +D+ ++ + + I + L++L L+
Sbjct: 21 LSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLE 79
Query: 414 RNRFQGNIPPSIG---NLKLFILYLSYNFLQGSIPS------SLGRYETLTTIDLSNNNL 464
R I ++ NL L F + ++ + L D + ++
Sbjct: 80 GLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHV 139
Query: 465 TGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSC 524
+ ++ + Q + + + LK +
Sbjct: 140 QVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQL 199
Query: 525 IKLEQLEMQE-NFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNN 583
L+ L + + L + L L + G + L L +L ++ +
Sbjct: 200 NYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALP---HLQINCS 256
Query: 584 DLEGVV-PTQGVFKNASI 600
+ PT G KN I
Sbjct: 257 HFTTIARPTIGNKKNQEI 274
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.5 bits (124), Expect = 2e-08
Identities = 21/151 (13%), Positives = 46/151 (30%), Gaps = 3/151 (1%)
Query: 132 SCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPS-SLGNLSSIRSLFLS 190
LR + + L + + + + + L L +R+L +
Sbjct: 6 CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64
Query: 191 GNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDY 250
+ L PD + L L ++ N L ++ S+ N + + L +
Sbjct: 65 KSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRW 123
Query: 251 GFSLQNLQFFSVGENQLTGAIPPTISNASNL 281
+ V E +L +++ N
Sbjct: 124 LQRWEEEGLGGVPEQKLQCHGQGPLAHMPNA 154
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.3 bits (95), Expect = 1e-04
Identities = 16/148 (10%), Positives = 45/148 (30%), Gaps = 2/148 (1%)
Query: 357 TTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPP-AIGELQNLKDLRLQRN 415
L + + + NL L + + + + + L L++L + ++
Sbjct: 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 416 RFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGL 475
+ P + S+ + +L + LS N L + +++
Sbjct: 67 GLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQR 126
Query: 476 SSSLIVLDLSRNQLTGSIPSEVGNLKNL 503
+ + +L + ++ N
Sbjct: 127 WEEEGLGGVPEQKLQCHGQGPLAHMPNA 154
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.2 bits (92), Expect = 3e-04
Identities = 20/137 (14%), Positives = 37/137 (27%), Gaps = 1/137 (0%)
Query: 433 LYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGS 492
L + + L E LT + + N + + + L L + ++ L
Sbjct: 13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFV 71
Query: 493 IPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLS 552
P L LN+ N L+ T+ E + L
Sbjct: 72 APDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEG 131
Query: 553 VLDLSQNNLSGKIPELL 569
+ + + L L
Sbjct: 132 LGGVPEQKLQCHGQGPL 148
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.4 bits (131), Expect = 2e-08
Identities = 17/90 (18%), Positives = 34/90 (37%), Gaps = 4/90 (4%)
Query: 454 LTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTG----SIPSEVGNLKNLEILNVF 509
+ ++D+ L+ + + L V+ L LT I S + L LN+
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 510 GNKLKGEIPSTLGSCIKLEQLEMQENFLQG 539
N+L + ++ ++Q+ LQ
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.7 bits (124), Expect = 1e-07
Identities = 15/113 (13%), Positives = 37/113 (32%), Gaps = 21/113 (18%)
Query: 476 SSSLIVLDLSRNQLTGSIPSEV-GNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQE 534
S + LD+ +L+ + +E+ L+ +++ + L +
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDI------------- 47
Query: 535 NFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEG 587
S+L L+ L+L N L +++ + + L+
Sbjct: 48 -------SSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.6 bits (116), Expect = 1e-06
Identities = 18/105 (17%), Positives = 33/105 (31%), Gaps = 23/105 (21%)
Query: 477 SSLIVLDLSRNQLTG----SIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEM 532
S L VL L+ ++ S+ + + +L L++ N L L ++
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVR------ 422
Query: 533 QENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKN 577
L L L S ++ + L L+ K
Sbjct: 423 -------------QPGCLLEQLVLYDIYWSEEMEDRLQALEKDKP 454
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (112), Expect = 4e-06
Identities = 18/90 (20%), Positives = 35/90 (38%), Gaps = 12/90 (13%)
Query: 429 KLFILYLSYNFLQG----SIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGL----SSSLI 480
L +L+L+ + S+ ++L +L +DLSNN L Q + L
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 481 VLDLSRNQLTGSIPSEVGNLK----NLEIL 506
L L + + + L+ +L ++
Sbjct: 430 QLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 6e-06
Identities = 16/84 (19%), Positives = 32/84 (38%), Gaps = 8/84 (9%)
Query: 451 YETLTTIDLSNNNLTGTIP---PQFIGLSSSLIVLDLSRNQLTGSIPSEVG-----NLKN 502
L + L++ +++ + + + SL LDLS N L + ++
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427
Query: 503 LEILNVFGNKLKGEIPSTLGSCIK 526
LE L ++ E+ L + K
Sbjct: 428 LEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 6e-06
Identities = 19/113 (16%), Positives = 32/113 (28%), Gaps = 24/113 (21%)
Query: 381 VNLQRLDMCSNRLSGT-IPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNF 439
+++Q LD+ LS + LQ + +RL
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARC----------------- 44
Query: 440 LQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGL----SSSLIVLDLSRNQ 488
I S+L L ++L +N L + S + L L
Sbjct: 45 --KDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 6e-06
Identities = 13/90 (14%), Positives = 30/90 (33%), Gaps = 5/90 (5%)
Query: 88 LKVLRLYNNSFNHEIPSE-FDRLRRLQVLALHYNSIGG----AIPANISSCSNLIQLRLF 142
++ L + + +E L++ QV+ L + I + + L +L L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 143 HNQLVGKIPSELSSLSKIEHISVNDNNLTG 172
N+L + + + +L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (107), Expect = 2e-05
Identities = 16/91 (17%), Positives = 33/91 (36%), Gaps = 5/91 (5%)
Query: 135 NLIQLRLFHNQLVGKIPSEL-SSLSKIEHISVNDNNLTG----SIPSSLGNLSSIRSLFL 189
++ L + +L +EL L + + + ++D LT I S+L ++ L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 190 SGNNLEGSIPDTLGWLKNLVNLTMAQNRLSG 220
N L + + + + L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 3e-05
Identities = 18/85 (21%), Positives = 30/85 (35%), Gaps = 9/85 (10%)
Query: 84 NLSFLKVLRLYNNSFNHE----IPSEFDRLRRLQVLALHYNSIGGAIPANISS-----CS 134
S L+VL L + + + + L+ L L N +G A +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 135 NLIQLRLFHNQLVGKIPSELSSLSK 159
L QL L+ ++ L +L K
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 4e-05
Identities = 15/97 (15%), Positives = 31/97 (31%), Gaps = 9/97 (9%)
Query: 94 YNNSFNHEIPSEFDRLRRLQVLALHYNSIGG----AIPANISSCSNLIQLRLFHNQLVGK 149
+ L+VL L + ++ A + + +L +L L +N L
Sbjct: 353 EDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 412
Query: 150 IPSELSS-----LSKIEHISVNDNNLTGSIPSSLGNL 181
+L +E + + D + + L L
Sbjct: 413 GILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 2e-04
Identities = 15/88 (17%), Positives = 32/88 (36%), Gaps = 9/88 (10%)
Query: 351 CISNLSTTLEVLLLDNNQI----FGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGE--- 403
+ + L VL L + + ++ A + +L+ LD+ +N L + E
Sbjct: 363 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVR 422
Query: 404 --LQNLKDLRLQRNRFQGNIPPSIGNLK 429
L+ L L + + + L+
Sbjct: 423 QPGCLLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 7e-04
Identities = 14/79 (17%), Positives = 27/79 (34%), Gaps = 9/79 (11%)
Query: 523 SCIKLEQLEMQENFLQG----PIPSSLSSLRGLSVLDLSQNNLSGKIPELLIR-----LQ 573
L L + + + + ++L + L LDLS N L L+
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 574 LVKNLNLSNNDLEGVVPTQ 592
L++ L L + + +
Sbjct: 427 LLEQLVLYDIYWSEEMEDR 445
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 8e-04
Identities = 16/88 (18%), Positives = 31/88 (35%), Gaps = 10/88 (11%)
Query: 330 NATRLKWLLININNFGG----SLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFV---- 381
+ L+ L + + SL A + +L L L NN + + + V
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLAN-HSLRELDLSNNCLGDAGILQLVESVRQPG 425
Query: 382 -NLQRLDMCSNRLSGTIPPAIGELQNLK 408
L++L + S + + L+ K
Sbjct: 426 CLLEQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 8e-04
Identities = 16/91 (17%), Positives = 34/91 (37%), Gaps = 4/91 (4%)
Query: 334 LKWLLININNFGGSLPACISNLSTTLEVLLLDNNQI----FGNIPAAIGKFVNLQRLDMC 389
++ L I + A + L +V+ LD+ + +I +A+ L L++
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 390 SNRLSGTIPPAIGELQNLKDLRLQRNRFQGN 420
SN L + + ++Q+ Q
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (89), Expect = 0.002
Identities = 12/74 (16%), Positives = 21/74 (28%), Gaps = 5/74 (6%)
Query: 160 IEHISVNDNNLTGS-IPSSLGNLSSIRSLFLSGNNLEG----SIPDTLGWLKNLVNLTMA 214
I+ + + L+ + L L + + L L I L L L +
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 215 QNRLSGTIPSSIFN 228
N L +
Sbjct: 64 SNELGDVGVHCVLQ 77
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 45.6 bits (106), Expect = 2e-05
Identities = 41/329 (12%), Positives = 86/329 (26%), Gaps = 41/329 (12%)
Query: 160 IEHISVNDNNLTG----SIPSSLGNLSSIRSLFLSGNNLEG----SIPDTLGWLKNLVNL 211
IE S+ + +T S+ + L S++ + LSGN + + + + K+L
Sbjct: 5 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 212 TMAQNRL----------SGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFS 261
+ + ++ + N L
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 124
Query: 262 VGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRD 321
G P + + K A P + ++ +
Sbjct: 125 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 184
Query: 322 LNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFV 381
L ++ + L C L + + A+ +
Sbjct: 185 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQ-ELKVLDLQDNTFTHLGSSALAIALKSWP 243
Query: 382 NLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQ 441
NL+ L + LS A+ + + N+ L L L YN ++
Sbjct: 244 NLRELGLNDCLLSARGAAAVVD-----------------AFSKLENIGLQTLRLQYNEIE 286
Query: 442 GSIPSSL-----GRYETLTTIDLSNNNLT 465
+L + L ++L+ N +
Sbjct: 287 LDAVRTLKTVIDEKMPDLLFLELNGNRFS 315
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.9 bits (99), Expect = 1e-04
Identities = 46/321 (14%), Positives = 94/321 (29%), Gaps = 27/321 (8%)
Query: 89 KVLRLYNNSFNH--EIPSEFDRLRRLQVLALHYNSIGG----AIPANISSCSNLIQLRLF 142
K L+L + + + ++ + L N+IG + NI+S +L
Sbjct: 8 KSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 143 HNQ---LVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIP 199
+ +IP L L + + + S + FLS + +
Sbjct: 68 DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127
Query: 200 DTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQF 259
L +A+ + N + G N+++ ++ + Q+ +
Sbjct: 128 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL 187
Query: 260 FSVGENQLTGAIPPTISNASNLEIFHGSV-------------NKLTGAAPYLEKLQRLLV 306
+ G P I + + + + A L+ L
Sbjct: 188 LHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRE 247
Query: 307 FGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGG----SLPACISNLSTTLEVL 362
G+ L +RG + S L+ L + N +L I L L
Sbjct: 248 LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFL 307
Query: 363 LLDNNQIFGNIPAAIGKFVNL 383
L+ N+ F + + +
Sbjct: 308 ELNGNR-FSEEDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.9 bits (99), Expect = 1e-04
Identities = 40/311 (12%), Positives = 85/311 (27%), Gaps = 27/311 (8%)
Query: 144 NQLVGKIPSELSSLSKIEHISVNDNNLTG----SIPSSLGNLSSIRSLFLSGN---NLEG 196
+ + + L ++ I ++ N + + ++ + + S ++
Sbjct: 17 TEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKD 76
Query: 197 SIPDTLGWL-------KNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLD 249
IP+ L L L + ++ N T + + S + +
Sbjct: 77 EIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQ 136
Query: 250 YGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGI 309
G + + A P + +GS+ + L +
Sbjct: 137 AGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLH-TVKMVQ 195
Query: 310 LGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQI 369
G L L L + G S A L L L++ +
Sbjct: 196 NGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLL 255
Query: 370 FGNIPAAIG------KFVNLQRLDMCSNRLSGTIPPAIGE-----LQNLKDLRLQRNRFQ 418
AA+ + + LQ L + N + + + +L L L NRF
Sbjct: 256 SARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF- 314
Query: 419 GNIPPSIGNLK 429
+ ++
Sbjct: 315 SEEDDVVDEIR 325
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.4 bits (95), Expect = 4e-04
Identities = 36/328 (10%), Positives = 93/328 (28%), Gaps = 29/328 (8%)
Query: 112 LQVLALHYNSIGG----AIPANISSCSNLIQLRLFHNQL----VGKIPSELSSLSKIEHI 163
++ +L ++I ++ A + ++ ++ L N + + ++S +E
Sbjct: 5 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 164 SVNDNNL----------TGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTM 213
+D + +L + ++ LS N + + L +
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 124
Query: 214 AQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPP 273
+ + + + VNK P + + +
Sbjct: 125 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 184
Query: 274 TISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATR 333
+ + +G + + + +L +
Sbjct: 185 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 244
Query: 334 LKWLLININNFGGSLPACISNL-----STTLEVLLLDNNQIFGNIPAAI-----GKFVNL 383
L+ L +N A + + + L+ L L N+I + + K +L
Sbjct: 245 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDL 304
Query: 384 QRLDMCSNRLSGTIPPAIGELQNLKDLR 411
L++ NR S + E++ + R
Sbjct: 305 LFLELNGNRFSE-EDDVVDEIREVFSTR 331
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.2 bits (92), Expect = 8e-04
Identities = 10/85 (11%), Positives = 25/85 (29%), Gaps = 12/85 (14%)
Query: 459 LSNNNLTGTIPPQFI-----GLSSSLIVLDLSRNQLTGSIPSEV-----GNLKNLEILNV 508
L++ L+ + + L L L N++ + + +L L +
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309
Query: 509 FGNKLK--GEIPSTLGSCIKLEQLE 531
GN+ ++ +
Sbjct: 310 NGNRFSEEDDVVDEIREVFSTRGRG 334
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 7e-05
Identities = 32/221 (14%), Positives = 61/221 (27%), Gaps = 18/221 (8%)
Query: 362 LLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNI 421
+ + + + A + L ++ + L NL L L+ N+
Sbjct: 24 IAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQIT--D 77
Query: 422 PPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIV 481
+ NL ++ + G T S T
Sbjct: 78 LAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSN------- 130
Query: 482 LDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPI 541
I + + + + + L + KL L+ +N +
Sbjct: 131 -LQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDIS 189
Query: 542 PSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSN 582
P L+SL L + L N +S P L + + L+N
Sbjct: 190 P--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 3e-04
Identities = 37/233 (15%), Positives = 71/233 (30%), Gaps = 26/233 (11%)
Query: 205 LKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGE 264
L N + + ++ ++ T+ + ++ IT A + + Y L NL + +
Sbjct: 18 LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTIEGVQY---LNNLIGLELKD 72
Query: 265 NQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNF 324
NQ+ ++ NL + + S L
Sbjct: 73 NQI-----TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAG 127
Query: 325 LCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQ 384
L +L + NI+ G + + L
Sbjct: 128 LSNLQVLYLDLNQITNISPLAGLTNLQYL-----------SIGNAQVSDLTPLANLSKLT 176
Query: 385 RLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNL-KLFILYLS 436
L N++S P + L NL ++ L+ N+ P + N LFI+ L+
Sbjct: 177 TLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 4e-04
Identities = 43/233 (18%), Positives = 86/233 (36%), Gaps = 25/233 (10%)
Query: 156 SLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQ 215
+L+ I+ +N+T ++ + +L I +L G + +I + +L NL+ L +
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72
Query: 216 NRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTI 275
N+++ P N + G L+N+ + ++ T + T
Sbjct: 73 NQITDLAPLK--------------NLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQ 118
Query: 276 SNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLK 335
++ L + + L L S G+ ++ L L N ++L
Sbjct: 119 ITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYL--SIGNAQVSDLTPLANLSKLT 176
Query: 336 WLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDM 388
L + N P +++L L + L NNQI P + NL + +
Sbjct: 177 TLKADDNKISDISP--LASL-PNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 9e-04
Identities = 28/217 (12%), Positives = 65/217 (29%), Gaps = 15/217 (6%)
Query: 253 SLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGN 312
+L N + G++ +T + T ++ + +T ++ L L+ + N
Sbjct: 17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTIEG-VQYLNNLIGLELKDN 73
Query: 313 SLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGN 372
+ + + ++ S+ + +V L
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 373 IPAAIGKFVNLQRLDMC-------SNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSI 425
+ + + N+ L + + L L L+ N+ P +
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191
Query: 426 GNLK-LFILYLSYNFLQGSIPSSLGRYETLTTIDLSN 461
+L L ++L N + P L L + L+N
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 0.001
Identities = 16/63 (25%), Positives = 31/63 (49%), Gaps = 4/63 (6%)
Query: 151 PSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVN 210
+ L++LSK+ + +DN ++ P L +L ++ + L N + P L NL
Sbjct: 166 LTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFI 221
Query: 211 LTM 213
+T+
Sbjct: 222 VTL 224
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (96), Expect = 1e-04
Identities = 19/131 (14%), Positives = 40/131 (30%), Gaps = 5/131 (3%)
Query: 380 FVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNF 439
V + LD+ ++ I L + N + + +L L ++ N
Sbjct: 17 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNNR 74
Query: 440 LQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLS---RNQLTGSIPSE 496
+ LT + L+NN+L + SL L +
Sbjct: 75 ICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYV 134
Query: 497 VGNLKNLEILN 507
+ + + +L+
Sbjct: 135 IYKVPQVRVLD 145
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (93), Expect = 3e-04
Identities = 19/137 (13%), Positives = 41/137 (29%), Gaps = 7/137 (5%)
Query: 79 SPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQ 138
+ N + L L I + L + + N I L
Sbjct: 11 AAQYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKT 67
Query: 139 LRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTG-SIPSSLGNLSSIRSLFLSGNN---L 194
L + +N++ +L + + + +N+L L +L S+ L + N
Sbjct: 68 LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNK 127
Query: 195 EGSIPDTLGWLKNLVNL 211
+ + + + L
Sbjct: 128 KHYRLYVIYKVPQVRVL 144
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.6 bits (98), Expect = 1e-04
Identities = 12/54 (22%), Positives = 25/54 (46%), Gaps = 3/54 (5%)
Query: 466 GTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPS 519
+P +S ++LD+SR ++ + NLK L + + K ++P+
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (97), Expect = 1e-04
Identities = 9/57 (15%), Positives = 17/57 (29%), Gaps = 4/57 (7%)
Query: 453 TLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVF 509
+ + +T IP L + I L +L +LE + +
Sbjct: 9 SNRVFLCQESKVT-EIPS---DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEIS 61
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 5e-04
Identities = 31/215 (14%), Positives = 63/215 (29%), Gaps = 6/215 (2%)
Query: 373 IPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFI 432
IP+ + N L +L A +L+ + + +N I + + +
Sbjct: 23 IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 80
Query: 433 LYLS----YNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQ 488
+ N L + + + + + L L+ + + N
Sbjct: 81 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 140
Query: 489 LTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSL 548
T S VG IL + N ++ E N L+
Sbjct: 141 HTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGA 200
Query: 549 RGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNN 583
G +LD+S+ + L L+ ++ + N
Sbjct: 201 SGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (90), Expect = 0.001
Identities = 28/234 (11%), Positives = 64/234 (27%), Gaps = 9/234 (3%)
Query: 166 NDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSS 225
++ +T IPS L + L L +L + ++QN + I +
Sbjct: 16 QESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD 72
Query: 226 IFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFH 285
+F+ F + + N I +
Sbjct: 73 VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNT---GIKHLPDVHKIHSLQK 129
Query: 286 GSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFG 345
++ + + + L + N T+L L ++ NN
Sbjct: 130 VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNL 189
Query: 346 GSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPP 399
LP + + ++ +L + +I + L+ + + +P
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (89), Expect = 0.001
Identities = 39/241 (16%), Positives = 70/241 (29%), Gaps = 9/241 (3%)
Query: 183 SIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKI 242
S R + + IP L +N + L +L + + + N +
Sbjct: 9 SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65
Query: 243 QGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQ 302
I D +L L + + I P + N P + K+
Sbjct: 66 LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125
Query: 303 RLLVFGILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVL 362
+ + + S + +L N + C N + E+
Sbjct: 126 S---LQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELN 182
Query: 363 LLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIP 422
L DNN + LD+ R+ ++P L+NLK LR + +P
Sbjct: 183 LSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYG--LENLKKLRARSTYNLKKLP 239
Query: 423 P 423
Sbjct: 240 T 240
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 1e-04
Identities = 39/222 (17%), Positives = 75/222 (33%), Gaps = 32/222 (14%)
Query: 308 GILGNSLGSRGDRDLNFLCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNN 367
G LG+ + + + S + + ++ + L +++ ++ +N+
Sbjct: 1 GPLGSETITVPT-PIKQIFSDDAFAETIKDNLKKKSVTDAVT--QNEL-NSIDQIIANNS 56
Query: 368 QIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGN 427
I I N+ +L + N+L+ P L NLK+L S
Sbjct: 57 DIKSVQG--IQYLPNVTKLFLNGNKLTDIKP-----LANLKNLGWLFLDENKVKDLSSLK 109
Query: 428 LKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQF--------------- 472
+ LS S + L L ++ L NN +T
Sbjct: 110 DLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQIS 169
Query: 473 ----IGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFG 510
+ + L L LS+N ++ + LKNL++L +F
Sbjct: 170 DIVPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.8 bits (89), Expect = 0.002
Identities = 37/208 (17%), Positives = 73/208 (35%), Gaps = 23/208 (11%)
Query: 205 LKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGE 264
+ + + ++ + + ++SI A + I+ + Y L N+ +
Sbjct: 23 FAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQY---LPNVTKLFLNG 77
Query: 265 NQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNF 324
N+LT ++N NL NK+ + + S ++
Sbjct: 78 NKLTD--IKPLANLKNLGWLFLDENKVKDLSSL---------KDLKKLKSLSLEHNGISD 126
Query: 325 LCSLTNATRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGNIPAAIGKFVNLQ 384
+ L + +L+ L + N TL + ++NQI +P + LQ
Sbjct: 127 INGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSL---EDNQISDIVP--LAGLTKLQ 181
Query: 385 RLDMCSNRLSGTIPPAIGELQNLKDLRL 412
L + N +S A+ L+NL L L
Sbjct: 182 NLYLSKNHISD--LRALAGLKNLDVLEL 207
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 39.3 bits (90), Expect = 9e-04
Identities = 31/179 (17%), Positives = 65/179 (36%), Gaps = 22/179 (12%)
Query: 347 SLPACISNLS--TTLEVLLLDNNQIFGNIP------AAIGKFVNLQRLDMCSNRLSGTIP 398
++ I ++ + ++ G IP A + + L + +N +
Sbjct: 6 TIKDAIRIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNI--EKI 63
Query: 399 PAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTID 458
++ ++NL+ L L RN + ++ + + L ++ Q + S + + L +
Sbjct: 64 SSLSGMENLRILSLGRNLIK--KIENLDAVADTLEELWISYNQIASLSGIEKLVNLRVLY 121
Query: 459 LSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSE----------VGNLKNLEILN 507
+SNN +T + L L L+ N L V L NL+ L+
Sbjct: 122 MSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 986 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.85 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.83 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.78 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.77 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.77 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.75 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.75 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.75 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.72 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.68 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.54 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.54 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.53 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.52 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.44 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.42 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.41 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.4 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.4 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.35 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.33 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.29 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.6 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.56 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.46 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.81 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.65 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.58 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.56 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.97 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.93 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.81 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.35 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.06 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-50 Score=425.75 Aligned_cols=252 Identities=21% Similarity=0.300 Sum_probs=202.5
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc-hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
.++|++.+.||+|+||+||+|+++.+++.||||+++.... ...+++.+|++++++++|||||+++++ +.+++..
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~-----~~~~~~~ 78 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH-----RREGNIQ 78 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEE-----EEETTEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeee-----eccCcee
Confidence 4679999999999999999999999999999999975432 334678999999999999999999999 4556889
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
|+||||+++|+|.++++ ..+.+++.+++.|+.||+.||+|||++ +|+||||||+|||+++++.+||+
T Consensus 79 ~ivmEy~~gg~L~~~l~----------~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~ 145 (271)
T d1nvra_ 79 YLFLEYCSGGELFDRIE----------PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKIS 145 (271)
T ss_dssp EEEEECCTTEEGGGGSB----------TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEEC
T ss_pred EEEEeccCCCcHHHHHh----------cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEc
Confidence 99999999999999995 234689999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccCCCc-CcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCC
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEV-SISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALP 924 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 924 (986)
|||+|+..............+||+.|||||++.+..+ +.++||||+||++|||+||+.||.........+.........
T Consensus 146 DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~ 225 (271)
T d1nvra_ 146 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY 225 (271)
T ss_dssp CCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT
T ss_pred cchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC
Confidence 9999987654444444556789999999999988876 678999999999999999999997443322221111110000
Q ss_pred CchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 925 DHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 925 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..+ ....+.++.+++.+||+.||++|||++||
T Consensus 226 ------------~~~------------------~~~~s~~~~~li~~~L~~dP~~R~t~~ei 257 (271)
T d1nvra_ 226 ------------LNP------------------WKKIDSAPLALLHKILVENPSARITIPDI 257 (271)
T ss_dssp ------------STT------------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred ------------CCc------------------cccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 000 01223456789999999999999998764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-49 Score=421.82 Aligned_cols=248 Identities=21% Similarity=0.291 Sum_probs=204.4
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 767 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 767 (986)
++|++.++||+|+||+||+|++..+++.||||+++.......+.+.+|++++++++|||||+++++ +..++..|+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~-----~~~~~~~~i 94 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS-----YLVGDELWV 94 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEE-----EEETTEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEE-----EEECCEEEE
Confidence 579999999999999999999999999999999987666667889999999999999999999999 445678999
Q ss_pred EEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccc
Q 046598 768 VFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDF 847 (986)
Q Consensus 768 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DF 847 (986)
||||++||+|.+++.. ..+++.+++.|+.||+.||+|||++ ||+||||||+|||++.++++||+||
T Consensus 95 vmEy~~gg~L~~~~~~-----------~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DF 160 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTE-----------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDF 160 (293)
T ss_dssp EEECCTTCBHHHHHHH-----------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCC
T ss_pred EEEecCCCcHHHHhhc-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccc
Confidence 9999999999998751 3589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCch
Q 046598 848 GLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHV 927 (986)
Q Consensus 848 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 927 (986)
|+|+.+.... .......||+.|+|||++.+..++.++||||+||++|||+||+.||......+ ..........+.
T Consensus 161 G~a~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~~~~~~~~~-- 235 (293)
T d1yhwa1 161 GFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTPE-- 235 (293)
T ss_dssp TTCEECCSTT--CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHHCSCC--
T ss_pred hhheeecccc--ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH-HHHHHHhCCCCC--
Confidence 9998764332 23345679999999999999999999999999999999999999996322111 001111100000
Q ss_pred hHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 928 MDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 928 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
. ..+...+.++.+++.+||+.||++|||++|+
T Consensus 236 -----------~----------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ei 267 (293)
T d1yhwa1 236 -----------L----------------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267 (293)
T ss_dssp -----------C----------------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred -----------C----------------CCcccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 0 0001234567799999999999999998763
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-49 Score=419.72 Aligned_cols=251 Identities=29% Similarity=0.464 Sum_probs=193.9
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc--CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
.++|++.+.||+|+||+||+|+++. .||||+++.. .....+.+.+|++++++++|||||++++++. +..
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~------~~~ 77 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST------APQ 77 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSS
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe------ccE
Confidence 4679999999999999999998753 5999998643 3445678999999999999999999999853 245
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.++||||+++|+|.+++.. ....+++.++..|+.||++||+|||++ +||||||||+|||++.++.+||
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~---------~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl 145 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHI---------IETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKI 145 (276)
T ss_dssp CEEEEECCCEEEHHHHHHT---------SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEE
T ss_pred EEEEEecCCCCCHHHHHhh---------ccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEE
Confidence 7999999999999999962 234689999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCccccccccccccccccccccC---CCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHh
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG---SEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLART 921 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~ 921 (986)
+|||+|+...............||+.|||||++.+ ..++.++|||||||++|||+||+.||........ .......
T Consensus 146 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~-~~~~~~~ 224 (276)
T d1uwha_ 146 GDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-IIFMVGR 224 (276)
T ss_dssp CCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHHHHHH
T ss_pred ccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH-HHHHHhc
Confidence 99999987654444444455679999999999864 3589999999999999999999999974322111 1111111
Q ss_pred hC-CCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 922 AL-PDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 922 ~~-~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.. +.... .....++.++.+++.+||+.||++||||+||
T Consensus 225 ~~~~p~~~---------------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i 263 (276)
T d1uwha_ 225 GYLSPDLS---------------------------KVRSNCPKAMKRLMAECLKKKRDERPLFPQI 263 (276)
T ss_dssp TSCCCCGG---------------------------GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCcch---------------------------hccccchHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 11 10000 0011345678899999999999999999764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=412.95 Aligned_cols=244 Identities=20% Similarity=0.283 Sum_probs=201.4
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
++|++.+.||+|+||+||+|+++.+++.||+|++... .....+.+.+|++++++++|||||+++++ +.+++.
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~-----~~~~~~ 80 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY-----FHDATR 80 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEE-----EECSSE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEE-----EEECCE
Confidence 5799999999999999999999999999999998642 23345678999999999999999999999 456688
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.|+||||+++|+|.+++.. .+.+++.+++.|+.||+.||+|||++ +|+||||||+|||++.++.+||
T Consensus 81 ~~ivmEy~~~g~L~~~l~~----------~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl 147 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQK----------LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKI 147 (263)
T ss_dssp EEEEEECCTTCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEE
T ss_pred EEEEEeecCCCcHHHHHhh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEee
Confidence 9999999999999999952 34689999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCC
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALP 924 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 924 (986)
+|||+|+...... .....||+.|||||++.+..++.++|||||||++|||++|+.||.... ........
T Consensus 148 ~DFG~a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-----~~~~~~~i-- 216 (263)
T d2j4za1 148 ADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYKRI-- 216 (263)
T ss_dssp CCCCSCSCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHH--
T ss_pred cccceeeecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC-----HHHHHHHH--
Confidence 9999998654322 234579999999999999999999999999999999999999996321 11111110
Q ss_pred CchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 925 DHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 925 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
....+. .+...+.++.+++.+||+.||++|||++||
T Consensus 217 ----------~~~~~~----------------~p~~~s~~~~~li~~~L~~dp~~R~t~~ei 252 (263)
T d2j4za1 217 ----------SRVEFT----------------FPDFVTEGARDLISRLLKHNPSQRPMLREV 252 (263)
T ss_dssp ----------HTTCCC----------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ----------HcCCCC----------------CCccCCHHHHHHHHHHccCCHhHCcCHHHH
Confidence 000000 000123457789999999999999999764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=417.15 Aligned_cols=248 Identities=22% Similarity=0.311 Sum_probs=200.6
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
++|++.+.||+|+||+||+|++..+++.||||+++.. .....+.+.+|++++++++||||++++++ +.+++.
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~-----~~~~~~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT-----FQDDEK 82 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEE-----EECSSE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEE-----EEECCE
Confidence 5799999999999999999999999999999999742 23345779999999999999999999999 556688
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.|+||||+++|+|.+++. ..+.+++.+++.++.|++.||+|||++ +|+||||||+|||+++++.+||
T Consensus 83 ~~ivmEy~~gg~L~~~~~----------~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl 149 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIR----------KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQI 149 (288)
T ss_dssp EEEEECCCTTEEHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEE
T ss_pred EEEEEEccCCCCHHHhhh----------ccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEe
Confidence 999999999999999985 234689999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCC
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALP 924 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 924 (986)
+|||+|+.+.............||+.|||||++.+..++.++||||+||++|||+||+.||..... ......
T Consensus 150 ~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----~~~~~~--- 221 (288)
T d1uu3a_ 150 TDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-----YLIFQK--- 221 (288)
T ss_dssp CCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH---
T ss_pred cccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH-----HHHHHH---
Confidence 999999987654444444556799999999999999999999999999999999999999963211 111111
Q ss_pred CchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 925 DHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 925 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+ ....+. . +...+.++.+++.+||+.||++|||++|+
T Consensus 222 -----i----~~~~~~-~---------------p~~~s~~~~~li~~~L~~dP~~R~t~~e~ 258 (288)
T d1uu3a_ 222 -----I----IKLEYD-F---------------PEKFFPKARDLVEKLLVLDATKRLGCEEM 258 (288)
T ss_dssp -----H----HTTCCC-C---------------CTTCCHHHHHHHHTTSCSSGGGSTTSGGG
T ss_pred -----H----HcCCCC-C---------------CccCCHHHHHHHHHHccCCHhHCcCHHHH
Confidence 0 000000 0 00123457799999999999999999874
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=418.86 Aligned_cols=250 Identities=23% Similarity=0.329 Sum_probs=203.2
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 767 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 767 (986)
+.|++.+.||+|+||+||+|++..+++.||||+++.......+.+.+|++++++++|||||++++++ .+++..++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF-----YYENNLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEE-----EETTEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----eeCCeEEE
Confidence 5689999999999999999999999999999999876667778899999999999999999999994 45688999
Q ss_pred EEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccc
Q 046598 768 VFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDF 847 (986)
Q Consensus 768 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DF 847 (986)
||||+++|+|.+++. ...+.+++.+++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 87 vmEy~~~g~L~~~~~---------~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DF 154 (288)
T d2jfla1 87 LIEFCAGGAVDAVML---------ELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADF 154 (288)
T ss_dssp EEECCTTEEHHHHHH---------HHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred EEecCCCCcHHHHHH---------hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEec
Confidence 999999999999985 2234699999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccccccccccccc-----CCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 046598 848 GLARFLPLSSAQTSSIGAKGSIGYIAPEYGL-----GSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 848 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 922 (986)
|+|+.... .........||+.|||||++. +..|+.++||||+||++|||+||+.||......+ .+.....
T Consensus 155 G~a~~~~~--~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-~~~~i~~-- 229 (288)
T d2jfla1 155 GVSAKNTR--TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-VLLKIAK-- 229 (288)
T ss_dssp TTCEECHH--HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-HHHHHHH--
T ss_pred hhhhccCC--CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-HHHHHHc--
Confidence 99976421 122234567999999999974 4568999999999999999999999997432211 1111111
Q ss_pred CCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 923 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..+.. ...+...+.++.+++.+||+.||++|||++|+
T Consensus 230 --------------~~~~~-------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~el 266 (288)
T d2jfla1 230 --------------SEPPT-------------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266 (288)
T ss_dssp --------------SCCCC-------------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred --------------CCCCC-------------CCccccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 00000 00011234567899999999999999998764
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-49 Score=415.26 Aligned_cols=257 Identities=22% Similarity=0.284 Sum_probs=192.0
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
.++|++.+.||+|+||+||+|+++.+++.||||+++... ....+.+.+|++++++++|||||++++++.+ ..+..
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~---~~~~~ 79 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTT 79 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------C
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe---CCCCE
Confidence 367999999999999999999999999999999986532 3445678999999999999999999998532 23466
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcC--CCCeEeecCCCCCeEecCCCcE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDC--QPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
.|+||||+++|+|.+++.... .....+++.+++.|+.||+.||+|||+.. ..+|+||||||+|||++.++.+
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~~------~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~v 153 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKGT------KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNV 153 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHHH------HHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCE
T ss_pred EEEEEecCCCCcHHHHHHhcc------ccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcE
Confidence 899999999999999985322 22456999999999999999999999971 1139999999999999999999
Q ss_pred EEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 046598 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 922 (986)
||+|||+|+.+.... .......||+.|||||++.+..++.++|||||||++|||+||+.||..... .....
T Consensus 154 kl~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~-----~~~~~-- 224 (269)
T d2java1 154 KLGDFGLARILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-----KELAG-- 224 (269)
T ss_dssp EECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHH--
T ss_pred EEeeccceeecccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH-----HHHHH--
Confidence 999999998764322 223446799999999999999999999999999999999999999963221 11111
Q ss_pred CCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 923 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+........+ ...+.++.+++.+||+.||++|||++|+
T Consensus 225 ------~i~~~~~~~~~-------------------~~~s~~l~~li~~~L~~dp~~Rps~~el 263 (269)
T d2java1 225 ------KIREGKFRRIP-------------------YRYSDELNEIITRMLNLKDYHRPSVEEI 263 (269)
T ss_dssp ------HHHHTCCCCCC-------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ------HHHcCCCCCCC-------------------cccCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 01110000000 0223467899999999999999999764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-48 Score=409.47 Aligned_cols=249 Identities=24% Similarity=0.353 Sum_probs=195.4
Q ss_pred CCCcccccccceeEEEEEECCCCeEEEEEEeecc--CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEE
Q 046598 691 SSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALV 768 (986)
Q Consensus 691 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 768 (986)
+..++||+|+||+||+|++..+++.||+|++... .....+.+.+|++++++++|||||++++++... ...+...|+|
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~~~~~iv 90 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeec-cccCCEEEEE
Confidence 5667899999999999999999999999998753 334456789999999999999999999986543 3445678999
Q ss_pred EEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEec-CCCcEEEccc
Q 046598 769 FEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLD-EDMIAHIGDF 847 (986)
Q Consensus 769 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kL~DF 847 (986)
|||+++|+|.+++.. ...+++.+++.|+.||++||+|||++ .++|+||||||+|||++ +++.+||+||
T Consensus 91 mE~~~~g~L~~~l~~----------~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DF 159 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKR----------FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDL 159 (270)
T ss_dssp EECCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred EeCCCCCcHHHHHhc----------cccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeec
Confidence 999999999999952 34689999999999999999999998 12299999999999996 5789999999
Q ss_pred ccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCch
Q 046598 848 GLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDHV 927 (986)
Q Consensus 848 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 927 (986)
|+|+..... ......||+.|||||++.+ .++.++|||||||++|||++|+.||..... .............
T Consensus 160 Gla~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~----~~~~~~~i~~~~~ 230 (270)
T d1t4ha_ 160 GLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN----AAQIYRRVTSGVK 230 (270)
T ss_dssp TGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----HHHHHHHHTTTCC
T ss_pred CcceeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc----HHHHHHHHHcCCC
Confidence 999864322 2234679999999999876 599999999999999999999999963221 1111111110000
Q ss_pred hHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 928 MDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 928 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+.. .....+.++.+++.+||+.||++||||+|+
T Consensus 231 -----------~~~---------------~~~~~~~~~~~li~~~l~~dp~~R~s~~el 263 (270)
T d1t4ha_ 231 -----------PAS---------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDL 263 (270)
T ss_dssp -----------CGG---------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred -----------Ccc---------------cCccCCHHHHHHHHHHccCCHhHCcCHHHH
Confidence 000 000123357789999999999999999764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-48 Score=420.32 Aligned_cols=199 Identities=26% Similarity=0.362 Sum_probs=176.4
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc-CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
.++|+++++||+|+||+||+|++..+++.||+|+++.. .....+++.+|+.++++++|||||+++++| .++...
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~~ 79 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGEI 79 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEE-----ECSSEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEE
Confidence 57899999999999999999999999999999999754 334456789999999999999999999994 556889
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHH-DCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
|+||||++||+|.+++.+ .+.+++..++.++.|++.||.|||+ + +|+||||||+|||++.++.+||
T Consensus 80 ~iVmEy~~gg~L~~~l~~----------~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl 146 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKK----------AGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKL 146 (322)
T ss_dssp EEEEECCTTEEHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEE
T ss_pred EEEEEcCCCCcHHHHHhh----------cCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEE
Confidence 999999999999999952 2468999999999999999999996 6 8999999999999999999999
Q ss_pred cccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
+|||+|+.... ......+||+.|||||++.+..|+.++||||+||++|||++|+.||..
T Consensus 147 ~DFGla~~~~~----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~ 205 (322)
T d1s9ja_ 147 CDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205 (322)
T ss_dssp CCCCCCHHHHH----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred eeCCCccccCC----CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 99999986532 223346799999999999999999999999999999999999999964
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.3e-48 Score=415.09 Aligned_cols=250 Identities=23% Similarity=0.414 Sum_probs=187.4
Q ss_pred cCCCCCcccccccceeEEEEEECCCC---eEEEEEEeecc-CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGR---TTIAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
++|++.+.||+|+||+||+|+++.++ ..||||++... .....++|.+|++++++++|||||+++|+| ..++
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~-----~~~~ 100 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVV-----TKST 100 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CSSS
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEE-----eeCC
Confidence 45667789999999999999997554 36889987643 334557899999999999999999999995 4457
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..++||||+++|+|.+++. ...+.+++.+++.|+.||++||+|||++ +|+||||||+|||++.++.+|
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~---------~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~K 168 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLR---------QNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCK 168 (299)
T ss_dssp SCEEEEECCTTEEHHHHHH---------TTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEE
T ss_pred EEEEEEEecCCCcceeeec---------cccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEE
Confidence 7999999999999999986 2234689999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCcc---ccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHH
Q 046598 844 IGDFGLARFLPLSSAQT---SSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLA 919 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~ 919 (986)
|+|||+|+......... ......||+.|||||++.++.++.++|||||||++|||+| |+.||...... ...
T Consensus 169 l~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~-----~~~ 243 (299)
T d1jpaa_ 169 VSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ-----DVI 243 (299)
T ss_dssp ECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHH
T ss_pred ECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH-----HHH
Confidence 99999998765432221 2223457899999999999999999999999999999998 89998632211 111
Q ss_pred HhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 920 RTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 920 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
. .+...... +.+.+++.++.+++.+||+.||++||||+||
T Consensus 244 ~---------~i~~~~~~------------------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei 283 (299)
T d1jpaa_ 244 N---------AIEQDYRL------------------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQI 283 (299)
T ss_dssp H---------HHHTTCCC------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred H---------HHHcCCCC------------------CCCccchHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 1 11110000 0111345668899999999999999999764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.3e-48 Score=414.70 Aligned_cols=252 Identities=25% Similarity=0.436 Sum_probs=203.5
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
..++|++.+.||+|+||+||+|++..+++.||||+++... ...+++.+|++++++++|||||+++++| .+++..
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~ 88 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPF 88 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSC
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccE-----eeCCee
Confidence 3567899999999999999999999889999999987543 3457899999999999999999999995 455788
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
++||||+++|+|.+++... ....+++..++.|+.||++||+|||++ +|+||||||+|||+++++.+||+
T Consensus 89 ~iv~E~~~~g~l~~~l~~~--------~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~ 157 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLREC--------NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVA 157 (287)
T ss_dssp EEEEECCTTCBHHHHHHHS--------CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEEeecccCcchHHHhhhc--------cccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEc
Confidence 9999999999999998632 234689999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCC
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPD 925 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 925 (986)
|||+|+...... ........|++.|+|||++.+..++.++|||||||++|||++|..||..... ....
T Consensus 158 DFG~a~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~----~~~~------- 225 (287)
T d1opja_ 158 DFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID----LSQV------- 225 (287)
T ss_dssp CCCCTTTCCSSS-SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC----HHHH-------
T ss_pred cccceeecCCCC-ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch----HHHH-------
Confidence 999998765332 2333445689999999999999999999999999999999997777542111 1111
Q ss_pred chhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 926 HVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 926 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+.+....... .+..++.++.+++.+||+.||++||||+||
T Consensus 226 --~~~i~~~~~~~------------------~~~~~~~~l~~li~~cl~~dP~~Rps~~ei 266 (287)
T d1opja_ 226 --YELLEKDYRME------------------RPEGCPEKVYELMRACWQWNPSDRPSFAEI 266 (287)
T ss_dssp --HHHHHTTCCCC------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred --HHHHhcCCCCC------------------CCccchHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 11111111000 001234568899999999999999999764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.3e-48 Score=415.56 Aligned_cols=251 Identities=23% Similarity=0.267 Sum_probs=186.6
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
..++|++.+.||+|+||+||+|+++.+++.||||++.... ....+.+.+|++++++++|||||+++++ +.+++.
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~-----~~~~~~ 81 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI-----YESGGH 81 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEE-----EECSSE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEE-----EEECCE
Confidence 3567999999999999999999999999999999997432 2334568899999999999999999999 556788
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEec---CCCc
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLD---EDMI 841 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~ 841 (986)
.|+||||++||+|.+++.. .+.+++.++..++.||+.||+|||++ +|+||||||+||++. +++.
T Consensus 82 ~~lvmE~~~gg~L~~~l~~----------~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~ 148 (307)
T d1a06a_ 82 LYLIMQLVSGGELFDRIVE----------KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSK 148 (307)
T ss_dssp EEEEECCCCSCBHHHHHHT----------CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCC
T ss_pred EEEEEeccCCCcHHHhhhc----------ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCce
Confidence 9999999999999999952 34699999999999999999999999 999999999999994 5789
Q ss_pred EEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHh
Q 046598 842 AHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLART 921 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~ 921 (986)
+||+|||+|+..... ......+||+.|||||++.+..|+.++||||+||++|||++|+.||...... .....
T Consensus 149 vkl~DFG~a~~~~~~---~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-----~~~~~ 220 (307)
T d1a06a_ 149 IMISDFGLSKMEDPG---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA-----KLFEQ 220 (307)
T ss_dssp EEECCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHH
T ss_pred EEEeccceeEEccCC---CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH-----HHHHH
Confidence 999999999865422 2233467999999999999999999999999999999999999999632111 11110
Q ss_pred hCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 922 ALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 922 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+......... +.....+.++.+++.+||+.||++|||++|+
T Consensus 221 --------i~~~~~~~~~----------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ei 261 (307)
T d1a06a_ 221 --------ILKAEYEFDS----------------PYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261 (307)
T ss_dssp --------HHTTCCCCCT----------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred --------HhccCCCCCC----------------ccccCCCHHHHHHHHHHccCCHhHCcCHHHH
Confidence 0000000000 0001234567899999999999999998764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=404.18 Aligned_cols=246 Identities=26% Similarity=0.413 Sum_probs=187.8
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 767 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 767 (986)
++|++.+.||+|+||+||+|++.+ ++.||||+++... ...+++.+|++++++++|||||+++|+| ..++..++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~-----~~~~~~~l 77 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVC-----LEQAPICL 77 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSCEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCccccccee-----ccCCceEE
Confidence 578899999999999999999976 6789999997533 3457899999999999999999999995 34577899
Q ss_pred EEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccc
Q 046598 768 VFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDF 847 (986)
Q Consensus 768 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DF 847 (986)
||||+++|+|.+++. .....+++..++.|+.|||+||+|||++ +|+||||||+||++++++.+||+||
T Consensus 78 v~E~~~~g~L~~~l~---------~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DF 145 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLR---------TQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDF 145 (263)
T ss_dssp EEECCTTCBHHHHHH---------TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSC
T ss_pred EEEecCCCcHHHHhh---------ccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEeccc
Confidence 999999999999986 2335689999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhC-CCCCCccccccccHHHHHHhhCCCc
Q 046598 848 GLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITR-KKPTDIMFEGDMNLHNLARTALPDH 926 (986)
Q Consensus 848 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~ 926 (986)
|+|+....... .......||+.|+|||++.+..++.++|||||||++|||+|+ ++||... .......
T Consensus 146 Gla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~-----~~~~~~~------ 213 (263)
T d1sm2a_ 146 GMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-----SNSEVVE------ 213 (263)
T ss_dssp C-------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC-----CHHHHHH------
T ss_pred chheeccCCCc-eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC-----CHHHHHH------
Confidence 99987643322 223345689999999999999999999999999999999995 5554321 1111111
Q ss_pred hhHHhhhhcc-cCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 927 VMDIVDSTLL-NDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 927 ~~~~~d~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+..... ..| ..++.++.+++.+||+.||++||||+||
T Consensus 214 ---~i~~~~~~~~p-------------------~~~~~~l~~li~~cl~~~p~~Rps~~~i 252 (263)
T d1sm2a_ 214 ---DISTGFRLYKP-------------------RLASTHVYQIMNHCWKERPEDRPAFSRL 252 (263)
T ss_dssp ---HHHHTCCCCCC-------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ---HHHhcCCCCCc-------------------cccCHHHHHHHHHHccCCHhHCcCHHHH
Confidence 0110000 001 1234567899999999999999999864
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.5e-47 Score=415.49 Aligned_cols=251 Identities=22% Similarity=0.296 Sum_probs=204.4
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
.++|++.+.||+|+||+||+|++..+++.||||++........+.+.+|++++++++|||||+++++ +.+++..|
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~-----~~~~~~~~ 99 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA-----FEDDNEMV 99 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEE-----EEETTEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEE-----EEECCEEE
Confidence 5689999999999999999999999999999999987666667889999999999999999999999 45568899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEec--CCCcEEE
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLD--EDMIAHI 844 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kL 844 (986)
+|||||+||+|.+++. ...+.+++.+++.|+.||+.||+|||++ +||||||||+|||++ .++.+||
T Consensus 100 ivmE~~~gg~L~~~l~---------~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL 167 (350)
T d1koaa2 100 MIYEFMSGGELFEKVA---------DEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKL 167 (350)
T ss_dssp EEECCCCSCBHHHHHT---------CTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEE
T ss_pred EEEEcCCCCCHHHHHH---------hhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEE
Confidence 9999999999999985 2234699999999999999999999999 999999999999996 4578999
Q ss_pred cccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCC
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALP 924 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 924 (986)
+|||+|+.+.... ......||+.|||||++.+..++.++||||+||++|||++|+.||..... ......
T Consensus 168 ~DFG~a~~~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~~~~--- 236 (350)
T d1koaa2 168 IDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-----DETLRN--- 236 (350)
T ss_dssp CCCTTCEECCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH---
T ss_pred eecchheeccccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH-----HHHHHH---
Confidence 9999998765332 23346799999999999999999999999999999999999999963211 111110
Q ss_pred CchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 925 DHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 925 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+......... . .....+.++.+++.+||+.||++|||++|+
T Consensus 237 -----i~~~~~~~~~-~---------------~~~~~s~~~~~li~~~L~~dP~~R~t~~ei 277 (350)
T d1koaa2 237 -----VKSCDWNMDD-S---------------AFSGISEDGKDFIRKLLLADPNTRMTIHQA 277 (350)
T ss_dssp -----HHHTCCCSCC-G---------------GGGGCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred -----HHhCCCCCCc-c---------------cccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 0000000000 0 001223457789999999999999998764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-47 Score=404.35 Aligned_cols=249 Identities=27% Similarity=0.435 Sum_probs=197.4
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
.++|++.+.||+|+||+||+|++++ ++.||||+++... ...+.+.+|++++++++|||||+++++|. ++..+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~------~~~~~ 83 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIY 83 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSSCE
T ss_pred HHHeEEeEEEecCCCcEEEEEEECC-CCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeec------cCCeE
Confidence 4678999999999999999999875 6889999997543 34578999999999999999999999853 24578
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+++|+|.+++.. .....+++.+++.|+.||++||+|||++ +|+||||||+|||+++++.+||+|
T Consensus 84 iv~Ey~~~g~L~~~~~~--------~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~D 152 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKT--------PSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIAD 152 (272)
T ss_dssp EEEECCTTCBHHHHTTS--------HHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECC
T ss_pred EEEEeCCCCcHHHHHhh--------cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeecc
Confidence 99999999999998852 2223589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCc
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDH 926 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 926 (986)
||+|+...... ........||+.|||||++.++.++.++|||||||++|||+||..|+..... .......
T Consensus 153 FGla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~----~~~~~~~----- 222 (272)
T d1qpca_ 153 FGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT----NPEVIQN----- 222 (272)
T ss_dssp CTTCEECSSSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC----HHHHHHH-----
T ss_pred ccceEEccCCc-cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC----HHHHHHH-----
Confidence 99999775332 2333456789999999999999999999999999999999996665432111 1111110
Q ss_pred hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 927 VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 927 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+....... .+..++.++.+++.+||+.||++||||+||
T Consensus 223 ----i~~~~~~~------------------~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei 260 (272)
T d1qpca_ 223 ----LERGYRMV------------------RPDNCPEELYQLMRLCWKERPEDRPTFDYL 260 (272)
T ss_dssp ----HHTTCCCC------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ----HHhcCCCC------------------CcccChHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 10000000 001234567899999999999999999764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-47 Score=404.23 Aligned_cols=249 Identities=23% Similarity=0.368 Sum_probs=197.7
Q ss_pred cCCCCCc-ccccccceeEEEEEECC--CCeEEEEEEeecc-CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 688 DRFSSVN-QIGEGSFGSVFKGILDD--GRTTIAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 688 ~~y~~~~-~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
++|.+.+ +||+|+||+||+|.++. ++..||||+++.. .....+++.+|++++++++|||||+++++|.. +
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------~ 81 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------E 81 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES------S
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc------C
Confidence 4566666 49999999999998753 3568999999753 33456789999999999999999999998632 4
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..|+||||+++|+|.+++. .....+++.++..|+.||++||+|||++ +|+||||||+||+++.++.+|
T Consensus 82 ~~~lvmE~~~~g~L~~~l~---------~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~K 149 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLV---------GKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAK 149 (285)
T ss_dssp SEEEEEECCTTEEHHHHHT---------TCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEE
T ss_pred eEEEEEEeCCCCcHHHHhh---------ccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCcee
Confidence 5799999999999999985 2234689999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCc-cccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHh
Q 046598 844 IGDFGLARFLPLSSAQ-TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLART 921 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~ 921 (986)
|+|||+|+.+...... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||...... ........
T Consensus 150 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--~~~~~i~~ 227 (285)
T d1u59a_ 150 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQ 227 (285)
T ss_dssp ECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHHHHT
T ss_pred eccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--HHHHHHHc
Confidence 9999999987544332 22334568999999999999999999999999999999998 99999743211 11111110
Q ss_pred hCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 922 ALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 922 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
... .+.+..++.++.+++.+||+.||++||||.+|
T Consensus 228 ~~~------------------------------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i 262 (285)
T d1u59a_ 228 GKR------------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTV 262 (285)
T ss_dssp TCC------------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred CCC------------------------------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 000 00011345568899999999999999998764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=396.03 Aligned_cols=248 Identities=24% Similarity=0.398 Sum_probs=202.2
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
.++|++.++||+|+||+||+|+++ +++.||||+++.... ..+++.+|+.++++++||||++++|+| .+++..+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~-----~~~~~~~ 75 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQRPIF 75 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEE-----CCSSSEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEE-----eeCCceE
Confidence 368999999999999999999996 478999999986443 457899999999999999999999995 4557899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+++|+|.+++. .....+++..+++|+.||++||+|||+. ||+||||||+||++++++.+||+|
T Consensus 76 iv~Ey~~~g~l~~~~~---------~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~D 143 (258)
T d1k2pa_ 76 IITEYMANGCLLNYLR---------EMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSD 143 (258)
T ss_dssp EEEECCTTEEHHHHHH---------SGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECC
T ss_pred EEEEccCCCcHHHhhh---------ccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECc
Confidence 9999999999999975 3345689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCC
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALPD 925 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 925 (986)
||+|+....... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||......+ ........
T Consensus 144 fG~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~--~~~~i~~~--- 217 (258)
T d1k2pa_ 144 FGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TAEHIAQG--- 217 (258)
T ss_dssp CSSCCBCSSSSC-CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHHHHTT---
T ss_pred chhheeccCCCc-eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH--HHHHHHhC---
Confidence 999987654322 23344678999999999999999999999999999999998 899987432211 11111100
Q ss_pred chhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 926 HVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 926 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.-...| ..++.++.+++.+||+.||++||||+||
T Consensus 218 --------~~~~~p-------------------~~~~~~l~~li~~cl~~dP~~RPt~~ei 251 (258)
T d1k2pa_ 218 --------LRLYRP-------------------HLASEKVYTIMYSCWHEKADERPTFKIL 251 (258)
T ss_dssp --------CCCCCC-------------------TTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred --------CCCCCc-------------------ccccHHHHHHHHHHccCCHhHCcCHHHH
Confidence 000001 1233567899999999999999999764
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.8e-46 Score=412.84 Aligned_cols=251 Identities=20% Similarity=0.263 Sum_probs=204.6
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
.++|++++.||+|+||+||+|++..+++.||||+++.......+.+.+|++++++++|||||+++++ +.+++..|
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~-----~~~~~~~~ 102 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA-----FEDKYEMV 102 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEE-----EECSSEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEE-----EEECCEEE
Confidence 4679999999999999999999999999999999987665666788999999999999999999999 56678899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEec--CCCcEEE
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLD--EDMIAHI 844 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kL 844 (986)
+||||++||+|.+++. .....+++.+++.|+.||+.||+|||++ ||+||||||+|||++ .++.+||
T Consensus 103 ivmE~~~gg~L~~~~~---------~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL 170 (352)
T d1koba_ 103 LILEFLSGGELFDRIA---------AEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKI 170 (352)
T ss_dssp EEEECCCCCBHHHHTT---------CTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEE
T ss_pred EEEEcCCCChHHHHHH---------hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEE
Confidence 9999999999999875 2334699999999999999999999999 999999999999998 6789999
Q ss_pred cccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCC
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALP 924 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 924 (986)
+|||+|+.+.... ......||+.|||||++.+..++.++||||+||++|||+||+.||......+ .+.........
T Consensus 171 ~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~i~~~~~~ 246 (352)
T d1koba_ 171 IDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-TLQNVKRCDWE 246 (352)
T ss_dssp CCCTTCEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHHCCCC
T ss_pred eecccceecCCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCC
Confidence 9999998875432 2334568999999999999999999999999999999999999996321110 01111110000
Q ss_pred CchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 925 DHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 925 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+.. .....+.++.+++.+||+.||++|||++|+
T Consensus 247 -------------~~~~---------------~~~~~s~~~~~li~~~L~~dp~~R~s~~ei 280 (352)
T d1koba_ 247 -------------FDED---------------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 280 (352)
T ss_dssp -------------CCSS---------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred -------------CCcc---------------cccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 0000 001233457799999999999999998763
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.3e-47 Score=408.46 Aligned_cols=244 Identities=25% Similarity=0.330 Sum_probs=196.4
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc---hhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH---GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
+.|+.++.||+|+||+||+|++..+++.||||+++.... ...+.+.+|++++++++|||||++++++ .+++.
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~ 89 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY-----LREHT 89 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEE-----EECCE
Confidence 459999999999999999999999999999999975432 3346789999999999999999999994 45578
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.|+|||||++|++..++. ..+.+++.+++.|+.||+.||.|||++ ||+||||||+|||++.++.+||
T Consensus 90 ~~iv~E~~~~g~l~~~~~----------~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl 156 (309)
T d1u5ra_ 90 AWLVMEYCLGSASDLLEV----------HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKL 156 (309)
T ss_dssp EEEEEECCSEEHHHHHHH----------HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEE
T ss_pred EEEEEEecCCCchHHHHH----------hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEE
Confidence 999999999999987763 234689999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCccccccccccccccccccccC---CCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHh
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG---SEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLART 921 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~ 921 (986)
+|||+|+.... .....||+.|||||++.+ +.|+.++|||||||++|||++|+.||......+ .+......
T Consensus 157 ~DFG~a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~-~~~~i~~~ 229 (309)
T d1u5ra_ 157 GDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQN 229 (309)
T ss_dssp CCCTTCBSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHS
T ss_pred eecccccccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhC
Confidence 99999986432 223569999999999864 468999999999999999999999986321110 01111110
Q ss_pred hCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 922 ALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 922 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..+. +. ....+.++.+++.+||+.||++||||+|+
T Consensus 230 ~~~~-------------~~-----------------~~~~s~~~~~li~~~L~~dP~~Rpt~~el 264 (309)
T d1u5ra_ 230 ESPA-------------LQ-----------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVL 264 (309)
T ss_dssp CCCC-------------CS-----------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCC-------------CC-----------------CCCCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence 0000 00 00123457799999999999999998764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-47 Score=412.71 Aligned_cols=261 Identities=24% Similarity=0.342 Sum_probs=201.3
Q ss_pred hcCCCCCcccccccceeEEEEEECCCC-----eEEEEEEeec-cCchhHHHHHHHHHHHhcC-CCCcceeeeeecccccc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGR-----TTIAVKVFNL-LHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDY 759 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 759 (986)
.++|++.+.||+|+||+||+|++...+ ..||||++.. ........+.+|+.++.++ +|||||+++++|
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~----- 110 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC----- 110 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE-----
Confidence 367899999999999999999986543 3699999854 2334456789999999998 899999999994
Q ss_pred CCCceEEEEEEeccCCCHhHhhccCCCCC-------------ccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 046598 760 QGNDFKALVFEFMHNRSLEEWLHPITRED-------------ETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAH 826 (986)
Q Consensus 760 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-------------~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH 826 (986)
.+.+..++||||+++|+|.++++...... ........+++.+++.|+.||++||+|||++ +|||
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiH 187 (325)
T d1rjba_ 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVH 187 (325)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceee
Confidence 45678999999999999999997543210 0012234689999999999999999999999 9999
Q ss_pred ecCCCCCeEecCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCC
Q 046598 827 CDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPT 905 (986)
Q Consensus 827 ~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf 905 (986)
|||||+||+++.++.+||+|||+|+...............||+.|||||++.++.++.++|||||||++|||+| |+.||
T Consensus 188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred ccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence 99999999999999999999999987655444444455678999999999999999999999999999999998 89999
Q ss_pred CccccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCC
Q 046598 906 DIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTN 985 (986)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 985 (986)
...... ..+...... ....+ .+..++.++.+++.+||+.||++||||+|
T Consensus 268 ~~~~~~-~~~~~~~~~------------~~~~~------------------~p~~~~~~l~~li~~cl~~dP~~RPt~~e 316 (325)
T d1rjba_ 268 PGIPVD-ANFYKLIQN------------GFKMD------------------QPFYATEEIYIIMQSCWAFDSRKRPSFPN 316 (325)
T ss_dssp TTCCCS-HHHHHHHHT------------TCCCC------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCHH-HHHHHHHhc------------CCCCC------------------CCCcCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 743221 111111111 11000 01123456889999999999999999987
Q ss_pred C
Q 046598 986 V 986 (986)
Q Consensus 986 V 986 (986)
|
T Consensus 317 i 317 (325)
T d1rjba_ 317 L 317 (325)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-46 Score=401.37 Aligned_cols=250 Identities=21% Similarity=0.252 Sum_probs=201.9
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC------chhHHHHHHHHHHHhcCCCCcceeeeeeccccccC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH------HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ 760 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 760 (986)
.++|++.+.||+|+||+||+|+++.+++.||||+++... ....+.+.+|++++++++|||||+++++ +.
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~-----~~ 83 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEV-----YE 83 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE-----EE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEE-----EE
Confidence 468999999999999999999999999999999986422 1235789999999999999999999999 55
Q ss_pred CCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCC
Q 046598 761 GNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDM 840 (986)
Q Consensus 761 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 840 (986)
+++..|+|||||++|+|.+++.. .+.+++.+++.++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 84 ~~~~~~iv~E~~~gg~L~~~i~~----------~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~ 150 (293)
T d1jksa_ 84 NKTDVILILELVAGGELFDFLAE----------KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRN 150 (293)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSS
T ss_pred ECCEEEEEEEcCCCccccchhcc----------ccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCC
Confidence 67899999999999999999952 24699999999999999999999999 999999999999998776
Q ss_pred ----cEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHH
Q 046598 841 ----IAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLH 916 (986)
Q Consensus 841 ----~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~ 916 (986)
.+|++|||+|+...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... .
T Consensus 151 ~~~~~vkl~DfG~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----~ 222 (293)
T d1jksa_ 151 VPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----Q 222 (293)
T ss_dssp SSSCCEEECCCTTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----H
T ss_pred CcccceEecchhhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH-----H
Confidence 59999999998764332 23345689999999999999999999999999999999999999963211 1
Q ss_pred HHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 917 NLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 917 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
...... ....... ........+.++.+++.+||+.||++|||++|+
T Consensus 223 ~~~~~i------------~~~~~~~------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ei 268 (293)
T d1jksa_ 223 ETLANV------------SAVNYEF------------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268 (293)
T ss_dssp HHHHHH------------HTTCCCC------------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred HHHHHH------------HhcCCCC------------CchhcCCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 111100 0000000 000111234567799999999999999998764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=399.51 Aligned_cols=242 Identities=24% Similarity=0.373 Sum_probs=190.6
Q ss_pred cccccccceeEEEEEECC--CCeEEEEEEeec--cCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEEE
Q 046598 694 NQIGEGSFGSVFKGILDD--GRTTIAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVF 769 (986)
Q Consensus 694 ~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 769 (986)
++||+|+||+||+|.++. +++.||||+++. .+....+++.+|++++++++|||||+++++|. . +..++||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~-----~-~~~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-----A-ESWMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----S-SSEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec-----c-CCEEEEE
Confidence 469999999999998753 457899999864 23344578999999999999999999999863 2 3578999
Q ss_pred EeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccccc
Q 046598 770 EFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFGL 849 (986)
Q Consensus 770 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~ 849 (986)
||+++|+|.++++. ...+++.++..|+.||++||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 87 E~~~~g~L~~~l~~----------~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGl 153 (277)
T d1xbba_ 87 EMAELGPLNKYLQQ----------NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGL 153 (277)
T ss_dssp ECCTTEEHHHHHHH----------CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred EcCCCCcHHHHHhh----------ccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhh
Confidence 99999999999852 34689999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCc-cccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCch
Q 046598 850 ARFLPLSSAQ-TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALPDHV 927 (986)
Q Consensus 850 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 927 (986)
|+........ .......||+.|||||++.+..++.++|||||||++|||+| |+.||...... .....
T Consensus 154 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--~~~~~--------- 222 (277)
T d1xbba_ 154 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAM--------- 222 (277)
T ss_dssp CEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHH---------
T ss_pred hhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH--HHHHH---------
Confidence 9876544332 22334568999999999999999999999999999999998 89999742211 11111
Q ss_pred hHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 928 MDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 928 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+..... .+.+..++.++.+++.+||+.||++||||+||
T Consensus 223 ---i~~~~~------------------~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i 260 (277)
T d1xbba_ 223 ---LEKGER------------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAV 260 (277)
T ss_dssp ---HHTTCC------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred ---HHcCCC------------------CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 111000 00011245568899999999999999999764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-46 Score=400.30 Aligned_cols=251 Identities=22% Similarity=0.413 Sum_probs=190.2
Q ss_pred cCCCCCcccccccceeEEEEEECCCC----eEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGR----TTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
+.|+..+.||+|+||+||+|.++.++ ..||||+++... ....+++.+|++++++++|||||+++|+| .+.
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~-----~~~ 81 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-----SKY 81 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEE-----ecC
Confidence 56888899999999999999987543 579999986533 33456789999999999999999999995 445
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
+..++||||+.++++.+++. .....+++.++..|+.||+.||+|||++ +|+||||||+|||++.++.+
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~---------~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~ 149 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLR---------EKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVC 149 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHH---------HTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCE
T ss_pred CceEEEEEecccCcchhhhh---------cccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeE
Confidence 77899999999999999885 3335699999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCc-cccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHh
Q 046598 843 HIGDFGLARFLPLSSAQ-TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLART 921 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~ 921 (986)
||+|||+|+........ .......||+.|||||++.+..++.++|||||||++|||++|..|+..... .....
T Consensus 150 Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~----~~~~~-- 223 (283)
T d1mqba_ 150 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS----NHEVM-- 223 (283)
T ss_dssp EECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHHH--
T ss_pred EEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC----HHHHH--
Confidence 99999999876543222 223345689999999999999999999999999999999997666532111 11111
Q ss_pred hCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 922 ALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 922 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+.+...... +.+.+++.++.+++.+||+.||++||||+||
T Consensus 224 -------~~i~~~~~~------------------~~~~~~~~~l~~li~~cl~~~p~~RPt~~ei 263 (283)
T d1mqba_ 224 -------KAINDGFRL------------------PTPMDCPSAIYQLMMQCWQQERARRPKFADI 263 (283)
T ss_dssp -------HHHHTTCCC------------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred -------HHHhccCCC------------------CCchhhHHHHHHHHHHHCcCCHhHCcCHHHH
Confidence 111111100 0011244568899999999999999999764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-45 Score=399.84 Aligned_cols=244 Identities=21% Similarity=0.257 Sum_probs=200.8
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
.++|++++.||+|+||.||+|+++.+++.||||+++.. .....+.+.+|+.++++++||||++++++ +.+++
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~-----~~~~~ 78 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYA-----FQTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEE-----EECSS
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEee-----ecccc
Confidence 35799999999999999999999999999999999742 23445778999999999999999999999 56778
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..|+||||++||+|.+++. ..+.+++.+++.++.||+.||+|||++ +|+||||||+|||++++|.+|
T Consensus 79 ~~~iv~ey~~gg~L~~~~~----------~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vk 145 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLS----------RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIK 145 (337)
T ss_dssp EEEEEEECCTTCBHHHHHH----------HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEE
T ss_pred ccccceeccCCCchhhhhh----------cccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEE
Confidence 9999999999999999995 234689999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhC
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTAL 923 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 923 (986)
|+|||+|+...... ......+||+.|||||++.+..|+.++||||+||++|||++|++||..... .....
T Consensus 146 l~DFG~a~~~~~~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~-----~~~~~--- 215 (337)
T d1o6la_ 146 ITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----ERLFE--- 215 (337)
T ss_dssp ECCCTTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH---
T ss_pred EeecccccccccCC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH-----HHHHH---
Confidence 99999998654322 223456799999999999999999999999999999999999999963221 11111
Q ss_pred CCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 046598 924 PDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSM 983 (986)
Q Consensus 924 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 983 (986)
......+. .+...+.++.+++.+||+.||++||+.
T Consensus 216 ---------~i~~~~~~----------------~p~~~s~~~~dli~~~L~~dP~~R~~~ 250 (337)
T d1o6la_ 216 ---------LILMEEIR----------------FPRTLSPEAKSLLAGLLKKDPKQRLGG 250 (337)
T ss_dssp ---------HHHHCCCC----------------CCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ---------HHhcCCCC----------------CCccCCHHHHHHHHhhccCCchhhccc
Confidence 00000000 000123456789999999999999963
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3e-45 Score=397.52 Aligned_cols=197 Identities=26% Similarity=0.359 Sum_probs=176.9
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
++|++.+.||+|+||+||+|+++.+++.||||+++.. .....+.+.+|+.++++++|||||+++++ +.+++.
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~-----~~~~~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGT-----FQDAQQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEE-----EECSSE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeee-----EeeCCe
Confidence 5799999999999999999999999999999999742 23345788999999999999999999999 556789
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.|+||||++||+|..++. ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||
T Consensus 79 ~~ivmE~~~gg~l~~~~~----------~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL 145 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLR----------KSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKI 145 (316)
T ss_dssp EEEEECCCCSCBHHHHHH----------HTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEE
T ss_pred eeeEeeecCCcccccccc----------ccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEE
Confidence 999999999999999985 334678889999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
+|||+|+..... ....+||+.|||||++.+..|+.++||||+||++|||+||+.||..
T Consensus 146 ~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~ 203 (316)
T d1fota_ 146 TDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD 203 (316)
T ss_dssp CCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ecCccceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCC
Confidence 999999876432 2346799999999999999999999999999999999999999963
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2e-45 Score=393.57 Aligned_cols=256 Identities=22% Similarity=0.323 Sum_probs=194.8
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
.++|++.+.||+|+||+||+|++..+++.||||+++.. +....+++.+|++++++++||||+++++++... .....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~-~~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE-TPAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE-CSSSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeec-cCCCc
Confidence 47899999999999999999999999999999999743 233456789999999999999999999986432 22334
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..|+||||++|++|.+++. ..+.+++.+++.|+.||+.||+|||++ +|+||||||+||+++.++..+
T Consensus 85 ~~~lvmE~~~g~~L~~~~~----------~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~ 151 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVH----------TEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVK 151 (277)
T ss_dssp EEEEEEECCCEEEHHHHHH----------HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEE
T ss_pred eEEEEEECCCCCEehhhhc----------ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccce
Confidence 5899999999999999884 234689999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCC-ccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 046598 844 IGDFGLARFLPLSSA-QTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTA 922 (986)
Q Consensus 844 L~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 922 (986)
++|||.++....... ........||+.|||||++.+..+++++||||+||++|||+||+.||...... ....
T Consensus 152 l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-----~~~~-- 224 (277)
T d1o6ya_ 152 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-----SVAY-- 224 (277)
T ss_dssp ECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHH--
T ss_pred eehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH-----HHHH--
Confidence 999999976543322 23344567999999999999999999999999999999999999999632211 1111
Q ss_pred CCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCC-CCCC
Q 046598 923 LPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRM-SMTN 985 (986)
Q Consensus 923 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~e 985 (986)
..+...+... .......+.++.+++.+|++.||++|| ||+|
T Consensus 225 ----------~~~~~~~~~~------------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~ 266 (277)
T d1o6ya_ 225 ----------QHVREDPIPP------------SARHEGLSADLDAVVLKALAKNPENRYQTAAE 266 (277)
T ss_dssp ----------HHHHCCCCCG------------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHH
T ss_pred ----------HHHhcCCCCC------------chhccCCCHHHHHHHHHHccCCHhHCHhHHHH
Confidence 0011110000 000012345678999999999999999 5554
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=401.13 Aligned_cols=249 Identities=24% Similarity=0.388 Sum_probs=193.9
Q ss_pred cCCCCCcccccccceeEEEEEECCCCe----EEEEEEeec-cCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRT----TIAVKVFNL-LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
++|++++.||+|+||+||+|++..+++ +||+|+++. ......+++.+|++++++++|||||+++++|..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~------ 82 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------ 82 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES------
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence 469999999999999999999976654 588888754 333456789999999999999999999999642
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
+..+++|||+.+|+|.+++. .....+++..++.|+.||+.||+|||++ +|+||||||+||+++.++.+
T Consensus 83 ~~~~~v~e~~~~~~l~~~~~---------~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~ 150 (317)
T d1xkka_ 83 STVQLITQLMPFGCLLDYVR---------EHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 150 (317)
T ss_dssp SSEEEEEECCTTCBHHHHHH---------HTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEE
T ss_pred CCeeEEEEeccCCccccccc---------ccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCe
Confidence 35688999999999999886 3345689999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHh
Q 046598 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLART 921 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~ 921 (986)
||+|||+|+...............||+.|||||++.++.++.++|||||||++|||+| |++||+..... .......
T Consensus 151 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~--~~~~~i~- 227 (317)
T d1xkka_ 151 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILE- 227 (317)
T ss_dssp EECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG--GHHHHHH-
T ss_pred EeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH--HHHHHHH-
Confidence 9999999988765544444455678999999999999999999999999999999999 78888643221 1111111
Q ss_pred hCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 922 ALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 922 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..... +.+..++.++.+++.+||+.||++||||+||
T Consensus 228 -----------~~~~~------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei 263 (317)
T d1xkka_ 228 -----------KGERL------------------PQPPICTIDVYMIMVKCWMIDADSRPKFREL 263 (317)
T ss_dssp -----------HTCCC------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -----------cCCCC------------------CCCcccCHHHHHHHHHhCCCChhhCcCHHHH
Confidence 10000 0011234567899999999999999998764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-45 Score=395.93 Aligned_cols=246 Identities=24% Similarity=0.333 Sum_probs=199.5
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHh-cCCCCcceeeeeeccccccCCCc
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLK-NIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
++|++.+.||+|+||+||+|++..+++.||||+++.. .....+.+..|..++. .++|||||+++++ +.+++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~-----~~~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCT-----FQTKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEE-----EECSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEE-----EccCC
Confidence 5799999999999999999999999999999999742 2334456777877765 6899999999999 56678
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..|+||||+++|+|.++++. ...+++.+++.++.||+.||+|||++ +|+||||||+|||+++++.+|
T Consensus 77 ~~yivmEy~~~g~L~~~i~~----------~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~k 143 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQS----------CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIK 143 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEE
T ss_pred ceeEEEeecCCCcHHHHhhc----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCcee
Confidence 89999999999999999952 34588999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhC
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTAL 923 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 923 (986)
|+|||+|+..... ........||+.|+|||++.+..++.++||||+||++|||+||+.||..... ......
T Consensus 144 l~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~-----~~~~~~-- 214 (320)
T d1xjda_ 144 IADFGMCKENMLG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-----EELFHS-- 214 (320)
T ss_dssp ECCCTTCBCCCCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH--
T ss_pred ccccchhhhcccc--cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH-----HHHHHH--
Confidence 9999999865432 2233446799999999999999999999999999999999999999963211 111110
Q ss_pred CCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCC-CC
Q 046598 924 PDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMT-NV 986 (986)
Q Consensus 924 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~-eV 986 (986)
.....+.- +...+.++.+++.+||+.||++|||++ ||
T Consensus 215 ----------i~~~~~~~----------------p~~~s~~~~dli~~~L~~dP~~R~s~~~~l 252 (320)
T d1xjda_ 215 ----------IRMDNPFY----------------PRWLEKEAKDLLVKLFVREPEKRLGVRGDI 252 (320)
T ss_dssp ----------HHHCCCCC----------------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCG
T ss_pred ----------HHcCCCCC----------------CccCCHHHHHHHHHhcccCCCCCcCHHHHH
Confidence 00011100 002234577999999999999999985 54
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.1e-45 Score=387.84 Aligned_cols=250 Identities=22% Similarity=0.288 Sum_probs=200.0
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc---------hhHHHHHHHHHHHhcCC-CCcceeeeeeccc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH---------GAFKSFIAECNTLKNIR-HRNLVKILTACSG 756 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 756 (986)
.++|++.+.||+|+||+||+|++..+++.||||+++.... ...+++.+|+.++++++ ||||++++++
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~--- 78 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT--- 78 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE---
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEee---
Confidence 3689999999999999999999998999999999865321 12346889999999996 9999999999
Q ss_pred cccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEe
Q 046598 757 VDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILL 836 (986)
Q Consensus 757 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 836 (986)
+.+++..|+||||+++|+|.++++ ..+.+++.+++.++.||+.||+|||++ +|+||||||+||++
T Consensus 79 --~~~~~~~~ivmE~~~~g~L~~~l~----------~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill 143 (277)
T d1phka_ 79 --YETNTFFFLVFDLMKKGELFDYLT----------EKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILL 143 (277)
T ss_dssp --EECSSEEEEEEECCTTCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred --cccCcceEEEEEcCCCchHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEE
Confidence 566789999999999999999995 234699999999999999999999999 99999999999999
Q ss_pred cCCCcEEEcccccceecCCCCCccccccccccccccccccccC------CCcCcccchhhHHHHHHHHHhCCCCCCcccc
Q 046598 837 DEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG------SEVSISGDVYSYGILLLELITRKKPTDIMFE 910 (986)
Q Consensus 837 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlGvvl~elltg~~pf~~~~~ 910 (986)
+.++.+||+|||+|+.+.... ......||+.|+|||++.+ ..++.++||||+||++|||+||+.||.....
T Consensus 144 ~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~ 220 (277)
T d1phka_ 144 DDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ 220 (277)
T ss_dssp CTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cCCCCeEEccchheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH
Confidence 999999999999998865432 2234679999999998753 3578899999999999999999999974321
Q ss_pred ccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 911 GDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.. ............ +. +.....+.++.+++.+||+.||++|||++||
T Consensus 221 ~~-~~~~i~~~~~~~-------------~~---------------~~~~~~s~~~~~li~~~L~~~p~~R~s~~ei 267 (277)
T d1phka_ 221 ML-MLRMIMSGNYQF-------------GS---------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267 (277)
T ss_dssp HH-HHHHHHHTCCCC-------------CT---------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred HH-HHHHHHhCCCCC-------------CC---------------cccccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 11 000111100000 00 0001234567899999999999999998764
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=393.71 Aligned_cols=249 Identities=28% Similarity=0.454 Sum_probs=192.0
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
.++|++.+.||+|+||+||+|+++++ +.||||+++... ...+.|.+|+.++++++|||||+++++|. ++..+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~------~~~~~ 87 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIY 87 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSSCE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe------cCCeE
Confidence 36799999999999999999999874 679999997543 34578999999999999999999999853 24578
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||+++|+|.+++.. .....+++.+++.|+.||+.||+|||++ +|+||||||+|||++.++++||+|
T Consensus 88 lv~Ey~~~g~l~~~~~~--------~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~D 156 (285)
T d1fmka3 88 IVTEYMSKGSLLDFLKG--------ETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVAD 156 (285)
T ss_dssp EEECCCTTCBHHHHHSH--------HHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECC
T ss_pred EEEEecCCCchhhhhhh--------cccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcc
Confidence 99999999999999852 2234689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCc
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDH 926 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 926 (986)
||+|+...... ........||+.|+|||++.++.++.++|||||||++|||+||..||..... ......
T Consensus 157 fGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~----~~~~~~------ 225 (285)
T d1fmka3 157 FGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV----NREVLD------ 225 (285)
T ss_dssp CCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC----HHHHHH------
T ss_pred cchhhhccCCC-ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC----HHHHHH------
Confidence 99998764332 2333446789999999999999999999999999999999997666542211 111111
Q ss_pred hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 927 VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 927 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+...... +...+++.++.+++.+||+.||++||||+||
T Consensus 226 ---~i~~~~~~------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i 264 (285)
T d1fmka3 226 ---QVERGYRM------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYL 264 (285)
T ss_dssp ---HHHTTCCC------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ---HHHhcCCC------------------CCCcccCHHHHHHHHHHcccCHhHCcCHHHH
Confidence 11110000 0011344568899999999999999999764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-45 Score=395.57 Aligned_cols=250 Identities=21% Similarity=0.298 Sum_probs=201.4
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
.++|++.+.||+|+||+||+|.+..+++.||||+++... .....+.+|++++++++|||||+++++ +.+++..|
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~-----~~~~~~~~ 77 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHES-----FESMEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEE-----EEETTEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEE-----EEECCEEE
Confidence 578999999999999999999999999999999997643 334568899999999999999999999 55668899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCC--CcEEE
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED--MIAHI 844 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kL 844 (986)
+|||||+||+|.+++. .....+++.+++.|+.||+.||+|||++ ||+||||||+|||++.+ ..+||
T Consensus 78 lvmE~~~gg~L~~~i~---------~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl 145 (321)
T d1tkia_ 78 MIFEFISGLDIFERIN---------TSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKI 145 (321)
T ss_dssp EEECCCCCCBHHHHHT---------SSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEE
T ss_pred EEEecCCCCcHHHHHH---------hcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEE
Confidence 9999999999999996 2234689999999999999999999999 99999999999999854 48999
Q ss_pred cccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCC
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALP 924 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 924 (986)
+|||+++...... ......+|+.|+|||...+..++.++||||+||++|+|++|+.||...... ....
T Consensus 146 ~DFG~~~~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~-----~~~~---- 213 (321)
T d1tkia_ 146 IEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-----QIIE---- 213 (321)
T ss_dssp CCCTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHH----
T ss_pred cccchhhccccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH-----HHHH----
Confidence 9999998764322 223456899999999999999999999999999999999999999632211 1111
Q ss_pred CchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 925 DHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 925 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+...... +. .......+.++.+++.+|+..||++|||++|+
T Consensus 214 ----~i~~~~~~--~~--------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ei 255 (321)
T d1tkia_ 214 ----NIMNAEYT--FD--------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255 (321)
T ss_dssp ----HHHHTCCC--CC--------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred ----HHHhCCCC--CC--------------hhhccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 01110000 00 00011234557799999999999999998763
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.7e-45 Score=399.41 Aligned_cols=197 Identities=22% Similarity=0.324 Sum_probs=177.2
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc---CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
++|++++.||+|+||.||+|+++.+++.||||+++.. .....+.+.+|+++++.++|||||+++++ +.....
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~-----~~~~~~ 115 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS-----FKDNSN 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEE-----EECSSE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccc-----cccccc
Confidence 5899999999999999999999999999999998642 23445678999999999999999999999 556688
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.++||||+.+|+|.+++.. .+.+++.+++.|+.||+.||.|||++ +||||||||+|||++.++.+||
T Consensus 116 ~~~v~e~~~~g~l~~~l~~----------~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL 182 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRR----------IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQV 182 (350)
T ss_dssp EEEEEECCTTCBHHHHHHH----------HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEE
T ss_pred cccccccccccchhhhHhh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEe
Confidence 9999999999999999952 34689999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 845 GDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
+|||+|+.+... .....||+.|||||++.+..++.++||||+||++|||+||+.||..
T Consensus 183 ~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~ 240 (350)
T d1rdqe_ 183 TDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240 (350)
T ss_dssp CCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eeceeeeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCC
Confidence 999999876422 2346799999999999999999999999999999999999999963
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-45 Score=398.64 Aligned_cols=265 Identities=26% Similarity=0.413 Sum_probs=203.4
Q ss_pred HHHHhhcCCCCCcccccccceeEEEEEECC-----CCeEEEEEEeeccCc-hhHHHHHHHHHHHhcCCCCcceeeeeecc
Q 046598 682 NLYNATDRFSSVNQIGEGSFGSVFKGILDD-----GRTTIAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTACS 755 (986)
Q Consensus 682 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 755 (986)
+++...++|++.+.||+|+||+||+|++++ +++.||||+++.... ...+++.+|++++++++||||++++++|
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~- 85 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC- 85 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee-
Confidence 344456789999999999999999999853 467899999875433 3456799999999999999999999995
Q ss_pred ccccCCCceEEEEEEeccCCCHhHhhccCCCCC--------------ccccCCCccCHHHHHHHHHHHHHHHHHHHhcCC
Q 046598 756 GVDYQGNDFKALVFEFMHNRSLEEWLHPITRED--------------ETDEAPRSLNLIQRLNISIDVACALNYLHHDCQ 821 (986)
Q Consensus 756 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ 821 (986)
......++||||+++|+|.++++...... ........+++.+++.|+.|++.||+|||++
T Consensus 86 ----~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~-- 159 (301)
T d1lufa_ 86 ----AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-- 159 (301)
T ss_dssp ----CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred ----ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC--
Confidence 44578999999999999999996433210 1112234589999999999999999999999
Q ss_pred CCeEeecCCCCCeEecCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhC
Q 046598 822 PPIAHCDLKPSNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITR 901 (986)
Q Consensus 822 ~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg 901 (986)
+||||||||+||+++.++.+||+|||+|+...............+++.|+|||.+.+..++.++|||||||++|||++|
T Consensus 160 -~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~ 238 (301)
T d1lufa_ 160 -KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238 (301)
T ss_dssp -TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred -CeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHcc
Confidence 9999999999999999999999999999876544444444456789999999999999999999999999999999998
Q ss_pred C-CCCCccccccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCC
Q 046598 902 K-KPTDIMFEGDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDR 980 (986)
Q Consensus 902 ~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R 980 (986)
. +||..... .+.... +.+......+ ..++.++.+++.+||+.||++|
T Consensus 239 ~~~p~~~~~~-----~e~~~~--------v~~~~~~~~p-------------------~~~~~~~~~li~~cl~~~P~~R 286 (301)
T d1lufa_ 239 GLQPYYGMAH-----EEVIYY--------VRDGNILACP-------------------ENCPLELYNLMRLCWSKLPADR 286 (301)
T ss_dssp TCCTTTTSCH-----HHHHHH--------HHTTCCCCCC-------------------TTCCHHHHHHHHHHTCSSGGGS
T ss_pred CCCCCCCCCH-----HHHHHH--------HHcCCCCCCC-------------------ccchHHHHHHHHHHcCCChhHC
Confidence 5 56653211 111111 0000000001 1234568899999999999999
Q ss_pred CCCCCC
Q 046598 981 MSMTNV 986 (986)
Q Consensus 981 Pt~~eV 986 (986)
|||.||
T Consensus 287 Pt~~ev 292 (301)
T d1lufa_ 287 PSFCSI 292 (301)
T ss_dssp CCHHHH
T ss_pred cCHHHH
Confidence 999874
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.1e-44 Score=400.99 Aligned_cols=244 Identities=21% Similarity=0.235 Sum_probs=193.3
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC---chhHHHH---HHHHHHHhcCCCCcceeeeeeccccccCC
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH---HGAFKSF---IAECNTLKNIRHRNLVKILTACSGVDYQG 761 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 761 (986)
++|++.+.||+|+||.||+|++..+++.||||++.... ......+ .+|+++++.++|||||+++++ +..
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~-----~~~ 78 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA-----FHT 78 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEE-----EEC
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEE-----EEE
Confidence 67999999999999999999999999999999986321 1112233 445777888899999999999 456
Q ss_pred CceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCc
Q 046598 762 NDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI 841 (986)
Q Consensus 762 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 841 (986)
++..|+||||++||+|.+++.. ...+++.+++.++.||+.||+|||++ +||||||||+|||++.++.
T Consensus 79 ~~~~~ivmE~~~gg~L~~~l~~----------~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~ 145 (364)
T d1omwa3 79 PDKLSFILDLMNGGDLHYHLSQ----------HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGH 145 (364)
T ss_dssp SSEEEEEECCCCSCBHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSC
T ss_pred CCEEEEEEEecCCCcHHHHHHh----------cccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCc
Confidence 6889999999999999999952 34688999999999999999999999 9999999999999999999
Q ss_pred EEEcccccceecCCCCCccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHH
Q 046598 842 AHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLAR 920 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~ 920 (986)
+||+|||+|+...... .....||+.|||||++.+ ..|+.++||||+||++|||+||+.||...... .......
T Consensus 146 iKl~DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~~~ 219 (364)
T d1omwa3 146 VRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--DKHEIDR 219 (364)
T ss_dssp EEECCCTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS--CHHHHHH
T ss_pred EEEeeeceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH--HHHHHHH
Confidence 9999999998764322 234579999999999875 56899999999999999999999999743221 1111111
Q ss_pred hhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 046598 921 TALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSM 983 (986)
Q Consensus 921 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 983 (986)
..... .+.. +...+.++.+++.+||+.||++|||.
T Consensus 220 ~~~~~------------~~~~----------------~~~~s~~~~~li~~~L~~dP~~R~t~ 254 (364)
T d1omwa3 220 MTLTM------------AVEL----------------PDSFSPELRSLLEGLLQRDVNRRLGC 254 (364)
T ss_dssp HSSSC------------CCCC----------------CSSSCHHHHHHHHHHTCSSTTTSTTT
T ss_pred hcccC------------CCCC----------------CCCCCHHHHHHHHHHcccCHHHhCCC
Confidence 11110 0000 00123457799999999999999994
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-45 Score=394.79 Aligned_cols=262 Identities=25% Similarity=0.326 Sum_probs=194.0
Q ss_pred hcCCCCCcccccccceeEEEEEECC-----CCeEEEEEEeecc-CchhHHHHHHHHHHHhcC-CCCcceeeeeecccccc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDD-----GRTTIAVKVFNLL-HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDY 759 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 759 (986)
.++|++.++||+|+||.||+|++.. +++.||||+++.. .....+.+.+|..++.++ +|+||+.+++++ .
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~----~ 87 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC----T 87 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE----C
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeee----c
Confidence 4679999999999999999999754 3478999998743 334456788888888777 789999999985 3
Q ss_pred CCCceEEEEEEeccCCCHhHhhccCCCCCc------cccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCC
Q 046598 760 QGNDFKALVFEFMHNRSLEEWLHPITREDE------TDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSN 833 (986)
Q Consensus 760 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~N 833 (986)
..+...++||||+++|+|.++++....... .......+++.+++.++.||++||+|||++ +|+||||||+|
T Consensus 88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~N 164 (299)
T d1ywna1 88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARN 164 (299)
T ss_dssp STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccc
Confidence 445678999999999999999974432100 011234689999999999999999999999 99999999999
Q ss_pred eEecCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCC-CCCCcccccc
Q 046598 834 ILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRK-KPTDIMFEGD 912 (986)
Q Consensus 834 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~-~pf~~~~~~~ 912 (986)
||+++++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+||. +||......
T Consensus 165 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~- 243 (299)
T d1ywna1 165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID- 243 (299)
T ss_dssp EEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS-
T ss_pred eeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH-
Confidence 999999999999999998765555444555677999999999999999999999999999999999964 567532211
Q ss_pred ccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 913 MNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..+......... ... +..++.++.+++.+||+.||++||||+||
T Consensus 244 ~~~~~~~~~~~~------------~~~------------------~~~~~~~l~~li~~cl~~dP~~Rpt~~ei 287 (299)
T d1ywna1 244 EEFCRRLKEGTR------------MRA------------------PDYTTPEMYQTMLDCWHGEPSQRPTFSEL 287 (299)
T ss_dssp HHHHHHHHHTCC------------CCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHhcCCC------------CCC------------------CccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 111111111100 000 01234467899999999999999999764
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-45 Score=388.35 Aligned_cols=249 Identities=22% Similarity=0.352 Sum_probs=188.2
Q ss_pred hcCCCCCcccccccceeEEEEEECCC---CeEEEEEEeecc-CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDG---RTTIAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 762 (986)
.++|++.+.||+|+||+||+|++..+ +..||||+++.. .....+.+.+|++++++++|||||+++++|. +
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~------~ 79 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------E 79 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC------S
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe------c
Confidence 46799999999999999999998643 456889988643 3344577999999999999999999999852 3
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
+..++||||+++|++.+++. .....+++.+++.++.||++||+|||++ +|+||||||+||+++.++.+
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~---------~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~ 147 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQ---------VRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCV 147 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHH---------HTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEE
T ss_pred CeEEEEEEeccCCcHHhhhh---------ccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcE
Confidence 56899999999999999875 2334689999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHh
Q 046598 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLART 921 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~ 921 (986)
||+|||+|+...... ........||+.|+|||++.+..++.++|||||||++|||+| |.+||...... ........
T Consensus 148 Kl~DfG~a~~~~~~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--~~~~~i~~ 224 (273)
T d1mp8a_ 148 KLGDFGLSRYMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIEN 224 (273)
T ss_dssp EECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHT
T ss_pred EEccchhheeccCCc-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH--HHHHHHHc
Confidence 999999998764322 223344568999999999999999999999999999999998 89998743221 11111111
Q ss_pred hCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 922 ALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 922 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.... . .+..++.++.+++.+||+.||++||||+||
T Consensus 225 ~~~~-----------~-------------------~~~~~~~~~~~li~~cl~~dp~~Rps~~ei 259 (273)
T d1mp8a_ 225 GERL-----------P-------------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 259 (273)
T ss_dssp TCCC-----------C-------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCC-----------C-------------------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 0000 0 011234568899999999999999999764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=395.20 Aligned_cols=255 Identities=20% Similarity=0.231 Sum_probs=197.9
Q ss_pred hcCCCCCc-ccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcC-CCCcceeeeeeccccccCCCce
Q 046598 687 TDRFSSVN-QIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 687 ~~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~ 764 (986)
.++|.+.. .||+|+||+||+|++..+++.||||+++.. +.+.+|+.++.++ +|||||++++++... ...+..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~-~~~~~~ 83 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC 83 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeec-ccCCCE
Confidence 46898875 599999999999999999999999998642 5677899987655 899999999986432 344577
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecC---CCc
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDE---DMI 841 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~ 841 (986)
.|+|||||+||+|.+++... ....+++.+++.|+.||+.||+|||++ +|+||||||+||+++. ++.
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~--------~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~ 152 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDR--------GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAI 152 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSC--------SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCC
T ss_pred EEEEEECCCCCcHHHHHHhc--------CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccc
Confidence 99999999999999999632 124699999999999999999999999 9999999999999985 557
Q ss_pred EEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHh
Q 046598 842 AHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLART 921 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~ 921 (986)
+||+|||+|+...... ......||+.|||||++.+..|+.++||||+||++|+|+||+.||....... .......
T Consensus 153 ~Kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~--~~~~~~~ 227 (335)
T d2ozaa1 153 LKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--ISPGMKT 227 (335)
T ss_dssp EEECCCTTCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------
T ss_pred ccccccceeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH--HHHHHHH
Confidence 9999999998765332 2334679999999999999999999999999999999999999996432211 0000000
Q ss_pred hCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 922 ALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 922 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+ ..... + . ........+.++.+++.+|++.||++|||++|+
T Consensus 228 ~i-----------~~~~~-~--------~---~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ei 269 (335)
T d2ozaa1 228 RI-----------RMGQY-E--------F---PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 269 (335)
T ss_dssp CC-----------CSCSS-S--------C---CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred HH-----------hcCCC-C--------C---CCcccccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 00 00000 0 0 001112345678899999999999999998763
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-45 Score=384.69 Aligned_cols=243 Identities=26% Similarity=0.367 Sum_probs=187.5
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 767 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 767 (986)
++|++.+.||+|+||.||+|+++ ++.||||+++.. ...+++.+|++++++++||||++++|+|. ++++..++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~----~~~~~~~l 78 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYI 78 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEEC----CC--CCEE
T ss_pred HHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEE----ecCCcEEE
Confidence 56888999999999999999996 578999999653 34578999999999999999999999863 34466899
Q ss_pred EEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEccc
Q 046598 768 VFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDF 847 (986)
Q Consensus 768 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DF 847 (986)
||||+++|+|.+++... ....+++..+++|+.||+.||.|||+. +|+||||||+||+++.++.+|++||
T Consensus 79 v~ey~~~g~L~~~l~~~--------~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~df 147 (262)
T d1byga_ 79 VTEYMAKGSLVDYLRSR--------GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDF 147 (262)
T ss_dssp EECCCTTEEHHHHHHHH--------HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCC
T ss_pred EEeccCCCCHHHHHHhc--------CCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeeccc
Confidence 99999999999999521 123589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCc
Q 046598 848 GLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLARTALPDH 926 (986)
Q Consensus 848 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 926 (986)
|+++..... .....++..|+|||++.+..+++++|||||||++|||+| |++||...... ............
T Consensus 148 g~s~~~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~--~~~~~i~~~~~~- 219 (262)
T d1byga_ 148 GLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKGYKM- 219 (262)
T ss_dssp CC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHHTTTCCC-
T ss_pred ccceecCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcCCCC-
Confidence 999865322 223457899999999999999999999999999999998 68877632111 111111110000
Q ss_pred hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 927 VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 927 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+.+..++.++.+++.+||+.||++||||+||
T Consensus 220 -----------------------------~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l 250 (262)
T d1byga_ 220 -----------------------------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQL 250 (262)
T ss_dssp -----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -----------------------------CCCccCCHHHHHHHHHHcccCHhHCcCHHHH
Confidence 0011233567899999999999999999764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-45 Score=387.93 Aligned_cols=250 Identities=25% Similarity=0.368 Sum_probs=189.1
Q ss_pred cCCCCCcccccccceeEEEEEECCC---CeEEEEEEeecc---CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCC
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDG---RTTIAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 761 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 761 (986)
++|++.+.||+|+||+||+|++... ...||||+++.. .....++|.+|++++++++||||++++|+|. +
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~-----~ 82 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-----T 82 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----e
Confidence 5699999999999999999987432 347899998642 3344578999999999999999999999963 2
Q ss_pred CceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCc
Q 046598 762 NDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI 841 (986)
Q Consensus 762 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 841 (986)
...++||||+++|++.+++. .....+++..++.++.||++||.|||++ +|+||||||+||+++.++.
T Consensus 83 -~~~~lv~e~~~~~~l~~~~~---------~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~ 149 (273)
T d1u46a_ 83 -PPMKMVTELAPLGSLLDRLR---------KHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDL 149 (273)
T ss_dssp -SSCEEEEECCTTCBHHHHHH---------HHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTE
T ss_pred -cchheeeeeecCcchhhhhh---------cccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccc
Confidence 35689999999999999885 3345699999999999999999999999 9999999999999999999
Q ss_pred EEEcccccceecCCCCCcc-ccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCccccccccHHHHH
Q 046598 842 AHIGDFGLARFLPLSSAQT-SSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFEGDMNLHNLA 919 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~ 919 (986)
+||+|||+++......... ......|+..|+|||++.+..++.++|||||||++|||+| |+.||..... ....
T Consensus 150 vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~-----~~~~ 224 (273)
T d1u46a_ 150 VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-----SQIL 224 (273)
T ss_dssp EEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHH
T ss_pred eeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH-----HHHH
Confidence 9999999999875543332 2334567889999999999999999999999999999998 8999863211 1111
Q ss_pred HhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 920 RTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 920 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
...... ... .+.+..++.++.+++.+||+.||++||||+||
T Consensus 225 ~~i~~~--------~~~------------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei 265 (273)
T d1u46a_ 225 HKIDKE--------GER------------------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 265 (273)
T ss_dssp HHHHTS--------CCC------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHhC--------CCC------------------CCCcccccHHHHHHHHHHcCCChhHCcCHHHH
Confidence 110000 000 00011234567899999999999999999764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-44 Score=387.74 Aligned_cols=270 Identities=23% Similarity=0.297 Sum_probs=194.2
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
.++|.+.++||+|+||.||+|++. ++.||||+++.... .......|+..+.+++|||||+++++|... .......+
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~~--g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~-~~~~~~~~ 77 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKD-NGTWTQLW 77 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEE-CSSSEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeC-CCcceEEE
Confidence 356788899999999999999975 68999999865322 122233455555678999999999998543 22334689
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEeecCCCCCeEecCCCc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHD-----CQPPIAHCDLKPSNILLDEDMI 841 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~ 841 (986)
+||||+++|+|.++++. ..+++.++++++.|+|.||+|+|+. ..++|+||||||+|||++.++.
T Consensus 78 lv~Ey~~~g~L~~~l~~-----------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~ 146 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNR-----------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 146 (303)
T ss_dssp EEEECCTTCBHHHHHHH-----------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC
T ss_pred EEEecccCCCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCC
Confidence 99999999999999962 2589999999999999999999973 1349999999999999999999
Q ss_pred EEEcccccceecCCCCCc--cccccccccccccccccccCC------CcCcccchhhHHHHHHHHHhCCCCCCccccccc
Q 046598 842 AHIGDFGLARFLPLSSAQ--TSSIGAKGSIGYIAPEYGLGS------EVSISGDVYSYGILLLELITRKKPTDIMFEGDM 913 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~ 913 (986)
+||+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|||+||..||........
T Consensus 147 ~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~ 226 (303)
T d1vjya_ 147 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 226 (303)
T ss_dssp EEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred eEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccccc
Confidence 999999999876443322 223456799999999998764 367899999999999999999998764332222
Q ss_pred cHHHHHHhhCCCchhHH----hhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 914 NLHNLARTALPDHVMDI----VDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 914 ~~~~~~~~~~~~~~~~~----~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.+...... ....... .+..+.++.. ......+.+..+.+++.+||+.||++||||.||
T Consensus 227 ~~~~~~~~--~~~~~~~~~~~~~~~~~p~~~-------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei 288 (303)
T d1vjya_ 227 PYYDLVPS--DPSVEEMRKVVCEQKLRPNIP-------------NRWQSCEALRVMAKIMRECWYANGAARLTALRI 288 (303)
T ss_dssp TTTTTSCS--SCCHHHHHHHHTTSCCCCCCC-------------GGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHH
T ss_pred chhhcccc--cchHHHHHHHHhccccCCCCC-------------cccCChHHHHHHHHHHHHHcccCHhHCcCHHHH
Confidence 11111000 0011111 1111111110 111122456678899999999999999998764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-44 Score=386.37 Aligned_cols=247 Identities=25% Similarity=0.383 Sum_probs=193.9
Q ss_pred CcccccccceeEEEEEECCC---CeEEEEEEeec-cCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEEEE
Q 046598 693 VNQIGEGSFGSVFKGILDDG---RTTIAVKVFNL-LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALV 768 (986)
Q Consensus 693 ~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 768 (986)
.++||+|+||+||+|++..+ ...||||+++. ......+++.+|++++++++||||++++|+|. ..+...++|
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~----~~~~~~~lv 107 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEGSPLVV 107 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE----ETTTEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEE----ecCCceEEE
Confidence 46899999999999998653 34699999864 34455688999999999999999999999863 345678999
Q ss_pred EEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcccc
Q 046598 769 FEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGDFG 848 (986)
Q Consensus 769 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG 848 (986)
|||+++|+|.++++ .....+++.++++++.|+++||.|+|+. +|+||||||+|||+++++.+||+|||
T Consensus 108 ~E~~~~g~l~~~~~---------~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG 175 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIR---------NETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFG 175 (311)
T ss_dssp EECCTTCBHHHHHH---------CTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSG
T ss_pred EEEeecCchhhhhc---------cccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEeccc
Confidence 99999999999986 2334578889999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCc--cccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCc
Q 046598 849 LARFLPLSSAQ--TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPDH 926 (986)
Q Consensus 849 ~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 926 (986)
+++........ .......||+.|+|||.+.+..++.++||||||+++|||+||..||........-.........+
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~-- 253 (311)
T d1r0pa_ 176 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL-- 253 (311)
T ss_dssp GGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCC--
T ss_pred chhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC--
Confidence 99876543222 22334568999999999999999999999999999999999888875322211111111100000
Q ss_pred hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 927 VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 927 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
..| ..++.++.+++.+||+.||++||||.||
T Consensus 254 ----------~~p-------------------~~~~~~l~~li~~cl~~dP~~RPs~~ei 284 (311)
T d1r0pa_ 254 ----------LQP-------------------EYCPDPLYEVMLKCWHPKAEMRPSFSEL 284 (311)
T ss_dssp ----------CCC-------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ----------CCc-------------------ccCcHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 001 1234567899999999999999999764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-44 Score=388.38 Aligned_cols=196 Identities=27% Similarity=0.381 Sum_probs=165.6
Q ss_pred CCcccccccceeEEEEEECCCCeEEEEEEeeccCch-----hHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 692 SVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHG-----AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 692 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
.+++||+|+||+||+|++..+++.||||+++..... ..+.+.+|++++++++|||||+++++ +..++..|
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~-----~~~~~~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDA-----FGHKSNIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEE-----ECCTTCCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEee-----eccCCcee
Confidence 457899999999999999999999999998643221 23568899999999999999999999 55668899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEcc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIGD 846 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 846 (986)
+||||++++++..+.. ....+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 77 ivmE~~~~~~~~~~~~----------~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~D 143 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIKD----------NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLAD 143 (299)
T ss_dssp EEEECCSEEHHHHHTT----------CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred ehhhhhcchHHhhhhh----------cccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCcccccc
Confidence 9999998887776663 234688889999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
||.|+...... ......+||+.|+|||++.+. .++.++||||+||++|||+||++||..
T Consensus 144 FG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~ 203 (299)
T d1ua2a_ 144 FGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG 203 (299)
T ss_dssp CGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CccccccCCCc--ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCC
Confidence 99998654322 223345799999999998654 679999999999999999999999864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-44 Score=386.04 Aligned_cols=274 Identities=27% Similarity=0.348 Sum_probs=197.6
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
++|++++.||+|+||+||+|++..+++.||||+++... ....+++.+|++++++++|||||+++++ +.++...
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~-----~~~~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV-----IHTENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEE-----EEETTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccc-----cccccce
Confidence 68999999999999999999999989999999996432 2335789999999999999999999999 4556889
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
|+||||+.++ +.+++.. .....+++.+++.++.||+.||+|||++ +||||||||+|||++.++.+||+
T Consensus 77 ~iv~e~~~~~-~~~~~~~--------~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~ 144 (298)
T d1gz8a_ 77 YLVFEFLHQD-LKKFMDA--------SALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLA 144 (298)
T ss_dssp EEEEECCSEE-HHHHHHH--------TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred eEEEeecCCc-hhhhhhh--------hcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceec
Confidence 9999999654 4444431 2234699999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccCCC-cCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhh-C
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSE-VSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTA-L 923 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~-~ 923 (986)
|||.|+...... .......||+.|+|||++.... ++.++||||+||++|+|++|+.||......+ ......... .
T Consensus 145 DFG~a~~~~~~~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~-~~~~i~~~~~~ 221 (298)
T d1gz8a_ 145 DFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGT 221 (298)
T ss_dssp STTHHHHHCCCS--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCC
T ss_pred cCCcceeccCCc--ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH-HHHHHHHhcCC
Confidence 999998764332 2333457999999999877765 5789999999999999999999997432211 111111111 1
Q ss_pred CCc-hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 924 PDH-VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 924 ~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
+.. ....+... .+............ ..........++.+++.+|++.||++|||++|+
T Consensus 222 ~~~~~~~~~~~~--~~~~~~~~~~~~~~---~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~el 280 (298)
T d1gz8a_ 222 PDEVVWPGVTSM--PDYKPSFPKWARQD---FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280 (298)
T ss_dssp CCTTTSTTGGGS--TTCCTTSCCCCCCC---HHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred Cchhhccccccc--cccccccccccccc---hhhhccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 111 00000000 00000000000000 011111234567889999999999999999764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-44 Score=387.54 Aligned_cols=261 Identities=26% Similarity=0.344 Sum_probs=204.2
Q ss_pred hcCCCCCcccccccceeEEEEEEC-----CCCeEEEEEEeeccC-chhHHHHHHHHHHHhcC-CCCcceeeeeecccccc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILD-----DGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDY 759 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 759 (986)
.++|++.++||+|+||.||+|++. .+++.||||+++... .....++.+|+.+++++ +|||||+++++|
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~----- 96 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC----- 96 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE-----
Confidence 468999999999999999999873 456789999997533 34456789999999999 699999999995
Q ss_pred CCCceEEEEEEeccCCCHhHhhccCCCCCc--------cccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCC
Q 046598 760 QGNDFKALVFEFMHNRSLEEWLHPITREDE--------TDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKP 831 (986)
Q Consensus 760 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~--------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 831 (986)
..+...++||||+++|+|.++++....... .......+++.++..++.||++||+|||++ ++|||||||
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp 173 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA 173 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccc
Confidence 445778999999999999999975432211 112345699999999999999999999999 999999999
Q ss_pred CCeEecCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCcccc
Q 046598 832 SNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFE 910 (986)
Q Consensus 832 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~ 910 (986)
+||+++.++.+|++|||.++...............||+.|+|||++.+..++.++|||||||++|||+| |.+||... .
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~-~ 252 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM-P 252 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-C
T ss_pred ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC-C
Confidence 999999999999999999998765555555566789999999999999999999999999999999999 45555422 2
Q ss_pred ccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 911 GDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
....+..... ....... +...+.++.+++.+||+.||++||||+||
T Consensus 253 ~~~~~~~~i~------------~~~~~~~------------------~~~~~~~l~~Li~~cl~~dP~~RPs~~~i 298 (311)
T d1t46a_ 253 VDSKFYKMIK------------EGFRMLS------------------PEHAPAEMYDIMKTCWDADPLKRPTFKQI 298 (311)
T ss_dssp SSHHHHHHHH------------HTCCCCC------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHHHh------------cCCCCCC------------------cccccHHHHHHHHHHcCCChhHCcCHHHH
Confidence 1111222221 1111100 01234567899999999999999999764
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=7.4e-43 Score=381.91 Aligned_cols=292 Identities=29% Similarity=0.455 Sum_probs=268.5
Q ss_pred CCHhHHHHHHHHHHhccCCCcCCCCCCCCCCCCC--cceeeEecCCC--CeEEEEeccCCCCcc--ccCcCccCCCCCCE
Q 046598 17 GNETDRLALLELKSKITHDPLGVLASWNESSHFC--QWRGVTCSRRH--QRVTILDLESLKLAG--SISPHVGNLSFLKV 90 (986)
Q Consensus 17 ~~~~~~~~ll~~k~~~~~~~~~~l~~w~~~~~~c--~w~gv~c~~~~--~~v~~l~l~~~~l~~--~~~~~~~~l~~L~~ 90 (986)
|.++||+||++||+++. || +.+++|..++||| .|.||+|+... .||+.|||++++++| .+|+++++|++|++
T Consensus 3 c~~~e~~aLl~~k~~~~-~~-~~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~ 80 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLG-NP-TTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF 80 (313)
T ss_dssp SCHHHHHHHHHHHHHTT-CC-GGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSE
T ss_pred CCHHHHHHHHHHHHHCC-CC-CcCCCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccccc
Confidence 89999999999999996 55 4799999889999 49999998754 489999999999998 57899999999999
Q ss_pred EEccC-CCccccCCcchhccccCceeeceecccCCCCccchhcCccccceecccccccCccCccccCCCCCCeEEccCCc
Q 046598 91 LRLYN-NSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNN 169 (986)
Q Consensus 91 L~L~~-n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 169 (986)
|+|++ |++.|.+|.+|++|++|++|+|++|++++..|..+..+.+|+++++++|.+.+.+|..|+++++|+++++++|.
T Consensus 81 L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~ 160 (313)
T d1ogqa_ 81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred cccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeeccccc
Confidence 99997 89999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCcccccCCCcCc-ceeeccCCcccCcCcchhhccCCCceeecccccccccCCccccCCCCccEEeccccccccccCC
Q 046598 170 LTGSIPSSLGNLSSI-RSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPL 248 (986)
Q Consensus 170 l~~~~p~~~~~l~~L-~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~ 248 (986)
+++.+|..+..+.++ +.+++++|++++..|..+..+..+ .+++++|...+.+|..+..+.+++.++++.|.+.+.+|.
T Consensus 161 l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~ 239 (313)
T d1ogqa_ 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK 239 (313)
T ss_dssp CEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG
T ss_pred cccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999886 899999999999999999888655 799999999999999999999999999999999988774
Q ss_pred cccccccccceEEecCceecccCCccccCCCCCcEEecccccccCCCchhhhhhhHhhhhhccCC
Q 046598 249 DYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNS 313 (986)
Q Consensus 249 ~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~l~~l~~L~~l~l~~n~ 313 (986)
...+++|+.|+|++|+++|.+|+.|+++++|+.|++++|+++|..|.+.++++|+.+++.+|.
T Consensus 240 --~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 240 --VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302 (313)
T ss_dssp --CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSS
T ss_pred --cccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCc
Confidence 335799999999999999999999999999999999999999877777777777777666663
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-44 Score=387.33 Aligned_cols=206 Identities=27% Similarity=0.380 Sum_probs=173.7
Q ss_pred hcCCCCCcccccccceeEEEEEECC-CCeEEEEEEeeccC--chhHHHHHHHHHHHhcC---CCCcceeeeeeccccccC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDD-GRTTIAVKVFNLLH--HGAFKSFIAECNTLKNI---RHRNLVKILTACSGVDYQ 760 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~ 760 (986)
.++|+++++||+|+||+||+|++.. +++.||||+++... ......+.+|+.+++.+ +||||++++++|......
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 4789999999999999999999964 46789999986432 22234566777777665 799999999997655455
Q ss_pred CCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCC
Q 046598 761 GNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDM 840 (986)
Q Consensus 761 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 840 (986)
.....+++|||++++.+..... .....+++..++.++.|++.||+|||++ +|+||||||+|||++.++
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~ 153 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK---------VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSG 153 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH---------SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTC
T ss_pred cCceEEEEEEeccCCchhhhhh---------ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCC
Confidence 6678999999998887765553 2335689999999999999999999999 999999999999999999
Q ss_pred cEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 841 IAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 841 ~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
.+||+|||.++... .........||+.|+|||++.+.+|+.++||||+||++|||++|+.||..
T Consensus 154 ~~kl~dfg~~~~~~---~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~ 217 (305)
T d1blxa_ 154 QIKLADFGLARIYS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG 217 (305)
T ss_dssp CEEECSCCSCCCCC---GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred Ceeecchhhhhhhc---ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCC
Confidence 99999999997643 22334457799999999999999999999999999999999999999974
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-44 Score=384.00 Aligned_cols=260 Identities=24% Similarity=0.369 Sum_probs=198.3
Q ss_pred hcCCCCCcccccccceeEEEEEECCCC-------eEEEEEEeeccCc-hhHHHHHHHHHHHhcC-CCCcceeeeeecccc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGR-------TTIAVKVFNLLHH-GAFKSFIAECNTLKNI-RHRNLVKILTACSGV 757 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 757 (986)
.++|++.+.||+|+||.||+|+....+ ..||||+++.... ....++.+|+..+.++ +|||||+++++|
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~--- 88 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC--- 88 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccc---
Confidence 468999999999999999999975433 5799999975433 4457788999999888 899999999995
Q ss_pred ccCCCceEEEEEEeccCCCHhHhhccCCCCC------ccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCC
Q 046598 758 DYQGNDFKALVFEFMHNRSLEEWLHPITRED------ETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKP 831 (986)
Q Consensus 758 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 831 (986)
.+++..++||||+++|+|.+++....... ........+++.+++.++.||+.||+|||+. +||||||||
T Consensus 89 --~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp 163 (299)
T d1fgka_ 89 --TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA 163 (299)
T ss_dssp --CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred --ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecc
Confidence 44578999999999999999997543211 1112345699999999999999999999999 999999999
Q ss_pred CCeEecCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCcccc
Q 046598 832 SNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELIT-RKKPTDIMFE 910 (986)
Q Consensus 832 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~ 910 (986)
+|||++.++.+||+|||+++...............+++.|+|||.+.++.|+.++|||||||++|||++ |++||.....
T Consensus 164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 164 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp GGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred cceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 999999999999999999987755444444555678999999999999999999999999999999998 7888763221
Q ss_pred ccccHHHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 911 GDMNLHNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.... +.+........ +..++.++.+++.+||+.||++||||+||
T Consensus 244 -----~~~~---------~~i~~~~~~~~------------------p~~~~~~l~~li~~cl~~dP~~Rps~~ei 287 (299)
T d1fgka_ 244 -----EELF---------KLLKEGHRMDK------------------PSNCTNELYMMMRDCWHAVPSQRPTFKQL 287 (299)
T ss_dssp -----HHHH---------HHHHTTCCCCC------------------CSSCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -----HHHH---------HHHHcCCCCCC------------------CccchHHHHHHHHHHccCCHhHCcCHHHH
Confidence 1111 11111100000 01234467899999999999999999874
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-44 Score=388.64 Aligned_cols=260 Identities=21% Similarity=0.376 Sum_probs=203.4
Q ss_pred hcCCCCCcccccccceeEEEEEECC-----CCeEEEEEEeecc-CchhHHHHHHHHHHHhcCCCCcceeeeeeccccccC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDD-----GRTTIAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ 760 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 760 (986)
.++|++.++||+|+||+||+|.+.. .++.||||+++.. .......+.+|++++++++||||++++++| .
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~-----~ 93 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----S 93 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE-----C
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE-----e
Confidence 4678899999999999999999852 3578999999743 334456789999999999999999999995 4
Q ss_pred CCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCC
Q 046598 761 GNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDM 840 (986)
Q Consensus 761 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 840 (986)
.++..++||||+++|+|.+++...............+++.++.+++.|+++||.|||++ +|+||||||+|||+++++
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCc
Confidence 45778999999999999999864322111122234579999999999999999999999 999999999999999999
Q ss_pred cEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCC-CCCCccccccccHHHHH
Q 046598 841 IAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRK-KPTDIMFEGDMNLHNLA 919 (986)
Q Consensus 841 ~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~-~pf~~~~~~~~~~~~~~ 919 (986)
++||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||+||. +||... ......
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~-----~~~~~~ 245 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-----SNEQVL 245 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-----CHHHHH
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC-----CHHHHH
Confidence 99999999998765444444455567899999999999999999999999999999999985 666422 111111
Q ss_pred HhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 920 RTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 920 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.. +.+......+ ..++.++.+++.+||+.+|++||||+||
T Consensus 246 ~~--------i~~~~~~~~p-------------------~~~~~~l~~li~~cl~~~P~~RPs~~~i 285 (308)
T d1p4oa_ 246 RF--------VMEGGLLDKP-------------------DNCPDMLFELMRMCWQYNPKMRPSFLEI 285 (308)
T ss_dssp HH--------HHTTCCCCCC-------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HH--------HHhCCCCCCc-------------------ccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence 11 1111110001 1234568899999999999999998764
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-44 Score=381.05 Aligned_cols=239 Identities=21% Similarity=0.262 Sum_probs=192.4
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc------hhHHHHHHHHHHHhcCC--CCcceeeeeeccccc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH------GAFKSFIAECNTLKNIR--HRNLVKILTACSGVD 758 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~ 758 (986)
.++|++.+.||+|+||+||+|++..+++.||||+++.... ....++.+|+.++++++ |||||+++++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~----- 77 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW----- 77 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE-----
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEE-----
Confidence 4689999999999999999999999999999999864221 12244678999999986 8999999999
Q ss_pred cCCCceEEEEEEeccC-CCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEec
Q 046598 759 YQGNDFKALVFEFMHN-RSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLD 837 (986)
Q Consensus 759 ~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 837 (986)
+.+++..++||||+.+ +++.+++. ....+++.+++.++.||+.||+|||++ +|+||||||+||+++
T Consensus 78 ~~~~~~~~lv~e~~~~~~~l~~~~~----------~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~ 144 (273)
T d1xwsa_ 78 FERPDSFVLILERPEPVQDLFDFIT----------ERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILID 144 (273)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHH----------HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred EeeCCeEEEEEEeccCcchHHHHHh----------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEe
Confidence 5566889999999976 67888874 234689999999999999999999999 999999999999998
Q ss_pred CC-CcEEEcccccceecCCCCCccccccccccccccccccccCCCc-CcccchhhHHHHHHHHHhCCCCCCccccccccH
Q 046598 838 ED-MIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEV-SISGDVYSYGILLLELITRKKPTDIMFEGDMNL 915 (986)
Q Consensus 838 ~~-~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~ 915 (986)
.+ +.+||+|||+|+..... ......||+.|+|||++.+..+ +.++||||+||++|||+||+.||....
T Consensus 145 ~~~~~vkl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------ 214 (273)
T d1xwsa_ 145 LNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 214 (273)
T ss_dssp TTTTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------
T ss_pred cCCCeEEECccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------
Confidence 54 79999999999875322 2334679999999999887765 677999999999999999999996310
Q ss_pred HHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 916 HNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 916 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.... ..... +. ..+.++.+++.+||+.||++|||++|+
T Consensus 215 -~i~~------------~~~~~-~~-------------------~~s~~~~~li~~~L~~dp~~R~s~~ei 252 (273)
T d1xwsa_ 215 -EIIR------------GQVFF-RQ-------------------RVSSECQHLIRWCLALRPSDRPTFEEI 252 (273)
T ss_dssp -HHHH------------CCCCC-SS-------------------CCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -HHhh------------cccCC-CC-------------------CCCHHHHHHHHHHccCCHhHCcCHHHH
Confidence 1111 00000 00 123457789999999999999998764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-44 Score=386.30 Aligned_cols=256 Identities=25% Similarity=0.384 Sum_probs=194.1
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeE--EEEEEeec-cCchhHHHHHHHHHHHhcC-CCCcceeeeeeccccccCCCc
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTT--IAVKVFNL-LHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~--vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 763 (986)
++|++.+.||+|+||+||+|+++.++.. ||||+++. ......+++.+|+++++++ +|||||+++++| ..++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~~ 84 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRG 84 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE-----EETT
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEE-----ecCC
Confidence 6788999999999999999999877664 67777653 2334567899999999998 799999999995 3457
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCC------ccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEec
Q 046598 764 FKALVFEFMHNRSLEEWLHPITRED------ETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLD 837 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 837 (986)
..++||||+++|+|.++++...... ........+++.++..++.||++||.|+|+. +|+||||||+|||++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG 161 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEc
Confidence 8999999999999999997432100 0012345799999999999999999999999 999999999999999
Q ss_pred CCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCC-CCCccccccccHH
Q 046598 838 EDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKK-PTDIMFEGDMNLH 916 (986)
Q Consensus 838 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~-pf~~~~~~~~~~~ 916 (986)
.++.+||+|||+|+..... .......||..|+|||.+.+..++.++|||||||++|||++|.. ||... +..
T Consensus 162 ~~~~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~-----~~~ 233 (309)
T d1fvra_ 162 ENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-----TCA 233 (309)
T ss_dssp GGGCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHH
T ss_pred CCCceEEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC-----CHH
Confidence 9999999999999764322 22234568999999999999999999999999999999999764 56421 111
Q ss_pred HHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 917 NLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 917 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
...... .... .+ +.+..++.++.+++.+||+.||++||||+||
T Consensus 234 ~~~~~i---------~~~~--~~----------------~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei 276 (309)
T d1fvra_ 234 ELYEKL---------PQGY--RL----------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQI 276 (309)
T ss_dssp HHHHHG---------GGTC--CC----------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHH---------HhcC--CC----------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 111110 0000 00 0011234568899999999999999999874
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.1e-42 Score=374.54 Aligned_cols=200 Identities=26% Similarity=0.401 Sum_probs=169.2
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
++|+++++||+|+||+||+|+++ +++.||||+++... ....+++.+|+.++++++||||++++++ +.+++..
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~-----~~~~~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV-----IHTKKRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEE-----EECSSCE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeee-----cccCCce
Confidence 68999999999999999999997 47899999996532 2335789999999999999999999999 4566889
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
++||||+.++.+..+.+ ..+.+++.+++.|+.||+.||+|||+. +||||||||+|||++.++.+|++
T Consensus 76 ~i~~e~~~~~~~~~~~~----------~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~ 142 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDV----------CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIA 142 (286)
T ss_dssp EEEEECCSEEHHHHHHT----------STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred eEEEEeehhhhHHHHHh----------hcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEec
Confidence 99999998777776653 235699999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCcc
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDIM 908 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~ 908 (986)
|||.|....... .......+++.|+|||.+.+. .++.++||||+||++|||++|+.||...
T Consensus 143 DfG~a~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~ 204 (286)
T d1ob3a_ 143 DFGLARAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (286)
T ss_dssp CTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccceecccCc--cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCC
Confidence 999998764332 223345689999999998764 5789999999999999999999999743
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-42 Score=382.88 Aligned_cols=208 Identities=24% Similarity=0.306 Sum_probs=172.3
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC-chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCce
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 764 (986)
.+++|+++++||+|+||+||+|++..+++.||||+++... ....+++++|++++++++||||+++++++....+.....
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 4568999999999999999999999999999999997533 344568899999999999999999999976544444445
Q ss_pred EEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEE
Q 046598 765 KALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHI 844 (986)
Q Consensus 765 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 844 (986)
.+++ +|+.+|+|.+++.. ..+++.+++.++.||+.||+|||++ |||||||||+|||++.++.+||
T Consensus 86 ~~l~-~~~~~g~L~~~l~~-----------~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl 150 (345)
T d1pmea_ 86 VYLV-THLMGADLYKLLKT-----------QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKI 150 (345)
T ss_dssp EEEE-EECCCEEHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEE
T ss_pred EEEE-EeecCCchhhhhhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEE
Confidence 5555 55669999999951 3589999999999999999999999 9999999999999999999999
Q ss_pred cccccceecCCCCCc-cccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCcc
Q 046598 845 GDFGLARFLPLSSAQ-TSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDIM 908 (986)
Q Consensus 845 ~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~ 908 (986)
+|||+|+........ .......||+.|+|||++.. ..++.++||||+||++|||++|+.||...
T Consensus 151 ~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~ 216 (345)
T d1pmea_ 151 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK 216 (345)
T ss_dssp CCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCC
Confidence 999999876433221 22345679999999999855 56789999999999999999999999743
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-42 Score=375.03 Aligned_cols=208 Identities=24% Similarity=0.374 Sum_probs=170.9
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc--CchhHHHHHHHHHHHhcCCCCcceeeeeeccccc---cCC
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD---YQG 761 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---~~~ 761 (986)
.++|+++++||+|+||+||+|++..+++.||||++... .....+++.+|++++++++||||+++++++.... ...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 47899999999999999999999988999999998543 3334577899999999999999999999874421 223
Q ss_pred CceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCc
Q 046598 762 NDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMI 841 (986)
Q Consensus 762 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 841 (986)
+...++||||++++.+..+.. ....+++.+++.++.||+.||.|||++ ||+||||||+|||++.++.
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~----------~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~ 155 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN----------VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGV 155 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC----------TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSC
T ss_pred CceEEEEEeccCCCccchhhh----------cccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCc
Confidence 467899999998877765542 334688999999999999999999999 9999999999999999999
Q ss_pred EEEcccccceecCCCCC--ccccccccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 842 AHIGDFGLARFLPLSSA--QTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 842 ~kL~DFG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
+||+|||+++.+..... ........||+.|+|||++.+. .+++++||||+||++|||++|+.||..
T Consensus 156 ~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~ 224 (318)
T d3blha1 156 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG 224 (318)
T ss_dssp EEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred EEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCC
Confidence 99999999987653322 1223345699999999998765 689999999999999999999999974
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.8e-42 Score=369.88 Aligned_cols=253 Identities=19% Similarity=0.270 Sum_probs=193.4
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceEE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
.++|++.+.||+|+||+||+|++..+++.||||++..... .+++..|+++++.++|++++..+..| ...++..+
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~----~~~~~~~~ 79 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWC----GAEGDYNV 79 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEE----EEETTEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEE----EecCCEEE
Confidence 3679999999999999999999999899999999875432 34678899999999888776666554 44567899
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecC---CCcEE
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDE---DMIAH 843 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~k 843 (986)
+||||+ ++++.+.+. ...+.+++..+..++.|++.||+|||++ +|+||||||+||+++. +..+|
T Consensus 80 ivme~~-~~~l~~~~~---------~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vk 146 (299)
T d1ckia_ 80 MVMELL-GPSLEDLFN---------FCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVY 146 (299)
T ss_dssp EEEECC-CCBHHHHHH---------HTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEE
T ss_pred EEEEEc-CCchhhhhh---------hccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceee
Confidence 999999 567776664 2335689999999999999999999999 9999999999999864 45799
Q ss_pred EcccccceecCCCCCc-----cccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHH--
Q 046598 844 IGDFGLARFLPLSSAQ-----TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLH-- 916 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~-- 916 (986)
|+|||+|+.+...... .......||+.|||||++.+..+++++|||||||++|||+||+.||...........
T Consensus 147 l~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~ 226 (299)
T d1ckia_ 147 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 226 (299)
T ss_dssp ECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HH
T ss_pred eeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHH
Confidence 9999999877543221 223446799999999999999999999999999999999999999974332211110
Q ss_pred HHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCC
Q 046598 917 NLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTN 985 (986)
Q Consensus 917 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 985 (986)
........... ......++.++.+++.+||+.+|++||++++
T Consensus 227 ~~~~~~~~~~~---------------------------~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~ 268 (299)
T d1ckia_ 227 RISEKKMSTPI---------------------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSY 268 (299)
T ss_dssp HHHHHHHHSCH---------------------------HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHH
T ss_pred HhhcccCCCCh---------------------------hHhccCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 00000000000 0001134566889999999999999999764
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-42 Score=379.73 Aligned_cols=202 Identities=26% Similarity=0.318 Sum_probs=168.3
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc--CchhHHHHHHHHHHHhcCCCCcceeeeeeccccc-cCCC
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-YQGN 762 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~ 762 (986)
..++|+++++||+|+||+||+|++..+++.||||+++.. .....+.+.+|+++|++++|||||+++++|.... ....
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 357899999999999999999999999999999999742 3344567899999999999999999999975432 2234
Q ss_pred ceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcE
Q 046598 763 DFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIA 842 (986)
Q Consensus 763 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 842 (986)
.+.|+||||+ +.+|..+.+ ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~-----------~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~ 160 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMK-----------HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCEL 160 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHH-----------HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCE
T ss_pred ceEEEEEecc-cccHHHHHH-----------hccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccc
Confidence 5689999999 678888774 23599999999999999999999999 99999999999999999999
Q ss_pred EEcccccceecCCCCCccccccccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 843 HIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 843 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
|++|||.|+..... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus 161 kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~ 221 (346)
T d1cm8a_ 161 KILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 221 (346)
T ss_dssp EECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCC
Confidence 99999999875422 2346799999999998764 578999999999999999999999964
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.8e-41 Score=372.53 Aligned_cols=195 Identities=26% Similarity=0.362 Sum_probs=169.9
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCC-CCcceeeeeeccccccCCCceEE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDFKA 766 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~ 766 (986)
++|+++++||+|+||+||+|++..+++.||||+++.. ..+++.+|++++++++ ||||+++++++. .......+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~---~~~~~~~~ 108 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVK---DPVSRTPA 108 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEE---CTTTCSEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEE---ecCCCcee
Confidence 6799999999999999999999999999999998753 3467889999999995 999999999853 23456799
Q ss_pred EEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCC-cEEEc
Q 046598 767 LVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDM-IAHIG 845 (986)
Q Consensus 767 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~ 845 (986)
+||||+++++|..+.+ .+++.+++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+
T Consensus 109 ~v~e~~~~~~L~~~~~-------------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~ 172 (328)
T d3bqca1 109 LVFEHVNNTDFKQLYQ-------------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLI 172 (328)
T ss_dssp EEEECCCSCBGGGTTT-------------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEEC
T ss_pred EEEeecCCCcHHHHhc-------------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeec
Confidence 9999999999987652 589999999999999999999999 999999999999998655 69999
Q ss_pred ccccceecCCCCCccccccccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
|||+|+....... .....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||..
T Consensus 173 DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~ 232 (328)
T d3bqca1 173 DWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 232 (328)
T ss_dssp CGGGCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred ccccceeccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCC
Confidence 9999987643322 3345689999999998775 579999999999999999999999864
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-41 Score=374.03 Aligned_cols=280 Identities=21% Similarity=0.190 Sum_probs=195.0
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeecc--CchhHHHHHHHHHHHhcCCCCcceeeeeeccccc-cCCCc
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-YQGND 763 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~ 763 (986)
.++|+++++||+|+||+||+|++..+++.||||+++.. .....+++.+|+.++++++||||+++++++.... .+...
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 36899999999999999999999999999999999743 3344567899999999999999999999975432 23567
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..|+||||+.++.+. .+. ..+++.+++.++.||+.||+|||++ ||+||||||+|||++.++.+|
T Consensus 96 ~~~iv~Ey~~~~l~~-~~~------------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~k 159 (355)
T d2b1pa1 96 DVYLVMELMDANLCQ-VIQ------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLK 159 (355)
T ss_dssp EEEEEEECCSEEHHH-HHT------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEE
T ss_pred eeEEEEeccchHHHH-hhh------------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCcccccccccccee
Confidence 899999999765554 442 2578999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhC
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTAL 923 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 923 (986)
++|||.++..... .......+|+.|+|||++.+..+++++||||+||++|||++|+.||....... ..........
T Consensus 160 l~df~~~~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~-~~~~i~~~~~ 235 (355)
T d2b1pa1 160 ILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLG 235 (355)
T ss_dssp ECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHC
T ss_pred eechhhhhccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHH-HHHHHHHhcc
Confidence 9999999765432 23344568999999999999999999999999999999999999996332111 1111111111
Q ss_pred ----------CCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 924 ----------PDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 924 ----------~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.....+..+...............................++.+++.+|++.||++||||+||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~el 308 (355)
T d2b1pa1 236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308 (355)
T ss_dssp CCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence 111112222111111000000000000011112233456678899999999999999999874
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-41 Score=366.71 Aligned_cols=274 Identities=21% Similarity=0.261 Sum_probs=201.9
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCceE
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 765 (986)
++|+++++||+|+||+||+|++..+++.||||+++... ....+++.+|+.+++.++||||++++++ +.+....
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~-----~~~~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV-----LHSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEE-----EECSSEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccc-----cccccce
Confidence 58999999999999999999999999999999996433 3446789999999999999999999999 4566889
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEEEc
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAHIG 845 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 845 (986)
++|||++.++++..+++ ..+.+++.+++.++.|++.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 77 ~iv~~~~~~~~l~~~~~----------~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~ 143 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDS----------CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLA 143 (292)
T ss_dssp EEEEECCSEEHHHHHHH----------TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEEC
T ss_pred eEEeeeccccccccccc----------cccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeee
Confidence 99999999999988874 234678999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccccCCC-cCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCC
Q 046598 846 DFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSE-VSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALP 924 (986)
Q Consensus 846 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 924 (986)
|||.|+....... ......+++.|+|||.+.+.. ++.++||||+||++|||++|+.||...................
T Consensus 144 DFG~a~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 221 (292)
T d1unla_ 144 NFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT 221 (292)
T ss_dssp CCTTCEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCC
T ss_pred ecchhhcccCCCc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCC
Confidence 9999987654332 223345788999999987765 6899999999999999999999974322211112221111111
Q ss_pred Cc--hhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 925 DH--VMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 925 ~~--~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
.. ................ ..... ...........++.+++.+|++.||++||||+||
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~--~~~~~---~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~ 280 (292)
T d1unla_ 222 PTEEQWPSMTKLPDYKPYPM--YPATT---SLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280 (292)
T ss_dssp CCTTTCTTGGGSTTCCCCCC--CCTTC---CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CChhhhhhhhhccccccccc--ccccc---hhhhccccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 10 0000000000000000 00000 0000111223456789999999999999999864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-41 Score=374.78 Aligned_cols=277 Identities=22% Similarity=0.255 Sum_probs=193.8
Q ss_pred CCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCcceeeeeeccccc-cCCCceEEE
Q 046598 689 RFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-YQGNDFKAL 767 (986)
Q Consensus 689 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~~~~l 767 (986)
+|+..++||+|+||+||+|++..+++.||||+++.... ...+|++++++++||||++++++|.... ..+..+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 68889999999999999999999999999999975432 2347999999999999999999975432 234556899
Q ss_pred EEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCC-cEEEcc
Q 046598 768 VFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDM-IAHIGD 846 (986)
Q Consensus 768 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~D 846 (986)
||||++++.+....+ .. .....+++.+++.|+.||+.||+|||++ ||+||||||+|||++.++ .+||+|
T Consensus 97 v~Ey~~~~~~~~l~~-~~------~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~D 166 (350)
T d1q5ka_ 97 VLDYVPETVYRVARH-YS------RAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCD 166 (350)
T ss_dssp EEECCSEEHHHHHHH-HH------HTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECC
T ss_pred EEeccCCccHHHHHh-hh------hccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEec
Confidence 999997654333321 11 2335699999999999999999999999 999999999999999775 899999
Q ss_pred cccceecCCCCCccccccccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCC
Q 046598 847 FGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLG-SEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHNLARTALPD 925 (986)
Q Consensus 847 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 925 (986)
||+++....... .....|++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+ .+...... ...
T Consensus 167 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~-~l~~i~~~-~g~ 241 (350)
T d1q5ka_ 167 FGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKV-LGT 241 (350)
T ss_dssp CTTCEECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHH-HCC
T ss_pred ccchhhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH-HHHHHHHH-hCC
Confidence 999987643322 234579999999998765 578999999999999999999999996432211 11111111 111
Q ss_pred chhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCCCC
Q 046598 926 HVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMTNV 986 (986)
Q Consensus 926 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV 986 (986)
...+.+....... .+............. ........++.+++.+|++.||++||||+|+
T Consensus 242 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~ 300 (350)
T d1q5ka_ 242 PTREQIREMNPNY-TEFKFPQIKAHPWTK-VFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300 (350)
T ss_dssp CCHHHHHHHCC----CCCCCCCCCCCGGG-TSCTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred ChHHhhhhhccch-hhccccccccCchhh-hcccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 1111111111000 000000000000000 0001223457789999999999999998764
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.7e-41 Score=361.77 Aligned_cols=251 Identities=16% Similarity=0.205 Sum_probs=195.7
Q ss_pred hcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCC-CcceeeeeeccccccCCCceE
Q 046598 687 TDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRH-RNLVKILTACSGVDYQGNDFK 765 (986)
Q Consensus 687 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~~~~~ 765 (986)
.++|++.+.||+|+||+||+|++..+++.||||+++... ..+.+.+|+++++.+.| +|++.++++ +..+...
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~-----~~~~~~~ 76 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYF-----GQEGLHN 76 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEE-----EEETTEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEE-----eecCCcc
Confidence 468999999999999999999999999999999986532 23457788999998865 899999988 4556889
Q ss_pred EEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecC-----CC
Q 046598 766 ALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDE-----DM 840 (986)
Q Consensus 766 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~~ 840 (986)
++||||+ +++|.++++. ....+++.++..++.|++.||+|||+. ||+||||||+||+++. ++
T Consensus 77 ~~vme~~-~~~l~~~~~~---------~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~ 143 (293)
T d1csna_ 77 VLVIDLL-GPSLEDLLDL---------CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNAN 143 (293)
T ss_dssp EEEEECC-CCBHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTT
T ss_pred EEEEEec-CCCHHHHHHh---------hccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCC
Confidence 9999999 7899999863 234689999999999999999999999 9999999999999974 56
Q ss_pred cEEEcccccceecCCCCCc-----cccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccccccccH
Q 046598 841 IAHIGDFGLARFLPLSSAQ-----TSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMFEGDMNL 915 (986)
Q Consensus 841 ~~kL~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~ 915 (986)
.+||+|||+|+........ .......||+.|||||++.+..+++++|||||||++|||+||+.||..........
T Consensus 144 ~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~ 223 (293)
T d1csna_ 144 MIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ 223 (293)
T ss_dssp CEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH
T ss_pred ceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH
Confidence 8999999999876433221 12334679999999999999999999999999999999999999997432221110
Q ss_pred --HHHHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 046598 916 --HNLARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSMT 984 (986)
Q Consensus 916 --~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 984 (986)
.............+ ....++.++.+++..|++.+|++||+++
T Consensus 224 ~~~~i~~~~~~~~~~~---------------------------l~~~~p~~l~~ii~~~~~~~~~~rP~y~ 267 (293)
T d1csna_ 224 KYERIGEKKQSTPLRE---------------------------LCAGFPEEFYKYMHYARNLAFDATPDYD 267 (293)
T ss_dssp HHHHHHHHHHHSCHHH---------------------------HTTTSCHHHHHHHHHHHHCCTTCCCCHH
T ss_pred HHHHHHhccCCCChHH---------------------------hcCCCCHHHHHHHHHHhcCCcccCcCHH
Confidence 00000000000000 0012345688999999999999999864
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-41 Score=374.99 Aligned_cols=203 Identities=25% Similarity=0.320 Sum_probs=169.7
Q ss_pred hhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccC--chhHHHHHHHHHHHhcCCCCcceeeeeeccccccCCCc
Q 046598 686 ATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 763 (986)
Q Consensus 686 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 763 (986)
..++|+++++||+|+||+||+|++..+++.||||+++... ....+++.+|++++++++|||||++++++......++.
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 4678999999999999999999999999999999997432 33456789999999999999999999986543332344
Q ss_pred eEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCCCcEE
Q 046598 764 FKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDEDMIAH 843 (986)
Q Consensus 764 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 843 (986)
..++||+|+.+|+|.++++ .+.+++.+++.++.||+.||+|||++ ||+||||||+||+++.++.+|
T Consensus 96 ~~~~i~~~~~gg~L~~~~~-----------~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~k 161 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVK-----------CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELK 161 (348)
T ss_dssp CCCEEEEECCSEEHHHHHT-----------TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred ceEEEEEeecCCchhhhcc-----------cccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCcccccccccccc
Confidence 4566677788999999985 13589999999999999999999999 999999999999999999999
Q ss_pred EcccccceecCCCCCccccccccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCc
Q 046598 844 IGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS-EVSISGDVYSYGILLLELITRKKPTDI 907 (986)
Q Consensus 844 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~ 907 (986)
++|||.|.... .......|++.|+|||...+. .++.++||||+||++|+|++|+.||..
T Consensus 162 l~dfg~a~~~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~ 221 (348)
T d2gfsa1 162 ILDFGLARHTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221 (348)
T ss_dssp ECCC----CCT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccchhcccC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCC
Confidence 99999997542 233446789999999987765 468999999999999999999999964
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-41 Score=366.55 Aligned_cols=248 Identities=23% Similarity=0.293 Sum_probs=194.8
Q ss_pred cCCCCCcccccccceeEEEEEE---CCCCeEEEEEEeecc----CchhHHHHHHHHHHHhcCCC-Ccceeeeeecccccc
Q 046598 688 DRFSSVNQIGEGSFGSVFKGIL---DDGRTTIAVKVFNLL----HHGAFKSFIAECNTLKNIRH-RNLVKILTACSGVDY 759 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~---~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 759 (986)
++|++++.||+|+||+||+|++ +.+++.||||+++.. +....+.+.+|++++++++| |||++++++ +
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~-----~ 98 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA-----F 98 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE-----E
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeee-----e
Confidence 6799999999999999999997 446899999998532 22335678899999999976 899999998 5
Q ss_pred CCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEecCC
Q 046598 760 QGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKPSNILLDED 839 (986)
Q Consensus 760 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 839 (986)
.+....++||||+.+|+|.+++.. .+.+++..++.++.||+.||+|+|+. +|+||||||+||+++.+
T Consensus 99 ~~~~~~~~v~e~~~~~~L~~~i~~----------~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~ 165 (322)
T d1vzoa_ 99 QTETKLHLILDYINGGELFTHLSQ----------RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSN 165 (322)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHH----------HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT
T ss_pred ccCCceeeeeecccccHHHHHHHh----------cccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCC
Confidence 556889999999999999999952 33578889999999999999999999 99999999999999999
Q ss_pred CcEEEcccccceecCCCCCccccccccccccccccccccCC--CcCcccchhhHHHHHHHHHhCCCCCCccccccccHHH
Q 046598 840 MIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGS--EVSISGDVYSYGILLLELITRKKPTDIMFEGDMNLHN 917 (986)
Q Consensus 840 ~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~ 917 (986)
+.+||+|||+|+.+.... ........|++.|+|||.+.+. .++.++||||+||++|||++|+.||......+. ...
T Consensus 166 ~~vkL~DFG~a~~~~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~-~~~ 243 (322)
T d1vzoa_ 166 GHVVLTDFGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAE 243 (322)
T ss_dssp SCEEESCSSEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHH
T ss_pred CCEEEeeccchhhhcccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHH
Confidence 999999999998764332 2233446799999999998764 468899999999999999999999975433221 111
Q ss_pred HHHhhCCCchhHHhhhhcccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 046598 918 LARTALPDHVMDIVDSTLLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSMESPEDRMSM 983 (986)
Q Consensus 918 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 983 (986)
.... .....+. .+...+.++.+++.+||++||++|||+
T Consensus 244 i~~~------------~~~~~~~----------------~~~~~s~~~~~li~~~l~~dP~~R~s~ 281 (322)
T d1vzoa_ 244 ISRR------------ILKSEPP----------------YPQEMSALAKDLIQRLLMKDPKKRLGC 281 (322)
T ss_dssp HHHH------------HHHCCCC----------------CCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred HHHh------------cccCCCC----------------CcccCCHHHHHHHHHHcccCHHHcCCC
Confidence 1111 0000000 001234567899999999999999974
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.7e-36 Score=334.08 Aligned_cols=280 Identities=20% Similarity=0.212 Sum_probs=190.3
Q ss_pred cCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCC-----------CCcceeeeeeccc
Q 046598 688 DRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIR-----------HRNLVKILTACSG 756 (986)
Q Consensus 688 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~ 756 (986)
++|+++++||+|+||+||+|++..+++.||||+++... ...+.+.+|+++++.++ |+||+++++++.
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~- 90 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN- 90 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE-
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee-
Confidence 46999999999999999999999999999999997532 23467788999888775 578999998853
Q ss_pred cccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCCeE
Q 046598 757 VDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHH-DCQPPIAHCDLKPSNIL 835 (986)
Q Consensus 757 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIl 835 (986)
.......+++|+++..+........ ......+++..++.++.||+.||+|||+ . ||+||||||+|||
T Consensus 91 --~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIl 158 (362)
T d1q8ya_ 91 --HKGPNGVHVVMVFEVLGENLLALIK-------KYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVL 158 (362)
T ss_dssp --EEETTEEEEEEEECCCCEEHHHHHH-------HTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEE
T ss_pred --eccccceeeeeeecccccccccccc-------cccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHee
Confidence 2234556667776655443222211 1234568899999999999999999998 6 9999999999999
Q ss_pred ecCCC------cEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCccc
Q 046598 836 LDEDM------IAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILLLELITRKKPTDIMF 909 (986)
Q Consensus 836 l~~~~------~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~ 909 (986)
++.++ .+|++|||.|..... ......||+.|+|||++.+..++.++||||+||++++|++|+.||....
T Consensus 159 l~~~~~~~~~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 159 MEIVDSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp EEEEETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred eeccCcccccceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence 98665 499999999986532 2234569999999999999999999999999999999999999997432
Q ss_pred cccc-----cHHHHHHhh--CCCchh-------HHhhhh-cccCCcchhhccchhhhhHhhHHHHHHHHHHHHHHhcccC
Q 046598 910 EGDM-----NLHNLARTA--LPDHVM-------DIVDST-LLNDGEDLIVHGNQRQRQARVKSRIECLISMVRIGVACSM 974 (986)
Q Consensus 910 ~~~~-----~~~~~~~~~--~~~~~~-------~~~d~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~ 974 (986)
.... ......... .+.... ...+.. .............................++.+++.+|++
T Consensus 234 ~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~ 313 (362)
T d1q8ya_ 234 GHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQ 313 (362)
T ss_dssp -----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGC
T ss_pred cccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCC
Confidence 2110 011111100 011100 000000 0000000000001111112222334567788999999999
Q ss_pred CCCCCCCCCCCC
Q 046598 975 ESPEDRMSMTNV 986 (986)
Q Consensus 975 ~dP~~RPt~~eV 986 (986)
+||++||||+|+
T Consensus 314 ~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 314 LDPRKRADAGGL 325 (362)
T ss_dssp SSTTTCBCHHHH
T ss_pred CChhHCcCHHHH
Confidence 999999998764
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=1e-32 Score=300.82 Aligned_cols=255 Identities=29% Similarity=0.484 Sum_probs=235.7
Q ss_pred cceEEEccCCcccc--cCCccccCCCCCCEEEccC-ccccCcCCCcccCCCCCCEEEccCccceeecCcccccc-cccEE
Q 046598 358 TLEVLLLDNNQIFG--NIPAAIGKFVNLQRLDMCS-NRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNL-KLFIL 433 (986)
Q Consensus 358 ~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~-~L~~L 433 (986)
.++.|+|++|++++ .+|..++++++|++|+|++ |.++|.+|..|+++++|++|+|++|+|.+..+..+... +|+++
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence 58889999999987 4789999999999999986 89999999999999999999999999999988877665 59999
Q ss_pred EecccccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccc
Q 046598 434 YLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKL 513 (986)
Q Consensus 434 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 513 (986)
++++|.+.+.+|..+.+++.|+.+++++|+++|.+|..+......++.+++++|++++..|..+..+..+ .+++++|.+
T Consensus 131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~ 209 (313)
T d1ogqa_ 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNML 209 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEE
T ss_pred ccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence 9999999999999999999999999999999999999855554445999999999999999988887655 699999999
Q ss_pred cccCcccccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCccccccCCcc
Q 046598 514 KGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQG 593 (986)
Q Consensus 514 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~ 593 (986)
.+.+|..+..+++|+.|++++|.+++.+| .++.+++|+.|+|++|+|+|.+|+.|+++++|++|+|++|+|+|.+|..+
T Consensus 210 ~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~ 288 (313)
T d1ogqa_ 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG 288 (313)
T ss_dssp EECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred ccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcc
Confidence 99999999999999999999999997654 68999999999999999999999999999999999999999999999988
Q ss_pred ccccccceeeeCCcccccCCC
Q 046598 594 VFKNASITSVFGNLKLCGGIP 614 (986)
Q Consensus 594 ~~~~~~~~~~~~n~~lcg~~~ 614 (986)
.++.++.+++.||+.+||.|+
T Consensus 289 ~L~~L~~l~l~~N~~l~g~pl 309 (313)
T d1ogqa_ 289 NLQRFDVSAYANNKCLCGSPL 309 (313)
T ss_dssp TGGGSCGGGTCSSSEEESTTS
T ss_pred cCCCCCHHHhCCCccccCCCC
Confidence 899999999999999999865
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=4e-29 Score=280.90 Aligned_cols=194 Identities=29% Similarity=0.425 Sum_probs=140.6
Q ss_pred CccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCcccccccccEEEecccccCCCCCcccCCCCC
Q 046598 374 PAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYET 453 (986)
Q Consensus 374 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~ 453 (986)
...+..+++++.+++++|.+++..| +...++|++|++++|+++.. +......+|+.|++++|.+++..+ +..+++
T Consensus 190 ~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~ 264 (384)
T d2omza2 190 ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI-GTLASLTNLTDLDLANNQISNLAP--LSGLTK 264 (384)
T ss_dssp CGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTT
T ss_pred ccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc-chhhcccccchhccccCccCCCCc--cccccc
Confidence 3445566666666666666664433 34456666666666666632 222222346677777777765433 677888
Q ss_pred CCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccCcccccCCccccEEecc
Q 046598 454 LTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQ 533 (986)
Q Consensus 454 L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 533 (986)
|++|++++|+++ .+++ +..++.++.++++.|++++ + ..+..+++++.|++++|++++.. .+..+++|++|+++
T Consensus 265 L~~L~l~~~~l~-~~~~--~~~~~~l~~l~~~~n~l~~-~-~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~ 337 (384)
T d2omza2 265 LTELKLGANQIS-NISP--LAGLTALTNLELNENQLED-I-SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFA 337 (384)
T ss_dssp CSEEECCSSCCC-CCGG--GTTCTTCSEEECCSSCCSC-C-GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECC
T ss_pred CCEeeccCcccC-CCCc--ccccccccccccccccccc-c-cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECC
Confidence 999999999888 4443 5566788899999998885 2 45788888999999999998643 37888999999999
Q ss_pred cccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCC
Q 046598 534 ENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNN 583 (986)
Q Consensus 534 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N 583 (986)
+|+|++ ++ .+.++++|++|+|++|+|++..| +.++++|++|+|++|
T Consensus 338 ~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 338 NNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp SSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 999885 33 68889999999999999987655 788999999999988
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=4.6e-28 Score=272.13 Aligned_cols=186 Identities=30% Similarity=0.399 Sum_probs=134.2
Q ss_pred cceEEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCcccccccccEEEecc
Q 046598 358 TLEVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSY 437 (986)
Q Consensus 358 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~ 437 (986)
.++.+++++|.+++..| +..+++|++|++++|.++. .+.+..+++|+.|++++|++++..+ .....+|++|++++
T Consensus 198 ~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~--~~~l~~l~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~l~~ 272 (384)
T d2omza2 198 NLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP-LSGLTKLTELKLGA 272 (384)
T ss_dssp TCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCS
T ss_pred ccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC--cchhhcccccchhccccCccCCCCc-ccccccCCEeeccC
Confidence 45556666666664433 3455666777777776663 2356666777777777777664332 22333577777777
Q ss_pred cccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccC
Q 046598 438 NFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEI 517 (986)
Q Consensus 438 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 517 (986)
|++++.. .+..++.++.+++++|++++ ++. +..+++++.|++++|++++.. .+..+++|++|+|++|+|++ +
T Consensus 273 ~~l~~~~--~~~~~~~l~~l~~~~n~l~~-~~~--~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l 344 (384)
T d2omza2 273 NQISNIS--PLAGLTALTNLELNENQLED-ISP--ISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-V 344 (384)
T ss_dssp SCCCCCG--GGTTCTTCSEEECCSSCCSC-CGG--GGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-C
T ss_pred cccCCCC--cccccccccccccccccccc-ccc--cchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-C
Confidence 7776443 36778888999999999874 432 566788999999999998643 37888999999999999984 4
Q ss_pred cccccCCccccEEecccccccccCCccccCCCCCCEEeCCCc
Q 046598 518 PSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQN 559 (986)
Q Consensus 518 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 559 (986)
+ .+.++++|++|++++|+|++..| +.++++|+.|+|++|
T Consensus 345 ~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 345 S-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp G-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred h-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 4 68899999999999999997654 888999999999988
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=1.1e-25 Score=243.69 Aligned_cols=129 Identities=26% Similarity=0.375 Sum_probs=75.0
Q ss_pred CCCCCcceeeEecCCCCeEEEEeccCCCCccccCcCccCCCCCCEEEccCCCccccCCcchhccccCceeeceecccCCC
Q 046598 46 SSHFCQWRGVTCSRRHQRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGA 125 (986)
Q Consensus 46 ~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 125 (986)
..+-|.|++|.|+. ++++ .+|+.+. +.+++|+|++|+|+...+.+|.++++|++|++++|.++..
T Consensus 6 ~~c~c~~~~~~C~~------------~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i 70 (305)
T d1xkua_ 6 FRCQCHLRVVQCSD------------LGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKI 70 (305)
T ss_dssp TTCEEETTEEECTT------------SCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCB
T ss_pred CCCEecCCEEEecC------------CCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhcccccccccccccccccc
Confidence 34557899999974 2344 5565543 4677777777777655555677777777777777776655
Q ss_pred CccchhcCccccceecccccccCccCccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeeccCC
Q 046598 126 IPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGN 192 (986)
Q Consensus 126 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 192 (986)
.|..|..+++|++|++++|+++ .+|..+. ..|+.|++.+|.+.+..+..+.....+..++...|
T Consensus 71 ~~~~f~~l~~L~~L~l~~n~l~-~l~~~~~--~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n 134 (305)
T d1xkua_ 71 SPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTN 134 (305)
T ss_dssp CTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSS
T ss_pred chhhhhCCCccCEecccCCccC-cCccchh--hhhhhhhccccchhhhhhhhhhccccccccccccc
Confidence 5666666666666666666666 3343222 34555555555555444434444444444444444
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=2.7e-25 Score=240.73 Aligned_cols=82 Identities=22% Similarity=0.347 Sum_probs=48.3
Q ss_pred cccceecccccccCccCccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeeccCCcccCcCcchhhccCCCceeecc
Q 046598 135 NLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMA 214 (986)
Q Consensus 135 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 214 (986)
.++.+|-++++++ .+|..+. +++++|+|++|+|+...+.+|.++++|++|++++|.++...|..|..+++|++|+++
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 3455555555555 4454443 456666666666664444456666666666666666665555666666666666666
Q ss_pred ccccc
Q 046598 215 QNRLS 219 (986)
Q Consensus 215 ~N~l~ 219 (986)
+|+++
T Consensus 88 ~n~l~ 92 (305)
T d1xkua_ 88 KNQLK 92 (305)
T ss_dssp SSCCS
T ss_pred CCccC
Confidence 66655
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=8e-26 Score=241.94 Aligned_cols=249 Identities=21% Similarity=0.196 Sum_probs=192.7
Q ss_pred EEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCcccccc-cccEEEe-cccc
Q 046598 362 LLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNL-KLFILYL-SYNF 439 (986)
Q Consensus 362 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~-~L~~L~L-~~N~ 439 (986)
+..++++++ .+|..+. +++++|+|++|+|++..+.+|.++++|++|++++|++....+..+... .+..+.. ..|.
T Consensus 16 v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~ 92 (284)
T d1ozna_ 16 TSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92 (284)
T ss_dssp EECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTT
T ss_pred EEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccc
Confidence 455566665 4454433 456777777777775555667777777777777777776666666544 3555554 4666
Q ss_pred cCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccCcc
Q 046598 440 LQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPS 519 (986)
Q Consensus 440 l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 519 (986)
++...|..|.++++|++|++++|.+. .++...+....+|+.+++++|+|+++.+..|..+++|+.|+|++|+|++..+.
T Consensus 93 ~~~l~~~~~~~l~~L~~L~l~~n~~~-~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~ 171 (284)
T d1ozna_ 93 LRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER 171 (284)
T ss_dssp CCCCCTTTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred cccccchhhcccccCCEEecCCcccc-cccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchh
Confidence 77677888999999999999999997 55555577888899999999999976677888899999999999999988888
Q ss_pred cccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCccccccCCcccccccc
Q 046598 520 TLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPTQGVFKNAS 599 (986)
Q Consensus 520 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~ 599 (986)
.|.++++|+++++++|++++..|..|..+++|++||+++|++++..|..|..+++|++|+|++|++.+..+.......++
T Consensus 172 ~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~~l~ 251 (284)
T d1ozna_ 172 AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQ 251 (284)
T ss_dssp TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHH
T ss_pred hhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccchHHHHHHH
Confidence 89999999999999999998889999999999999999999998888899999999999999999998776543333445
Q ss_pred ceeeeCCcccccCCC
Q 046598 600 ITSVFGNLKLCGGIP 614 (986)
Q Consensus 600 ~~~~~~n~~lcg~~~ 614 (986)
......+...|..|.
T Consensus 252 ~~~~~~~~~~C~~p~ 266 (284)
T d1ozna_ 252 KFRGSSSEVPCSLPQ 266 (284)
T ss_dssp HCCSEECCCBEEESG
T ss_pred hCcCCCCceEeCCch
Confidence 555555666665443
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.3e-24 Score=232.37 Aligned_cols=225 Identities=20% Similarity=0.215 Sum_probs=200.4
Q ss_pred eccCCCCccccCcCccCCCCCCEEEccCCCccccCCcchhccccCceeeceecccCCCCccchhcCccccceecc-cccc
Q 046598 68 DLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLF-HNQL 146 (986)
Q Consensus 68 ~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls-~N~l 146 (986)
+.++.+++ .+|..+. +.+++|+|++|+|++..+.+|.++++|++|++++|++....+..+..+..++.++.+ .|.+
T Consensus 17 ~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~ 93 (284)
T d1ozna_ 17 SCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93 (284)
T ss_dssp ECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTC
T ss_pred EcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccccc
Confidence 44566666 6676554 578999999999998778899999999999999999998888889999999998765 6677
Q ss_pred cCccCccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeeccCCcccCcCcchhhccCCCceeecccccccccCCccc
Q 046598 147 VGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSI 226 (986)
Q Consensus 147 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l 226 (986)
+...|.+|+++++|++|++++|.+....+..+....+|+.+++++|+|+++.+..|..+++|++|+|++|++++..+..+
T Consensus 94 ~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f 173 (284)
T d1ozna_ 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAF 173 (284)
T ss_dssp CCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTT
T ss_pred ccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhh
Confidence 77778899999999999999999998888889999999999999999998778899999999999999999998888999
Q ss_pred cCCCCccEEeccccccccccCCcccccccccceEEecCceecccCCccccCCCCCcEEecccccccCCCc
Q 046598 227 FNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSVNKLTGAAP 296 (986)
Q Consensus 227 ~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~ 296 (986)
.++++|+.++++.|++.+..|.. +.++++|++|++++|++++..+..|..+++|+.+++++|.+...-+
T Consensus 174 ~~l~~L~~l~l~~N~l~~i~~~~-f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~ 242 (284)
T d1ozna_ 174 RGLHSLDRLLLHQNRVAHVHPHA-FRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (284)
T ss_dssp TTCTTCCEEECCSSCCCEECTTT-TTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred ccccccchhhhhhccccccChhH-hhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc
Confidence 99999999999999999766654 5579999999999999999999999999999999999999986544
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=7.7e-24 Score=223.71 Aligned_cols=202 Identities=27% Similarity=0.287 Sum_probs=113.0
Q ss_pred cCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCcccccc-cccEEEecccccCCCCCcccCCCCCCCe
Q 046598 378 GKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNL-KLFILYLSYNFLQGSIPSSLGRYETLTT 456 (986)
Q Consensus 378 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 456 (986)
.+...+.++|.+++.|+ .+|..+. ++|++|+|++|+|++..+..|..+ +|++|+|++|+|+. +| .++.+++|++
T Consensus 7 ~~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~ 81 (266)
T d1p9ag_ 7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGT 81 (266)
T ss_dssp ECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCE
T ss_pred cccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-cccccccccc
Confidence 44556667788888887 4565543 467777777777775555555443 35566666655552 22 2345555555
Q ss_pred eecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccCcccccCCccccEEeccccc
Q 046598 457 IDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQENF 536 (986)
Q Consensus 457 L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 536 (986)
|+|++|+++ .++.. +..+++|+.|++++|.+.+..+..+..+.+++.|++++|.+++..+..+..+++|+.|++++|+
T Consensus 82 L~Ls~N~l~-~~~~~-~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~ 159 (266)
T d1p9ag_ 82 LDLSHNQLQ-SLPLL-GQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (266)
T ss_dssp EECCSSCCS-SCCCC-TTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred ccccccccc-ccccc-cccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccc
Confidence 555555555 33333 4444555555555555554444555555555555555555554444445555555555555555
Q ss_pred ccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCcccc
Q 046598 537 LQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEG 587 (986)
Q Consensus 537 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~ 587 (986)
|++..+..|..+++|++|||++|+|+ .+|+.+..+++|+.|+|++|++.+
T Consensus 160 l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred ccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCC
Confidence 55555555555555555555555555 455555555555555555555544
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=1.9e-23 Score=220.67 Aligned_cols=197 Identities=25% Similarity=0.185 Sum_probs=155.6
Q ss_pred eEEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCcccccccccEEEecccc
Q 046598 360 EVLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNF 439 (986)
Q Consensus 360 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~ 439 (986)
.+++.++++|+ .+|..+. +++++|+|++|+|++..+.+|.++++|++|+|++|+|+.. |......+|++|+|++|+
T Consensus 13 ~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~~~~~l~~L~~L~Ls~N~ 88 (266)
T d1p9ag_ 13 LEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-QVDGTLPVLGTLDLSHNQ 88 (266)
T ss_dssp CEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-ECCSCCTTCCEEECCSSC
T ss_pred eEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-cccccccccccccccccc
Confidence 34456666665 3444443 3566666666666655556666666677777777766643 222222357777777777
Q ss_pred cCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccCcc
Q 046598 440 LQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPS 519 (986)
Q Consensus 440 l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 519 (986)
++ ..+..+..+++|+.|++++|++. .++...+..+.+++.|++++|.+++..+..+..+++|+.|++++|+|++..+.
T Consensus 89 l~-~~~~~~~~l~~L~~L~l~~~~~~-~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~ 166 (266)
T d1p9ag_ 89 LQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAG 166 (266)
T ss_dssp CS-SCCCCTTTCTTCCEEECCSSCCC-CCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTT
T ss_pred cc-ccccccccccccccccccccccc-eeeccccccccccccccccccccceeccccccccccchhcccccccccccCcc
Confidence 77 45778899999999999999998 66667688899999999999999987778888999999999999999988888
Q ss_pred cccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcc
Q 046598 520 TLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSG 563 (986)
Q Consensus 520 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 563 (986)
.|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|++..
T Consensus 167 ~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 167 LLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp TTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred ccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCC
Confidence 8999999999999999999 789889999999999999999873
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=1.1e-22 Score=202.79 Aligned_cols=170 Identities=18% Similarity=0.141 Sum_probs=120.6
Q ss_pred CCCCcccccccceeEEEEEECCCCeEEEEEEeeccCc------------------hhHHHHHHHHHHHhcCCCCcceeee
Q 046598 690 FSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHH------------------GAFKSFIAECNTLKNIRHRNLVKIL 751 (986)
Q Consensus 690 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~ 751 (986)
+.+.++||+|+||+||+|.+.+ ++.||||+++.... .......+|...+.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~-g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETT-TEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECCC-CCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 3467899999999999999875 78999998753110 0123345688899999999999988
Q ss_pred eeccccccCCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCC
Q 046598 752 TACSGVDYQGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDCQPPIAHCDLKP 831 (986)
Q Consensus 752 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 831 (986)
++ ...++||||+++..+.+ ++...+..++.|+++|++|||++ ||+||||||
T Consensus 81 ~~---------~~~~lvme~~~~~~~~~-----------------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP 131 (191)
T d1zara2 81 AW---------EGNAVLMELIDAKELYR-----------------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQ 131 (191)
T ss_dssp EE---------ETTEEEEECCCCEEGGG-----------------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCST
T ss_pred Ee---------cCCEEEEEeeccccccc-----------------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCCh
Confidence 76 22379999998765543 22334567999999999999999 999999999
Q ss_pred CCeEecCCCcEEEcccccceecCCCCCccccccccccccccccccccCCCcCcccchhhHHHHH
Q 046598 832 SNILLDEDMIAHIGDFGLARFLPLSSAQTSSIGAKGSIGYIAPEYGLGSEVSISGDVYSYGILL 895 (986)
Q Consensus 832 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl 895 (986)
+|||++++ .++|+|||.|+............. .... -.|. ..+.|+.++|+||..--+
T Consensus 132 ~NILv~~~-~~~liDFG~a~~~~~~~~~~~l~r---d~~~-~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 132 YNVLVSEE-GIWIIDFPQSVEVGEEGWREILER---DVRN-IITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TSEEEETT-EEEECCCTTCEETTSTTHHHHHHH---HHHH-HHHH-HHHHHCCCCCHHHHHHHH
T ss_pred hheeeeCC-CEEEEECCCcccCCCCCcHHHHHH---HHHH-HHHH-HcCCCCCcccHHHHHHHH
Confidence 99999965 589999999986542222111000 0000 0111 135688899999976443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.85 E-value=5.7e-20 Score=202.62 Aligned_cols=96 Identities=24% Similarity=0.320 Sum_probs=66.1
Q ss_pred ccCceeeceecccCCCCccchhcCccccceecccccccCccCccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeec
Q 046598 110 RRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFL 189 (986)
Q Consensus 110 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 189 (986)
.+|++|||++|.++ .+|+. .++|++|+|++|+|+ .+|..+ .+|++|++++|+++ .++.. .+.|++|++
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEEC
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccc
Confidence 46788888888887 56753 457788888888887 667553 46777888888777 33321 135777777
Q ss_pred cCCcccCcCcchhhccCCCceeeccccccc
Q 046598 190 SGNNLEGSIPDTLGWLKNLVNLTMAQNRLS 219 (986)
Q Consensus 190 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 219 (986)
++|.++ .+|. ++.+++|++|++++|.++
T Consensus 106 ~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~ 133 (353)
T d1jl5a_ 106 SNNQLE-KLPE-LQNSSFLKIIDVDNNSLK 133 (353)
T ss_dssp CSSCCS-SCCC-CTTCTTCCEEECCSSCCS
T ss_pred cccccc-cccc-hhhhccceeecccccccc
Confidence 777777 4453 466777777777777765
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.83 E-value=7.9e-19 Score=193.36 Aligned_cols=59 Identities=34% Similarity=0.435 Sum_probs=35.8
Q ss_pred CCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccCcc
Q 046598 451 YETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPS 519 (986)
Q Consensus 451 l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 519 (986)
+++|++|+|++|+|+ .+|.. +++|+.|+|++|+|+ .+|.. +++|++|+|++|+|+ .+|.
T Consensus 283 ~~~L~~L~Ls~N~l~-~lp~~----~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~ 341 (353)
T d1jl5a_ 283 PPSLEELNVSNNKLI-ELPAL----PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPD 341 (353)
T ss_dssp CTTCCEEECCSSCCS-CCCCC----CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCC
T ss_pred CCCCCEEECCCCccC-ccccc----cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCc
Confidence 456666666666666 55542 356666777777666 45532 345666677777766 4554
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.78 E-value=1.6e-19 Score=179.86 Aligned_cols=155 Identities=21% Similarity=0.271 Sum_probs=128.1
Q ss_pred eccCCCCccccCcCccCCCCCCEEEccCCCcccc-CCcchhccccCceeeceecccCCCCccchhcCccccceecccccc
Q 046598 68 DLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHE-IPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQL 146 (986)
Q Consensus 68 ~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 146 (986)
|.++++++ .+|+.+. +.+++|+|++|+|++. .+..|.++++|+.|+|++|.+++..+..|..+++|++|+|++|+|
T Consensus 14 ~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l 90 (192)
T d1w8aa_ 14 DCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKI 90 (192)
T ss_dssp ECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCC
T ss_pred EEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccc
Confidence 34455666 6777664 6899999999999864 467889999999999999999989999999999999999999999
Q ss_pred cCccCccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeeccCCcccCcCcchhhccCCCceeecccccccccCCccc
Q 046598 147 VGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSI 226 (986)
Q Consensus 147 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l 226 (986)
+...|.+|.++++|++|+|++|+|++..+..|.++++|++|+|++|.+....+ ...-...++.+.+..|.++...|..+
T Consensus 91 ~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~-~~~~~~~l~~~~l~~~~~~c~~p~~l 169 (192)
T d1w8aa_ 91 KEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH-LAWFAEWLRKKSLNGGAARCGAPSKV 169 (192)
T ss_dssp CEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG-GHHHHHHHHHHCCSGGGCBBCSSTTT
T ss_pred cccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc-hHHHhhhhhhhcccCCCeEeCCChhh
Confidence 98888899999999999999999998888899999999999999999974332 22223446777788888776666544
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.77 E-value=4.7e-19 Score=176.38 Aligned_cols=178 Identities=20% Similarity=0.242 Sum_probs=136.1
Q ss_pred ccEEEecccccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhcc
Q 046598 430 LFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVF 509 (986)
Q Consensus 430 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 509 (986)
.++++.++|+++ .+|..+. +++++|+|++|+|++.++...|..+++|+.|+|++|++++..+..|..+++|++|+|+
T Consensus 10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 345667777777 5666543 5788889999988766777778888889999999998888888888888899999999
Q ss_pred CccccccCcccccCCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCcccccc
Q 046598 510 GNKLKGEIPSTLGSCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVV 589 (986)
Q Consensus 510 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~ 589 (986)
+|+|++..|..|.++++|++|+|++|+|++..|.+|..+++|++|+|++|++....+. ..-...++.+.+..|.+++..
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~-~~~~~~l~~~~l~~~~~~c~~ 165 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL-AWFAEWLRKKSLNGGAARCGA 165 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG-HHHHHHHHHHCCSGGGCBBCS
T ss_pred cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccch-HHHhhhhhhhcccCCCeEeCC
Confidence 9999877778888899999999999999888888888899999999999988754332 222334667778888888777
Q ss_pred CCccccccccceeeeCCcccccCC
Q 046598 590 PTQGVFKNASITSVFGNLKLCGGI 613 (986)
Q Consensus 590 p~~~~~~~~~~~~~~~n~~lcg~~ 613 (986)
|.. +..+...++..|.-.|..+
T Consensus 166 p~~--l~~~~l~~L~~n~l~C~~~ 187 (192)
T d1w8aa_ 166 PSK--VRDVQIKDLPHSEFKCSSE 187 (192)
T ss_dssp STT--TTTSBGGGSCTTTCCCCCC
T ss_pred Chh--hcCCEeeecCHhhCcCCCC
Confidence 654 5555556667676666543
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=1.3e-18 Score=180.71 Aligned_cols=218 Identities=17% Similarity=0.144 Sum_probs=147.8
Q ss_pred EEEccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecC-cccccc-cccEEEec-c
Q 046598 361 VLLLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIP-PSIGNL-KLFILYLS-Y 437 (986)
Q Consensus 361 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~~-~L~~L~L~-~ 437 (986)
.++.+++.++ .+|..+. +++++|+|++|.|+...+.+|.++++|++|+|++|.+...++ ..|..+ .++++.+. .
T Consensus 12 ~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~ 88 (242)
T d1xwdc1 12 VFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88 (242)
T ss_dssp EEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred EEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccc
Confidence 4455555555 3443332 356666666666664444556666666666666666655433 334433 45666554 3
Q ss_pred cccCCCCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCccccccc-ccchhhccCcccccc
Q 046598 438 NFLQGSIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLK-NLEILNVFGNKLKGE 516 (986)
Q Consensus 438 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~ 516 (986)
|.+....+..|.++++|++|++++|++....+..+...+..+..+..+++.+....+..|..++ .++.|++++|+++.
T Consensus 89 n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~- 167 (242)
T d1xwdc1 89 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE- 167 (242)
T ss_dssp TTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE-
T ss_pred ccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccc-
Confidence 5666677777888889999999998887333333345566777778888888866666777664 78889999999984
Q ss_pred CcccccCCccccE-EecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccC
Q 046598 517 IPSTLGSCIKLEQ-LEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSN 582 (986)
Q Consensus 517 ~p~~~~~l~~L~~-L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~ 582 (986)
++.......++++ +++++|+|+...+..|.++++|+.|+|++|+|+...+..|.++++|+.+++.+
T Consensus 168 i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 168 IHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN 234 (242)
T ss_dssp ECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred cccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence 4444444555544 46788889865566789999999999999999966666788888888877754
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=8.1e-22 Score=226.08 Aligned_cols=184 Identities=16% Similarity=0.147 Sum_probs=101.9
Q ss_pred ccCCCCCCEEEccCccccCc----CCCcccCCCCCCEEEccCccceeecCcccccccccEEEecccccCCCCCcccCCCC
Q 046598 377 IGKFVNLQRLDMCSNRLSGT----IPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYE 452 (986)
Q Consensus 377 ~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~ 452 (986)
......++.|++++|.+... ....+...+.++.+++++|.+.......+.. .......
T Consensus 251 ~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~------------------~l~~~~~ 312 (460)
T d1z7xw1 251 LHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE------------------TLLEPGC 312 (460)
T ss_dssp TSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHH------------------HHTSTTC
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhc------------------ccccccc
Confidence 34455677777777766522 1223345566666666666665321111100 0001123
Q ss_pred CCCeeecCCCccCCCCCcc---cccCCCcceEEEccCCccccc----CCcccc-cccccchhhccCccccc----cCccc
Q 046598 453 TLTTIDLSNNNLTGTIPPQ---FIGLSSSLIVLDLSRNQLTGS----IPSEVG-NLKNLEILNVFGNKLKG----EIPST 520 (986)
Q Consensus 453 ~L~~L~L~~N~l~~~ip~~---~~~~~~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~Ls~N~l~~----~~p~~ 520 (986)
.|+.+++++|.++..-... ++....+|++|+|++|+|++. ++..+. ..+.|++|+|++|.|+. .++..
T Consensus 313 ~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~ 392 (460)
T d1z7xw1 313 QLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAAT 392 (460)
T ss_dssp CCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHH
T ss_pred ccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHH
Confidence 5666666666654221111 122334677777777777542 222222 34567778888887763 24455
Q ss_pred ccCCccccEEecccccccccCCccc----c-CCCCCCEEeCCCccCcccCchhhh----ccccccee
Q 046598 521 LGSCIKLEQLEMQENFLQGPIPSSL----S-SLRGLSVLDLSQNNLSGKIPELLI----RLQLVKNL 578 (986)
Q Consensus 521 ~~~l~~L~~L~L~~N~l~~~~p~~~----~-~l~~L~~L~Ls~N~l~~~~p~~~~----~l~~L~~l 578 (986)
+..+++|++|+|++|+|++.....| . +...|+.|++++|.+.......+. +.++|++|
T Consensus 393 l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~~~~l~~l~~~~~~l~~~ 459 (460)
T d1z7xw1 393 LLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459 (460)
T ss_dssp HHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHHHHHHHHHHCTTSEEE
T ss_pred HhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHHHHHHHHHHHHhCCCCEEe
Confidence 6667888888888888875433333 2 334799999999999866555543 44566554
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=2.7e-18 Score=178.15 Aligned_cols=221 Identities=14% Similarity=0.185 Sum_probs=170.4
Q ss_pred CcceeeEecCCCCeEEEEeccCCCCccccCcCccCCCCCCEEEccCCCccccCCcchhccccCceeeceecccCCCC-cc
Q 046598 50 CQWRGVTCSRRHQRVTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAI-PA 128 (986)
Q Consensus 50 c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~ 128 (986)
|+++.|.|.. .+++ .+|+.+. +.+++|+|++|+|+...+.+|.++++|++|+|++|.+...+ +.
T Consensus 8 C~~~~i~c~~------------~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~ 72 (242)
T d1xwdc1 8 CSNRVFLCQE------------SKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD 72 (242)
T ss_dssp ECSSEEEEES------------CSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSS
T ss_pred CcCCEEEEeC------------CCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecc
Confidence 5566666653 3455 5666553 57899999999999777778999999999999999998655 45
Q ss_pred chhcCccccceeccc-ccccCccCccccCCCCCCeEEccCCcCCCCcc-cccCCCcCcceeeccCCcccCcCcchhhccC
Q 046598 129 NISSCSNLIQLRLFH-NQLVGKIPSELSSLSKIEHISVNDNNLTGSIP-SSLGNLSSIRSLFLSGNNLEGSIPDTLGWLK 206 (986)
Q Consensus 129 ~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 206 (986)
.|.+++++++|++.. |.+....+..|.++++|++|++++|++....+ ..+..+..+..+..+++.+....+..|..++
T Consensus 73 ~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~ 152 (242)
T d1xwdc1 73 VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLS 152 (242)
T ss_dssp SEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSB
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhccccccccccccccccccccccccccccccccccccc
Confidence 788999999999864 67887888889999999999999999974433 2345667777778888888877777777765
Q ss_pred -CCceeecccccccccCCccccCCCCccEE-eccccccccccCCcccccccccceEEecCceecccCCccccCCCCCcEE
Q 046598 207 -NLVNLTMAQNRLSGTIPSSIFNISSITGF-DAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIF 284 (986)
Q Consensus 207 -~L~~L~L~~N~l~~~~p~~l~~l~~L~~L-~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 284 (986)
.++.|++++|+++ .++...++..++..+ +++.|.++ .+|...+.++++|++|+|++|+++...+..|.++++|+.+
T Consensus 153 ~~l~~L~l~~n~l~-~i~~~~~~~~~l~~~~~l~~n~l~-~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l 230 (242)
T d1xwdc1 153 FESVILWLNKNGIQ-EIHNCAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRAR 230 (242)
T ss_dssp SSCEEEECCSSCCC-EECTTTTTTCCEEEEECTTCTTCC-CCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESS
T ss_pred ccceeeeccccccc-ccccccccchhhhccccccccccc-cccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccC
Confidence 7899999999998 556666666666555 56777776 6777777788888888888888886656667777777766
Q ss_pred ecc
Q 046598 285 HGS 287 (986)
Q Consensus 285 ~ls 287 (986)
++.
T Consensus 231 ~~~ 233 (242)
T d1xwdc1 231 STY 233 (242)
T ss_dssp SEE
T ss_pred cCC
Confidence 553
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=2.3e-21 Score=222.20 Aligned_cols=393 Identities=18% Similarity=0.178 Sum_probs=211.9
Q ss_pred ccCceeeceecccCCCC-ccchhcCccccceecccccccC----ccCccccCCCCCCeEEccCCcCCCC----cccccC-
Q 046598 110 RRLQVLALHYNSIGGAI-PANISSCSNLIQLRLFHNQLVG----KIPSELSSLSKIEHISVNDNNLTGS----IPSSLG- 179 (986)
Q Consensus 110 ~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~- 179 (986)
.+|+.||+++|++++.. .+-+..+++|++|+|++|.++. .+...+..+++|++|+|++|+++.. +...+.
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 36888899888887432 3445677888888888888763 2345566778888888888877521 222222
Q ss_pred CCcCcceeeccCCcccCc----CcchhhccCCCceeecccccccccCCccccCCCCccEEeccccccccccCCccccccc
Q 046598 180 NLSSIRSLFLSGNNLEGS----IPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQ 255 (986)
Q Consensus 180 ~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~l~ 255 (986)
...+|++|+|++|+++.. ++..+..+++|++|+|++|+++......+... ......
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~--------------------l~~~~~ 141 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEG--------------------LLDPQC 141 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHH--------------------HTSTTC
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhc--------------------cccccc
Confidence 224678888888877633 34455667777777777777653211111100 000000
Q ss_pred ccceEEecCceecc----cCCccccCCCCCcEEecccccccCCCchhhhhhhHhhhhhccCCCCCCCCCCcccccccccc
Q 046598 256 NLQFFSVGENQLTG----AIPPTISNASNLEIFHGSVNKLTGAAPYLEKLQRLLVFGILGNSLGSRGDRDLNFLCSLTNA 331 (986)
Q Consensus 256 ~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~ls~N~l~~~~~~l~~l~~L~~l~l~~n~l~~~~~~~l~~l~~l~~~ 331 (986)
...........+.. ..-..+.....++.++++++...... ..
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ls~~~~~~~~-----~~----------------------------- 187 (460)
T d1z7xw1 142 RLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAG-----VR----------------------------- 187 (460)
T ss_dssp CCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHH-----HH-----------------------------
T ss_pred ccccccccccccchhhhccccccccccccccccccccccccccc-----cc-----------------------------
Confidence 01111111111100 00011122233333333333221000 00
Q ss_pred cccceeeccccccccCCCcccccccccceEEEccCCccccc----CCccccCCCCCCEEEccCccccC-----cCCCccc
Q 046598 332 TRLKWLLININNFGGSLPACISNLSTTLEVLLLDNNQIFGN----IPAAIGKFVNLQRLDMCSNRLSG-----TIPPAIG 402 (986)
Q Consensus 332 ~~L~~l~l~~n~~~~~~p~~~~~~~~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~-----~~~~~~~ 402 (986)
.+...+.........+.+..+.+... ....+...+.++.+++++|.+.. ..+..+.
T Consensus 188 ---------------~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~ 252 (460)
T d1z7xw1 188 ---------------VLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLH 252 (460)
T ss_dssp ---------------HHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTS
T ss_pred ---------------ccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccccchhhccccc
Confidence 00000000011223344444443311 11223345566666666665531 1122233
Q ss_pred CCCCCCEEEccCccceeecCcccccccccEEEecccccCCCCCcccCCCCCCCeeecCCCccCCCCC----cccccCCCc
Q 046598 403 ELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQGSIPSSLGRYETLTTIDLSNNNLTGTIP----PQFIGLSSS 478 (986)
Q Consensus 403 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip----~~~~~~~~~ 478 (986)
....++.|++++|.+...... .....+...+.++.+++++|.++.... .........
T Consensus 253 ~~~~l~~l~l~~n~i~~~~~~-------------------~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~ 313 (460)
T d1z7xw1 253 PSSRLRTLWIWECGITAKGCG-------------------DLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQ 313 (460)
T ss_dssp TTCCCCEEECTTSCCCHHHHH-------------------HHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCC
T ss_pred ccccccccccccccccccccc-------------------cccccccccccccccccccccccccccchhhccccccccc
Confidence 344555555555554421110 111223446678888888888752111 111223457
Q ss_pred ceEEEccCCcccccCCccc----ccccccchhhccCcccccc----Cccccc-CCccccEEeccccccccc----CCccc
Q 046598 479 LIVLDLSRNQLTGSIPSEV----GNLKNLEILNVFGNKLKGE----IPSTLG-SCIKLEQLEMQENFLQGP----IPSSL 545 (986)
Q Consensus 479 L~~L~Ls~N~l~~~~p~~~----~~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~L~~N~l~~~----~p~~~ 545 (986)
|+.+++++|.++......+ ...++|++|+|++|+|++. ++..+. ..+.|++|+|++|.|++. ++..+
T Consensus 314 L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l 393 (460)
T d1z7xw1 314 LESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATL 393 (460)
T ss_dssp CCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHH
T ss_pred cccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHH
Confidence 9999999999885433333 3456899999999999743 344443 467799999999999753 34556
Q ss_pred cCCCCCCEEeCCCccCcccCchhhh-----cccccceeeccCCccccccC
Q 046598 546 SSLRGLSVLDLSQNNLSGKIPELLI-----RLQLVKNLNLSNNDLEGVVP 590 (986)
Q Consensus 546 ~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~l~ls~N~l~~~~p 590 (986)
..+++|++|||++|+|+......+. +...|+.|++++|.+.....
T Consensus 394 ~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~~ 443 (460)
T d1z7xw1 394 LANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEME 443 (460)
T ss_dssp HHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHH
T ss_pred hcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHHHH
Confidence 6779999999999999864443332 23479999999999875433
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=4.1e-18 Score=174.67 Aligned_cols=202 Identities=24% Similarity=0.307 Sum_probs=135.1
Q ss_pred EccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCcccccccccEEEecccccCC
Q 046598 363 LLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQG 442 (986)
Q Consensus 363 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~ 442 (986)
+++.+++++.. .+..+.+|+.|++++|.|+. + +.+..+++|++|++++|++++..| .....+++++++++|.++.
T Consensus 25 ~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~~-l~~l~~l~~l~~~~n~~~~ 99 (227)
T d1h6ua2 25 AAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLKN 99 (227)
T ss_dssp HTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCSC
T ss_pred HhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeecccc-ccccccccccccccccccc
Confidence 34444444322 33445556666666666653 2 235556666666666666554332 1122245666666666652
Q ss_pred CCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccCccccc
Q 046598 443 SIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLG 522 (986)
Q Consensus 443 ~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 522 (986)
+ ..++.+++|+.+++++|...+. +. +...+.+..+.++.+.+... ..+..+++|+.|++++|++++. ..++
T Consensus 100 -i-~~l~~l~~L~~l~l~~~~~~~~-~~--~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~--~~l~ 170 (227)
T d1h6ua2 100 -V-SAIAGLQSIKTLDLTSTQITDV-TP--LAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL--TPLA 170 (227)
T ss_dssp -C-GGGTTCTTCCEEECTTSCCCCC-GG--GTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGT
T ss_pred -c-cccccccccccccccccccccc-ch--hccccchhhhhchhhhhchh--hhhccccccccccccccccccc--hhhc
Confidence 3 2477788888888888888733 22 44567788888888888743 3467788899999999988743 2388
Q ss_pred CCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccC
Q 046598 523 SCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSN 582 (986)
Q Consensus 523 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~ 582 (986)
++++|++|+|++|++++. + .++.+++|++|+|++|+|++. + .+.++++|+.|++++
T Consensus 171 ~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i-~-~l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 171 NLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDV-S-PLANTSNLFIVTLTN 226 (227)
T ss_dssp TCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBC-G-GGTTCTTCCEEEEEE
T ss_pred ccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCC-c-ccccCCCCCEEEeeC
Confidence 889999999999998853 3 378889999999999999854 3 278889999998874
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=6.8e-18 Score=173.01 Aligned_cols=206 Identities=23% Similarity=0.321 Sum_probs=151.8
Q ss_pred EEEEeccCCCCccccCcCccCCCCCCEEEccCCCccccCCcchhccccCceeeceecccCCCCccchhcCccccceeccc
Q 046598 64 VTILDLESLKLAGSISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFH 143 (986)
Q Consensus 64 v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 143 (986)
++.++++.+++++.+ .++.|..|++|++++|+++. ++ .+.++++|++|+|++|++++..| +..+++|++|++++
T Consensus 21 ~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~ 94 (227)
T d1h6ua2 21 AIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSG 94 (227)
T ss_dssp HHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCS
T ss_pred HHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeecccc--cccccccccccccc
Confidence 344566666666543 45667788888888888874 43 58888888888888888885543 78888888888888
Q ss_pred ccccCccCccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeeccCCcccCcCcchhhccCCCceeecccccccccCC
Q 046598 144 NQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIP 223 (986)
Q Consensus 144 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 223 (986)
|.++. ++ .+.++++|+++++++|...+.. .+...+.++.+.++++.+... ..+..+++|++|++++|++++.
T Consensus 95 n~~~~-i~-~l~~l~~L~~l~l~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~-- 166 (227)
T d1h6ua2 95 NPLKN-VS-AIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL-- 166 (227)
T ss_dssp CCCSC-CG-GGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCC--
T ss_pred ccccc-cc-cccccccccccccccccccccc--hhccccchhhhhchhhhhchh--hhhccccccccccccccccccc--
Confidence 88873 33 5778888888888888877443 356677888888888888643 3467788888888888888643
Q ss_pred ccccCCCCccEEeccccccccccCCcccccccccceEEecCceecccCCccccCCCCCcEEeccc
Q 046598 224 SSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSV 288 (986)
Q Consensus 224 ~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~ 288 (986)
..+.++++|+.||+++|++.+ ++. +.++++|++|+|++|++++.. .++++++|+.|++++
T Consensus 167 ~~l~~l~~L~~L~Ls~n~l~~-l~~--l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 167 TPLANLSKLTTLKADDNKISD-ISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTN 226 (227)
T ss_dssp GGGTTCTTCCEEECCSSCCCC-CGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEE
T ss_pred hhhcccccceecccCCCccCC-Chh--hcCCCCCCEEECcCCcCCCCc--ccccCCCCCEEEeeC
Confidence 237778888888888888774 332 346788888888888888543 377888888888764
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.72 E-value=1.1e-17 Score=168.98 Aligned_cols=180 Identities=22% Similarity=0.289 Sum_probs=110.0
Q ss_pred EccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCcccccccccEEEecccccCC
Q 046598 363 LLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQG 442 (986)
Q Consensus 363 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~ 442 (986)
.+..+.+++.++. ..+.+|+.|++++|.++... .+..+++|++|+|++|+|++.
T Consensus 30 ~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l---------------------- 83 (210)
T d1h6ta2 30 NLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDI---------------------- 83 (210)
T ss_dssp HTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCC----------------------
T ss_pred HhCcCccCCccCH--HHhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCc----------------------
Confidence 4555555544432 34567777888888777432 366777777777777766632
Q ss_pred CCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccCccccc
Q 046598 443 SIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLG 522 (986)
Q Consensus 443 ~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 522 (986)
+ .++.+++|++|++++|+|+ .+|. +..+++|+.|++++|.+.. + ..+..+++|+.+++++|.+++ +..+.
T Consensus 84 --~-~~~~l~~L~~L~l~~n~i~-~l~~--l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~--~~~~~ 153 (210)
T d1h6ta2 84 --K-PLANLKNLGWLFLDENKVK-DLSS--LKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITD--ITVLS 153 (210)
T ss_dssp --G-GGTTCTTCCEEECCSSCCC-CGGG--GTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCC--CGGGG
T ss_pred --c-ccccCcccccccccccccc-cccc--ccccccccccccccccccc-c-ccccccccccccccccccccc--ccccc
Confidence 1 1345556666666666665 3442 4455666666666666652 2 245666666666666666653 23455
Q ss_pred CCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccC
Q 046598 523 SCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSN 582 (986)
Q Consensus 523 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~ 582 (986)
.+++|+++++++|++++. + .+.++++|+.|+|++|+|+. +| .+.++++|++|+|++
T Consensus 154 ~l~~L~~l~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 154 RLTKLDTLSLEDNQISDI-V-PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp GCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred cccccccccccccccccc-c-cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence 666777777777777643 2 26677777777777777763 44 467777777777753
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=5.9e-17 Score=163.39 Aligned_cols=180 Identities=19% Similarity=0.327 Sum_probs=95.8
Q ss_pred EccCCCccccCCcchhccccCceeeceecccCCCCccchhcCccccceecccccccCccCccccCCCCCCeEEccCCcCC
Q 046598 92 RLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLT 171 (986)
Q Consensus 92 ~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 171 (986)
+++.+.+++.++. ..+.+|++|++++|.++.. + .+..+++|++|+|++|++++.. .++.+++|++|++++|+++
T Consensus 30 ~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~ 103 (210)
T d1h6ta2 30 NLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVK 103 (210)
T ss_dssp HTTCSCTTSEECH--HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred HhCcCccCCccCH--HHhcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCcc--ccccCcccccccccccccc
Confidence 4444444433332 3345555555555555532 2 2455555555555555555322 2455555555666555555
Q ss_pred CCcccccCCCcCcceeeccCCcccCcCcchhhccCCCceeecccccccccCCccccCCCCccEEeccccccccccCCccc
Q 046598 172 GSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYG 251 (986)
Q Consensus 172 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~ 251 (986)
+ +| .+.++++|+.|++++|.+.. + ..+..+++|+.+++++|.+++ +..+..+++|+.+++++|++.+..+ +
T Consensus 104 ~-l~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~~---l 174 (210)
T d1h6ta2 104 D-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVP---L 174 (210)
T ss_dssp C-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGG---G
T ss_pred c-cc-cccccccccccccccccccc-c-ccccccccccccccccccccc--ccccccccccccccccccccccccc---c
Confidence 2 33 35555556666666555542 2 245555556666666655542 2234445555555555555543211 2
Q ss_pred ccccccceEEecCceecccCCccccCCCCCcEEeccc
Q 046598 252 FSLQNLQFFSVGENQLTGAIPPTISNASNLEIFHGSV 288 (986)
Q Consensus 252 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~ 288 (986)
.++++|+.|+|++|+++. +| .+.++++|++|++++
T Consensus 175 ~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 175 AGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp TTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred cCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence 356667777777777763 33 477777777777653
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=5.6e-17 Score=162.12 Aligned_cols=176 Identities=26% Similarity=0.387 Sum_probs=111.2
Q ss_pred EccCCcccccCCccccCCCCCCEEEccCccccCcCCCcccCCCCCCEEEccCccceeecCcccccccccEEEecccccCC
Q 046598 363 LLDNNQIFGNIPAAIGKFVNLQRLDMCSNRLSGTIPPAIGELQNLKDLRLQRNRFQGNIPPSIGNLKLFILYLSYNFLQG 442 (986)
Q Consensus 363 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~ 442 (986)
.++.+.+++.++ ...+.++++|++++|.++. + +.+..+++|++|++++|+|++
T Consensus 24 ~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~----------------------- 76 (199)
T d2omxa2 24 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTD----------------------- 76 (199)
T ss_dssp HTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCC-----------------------
T ss_pred HhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccC-----------------------
Confidence 455565554332 2456677777777777763 2 246666666666666666652
Q ss_pred CCCcccCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccCccccc
Q 046598 443 SIPSSLGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLG 522 (986)
Q Consensus 443 ~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 522 (986)
++ .++++++|++|++++|.+. .++. +..++.|+.|++++|.+... ..+..+++|+.|++++|++. .++ .+.
T Consensus 77 -~~-~l~~l~~L~~L~l~~n~~~-~~~~--l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~-~~~-~l~ 147 (199)
T d2omxa2 77 -IT-PLKNLTKLVDILMNNNQIA-DITP--LANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTIS-DIS-ALS 147 (199)
T ss_dssp -CG-GGTTCTTCCEEECCSSCCC-CCGG--GTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCC-CCG-GGT
T ss_pred -cc-cccCCcccccccccccccc-cccc--cccccccccccccccccccc--cccchhhhhHHhhhhhhhhc-ccc-ccc
Confidence 11 1556666777777777665 4443 55666777777777766632 24666777777777777776 333 466
Q ss_pred CCccccEEecccccccccCCccccCCCCCCEEeCCCccCcccCchhhhccccccee
Q 046598 523 SCIKLEQLEMQENFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNL 578 (986)
Q Consensus 523 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l 578 (986)
.+++|++|++++|++++. + .++++++|+.|+|++|++++ ++ .+..+++|++|
T Consensus 148 ~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 148 GLTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp TCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred ccccccccccccccccCC-c-cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 777777777777777753 2 36777777777777777774 33 46667776654
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.68 E-value=1e-16 Score=160.27 Aligned_cols=162 Identities=22% Similarity=0.395 Sum_probs=79.0
Q ss_pred CCCCCCEEEccCCCccccCCcchhccccCceeeceecccCCCCccchhcCccccceecccccccCccCccccCCCCCCeE
Q 046598 84 NLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHI 163 (986)
Q Consensus 84 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 163 (986)
.+..+++|++++|+++. + +.+..+++|++|+|++|++++..| ++++++|++|++++|.+.. ++ .++++++|++|
T Consensus 38 ~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L 111 (199)
T d2omxa2 38 DLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGL 111 (199)
T ss_dssp HHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEE
T ss_pred HhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCccccccccccccccc-cc-ccccccccccc
Confidence 34445555555555542 2 134455555555555555553222 4555555555555555442 22 24455555555
Q ss_pred EccCCcCCCCcccccCCCcCcceeeccCCcccCcCcchhhccCCCceeecccccccccCCccccCCCCccEEeccccccc
Q 046598 164 SVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQ 243 (986)
Q Consensus 164 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~ 243 (986)
++++|.+... ..+.++++|+.|++++|++.. + +.+..+++|++|++++|++++. + .+.
T Consensus 112 ~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l-~-~l~---------------- 169 (199)
T d2omxa2 112 TLFNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDL-K-PLA---------------- 169 (199)
T ss_dssp ECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCC-G-GGT----------------
T ss_pred cccccccccc--cccchhhhhHHhhhhhhhhcc-c-ccccccccccccccccccccCC-c-ccc----------------
Confidence 5555544422 124445555555555555442 2 2344455555555555554421 1 123
Q ss_pred cccCCcccccccccceEEecCceecccCCccccCCCCCcEE
Q 046598 244 GAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNASNLEIF 284 (986)
Q Consensus 244 ~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 284 (986)
++++|++|++++|++++ ++ .++++++|+.|
T Consensus 170 ---------~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 170 ---------NLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp ---------TCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred ---------CCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 45666666666666664 22 46677777654
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.54 E-value=6.9e-15 Score=133.52 Aligned_cols=101 Identities=28% Similarity=0.400 Sum_probs=48.3
Q ss_pred eeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccCcccccCCccccEEecccc
Q 046598 456 TIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKLEQLEMQEN 535 (986)
Q Consensus 456 ~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 535 (986)
+|+|++|+|+ .++. ++.+++|++|++++|+|+ .+|..++.+++|+.|++++|+|++ +| .++.+++|++|++++|
T Consensus 2 ~L~Ls~n~l~-~l~~--l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 2 VLHLAHKDLT-VLCH--LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp EEECTTSCCS-SCCC--GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred EEEcCCCCCC-CCcc--cccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 4455555554 3332 344444555555555554 344444555555555555555542 22 2455555555555555
Q ss_pred cccccCC-ccccCCCCCCEEeCCCccCc
Q 046598 536 FLQGPIP-SSLSSLRGLSVLDLSQNNLS 562 (986)
Q Consensus 536 ~l~~~~p-~~~~~l~~L~~L~Ls~N~l~ 562 (986)
+|++... ..+..+++|+.|++++|+++
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 5543221 34455555555555555554
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=2.8e-15 Score=143.33 Aligned_cols=128 Identities=15% Similarity=0.108 Sum_probs=75.0
Q ss_pred CccCCCCCCEEEccCCCccccCCcchhccccCceeeceecccCCCCccchhcCccccceecccccccCccCccccCCCCC
Q 046598 81 HVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKI 160 (986)
Q Consensus 81 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 160 (986)
.+.+...|++|+|++|+|+. +|..+..+++|++|+|++|+|+ .++ .|..+++|++|++++|+++...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccc
Confidence 34556666677777777663 3555566666777777777666 332 35666666666666666664444445556666
Q ss_pred CeEEccCCcCCCCcc-cccCCCcCcceeeccCCcccCcCcc----hhhccCCCceee
Q 046598 161 EHISVNDNNLTGSIP-SSLGNLSSIRSLFLSGNNLEGSIPD----TLGWLKNLVNLT 212 (986)
Q Consensus 161 ~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~L~ 212 (986)
++|++++|+++.... ..+.++++|++|++++|.++ ..|. .+..+++|+.||
T Consensus 90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred ccceeccccccccccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeC
Confidence 666666666653211 34556666666666666665 2332 345555555554
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.53 E-value=1.3e-14 Score=131.78 Aligned_cols=102 Identities=23% Similarity=0.319 Sum_probs=67.6
Q ss_pred CEEEccCCCccccCCcchhccccCceeeceecccCCCCccchhcCccccceecccccccCccCccccCCCCCCeEEccCC
Q 046598 89 KVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDN 168 (986)
Q Consensus 89 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 168 (986)
+.|+|++|+++ .++ .++++++|++|+|++|+|+ .+|..|+.+++|++|++++|+|++ +| .++++++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 46777777776 333 3677777777777777776 456667777777777777777763 33 3667777777777777
Q ss_pred cCCCCc-ccccCCCcCcceeeccCCccc
Q 046598 169 NLTGSI-PSSLGNLSSIRSLFLSGNNLE 195 (986)
Q Consensus 169 ~l~~~~-p~~~~~l~~L~~L~L~~N~l~ 195 (986)
+++... ...+..+++|++|++++|+++
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 776332 245666667777777777665
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=4.8e-15 Score=141.74 Aligned_cols=128 Identities=19% Similarity=0.175 Sum_probs=87.6
Q ss_pred cCCCCCCCeeecCCCccCCCCCcccccCCCcceEEEccCCcccccCCcccccccccchhhccCccccccCcccccCCccc
Q 046598 448 LGRYETLTTIDLSNNNLTGTIPPQFIGLSSSLIVLDLSRNQLTGSIPSEVGNLKNLEILNVFGNKLKGEIPSTLGSCIKL 527 (986)
Q Consensus 448 ~~~l~~L~~L~L~~N~l~~~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 527 (986)
|.+..+|++|+|++|+|+ .+|. .+..+++|+.|+|++|+|+. ++ .|..+++|++|++++|++++..+..+..+++|
T Consensus 14 ~~n~~~lr~L~L~~n~I~-~i~~-~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred ccCcCcCcEEECCCCCCC-ccCc-cccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCcccccccccc
Confidence 455667777777777776 5654 34556777777777777773 43 46777777777777777775444555667778
Q ss_pred cEEecccccccccCC-ccccCCCCCCEEeCCCccCcccC---chhhhcccccceee
Q 046598 528 EQLEMQENFLQGPIP-SSLSSLRGLSVLDLSQNNLSGKI---PELLIRLQLVKNLN 579 (986)
Q Consensus 528 ~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~---p~~~~~l~~L~~l~ 579 (986)
+.|+|++|+|+.... ..+..+++|++|++++|+++... +..+..+++|+.||
T Consensus 90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred ccceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 888888887774322 45677788888888888876432 23567778887776
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.44 E-value=1.3e-14 Score=153.25 Aligned_cols=158 Identities=17% Similarity=0.171 Sum_probs=71.9
Q ss_pred cccCceeeceecccCCC-CccchhcCccccceecccccccCccCccccCCCCCCeEEccCC-cCCCC-cccccCCCcCcc
Q 046598 109 LRRLQVLALHYNSIGGA-IPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDN-NLTGS-IPSSLGNLSSIR 185 (986)
Q Consensus 109 l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~ 185 (986)
..+|++|||++|.++.. ++..+..+++|++|+|++|.+++..+..++.+++|++|+++++ .++.. +...+.++++|+
T Consensus 45 ~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~ 124 (284)
T d2astb2 45 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLD 124 (284)
T ss_dssp CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCC
T ss_pred CCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhcc
Confidence 34555555555555422 2233445555555555555555444555555555555555553 33311 111223445555
Q ss_pred eeeccCC-cccCc-Ccchhhc-cCCCceeecccccccccCCccccCCCCccEEeccccccccccCCcccccccccceEEe
Q 046598 186 SLFLSGN-NLEGS-IPDTLGW-LKNLVNLTMAQNRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSV 262 (986)
Q Consensus 186 ~L~L~~N-~l~~~-~p~~~~~-l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L 262 (986)
+|+++++ .++.. +...+.. .++|+.|+++++. +.+....-..+...+++|++|++
T Consensus 125 ~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~----------------------~~i~~~~l~~l~~~~~~L~~L~L 182 (284)
T d2astb2 125 ELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYR----------------------KNLQKSDLSTLVRRCPNLVHLDL 182 (284)
T ss_dssp EEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCG----------------------GGSCHHHHHHHHHHCTTCSEEEC
T ss_pred ccccccccccccccchhhhcccccccchhhhcccc----------------------ccccccccccccccccccccccc
Confidence 5555553 22211 1112222 2345555554421 11111111112223455666666
Q ss_pred cCc-eecccCCccccCCCCCcEEeccc
Q 046598 263 GEN-QLTGAIPPTISNASNLEIFHGSV 288 (986)
Q Consensus 263 ~~N-~l~~~~p~~l~~l~~L~~L~ls~ 288 (986)
++| .+++.....+.++++|++|++++
T Consensus 183 ~~~~~itd~~~~~l~~~~~L~~L~L~~ 209 (284)
T d2astb2 183 SDSVMLKNDCFQEFFQLNYLQHLSLSR 209 (284)
T ss_dssp TTCTTCCGGGGGGGGGCTTCCEEECTT
T ss_pred ccccCCCchhhhhhcccCcCCEEECCC
Confidence 554 35555555666666666666665
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.42 E-value=1.2e-14 Score=153.63 Aligned_cols=210 Identities=18% Similarity=0.186 Sum_probs=122.7
Q ss_pred CCCCCCEEEccCccccCc-CCCcccCCCCCCEEEccCccceeecCccccc-ccccEEEeccc-ccCCC-CCcccCCCCCC
Q 046598 379 KFVNLQRLDMCSNRLSGT-IPPAIGELQNLKDLRLQRNRFQGNIPPSIGN-LKLFILYLSYN-FLQGS-IPSSLGRYETL 454 (986)
Q Consensus 379 ~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-~~L~~L~L~~N-~l~~~-~p~~~~~l~~L 454 (986)
...+|++||++++.++.. +...+..+++|++|+|++|.+++..+..+.. .+|++|+++++ .++.. +...+..+++|
T Consensus 44 ~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L 123 (284)
T d2astb2 44 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL 123 (284)
T ss_dssp CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTC
T ss_pred cCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhc
Confidence 445677777777766532 2334566677777777777666544444432 34666666663 34321 11123456778
Q ss_pred CeeecCCC-ccCCC-CCcccccCCCcceEEEccCC--ccccc-CCcccccccccchhhccCc-cccccCcccccCCcccc
Q 046598 455 TTIDLSNN-NLTGT-IPPQFIGLSSSLIVLDLSRN--QLTGS-IPSEVGNLKNLEILNVFGN-KLKGEIPSTLGSCIKLE 528 (986)
Q Consensus 455 ~~L~L~~N-~l~~~-ip~~~~~~~~~L~~L~Ls~N--~l~~~-~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~ 528 (986)
++|+++++ .++.. +...+....+.|+.|+++++ .++.. +...+.++++|++|++++| .+++.....+.++++|+
T Consensus 124 ~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~ 203 (284)
T d2astb2 124 DELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQ 203 (284)
T ss_dssp CEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCC
T ss_pred cccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCC
Confidence 88888774 34311 11111223467888888764 33321 2223345677888888775 46666667777888888
Q ss_pred EEeccc-ccccccCCccccCCCCCCEEeCCCccCcccCchhhhcccccceeeccCCccccccCC
Q 046598 529 QLEMQE-NFLQGPIPSSLSSLRGLSVLDLSQNNLSGKIPELLIRLQLVKNLNLSNNDLEGVVPT 591 (986)
Q Consensus 529 ~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~ 591 (986)
+|+|++ +.+++.....++++++|+.|+++++--.+.++.....+++ |.++.++++...+.
T Consensus 204 ~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~~~d~~l~~l~~~lp~---L~i~~~~ls~~~~~ 264 (284)
T d2astb2 204 HLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPH---LQINCSHFTTIARP 264 (284)
T ss_dssp EEECTTCTTCCGGGGGGGGGCTTCCEEECTTSSCTTCHHHHHHHSTT---SEESCCCSCCTTCS
T ss_pred EEECCCCCCCChHHHHHHhcCCCCCEEeeeCCCCHHHHHHHHHhCcc---ccccCccCCCCCCC
Confidence 888887 4677666667777888888888777222222322233444 45567777765443
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.41 E-value=9.7e-15 Score=159.48 Aligned_cols=242 Identities=12% Similarity=0.151 Sum_probs=157.5
Q ss_pred eEEEEeccCCCCcc----ccCcCccCCCCCCEEEccCCCcccc----------CCcchhccccCceeeceecccCCC---
Q 046598 63 RVTILDLESLKLAG----SISPHVGNLSFLKVLRLYNNSFNHE----------IPSEFDRLRRLQVLALHYNSIGGA--- 125 (986)
Q Consensus 63 ~v~~l~l~~~~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~----------~p~~~~~l~~L~~L~L~~N~l~~~--- 125 (986)
.++.|+|++|.+.. .+...+...+.|+.|+++++..... +...+..+++|+.|+|++|.++..
T Consensus 32 ~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~ 111 (344)
T d2ca6a1 32 SVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQE 111 (344)
T ss_dssp CCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHH
T ss_pred CCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccccccccccccc
Confidence 46778888887754 2445677778888888887755322 123345667888888888888754
Q ss_pred -CccchhcCccccceecccccccCccCcc-------------ccCCCCCCeEEccCCcCCCC----cccccCCCcCccee
Q 046598 126 -IPANISSCSNLIQLRLFHNQLVGKIPSE-------------LSSLSKIEHISVNDNNLTGS----IPSSLGNLSSIRSL 187 (986)
Q Consensus 126 -~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-------------~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L 187 (986)
+...+..+++|++|++++|.+....... ....+.|+.|++++|+++.. +...+...+.|++|
T Consensus 112 ~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L 191 (344)
T d2ca6a1 112 PLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTV 191 (344)
T ss_dssp HHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEE
T ss_pred chhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhccc
Confidence 3344556788888888888765221111 13456788888888887632 23345566788888
Q ss_pred eccCCcccCc-----CcchhhccCCCceeeccccccccc----CCccccCCCCccEEeccccccccccCCccc-----cc
Q 046598 188 FLSGNNLEGS-----IPDTLGWLKNLVNLTMAQNRLSGT----IPSSIFNISSITGFDAGVNKIQGAIPLDYG-----FS 253 (986)
Q Consensus 188 ~L~~N~l~~~-----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~-----~~ 253 (986)
+|++|+++.. +...+..+++|+.|+|++|.++.. +...+..+++|+.|++++|.+.+.-...+. ..
T Consensus 192 ~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~ 271 (344)
T d2ca6a1 192 KMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLE 271 (344)
T ss_dssp ECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCS
T ss_pred ccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhcc
Confidence 8888887632 234466678888888888887643 345566778888888888887643222221 12
Q ss_pred ccccceEEecCceeccc----CCcccc-CCCCCcEEecccccccCCCchhhhhhhH
Q 046598 254 LQNLQFFSVGENQLTGA----IPPTIS-NASNLEIFHGSVNKLTGAAPYLEKLQRL 304 (986)
Q Consensus 254 l~~L~~L~L~~N~l~~~----~p~~l~-~l~~L~~L~ls~N~l~~~~~~l~~l~~L 304 (986)
...|++|++++|+++.. +...+. ++++|+.|++++|++......+..+..+
T Consensus 272 ~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~~~~~~~~l~~~ 327 (344)
T d2ca6a1 272 NIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREV 327 (344)
T ss_dssp SCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSHHHHHHHHH
T ss_pred CCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCCcchHHHHHHHH
Confidence 35688888888887642 233332 5677888888888887655555444443
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.40 E-value=6.4e-15 Score=146.07 Aligned_cols=113 Identities=27% Similarity=0.352 Sum_probs=59.3
Q ss_pred CCcchhccccCceeeceecccCCCCccchhcCccccceecccccccCccCccccCCCCCCeEEccCCcCCCCcccccCCC
Q 046598 102 IPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSIPSSLGNL 181 (986)
Q Consensus 102 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 181 (986)
+|.+|..+++|++|+|++|+|+ .++ .|..+++|++|+|++|+++ .+|..+..+++|++|++++|+++. ++ .+.++
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l 114 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKL 114 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHHH
T ss_pred hhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-cc-ccccc
Confidence 3445555555555555555555 232 3555555555555555555 344444444455555555555552 22 24555
Q ss_pred cCcceeeccCCcccCcCc-chhhccCCCceeeccccccc
Q 046598 182 SSIRSLFLSGNNLEGSIP-DTLGWLKNLVNLTMAQNRLS 219 (986)
Q Consensus 182 ~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~ 219 (986)
++|++|+|++|+|+.... ..|..+++|++|+|++|++.
T Consensus 115 ~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp HHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred ccccccccccchhccccccccccCCCccceeecCCCccc
Confidence 556666666666552211 34555566666666666554
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.40 E-value=1.3e-14 Score=158.42 Aligned_cols=138 Identities=17% Similarity=0.209 Sum_probs=93.1
Q ss_pred CCCCCCeeecCCCccCCCCCcc---cccCCCcceEEEccCCccccc-----CCcccccccccchhhccCcccccc----C
Q 046598 450 RYETLTTIDLSNNNLTGTIPPQ---FIGLSSSLIVLDLSRNQLTGS-----IPSEVGNLKNLEILNVFGNKLKGE----I 517 (986)
Q Consensus 450 ~l~~L~~L~L~~N~l~~~ip~~---~~~~~~~L~~L~Ls~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~~~----~ 517 (986)
..+.|+.+++++|+++...-.. .+...+.|+.|+|++|+|+.. +...+..+++|+.|+|++|.++.. +
T Consensus 156 ~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L 235 (344)
T d2ca6a1 156 NAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSAL 235 (344)
T ss_dssp TCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHH
T ss_pred cCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccc
Confidence 3457788888888775221111 123456788888888887632 234566778888888888887632 4
Q ss_pred cccccCCccccEEecccccccccCCccc----c--CCCCCCEEeCCCccCccc----Cchhhh-cccccceeeccCCccc
Q 046598 518 PSTLGSCIKLEQLEMQENFLQGPIPSSL----S--SLRGLSVLDLSQNNLSGK----IPELLI-RLQLVKNLNLSNNDLE 586 (986)
Q Consensus 518 p~~~~~l~~L~~L~L~~N~l~~~~p~~~----~--~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~l~ls~N~l~ 586 (986)
...+..+++|++|+|++|.|++.....+ . ..+.|++|||++|+|+.. +...+. +.++|++|+|++|++.
T Consensus 236 ~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 236 AIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp HHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred cccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 4567788888899999988875433333 2 236789999999988753 233332 5678899999999886
Q ss_pred c
Q 046598 587 G 587 (986)
Q Consensus 587 ~ 587 (986)
.
T Consensus 316 ~ 316 (344)
T d2ca6a1 316 E 316 (344)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.35 E-value=1.5e-14 Score=143.37 Aligned_cols=131 Identities=24% Similarity=0.334 Sum_probs=107.8
Q ss_pred ccCcCccCCCCCCEEEccCCCccccCCcchhccccCceeeceecccCCCCccchhcCccccceecccccccCccCccccC
Q 046598 77 SISPHVGNLSFLKVLRLYNNSFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSS 156 (986)
Q Consensus 77 ~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 156 (986)
.++.++..|++|++|+|++|+|+. ++ .|.++++|++|+|++|+|+ .+|..+..+.+|++|++++|+++. + ..+..
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~ 113 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEK 113 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHH
T ss_pred hhhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-ccccc
Confidence 345678899999999999999985 44 5999999999999999998 677777778899999999999985 4 35888
Q ss_pred CCCCCeEEccCCcCCCCcc-cccCCCcCcceeeccCCcccCcCcch----------hhccCCCceee
Q 046598 157 LSKIEHISVNDNNLTGSIP-SSLGNLSSIRSLFLSGNNLEGSIPDT----------LGWLKNLVNLT 212 (986)
Q Consensus 157 l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~----------~~~l~~L~~L~ 212 (986)
+++|++|+|++|+++.... ..|.++++|++|+|++|.+....+.. +..+++|+.||
T Consensus 114 l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 114 LVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp HHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred cccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 9999999999999984432 57899999999999999987443322 45566666664
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.33 E-value=1.3e-12 Score=123.67 Aligned_cols=141 Identities=15% Similarity=0.159 Sum_probs=64.2
Q ss_pred cceecccccccCccCccccCCCCCCeEEccCC-cCCCCcccccCCCcCcceeeccCCcccCcCcchhhccCCCceeeccc
Q 046598 137 IQLRLFHNQLVGKIPSELSSLSKIEHISVNDN-NLTGSIPSSLGNLSSIRSLFLSGNNLEGSIPDTLGWLKNLVNLTMAQ 215 (986)
Q Consensus 137 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 215 (986)
+.++.+++.+. ..|..+..+++|++|++++| .++...+.+|.++++|+.|+|++|+|+.+.|+.|..+++|++|+|++
T Consensus 11 ~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~ 89 (156)
T d2ifga3 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (156)
T ss_dssp SCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred CeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccC
Confidence 34444444444 33444444555555555433 24433344455555555555555555544455555555555555555
Q ss_pred ccccccCCccccCCCCccEEeccccccccccCCcccccccccceEEecCceecccCCccccCCC
Q 046598 216 NRLSGTIPSSIFNISSITGFDAGVNKIQGAIPLDYGFSLQNLQFFSVGENQLTGAIPPTISNAS 279 (986)
Q Consensus 216 N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 279 (986)
|+|+ .+|...+...+|+.|++++|.+.-.....++..........+..++++..-|..+.+++
T Consensus 90 N~l~-~l~~~~~~~~~l~~L~L~~Np~~C~C~~~~l~~~~~~~~~~~~~~~~~C~~p~~l~~~p 152 (156)
T d2ifga3 90 NALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMP 152 (156)
T ss_dssp SCCS-CCCSTTTCSCCCCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSSCSSCCC
T ss_pred CCCc-ccChhhhccccccccccCCCcccCCchHHHHHHHHHhccCccCcCCcEECcChHHCcCC
Confidence 5555 33333333334555555555543211111111111222333344555555555555544
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.29 E-value=3.2e-12 Score=120.83 Aligned_cols=94 Identities=17% Similarity=0.165 Sum_probs=61.4
Q ss_pred ccCcCccCCCCCCEEEccCC-CccccCCcchhccccCceeeceecccCCCCccchhcCccccceecccccccCccCcccc
Q 046598 77 SISPHVGNLSFLKVLRLYNN-SFNHEIPSEFDRLRRLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELS 155 (986)
Q Consensus 77 ~~~~~~~~l~~L~~L~L~~n-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 155 (986)
..|..+..+++|++|++++| .++.+.+.+|.++++|+.|+|++|+|+.+.|..|..+++|++|+|++|+|+...+..|.
T Consensus 22 ~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~ 101 (156)
T d2ifga3 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQ 101 (156)
T ss_dssp TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTC
T ss_pred cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCcccChhhhc
Confidence 45666777777888888655 47666666777777777777777777766666677777777777777777633333333
Q ss_pred CCCCCCeEEccCCcCC
Q 046598 156 SLSKIEHISVNDNNLT 171 (986)
Q Consensus 156 ~l~~L~~L~L~~N~l~ 171 (986)
. .+|++|+|++|.+.
T Consensus 102 ~-~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 102 G-LSLQELVLSGNPLH 116 (156)
T ss_dssp S-CCCCEEECCSSCCC
T ss_pred c-ccccccccCCCccc
Confidence 3 34666666666553
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.60 E-value=3.8e-09 Score=100.07 Aligned_cols=65 Identities=20% Similarity=0.292 Sum_probs=25.9
Q ss_pred hcCccccceecccccccCc--cCccccCCCCCCeEEccCCcCCCCcccccCCCcCcceeeccCCccc
Q 046598 131 SSCSNLIQLRLFHNQLVGK--IPSELSSLSKIEHISVNDNNLTGSIPSSLGNLSSIRSLFLSGNNLE 195 (986)
Q Consensus 131 ~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 195 (986)
..+++|++|+|++|+|+.. ++..+..+++|++|+|++|+++...+-.+.+..+|+.|+|++|.+.
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~ 128 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTS
T ss_pred HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcC
Confidence 3444444444444444422 1122333444444444444444222212222233444444444444
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.56 E-value=5.6e-09 Score=98.83 Aligned_cols=108 Identities=18% Similarity=0.094 Sum_probs=77.2
Q ss_pred cCceeeceecccCCCCccchhcCccccceecccccccCccCccccCCCCCCeEEccCCcCCCCc--ccccCCCcCcceee
Q 046598 111 RLQVLALHYNSIGGAIPANISSCSNLIQLRLFHNQLVGKIPSELSSLSKIEHISVNDNNLTGSI--PSSLGNLSSIRSLF 188 (986)
Q Consensus 111 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~ 188 (986)
..+.|++++++.. ..+..+..+..|+..++... .++..+.++++|++|+|++|+|+... +..+..+++|+.|+
T Consensus 23 ~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~ 97 (162)
T d1koha1 23 SQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN 97 (162)
T ss_dssp SSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCC
T ss_pred hhCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccc
Confidence 3555666655432 23455566666777666554 55666678899999999999998543 45677899999999
Q ss_pred ccCCcccCcCcchhhccCCCceeecccccccccCC
Q 046598 189 LSGNNLEGSIPDTLGWLKNLVNLTMAQNRLSGTIP 223 (986)
Q Consensus 189 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 223 (986)
|++|+|+...+-.+....+|+.|++++|.+.....
T Consensus 98 Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~ 132 (162)
T d1koha1 98 LSGNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132 (162)
T ss_dssp CTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSS
T ss_pred cccCccccchhhhhhhccccceeecCCCCcCcCcc
Confidence 99999985444345555679999999999875443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.46 E-value=2e-07 Score=95.94 Aligned_cols=150 Identities=15% Similarity=0.123 Sum_probs=100.5
Q ss_pred HHHHHhhcCCCCCcccccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCC-CCcceeeeeecccccc
Q 046598 681 QNLYNATDRFSSVNQIGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDY 759 (986)
Q Consensus 681 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 759 (986)
.++....+.|++++..+-++.+.||+.... ++.++||+...........+.+|...+..+. +--+.+++++ .
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~--~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~-----~ 79 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHF-----E 79 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEE-----E
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeC--CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEE-----E
Confidence 366677778887776555556789988654 4667889886554444456778888877663 3335556655 2
Q ss_pred CCCceEEEEEEeccCCCHhHhhccCCCCCccccCCCccCHHHHHHHHHHHHHHHHHHHhcC-------------------
Q 046598 760 QGNDFKALVFEFMHNRSLEEWLHPITREDETDEAPRSLNLIQRLNISIDVACALNYLHHDC------------------- 820 (986)
Q Consensus 760 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~------------------- 820 (986)
..++..++||++++|.++.+..... .....++.++++.++.||+..
T Consensus 80 ~~~~~~~lv~~~l~G~~~~~~~~~~---------------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~ 144 (263)
T d1j7la_ 80 RHDGWSNLLMSEADGVLCSEEYEDE---------------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDY 144 (263)
T ss_dssp EETTEEEEEEECCSSEEHHHHTTTC---------------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHH
T ss_pred ecCCceEEEEEeccccccccccccc---------------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHH
Confidence 3447789999999998886654210 012234455555555555421
Q ss_pred -------------------------------------CCCeEeecCCCCCeEecCCCcEEEccccccee
Q 046598 821 -------------------------------------QPPIAHCDLKPSNILLDEDMIAHIGDFGLARF 852 (986)
Q Consensus 821 -------------------------------------~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~ 852 (986)
.+.++|+|+.|.||++++++.+-|+||+.+..
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 145 LLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 22489999999999999877677999998863
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.81 E-value=3.1e-05 Score=78.51 Aligned_cols=76 Identities=16% Similarity=0.075 Sum_probs=49.5
Q ss_pred ccccccc-eeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCC--CCcceeeeeeccccccCCCceEEEEEEe
Q 046598 695 QIGEGSF-GSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIR--HRNLVKILTACSGVDYQGNDFKALVFEF 771 (986)
Q Consensus 695 ~lg~G~~-g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~~~~~~lv~e~ 771 (986)
.+..|.. +.||+..... +..+++|...... ...+..|+..++.+. .-.+.++++++ .+++..++|||+
T Consensus 17 ~~~~G~s~~~v~r~~~~~-~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~-----~~~~~~~~v~~~ 87 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQG-RPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVV-----TEAGRDWLLLGE 87 (255)
T ss_dssp ECSCTTSSCEEEEEECTT-SCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEE-----ECSSCEEEEEEC
T ss_pred EcCCcccCCeEEEEEeCC-CCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeec-----ccccceEEEEEe
Confidence 4455554 6789998765 5668889865433 234567777776663 22355566652 345678999999
Q ss_pred ccCCCHhH
Q 046598 772 MHNRSLEE 779 (986)
Q Consensus 772 ~~~gsL~~ 779 (986)
++|.++.+
T Consensus 88 i~G~~~~~ 95 (255)
T d1nd4a_ 88 VPGQDLLS 95 (255)
T ss_dssp CSSEETTT
T ss_pred eecccccc
Confidence 98876543
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.65 E-value=7e-06 Score=77.28 Aligned_cols=87 Identities=13% Similarity=0.148 Sum_probs=46.7
Q ss_pred cccccchhhccCccccc----cCcccccCCccccEEecccccccccC----CccccCCCCCCEEeCCCccCccc------
Q 046598 499 NLKNLEILNVFGNKLKG----EIPSTLGSCIKLEQLEMQENFLQGPI----PSSLSSLRGLSVLDLSQNNLSGK------ 564 (986)
Q Consensus 499 ~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~------ 564 (986)
..+.|+.|+|++|.+.. .+...+...+.|++|+|++|.|++.. -..+...++|++|+|++|.+...
T Consensus 42 ~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~ 121 (167)
T d1pgva_ 42 NSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEM 121 (167)
T ss_dssp TCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHH
T ss_pred hCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHH
Confidence 33445555555555442 12223344555666666666665421 22345556677777777765422
Q ss_pred -CchhhhcccccceeeccCCcc
Q 046598 565 -IPELLIRLQLVKNLNLSNNDL 585 (986)
Q Consensus 565 -~p~~~~~l~~L~~l~ls~N~l 585 (986)
+...+...++|+.|+++++..
T Consensus 122 ~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 122 DMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHHhCCCccEeeCcCCCc
Confidence 334445567777777766643
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.58 E-value=1.3e-05 Score=75.29 Aligned_cols=64 Identities=17% Similarity=0.173 Sum_probs=32.3
Q ss_pred CCCCCCEEEccCC-Ccccc----CCcchhccccCceeeceecccCC----CCccchhcCccccceeccccccc
Q 046598 84 NLSFLKVLRLYNN-SFNHE----IPSEFDRLRRLQVLALHYNSIGG----AIPANISSCSNLIQLRLFHNQLV 147 (986)
Q Consensus 84 ~l~~L~~L~L~~n-~l~~~----~p~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~ 147 (986)
+-+.|++|+|+++ .+... +-.++...+.|++|+|++|.++. .+...+...+.|++|+|++|.+.
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~ 85 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 85 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcc
Confidence 3466777777653 34321 22334455566666666666652 12223334445555555555544
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.56 E-value=6.4e-05 Score=81.28 Aligned_cols=77 Identities=13% Similarity=0.139 Sum_probs=49.1
Q ss_pred CcccccccceeEEEEEECCCCeEEEEEEeecc-------CchhHHHHHHHHHHHhcCC---CCcceeeeeeccccccCCC
Q 046598 693 VNQIGEGSFGSVFKGILDDGRTTIAVKVFNLL-------HHGAFKSFIAECNTLKNIR---HRNLVKILTACSGVDYQGN 762 (986)
Q Consensus 693 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~~ 762 (986)
.+.||.|....||++....+++.|+||..... ......+...|.+.++.+. ...+.+++.+. +
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d-------~ 103 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-------T 103 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-------T
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc-------C
Confidence 45689999999999998877888999975421 1112345566887777652 24566666552 2
Q ss_pred ceEEEEEEeccCCC
Q 046598 763 DFKALVFEFMHNRS 776 (986)
Q Consensus 763 ~~~~lv~e~~~~gs 776 (986)
...++|||++++..
T Consensus 104 ~~~~lvmE~L~~~~ 117 (392)
T d2pula1 104 EMAVTVMEDLSHLK 117 (392)
T ss_dssp TTTEEEECCCTTSE
T ss_pred CCCEEEEeccCCcc
Confidence 34579999997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.97 E-value=0.0014 Score=68.48 Aligned_cols=147 Identities=15% Similarity=0.092 Sum_probs=79.4
Q ss_pred ceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCc--ceeeeeeccccccCCCceEEEEEEeccCCCHh
Q 046598 701 FGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRN--LVKILTACSGVDYQGNDFKALVFEFMHNRSLE 778 (986)
Q Consensus 701 ~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~ 778 (986)
--.||++...+ |+.|++|+.+... ...+++..|...+..+.... ++.............++..+.|+++++|..+.
T Consensus 35 EN~vy~v~~~d-g~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 35 ENRVYQFQDED-RRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SSEEEEECCTT-CCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred cceeEEEEcCC-CCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 46899998876 6789999987543 23466778888887763221 22222221122234456789999999774331
Q ss_pred H--------------hhccCCCCCccccCCCc-------------------cCHHHHHHHHHHHHHHHHHHHh----cCC
Q 046598 779 E--------------WLHPITREDETDEAPRS-------------------LNLIQRLNISIDVACALNYLHH----DCQ 821 (986)
Q Consensus 779 ~--------------~l~~~~~~~~~~~~~~~-------------------l~~~~~~~i~~qi~~~L~~LH~----~~~ 821 (986)
. .++...... ....... ++......+...+.+.++.+.. ...
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~-~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p 191 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQ-LFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT 191 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSS-CCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccC-CccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCC
Confidence 1 011100000 0000011 1111111222222233333322 224
Q ss_pred CCeEeecCCCCCeEecCCCcEEEccccccee
Q 046598 822 PPIAHCDLKPSNILLDEDMIAHIGDFGLARF 852 (986)
Q Consensus 822 ~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~ 852 (986)
.++||+|+.+.|||++++ ..++||+-+..
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 579999999999999743 45899998864
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.93 E-value=6.9e-05 Score=70.21 Aligned_cols=89 Identities=16% Similarity=0.264 Sum_probs=50.5
Q ss_pred ccccccchhhccCcccccc----CcccccCCccccEEeccccccccc----CCccccCCCCCCEEeC--CCccCcc----
Q 046598 498 GNLKNLEILNVFGNKLKGE----IPSTLGSCIKLEQLEMQENFLQGP----IPSSLSSLRGLSVLDL--SQNNLSG---- 563 (986)
Q Consensus 498 ~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L--s~N~l~~---- 563 (986)
...+.|++|+|++|.++.. +...+...+.++.|++++|.+... +...+...++|+.++| ++|++..
T Consensus 43 ~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~ 122 (166)
T d1io0a_ 43 KTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEM 122 (166)
T ss_dssp TTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHH
T ss_pred hcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHH
Confidence 3445555555555555422 223344456667777777766532 2245556677776444 4666653
Q ss_pred cCchhhhcccccceeeccCCccc
Q 046598 564 KIPELLIRLQLVKNLNLSNNDLE 586 (986)
Q Consensus 564 ~~p~~~~~l~~L~~l~ls~N~l~ 586 (986)
.+.+.+...++|++|+++.|...
T Consensus 123 ~La~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 123 EIANMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp HHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHhCCCcCEEeCcCCCCc
Confidence 34445566777888887766543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.81 E-value=4.5e-05 Score=71.53 Aligned_cols=61 Identities=18% Similarity=0.267 Sum_probs=26.2
Q ss_pred CCCCCeEEccCCcCCCC----cccccCCCcCcceeec--cCCcccC----cCcchhhccCCCceeeccccc
Q 046598 157 LSKIEHISVNDNNLTGS----IPSSLGNLSSIRSLFL--SGNNLEG----SIPDTLGWLKNLVNLTMAQNR 217 (986)
Q Consensus 157 l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L--~~N~l~~----~~p~~~~~l~~L~~L~L~~N~ 217 (986)
.++|+.|++++|.+... +...+...++|+.++| ++|.+.. .+.+.+...++|++|+++.+.
T Consensus 73 ~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 73 NNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp CSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred cccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCC
Confidence 34444445544444311 2233444455554333 3444432 222334444555555555443
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.35 E-value=0.015 Score=59.98 Aligned_cols=172 Identities=15% Similarity=0.045 Sum_probs=86.7
Q ss_pred CcChHHHHHhhcCCCCCcc-----cccccceeEEEEEECCCCeEEEEEEeeccCchhHHHHHHHHHHHhcCCCCc--cee
Q 046598 677 NISYQNLYNATDRFSSVNQ-----IGEGSFGSVFKGILDDGRTTIAVKVFNLLHHGAFKSFIAECNTLKNIRHRN--LVK 749 (986)
Q Consensus 677 ~~~~~~~~~~~~~y~~~~~-----lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~ 749 (986)
..+-+++.....+|.+.+. |..|---+.|+....+ + .+++|++.... ..++...|++++..+.... +..
T Consensus 2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~-g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~ 77 (316)
T d2ppqa1 2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPL 77 (316)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECC-C-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccc
Confidence 3567788888889987544 3456667889998875 3 48999986431 2244555666666653211 111
Q ss_pred eeeeccc-cccCCCceEEEEEEeccCCCHhH--------------hhccCCCCC-ccccCCCc----------------c
Q 046598 750 ILTACSG-VDYQGNDFKALVFEFMHNRSLEE--------------WLHPITRED-ETDEAPRS----------------L 797 (986)
Q Consensus 750 l~~~~~~-~~~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~~~-~~~~~~~~----------------l 797 (986)
......+ ....-....+.++.++.+..... .++...... ........ .
T Consensus 78 pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (316)
T d2ppqa1 78 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 157 (316)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred cceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhh
Confidence 1111100 00112345667777776643211 011000000 00000000 0
Q ss_pred CHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCCeEecCCCcEEEccccccee
Q 046598 798 NLIQRLNISIDVACALNYLHH-DCQPPIAHCDLKPSNILLDEDMIAHIGDFGLARF 852 (986)
Q Consensus 798 ~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~ 852 (986)
........+..+...+...+. ....|+||+|+.++||+++.+...-+.||+.+..
T Consensus 158 ~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 158 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 000111222222222222222 2345899999999999999888778999999864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.06 E-value=0.0052 Score=65.87 Aligned_cols=74 Identities=16% Similarity=0.193 Sum_probs=50.0
Q ss_pred CcccccccceeEEEEEECC-------CCeEEEEEEeeccCchhHHHHHHHHHHHhcCC-CCcceeeeeeccccccCCCce
Q 046598 693 VNQIGEGSFGSVFKGILDD-------GRTTIAVKVFNLLHHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDF 764 (986)
Q Consensus 693 ~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~ 764 (986)
++.|+.|-.-.+|++.... ..+.|++++.-.. .......+|..+++.+. +.-..++++++.
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~--------- 115 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--------- 115 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET---------
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcC---------
Confidence 4678888889999998754 2456788876532 22344567888888874 433457777642
Q ss_pred EEEEEEeccCCCH
Q 046598 765 KALVFEFMHNRSL 777 (986)
Q Consensus 765 ~~lv~e~~~~gsL 777 (986)
-.+||||++|.++
T Consensus 116 ~g~I~efi~g~~l 128 (395)
T d1nw1a_ 116 GGRLEEYIPSRPL 128 (395)
T ss_dssp TEEEECCCCEEEC
T ss_pred CceEEEEeccccC
Confidence 1689999987554
|